data_2kb4_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kb4 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 t30 . . . . . 0 C--O 1.233 0.208 0 CA-C-O 121.202 0.525 . . . . 72.530000000000001 111.077 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.01 25.75 27.01 Favored Glycine 0 N--CA 1.439 -1.134 0 C-N-CA 120.894 -0.67 . . . . 72.129999999999995 111.648 -178.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 61.7 m -87.28 123.51 69.76 Favored Pre-proline 0 N--CA 1.433 -1.278 0 N-CA-C 108.872 -0.788 . . . . 75.030000000000001 108.872 177.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -68.25 127.49 15.91 Favored 'Trans proline' 0 N--CA 1.448 -1.182 0 C-N-CA 121.659 1.573 . . . . 75.209999999999994 110.437 174.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -100.94 139.13 20.27 Favored Pre-proline 0 C--N 1.296 -1.736 0 N-CA-C 108.787 -0.82 . . . . 74.230000000000004 108.787 177.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -75.51 118.03 5.0 Favored 'Trans proline' 0 N--CA 1.441 -1.579 0 C-N-CA 121.845 1.697 . . . . 73.129999999999995 111.335 -177.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -76.82 173.74 11.34 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 108.953 -0.758 . . . . 71.400000000000006 108.953 177.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 45.1 t 61.21 81.09 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 108.189 -1.041 . . . . 72.439999999999998 108.189 -173.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -74.73 132.27 41.51 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 115.309 -0.86 . . . . 73.549999999999997 110.067 -176.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.9 t -124.21 108.71 12.57 Favored 'General case' 0 N--CA 1.407 -2.609 0 CA-C-O 121.794 0.807 . . . . 71.329999999999998 109.67 -178.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 15.2 t -112.61 -3.78 14.26 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 122.331 1.062 . . . . 70.340000000000003 108.361 176.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.6 p -92.07 35.88 0.98 Allowed 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 114.417 -1.265 . . . . 75.439999999999998 109.157 179.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.9 m . . . . . 0 N--CA 1.427 -1.612 0 CA-C-N 114.36 -1.291 . . . . 74.150000000000006 111.248 -177.027 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.471 0 N-CA-C 113.866 0.306 . . . . 62.450000000000003 113.866 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 9.0 m -113.69 153.79 28.37 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 109.715 -0.476 . . . . 74.549999999999997 109.715 -177.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.81 174.0 10.94 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.856 -0.794 . . . . 72.519999999999996 108.856 -178.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.5 pp -135.28 160.14 39.34 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 119.22 -0.992 . . . . 70.230000000000004 112.256 -177.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.9 pp -137.75 149.28 46.31 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 109.003 -0.739 . . . . 75.140000000000001 109.003 175.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 22.6 m -121.33 141.52 41.45 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.175 0 N-CA-C 107.14 -1.429 . . . . 65.400000000000006 107.14 175.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.0 t -92.85 116.81 34.81 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.614 0 N-CA-C 107.463 -1.31 . . . . 72.530000000000001 107.463 177.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.417 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 82.5 tttt -77.62 -21.76 51.8 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.109 -0.95 . . . . 73.510000000000005 109.214 -176.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.417 ' HB2' ' O ' ' A' ' 52' ' ' LYS . 65.6 ttt180 168.26 131.03 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.51 1.524 . . . . 74.209999999999994 109.536 163.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 175.88 152.69 9.72 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 121.044 -0.598 . . . . 75.420000000000002 112.032 178.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -69.84 -9.28 25.7 Favored 'Trans proline' 0 C--N 1.36 1.147 0 C-N-CA 123.795 2.997 . . . . 71.049999999999997 112.489 177.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -60.94 -42.64 98.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.795 -0.639 . . . . 74.420000000000002 110.656 -178.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -164.47 -58.99 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 109.254 -0.647 . . . . 64.420000000000002 109.254 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.45 32.82 36.91 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.692 -0.766 . . . . 75.219999999999999 111.614 -178.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -144.11 -164.74 1.96 Allowed 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 108.109 -1.071 . . . . 75.420000000000002 108.109 -177.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -115.48 138.56 50.89 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 120.769 0.319 . . . . 74.519999999999996 110.311 177.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -130.33 147.5 52.05 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.647 -0.706 . . . . 74.420000000000002 110.525 -170.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 93.2 mt -105.06 134.52 48.03 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.052 -0.721 . . . . 73.230000000000004 109.052 177.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.4 mp -110.78 114.37 27.68 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.221 -0.659 . . . . 75.530000000000001 109.221 178.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -131.76 4.66 4.22 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.828 -1.175 . . . . 74.340000000000003 107.828 172.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -83.56 124.79 75.05 Favored Pre-proline 0 N--CA 1.441 -0.911 0 N-CA-C 106.838 -1.542 . . . . 73.299999999999997 106.838 178.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.445 ' O ' ' HG3' ' A' ' 93' ' ' ARG . 1.2 Cg_endo -45.81 -46.23 15.74 Favored 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 123.291 2.661 . . . . 75.430000000000007 112.912 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 32.1 m -136.37 117.53 14.45 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 109.546 -0.539 . . . . 75.530000000000001 109.546 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 20.4 m -113.37 113.28 25.01 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 107.967 -1.123 . . . . 65.310000000000002 107.967 177.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.5 m -97.79 131.04 44.66 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.197 0.523 . . . . 75.239999999999995 110.756 -176.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.418 ' HB3' ' HB2' ' A' ' 80' ' ' LEU . . . -97.57 110.59 23.12 Favored 'General case' 0 N--CA 1.428 -1.526 0 CA-C-N 115.849 -0.614 . . . . 53.520000000000003 110.52 -178.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -136.47 -143.09 4.57 Favored Glycine 0 N--CA 1.437 -1.254 0 N-CA-C 108.703 -1.759 . . . . 64.230000000000004 108.703 178.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.516 ' O ' ' HD3' ' A' ' 72' ' ' ARG . 4.7 tmt_? -161.19 12.23 0.09 Allowed 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 122.128 0.965 . . . . 75.040000000000006 109.63 176.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 34.5 m170 -99.45 157.7 33.52 Favored Pre-proline 0 N--CA 1.433 -1.283 0 N-CA-C 108.03 -1.1 . . . . 72.540000000000006 108.03 -178.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_exo -56.48 -21.2 36.63 Favored 'Trans proline' 0 N--CA 1.478 0.582 0 C-N-CA 122.969 2.446 . . . . 75.409999999999997 113.88 -178.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.62 -1.68 43.21 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 112.253 0.464 . . . . 74.0 112.253 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 16.0 m -83.14 146.79 28.45 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 108.248 -1.019 . . . . 64.400000000000006 108.248 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -61.26 -60.03 4.38 Favored 'General case' 0 C--N 1.322 -0.618 0 O-C-N 123.273 0.358 . . . . 74.349999999999994 110.968 -176.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 38.2 pt -122.77 157.89 27.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-O 120.746 0.307 . . . . 73.310000000000002 110.194 176.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -97.07 126.54 42.3 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.017 -1.105 . . . . 74.25 108.017 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.418 ' HB2' ' HB3' ' A' ' 70' ' ' ALA . 1.2 tm? -108.71 -90.25 0.46 Allowed 'General case' 0 N--CA 1.418 -2.055 0 CA-C-O 121.153 0.501 . . . . 73.329999999999998 111.711 -175.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -96.81 118.04 32.38 Favored 'General case' 0 C--N 1.262 -3.211 0 CA-C-O 121.658 0.742 . . . . 74.230000000000004 109.238 -176.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -94.22 -40.25 10.1 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-N 114.412 -1.267 . . . . 74.510000000000005 112.273 -175.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 8.2 p -80.74 -31.66 12.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-N 115.63 -0.714 . . . . 72.109999999999999 110.423 -174.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 5.1 p -133.97 73.68 1.51 Allowed 'General case' 0 C--N 1.294 -1.829 0 CA-C-O 122.242 1.02 . . . . 74.310000000000002 109.291 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.8 p -82.31 124.65 39.44 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 N-CA-C 114.55 1.315 . . . . 75.409999999999997 114.55 -169.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 51.0 m -96.54 139.5 32.55 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 105.514 -2.032 . . . . 63.329999999999998 105.514 167.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 8.8 ptp85 -56.69 -39.3 73.58 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 121.678 0.751 . . . . 75.239999999999995 112.045 -176.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 23.1 mmt180 -133.06 103.22 5.92 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 106.026 -1.842 . . . . 64.400000000000006 106.026 173.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 12.9 t60 -84.73 -69.92 0.61 Allowed 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.267 0.556 . . . . 73.010000000000005 110.341 -173.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -144.62 170.69 15.59 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.971 -0.752 . . . . 61.530000000000001 108.971 -176.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -144.45 128.19 17.24 Favored 'General case' 0 N--CA 1.419 -2.008 0 CA-C-O 121.317 0.58 . . . . 74.129999999999995 109.649 178.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -107.34 117.34 33.83 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.661 -1.237 . . . . 73.209999999999994 107.661 -177.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.445 ' HG3' ' O ' ' A' ' 66' ' ' PRO . 40.3 ttp85 -126.17 140.98 52.13 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-O 121.527 0.68 . . . . 73.329999999999998 111.053 -177.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.9 pp -115.16 126.76 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.967 0 N-CA-C 106.865 -1.532 . . . . 74.540000000000006 106.865 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -118.43 146.25 44.59 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 108.698 -0.852 . . . . 73.040000000000006 108.698 -174.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.35 -29.52 4.03 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 114.267 1.21 . . . . 72.230000000000004 114.267 -177.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -96.7 -40.57 3.82 Favored Glycine 0 N--CA 1.432 -1.577 0 C-N-CA 120.755 -0.736 . . . . 72.439999999999998 114.088 177.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -150.65 171.02 17.79 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 117.417 0.608 . . . . 74.140000000000001 111.26 -172.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -105.46 128.6 53.63 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.109 -1.071 . . . . 75.239999999999995 108.109 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -132.5 135.18 45.83 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 120.321 -0.551 . . . . 71.310000000000002 111.596 -177.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.5 p -117.68 122.7 70.43 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 N-CA-C 109.166 -0.679 . . . . 74.109999999999999 109.166 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.3 m -119.95 137.63 53.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 112.694 0.627 . . . . 70.209999999999994 112.694 -177.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -83.26 126.33 32.55 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.622 -1.251 . . . . 75.540000000000006 107.622 171.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 8.2 p -105.33 1.8 10.32 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 CA-C-O 121.734 0.778 . . . . 75.129999999999995 110.518 -177.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 136.47 42.22 0.11 Allowed Glycine 0 N--CA 1.441 -0.976 0 C-N-CA 119.701 -1.238 . . . . 70.310000000000002 113.698 175.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 67.6 p -73.85 124.85 26.9 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-N 117.176 0.488 . . . . 53.329999999999998 109.706 178.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 51.1 tp -78.15 -26.01 47.58 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.447 0.642 . . . . 74.150000000000006 109.327 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -76.66 -23.54 53.26 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.505 -0.77 . . . . 74.329999999999998 110.388 178.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 94.93 132.56 6.86 Favored Glycine 0 N--CA 1.431 -1.634 0 CA-C-N 115.464 -0.789 . . . . 63.310000000000002 112.802 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 79.7 m -109.18 119.82 40.68 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.381 -0.97 . . . . 74.519999999999996 108.381 175.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -125.2 141.54 52.03 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 109.285 -0.635 . . . . 74.340000000000003 109.285 -175.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 28.3 m -98.86 111.45 28.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 N-CA-C 108.687 -0.857 . . . . 73.420000000000002 108.687 175.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 65.89 -76.99 0.04 OUTLIER 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 125.449 1.5 . . . . 70.430000000000007 109.007 -172.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -147.1 10.48 1.01 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.208 1.003 . . . . 74.099999999999994 109.916 177.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -100.58 122.0 51.05 Favored Pre-proline 0 C--O 1.242 0.664 0 CA-C-O 119.648 -0.215 . . . . 70.430000000000007 110.592 -176.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -69.91 112.99 3.25 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.527 2.151 . . . . 73.420000000000002 110.238 174.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -138.44 120.19 15.26 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 109.501 -0.555 . . . . 72.049999999999997 109.501 -177.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -86.08 -21.99 27.39 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 119.914 -0.714 . . . . 75.239999999999995 109.146 176.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -136.67 136.38 39.03 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 106.475 -1.676 . . . . 73.510000000000005 106.475 169.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.95 151.07 40.53 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 109.761 -0.459 . . . . 75.040000000000006 109.761 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.2 p -79.3 123.83 36.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 105.153 -2.166 . . . . 72.239999999999995 105.153 170.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 34.8 ttp -73.54 115.23 12.69 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 121.463 0.649 . . . . 74.120000000000005 110.452 -170.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -103.86 136.96 42.56 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 114.192 -1.367 . . . . 72.409999999999997 109.976 -172.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 40.7 p -88.45 122.27 31.75 Favored 'General case' 0 N--CA 1.411 -2.421 0 CA-C-N 115.047 -0.979 . . . . 74.150000000000006 109.506 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 120.82 -29.09 5.94 Favored Glycine 0 N--CA 1.438 -1.181 0 C-N-CA 120.816 -0.707 . . . . 73.400000000000006 112.306 177.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -93.22 164.08 13.37 Favored 'General case' 0 C--O 1.248 1.002 0 N-CA-C 109.101 -0.703 . . . . 62.399999999999999 109.101 -175.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -108.93 134.86 51.03 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-O 121.989 0.9 . . . . 70.340000000000003 112.052 -176.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 66.4 mt -97.88 121.12 48.08 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 N-CA-C 108.23 -1.026 . . . . 75.230000000000004 108.23 -178.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -89.66 112.54 23.82 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 107.98 -1.119 . . . . 73.230000000000004 107.98 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.405 HG13 ' HB2' ' A' ' 133' ' ' PHE . 6.2 pt -100.99 97.15 5.37 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.572 0 N-CA-C 108.002 -1.11 . . . . 72.140000000000001 108.002 177.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 67.6 -109.52 2.95 Favored Glycine 0 N--CA 1.427 -1.919 0 N-CA-C 109.84 -1.304 . . . . 75.340000000000003 109.84 -173.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -104.72 -17.55 14.59 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 109.237 -0.653 . . . . 75.319999999999993 109.237 176.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.405 ' HB2' HG13 ' A' ' 130' ' ' ILE . 55.1 m-85 -82.92 165.7 19.52 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.659 -0.7 . . . . 71.409999999999997 111.04 -173.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 13.1 ptt180 -126.87 122.1 33.69 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 121.719 0.771 . . . . 74.530000000000001 112.294 -170.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 7.8 tt -125.04 142.16 51.67 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.328 -1.36 . . . . 73.420000000000002 107.328 177.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.408 HG23 ' HB2' ' A' ' 52' ' ' LYS . 18.8 t -122.65 131.6 72.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 107.916 -1.142 . . . . 62.140000000000001 107.916 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -102.67 128.88 49.19 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.534 -1.284 . . . . 75.140000000000001 107.534 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -124.75 164.34 20.17 Favored 'General case' 0 C--O 1.253 1.25 0 CA-C-O 121.946 0.879 . . . . 75.120000000000005 111.42 -176.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -72.07 119.84 16.83 Favored 'General case' 0 N--CA 1.416 -2.169 0 CA-C-N 114.446 -1.252 . . . . 75.230000000000004 108.522 176.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -75.64 -160.19 8.78 Favored Glycine 0 N--CA 1.42 -2.425 0 CA-C-N 115.346 -0.843 . . . . 74.310000000000002 111.64 178.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo . . . . . 0 N--CA 1.425 -2.531 0 C-N-CA 121.892 1.728 . . . . 73.25 113.829 -176.151 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 10.0 p30 . . . . . 0 C--O 1.251 1.149 0 CA-C-O 121.376 0.608 . . . . 74.239999999999995 110.302 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -121.29 95.89 0.58 Allowed Glycine 0 N--CA 1.421 -2.338 0 N-CA-C 108.729 -1.748 . . . . 75.019999999999996 108.729 176.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.5 p -99.29 124.54 44.56 Favored Pre-proline 0 C--N 1.291 -1.939 0 N-CA-C 110.571 -0.159 . . . . 72.530000000000001 110.571 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -66.41 134.87 37.45 Favored 'Trans proline' 0 C--O 1.242 0.708 0 C-N-CA 122.46 2.107 . . . . 64.420000000000002 110.016 175.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -92.36 129.66 40.26 Favored Pre-proline 0 C--N 1.294 -1.834 0 N-CA-C 109.821 -0.437 . . . . 72.510000000000005 109.821 -179.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -54.48 148.02 45.04 Favored 'Trans proline' 0 C--O 1.251 1.15 0 C-N-CA 123.683 2.922 . . . . 54.450000000000003 114.003 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -128.3 153.22 47.23 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 115.002 -0.999 . . . . 74.319999999999993 108.655 -178.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.8 p -126.27 136.38 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.805 0 N-CA-C 109.079 -0.711 . . . . 74.439999999999998 109.079 178.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -92.24 136.1 33.47 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.85 -1.167 . . . . 75.420000000000002 107.85 176.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.3 p -78.93 88.49 4.73 Favored 'General case' 0 N--CA 1.427 -1.623 0 CA-C-O 122.239 1.018 . . . . 75.010000000000005 110.948 -177.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.6 m -97.29 103.93 15.91 Favored 'General case' 0 N--CA 1.417 -2.103 0 CA-C-N 114.844 -1.071 . . . . 73.319999999999993 108.349 -177.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.8 m -111.72 154.68 24.64 Favored 'General case' 0 N--CA 1.417 -2.119 0 CA-C-N 115.832 -0.622 . . . . 63.43 109.818 -175.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 66.3 t . . . . . 0 C--N 1.291 -1.973 0 CA-C-N 115.577 -0.738 . . . . 74.329999999999998 109.267 179.376 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.622 0 N-CA-C 109.044 -1.623 . . . . 74.219999999999999 109.044 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.0 m -89.33 164.73 14.78 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 121.64 0.734 . . . . 75.109999999999999 112.658 -173.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.495 ' HB2' ' O ' ' A' ' 138' ' ' LEU . . . -131.93 165.42 23.95 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 107.94 -1.133 . . . . 72.040000000000006 107.94 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -127.6 154.8 44.79 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 120.647 -0.421 . . . . 72.099999999999994 111.802 -176.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.428 ' HB2' HD12 ' A' ' 135' ' ' LEU . 2.8 pp -126.23 144.13 50.89 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 115.829 -0.623 . . . . 71.340000000000003 109.974 177.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.406 HG13 ' CB ' ' A' ' 60' ' ' ARG . 1.8 m -128.02 138.99 53.12 Favored 'Isoleucine or valine' 0 C--O 1.252 1.207 0 N-CA-C 109.348 -0.612 . . . . 74.120000000000005 109.348 178.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 93.8 t -93.62 115.98 33.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 109.792 -0.447 . . . . 73.109999999999999 109.792 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -69.38 -38.17 77.88 Favored 'General case' 0 CA--C 1.506 -0.748 0 O-C-N 123.273 0.358 . . . . 73.299999999999997 110.506 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 42.6 ttt180 -168.84 135.49 1.83 Allowed 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.352 -0.84 . . . . 71.519999999999996 109.655 178.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 149.24 145.54 4.15 Favored Glycine 0 N--CA 1.416 -2.639 0 N-CA-C 110.862 -0.895 . . . . 75.109999999999999 110.862 177.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -67.63 -9.16 24.53 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.796 2.331 . . . . 72.040000000000006 112.105 177.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.44 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 87.9 m-20 -51.25 -46.8 62.48 Favored 'General case' 0 C--O 1.21 -1.009 0 C-N-CA 124.674 1.19 . . . . 74.519999999999996 110.333 175.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -172.79 -176.78 1.53 Allowed 'General case' 0 C--O 1.215 -0.714 0 N-CA-C 107.632 -1.247 . . . . 73.299999999999997 107.632 178.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -161.8 41.9 0.39 Allowed Glycine 0 C--N 1.29 -1.987 0 N-CA-C 109.938 -1.265 . . . . 65.430000000000007 109.938 -178.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -159.46 -166.39 1.78 Allowed 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 107.863 -1.162 . . . . 75.329999999999998 107.863 -176.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.406 ' CB ' HG13 ' A' ' 50' ' ' VAL . 19.6 ptt180 -115.71 135.03 54.44 Favored 'General case' 0 N--CA 1.433 -1.317 0 O-C-N 123.934 0.771 . . . . 73.25 109.294 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -126.75 121.77 32.93 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 120.772 0.32 . . . . 75.030000000000001 111.152 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 44.2 tp -88.04 119.32 28.3 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 106.913 -1.514 . . . . 74.209999999999994 106.913 177.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -79.66 114.8 18.87 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 120.57 -0.452 . . . . 74.030000000000001 110.137 -177.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -95.91 -20.82 18.47 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.663 0.744 . . . . 71.109999999999999 110.368 -176.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -97.22 139.66 21.6 Favored Pre-proline 0 C--N 1.304 -1.409 0 CA-C-N 114.91 -1.041 . . . . 74.150000000000006 112.098 -175.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.401 ' HA ' ' CG2' ' A' ' 94' ' ' ILE . 29.9 Cg_endo -64.42 -24.53 64.08 Favored 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 123.488 2.792 . . . . 75.140000000000001 114.347 -177.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.8 m -135.25 103.93 5.7 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 121.445 0.641 . . . . 72.219999999999999 109.972 178.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 17.0 m -103.13 121.69 43.16 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 115.456 -0.793 . . . . 74.230000000000004 109.658 -178.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.6 m -97.8 119.86 37.16 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 109.933 -0.395 . . . . 74.340000000000003 109.933 -177.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.82 133.84 42.56 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 121.217 0.532 . . . . 75.200000000000003 109.851 178.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -170.13 -152.71 8.18 Favored Glycine 0 N--CA 1.424 -2.139 0 N-CA-C 108.456 -1.857 . . . . 70.120000000000005 108.456 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.5 ttt180 -90.37 -38.77 13.1 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 118.765 -1.174 . . . . 75.319999999999993 111.901 -178.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -176.73 -56.22 0.0 OUTLIER Pre-proline 0 CA--C 1.569 1.677 0 N-CA-C 114.679 1.362 . . . . 73.219999999999999 114.679 -178.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -49.88 -41.65 46.73 Favored 'Trans proline' 0 C--N 1.388 2.641 0 C-N-CA 123.325 2.683 . . . . 74.329999999999998 116.697 -167.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.416 ' OE2' ' HB2' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -126.17 7.97 7.23 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 122.415 1.102 . . . . 73.230000000000004 108.34 178.31 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.5 m -82.72 121.28 26.67 Favored 'General case' 0 N--CA 1.4 -2.941 0 CA-C-N 114.082 -1.417 . . . . 73.040000000000006 108.524 -175.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -66.3 -31.63 72.54 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.777 0.799 . . . . 73.540000000000006 109.633 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.44 141.17 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.391 0 N-CA-C 106.322 -1.733 . . . . 73.349999999999994 106.322 172.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -97.47 117.73 32.37 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 120.959 0.409 . . . . 63.399999999999999 111.746 -176.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.44 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 5.9 mp -102.51 179.06 4.41 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 107.891 -1.151 . . . . 53.409999999999997 107.891 178.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -163.99 84.24 0.45 Allowed 'General case' 0 N--CA 1.442 -0.841 0 CA-C-O 121.791 0.805 . . . . 74.140000000000001 110.671 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.451 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 11.2 t70 -97.48 165.0 12.21 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 105.458 -2.052 . . . . 73.540000000000006 105.458 170.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.8 p -69.39 -27.22 33.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 CA-C-N 119.08 0.855 . . . . 72.010000000000005 110.615 -178.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.448 ' HB ' ' ND2' ' A' ' 108' ' ' ASN . 4.2 m -119.45 36.82 4.36 Favored 'General case' 0 CA--C 1.556 1.187 0 CA-C-O 121.855 0.835 . . . . 75.409999999999997 108.756 -179.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.451 ' HB ' ' HB3' ' A' ' 82' ' ' ASP . 11.8 p -81.75 140.14 16.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 108.958 -0.756 . . . . 65.140000000000001 108.958 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 26.3 m -121.34 147.33 45.84 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 110.016 -0.365 . . . . 75.230000000000004 110.016 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.416 ' HB2' ' OE2' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -59.76 132.19 53.21 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 107.222 -1.399 . . . . 75.209999999999994 107.222 170.683 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 42.1 mtm180 58.8 74.17 0.45 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.568 0.699 . . . . 75.209999999999994 109.758 -169.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -100.13 -58.55 1.89 Allowed 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 108.181 -1.044 . . . . 72.439999999999998 108.181 -177.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -136.58 135.93 38.81 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.507 -0.924 . . . . 55.149999999999999 108.507 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -108.3 126.76 53.2 Favored 'General case' 0 C--N 1.278 -2.503 0 N-CA-C 107.88 -1.155 . . . . 74.409999999999997 107.88 178.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -104.51 112.68 25.84 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.525 -0.917 . . . . 60.420000000000002 108.525 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 35.2 ttt180 -116.65 147.55 41.82 Favored 'General case' 0 C--N 1.275 -2.657 0 N-CA-C 108.331 -0.989 . . . . 74.030000000000001 108.331 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.401 ' CG2' ' HA ' ' A' ' 66' ' ' PRO . 6.7 tt -114.62 137.67 47.25 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.341 0 N-CA-C 108.436 -0.95 . . . . 74.310000000000002 108.436 177.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -118.31 147.48 43.42 Favored 'General case' 0 N--CA 1.419 -2.003 0 N-CA-C 105.942 -1.873 . . . . 74.209999999999994 105.942 177.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -42.48 -19.13 0.01 OUTLIER 'General case' 0 CA--C 1.559 1.326 0 N-CA-C 116.719 2.118 . . . . 73.219999999999999 116.719 -174.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -119.14 -29.1 1.86 Allowed Glycine 0 N--CA 1.43 -1.73 0 C-N-CA 120.751 -0.738 . . . . 60.009999999999998 113.527 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -161.24 177.57 10.08 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-N 118.089 0.944 . . . . 71.219999999999999 109.765 -174.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -103.47 138.67 39.87 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 113.596 0.962 . . . . 72.420000000000002 113.596 -173.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -112.93 116.82 30.59 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.273 -1.01 . . . . 62.439999999999998 108.273 178.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 59.3 t -119.4 119.52 60.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 108.752 -0.832 . . . . 75.349999999999994 108.752 -178.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.6 m -111.4 131.79 61.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-O 121.417 0.627 . . . . 71.540000000000006 111.276 -179.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -91.29 113.29 25.52 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.125 -0.943 . . . . 74.049999999999997 109.486 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 19.1 m -114.79 9.88 7.72 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 CA-C-O 121.463 0.649 . . . . 74.030000000000001 109.954 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -127.75 53.29 0.8 Allowed Glycine 0 N--CA 1.431 -1.641 0 N-CA-C 110.367 -1.093 . . . . 50.439999999999998 110.367 179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.4 m -61.42 -7.61 3.24 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 124.42 1.088 . . . . 75.349999999999994 113.059 -177.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 69.0 tp -58.15 -44.76 88.03 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 107.996 -1.112 . . . . 75.329999999999998 107.996 174.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.529 ' OD1' ' HA2' ' A' ' 131' ' ' GLY . 52.3 t-20 -98.9 -53.1 3.37 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 106.409 -1.7 . . . . 72.340000000000003 106.409 175.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 94.96 135.87 8.24 Favored Glycine 0 N--CA 1.432 -1.604 0 CA-C-N 115.037 -0.983 . . . . 62.509999999999998 112.716 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 26.9 m -91.94 123.65 35.47 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 108.211 -1.033 . . . . 71.319999999999993 108.211 173.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -102.29 133.87 46.49 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-O 120.994 0.426 . . . . 74.200000000000003 110.277 -177.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.6 p -105.23 115.74 47.67 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 N-CA-C 106.536 -1.653 . . . . 75.430000000000007 106.536 173.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 12.2 m120 64.73 -78.41 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 124.737 1.215 . . . . 74.25 110.767 -173.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 -140.18 -3.75 1.37 Allowed 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 123.703 0.801 . . . . 71.319999999999993 110.44 -176.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -118.03 130.21 24.87 Favored Pre-proline 0 C--N 1.325 -0.462 0 C-N-CA 120.688 -0.405 . . . . 75.439999999999998 111.711 -170.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -79.64 117.3 3.65 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.394 2.063 . . . . 74.340000000000003 111.104 177.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 36.9 mmt180 -118.76 153.84 33.78 Favored 'General case' 0 C--N 1.308 -1.238 0 O-C-N 121.762 -0.586 . . . . 75.019999999999996 109.868 -177.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -84.73 -25.39 28.36 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.71 0.767 . . . . 74.319999999999993 109.123 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -157.56 139.17 13.9 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 107.539 -1.282 . . . . 61.219999999999999 107.539 175.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -140.62 149.25 42.07 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-O 121.033 0.444 . . . . 73.430000000000007 110.973 178.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 41.1 t -104.52 105.04 17.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 105.294 -2.113 . . . . 72.219999999999999 105.294 175.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 65.7 mtp -103.25 151.35 22.77 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 113.488 0.921 . . . . 75.129999999999995 113.488 -171.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -113.96 153.33 29.49 Favored 'General case' 0 N--CA 1.418 -2.049 0 CA-C-N 113.813 -1.539 . . . . 74.150000000000006 108.269 -177.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.7 p -77.71 129.36 35.42 Favored 'General case' 0 N--CA 1.417 -2.093 0 CA-C-O 121.532 0.682 . . . . 64.129999999999995 111.646 -176.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 111.82 8.64 22.12 Favored Glycine 0 N--CA 1.442 -0.91 0 N-CA-C 110.539 -1.025 . . . . 52.210000000000001 110.539 -177.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -109.89 169.34 8.78 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-O 120.445 0.164 . . . . 73.25 110.989 -175.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.402 ' OE2' ' HD2' ' A' ' 134' ' ' ARG . 38.2 tt0 -108.73 139.97 42.8 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 113.299 0.851 . . . . 74.409999999999997 113.299 -172.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 58.4 mt -125.31 131.23 72.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 124.436 1.094 . . . . 74.209999999999994 109.704 -176.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -113.94 124.05 51.22 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 121.404 0.621 . . . . 73.239999999999995 110.069 173.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 27.7 mt -108.5 100.07 9.98 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 N-CA-C 107.311 -1.366 . . . . 75.430000000000007 107.311 -177.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.529 ' HA2' ' OD1' ' A' ' 108' ' ' ASN . . . 71.04 -100.6 0.87 Allowed Glycine 0 N--CA 1.425 -2.06 0 O-C-N 124.25 0.969 . . . . 72.140000000000001 110.788 -177.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -114.6 -9.81 12.59 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-O 121.16 0.505 . . . . 74.129999999999995 110.685 177.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -104.27 142.61 34.23 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 118.993 -1.083 . . . . 74.439999999999998 112.32 -171.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.402 ' HD2' ' OE2' ' A' ' 127' ' ' GLU . 11.9 ttp180 -106.79 128.78 54.53 Favored 'General case' 0 C--O 1.248 0.992 0 N-CA-C 113.792 1.034 . . . . 72.319999999999993 113.792 -167.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.428 HD12 ' HB2' ' A' ' 49' ' ' LEU . 38.8 tp -123.94 145.04 49.42 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 126.449 1.9 . . . . 62.509999999999998 109.551 -174.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.405 ' CG1' HG23 ' A' ' 50' ' ' VAL . 7.3 p -123.17 135.24 63.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 108.84 -0.8 . . . . 73.340000000000003 108.84 171.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -112.11 118.41 35.3 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.499 -0.926 . . . . 74.420000000000002 108.499 -174.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.495 ' O ' ' HB2' ' A' ' 47' ' ' ALA . 4.5 mp -120.88 164.42 16.69 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 120.891 0.377 . . . . 72.310000000000002 111.089 -175.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -75.25 145.74 41.68 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.298 -0.63 . . . . 55.100000000000001 109.298 177.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -103.7 -178.62 25.79 Favored Glycine 0 N--CA 1.429 -1.789 0 C-N-CA 120.608 -0.806 . . . . 64.439999999999998 111.638 -178.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo . . . . . 0 C--O 1.242 0.686 0 C-N-CA 122.628 2.219 . . . . 60.130000000000003 112.515 -179.394 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 51.6 t30 . . . . . 0 N--CA 1.478 0.951 0 CA-C-O 121.266 0.555 . . . . 75.200000000000003 111.459 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -108.48 175.63 19.69 Favored Glycine 0 N--CA 1.426 -1.992 0 N-CA-C 110.258 -1.137 . . . . 74.140000000000001 110.258 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.1 m -68.98 130.92 91.15 Favored Pre-proline 0 C--N 1.3 -1.578 0 N-CA-C 108.294 -1.002 . . . . 74.239999999999995 108.294 178.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.553 ' O ' ' HD3' ' A' ' 10' ' ' PRO . 10.7 Cg_endo -53.46 149.86 29.02 Favored 'Trans proline' 0 C--N 1.358 1.059 0 C-N-CA 123.22 2.614 . . . . 72.400000000000006 111.814 -179.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -85.74 105.11 6.29 Favored Pre-proline 0 N--CA 1.422 -1.831 0 N-CA-C 107.741 -1.207 . . . . 74.239999999999995 107.741 178.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.553 ' HD3' ' O ' ' A' ' 8' ' ' PRO . 86.8 Cg_endo -103.26 155.0 0.25 Allowed 'Trans proline' 0 N--CA 1.437 -1.823 0 C-N-CA 122.596 2.197 . . . . 74.450000000000003 112.981 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -80.73 72.47 7.69 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 122.452 1.12 . . . . 75.530000000000001 109.412 173.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.8 p -62.02 142.48 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 CA-C-N 113.454 -1.703 . . . . 75.209999999999994 109.998 -177.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.05 137.59 51.39 Favored 'General case' 0 N--CA 1.423 -1.779 0 C-N-CA 119.72 -0.792 . . . . 73.540000000000006 110.16 179.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.4 m -129.53 90.99 3.08 Favored 'General case' 0 C--N 1.274 -2.674 0 N-CA-C 107.495 -1.298 . . . . 72.219999999999999 107.495 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 94.3 m -69.28 97.0 0.9 Allowed 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 115.066 -0.97 . . . . 72.209999999999994 111.183 -177.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 25.3 t -136.51 112.9 9.94 Favored 'General case' 0 N--CA 1.419 -2.005 0 N-CA-C 105.741 -1.948 . . . . 71.230000000000004 105.741 178.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.7 m . . . . . 0 C--N 1.292 -1.913 0 CA-C-N 116.051 -0.522 . . . . 75.010000000000005 111.22 -174.382 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.689 0 N-CA-C 108.122 -1.991 . . . . 54.329999999999998 108.122 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.3 m -91.14 167.84 12.06 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 114.252 -0.974 . . . . 60.299999999999997 110.033 -176.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -102.19 166.84 10.37 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 109.907 -0.405 . . . . 72.530000000000001 109.907 -179.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -134.35 152.64 51.92 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.841 -0.8 . . . . 74.040000000000006 108.841 176.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.403 ' O ' HD12 ' A' ' 49' ' ' LEU . 4.4 pp -109.27 134.63 51.54 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 108.772 -0.825 . . . . 72.349999999999994 108.772 178.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 94.1 t -117.08 117.81 56.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 CA-C-N 116.032 -0.531 . . . . 75.25 109.604 -177.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.447 HG22 ' HB2' ' A' ' 57' ' ' ALA . 15.6 t -93.15 118.96 40.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 107.711 -1.218 . . . . 72.540000000000006 107.711 178.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -75.99 -42.35 48.49 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 115.664 -0.698 . . . . 64.340000000000003 109.156 -178.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 62.3 ttt180 -177.34 157.64 1.35 Allowed 'General case' 0 C--O 1.245 0.865 0 CA-C-N 115.047 -0.979 . . . . 72.120000000000005 108.921 -177.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 124.88 142.85 5.97 Favored Glycine 0 C--O 1.202 -1.866 0 CA-C-O 119.201 -0.777 . . . . 65.340000000000003 111.563 176.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.556 ' HD2' ' CE1' ' A' ' 133' ' ' PHE . 9.3 Cg_endo -51.62 -7.4 0.2 Allowed 'Trans proline' 0 N--CA 1.499 1.828 0 C-N-CA 124.963 3.775 . . . . 75.329999999999998 115.311 177.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.475 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -56.64 -51.59 68.14 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 108.225 -1.028 . . . . 74.430000000000007 108.225 175.079 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.447 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -179.5 -171.51 0.19 Allowed 'General case' 0 C--O 1.214 -0.783 0 N-CA-C 106.585 -1.635 . . . . 71.540000000000006 106.585 -178.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -166.96 56.4 0.23 Allowed Glycine 0 C--N 1.291 -1.932 0 N-CA-C 110.416 -1.073 . . . . 75.510000000000005 110.416 -177.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -163.04 -171.01 2.5 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.595 -1.261 . . . . 74.400000000000006 107.595 -178.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 18.4 ptp180 -136.66 138.26 40.92 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.618 -0.882 . . . . 74.319999999999993 108.618 178.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -142.0 148.23 38.22 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 120.128 -0.629 . . . . 73.349999999999994 111.686 176.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.1 tt -84.06 133.97 34.63 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 113.943 -1.481 . . . . 73.230000000000004 107.519 -177.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.5 mp -87.51 112.92 22.73 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 108.501 -0.926 . . . . 73.319999999999993 108.501 178.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -125.12 18.02 8.4 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 122.42 1.105 . . . . 71.439999999999998 108.136 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -119.2 149.31 46.96 Favored Pre-proline 0 C--N 1.296 -1.717 0 CA-C-N 113.874 -1.512 . . . . 74.409999999999997 108.257 -176.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -63.68 -35.23 59.44 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 122.409 2.073 . . . . 75.310000000000002 112.582 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' A' ' 92' ' ' PHE . 44.1 m -137.53 123.06 19.68 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 116.516 -0.311 . . . . 71.420000000000002 111.133 179.127 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.446 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 31.3 m -98.12 116.89 31.27 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 106.566 -1.642 . . . . 72.219999999999999 106.566 171.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.491 ' HB ' ' NE2' ' A' ' 73' ' ' HIS . 0.1 OUTLIER -104.86 102.6 12.13 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-O 121.23 0.538 . . . . 74.230000000000004 112.102 -174.37 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -105.87 117.74 34.8 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.088 0.47 . . . . 70.25 110.173 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 172.41 -163.75 35.93 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.949 -1.26 . . . . 74.120000000000005 109.949 -179.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.7 ptp180 -110.96 21.45 16.44 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 122.045 0.926 . . . . 70.349999999999994 109.561 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.491 ' NE2' ' HB ' ' A' ' 69' ' ' THR . 12.1 p-80 -84.95 163.67 45.06 Favored Pre-proline 0 C--N 1.299 -1.599 0 CA-C-N 114.672 -1.149 . . . . 72.310000000000002 109.799 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -51.01 -40.42 58.89 Favored 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 123.602 2.868 . . . . 72.120000000000005 115.693 -174.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -97.13 30.21 2.85 Favored 'General case' 0 C--N 1.318 -0.801 0 O-C-N 121.515 -0.741 . . . . 73.209999999999994 112.873 -176.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.0 p -56.91 116.9 3.47 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.268 -0.424 . . . . 75.540000000000006 111.208 178.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -67.23 -49.79 63.14 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 106.301 -1.741 . . . . 74.310000000000002 106.301 173.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 30.4 pt -134.28 138.26 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 CA-C-N 113.606 -1.634 . . . . 74.239999999999995 107.236 174.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -104.09 117.54 34.51 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 108.676 -0.861 . . . . 62.25 108.676 177.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 2.1 pt? -75.38 111.58 10.81 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.369 -0.975 . . . . 61.109999999999999 108.369 177.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -85.59 73.6 10.43 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 118.954 -1.099 . . . . 74.099999999999994 112.752 -173.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -119.85 150.8 39.87 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 115.031 -0.986 . . . . 73.519999999999996 108.901 170.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.0 p -73.38 -20.17 18.36 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 C-N-CA 122.921 0.488 . . . . 74.430000000000007 112.281 -176.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.449 ' HB ' ' ND2' ' A' ' 108' ' ' ASN . 1.3 m -89.53 6.68 39.95 Favored 'General case' 0 CA--C 1.557 1.25 0 CA-C-O 121.057 0.455 . . . . 74.409999999999997 111.943 -172.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.4 t -82.27 137.16 21.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 109.409 -0.589 . . . . 62.409999999999997 109.409 -178.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 15.3 p -86.01 -71.1 0.56 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.989 0.423 . . . . 62.109999999999999 112.104 -178.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 21.2 tpp180 -150.19 -66.96 0.2 Allowed 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 106.953 -1.499 . . . . 74.340000000000003 106.953 -178.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.47 ' HA ' ' HD1' ' A' ' 73' ' ' HIS . 48.0 mtt180 -96.56 167.81 10.92 Favored 'General case' 0 CA--C 1.486 -1.516 0 N-CA-C 106.228 -1.768 . . . . 71.400000000000006 106.228 171.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -151.49 -70.72 0.17 Allowed 'General case' 0 C--N 1.292 -1.934 0 C-N-CA 118.921 -1.112 . . . . 73.129999999999995 109.753 -177.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -133.45 104.05 6.23 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-O 121.155 0.502 . . . . 73.140000000000001 109.908 -178.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.415 ' OE1' ' HD3' ' A' ' 88' ' ' ARG . 3.0 mp0 -104.01 132.24 50.45 Favored 'General case' 0 N--CA 1.419 -1.983 0 C-N-CA 119.738 -0.785 . . . . 73.219999999999999 109.961 176.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.446 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 29.9 m-85 -97.1 112.22 24.1 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 105.287 -2.116 . . . . 73.340000000000003 105.287 175.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 72.8 mtt180 -118.3 115.31 24.46 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 106.63 -1.619 . . . . 74.5 106.63 -175.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.9 pp -115.48 143.03 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.927 0 C-N-CA 119.58 -0.848 . . . . 74.239999999999995 111.734 -172.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -117.71 146.77 43.52 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 105.219 -2.141 . . . . 64.209999999999994 105.219 175.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -49.01 -32.97 10.19 Favored 'General case' 0 C--N 1.315 -0.912 0 O-C-N 123.575 0.547 . . . . 71.510000000000005 112.453 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -85.35 -48.27 4.86 Favored Glycine 0 N--CA 1.433 -1.538 0 C-N-CA 120.733 -0.746 . . . . 64.439999999999998 112.749 179.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -133.2 131.55 40.5 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-O 121.682 0.753 . . . . 75.140000000000001 112.581 -177.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -99.74 124.55 45.12 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.209 -1.034 . . . . 72.219999999999999 108.209 -178.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -129.19 136.54 50.28 Favored 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 113.829 1.048 . . . . 64.530000000000001 113.829 -176.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.2 p -110.84 118.9 58.36 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 CA-C-N 114.73 -1.123 . . . . 65.120000000000005 108.884 175.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.8 m -120.37 120.8 63.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 N-CA-C 113.166 0.802 . . . . 71.340000000000003 113.166 -177.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.422 ' HB3' ' HB2' ' A' ' 118' ' ' ASN . 4.6 t70 -84.76 122.7 29.49 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 109.164 -0.68 . . . . 63.420000000000002 109.164 169.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 26.8 m -114.53 -1.12 9.48 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 CA-C-N 115.625 -0.716 . . . . 62.140000000000001 109.47 177.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.433 ' C ' ' H ' ' A' ' 107' ' ' LEU . . . -112.85 59.95 0.36 Allowed Glycine 0 N--CA 1.434 -1.486 0 N-CA-C 110.619 -0.993 . . . . 65.430000000000007 110.619 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 19.1 m -72.41 19.25 0.08 Allowed 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 123.671 0.788 . . . . 71.219999999999999 112.913 -175.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.433 ' H ' ' C ' ' A' ' 105' ' ' GLY . 6.2 mp -75.58 -33.61 60.6 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 109.58 -0.526 . . . . 75.219999999999999 109.58 178.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.449 ' ND2' ' HB ' ' A' ' 84' ' ' THR . 10.0 m120 -80.25 -24.27 40.25 Favored 'General case' 0 CA--C 1.5 -0.962 0 CA-C-N 116.15 -0.477 . . . . 71.030000000000001 110.54 176.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 86.59 82.58 1.15 Allowed Glycine 0 N--CA 1.428 -1.889 0 N-CA-C 109.956 -1.258 . . . . 71.120000000000005 109.956 -177.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 64.7 m -87.18 119.51 27.49 Favored 'General case' 0 N--CA 1.42 -1.938 0 CA-C-O 121.305 0.574 . . . . 70.540000000000006 109.803 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -116.66 134.07 55.26 Favored 'General case' 0 N--CA 1.425 -1.688 0 N-CA-C 107.54 -1.282 . . . . 73.120000000000005 107.54 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.443 HG11 ' O ' ' A' ' 117' ' ' ARG . 7.4 p -117.68 132.23 68.09 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.713 0 N-CA-C 107.264 -1.384 . . . . 72.430000000000007 107.264 175.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 64.93 26.33 12.79 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 107.837 -1.171 . . . . 64.439999999999998 107.837 -175.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.429 ' HG2' ' OE1' ' A' ' 129' ' ' GLN . 16.9 mtt-85 70.27 7.48 6.24 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 126.638 1.975 . . . . 73.310000000000002 111.698 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -106.69 144.62 29.42 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 109.831 -0.433 . . . . 74.299999999999997 109.831 -176.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -68.11 91.74 0.38 Allowed 'Trans proline' 0 C--N 1.356 0.93 0 C-N-CA 122.223 1.949 . . . . 72.340000000000003 112.402 176.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.443 ' O ' HG11 ' A' ' 112' ' ' VAL . 5.2 ptt180 -154.61 116.55 4.19 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 125.034 1.333 . . . . 73.450000000000003 108.881 174.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.422 ' HB2' ' HB3' ' A' ' 103' ' ' ASP . 23.5 p-10 -83.74 -30.99 26.24 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 114.888 -1.051 . . . . 72.349999999999994 113.125 -174.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -105.53 138.26 42.01 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.675 -0.81 . . . . 71.409999999999997 110.929 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -140.46 149.36 42.46 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 113.394 0.887 . . . . 71.030000000000001 113.394 178.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.7 p -91.34 135.76 26.09 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 N-CA-C 106.67 -1.604 . . . . 75.400000000000006 106.67 173.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 23.2 ttt -39.45 102.52 0.02 OUTLIER 'General case' 0 C--O 1.247 0.954 0 N-CA-C 114.001 1.111 . . . . 74.439999999999998 114.001 178.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -123.23 123.39 40.66 Favored 'General case' 0 N--CA 1.424 -1.77 0 N-CA-C 105.605 -1.998 . . . . 74.209999999999994 105.605 173.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 7.3 t -81.92 129.06 34.65 Favored 'General case' 0 C--N 1.291 -1.959 0 C-N-CA 120.565 -0.454 . . . . 74.430000000000007 110.363 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 100.36 18.54 21.19 Favored Glycine 0 N--CA 1.433 -1.532 0 CA-C-N 115.55 -0.75 . . . . 64.420000000000002 112.18 177.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -110.77 150.05 29.64 Favored 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 119.581 -0.848 . . . . 72.049999999999997 109.501 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -110.48 132.26 54.34 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.558 0.694 . . . . 74.430000000000007 112.519 -174.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 66.2 mt -108.42 118.43 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.591 0 CA-C-N 114.68 -1.146 . . . . 75.120000000000005 107.991 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.429 ' OE1' ' HG2' ' A' ' 114' ' ' ARG . 54.6 mt-30 -109.54 112.61 24.81 Favored 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 109.221 -0.659 . . . . 74.400000000000006 109.221 178.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 130' ' ' ILE . 23.4 pt -95.09 96.94 6.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 108.771 -0.825 . . . . 75.549999999999997 108.771 177.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 61.67 -85.31 0.03 OUTLIER Glycine 0 CA--C 1.528 0.853 0 CA-C-N 115.35 -0.841 . . . . 54.420000000000002 112.897 -176.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.486 ' HE3' ' CZ ' ' A' ' 133' ' ' PHE . 48.2 mtmt -113.66 -13.38 12.71 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 123.175 0.59 . . . . 74.400000000000006 111.237 -175.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.556 ' CE1' ' HD2' ' A' ' 55' ' ' PRO . 19.3 m-85 -107.3 154.07 21.81 Favored 'General case' 0 CA--C 1.501 -0.923 0 C-N-CA 119.748 -0.781 . . . . 74.219999999999999 112.227 -169.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 74.2 mtp180 -119.27 122.57 42.21 Favored 'General case' 0 C--O 1.248 0.987 0 CA-C-O 121.603 0.716 . . . . 64.329999999999998 112.623 -172.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 56.9 tp -123.95 131.21 53.54 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 114.466 -1.243 . . . . 74.209999999999994 107.841 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.7 t -115.58 138.76 44.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 N-CA-C 108.17 -1.048 . . . . 74.109999999999999 108.17 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -111.13 117.0 32.06 Favored 'General case' 0 C--N 1.309 -1.152 0 N-CA-C 109.302 -0.629 . . . . 74.530000000000001 109.302 -176.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -123.69 158.99 30.33 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.861 -0.422 . . . . 70.519999999999996 109.861 -177.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -79.91 140.67 36.62 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.049 -1.463 . . . . 64.340000000000003 107.049 172.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -97.96 -143.2 14.39 Favored Glycine 0 C--N 1.292 -1.861 0 C-N-CA 120.329 -0.939 . . . . 52.149999999999999 112.232 -176.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo . . . . . 0 N--CA 1.44 -1.668 0 C-N-CA 122.259 1.973 . . . . 73.010000000000005 113.662 -177.484 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 . . . . . 0 N--CA 1.439 -0.994 0 N-CA-C 107.848 -1.167 . . . . 74.530000000000001 107.848 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -94.05 76.62 1.03 Allowed Glycine 0 N--CA 1.426 -1.969 0 CA-C-N 113.987 -1.46 . . . . 71.120000000000005 110.863 -178.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.3 p -77.25 123.88 87.07 Favored Pre-proline 0 C--N 1.291 -1.978 0 CA-C-N 115.332 -0.434 . . . . 73.310000000000002 110.396 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -65.6 146.35 84.28 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 121.617 1.545 . . . . 75.530000000000001 110.384 177.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -68.6 122.57 85.18 Favored Pre-proline 0 C--N 1.302 -1.494 0 N-CA-C 109.733 -0.469 . . . . 72.519999999999996 109.733 -174.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -50.23 159.27 1.98 Allowed 'Trans proline' 0 C--N 1.37 1.686 0 C-N-CA 124.281 3.321 . . . . 73.400000000000006 112.624 -178.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 53.3 tp60 -51.14 107.0 0.15 Allowed 'General case' 0 C--O 1.242 0.7 0 C-N-CA 123.666 0.786 . . . . 73.219999999999999 112.418 -174.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.4 p -84.57 146.73 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 107.539 -1.282 . . . . 72.400000000000006 107.539 175.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -104.76 121.48 43.71 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 107.414 -1.328 . . . . 73.319999999999993 107.414 -178.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.4 m -132.94 120.33 21.3 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.96 -0.755 . . . . 52.210000000000001 108.96 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.9 t -115.08 133.01 56.41 Favored 'General case' 0 N--CA 1.412 -2.355 0 CA-C-O 121.666 0.746 . . . . 74.319999999999993 109.562 -177.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 21.0 m -92.88 127.81 38.52 Favored 'General case' 0 C--N 1.283 -2.321 0 N-CA-C 108.169 -1.049 . . . . 75.239999999999995 108.169 178.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.5 m . . . . . 0 C--N 1.282 -2.329 0 N-CA-C 108.496 -0.928 . . . . 74.109999999999999 108.496 178.799 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.413 -2.86 0 N-CA-C 111.572 -0.611 . . . . 73.439999999999998 111.572 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 42.6 m -90.85 166.69 12.94 Favored 'General case' 0 N--CA 1.407 -2.598 0 N-CA-C 107.975 -1.12 . . . . 74.109999999999999 107.975 177.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -91.59 154.38 19.1 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 109.763 -0.458 . . . . 64.319999999999993 109.763 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -131.31 148.51 52.69 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.721 -0.844 . . . . 74.439999999999998 108.721 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.436 ' HB2' HD22 ' A' ' 135' ' ' LEU . 4.4 pp -112.66 138.59 49.23 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 109.511 -0.552 . . . . 71.109999999999999 109.511 178.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 38.7 t -114.54 120.0 63.04 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 108.087 -1.079 . . . . 63.140000000000001 108.087 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 26.3 t -93.2 115.6 32.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 107.523 -1.288 . . . . 74.430000000000007 107.523 178.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -85.38 -40.16 16.79 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.117 -0.947 . . . . 63.310000000000002 109.991 -176.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 36.9 mmt180 -144.32 153.67 42.24 Favored 'General case' 0 CA--C 1.495 -1.17 0 CA-C-N 115.589 -0.732 . . . . 75.120000000000005 110.185 -177.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 131.89 140.23 4.49 Favored Glycine 0 N--CA 1.426 -2.022 0 O-C-N 124.185 0.928 . . . . 65.319999999999993 111.57 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.422 ' HB2' ' O ' ' A' ' 81' ' ' ASP . 14.1 Cg_exo -69.08 -14.95 39.2 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 122.533 2.156 . . . . 74.530000000000001 111.508 175.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.55 ' HA ' ' H ' ' A' ' 81' ' ' ASP . 4.7 p-10 -61.72 -48.77 79.24 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.417 1.087 . . . . 73.450000000000003 111.162 178.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -166.89 171.09 11.6 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.756 -0.831 . . . . 63.210000000000001 108.756 -176.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -155.05 30.28 0.65 Allowed Glycine 0 C--N 1.303 -1.287 0 N-CA-C 110.042 -1.223 . . . . 72.409999999999997 110.042 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -132.78 -168.51 2.08 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 109.261 -0.644 . . . . 73.420000000000002 109.261 -177.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -135.02 137.18 42.71 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 109.187 -0.671 . . . . 75.030000000000001 109.187 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.426 ' CE2' HD11 ' A' ' 49' ' ' LEU . 53.0 p90 -135.28 148.42 49.53 Favored 'General case' 0 C--N 1.293 -1.885 0 C-N-CA 120.044 -0.662 . . . . 73.219999999999999 110.579 178.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 36.2 tp -86.69 122.83 31.15 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 124.241 0.963 . . . . 74.430000000000007 108.459 -178.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.4 mp -83.99 114.56 21.8 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.103 0.478 . . . . 73.049999999999997 111.408 -176.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -129.49 7.03 5.28 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.11 -0.95 . . . . 75.109999999999999 108.576 172.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.523 ' OE1' ' HA ' ' A' ' 68' ' ' THR . 8.4 tt0 -88.87 123.52 67.42 Favored Pre-proline 0 N--CA 1.421 -1.888 0 CA-C-N 114.377 -1.283 . . . . 73.299999999999997 107.952 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -51.54 -44.93 40.81 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 123.437 2.758 . . . . 74.439999999999998 112.049 -177.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 91.2 m -136.15 99.38 4.11 Favored 'General case' 0 N--CA 1.425 -1.681 0 N-CA-C 109.026 -0.731 . . . . 72.219999999999999 109.026 174.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.523 ' HA ' ' OE1' ' A' ' 65' ' ' GLN . 16.9 m -77.7 116.45 18.25 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 107.196 -1.409 . . . . 64.040000000000006 107.196 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.492 HG22 ' CE1' ' A' ' 73' ' ' HIS . 2.3 m -92.81 92.54 7.98 Favored 'General case' 0 N--CA 1.419 -1.987 0 CA-C-O 121.152 0.501 . . . . 72.120000000000005 110.435 -171.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.94 131.87 44.01 Favored 'General case' 0 C--O 1.246 0.893 0 CA-C-N 115.723 -0.671 . . . . 73.310000000000002 111.007 -178.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 155.75 -137.66 5.66 Favored Glycine 0 CA--C 1.472 -2.635 0 N-CA-C 107.442 -2.263 . . . . 71.040000000000006 107.442 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -103.51 -83.33 0.49 Allowed 'General case' 0 N--CA 1.418 -2.074 0 N-CA-C 107.538 -1.282 . . . . 74.420000000000002 107.538 170.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.492 ' CE1' HG22 ' A' ' 69' ' ' THR . 31.6 m80 67.03 161.32 0.14 Allowed Pre-proline 0 N--CA 1.475 0.824 0 C-N-CA 123.994 0.918 . . . . 61.109999999999999 110.86 178.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -67.34 -22.01 46.55 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 121.903 1.736 . . . . 73.430000000000007 110.098 167.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -120.82 78.34 1.38 Allowed 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 108.519 -0.919 . . . . 74.140000000000001 108.519 -177.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.0 m -79.9 109.88 14.74 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-N 115.834 -0.621 . . . . 63.420000000000002 109.464 178.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.468 ' CG ' HE22 ' A' ' 65' ' ' GLN . 35.3 t70 -69.76 -43.11 72.91 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 106.936 -1.505 . . . . 44.350000000000001 106.936 173.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.86 147.17 23.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 N-CA-C 104.753 -2.314 . . . . 74.340000000000003 104.753 170.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -116.83 127.48 54.35 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-O 122.009 0.909 . . . . 74.239999999999995 112.347 -173.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.521 ' HA ' ' CB ' ' A' ' 56' ' ' ASN . 8.7 mp -84.8 102.35 12.98 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 115.163 -0.926 . . . . 74.239999999999995 108.932 174.147 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.55 ' H ' ' HA ' ' A' ' 56' ' ' ASN . 37.1 t70 -80.64 64.79 5.55 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 122.836 1.303 . . . . 74.109999999999999 110.975 -178.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -131.91 146.28 52.01 Favored 'General case' 0 C--N 1.283 -2.307 0 CA-C-N 113.89 -1.504 . . . . 62.340000000000003 108.436 175.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 28.3 m -81.92 2.06 3.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 113.729 1.011 . . . . 74.420000000000002 113.729 -174.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.72 12.55 25.67 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 121.816 0.817 . . . . 74.219999999999999 109.298 -179.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 98.8 t -83.08 132.01 32.38 Favored 'Isoleucine or valine' 0 C--O 1.244 0.789 0 CA-C-N 115.28 -0.873 . . . . 74.230000000000004 111.844 -177.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 7.6 m -103.73 165.42 11.05 Favored 'General case' 0 C--O 1.25 1.121 0 CA-C-N 115.1 -0.955 . . . . 65.450000000000003 110.252 -177.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.427 ' O ' ' HD2' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -74.13 132.69 42.5 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 107.405 -1.331 . . . . 75.099999999999994 107.405 169.11 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.42 ' O ' HG22 ' A' ' 104' ' ' VAL . 9.2 mmm180 61.72 83.54 0.15 Allowed 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 106.412 -1.699 . . . . 73.140000000000001 106.412 -168.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 12.5 t60 -104.87 -73.58 0.67 Allowed 'General case' 0 N--CA 1.428 -1.557 0 CA-C-N 115.366 -0.834 . . . . 73.420000000000002 110.149 -174.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -121.71 108.87 14.04 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.633 -0.877 . . . . 74.340000000000003 108.633 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -99.72 126.1 45.71 Favored 'General case' 0 C--N 1.28 -2.42 0 C-N-CA 119.373 -0.931 . . . . 74.150000000000006 109.678 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.461 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 58.5 m-85 -107.12 112.62 25.62 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 105.955 -1.868 . . . . 75.030000000000001 105.955 176.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.421 ' NH1' HG22 ' A' ' 102' ' ' VAL . 99.2 mtt180 -112.7 133.05 54.91 Favored 'General case' 0 C--N 1.277 -2.547 0 N-CA-C 109.035 -0.728 . . . . 75.030000000000001 109.035 -174.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 18.9 pt -116.76 138.14 48.35 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.429 0 C-N-CA 119.332 -0.947 . . . . 64.420000000000002 108.842 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -121.28 146.33 46.94 Favored 'General case' 0 C--N 1.266 -3.046 0 N-CA-C 106.207 -1.775 . . . . 74.230000000000004 106.207 174.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -60.08 -17.19 37.82 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.202 0.525 . . . . 73.040000000000006 112.288 177.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -91.31 -36.73 6.47 Favored Glycine 0 N--CA 1.439 -1.155 0 C-N-CA 121.415 -0.421 . . . . 61.299999999999997 113.081 178.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -169.18 161.69 10.36 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 109.46 -0.57 . . . . 75.0 109.46 -178.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.418 ' HB2' ' HB2' ' A' ' 122' ' ' MET . 59.2 m-85 -97.05 139.16 33.47 Favored 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 122.919 0.488 . . . . 64.439999999999998 110.997 -177.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -125.35 135.34 52.34 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 123.157 0.583 . . . . 75.040000000000006 111.148 -176.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.9 p -115.02 125.4 72.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 121.972 -0.455 . . . . 75.150000000000006 110.485 177.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.421 HG22 ' NH1' ' A' ' 93' ' ' ARG . 96.0 t -119.33 125.46 74.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-O 121.041 0.448 . . . . 75.409999999999997 111.2 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -104.99 122.14 45.24 Favored 'General case' 0 CA--C 1.489 -1.372 0 CA-C-N 115.907 -0.588 . . . . 72.239999999999995 110.624 176.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.42 HG22 ' O ' ' A' ' 88' ' ' ARG . 0.9 OUTLIER -131.51 11.08 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.433 0 CA-C-N 114.976 -1.011 . . . . 72.25 109.675 173.165 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -110.22 44.94 1.4 Allowed Glycine 0 N--CA 1.438 -1.197 0 N-CA-C 109.23 -1.548 . . . . 74.439999999999998 109.23 178.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.4 m -67.58 -3.29 8.41 Favored 'General case' 0 C--N 1.31 -1.109 0 C-N-CA 124.92 1.288 . . . . 74.409999999999997 112.498 -175.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 33.7 tp -68.21 -40.26 82.17 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 107.798 -1.186 . . . . 72.219999999999999 107.798 174.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -89.59 -40.97 12.26 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 107.835 -1.172 . . . . 71.209999999999994 107.835 175.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 96.36 92.96 1.81 Allowed Glycine 0 N--CA 1.44 -1.086 0 CA-C-N 115.347 -0.842 . . . . 54.509999999999998 113.377 176.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 24.2 m -88.87 119.56 29.48 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.259 -1.015 . . . . 64.010000000000005 108.259 175.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.449 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 41.9 m-85 -112.6 134.83 53.93 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 108.008 -1.108 . . . . 75.219999999999999 108.008 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.3 p -109.03 136.27 45.42 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.444 0 N-CA-C 107.848 -1.167 . . . . 75.310000000000002 107.848 179.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.601 ' O ' ' HD2' ' A' ' 114' ' ' ARG . 20.5 m120 70.64 -81.46 0.03 OUTLIER 'General case' 0 CA--C 1.501 -0.904 0 N-CA-C 107.429 -1.323 . . . . 74.120000000000005 107.429 -172.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.601 ' HD2' ' O ' ' A' ' 113' ' ' ASN . 26.4 mmm180 -154.97 12.8 0.38 Allowed 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 107.648 -1.241 . . . . 75.239999999999995 107.648 173.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -123.64 146.07 49.1 Favored Pre-proline 0 N--CA 1.464 0.274 0 N-CA-C 113.089 0.774 . . . . 73.329999999999998 113.089 -168.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -77.5 119.29 4.84 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.658 2.239 . . . . 71.299999999999997 109.809 175.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 14.8 mmm180 -136.1 148.29 48.2 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 109.391 -0.596 . . . . 75.439999999999998 109.391 -177.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -86.87 -40.54 14.79 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.534 -0.913 . . . . 74.219999999999999 108.534 173.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -142.58 137.38 30.05 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 107.663 -1.236 . . . . 72.109999999999999 107.663 172.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 24.0 tm0? -142.43 147.01 35.45 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.261 -1.014 . . . . 75.430000000000007 108.261 177.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.5 p -84.63 112.83 22.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-O 121.071 0.462 . . . . 63.350000000000001 109.758 177.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.418 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 64.2 mtt -54.22 142.16 26.98 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.873 1.064 . . . . 74.129999999999995 113.873 -171.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -122.13 135.38 54.79 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 115.209 -0.905 . . . . 75.420000000000002 109.068 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 6.7 t -79.89 132.53 36.1 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.855 -0.611 . . . . 54.240000000000002 111.538 -178.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 95.46 16.7 39.04 Favored Glycine 0 CA--C 1.488 -1.607 0 CA-C-N 115.685 -0.689 . . . . 73.040000000000006 111.855 176.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -124.92 -170.99 2.26 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.892 -0.781 . . . . 50.5 108.892 -177.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -133.59 150.83 51.62 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 113.641 0.978 . . . . 74.219999999999999 113.641 -172.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 67.5 mt -113.13 126.98 70.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 107.818 -1.178 . . . . 61.210000000000001 107.818 176.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.449 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 14.5 tp60 -102.11 111.94 24.41 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 107.306 -1.368 . . . . 72.510000000000005 107.306 -178.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.401 HG13 ' HB2' ' A' ' 133' ' ' PHE . 14.7 pt -102.35 98.46 6.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 CA-C-O 121.344 0.593 . . . . 71.219999999999999 109.784 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 66.11 -89.74 0.13 Allowed Glycine 0 N--CA 1.438 -1.205 0 CA-C-N 115.208 -0.906 . . . . 60.100000000000001 111.793 -176.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -126.33 -1.04 6.97 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 122.846 0.458 . . . . 73.120000000000005 110.123 -178.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.401 ' HB2' HG13 ' A' ' 130' ' ' ILE . 11.5 m-85 -108.85 156.33 19.78 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.44 -0.948 . . . . 75.439999999999998 108.44 -174.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -124.78 136.0 53.45 Favored 'General case' 0 C--O 1.249 1.05 0 CA-C-O 121.81 0.814 . . . . 74.420000000000002 112.642 -174.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.436 HD22 ' HB2' ' A' ' 49' ' ' LEU . 5.0 tt -124.2 139.82 53.55 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 114.086 -1.415 . . . . 75.129999999999995 107.603 -178.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 9.4 p -113.11 139.25 39.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 109.386 -0.598 . . . . 63.299999999999997 109.386 178.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -116.05 121.37 42.0 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 120.587 0.232 . . . . 73.439999999999998 111.011 -174.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -128.81 143.13 50.83 Favored 'General case' 0 C--O 1.217 -0.643 0 CA-C-O 120.856 0.36 . . . . 74.540000000000006 111.209 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -103.41 44.17 1.03 Allowed 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 105.744 -1.947 . . . . 72.129999999999995 105.744 172.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -60.08 -64.97 3.7 Favored Glycine 0 C--N 1.31 -0.881 0 CA-C-N 112.532 -2.122 . . . . 70.549999999999997 117.691 -168.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo . . . . . 0 N--CA 1.45 -1.044 0 CA-C-N 119.9 1.85 . . . . 70.400000000000006 114.116 -171.359 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 19.2 m120 . . . . . 0 CA--C 1.493 -1.246 0 N-CA-C 107.944 -1.132 . . . . 64.140000000000001 107.944 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -64.2 107.7 1.92 Allowed Glycine 0 N--CA 1.44 -1.083 0 O-C-N 123.854 0.722 . . . . 63.200000000000003 111.347 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.7 t -96.11 135.1 22.9 Favored Pre-proline 0 N--CA 1.427 -1.586 0 N-CA-C 109.62 -0.511 . . . . 73.200000000000003 109.62 -177.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -63.64 134.43 44.16 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 121.903 1.736 . . . . 75.409999999999997 109.588 174.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -102.95 141.73 23.08 Favored Pre-proline 0 C--N 1.284 -2.266 0 N-CA-C 109.087 -0.708 . . . . 75.230000000000004 109.087 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -38.69 115.1 0.2 Allowed 'Trans proline' 0 C--N 1.368 1.562 0 C-N-CA 124.334 3.356 . . . . 74.010000000000005 113.056 -176.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -64.83 122.45 16.96 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.83 -1.077 . . . . 65.409999999999997 110.848 -178.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.1 p -86.22 119.61 34.68 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 CA-C-N 115.305 -0.862 . . . . 72.319999999999993 111.221 -177.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -121.6 140.8 51.79 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 107.262 -1.385 . . . . 75.310000000000002 107.262 178.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.0 t -85.17 136.57 33.48 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 108.606 -0.887 . . . . 64.310000000000002 108.606 -178.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.8 p -93.52 16.35 13.83 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 121.695 0.76 . . . . 74.400000000000006 110.452 -179.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 18.3 m -79.5 97.28 6.37 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 115.295 -0.866 . . . . 64.230000000000004 112.004 -177.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.8 m . . . . . 0 C--N 1.305 -1.332 0 N-CA-C 107.922 -1.14 . . . . 74.329999999999998 107.922 174.133 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.033 0 N-CA-C 109.996 -1.242 . . . . 45.409999999999997 109.996 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 12.9 m -101.53 162.93 12.54 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 108.2 -1.037 . . . . 74.329999999999998 108.2 -179.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -137.97 164.54 28.77 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.398 -0.593 . . . . 65.239999999999995 109.398 -177.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.6 pp -134.89 160.01 39.63 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 120.825 0.345 . . . . 74.120000000000005 111.827 -177.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.6 pp -128.45 146.71 50.72 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 116.512 -0.313 . . . . 74.409999999999997 110.44 178.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 47.7 t -126.65 122.34 60.59 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 N-CA-C 108.314 -0.995 . . . . 74.0 108.314 178.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 19.6 t -93.35 118.1 38.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 N-CA-C 108.669 -0.863 . . . . 73.120000000000005 108.669 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -89.52 -31.81 17.47 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 116.079 -0.51 . . . . 63.399999999999999 111.047 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 27.9 tpt180 -156.99 129.3 7.4 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.308 -0.405 . . . . 72.439999999999998 110.147 178.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 139.71 136.05 3.32 Favored Glycine 0 N--CA 1.422 -2.277 0 CA-C-N 115.743 -0.662 . . . . 71.25 112.542 176.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -59.98 -9.07 9.07 Favored 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 124.226 3.284 . . . . 74.430000000000007 111.894 175.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.573 ' ND2' ' HB2' ' A' ' 80' ' ' LEU . 20.6 t-20 -35.16 -50.75 0.53 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 127.764 2.426 . . . . 72.129999999999995 109.245 168.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -169.67 -58.14 0.02 OUTLIER 'General case' 0 CA--C 1.504 -0.793 0 CA-C-N 115.511 -0.768 . . . . 64.310000000000002 108.963 176.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.08 30.12 55.8 Favored Glycine 0 C--N 1.318 -0.42 0 N-CA-C 110.342 -1.103 . . . . 72.420000000000002 110.342 -177.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -142.58 -175.53 4.51 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 108.727 -0.842 . . . . 54.240000000000002 108.727 -176.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 16.6 ptt-85 -135.54 137.13 41.74 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.191 -0.67 . . . . 71.230000000000004 109.191 178.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -156.51 154.7 30.75 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.59 -0.277 . . . . 71.349999999999994 111.074 -179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.1 tt -96.19 139.72 31.93 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.495 -0.775 . . . . 71.219999999999999 110.424 -178.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.2 mp -110.39 126.94 54.81 Favored 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 123.996 0.918 . . . . 60.420000000000002 108.87 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -139.04 24.08 2.56 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 121.769 0.795 . . . . 74.530000000000001 109.957 177.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -90.44 146.81 35.22 Favored Pre-proline 0 C--N 1.315 -0.92 0 N-CA-C 108.132 -1.062 . . . . 75.409999999999997 108.132 178.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -56.71 -45.42 36.94 Favored 'Trans proline' 0 C--N 1.361 1.228 0 C-N-CA 122.956 2.437 . . . . 74.109999999999999 111.664 -177.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 90.2 m -136.1 97.41 3.6 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 115.054 -0.975 . . . . 75.140000000000001 110.238 177.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 21.7 m -88.07 114.15 24.41 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.359 -1.348 . . . . 63.329999999999998 107.359 177.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.2 m -100.25 120.14 39.45 Favored 'General case' 0 C--O 1.25 1.131 0 C-N-CA 120.622 -0.431 . . . . 74.129999999999995 110.65 -176.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.447 ' CB ' HD22 ' A' ' 80' ' ' LEU . . . -98.01 129.72 44.87 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 123.99 0.916 . . . . 73.150000000000006 110.734 -177.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.456 ' O ' ' HA ' ' A' ' 79' ' ' PHE . . . -178.43 -106.22 0.2 Allowed Glycine 0 C--O 1.242 0.65 0 N-CA-C 110.439 -1.064 . . . . 75.299999999999997 110.439 178.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.426 ' HG2' HG21 ' A' ' 85' ' ' VAL . 18.0 mmm180 -131.38 -81.91 0.52 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.152 0.581 . . . . 74.239999999999995 110.218 174.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.42 ' HB3' ' HD3' ' A' ' 74' ' ' PRO . 10.8 t60 -150.78 -61.29 0.02 OUTLIER Pre-proline 0 CA--C 1.553 1.08 0 CA-C-O 118.867 -0.587 . . . . 52.100000000000001 111.838 -177.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.42 ' HD3' ' HB3' ' A' ' 73' ' ' HIS . 83.3 Cg_exo -50.28 -37.89 50.76 Favored 'Trans proline' 0 C--N 1.374 1.899 0 C-N-CA 122.514 2.142 . . . . 62.420000000000002 114.781 179.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.579 ' OE2' ' HD2' ' A' ' 87' ' ' ARG . 45.5 mt-10 -109.42 2.62 20.72 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 112.657 0.614 . . . . 75.010000000000005 112.657 -177.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 36.1 p -148.88 -175.31 4.9 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.119 -1.033 . . . . 75.010000000000005 113.023 -171.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -102.79 -42.29 5.91 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.684 0.754 . . . . 64.400000000000006 110.055 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 21.5 pt -118.91 153.17 21.19 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 115.747 -0.66 . . . . 71.329999999999998 111.087 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.456 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 40.7 p90 -105.83 129.26 54.04 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.036 -0.727 . . . . 73.420000000000002 109.036 177.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.573 ' HB2' ' ND2' ' A' ' 56' ' ' ASN . 1.4 pt? -156.2 6.27 0.19 Allowed 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 113.773 1.027 . . . . 45.210000000000001 113.773 -175.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -122.62 128.53 50.79 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 118.996 -1.081 . . . . 73.140000000000001 108.337 173.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -127.6 -4.11 5.96 Favored 'General case' 0 C--N 1.286 -2.159 0 CA-C-N 115.018 -0.992 . . . . 74.519999999999996 111.538 -176.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.403 ' C ' ' HG1' ' A' ' 84' ' ' THR . 13.1 p -87.36 -37.52 11.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 C-N-CA 119.043 -1.063 . . . . 75.510000000000005 109.374 -174.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.403 ' HG1' ' C ' ' A' ' 83' ' ' VAL . 23.3 m -171.8 81.98 0.07 Allowed 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.08 -1.082 . . . . 70.049999999999997 108.08 -178.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.426 HG21 ' HG2' ' A' ' 72' ' ' ARG . 8.9 p -82.91 104.56 11.72 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.366 0 C-N-CA 116.535 -2.066 . . . . 73.030000000000001 109.647 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 58.2 m -76.75 -44.77 31.76 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 113.972 -1.467 . . . . 72.519999999999996 112.212 -175.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.579 ' HD2' ' OE2' ' A' ' 75' ' ' GLU . 13.7 mmt180 -166.15 -167.04 0.98 Allowed 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 105.083 -2.191 . . . . 74.209999999999994 105.083 -176.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.78 126.61 20.62 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 106.55 -1.648 . . . . 74.109999999999999 106.55 166.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.402 ' NE2' ' HB ' ' A' ' 130' ' ' ILE . 40.6 t60 -92.83 -49.56 6.0 Favored 'General case' 0 C--N 1.284 -2.269 0 CA-C-N 115.501 -0.772 . . . . 62.340000000000003 111.845 -164.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -139.66 142.65 36.97 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 120.296 -0.562 . . . . 72.450000000000003 110.362 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -117.23 127.3 53.96 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 109.136 -0.69 . . . . 73.299999999999997 109.136 176.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -108.72 112.28 24.5 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 106.827 -1.546 . . . . 72.340000000000003 106.827 176.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 20.0 mtm180 -123.74 124.67 43.23 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 109.426 -0.583 . . . . 73.239999999999995 109.426 -177.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.488 ' O ' HD11 ' A' ' 94' ' ' ILE . 2.8 pp -115.47 122.48 69.41 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.222 0 CA-C-O 121.76 0.79 . . . . 75.099999999999994 112.041 -175.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -119.08 145.65 45.74 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 107.018 -1.475 . . . . 71.230000000000004 107.018 177.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -54.81 -29.7 55.32 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 122.641 0.377 . . . . 61.130000000000003 111.937 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -80.45 -46.69 7.27 Favored Glycine 0 N--CA 1.43 -1.706 0 CA-C-O 119.692 -0.504 . . . . 64.540000000000006 112.34 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -144.99 142.76 30.08 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 117.211 0.505 . . . . 74.430000000000007 110.472 -179.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -95.67 114.79 26.57 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 106.64 -1.615 . . . . 72.140000000000001 106.64 176.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -119.61 116.25 25.64 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.332 0.587 . . . . 73.129999999999995 112.343 -170.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 5.6 p -105.88 124.44 61.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 108.265 -1.013 . . . . 74.150000000000006 108.265 172.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 33.8 t -111.66 115.01 48.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 CA-C-N 115.869 -0.605 . . . . 72.030000000000001 109.435 -176.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.56 ' HB3' ' CB ' ' A' ' 110' ' ' THR . 4.9 m-20 -85.41 109.69 18.61 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 114.796 -1.093 . . . . 74.430000000000007 108.855 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 12.3 m -118.3 16.83 7.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 111.95 0.352 . . . . 73.109999999999999 111.95 -176.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -114.22 48.43 0.94 Allowed Glycine 0 C--O 1.241 0.589 0 N-CA-C 110.771 -0.932 . . . . 64.010000000000005 110.771 177.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 6.9 m -65.52 -22.58 66.73 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 124.126 0.97 . . . . 75.010000000000005 112.425 -175.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -58.77 -42.14 88.26 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.209 0.528 . . . . 74.329999999999998 110.296 177.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -76.94 -52.9 8.59 Favored 'General case' 0 CA--C 1.485 -1.554 0 N-CA-C 106.456 -1.683 . . . . 73.019999999999996 106.456 175.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 123.91 103.0 1.55 Allowed Glycine 0 N--CA 1.406 -3.31 0 CA-C-N 113.892 -1.504 . . . . 70.329999999999998 110.116 -177.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.56 ' CB ' ' HB3' ' A' ' 103' ' ' ASP . 1.5 p -92.82 119.16 31.88 Favored 'General case' 0 N--CA 1.409 -2.525 0 N-CA-C 107.501 -1.296 . . . . 72.200000000000003 107.501 175.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.411 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 65.6 m-85 -121.99 139.44 53.68 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-O 121.554 0.692 . . . . 73.510000000000005 112.506 -172.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.678 ' HB ' ' NE ' ' A' ' 117' ' ' ARG . 7.1 p -104.87 111.71 35.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 106.333 -1.728 . . . . 71.310000000000002 106.333 170.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 46.7 m-80 54.23 35.7 23.28 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.922 0.489 . . . . 72.299999999999997 111.295 -177.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 49.2 mtm-85 83.81 3.09 0.88 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.676 1.59 . . . . 74.310000000000002 115.257 178.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -110.47 139.5 21.6 Favored Pre-proline 0 C--N 1.314 -0.957 0 C-N-CA 119.645 -0.822 . . . . 70.099999999999994 110.069 175.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.27 142.32 97.92 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 122.869 2.38 . . . . 74.200000000000003 113.767 -175.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.678 ' NE ' ' HB ' ' A' ' 112' ' ' VAL . 13.1 ptt180 -147.14 163.94 34.72 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.842 -0.617 . . . . 75.030000000000001 111.744 176.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.431 ' HA ' ' HB2' ' A' ' 103' ' ' ASP . 11.1 m120 -124.75 -17.86 5.78 Favored 'General case' 0 CA--C 1.513 -0.452 0 O-C-N 124.094 0.871 . . . . 75.209999999999994 111.959 173.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -155.42 138.28 15.33 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.162 -0.681 . . . . 74.140000000000001 109.162 174.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 21.6 tm0? -141.47 149.28 40.75 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.174 -1.047 . . . . 71.140000000000001 108.174 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.3 p -101.83 113.76 39.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 109.389 -0.597 . . . . 74.439999999999998 109.389 176.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -32.91 116.95 0.24 Allowed 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 115.796 1.776 . . . . 74.409999999999997 115.796 -172.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -118.3 145.48 45.04 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 106.795 -1.557 . . . . 65.010000000000005 106.795 172.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 15.0 t -89.46 130.94 35.72 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 119.766 -0.774 . . . . 74.099999999999994 109.856 -178.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 94.27 19.02 34.27 Favored Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 110.88 -0.888 . . . . 74.409999999999997 110.88 -178.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -96.66 142.13 29.07 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 108.538 -0.912 . . . . 71.109999999999999 108.538 -178.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -109.5 127.32 54.36 Favored 'General case' 0 N--CA 1.422 -1.867 0 CA-C-O 122.086 0.946 . . . . 62.409999999999997 111.127 179.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.512 HG12 ' NH2' ' A' ' 117' ' ' ARG . 25.6 mt -106.7 125.65 62.61 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.285 0 CA-C-N 114.477 -1.238 . . . . 73.319999999999993 108.043 -177.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.411 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 51.0 tt0 -105.42 111.9 24.79 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 107.313 -1.365 . . . . 73.099999999999994 107.313 172.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.435 HD11 ' ND2' ' A' ' 56' ' ' ASN . 17.3 pt -102.05 101.0 11.51 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 N-CA-C 108.593 -0.892 . . . . 75.450000000000003 108.593 177.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 73.62 -90.99 0.65 Allowed Glycine 0 N--CA 1.419 -2.463 0 CA-C-N 114.866 -1.061 . . . . 63.240000000000002 110.757 -177.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 45.0 tttp -131.88 3.53 4.1 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 121.117 0.484 . . . . 75.129999999999995 110.345 -176.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -101.61 144.35 30.45 Favored 'General case' 0 C--N 1.311 -1.069 0 O-C-N 121.918 -0.489 . . . . 74.239999999999995 109.743 -176.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -106.85 121.04 43.62 Favored 'General case' 0 C--O 1.247 0.95 0 N-CA-C 107.711 -1.218 . . . . 75.349999999999994 107.711 -177.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 42.9 tp -123.89 142.42 51.15 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 114.993 -1.003 . . . . 73.349999999999994 108.362 -176.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 11.1 p -117.09 130.51 71.88 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 N-CA-C 107.553 -1.277 . . . . 71.5 107.553 174.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -111.47 130.27 55.77 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 116.233 -0.44 . . . . 71.319999999999993 110.055 -173.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -127.94 170.16 13.16 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.92 -0.77 . . . . 64.239999999999995 108.92 -178.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -89.53 164.61 14.72 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 109.031 -0.729 . . . . 53.329999999999998 109.031 176.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -82.87 142.96 21.96 Favored Glycine 0 N--CA 1.435 -1.394 0 N-CA-C 109.723 -1.351 . . . . 63.450000000000003 109.723 177.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo . . . . . 0 N--CA 1.444 -1.423 0 CA-C-N 119.608 1.704 . . . . 63.329999999999998 111.377 179.987 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 . . . . . 0 CA--C 1.501 -0.927 0 CA-C-O 120.971 0.415 . . . . 74.340000000000003 110.187 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -119.95 101.1 0.81 Allowed Glycine 0 N--CA 1.425 -2.045 0 N-CA-C 111.107 -0.797 . . . . 64.25 111.107 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.2 m -78.78 124.03 85.15 Favored Pre-proline 0 C--N 1.306 -1.29 0 N-CA-C 108.555 -0.906 . . . . 73.530000000000001 108.555 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -60.49 128.02 24.65 Favored 'Trans proline' 0 C--O 1.252 1.19 0 C-N-CA 122.363 2.042 . . . . 74.200000000000003 111.601 178.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -100.98 131.67 23.02 Favored Pre-proline 0 C--N 1.299 -1.604 0 CA-C-N 115.919 -0.582 . . . . 72.510000000000005 110.188 -178.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -65.1 127.18 17.85 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 121.982 1.788 . . . . 74.340000000000003 111.225 178.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -82.12 104.91 12.8 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.844 -1.169 . . . . 64.209999999999994 107.844 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 23.5 t -111.83 148.95 14.65 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 N-CA-C 107.459 -1.311 . . . . 73.129999999999995 107.459 -178.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -82.47 121.57 26.93 Favored 'General case' 0 N--CA 1.408 -2.533 0 N-CA-C 106.143 -1.799 . . . . 64.010000000000005 106.143 170.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 58.4 m -60.53 104.28 0.32 Allowed 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.78 -0.645 . . . . 75.519999999999996 109.642 -177.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 18.2 m -81.25 94.64 6.75 Favored 'General case' 0 N--CA 1.415 -2.189 0 CA-C-N 114.781 -1.1 . . . . 73.310000000000002 110.586 -174.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 21.2 m -134.35 83.68 2.05 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 114.697 -1.138 . . . . 72.209999999999994 108.221 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 39.4 t . . . . . 0 C--N 1.301 -1.533 0 N-CA-C 108.453 -0.943 . . . . 62.210000000000001 108.453 -178.275 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.488 -1.65 0 N-CA-C 107.877 -2.089 . . . . 34.539999999999999 107.877 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 10.1 m -89.47 152.12 21.63 Favored 'General case' 0 N--CA 1.422 -1.832 0 CA-C-O 121.684 0.754 . . . . 75.109999999999999 112.374 -166.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.413 ' HB3' ' O ' ' A' ' 138' ' ' LEU . . . -112.32 -164.38 0.91 Allowed 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 114.114 -1.403 . . . . 62.32 107.434 178.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.7 pp -131.07 155.4 46.98 Favored 'General case' 0 N--CA 1.438 -1.051 0 C-N-CA 120.277 -0.569 . . . . 75.140000000000001 111.96 -177.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.6 pp -132.1 141.29 49.12 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 115.771 -0.649 . . . . 74.209999999999994 109.985 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 59.8 t -119.07 126.04 75.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 109.655 -0.498 . . . . 74.209999999999994 109.655 -177.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.5 t -93.17 115.87 32.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 107.553 -1.277 . . . . 73.430000000000007 107.553 176.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.402 ' HE3' ' CG2' ' A' ' 136' ' ' VAL . 94.5 mttt -66.02 -43.93 86.23 Favored 'General case' 0 CA--C 1.496 -1.125 0 CA-C-N 115.105 -0.952 . . . . 73.0 109.088 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 30.0 tpt180 -168.9 135.13 1.75 Allowed 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.067 -1.457 . . . . 65.439999999999998 107.067 179.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.43 135.73 2.02 Favored Glycine 0 N--CA 1.42 -2.393 0 N-CA-C 109.267 -1.533 . . . . 72.310000000000002 109.267 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.542 ' HB2' ' O ' ' A' ' 81' ' ' ASP . 15.0 Cg_exo -67.52 -10.95 30.43 Favored 'Trans proline' 0 CA--C 1.53 0.307 0 C-N-CA 122.372 2.048 . . . . 73.409999999999997 112.723 -176.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.541 ' HA ' ' N ' ' A' ' 81' ' ' ASP . 29.5 p-10 -53.92 -42.36 68.67 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.708 0.803 . . . . 73.450000000000003 110.673 178.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -168.17 -47.18 0.02 OUTLIER 'General case' 0 N--CA 1.444 -0.732 0 O-C-N 123.411 0.444 . . . . 64.129999999999995 110.769 178.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.28 64.73 2.86 Favored Glycine 0 C--O 1.239 0.466 0 N-CA-C 110.727 -0.949 . . . . 74.219999999999999 110.727 -176.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -166.45 -178.49 4.49 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 107.449 -1.315 . . . . 72.5 107.449 -177.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 13.3 ptt180 -112.64 144.97 41.22 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 109.199 -0.667 . . . . 75.25 109.199 175.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -132.33 154.31 49.86 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 116.372 -0.377 . . . . 70.319999999999993 110.553 -177.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.1 tt -111.48 140.27 46.22 Favored 'General case' 0 C--N 1.28 -2.439 0 N-CA-C 103.544 -2.762 . . . . 71.450000000000003 103.544 173.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.8 mp -70.38 113.74 7.82 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 118.555 -1.258 . . . . 72.010000000000005 109.115 -176.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -72.36 -60.59 2.16 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 114.081 -1.418 . . . . 62.43 109.632 -173.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -103.02 132.92 20.66 Favored Pre-proline 0 N--CA 1.419 -1.992 0 CA-C-N 115.168 -0.924 . . . . 72.109999999999999 109.39 -178.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -37.6 -46.94 1.89 Allowed 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 124.9 3.733 . . . . 75.219999999999999 113.515 175.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 87.3 m -106.61 96.44 6.45 Favored 'General case' 0 N--CA 1.423 -1.817 0 N-CA-C 108.189 -1.041 . . . . 64.340000000000003 108.189 173.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.428 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 22.3 m -89.16 114.61 25.92 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 108.404 -0.961 . . . . 74.010000000000005 108.404 -179.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.4 t -96.85 120.08 36.53 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.583 0.706 . . . . 72.329999999999998 109.86 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -110.28 148.94 30.92 Favored 'General case' 0 N--CA 1.428 -1.569 0 CA-C-N 115.837 -0.62 . . . . 62.530000000000001 110.579 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 147.71 -137.82 6.78 Favored Glycine 0 CA--C 1.466 -2.994 0 N-CA-C 107.389 -2.285 . . . . 65.0 107.389 -178.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.296 4.5 ptt85 -110.94 -88.94 0.5 Allowed 'General case' 0 C--N 1.284 -2.268 0 CA-C-O 118.428 -0.796 . . . . 75.109999999999999 111.857 174.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.443 ' HB3' ' HD2' ' A' ' 74' ' ' PRO . 32.7 m170 60.63 173.74 0.05 OUTLIER Pre-proline 0 CA--C 1.559 1.298 0 CA-C-N 118.598 0.635 . . . . 73.209999999999994 110.879 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.443 ' HD2' ' HB3' ' A' ' 73' ' ' HIS . 28.4 Cg_endo -66.77 -21.74 50.75 Favored 'Trans proline' 0 CA--C 1.545 1.026 0 C-N-CA 121.394 1.396 . . . . 74.25 111.81 169.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -134.33 92.96 2.99 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-O 121.337 0.589 . . . . 73.420000000000002 110.363 -176.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 13.1 m -77.38 117.32 18.76 Favored 'General case' 0 C--N 1.279 -2.494 0 N-CA-C 107.084 -1.45 . . . . 73.319999999999993 107.084 172.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -70.99 -35.06 71.96 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 108.522 -0.918 . . . . 73.400000000000006 108.522 -178.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.7 pp -130.15 162.47 37.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 106.14 -1.8 . . . . 74.150000000000006 106.14 165.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -101.33 136.64 40.85 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 113.974 1.102 . . . . 74.420000000000002 113.974 -170.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.451 ' HA ' ' HB2' ' A' ' 56' ' ' ASN . 94.4 mt -128.91 150.18 50.47 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 106.971 -1.492 . . . . 73.239999999999995 106.971 175.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.542 ' O ' ' HB2' ' A' ' 55' ' ' PRO . 16.9 t70 -156.93 94.59 1.44 Allowed 'General case' 0 C--N 1.288 -2.071 0 O-C-N 124.0 0.812 . . . . 72.519999999999996 109.425 -177.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.447 ' O ' HG11 ' A' ' 85' ' ' VAL . 14.1 t70 -157.82 152.92 25.62 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 107.802 -1.185 . . . . 72.030000000000001 107.802 175.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.6 p -61.31 -27.5 41.99 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.061 0 C-N-CA 122.893 0.477 . . . . 74.349999999999994 112.202 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 17.6 p -96.77 21.85 8.96 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 113.88 1.067 . . . . 72.430000000000007 113.88 -177.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.447 HG11 ' O ' ' A' ' 82' ' ' ASP . 13.9 p -82.06 124.74 39.45 Favored 'Isoleucine or valine' 0 C--O 1.249 1.038 0 CA-C-O 122.044 0.925 . . . . 74.239999999999995 110.266 179.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 16.2 m -80.9 163.32 23.45 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.805 -0.813 . . . . 70.549999999999997 108.805 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.49 -43.21 97.26 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 119.677 -0.809 . . . . 73.120000000000005 108.931 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -110.4 110.81 21.72 Favored 'General case' 0 N--CA 1.419 -2.02 0 N-CA-C 102.565 -3.124 . . . . 74.319999999999993 102.565 176.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 14.6 t60 -110.62 -85.88 0.55 Allowed 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 117.878 -1.529 . . . . 73.25 112.398 -172.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -126.6 123.82 38.51 Favored 'General case' 0 C--N 1.292 -1.932 0 C-N-CA 120.167 -0.613 . . . . 55.009999999999998 109.722 -175.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -110.04 127.53 54.89 Favored 'General case' 0 C--N 1.275 -2.642 0 C-N-CA 118.938 -1.105 . . . . 71.439999999999998 110.419 177.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.428 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 53.0 m-85 -103.41 113.64 27.3 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 114.61 -1.177 . . . . 75.409999999999997 108.116 -176.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 48.6 mtm180 -108.78 122.6 47.5 Favored 'General case' 0 C--N 1.288 -2.109 0 N-CA-C 109.632 -0.507 . . . . 74.450000000000003 109.632 178.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.2 116.95 54.09 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.495 0 N-CA-C 106.888 -1.523 . . . . 74.319999999999993 106.888 175.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -117.8 146.06 44.09 Favored 'General case' 0 C--N 1.278 -2.533 0 CA-C-N 113.575 -1.648 . . . . 74.140000000000001 106.6 178.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -56.1 -22.02 25.68 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 112.396 0.517 . . . . 72.230000000000004 112.396 -177.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -95.95 -33.6 6.28 Favored Glycine 0 N--CA 1.435 -1.368 0 C-N-CA 121.042 -0.599 . . . . 60.119999999999997 113.611 178.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -148.16 144.3 27.67 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 117.494 0.647 . . . . 73.519999999999996 111.687 -176.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.476 ' HB3' ' SD ' ' A' ' 122' ' ' MET . 5.1 m-85 -106.67 114.3 28.32 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 106.986 -1.487 . . . . 74.299999999999997 106.986 176.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -132.37 135.12 45.92 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.43 -0.794 . . . . 70.129999999999995 111.901 -176.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.5 p -114.53 119.53 61.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 109.066 -0.716 . . . . 75.299999999999997 109.066 176.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 50.0 t -110.83 114.09 46.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 108.168 -1.049 . . . . 73.409999999999997 108.168 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -105.43 127.44 52.99 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-O 121.235 0.54 . . . . 63.350000000000001 110.556 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 28.7 m -116.67 12.61 7.55 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.176 0 CA-C-N 115.052 -0.976 . . . . 62.240000000000002 109.51 174.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -100.89 52.5 0.92 Allowed Glycine 0 N--CA 1.437 -1.284 0 N-CA-C 110.596 -1.001 . . . . 60.140000000000001 110.596 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.5 m -60.96 -17.16 50.06 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.201 1.4 . . . . 74.040000000000006 112.331 -176.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 82.6 mt -58.3 -39.9 80.56 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.698 0.761 . . . . 75.239999999999995 109.395 174.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -90.64 -48.99 6.73 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 106.706 -1.59 . . . . 73.530000000000001 106.706 176.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.66 94.0 1.24 Allowed Glycine 0 N--CA 1.442 -0.948 0 CA-C-N 114.767 -1.106 . . . . 63.140000000000001 113.982 175.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 42.0 m -93.72 120.09 33.55 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 109.208 -0.664 . . . . 72.420000000000002 109.208 175.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -135.65 168.74 18.7 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 107.923 -1.14 . . . . 74.010000000000005 107.923 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 52.5 t -106.84 141.67 21.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 107.932 -1.136 . . . . 74.319999999999993 107.932 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -51.48 -38.11 52.25 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 123.88 0.872 . . . . 74.329999999999998 111.563 178.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 53.5 ttt180 -84.06 -36.46 23.04 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 116.072 -0.513 . . . . 75.329999999999998 111.343 176.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 21.3 tp10 -124.2 114.21 27.73 Favored Pre-proline 0 C--N 1.306 -1.295 0 N-CA-C 112.125 0.417 . . . . 72.150000000000006 112.125 -169.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -78.75 38.82 0.74 Allowed 'Trans proline' 0 CA--C 1.547 1.146 0 C-N-CA 123.409 2.739 . . . . 64.140000000000001 113.206 -178.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 64.8 mtm180 -109.45 145.06 36.81 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 116.197 -0.456 . . . . 74.219999999999999 110.286 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -71.28 -38.64 71.82 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 123.941 0.776 . . . . 70.25 110.992 -172.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -115.04 136.9 52.62 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 107.13 -1.433 . . . . 71.409999999999997 107.13 173.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 -142.58 150.85 40.88 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 114.518 1.303 . . . . 72.140000000000001 114.518 -177.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.1 p -79.88 128.82 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.915 0 N-CA-C 105.252 -2.129 . . . . 73.120000000000005 105.252 167.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.476 ' SD ' ' HB3' ' A' ' 99' ' ' PHE . 59.4 mtt -60.59 136.68 58.13 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 123.29 0.636 . . . . 74.319999999999993 112.095 -171.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.416 HE21 ' HB2' ' A' ' 126' ' ' ASP . 0.2 OUTLIER -108.39 125.06 51.31 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 105.435 -2.061 . . . . 74.329999999999998 105.435 178.065 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 21.7 p -78.89 115.39 18.55 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.222 0.534 . . . . 75.310000000000002 111.507 -176.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 101.53 13.77 31.77 Favored Glycine 0 N--CA 1.432 -1.606 0 C-N-CA 120.758 -0.734 . . . . 63.200000000000003 112.505 179.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.416 ' HB2' HE21 ' A' ' 123' ' ' GLN . 8.1 t70 -116.6 176.33 5.16 Favored 'General case' 0 C--O 1.248 0.986 0 C-N-CA 119.531 -0.868 . . . . 64.530000000000001 109.476 178.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.531 ' OE1' ' HD3' ' A' ' 134' ' ' ARG . 40.6 tt0 -110.48 135.11 51.65 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-O 121.296 0.57 . . . . 72.430000000000007 109.984 -171.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 67.4 mt -103.37 122.95 56.55 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.406 0 N-CA-C 107.889 -1.152 . . . . 75.409999999999997 107.889 178.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -97.32 112.45 24.26 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 115.913 -0.585 . . . . 74.049999999999997 109.454 -179.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.1 pt -102.01 98.21 6.57 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.343 0 N-CA-C 107.549 -1.278 . . . . 74.209999999999994 107.549 175.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 75.08 -113.86 4.12 Favored Glycine 0 N--CA 1.421 -2.315 0 N-CA-C 108.198 -1.961 . . . . 70.120000000000005 108.198 -172.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -124.66 6.27 8.19 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 120.971 0.415 . . . . 72.329999999999998 110.397 175.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -98.78 151.64 20.57 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 109.224 -0.658 . . . . 74.340000000000003 109.224 174.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.531 ' HD3' ' OE1' ' A' ' 127' ' ' GLU . 77.9 mtt-85 -117.85 132.5 56.42 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 115.104 1.52 . . . . 74.439999999999998 115.104 -164.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 5.6 tt -124.3 136.33 54.03 Favored 'General case' 0 C--O 1.195 -1.773 0 CA-C-N 114.008 -1.451 . . . . 75.0 107.466 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.402 ' CG2' ' HE3' ' A' ' 52' ' ' LYS . 25.9 t -112.58 137.63 44.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.941 -0.763 . . . . 61.539999999999999 108.941 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -107.26 117.36 33.86 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 110.014 -0.365 . . . . 71.25 110.014 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.413 ' O ' ' HB3' ' A' ' 47' ' ' ALA . 2.5 mm? -117.34 143.87 45.5 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.35 0.595 . . . . 72.439999999999998 110.976 -177.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -97.57 91.27 5.35 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.415 -0.957 . . . . 65.329999999999998 108.415 177.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -107.16 -72.28 0.79 Allowed Glycine 0 N--CA 1.43 -1.727 0 CA-C-N 115.358 -0.837 . . . . 42.109999999999999 111.176 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo . . . . . 0 N--CA 1.446 -1.28 0 C-N-CA 121.935 1.757 . . . . 72.109999999999999 112.441 179.717 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 55.7 t30 . . . . . 0 N--CA 1.45 -0.455 0 N-CA-C 109.317 -0.623 . . . . 72.200000000000003 109.317 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -73.85 106.15 1.96 Allowed Glycine 0 N--CA 1.436 -1.305 0 N-CA-C 110.66 -0.976 . . . . 72.010000000000005 110.66 178.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.1 t -98.02 126.73 39.28 Favored Pre-proline 0 C--N 1.296 -1.721 0 N-CA-C 110.122 -0.325 . . . . 72.209999999999994 110.122 -179.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -66.3 128.37 19.25 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.388 2.059 . . . . 71.540000000000006 111.205 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -90.77 131.68 36.93 Favored Pre-proline 0 C--N 1.294 -1.808 0 N-CA-C 108.898 -0.779 . . . . 71.010000000000005 108.898 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_exo -49.14 129.36 21.77 Favored 'Trans proline' 0 C--O 1.239 0.541 0 C-N-CA 123.508 2.805 . . . . 75.530000000000001 114.707 -174.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -110.18 107.95 17.93 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.007 -1.849 . . . . 73.450000000000003 106.007 174.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.6 p -114.65 107.49 23.0 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 CA-C-O 122.01 0.91 . . . . 70.510000000000005 111.7 -175.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -139.57 140.95 37.2 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 105.676 -1.972 . . . . 65.420000000000002 105.676 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 67.8 m -150.71 95.57 2.24 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 109.897 -0.408 . . . . 71.340000000000003 109.897 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.9 p -113.33 104.18 12.06 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-O 121.363 0.601 . . . . 74.0 111.547 177.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 39.9 t -164.9 115.2 1.14 Allowed 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 107.498 -1.297 . . . . 72.530000000000001 107.498 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.8 p . . . . . 0 C--N 1.309 -1.194 0 N-CA-C 109.792 -0.447 . . . . 73.319999999999993 109.792 179.589 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.476 ' HA2' ' O ' ' A' ' 141' ' ' PRO . . . . . . . . 0 CA--C 1.48 -2.154 0 N-CA-C 106.015 -2.834 . . . . 73.040000000000006 106.015 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 13.6 m -89.98 164.79 14.4 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 113.56 -1.32 . . . . 70.420000000000002 111.264 -169.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -92.91 164.58 13.26 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 116.015 -0.539 . . . . 74.439999999999998 109.773 -179.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -133.83 155.91 48.99 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 110.261 -0.274 . . . . 75.239999999999995 110.261 -178.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.468 HD23 ' O ' ' A' ' 61' ' ' PHE . 2.7 pt? -108.79 132.77 53.66 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 107.065 -1.457 . . . . 75.439999999999998 107.065 176.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.8 t -117.68 114.66 46.13 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 N-CA-C 108.661 -0.866 . . . . 73.510000000000005 108.661 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.461 HG12 ' OD1' ' A' ' 56' ' ' ASN . 61.9 t -92.9 116.03 33.09 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 N-CA-C 107.722 -1.214 . . . . 70.219999999999999 107.722 177.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.434 ' HB3' ' HZ1' ' A' ' 52' ' ' LYS . 2.4 mmmp? -82.56 -39.12 22.75 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.381 -0.827 . . . . 71.219999999999999 108.831 -178.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.437 ' O ' ' HB3' ' A' ' 133' ' ' PHE . 72.8 ttt180 -147.86 115.65 6.4 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 115.196 -0.911 . . . . 75.400000000000006 108.94 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 175.74 134.18 1.88 Allowed Glycine 0 N--CA 1.438 -1.174 0 C-N-CA 120.127 -1.035 . . . . 72.219999999999999 113.433 176.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.55 -9.25 25.7 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 123.957 3.105 . . . . 64.510000000000005 111.897 175.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.461 ' OD1' HG12 ' A' ' 51' ' ' VAL . 13.2 p30 -48.54 -46.05 38.26 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.488 1.115 . . . . 72.349999999999994 111.495 177.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -171.34 -40.53 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 125.203 1.401 . . . . 75.150000000000006 107.381 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 64.6 46.35 90.34 Favored Glycine 0 CA--C 1.495 -1.192 0 N-CA-C 110.191 -1.163 . . . . 71.099999999999994 110.191 -178.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -143.11 -178.01 5.63 Favored 'General case' 0 N--CA 1.424 -1.775 0 N-CA-C 108.513 -0.921 . . . . 75.420000000000002 108.513 -173.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.403 ' HA ' ' O ' ' A' ' 49' ' ' LEU . 11.2 ptt180 -141.49 131.94 25.27 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 123.416 0.447 . . . . 75.530000000000001 109.969 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.468 ' O ' HD23 ' A' ' 49' ' ' LEU . 30.7 p90 -154.36 154.96 34.19 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 112.415 0.524 . . . . 71.540000000000006 112.415 -177.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.2 tt -81.08 139.69 35.54 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.019 -0.991 . . . . 72.230000000000004 110.874 -176.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -101.71 115.77 31.27 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 110.253 -0.277 . . . . 72.420000000000002 110.253 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -111.31 -4.45 14.93 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 122.393 1.092 . . . . 72.129999999999995 108.392 177.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -78.73 123.6 85.31 Favored Pre-proline 0 C--N 1.314 -0.959 0 CA-C-N 114.587 -1.188 . . . . 74.120000000000005 109.98 -175.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.02 -27.71 85.08 Favored 'Trans proline' 0 C--N 1.361 1.225 0 C-N-CA 122.878 2.385 . . . . 73.430000000000007 111.308 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 91.8 m -134.93 116.63 14.94 Favored 'General case' 0 N--CA 1.408 -2.535 0 N-CA-C 107.13 -1.433 . . . . 71.310000000000002 107.13 173.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 88.9 m -105.24 114.4 28.56 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 108.969 -0.752 . . . . 73.420000000000002 108.969 -179.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 28.3 p -82.67 130.24 35.09 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 115.35 -0.841 . . . . 74.219999999999999 111.577 -178.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -108.58 115.5 30.21 Favored 'General case' 0 C--O 1.252 1.212 0 CA-C-O 121.385 0.612 . . . . 70.109999999999999 110.947 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 165.74 -158.5 31.41 Favored Glycine 0 CA--C 1.487 -1.691 0 N-CA-C 106.046 -2.822 . . . . 74.040000000000006 106.046 -179.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.8 ttp180 -159.32 78.18 0.72 Allowed 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 119.093 1.446 . . . . 75.239999999999995 111.417 174.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.416 ' HB3' ' HD3' ' A' ' 74' ' ' PRO . 13.0 t60 -175.53 -77.98 0.0 OUTLIER Pre-proline 0 CA--C 1.556 1.176 0 N-CA-C 113.392 0.886 . . . . 74.329999999999998 113.392 175.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.416 ' HD3' ' HB3' ' A' ' 73' ' ' HIS . 48.2 Cg_endo -66.71 -41.87 10.14 Favored 'Trans proline' 0 C--N 1.394 2.966 0 CA-C-N 120.839 1.335 . . . . 75.420000000000002 113.372 -169.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -166.71 114.54 0.85 Allowed 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 102.582 -3.118 . . . . 52.350000000000001 102.582 -178.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 19.7 m -136.33 103.07 5.17 Favored 'General case' 0 C--N 1.26 -3.319 0 CA-C-N 115.888 -0.597 . . . . 73.120000000000005 109.647 -178.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -74.07 -31.98 63.07 Favored 'General case' 0 CA--C 1.493 -1.227 0 CA-C-N 115.218 -0.901 . . . . 75.219999999999999 109.363 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 39.0 pt -119.75 137.82 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.871 0 N-CA-C 107.086 -1.45 . . . . 75.319999999999993 107.086 170.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -85.73 124.14 31.91 Favored 'General case' 0 C--N 1.284 -2.272 0 N-CA-C 108.145 -1.057 . . . . 73.140000000000001 108.145 179.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.414 ' HA ' ' HB2' ' A' ' 56' ' ' ASN . 35.4 tp -122.02 155.58 35.3 Favored 'General case' 0 N--CA 1.414 -2.248 0 CA-C-N 115.929 -0.578 . . . . 74.439999999999998 109.712 -174.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.419 ' CB ' ' HA ' ' A' ' 56' ' ' ASN . 9.8 t70 -168.94 150.32 4.57 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 104.583 -2.376 . . . . 64.230000000000004 104.583 178.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -169.41 164.28 10.61 Favored 'General case' 0 C--N 1.26 -3.298 0 N-CA-C 106.647 -1.612 . . . . 73.230000000000004 106.647 -176.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.8 m -63.2 -23.72 34.05 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 O-C-N 123.309 0.381 . . . . 73.319999999999993 111.367 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.507 ' HB ' ' HB2' ' A' ' 108' ' ' ASN . 45.8 m -144.2 70.77 1.3 Allowed 'General case' 0 N--CA 1.423 -1.793 0 CA-C-O 122.39 1.091 . . . . 72.109999999999999 109.802 175.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.5 p -95.84 140.19 17.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 114.499 -1.228 . . . . 74.049999999999997 110.466 -177.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 24.1 t -92.72 159.95 15.19 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 110.054 -0.35 . . . . 75.400000000000006 110.054 178.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 4.5 tpp180 -57.88 -47.97 81.19 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.864 0.865 . . . . 71.439999999999998 109.024 177.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -119.08 86.93 2.64 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 104.685 -2.339 . . . . 75.519999999999996 104.685 174.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 25.5 t60 -81.39 -52.49 7.22 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.962 -0.563 . . . . 71.140000000000001 111.204 -172.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.97 160.6 42.16 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 120.02 -0.672 . . . . 72.239999999999995 110.239 -177.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -131.18 127.22 37.51 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 108.345 -0.983 . . . . 75.310000000000002 108.345 174.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -106.74 123.91 48.84 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 109.692 -0.484 . . . . 74.219999999999999 109.692 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -113.74 136.33 52.97 Favored 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 107.858 -1.164 . . . . 74.319999999999993 107.858 177.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 12.5 tt -116.1 131.44 68.6 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.236 0 C-N-CA 119.522 -0.871 . . . . 75.030000000000001 109.844 -178.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -109.4 145.97 35.23 Favored 'General case' 0 C--N 1.282 -2.359 0 N-CA-C 105.171 -2.159 . . . . 73.540000000000006 105.171 175.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -54.75 -22.94 15.66 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 113.226 0.825 . . . . 75.140000000000001 113.226 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -117.07 5.73 17.82 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 120.321 -0.943 . . . . 61.310000000000002 114.094 177.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -162.44 148.49 12.86 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 118.778 1.289 . . . . 62.299999999999997 111.642 -177.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -117.79 114.51 23.39 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.491 -0.929 . . . . 73.340000000000003 108.491 -176.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -132.25 135.13 46.06 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 119.638 -0.825 . . . . 61.409999999999997 112.498 -177.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.2 p -121.83 131.36 73.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-N 115.883 -0.599 . . . . 71.409999999999997 110.243 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.2 m -106.37 134.77 47.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-O 120.905 0.383 . . . . 70.120000000000005 110.907 178.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -90.0 108.95 20.03 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.283 -1.377 . . . . 74.439999999999998 107.283 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 21.2 m -113.52 11.7 8.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-N 115.942 -0.572 . . . . 74.439999999999998 111.29 -178.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -144.15 63.17 0.48 Allowed Glycine 0 N--CA 1.432 -1.584 0 N-CA-C 109.444 -1.462 . . . . 73.5 109.444 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 13.3 m -74.93 61.35 1.03 Allowed 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 123.549 0.74 . . . . 64.230000000000004 112.722 -173.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 85.4 mt -89.09 -49.11 6.95 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.467 -0.938 . . . . 74.230000000000004 108.467 176.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.507 ' HB2' ' HB ' ' A' ' 84' ' ' THR . 53.6 t30 -114.74 -33.0 5.64 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.592 -0.731 . . . . 74.310000000000002 109.506 -179.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 102.68 138.89 10.2 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.568 -0.825 . . . . 71.109999999999999 114.79 171.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.2 m -97.24 138.16 35.15 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.251 -1.018 . . . . 74.340000000000003 108.251 174.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.485 ' CE2' ' HB3' ' A' ' 116' ' ' PRO . 52.8 m-85 -130.89 151.91 50.8 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 109.321 -0.622 . . . . 72.329999999999998 109.321 -177.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.413 HG13 HE21 ' A' ' 120' ' ' GLN . 8.6 p -128.8 118.53 47.36 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 N-CA-C 108.017 -1.105 . . . . 73.209999999999994 108.017 168.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 48.82 51.8 15.25 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 116.21 -0.45 . . . . 75.230000000000004 111.563 -175.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 70.5 mtp180 74.42 -17.48 0.47 Allowed 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 124.763 1.225 . . . . 74.430000000000007 114.192 -179.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -76.07 115.04 43.17 Favored Pre-proline 0 C--O 1.247 0.952 0 CA-C-N 117.79 0.268 . . . . 63.539999999999999 111.23 -177.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.485 ' HB3' ' CE2' ' A' ' 111' ' ' TYR . 36.3 Cg_endo -91.8 102.9 0.22 Allowed 'Trans proline' 0 N--CA 1.443 -1.469 0 C-N-CA 123.141 2.561 . . . . 73.519999999999996 112.202 178.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 25.5 mtp180 -130.34 161.35 31.49 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 122.107 -0.37 . . . . 62.530000000000001 110.561 176.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -84.95 -8.94 58.55 Favored 'General case' 0 CA--C 1.496 -1.134 0 N-CA-C 113.434 0.902 . . . . 73.420000000000002 113.434 -177.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -153.42 137.9 16.77 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 105.432 -2.062 . . . . 72.420000000000002 105.432 170.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.413 HE21 HG13 ' A' ' 112' ' ' VAL . 9.0 mm100 -141.34 149.21 40.87 Favored 'General case' 0 CA--C 1.472 -2.033 0 N-CA-C 114.451 1.278 . . . . 73.219999999999999 114.451 -178.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 25.5 t -88.33 122.88 40.38 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.261 0 N-CA-C 105.878 -1.897 . . . . 72.230000000000004 105.878 174.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 52.8 mtt -70.91 139.34 50.69 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 120.85 0.357 . . . . 75.25 110.808 -178.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 60.6 tp60 -104.75 131.48 52.15 Favored 'General case' 0 N--CA 1.425 -1.723 0 N-CA-C 108.896 -0.779 . . . . 72.230000000000004 108.896 -177.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -78.51 115.6 18.33 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 115.735 -0.666 . . . . 74.200000000000003 111.177 -178.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 98.84 8.8 53.81 Favored Glycine 0 N--CA 1.438 -1.227 0 CA-C-N 115.617 -0.72 . . . . 71.439999999999998 111.687 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -125.58 -176.55 3.63 Favored 'General case' 0 C--O 1.245 0.816 0 N-CA-C 112.193 0.442 . . . . 74.120000000000005 112.193 -178.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.406 ' HG2' HG21 ' A' ' 136' ' ' VAL . 43.0 mt-10 -108.55 132.21 54.08 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 113.755 1.02 . . . . 72.340000000000003 113.755 -170.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.7 mp -114.1 120.09 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.991 0 N-CA-C 105.959 -1.867 . . . . 75.439999999999998 105.959 175.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.406 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 51.1 tt0 -103.7 122.31 44.79 Favored 'General case' 0 C--N 1.282 -2.329 0 CA-C-O 121.223 0.535 . . . . 71.140000000000001 110.264 -177.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.3 pp -103.28 98.85 7.32 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.182 0 CA-C-N 115.309 -0.86 . . . . 72.409999999999997 109.979 178.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 78.82 -106.6 2.38 Favored Glycine 0 N--CA 1.421 -2.351 0 N-CA-C 109.838 -1.305 . . . . 51.350000000000001 109.838 -176.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -111.35 -12.92 13.99 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 122.419 0.288 . . . . 74.409999999999997 111.464 177.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.437 ' HB3' ' O ' ' A' ' 53' ' ' ARG . 79.6 m-85 -97.77 151.15 20.47 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 112.605 0.594 . . . . 74.439999999999998 112.605 -172.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 20.0 mtp180 -112.49 128.3 56.29 Favored 'General case' 0 C--O 1.252 1.21 0 CA-C-O 121.949 0.881 . . . . 73.140000000000001 112.577 -168.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 5.0 tt -120.98 136.41 54.98 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 114.056 -1.429 . . . . 75.049999999999997 107.735 -178.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.406 HG21 ' HG2' ' A' ' 127' ' ' GLU . 22.0 t -109.01 127.98 65.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 106.985 -1.487 . . . . 61.020000000000003 106.985 176.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -105.67 122.86 46.93 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 109.147 -0.686 . . . . 64.530000000000001 109.147 -177.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.8 mp -130.51 159.04 38.27 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.857 -0.423 . . . . 73.530000000000001 109.857 -178.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -79.26 133.07 36.66 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 107.15 -1.426 . . . . 63.219999999999999 107.15 173.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -91.85 -160.92 36.53 Favored Glycine 0 N--CA 1.435 -1.414 0 C-N-CA 120.514 -0.851 . . . . 65.209999999999994 113.736 -173.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.476 ' O ' ' HA2' ' A' ' 45' ' ' GLY . 86.9 Cg_endo . . . . . 0 N--CA 1.452 -0.935 0 C-N-CA 122.992 2.462 . . . . 61.329999999999998 113.945 -175.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 42.9 t30 . . . . . 0 C--O 1.247 0.947 0 CA-C-O 121.351 0.596 . . . . 73.219999999999999 110.044 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -146.37 86.79 0.17 Allowed Glycine 0 N--CA 1.425 -2.062 0 N-CA-C 108.665 -1.774 . . . . 74.109999999999999 108.665 178.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.6 m -78.83 122.8 85.11 Favored Pre-proline 0 C--N 1.305 -1.339 0 CA-C-N 115.755 -0.223 . . . . 72.140000000000001 111.414 -174.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -69.22 138.43 39.52 Favored 'Trans proline' 0 C--O 1.25 1.095 0 C-N-CA 122.93 2.42 . . . . 74.439999999999998 110.804 172.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.4 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 8.4 pt-20 -95.52 137.83 21.94 Favored Pre-proline 0 C--O 1.251 1.183 0 C-N-CA 118.864 -1.134 . . . . 65.109999999999999 109.788 176.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 9' ' ' GLU . 5.3 Cg_exo -75.72 127.2 10.02 Favored 'Trans proline' 0 N--CA 1.439 -1.714 0 C-N-CA 122.242 1.961 . . . . 70.150000000000006 109.982 175.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -68.11 123.41 20.59 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 109.023 -0.732 . . . . 74.299999999999997 109.023 178.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.2 t -92.09 94.7 4.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 107.659 -1.237 . . . . 74.129999999999995 107.659 175.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.439 ' OE2' HG21 ' A' ' 15' ' ' THR . 0.4 OUTLIER -70.23 127.05 31.44 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 106.504 -1.665 . . . . 75.140000000000001 106.504 -179.123 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.6 m -100.48 -24.64 14.43 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 113.329 0.863 . . . . 74.329999999999998 113.329 -169.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.439 HG21 ' OE2' ' A' ' 13' ' ' GLU 0.313 14.0 t -83.63 72.14 10.33 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-O 123.896 1.808 . . . . 73.239999999999995 112.936 -174.314 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 57.3 m -139.37 138.55 36.69 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 104.521 -2.4 . . . . 73.319999999999993 104.521 174.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.1 t . . . . . 0 C--O 1.244 0.805 0 N-CA-C 107.35 -1.352 . . . . 73.219999999999999 107.35 -170.084 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.167 0 N-CA-C 111.06 -0.816 . . . . 53.329999999999998 111.06 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.7 m -129.67 146.1 51.48 Favored 'General case' 0 N--CA 1.414 -2.229 0 N-CA-C 107.266 -1.383 . . . . 52.420000000000002 107.266 177.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.83 175.1 10.67 Favored 'General case' 0 C--N 1.282 -2.362 0 N-CA-C 106.875 -1.528 . . . . 62.310000000000002 106.875 -178.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.8 pp -133.82 154.26 51.14 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 112.885 0.698 . . . . 75.030000000000001 112.885 -175.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.596 ' O ' ' HA ' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -118.94 140.9 49.22 Favored 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 108.312 -0.995 . . . . 73.409999999999997 108.312 175.575 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.8 t -121.3 114.32 42.8 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 108.566 -0.901 . . . . 75.239999999999995 108.566 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 78.5 t -93.8 115.54 32.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 107.592 -1.262 . . . . 63.310000000000002 107.592 175.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 51.7 tttm -90.38 -24.1 20.89 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.771 -0.649 . . . . 74.239999999999995 110.505 -173.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.402 ' O ' ' HB3' ' A' ' 133' ' ' PHE . 30.8 ttp-105 -146.69 119.3 8.54 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 106.878 -1.527 . . . . 74.340000000000003 106.878 176.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 143.15 116.86 1.18 Allowed Glycine 0 N--CA 1.417 -2.575 0 C-N-CA 120.176 -1.011 . . . . 74.299999999999997 112.181 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.424 ' HB2' ' HB3' ' A' ' 81' ' ' ASP . 27.8 Cg_exo -65.44 -10.81 27.59 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 123.423 2.749 . . . . 72.25 111.089 178.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.503 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 2.2 m-20 -48.38 -36.16 14.07 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 126.295 1.838 . . . . 75.439999999999998 110.212 174.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -152.16 -62.09 0.16 Allowed 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 107.978 -1.119 . . . . 71.430000000000007 107.978 175.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.61 23.83 75.36 Favored Glycine 0 CA--C 1.508 -0.363 0 CA-C-N 115.596 -0.729 . . . . 72.120000000000005 112.958 177.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -157.25 -179.43 8.19 Favored 'General case' 0 N--CA 1.428 -1.525 0 N-CA-C 108.478 -0.934 . . . . 62.399999999999999 108.478 -176.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.596 ' HA ' ' O ' ' A' ' 49' ' ' LEU . 9.8 ptp85 -111.1 133.87 53.14 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 124.04 0.838 . . . . 73.019999999999996 109.515 175.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -141.51 153.05 44.67 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.556 -0.535 . . . . 75.219999999999999 109.556 173.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.0 pp -94.41 140.4 29.86 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 112.114 0.413 . . . . 64.510000000000005 112.114 -177.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -78.6 114.94 17.95 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.646 -0.706 . . . . 72.420000000000002 109.918 178.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -146.47 16.83 1.31 Allowed 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 123.267 1.508 . . . . 71.239999999999995 107.596 175.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -126.49 104.34 24.71 Favored Pre-proline 0 C--N 1.301 -1.535 0 CA-C-N 114.352 -1.295 . . . . 74.420000000000002 108.029 178.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -45.92 -47.43 14.19 Favored 'Trans proline' 0 C--N 1.369 1.614 0 C-N-CA 124.133 3.222 . . . . 62.350000000000001 114.279 -174.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 50.3 m -113.24 97.33 6.42 Favored 'General case' 0 N--CA 1.424 -1.769 0 CA-C-O 121.319 0.58 . . . . 72.409999999999997 110.467 178.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.405 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 93.1 m -109.03 114.14 27.62 Favored 'General case' 0 N--CA 1.424 -1.771 0 N-CA-C 108.695 -0.854 . . . . 74.109999999999999 108.695 177.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 41.6 m -105.01 131.44 52.52 Favored 'General case' 0 N--CA 1.421 -1.895 0 CA-C-O 121.037 0.446 . . . . 75.230000000000004 109.904 -175.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -103.78 130.41 51.31 Favored 'General case' 0 N--CA 1.419 -1.981 0 N-CA-C 107.905 -1.146 . . . . 74.530000000000001 107.905 176.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -170.39 -140.86 3.11 Favored Glycine 0 N--CA 1.425 -2.058 0 N-CA-C 110.672 -0.971 . . . . 73.209999999999994 110.672 -178.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 27.1 ttm-85 -79.84 -59.12 2.86 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 120.469 -0.492 . . . . 75.129999999999995 109.854 -176.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 28.2 t-80 175.22 -47.76 0.0 OUTLIER Pre-proline 0 CA--C 1.562 1.431 0 O-C-N 124.203 0.939 . . . . 73.439999999999998 113.167 177.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -57.55 -27.9 78.71 Favored 'Trans proline' 0 C--N 1.384 2.421 0 C-N-CA 122.065 1.844 . . . . 74.310000000000002 114.13 -174.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -125.12 26.47 6.94 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 109.697 -0.483 . . . . 72.129999999999995 109.697 -177.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.3 m -145.01 140.37 28.1 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 122.298 -0.252 . . . . 71.25 110.558 -175.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -69.03 -42.36 76.49 Favored 'General case' 0 C--O 1.242 0.708 0 C-N-CA 120.191 -0.604 . . . . 75.209999999999994 110.394 178.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 21.0 pt -100.86 144.32 12.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 CA-C-N 115.118 -0.946 . . . . 75.340000000000003 109.934 178.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -100.61 117.73 35.32 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.106 0.479 . . . . 75.230000000000004 109.969 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.503 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 6.9 mp -98.71 122.9 42.52 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 120.842 0.353 . . . . 72.230000000000004 111.917 -178.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.424 ' HB3' ' HB2' ' A' ' 55' ' ' PRO . 24.3 t70 -99.83 73.78 1.79 Allowed 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 106.01 -1.848 . . . . 72.129999999999995 106.01 168.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.406 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 13.2 t70 -81.56 -175.87 5.74 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.141 -1.391 . . . . 72.430000000000007 107.718 -177.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.8 p -88.94 -23.64 6.23 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 N-CA-C 108.182 -1.044 . . . . 72.340000000000003 108.182 178.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 17.7 m -154.35 84.69 1.12 Allowed 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 116.033 -0.531 . . . . 74.219999999999999 110.069 176.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.406 ' HB ' ' HB3' ' A' ' 82' ' ' ASP . 7.4 p -108.7 136.28 44.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.912 -0.586 . . . . 72.219999999999999 110.03 -178.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 23.7 p -90.99 -81.98 0.3 Allowed 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.575 0.703 . . . . 73.430000000000007 111.616 -178.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -162.72 -34.09 0.04 OUTLIER 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 125.203 1.401 . . . . 72.310000000000002 108.333 -179.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 11.5 mmt180 -125.69 101.09 6.72 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 105.033 -2.21 . . . . 71.310000000000002 105.033 174.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 18.4 t60 -95.79 -60.61 1.61 Allowed 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.657 -0.868 . . . . 71.0 108.657 -173.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -145.57 144.31 30.43 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 115.771 -0.649 . . . . 72.5 110.055 -178.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -104.34 127.99 52.09 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 115.653 -0.703 . . . . 73.439999999999998 109.164 176.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.405 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 95.5 m-85 -104.68 112.02 24.96 Favored 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 107.061 -1.459 . . . . 74.340000000000003 107.061 174.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -104.4 122.1 44.79 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-N 114.528 -1.214 . . . . 74.219999999999999 110.259 -177.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.8 116.03 50.86 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.654 0 N-CA-C 105.978 -1.86 . . . . 73.209999999999994 105.978 171.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.491 ' C ' ' H ' ' A' ' 97' ' ' GLY . 52.5 t30 -114.08 148.05 37.73 Favored 'General case' 0 C--N 1.276 -2.6 0 N-CA-C 106.343 -1.725 . . . . 72.319999999999993 106.343 -178.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -52.59 24.52 0.0 OUTLIER 'General case' 0 CA--C 1.578 2.04 0 C-N-CA 126.847 2.059 . . . . 72.310000000000002 115.296 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.491 ' H ' ' C ' ' A' ' 95' ' ' ASN . . . -168.29 -43.66 0.03 OUTLIER Glycine 0 N--CA 1.426 -2.006 0 N-CA-C 110.123 -1.191 . . . . 63.420000000000002 110.123 -178.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -120.23 143.66 48.16 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 113.035 0.754 . . . . 73.430000000000007 113.035 -175.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.472 ' HB3' ' SD ' ' A' ' 122' ' ' MET . 84.1 m-85 -105.12 121.5 43.93 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 105.522 -2.029 . . . . 75.319999999999993 105.522 173.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -127.75 136.3 51.33 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 112.701 0.63 . . . . 74.230000000000004 112.701 -174.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.2 p -115.19 118.85 60.08 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 N-CA-C 108.836 -0.801 . . . . 72.400000000000006 108.836 177.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 42.7 t -120.27 129.99 74.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-N 116.282 -0.417 . . . . 71.129999999999995 110.21 -177.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.574 ' OD2' ' HB3' ' A' ' 106' ' ' SER . 10.9 t70 -83.37 130.26 35.04 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 107.239 -1.393 . . . . 73.349999999999994 107.239 172.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.0 m -124.01 13.57 4.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 112.946 0.721 . . . . 72.140000000000001 112.946 -177.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 152.94 26.61 0.04 OUTLIER Glycine 0 N--CA 1.438 -1.209 0 C-N-CA 118.59 -1.767 . . . . 44.5 114.42 178.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.574 ' HB3' ' OD2' ' A' ' 103' ' ' ASP . 32.7 t -79.8 131.57 35.93 Favored 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 108.075 -1.083 . . . . 75.420000000000002 108.075 175.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -76.07 -18.46 59.19 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.517 0.675 . . . . 73.310000000000002 110.171 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -88.9 -37.03 15.61 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 115.186 -0.915 . . . . 72.239999999999995 109.16 178.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 92.22 121.04 2.77 Favored Glycine 0 C--N 1.306 -1.11 0 CA-C-N 114.86 -1.064 . . . . 61.310000000000002 112.589 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 24.0 m -85.23 120.15 26.41 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 109.147 -0.686 . . . . 64.129999999999995 109.147 176.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -139.12 163.09 33.35 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.719 -0.474 . . . . 72.129999999999995 109.719 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.48 ' HB ' ' HB3' ' A' ' 115' ' ' GLU . 23.9 t -100.36 141.49 17.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 106.511 -1.663 . . . . 65.349999999999994 106.511 177.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -60.05 -25.07 65.07 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-O 120.969 0.414 . . . . 73.219999999999999 111.419 -175.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 81.8 mtt85 -106.58 -9.28 16.64 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.387 -0.37 . . . . 65.219999999999999 111.773 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.519 ' HG2' ' NE2' ' A' ' 120' ' ' GLN . 9.5 tp10 -133.16 112.9 13.33 Favored Pre-proline 0 C--O 1.252 1.231 0 C-N-CA 119.983 -0.687 . . . . 73.329999999999998 110.858 -172.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -75.25 60.61 5.66 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.516 2.811 . . . . 63.219999999999999 111.77 177.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.433 ' HB3' ' O ' ' A' ' 119' ' ' ALA . 28.4 mmm-85 -128.92 131.86 47.6 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.919 -1.141 . . . . 73.140000000000001 107.919 -179.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 31.4 p-10 -83.62 -18.35 38.46 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-O 121.96 0.886 . . . . 74.140000000000001 109.67 177.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.433 ' O ' ' HB3' ' A' ' 117' ' ' ARG . . . -128.98 133.85 47.94 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 106.551 -1.648 . . . . 74.319999999999993 106.551 165.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.519 ' NE2' ' HG2' ' A' ' 115' ' ' GLU . 5.0 tp60 -144.59 150.77 38.02 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 123.655 0.597 . . . . 64.109999999999999 112.171 -177.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.457 ' O ' ' HG3' ' A' ' 120' ' ' GLN . 7.3 p -79.65 130.62 35.78 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 N-CA-C 106.195 -1.78 . . . . 74.099999999999994 106.195 168.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.472 ' SD ' ' HB3' ' A' ' 99' ' ' PHE . 65.2 mtt -66.92 156.2 36.46 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 112.7 0.63 . . . . 71.310000000000002 112.7 -173.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -132.67 134.6 45.04 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.374 -1.343 . . . . 74.439999999999998 107.374 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 7.6 t -79.68 128.23 33.16 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 109.122 -0.696 . . . . 72.340000000000003 109.122 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 93.46 20.75 31.27 Favored Glycine 0 N--CA 1.421 -2.3 0 C-N-CA 120.229 -0.986 . . . . 74.340000000000003 111.298 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -123.4 172.9 8.34 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.235 -1.394 . . . . 72.299999999999997 107.235 178.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -129.05 125.68 37.8 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-O 121.383 0.611 . . . . 73.109999999999999 110.826 -173.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 59.4 mt -109.49 130.77 61.95 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 CA-C-N 115.015 -0.993 . . . . 75.349999999999994 108.641 -175.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -98.43 112.64 24.59 Favored 'General case' 0 N--CA 1.423 -1.816 0 N-CA-C 108.659 -0.867 . . . . 61.340000000000003 108.659 178.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 18.8 pt -90.92 98.36 8.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-O 121.727 0.775 . . . . 71.409999999999997 109.577 -178.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 75.28 -82.0 0.92 Allowed Glycine 0 N--CA 1.426 -2.027 0 CA-C-N 114.571 -1.195 . . . . 54.310000000000002 110.123 -176.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -136.1 -11.03 1.98 Allowed 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 109.917 -0.401 . . . . 65.150000000000006 109.917 176.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.402 ' HB3' ' O ' ' A' ' 53' ' ' ARG . 89.3 m-85 -94.5 157.08 16.16 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 113.185 0.809 . . . . 74.5 113.185 -172.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 45.9 ttt180 -99.66 120.58 39.92 Favored 'General case' 0 C--O 1.245 0.867 0 CA-C-N 115.66 -0.7 . . . . 72.120000000000005 111.452 -167.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.5 tt -125.23 129.21 49.62 Favored 'General case' 0 C--O 1.218 -0.586 0 C-N-CA 123.973 0.909 . . . . 72.209999999999994 109.721 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 40.6 t -107.83 128.05 63.41 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 N-CA-C 107.606 -1.257 . . . . 74.209999999999994 107.606 177.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -102.28 125.76 49.07 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 109.729 -0.471 . . . . 72.329999999999998 109.729 -178.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 84.2 mt -138.73 138.18 37.45 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.533 0.682 . . . . 73.450000000000003 111.282 -176.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -80.19 90.92 5.51 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 108.18 -1.045 . . . . 72.040000000000006 108.18 174.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -65.6 -79.83 0.18 Allowed Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 115.388 -0.823 . . . . 62.310000000000002 111.409 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo . . . . . 0 N--CA 1.437 -1.849 0 C-N-CA 121.608 1.539 . . . . 73.200000000000003 111.968 177.685 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 . . . . . 0 N--CA 1.441 -0.879 0 N-CA-C 109.769 -0.456 . . . . 74.299999999999997 109.769 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 159.87 138.11 2.38 Favored Glycine 0 N--CA 1.429 -1.775 0 C-N-CA 120.893 -0.67 . . . . 65.129999999999995 111.986 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.9 t -105.61 132.96 20.43 Favored Pre-proline 0 N--CA 1.427 -1.58 0 N-CA-C 109.12 -0.696 . . . . 64.450000000000003 109.12 178.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -66.84 132.28 28.01 Favored 'Trans proline' 0 C--O 1.243 0.762 0 C-N-CA 122.232 1.955 . . . . 73.430000000000007 110.342 176.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -80.89 146.45 59.61 Favored Pre-proline 0 C--N 1.306 -1.324 0 CA-C-N 116.587 -0.279 . . . . 75.430000000000007 110.501 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -62.01 139.07 77.03 Favored 'Trans proline' 0 C--O 1.243 0.765 0 C-N-CA 122.403 2.069 . . . . 65.430000000000007 110.983 178.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -84.52 137.43 33.34 Favored 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 108.154 -1.054 . . . . 74.310000000000002 108.154 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.4 m -74.44 85.34 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 CA-C-O 122.55 1.166 . . . . 73.310000000000002 111.277 178.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -92.85 137.54 32.27 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 114.737 -1.119 . . . . 73.209999999999994 108.568 -178.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.0 p -72.48 130.19 40.09 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 116.458 -0.337 . . . . 64.329999999999998 111.019 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.2 t -77.73 -8.19 57.61 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-O 122.601 1.191 . . . . 74.430000000000007 108.276 176.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.9 m -76.8 100.13 5.38 Favored 'General case' 0 N--CA 1.412 -2.367 0 CA-C-N 113.702 -1.59 . . . . 73.430000000000007 107.073 174.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.6 m . . . . . 0 N--CA 1.426 -1.673 0 CA-C-O 122.392 1.091 . . . . 75.349999999999994 111.245 -178.744 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.483 -1.958 0 N-CA-C 109.566 -1.413 . . . . 71.120000000000005 109.566 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.7 p -89.12 152.69 21.49 Favored 'General case' 0 C--N 1.279 -2.474 0 CA-C-N 114.461 -0.87 . . . . 73.540000000000006 111.446 -177.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.92 167.2 20.67 Favored 'General case' 0 C--N 1.284 -2.268 0 CA-C-N 115.166 -0.924 . . . . 75.310000000000002 109.891 -175.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -128.89 138.87 52.26 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.387 0.613 . . . . 72.209999999999994 110.688 -177.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.7 pp -127.91 149.09 50.47 Favored 'General case' 0 C--N 1.282 -2.354 0 CA-C-N 115.671 -0.695 . . . . 74.219999999999999 110.028 178.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.425 HG12 ' CB ' ' A' ' 60' ' ' ARG . 27.2 m -125.87 140.13 49.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 N-CA-C 109.802 -0.444 . . . . 71.409999999999997 109.802 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.4 t -104.19 116.49 48.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 106.484 -1.673 . . . . 71.310000000000002 106.484 175.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -103.59 -25.04 13.34 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 120.264 -0.574 . . . . 74.299999999999997 112.184 -175.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.417 ' O ' ' HA ' ' A' ' 133' ' ' PHE . 24.9 tpt180 -141.35 115.48 9.3 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 120.213 -0.595 . . . . 74.420000000000002 110.957 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 138.15 139.35 3.84 Favored Glycine 0 N--CA 1.433 -1.517 0 C-N-CA 119.796 -1.193 . . . . 75.140000000000001 113.414 173.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -52.49 -8.06 0.36 Allowed 'Trans proline' 0 N--CA 1.506 2.26 0 C-N-CA 125.056 3.837 . . . . 73.340000000000003 115.402 176.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.429 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 37.2 t30 -58.94 -51.42 70.14 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.579 0.752 . . . . 74.310000000000002 109.565 177.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -173.81 -177.39 1.38 Allowed 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.941 -0.763 . . . . 63.299999999999997 108.941 -177.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -164.22 53.87 0.28 Allowed Glycine 0 N--CA 1.425 -2.07 0 N-CA-C 109.512 -1.435 . . . . 51.119999999999997 109.512 178.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -153.69 -176.98 6.07 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 108.523 -0.917 . . . . 63.340000000000003 108.523 -177.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.425 ' CB ' HG12 ' A' ' 50' ' ' VAL . 0.4 OUTLIER -108.55 139.2 43.65 Favored 'General case' 0 C--N 1.309 -1.192 0 O-C-N 123.885 0.741 . . . . 73.219999999999999 109.049 178.8 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -128.49 129.04 45.49 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 110.093 -0.336 . . . . 70.439999999999998 110.093 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -97.09 116.25 28.95 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 105.945 -1.872 . . . . 74.109999999999999 105.945 175.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -99.99 115.65 30.2 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 112.811 0.671 . . . . 74.219999999999999 112.811 -174.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -109.02 -5.88 15.87 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 105.956 -1.868 . . . . 74.5 105.956 168.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -66.1 112.54 9.3 Favored Pre-proline 0 N--CA 1.443 -0.787 0 CA-C-N 112.937 -1.938 . . . . 73.510000000000005 109.124 176.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -62.04 -30.83 83.47 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.663 2.242 . . . . 74.219999999999999 113.003 -177.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 85.5 m -137.17 111.07 8.21 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-O 121.024 0.44 . . . . 75.430000000000007 111.825 -178.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 55.5 m -110.14 114.08 27.3 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 108.624 -0.88 . . . . 73.010000000000005 108.624 176.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.5 p -93.33 140.82 29.13 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 122.091 -0.38 . . . . 74.310000000000002 111.048 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -116.08 140.06 49.66 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 109.473 -0.566 . . . . 72.409999999999997 109.473 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 170.01 -148.71 12.02 Favored Glycine 0 N--CA 1.421 -2.316 0 C-N-CA 120.254 -0.974 . . . . 71.109999999999999 112.372 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.427 ' HB2' ' HA ' ' A' ' 87' ' ' ARG . 56.5 ttt180 -51.47 -75.19 0.03 OUTLIER 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 125.541 1.537 . . . . 75.140000000000001 113.915 -175.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.434 ' HB3' ' CD ' ' A' ' 74' ' ' PRO . 7.9 t60 -172.12 -76.65 0.0 OUTLIER Pre-proline 0 CA--C 1.56 1.347 0 CA-C-O 118.798 -0.62 . . . . 72.329999999999998 110.798 -178.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.434 ' CD ' ' HB3' ' A' ' 73' ' ' HIS . 49.8 Cg_endo -68.55 -24.84 35.47 Favored 'Trans proline' 0 C--N 1.389 2.701 0 CA-C-N 121.135 1.441 . . . . 72.010000000000005 111.136 178.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.407 ' HB3' ' CZ ' ' A' ' 88' ' ' ARG . 34.9 mt-10 -89.0 15.6 8.35 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 114.119 -1.4 . . . . 75.120000000000005 111.526 -173.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.1 p -153.44 166.85 31.37 Favored 'General case' 0 N--CA 1.421 -1.907 0 CA-C-N 116.682 -0.236 . . . . 75.319999999999993 110.751 -178.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -79.98 -46.37 16.78 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.344 -0.984 . . . . 64.099999999999994 108.344 177.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 34.5 pt -104.91 143.57 16.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 108.747 -0.834 . . . . 75.219999999999999 108.747 175.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 33.7 p90 -115.27 117.64 31.04 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 121.495 0.664 . . . . 75.329999999999998 112.49 -174.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.544 HD22 ' CE2' ' A' ' 133' ' ' PHE . 4.5 mp -90.18 111.94 23.27 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.876 -1.157 . . . . 75.340000000000003 107.876 178.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -84.29 10.34 10.74 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-O 121.702 0.763 . . . . 74.349999999999994 112.697 -173.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -77.55 146.02 36.56 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 108.995 -0.743 . . . . 74.25 108.995 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.5 p -67.87 -22.14 27.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-O 121.256 0.55 . . . . 74.400000000000006 111.828 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -96.07 23.16 6.72 Favored 'General case' 0 CA--C 1.557 1.239 0 CA-C-O 121.185 0.516 . . . . 74.340000000000003 110.751 -176.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.2 p -81.94 140.84 15.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 O-C-N 121.921 -0.487 . . . . 72.230000000000004 110.297 -178.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 19.6 m -83.03 156.33 23.44 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.549 -0.908 . . . . 64.239999999999995 108.549 175.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.427 ' HA ' ' HB2' ' A' ' 72' ' ' ARG . 36.5 mtp-105 -63.06 -54.64 34.91 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-O 121.332 0.586 . . . . 74.319999999999993 109.539 -178.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.407 ' CZ ' ' HB3' ' A' ' 75' ' ' GLU . 13.1 mmt180 -117.22 112.55 20.96 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 105.347 -2.094 . . . . 75.040000000000006 105.347 175.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 11.3 t60 -98.13 -76.74 0.52 Allowed 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.16 0.505 . . . . 71.239999999999995 110.534 -174.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.37 167.49 23.45 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.553 -0.717 . . . . 61.409999999999997 110.543 -176.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -127.87 128.19 44.76 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 115.811 -0.631 . . . . 74.019999999999996 109.507 177.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -104.69 120.24 40.88 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.423 -0.954 . . . . 74.230000000000004 108.423 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 78.9 mtt180 -119.25 141.8 48.61 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-O 121.553 0.692 . . . . 75.209999999999994 111.288 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.64 119.79 62.86 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 104.359 -2.46 . . . . 73.430000000000007 104.359 171.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.537 ' C ' ' H ' ' A' ' 97' ' ' GLY . 51.4 t-20 -111.4 147.08 35.98 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 115.299 -0.864 . . . . 74.519999999999996 109.16 -170.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -63.43 31.8 0.01 OUTLIER 'General case' 0 CA--C 1.581 2.136 0 C-N-CA 125.853 1.661 . . . . 75.310000000000002 111.869 176.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.537 ' H ' ' C ' ' A' ' 95' ' ' ASN . . . -171.1 -38.32 0.03 OUTLIER Glycine 0 N--CA 1.428 -1.887 0 N-CA-C 111.46 -0.656 . . . . 72.450000000000003 111.46 -179.05 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -133.11 177.41 7.69 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-O 121.509 0.671 . . . . 73.519999999999996 111.201 -177.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.418 ' HB3' ' HB3' ' A' ' 122' ' ' MET . 87.7 m-85 -122.63 121.33 36.17 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 104.418 -2.438 . . . . 74.409999999999997 104.418 171.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -131.14 127.27 37.71 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 120.661 -0.416 . . . . 64.439999999999998 111.445 -169.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 5.5 p -126.12 119.27 53.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-O 121.526 0.679 . . . . 73.329999999999998 109.472 176.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 23.3 m -119.51 136.6 56.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-N 115.425 -0.807 . . . . 75.209999999999994 112.04 -176.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -83.11 132.34 35.1 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 106.542 -1.651 . . . . 73.540000000000006 106.542 174.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 30.5 m -104.09 8.06 9.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 C-N-CA 119.653 -0.819 . . . . 73.340000000000003 112.285 -179.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 127.89 52.04 0.14 Allowed Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.593 -0.813 . . . . 63.530000000000001 112.447 179.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 14.2 m -80.87 126.18 31.04 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 112.319 0.488 . . . . 73.140000000000001 112.319 -176.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.0 mp -82.47 -22.06 35.33 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 107.493 -1.299 . . . . 74.310000000000002 107.493 173.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.498 ' OD1' ' HA3' ' A' ' 131' ' ' GLY . 22.8 t-20 -75.12 -30.52 60.87 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.372 -1.286 . . . . 74.310000000000002 109.989 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 92.07 117.94 2.36 Favored Glycine 0 C--O 1.221 -0.698 0 N-CA-C 114.566 0.587 . . . . 62.329999999999998 114.566 174.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 88.4 m -99.34 119.81 38.56 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-O 120.966 0.412 . . . . 70.230000000000004 110.093 178.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -115.19 134.78 54.84 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 109.411 -0.588 . . . . 73.219999999999999 109.411 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 5.4 p -113.09 121.16 64.78 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.582 0 N-CA-C 106.557 -1.645 . . . . 74.439999999999998 106.557 171.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 17.6 m120 58.9 26.27 14.7 Favored 'General case' 0 N--CA 1.48 1.05 0 O-C-N 123.163 0.289 . . . . 74.430000000000007 110.266 -175.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 80.38 6.29 1.62 Allowed 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.982 1.313 . . . . 73.349999999999994 113.467 -177.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -100.83 121.47 52.43 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 109.315 -0.624 . . . . 73.409999999999997 109.315 176.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.415 ' HA ' ' O ' ' A' ' 110' ' ' THR . 57.3 Cg_endo -78.14 126.42 7.78 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 121.993 1.795 . . . . 75.329999999999998 111.157 177.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -150.18 -176.96 5.67 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 109.908 -0.404 . . . . 72.439999999999998 109.908 177.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -96.12 -57.37 2.36 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 123.189 0.306 . . . . 73.129999999999995 111.795 -177.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -117.92 139.72 50.73 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 109.629 -0.508 . . . . 62.240000000000002 109.629 -177.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 54.7 tp60 -139.25 140.73 37.77 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 116.207 -0.451 . . . . 73.239999999999995 110.472 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 59.5 t -80.25 114.22 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 104.936 -2.246 . . . . 64.420000000000002 104.936 170.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.472 ' HE2' ' CD1' ' A' ' 137' ' ' PHE . 16.6 ttt -63.36 123.01 17.62 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.973 -0.751 . . . . 74.109999999999999 108.973 -173.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -104.57 136.8 43.45 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-O 121.333 0.587 . . . . 74.420000000000002 111.457 -171.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 14.4 p -79.37 118.55 21.37 Favored 'General case' 0 N--CA 1.416 -2.158 0 CA-C-N 114.891 -1.049 . . . . 74.099999999999994 111.079 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 107.07 -13.33 40.86 Favored Glycine 0 N--CA 1.44 -1.057 0 CA-C-N 115.715 -0.675 . . . . 62.229999999999997 112.219 177.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -99.35 172.95 7.01 Favored 'General case' 0 C--O 1.25 1.088 0 N-CA-C 113.564 0.95 . . . . 74.530000000000001 113.564 -175.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.514 ' OE1' ' HD3' ' A' ' 134' ' ' ARG . 17.1 pt-20 -108.97 140.47 42.42 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 114.528 -1.214 . . . . 73.129999999999995 111.333 -174.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 71.9 mt -123.31 119.28 57.08 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 N-CA-C 106.765 -1.568 . . . . 74.209999999999994 106.765 177.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -115.75 121.88 43.79 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 109.278 -0.638 . . . . 72.439999999999998 109.278 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.503 ' O ' ' HD2' ' A' ' 133' ' ' PHE . 18.5 pt -103.83 98.68 7.13 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.171 0 N-CA-C 108.271 -1.011 . . . . 74.340000000000003 108.271 176.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.498 ' HA3' ' OD1' ' A' ' 108' ' ' ASN . . . 62.97 -95.01 0.12 Allowed Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.273 -0.876 . . . . 75.299999999999997 113.667 -178.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 3.8 ttmp? -101.72 -22.28 14.45 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 123.27 0.628 . . . . 74.150000000000006 109.891 -177.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.544 ' CE2' HD22 ' A' ' 80' ' ' LEU . 5.5 m-85 -92.17 112.14 23.96 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.617 -0.72 . . . . 73.439999999999998 110.038 -170.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.514 ' HD3' ' OE1' ' A' ' 127' ' ' GLU . 13.4 ttm180 -104.52 124.95 50.2 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 120.395 -0.522 . . . . 74.400000000000006 109.943 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.8 tt -124.25 140.33 53.07 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.547 -1.206 . . . . 74.329999999999998 108.604 -177.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 8.9 p -116.35 136.52 53.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 109.036 -0.727 . . . . 74.030000000000001 109.036 175.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . 0.472 ' CD1' ' HE2' ' A' ' 122' ' ' MET . 80.5 t80 -108.42 122.13 46.37 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.26 -0.427 . . . . 74.310000000000002 111.757 -173.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -121.83 150.23 42.21 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.119 -0.697 . . . . 75.209999999999994 109.119 178.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -129.4 148.64 51.34 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 109.691 -0.485 . . . . 75.549999999999997 109.691 178.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -169.21 -70.52 0.03 OUTLIER Glycine 0 C--N 1.303 -1.253 0 C-N-CA 120.019 -1.086 . . . . 61.140000000000001 112.708 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo . . . . . 0 C--N 1.357 0.988 0 C-N-CA 123.451 2.767 . . . . 71.019999999999996 116.344 -177.07 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 50.3 t30 . . . . . 0 CA--C 1.541 0.63 0 N-CA-C 110.52 -0.178 . . . . 74.519999999999996 110.52 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -58.07 149.5 34.45 Favored Glycine 0 C--O 1.239 0.449 0 N-CA-C 112.518 -0.233 . . . . 73.099999999999994 112.518 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 60.5 m -67.46 124.83 90.13 Favored Pre-proline 0 C--N 1.311 -1.105 0 C-N-CA 122.763 0.425 . . . . 75.219999999999999 111.108 -177.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -67.7 151.82 78.54 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.491 2.794 . . . . 72.200000000000003 111.28 176.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -69.97 111.87 10.55 Favored Pre-proline 0 C--N 1.315 -0.895 0 N-CA-C 105.6 -2.0 . . . . 70.120000000000005 105.6 170.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -53.61 109.9 0.43 Allowed 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 123.187 2.592 . . . . 74.209999999999994 114.507 -170.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -90.11 107.86 19.39 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 114.585 -1.188 . . . . 64.120000000000005 108.635 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 46.9 t -89.69 94.02 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.528 0 N-CA-C 108.526 -0.916 . . . . 75.400000000000006 108.526 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -70.01 134.39 48.25 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 114.877 -1.056 . . . . 73.329999999999998 109.486 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 28.5 m -65.87 112.26 3.69 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-O 121.522 0.677 . . . . 73.140000000000001 112.046 -176.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 86.9 m -43.61 125.23 3.93 Favored 'General case' 0 N--CA 1.42 -1.93 0 C-N-CA 127.08 2.152 . . . . 74.219999999999999 114.598 -178.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.8 t -118.32 99.85 7.11 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 113.441 -1.709 . . . . 55.32 108.243 176.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.3 m . . . . . 0 CA--C 1.516 -0.349 0 CA-C-O 120.745 0.307 . . . . 74.200000000000003 111.024 -179.178 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.62 0 N-CA-C 109.793 -1.323 . . . . 74.540000000000006 109.793 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 16.2 m -90.63 168.51 11.73 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 114.344 -0.928 . . . . 73.439999999999998 110.427 -177.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -95.52 177.18 5.9 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.995 -0.742 . . . . 74.319999999999993 108.995 178.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.98 160.25 38.29 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.619 0.6 . . . . 75.109999999999999 112.619 -174.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.416 ' O ' HD13 ' A' ' 49' ' ' LEU . 3.0 pp -131.61 144.11 50.82 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 115.463 -0.789 . . . . 74.25 110.06 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.7 t -124.73 139.61 50.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 N-CA-C 108.411 -0.959 . . . . 75.049999999999997 108.411 -178.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.1 t -92.29 116.39 33.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-O 121.565 0.698 . . . . 50.420000000000002 109.195 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -76.71 -45.93 27.51 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 114.43 -1.259 . . . . 73.519999999999996 108.598 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.405 ' O ' ' HB3' ' A' ' 133' ' ' PHE . 2.6 tpm_? -151.65 111.3 4.0 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.283 -1.006 . . . . 72.209999999999994 108.283 -176.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 161.4 118.27 0.47 Allowed Glycine 0 N--CA 1.432 -1.568 0 C-N-CA 118.851 -1.642 . . . . 75.140000000000001 114.769 176.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -63.77 -7.62 13.47 Favored 'Trans proline' 0 C--N 1.366 1.498 0 C-N-CA 123.745 2.963 . . . . 73.010000000000005 112.161 176.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.543 ' OD1' ' HG ' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -44.2 -42.01 6.19 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.657 1.183 . . . . 74.239999999999995 107.812 172.218 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -154.2 -64.55 0.14 Allowed 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.426 -0.806 . . . . 74.519999999999996 109.163 176.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.09 34.9 28.73 Favored Glycine 0 C--O 1.226 -0.39 0 C-N-CA 121.003 -0.618 . . . . 60.43 111.639 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -149.79 -164.7 2.08 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.999 -1.112 . . . . 75.230000000000004 107.999 -177.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 17.0 ptt180 -126.39 152.93 45.65 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 106.733 -1.581 . . . . 72.230000000000004 106.733 177.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.412 ' CZ ' HD11 ' A' ' 49' ' ' LEU . 51.1 p90 -156.5 149.46 24.0 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-O 121.509 0.671 . . . . 75.319999999999993 112.639 173.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 41.8 tp -87.03 140.31 29.69 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 113.784 -1.553 . . . . 73.0 107.474 178.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -78.38 114.69 17.51 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 119.709 -0.796 . . . . 73.510000000000005 110.148 177.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -127.39 -2.46 6.23 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 121.982 0.896 . . . . 75.019999999999996 109.799 178.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 6.3 pm0 -111.48 114.15 52.99 Favored Pre-proline 0 N--CA 1.42 -1.929 0 CA-C-N 115.155 -0.929 . . . . 72.019999999999996 109.466 178.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.424 ' HA ' ' CG1' ' A' ' 94' ' ' ILE . 9.6 Cg_endo -49.95 -34.9 39.05 Favored 'Trans proline' 0 C--N 1.371 1.756 0 C-N-CA 124.437 3.425 . . . . 63.32 115.62 -173.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 92.4 m -133.62 105.46 6.87 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-O 121.262 0.553 . . . . 73.0 109.846 177.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.491 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 3.5 m -102.19 113.13 26.14 Favored 'General case' 0 N--CA 1.422 -1.863 0 N-CA-C 108.235 -1.024 . . . . 74.310000000000002 108.235 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.412 ' HB ' ' HA ' ' A' ' 76' ' ' SER . 57.4 m -93.61 141.43 28.49 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 108.685 -0.858 . . . . 74.129999999999995 108.685 177.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -120.91 126.67 50.59 Favored 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 108.92 -0.77 . . . . 75.129999999999995 108.92 177.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -176.03 -140.8 3.59 Favored Glycine 0 N--CA 1.425 -2.091 0 C-N-CA 120.613 -0.803 . . . . 53.43 112.081 -177.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 22.8 ttm180 -114.15 -25.91 8.29 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.245 0.545 . . . . 72.409999999999997 111.837 -174.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.428 ' NE2' ' HG2' ' A' ' 87' ' ' ARG . 25.3 m-70 -99.54 157.41 34.03 Favored Pre-proline 0 C--N 1.305 -1.342 0 CA-C-N 116.386 -0.37 . . . . 70.219999999999999 110.101 -172.126 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -51.94 -21.38 11.98 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 124.089 3.193 . . . . 73.450000000000003 114.387 -178.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -60.51 -21.88 62.94 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.389 0.614 . . . . 65.439999999999998 110.045 176.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.412 ' HA ' ' HB ' ' A' ' 69' ' ' THR . 34.4 m -86.94 139.36 30.69 Favored 'General case' 0 N--CA 1.421 -1.9 0 CA-C-N 115.376 -0.829 . . . . 73.400000000000006 109.042 175.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -80.12 -30.68 39.08 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.204 0.526 . . . . 71.219999999999999 109.678 -179.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.95 136.49 60.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 109.244 -0.651 . . . . 72.430000000000007 109.244 175.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -103.11 117.73 35.21 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 115.809 -0.632 . . . . 74.439999999999998 109.54 -176.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.543 ' HG ' ' OD1' ' A' ' 56' ' ' ASN . 5.5 mp -70.02 115.94 9.82 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.851 -1.166 . . . . 71.0 107.851 175.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.418 ' H ' ' HA ' ' A' ' 56' ' ' ASN . 24.4 t0 -88.44 61.59 6.21 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 122.68 1.229 . . . . 74.25 110.459 177.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -111.29 156.04 22.11 Favored 'General case' 0 C--N 1.286 -2.189 0 CA-C-N 113.136 -1.847 . . . . 71.129999999999995 107.872 174.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.9 p -74.42 -25.61 19.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 111.914 0.338 . . . . 74.450000000000003 111.914 -177.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.8 m -116.2 72.04 0.8 Allowed 'General case' 0 CA--C 1.548 0.904 0 CA-C-O 121.977 0.894 . . . . 73.040000000000006 110.829 -177.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 47.7 t -112.65 139.53 37.12 Favored 'Isoleucine or valine' 0 C--O 1.249 1.074 0 CA-C-N 115.766 -0.652 . . . . 73.319999999999993 110.844 -178.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 42.6 t -83.71 179.44 7.6 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.621 -0.881 . . . . 73.109999999999999 108.621 178.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.428 ' HG2' ' NE2' ' A' ' 73' ' ' HIS . 93.4 mtt180 -78.4 -54.09 6.56 Favored 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 105.854 -1.906 . . . . 70.120000000000005 105.854 175.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 5.6 ptm180 -105.32 100.37 9.95 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 106.105 -1.813 . . . . 74.450000000000003 106.105 171.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 11.0 t60 -99.59 -59.32 1.74 Allowed 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.959 -0.756 . . . . 75.109999999999999 108.959 -174.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -136.81 152.7 50.58 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.479 -0.934 . . . . 75.310000000000002 108.479 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -135.54 128.26 30.97 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 109.554 -0.535 . . . . 75.239999999999995 109.554 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.491 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 67.8 m-85 -101.81 115.98 31.71 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 107.762 -1.199 . . . . 74.109999999999999 107.762 179.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 18.8 mmt180 -108.33 140.0 42.23 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 109.319 -0.622 . . . . 74.129999999999995 109.319 178.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.424 ' CG1' ' HA ' ' A' ' 66' ' ' PRO . 2.6 pp -115.98 116.91 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.192 0 N-CA-C 106.965 -1.494 . . . . 74.109999999999999 106.965 172.071 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.53 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 46.6 t-20 -108.97 146.13 34.35 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 107.26 -1.385 . . . . 73.340000000000003 107.26 -174.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -59.49 -16.46 24.38 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 124.449 1.099 . . . . 74.409999999999997 111.551 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -87.42 -47.11 4.73 Favored Glycine 0 N--CA 1.431 -1.675 0 N-CA-C 111.594 -0.602 . . . . 72.310000000000002 111.594 176.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.53 ' O ' ' HB3' ' A' ' 95' ' ' ASN . 26.2 tt0 -173.36 169.15 4.51 Favored 'General case' 0 C--O 1.218 -0.573 0 N-CA-C 105.856 -1.905 . . . . 62.030000000000001 105.856 -179.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.401 ' CD1' ' HB ' ' A' ' 94' ' ' ILE . 10.1 m-85 -104.49 131.71 51.56 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 119.262 0.937 . . . . 73.420000000000002 110.479 -173.038 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -131.7 138.13 48.55 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 122.566 1.174 . . . . 72.239999999999995 113.226 -178.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 44.3 t -102.57 129.79 53.57 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.258 0 N-CA-C 106.945 -1.502 . . . . 75.439999999999998 106.945 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.4 t -118.73 136.0 57.34 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 C-N-CA 120.926 -0.31 . . . . 73.530000000000001 110.283 -177.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -82.67 110.59 17.87 Favored 'General case' 0 N--CA 1.437 -1.109 0 N-CA-C 106.536 -1.653 . . . . 73.010000000000005 106.536 170.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 30.0 m -100.51 7.04 9.42 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 CA-C-N 114.935 -1.029 . . . . 75.230000000000004 111.518 -173.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 134.51 52.18 0.07 OUTLIER Glycine 0 N--CA 1.425 -2.084 0 C-N-CA 119.815 -1.183 . . . . 73.209999999999994 112.054 178.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 50.4 m -59.11 128.24 36.2 Favored 'General case' 0 C--O 1.25 1.131 0 N-CA-C 109.667 -0.494 . . . . 65.120000000000005 109.667 176.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.83 -51.15 63.68 Favored 'General case' 0 C--O 1.217 -0.609 0 N-CA-C 108.62 -0.882 . . . . 73.310000000000002 108.62 -178.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.412 ' OD1' ' HA2' ' A' ' 131' ' ' GLY . 7.9 p30 -91.61 -45.66 8.36 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 112.281 0.475 . . . . 63.520000000000003 112.281 177.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 143.71 139.56 3.53 Favored Glycine 0 C--O 1.219 -0.82 0 C-N-CA 119.506 -1.331 . . . . 71.099999999999994 114.063 174.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 59.8 m -105.26 120.14 40.82 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 108.908 -0.775 . . . . 73.400000000000006 108.908 174.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -122.04 137.91 54.63 Favored 'General case' 0 C--O 1.198 -1.645 0 CA-C-N 115.649 -0.705 . . . . 74.510000000000005 109.715 -174.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.402 HG21 ' HG3' ' A' ' 120' ' ' GLN . 59.6 t -99.18 117.08 43.76 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.485 0 N-CA-C 106.708 -1.59 . . . . 71.510000000000005 106.708 177.088 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 68.58 -71.07 0.12 Allowed 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 125.341 1.457 . . . . 73.030000000000001 108.877 -172.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 55.9 ttp85 -157.67 6.79 0.14 Allowed 'General case' 0 CA--C 1.553 1.073 0 CA-C-O 121.339 0.59 . . . . 72.450000000000003 109.775 172.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -114.8 131.74 23.29 Favored Pre-proline 0 N--CA 1.449 -0.476 0 O-C-N 121.845 -0.535 . . . . 75.209999999999994 110.026 -174.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -68.87 131.38 22.39 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.203 1.935 . . . . 62.219999999999999 112.241 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 -122.27 145.07 48.57 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 106.767 -1.568 . . . . 71.019999999999996 106.767 176.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -78.76 -46.54 18.65 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.989 -1.115 . . . . 75.120000000000005 107.989 178.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -138.35 143.48 39.9 Favored 'General case' 0 N--CA 1.421 -1.891 0 N-CA-C 106.609 -1.626 . . . . 71.209999999999994 106.609 175.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.402 ' HG3' HG21 ' A' ' 112' ' ' VAL . 22.1 tm0? -129.69 141.86 50.82 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 107.345 -1.354 . . . . 75.040000000000006 107.345 -176.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.3 p -103.15 119.05 51.06 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.297 0 N-CA-C 108.554 -0.906 . . . . 74.099999999999994 108.554 178.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.548 ' HB3' ' CE1' ' A' ' 137' ' ' PHE . 64.9 mtt -41.84 111.93 0.28 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.217 1.007 . . . . 74.230000000000004 112.588 -170.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -114.83 136.3 53.24 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-N 114.929 -1.032 . . . . 75.319999999999993 109.619 -170.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.423 ' HB ' ' HB2' ' A' ' 139' ' ' ALA . 14.6 t -79.4 127.59 32.29 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 121.666 0.746 . . . . 71.239999999999995 112.778 -176.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 80.97 33.51 29.47 Favored Glycine 0 N--CA 1.428 -1.849 0 CA-C-N 115.124 -0.943 . . . . 54.329999999999998 111.958 173.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -137.2 155.78 49.13 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.427 -0.953 . . . . 74.420000000000002 108.427 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -118.8 135.57 54.46 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-O 121.97 0.891 . . . . 74.510000000000005 113.206 -175.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 64.6 mt -111.35 130.4 64.92 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 CA-C-N 114.386 -1.279 . . . . 74.120000000000005 108.706 -177.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -91.9 111.49 23.05 Favored 'General case' 0 N--CA 1.417 -2.109 0 N-CA-C 107.707 -1.22 . . . . 73.540000000000006 107.707 175.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 10.9 pt -93.97 98.84 8.65 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 N-CA-C 107.911 -1.144 . . . . 74.209999999999994 107.911 177.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.412 ' HA2' ' OD1' ' A' ' 108' ' ' ASN . . . 79.58 -104.07 2.14 Favored Glycine 0 N--CA 1.412 -2.907 0 N-CA-C 109.363 -1.495 . . . . 65.409999999999997 109.363 -174.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -123.68 5.3 8.86 Favored 'General case' 0 C--N 1.298 -1.63 0 N-CA-C 109.965 -0.383 . . . . 75.530000000000001 109.965 178.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.405 ' HB3' ' O ' ' A' ' 53' ' ' ARG . 35.2 m-85 -113.03 152.71 29.16 Favored 'General case' 0 C--O 1.211 -0.954 0 CA-C-N 116.375 -0.375 . . . . 74.239999999999995 110.625 -177.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 66.4 mtp85 -113.61 128.31 56.39 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.52 0.676 . . . . 73.310000000000002 112.611 -170.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 45.1 tp -119.43 132.6 55.84 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 124.92 1.288 . . . . 74.310000000000002 108.552 -177.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 9.9 p -108.17 132.36 56.13 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 108.765 -0.828 . . . . 74.420000000000002 108.765 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . 0.548 ' CE1' ' HB3' ' A' ' 122' ' ' MET . 39.8 t80 -109.04 131.38 55.13 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 121.077 -0.249 . . . . 73.120000000000005 110.948 -175.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.4 mp -124.44 124.18 41.76 Favored 'General case' 0 C--O 1.244 0.79 0 CA-C-O 121.131 0.491 . . . . 74.319999999999993 109.927 177.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.423 ' HB2' ' HB ' ' A' ' 124' ' ' THR . . . -94.64 82.91 4.0 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-O 121.536 0.684 . . . . 73.120000000000005 111.072 -177.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -127.12 96.87 0.46 Allowed Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 109.021 -1.631 . . . . 71.030000000000001 109.021 177.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo . . . . . 0 C--N 1.355 0.881 0 C-N-CA 123.159 2.573 . . . . 74.420000000000002 113.271 -176.917 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.6 p30 . . . . . 0 C--O 1.245 0.866 0 CA-C-O 120.812 0.339 . . . . 64.430000000000007 110.464 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 161.23 176.47 33.37 Favored Glycine 0 N--CA 1.431 -1.688 0 N-CA-C 110.733 -0.947 . . . . 64.510000000000005 110.733 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.3 p -92.2 124.62 59.2 Favored Pre-proline 0 C--N 1.292 -1.9 0 CA-C-N 116.624 0.212 . . . . 74.349999999999994 110.909 -178.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -63.83 128.92 23.22 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.314 2.01 . . . . 73.030000000000001 110.326 176.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -86.4 130.55 49.08 Favored Pre-proline 0 C--N 1.299 -1.615 0 CA-C-N 116.32 -0.4 . . . . 74.420000000000002 111.856 -174.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -65.15 145.33 84.28 Favored 'Trans proline' 0 C--O 1.247 0.934 0 C-N-CA 122.632 2.221 . . . . 74.319999999999993 111.377 178.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -57.8 128.34 36.58 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-N 115.685 -0.689 . . . . 72.409999999999997 112.483 -178.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.4 m -73.53 76.25 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 CA-C-O 122.66 1.219 . . . . 62.43 109.903 173.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -88.83 122.59 32.37 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-N 114.231 -1.35 . . . . 74.200000000000003 111.033 -174.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.6 t -145.27 89.29 1.93 Allowed 'General case' 0 N--CA 1.407 -2.597 0 CA-C-O 122.583 1.182 . . . . 70.219999999999999 107.944 174.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 28.6 m -92.5 105.82 17.92 Favored 'General case' 0 N--CA 1.415 -2.212 0 CA-C-N 114.79 -1.096 . . . . 62.140000000000001 109.444 -177.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.9 m -72.32 113.99 9.95 Favored 'General case' 0 N--CA 1.418 -2.075 0 CA-C-N 115.065 -0.97 . . . . 63.039999999999999 109.029 177.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.1 m . . . . . 0 C--N 1.312 -1.029 0 CA-C-O 121.125 0.488 . . . . 75.319999999999993 110.506 179.556 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.484 -1.851 0 N-CA-C 107.261 -2.336 . . . . 75.439999999999998 107.261 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 20.2 m -90.89 167.08 12.7 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 114.107 -1.046 . . . . 72.430000000000007 110.609 -174.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -127.4 171.13 11.81 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.137 -1.431 . . . . 65.329999999999998 107.137 177.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -134.04 145.5 49.48 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 120.039 -0.664 . . . . 72.420000000000002 111.109 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.453 ' O ' ' HA ' ' A' ' 60' ' ' ARG . 4.1 pp -110.56 132.72 53.94 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 115.217 -0.901 . . . . 75.209999999999994 108.934 176.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 51.5 t -116.67 113.88 44.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 108.509 -0.923 . . . . 64.209999999999994 108.509 179.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 36.3 t -96.21 115.61 35.94 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 N-CA-C 109.033 -0.729 . . . . 72.439999999999998 109.033 -179.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -86.14 -32.86 21.06 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.377 0.608 . . . . 75.120000000000005 110.183 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.438 ' O ' ' HB3' ' A' ' 133' ' ' PHE . 10.1 tpt180 -147.55 131.08 16.75 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 106.535 -1.654 . . . . 73.209999999999994 106.535 179.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 145.14 110.74 0.7 Allowed Glycine 0 C--N 1.298 -1.555 0 N-CA-C 111.376 -0.689 . . . . 72.549999999999997 111.376 -178.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -58.36 -20.7 49.42 Favored 'Trans proline' 0 C--N 1.358 1.052 0 C-N-CA 123.403 2.735 . . . . 72.329999999999998 113.689 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -48.0 -35.9 11.77 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.225 1.01 . . . . 74.319999999999993 111.82 175.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -152.21 -72.04 0.15 Allowed 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 109.241 -0.651 . . . . 73.109999999999999 109.241 176.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.96 36.64 35.37 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.652 -0.704 . . . . 64.129999999999995 111.752 -179.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -158.38 -171.61 3.54 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 107.672 -1.232 . . . . 70.340000000000003 107.672 -178.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.453 ' HA ' ' O ' ' A' ' 49' ' ' LEU . 36.6 ptt180 -113.37 133.02 55.38 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 109.546 -0.539 . . . . 74.420000000000002 109.546 178.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -135.57 134.7 39.65 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 116.483 -0.326 . . . . 75.400000000000006 110.681 -176.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.5 mp -91.57 130.16 37.43 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.921 -0.581 . . . . 74.510000000000005 109.438 178.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -71.34 121.34 18.34 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.546 0.689 . . . . 75.409999999999997 110.761 -177.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -123.78 -24.95 4.37 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.206 -1.361 . . . . 72.010000000000005 111.383 -175.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -92.27 141.34 24.87 Favored Pre-proline 0 C--N 1.295 -1.781 0 CA-C-N 115.021 -0.99 . . . . 74.549999999999997 111.032 -174.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.68 -34.29 32.47 Favored 'Trans proline' 0 C--O 1.242 0.709 0 C-N-CA 123.075 2.516 . . . . 62.439999999999998 112.798 -176.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 39.5 m -132.61 99.71 4.72 Favored 'General case' 0 N--CA 1.415 -2.187 0 N-CA-C 107.57 -1.27 . . . . 73.540000000000006 107.57 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.464 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 6.1 m -90.74 112.92 24.89 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.506 -0.924 . . . . 73.329999999999998 108.506 179.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 51.7 m -94.04 119.94 33.6 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 109.296 -0.631 . . . . 75.310000000000002 109.296 177.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -109.69 120.31 42.1 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 108.59 -0.893 . . . . 63.119999999999997 108.59 178.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 175.29 -147.09 8.69 Favored Glycine 0 C--N 1.289 -2.067 0 N-CA-C 109.221 -1.552 . . . . 74.420000000000002 109.221 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.504 ' HD3' ' O ' ' A' ' 80' ' ' LEU . 10.2 tpt180 -134.32 66.16 1.55 Allowed 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 108.424 -0.954 . . . . 73.409999999999997 108.424 179.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 30.1 m170 -126.87 166.01 25.05 Favored Pre-proline 0 C--N 1.303 -1.414 0 N-CA-C 107.568 -1.271 . . . . 75.310000000000002 107.568 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -61.13 -32.94 91.71 Favored 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 121.755 1.637 . . . . 72.340000000000003 109.986 172.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 -97.82 72.3 2.25 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-O 122.35 1.071 . . . . 71.400000000000006 109.898 177.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 48.9 m -142.62 125.92 16.55 Favored 'General case' 0 C--N 1.277 -2.545 0 CA-C-N 114.087 -1.415 . . . . 72.219999999999999 107.557 174.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -69.48 -50.66 43.27 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 107.774 -1.195 . . . . 62.32 107.774 -179.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 30.1 pt -109.09 123.59 65.09 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.222 0 N-CA-C 107.083 -1.451 . . . . 74.099999999999994 107.083 172.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -108.04 116.91 32.82 Favored 'General case' 0 C--N 1.28 -2.455 0 CA-C-O 122.177 0.989 . . . . 74.409999999999997 111.524 -177.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.504 ' O ' ' HD3' ' A' ' 72' ' ' ARG . 6.3 mp -79.89 135.28 36.4 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 113.835 -1.53 . . . . 51.009999999999998 109.272 -177.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -134.13 23.79 3.85 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 105.472 -2.047 . . . . 73.319999999999993 105.472 179.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -78.44 179.19 7.17 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 111.796 -2.456 . . . . 72.219999999999999 109.906 -175.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.9 p -83.34 1.59 3.91 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-O 122.073 0.94 . . . . 74.040000000000006 110.13 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 12.0 p -109.89 14.32 23.18 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 115.932 -0.576 . . . . 71.540000000000006 111.778 -175.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.2 m -81.83 139.09 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.634 0 CA-C-O 121.346 0.593 . . . . 74.200000000000003 111.915 -174.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 13.0 p -130.98 -81.44 0.53 Allowed 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.24 -0.891 . . . . 72.140000000000001 111.367 -179.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 20.0 tpp85 -156.33 -92.39 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.002 -1.11 . . . . 75.219999999999999 108.002 178.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.411 ' HB3' HG21 ' A' ' 104' ' ' VAL . 5.4 mpt_? -85.65 107.06 17.37 Favored 'General case' 0 CA--C 1.493 -1.243 0 N-CA-C 105.168 -2.16 . . . . 74.340000000000003 105.168 171.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -91.53 -75.58 0.47 Allowed 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 120.287 -0.565 . . . . 65.340000000000003 110.255 -174.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -144.51 155.0 43.48 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.991 -0.744 . . . . 74.409999999999997 108.991 -178.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -140.34 128.2 21.93 Favored 'General case' 0 C--N 1.287 -2.131 0 C-N-CA 119.994 -0.682 . . . . 73.040000000000006 109.326 179.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.464 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 42.3 m-85 -97.55 113.09 24.73 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 106.887 -1.523 . . . . 74.340000000000003 106.887 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 46.1 mtt-85 -112.56 152.12 29.23 Favored 'General case' 0 C--N 1.269 -2.913 0 C-N-CA 120.527 -0.469 . . . . 74.329999999999998 109.922 179.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.43 116.12 51.69 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.3 0 CA-C-O 123.111 1.434 . . . . 75.109999999999999 108.177 177.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -97.64 96.44 8.28 Favored 'General case' 0 N--CA 1.42 -1.928 0 CA-C-N 113.256 -1.793 . . . . 71.109999999999999 109.8 -173.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 43.45 13.6 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 127.477 2.311 . . . . 55.530000000000001 116.667 175.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 158.48 -13.15 0.23 Allowed Glycine 0 N--CA 1.417 -2.599 0 C-N-CA 120.234 -0.984 . . . . 75.099999999999994 113.606 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -146.36 152.82 39.71 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 118.05 -1.46 . . . . 73.239999999999995 110.513 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -89.99 138.46 31.49 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.377 0.608 . . . . 75.340000000000003 110.851 -176.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -128.07 125.36 39.13 Favored 'General case' 0 C--N 1.28 -2.417 0 N-CA-C 107.61 -1.256 . . . . 74.430000000000007 107.61 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.5 p -103.07 118.55 50.18 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-O 121.602 0.715 . . . . 75.409999999999997 109.862 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 29.9 m -119.96 137.67 53.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-N 115.033 -0.985 . . . . 75.430000000000007 111.686 -179.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -83.23 122.96 29.1 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 104.742 -2.318 . . . . 72.200000000000003 104.742 171.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.411 HG21 ' HB3' ' A' ' 88' ' ' ARG . 16.8 m -106.15 9.59 9.37 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 N-CA-C 112.816 0.673 . . . . 73.329999999999998 112.816 -172.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -126.41 -45.96 0.22 Allowed Glycine 0 N--CA 1.43 -1.701 0 C-N-CA 119.018 -1.563 . . . . 55.340000000000003 112.96 -179.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 21.7 m 67.18 9.97 7.35 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.205 1.402 . . . . 73.319999999999993 110.659 -175.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 94.4 mt -74.92 -48.6 23.75 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 114.663 -1.153 . . . . 75.25 109.292 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -83.36 -50.34 8.44 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 108.643 -0.873 . . . . 71.430000000000007 108.643 175.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.01 76.99 1.32 Allowed Glycine 0 N--CA 1.431 -1.646 0 N-CA-C 109.486 -1.446 . . . . 75.299999999999997 109.486 -175.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 32.1 m -73.09 135.35 44.78 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 109.671 -0.492 . . . . 74.219999999999999 109.671 -179.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -102.18 133.2 47.43 Favored 'General case' 0 N--CA 1.422 -1.838 0 N-CA-C 106.925 -1.509 . . . . 74.25 106.925 178.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.429 HG22 HG12 ' A' ' 128' ' ' ILE . 7.5 p -128.41 137.29 57.8 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.179 0 N-CA-C 107.57 -1.27 . . . . 72.209999999999994 107.57 -175.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 60.61 21.95 11.78 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 108.149 -1.056 . . . . 75.519999999999996 108.149 -171.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 64.1 mtp180 54.7 37.38 28.18 Favored 'General case' 0 C--N 1.352 0.704 0 CA-C-N 114.412 -1.267 . . . . 73.019999999999996 112.582 -172.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -132.63 149.5 73.2 Favored Pre-proline 0 C--N 1.312 -1.061 0 N-CA-C 108.298 -1.001 . . . . 73.450000000000003 108.298 174.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -76.28 87.65 1.41 Allowed 'Trans proline' 0 N--CA 1.443 -1.476 0 C-N-CA 121.49 1.46 . . . . 65.420000000000002 110.554 174.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -120.14 149.73 41.76 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.758 -1.201 . . . . 74.030000000000001 107.758 178.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -89.27 -28.9 19.6 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 109.467 -0.568 . . . . 74.239999999999995 109.467 179.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -140.92 140.36 34.47 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 115.413 -0.812 . . . . 74.329999999999998 109.514 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.5 142.23 37.3 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.737 -1.208 . . . . 64.340000000000003 107.737 174.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 11.3 p -98.07 135.84 31.22 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.232 0 N-CA-C 109.641 -0.503 . . . . 74.549999999999997 109.641 -177.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 48.6 ttp -31.58 108.99 0.05 Allowed 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 125.97 1.708 . . . . 73.230000000000004 112.24 -177.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -133.06 138.71 46.84 Favored 'General case' 0 N--CA 1.419 -2.015 0 N-CA-C 106.763 -1.569 . . . . 70.129999999999995 106.763 179.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 12.3 t -80.06 131.37 35.76 Favored 'General case' 0 N--CA 1.423 -1.823 0 N-CA-C 109.12 -0.696 . . . . 63.32 109.12 -179.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 91.39 18.14 46.87 Favored Glycine 0 N--CA 1.438 -1.176 0 C-N-CA 120.314 -0.946 . . . . 71.450000000000003 111.125 178.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -81.51 140.64 34.44 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 106.657 -1.609 . . . . 75.530000000000001 106.657 178.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -124.77 120.88 33.03 Favored 'General case' 0 C--N 1.277 -2.552 0 CA-C-O 122.41 1.1 . . . . 61.329999999999998 110.576 -179.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.429 HG12 HG22 ' A' ' 112' ' ' VAL . 61.0 mt -103.66 128.49 56.81 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.095 0 CA-C-N 113.885 -1.507 . . . . 72.450000000000003 108.908 -174.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -120.6 124.82 46.22 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 109.793 -0.447 . . . . 74.430000000000007 109.793 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.403 HG13 ' HB2' ' A' ' 133' ' ' PHE . 22.0 pt -109.76 98.24 6.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 108.404 -0.961 . . . . 73.239999999999995 108.404 173.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 70.4 -82.81 0.36 Allowed Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.074 -0.966 . . . . 34.329999999999998 111.615 -175.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -130.77 -12.79 3.75 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 123.104 0.562 . . . . 75.109999999999999 110.182 179.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.438 ' HB3' ' O ' ' A' ' 53' ' ' ARG . 42.3 m-85 -85.63 131.74 34.29 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.852 -0.795 . . . . 72.019999999999996 108.852 -176.039 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 21.4 ptt180 -118.33 135.05 54.54 Favored 'General case' 0 C--O 1.258 1.541 0 CA-C-O 121.993 0.902 . . . . 75.219999999999999 112.821 -175.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 5.2 tt -120.04 133.23 55.59 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 113.473 -1.694 . . . . 71.530000000000001 107.302 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 40.7 t -107.91 120.75 59.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 107.318 -1.364 . . . . 70.439999999999998 107.318 177.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -102.48 121.9 43.26 Favored 'General case' 0 C--N 1.288 -2.078 0 CA-C-N 115.7 -0.682 . . . . 73.5 109.497 -176.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -121.52 159.52 26.18 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 109.606 -0.516 . . . . 72.420000000000002 109.606 -178.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -72.0 148.78 45.58 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 106.772 -1.566 . . . . 63.32 106.772 172.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -113.86 -140.62 7.57 Favored Glycine 0 C--N 1.29 -1.983 0 C-N-CA 119.546 -1.311 . . . . 53.409999999999997 112.874 -173.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 N--CA 1.435 -1.915 0 C-N-CA 122.57 2.18 . . . . 73.109999999999999 113.061 -179.303 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.7 p30 . . . . . 0 N--CA 1.437 -1.111 0 CA-C-O 121.046 0.45 . . . . 75.230000000000004 112.131 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -179.59 -165.18 33.24 Favored Glycine 0 N--CA 1.428 -1.876 0 N-CA-C 107.67 -2.172 . . . . 74.439999999999998 107.67 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.8 p -77.29 124.26 87.02 Favored Pre-proline 0 C--N 1.3 -1.55 0 CA-C-N 118.212 1.006 . . . . 71.120000000000005 109.667 179.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -61.21 148.12 93.76 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 123.175 2.583 . . . . 74.200000000000003 112.855 -175.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -69.77 117.62 55.23 Favored Pre-proline 0 C--O 1.247 0.925 0 N-CA-C 109.556 -0.535 . . . . 72.420000000000002 109.556 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -82.24 142.53 12.11 Favored 'Trans proline' 0 N--CA 1.444 -1.44 0 C-N-CA 122.738 2.292 . . . . 75.230000000000004 112.63 -176.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -70.55 134.35 47.59 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-N 115.456 -0.793 . . . . 75.019999999999996 109.801 178.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.7 t -73.86 89.22 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 CA-C-N 115.483 -0.78 . . . . 62.329999999999998 109.591 -179.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -72.96 124.41 25.39 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 114.546 -1.206 . . . . 73.340000000000003 108.95 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.4 m -67.29 98.32 0.61 Allowed 'General case' 0 N--CA 1.427 -1.621 0 CA-C-N 115.709 -0.678 . . . . 74.530000000000001 109.844 -179.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.1 t -79.3 75.05 5.88 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 123.037 1.398 . . . . 75.299999999999997 110.394 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.8 m -155.69 164.05 39.1 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 106.452 -1.684 . . . . 74.230000000000004 106.452 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.7 m . . . . . 0 N--CA 1.427 -1.591 0 N-CA-C 108.863 -0.792 . . . . 72.540000000000006 108.863 175.648 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.485 -1.829 0 N-CA-C 109.605 -1.398 . . . . 75.150000000000006 109.605 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.555 ' HB3' ' O ' ' A' ' 63' ' ' LEU . 4.8 m -90.0 154.64 19.67 Favored 'General case' 0 N--CA 1.41 -2.448 0 CA-C-N 114.446 -0.877 . . . . 73.200000000000003 108.892 -177.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -116.26 175.89 5.35 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.303 -0.999 . . . . 64.329999999999998 108.303 -178.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -130.27 159.66 36.23 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 121.327 0.584 . . . . 65.140000000000001 111.348 -175.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.401 ' O ' HD13 ' A' ' 49' ' ' LEU . 1.7 pp -122.17 147.63 45.93 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 115.356 -0.838 . . . . 74.340000000000003 110.097 177.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.469 ' CG2' ' HB ' ' A' ' 136' ' ' VAL . 24.6 m -123.28 134.05 67.37 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 108.603 -0.888 . . . . 73.430000000000007 108.603 175.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.407 HG22 ' HB1' ' A' ' 57' ' ' ALA . 48.5 t -92.54 115.69 32.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 106.457 -1.683 . . . . 71.400000000000006 106.457 176.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -73.96 -39.98 63.35 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 114.524 -1.217 . . . . 74.540000000000006 108.417 -176.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 31.7 tpt180 -168.31 138.51 2.55 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 107.157 -1.423 . . . . 72.049999999999997 107.157 177.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 139.28 127.67 2.47 Favored Glycine 0 N--CA 1.425 -2.077 0 C-N-CA 119.724 -1.227 . . . . 45.030000000000001 114.382 178.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.499 ' HD2' ' CE2' ' A' ' 133' ' ' PHE . 80.3 Cg_exo -54.0 -8.74 1.04 Allowed 'Trans proline' 0 C--N 1.368 1.553 0 C-N-CA 125.237 3.958 . . . . 74.219999999999999 114.117 173.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.464 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 4.3 t-20 -40.99 -45.44 2.6 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.717 1.207 . . . . 64.400000000000006 109.792 170.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.407 ' HB1' HG22 ' A' ' 51' ' ' VAL . . . -162.95 -48.55 0.04 OUTLIER 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 115.989 -0.551 . . . . 74.040000000000006 109.601 176.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 67.82 48.52 54.7 Favored Glycine 0 C--N 1.324 -0.134 0 N-CA-C 111.225 -0.75 . . . . 62.130000000000003 111.225 -179.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -161.64 -173.02 3.56 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.25 -1.018 . . . . 74.150000000000006 108.25 -178.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 19.1 ptp180 -140.5 135.41 31.89 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.777 -0.824 . . . . 75.400000000000006 108.777 175.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -156.46 155.42 32.01 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 120.743 0.306 . . . . 73.010000000000005 111.609 -176.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 14.7 tp -79.87 139.7 37.05 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.035 -0.984 . . . . 71.049999999999997 108.642 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.555 ' O ' ' HB3' ' A' ' 46' ' ' SER . 94.3 mt -95.17 114.09 25.84 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 120.138 -0.625 . . . . 74.120000000000005 109.623 177.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -96.86 -28.87 14.03 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 121.561 0.696 . . . . 75.230000000000004 109.786 177.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -74.77 115.8 47.65 Favored Pre-proline 0 C--N 1.309 -1.157 0 CA-C-N 114.086 -1.416 . . . . 74.329999999999998 109.621 -177.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.443 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 15.2 Cg_endo -57.93 -28.25 82.12 Favored 'Trans proline' 0 C--N 1.363 1.307 0 C-N-CA 123.045 2.497 . . . . 74.010000000000005 112.402 -176.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 90.8 m -136.46 109.86 7.91 Favored 'General case' 0 N--CA 1.418 -2.055 0 N-CA-C 108.874 -0.787 . . . . 64.349999999999994 108.874 174.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 23.4 m -105.64 114.32 28.41 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.296 -1.002 . . . . 73.329999999999998 108.296 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.444 HG22 ' HG2' ' A' ' 91' ' ' GLU . 65.6 p -91.96 133.77 35.4 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 109.802 -0.444 . . . . 75.299999999999997 109.802 -178.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -127.28 133.53 50.15 Favored 'General case' 0 C--O 1.243 0.724 0 O-C-N 122.249 -0.282 . . . . 63.229999999999997 111.118 -179.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 161.41 -105.29 0.26 Allowed Glycine 0 N--CA 1.437 -1.282 0 C-N-CA 119.894 -1.146 . . . . 63.329999999999998 114.044 175.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 66.8 ttt180 -91.19 99.54 12.52 Favored 'General case' 0 N--CA 1.42 -1.938 0 N-CA-C 107.991 -1.114 . . . . 75.549999999999997 107.991 -174.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -12.63 -68.48 0.02 OUTLIER Pre-proline 0 N--CA 1.5 2.056 0 C-N-CA 127.758 2.423 . . . . 75.230000000000004 115.306 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -66.32 -21.9 53.69 Favored 'Trans proline' 0 C--N 1.387 2.563 0 C-N-CA 122.082 1.855 . . . . 70.209999999999994 114.43 -177.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -112.86 18.29 18.29 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.428 0.632 . . . . 71.310000000000002 110.631 -175.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 40.0 m -144.35 165.71 27.14 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.365 -0.976 . . . . 72.120000000000005 108.365 178.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -81.37 -57.13 3.63 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 109.185 -0.672 . . . . 72.549999999999997 109.185 176.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 49.4 pt -106.78 166.94 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 CA-C-O 121.604 0.716 . . . . 72.230000000000004 110.712 177.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -123.27 137.02 54.96 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-N 114.954 -1.021 . . . . 74.450000000000003 109.211 -175.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.464 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 2.5 pt? -114.11 121.79 44.87 Favored 'General case' 0 N--CA 1.406 -2.664 0 N-CA-C 105.933 -1.877 . . . . 54.109999999999999 105.933 170.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -80.72 78.19 7.51 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 122.018 0.913 . . . . 72.230000000000004 110.411 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.459 ' OD2' HG21 ' A' ' 84' ' ' THR . 17.3 t70 -117.58 -167.31 1.3 Allowed 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 114.244 -1.344 . . . . 72.530000000000001 108.252 177.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.457 ' H ' ' CG ' ' A' ' 82' ' ' ASP . 11.0 p -129.65 -19.36 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 CA-C-N 118.241 0.473 . . . . 75.400000000000006 111.225 -177.104 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.459 HG21 ' OD2' ' A' ' 82' ' ' ASP . 12.3 t -99.12 20.99 12.43 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.52 0.676 . . . . 74.510000000000005 110.497 -177.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.7 p -81.24 111.02 17.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 108.607 -0.886 . . . . 71.239999999999995 108.607 178.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.8 m -76.51 -89.83 0.03 OUTLIER 'General case' 0 CA--C 1.562 1.412 0 N-CA-C 113.478 0.918 . . . . 75.140000000000001 113.478 -172.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -84.09 -48.25 10.07 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 106.802 -1.555 . . . . 75.430000000000007 106.802 177.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -162.55 176.42 10.42 Favored 'General case' 0 C--N 1.274 -2.717 0 N-CA-C 100.269 -3.974 . . . . 74.540000000000006 100.269 170.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 21.3 t60 -96.27 -74.18 0.57 Allowed 'General case' 0 C--N 1.276 -2.617 0 C-N-CA 116.443 -2.103 . . . . 72.540000000000006 111.979 -170.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.15 163.66 34.68 Favored 'General case' 0 C--N 1.294 -1.809 0 C-N-CA 120.012 -0.675 . . . . 75.5 110.474 -174.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.444 ' HG2' HG22 ' A' ' 69' ' ' THR . 52.1 mt-10 -116.21 127.35 54.69 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.624 -0.88 . . . . 75.540000000000006 108.624 175.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -100.51 112.89 25.31 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 107.595 -1.261 . . . . 74.510000000000005 107.595 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 60.0 mtp180 -103.3 112.93 26.03 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 106.89 -1.522 . . . . 73.310000000000002 106.89 -179.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.443 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -120.14 111.43 32.4 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.328 0 N-CA-C 106.954 -1.499 . . . . 74.019999999999996 106.954 -179.756 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -122.33 147.23 46.51 Favored 'General case' 0 N--CA 1.393 -3.302 0 CA-C-N 114.469 -1.241 . . . . 71.25 111.004 176.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.27 -30.35 70.41 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 107.58 -1.267 . . . . 74.109999999999999 107.58 175.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -69.58 -61.39 4.45 Favored Glycine 0 N--CA 1.429 -1.824 0 CA-C-N 113.442 -1.708 . . . . 62.0 111.304 175.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -147.2 146.63 29.9 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.962 0.381 . . . . 74.049999999999997 110.972 -179.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -104.39 116.22 31.74 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.002 -0.74 . . . . 74.439999999999998 109.002 -178.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -133.16 135.4 45.12 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 113.503 0.927 . . . . 72.140000000000001 113.503 -177.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.7 p -116.31 119.07 60.83 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.295 0 N-CA-C 108.959 -0.756 . . . . 62.409999999999997 108.959 176.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.6 p -120.84 131.75 72.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 112.591 0.589 . . . . 72.239999999999995 112.591 -177.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -83.06 136.67 34.4 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 108.596 -0.89 . . . . 71.409999999999997 108.596 172.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.6 m -89.57 -16.95 8.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-O 121.189 0.518 . . . . 73.400000000000006 111.872 -176.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 142.28 53.06 0.04 OUTLIER Glycine 0 N--CA 1.424 -2.136 0 N-CA-C 109.746 -1.341 . . . . 64.319999999999993 109.746 -173.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.6 t -154.7 28.6 0.43 Allowed 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 106.462 -1.681 . . . . 53.0 106.462 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 32.9 tp -62.64 -11.52 17.52 Favored 'General case' 0 C--N 1.356 0.882 0 C-N-CA 125.794 1.637 . . . . 72.340000000000003 111.57 -174.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -60.45 -26.76 67.0 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 115.156 -0.929 . . . . 75.530000000000001 109.472 173.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -123.54 3.45 9.45 Favored Glycine 0 N--CA 1.429 -1.785 0 C-N-CA 120.975 -0.631 . . . . 65.319999999999993 113.69 178.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.7 m -102.31 118.69 37.41 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 118.79 1.295 . . . . 73.310000000000002 109.757 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -139.16 137.32 35.98 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.483 -0.562 . . . . 64.530000000000001 109.483 -178.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.2 p -103.14 119.18 51.24 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 106.348 -1.723 . . . . 71.420000000000002 106.348 170.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 18.9 m120 70.63 -78.01 0.05 Allowed 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 108.479 -0.934 . . . . 73.329999999999998 108.479 -171.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -152.31 2.16 0.34 Allowed 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.253 -0.885 . . . . 74.310000000000002 108.862 174.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -101.19 119.01 59.04 Favored Pre-proline 0 N--CA 1.438 -1.033 0 O-C-N 122.022 -0.424 . . . . 75.230000000000004 110.976 -171.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -81.02 90.99 1.17 Allowed 'Trans proline' 0 N--CA 1.43 -2.226 0 C-N-CA 121.777 1.651 . . . . 74.340000000000003 109.538 174.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.03 -94.62 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.662 -0.699 . . . . 74.120000000000005 109.594 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 7.4 t30 167.83 -60.44 0.01 OUTLIER 'General case' 0 CA--C 1.489 -1.39 0 N-CA-C 104.431 -2.433 . . . . 72.140000000000001 104.431 175.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -123.91 138.71 54.44 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 106.313 -1.736 . . . . 64.439999999999998 106.313 171.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 55.1 tp60 -140.45 150.52 43.92 Favored 'General case' 0 C--N 1.278 -2.526 0 N-CA-C 109.868 -0.419 . . . . 71.219999999999999 109.868 -176.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 97.4 t -77.89 118.75 25.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 105.485 -2.043 . . . . 75.519999999999996 105.485 171.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.416 ' HE2' ' CD1' ' A' ' 137' ' ' PHE . 21.1 ttt -75.48 113.21 12.63 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 114.919 -1.037 . . . . 74.319999999999993 108.409 -173.079 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -104.95 139.21 40.0 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.755 -0.657 . . . . 72.230000000000004 111.526 -171.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 3.5 t -79.0 131.99 36.49 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 114.932 -1.031 . . . . 75.319999999999993 110.56 -179.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 97.66 11.05 52.02 Favored Glycine 0 N--CA 1.434 -1.485 0 CA-C-N 115.604 -0.726 . . . . 53.200000000000003 112.14 177.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -124.2 173.1 8.55 Favored 'General case' 0 C--O 1.253 1.284 0 N-CA-C 108.228 -1.027 . . . . 72.530000000000001 108.228 178.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.584 ' OE2' ' HD3' ' A' ' 134' ' ' ARG . 36.9 tt0 -123.82 123.77 41.2 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 121.337 0.589 . . . . 72.030000000000001 109.665 -172.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 67.6 mt -105.18 130.37 56.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 108.645 -0.872 . . . . 73.430000000000007 108.645 -177.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -98.3 118.83 35.84 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 109.142 -0.688 . . . . 72.150000000000006 109.142 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 17.0 pt -120.06 109.04 24.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 CA-C-O 121.915 0.865 . . . . 75.129999999999995 110.002 -177.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 81.98 -124.34 6.43 Favored Glycine 0 N--CA 1.416 -2.666 0 N-CA-C 109.198 -1.561 . . . . 75.329999999999998 109.198 -178.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -102.23 -4.03 26.38 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 108.916 -0.772 . . . . 74.140000000000001 108.916 176.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.499 ' CE2' ' HD2' ' A' ' 55' ' ' PRO . 45.2 m-85 -115.82 -179.96 3.8 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.254 -0.43 . . . . 72.239999999999995 111.599 -172.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.584 ' HD3' ' OE2' ' A' ' 127' ' ' GLU . 10.4 ptp180 -137.86 140.83 40.64 Favored 'General case' 0 C--O 1.247 0.932 0 N-CA-C 113.515 0.932 . . . . 74.019999999999996 113.515 -172.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 29.5 tp -123.86 133.15 53.83 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.21 -1.359 . . . . 73.25 108.751 -175.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.469 ' HB ' ' CG2' ' A' ' 50' ' ' VAL . 25.7 t -107.81 132.29 55.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 107.689 -1.226 . . . . 74.049999999999997 107.689 178.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . 0.416 ' CD1' ' HE2' ' A' ' 122' ' ' MET . 73.9 t80 -104.18 123.83 48.02 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 120.617 0.246 . . . . 74.049999999999997 110.55 -176.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -126.41 138.58 53.56 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-O 121.809 0.814 . . . . 63.439999999999998 111.462 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -106.53 91.9 3.89 Favored 'General case' 0 C--N 1.278 -2.509 0 N-CA-C 107.163 -1.421 . . . . 72.510000000000005 107.163 172.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -93.63 -127.2 4.58 Favored Glycine 0 CA--C 1.497 -1.039 0 N-CA-C 110.47 -1.052 . . . . 41.25 110.47 -177.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo . . . . . 0 N--CA 1.445 -1.33 0 C-N-CA 121.588 1.525 . . . . 63.509999999999998 109.031 175.955 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.7 t30 . . . . . 0 N--CA 1.44 -0.947 0 N-CA-C 108.724 -0.843 . . . . 65.510000000000005 108.724 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -107.61 56.21 0.49 Allowed Glycine 0 N--CA 1.429 -1.811 0 C-N-CA 120.806 -0.711 . . . . 62.530000000000001 112.184 -176.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.6 m -92.59 123.21 62.54 Favored Pre-proline 0 C--N 1.303 -1.445 0 N-CA-C 109.239 -0.652 . . . . 61.32 109.239 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -67.07 128.55 18.84 Favored 'Trans proline' 0 C--O 1.243 0.744 0 C-N-CA 122.537 2.158 . . . . 73.310000000000002 111.037 175.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -85.89 144.98 40.17 Favored Pre-proline 0 C--N 1.294 -1.82 0 CA-C-N 116.137 -0.483 . . . . 71.340000000000003 109.942 -179.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -72.85 117.3 5.06 Favored 'Trans proline' 0 N--CA 1.446 -1.3 0 C-N-CA 122.207 1.938 . . . . 74.430000000000007 112.683 -177.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -100.75 136.85 39.96 Favored 'General case' 0 C--N 1.282 -2.364 0 CA-C-N 115.03 -0.986 . . . . 74.340000000000003 108.768 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.1 p -127.37 122.89 60.63 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 CA-C-O 121.72 0.771 . . . . 75.230000000000004 110.809 178.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -122.63 133.17 54.53 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 108.205 -1.035 . . . . 71.439999999999998 108.205 177.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.4 t -163.9 99.66 0.87 Allowed 'General case' 0 N--CA 1.42 -1.958 0 CA-C-O 122.054 0.931 . . . . 71.140000000000001 109.367 -178.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 21.0 m -84.44 79.26 9.63 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 108.532 -0.914 . . . . 72.310000000000002 108.532 178.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.9 p -125.47 84.45 2.28 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 115.108 -0.951 . . . . 73.25 111.53 -176.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 50.4 t . . . . . 0 C--N 1.308 -1.21 0 N-CA-C 108.024 -1.102 . . . . 73.299999999999997 108.024 -178.585 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.477 -2.294 0 N-CA-C 106.084 -2.806 . . . . 64.510000000000005 106.084 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 25.0 m -88.74 163.0 15.93 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-O 121.835 0.826 . . . . 63.409999999999997 112.405 -167.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.501 ' HA ' ' N ' ' A' ' 140' ' ' GLY . . . -129.48 171.14 12.86 Favored 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 107.604 -1.258 . . . . 54.219999999999999 107.604 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.7 pp -133.71 143.87 48.78 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 112.314 0.487 . . . . 71.329999999999998 112.314 -175.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.515 HD23 ' O ' ' A' ' 61' ' ' PHE . 2.4 pt? -109.75 132.01 54.54 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.91 -1.145 . . . . 71.239999999999995 107.91 178.044 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 23.5 t -119.04 126.37 75.3 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 109.111 -0.7 . . . . 75.230000000000004 109.111 -176.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 15.4 t -92.77 118.35 38.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.761 0 N-CA-C 107.234 -1.395 . . . . 74.340000000000003 107.234 177.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.45 ' HB2' ' HG3' ' A' ' 134' ' ' ARG . 31.8 mmmt -70.68 -38.22 73.72 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 108.72 -0.844 . . . . 75.25 108.72 -179.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.436 ' HA ' ' HE ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -174.3 133.74 0.41 Allowed 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.011 -0.995 . . . . 71.540000000000006 108.805 178.076 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -177.91 158.26 23.15 Favored Glycine 0 N--CA 1.43 -1.715 0 N-CA-C 108.648 -1.781 . . . . 53.109999999999999 108.648 176.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -68.42 -25.47 35.66 Favored 'Trans proline' 0 N--CA 1.48 0.73 0 C-N-CA 122.292 1.995 . . . . 74.230000000000004 110.477 176.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.459 ' CB ' ' HA ' ' A' ' 80' ' ' LEU . 9.7 p30 -58.55 -58.64 7.66 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 113.91 -1.495 . . . . 73.329999999999998 111.9 177.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -162.96 -179.75 6.98 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 108.761 -0.829 . . . . 63.329999999999998 108.761 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -155.31 36.04 0.65 Allowed Glycine 0 C--N 1.3 -1.46 0 N-CA-C 109.97 -1.252 . . . . 71.420000000000002 109.97 178.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -140.04 -171.25 3.14 Favored 'General case' 0 N--CA 1.424 -1.763 0 N-CA-C 108.851 -0.796 . . . . 71.310000000000002 108.851 -175.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 23.7 ptt180 -112.62 146.02 39.35 Favored 'General case' 0 C--N 1.294 -1.839 0 O-C-N 123.578 0.549 . . . . 75.329999999999998 110.577 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.515 ' O ' HD23 ' A' ' 49' ' ' LEU . 93.5 m-85 -129.45 131.64 46.78 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.885 -0.598 . . . . 75.010000000000005 109.613 178.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 53.8 tp -90.45 129.38 36.64 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.033 -0.728 . . . . 75.450000000000003 109.033 178.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -79.75 113.84 18.21 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 119.855 -0.738 . . . . 75.120000000000005 110.379 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -112.2 -24.99 9.52 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 122.186 0.994 . . . . 75.409999999999997 108.506 174.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -92.39 127.55 48.25 Favored Pre-proline 0 C--N 1.306 -1.291 0 CA-C-N 114.305 -1.316 . . . . 75.349999999999994 110.171 -174.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.473 ' O ' ' HA ' ' A' ' 93' ' ' ARG . 10.4 Cg_endo -57.78 -41.79 66.21 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 122.852 2.368 . . . . 53.310000000000002 112.783 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 32.0 m -118.34 109.35 16.18 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 109.386 -0.598 . . . . 73.299999999999997 109.386 178.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 64.1 m -106.32 115.39 30.13 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 115.913 -0.585 . . . . 73.129999999999995 109.594 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.7 m -86.49 120.61 28.0 Favored 'General case' 0 C--O 1.25 1.127 0 CA-C-N 116.184 -0.462 . . . . 74.340000000000003 109.942 -177.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -101.99 112.98 25.82 Favored 'General case' 0 C--O 1.252 1.232 0 CA-C-O 120.88 0.372 . . . . 64.439999999999998 110.445 179.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 170.4 -173.19 44.3 Favored Glycine 0 N--CA 1.426 -1.993 0 N-CA-C 110.07 -1.212 . . . . 53.530000000000001 110.07 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -119.26 95.42 4.8 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 105.808 -1.923 . . . . 64.400000000000006 105.808 178.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 8.7 m80 -134.65 178.26 1.85 Allowed Pre-proline 0 C--N 1.287 -2.127 0 N-CA-C 106.289 -1.745 . . . . 73.109999999999999 106.289 -177.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -64.21 -21.54 67.38 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 121.45 1.434 . . . . 74.519999999999996 109.732 167.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -116.66 78.79 1.24 Allowed 'General case' 0 N--CA 1.434 -1.24 0 C-N-CA 123.958 0.903 . . . . 72.400000000000006 109.754 178.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 74.2 m -104.58 118.45 36.61 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-N 115.467 -0.788 . . . . 70.209999999999994 109.482 172.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -78.01 -43.43 29.5 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 108.694 -0.854 . . . . 75.25 108.694 177.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.8 pp -120.5 166.49 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 N-CA-C 107.786 -1.191 . . . . 74.340000000000003 107.786 171.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -107.53 135.96 48.12 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 115.161 1.541 . . . . 71.129999999999995 115.161 -168.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.459 ' HA ' ' CB ' ' A' ' 56' ' ' ASN . 4.0 mm? -125.08 153.41 42.97 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 104.429 -2.434 . . . . 74.109999999999999 104.429 171.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -144.72 -14.86 0.55 Allowed 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 118.793 -1.163 . . . . 73.019999999999996 112.557 -175.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -72.89 161.49 30.65 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 123.579 0.751 . . . . 71.310000000000002 110.747 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.3 p -77.12 -16.32 14.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-O 122.202 1.001 . . . . 74.450000000000003 110.377 -176.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -82.93 11.45 6.11 Favored 'General case' 0 N--CA 1.42 -1.928 0 CA-C-N 114.768 -1.106 . . . . 71.420000000000002 112.973 -179.206 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.0 p -83.3 139.74 17.28 Favored 'Isoleucine or valine' 0 C--O 1.244 0.783 0 CA-C-O 121.068 0.461 . . . . 63.140000000000001 109.833 176.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 28.4 t -105.37 157.11 17.56 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.446 -0.946 . . . . 72.299999999999997 108.446 179.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -69.98 110.69 5.2 Favored 'General case' 0 C--O 1.249 1.035 0 N-CA-C 106.839 -1.541 . . . . 73.209999999999994 106.839 174.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 59.4 mtt180 60.49 78.15 0.29 Allowed 'General case' 0 C--N 1.316 -0.867 0 O-C-N 124.536 1.147 . . . . 73.420000000000002 107.964 -166.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 45.0 t60 -77.29 -43.06 34.54 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 113.554 -1.657 . . . . 74.420000000000002 108.46 -176.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -150.67 159.19 44.69 Favored 'General case' 0 N--CA 1.422 -1.838 0 N-CA-C 107.251 -1.389 . . . . 74.450000000000003 107.251 178.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -136.73 127.86 27.9 Favored 'General case' 0 C--N 1.283 -2.311 0 N-CA-C 107.615 -1.254 . . . . 74.340000000000003 107.615 176.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -110.28 124.48 51.72 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.955 -0.757 . . . . 74.310000000000002 108.955 -177.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.473 ' HA ' ' O ' ' A' ' 66' ' ' PRO . 42.7 mtp85 -119.09 138.18 53.06 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-O 121.317 0.58 . . . . 74.450000000000003 112.449 175.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.46 ' O ' HD13 ' A' ' 94' ' ' ILE . 2.8 pp -116.02 116.47 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.152 0 N-CA-C 106.664 -1.606 . . . . 72.239999999999995 106.664 173.266 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -118.68 147.49 43.74 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 115.452 -0.794 . . . . 72.040000000000006 110.666 -173.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -45.82 -32.22 2.48 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.896 1.278 . . . . 72.409999999999997 112.385 178.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -78.72 -59.19 2.87 Favored Glycine 0 N--CA 1.436 -1.355 0 N-CA-C 111.488 -0.645 . . . . 74.150000000000006 111.488 175.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -158.28 173.77 16.18 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 123.777 0.831 . . . . 75.219999999999999 109.304 -175.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -102.68 134.73 45.57 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.068 -1.086 . . . . 72.230000000000004 108.068 -178.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -132.31 135.73 46.41 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 114.117 1.154 . . . . 74.329999999999998 114.117 -177.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 6.9 p -110.98 127.62 67.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 CA-C-N 114.532 -1.213 . . . . 72.140000000000001 107.973 177.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.6 p -119.09 130.3 74.04 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 C-N-CA 120.347 -0.541 . . . . 75.549999999999997 111.779 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -81.37 106.22 13.17 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 105.533 -2.025 . . . . 63.210000000000001 105.533 174.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.6 m -104.35 13.86 7.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 112.761 0.652 . . . . 62.100000000000001 112.761 -175.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 114.02 73.82 0.61 Allowed Glycine 0 CA--C 1.489 -1.544 0 C-N-CA 120.537 -0.84 . . . . 53.240000000000002 111.239 178.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 14.0 p -91.76 138.23 31.72 Favored 'General case' 0 N--CA 1.416 -2.154 0 CA-C-N 115.337 -0.432 . . . . 75.310000000000002 110.218 -177.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 5.8 tt -82.75 -47.55 11.83 Favored 'General case' 0 C--N 1.315 -0.935 0 N-CA-C 108.016 -1.105 . . . . 71.430000000000007 108.016 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.433 ' OD1' ' HA3' ' A' ' 131' ' ' GLY . 11.6 t-20 -68.42 -32.64 72.82 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.679 -0.691 . . . . 72.450000000000003 109.901 179.207 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 130' ' ' ILE . . . 112.53 131.68 5.63 Favored Glycine 0 C--O 1.223 -0.573 0 CA-C-N 116.093 -0.503 . . . . 52.399999999999999 112.233 179.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -109.16 122.03 46.43 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 123.389 0.676 . . . . 73.510000000000005 109.717 176.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -123.76 133.06 53.91 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 108.616 -0.883 . . . . 71.200000000000003 108.616 178.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 45.4 t -121.35 117.45 52.77 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 N-CA-C 106.128 -1.804 . . . . 72.409999999999997 106.128 177.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.461 ' HB2' HH21 ' A' ' 117' ' ' ARG . 20.3 m120 66.88 24.74 9.66 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 108.556 -0.905 . . . . 74.140000000000001 108.556 -172.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.524 ' HG2' ' OE1' ' A' ' 129' ' ' GLN . 96.2 mtt180 75.77 2.84 3.77 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 126.001 1.72 . . . . 74.150000000000006 112.833 -178.156 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 55.0 mm-40 -104.97 129.49 24.75 Favored Pre-proline 0 C--N 1.311 -1.071 0 N-CA-C 109.11 -0.7 . . . . 72.329999999999998 109.11 178.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -71.56 124.76 10.57 Favored 'Trans proline' 0 C--O 1.247 0.957 0 C-N-CA 122.116 1.878 . . . . 64.030000000000001 108.881 174.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.461 HH21 ' HB2' ' A' ' 113' ' ' ASN . 47.4 mtt180 -119.98 -158.78 0.75 Allowed 'General case' 0 C--N 1.31 -1.113 0 O-C-N 121.951 -0.468 . . . . 73.209999999999994 111.24 -172.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -121.74 -45.24 2.29 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 108.104 -1.073 . . . . 73.0 108.104 174.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -156.7 138.87 14.61 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 107.28 -1.378 . . . . 63.329999999999998 107.28 171.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 53.8 tp60 -141.73 150.85 42.33 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 110.437 -0.209 . . . . 74.439999999999998 110.437 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 78.7 t -78.87 127.96 38.7 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 107.24 -1.393 . . . . 71.239999999999995 107.24 174.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 82.0 mtp -71.68 120.02 16.67 Favored 'General case' 0 CA--C 1.497 -1.085 0 CA-C-N 115.757 -0.656 . . . . 72.120000000000005 109.28 -175.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 14.2 tp60 -105.39 130.17 53.55 Favored 'General case' 0 N--CA 1.415 -2.182 0 N-CA-C 108.362 -0.977 . . . . 74.049999999999997 108.362 -177.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 18.9 p -78.35 123.54 27.1 Favored 'General case' 0 N--CA 1.424 -1.769 0 CA-C-O 121.1 0.476 . . . . 75.450000000000003 110.606 -177.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 123.62 -17.61 7.77 Favored Glycine 0 N--CA 1.416 -2.664 0 CA-C-N 115.432 -0.803 . . . . 63.140000000000001 111.791 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -104.32 -169.73 1.67 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 120.133 -0.627 . . . . 64.299999999999997 110.941 -176.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -136.97 136.11 38.25 Favored 'General case' 0 C--O 1.25 1.123 0 CA-C-O 121.829 0.823 . . . . 75.120000000000005 112.141 -171.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 74.4 mt -110.29 130.59 63.29 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 C-N-CA 125.418 1.487 . . . . 71.219999999999999 107.926 -179.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.524 ' OE1' ' HG2' ' A' ' 114' ' ' ARG . 52.0 mt-30 -109.74 133.46 53.11 Favored 'General case' 0 C--N 1.29 -2.02 0 C-N-CA 120.347 -0.541 . . . . 74.349999999999994 110.713 -178.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.439 ' HA ' ' O ' ' A' ' 109' ' ' GLY . 0.2 OUTLIER -107.44 97.71 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.963 0 N-CA-C 106.783 -1.562 . . . . 74.420000000000002 106.783 171.859 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.433 ' HA3' ' OD1' ' A' ' 108' ' ' ASN . . . 70.78 -115.25 5.77 Favored Glycine 0 N--CA 1.427 -1.95 0 N-CA-C 108.81 -1.716 . . . . 65.450000000000003 108.81 -170.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -112.3 2.31 16.48 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.074 0.464 . . . . 64.099999999999994 110.689 176.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -85.78 140.19 30.68 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 106.402 -1.703 . . . . 75.310000000000002 106.402 177.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.45 ' HG3' ' HB2' ' A' ' 52' ' ' LYS . 15.3 ptm180 -116.75 131.63 56.9 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.043 -1.063 . . . . 74.540000000000006 113.856 -168.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 34.3 tp -122.58 121.5 36.63 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 114.032 -1.44 . . . . 74.420000000000002 108.715 -177.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 10.7 p -106.66 137.54 36.75 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.15 0 N-CA-C 108.863 -0.791 . . . . 74.319999999999993 108.863 -178.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -114.33 115.67 27.74 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 110.293 -0.262 . . . . 70.010000000000005 110.293 -173.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -121.47 163.62 18.5 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 109.065 -0.717 . . . . 75.549999999999997 109.065 -178.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -75.3 147.03 40.53 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 109.461 -0.57 . . . . 62.009999999999998 109.461 177.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.501 ' N ' ' HA ' ' A' ' 47' ' ' ALA . . . -104.39 -149.88 20.22 Favored Glycine 0 N--CA 1.426 -2.013 0 C-N-CA 120.551 -0.833 . . . . 72.450000000000003 111.403 -176.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo . . . . . 0 N--CA 1.427 -2.391 0 C-N-CA 122.529 2.152 . . . . 74.409999999999997 112.693 179.505 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 58.6 t30 . . . . . 0 C--O 1.237 0.439 0 N-CA-C 109.816 -0.438 . . . . 74.409999999999997 109.816 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -56.63 100.03 0.1 Allowed Glycine 0 CA--C 1.506 -0.484 0 O-C-N 123.679 0.612 . . . . 64.120000000000005 112.965 -178.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.7 m -119.05 130.95 24.56 Favored Pre-proline 0 C--N 1.304 -1.375 0 N-CA-C 109.438 -0.579 . . . . 75.040000000000006 109.438 -176.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.91 127.38 16.85 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 121.667 1.578 . . . . 72.209999999999994 110.13 175.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -97.12 113.99 63.98 Favored Pre-proline 0 C--N 1.301 -1.518 0 N-CA-C 109.053 -0.721 . . . . 72.129999999999995 109.053 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -62.26 136.32 59.29 Favored 'Trans proline' 0 C--O 1.237 0.457 0 C-N-CA 123.342 2.694 . . . . 74.329999999999998 113.867 -173.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.0 tm0? -126.95 109.26 11.75 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 107.145 -1.428 . . . . 71.129999999999995 107.145 178.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.7 p -94.14 132.91 36.9 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 109.297 -0.631 . . . . 70.219999999999999 109.297 178.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -114.43 139.25 49.66 Favored 'General case' 0 N--CA 1.424 -1.727 0 N-CA-C 109.083 -0.71 . . . . 74.340000000000003 109.083 -178.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.0 m -100.86 118.41 36.87 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.735 -0.839 . . . . 74.129999999999995 108.735 -177.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 40.0 p -116.17 103.83 10.92 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 121.352 0.596 . . . . 73.109999999999999 111.843 -178.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.6 p -112.42 138.77 48.68 Favored 'General case' 0 N--CA 1.42 -1.932 0 N-CA-C 107.42 -1.326 . . . . 61.130000000000003 107.42 176.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.1 m . . . . . 0 C--N 1.3 -1.581 0 CA-C-O 121.372 0.606 . . . . 74.099999999999994 111.9 -177.7 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.376 0 N-CA-C 111.446 -0.662 . . . . 71.409999999999997 111.446 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.5 m -112.32 153.82 26.64 Favored 'General case' 0 N--CA 1.424 -1.761 0 N-CA-C 108.707 -0.849 . . . . 75.140000000000001 108.707 177.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.418 ' O ' ' HG ' ' A' ' 62' ' ' LEU . . . -153.43 146.4 24.51 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 108.756 -0.831 . . . . 70.239999999999995 108.756 -178.062 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -130.23 160.12 34.8 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 109.484 -0.561 . . . . 75.299999999999997 109.484 -178.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.415 HD13 ' CZ ' ' A' ' 61' ' ' PHE . 3.7 pp -133.93 147.77 51.12 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 116.349 -0.387 . . . . 75.5 110.672 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.471 HG12 ' HB3' ' A' ' 60' ' ' ARG . 27.9 m -117.03 129.24 73.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 108.961 -0.755 . . . . 64.219999999999999 108.961 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.5 t -97.79 118.79 44.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 N-CA-C 107.754 -1.202 . . . . 71.340000000000003 107.754 176.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -110.81 -13.56 14.13 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.827 -0.624 . . . . 74.400000000000006 112.626 -173.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 16.6 tpp180 -150.1 125.94 10.45 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.86 -0.793 . . . . 71.140000000000001 108.86 176.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 139.9 135.76 3.28 Favored Glycine 0 C--O 1.206 -1.622 0 C-N-CA 120.722 -0.751 . . . . 65.230000000000004 112.472 176.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.517 ' HD2' ' CE1' ' A' ' 133' ' ' PHE . 39.2 Cg_exo -67.71 -8.66 23.06 Favored 'Trans proline' 0 N--CA 1.484 0.939 0 C-N-CA 123.134 2.556 . . . . 75.430000000000007 112.951 174.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -66.02 -40.13 90.81 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.203 -0.453 . . . . 73.540000000000006 110.667 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -169.26 173.56 6.61 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 109.252 -0.647 . . . . 73.439999999999998 109.252 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.93 43.61 0.41 Allowed Glycine 0 CA--C 1.487 -1.707 0 N-CA-C 108.997 -1.641 . . . . 74.030000000000001 108.997 178.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -147.15 -173.18 4.18 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.722 -0.844 . . . . 75.439999999999998 108.722 -174.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.471 ' HB3' HG12 ' A' ' 50' ' ' VAL . 14.1 ptt180 -121.69 141.48 51.11 Favored 'General case' 0 N--CA 1.434 -1.233 0 O-C-N 123.687 0.617 . . . . 75.299999999999997 110.116 179.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.415 ' CZ ' HD13 ' A' ' 49' ' ' LEU . 52.6 p90 -149.39 152.45 35.77 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 109.042 -0.725 . . . . 74.099999999999994 109.042 175.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 47' ' ' ALA . 9.2 tt -99.43 140.51 33.51 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 123.622 0.576 . . . . 71.409999999999997 109.621 -176.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 84.3 mt -81.13 114.26 19.85 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 121.279 0.562 . . . . 73.319999999999993 110.955 -176.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -122.25 -36.78 2.91 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.253 -1.017 . . . . 74.129999999999995 108.253 174.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.5 pm0 -64.46 130.18 94.54 Favored Pre-proline 0 N--CA 1.436 -1.148 0 CA-C-N 114.965 -1.016 . . . . 74.219999999999999 110.031 175.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.47 -30.64 91.22 Favored 'Trans proline' 0 N--CA 1.479 0.663 0 C-N-CA 123.846 3.031 . . . . 75.120000000000005 113.477 -173.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 90.0 m -135.92 116.14 13.47 Favored 'General case' 0 N--CA 1.416 -2.158 0 CA-C-N 115.929 -0.578 . . . . 75.219999999999999 109.801 178.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.473 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 11.9 m -100.65 115.36 30.02 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 106.717 -1.586 . . . . 72.420000000000002 106.717 176.322 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.7 p -96.82 108.8 21.54 Favored 'General case' 0 N--CA 1.425 -1.679 0 CA-C-O 121.414 0.626 . . . . 74.299999999999997 112.169 -176.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.4 ' O ' ' HB3' ' A' ' 89' ' ' HIS . . . -102.32 92.55 4.76 Favored 'General case' 0 N--CA 1.425 -1.71 0 N-CA-C 107.836 -1.172 . . . . 71.540000000000006 107.836 174.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.613 ' O ' ' HA ' ' A' ' 88' ' ' ARG . . . 99.97 102.01 2.42 Favored Glycine 0 N--CA 1.428 -1.871 0 N-CA-C 110.5 -1.04 . . . . 71.239999999999995 110.5 -178.19 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.3 mmt85 -155.14 -61.1 0.11 Allowed 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 124.866 1.266 . . . . 72.420000000000002 108.488 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.413 ' HB3' ' HD2' ' A' ' 74' ' ' PRO . 94.4 m-70 -146.2 177.21 1.85 Allowed Pre-proline 0 C--N 1.295 -1.786 0 N-CA-C 106.751 -1.574 . . . . 72.030000000000001 106.751 -178.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.413 ' HD2' ' HB3' ' A' ' 73' ' ' HIS . 6.3 Cg_endo -54.24 -30.69 62.97 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 121.88 1.72 . . . . 74.439999999999998 110.508 170.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -107.79 72.58 0.86 Allowed 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 115.16 -0.927 . . . . 74.120000000000005 109.678 178.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.423 ' HB2' ' O ' ' A' ' 78' ' ' ILE . 41.5 m -91.01 -174.82 4.13 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.502 -1.296 . . . . 75.439999999999998 107.502 173.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -60.9 -44.33 97.29 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 108.32 -0.992 . . . . 72.340000000000003 108.32 177.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.423 ' O ' ' HB2' ' A' ' 76' ' ' SER . 36.8 pt -128.02 143.59 40.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 105.582 -2.007 . . . . 73.409999999999997 105.582 170.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -99.48 126.45 45.41 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 118.568 -1.253 . . . . 75.219999999999999 112.113 -175.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.5 mp -85.46 89.6 7.74 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 106.361 -1.718 . . . . 74.310000000000002 106.361 175.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -45.27 -58.73 3.07 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.552 -1.204 . . . . 75.519999999999996 113.542 -173.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -162.84 -167.05 1.42 Allowed 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 106.69 -1.596 . . . . 54.219999999999999 106.69 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 83.2 t 74.3 -41.95 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.246 1.418 . . . . 72.349999999999994 112.58 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.533 ' HB ' ' CZ ' ' A' ' 133' ' ' PHE . 56.6 m -154.04 71.96 0.87 Allowed 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.358 0.599 . . . . 61.43 110.331 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.3 p -114.45 109.03 27.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 O-C-N 121.617 -0.677 . . . . 75.420000000000002 112.401 176.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 36.0 t -97.74 170.29 9.09 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.699 -0.852 . . . . 73.430000000000007 108.699 174.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 60.0 ttt180 -78.39 -8.23 58.23 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 122.952 1.358 . . . . 74.439999999999998 109.381 -179.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.613 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -170.61 125.65 0.72 Allowed 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 104.154 -2.536 . . . . 74.530000000000001 104.154 173.047 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.4 ' HB3' ' O ' ' A' ' 70' ' ' ALA . 11.7 t60 -128.46 -76.97 0.56 Allowed 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 118.939 -1.105 . . . . 74.519999999999996 112.914 -172.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -127.7 119.26 25.44 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-O 121.272 0.558 . . . . 73.310000000000002 109.605 -176.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -114.03 128.01 56.2 Favored 'General case' 0 C--N 1.276 -2.594 0 C-N-CA 120.02 -0.672 . . . . 65.530000000000001 110.439 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.473 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 56.2 m-85 -97.41 121.21 39.05 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 107.991 -1.114 . . . . 75.140000000000001 107.991 -178.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 34.3 mmt-85 -104.91 129.13 53.36 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.437 -0.949 . . . . 71.420000000000002 108.437 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 11.4 pt -115.88 130.96 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.201 0 C-N-CA 118.504 -1.279 . . . . 73.019999999999996 108.022 173.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.435 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 56.0 t-20 -120.03 145.47 46.79 Favored 'General case' 0 C--N 1.269 -2.93 0 N-CA-C 106.547 -1.649 . . . . 74.109999999999999 106.547 -175.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -59.7 -20.27 55.26 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-O 121.357 0.598 . . . . 64.530000000000001 110.267 174.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -77.61 -61.81 2.52 Favored Glycine 0 N--CA 1.423 -2.172 0 CA-C-N 115.488 -0.778 . . . . 63.549999999999997 111.604 174.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.435 ' O ' ' HB3' ' A' ' 95' ' ' ASN . 27.3 tt0 -157.4 -178.11 7.1 Favored 'General case' 0 CA--C 1.552 1.023 0 CA-C-N 117.475 0.637 . . . . 74.0 109.346 -176.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.633 ' HB3' ' SD ' ' A' ' 122' ' ' MET . 81.5 m-85 -109.71 130.05 55.55 Favored 'General case' 0 C--N 1.311 -1.091 0 O-C-N 121.963 -0.46 . . . . 72.099999999999994 110.52 -176.183 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -132.53 135.84 46.23 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-O 120.633 0.254 . . . . 74.400000000000006 111.464 -175.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 8.9 p -114.56 129.62 70.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 O-C-N 121.845 -0.534 . . . . 74.420000000000002 110.073 176.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 59.4 t -118.92 128.97 75.72 Favored 'Isoleucine or valine' 0 C--O 1.248 0.98 0 CA-C-N 116.313 -0.403 . . . . 75.25 111.321 -177.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -83.95 117.96 23.7 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.637 -0.71 . . . . 63.210000000000001 109.215 173.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.416 ' O ' ' HG2' ' A' ' 88' ' ' ARG . 17.8 m -118.2 8.0 6.9 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.35 0 N-CA-C 108.258 -1.016 . . . . 73.239999999999995 108.258 176.02 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.436 ' HA2' ' O ' ' A' ' 88' ' ' ARG . . . -91.2 -66.15 1.16 Allowed Glycine 0 N--CA 1.404 -3.446 0 CA-C-N 114.578 -1.192 . . . . 72.439999999999998 111.091 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 14.0 m 60.07 1.46 0.34 Allowed 'General case' 0 CA--C 1.566 1.573 0 C-N-CA 124.252 1.021 . . . . 74.299999999999997 112.282 -179.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.419 ' H ' ' C ' ' A' ' 105' ' ' GLY . 49.1 tp -72.98 -50.82 21.01 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.099 0.959 . . . . 70.310000000000002 109.656 -177.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -99.23 -35.44 9.97 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.114 -0.948 . . . . 73.5 109.397 176.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 104.05 133.84 7.98 Favored Glycine 0 N--CA 1.427 -1.964 0 N-CA-C 110.584 -1.006 . . . . 73.129999999999995 110.584 -178.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 97.7 m -101.87 119.62 39.08 Favored 'General case' 0 C--N 1.281 -2.374 0 N-CA-C 108.847 -0.797 . . . . 75.099999999999994 108.847 178.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 116' ' ' PRO . 3.9 m-85 -111.32 132.48 54.36 Favored 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 106.487 -1.671 . . . . 74.019999999999996 106.487 -177.229 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.7 p -131.16 131.92 63.51 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.776 0 C-N-CA 119.953 -0.699 . . . . 73.140000000000001 110.696 178.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 66.56 -72.46 0.08 Allowed 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 125.506 1.523 . . . . 73.010000000000005 110.841 -177.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -154.59 4.26 0.24 Allowed 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.902 -0.59 . . . . 75.040000000000006 109.489 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -132.98 134.72 24.78 Favored Pre-proline 0 C--O 1.237 0.43 0 O-C-N 121.319 -0.863 . . . . 74.439999999999998 112.487 -174.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.417 ' HA ' ' HA ' ' A' ' 111' ' ' TYR . 2.9 Cg_exo -77.23 116.01 4.07 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 122.332 2.021 . . . . 75.230000000000004 108.702 170.144 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.437 HH11 ' HG3' ' A' ' 120' ' ' GLN . 7.0 ptp180 -144.06 151.41 39.61 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.112 -1.07 . . . . 74.299999999999997 108.112 -178.299 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -76.22 -42.19 46.86 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 112.529 0.566 . . . . 74.349999999999994 112.529 -174.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -125.84 140.61 52.52 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 109.331 -0.618 . . . . 75.540000000000006 109.331 179.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.437 ' HG3' HH11 ' A' ' 117' ' ' ARG . 1.6 tm0? -138.94 149.85 45.23 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 116.41 -0.359 . . . . 71.420000000000002 110.561 -178.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 81.1 t -104.5 117.68 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 N-CA-C 105.743 -1.947 . . . . 75.319999999999993 105.743 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.633 ' SD ' ' HB3' ' A' ' 99' ' ' PHE . 66.7 mtt -59.86 128.67 38.04 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 113.87 1.063 . . . . 72.530000000000001 113.87 -169.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -112.07 137.73 49.71 Favored 'General case' 0 N--CA 1.418 -2.044 0 N-CA-C 107.079 -1.452 . . . . 74.329999999999998 107.079 178.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.8 t -79.37 129.76 34.78 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-O 121.368 0.604 . . . . 62.509999999999998 110.826 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 83.79 38.21 10.79 Favored Glycine 0 N--CA 1.424 -2.118 0 N-CA-C 110.014 -1.234 . . . . 71.109999999999999 110.014 -178.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -125.25 166.81 15.82 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.722 -0.391 . . . . 74.319999999999993 110.985 -177.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 19.1 tp10 -107.47 120.56 42.51 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 123.405 0.682 . . . . 75.030000000000001 109.181 -172.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 61.6 mt -114.96 117.6 56.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 108.006 -1.109 . . . . 72.25 108.006 179.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -116.49 111.8 20.49 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.255 0.55 . . . . 73.209999999999994 109.787 -175.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 25.6 pt -101.71 98.36 6.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-O 121.83 0.824 . . . . 74.239999999999995 109.384 179.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 70.36 -100.09 0.78 Allowed Glycine 0 N--CA 1.435 -1.386 0 N-CA-C 110.384 -1.087 . . . . 70.120000000000005 110.384 -175.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -115.18 0.35 13.53 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 120.938 0.399 . . . . 75.019999999999996 110.603 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.533 ' CZ ' ' HB ' ' A' ' 84' ' ' THR . 9.7 m-30 -93.27 141.15 28.76 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.035 -0.728 . . . . 74.409999999999997 109.035 -176.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 41.0 mtm180 -121.81 122.55 39.73 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.889 0.852 . . . . 75.049999999999997 111.193 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.8 tt -124.72 131.1 53.48 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 113.744 -1.571 . . . . 74.420000000000002 108.77 -176.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 57.5 t -108.09 128.41 63.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 108.697 -0.853 . . . . 73.120000000000005 108.697 178.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -100.78 130.05 46.75 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.953 -0.567 . . . . 74.340000000000003 110.438 -176.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.4 mp -130.66 130.45 43.93 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.692 -0.484 . . . . 75.409999999999997 109.692 179.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -122.38 117.67 26.6 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 108.07 -1.085 . . . . 74.129999999999995 108.07 177.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -174.04 -60.11 0.05 OUTLIER Glycine 0 C--N 1.294 -1.786 0 C-N-CA 120.125 -1.036 . . . . 73.319999999999993 112.673 -176.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo . . . . . 0 C--N 1.358 1.045 0 C-N-CA 121.917 1.744 . . . . 73.420000000000002 110.895 176.936 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 . . . . . 0 CA--C 1.493 -1.221 0 N-CA-C 107.277 -1.379 . . . . 74.0 107.277 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 93.11 45.65 3.51 Favored Glycine 0 N--CA 1.431 -1.682 0 N-CA-C 109.631 -1.388 . . . . 73.049999999999997 109.631 -175.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 55.9 m -92.28 122.91 63.86 Favored Pre-proline 0 N--CA 1.416 -2.141 0 N-CA-C 107.833 -1.173 . . . . 73.510000000000005 107.833 178.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.56 128.95 19.02 Favored 'Trans proline' 0 N--CA 1.448 -1.205 0 C-N-CA 122.211 1.941 . . . . 71.030000000000001 111.272 177.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -73.67 109.73 7.32 Favored Pre-proline 0 C--N 1.315 -0.9 0 N-CA-C 107.168 -1.419 . . . . 71.420000000000002 107.168 173.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -73.24 132.84 18.48 Favored 'Trans proline' 0 N--CA 1.443 -1.465 0 C-N-CA 122.186 1.924 . . . . 73.439999999999998 113.016 -171.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -110.27 116.73 32.0 Favored 'General case' 0 N--CA 1.422 -1.837 0 CA-C-N 115.573 -0.74 . . . . 64.340000000000003 109.323 175.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.9 p -86.01 88.84 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.519 0 CA-C-O 122.542 1.163 . . . . 72.439999999999998 110.062 178.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -125.52 120.35 30.66 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 106.667 -1.605 . . . . 60.310000000000002 106.667 178.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.5 m -113.4 98.98 7.43 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-O 121.321 0.581 . . . . 64.239999999999995 111.281 -175.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.5 m -105.85 -11.58 16.18 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 122.557 1.17 . . . . 74.150000000000006 108.459 175.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.2 t -83.26 91.83 7.36 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 114.218 -1.355 . . . . 74.519999999999996 108.24 176.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 59.8 t . . . . . 0 C--N 1.311 -1.087 0 N-CA-C 107.721 -1.215 . . . . 73.010000000000005 107.721 -178.502 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.257 0 N-CA-C 110.473 -1.051 . . . . 70.450000000000003 110.473 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.9 m -132.83 158.11 43.33 Favored 'General case' 0 N--CA 1.426 -1.635 0 N-CA-C 109.312 -0.625 . . . . 74.540000000000006 109.312 179.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -162.31 167.45 23.84 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.013 -1.477 . . . . 74.409999999999997 107.013 -177.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -134.55 158.26 44.43 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 109.231 -0.655 . . . . 74.340000000000003 109.231 178.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.4 pp -114.45 136.49 52.95 Favored 'General case' 0 N--CA 1.412 -2.337 0 N-CA-C 108.179 -1.045 . . . . 72.450000000000003 108.179 175.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 60.8 t -121.67 124.99 72.83 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.397 0 N-CA-C 107.895 -1.15 . . . . 74.310000000000002 107.895 -179.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.404 HG12 ' OD1' ' A' ' 56' ' ' ASN . 42.0 t -92.65 115.57 31.82 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 N-CA-C 107.446 -1.316 . . . . 75.409999999999997 107.446 177.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -85.12 -36.57 21.03 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-N 114.491 -1.231 . . . . 71.340000000000003 110.513 -174.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.461 ' O ' ' HB3' ' A' ' 133' ' ' PHE . 16.1 tpp180 -155.3 121.33 5.14 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 120.143 -0.623 . . . . 75.340000000000003 110.906 -178.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.416 ' HA2' ' CD1' ' A' ' 133' ' ' PHE . . . 162.08 141.97 3.27 Favored Glycine 0 C--O 1.194 -2.361 0 O-C-N 124.038 0.837 . . . . 73.109999999999999 111.102 176.017 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.407 ' HB2' ' OD2' ' A' ' 81' ' ' ASP . 17.0 Cg_exo -68.64 -10.07 27.99 Favored 'Trans proline' 0 N--CA 1.477 0.527 0 C-N-CA 122.45 2.1 . . . . 60.210000000000001 111.603 177.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.465 ' HA ' ' N ' ' A' ' 81' ' ' ASP . 4.4 p30 -59.35 -53.88 53.2 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 115.134 -0.939 . . . . 71.310000000000002 109.775 175.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -164.29 174.49 11.06 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-N 115.809 -0.632 . . . . 64.239999999999995 109.471 -179.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -163.45 54.36 0.29 Allowed Glycine 0 C--N 1.289 -2.083 0 N-CA-C 108.531 -1.828 . . . . 62.25 108.531 179.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -150.04 178.42 8.96 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 108.184 -1.043 . . . . 71.439999999999998 108.184 -175.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -102.36 137.81 40.11 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 108.147 -1.057 . . . . 75.329999999999998 108.147 179.151 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -132.43 129.89 39.87 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.095 -0.706 . . . . 75.439999999999998 109.095 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 52.4 tp -88.88 128.05 35.66 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 116.34 -0.391 . . . . 75.349999999999994 110.897 -176.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -77.73 115.47 17.51 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 108.267 -1.012 . . . . 71.120000000000005 108.267 176.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -143.14 -53.09 0.38 Allowed 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 115.029 -0.987 . . . . 72.510000000000005 109.348 -177.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -69.63 121.31 82.01 Favored Pre-proline 0 C--N 1.312 -1.061 0 N-CA-C 108.505 -0.924 . . . . 72.129999999999995 108.505 177.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -42.07 -51.37 4.74 Favored 'Trans proline' 0 C--N 1.372 1.795 0 C-N-CA 124.745 3.63 . . . . 61.130000000000003 113.958 -173.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.5 m -102.97 99.88 9.8 Favored 'General case' 0 N--CA 1.415 -2.205 0 CA-C-N 116.144 -0.48 . . . . 70.239999999999995 109.844 179.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 86.2 m -98.14 114.05 26.13 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.422 -1.325 . . . . 72.209999999999994 107.422 175.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.7 m -105.58 133.92 49.54 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 112.925 0.713 . . . . 73.230000000000004 112.925 -171.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -108.63 117.5 34.34 Favored 'General case' 0 C--O 1.253 1.243 0 N-CA-C 108.386 -0.968 . . . . 64.129999999999995 108.386 175.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -158.68 -179.83 33.82 Favored Glycine 0 N--CA 1.438 -1.209 0 C-N-CA 120.158 -1.02 . . . . 74.319999999999993 111.188 -177.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.6 ttp180 -90.21 8.5 32.75 Favored 'General case' 0 CA--C 1.553 1.064 0 CA-C-O 121.949 0.881 . . . . 64.310000000000002 110.089 -176.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 60.8 m-70 -88.94 146.54 36.84 Favored Pre-proline 0 C--N 1.298 -1.64 0 N-CA-C 108.805 -0.813 . . . . 72.299999999999997 108.805 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -66.83 -28.73 42.8 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 121.729 1.619 . . . . 73.219999999999999 109.534 174.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -90.69 65.57 5.94 Favored 'General case' 0 N--CA 1.423 -1.819 0 CA-C-N 114.385 -1.28 . . . . 74.420000000000002 109.236 177.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.6 p -121.35 -174.76 2.92 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 106.066 -1.828 . . . . 72.340000000000003 106.066 175.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -100.67 -41.09 7.06 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 119.374 -0.931 . . . . 75.150000000000006 108.956 178.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 41.7 pt -114.78 150.58 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.618 0 N-CA-C 106.99 -1.485 . . . . 73.400000000000006 106.99 170.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -87.51 136.18 33.05 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 109.441 -0.577 . . . . 75.310000000000002 109.441 -179.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 50.4 tp -125.26 122.7 37.7 Favored 'General case' 0 N--CA 1.413 -2.319 0 CA-C-O 121.832 0.825 . . . . 75.420000000000002 111.043 -175.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.465 ' N ' ' HA ' ' A' ' 56' ' ' ASN . 33.9 t70 -142.59 108.5 5.17 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 114.561 -1.2 . . . . 71.540000000000006 108.304 176.078 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -137.04 161.84 34.96 Favored 'General case' 0 C--N 1.264 -3.137 0 CA-C-N 113.116 -1.856 . . . . 75.420000000000002 107.934 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.7 m -80.43 -15.46 12.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-O 121.441 0.639 . . . . 73.239999999999995 112.095 -177.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.495 ' OG1' ' HB3' ' A' ' 108' ' ' ASN . 3.1 p -128.54 45.73 2.73 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 122.261 1.029 . . . . 62.049999999999997 108.5 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.8 p -81.21 139.68 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 CA-C-N 113.672 -1.604 . . . . 64.209999999999994 110.789 -173.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 24.4 t -101.28 163.09 12.45 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 107.26 -1.385 . . . . 62.130000000000003 107.26 177.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 26.4 ttm180 -60.91 -43.3 98.73 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 108.946 -0.761 . . . . 71.420000000000002 108.946 179.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.0 133.23 54.37 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 105.434 -2.061 . . . . 74.230000000000004 105.434 175.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 21.1 t60 -113.19 -68.63 0.92 Allowed 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.232 -0.987 . . . . 74.209999999999994 111.273 -174.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.37 153.65 40.75 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 116.295 -0.412 . . . . 74.409999999999997 109.889 -176.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -117.59 127.34 53.87 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 108.299 -1.0 . . . . 71.510000000000005 108.299 178.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -100.51 115.58 30.45 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 107.744 -1.206 . . . . 74.400000000000006 107.744 178.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 61.9 mtp85 -106.85 123.13 47.71 Favored 'General case' 0 C--N 1.285 -2.238 0 N-CA-C 108.566 -0.902 . . . . 74.150000000000006 108.566 -176.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.3 tp -115.67 116.08 51.31 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 CA-C-O 121.639 0.733 . . . . 73.340000000000003 109.91 -176.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -118.71 143.81 46.64 Favored 'General case' 0 N--CA 1.41 -2.455 0 N-CA-C 103.986 -2.598 . . . . 63.32 103.986 175.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -70.91 -9.33 57.57 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 121.235 0.54 . . . . 73.150000000000006 111.658 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -80.86 -55.7 3.27 Favored Glycine 0 N--CA 1.433 -1.56 0 N-CA-C 111.025 -0.83 . . . . 70.239999999999995 111.025 171.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -148.89 166.24 29.13 Favored 'General case' 0 C--N 1.348 0.526 0 C-N-CA 122.801 0.44 . . . . 72.310000000000002 110.479 -178.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.463 ' HB2' ' HB2' ' A' ' 122' ' ' MET . 8.0 m-85 -111.03 128.74 55.96 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.947 -1.131 . . . . 72.030000000000001 107.947 -175.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -130.23 136.16 48.91 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.524 0.202 . . . . 73.299999999999997 110.89 -173.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.4 p -125.74 126.83 70.78 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-O 121.04 0.447 . . . . 75.430000000000007 110.165 175.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 51.9 t -119.21 133.41 66.14 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 CA-C-N 115.781 -0.645 . . . . 64.530000000000001 109.826 -178.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -82.9 131.53 35.19 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 107.18 -1.415 . . . . 71.209999999999994 107.18 173.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.4 m -111.97 20.22 6.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-O 121.086 0.469 . . . . 74.420000000000002 112.152 -177.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 120.06 54.85 0.25 Allowed Glycine 0 N--CA 1.433 -1.563 0 C-N-CA 119.981 -1.104 . . . . 75.010000000000005 114.367 174.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 77.7 p -78.86 145.77 34.02 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 117.253 0.526 . . . . 72.409999999999997 109.819 177.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 98.1 mt -80.19 -31.2 38.79 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 121.514 0.673 . . . . 71.219999999999999 109.931 178.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.495 ' HB3' ' OG1' ' A' ' 84' ' ' THR . 23.4 p30 -85.29 -24.52 27.68 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.01 -0.996 . . . . 75.109999999999999 112.841 -177.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 88.5 105.57 1.0 Allowed Glycine 0 N--CA 1.433 -1.502 0 C-N-CA 120.865 -0.683 . . . . 74.549999999999997 111.763 -179.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.6 m -75.63 123.94 26.38 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.794 -0.817 . . . . 74.010000000000005 108.794 176.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -136.97 153.71 50.62 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 109.796 -0.446 . . . . 74.219999999999999 109.796 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 31.1 t -98.07 142.63 14.18 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.006 0 N-CA-C 106.526 -1.657 . . . . 73.319999999999993 106.526 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 33.6 p-10 -55.21 -25.21 31.62 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 112.573 0.583 . . . . 73.439999999999998 112.573 -175.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 33.5 mtm105 -100.9 -32.51 10.62 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.369 -0.378 . . . . 75.340000000000003 111.809 177.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -130.65 125.29 21.41 Favored Pre-proline 0 C--N 1.316 -0.848 0 C-N-CA 121.078 -0.249 . . . . 63.149999999999999 111.589 -169.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.15 39.47 0.73 Allowed 'Trans proline' 0 CA--C 1.554 1.507 0 C-N-CA 122.838 2.359 . . . . 74.219999999999999 112.043 178.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.416 ' HB3' ' O ' ' A' ' 119' ' ' ALA . 31.1 mmt180 -90.51 131.33 36.31 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 123.537 0.735 . . . . 74.129999999999995 110.262 -177.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -78.64 -38.61 39.24 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.141 0.496 . . . . 75.430000000000007 110.021 174.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.416 ' O ' ' HB3' ' A' ' 117' ' ' ARG . . . -105.47 137.93 42.49 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 105.398 -2.075 . . . . 70.450000000000003 105.398 170.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -139.47 140.22 37.21 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-O 121.256 0.551 . . . . 74.530000000000001 111.932 -172.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 48.1 t -85.61 118.27 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 104.846 -2.279 . . . . 65.019999999999996 104.846 169.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.463 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 12.6 mmt -58.26 150.04 22.78 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 114.506 1.299 . . . . 73.540000000000006 114.506 -173.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -125.67 129.53 49.75 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 105.09 -2.189 . . . . 73.109999999999999 105.09 172.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 45.9 p -83.07 123.57 29.61 Favored 'General case' 0 C--N 1.283 -2.297 0 C-N-CA 121.002 -0.279 . . . . 75.200000000000003 110.676 -174.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 92.4 38.55 5.59 Favored Glycine 0 CA--C 1.497 -1.071 0 N-CA-C 109.528 -1.429 . . . . 75.25 109.528 -175.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -139.56 170.35 16.07 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 107.437 -1.32 . . . . 54.32 107.437 -176.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -140.52 139.75 35.13 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 122.285 1.04 . . . . 73.129999999999995 113.261 -174.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 60.0 mt -112.33 131.63 63.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-N 114.417 -1.265 . . . . 74.409999999999997 109.987 -175.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -93.76 112.53 24.42 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-O 121.843 0.83 . . . . 72.099999999999994 110.257 -178.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.9 pt -95.34 98.54 8.03 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 N-CA-C 107.641 -1.244 . . . . 71.099999999999994 107.641 176.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 76.06 -98.95 1.24 Allowed Glycine 0 N--CA 1.428 -1.885 0 N-CA-C 110.476 -1.05 . . . . 73.129999999999995 110.476 -176.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -127.64 10.19 6.59 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.197 0.523 . . . . 71.430000000000007 109.839 178.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.461 ' HB3' ' O ' ' A' ' 53' ' ' ARG . 57.4 m-85 -119.92 157.17 29.33 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.952 -0.567 . . . . 75.040000000000006 109.697 -175.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 20.1 ptp180 -125.77 131.33 52.52 Favored 'General case' 0 C--O 1.256 1.398 0 N-CA-C 114.087 1.143 . . . . 75.420000000000002 114.087 -170.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.5 tt -114.71 134.35 55.16 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 114.072 -1.422 . . . . 75.340000000000003 108.213 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 38.2 t -107.54 139.14 30.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 108.824 -0.806 . . . . 73.430000000000007 108.824 -176.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -115.84 126.3 53.8 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 109.883 -0.414 . . . . 75.140000000000001 109.883 -179.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 66.5 mt -132.69 137.57 46.97 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.63 -0.259 . . . . 74.439999999999998 110.749 -177.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -103.31 41.1 1.3 Allowed 'General case' 0 N--CA 1.482 1.141 0 CA-C-O 122.142 0.972 . . . . 75.319999999999993 108.719 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -75.81 -50.09 8.24 Favored Glycine 0 C--N 1.294 -1.759 0 CA-C-N 113.834 -1.53 . . . . 73.129999999999995 116.19 -174.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo . . . . . 0 C--N 1.368 1.588 0 CA-C-N 120.214 2.007 . . . . 73.319999999999993 115.407 -170.278 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 . . . . . 0 CA--C 1.492 -1.251 0 N-CA-C 106.878 -1.527 . . . . 74.329999999999998 106.878 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -89.4 166.28 33.13 Favored Glycine 0 N--CA 1.429 -1.792 0 C-N-CA 119.766 -1.207 . . . . 73.329999999999998 110.398 178.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.2 p -84.65 133.32 44.3 Favored Pre-proline 0 N--CA 1.421 -1.907 0 N-CA-C 109.165 -0.68 . . . . 73.120000000000005 109.165 177.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -66.2 127.49 17.63 Favored 'Trans proline' 0 N--CA 1.448 -1.157 0 N-CA-C 107.923 -1.607 . . . . 61.039999999999999 107.923 174.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -95.89 118.08 66.03 Favored Pre-proline 0 C--N 1.288 -2.07 0 N-CA-C 112.926 0.713 . . . . 75.040000000000006 112.926 -174.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -66.13 140.58 60.05 Favored 'Trans proline' 0 C--O 1.245 0.862 0 C-N-CA 122.644 2.23 . . . . 62.25 108.948 173.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -149.23 98.69 2.84 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-O 122.075 0.94 . . . . 62.130000000000003 109.161 -176.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 49.2 t -69.4 118.24 13.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 114.06 -1.427 . . . . 74.319999999999993 112.259 -172.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -95.7 135.96 36.71 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 107.308 -1.367 . . . . 73.25 107.308 173.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.5 t -152.17 151.92 31.63 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-O 121.302 0.573 . . . . 74.120000000000005 110.756 -175.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.8 m -122.13 81.52 1.84 Allowed 'General case' 0 N--CA 1.41 -2.458 0 N-CA-C 107.805 -1.183 . . . . 73.109999999999999 107.805 173.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.7 m -82.36 99.33 9.32 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 115.551 -0.75 . . . . 61.149999999999999 109.224 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.9 p . . . . . 0 C--N 1.304 -1.374 0 N-CA-C 108.659 -0.867 . . . . 73.120000000000005 108.659 -179.713 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.002 0 N-CA-C 110.409 -1.076 . . . . 70.219999999999999 110.409 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 18.8 m -134.07 166.82 21.85 Favored 'General case' 0 N--CA 1.419 -2.016 0 N-CA-C 108.761 -0.829 . . . . 75.209999999999994 108.761 -179.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.507 ' HB3' ' CZ ' ' A' ' 137' ' ' PHE . . . -151.15 -170.9 3.79 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 107.939 -1.134 . . . . 73.340000000000003 107.939 178.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.22 152.25 41.47 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 120.366 -0.533 . . . . 74.430000000000007 111.399 -176.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.0 pp -127.78 145.01 51.06 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 115.555 -0.748 . . . . 72.549999999999997 110.922 178.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.3 m -131.28 142.34 43.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 109.394 -0.595 . . . . 61.219999999999999 109.394 178.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 76.5 t -93.82 115.93 33.83 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 N-CA-C 107.878 -1.156 . . . . 74.209999999999994 107.878 176.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.5 tmtm? -82.16 -38.81 24.13 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.756 -0.831 . . . . 74.319999999999993 108.756 -175.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.45 ' O ' ' HB3' ' A' ' 133' ' ' PHE . 13.8 tpp180 -142.41 117.3 9.92 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 108.181 -1.044 . . . . 75.329999999999998 108.181 -178.105 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 148.42 125.18 1.46 Allowed Glycine 0 N--CA 1.427 -1.955 0 C-N-CA 119.784 -1.198 . . . . 72.420000000000002 114.057 177.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -67.54 -8.92 23.67 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 123.768 2.979 . . . . 74.340000000000003 110.509 174.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.566 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 2.1 m-20 -51.18 -26.5 6.95 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 126.852 2.061 . . . . 73.120000000000005 111.215 177.241 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -166.88 -62.16 0.03 OUTLIER 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 123.45 0.7 . . . . 73.120000000000005 109.403 176.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 61.3 44.82 97.59 Favored Glycine 0 C--N 1.336 0.557 0 CA-C-N 115.741 -0.663 . . . . 72.420000000000002 111.85 -179.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -151.62 -171.68 4.0 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 108.927 -0.768 . . . . 74.430000000000007 108.927 -176.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.8 ptt180 -119.93 138.51 53.4 Favored 'General case' 0 C--N 1.312 -1.064 0 O-C-N 124.002 0.814 . . . . 72.430000000000007 109.221 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -138.54 129.43 26.68 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-O 120.896 0.379 . . . . 74.140000000000001 110.807 179.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 65.3 tp -91.45 129.59 37.41 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 107.505 -1.294 . . . . 74.450000000000003 107.505 176.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 79.7 mt -72.16 120.15 17.35 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 113.018 0.748 . . . . 74.409999999999997 113.018 -176.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -146.29 -39.99 0.21 Allowed 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.884 -1.053 . . . . 73.349999999999994 110.56 175.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -61.28 113.89 9.26 Favored Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 123.888 0.875 . . . . 74.510000000000005 110.297 173.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.556 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 8.4 Cg_endo -53.8 -41.31 75.51 Favored 'Trans proline' 0 C--N 1.361 1.185 0 C-N-CA 122.983 2.455 . . . . 71.0 113.253 -175.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 50.2 m -119.82 105.89 11.55 Favored 'General case' 0 N--CA 1.423 -1.8 0 CA-C-O 121.21 0.528 . . . . 73.329999999999998 109.79 178.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.433 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 40.1 m -107.01 113.8 27.5 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 107.259 -1.386 . . . . 61.539999999999999 107.259 174.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.4 p -98.04 133.64 42.23 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 116.002 -0.544 . . . . 71.040000000000006 112.369 -175.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -115.21 120.29 39.22 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 115.574 -0.739 . . . . 72.519999999999996 109.135 176.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.42 ' HA2' ' CG2' ' A' ' 85' ' ' VAL . . . 167.63 -160.44 34.05 Favored Glycine 0 N--CA 1.422 -2.254 0 N-CA-C 110.051 -1.22 . . . . 73.5 110.051 178.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.475 ' O ' ' HG2' ' A' ' 87' ' ' ARG . 18.6 tpt180 -132.42 89.56 2.67 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 109.445 -0.576 . . . . 75.120000000000005 109.445 174.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.52 ' CD2' ' H ' ' A' ' 88' ' ' ARG . 5.1 p80 -161.59 165.76 15.93 Favored Pre-proline 0 C--N 1.304 -1.402 0 N-CA-C 107.686 -1.227 . . . . 63.520000000000003 107.686 177.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.487 ' HD2' ' HB2' ' A' ' 73' ' ' HIS . 3.1 Cg_endo -47.89 -35.44 24.61 Favored 'Trans proline' 0 C--N 1.359 1.101 0 C-N-CA 123.317 2.678 . . . . 72.329999999999998 115.7 -175.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -99.33 14.6 29.06 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 119.237 -0.985 . . . . 64.530000000000001 113.52 -175.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 24.0 m -73.2 133.24 43.96 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.635 -0.506 . . . . 75.340000000000003 109.635 176.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -80.19 -56.02 4.51 Favored 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 108.441 -0.948 . . . . 74.530000000000001 108.441 176.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 32.4 pt -97.69 134.46 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 N-CA-C 109.117 -0.697 . . . . 73.409999999999997 109.117 177.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -104.42 116.87 32.88 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 121.764 0.792 . . . . 73.030000000000001 110.529 -177.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.566 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 7.0 mp -82.02 106.53 14.01 Favored 'General case' 0 N--CA 1.422 -1.831 0 CA-C-N 114.817 -1.083 . . . . 74.519999999999996 111.09 -177.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -85.0 69.49 10.82 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 122.432 1.111 . . . . 75.340000000000003 109.743 176.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -148.62 164.26 34.82 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 113.94 -1.482 . . . . 70.319999999999993 108.279 176.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.1 p -94.69 -6.65 10.15 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-O 121.083 0.468 . . . . 74.409999999999997 111.516 -176.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.7 m -91.96 13.45 18.58 Favored 'General case' 0 CA--C 1.548 0.899 0 O-C-N 121.491 -0.755 . . . . 74.430000000000007 110.267 -177.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.42 ' CG2' ' HA2' ' A' ' 71' ' ' GLY . 10.6 p -102.77 133.11 47.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-O 121.258 0.551 . . . . 74.109999999999999 111.312 -178.269 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 18.3 m -102.05 169.95 8.42 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 108.94 -0.763 . . . . 51.420000000000002 108.94 176.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.475 ' HG2' ' O ' ' A' ' 72' ' ' ARG . 63.1 mtm180 -75.27 134.7 41.04 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 106.674 -1.602 . . . . 72.540000000000006 106.674 173.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.52 ' H ' ' CD2' ' A' ' 73' ' ' HIS 0.36 0.0 OUTLIER 50.38 71.76 0.39 Allowed 'General case' 0 C--O 1.22 -0.497 0 CA-C-O 122.654 1.216 . . . . 74.340000000000003 111.096 -171.507 . . . . . . . . 4 4 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 11.4 t60 -95.39 -60.14 1.73 Allowed 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 113.828 -1.533 . . . . 72.209999999999994 109.846 -173.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -130.94 127.47 38.52 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 109.215 -0.661 . . . . 63.240000000000002 109.215 -179.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -109.75 127.19 54.46 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 109.049 -0.723 . . . . 75.329999999999998 109.049 177.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.433 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 97.5 m-85 -104.09 112.62 25.69 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 107.651 -1.241 . . . . 74.140000000000001 107.651 177.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 27.5 mtp85 -108.48 113.59 26.74 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 115.368 -0.833 . . . . 75.420000000000002 109.072 -177.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.556 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -128.48 124.22 61.38 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.522 0 CA-C-O 122.085 0.945 . . . . 75.099999999999994 110.077 -177.778 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -110.52 147.71 33.6 Favored 'General case' 0 C--N 1.269 -2.906 0 N-CA-C 106.765 -1.568 . . . . 63.409999999999997 106.765 177.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -42.42 -26.57 0.12 Allowed 'General case' 0 CA--C 1.56 1.354 0 N-CA-C 114.234 1.198 . . . . 73.219999999999999 114.234 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -128.77 23.85 4.96 Favored Glycine 0 N--CA 1.437 -1.249 0 C-N-CA 120.617 -0.802 . . . . 42.310000000000002 113.513 179.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -165.44 144.25 6.32 Favored 'General case' 0 C--O 1.213 -0.868 0 CA-C-N 117.852 0.826 . . . . 73.040000000000006 110.84 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.457 ' HB2' ' SD ' ' A' ' 122' ' ' MET . 1.3 p90 -132.15 115.83 16.23 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-O 121.873 0.844 . . . . 74.019999999999996 112.085 -177.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -129.9 135.24 48.12 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.468 -0.787 . . . . 72.540000000000006 111.559 -172.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.6 p -116.5 128.38 73.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 109.561 -0.533 . . . . 74.450000000000003 109.561 178.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 58.6 t -118.82 130.61 73.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-N 116.325 -0.398 . . . . 71.420000000000002 110.943 -175.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -101.31 115.24 30.04 Favored 'General case' 0 CA--C 1.496 -1.127 0 CA-C-O 121.074 0.464 . . . . 75.439999999999998 109.802 176.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.454 HG22 ' O ' ' A' ' 88' ' ' ARG . 5.3 m -122.42 -1.64 7.22 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 CA-C-O 121.671 0.748 . . . . 74.209999999999994 111.459 178.233 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -100.22 39.83 2.62 Favored Glycine 0 N--CA 1.429 -1.771 0 N-CA-C 109.401 -1.48 . . . . 61.310000000000002 109.401 176.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 11.4 m -63.45 4.52 0.23 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.042 1.737 . . . . 64.129999999999995 113.479 -176.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -68.95 -41.09 78.48 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 106.693 -1.595 . . . . 73.349999999999994 106.693 171.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -110.18 -41.19 4.49 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.071 -1.422 . . . . 71.319999999999993 108.355 177.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 92.65 131.53 5.67 Favored Glycine 0 N--CA 1.438 -1.202 0 N-CA-C 115.71 1.044 . . . . 74.200000000000003 115.71 173.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 18.6 m -94.65 135.59 35.94 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 105.941 -1.874 . . . . 74.319999999999993 105.941 169.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -117.69 134.42 54.92 Favored 'General case' 0 C--N 1.294 -1.833 0 C-N-CA 120.013 -0.675 . . . . 73.109999999999999 109.659 -177.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 22.3 m -100.43 110.56 27.75 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.935 0 N-CA-C 106.973 -1.491 . . . . 73.409999999999997 106.973 172.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 66.96 -79.72 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 125.843 1.657 . . . . 71.209999999999994 108.944 -171.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 51.9 mtp180 -148.11 13.8 1.0 Allowed 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 124.652 1.181 . . . . 73.129999999999995 109.147 176.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -102.51 113.74 65.72 Favored Pre-proline 0 N--CA 1.439 -1.005 0 CA-C-N 115.327 -0.851 . . . . 71.219999999999999 110.39 -175.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -84.26 94.8 0.72 Allowed 'Trans proline' 0 N--CA 1.446 -1.283 0 C-N-CA 122.444 2.096 . . . . 73.439999999999998 109.182 173.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -121.28 146.22 47.05 Favored 'General case' 0 CA--C 1.502 -0.885 0 CA-C-N 116.397 -0.365 . . . . 72.329999999999998 111.191 -174.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -66.05 -42.22 89.79 Favored 'General case' 0 C--N 1.319 -0.719 0 O-C-N 124.145 0.903 . . . . 75.450000000000003 110.73 -177.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -149.64 138.89 21.34 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 108.363 -0.977 . . . . 73.319999999999993 108.363 175.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 6.0 tp60 -140.98 150.49 43.15 Favored 'General case' 0 C--N 1.292 -1.935 0 C-N-CA 122.821 0.448 . . . . 75.349999999999994 110.117 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 64.1 t -79.82 134.03 28.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 105.508 -2.034 . . . . 72.430000000000007 105.508 173.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.457 ' SD ' ' HB2' ' A' ' 99' ' ' PHE . 64.7 mtt -61.0 126.33 26.97 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 109.61 -0.515 . . . . 65.030000000000001 109.61 -176.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -104.95 130.35 53.15 Favored 'General case' 0 N--CA 1.418 -2.061 0 CA-C-O 121.346 0.594 . . . . 55.229999999999997 110.098 -178.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 18.6 p -78.3 131.9 37.24 Favored 'General case' 0 N--CA 1.416 -2.167 0 CA-C-N 114.782 -1.099 . . . . 75.540000000000006 109.479 -177.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 85.0 22.88 51.4 Favored Glycine 0 N--CA 1.431 -1.671 0 N-CA-C 110.647 -0.981 . . . . 74.5 110.647 179.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -123.61 171.16 9.76 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 120.165 -0.614 . . . . 71.0 109.749 -178.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -118.84 121.42 39.99 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 123.412 0.685 . . . . 74.439999999999998 110.393 -170.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 64.1 mt -106.15 118.2 53.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 N-CA-C 109.614 -0.513 . . . . 74.420000000000002 109.614 -178.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -95.14 114.17 25.94 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 109.455 -0.572 . . . . 74.430000000000007 109.455 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 9.8 pt -99.9 97.58 6.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 CA-C-O 122.215 1.007 . . . . 73.400000000000006 109.101 178.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 73.15 -87.35 0.58 Allowed Glycine 0 N--CA 1.435 -1.42 0 CA-C-N 114.498 -1.228 . . . . 62.450000000000003 111.088 -177.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -120.1 -33.03 4.03 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 120.974 0.416 . . . . 74.409999999999997 110.513 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.45 ' HB3' ' O ' ' A' ' 53' ' ' ARG . 77.9 m-85 -95.5 161.21 14.16 Favored 'General case' 0 CA--C 1.496 -1.125 0 CA-C-N 116.293 -0.412 . . . . 72.530000000000001 110.95 -173.109 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 27.9 ptt180 -131.42 141.5 49.85 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 114.155 1.168 . . . . 54.439999999999998 114.155 -171.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.4 tt -117.69 140.03 50.22 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 112.935 -1.939 . . . . 71.540000000000006 107.48 -177.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 7.7 p -115.93 131.56 68.02 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 CA-C-O 121.046 0.451 . . . . 74.239999999999995 109.787 179.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . 0.507 ' CZ ' ' HB3' ' A' ' 47' ' ' ALA . 71.4 t80 -102.91 119.0 38.07 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.53 -0.759 . . . . 74.340000000000003 109.057 -175.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.46 ' O ' ' HB2' ' A' ' 47' ' ' ALA . 2.5 mm? -114.68 147.1 40.11 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 120.966 0.412 . . . . 74.439999999999998 111.282 -175.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -81.94 118.23 22.79 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 107.827 -1.175 . . . . 74.530000000000001 107.827 175.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -93.57 -135.92 7.74 Favored Glycine 0 N--CA 1.427 -1.913 0 C-N-CA 120.64 -0.791 . . . . 60.439999999999998 111.874 -177.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo . . . . . 0 N--CA 1.441 -1.617 0 C-N-CA 122.492 2.128 . . . . 61.409999999999997 112.305 179.691 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.6 t30 . . . . . 0 N--CA 1.437 -1.098 0 N-CA-C 108.647 -0.872 . . . . 74.549999999999997 108.647 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -143.69 108.98 0.53 Allowed Glycine 0 N--CA 1.428 -1.85 0 N-CA-C 109.892 -1.283 . . . . 74.109999999999999 109.892 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.7 t -94.07 125.01 54.36 Favored Pre-proline 0 C--N 1.301 -1.537 0 CA-C-O 120.801 0.334 . . . . 75.219999999999999 110.969 -177.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -66.22 144.73 76.01 Favored 'Trans proline' 0 C--O 1.244 0.809 0 C-N-CA 122.22 1.947 . . . . 71.140000000000001 109.59 174.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -89.81 138.68 27.79 Favored Pre-proline 0 C--N 1.29 -2.011 0 C-N-CA 121.361 -0.136 . . . . 74.420000000000002 110.638 -177.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -74.64 103.78 1.77 Allowed 'Trans proline' 0 N--CA 1.44 -1.668 0 C-N-CA 121.24 1.293 . . . . 75.400000000000006 109.163 172.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -92.94 119.65 32.45 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 115.373 -0.831 . . . . 63.509999999999998 111.513 -174.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.9 p -88.64 136.86 22.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 CA-C-N 115.812 -0.631 . . . . 74.329999999999998 109.449 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -77.53 134.92 38.18 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 108.542 -0.91 . . . . 64.519999999999996 108.542 178.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.8 m -134.1 71.55 1.46 Allowed 'General case' 0 C--N 1.294 -1.829 0 CA-C-O 121.396 0.617 . . . . 73.430000000000007 110.241 -178.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.8 t 167.43 137.11 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 126.596 1.958 . . . . 73.430000000000007 106.638 176.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 53.4 m -152.16 37.22 0.55 Allowed 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 108.069 -1.086 . . . . 75.200000000000003 108.069 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.8 t . . . . . 0 N--CA 1.438 -1.072 0 CA-C-N 114.554 -1.203 . . . . 72.120000000000005 108.424 178.75 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.413 -2.835 0 N-CA-C 109.333 -1.507 . . . . 63.509999999999998 109.333 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.8 m -100.17 164.49 11.94 Favored 'General case' 0 C--N 1.279 -2.494 0 N-CA-C 108.815 -0.809 . . . . 74.310000000000002 108.815 178.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -124.64 132.88 53.39 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.751 -0.463 . . . . 72.209999999999994 109.751 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -115.81 140.79 48.88 Favored 'General case' 0 C--N 1.29 -2.008 0 C-N-CA 120.312 -0.555 . . . . 75.5 110.837 179.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.424 ' O ' HD13 ' A' ' 49' ' ' LEU . 3.1 pp -120.39 140.01 51.96 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 115.542 -0.753 . . . . 74.230000000000004 110.352 178.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 47.4 t -117.75 126.51 74.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 108.581 -0.896 . . . . 64.519999999999996 108.581 179.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 53.2 t -93.1 115.56 32.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 108.942 -0.762 . . . . 75.510000000000005 108.942 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -82.56 -46.31 13.52 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.38 -0.97 . . . . 72.530000000000001 108.38 176.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -147.84 149.1 31.67 Favored 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 106.968 -1.494 . . . . 75.030000000000001 106.968 179.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 144.99 145.67 4.34 Favored Glycine 0 N--CA 1.425 -2.045 0 N-CA-C 110.527 -1.029 . . . . 73.420000000000002 110.527 -178.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.417 ' HB2' ' H ' ' A' ' 82' ' ' ASP . 13.8 Cg_exo -67.93 -9.18 24.81 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.419 2.746 . . . . 71.319999999999993 113.359 -177.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.437 ' HB2' ' HA ' ' A' ' 80' ' ' LEU . 5.6 t-20 -42.87 -60.3 1.65 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.098 0.959 . . . . 75.540000000000006 111.451 175.356 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 174.37 -64.19 0.01 OUTLIER 'General case' 0 CA--C 1.504 -0.827 0 C-N-CA 124.814 1.245 . . . . 74.409999999999997 107.991 -178.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 116.83 52.91 0.34 Allowed Glycine 0 N--CA 1.441 -0.969 0 N-CA-C 110.023 -1.231 . . . . 62.299999999999997 110.023 -176.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -139.9 -174.3 3.87 Favored 'General case' 0 N--CA 1.434 -1.275 0 N-CA-C 108.881 -0.785 . . . . 71.129999999999995 108.881 -176.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 34.9 ptt180 -122.05 134.65 54.78 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.486 -0.931 . . . . 64.230000000000004 108.486 177.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -127.13 139.5 52.93 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 109.85 -0.426 . . . . 72.439999999999998 109.85 -177.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 58.3 tp -101.98 112.05 24.54 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 108.22 -1.03 . . . . 65.430000000000007 108.22 178.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -94.68 116.75 29.12 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.324 0.583 . . . . 75.129999999999995 110.469 -176.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -121.81 8.24 9.96 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.448 -1.315 . . . . 75.530000000000001 107.448 176.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -93.05 115.96 65.77 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 114.139 -1.391 . . . . 71.439999999999998 109.684 178.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -50.52 -43.56 44.32 Favored 'Trans proline' 0 C--N 1.361 1.215 0 C-N-CA 123.541 2.827 . . . . 74.010000000000005 113.917 -174.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 31.9 m -106.85 102.77 12.11 Favored 'General case' 0 N--CA 1.423 -1.812 0 N-CA-C 109.63 -0.508 . . . . 74.340000000000003 109.63 177.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 79.4 m -108.79 114.05 27.5 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 107.444 -1.317 . . . . 74.129999999999995 107.444 176.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 14.5 t -117.61 128.79 55.28 Favored 'General case' 0 C--N 1.296 -1.761 0 C-N-CA 119.221 -0.992 . . . . 71.219999999999999 110.693 -175.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' A' ' 78' ' ' ILE . . . -115.08 106.44 14.12 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 115.504 -0.771 . . . . 65.109999999999999 109.576 -176.211 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.46 73.11 1.28 Allowed Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 109.314 -1.515 . . . . 75.129999999999995 109.314 -175.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.528 ' HA ' ' O ' ' A' ' 87' ' ' ARG . 1.1 tmm_? -145.07 85.55 1.75 Allowed 'General case' 0 N--CA 1.423 -1.805 0 N-CA-C 107.294 -1.372 . . . . 74.510000000000005 107.294 -178.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.551 ' CG ' ' HD2' ' A' ' 74' ' ' PRO . 1.3 t-80 68.3 170.71 0.1 Allowed Pre-proline 0 CA--C 1.575 1.935 0 O-C-N 124.545 1.153 . . . . 74.5 109.075 177.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.551 ' HD2' ' CG ' ' A' ' 73' ' ' HIS . 96.3 Cg_exo -48.38 -39.63 35.83 Favored 'Trans proline' 0 C--N 1.369 1.645 0 C-N-CA 121.981 1.787 . . . . 65.519999999999996 112.789 175.322 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.9 pm0 -92.07 58.27 3.3 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 122.202 1.001 . . . . 73.409999999999997 111.636 178.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 66.2 m -65.28 150.47 48.19 Favored 'General case' 0 C--O 1.244 0.783 0 CA-C-N 115.143 -0.935 . . . . 75.420000000000002 108.997 175.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -68.97 -45.2 71.29 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 107.434 -1.321 . . . . 71.150000000000006 107.434 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.492 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 46.1 pt -139.97 143.82 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 N-CA-C 108.135 -1.061 . . . . 75.099999999999994 108.135 171.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -102.47 130.8 49.38 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 119.251 -0.98 . . . . 63.409999999999997 108.403 172.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.437 ' HA ' ' HB2' ' A' ' 56' ' ' ASN . 30.8 tp -108.53 -26.15 10.57 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-O 122.552 1.168 . . . . 74.540000000000006 109.786 -174.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -138.23 134.09 34.0 Favored 'General case' 0 C--N 1.266 -3.022 0 N-CA-C 105.854 -1.906 . . . . 72.0 105.854 177.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.417 ' H ' ' HB2' ' A' ' 55' ' ' PRO . 33.1 t70 -117.79 -15.49 10.07 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 115.534 -0.757 . . . . 74.239999999999995 111.21 -177.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.4 m -91.3 -21.91 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.812 0 N-CA-C 108.087 -1.079 . . . . 73.120000000000005 108.087 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 22.4 m -138.34 83.51 1.97 Allowed 'General case' 0 N--CA 1.414 -2.24 0 CA-C-N 114.56 -1.2 . . . . 72.239999999999995 108.375 174.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.8 p -112.16 139.88 34.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 108.48 -0.933 . . . . 75.319999999999993 108.48 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 15.5 m -124.44 168.83 12.52 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 109.582 -0.525 . . . . 75.120000000000005 109.582 -177.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.528 ' O ' ' HA ' ' A' ' 72' ' ' ARG . 20.5 mtp180 -68.56 -31.59 70.91 Favored 'General case' 0 C--O 1.212 -0.897 0 CA-C-O 121.042 0.449 . . . . 74.319999999999993 110.074 175.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.82 101.7 3.79 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 106.277 -1.749 . . . . 73.120000000000005 106.277 170.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.497 ' O ' HG22 ' A' ' 104' ' ' VAL . 19.0 t60 -98.74 -71.7 0.68 Allowed 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 114.466 -1.243 . . . . 75.030000000000001 111.075 -174.343 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -144.75 160.69 40.83 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 107.738 -1.208 . . . . 74.030000000000001 107.738 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -146.19 139.46 25.89 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.907 -0.717 . . . . 74.420000000000002 110.262 -177.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -115.61 123.0 47.32 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.898 -0.778 . . . . 73.510000000000005 108.898 -177.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 52.8 mtm-85 -107.8 123.65 48.89 Favored 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 107.831 -1.174 . . . . 72.349999999999994 107.831 176.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.3 pp -115.42 116.08 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.128 0 C-N-CA 118.684 -1.207 . . . . 74.510000000000005 108.38 177.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.528 ' ND2' ' HG2' ' A' ' 96' ' ' GLU . 4.9 t30 -120.09 147.05 45.34 Favored 'General case' 0 C--N 1.28 -2.424 0 CA-C-N 114.121 -1.399 . . . . 61.539999999999999 107.55 -179.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.528 ' HG2' ' ND2' ' A' ' 95' ' ' ASN . 8.8 pt-20 -29.12 -36.6 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 126.898 2.079 . . . . 72.239999999999995 115.908 -177.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -131.95 3.04 5.24 Favored Glycine 0 CA--C 1.504 -0.6 0 C-N-CA 119.387 -1.387 . . . . 65.239999999999995 113.28 -175.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -148.05 118.2 7.28 Favored 'General case' 0 N--CA 1.411 -2.399 0 CA-C-O 122.401 1.096 . . . . 72.510000000000005 111.098 -177.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.507 ' HD1' ' SD ' ' A' ' 122' ' ' MET . 71.0 m-85 -107.09 115.83 30.86 Favored 'General case' 0 C--N 1.275 -2.663 0 CA-C-N 114.423 -1.262 . . . . 73.549999999999997 107.62 -179.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -110.18 135.92 50.2 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 113.612 0.967 . . . . 53.119999999999997 113.612 -173.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.5 p -116.33 117.64 56.15 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.116 0 CA-C-N 114.377 -1.283 . . . . 75.140000000000001 107.709 173.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 39.7 t -120.86 125.36 73.96 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 CA-C-N 115.831 -0.622 . . . . 73.519999999999996 110.768 -177.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.445 ' HB2' ' HB ' ' A' ' 110' ' ' THR . 18.0 t0 -92.45 115.46 28.11 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 102.333 -3.21 . . . . 74.019999999999996 102.333 168.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.497 HG22 ' O ' ' A' ' 89' ' ' HIS . 19.2 m -59.67 -23.35 25.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 113.278 0.844 . . . . 73.439999999999998 113.278 -169.165 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -152.76 16.06 0.72 Allowed Glycine 0 C--N 1.305 -1.176 0 C-N-CA 117.8 -2.143 . . . . 74.420000000000002 113.796 178.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 50.3 m 57.17 36.6 27.7 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 122.824 1.297 . . . . 34.329999999999998 107.514 -175.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 49.5 tp -73.66 -47.43 39.93 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 112.828 -1.987 . . . . 75.099999999999994 112.761 -168.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -107.4 -11.52 15.51 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 119.2 -1.0 . . . . 70.420000000000002 109.791 179.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 97.5 65.12 0.89 Allowed Glycine 0 N--CA 1.433 -1.53 0 C-N-CA 120.413 -0.899 . . . . 61.32 113.247 173.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.445 ' HB ' ' HB2' ' A' ' 103' ' ' ASP . 18.9 m -85.24 119.66 25.87 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.683 -0.858 . . . . 64.200000000000003 108.683 174.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.412 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 2.1 m-85 -116.91 140.87 48.95 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.419 -0.956 . . . . 64.239999999999995 108.419 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.5 p -99.58 116.46 42.81 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 N-CA-C 108.197 -1.038 . . . . 74.340000000000003 108.197 176.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 71.17 -73.53 0.1 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.131 0.972 . . . . 74.329999999999998 109.476 -175.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 48.5 ttp180 -161.3 14.37 0.1 Allowed 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 107.538 -1.282 . . . . 74.109999999999999 107.538 172.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -102.27 116.36 63.13 Favored Pre-proline 0 N--CA 1.429 -1.479 0 CA-C-N 115.513 -0.767 . . . . 72.109999999999999 108.94 -172.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -76.24 103.67 1.78 Allowed 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.85 2.367 . . . . 74.5 111.195 178.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 15.1 mmt180 -130.79 157.23 43.43 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 109.348 -0.612 . . . . 74.239999999999995 109.348 -179.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 50.8 m-20 -76.88 -42.57 39.37 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.487 -1.301 . . . . 70.120000000000005 107.487 178.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -147.87 146.04 28.92 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 114.561 -1.2 . . . . 73.209999999999994 108.886 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -138.58 138.17 37.67 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 108.545 -0.909 . . . . 74.25 108.545 178.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 39.0 t -94.82 95.46 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.527 0 C-N-CA 119.477 -0.889 . . . . 71.340000000000003 108.61 177.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.507 ' SD ' ' HD1' ' A' ' 99' ' ' PHE . 25.5 ptt? 44.56 139.02 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 119.087 2.995 . . . . 72.230000000000004 119.087 177.188 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -132.97 122.81 24.81 Favored 'General case' 0 N--CA 1.401 -2.92 1 N-CA-C 99.815 -4.143 . . . . 73.010000000000005 99.815 166.308 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 13.1 t -108.04 127.39 53.74 Favored 'General case' 0 C--N 1.288 -2.077 0 C-N-CA 118.606 -1.238 . . . . 74.519999999999996 112.034 -171.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 83.84 22.35 55.69 Favored Glycine 0 N--CA 1.424 -2.113 0 N-CA-C 109.993 -1.243 . . . . 73.030000000000001 109.993 -179.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -122.76 -175.88 3.26 Favored 'General case' 0 C--O 1.249 1.053 0 N-CA-C 108.36 -0.978 . . . . 74.319999999999993 108.36 -177.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.455 ' OE2' ' HD3' ' A' ' 134' ' ' ARG . 40.0 mt-10 -116.65 130.98 57.05 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 121.784 0.802 . . . . 73.310000000000002 111.492 -175.027 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 66.0 mt -100.47 126.43 54.07 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 N-CA-C 107.151 -1.426 . . . . 74.400000000000006 107.151 176.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.412 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 34.4 tt0 -93.43 112.65 24.61 Favored 'General case' 0 C--N 1.282 -2.334 0 N-CA-C 108.339 -0.986 . . . . 73.049999999999997 108.339 -178.281 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.451 HG13 ' HB2' ' A' ' 133' ' ' PHE . 19.2 pt -101.92 97.95 6.27 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.07 0 N-CA-C 108.747 -0.834 . . . . 72.420000000000002 108.747 179.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 70.13 -98.86 0.66 Allowed Glycine 0 N--CA 1.432 -1.575 0 N-CA-C 109.738 -1.345 . . . . 62.340000000000003 109.738 -176.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -122.71 5.08 9.48 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 120.707 0.289 . . . . 73.340000000000003 110.72 177.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.451 ' HB2' HG13 ' A' ' 130' ' ' ILE . 27.1 m-85 -104.72 171.38 7.35 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 108.784 -0.821 . . . . 74.5 108.784 -179.372 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.455 ' HD3' ' OE2' ' A' ' 127' ' ' GLU . 14.0 ptp180 -130.67 132.67 45.55 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.73 0.776 . . . . 71.439999999999998 112.057 -179.201 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 48.9 tp -117.48 143.46 46.02 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 114.167 -1.379 . . . . 74.540000000000006 107.411 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 34.2 t -106.72 129.95 59.41 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 N-CA-C 106.553 -1.647 . . . . 71.310000000000002 106.553 177.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -121.64 119.89 33.17 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 120.964 0.411 . . . . 73.239999999999995 111.188 -174.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.4 mp -117.53 116.68 27.6 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 107.873 -1.158 . . . . 75.510000000000005 107.873 177.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -122.1 122.87 40.24 Favored 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 121.02 -0.272 . . . . 72.439999999999998 110.382 -175.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.483 ' N ' ' HD2' ' A' ' 141' ' ' PRO . . . 152.48 -52.72 0.48 Allowed Glycine 0 C--N 1.306 -1.095 0 C-N-CA 118.376 -1.868 . . . . 73.049999999999997 115.353 178.181 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.483 ' HD2' ' N ' ' A' ' 140' ' ' GLY . 5.2 Cg_endo . . . . . 0 C--N 1.374 1.904 0 C-N-CA 123.489 2.793 . . . . 74.239999999999995 114.672 -177.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.506 -0.732 0 N-CA-C 107.655 -1.239 . . . . 74.209999999999994 107.655 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -82.13 105.52 2.58 Favored Glycine 0 C--N 1.303 -1.292 0 N-CA-C 111.178 -0.769 . . . . 73.049999999999997 111.178 -177.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.5 t -83.18 135.32 44.66 Favored Pre-proline 0 C--N 1.302 -1.463 0 N-CA-C 109.035 -0.728 . . . . 73.540000000000006 109.035 -178.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -66.75 150.15 83.51 Favored 'Trans proline' 0 C--O 1.236 0.419 0 C-N-CA 122.574 2.182 . . . . 74.120000000000005 112.072 -178.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.402 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 0.7 OUTLIER -79.79 112.19 27.51 Favored Pre-proline 0 C--N 1.316 -0.885 0 N-CA-C 109.598 -0.519 . . . . 75.319999999999993 109.598 176.983 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 9' ' ' GLU . 16.5 Cg_exo -65.23 118.09 5.15 Favored 'Trans proline' 0 C--O 1.246 0.921 0 C-N-CA 122.465 2.11 . . . . 73.340000000000003 112.256 -175.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.417 ' HA ' ' OE1' ' A' ' 11' ' ' GLN . 5.0 tp60 -93.39 81.02 4.39 Favored 'General case' 0 N--CA 1.42 -1.95 0 CA-C-O 122.115 0.96 . . . . 74.239999999999995 109.814 177.59 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.4 t -104.53 120.05 54.33 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 N-CA-C 106.634 -1.617 . . . . 75.049999999999997 106.634 177.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.63 140.95 51.72 Favored 'General case' 0 N--CA 1.433 -1.317 0 CA-C-O 120.943 0.401 . . . . 74.420000000000002 111.044 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.7 m -113.2 88.28 2.8 Favored 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 109.217 -0.661 . . . . 73.019999999999996 109.217 -179.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 42.7 m -100.29 95.06 6.53 Favored 'General case' 0 N--CA 1.411 -2.406 0 N-CA-C 108.901 -0.777 . . . . 73.430000000000007 108.901 178.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.0 t -101.19 98.06 8.51 Favored 'General case' 0 N--CA 1.42 -1.946 0 N-CA-C 108.135 -1.061 . . . . 62.030000000000001 108.135 -178.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 23.5 t . . . . . 0 N--CA 1.429 -1.477 0 N-CA-C 109.162 -0.681 . . . . 74.030000000000001 109.162 -178.614 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.516 0 N-CA-C 112.186 -0.365 . . . . 74.430000000000007 112.186 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.438 ' HB2' ' O ' ' A' ' 141' ' ' PRO . 8.7 m -90.19 152.96 20.85 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 121.464 0.65 . . . . 64.239999999999995 109.5 -178.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -153.73 164.15 38.81 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.234 -1.025 . . . . 64.510000000000005 108.234 -177.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -130.12 142.13 50.62 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.402 0.62 . . . . 73.400000000000006 111.471 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.41 ' O ' HD11 ' A' ' 49' ' ' LEU . 4.2 pp -109.78 133.25 53.36 Favored 'General case' 0 N--CA 1.423 -1.825 0 N-CA-C 107.736 -1.209 . . . . 73.25 107.736 175.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 48.1 t -119.08 117.46 54.31 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 N-CA-C 109.69 -0.485 . . . . 65.109999999999999 109.69 -176.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 57.3 t -93.04 114.45 29.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 106.016 -1.846 . . . . 73.310000000000002 106.016 175.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -93.39 -33.11 13.99 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.389 -0.597 . . . . 75.409999999999997 109.389 -176.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.465 ' O ' ' HB3' ' A' ' 133' ' ' PHE . 60.5 mtt180 -138.53 123.19 18.63 Favored 'General case' 0 CA--C 1.487 -1.444 0 N-CA-C 108.559 -0.904 . . . . 74.319999999999993 108.559 177.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.407 ' HA2' ' HD2' ' A' ' 55' ' ' PRO . . . 146.98 116.33 0.94 Allowed Glycine 0 N--CA 1.415 -2.761 0 C-N-CA 120.911 -0.662 . . . . 71.329999999999998 112.525 179.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.407 ' HD2' ' HA2' ' A' ' 54' ' ' GLY . 11.9 Cg_endo -59.55 -9.22 8.54 Favored 'Trans proline' 0 C--N 1.37 1.689 0 C-N-CA 124.058 3.172 . . . . 73.239999999999995 112.269 176.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.436 ' HA ' ' N ' ' A' ' 81' ' ' ASP . 2.3 m-20 -45.99 -49.42 16.03 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 125.39 1.476 . . . . 74.140000000000001 108.901 172.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -149.37 -58.65 0.21 Allowed 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 115.407 -0.815 . . . . 73.140000000000001 109.54 -179.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.21 31.71 63.56 Favored Glycine 0 CA--C 1.507 -0.465 0 N-CA-C 110.099 -1.2 . . . . 73.310000000000002 110.099 -176.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -152.93 176.05 12.27 Favored 'General case' 0 N--CA 1.42 -1.952 0 N-CA-C 108.834 -0.802 . . . . 73.209999999999994 108.834 -175.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -109.17 153.44 23.76 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.888 -0.597 . . . . 74.430000000000007 109.557 177.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -143.64 134.24 24.96 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 108.141 -1.059 . . . . 73.549999999999997 108.141 -179.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -104.21 135.81 44.98 Favored 'General case' 0 N--CA 1.428 -1.539 0 CA-C-O 120.877 0.37 . . . . 75.239999999999995 110.571 178.146 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 81.6 mt -82.6 115.07 21.4 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.684 -0.689 . . . . 72.030000000000001 109.471 -178.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -126.63 9.18 7.05 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 107.582 -1.266 . . . . 73.150000000000006 107.582 176.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -131.19 147.51 66.54 Favored Pre-proline 0 C--N 1.295 -1.781 0 CA-C-N 113.571 -1.649 . . . . 73.019999999999996 107.621 -175.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -57.42 -53.52 4.6 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 122.759 2.306 . . . . 75.25 114.859 -175.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 85.0 m -131.67 109.78 10.44 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.224 0.535 . . . . 73.219999999999999 112.365 -177.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 41.4 m -98.55 118.07 34.42 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.309 -0.997 . . . . 72.540000000000006 108.309 175.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.492 ' OG1' ' HG2' ' A' ' 88' ' ' ARG . 12.5 t -102.59 147.79 26.35 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 119.308 -0.957 . . . . 74.430000000000007 110.697 179.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -108.1 132.67 53.34 Favored 'General case' 0 N--CA 1.424 -1.726 0 CA-C-N 115.437 -0.801 . . . . 71.129999999999995 109.509 179.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.534 ' O ' ' HA ' ' A' ' 79' ' ' PHE . . . -161.53 -146.05 4.51 Favored Glycine 0 N--CA 1.428 -1.852 0 N-CA-C 108.645 -1.782 . . . . 64.400000000000006 108.645 176.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 18.2 ttp85 -164.76 58.76 0.13 Allowed 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.166 -1.05 . . . . 74.519999999999996 108.166 173.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 70.1 m80 -139.38 165.24 33.11 Favored Pre-proline 0 C--N 1.279 -2.499 0 N-CA-C 106.738 -1.579 . . . . 71.200000000000003 106.738 179.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 99.5 Cg_exo -48.99 -33.43 26.16 Favored 'Trans proline' 0 C--N 1.358 1.055 0 C-N-CA 122.715 2.277 . . . . 71.439999999999998 112.556 177.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -106.71 74.39 1.0 Allowed 'General case' 0 N--CA 1.432 -1.347 0 CA-C-O 122.016 0.912 . . . . 73.140000000000001 109.855 176.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 37.7 m -146.1 123.42 11.6 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 113.957 -1.474 . . . . 53.240000000000002 108.159 174.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -65.21 -52.1 56.8 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-O 120.605 0.241 . . . . 75.349999999999994 110.83 -178.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 41.8 pt -123.61 178.78 3.15 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 109.627 -0.509 . . . . 73.299999999999997 109.627 175.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.534 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 97.2 m-85 -122.89 136.98 55.06 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 112.623 0.601 . . . . 75.010000000000005 112.623 -172.101 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -117.92 132.23 56.43 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.187 -1.412 . . . . 74.329999999999998 107.187 167.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.436 ' N ' ' HA ' ' A' ' 56' ' ' ASN . 38.1 t70 -127.98 70.21 1.34 Allowed 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 122.437 1.113 . . . . 63.009999999999998 109.439 -175.183 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -122.92 -163.56 1.11 Allowed 'General case' 0 C--N 1.284 -2.273 0 CA-C-N 113.668 -1.606 . . . . 72.310000000000002 108.542 176.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 44.7 t -65.27 -38.03 81.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 C-N-CA 123.389 0.676 . . . . 75.329999999999998 112.133 -176.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 26.2 m -121.95 93.5 4.01 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.868 0.842 . . . . 74.430000000000007 112.75 -175.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 6.0 p -111.63 128.89 67.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 CA-C-N 114.91 -1.041 . . . . 64.010000000000005 110.793 -178.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 8.9 m -112.64 -170.4 1.66 Allowed 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.232 -0.655 . . . . 65.310000000000002 109.232 178.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -78.98 -76.05 0.21 Allowed 'General case' 0 C--O 1.217 -0.609 0 N-CA-C 109.982 -0.377 . . . . 71.209999999999994 109.982 177.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.492 ' HG2' ' OG1' ' A' ' 69' ' ' THR . 1.5 tmm_? -101.48 82.58 2.32 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 105.386 -2.079 . . . . 75.25 105.386 174.521 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 67.1 t60 -87.37 -70.76 0.6 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.219 -0.901 . . . . 75.420000000000002 112.49 -170.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -110.86 147.57 34.27 Favored 'General case' 0 CA--C 1.483 -1.631 0 N-CA-C 108.793 -0.818 . . . . 73.420000000000002 108.793 -177.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -128.3 127.81 43.44 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-O 121.201 0.524 . . . . 75.230000000000004 110.412 178.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -105.81 113.13 26.5 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 105.602 -1.999 . . . . 75.420000000000002 105.602 177.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 71.7 mtp180 -118.45 147.32 43.72 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 121.864 0.84 . . . . 73.409999999999997 112.961 -172.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.53 117.12 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.321 0 N-CA-C 103.428 -2.804 . . . . 74.409999999999997 103.428 170.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 32.1 t-20 -118.36 147.25 43.71 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 108.161 -1.052 . . . . 72.019999999999996 108.161 -173.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.63 -20.09 53.62 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 113.195 0.813 . . . . 65.099999999999994 113.195 -179.104 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -78.82 -49.86 6.27 Favored Glycine 0 N--CA 1.423 -2.18 0 N-CA-C 111.14 -0.784 . . . . 71.030000000000001 111.14 173.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -177.77 -172.94 0.37 Allowed 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 107.363 -1.347 . . . . 74.319999999999993 107.363 -177.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.428 ' CB ' ' HB3' ' A' ' 122' ' ' MET . 89.9 m-85 -89.84 138.68 31.28 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 118.919 0.781 . . . . 70.549999999999997 109.393 -178.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -131.9 135.19 46.46 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 116.274 -0.421 . . . . 74.299999999999997 110.431 -174.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.6 p -128.95 117.71 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 108.934 -0.765 . . . . 74.450000000000003 108.934 174.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 19.4 m -121.09 135.55 60.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 CA-C-N 115.307 -0.86 . . . . 74.0 112.051 -178.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -99.07 107.38 19.77 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 106.093 -1.817 . . . . 75.120000000000005 106.093 170.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.4 m -94.21 9.35 5.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-O 121.402 0.62 . . . . 72.049999999999997 111.224 -176.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -90.04 -42.41 5.32 Favored Glycine 0 N--CA 1.428 -1.844 0 N-CA-C 108.159 -1.976 . . . . 73.420000000000002 108.159 172.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 39.7 m 70.23 -37.82 0.39 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.739 2.016 . . . . 60.399999999999999 114.348 174.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -58.66 -42.51 88.6 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 123.111 0.564 . . . . 75.120000000000005 111.658 177.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -86.05 -52.09 5.92 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.894 -0.78 . . . . 72.329999999999998 108.894 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 77.31 103.28 0.17 Allowed Glycine 0 N--CA 1.434 -1.456 0 CA-C-N 115.33 -0.85 . . . . 73.349999999999994 114.545 177.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 89.3 m -76.21 120.01 20.91 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 106.414 -1.698 . . . . 73.25 106.414 169.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -114.3 171.98 7.29 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.883 0.849 . . . . 73.319999999999993 111.591 -171.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 21.9 t -98.53 142.74 14.19 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.122 0 N-CA-C 104.758 -2.312 . . . . 74.140000000000001 104.758 173.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -40.03 -36.84 0.52 Allowed 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 114.204 1.187 . . . . 73.040000000000006 114.204 -176.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -118.56 -13.0 9.7 Favored 'General case' 0 C--O 1.222 -0.387 0 N-CA-C 112.386 0.513 . . . . 75.140000000000001 112.386 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -114.43 107.42 51.28 Favored Pre-proline 0 C--N 1.315 -0.933 0 N-CA-C 111.892 0.33 . . . . 74.409999999999997 111.892 -178.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -83.65 101.35 0.92 Allowed 'Trans proline' 0 N--CA 1.44 -1.665 0 C-N-CA 122.4 2.067 . . . . 62.439999999999998 110.739 176.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.573 ' HD2' ' OE1' ' A' ' 120' ' ' GLN . 15.5 ptp180 -153.63 152.94 31.42 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.884 -1.154 . . . . 72.310000000000002 107.884 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -81.16 -26.96 35.64 Favored 'General case' 0 C--N 1.313 -1.022 0 N-CA-C 112.425 0.528 . . . . 74.5 112.425 -175.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -129.38 139.04 51.82 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 109.273 -0.64 . . . . 62.210000000000001 109.273 178.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.573 ' OE1' ' HD2' ' A' ' 117' ' ' ARG . 51.8 tp60 -140.45 149.48 42.62 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.491 -0.777 . . . . 64.400000000000006 109.925 -176.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.4 p -79.47 121.4 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 105.764 -1.939 . . . . 70.519999999999996 105.764 169.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.515 ' HE3' ' CD1' ' A' ' 137' ' ' PHE . 10.9 ttt -71.35 115.02 10.02 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 121.575 0.702 . . . . 75.129999999999995 109.159 -170.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 21.5 tp60 -104.76 135.13 46.71 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.254 -0.885 . . . . 74.420000000000002 108.776 -173.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.1 t -78.86 131.33 36.41 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-O 121.049 0.452 . . . . 73.0 110.256 178.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 89.14 24.76 30.84 Favored Glycine 0 N--CA 1.426 -2.012 0 N-CA-C 111.024 -0.83 . . . . 71.409999999999997 111.024 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -116.49 169.45 9.32 Favored 'General case' 0 C--O 1.251 1.139 0 N-CA-C 109.16 -0.682 . . . . 70.340000000000003 109.16 -178.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -114.07 121.22 43.16 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.819 -1.178 . . . . 65.510000000000005 107.819 -174.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 65.2 mt -107.93 131.43 58.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 C-N-CA 123.93 0.892 . . . . 64.439999999999998 110.577 -175.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -101.13 111.87 24.2 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.803 -0.635 . . . . 75.519999999999996 109.296 -177.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 5.1 pt -103.1 98.14 6.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 CA-C-O 121.575 0.702 . . . . 74.519999999999996 109.808 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 71.88 -100.4 0.92 Allowed Glycine 0 N--CA 1.44 -1.088 0 N-CA-C 109.228 -1.549 . . . . 75.549999999999997 109.228 -174.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -124.41 5.7 8.36 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 108.953 -0.758 . . . . 74.219999999999999 108.953 175.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.465 ' HB3' ' O ' ' A' ' 53' ' ' ARG . 63.0 m-85 -103.19 173.54 6.26 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 115.408 -0.815 . . . . 75.430000000000007 110.563 -175.201 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 34.2 ttt180 -132.26 125.21 30.53 Favored 'General case' 0 C--O 1.255 1.365 0 C-N-CA 119.698 -0.801 . . . . 75.129999999999995 112.988 -165.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 5.9 tt -124.57 139.7 53.63 Favored 'General case' 0 C--O 1.21 -0.984 0 C-N-CA 124.792 1.237 . . . . 71.310000000000002 109.495 -178.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 8.6 t -109.95 136.39 46.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 107.088 -1.449 . . . . 75.25 107.088 176.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . 0.515 ' CD1' ' HE3' ' A' ' 122' ' ' MET . 73.5 t80 -115.06 126.8 55.12 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 120.195 -0.602 . . . . 71.549999999999997 110.983 179.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.0 mp -133.35 133.07 42.01 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.961 -0.385 . . . . 75.530000000000001 109.961 178.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -93.44 141.42 28.48 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 105.102 -2.184 . . . . 73.25 105.102 170.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 177.15 -52.44 0.1 Allowed Glycine 0 C--N 1.289 -2.057 0 C-N-CA 118.273 -1.917 . . . . 44.130000000000003 114.307 -174.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.438 ' O ' ' HB2' ' A' ' 46' ' ' SER . 33.2 Cg_exo . . . . . 0 C--N 1.368 1.565 0 CA-C-N 119.906 1.853 . . . . 74.329999999999998 112.194 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 45.3 t30 . . . . . 0 C--O 1.245 0.843 0 CA-C-O 120.644 0.259 . . . . 73.200000000000003 110.785 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.38 104.51 3.18 Favored Glycine 0 N--CA 1.437 -1.282 0 N-CA-C 111.145 -0.782 . . . . 65.120000000000005 111.145 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 50.3 m -101.63 124.44 40.68 Favored Pre-proline 0 C--N 1.301 -1.521 0 N-CA-C 109.838 -0.43 . . . . 75.510000000000005 109.838 -178.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -66.33 145.23 77.06 Favored 'Trans proline' 0 C--O 1.247 0.926 0 C-N-CA 121.837 1.691 . . . . 74.409999999999997 110.007 175.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -69.76 138.71 88.18 Favored Pre-proline 0 C--N 1.3 -1.548 0 CA-C-N 116.336 -0.393 . . . . 75.150000000000006 109.996 -175.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.32 134.3 60.61 Favored 'Trans proline' 0 C--O 1.252 1.185 0 C-N-CA 122.845 2.363 . . . . 74.219999999999999 113.098 -174.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 73.84 80.33 0.12 Allowed 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 125.903 1.681 . . . . 63.43 110.705 -176.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.5 p -103.38 136.57 35.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-N 114.754 -1.112 . . . . 64.310000000000002 109.189 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.28 131.54 36.04 Favored 'General case' 0 N--CA 1.42 -1.969 0 CA-C-O 120.941 0.401 . . . . 72.310000000000002 109.939 179.06 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.9 t -82.84 147.36 28.39 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 109.012 -0.736 . . . . 64.140000000000001 109.012 176.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.0 t -85.06 114.37 22.16 Favored 'General case' 0 N--CA 1.407 -2.577 0 CA-C-O 121.761 0.791 . . . . 61.329999999999998 109.311 178.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 37.4 m -138.68 85.45 2.08 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 115.131 -0.94 . . . . 75.439999999999998 108.754 175.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.1 p . . . . . 0 C--N 1.298 -1.635 0 N-CA-C 106.934 -1.506 . . . . 73.019999999999996 106.934 -176.402 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 109.401 -1.48 . . . . 63.200000000000003 109.401 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.9 m -132.75 151.49 51.98 Favored 'General case' 0 N--CA 1.421 -1.895 0 N-CA-C 104.926 -2.25 . . . . 53.329999999999998 104.926 175.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.417 ' HB2' ' CZ ' ' A' ' 137' ' ' PHE . . . -142.88 164.81 29.09 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 108.497 -0.927 . . . . 64.010000000000005 108.497 -178.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -119.44 150.43 40.22 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 120.32 -0.552 . . . . 73.439999999999998 111.677 -174.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.476 ' O ' HD12 ' A' ' 49' ' ' LEU . 2.8 pp -109.77 138.95 45.4 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 115.312 -0.858 . . . . 73.430000000000007 109.325 176.108 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.432 ' O ' HD12 ' A' ' 135' ' ' LEU . 29.8 m -112.66 131.79 63.21 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 N-CA-C 108.093 -1.077 . . . . 71.239999999999995 108.093 177.062 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 37.1 t -92.05 114.34 28.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 N-CA-C 104.442 -2.429 . . . . 73.409999999999997 104.442 175.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 50.5 tttp -84.72 -32.46 23.49 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 108.328 -0.99 . . . . 73.5 108.328 -173.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.445 ' HA ' ' NE ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -170.44 108.9 0.35 Allowed 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 107.721 -1.215 . . . . 73.200000000000003 107.721 174.213 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -168.86 117.75 0.74 Allowed Glycine 0 N--CA 1.424 -2.111 0 C-N-CA 120.465 -0.874 . . . . 64.510000000000005 111.099 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -51.6 -12.77 1.16 Allowed 'Trans proline' 0 CA--C 1.555 1.532 0 C-N-CA 124.423 3.415 . . . . 75.299999999999997 116.127 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.462 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 31.3 p30 -71.67 -29.48 64.66 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 122.115 -0.365 . . . . 74.450000000000003 111.6 179.426 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -163.47 -148.88 0.13 Allowed 'General case' 0 C--O 1.24 0.576 0 N-CA-C 108.57 -0.9 . . . . 71.450000000000003 108.57 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 169.23 53.57 0.03 OUTLIER Glycine 0 CA--C 1.488 -1.608 0 N-CA-C 110.489 -1.044 . . . . 71.450000000000003 110.489 177.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -154.57 -170.24 3.47 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 108.303 -0.999 . . . . 54.439999999999998 108.303 -176.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 27.3 ptt180 -131.23 135.69 47.58 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 107.835 -1.172 . . . . 73.329999999999998 107.835 175.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -143.73 141.66 30.58 Favored 'General case' 0 C--N 1.291 -1.969 0 C-N-CA 120.518 -0.473 . . . . 74.319999999999993 111.226 178.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 28.3 tp -75.98 129.85 37.53 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 114.784 -1.098 . . . . 72.239999999999995 109.224 -178.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 81.9 mt -86.87 114.5 23.57 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 108.485 -0.932 . . . . 75.140000000000001 108.485 176.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -150.0 37.21 0.7 Allowed 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 103.761 -2.681 . . . . 73.409999999999997 103.761 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -133.98 128.64 19.74 Favored Pre-proline 0 C--N 1.297 -1.689 0 CA-C-N 113.486 -1.688 . . . . 73.340000000000003 107.768 -174.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -45.65 -55.41 3.58 Favored 'Trans proline' 0 C--N 1.362 1.237 0 C-N-CA 123.937 3.091 . . . . 75.340000000000003 113.562 -174.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 57.9 m -137.16 98.75 3.81 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 121.713 0.768 . . . . 75.329999999999998 112.963 179.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.411 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 90.1 m -80.57 112.83 18.29 Favored 'General case' 0 N--CA 1.417 -2.093 0 N-CA-C 106.42 -1.696 . . . . 75.120000000000005 106.42 174.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.411 ' HB ' ' HA ' ' A' ' 76' ' ' SER . 27.1 m -108.64 128.02 54.48 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 116.36 -0.382 . . . . 70.439999999999998 110.333 -175.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -105.0 120.02 40.45 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 108.873 -0.788 . . . . 72.239999999999995 108.873 177.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 158.39 -127.34 1.86 Allowed Glycine 0 N--CA 1.431 -1.664 0 N-CA-C 110.649 -0.98 . . . . 62.149999999999999 110.649 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.495 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 41.1 ttm180 -154.23 84.27 1.13 Allowed 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 121.436 0.636 . . . . 75.219999999999999 110.18 179.187 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 11.2 m170 -137.3 167.18 21.87 Favored Pre-proline 0 C--N 1.288 -2.088 0 N-CA-C 107.616 -1.253 . . . . 72.349999999999994 107.616 175.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -60.07 -21.56 65.98 Favored 'Trans proline' 0 C--N 1.358 1.069 0 C-N-CA 122.308 2.005 . . . . 74.239999999999995 111.024 174.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -112.53 78.72 1.15 Allowed 'General case' 0 N--CA 1.424 -1.758 0 N-CA-C 107.963 -1.125 . . . . 72.519999999999996 107.963 177.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.411 ' HA ' ' HB ' ' A' ' 69' ' ' THR . 55.4 m -139.35 151.53 46.44 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 115.108 -0.951 . . . . 72.430000000000007 110.525 177.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -104.36 -46.85 4.28 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 109.018 -0.734 . . . . 74.349999999999994 109.018 -178.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 33.8 pt -133.31 156.01 41.36 Favored 'Isoleucine or valine' 0 C--O 1.245 0.865 0 CA-C-N 115.58 -0.736 . . . . 70.230000000000004 109.685 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -120.29 135.45 55.0 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.583 -0.895 . . . . 74.450000000000003 108.583 178.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 4.5 mp -75.42 106.01 6.74 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 122.849 0.46 . . . . 73.510000000000005 110.94 -178.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -86.26 63.51 8.05 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 122.718 1.246 . . . . 61.210000000000001 109.913 177.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -143.66 167.58 21.93 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 113.726 -1.579 . . . . 65.329999999999998 107.301 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.1 m -66.4 -33.87 66.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 117.801 0.273 . . . . 71.310000000000002 111.375 178.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 11.7 p -90.63 72.22 6.79 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-O 121.603 0.716 . . . . 75.530000000000001 112.425 179.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 6.9 p -113.58 113.41 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 CA-C-N 114.872 -1.058 . . . . 74.230000000000004 111.257 177.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 7.0 m -92.83 148.23 22.2 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 105.281 -2.118 . . . . 61.520000000000003 105.281 171.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.495 ' HB2' ' O ' ' A' ' 72' ' ' ARG . 9.1 ptm180 -73.47 -21.92 60.31 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 118.421 -1.312 . . . . 74.049999999999997 110.481 -179.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 26.8 ptt180 -122.24 97.77 5.63 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 106.526 -1.657 . . . . 74.129999999999995 106.526 165.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 8.6 t60 -109.66 -52.29 2.79 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.923 -0.711 . . . . 74.450000000000003 110.941 -173.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -144.96 131.94 20.28 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 120.188 -0.605 . . . . 71.219999999999999 110.104 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -114.91 126.81 55.22 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 108.794 -0.817 . . . . 74.019999999999996 108.794 177.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.411 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 79.8 m-85 -113.61 113.45 25.08 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 107.72 -1.215 . . . . 74.310000000000002 107.72 -179.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 51.5 mtm180 -115.25 152.64 32.33 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-O 121.116 0.484 . . . . 74.420000000000002 110.977 -175.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.49 ' O ' HD11 ' A' ' 94' ' ' ILE . 2.9 pp -113.83 117.07 54.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 CA-C-O 122.414 1.102 . . . . 73.439999999999998 108.459 175.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 38.1 t-20 -103.05 147.65 26.7 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 106.893 -1.521 . . . . 74.099999999999994 106.893 -173.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -49.81 -32.94 15.2 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 112.505 0.557 . . . . 72.450000000000003 112.505 -177.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -94.19 -40.72 4.47 Favored Glycine 0 N--CA 1.422 -2.296 0 C-N-CA 120.265 -0.969 . . . . 72.349999999999994 113.371 -179.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -149.32 178.47 8.74 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 121.872 0.844 . . . . 73.120000000000005 112.574 -173.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.428 ' HB3' ' HE3' ' A' ' 122' ' ' MET . 89.4 m-85 -93.35 127.18 38.85 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 107.455 -1.313 . . . . 74.530000000000001 107.455 177.272 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -123.03 130.78 53.23 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 120.858 0.361 . . . . 73.420000000000002 111.973 -171.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 9.0 p -121.54 131.05 73.97 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 109.139 -0.689 . . . . 75.049999999999997 109.139 175.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.7 m -117.76 128.02 75.0 Favored 'Isoleucine or valine' 0 C--O 1.259 1.578 0 CA-C-O 121.569 0.699 . . . . 71.430000000000007 111.02 178.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -83.79 114.5 21.66 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.679 -1.146 . . . . 71.239999999999995 110.065 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 23.4 m -122.35 3.18 5.99 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 CA-C-O 121.923 0.868 . . . . 75.019999999999996 108.903 173.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -109.17 53.26 0.6 Allowed Glycine 0 N--CA 1.427 -1.955 0 CA-C-N 114.596 -1.184 . . . . 75.219999999999999 110.36 -178.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.2 p -64.85 -2.85 2.83 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.455 1.102 . . . . 72.319999999999993 112.107 -178.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -62.83 -35.64 80.59 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 108.454 -0.943 . . . . 73.140000000000001 108.454 174.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -114.49 -45.93 2.99 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.237 -1.023 . . . . 74.030000000000001 108.237 177.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 94.37 120.97 3.35 Favored Glycine 0 N--CA 1.435 -1.419 0 CA-C-N 115.012 -0.994 . . . . 71.129999999999995 111.398 -178.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.4 m -79.56 119.53 22.66 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.999 -0.741 . . . . 73.25 108.999 176.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -103.4 134.42 46.8 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.967 -0.753 . . . . 74.099999999999994 108.967 178.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.402 HG13 ' HG2' ' A' ' 120' ' ' GLN . 61.9 t -115.91 117.93 57.15 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.359 0 N-CA-C 105.923 -1.88 . . . . 73.140000000000001 105.923 175.053 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 59.46 31.67 21.2 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-O 122.286 1.041 . . . . 72.209999999999994 108.392 -175.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 44.4 mtp180 74.39 5.03 4.56 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.127 1.371 . . . . 74.349999999999994 114.304 -178.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -103.05 134.95 19.5 Favored Pre-proline 0 C--N 1.309 -1.167 0 O-C-N 121.705 -0.622 . . . . 74.510000000000005 109.671 177.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -69.72 119.28 6.26 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.086 1.857 . . . . 74.230000000000004 110.096 177.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -123.35 129.98 52.07 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.715 -0.846 . . . . 70.010000000000005 108.715 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -69.64 -42.11 74.73 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 121.363 0.602 . . . . 74.230000000000004 109.904 178.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -144.61 138.39 27.38 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 105.814 -1.921 . . . . 75.530000000000001 105.814 173.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.402 ' HG2' HG13 ' A' ' 112' ' ' VAL . 57.8 tp60 -141.44 148.9 40.28 Favored 'General case' 0 C--N 1.282 -2.369 0 CA-C-O 120.732 0.301 . . . . 74.239999999999995 110.405 -177.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 89.1 t -80.46 120.88 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.669 0 N-CA-C 104.997 -2.223 . . . . 74.109999999999999 104.997 169.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.428 ' HE3' ' HB3' ' A' ' 99' ' ' PHE . 76.8 mtm -60.37 138.64 57.94 Favored 'General case' 0 CA--C 1.499 -0.985 0 CA-C-O 121.249 0.547 . . . . 74.230000000000004 111.339 -176.349 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 8.4 tp60 -103.79 123.48 47.15 Favored 'General case' 0 N--CA 1.417 -2.1 0 CA-C-N 115.146 -0.934 . . . . 73.540000000000006 108.483 -168.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 21.4 p -83.23 117.67 23.1 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.848 -0.615 . . . . 73.129999999999995 109.953 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 95.68 13.52 50.34 Favored Glycine 0 N--CA 1.436 -1.359 0 N-CA-C 111.631 -0.588 . . . . 71.219999999999999 111.631 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -132.5 -175.42 3.75 Favored 'General case' 0 C--O 1.248 0.976 0 N-CA-C 109.186 -0.672 . . . . 73.329999999999998 109.186 -177.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -112.03 149.05 32.59 Favored 'General case' 0 C--O 1.251 1.15 0 N-CA-C 114.997 1.48 . . . . 73.010000000000005 114.997 -171.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.3 mm -121.79 117.69 53.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 105.983 -1.858 . . . . 72.430000000000007 105.983 174.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -120.35 116.78 26.19 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 107.357 -1.349 . . . . 73.219999999999999 107.357 -177.238 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.0 tt -128.79 108.92 18.02 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.226 0 CA-C-O 121.417 0.627 . . . . 74.030000000000001 110.589 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 70.67 -103.98 1.3 Allowed Glycine 0 C--N 1.314 -0.669 0 N-CA-C 110.439 -1.064 . . . . 73.239999999999995 110.439 -177.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -120.09 6.56 10.79 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.056 -0.72 . . . . 74.439999999999998 109.056 173.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.462 ' CE2' HD23 ' A' ' 80' ' ' LEU . 56.3 m-85 -91.43 106.56 18.58 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 108.965 -0.754 . . . . 74.420000000000002 108.965 -177.081 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 14.5 ptt180 -96.41 120.95 37.65 Favored 'General case' 0 N--CA 1.432 -1.375 0 CA-C-O 122.168 0.985 . . . . 72.319999999999993 110.203 177.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.432 HD12 ' O ' ' A' ' 50' ' ' VAL . 25.3 tp -124.51 142.98 50.92 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 113.643 -1.617 . . . . 73.450000000000003 108.378 -174.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 29.8 t -124.5 134.89 65.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 107.499 -1.297 . . . . 71.099999999999994 107.499 176.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . 0.417 ' CZ ' ' HB2' ' A' ' 47' ' ' ALA . 64.1 t80 -108.32 120.34 42.09 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.057 -0.72 . . . . 74.239999999999995 109.057 -176.097 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -121.85 144.04 49.06 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.6 0.714 . . . . 70.430000000000007 112.337 -175.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -91.82 80.27 5.27 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 106.533 -1.654 . . . . 63.310000000000002 106.533 172.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -77.61 -71.69 1.19 Allowed Glycine 0 C--N 1.301 -1.414 0 CA-C-N 114.791 -1.095 . . . . 73.510000000000005 113.778 -174.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo . . . . . 0 N--CA 1.445 -1.326 0 C-N-CA 122.139 1.892 . . . . 72.430000000000007 113.023 -177.705 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 48.3 t30 . . . . . 0 C--O 1.244 0.8 0 N-CA-C 107.143 -1.429 . . . . 60.539999999999999 107.143 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -136.82 -133.28 3.16 Favored Glycine 0 N--CA 1.425 -2.064 0 C-N-CA 120.233 -0.984 . . . . 71.230000000000004 112.997 -176.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.8 t -85.09 143.22 39.36 Favored Pre-proline 0 C--N 1.302 -1.474 0 C-N-CA 122.599 0.36 . . . . 62.240000000000002 111.223 -176.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -66.73 150.34 83.51 Favored 'Trans proline' 0 C--O 1.249 1.037 0 C-N-CA 122.601 2.201 . . . . 72.430000000000007 110.385 171.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.9 mp0 -76.94 128.34 81.62 Favored Pre-proline 0 C--O 1.245 0.861 0 N-CA-C 109.612 -0.514 . . . . 74.299999999999997 109.612 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -63.05 150.43 88.66 Favored 'Trans proline' 0 C--O 1.25 1.079 0 C-N-CA 122.817 2.344 . . . . 74.420000000000002 111.191 175.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -92.77 173.89 7.53 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-O 121.028 0.442 . . . . 72.299999999999997 110.698 -175.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.5 m -121.18 169.57 12.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-N 115.698 -0.683 . . . . 72.400000000000006 110.779 -178.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -78.49 140.94 38.55 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 109.594 -0.521 . . . . 75.230000000000004 109.594 178.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.1 t -111.47 148.52 32.96 Favored 'General case' 0 N--CA 1.422 -1.833 0 CA-C-O 121.079 0.466 . . . . 75.209999999999994 110.311 -178.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.6 p -100.51 8.79 43.29 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 112.282 0.475 . . . . 72.030000000000001 112.282 178.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.4 p -78.94 32.54 0.21 Allowed 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.421 0.689 . . . . 73.150000000000006 112.621 -177.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.9 m . . . . . 0 N--CA 1.431 -1.42 0 N-CA-C 108.45 -0.945 . . . . 75.400000000000006 108.45 178.74 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.693 0 N-CA-C 109.178 -1.569 . . . . 72.25 109.178 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.5 m -90.67 165.89 13.46 Favored 'General case' 0 N--CA 1.425 -1.692 0 CA-C-N 114.548 -0.826 . . . . 74.329999999999998 111.192 -174.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -90.86 163.42 14.41 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 108.104 -1.073 . . . . 63.350000000000001 108.104 175.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.412 ' HB3' ' HG ' ' A' ' 62' ' ' LEU . 2.5 pt? -133.93 159.96 39.14 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.453 0.644 . . . . 73.329999999999998 110.733 -177.253 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -122.97 132.84 54.33 Favored 'General case' 0 C--N 1.278 -2.528 0 CA-C-N 115.018 -0.992 . . . . 75.209999999999994 108.806 176.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.4 m -110.01 116.35 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.019 0 N-CA-C 107.14 -1.43 . . . . 74.329999999999998 107.14 175.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.1 t -93.03 115.62 32.25 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.467 0 N-CA-C 107.88 -1.156 . . . . 75.540000000000006 107.88 -176.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -72.66 -38.6 67.59 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.584 -1.265 . . . . 73.299999999999997 107.584 -177.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 50.9 ttt180 -176.18 111.22 0.1 Allowed 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 106.359 -1.719 . . . . 74.230000000000004 106.359 174.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.458 ' HA2' ' HB3' ' A' ' 133' ' ' PHE . . . -122.84 166.17 15.33 Favored Glycine 0 N--CA 1.418 -2.53 0 N-CA-C 111.412 -0.675 . . . . 62.340000000000003 111.412 -177.307 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -69.09 -23.73 33.55 Favored 'Trans proline' 0 C--N 1.322 -0.847 0 C-N-CA 122.954 2.436 . . . . 64.319999999999993 111.481 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -98.87 -52.03 3.7 Favored 'General case' 0 N--CA 1.426 -1.63 0 CA-C-N 114.595 -1.184 . . . . 73.120000000000005 111.322 -177.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -144.25 -173.08 3.92 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-O 120.808 0.337 . . . . 72.540000000000006 110.496 -173.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.38 46.02 0.41 Allowed Glycine 0 N--CA 1.435 -1.399 0 N-CA-C 109.114 -1.594 . . . . 53.340000000000003 109.114 178.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -133.67 -169.87 2.38 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.888 -0.782 . . . . 74.329999999999998 108.888 -175.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -125.84 135.26 51.76 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 110.462 -0.199 . . . . 73.519999999999996 110.462 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -156.26 149.3 24.2 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 112.947 0.721 . . . . 72.140000000000001 112.947 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.412 ' HG ' ' HB3' ' A' ' 48' ' ' LEU . 6.8 mp -93.06 141.98 27.8 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 124.581 1.152 . . . . 74.109999999999999 109.73 177.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -74.49 115.3 13.86 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.592 -0.443 . . . . 75.129999999999995 110.065 176.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -113.13 8.97 18.46 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 108.606 -0.887 . . . . 71.409999999999997 108.606 -179.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -136.69 134.4 19.45 Favored Pre-proline 0 C--N 1.3 -1.571 0 N-CA-C 112.258 0.466 . . . . 71.209999999999994 112.258 -167.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -52.43 -62.49 0.35 Allowed 'Trans proline' 0 C--N 1.371 1.721 0 C-N-CA 124.538 3.492 . . . . 75.230000000000004 113.853 -177.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 94.7 m -116.49 110.64 18.87 Favored 'General case' 0 N--CA 1.422 -1.831 0 N-CA-C 109.354 -0.61 . . . . 75.409999999999997 109.354 178.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.411 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 91.2 m -109.56 113.63 26.58 Favored 'General case' 0 C--N 1.283 -2.314 0 N-CA-C 109.045 -0.724 . . . . 71.420000000000002 109.045 177.107 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.8 t -95.75 132.83 40.56 Favored 'General case' 0 C--O 1.256 1.424 0 N-CA-C 109.381 -0.6 . . . . 73.209999999999994 109.381 -178.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -127.88 124.92 38.65 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 115.739 -0.664 . . . . 61.520000000000003 110.282 -177.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.79 33.46 15.7 Favored Glycine 0 C--N 1.3 -1.445 0 C-N-CA 119.092 -1.527 . . . . 75.140000000000001 111.913 177.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.631 ' HA ' ' O ' ' A' ' 87' ' ' ARG . 2.1 tmt_? -123.73 87.66 2.78 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 105.993 -1.854 . . . . 74.519999999999996 105.993 176.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 20.3 m170 66.05 171.2 0.1 OUTLIER Pre-proline 0 CA--C 1.552 1.033 0 O-C-N 124.106 0.879 . . . . 72.219999999999999 109.795 -175.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -65.47 -20.18 60.91 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 121.686 1.591 . . . . 75.549999999999997 109.33 170.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -75.78 7.77 3.6 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 126.027 1.731 . . . . 74.239999999999995 112.381 -177.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 10.1 p -84.73 175.23 9.31 Favored 'General case' 0 C--N 1.322 -0.607 0 O-C-N 121.973 -0.454 . . . . 64.420000000000002 110.526 177.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -62.85 -56.74 14.71 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 108.791 -0.818 . . . . 73.230000000000004 108.791 -178.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.65 123.55 64.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 106.3 -1.741 . . . . 75.099999999999994 106.3 172.457 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -99.38 121.57 41.3 Favored 'General case' 0 C--N 1.29 -2.015 0 C-N-CA 119.829 -0.748 . . . . 72.540000000000006 112.872 -171.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.6 mp -69.09 128.95 38.46 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 107.418 -1.327 . . . . 75.439999999999998 107.418 170.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -116.06 24.04 11.74 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-O 122.46 1.124 . . . . 64.430000000000007 110.093 -175.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -103.84 -164.85 1.1 Allowed 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.745 -0.782 . . . . 74.019999999999996 109.889 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.7 p -92.19 -6.74 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.319 0 CA-C-O 121.339 0.59 . . . . 74.430000000000007 111.779 -174.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 7.4 m -87.45 12.87 11.15 Favored 'General case' 0 CA--C 1.555 1.139 0 CA-C-O 121.666 0.746 . . . . 72.329999999999998 110.543 -177.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 87.7 t -81.59 104.77 10.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-O 121.993 0.901 . . . . 75.430000000000007 110.83 -177.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 16.8 m -86.64 42.52 1.01 Allowed 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 124.388 1.075 . . . . 72.340000000000003 112.096 -176.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.631 ' O ' ' HA ' ' A' ' 72' ' ' ARG . 82.7 mtm180 72.65 -48.22 0.68 Allowed 'General case' 0 N--CA 1.513 2.724 0 C-N-CA 124.496 1.118 . . . . 71.329999999999998 110.39 -175.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -139.73 120.3 14.16 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 103.113 -2.921 . . . . 75.150000000000006 103.113 171.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 54.8 t60 -110.19 -71.45 0.76 Allowed 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 117.664 -1.614 . . . . 73.420000000000002 113.76 -174.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -117.85 143.24 46.47 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.974 -0.691 . . . . 74.109999999999999 111.911 -173.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.4 mm-40 -121.65 127.53 50.91 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.087 -1.079 . . . . 72.120000000000005 108.087 177.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.411 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 91.6 m-85 -103.67 113.47 27.01 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 106.628 -1.619 . . . . 73.319999999999993 106.628 175.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 89.5 mtt-85 -120.52 146.12 46.61 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 121.185 0.517 . . . . 75.319999999999993 110.795 -174.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 5.6 tt -115.87 130.93 69.72 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 N-CA-C 108.737 -0.838 . . . . 73.25 108.737 175.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -118.68 146.31 44.8 Favored 'General case' 0 C--N 1.282 -2.335 0 N-CA-C 106.166 -1.79 . . . . 64.409999999999997 106.166 178.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.97 -10.29 20.6 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 112.886 0.699 . . . . 72.209999999999994 112.886 -176.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -103.81 -41.85 2.07 Favored Glycine 0 N--CA 1.436 -1.361 0 CA-C-N 116.424 -0.353 . . . . 74.439999999999998 112.661 175.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -141.44 162.9 34.36 Favored 'General case' 0 C--O 1.216 -0.684 0 CA-C-O 121.277 0.56 . . . . 73.129999999999995 111.724 -176.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -108.2 121.19 44.36 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 106.674 -1.602 . . . . 74.109999999999999 106.674 173.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -125.52 135.55 52.39 Favored 'General case' 0 CA--C 1.49 -1.328 0 CA-C-O 122.087 0.946 . . . . 74.040000000000006 113.162 -176.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 6.0 p -108.28 119.38 57.76 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.333 0 CA-C-N 114.12 -1.4 . . . . 72.510000000000005 108.269 176.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 29.5 m -119.0 131.72 70.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 C-N-CA 120.595 -0.442 . . . . 62.350000000000001 109.852 -177.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -105.16 116.41 31.91 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.025 -1.472 . . . . 74.120000000000005 107.025 176.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.3 m -89.9 0.93 7.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-O 120.911 0.386 . . . . 71.010000000000005 111.025 -174.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -126.46 36.06 2.77 Favored Glycine 0 N--CA 1.429 -1.783 0 N-CA-C 108.673 -1.771 . . . . 65.219999999999999 108.673 175.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.7 p -68.8 7.35 0.68 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 113.826 1.047 . . . . 62.119999999999997 113.826 -175.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 78.3 mt -70.8 -21.51 62.47 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 108.885 -0.783 . . . . 73.129999999999995 108.885 176.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -77.23 -7.42 55.89 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.723 -0.671 . . . . 71.129999999999995 110.039 177.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 88.84 78.14 1.3 Allowed Glycine 0 N--CA 1.439 -1.126 0 N-CA-C 111.795 -0.522 . . . . 72.340000000000003 111.795 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 11.1 m -81.7 123.95 29.18 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 109.005 -0.739 . . . . 63.210000000000001 109.005 178.276 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -115.38 134.77 54.79 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 120.033 -0.667 . . . . 74.239999999999995 110.891 -176.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 29.1 m -112.68 110.37 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.135 0 N-CA-C 106.876 -1.527 . . . . 64.200000000000003 106.876 169.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 62.5 t30 58.18 36.66 25.97 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 125.355 1.462 . . . . 74.099999999999994 109.708 -177.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 52.8 mtp180 81.74 -0.62 1.57 Allowed 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 126.753 2.021 . . . . 74.540000000000006 113.545 -178.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -92.42 115.79 65.36 Favored Pre-proline 0 C--N 1.313 -1.004 0 N-CA-C 109.372 -0.603 . . . . 72.219999999999999 109.372 178.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.454 ' HA ' ' O ' ' A' ' 110' ' ' THR . 36.4 Cg_endo -66.34 121.5 8.8 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.905 2.403 . . . . 74.310000000000002 112.182 -179.024 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 8.8 mmm180 -136.1 163.73 29.66 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 120.833 0.349 . . . . 72.299999999999997 110.144 -177.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -98.94 -45.9 5.81 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.114 -1.069 . . . . 74.239999999999995 108.114 176.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -139.86 142.26 36.58 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 107.263 -1.384 . . . . 63.439999999999998 107.263 -179.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -134.68 141.06 46.44 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-O 121.316 0.579 . . . . 73.239999999999995 111.126 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.3 p -90.73 134.81 28.35 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 106.337 -1.727 . . . . 75.340000000000003 106.337 177.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 20.9 ptt? -41.01 123.84 2.06 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 122.143 0.973 . . . . 54.520000000000003 112.847 -177.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -127.01 124.71 40.03 Favored 'General case' 0 N--CA 1.413 -2.325 0 N-CA-C 106.17 -1.789 . . . . 73.109999999999999 106.17 177.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 31.1 p -78.48 124.45 28.15 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 116.138 -0.483 . . . . 75.200000000000003 111.821 -172.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 92.67 1.38 68.32 Favored Glycine 0 N--CA 1.44 -1.089 0 CA-C-N 115.207 -0.906 . . . . 51.210000000000001 110.894 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -90.41 151.54 21.38 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 108.312 -0.995 . . . . 73.129999999999995 108.312 -177.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -113.31 129.3 56.57 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 112.264 0.468 . . . . 75.430000000000007 112.264 -175.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 61.9 mt -95.27 115.78 35.09 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.164 0 N-CA-C 105.9 -1.889 . . . . 75.329999999999998 105.9 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -118.26 119.37 34.46 Favored 'General case' 0 N--CA 1.418 -2.059 0 CA-C-N 115.124 -0.944 . . . . 75.519999999999996 110.12 -172.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 7.5 pt -123.32 125.53 71.93 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 CA-C-N 114.962 -1.017 . . . . 75.530000000000001 109.222 179.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 68.5 -102.11 0.84 Allowed Glycine 0 N--CA 1.434 -1.499 0 N-CA-C 108.746 -1.741 . . . . 72.420000000000002 108.746 -171.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -137.32 18.76 2.94 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.947 -0.761 . . . . 73.239999999999995 108.947 174.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.458 ' HB3' ' HA2' ' A' ' 54' ' ' GLY . 81.6 m-85 -93.03 150.13 20.74 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.679 -0.692 . . . . 75.040000000000006 110.225 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 75.6 mtt180 -123.81 122.9 39.25 Favored 'General case' 0 C--O 1.252 1.206 0 CA-C-O 121.498 0.666 . . . . 64.439999999999998 111.47 -172.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 5.5 tt -123.67 129.99 51.96 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 106.682 -1.599 . . . . 73.5 106.682 177.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 12.2 t -108.14 128.73 63.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 N-CA-C 108.297 -1.001 . . . . 73.129999999999995 108.297 -178.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -105.92 129.38 54.08 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 120.71 -0.396 . . . . 75.129999999999995 110.408 -176.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -132.65 169.22 16.97 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.872 0.368 . . . . 74.230000000000004 110.263 -177.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -91.72 139.0 31.1 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 107.728 -1.212 . . . . 65.239999999999995 107.728 174.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -102.95 171.17 20.54 Favored Glycine 0 N--CA 1.439 -1.162 0 C-N-CA 120.119 -1.038 . . . . 71.530000000000001 113.005 -175.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo . . . . . 0 N--CA 1.451 -0.994 0 C-N-CA 122.583 2.189 . . . . 72.019999999999996 111.586 177.868 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 54.9 t30 . . . . . 0 N--CA 1.441 -0.888 0 N-CA-C 108.899 -0.778 . . . . 75.099999999999994 108.899 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -78.74 158.81 45.36 Favored Glycine 0 N--CA 1.431 -1.671 0 N-CA-C 110.786 -0.925 . . . . 62.149999999999999 110.786 179.187 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.5 m -75.14 125.28 89.31 Favored Pre-proline 0 C--N 1.299 -1.624 0 N-CA-C 109.987 -0.375 . . . . 71.340000000000003 109.987 -178.894 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -63.92 127.73 20.2 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 121.628 1.552 . . . . 74.430000000000007 109.121 175.158 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.429 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -89.99 144.12 30.94 Favored Pre-proline 0 C--N 1.298 -1.641 0 N-CA-C 112.489 0.552 . . . . 65.310000000000002 112.489 -176.844 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 9' ' ' GLU . 4.1 Cg_exo -76.66 141.67 22.25 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.373 2.049 . . . . 60.439999999999998 111.722 178.282 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -81.51 118.31 22.63 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.498 -0.927 . . . . 75.450000000000003 108.498 179.386 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.2 p -75.62 118.62 22.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 109.521 -0.548 . . . . 73.239999999999995 109.521 178.764 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -81.55 120.92 25.65 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 109.704 -0.48 . . . . 75.450000000000003 109.704 -179.078 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.0 t -129.6 117.44 20.4 Favored 'General case' 0 N--CA 1.414 -2.262 0 CA-C-N 115.496 -0.774 . . . . 73.319999999999993 110.19 -178.495 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.9 p -95.5 101.15 12.84 Favored 'General case' 0 N--CA 1.425 -1.688 0 CA-C-N 115.856 -0.611 . . . . 73.200000000000003 110.978 179.867 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.4 t -81.16 103.18 10.78 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 108.97 -0.752 . . . . 74.319999999999993 108.97 178.702 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 42.6 t . . . . . 0 C--N 1.294 -1.827 0 N-CA-C 107.75 -1.204 . . . . 74.099999999999994 107.75 179.0 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.401 ' O ' HD12 ' A' ' 94' ' ' ILE . . . . . . . . 0 CA--C 1.48 -2.106 0 N-CA-C 107.275 -2.33 . . . . 71.109999999999999 107.275 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.3 m -90.15 153.22 20.68 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-O 122.055 0.931 . . . . 71.409999999999997 112.311 -166.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.27 166.56 22.2 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 107.878 -1.156 . . . . 74.150000000000006 107.878 179.149 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.45 148.32 50.58 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.163 0.506 . . . . 72.340000000000003 112.093 -179.434 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.436 HD22 HD11 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -123.51 140.3 53.15 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.72 -0.845 . . . . 75.299999999999997 108.72 176.336 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 35.7 t -126.43 133.5 68.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 N-CA-C 108.249 -1.019 . . . . 73.319999999999993 108.249 -179.05 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 35.1 t -92.22 115.23 30.7 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.077 0 N-CA-C 106.328 -1.73 . . . . 63.109999999999999 106.328 177.522 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -86.02 -31.62 21.91 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 114.992 -1.004 . . . . 74.409999999999997 109.888 -172.488 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.476 ' O ' ' HB3' ' A' ' 133' ' ' PHE . 53.5 ttt180 -159.3 139.66 12.17 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.438 -0.578 . . . . 74.430000000000007 109.438 -179.218 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 132.68 148.83 6.08 Favored Glycine 0 N--CA 1.435 -1.387 0 C-N-CA 120.423 -0.894 . . . . 73.319999999999993 114.292 176.737 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -65.59 -8.62 19.79 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 124.126 3.217 . . . . 73.219999999999999 112.418 174.132 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -49.06 -56.67 8.33 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.139 0.976 . . . . 74.25 108.724 174.543 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -179.41 -172.09 0.22 Allowed 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.702 1.201 . . . . 70.140000000000001 107.968 179.729 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -154.23 30.45 0.71 Allowed Glycine 0 CA--C 1.483 -1.915 0 N-CA-C 107.809 -2.116 . . . . 72.25 107.809 178.019 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -116.88 -179.75 3.78 Favored 'General case' 0 N--CA 1.412 -2.369 0 CA-C-N 113.676 -1.262 . . . . 64.230000000000004 108.814 -175.328 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 7.6 ptt180 -138.12 131.01 29.83 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 108.312 -0.996 . . . . 70.129999999999995 108.312 -179.801 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -122.02 148.44 44.83 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 116.354 -0.385 . . . . 74.349999999999994 110.852 -172.711 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.1 tt -98.76 117.36 33.07 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.367 -0.975 . . . . 73.329999999999998 108.367 178.497 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 94.0 mt -90.76 115.58 27.95 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.656 -0.702 . . . . 74.140000000000001 109.585 179.802 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -121.37 -34.03 3.54 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 107.667 -1.235 . . . . 73.540000000000006 107.667 177.913 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 15.5 pm0 -64.99 130.15 94.76 Favored Pre-proline 0 N--CA 1.436 -1.159 0 CA-C-N 113.987 -1.461 . . . . 74.019999999999996 109.95 175.971 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -61.5 -33.06 88.55 Favored 'Trans proline' 0 C--O 1.244 0.811 0 C-N-CA 123.299 2.666 . . . . 73.109999999999999 114.269 -175.968 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.7 m -111.97 120.38 41.71 Favored 'General case' 0 N--CA 1.435 -1.183 0 O-C-N 122.177 -0.327 . . . . 72.230000000000004 110.825 -178.061 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.451 ' HB ' ' HB3' ' A' ' 92' ' ' PHE . 41.4 m -118.74 114.1 22.18 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.841 -0.799 . . . . 53.43 108.841 176.181 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 36.7 m -102.0 127.56 48.82 Favored 'General case' 0 C--N 1.312 -1.054 0 O-C-N 121.658 -0.651 . . . . 74.310000000000002 111.245 -179.462 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -106.1 125.2 50.7 Favored 'General case' 0 C--O 1.248 0.985 0 CA-C-N 115.652 -0.703 . . . . 43.210000000000001 109.153 177.985 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 167.43 -151.1 18.4 Favored Glycine 0 CA--C 1.49 -1.513 0 N-CA-C 110.624 -0.99 . . . . 74.230000000000004 110.624 179.866 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -130.54 83.72 2.14 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 122.573 1.178 . . . . 75.409999999999997 111.311 179.45 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 31.3 m80 -146.83 174.72 3.17 Favored Pre-proline 0 C--N 1.293 -1.874 0 N-CA-C 106.999 -1.482 . . . . 75.319999999999993 106.999 178.452 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -66.49 -22.25 51.99 Favored 'Trans proline' 0 C--N 1.354 0.848 0 N-CA-C 107.544 -1.752 . . . . 73.540000000000006 107.544 164.733 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -89.64 68.42 7.64 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 113.854 -1.521 . . . . 71.140000000000001 108.164 176.511 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 53.6 m -139.33 113.41 8.76 Favored 'General case' 0 C--N 1.275 -2.646 0 CA-C-N 114.395 -1.275 . . . . 72.239999999999995 107.56 175.54 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -71.84 -35.6 69.91 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.909 -1.041 . . . . 71.319999999999993 109.38 -174.669 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.41 160.56 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.252 0 N-CA-C 106.667 -1.605 . . . . 72.409999999999997 106.667 175.348 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -107.02 135.92 47.77 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-O 121.33 0.586 . . . . 75.319999999999993 111.861 -175.385 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.0 mp -125.66 137.85 53.88 Favored 'General case' 0 N--CA 1.424 -1.77 0 N-CA-C 108.061 -1.088 . . . . 70.439999999999998 108.061 179.05 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -140.37 75.76 1.52 Allowed 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.376 -1.342 . . . . 74.310000000000002 107.376 179.543 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.412 ' OD2' ' HA3' ' A' ' 131' ' ' GLY . 18.6 t70 -120.35 159.9 24.12 Favored 'General case' 0 C--N 1.275 -2.651 0 CA-C-N 113.34 -1.755 . . . . 73.230000000000004 108.209 179.761 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 10.2 p -71.45 -27.25 28.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 CA-C-O 121.176 0.513 . . . . 71.25 111.076 -178.46 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.5 p -113.04 14.7 19.65 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 113.437 0.902 . . . . 72.439999999999998 113.437 -176.809 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.8 p -82.61 120.43 34.02 Favored 'Isoleucine or valine' 0 C--O 1.253 1.261 0 C-N-CA 118.792 -1.163 . . . . 74.329999999999998 108.878 173.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 9.1 t -80.62 -172.4 3.59 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 115.208 -0.906 . . . . 70.129999999999995 111.602 -173.616 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 18.8 ttp180 -62.29 -51.69 66.66 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.109 0.963 . . . . 74.209999999999994 110.988 -179.584 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -134.06 97.61 3.91 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 104.608 -2.367 . . . . 73.140000000000001 104.608 177.532 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -88.76 -55.29 3.76 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 116.049 -0.523 . . . . 73.420000000000002 111.301 -168.299 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.79 151.13 36.63 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 120.278 -0.569 . . . . 75.450000000000003 110.532 -177.231 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -120.74 128.06 52.58 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 107.428 -1.323 . . . . 73.329999999999998 107.428 174.521 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.546 ' CE2' ' HB ' ' A' ' 94' ' ' ILE . 69.8 t80 -104.49 127.77 52.27 Favored 'General case' 0 C--N 1.277 -2.553 0 N-CA-C 108.888 -0.782 . . . . 74.150000000000006 108.888 178.03 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 -109.83 122.21 46.99 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 107.137 -1.431 . . . . 75.409999999999997 107.137 -179.689 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.546 ' HB ' ' CE2' ' A' ' 92' ' ' PHE . 0.0 OUTLIER -116.05 125.93 73.34 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.246 0 CA-C-O 121.777 0.799 . . . . 71.310000000000002 110.824 -177.789 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.413 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 20.7 t-20 -118.42 145.77 44.96 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 105.507 -2.035 . . . . 73.540000000000006 105.507 174.651 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -61.92 -19.14 62.38 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 112.526 0.565 . . . . 71.209999999999994 112.526 -175.19 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -104.58 -31.89 4.39 Favored Glycine 0 N--CA 1.431 -1.635 0 C-N-CA 120.72 -0.752 . . . . 75.519999999999996 113.178 178.492 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.413 ' O ' ' HB3' ' A' ' 95' ' ' ASN . 8.8 pt-20 -143.06 155.71 44.68 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 117.363 0.582 . . . . 75.439999999999998 111.604 -174.7 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -127.35 128.67 46.28 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 110.099 -0.334 . . . . 74.329999999999998 110.099 -173.813 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -128.19 135.35 49.6 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 110.262 -0.273 . . . . 70.329999999999998 110.262 -178.531 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 14.6 p -120.7 129.73 75.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 108.919 -0.771 . . . . 74.340000000000003 108.919 174.844 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 25.4 m -115.85 129.73 71.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 CA-C-O 121.445 0.64 . . . . 73.409999999999997 111.185 179.635 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -86.55 121.34 28.95 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 114.977 -1.01 . . . . 73.310000000000002 109.067 179.231 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 18.5 m -118.44 -1.16 8.81 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 CA-C-N 115.546 -0.752 . . . . 73.340000000000003 110.009 179.055 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -111.83 52.04 0.66 Allowed Glycine 0 N--CA 1.427 -1.956 0 N-CA-C 109.73 -1.348 . . . . 71.510000000000005 109.73 178.62 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 14.2 m -62.91 -4.92 2.43 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.538 1.135 . . . . 74.140000000000001 112.192 -177.633 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 81.2 mt -61.99 -30.2 70.77 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 124.253 1.021 . . . . 65.329999999999998 109.244 174.707 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -125.71 -40.41 2.06 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.131 -0.94 . . . . 75.409999999999997 108.771 179.251 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.74 132.21 5.14 Favored Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.349 -0.841 . . . . 74.109999999999999 113.312 178.333 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 28.9 m -81.56 136.26 35.58 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.312 -0.996 . . . . 65.329999999999998 108.312 173.353 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -114.43 134.17 55.19 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 108.268 -1.012 . . . . 75.109999999999999 108.268 -177.595 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 60.0 t -120.76 111.04 30.23 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 N-CA-C 106.926 -1.509 . . . . 75.409999999999997 106.926 176.784 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 42.7 t-20 44.08 70.36 0.33 Allowed 'General case' 0 C--O 1.241 0.634 0 O-C-N 125.143 1.527 . . . . 72.420000000000002 111.59 -176.114 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 73.98 -26.62 0.19 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.503 1.521 . . . . 75.219999999999999 113.388 177.362 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -90.77 118.1 68.41 Favored Pre-proline 0 C--N 1.311 -1.07 0 N-CA-C 112.343 0.497 . . . . 75.329999999999998 112.343 -175.68 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -63.38 128.24 22.05 Favored 'Trans proline' 0 C--O 1.247 0.965 0 C-N-CA 122.295 1.997 . . . . 75.310000000000002 108.584 172.299 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 3.1 mmp_? -123.04 145.23 48.71 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 116.991 -0.095 . . . . 75.120000000000005 110.81 -175.356 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -95.33 -36.66 11.31 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 108.181 -1.044 . . . . 72.010000000000005 108.181 172.11 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -149.19 139.49 22.33 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 105.89 -1.893 . . . . 75.409999999999997 105.89 174.308 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 7.7 tp60 -140.09 148.55 41.91 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 110.32 -0.252 . . . . 73.230000000000004 110.32 -178.714 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 67.4 t -93.11 123.12 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 N-CA-C 105.124 -2.176 . . . . 75.209999999999994 105.124 173.239 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 83.5 mmm -78.7 143.94 35.77 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 114.204 1.187 . . . . 75.030000000000001 114.204 -173.338 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -121.89 137.14 54.9 Favored 'General case' 0 N--CA 1.419 -1.99 0 CA-C-N 113.823 -1.535 . . . . 72.129999999999995 108.852 -177.581 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 7.1 t -79.54 126.69 31.2 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 109.024 -0.732 . . . . 74.409999999999997 109.024 178.502 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 95.74 19.33 29.65 Favored Glycine 0 N--CA 1.434 -1.454 0 C-N-CA 120.747 -0.739 . . . . 75.319999999999993 111.578 -179.175 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -118.93 160.91 21.08 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.816 -0.809 . . . . 72.310000000000002 108.816 178.246 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.442 ' OE1' ' HD2' ' A' ' 134' ' ' ARG . 44.0 tt0 -115.4 131.49 56.91 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.494 0.664 . . . . 73.299999999999997 111.495 -172.183 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.409 ' N ' HD13 ' A' ' 128' ' ' ILE . 3.5 mp -105.35 131.44 54.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 107.681 -1.229 . . . . 72.049999999999997 107.681 -176.728 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -102.26 113.21 26.3 Favored 'General case' 0 N--CA 1.425 -1.702 0 C-N-CA 119.178 -1.009 . . . . 74.010000000000005 108.375 177.849 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 8.0 pt -100.73 98.14 6.56 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.361 0 CA-C-N 114.743 -1.117 . . . . 74.310000000000002 108.549 178.826 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.412 ' HA3' ' OD2' ' A' ' 82' ' ' ASP . . . 77.73 -110.96 3.15 Favored Glycine 0 N--CA 1.426 -2.029 0 CA-C-N 113.976 -1.466 . . . . 65.230000000000004 109.522 -174.923 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.453 ' HZ2' ' HB3' ' A' ' 132' ' ' LYS . 7.8 mtpm? -104.87 -19.88 13.74 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 116.918 0.359 . . . . 73.109999999999999 110.083 175.0 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.476 ' HB3' ' O ' ' A' ' 53' ' ' ARG . 57.4 m-85 -97.77 161.76 13.6 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-O 120.856 0.36 . . . . 63.219999999999999 111.571 -171.181 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.442 ' HD2' ' OE1' ' A' ' 127' ' ' GLU . 70.3 mtm180 -121.0 140.55 51.75 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 113.817 1.043 . . . . 74.040000000000006 113.817 -169.023 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.436 HD11 HD22 ' A' ' 49' ' ' LEU . 47.6 tp -121.41 136.47 54.96 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 113.734 -1.575 . . . . 74.409999999999997 108.25 -177.325 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 10.7 p -111.21 132.4 59.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 C-N-CA 120.195 -0.602 . . . . 74.430000000000007 109.541 177.666 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -111.29 129.68 55.9 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.162 -0.472 . . . . 74.329999999999998 111.445 -176.368 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -129.45 148.82 51.4 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.308 -0.627 . . . . 75.019999999999996 109.308 176.799 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -95.36 137.83 33.89 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.286 -1.005 . . . . 73.439999999999998 108.286 175.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -120.23 -127.99 3.59 Favored Glycine 0 N--CA 1.435 -1.433 0 C-N-CA 119.509 -1.329 . . . . 72.430000000000007 114.339 -173.895 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo . . . . . 0 C--O 1.235 0.367 0 C-N-CA 123.305 2.67 . . . . 64.329999999999998 114.94 -172.491 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 41.9 t30 . . . . . 0 N--CA 1.434 -1.253 0 N-CA-C 107.582 -1.266 . . . . 72.310000000000002 107.582 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.87 80.4 0.57 Allowed Glycine 0 CA--C 1.503 -0.709 0 N-CA-C 109.132 -1.587 . . . . 73.239999999999995 109.132 175.688 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.8 m -78.67 124.52 85.17 Favored Pre-proline 0 N--CA 1.418 -2.042 0 C-N-CA 123.675 0.79 . . . . 73.239999999999995 111.289 -169.963 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -66.36 134.73 37.08 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 122.485 2.123 . . . . 54.520000000000003 109.573 174.545 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.3 135.71 79.16 Favored Pre-proline 0 C--N 1.303 -1.444 0 C-N-CA 119.976 -0.69 . . . . 64.129999999999995 110.67 177.093 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -60.27 121.61 10.05 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 122.204 1.936 . . . . 73.310000000000002 111.82 -178.225 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -79.63 108.53 13.25 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 106.631 -1.618 . . . . 74.319999999999993 106.631 178.636 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.8 m -63.95 126.14 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.305 0 CA-C-O 121.66 0.743 . . . . 75.010000000000005 112.44 -174.008 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -88.08 141.16 28.79 Favored 'General case' 0 N--CA 1.425 -1.678 0 CA-C-N 114.953 -1.021 . . . . 73.140000000000001 109.755 178.826 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.8 t -138.65 141.78 39.06 Favored 'General case' 0 C--N 1.285 -2.231 0 N-CA-C 108.156 -1.054 . . . . 73.409999999999997 108.156 179.027 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.8 t -105.23 124.95 50.4 Favored 'General case' 0 N--CA 1.406 -2.644 0 N-CA-C 108.171 -1.048 . . . . 72.120000000000005 108.171 -179.829 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.0 m -143.03 93.53 2.51 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-N 115.691 -0.686 . . . . 64.349999999999994 110.319 -178.811 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 C--N 1.312 -1.048 0 N-CA-C 108.629 -0.878 . . . . 75.030000000000001 108.629 179.333 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.644 0 N-CA-C 111.05 -0.82 . . . . 54.32 111.05 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.2 m -89.65 152.74 21.21 Favored 'General case' 0 N--CA 1.428 -1.526 0 N-CA-C 107.228 -1.397 . . . . 63.439999999999998 107.228 176.347 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.481 ' HB3' ' CZ ' ' A' ' 137' ' ' PHE . . . -97.64 178.54 5.13 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 110.201 -0.296 . . . . 65.540000000000006 110.201 -176.991 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -134.16 158.03 44.71 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.121 0.486 . . . . 73.340000000000003 111.507 -175.524 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.6 pp -121.34 140.26 52.33 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 115.354 -0.839 . . . . 74.299999999999997 109.023 174.869 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.432 HG13 ' CB ' ' A' ' 60' ' ' ARG . 33.1 m -115.52 138.51 45.66 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 CA-C-O 121.043 0.449 . . . . 62.549999999999997 109.834 179.611 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.0 t -93.61 115.62 32.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 107.818 -1.178 . . . . 74.209999999999994 107.818 179.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -88.56 -36.2 16.49 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.241 0.543 . . . . 72.219999999999999 109.551 -179.411 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.425 ' O ' ' HB3' ' A' ' 133' ' ' PHE . 37.6 ttm180 -149.84 125.5 10.36 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.309 -0.997 . . . . 74.400000000000006 108.309 -179.879 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 153.94 121.85 0.83 Allowed Glycine 0 N--CA 1.418 -2.539 0 C-N-CA 120.959 -0.639 . . . . 52.219999999999999 111.662 179.821 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -55.85 -9.04 2.58 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 124.522 3.481 . . . . 64.430000000000007 113.876 178.802 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.432 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 7.2 t30 -51.86 -38.39 55.82 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 124.106 0.962 . . . . 73.230000000000004 110.786 176.01 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -178.57 -59.87 0.01 OUTLIER 'General case' 0 C--N 1.354 0.764 0 CA-C-N 116.318 -0.401 . . . . 74.329999999999998 111.735 179.738 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.55 54.07 4.12 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 109.515 -1.434 . . . . 74.310000000000002 109.515 -173.837 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -154.63 -171.52 3.88 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 107.926 -1.138 . . . . 64.409999999999997 107.926 -175.752 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.432 ' CB ' HG13 ' A' ' 50' ' ' VAL . 18.7 ptp180 -110.15 140.2 44.5 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 109.875 -0.417 . . . . 72.040000000000006 109.875 -178.368 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -135.24 119.02 17.2 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 120.673 0.273 . . . . 74.329999999999998 110.891 179.765 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.0 tt -86.55 139.56 30.73 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 107.073 -1.454 . . . . 75.239999999999995 107.073 174.724 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 87.8 mt -71.19 114.07 8.87 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 119.923 -0.711 . . . . 75.319999999999993 109.385 -176.433 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -117.45 -32.26 4.98 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 114.793 -1.094 . . . . 71.319999999999993 110.989 -172.655 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -96.97 132.25 26.22 Favored Pre-proline 0 C--N 1.303 -1.454 0 N-CA-C 107.686 -1.227 . . . . 73.530000000000001 107.686 178.653 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.406 ' HA ' ' CG1' ' A' ' 94' ' ' ILE . 10.5 Cg_endo -53.45 -26.48 36.09 Favored 'Trans proline' 0 C--N 1.371 1.748 0 C-N-CA 124.034 3.156 . . . . 73.319999999999993 113.411 -176.207 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 51.8 m -133.39 98.09 4.14 Favored 'General case' 0 N--CA 1.407 -2.586 0 N-CA-C 108.404 -0.961 . . . . 75.019999999999996 108.404 174.282 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 98.2 m -88.75 115.4 26.26 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 114.868 -1.06 . . . . 74.0 108.469 -178.685 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.6 t -107.78 121.51 44.87 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-O 121.554 0.693 . . . . 74.239999999999995 111.369 -177.277 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -104.7 115.32 30.12 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 114.868 -1.06 . . . . 74.030000000000001 109.022 179.185 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.736 ' O ' ' HA ' ' A' ' 88' ' ' ARG . . . 90.64 85.33 1.39 Allowed Glycine 0 CA--C 1.475 -2.446 0 N-CA-C 107.798 -2.121 . . . . 73.329999999999998 107.798 -177.375 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.401 ' HG2' ' O ' ' A' ' 75' ' ' GLU . 23.5 tpt180 -177.57 142.79 0.33 Allowed 'General case' 0 N--CA 1.407 -2.59 0 N-CA-C 102.243 -3.243 . . . . 73.310000000000002 102.243 -171.513 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -109.16 -60.55 0.04 OUTLIER Pre-proline 0 C--N 1.274 -2.705 0 N-CA-C 115.316 1.599 . . . . 73.420000000000002 115.316 -177.701 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_exo -66.67 -40.63 12.82 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 121.871 1.714 . . . . 73.109999999999999 113.862 -173.249 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.401 ' O ' ' HG2' ' A' ' 72' ' ' ARG . 38.7 tt0 -130.42 75.55 1.66 Allowed 'General case' 0 N--CA 1.422 -1.87 0 N-CA-C 107.378 -1.341 . . . . 71.120000000000005 107.378 -177.309 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.4 p -112.24 170.44 8.16 Favored 'General case' 0 C--N 1.285 -2.231 0 N-CA-C 113.365 0.876 . . . . 73.510000000000005 113.365 -171.689 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -112.14 -55.71 2.48 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 107.166 -1.42 . . . . 72.150000000000006 107.166 173.857 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 24.2 pt -125.43 152.28 32.05 Favored 'Isoleucine or valine' 0 C--O 1.25 1.12 0 CA-C-N 115.539 -0.755 . . . . 74.010000000000005 109.422 174.797 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.432 ' O ' ' HA ' ' A' ' 56' ' ' ASN . 87.8 m-85 -112.89 117.53 32.38 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 112.293 0.479 . . . . 72.219999999999999 112.293 -173.131 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.2 mp -74.12 107.39 6.28 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 108.743 -0.836 . . . . 72.430000000000007 108.743 170.1 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -82.04 1.4 35.95 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 123.993 0.917 . . . . 64.409999999999997 110.976 -178.02 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -98.4 164.44 12.28 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.55 -0.75 . . . . 70.340000000000003 109.857 -177.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.2 p -69.92 -18.8 22.2 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.134 0 C-N-CA 123.35 0.66 . . . . 75.230000000000004 111.64 -178.769 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 13.3 p -73.05 11.44 0.7 Allowed 'General case' 0 CA--C 1.555 1.15 0 N-CA-C 113.698 0.999 . . . . 75.140000000000001 113.698 -178.807 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.6 p -82.58 125.0 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 CA-C-O 121.436 0.636 . . . . 73.209999999999994 111.931 -177.187 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 41.9 t -84.68 169.34 14.41 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.343 -0.984 . . . . 64.329999999999998 108.343 174.624 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 52.3 mtm-85 -56.76 -40.76 76.4 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 108.946 -0.761 . . . . 73.230000000000004 108.946 175.87 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.736 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -146.07 129.45 16.82 Favored 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 105.754 -1.943 . . . . 72.0 105.754 165.392 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 30.1 t60 -108.74 -74.04 0.67 Allowed 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 113.213 0.819 . . . . 72.409999999999997 113.213 -171.088 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -117.29 119.39 35.0 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 121.652 -0.655 . . . . 65.400000000000006 109.756 -177.443 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -109.69 127.18 54.4 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 108.277 -1.009 . . . . 73.120000000000005 108.277 -179.608 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -112.33 112.8 24.63 Favored 'General case' 0 N--CA 1.425 -1.693 0 N-CA-C 107.619 -1.252 . . . . 74.219999999999999 107.619 -178.763 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 30.8 ttm-85 -101.91 143.32 31.94 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 107.819 -1.178 . . . . 72.519999999999996 107.819 179.791 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.406 ' CG1' ' HA ' ' A' ' 66' ' ' PRO . 2.6 pp -115.53 140.46 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.479 0 N-CA-C 107.578 -1.267 . . . . 71.450000000000003 107.578 175.298 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.505 ' C ' ' H ' ' A' ' 97' ' ' GLY . 40.0 t-20 -118.44 147.08 43.95 Favored 'General case' 0 C--N 1.268 -2.972 0 N-CA-C 104.541 -2.392 . . . . 70.099999999999994 104.541 -178.807 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -59.84 26.5 0.01 OUTLIER 'General case' 0 CA--C 1.574 1.881 0 N-CA-C 114.62 1.341 . . . . 75.25 114.62 -176.945 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.505 ' H ' ' C ' ' A' ' 95' ' ' ASN . . . -169.16 -38.31 0.03 OUTLIER Glycine 0 N--CA 1.426 -2.011 0 N-CA-C 111.074 -0.81 . . . . 71.129999999999995 111.074 -179.445 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -127.61 170.9 12.14 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.95 0.405 . . . . 73.409999999999997 111.283 -176.392 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -116.89 129.3 55.98 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 116.276 -0.42 . . . . 73.409999999999997 110.101 -179.912 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -122.07 119.52 31.64 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.907 -0.405 . . . . 74.019999999999996 109.907 -176.845 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.469 HG13 ' SD ' ' A' ' 122' ' ' MET . 27.9 m -121.93 128.92 75.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 C-N-CA 119.835 -0.746 . . . . 74.299999999999997 110.944 178.371 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 29.4 m -119.84 137.46 53.65 Favored 'Isoleucine or valine' 0 C--O 1.252 1.234 0 N-CA-C 112.76 0.652 . . . . 73.120000000000005 112.76 -178.243 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -92.68 108.37 19.93 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.485 -0.78 . . . . 72.319999999999993 110.228 174.98 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.3 m -114.56 5.46 7.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 CA-C-O 121.86 0.838 . . . . 75.310000000000002 109.709 177.417 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -105.86 36.32 4.48 Favored Glycine 0 N--CA 1.431 -1.676 0 N-CA-C 109.725 -1.35 . . . . 71.099999999999994 109.725 179.351 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 14.0 m -65.01 5.47 0.34 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.736 1.615 . . . . 74.239999999999995 113.158 -176.689 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.4 mp -69.37 -34.27 74.3 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 107.505 -1.295 . . . . 71.329999999999998 107.505 172.918 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -119.01 -40.06 2.87 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 107.293 -1.373 . . . . 75.519999999999996 107.293 174.1 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 104.96 141.89 11.08 Favored Glycine 0 N--CA 1.44 -1.08 0 CA-C-N 115.79 -0.641 . . . . 74.540000000000006 113.485 176.108 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 27.6 m -108.52 125.45 51.82 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 107.362 -1.347 . . . . 73.430000000000007 107.362 173.205 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -103.64 134.52 46.85 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.56 -0.533 . . . . 73.299999999999997 109.56 -176.684 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.2 p -125.77 127.51 71.42 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.428 0 N-CA-C 106.973 -1.491 . . . . 73.420000000000002 106.973 175.391 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 18.4 m120 64.71 22.6 12.62 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 109.108 -0.701 . . . . 70.239999999999995 109.108 -174.842 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 18.3 mmm180 76.54 5.41 3.53 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.729 1.212 . . . . 75.209999999999994 112.779 -175.291 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -112.41 130.07 23.73 Favored Pre-proline 0 C--N 1.315 -0.924 0 N-CA-C 110.386 -0.227 . . . . 71.400000000000006 110.386 -179.4 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -74.85 110.48 3.12 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 121.823 1.682 . . . . 74.510000000000005 109.772 175.858 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 43.2 ttt180 -126.83 154.64 44.07 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.508 -1.293 . . . . 75.310000000000002 107.508 -176.235 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -81.2 -50.52 9.48 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.271 -0.572 . . . . 75.319999999999993 110.664 -175.182 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -130.18 140.16 50.77 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 108.406 -0.961 . . . . 64.439999999999998 108.406 178.875 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 55.2 tp60 -139.72 148.03 41.74 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 109.692 -0.485 . . . . 75.140000000000001 109.692 -179.926 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 98.8 t -88.17 117.29 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 N-CA-C 105.195 -2.15 . . . . 74.420000000000002 105.195 167.86 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.469 ' SD ' HG13 ' A' ' 101' ' ' VAL . 4.6 tpt -55.89 116.73 3.13 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 124.071 0.948 . . . . 70.310000000000002 111.468 -171.74 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -105.26 129.83 53.53 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.662 -0.699 . . . . 75.230000000000004 109.6 -174.336 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 7.0 t -79.61 129.16 34.22 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 121.628 0.728 . . . . 54.450000000000003 112.571 -175.217 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 108.18 -11.43 37.03 Favored Glycine 0 N--CA 1.423 -2.17 0 CA-C-N 115.249 -0.887 . . . . 62.530000000000001 111.638 178.196 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -102.35 172.59 6.8 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 112.867 0.692 . . . . 74.430000000000007 112.867 -177.344 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -108.32 142.52 38.5 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-N 115.056 -0.974 . . . . 74.099999999999994 112.115 -172.891 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.4 mp -124.1 113.17 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.922 0 N-CA-C 105.74 -1.948 . . . . 74.040000000000006 105.74 178.216 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.427 ' HA ' ' O ' ' A' ' 133' ' ' PHE . 66.4 mt-30 -102.95 119.64 39.21 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 109.667 -0.494 . . . . 73.439999999999998 109.667 -177.056 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 20.9 pt -91.41 99.72 10.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 N-CA-C 107.999 -1.112 . . . . 74.310000000000002 107.999 176.884 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 79.19 -94.03 1.34 Allowed Glycine 0 N--CA 1.422 -2.299 0 N-CA-C 108.755 -1.738 . . . . 72.230000000000004 108.755 -174.376 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -137.54 15.94 2.94 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.205 0.526 . . . . 74.209999999999994 110.306 177.128 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.427 ' O ' ' HA ' ' A' ' 129' ' ' GLN . 53.1 m-85 -103.52 131.3 50.76 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 109.664 -0.495 . . . . 75.299999999999997 109.664 -179.868 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 48.7 ttt180 -95.27 121.76 37.26 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-O 121.631 0.729 . . . . 70.049999999999997 111.708 -169.214 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 9.5 mp -121.96 143.87 49.21 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 107.668 -1.234 . . . . 74.530000000000001 107.668 175.672 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 6.3 p -126.95 130.67 71.37 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.435 0 C-N-CA 120.633 -0.427 . . . . 71.200000000000003 110.318 179.342 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . 0.481 ' CZ ' ' HB3' ' A' ' 47' ' ' ALA . 90.7 t80 -97.22 125.21 41.61 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.585 -0.734 . . . . 74.319999999999993 110.115 -176.759 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -128.56 144.24 51.11 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.385 0.612 . . . . 74.140000000000001 110.785 -179.752 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -87.01 86.21 7.3 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 106.996 -1.483 . . . . 73.340000000000003 106.996 171.926 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -75.27 -174.09 34.18 Favored Glycine 0 N--CA 1.439 -1.121 0 CA-C-N 114.983 -1.008 . . . . 52.409999999999997 113.945 -174.719 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo . . . . . 0 N--CA 1.447 -1.218 0 C-N-CA 122.716 2.278 . . . . 74.120000000000005 112.801 -179.14 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 13.6 m120 . . . . . 0 CA--C 1.506 -0.716 0 CA-C-O 121.178 0.513 . . . . 72.439999999999998 111.278 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -138.12 55.23 0.68 Allowed Glycine 0 N--CA 1.438 -1.229 0 N-CA-C 109.916 -1.273 . . . . 61.310000000000002 109.916 179.398 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.3 t -64.8 127.98 93.14 Favored Pre-proline 0 N--CA 1.439 -0.987 0 CA-C-N 115.191 -0.504 . . . . 74.010000000000005 109.834 -177.907 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -61.1 127.65 22.86 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.198 1.932 . . . . 73.319999999999993 111.212 179.849 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -101.74 115.69 64.5 Favored Pre-proline 0 C--N 1.302 -1.496 0 N-CA-C 109.505 -0.554 . . . . 75.109999999999999 109.505 179.606 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -73.03 128.87 13.53 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.744 2.296 . . . . 72.219999999999999 113.894 -176.59 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -106.69 108.04 19.36 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 106.057 -1.831 . . . . 74.010000000000005 106.057 176.369 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.2 p -124.54 135.48 63.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 N-CA-C 109.396 -0.594 . . . . 70.239999999999995 109.396 -179.314 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -105.92 130.77 53.8 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.121 0.486 . . . . 74.040000000000006 110.825 -178.98 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 95.6 m -151.63 106.43 3.25 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.238 -1.023 . . . . 64.310000000000002 108.238 174.693 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 17.1 p -96.99 122.98 40.58 Favored 'General case' 0 N--CA 1.412 -2.327 0 CA-C-O 121.422 0.63 . . . . 72.200000000000003 110.506 -178.049 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 27.5 t -80.66 108.78 14.6 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 114.747 -1.115 . . . . 74.030000000000001 110.336 -177.331 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 91.5 t . . . . . 0 C--N 1.306 -1.302 0 N-CA-C 108.416 -0.957 . . . . 74.439999999999998 108.416 178.497 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.149 0 N-CA-C 111.149 -0.78 . . . . 73.200000000000003 111.149 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.454 ' O ' ' HA ' ' A' ' 141' ' ' PRO . 10.8 m -90.53 159.77 16.31 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.342 -0.614 . . . . 55.049999999999997 109.342 -178.282 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -113.98 178.38 4.3 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 117.741 0.246 . . . . 73.450000000000003 111.064 -176.261 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.5 pp -132.36 158.94 40.64 Favored 'General case' 0 C--O 1.244 0.788 0 N-CA-C 112.909 0.707 . . . . 70.349999999999994 112.909 -173.389 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.4 pp -119.24 147.74 43.91 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.58 -0.736 . . . . 74.040000000000006 109.817 176.914 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 25.3 t -130.23 149.86 34.02 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 C-N-CA 123.606 0.763 . . . . 70.150000000000006 109.284 -175.577 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.54 118.05 33.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-O 122.375 1.083 . . . . 74.319999999999993 111.05 179.475 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -95.6 -39.05 10.12 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-N 115.244 -0.889 . . . . 74.450000000000003 108.785 174.016 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -154.04 89.17 1.28 Allowed 'General case' 0 C--O 1.215 -0.748 0 N-CA-C 109.051 -0.722 . . . . 63.450000000000003 109.051 176.211 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 20.87 54.04 0.01 OUTLIER Glycine 0 N--CA 1.508 3.495 0 N-CA-C 119.842 2.697 . . . . 72.519999999999996 119.842 177.44 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.91 -40.37 2.69 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 CA-C-N 120.821 2.31 . . . . 72.129999999999995 113.89 -178.783 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.592 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 15.6 m120 -134.17 -84.42 0.43 Allowed 'General case' 0 C--O 1.209 -1.055 0 CA-C-O 121.183 0.516 . . . . 62.420000000000002 112.079 -171.504 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.64 -6.82 26.59 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.528 0.566 . . . . 73.239999999999995 112.528 -173.825 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.24 40.57 99.2 Favored Glycine 0 CA--C 1.523 0.579 0 C-N-CA 120.756 -0.735 . . . . 71.109999999999999 112.256 -178.199 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -157.09 -163.7 1.45 Allowed 'General case' 0 C--O 1.254 1.331 0 N-CA-C 108.886 -0.783 . . . . 44.520000000000003 108.886 -177.122 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -132.34 139.49 48.17 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 108.354 -0.98 . . . . 72.340000000000003 108.354 176.134 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -156.46 154.5 30.5 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.057 0.456 . . . . 73.150000000000006 111.786 179.477 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 31.2 tp -80.08 139.49 36.87 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 114.55 -1.204 . . . . 75.340000000000003 109.172 179.655 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.9 mp -82.77 114.38 21.06 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 106.52 -1.659 . . . . 74.230000000000004 106.52 173.704 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -112.42 3.8 17.14 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 116.132 -0.486 . . . . 74.219999999999999 110.233 -175.012 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -121.82 141.11 33.21 Favored Pre-proline 0 C--N 1.301 -1.541 0 N-CA-C 107.741 -1.207 . . . . 75.319999999999993 107.741 -179.391 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -55.08 -49.89 14.99 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.167 2.578 . . . . 63.109999999999999 111.924 -177.413 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 92' ' ' PHE . 44.3 m -121.08 108.54 13.94 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-N 115.509 -0.769 . . . . 74.239999999999995 110.455 178.924 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.419 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 4.7 m -91.66 114.81 27.44 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.264 -1.013 . . . . 75.430000000000007 108.264 179.116 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 16.7 p -90.79 122.76 33.8 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 116.742 -0.208 . . . . 75.340000000000003 110.693 -179.774 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.433 ' HA ' ' O ' ' A' ' 78' ' ' ILE . . . -109.5 121.84 46.08 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 109.877 -0.416 . . . . 71.209999999999994 109.877 178.178 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -164.6 -136.22 1.96 Allowed Glycine 0 N--CA 1.432 -1.604 0 N-CA-C 111.117 -0.793 . . . . 70.439999999999998 111.117 178.52 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.443 ' NH2' ' HA ' ' A' ' 81' ' ' ASP . 4.2 tpp180 -159.57 84.65 0.77 Allowed 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.025 -1.472 . . . . 75.25 107.025 176.992 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -179.97 151.18 0.57 Allowed Pre-proline 0 C--N 1.296 -1.756 0 N-CA-C 104.745 -2.317 . . . . 75.439999999999998 104.745 -177.514 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.44 -22.15 70.52 Favored 'Trans proline' 0 N--CA 1.48 0.709 0 C-N-CA 122.41 2.073 . . . . 74.120000000000005 113.211 -178.149 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -79.54 -18.34 52.03 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.431 -0.35 . . . . 71.219999999999999 111.064 -179.148 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.0 m -88.42 131.86 34.69 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 107.162 -1.422 . . . . 73.010000000000005 107.162 176.167 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -70.84 -50.38 36.02 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 120.956 -0.297 . . . . 63.310000000000002 111.451 -176.851 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.433 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 39.2 pt -112.37 154.55 13.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 C-N-CA 120.133 -0.627 . . . . 65.299999999999997 109.883 178.991 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -116.58 136.05 53.3 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 116.399 -0.364 . . . . 72.450000000000003 110.501 -179.023 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.592 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 1.5 pt? -84.99 139.92 31.44 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 106.647 -1.612 . . . . 73.329999999999998 106.647 171.553 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.443 ' HA ' ' NH2' ' A' ' 72' ' ' ARG . 19.8 t70 -106.56 58.0 0.64 Allowed 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 118.415 -1.314 . . . . 70.239999999999995 112.583 -172.098 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -104.07 151.19 23.55 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 106.641 -1.615 . . . . 72.25 106.641 171.476 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.4 m -74.38 -12.45 15.14 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 N-CA-C 112.284 0.476 . . . . 72.329999999999998 112.284 -178.621 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -113.42 51.52 0.84 Allowed 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 106.956 -1.498 . . . . 72.329999999999998 106.956 179.16 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.422 ' CG2' ' HB2' ' A' ' 72' ' ' ARG . 7.6 p -82.24 135.59 24.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 115.469 -0.787 . . . . 73.540000000000006 113.004 -173.038 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 8.0 m -101.75 144.21 30.72 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.625 -0.716 . . . . 74.439999999999998 110.93 -177.925 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -67.39 120.79 14.47 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 106.172 -1.788 . . . . 74.409999999999997 106.172 170.569 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 58.1 81.35 0.15 Allowed 'General case' 0 N--CA 1.466 0.357 0 O-C-N 123.9 0.75 . . . . 73.420000000000002 110.396 -172.421 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 19.1 t60 -98.81 -35.65 10.06 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 109.398 -0.593 . . . . 72.349999999999994 109.398 -178.626 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -149.22 136.27 19.83 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 120.335 -0.546 . . . . 73.040000000000006 110.031 -179.447 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -112.89 126.98 56.05 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 108.313 -0.995 . . . . 75.150000000000006 108.313 173.989 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.435 ' O ' ' HA ' ' A' ' 67' ' ' THR . 86.1 m-85 -105.37 122.39 45.88 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.049 -1.093 . . . . 73.409999999999997 108.049 179.058 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.43 ' HB3' ' HB3' ' A' ' 100' ' ' GLU . 51.4 ttt180 -113.06 119.16 36.89 Favored 'General case' 0 C--N 1.281 -2.385 0 N-CA-C 108.34 -0.985 . . . . 71.510000000000005 108.34 179.569 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.79 116.43 52.38 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 N-CA-C 107.48 -1.304 . . . . 74.329999999999998 107.48 179.553 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 27.4 t30 -101.88 145.55 29.06 Favored 'General case' 0 C--N 1.275 -2.634 0 CA-C-N 113.758 -1.565 . . . . 75.120000000000005 106.864 -179.787 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -42.88 -29.5 0.33 Allowed 'General case' 0 C--N 1.313 -0.995 0 C-N-CA 125.049 1.34 . . . . 73.120000000000005 113.668 -178.388 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -138.7 29.52 2.57 Favored Glycine 0 N--CA 1.43 -1.72 0 C-N-CA 120.373 -0.918 . . . . 75.239999999999995 112.75 177.331 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -165.07 152.99 11.49 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 117.883 0.841 . . . . 64.239999999999995 110.989 -179.866 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -124.96 126.87 46.16 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.845 -0.428 . . . . 74.129999999999995 109.845 -176.549 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.43 ' HB3' ' HB3' ' A' ' 93' ' ' ARG . 37.3 tt0 -132.26 135.19 46.09 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 122.568 0.347 . . . . 73.129999999999995 110.269 -175.992 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.7 p -128.7 129.01 68.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 O-C-N 121.946 -0.472 . . . . 73.340000000000003 110.908 177.608 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 97.5 t -119.47 124.53 73.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 116.008 -0.542 . . . . 72.239999999999995 110.816 179.722 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -83.6 125.16 31.52 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 123.2 0.6 . . . . 74.450000000000003 110.272 174.725 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.8 t -118.72 7.6 6.79 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 N-CA-C 107.936 -1.135 . . . . 71.519999999999996 107.936 178.393 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -116.7 45.56 1.27 Allowed Glycine 0 N--CA 1.441 -1.009 0 N-CA-C 110.498 -1.041 . . . . 62.530000000000001 110.498 -178.873 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 12.3 m -63.72 -12.62 36.29 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 123.977 0.911 . . . . 74.129999999999995 111.61 -177.538 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 92.0 mt -61.35 -35.84 78.55 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.8 0.84 . . . . 75.200000000000003 109.892 174.748 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -93.69 -37.59 11.75 Favored 'General case' 0 CA--C 1.496 -1.118 0 N-CA-C 108.327 -0.99 . . . . 74.439999999999998 108.327 178.257 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 93.65 88.63 1.62 Allowed Glycine 0 N--CA 1.432 -1.614 0 CA-C-N 114.943 -1.026 . . . . 74.019999999999996 111.499 -179.99 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 55.1 m -82.3 120.62 25.63 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 109.37 -0.604 . . . . 71.450000000000003 109.37 177.634 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.448 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 37.4 m-85 -106.2 134.93 48.56 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 107.818 -1.178 . . . . 74.120000000000005 107.818 -179.927 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 23.8 t -105.88 121.33 58.09 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.235 0 N-CA-C 106.8 -1.556 . . . . 72.239999999999995 106.8 177.898 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 61.96 25.51 15.32 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.704 1.202 . . . . 54.140000000000001 109.809 -175.102 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 65.6 mtp180 75.08 14.53 3.1 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.248 1.819 . . . . 71.010000000000005 112.363 -178.523 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 25.1 tp10 -110.76 123.94 34.29 Favored Pre-proline 0 C--N 1.307 -1.279 0 N-CA-C 108.039 -1.097 . . . . 71.310000000000002 108.039 174.798 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -57.21 103.83 0.14 Allowed 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.226 1.951 . . . . 72.310000000000002 110.762 176.073 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? -143.41 111.07 5.92 Favored 'General case' 0 N--CA 1.414 -2.229 0 N-CA-C 105.391 -2.077 . . . . 71.140000000000001 105.391 -176.697 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -81.21 -23.73 37.92 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 120.553 -0.459 . . . . 72.409999999999997 111.638 -173.856 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -130.77 137.05 49.28 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.264 -1.384 . . . . 73.219999999999999 107.264 172.286 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.43 145.85 37.55 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 108.229 -1.026 . . . . 75.129999999999995 108.229 -178.734 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 44.9 t -95.53 103.45 14.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 104.955 -2.239 . . . . 72.430000000000007 104.955 174.694 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 24.7 mtt -58.11 129.44 41.97 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 116.296 1.962 . . . . 73.230000000000004 116.296 -168.927 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.461 HE21 ' CA ' ' A' ' 123' ' ' GLN . 0.0 OUTLIER -106.99 153.3 22.78 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 112.715 -2.039 . . . . 64.239999999999995 107.334 176.418 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 9.5 t -76.75 115.58 16.65 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 122.367 1.079 . . . . 74.349999999999994 109.575 -178.571 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 113.46 3.74 23.85 Favored Glycine 0 N--CA 1.426 -2.016 0 CA-C-N 114.865 -1.062 . . . . 62.520000000000003 110.821 -176.057 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -62.31 133.98 55.86 Favored 'General case' 0 CA--C 1.491 -1.305 0 CA-C-O 121.258 0.551 . . . . 75.209999999999994 111.283 178.991 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -114.33 127.66 55.97 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 115.032 -0.986 . . . . 74.120000000000005 110.32 -178.378 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.438 ' O ' ' HA ' ' A' ' 134' ' ' ARG . 65.4 mt -97.67 118.94 45.02 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.234 0 N-CA-C 108.039 -1.097 . . . . 73.209999999999994 108.039 177.086 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.448 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 48.9 tp60 -103.39 112.71 25.73 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 115.326 -0.852 . . . . 74.400000000000006 109.148 -177.086 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.409 HG13 ' HB2' ' A' ' 133' ' ' PHE . 14.0 pt -124.34 97.9 4.91 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 108.426 -0.953 . . . . 74.040000000000006 108.426 174.25 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 68.46 -108.65 2.54 Favored Glycine 0 N--CA 1.435 -1.4 0 CA-C-N 114.865 -1.061 . . . . 73.340000000000003 110.62 -175.663 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -108.34 -1.86 19.66 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 120.769 0.318 . . . . 73.430000000000007 111.004 177.638 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.409 ' HB2' HG13 ' A' ' 130' ' ' ILE . 71.0 m-85 -93.54 147.55 22.88 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.724 0.297 . . . . 73.430000000000007 110.984 -177.902 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.438 ' HA ' ' O ' ' A' ' 128' ' ' ILE . 84.1 mtt180 -133.74 129.65 36.98 Favored 'General case' 0 C--O 1.257 1.453 0 CA-C-N 115.785 -0.643 . . . . 75.519999999999996 111.829 -178.979 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.477 HD12 ' N ' ' A' ' 136' ' ' VAL . 3.4 tm? -109.39 144.68 37.27 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 106.185 -1.783 . . . . 74.030000000000001 106.185 172.628 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.477 ' N ' HD12 ' A' ' 135' ' ' LEU . 12.9 p -130.09 128.03 64.1 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.704 0 N-CA-C 109.377 -0.601 . . . . 72.329999999999998 109.377 -178.82 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -110.69 129.88 55.71 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.656 -0.702 . . . . 71.430000000000007 109.569 -176.871 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.3 mp -127.7 140.66 51.94 Favored 'General case' 0 C--O 1.253 1.25 0 CA-C-O 121.363 0.601 . . . . 74.420000000000002 110.804 -179.455 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -86.73 87.88 7.55 Favored 'General case' 0 N--CA 1.422 -1.852 0 CA-C-N 115.339 -0.846 . . . . 74.310000000000002 109.363 179.08 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -120.27 84.13 0.37 Allowed Glycine 0 C--N 1.292 -1.884 0 N-CA-C 107.536 -2.226 . . . . 53.420000000000002 107.536 174.517 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.454 ' HA ' ' O ' ' A' ' 46' ' ' SER . 14.9 Cg_endo . . . . . 0 N--CA 1.445 -1.376 0 C-N-CA 122.541 2.16 . . . . 73.299999999999997 114.775 -172.049 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 56.0 t30 . . . . . 0 N--CA 1.468 0.466 0 N-CA-C 112.224 0.453 . . . . 75.530000000000001 112.224 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 88.61 130.11 3.52 Favored Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 120.884 -0.674 . . . . 72.209999999999994 112.189 178.599 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.5 m -111.48 124.69 32.0 Favored Pre-proline 0 C--N 1.302 -1.496 0 N-CA-C 109.777 -0.453 . . . . 74.310000000000002 109.777 179.272 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -66.14 142.24 66.71 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.925 2.417 . . . . 73.549999999999997 112.098 177.736 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -121.75 146.82 46.71 Favored Pre-proline 0 C--N 1.296 -1.721 0 N-CA-C 108.113 -1.069 . . . . 72.0 108.113 178.465 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -61.44 155.14 54.31 Favored 'Trans proline' 0 C--O 1.251 1.164 0 C-N-CA 122.548 2.165 . . . . 64.049999999999997 111.97 178.053 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -66.66 150.86 48.45 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.731 -0.668 . . . . 75.409999999999997 109.934 179.548 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.2 p -88.4 129.09 40.15 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.353 0 CA-C-N 116.114 -0.494 . . . . 74.230000000000004 110.386 179.978 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -78.25 140.74 38.87 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 116.035 -0.529 . . . . 72.409999999999997 110.24 -178.862 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.8 t -101.67 142.23 33.32 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.285 -1.006 . . . . 74.340000000000003 108.285 177.01 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.9 t -157.35 158.43 35.96 Favored 'General case' 0 N--CA 1.422 -1.847 0 N-CA-C 107.555 -1.276 . . . . 74.200000000000003 107.555 -179.004 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.7 t -98.64 101.54 12.99 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.246 -1.02 . . . . 75.040000000000006 108.246 179.788 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.8 p . . . . . 0 C--N 1.315 -0.92 0 CA-C-O 122.339 1.066 . . . . 74.040000000000006 113.299 -176.79 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.537 0 N-CA-C 109.404 -1.479 . . . . 74.420000000000002 109.404 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 65.8 m -89.94 165.15 14.25 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.481 0.658 . . . . 72.129999999999995 111.606 -175.94 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -119.18 163.78 16.56 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 108.329 -0.989 . . . . 73.140000000000001 108.329 179.707 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -135.17 156.29 49.25 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 120.814 0.34 . . . . 72.150000000000006 111.186 -177.821 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -114.76 132.8 56.33 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.675 -0.861 . . . . 64.109999999999999 108.675 174.307 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 24.8 t -116.03 134.02 60.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.566 -0.901 . . . . 75.540000000000006 108.566 -178.872 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 24.4 t -92.74 121.5 43.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-O 121.018 0.437 . . . . 74.420000000000002 110.158 -177.893 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -94.43 -41.59 9.31 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.698 -0.683 . . . . 73.230000000000004 110.306 177.964 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -153.14 123.88 7.31 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 109.299 -0.63 . . . . 74.140000000000001 109.299 -176.505 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 151.53 130.32 1.64 Allowed Glycine 0 N--CA 1.427 -1.918 0 N-CA-C 111.261 -0.735 . . . . 72.540000000000006 111.261 178.277 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -61.47 -8.62 11.16 Favored 'Trans proline' 0 N--CA 1.481 0.761 0 C-N-CA 123.534 2.823 . . . . 73.230000000000004 113.433 178.051 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.489 ' CB ' ' HA ' ' A' ' 80' ' ' LEU . 5.1 p-10 -56.06 -41.04 74.46 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.28 0.632 . . . . 72.140000000000001 110.611 177.475 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -178.75 -168.99 0.15 Allowed 'General case' 0 C--O 1.217 -0.64 0 C-N-CA 123.936 0.894 . . . . 53.350000000000001 109.093 -179.145 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -159.48 28.95 0.39 Allowed Glycine 0 C--N 1.312 -0.775 0 N-CA-C 110.184 -1.167 . . . . 54.509999999999998 110.184 179.122 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -130.19 -166.23 1.65 Allowed 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.295 -1.002 . . . . 74.219999999999999 108.295 -175.471 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.96 139.96 53.52 Favored 'General case' 0 N--CA 1.412 -2.335 0 N-CA-C 108.771 -0.826 . . . . 73.510000000000005 108.771 178.382 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -118.94 121.78 40.73 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 109.835 -0.432 . . . . 74.239999999999995 109.835 -177.992 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 47.7 tp -91.25 133.98 34.95 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.541 -0.911 . . . . 75.310000000000002 108.541 178.521 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 7.0 mp -83.27 114.93 21.73 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 120.394 -0.523 . . . . 64.329999999999998 111.219 -179.721 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -120.24 18.35 12.27 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.148 -1.056 . . . . 75.439999999999998 108.148 174.56 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -133.94 142.99 45.53 Favored Pre-proline 0 N--CA 1.438 -1.03 0 CA-C-N 113.881 -1.509 . . . . 75.299999999999997 108.045 178.374 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -63.16 -31.26 75.17 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.898 2.398 . . . . 71.310000000000002 113.683 -177.371 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 41.2 m -136.49 120.75 17.93 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.82 -0.55 . . . . 74.010000000000005 110.0 179.417 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.478 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 9.2 m -102.99 119.85 39.58 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 106.471 -1.677 . . . . 72.310000000000002 106.471 176.645 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.405 HG22 ' HA ' ' A' ' 76' ' ' SER . 7.9 t -101.47 131.86 47.37 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 109.08 -0.711 . . . . 73.120000000000005 109.08 -176.604 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -127.5 119.47 26.13 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-O 120.845 0.355 . . . . 74.439999999999998 111.826 -174.577 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 60.3 44.81 97.12 Favored Glycine 0 CA--C 1.496 -1.133 0 CA-C-N 115.707 -0.678 . . . . 74.540000000000006 111.641 178.15 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.409 ' HA ' ' HA ' ' A' ' 88' ' ' ARG . 46.9 ttt180 -137.9 -31.1 0.79 Allowed 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 120.592 -0.443 . . . . 75.299999999999997 111.507 -173.619 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 32.3 m-70 -128.78 160.29 63.89 Favored Pre-proline 0 C--N 1.303 -1.434 0 N-CA-C 107.815 -1.18 . . . . 75.25 107.815 179.837 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -64.32 -25.4 64.22 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 121.303 1.335 . . . . 74.310000000000002 110.195 172.479 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -99.08 29.46 3.86 Favored 'General case' 0 C--O 1.243 0.756 0 CA-C-N 115.401 -0.818 . . . . 74.340000000000003 111.58 179.422 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.405 ' HA ' HG22 ' A' ' 69' ' ' THR . 70.2 m -54.43 136.53 44.01 Favored 'General case' 0 C--O 1.244 0.814 0 CA-C-O 120.898 0.38 . . . . 75.439999999999998 111.158 178.765 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -61.27 -43.91 98.1 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 115.025 -0.989 . . . . 63.43 109.911 -177.347 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 48.4 pt -124.93 156.72 33.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 CA-C-N 115.167 -0.924 . . . . 75.099999999999994 108.649 176.766 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -106.73 136.18 46.98 Favored 'General case' 0 C--N 1.284 -2.25 0 CA-C-N 115.846 -0.615 . . . . 74.209999999999994 110.026 -179.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.489 ' HA ' ' CB ' ' A' ' 56' ' ' ASN . 94.2 mt -107.38 171.74 7.21 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 108.67 -0.863 . . . . 75.400000000000006 108.67 -179.471 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -66.16 122.52 17.62 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 121.971 0.891 . . . . 71.450000000000003 110.213 -178.996 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -67.16 -16.54 64.37 Favored 'General case' 0 C--N 1.278 -2.535 0 CA-C-N 113.888 -1.505 . . . . 55.219999999999999 114.52 -174.784 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.3 t -90.8 -24.66 5.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-O 121.825 0.822 . . . . 74.200000000000003 109.183 -179.283 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 11.2 p -103.26 -3.34 25.8 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.702 -0.681 . . . . 64.430000000000007 112.816 -179.628 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.7 p -81.47 121.56 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 N-CA-C 107.971 -1.122 . . . . 72.540000000000006 107.971 179.254 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 27.0 p -115.03 46.31 1.46 Allowed 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 112.122 0.415 . . . . 64.420000000000002 112.122 -175.026 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 68.6 mtt180 67.52 108.12 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.883 0.873 . . . . 72.209999999999994 110.928 -178.998 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.413 ' O ' HG22 ' A' ' 104' ' ' VAL . 93.7 mtt180 63.71 78.11 0.3 Allowed 'General case' 0 CA--C 1.506 -0.725 0 N-CA-C 108.815 -0.809 . . . . 74.200000000000003 108.815 178.669 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 41.1 t60 -85.34 -67.27 0.81 Allowed 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 118.701 -1.2 . . . . 74.400000000000006 113.905 -172.522 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -137.8 156.45 47.94 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 118.324 -1.351 . . . . 74.340000000000003 113.589 -173.284 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -127.1 127.76 45.15 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 114.358 -1.292 . . . . 71.109999999999999 108.104 175.172 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.478 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 79.1 m-85 -108.69 112.72 25.18 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 106.085 -1.82 . . . . 75.420000000000002 106.085 174.865 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -117.08 144.4 44.7 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 121.64 0.733 . . . . 73.140000000000001 111.535 -173.396 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.441 ' O ' HD11 ' A' ' 94' ' ' ILE . 2.8 pp -116.17 116.4 52.18 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.64 0 N-CA-C 104.119 -2.549 . . . . 74.109999999999999 104.119 167.347 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.587 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 46.6 t-20 -108.09 145.03 34.65 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 107.734 -1.209 . . . . 72.420000000000002 107.734 -172.647 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -54.66 -26.75 35.17 Favored 'General case' 0 C--N 1.311 -1.078 0 O-C-N 123.645 0.591 . . . . 74.120000000000005 111.076 178.692 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -72.7 -63.35 2.9 Favored Glycine 0 N--CA 1.43 -1.759 0 N-CA-C 110.816 -0.914 . . . . 74.409999999999997 110.816 173.785 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.587 ' O ' ' HB3' ' A' ' 95' ' ' ASN . 44.2 mt-10 -159.26 168.36 26.66 Favored 'General case' 0 C--O 1.212 -0.893 0 N-CA-C 106.202 -1.777 . . . . 73.230000000000004 106.202 -178.38 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.435 ' HB2' ' CB ' ' A' ' 122' ' ' MET . 9.3 m-85 -91.31 134.84 34.25 Favored 'General case' 0 C--N 1.295 -1.767 0 C-N-CA 119.414 -0.914 . . . . 74.530000000000001 109.534 -177.379 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -132.2 136.22 46.87 Favored 'General case' 0 CA--C 1.501 -0.904 0 N-CA-C 113.218 0.821 . . . . 75.319999999999993 113.218 -175.858 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 90.1 t -111.01 119.91 60.6 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.077 0 N-CA-C 108.11 -1.07 . . . . 65.150000000000006 108.11 176.629 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 35.3 t -119.2 116.63 51.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 116.367 -0.379 . . . . 74.450000000000003 110.012 -176.733 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -104.26 108.93 20.55 Favored 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 107.551 -1.277 . . . . 75.120000000000005 107.551 175.97 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.413 HG22 ' O ' ' A' ' 88' ' ' ARG . 26.3 m -92.13 -9.56 10.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-O 121.128 0.489 . . . . 64.439999999999998 110.995 -177.886 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.41 ' C ' ' H ' ' A' ' 107' ' ' LEU . . . -92.16 27.33 10.49 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 109.759 -1.336 . . . . 72.409999999999997 109.759 176.049 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.432 ' HA ' ' OG1' ' A' ' 110' ' ' THR . 1.1 p -69.52 10.03 0.41 Allowed 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 125.532 1.533 . . . . 74.340000000000003 113.282 -177.455 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.422 ' O ' HD23 ' A' ' 107' ' ' LEU . 6.0 tt -68.22 -24.78 64.96 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 106.251 -1.759 . . . . 72.140000000000001 106.251 172.994 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -78.07 -1.84 34.37 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 115.054 -0.975 . . . . 62.450000000000003 110.657 177.393 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 77.28 56.44 3.97 Favored Glycine 0 N--CA 1.439 -1.123 0 N-CA-C 110.471 -1.052 . . . . 71.329999999999998 110.471 -178.203 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.432 ' OG1' ' HA ' ' A' ' 106' ' ' SER . 17.9 m -72.89 121.42 19.98 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-O 121.606 0.717 . . . . 64.340000000000003 111.507 -176.692 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -102.13 133.27 47.25 Favored 'General case' 0 N--CA 1.416 -2.158 0 N-CA-C 106.199 -1.778 . . . . 72.340000000000003 106.199 175.449 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 25.9 t -125.17 128.78 73.12 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.063 0 N-CA-C 105.537 -2.023 . . . . 74.319999999999993 105.537 179.822 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 63.55 27.24 14.97 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 107.841 -1.17 . . . . 73.319999999999993 107.841 -173.658 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 67.72 9.31 7.0 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 124.899 1.279 . . . . 73.510000000000005 112.254 -175.226 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.569 ' OE1' ' HD2' ' A' ' 116' ' ' PRO . 9.2 tp10 -111.51 126.38 28.68 Favored Pre-proline 0 C--N 1.305 -1.359 0 N-CA-C 108.452 -0.944 . . . . 75.120000000000005 108.452 -178.826 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.569 ' HD2' ' OE1' ' A' ' 115' ' ' GLU . 32.9 Cg_exo -53.75 113.24 1.23 Allowed 'Trans proline' 0 C--O 1.25 1.099 0 C-N-CA 121.967 1.778 . . . . 74.5 109.309 173.105 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 12.5 tpp85 -160.13 143.31 13.77 Favored 'General case' 0 N--CA 1.425 -1.704 0 N-CA-C 108.508 -0.923 . . . . 75.25 108.508 -173.349 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -87.98 -41.57 13.05 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.448 -0.575 . . . . 75.530000000000001 109.448 -179.062 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -132.72 139.34 47.58 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.399 -0.963 . . . . 53.340000000000003 108.399 177.429 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.07 148.83 47.01 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 107.249 -1.389 . . . . 73.420000000000002 107.249 -176.744 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 8.7 p -84.58 134.33 27.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 108.518 -0.919 . . . . 74.209999999999994 108.518 179.876 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.435 ' CB ' ' HB2' ' A' ' 99' ' ' PHE . 1.5 tmt? -50.24 124.39 10.27 Favored 'General case' 0 C--N 1.313 -1.008 0 O-C-N 123.739 0.649 . . . . 72.030000000000001 112.671 -175.489 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -129.85 151.09 50.8 Favored 'General case' 0 N--CA 1.424 -1.761 0 CA-C-N 115.148 -0.933 . . . . 74.120000000000005 108.817 173.461 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 6.6 p -78.53 115.17 18.05 Favored 'General case' 0 C--N 1.283 -2.306 0 CA-C-N 115.738 -0.665 . . . . 71.530000000000001 109.636 177.681 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 95.16 33.55 6.52 Favored Glycine 0 N--CA 1.437 -1.271 0 N-CA-C 110.334 -1.107 . . . . 73.239999999999995 110.334 -178.234 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -91.48 150.59 21.16 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 107.125 -1.435 . . . . 72.329999999999998 107.125 -179.79 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -137.85 123.13 19.38 Favored 'General case' 0 C--N 1.29 -2.003 0 CA-C-O 122.093 0.949 . . . . 53.119999999999997 111.069 -177.082 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 58.9 mt -101.92 126.09 55.96 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.22 0 CA-C-N 114.162 -1.381 . . . . 74.5 108.46 -176.727 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -119.69 112.78 19.72 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 109.412 -0.588 . . . . 65.510000000000005 109.412 177.94 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 23.1 pt -105.64 97.48 5.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-N 115.139 -0.937 . . . . 61.140000000000001 109.981 -178.826 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 69.36 -72.6 0.45 Allowed Glycine 0 CA--C 1.526 0.747 0 CA-C-N 115.438 -0.801 . . . . 72.420000000000002 113.69 178.502 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -132.15 -12.71 3.19 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 123.096 0.558 . . . . 75.150000000000006 110.256 -176.076 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -107.72 156.31 19.24 Favored 'General case' 0 C--N 1.321 -0.656 0 O-C-N 121.76 -0.588 . . . . 72.510000000000005 112.023 -171.29 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 50.4 mtp180 -131.32 127.02 36.81 Favored 'General case' 0 C--O 1.251 1.14 0 CA-C-O 121.616 0.722 . . . . 74.25 111.791 -174.745 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 58.6 tp -122.06 135.17 54.79 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 114.531 -1.213 . . . . 72.129999999999995 107.748 -179.693 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 14.9 p -112.06 138.63 40.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 N-CA-C 109.326 -0.62 . . . . 73.140000000000001 109.326 -179.737 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -116.25 129.79 56.46 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 109.334 -0.617 . . . . 74.450000000000003 109.334 -177.359 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 58.4 mt -135.66 172.5 12.92 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.306 -0.627 . . . . 64.430000000000007 109.306 -177.078 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -91.11 146.56 23.74 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 107.639 -1.245 . . . . 73.129999999999995 107.639 175.694 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -96.58 -127.53 5.52 Favored Glycine 0 N--CA 1.429 -1.772 0 C-N-CA 120.374 -0.917 . . . . 71.439999999999998 111.68 -176.705 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo . . . . . 0 N--CA 1.444 -1.412 0 C-N-CA 122.192 1.928 . . . . 74.510000000000005 112.03 179.973 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 . . . . . 0 C--O 1.247 0.928 0 N-CA-C 107.402 -1.332 . . . . 74.430000000000007 107.402 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -133.15 -166.1 11.33 Favored Glycine 0 N--CA 1.424 -2.118 0 C-N-CA 119.908 -1.139 . . . . 73.530000000000001 111.656 -178.001 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.3 t -100.76 143.57 26.83 Favored Pre-proline 0 N--CA 1.417 -2.104 0 N-CA-C 108.169 -1.048 . . . . 62.310000000000002 108.169 -179.765 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -58.45 128.03 26.89 Favored 'Trans proline' 0 C--O 1.245 0.858 0 C-N-CA 122.409 2.072 . . . . 75.319999999999993 110.658 177.67 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -82.97 126.85 71.61 Favored Pre-proline 0 C--N 1.295 -1.793 0 CA-C-N 115.836 -0.62 . . . . 74.099999999999994 110.668 -176.535 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.76 151.33 28.12 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.298 1.999 . . . . 74.25 111.277 178.9 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -118.68 110.44 17.3 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.755 0.788 . . . . 73.340000000000003 111.467 179.671 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.9 p -90.23 158.02 2.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 107.283 -1.377 . . . . 64.519999999999996 107.283 177.654 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -92.28 133.32 35.94 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 120.059 -0.656 . . . . 70.140000000000001 111.527 -179.325 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.5 m -106.26 91.78 3.86 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 104.899 -2.26 . . . . 75.239999999999995 104.899 171.569 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 14.9 t -83.13 -175.19 5.71 Favored 'General case' 0 N--CA 1.413 -2.309 0 CA-C-O 121.607 0.718 . . . . 72.409999999999997 111.916 -169.005 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.1 m -81.8 40.35 0.6 Allowed 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 124.952 1.301 . . . . 75.420000000000002 111.65 -173.312 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.7 p . . . . . 0 C--N 1.323 -0.561 0 CA-C-O 122.613 1.197 . . . . 74.040000000000006 110.589 -177.59 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.073 0 N-CA-C 109.682 -1.367 . . . . 61.25 109.682 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.0 m -100.39 156.81 17.05 Favored 'General case' 0 N--CA 1.416 -2.158 0 N-CA-C 108.988 -0.745 . . . . 64.219999999999999 108.988 -178.111 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.484 ' HB1' ' CE1' ' A' ' 137' ' ' PHE . . . -140.63 162.88 34.34 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 106.273 -1.751 . . . . 75.310000000000002 106.273 176.927 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.3 pp -134.31 142.39 47.25 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 118.246 -1.382 . . . . 74.549999999999997 111.836 179.436 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.474 ' O ' HD13 ' A' ' 49' ' ' LEU . 2.2 pp -109.38 140.81 42.61 Favored 'General case' 0 N--CA 1.424 -1.754 0 CA-C-N 115.453 -0.794 . . . . 74.120000000000005 110.266 179.51 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 45.2 t -123.6 113.5 37.6 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 N-CA-C 106.299 -1.741 . . . . 74.120000000000005 106.299 174.12 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 42.1 t -96.28 115.59 35.99 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.115 0 C-N-CA 118.915 -1.114 . . . . 74.219999999999999 108.49 179.476 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -68.99 -38.71 79.45 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 114.728 -1.123 . . . . 74.319999999999993 109.528 -176.559 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 26.4 ttm180 -177.25 142.3 0.35 Allowed 'General case' 0 C--O 1.244 0.773 0 CA-C-N 115.699 -0.682 . . . . 71.510000000000005 109.812 -179.95 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 143.31 165.91 10.94 Favored Glycine 0 N--CA 1.436 -1.36 0 CA-C-N 116.232 -0.44 . . . . 73.420000000000002 112.435 177.266 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -67.53 -8.21 21.55 Favored 'Trans proline' 0 N--CA 1.486 1.044 0 C-N-CA 123.659 2.906 . . . . 74.129999999999995 112.949 178.258 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.53 ' HA ' ' CB ' ' A' ' 80' ' ' LEU . 26.3 t-20 -65.15 -54.13 34.51 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.925 -0.58 . . . . 73.239999999999995 109.898 178.564 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -172.56 -176.51 1.54 Allowed 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.897 0.879 . . . . 74.310000000000002 108.822 -179.692 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -158.46 46.28 0.45 Allowed Glycine 0 CA--C 1.494 -1.235 0 N-CA-C 110.155 -1.178 . . . . 74.450000000000003 110.155 179.588 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -162.62 -173.83 3.71 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.157 -1.423 . . . . 72.030000000000001 107.157 -177.797 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.51 132.24 37.06 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 120.673 0.273 . . . . 72.510000000000005 110.46 177.73 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -156.75 155.03 30.92 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 116.002 -0.545 . . . . 75.209999999999994 110.425 -178.346 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -79.13 139.74 37.97 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 122.063 0.935 . . . . 73.25 113.056 -178.062 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 75.3 mt -99.84 133.49 44.13 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 104.87 -2.27 . . . . 71.010000000000005 104.87 172.089 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -147.28 78.52 1.48 Allowed 'General case' 0 C--N 1.296 -1.737 0 CA-C-O 121.568 0.699 . . . . 72.430000000000007 111.449 -178.638 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -147.9 149.69 33.78 Favored Pre-proline 0 C--N 1.306 -1.299 0 N-CA-C 106.918 -1.512 . . . . 72.230000000000004 106.918 174.679 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -58.54 -40.65 72.21 Favored 'Trans proline' 0 C--N 1.366 1.455 0 C-N-CA 122.612 2.208 . . . . 74.430000000000007 110.301 -179.682 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 33.9 m -128.58 100.06 5.61 Favored 'General case' 0 N--CA 1.414 -2.264 0 CA-C-N 114.519 -1.219 . . . . 74.319999999999993 108.322 175.547 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 57.8 m -95.32 113.87 25.59 Favored 'General case' 0 N--CA 1.423 -1.807 0 N-CA-C 107.121 -1.437 . . . . 74.540000000000006 107.121 179.762 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.1 t -108.98 135.77 49.61 Favored 'General case' 0 C--N 1.283 -2.318 0 C-N-CA 120.033 -0.667 . . . . 72.439999999999998 110.717 -174.416 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -119.9 131.7 55.31 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 108.97 -0.752 . . . . 74.549999999999997 108.97 179.466 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 178.73 -122.92 0.83 Allowed Glycine 0 N--CA 1.411 -2.985 0 C-N-CA 120.641 -0.79 . . . . 72.340000000000003 111.145 179.153 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 18.7 tpt180 -146.94 14.92 1.18 Allowed 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 109.658 -0.497 . . . . 74.329999999999998 109.658 -176.078 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.404 ' HB3' ' HB3' ' A' ' 87' ' ' ARG . 38.0 p-80 -98.3 156.34 35.9 Favored Pre-proline 0 C--N 1.318 -0.765 0 N-CA-C 108.253 -1.017 . . . . 64.340000000000003 108.253 179.893 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -49.02 -30.71 18.7 Favored 'Trans proline' 0 N--CA 1.488 1.15 0 C-N-CA 123.907 3.071 . . . . 72.040000000000006 115.766 -174.831 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -93.27 12.76 23.48 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 113.298 0.851 . . . . 71.439999999999998 113.298 -177.439 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 24.2 m -65.76 135.78 55.36 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.632 -0.877 . . . . 73.239999999999995 108.632 176.738 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -68.65 -46.12 70.02 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 107.716 -1.216 . . . . 74.040000000000006 107.716 179.055 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.82 135.35 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 CA-C-N 113.631 -1.622 . . . . 73.400000000000006 109.226 176.929 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -103.86 117.49 34.47 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 115.83 -0.623 . . . . 75.340000000000003 109.373 178.873 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.53 ' CB ' ' HA ' ' A' ' 56' ' ' ASN . 0.9 OUTLIER -86.94 119.89 27.63 Favored 'General case' 0 N--CA 1.418 -2.062 0 N-CA-C 107.548 -1.279 . . . . 75.340000000000003 107.548 174.418 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -84.95 60.57 6.31 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 122.38 1.086 . . . . 72.349999999999994 111.918 -176.109 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -93.04 -175.33 3.83 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 106.311 -1.737 . . . . 70.230000000000004 106.311 171.71 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.6 p -126.99 -6.98 4.65 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 CA-C-O 121.861 0.839 . . . . 75.109999999999999 109.987 -179.029 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 5.8 m -115.22 15.58 16.98 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 122.303 1.049 . . . . 64.120000000000005 108.249 179.376 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.7 p -84.34 138.56 18.96 Favored 'Isoleucine or valine' 0 C--O 1.248 1.011 0 CA-C-N 115.005 -0.998 . . . . 70.439999999999998 110.796 -179.851 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 19.6 m -77.03 166.57 23.14 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.944 -0.571 . . . . 73.030000000000001 110.2 178.37 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.404 ' HB3' ' HB3' ' A' ' 73' ' ' HIS . 18.4 mmt180 -63.12 -37.75 88.43 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 121.317 0.58 . . . . 75.25 109.884 178.495 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.1 119.71 29.36 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 106.517 -1.66 . . . . 72.219999999999999 106.517 167.831 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 9.1 t60 -106.62 -63.11 1.31 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.683 -0.488 . . . . 63.030000000000001 109.683 -175.814 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -134.74 119.43 18.22 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.246 -1.02 . . . . 73.129999999999995 108.246 -179.858 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -104.92 128.04 53.0 Favored 'General case' 0 C--N 1.287 -2.123 0 C-N-CA 119.883 -0.727 . . . . 75.420000000000002 109.368 179.34 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -105.58 119.72 39.82 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 107.673 -1.232 . . . . 65.129999999999995 107.673 -176.366 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -118.59 148.96 42.14 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 109.388 -0.597 . . . . 74.400000000000006 109.388 -178.944 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 4.3 tp -115.58 127.63 73.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 CA-C-O 121.769 0.795 . . . . 74.540000000000006 109.651 -179.83 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -108.17 146.63 32.45 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 106.19 -1.781 . . . . 75.349999999999994 106.19 -179.67 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -54.93 -18.24 4.72 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 113.53 0.937 . . . . 73.340000000000003 113.53 -177.718 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -108.06 -44.51 1.18 Allowed Glycine 0 N--CA 1.431 -1.647 0 C-N-CA 121.377 -0.44 . . . . 64.25 113.037 177.666 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -133.88 175.57 9.34 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-O 121.615 0.721 . . . . 75.099999999999994 111.935 -174.687 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -104.68 137.45 42.48 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 106.508 -1.664 . . . . 73.400000000000006 106.508 174.785 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -130.54 130.05 43.61 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 118.28 0.491 . . . . 74.209999999999994 110.039 -178.226 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 6.9 p -117.29 127.64 74.77 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-O 120.926 0.393 . . . . 72.420000000000002 110.35 -179.636 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 30.9 m -118.88 121.38 66.72 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 CA-C-O 121.497 0.665 . . . . 73.129999999999995 111.873 178.544 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -83.41 124.42 30.65 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.281 -0.872 . . . . 61.219999999999999 110.506 175.473 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 6.7 m -125.89 17.42 3.99 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.227 0 CA-C-N 114.837 -1.074 . . . . 64.450000000000003 109.849 176.739 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -127.5 46.92 1.05 Allowed Glycine 0 N--CA 1.443 -0.865 0 N-CA-C 108.866 -1.694 . . . . 75.319999999999993 108.866 177.495 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.7 m -59.52 -23.49 62.87 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 124.359 1.064 . . . . 73.239999999999995 113.643 -173.039 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 85.1 mt -77.62 -21.31 52.49 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.054 -0.658 . . . . 73.519999999999996 112.0 -179.33 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -81.72 -36.0 29.13 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 107.378 -1.341 . . . . 71.519999999999996 107.378 176.008 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 103.78 88.24 2.04 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 114.635 -1.166 . . . . 75.420000000000002 113.995 176.793 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 27.9 m -99.59 120.12 39.16 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.655 -0.868 . . . . 74.219999999999999 108.655 175.211 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -127.2 152.35 47.49 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 108.792 -0.818 . . . . 74.340000000000003 108.792 -177.726 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 74.7 t -106.32 113.41 42.93 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.111 0 N-CA-C 107.215 -1.402 . . . . 73.319999999999993 107.215 175.525 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 67.07 -73.59 0.08 Allowed 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 126.427 1.891 . . . . 73.239999999999995 109.862 -174.592 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -141.13 -12.56 0.94 Allowed 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 123.235 0.614 . . . . 75.430000000000007 111.106 177.099 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -106.78 140.72 21.64 Favored Pre-proline 0 C--N 1.321 -0.646 0 N-CA-C 112.503 0.557 . . . . 73.010000000000005 112.503 -169.787 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -71.27 93.27 0.65 Allowed 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.695 2.263 . . . . 63.119999999999997 112.777 178.562 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 12.6 mmt85 -110.54 100.51 9.31 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 106.464 -1.68 . . . . 74.329999999999998 106.464 176.032 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -75.85 -31.88 59.51 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 119.896 -0.721 . . . . 72.120000000000005 110.612 -176.101 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -124.35 136.13 53.86 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 105.265 -2.124 . . . . 73.109999999999999 105.265 167.854 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 55.7 tp60 -142.54 148.82 38.22 Favored 'General case' 0 C--N 1.283 -2.285 0 C-N-CA 120.922 -0.311 . . . . 72.349999999999994 110.928 -178.063 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.0 p -79.58 114.62 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.662 0 N-CA-C 103.893 -2.632 . . . . 75.239999999999995 103.893 167.126 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.509 ' HE1' ' CD1' ' A' ' 137' ' ' PHE . 9.7 ttt -68.52 120.35 14.43 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 115.033 -0.985 . . . . 75.420000000000002 111.079 -166.771 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 30.1 tp60 -104.25 124.9 49.98 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.252 -0.886 . . . . 73.510000000000005 110.325 -172.69 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.2 t -78.94 131.69 36.45 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 114.913 -1.04 . . . . 71.140000000000001 108.577 177.458 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 110.0 -9.73 31.73 Favored Glycine 0 N--CA 1.437 -1.266 0 CA-C-N 115.995 -0.548 . . . . 74.239999999999995 112.316 178.856 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -113.82 169.9 8.66 Favored 'General case' 0 C--O 1.25 1.118 0 N-CA-C 108.806 -0.813 . . . . 74.219999999999999 108.806 -177.357 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -110.63 144.98 38.69 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.791 0.805 . . . . 71.299999999999997 111.747 -178.25 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 65.2 mt -106.55 124.78 62.28 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 N-CA-C 107.367 -1.346 . . . . 61.130000000000003 107.367 177.139 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 58.2 tp60 -97.73 116.55 30.17 Favored 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 108.899 -0.778 . . . . 73.409999999999997 108.899 -176.896 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.1 pt -115.41 97.71 5.95 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.301 0 CA-C-O 122.177 0.989 . . . . 72.409999999999997 109.565 177.904 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 68.85 -116.55 7.4 Favored Glycine 0 N--CA 1.429 -1.786 0 CA-C-N 114.454 -1.248 . . . . 73.010000000000005 111.4 -175.697 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 17.9 tppt? -94.14 -22.14 18.65 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.239 0.542 . . . . 74.510000000000005 110.588 179.64 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -101.34 161.17 13.82 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 116.24 -0.437 . . . . 73.430000000000007 112.121 -174.919 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 9.8 ptp85 -137.28 144.37 42.66 Favored 'General case' 0 C--O 1.245 0.847 0 N-CA-C 113.419 0.896 . . . . 75.540000000000006 113.419 -172.984 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.8 tt -121.99 138.57 54.37 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 106.915 -1.513 . . . . 75.120000000000005 106.915 -179.247 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 27.7 t -106.83 130.49 58.68 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 N-CA-C 106.772 -1.566 . . . . 71.430000000000007 106.772 179.401 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . 0.509 ' CD1' ' HE1' ' A' ' 122' ' ' MET . 86.4 t80 -104.37 128.19 52.16 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 112.086 0.402 . . . . 74.340000000000003 112.086 -174.78 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -128.57 151.13 49.8 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 108.211 -1.033 . . . . 73.430000000000007 108.211 173.882 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -62.81 149.54 43.89 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.892 -0.781 . . . . 43.520000000000003 108.892 175.47 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.437 ' N ' ' HA ' ' A' ' 47' ' ' ALA . . . -69.42 169.32 44.27 Favored Glycine 0 N--CA 1.434 -1.485 0 C-N-CA 120.88 -0.676 . . . . 54.310000000000002 113.405 -175.499 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo . . . . . 0 C--O 1.241 0.637 0 C-N-CA 123.25 2.633 . . . . 75.099999999999994 111.734 -179.881 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.0 p30 . . . . . 0 C--O 1.251 1.141 0 N-CA-C 109.019 -0.734 . . . . 72.400000000000006 109.019 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -81.95 149.12 27.83 Favored Glycine 0 N--CA 1.421 -2.307 0 N-CA-C 110.736 -0.945 . . . . 74.319999999999993 110.736 179.289 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.3 m -63.28 139.61 97.58 Favored Pre-proline 0 C--N 1.303 -1.425 0 N-CA-C 107.452 -1.314 . . . . 75.239999999999995 107.452 176.568 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -51.14 137.02 45.94 Favored 'Trans proline' 0 C--O 1.25 1.1 0 C-N-CA 122.326 2.017 . . . . 74.549999999999997 110.36 177.845 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -68.58 143.68 95.46 Favored Pre-proline 0 C--N 1.307 -1.254 0 CA-C-N 116.129 -0.487 . . . . 75.329999999999998 110.183 -174.565 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -36.94 114.78 0.13 Allowed 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 124.823 3.682 . . . . 62.240000000000002 113.784 -177.079 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -102.27 156.58 17.48 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.104 -1.443 . . . . 75.319999999999993 107.104 -178.895 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.4 m -90.26 148.36 4.6 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 CA-C-O 120.895 0.378 . . . . 73.209999999999994 110.222 177.533 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -103.5 141.52 35.85 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.14 -1.059 . . . . 52.240000000000002 108.14 177.315 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.5 t -68.92 152.7 44.94 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.705 -0.85 . . . . 72.239999999999995 108.705 179.007 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.9 t -145.11 105.45 4.08 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-O 121.748 0.785 . . . . 74.450000000000003 112.039 -176.88 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.6 t -94.21 96.03 9.33 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 105.589 -2.004 . . . . 75.530000000000001 105.589 174.982 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.1 p . . . . . 0 C--N 1.301 -1.511 0 CA-C-O 121.986 0.898 . . . . 72.340000000000003 112.209 -173.0 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.426 -2.015 0 N-CA-C 107.29 -2.324 . . . . 74.340000000000003 107.29 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.2 m -103.09 155.26 18.52 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-O 121.179 0.514 . . . . 75.409999999999997 111.155 -174.726 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.3 151.37 37.41 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.145 -1.428 . . . . 75.450000000000003 107.145 177.705 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.401 ' HB3' ' HG ' ' A' ' 62' ' ' LEU . 2.6 pt? -123.03 151.38 41.98 Favored 'General case' 0 CA--C 1.493 -1.243 0 CA-C-O 121.576 0.703 . . . . 73.430000000000007 111.392 -175.041 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -129.74 132.72 46.68 Favored 'General case' 0 C--N 1.276 -2.595 0 CA-C-N 115.259 -0.882 . . . . 71.310000000000002 108.651 175.23 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 23.5 m -104.37 141.41 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 N-CA-C 108.749 -0.834 . . . . 75.310000000000002 108.749 -178.222 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.9 t -92.92 114.97 30.68 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 N-CA-C 107.591 -1.263 . . . . 65.209999999999994 107.591 178.558 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.9 tmtm? -73.23 -44.34 59.69 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 106.157 -1.794 . . . . 73.219999999999999 106.157 -178.723 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 35.1 ttm180 -165.16 128.0 2.21 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 106.59 -1.633 . . . . 74.340000000000003 106.59 176.815 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 158.52 133.84 1.61 Allowed Glycine 0 N--CA 1.42 -2.414 0 C-N-CA 120.183 -1.008 . . . . 75.510000000000005 111.924 -179.697 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -59.62 -7.83 6.3 Favored 'Trans proline' 0 N--CA 1.484 0.963 0 C-N-CA 124.201 3.267 . . . . 65.510000000000005 114.116 178.612 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -44.16 -48.16 9.16 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.565 1.146 . . . . 75.239999999999995 111.379 175.349 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -165.29 -48.14 0.03 OUTLIER 'General case' 0 CA--C 1.51 -0.581 0 CA-C-O 121.329 0.585 . . . . 75.219999999999999 109.979 -179.348 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.12 25.58 57.24 Favored Glycine 0 C--O 1.225 -0.441 0 N-CA-C 110.528 -1.029 . . . . 73.519999999999996 110.528 -177.847 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -146.84 -157.32 0.8 Allowed 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.704 -1.221 . . . . 74.299999999999997 107.704 -177.494 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.54 141.39 50.99 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 108.251 -1.018 . . . . 73.140000000000001 108.251 177.309 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -140.6 153.69 46.17 Favored 'General case' 0 C--N 1.291 -1.955 0 C-N-CA 120.544 -0.462 . . . . 74.420000000000002 109.99 178.064 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.401 ' HG ' ' HB3' ' A' ' 48' ' ' LEU . 8.4 mp -103.68 140.61 37.36 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 115.728 -0.669 . . . . 75.129999999999995 109.605 -179.177 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 88.1 mt -72.14 114.13 9.92 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.085 -1.08 . . . . 73.400000000000006 108.085 175.388 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -117.91 4.8 12.15 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.588 -0.893 . . . . 71.010000000000005 108.588 -179.633 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.484 ' HB2' ' OG1' ' A' ' 68' ' ' THR . 1.0 OUTLIER -122.13 131.81 24.35 Favored Pre-proline 0 N--CA 1.437 -1.075 0 CA-C-N 115.893 -0.594 . . . . 64.239999999999995 109.726 -174.9 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -54.52 -40.15 84.92 Favored 'Trans proline' 0 C--N 1.36 1.142 0 C-N-CA 123.302 2.668 . . . . 71.340000000000003 110.904 177.822 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 97.6 m -126.34 103.28 7.56 Favored 'General case' 0 N--CA 1.42 -1.941 0 CA-C-N 114.964 -1.016 . . . . 52.350000000000001 108.716 175.829 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.484 ' OG1' ' HB2' ' A' ' 65' ' ' GLN . 38.3 m -107.24 113.07 26.25 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 108.1 -1.074 . . . . 74.349999999999994 108.1 179.047 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.1 m -105.2 121.05 43.03 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 120.469 -0.492 . . . . 73.219999999999999 109.898 -178.57 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.414 ' HB1' HD12 ' A' ' 80' ' ' LEU . . . -95.68 124.08 39.54 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 109.074 -0.713 . . . . 74.519999999999996 109.074 -179.878 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 79' ' ' PHE . . . -159.62 -179.01 34.14 Favored Glycine 0 N--CA 1.437 -1.248 0 C-N-CA 120.237 -0.983 . . . . 74.450000000000003 112.401 179.85 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.69 ' NH1' ' HA ' ' A' ' 81' ' ' ASP . 25.3 tpt180 -112.99 84.89 2.07 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.602 -0.888 . . . . 74.519999999999996 108.602 177.641 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -177.73 147.85 0.66 Allowed Pre-proline 0 C--N 1.314 -0.936 0 C-N-CA 125.509 1.524 . . . . 73.209999999999994 106.936 178.43 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -56.7 -40.47 84.09 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.787 2.325 . . . . 72.010000000000005 112.487 179.389 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -87.9 64.8 8.04 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-O 122.684 1.23 . . . . 70.439999999999998 112.467 177.855 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 19.6 m -133.59 159.9 39.08 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 104.684 -2.339 . . . . 71.040000000000006 104.684 172.601 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -64.96 -42.58 94.47 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 118.972 0.805 . . . . 71.510000000000005 109.592 -178.532 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.95 138.5 43.76 Favored 'Isoleucine or valine' 0 C--O 1.251 1.133 0 N-CA-C 106.944 -1.502 . . . . 75.409999999999997 106.944 171.735 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.422 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 53.5 p90 -107.62 125.34 51.22 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.734 -0.786 . . . . 74.420000000000002 111.813 -179.601 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.446 ' O ' ' HD3' ' A' ' 72' ' ' ARG . 5.3 mp -80.51 135.83 36.18 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.76 -1.2 . . . . 75.140000000000001 107.76 178.685 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.69 ' HA ' ' NH1' ' A' ' 72' ' ' ARG . 25.5 t70 -92.13 39.81 1.03 Allowed 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.682 0.753 . . . . 74.420000000000002 111.878 -174.648 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -123.5 151.36 42.88 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.928 -0.767 . . . . 54.030000000000001 108.928 178.511 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 33.3 m -90.26 -5.89 10.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 113.015 0.746 . . . . 73.099999999999994 113.015 -174.963 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.2 t -83.65 -13.1 54.99 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-O 121.816 0.817 . . . . 73.140000000000001 108.987 178.424 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 51.3 t -82.83 134.49 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 CA-C-N 114.906 -1.043 . . . . 75.450000000000003 110.023 -175.998 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.524 ' OG ' HD23 ' A' ' 107' ' ' LEU . 58.3 m -82.74 -174.01 4.98 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 116.155 -0.475 . . . . 75.140000000000001 111.534 -179.949 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -56.05 -50.49 70.81 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 108.204 -1.035 . . . . 75.310000000000002 108.204 175.099 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 59.0 mtt180 -126.74 115.78 19.92 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 105.597 -2.001 . . . . 72.439999999999998 105.597 174.376 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 11.0 t60 -100.02 -51.34 3.72 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 121.656 0.741 . . . . 75.430000000000007 109.812 -177.149 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -145.51 145.01 30.89 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 108.416 -0.957 . . . . 62.130000000000003 108.416 -179.786 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -121.89 127.86 50.93 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-O 121.699 0.761 . . . . 74.140000000000001 109.75 178.453 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -107.82 113.69 27.1 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 107.39 -1.337 . . . . 62.399999999999999 107.39 -178.27 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 41.9 mtp180 -117.52 147.57 42.65 Favored 'General case' 0 C--N 1.283 -2.29 0 C-N-CA 119.936 -0.706 . . . . 72.510000000000005 110.277 -179.033 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.44 122.56 70.07 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.132 0 N-CA-C 106.872 -1.529 . . . . 74.409999999999997 106.872 175.977 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -108.47 146.8 32.61 Favored 'General case' 0 C--N 1.275 -2.669 0 N-CA-C 107.434 -1.321 . . . . 74.409999999999997 107.434 -178.641 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -51.12 -22.83 2.72 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 123.769 0.827 . . . . 74.340000000000003 112.581 179.828 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -91.73 -51.33 2.51 Favored Glycine 0 N--CA 1.432 -1.618 0 C-N-CA 121.046 -0.597 . . . . 75.219999999999999 112.693 175.322 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -149.95 175.21 11.88 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 117.496 0.648 . . . . 65.099999999999994 112.387 -175.223 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.414 ' HB2' ' CB ' ' A' ' 122' ' ' MET . 63.1 m-85 -99.0 132.08 44.57 Favored 'General case' 0 C--O 1.247 0.951 0 N-CA-C 108.318 -0.993 . . . . 72.530000000000001 108.318 176.407 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -131.89 128.75 39.24 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 121.038 0.447 . . . . 74.400000000000006 111.196 -175.964 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 5.3 p -116.46 122.19 69.26 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-O 121.244 0.545 . . . . 74.230000000000004 110.507 177.804 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.7 m -119.53 136.96 55.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-N 115.736 -0.665 . . . . 75.219999999999999 109.999 177.833 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.416 ' OD2' ' HA ' ' A' ' 118' ' ' ASN . 1.4 p30 -86.39 143.12 27.98 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 118.727 -1.189 . . . . 72.230000000000004 108.345 175.409 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 15.7 m -127.68 12.31 3.29 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 CA-C-O 122.033 0.92 . . . . 74.030000000000001 109.298 176.773 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -161.67 67.69 0.24 Allowed Glycine 0 N--CA 1.427 -1.926 0 CA-C-N 114.569 -1.196 . . . . 73.409999999999997 110.965 -179.729 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.405 ' HB2' ' OD1' ' A' ' 103' ' ' ASP . 22.1 t -88.99 80.44 7.05 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 122.045 -0.68 . . . . 75.450000000000003 109.438 178.425 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.524 HD23 ' OG ' ' A' ' 86' ' ' SER . 1.9 mm? -81.03 -51.95 7.95 Favored 'General case' 0 CA--C 1.501 -0.908 0 C-N-CA 120.143 -0.623 . . . . 75.409999999999997 109.609 179.324 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -100.04 2.91 43.79 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.667 -0.697 . . . . 74.109999999999999 109.288 -175.869 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 100.93 130.72 7.15 Favored Glycine 0 N--CA 1.427 -1.955 0 CA-C-N 115.483 -0.781 . . . . 71.109999999999999 112.296 -178.662 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.425 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 26.9 m -105.68 119.52 39.35 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 106.764 -1.569 . . . . 73.340000000000003 106.764 172.79 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -125.67 144.23 50.69 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 120.843 0.354 . . . . 75.109999999999999 111.32 -173.736 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 5.2 p -121.81 111.74 32.15 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 N-CA-C 106.378 -1.712 . . . . 75.150000000000006 106.378 169.655 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 56.51 41.79 28.21 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.219 0.533 . . . . 73.019999999999996 111.228 -176.642 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 74.77 4.55 4.36 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.643 1.177 . . . . 75.239999999999995 112.782 179.749 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -97.27 115.6 65.77 Favored Pre-proline 0 C--N 1.315 -0.908 0 N-CA-C 110.008 -0.367 . . . . 75.120000000000005 110.008 178.261 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.425 ' HA ' ' O ' ' A' ' 110' ' ' THR . 41.8 Cg_endo -78.2 95.68 1.08 Allowed 'Trans proline' 0 N--CA 1.449 -1.122 0 C-N-CA 121.986 1.79 . . . . 70.219999999999999 110.688 176.866 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 27.8 mmm180 -114.23 146.32 40.56 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.601 -1.259 . . . . 75.150000000000006 107.601 -177.583 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.416 ' HA ' ' OD2' ' A' ' 103' ' ' ASP . 2.7 t-20 -84.17 -38.58 20.46 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.568 0.699 . . . . 73.150000000000006 110.46 -177.801 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -130.73 139.0 50.25 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 108.322 -0.992 . . . . 62.119999999999997 108.322 177.038 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 5.6 tp60 -139.81 145.45 38.18 Favored 'General case' 0 N--CA 1.425 -1.703 0 CA-C-O 121.299 0.571 . . . . 63.310000000000002 111.505 179.536 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 60.7 t -92.11 134.24 30.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 106.049 -1.834 . . . . 60.310000000000002 106.049 175.433 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.414 ' CB ' ' HB2' ' A' ' 99' ' ' PHE . 17.0 tmm? -39.36 127.09 1.81 Allowed 'General case' 0 N--CA 1.483 1.188 0 O-C-N 124.443 1.089 . . . . 74.120000000000005 113.366 -177.632 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -128.79 124.1 34.59 Favored 'General case' 0 N--CA 1.417 -2.088 0 N-CA-C 105.982 -1.859 . . . . 75.200000000000003 105.982 177.844 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 4.9 t -92.87 130.86 38.32 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 121.56 0.695 . . . . 72.120000000000005 112.221 -173.874 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 94.64 3.03 62.86 Favored Glycine 0 N--CA 1.438 -1.201 0 CA-C-N 115.24 -0.891 . . . . 63.119999999999997 111.393 177.784 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -106.43 168.02 9.44 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.533 -0.333 . . . . 75.400000000000006 111.157 -177.579 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -108.73 131.64 54.74 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.291 0.567 . . . . 72.439999999999998 111.88 -172.71 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 61.9 mt -119.05 113.22 40.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-N 115.344 -0.843 . . . . 65.319999999999993 109.211 179.816 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -95.32 112.75 24.41 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 109.098 -0.705 . . . . 75.019999999999996 109.098 177.425 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.5 pt -100.98 103.42 14.81 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 CA-C-O 122.127 0.965 . . . . 73.209999999999994 108.741 176.083 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 80.3 -104.96 2.31 Favored Glycine 0 N--CA 1.413 -2.86 0 CA-C-N 114.678 -1.146 . . . . 74.549999999999997 110.765 179.822 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -119.92 1.2 10.94 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 121.158 0.504 . . . . 72.040000000000006 110.954 -176.786 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -127.97 160.06 33.06 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 116.265 -0.425 . . . . 74.040000000000006 110.883 -178.114 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 11.1 ptp180 -129.59 139.16 51.55 Favored 'General case' 0 C--O 1.252 1.224 0 N-CA-C 114.818 1.414 . . . . 72.430000000000007 114.818 -169.517 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 8.2 mp -121.86 144.23 48.96 Favored 'General case' 0 N--CA 1.424 -1.747 0 CA-C-N 113.406 -1.724 . . . . 73.519999999999996 108.596 179.052 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 58.3 t -107.37 124.16 63.1 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.141 0 N-CA-C 106.907 -1.516 . . . . 73.409999999999997 106.907 179.433 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -100.33 130.33 46.42 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.92 -0.4 . . . . 75.439999999999998 109.92 -173.12 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -126.55 151.72 47.52 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 121.1 0.476 . . . . 74.140000000000001 109.774 -179.847 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -69.58 135.98 50.69 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.108 -1.441 . . . . 71.239999999999995 107.108 172.766 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -82.98 -177.25 51.92 Favored Glycine 0 N--CA 1.439 -1.131 0 C-N-CA 120.102 -1.047 . . . . 54.329999999999998 112.603 -174.907 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo . . . . . 0 N--CA 1.439 -1.732 0 C-N-CA 122.204 1.936 . . . . 63.420000000000002 109.715 175.922 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 18.1 m120 . . . . . 0 CA--C 1.501 -0.932 0 CA-C-O 121.061 0.457 . . . . 71.430000000000007 110.751 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 154.51 115.86 0.56 Allowed Glycine 0 C--N 1.294 -1.759 0 N-CA-C 109.849 -1.3 . . . . 72.439999999999998 109.849 -178.692 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.3 m -82.65 124.8 77.1 Favored Pre-proline 0 C--N 1.299 -1.626 0 N-CA-C 109.236 -0.653 . . . . 73.109999999999999 109.236 -179.024 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.17 128.05 28.17 Favored 'Trans proline' 0 C--N 1.36 1.159 0 C-N-CA 122.331 2.02 . . . . 73.329999999999998 109.718 175.852 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -75.4 120.27 80.88 Favored Pre-proline 0 C--N 1.308 -1.229 0 CA-C-N 116.063 -0.517 . . . . 65.219999999999999 111.992 -173.141 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -82.16 129.55 6.07 Favored 'Trans proline' 0 N--CA 1.443 -1.487 0 C-N-CA 122.238 1.959 . . . . 75.230000000000004 110.321 175.935 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -89.21 119.58 29.83 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.624 -0.88 . . . . 74.310000000000002 108.624 179.381 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.9 m -91.77 166.82 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 116.32 -0.4 . . . . 72.439999999999998 111.389 -175.586 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -96.49 141.13 30.14 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 108.823 -0.806 . . . . 75.209999999999994 108.823 176.119 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 50.3 m -120.06 102.33 8.46 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-O 121.301 0.572 . . . . 73.010000000000005 109.911 178.89 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.9 m -123.9 141.49 51.99 Favored 'General case' 0 N--CA 1.408 -2.545 0 N-CA-C 105.644 -1.984 . . . . 74.319999999999993 105.644 177.533 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.3 t -132.17 146.4 52.0 Favored 'General case' 0 C--N 1.271 -2.805 0 N-CA-C 108.709 -0.848 . . . . 64.140000000000001 108.709 -177.888 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.7 m . . . . . 0 N--CA 1.43 -1.441 0 CA-C-O 121.11 0.481 . . . . 72.150000000000006 110.092 179.707 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.482 -2.023 0 N-CA-C 106.635 -2.586 . . . . 55.130000000000003 106.635 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.7 m -90.88 167.42 12.45 Favored 'General case' 0 N--CA 1.414 -2.226 0 CA-C-N 113.058 -1.571 . . . . 74.109999999999999 111.383 -171.549 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.66 157.4 44.93 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 106.775 -1.565 . . . . 75.299999999999997 106.775 176.394 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.4 pp -134.63 151.97 51.44 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 119.632 -0.827 . . . . 61.130000000000003 111.787 -178.822 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -126.79 136.76 52.82 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.734 -0.666 . . . . 74.439999999999998 109.565 -179.6 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.431 ' CG2' ' HB ' ' A' ' 136' ' ' VAL . 33.5 m -114.24 128.97 71.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 109.202 -0.666 . . . . 71.420000000000002 109.202 175.475 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.6 t -95.14 125.57 47.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 109.439 -0.578 . . . . 72.420000000000002 109.439 -177.2 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -96.66 -34.07 11.52 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.879 -0.6 . . . . 75.030000000000001 110.078 176.17 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.44 ' O ' ' HB3' ' A' ' 133' ' ' PHE . 30.9 tpt180 -165.46 121.51 1.37 Allowed 'General case' 0 CA--C 1.496 -1.133 0 N-CA-C 108.992 -0.744 . . . . 75.140000000000001 108.992 175.938 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -163.19 164.88 36.3 Favored Glycine 0 N--CA 1.415 -2.714 0 N-CA-C 108.218 -1.953 . . . . 53.119999999999997 108.218 177.353 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.402 ' HB2' ' HB3' ' A' ' 82' ' ' ASP . 14.3 Cg_exo -68.82 -20.81 39.05 Favored 'Trans proline' 0 C--O 1.238 0.518 0 C-N-CA 122.385 2.057 . . . . 72.030000000000001 111.397 179.997 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.405 ' HB3' ' CA ' ' A' ' 80' ' ' LEU . 21.8 p-10 -68.52 -59.34 3.22 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 114.761 -1.109 . . . . 72.030000000000001 112.387 -178.651 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -175.75 -153.52 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 108.18 -1.044 . . . . 73.200000000000003 108.18 -173.096 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.03 54.05 0.35 Allowed Glycine 0 N--CA 1.428 -1.888 0 N-CA-C 107.708 -2.157 . . . . 73.150000000000006 107.708 178.677 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -135.91 -167.41 2.03 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 108.52 -0.918 . . . . 62.229999999999997 108.52 -173.93 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 17.7 ptp180 -116.12 144.95 43.47 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 120.546 0.213 . . . . 74.049999999999997 110.502 -177.95 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -136.81 140.48 42.5 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 108.516 -0.92 . . . . 74.420000000000002 108.516 179.97 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.1 tt -117.97 136.29 53.6 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 109.072 -0.714 . . . . 74.340000000000003 109.072 177.979 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -93.36 115.27 27.84 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.853 -0.425 . . . . 72.340000000000003 109.853 -178.889 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -109.6 13.41 23.89 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 122.439 1.114 . . . . 74.349999999999994 108.569 179.082 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -123.93 144.49 45.14 Favored Pre-proline 0 C--N 1.309 -1.172 0 CA-C-N 115.307 -0.861 . . . . 71.239999999999995 109.927 -177.628 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.531 ' HA ' ' CD1' ' A' ' 94' ' ' ILE . 10.1 Cg_endo -55.34 -54.98 3.5 Favored 'Trans proline' 0 C--N 1.358 1.037 0 C-N-CA 123.468 2.779 . . . . 73.430000000000007 113.851 -177.773 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 42.6 m -113.41 108.61 17.44 Favored 'General case' 0 N--CA 1.425 -1.676 0 N-CA-C 109.581 -0.525 . . . . 74.200000000000003 109.581 -178.718 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 24.8 m -103.23 114.16 28.22 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 108.982 -0.748 . . . . 73.140000000000001 108.982 175.899 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.6 p -98.51 115.25 28.16 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 121.794 0.806 . . . . 74.420000000000002 111.814 -179.555 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.63 134.87 41.89 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 106.901 -1.518 . . . . 70.400000000000006 106.901 175.685 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 82.57 73.56 1.22 Allowed Glycine 0 C--N 1.3 -1.436 0 C-N-CA 119.702 -1.237 . . . . 71.209999999999994 110.327 -175.183 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 56.9 ttt180 -158.35 106.61 1.95 Allowed 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 105.206 -2.146 . . . . 75.129999999999995 105.206 -178.472 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 19.0 m-70 -52.01 -68.37 0.42 Allowed Pre-proline 0 CA--C 1.55 0.959 0 N-CA-C 116.069 1.877 . . . . 75.239999999999995 116.069 -169.999 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -66.97 -40.15 12.51 Favored 'Trans proline' 0 C--N 1.359 1.093 0 C-N-CA 121.286 1.324 . . . . 73.200000000000003 114.101 -176.18 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -125.77 75.58 1.51 Allowed 'General case' 0 C--N 1.32 -0.675 0 O-C-N 122.293 -0.254 . . . . 72.349999999999994 110.521 -175.588 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 18.0 p -78.31 123.17 26.66 Favored 'General case' 0 C--N 1.28 -2.454 0 C-N-CA 119.11 -1.036 . . . . 73.239999999999995 109.093 176.391 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -67.09 -55.56 13.76 Favored 'General case' 0 CA--C 1.485 -1.537 0 N-CA-C 107.365 -1.346 . . . . 73.219999999999999 107.365 175.696 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 45.4 pt -125.67 148.0 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.847 0 CA-C-N 115.047 -0.979 . . . . 65.239999999999995 108.427 173.998 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -97.51 136.22 38.24 Favored 'General case' 0 C--N 1.276 -2.592 0 CA-C-N 115.321 -0.854 . . . . 75.200000000000003 108.929 177.151 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.405 ' CA ' ' HB3' ' A' ' 56' ' ' ASN . 58.1 tp -144.21 -88.62 0.12 Allowed 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.799 -0.815 . . . . 74.239999999999995 108.799 -175.158 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -76.34 96.93 4.1 Favored 'General case' 0 C--N 1.261 -3.242 0 N-CA-C 108.36 -0.978 . . . . 74.040000000000006 108.36 171.478 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.402 ' HB3' ' HB2' ' A' ' 55' ' ' PRO . 14.6 t70 -81.09 -54.96 5.09 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.269 -0.878 . . . . 54.340000000000003 110.206 -179.077 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.9 t -85.11 -39.91 14.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 CA-C-N 114.882 -1.054 . . . . 75.319999999999993 109.123 -178.994 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.6 p -87.47 32.78 0.7 Allowed 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 124.386 1.075 . . . . 61.020000000000003 111.395 -178.328 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.9 p -81.3 139.87 17.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 CA-C-N 115.171 -0.922 . . . . 71.140000000000001 112.137 -171.909 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 23.3 t -128.52 -176.86 3.95 Favored 'General case' 0 N--CA 1.424 -1.767 0 N-CA-C 107.625 -1.25 . . . . 75.450000000000003 107.625 175.88 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -100.77 120.41 40.07 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 123.446 0.699 . . . . 74.340000000000003 109.227 -177.94 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 64.49 32.92 11.42 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 108.419 -0.956 . . . . 73.530000000000001 108.419 -176.372 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 67.4 t60 -46.79 -66.45 0.4 Allowed 'General case' 0 C--O 1.241 0.641 0 C-N-CA 124.759 1.224 . . . . 75.219999999999999 112.429 -175.317 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.465 ' HA ' ' HA ' ' A' ' 103' ' ' ASP . . . -141.05 141.34 34.3 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 121.147 -0.221 . . . . 54.43 110.776 -178.129 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -116.32 127.75 54.96 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.33 0.586 . . . . 75.400000000000006 110.791 177.495 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -105.11 112.64 25.84 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 105.611 -1.996 . . . . 72.409999999999997 105.611 174.302 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -124.38 150.09 45.94 Favored 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 120.49 -0.484 . . . . 75.420000000000002 109.742 -176.522 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.531 ' CD1' ' HA ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -116.95 139.1 45.32 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.063 0 C-N-CA 118.985 -1.086 . . . . 72.510000000000005 108.444 172.233 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -119.22 145.33 46.14 Favored 'General case' 0 C--N 1.27 -2.884 0 N-CA-C 105.793 -1.929 . . . . 75.519999999999996 105.793 176.696 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.94 -20.15 8.33 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 114.038 1.125 . . . . 75.439999999999998 114.038 -173.457 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -106.46 -31.95 3.84 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 119.953 -1.118 . . . . 74.200000000000003 114.16 177.789 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -145.33 147.34 32.21 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-N 117.65 0.725 . . . . 73.400000000000006 109.803 -175.026 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.407 ' HB2' ' HB3' ' A' ' 122' ' ' MET . 30.5 m-85 -94.9 129.88 41.73 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 106.974 -1.491 . . . . 74.239999999999995 106.974 176.4 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -132.3 129.26 39.32 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 119.535 -0.866 . . . . 74.439999999999998 111.76 -175.061 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 61.4 t -114.11 118.1 57.44 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 107.842 -1.17 . . . . 73.340000000000003 107.842 177.552 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 30.8 m -121.06 130.82 74.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 CA-C-N 115.934 -0.576 . . . . 75.310000000000002 109.991 178.9 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.465 ' HA ' ' HA ' ' A' ' 90' ' ' ALA . 0.7 OUTLIER -97.0 138.78 34.0 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 117.326 -1.75 . . . . 74.319999999999993 108.406 170.718 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.8 m -124.18 -2.46 6.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 112.183 0.438 . . . . 61.409999999999997 112.183 179.948 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -89.86 -44.9 4.69 Favored Glycine 0 CA--C 1.509 -0.319 0 N-CA-C 109.752 -1.339 . . . . 65.099999999999994 109.752 175.97 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 14.2 m 58.79 29.2 18.41 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 114.414 1.264 . . . . 72.200000000000003 114.414 174.013 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 49.3 tp -85.32 -48.21 9.28 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 120.109 -0.636 . . . . 72.519999999999996 112.541 -177.659 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -87.64 -19.45 27.71 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 119.448 -0.901 . . . . 62.310000000000002 111.315 -176.247 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 97.34 127.97 5.81 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 120.418 -0.896 . . . . 74.310000000000002 113.666 176.855 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.406 HG21 ' HB3' ' A' ' 103' ' ' ASP . 5.7 p -109.47 134.33 52.01 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 123.281 0.632 . . . . 74.120000000000005 111.335 -179.407 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.438 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 26.6 m-85 -138.78 147.47 42.63 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 107.583 -1.265 . . . . 74.340000000000003 107.583 178.435 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.6 p -123.19 125.81 72.52 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 N-CA-C 106.088 -1.819 . . . . 74.310000000000002 106.088 171.271 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 17.6 m120 62.93 22.15 13.28 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.068 0.547 . . . . 72.040000000000006 109.796 -175.952 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 40.8 mtp180 75.05 12.25 3.46 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.334 1.453 . . . . 75.109999999999999 112.396 -177.126 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -102.85 118.27 58.68 Favored Pre-proline 0 C--N 1.31 -1.115 0 N-CA-C 105.983 -1.858 . . . . 74.409999999999997 105.983 176.27 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -46.66 119.61 3.37 Favored 'Trans proline' 0 C--N 1.362 1.273 0 C-N-CA 123.767 2.978 . . . . 74.340000000000003 112.508 -178.122 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 12.0 tpt180 -153.25 118.91 5.3 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 109.936 -0.394 . . . . 75.439999999999998 109.936 -173.627 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -81.63 -38.76 25.47 Favored 'General case' 0 C--N 1.317 -0.839 0 O-C-N 123.521 0.513 . . . . 72.239999999999995 112.103 -179.085 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -125.4 139.46 53.64 Favored 'General case' 0 N--CA 1.437 -1.119 0 C-N-CA 120.444 -0.502 . . . . 73.439999999999998 110.171 -178.857 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -139.36 137.95 36.18 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 109.044 -0.725 . . . . 75.340000000000003 109.044 175.66 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.2 t -111.83 97.72 6.11 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 CA-C-N 115.404 -0.816 . . . . 73.209999999999994 108.91 -177.828 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.407 ' HB3' ' HB2' ' A' ' 99' ' ' PHE . 26.3 ptt? 41.5 98.11 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 127.118 2.167 . . . . 70.319999999999993 116.293 179.091 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 52.1 tp60 -121.69 122.34 39.36 Favored 'General case' 0 N--CA 1.385 -3.706 0 N-CA-C 101.28 -3.6 . . . . 74.439999999999998 101.28 174.52 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 14.9 t -110.29 127.74 55.17 Favored 'General case' 0 C--N 1.29 -2.003 0 C-N-CA 119.194 -1.003 . . . . 74.430000000000007 110.666 -172.404 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 87.62 16.9 59.35 Favored Glycine 0 N--CA 1.425 -2.077 0 N-CA-C 110.218 -1.153 . . . . 74.450000000000003 110.218 -178.334 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -112.61 162.15 16.01 Favored 'General case' 0 CA--C 1.484 -1.589 0 N-CA-C 112.527 0.565 . . . . 73.150000000000006 112.527 -179.68 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -107.58 122.58 46.96 Favored 'General case' 0 N--CA 1.421 -1.878 0 CA-C-N 114.761 -1.109 . . . . 71.430000000000007 111.049 -172.148 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 68.7 mt -101.37 129.87 51.79 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 N-CA-C 106.967 -1.494 . . . . 72.540000000000006 106.967 176.499 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.438 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 34.6 tt0 -110.76 125.46 53.56 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 109.2 -0.667 . . . . 72.439999999999998 109.2 -179.659 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -112.5 109.87 30.13 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 N-CA-C 108.6 -0.889 . . . . 74.420000000000002 108.6 177.667 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 71.21 -82.37 0.45 Allowed Glycine 0 C--N 1.308 -0.991 0 CA-C-N 115.735 -0.666 . . . . 52.109999999999999 112.094 -176.995 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -146.14 8.16 1.07 Allowed 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.771 -0.826 . . . . 74.420000000000002 108.771 179.118 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.44 ' HB3' ' O ' ' A' ' 53' ' ' ARG . 35.4 m-85 -104.7 150.83 24.39 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.781 -0.822 . . . . 73.510000000000005 108.781 -175.429 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.34 130.74 55.51 Favored 'General case' 0 C--O 1.258 1.505 0 C-N-CA 119.05 -1.06 . . . . 74.420000000000002 112.931 -177.701 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.7 tt -123.79 137.99 54.58 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 125.808 1.643 . . . . 70.549999999999997 107.287 -177.245 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.431 ' HB ' ' CG2' ' A' ' 50' ' ' VAL . 60.8 t -108.81 127.15 65.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 108.677 -0.86 . . . . 70.409999999999997 108.677 177.021 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -102.47 130.4 49.27 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 116.209 -0.45 . . . . 65.409999999999997 110.558 -175.071 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -125.34 148.94 48.53 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 109.239 -0.652 . . . . 75.430000000000007 109.239 178.843 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -81.33 135.23 35.68 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.433 -0.951 . . . . 74.420000000000002 108.433 176.739 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.49 153.71 52.66 Favored Glycine 0 N--CA 1.437 -1.281 0 C-N-CA 120.933 -0.651 . . . . 74.209999999999994 111.518 -178.03 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo . . . . . 0 N--CA 1.445 -1.336 0 C-N-CA 122.401 2.068 . . . . 73.299999999999997 113.002 -177.809 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 . . . . . 0 N--CA 1.437 -1.079 0 N-CA-C 109.16 -0.682 . . . . 60.210000000000001 109.16 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.85 123.97 8.07 Favored Glycine 0 N--CA 1.435 -1.424 0 N-CA-C 110.905 -0.878 . . . . 73.310000000000002 110.905 -178.966 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.0 p -94.42 126.13 49.29 Favored Pre-proline 0 C--N 1.299 -1.606 0 CA-C-N 116.687 0.244 . . . . 73.25 111.2 -179.099 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.477 ' O ' ' HD3' ' A' ' 10' ' ' PRO . 24.1 Cg_exo -65.39 129.76 23.49 Favored 'Trans proline' 0 C--O 1.245 0.83 0 C-N-CA 121.954 1.769 . . . . 73.549999999999997 110.309 175.748 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -103.64 95.8 7.92 Favored Pre-proline 0 C--N 1.315 -0.933 0 N-CA-C 108.23 -1.026 . . . . 71.200000000000003 108.23 178.672 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' A' ' 8' ' ' PRO . 90.9 Cg_endo -92.8 179.14 1.23 Allowed 'Trans proline' 0 N--CA 1.445 -1.366 0 C-N-CA 122.823 2.349 . . . . 73.200000000000003 113.298 -174.469 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 67.96 84.79 0.15 Allowed 'General case' 0 CA--C 1.509 -0.621 0 C-N-CA 125.285 1.434 . . . . 73.140000000000001 112.14 -179.159 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 24.5 t -113.62 78.03 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 108.503 -0.925 . . . . 74.409999999999997 108.503 178.543 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -140.01 131.23 26.57 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.057 -1.09 . . . . 75.310000000000002 108.057 177.816 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.0 m -143.98 76.67 1.52 Allowed 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 106.551 -1.648 . . . . 73.099999999999994 106.551 172.93 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.1 m -99.59 90.33 4.45 Favored 'General case' 0 N--CA 1.413 -2.299 0 CA-C-N 115.406 -0.815 . . . . 74.230000000000004 110.013 -177.907 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.7 m -125.02 70.31 1.15 Allowed 'General case' 0 N--CA 1.415 -2.194 0 N-CA-C 107.148 -1.427 . . . . 71.340000000000003 107.148 175.698 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.8 m . . . . . 0 N--CA 1.428 -1.562 0 CA-C-N 114.876 -1.056 . . . . 65.109999999999999 109.575 -176.966 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.504 0 N-CA-C 108.132 -1.987 . . . . 73.310000000000002 108.132 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.518 ' O ' ' HA ' ' A' ' 141' ' ' PRO . 16.3 m -90.7 162.05 15.09 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 115.1 -0.55 . . . . 74.150000000000006 111.166 -173.993 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -136.77 177.6 7.73 Favored 'General case' 0 C--O 1.253 1.278 0 N-CA-C 107.816 -1.179 . . . . 64.219999999999999 107.816 176.482 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -118.54 146.67 44.38 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 120.171 -0.612 . . . . 73.230000000000004 112.536 -172.471 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -124.38 132.95 53.54 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.161 -1.051 . . . . 74.329999999999998 108.161 177.501 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 26.0 t -125.9 144.75 34.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 108.849 -0.797 . . . . 74.420000000000002 108.849 -176.823 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 57.7 t -92.46 127.73 44.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 108.624 -0.88 . . . . 74.140000000000001 108.624 179.795 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -94.45 -38.33 10.99 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.655 -0.702 . . . . 70.0 110.142 -179.604 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 5.5 tpm_? -160.51 114.14 2.11 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.625 -0.716 . . . . 75.319999999999993 110.125 -175.094 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 158.32 125.64 0.84 Allowed Glycine 0 N--CA 1.426 -1.968 0 O-C-N 124.106 0.879 . . . . 73.099999999999994 111.189 176.845 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.559 ' HD2' ' CZ ' ' A' ' 133' ' ' PHE . 50.4 Cg_exo -59.76 -10.63 12.32 Favored 'Trans proline' 0 N--CA 1.489 1.261 0 C-N-CA 123.291 2.661 . . . . 71.549999999999997 113.646 177.599 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.555 ' HB2' ' O ' ' A' ' 79' ' ' PHE . 4.3 p-10 -52.44 -36.41 54.48 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.297 1.039 . . . . 73.230000000000004 110.046 179.59 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -171.93 -162.28 0.21 Allowed 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.513 1.125 . . . . 62.450000000000003 108.123 -179.681 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 172.58 62.64 0.05 OUTLIER Glycine 0 CA--C 1.491 -1.408 0 N-CA-C 110.205 -1.158 . . . . 65.209999999999994 110.205 -179.266 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -163.53 -176.4 4.68 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 107.329 -1.36 . . . . 75.049999999999997 107.329 -176.762 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -103.54 136.06 43.97 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 124.013 0.821 . . . . 75.430000000000007 109.374 176.687 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -121.76 149.93 42.59 Favored 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 108.664 -0.865 . . . . 74.409999999999997 108.664 178.161 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 38.6 tp -114.55 135.81 53.71 Favored 'General case' 0 C--N 1.285 -2.212 0 N-CA-C 106.294 -1.743 . . . . 74.340000000000003 106.294 178.122 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 94.7 mt -79.73 112.94 17.49 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 118.519 -1.272 . . . . 72.209999999999994 109.575 179.064 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -121.02 -0.59 9.99 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-O 121.58 0.705 . . . . 70.230000000000004 109.397 178.973 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -115.63 138.71 24.02 Favored Pre-proline 0 C--N 1.303 -1.431 0 N-CA-C 108.532 -0.914 . . . . 74.319999999999993 108.532 -177.693 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -63.33 -30.92 73.57 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.367 2.044 . . . . 74.329999999999998 112.055 -179.801 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 40.9 m -136.73 114.92 11.6 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 109.892 -0.41 . . . . 74.439999999999998 109.892 177.571 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 24.7 m -110.66 114.11 27.25 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 109.029 -0.73 . . . . 74.219999999999999 109.029 179.318 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 49.4 p -93.27 124.85 37.54 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.118 0.485 . . . . 70.140000000000001 111.633 -179.384 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -109.15 126.45 53.25 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 109.1 -0.704 . . . . 64.349999999999994 109.1 176.498 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -173.94 -171.92 38.78 Favored Glycine 0 N--CA 1.43 -1.706 0 C-N-CA 120.377 -0.916 . . . . 64.099999999999994 111.323 178.538 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -109.69 88.04 2.65 Favored 'General case' 0 N--CA 1.423 -1.777 0 N-CA-C 107.294 -1.373 . . . . 72.239999999999995 107.294 179.467 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 9.8 t-160 -164.18 133.19 2.86 Favored Pre-proline 0 C--N 1.279 -2.476 0 N-CA-C 105.185 -2.154 . . . . 72.329999999999998 105.185 -179.872 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -51.06 -37.06 56.72 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 123.16 2.573 . . . . 61.109999999999999 112.933 -178.917 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -102.07 70.13 1.19 Allowed 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 122.569 1.176 . . . . 74.430000000000007 111.828 179.298 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 31.1 m -126.25 169.28 13.04 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 113.29 -1.777 . . . . 74.340000000000003 106.673 174.582 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -79.38 -38.53 34.7 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 119.872 -0.731 . . . . 60.43 110.579 -178.29 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 39.0 pt -136.73 171.06 17.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 108.591 -0.892 . . . . 73.430000000000007 108.591 173.125 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.555 ' O ' ' HB2' ' A' ' 56' ' ' ASN . 98.0 m-85 -105.25 137.23 43.37 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 112.448 0.536 . . . . 75.030000000000001 112.448 -175.807 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.465 ' HA ' ' HB2' ' A' ' 56' ' ' ASN . 1.7 tt -146.96 104.8 3.73 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 104.658 -2.349 . . . . 74.120000000000005 104.658 177.16 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -115.78 13.5 16.15 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 114.378 1.251 . . . . 64.120000000000005 114.378 -171.252 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.509 ' OD2' ' HB ' ' A' ' 85' ' ' VAL 0.292 3.1 p30 -31.76 -88.72 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.378 0 N-CA-C 115.785 1.772 . . . . 71.239999999999995 115.785 -174.744 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.483 ' H ' ' CG ' ' A' ' 82' ' ' ASP . 7.5 p -163.99 -46.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 C-N-CA 123.13 0.572 . . . . 74.510000000000005 110.732 178.25 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 18.0 m -110.12 27.41 9.64 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 123.337 1.541 . . . . 63.109999999999999 109.007 -177.41 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.509 ' HB ' ' OD2' ' A' ' 82' ' ' ASP . 6.3 p -82.25 138.96 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.935 0 CA-C-N 113.48 -1.691 . . . . 74.329999999999998 109.177 178.333 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 20.2 m -87.59 178.01 6.9 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 115.629 -0.714 . . . . 74.200000000000003 110.186 -179.318 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 45.5 mtm180 -64.84 -46.1 83.31 Favored 'General case' 0 C--O 1.221 -0.414 0 N-CA-C 109.964 -0.384 . . . . 73.450000000000003 109.964 178.095 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.56 112.12 17.08 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 104.985 -2.228 . . . . 74.310000000000002 104.985 163.774 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.414 ' CE1' ' HA3' ' A' ' 105' ' ' GLY . 27.2 t60 -104.64 -54.8 2.45 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 115.483 -0.781 . . . . 73.109999999999999 110.916 -170.702 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -120.01 129.67 54.37 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 108.827 -0.805 . . . . 73.200000000000003 108.827 -178.808 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -106.49 127.0 52.96 Favored 'General case' 0 C--N 1.287 -2.142 0 C-N-CA 120.159 -0.616 . . . . 75.230000000000004 109.987 178.478 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -106.94 113.07 26.33 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 106.355 -1.72 . . . . 74.519999999999996 106.355 176.784 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -128.92 150.97 50.14 Favored 'General case' 0 C--N 1.282 -2.35 0 C-N-CA 119.658 -0.817 . . . . 75.420000000000002 111.963 -176.578 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.445 HD12 ' CD2' ' A' ' 99' ' ' PHE . 4.0 tp -115.62 120.14 63.88 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 CA-C-N 114.919 -1.037 . . . . 75.150000000000006 109.252 -179.828 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -101.24 146.72 27.16 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 107.266 -1.383 . . . . 63.210000000000001 107.266 178.409 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.41 -14.21 7.16 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.436 0.532 . . . . 74.340000000000003 112.436 179.866 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -86.29 -64.85 1.44 Allowed Glycine 0 N--CA 1.42 -2.414 0 N-CA-C 110.95 -0.86 . . . . 75.129999999999995 110.95 171.427 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -146.45 177.89 8.69 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 117.306 0.553 . . . . 74.219999999999999 111.348 -175.15 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.445 ' CD2' HD12 ' A' ' 94' ' ' ILE . 89.7 m-85 -90.93 130.59 36.85 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.724 -1.213 . . . . 72.239999999999995 107.724 176.693 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -132.29 135.29 46.12 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 120.53 -0.468 . . . . 73.439999999999998 110.78 -176.63 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 5.0 p -120.91 119.69 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.095 0 CA-C-O 121.599 0.714 . . . . 71.219999999999999 109.765 179.671 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 30.5 m -119.35 128.26 75.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-N 115.228 -0.896 . . . . 74.049999999999997 111.004 -178.089 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -91.73 132.45 36.38 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 115.682 -0.69 . . . . 75.129999999999995 109.754 176.153 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 26.8 m -115.02 11.52 7.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 CA-C-O 121.274 0.559 . . . . 70.140000000000001 110.781 175.096 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.414 ' HA3' ' CE1' ' A' ' 89' ' ' HIS . . . -122.99 56.09 0.67 Allowed Glycine 0 C--O 1.247 0.928 0 N-CA-C 109.651 -1.38 . . . . 75.209999999999994 109.651 179.17 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 12.5 m -68.9 -8.56 45.29 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 113.288 0.847 . . . . 72.530000000000001 113.288 -171.773 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.6 tt -71.31 -37.78 71.78 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 107.551 -1.278 . . . . 74.409999999999997 107.551 176.829 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -84.97 -42.31 15.04 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.527 -1.286 . . . . 72.409999999999997 107.527 176.746 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 88.38 122.73 1.94 Allowed Glycine 0 N--CA 1.439 -1.16 0 CA-C-N 114.971 -1.013 . . . . 64.420000000000002 114.965 174.35 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 31.5 m -100.85 140.33 35.3 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.066 -1.087 . . . . 64.129999999999995 108.066 172.781 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -127.41 168.41 14.89 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.732 0.777 . . . . 74.209999999999994 111.186 -174.69 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 13.7 p -122.81 143.66 34.94 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 N-CA-C 105.846 -1.909 . . . . 75.129999999999995 105.846 174.173 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -19.05 90.91 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 126.322 1.849 . . . . 74.299999999999997 113.874 -176.944 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 67.04 2.1 2.6 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 127.982 2.513 . . . . 71.519999999999996 115.392 175.209 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -124.86 142.31 40.61 Favored Pre-proline 0 C--N 1.312 -1.044 0 O-C-N 121.45 -0.781 . . . . 75.140000000000001 112.169 -178.822 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -79.04 98.91 1.22 Allowed 'Trans proline' 0 C--O 1.246 0.899 0 C-N-CA 122.766 2.311 . . . . 75.439999999999998 114.493 -175.998 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 65.5 mtp180 -140.2 119.91 13.35 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.417 -0.957 . . . . 74.200000000000003 108.417 174.3 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -85.92 -23.31 27.03 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 124.103 0.877 . . . . 72.299999999999997 109.92 -175.688 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -125.1 138.36 54.17 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 107.183 -1.414 . . . . 61.310000000000002 107.183 174.177 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -141.47 149.84 41.46 Favored 'General case' 0 C--N 1.288 -2.072 0 CA-C-N 116.045 -0.525 . . . . 73.239999999999995 110.899 -177.119 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.3 p -85.66 122.66 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.684 0 N-CA-C 103.372 -2.825 . . . . 73.510000000000005 103.372 170.187 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.45 ' HE3' ' CD1' ' A' ' 137' ' ' PHE . 12.3 ttt -65.69 113.3 4.17 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.426 0.631 . . . . 71.540000000000006 109.923 -168.806 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -103.64 133.92 47.84 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 115.148 -0.933 . . . . 74.329999999999998 109.944 -171.252 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.4 ' CB ' ' HB3' ' A' ' 139' ' ' ALA . 41.1 p -83.15 129.54 35.03 Favored 'General case' 0 N--CA 1.412 -2.336 0 CA-C-N 115.463 -0.789 . . . . 70.319999999999993 110.53 -177.732 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 107.75 -9.55 37.6 Favored Glycine 0 N--CA 1.416 -2.674 0 CA-C-N 115.689 -0.687 . . . . 74.129999999999995 111.654 177.239 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -116.26 176.18 5.22 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 118.504 -1.278 . . . . 70.310000000000002 112.592 -175.82 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -109.16 128.22 54.84 Favored 'General case' 0 N--CA 1.428 -1.575 0 C-N-CA 125.318 1.447 . . . . 73.140000000000001 110.348 -174.521 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 68.6 mt -115.97 130.3 70.91 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 N-CA-C 107.194 -1.409 . . . . 75.129999999999995 107.194 179.253 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -104.29 111.5 24.16 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 119.945 -0.702 . . . . 74.209999999999994 109.833 -177.682 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.8 pp -95.17 113.71 30.16 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 CA-C-N 115.567 -0.742 . . . . 75.010000000000005 110.812 179.68 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 72.28 -89.25 0.51 Allowed Glycine 0 N--CA 1.437 -1.262 0 N-CA-C 109.648 -1.381 . . . . 71.120000000000005 109.648 -174.033 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -142.3 3.8 1.56 Allowed 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 109.435 -0.58 . . . . 71.329999999999998 109.435 177.128 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.559 ' CZ ' ' HD2' ' A' ' 55' ' ' PRO . 21.7 m-85 -102.52 150.37 23.46 Favored 'General case' 0 CA--C 1.513 -0.47 0 O-C-N 122.026 -0.422 . . . . 74.310000000000002 110.42 -176.807 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -104.6 122.93 46.64 Favored 'General case' 0 C--O 1.252 1.231 0 CA-C-O 121.505 0.669 . . . . 73.209999999999994 112.331 -174.219 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 31.1 tp -117.78 138.47 52.03 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 114.546 -1.207 . . . . 75.200000000000003 107.828 179.729 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 10.2 p -115.08 138.75 44.37 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 N-CA-C 108.683 -0.858 . . . . 71.019999999999996 108.683 177.639 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . 0.45 ' CD1' ' HE3' ' A' ' 122' ' ' MET . 42.3 t80 -114.5 123.4 49.29 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.776 -0.824 . . . . 73.230000000000004 108.776 -177.937 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -114.62 148.24 38.38 Favored 'General case' 0 C--O 1.253 1.259 0 CA-C-O 121.111 0.481 . . . . 74.5 111.549 -175.649 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.4 ' HB3' ' CB ' ' A' ' 124' ' ' THR . . . -85.18 99.31 11.0 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-N 115.491 -0.777 . . . . 73.129999999999995 109.731 177.768 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -140.09 77.17 0.32 Allowed Glycine 0 C--N 1.281 -2.526 0 N-CA-C 107.817 -2.113 . . . . 74.549999999999997 107.817 175.002 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.518 ' HA ' ' O ' ' A' ' 46' ' ' SER . 14.9 Cg_endo . . . . . 0 CA--C 1.498 -1.323 0 C-N-CA 122.674 2.249 . . . . 74.430000000000007 113.799 -173.759 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.4 p30 . . . . . 0 CA--C 1.508 -0.668 0 N-CA-C 108.292 -1.003 . . . . 71.329999999999998 108.292 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -92.02 156.5 23.67 Favored Glycine 0 N--CA 1.427 -1.92 0 C-N-CA 120.619 -0.8 . . . . 53.530000000000001 111.435 179.94 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.0 m -82.7 129.71 61.24 Favored Pre-proline 0 C--N 1.294 -1.823 0 N-CA-C 109.106 -0.702 . . . . 74.420000000000002 109.106 179.131 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -66.61 127.9 18.07 Favored 'Trans proline' 0 N--CA 1.447 -1.233 0 C-N-CA 121.553 1.502 . . . . 75.420000000000002 109.321 173.295 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -83.34 136.73 42.79 Favored Pre-proline 0 C--N 1.295 -1.794 0 N-CA-C 108.524 -0.917 . . . . 75.219999999999999 108.524 179.132 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_exo -70.41 116.02 4.44 Favored 'Trans proline' 0 N--CA 1.441 -1.578 0 C-N-CA 121.426 1.417 . . . . 72.030000000000001 109.611 176.209 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 25.7 mp0 -66.96 124.22 22.4 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.429 -0.952 . . . . 72.129999999999995 108.429 179.128 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.6 m -53.36 126.51 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 O-C-N 124.279 0.987 . . . . 72.340000000000003 110.526 -178.621 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -70.23 139.37 52.23 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-N 115.539 -0.755 . . . . 53.32 110.826 -177.147 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 64.4 m -144.56 138.88 27.8 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 107.881 -1.155 . . . . 64.400000000000006 107.881 179.162 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 21.1 m -116.56 126.83 53.86 Favored 'General case' 0 N--CA 1.414 -2.243 0 N-CA-C 108.771 -0.826 . . . . 71.140000000000001 108.771 -177.025 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.4 t -60.88 -54.13 48.86 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 121.811 0.815 . . . . 73.510000000000005 110.036 179.696 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.9 m . . . . . 0 C--N 1.269 -2.906 0 CA-C-N 113.982 -1.463 . . . . 74.409999999999997 109.964 177.927 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.272 0 N-CA-C 109.718 -1.353 . . . . 64.310000000000002 109.718 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.1 m -91.19 163.57 14.21 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 121.711 0.767 . . . . 63.32 112.327 -173.746 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.557 ' HA ' ' N ' ' A' ' 140' ' ' GLY . . . -126.71 165.95 18.29 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 106.981 -1.489 . . . . 74.099999999999994 106.981 176.625 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.1 pp -129.91 150.66 51.1 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 113.087 0.773 . . . . 74.209999999999994 113.087 -173.83 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.5 HD12 ' CE1' ' A' ' 61' ' ' PHE . 4.4 pp -119.46 147.73 44.07 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.614 -0.721 . . . . 75.530000000000001 109.774 178.044 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.9 t -124.87 125.58 69.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 107.745 -1.205 . . . . 74.329999999999998 107.745 179.221 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.0 t -93.02 118.1 37.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 108.394 -0.965 . . . . 74.040000000000006 108.394 178.632 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -83.77 -34.12 24.86 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.354 0.597 . . . . 73.319999999999993 110.02 -178.428 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -155.55 125.94 6.76 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.269 -0.878 . . . . 74.519999999999996 108.783 176.283 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 155.44 109.52 0.32 Allowed Glycine 0 N--CA 1.415 -2.727 0 N-CA-C 111.649 -0.58 . . . . 74.200000000000003 111.649 -179.545 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -58.5 -8.58 5.6 Favored 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 124.47 3.446 . . . . 73.049999999999997 112.808 177.997 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 50.5 m-20 -52.34 -37.28 55.59 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.213 1.405 . . . . 71.420000000000002 109.229 174.306 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -159.97 -63.45 0.07 Allowed 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.659 -0.701 . . . . 72.519999999999996 109.873 -179.872 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.89 34.27 59.21 Favored Glycine 0 C--O 1.223 -0.553 0 CA-C-N 115.981 -0.554 . . . . 74.450000000000003 111.93 -179.861 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -149.42 -173.86 4.51 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 108.15 -1.056 . . . . 63.549999999999997 108.15 -178.159 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.2 ptt180 -119.79 150.1 40.96 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 108.454 -0.943 . . . . 75.109999999999999 108.454 175.777 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.5 ' CE1' HD12 ' A' ' 49' ' ' LEU . 52.0 p90 -157.23 151.72 25.25 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.598 -0.519 . . . . 72.239999999999995 109.598 173.031 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.2 pp -88.11 140.85 29.07 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 108.886 -0.783 . . . . 63.109999999999999 108.886 176.05 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 90.9 mt -71.58 113.04 8.21 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.672 -0.862 . . . . 74.310000000000002 108.672 179.667 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -110.67 -33.48 6.55 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 114.71 -1.132 . . . . 43.340000000000003 109.542 -178.967 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -79.23 122.27 84.01 Favored Pre-proline 0 C--N 1.308 -1.207 0 N-CA-C 107.22 -1.4 . . . . 74.310000000000002 107.22 179.728 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -51.55 -31.77 41.16 Favored 'Trans proline' 0 C--N 1.367 1.552 0 C-N-CA 123.509 2.806 . . . . 61.420000000000002 112.634 -176.8 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.4 m -134.5 97.05 3.71 Favored 'General case' 0 N--CA 1.417 -2.098 0 N-CA-C 107.904 -1.147 . . . . 64.230000000000004 107.904 173.404 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 86.0 m -91.73 118.46 30.69 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.963 -1.125 . . . . 71.549999999999997 107.963 -179.277 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 27.6 m -108.41 121.04 44.12 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-O 121.775 0.797 . . . . 72.049999999999997 111.919 -176.478 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.459 ' O ' ' HB3' ' A' ' 89' ' ' HIS . . . -98.16 103.3 15.23 Favored 'General case' 0 N--CA 1.416 -2.168 0 N-CA-C 106.876 -1.527 . . . . 64.299999999999997 106.876 174.232 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 111.07 69.86 0.59 Allowed Glycine 0 N--CA 1.429 -1.795 0 C-N-CA 119.76 -1.21 . . . . 54.350000000000001 111.224 -177.9 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -151.0 61.11 0.92 Allowed 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 104.093 -2.558 . . . . 71.040000000000006 104.093 177.993 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 16.5 t60 -37.95 -43.97 1.74 Allowed Pre-proline 0 CA--C 1.578 2.021 0 N-CA-C 116.559 2.059 . . . . 73.409999999999997 116.559 -167.338 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -60.15 -40.25 61.92 Favored 'Trans proline' 0 C--N 1.374 1.921 0 CA-C-N 121.559 1.593 . . . . 62.109999999999999 113.207 175.405 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -149.84 88.03 1.52 Allowed 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 108.946 -0.761 . . . . 74.120000000000005 108.946 -179.078 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 53.4 m -101.61 152.17 21.13 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 116.439 -0.346 . . . . 74.209999999999994 110.425 179.577 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -72.22 -43.8 63.88 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 106.136 -1.801 . . . . 74.129999999999995 106.136 171.103 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 30.0 pt -131.68 130.26 61.95 Favored 'Isoleucine or valine' 0 C--O 1.245 0.868 0 CA-C-N 114.407 -1.27 . . . . 75.140000000000001 108.507 171.802 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -90.73 116.99 29.02 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 116.314 -0.403 . . . . 73.239999999999995 109.978 -177.063 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 97.2 mt -66.86 172.33 4.48 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.318 0.58 . . . . 73.450000000000003 111.251 -179.859 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -73.87 -12.16 60.59 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.792 -0.64 . . . . 60.030000000000001 110.732 179.04 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.417 ' HA ' HG22 ' A' ' 85' ' ' VAL . 1.6 m-20 54.05 78.4 0.16 Allowed 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 115.085 -0.962 . . . . 73.230000000000004 113.369 -176.74 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 44.2 t -93.06 -37.04 8.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 106.92 -1.511 . . . . 71.329999999999998 106.92 173.727 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 76.1 m -179.55 84.37 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 127.971 2.508 . . . . 73.310000000000002 105.473 -178.616 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.417 HG22 ' HA ' ' A' ' 82' ' ' ASP . 78.8 t -103.34 136.18 37.33 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.192 0 CA-C-N 115.204 -0.907 . . . . 73.219999999999999 109.726 -176.662 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 23.3 t -74.3 180.0 4.23 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 115.147 -0.933 . . . . 75.409999999999997 111.04 -176.096 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 -68.15 -34.19 75.88 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 107.615 -1.254 . . . . 75.019999999999996 107.615 178.841 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.469 ' O ' HG21 ' A' ' 104' ' ' VAL . 0.2 OUTLIER -139.45 125.66 20.08 Favored 'General case' 0 CA--C 1.495 -1.145 0 N-CA-C 101.236 -3.616 . . . . 74.510000000000005 101.236 167.572 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.459 ' HB3' ' O ' ' A' ' 70' ' ' ALA . 6.7 t60 -100.65 -79.32 0.5 Allowed 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 118.619 -1.233 . . . . 73.510000000000005 112.403 -173.996 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -120.07 107.81 13.51 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.152 0.501 . . . . 73.019999999999996 109.772 -178.867 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -95.5 127.89 41.91 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 109.027 -0.731 . . . . 74.040000000000006 109.027 178.909 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -112.74 112.27 23.66 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 107.321 -1.363 . . . . 74.219999999999999 107.321 176.737 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 54.7 ttp180 -103.59 124.19 48.35 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.325 -0.991 . . . . 75.310000000000002 108.325 178.42 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.36 117.02 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.319 0 CA-C-O 122.122 0.963 . . . . 62.229999999999997 109.443 -173.243 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 -118.41 144.69 45.75 Favored 'General case' 0 C--N 1.28 -2.415 0 N-CA-C 103.174 -2.899 . . . . 62.549999999999997 103.174 172.142 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.09 -16.07 63.63 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 121.067 0.46 . . . . 70.219999999999999 112.196 -177.627 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -90.07 -45.19 4.54 Favored Glycine 0 N--CA 1.431 -1.688 0 CA-C-N 115.534 -0.757 . . . . 74.150000000000006 112.695 174.883 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -136.41 140.88 43.51 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 121.297 0.57 . . . . 64.310000000000002 110.96 -176.977 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -112.54 125.95 54.81 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 107.177 -1.416 . . . . 75.239999999999995 107.177 179.561 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -132.39 137.78 47.46 Favored 'General case' 0 C--N 1.309 -1.178 0 C-N-CA 120.051 -0.659 . . . . 74.540000000000006 112.179 -179.051 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.8 p -115.85 125.95 73.18 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 CA-C-N 115.211 -0.904 . . . . 64.340000000000003 109.551 179.518 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 46.3 t -112.97 115.52 50.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 CA-C-N 115.951 -0.568 . . . . 74.420000000000002 109.697 -179.28 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -95.95 107.5 19.78 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 121.644 0.735 . . . . 75.349999999999994 110.048 177.034 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.469 HG21 ' O ' ' A' ' 88' ' ' ARG . 1.3 m -114.0 16.02 8.07 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.277 0 CA-C-N 115.075 -0.966 . . . . 74.25 109.659 175.5 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -122.35 45.43 1.21 Allowed Glycine 0 N--CA 1.438 -1.189 0 N-CA-C 109.119 -1.593 . . . . 73.219999999999999 109.119 176.265 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.5 p -69.68 -13.65 62.41 Favored 'General case' 0 C--O 1.249 1.037 0 C-N-CA 124.702 1.201 . . . . 71.549999999999997 112.973 -175.427 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 49.9 tp -67.73 -43.84 79.03 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 108.212 -1.033 . . . . 73.450000000000003 108.212 175.442 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -74.77 -47.68 29.68 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 107.123 -1.436 . . . . 72.340000000000003 107.123 173.065 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 100.31 96.02 2.18 Favored Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 115.16 0.824 . . . . 63.329999999999998 115.16 175.01 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 51.7 m -91.2 120.11 31.85 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.359 -0.978 . . . . 71.310000000000002 108.359 173.044 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.444 ' HB3' ' HA ' ' A' ' 114' ' ' ARG . 59.9 m-85 -102.35 134.58 45.42 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 108.574 -0.898 . . . . 74.239999999999995 108.574 178.774 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 34.5 t -117.62 121.95 68.68 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 N-CA-C 105.415 -2.069 . . . . 75.200000000000003 105.415 176.131 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.447 ' HA ' ' OD1' ' A' ' 126' ' ' ASP . 14.2 m120 67.52 18.19 10.0 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 107.211 -1.403 . . . . 75.200000000000003 107.211 -172.672 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.444 ' HA ' ' HB3' ' A' ' 111' ' ' TYR 0.344 44.7 mtt85 68.79 12.67 8.73 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 113.626 -1.625 . . . . 74.209999999999994 114.207 -173.354 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -97.85 135.96 21.32 Favored Pre-proline 0 N--CA 1.442 -0.865 0 N-CA-C 107.866 -1.161 . . . . 74.450000000000003 107.866 174.681 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -68.61 115.81 4.1 Favored 'Trans proline' 0 C--O 1.24 0.605 0 C-N-CA 121.864 1.71 . . . . 72.140000000000001 109.12 172.787 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 37.9 mmt180 -134.76 131.11 37.17 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 107.97 -1.122 . . . . 75.239999999999995 107.97 -178.285 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -77.85 -29.49 50.5 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.823 0.821 . . . . 73.109999999999999 109.092 176.682 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -144.35 137.52 27.18 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 107.132 -1.432 . . . . 71.439999999999998 107.132 171.343 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -142.06 150.42 41.21 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 109.66 -0.496 . . . . 74.420000000000002 109.66 177.96 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 48.5 t -80.62 112.66 18.93 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.156 0 N-CA-C 105.107 -2.183 . . . . 75.120000000000005 105.107 173.414 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.408 ' HG2' ' CE2' ' A' ' 137' ' ' PHE . 22.1 ttt -64.27 122.54 16.91 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.183 -0.917 . . . . 73.400000000000006 109.325 -171.817 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 56.1 tp60 -104.73 125.91 51.28 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.766 -0.652 . . . . 72.400000000000006 111.145 -171.182 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 10.5 p -79.31 116.38 19.52 Favored 'General case' 0 N--CA 1.434 -1.232 0 C-N-CA 123.271 0.628 . . . . 74.530000000000001 109.945 178.793 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 115.33 7.11 17.06 Favored Glycine 0 N--CA 1.435 -1.38 0 C-N-CA 120.547 -0.835 . . . . 60.340000000000003 112.881 178.178 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.447 ' OD1' ' HA ' ' A' ' 113' ' ' ASN . 8.0 t70 -128.63 -165.7 1.54 Allowed 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.584 -0.895 . . . . 65.120000000000005 108.584 -179.606 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -128.99 149.86 50.64 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.773 0.797 . . . . 72.519999999999996 113.133 -172.294 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 65.8 mt -124.02 129.9 74.04 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 107.912 -1.144 . . . . 72.349999999999994 107.912 -178.188 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -117.91 112.77 20.77 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 109.616 -0.512 . . . . 75.540000000000006 109.616 -177.125 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.415 HD12 ' H ' ' A' ' 130' ' ' ILE . 0.2 OUTLIER -94.19 105.69 17.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 109.367 -0.605 . . . . 75.150000000000006 109.367 178.708 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 71.07 -104.26 1.38 Allowed Glycine 0 N--CA 1.433 -1.53 0 N-CA-C 110.297 -1.121 . . . . 73.239999999999995 110.297 -176.633 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 42.8 mtpt -123.72 14.58 9.38 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 120.996 0.427 . . . . 72.109999999999999 109.927 177.67 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -101.04 132.12 46.62 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.915 -0.402 . . . . 64.540000000000006 109.915 -179.11 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 17.8 ptt180 -96.98 121.43 38.85 Favored 'General case' 0 C--O 1.254 1.341 0 CA-C-O 121.726 0.774 . . . . 74.010000000000005 112.234 -176.773 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.4 tt -125.19 142.99 51.16 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 114.466 -1.243 . . . . 72.140000000000001 107.715 178.415 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 10.0 p -119.2 140.27 43.72 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 N-CA-C 108.661 -0.866 . . . . 74.439999999999998 108.661 177.671 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . 0.408 ' CE2' ' HG2' ' A' ' 122' ' ' MET . 59.6 t80 -120.2 118.0 29.36 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 120.976 0.417 . . . . 73.420000000000002 110.482 -176.4 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -118.61 173.92 6.57 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 109.401 -0.592 . . . . 75.329999999999998 109.401 -176.626 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -71.1 149.89 46.02 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.629 -1.249 . . . . 74.430000000000007 107.629 172.804 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.557 ' N ' ' HA ' ' A' ' 47' ' ' ALA . . . -96.34 -160.52 32.41 Favored Glycine 0 C--N 1.287 -2.163 0 C-N-CA 120.46 -0.876 . . . . 64.400000000000006 111.478 -176.844 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo . . . . . 0 N--CA 1.434 -1.995 0 C-N-CA 121.823 1.682 . . . . 74.430000000000007 110.895 179.634 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 . . . . . 0 N--CA 1.443 -0.798 0 N-CA-C 108.843 -0.799 . . . . 75.219999999999999 108.843 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -152.68 32.89 0.82 Allowed Glycine 0 C--N 1.29 -1.995 0 N-CA-C 109.815 -1.314 . . . . 71.510000000000005 109.815 178.492 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.8 p -75.76 129.69 80.73 Favored Pre-proline 0 N--CA 1.424 -1.756 0 CA-C-N 115.007 -0.596 . . . . 74.109999999999999 110.381 -177.381 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -55.49 133.03 55.69 Favored 'Trans proline' 0 C--O 1.241 0.658 0 C-N-CA 123.137 2.558 . . . . 71.510000000000005 112.587 -178.592 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -96.59 125.49 46.89 Favored Pre-proline 0 N--CA 1.431 -1.383 0 N-CA-C 107.974 -1.121 . . . . 75.010000000000005 107.974 175.987 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -55.42 136.01 71.8 Favored 'Trans proline' 0 C--O 1.245 0.835 0 C-N-CA 122.958 2.438 . . . . 75.209999999999994 112.157 -178.496 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -72.31 108.84 5.65 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.162 -0.681 . . . . 75.340000000000003 109.162 -178.885 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 36.2 t -87.88 115.82 28.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 109.657 -0.497 . . . . 75.099999999999994 109.657 -176.812 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -135.01 121.77 20.9 Favored 'General case' 0 N--CA 1.424 -1.77 0 N-CA-C 108.376 -0.972 . . . . 74.5 108.376 177.085 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.4 t -78.57 -25.07 45.26 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.215 0.531 . . . . 71.349999999999994 109.799 178.914 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.8 m 68.31 12.32 8.7 Favored 'General case' 0 CA--C 1.564 1.485 0 C-N-CA 124.426 1.09 . . . . 74.129999999999995 110.751 177.375 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.2 t -146.34 111.18 5.26 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 107.33 -1.359 . . . . 75.340000000000003 107.33 -179.452 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 46.5 t . . . . . 0 C--N 1.297 -1.687 0 N-CA-C 109.809 -0.441 . . . . 72.310000000000002 109.809 -176.458 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.489 -1.582 0 N-CA-C 107.212 -2.355 . . . . 74.150000000000006 107.212 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.6 p -88.78 152.74 21.59 Favored 'General case' 0 C--N 1.28 -2.429 0 N-CA-C 114.294 1.22 . . . . 74.450000000000003 114.294 -170.302 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -122.43 178.36 5.0 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 106.386 -1.709 . . . . 65.230000000000004 106.386 176.223 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -133.03 146.65 51.92 Favored 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 118.78 -1.168 . . . . 70.239999999999995 111.86 -176.742 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -109.49 131.73 54.79 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 107.365 -1.346 . . . . 74.439999999999998 107.365 176.959 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.4 t -114.07 118.49 58.56 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 N-CA-C 107.969 -1.122 . . . . 74.430000000000007 107.969 -179.077 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 6.5 t -92.86 116.19 33.42 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.151 0 N-CA-C 107.433 -1.321 . . . . 75.140000000000001 107.433 -179.44 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -74.4 -35.12 63.45 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.724 -0.843 . . . . 73.310000000000002 108.724 -178.943 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.515 ' O ' ' HB3' ' A' ' 133' ' ' PHE . 76.7 ttt180 -170.3 126.97 0.81 Allowed 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 103.578 -2.749 . . . . 75.129999999999995 103.578 176.084 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.478 ' HA2' ' HB3' ' A' ' 133' ' ' PHE . . . -151.35 174.15 30.6 Favored Glycine 0 N--CA 1.421 -2.321 0 C-N-CA 118.293 -1.908 . . . . 74.329999999999998 114.825 -174.745 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -68.65 -39.95 8.21 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 123.321 2.681 . . . . 61.409999999999997 111.748 -179.753 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -79.86 -56.26 4.4 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.609 -0.723 . . . . 75.129999999999995 110.449 -179.374 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -158.91 -160.99 0.91 Allowed 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 108.737 -0.838 . . . . 73.439999999999998 108.737 -175.801 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -152.06 46.81 0.58 Allowed Glycine 0 N--CA 1.43 -1.721 0 N-CA-C 107.384 -2.286 . . . . 70.439999999999998 107.384 -178.711 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -133.69 -172.78 3.05 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 107.384 -1.339 . . . . 65.430000000000007 107.384 -175.641 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 37.2 ptt180 -116.64 139.87 50.04 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 119.811 -0.756 . . . . 73.549999999999997 110.798 179.793 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -126.71 153.94 44.78 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.923 -0.769 . . . . 73.310000000000002 108.923 -177.239 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.0 mp -110.23 140.57 44.23 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.68 -0.859 . . . . 75.25 108.68 178.613 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -71.24 115.59 10.57 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 109.019 -0.734 . . . . 74.430000000000007 109.019 177.719 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -135.83 -26.46 1.2 Allowed 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 115.282 -0.872 . . . . 74.120000000000005 111.44 -175.32 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -108.83 125.88 30.67 Favored Pre-proline 0 C--N 1.311 -1.071 0 N-CA-C 108.49 -0.93 . . . . 75.400000000000006 108.49 179.244 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -41.41 -58.02 1.23 Allowed 'Trans proline' 0 C--N 1.37 1.676 0 C-N-CA 124.57 3.514 . . . . 73.420000000000002 114.738 -176.791 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 26.1 m -109.73 115.95 30.81 Favored 'General case' 0 N--CA 1.434 -1.271 0 C-N-CA 120.158 -0.617 . . . . 74.140000000000001 109.555 178.777 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 87.5 m -116.8 116.16 26.94 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.124 -1.435 . . . . 74.140000000000001 107.124 176.302 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.6 t -110.06 125.21 52.72 Favored 'General case' 0 N--CA 1.434 -1.235 0 C-N-CA 118.853 -1.139 . . . . 72.030000000000001 111.245 -175.576 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -100.22 110.0 22.25 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 115.161 -0.927 . . . . 53.350000000000001 109.142 179.5 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -178.96 -144.04 5.56 Favored Glycine 0 CA--C 1.468 -2.85 0 N-CA-C 109.005 -1.638 . . . . 52.530000000000001 109.005 -179.729 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 21.4 ttt180 -112.75 -89.8 0.52 Allowed 'General case' 0 N--CA 1.404 -2.763 0 C-N-CA 119.322 -0.951 . . . . 72.329999999999998 111.141 178.098 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 35.6 m170 59.97 156.96 0.1 Allowed Pre-proline 0 CA--C 1.547 0.859 0 CA-C-O 121.507 0.67 . . . . 74.540000000000006 111.576 -172.931 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -66.97 -25.55 44.52 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 121.248 1.299 . . . . 73.230000000000004 108.823 168.549 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -111.71 70.94 0.73 Allowed 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 114.355 -1.293 . . . . 54.509999999999998 108.378 -177.443 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.3 m -73.76 134.01 43.37 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.7 -0.682 . . . . 74.200000000000003 110.452 -178.948 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -78.8 -49.6 12.72 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 107.355 -1.35 . . . . 73.150000000000006 107.355 173.899 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 39.7 pt -125.43 141.84 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 N-CA-C 106.155 -1.795 . . . . 73.329999999999998 106.155 169.253 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -95.1 121.83 37.14 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-O 121.588 0.708 . . . . 61.109999999999999 111.903 -174.45 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.0 mp -88.25 118.1 27.61 Favored 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 107.777 -1.194 . . . . 72.400000000000006 107.777 172.411 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -96.65 -6.03 37.58 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.364 -1.289 . . . . 71.5 113.047 -165.699 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -78.75 -170.3 2.08 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 115.98 -0.554 . . . . 65.109999999999999 110.479 -177.554 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.8 p -122.36 7.83 5.61 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.42 0 CA-C-O 121.341 0.591 . . . . 73.430000000000007 111.63 -176.263 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 8.2 t -120.51 20.25 11.86 Favored 'General case' 0 C--N 1.308 -1.235 0 O-C-N 121.197 -0.94 . . . . 72.319999999999993 108.907 -179.775 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 86' ' ' SER . 6.1 p -81.42 131.27 34.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-N 114.496 -1.229 . . . . 61.509999999999998 111.737 -176.089 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.465 ' O ' HG23 ' A' ' 85' ' ' VAL . 44.7 t -70.34 157.03 38.48 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 114.629 -1.169 . . . . 70.510000000000005 108.103 175.653 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -52.58 -41.83 63.96 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.563 0.696 . . . . 74.439999999999998 110.398 179.209 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -138.0 130.81 29.82 Favored 'General case' 0 CA--C 1.488 -1.423 0 N-CA-C 103.786 -2.672 . . . . 75.530000000000001 103.786 168.299 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 37.7 t60 -107.71 -63.64 1.29 Allowed 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 119.45 -0.9 . . . . 71.430000000000007 110.588 -176.477 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -136.22 125.7 25.13 Favored 'General case' 0 C--N 1.292 -1.902 0 C-N-CA 120.08 -0.648 . . . . 75.150000000000006 110.036 -177.505 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -97.67 127.22 43.47 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 107.573 -1.269 . . . . 74.420000000000002 107.573 175.722 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -106.01 112.96 26.22 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.569 -1.271 . . . . 74.409999999999997 107.569 179.352 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -113.86 126.98 55.79 Favored 'General case' 0 C--N 1.277 -2.551 0 N-CA-C 108.524 -0.917 . . . . 73.439999999999998 108.524 -178.676 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.5 116.81 53.63 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 CA-C-O 122.048 0.928 . . . . 75.409999999999997 109.98 -178.357 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -108.7 145.75 34.57 Favored 'General case' 0 N--CA 1.419 -2.021 0 N-CA-C 106.0 -1.852 . . . . 73.439999999999998 106.0 174.506 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -50.62 -28.03 8.0 Favored 'General case' 0 C--N 1.308 -1.197 0 O-C-N 124.059 0.85 . . . . 73.409999999999997 112.078 179.599 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -85.03 -51.35 3.8 Favored Glycine 0 N--CA 1.426 -2.027 0 C-N-CA 120.617 -0.801 . . . . 74.150000000000006 112.728 179.026 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -144.06 153.44 42.19 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-O 121.073 0.463 . . . . 75.329999999999998 111.087 -173.831 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -95.46 123.85 39.2 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.216 -1.031 . . . . 74.230000000000004 108.216 177.125 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -115.93 134.29 55.13 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.786 -0.45 . . . . 73.099999999999994 109.786 -178.407 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.6 p -125.33 126.2 70.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 109.272 -0.64 . . . . 74.329999999999998 109.272 177.437 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.7 t -114.56 123.68 70.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 CA-C-N 116.01 -0.541 . . . . 72.439999999999998 110.274 -179.35 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -89.5 115.91 27.27 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 121.567 0.699 . . . . 62.219999999999999 110.288 176.958 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 13.9 m -118.42 11.34 7.0 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.373 0 N-CA-C 108.184 -1.043 . . . . 62.130000000000003 108.184 173.94 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -110.17 34.57 5.34 Favored Glycine 0 N--CA 1.421 -2.335 0 N-CA-C 109.862 -1.295 . . . . 74.409999999999997 109.862 178.879 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.4 m -63.15 -9.73 12.11 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.947 1.299 . . . . 65.230000000000004 110.299 179.893 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 49.8 tp -58.27 -37.92 75.95 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 125.217 1.407 . . . . 64.439999999999998 107.825 174.707 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -110.15 -41.2 4.49 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 115.316 -0.856 . . . . 55.240000000000002 109.297 176.684 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 107.99 123.67 4.96 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 120.628 -0.796 . . . . 71.409999999999997 114.749 174.052 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 87.1 m -109.17 120.18 41.75 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.267 -1.012 . . . . 74.129999999999995 108.267 173.61 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . 0.25 40.5 p90 -123.48 135.81 54.25 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 114.407 1.262 . . . . 75.319999999999993 114.407 -177.83 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 18.2 m -105.09 136.33 39.35 Favored 'Isoleucine or valine' 0 C--O 1.257 1.448 0 CA-C-N 114.657 -1.156 . . . . 73.230000000000004 108.291 -179.994 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 12.6 m120 62.06 -83.02 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 124.685 1.194 . . . . 64.329999999999998 108.744 -169.549 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 27.5 mmm180 -139.74 -12.67 1.13 Allowed 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 124.052 0.941 . . . . 73.540000000000006 110.843 177.654 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -110.5 131.08 22.24 Favored Pre-proline 0 C--O 1.245 0.821 0 N-CA-C 113.891 1.071 . . . . 71.450000000000003 113.891 -168.205 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -65.14 136.05 46.21 Favored 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 122.748 2.299 . . . . 71.409999999999997 110.17 175.282 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -131.35 164.06 26.49 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.645 -0.502 . . . . 64.150000000000006 109.645 -178.156 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -93.48 -56.03 3.07 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 108.911 -0.774 . . . . 72.439999999999998 108.911 176.733 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -130.99 139.74 50.04 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 108.778 -0.823 . . . . 74.329999999999998 108.778 179.572 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -138.88 149.94 45.42 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-O 121.536 0.684 . . . . 74.340000000000003 112.828 -178.453 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 39.7 t -92.34 105.08 16.29 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.101 0 N-CA-C 104.107 -2.553 . . . . 74.219999999999999 104.107 172.328 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 9.6 tpt -50.38 120.47 4.61 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 125.065 1.346 . . . . 72.120000000000005 110.297 -171.561 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -104.92 132.07 51.62 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 121.26 0.552 . . . . 74.310000000000002 111.577 -172.083 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.2 p -79.16 115.77 19.03 Favored 'General case' 0 N--CA 1.424 -1.73 0 CA-C-N 115.014 -0.994 . . . . 75.209999999999994 110.756 -179.201 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 119.82 -7.01 12.18 Favored Glycine 0 N--CA 1.429 -1.788 0 C-N-CA 121.033 -0.604 . . . . 65.239999999999995 112.823 177.768 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -106.8 157.9 17.39 Favored 'General case' 0 C--O 1.247 0.932 0 C-N-CA 119.944 -0.702 . . . . 64.140000000000001 111.637 -177.731 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -114.51 121.36 43.28 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-O 122.153 0.978 . . . . 73.349999999999994 109.081 177.587 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 71.6 mt -111.79 130.42 65.42 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.358 0 CA-C-N 113.968 -1.469 . . . . 74.230000000000004 109.962 -170.586 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.482 ' HG3' ' O ' ' A' ' 133' ' ' PHE . 42.8 tt0 -97.36 124.85 41.66 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.99 -0.684 . . . . 74.5 111.438 178.028 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 11.8 pt -105.55 101.95 13.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 114.504 -1.226 . . . . 74.530000000000001 108.481 178.355 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 72.44 -101.76 1.11 Allowed Glycine 0 N--CA 1.437 -1.278 0 N-CA-C 110.273 -1.131 . . . . 74.439999999999998 110.273 -176.559 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 32.8 mmmt -126.0 9.75 7.51 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.23 0.538 . . . . 75.409999999999997 110.307 178.6 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.515 ' HB3' ' O ' ' A' ' 53' ' ' ARG . 78.5 m-85 -114.36 158.04 22.03 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 108.901 -0.777 . . . . 73.439999999999998 108.901 -179.013 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 51.4 ttp180 -127.49 135.61 50.62 Favored 'General case' 0 C--O 1.249 1.063 0 C-N-CA 118.567 -1.253 . . . . 74.030000000000001 112.731 -176.105 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 5.7 tt -122.16 132.11 54.29 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 114.191 -1.368 . . . . 71.299999999999997 107.465 -178.268 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 9.6 p -111.12 135.17 51.11 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 N-CA-C 108.631 -0.878 . . . . 55.310000000000002 108.631 178.294 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -113.84 121.41 43.93 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 109.631 -0.507 . . . . 72.140000000000001 109.631 -175.918 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -123.27 165.98 16.04 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 109.396 -0.594 . . . . 75.409999999999997 109.396 -177.983 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -71.16 130.3 41.13 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 107.522 -1.288 . . . . 74.439999999999998 107.522 174.167 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -116.99 -174.19 17.01 Favored Glycine 0 N--CA 1.418 -2.564 0 C-N-CA 120.115 -1.04 . . . . 64.340000000000003 112.952 -173.485 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo . . . . . 0 N--CA 1.428 -2.381 0 C-N-CA 122.5 2.133 . . . . 70.409999999999997 112.156 -179.626 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.8 ptt? . . . . . 0 CA--C 1.514 -0.429 0 CA-C-O 121.521 0.677 . . . . 75.049999999999997 110.678 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.3 p -73.32 -34.86 65.93 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 115.699 -0.682 . . . . 61.340000000000003 111.232 -177.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -93.03 152.5 19.26 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 109.15 -0.685 . . . . 73.200000000000003 109.15 178.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 18.0 m120 73.07 -34.59 0.3 Allowed 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 125.074 1.35 . . . . 54.119999999999997 113.802 176.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -75.73 -23.42 56.05 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 121.202 0.525 . . . . 72.530000000000001 111.077 177.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.01 25.75 27.01 Favored Glycine 0 N--CA 1.439 -1.134 0 C-N-CA 120.894 -0.67 . . . . 72.129999999999995 111.648 -178.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 61.7 m -87.28 123.51 69.76 Favored Pre-proline 0 N--CA 1.433 -1.278 0 N-CA-C 108.872 -0.788 . . . . 75.030000000000001 108.872 177.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -68.25 127.49 15.91 Favored 'Trans proline' 0 N--CA 1.448 -1.182 0 C-N-CA 121.659 1.573 . . . . 75.209999999999994 110.437 174.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -100.94 139.13 20.27 Favored Pre-proline 0 C--N 1.296 -1.736 0 N-CA-C 108.787 -0.82 . . . . 74.230000000000004 108.787 177.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -75.51 118.03 5.0 Favored 'Trans proline' 0 N--CA 1.441 -1.579 0 C-N-CA 121.845 1.697 . . . . 73.129999999999995 111.335 -177.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -76.82 173.74 11.34 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 108.953 -0.758 . . . . 71.400000000000006 108.953 177.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 45.1 t 61.21 81.09 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 108.189 -1.041 . . . . 72.439999999999998 108.189 -173.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -74.73 132.27 41.51 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 115.309 -0.86 . . . . 73.549999999999997 110.067 -176.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.9 t -124.21 108.71 12.57 Favored 'General case' 0 N--CA 1.407 -2.609 0 CA-C-O 121.794 0.807 . . . . 71.329999999999998 109.67 -178.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 15.2 t -112.61 -3.78 14.26 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 122.331 1.062 . . . . 70.340000000000003 108.361 176.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.6 p -92.07 35.88 0.98 Allowed 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 114.417 -1.265 . . . . 75.439999999999998 109.157 179.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.9 m -70.36 158.83 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.612 0 CA-C-N 114.36 -1.291 . . . . 74.150000000000006 111.248 -177.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -136.04 170.67 15.63 Favored 'General case' 0 C--N 1.274 -2.704 0 N-CA-C 106.954 -1.499 . . . . 74.25 106.954 178.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.8 mpt_? -78.0 129.88 35.82 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 109.44 -0.578 . . . . 63.340000000000003 109.44 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.85 97.28 6.61 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 107.819 -1.178 . . . . 72.450000000000003 107.819 176.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -81.42 -22.14 38.43 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 109.251 -0.648 . . . . 74.319999999999993 109.251 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 58.1 tp 73.19 88.08 0.1 Allowed 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 125.806 1.642 . . . . 74.340000000000003 111.09 -179.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.463 ' H ' HD21 ' A' ' 23' ' ' LEU . 2.2 pt? -86.59 124.04 32.44 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.655 -1.239 . . . . 72.230000000000004 107.655 175.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.4 mtpt -100.46 110.12 22.28 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 120.283 -0.567 . . . . 72.099999999999994 111.487 -176.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -78.83 147.4 33.25 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.729 -0.669 . . . . 74.519999999999996 110.0 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 25.2 ptp -166.76 -179.24 4.68 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.94 -0.763 . . . . 74.209999999999994 108.94 -177.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -143.42 152.52 41.66 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.302 -0.999 . . . . 65.010000000000005 108.302 177.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.0 t -133.18 -30.45 1.33 Allowed 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 110.021 -0.362 . . . . 64.219999999999999 110.021 -179.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 41.9 m -88.87 140.21 29.67 Favored 'General case' 0 N--CA 1.439 -1.006 0 O-C-N 122.159 -0.338 . . . . 63.350000000000001 110.152 -178.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.9 p -67.73 106.9 2.38 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 122.826 0.45 . . . . 72.5 110.965 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -136.09 51.4 0.81 Allowed Glycine 0 N--CA 1.429 -1.789 0 C-N-CA 120.606 -0.807 . . . . 64.519999999999996 113.096 -176.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 47.2 m -85.66 138.98 31.76 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 106.47 -1.678 . . . . 74.409999999999997 106.47 174.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.52 116.05 11.8 Favored Pre-proline 0 C--O 1.241 0.642 0 O-C-N 124.021 0.825 . . . . 62.32 110.448 -177.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -64.22 115.93 3.44 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.805 2.337 . . . . 72.319999999999993 113.613 -175.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.95 108.97 11.59 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.647 -1.242 . . . . 74.549999999999997 107.647 176.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.2 m 67.73 100.06 0.05 Allowed 'General case' 0 C--O 1.239 0.502 0 O-C-N 124.427 1.079 . . . . 63.340000000000003 111.139 -177.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 23.5 m -79.93 81.47 6.19 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 109.032 -0.729 . . . . 75.219999999999999 109.032 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -150.05 -138.21 2.86 Favored Glycine 0 N--CA 1.425 -2.043 0 N-CA-C 110.804 -0.918 . . . . 74.310000000000002 110.804 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.06 -32.83 72.46 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 123.312 0.645 . . . . 75.329999999999998 112.288 -176.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -82.25 -12.61 57.96 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 112.43 0.53 . . . . 74.010000000000005 112.43 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -83.79 -45.8 12.91 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 108.261 -1.014 . . . . 74.329999999999998 108.261 176.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.4 mp -72.81 157.91 88.04 Favored Pre-proline 0 C--N 1.318 -0.792 0 CA-C-N 114.627 -1.169 . . . . 71.230000000000004 111.131 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.406 ' HG3' ' H ' ' A' ' 140' ' ' GLY . 55.9 Cg_endo -85.76 176.59 5.32 Favored 'Trans proline' 0 C--O 1.24 0.592 0 C-N-CA 122.573 2.182 . . . . 62.240000000000002 112.524 -178.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -115.63 109.79 18.26 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 116.404 -0.362 . . . . 53.229999999999997 110.791 -179.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 84.24 -55.2 5.0 Favored Glycine 0 C--N 1.314 -0.661 0 N-CA-C 113.866 0.306 . . . . 62.450000000000003 113.866 175.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 9.0 m -113.69 153.79 28.37 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 109.715 -0.476 . . . . 74.549999999999997 109.715 -177.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.81 174.0 10.94 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.856 -0.794 . . . . 72.519999999999996 108.856 -178.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.5 pp -135.28 160.14 39.34 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 119.22 -0.992 . . . . 70.230000000000004 112.256 -177.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.9 pp -137.75 149.28 46.31 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 109.003 -0.739 . . . . 75.140000000000001 109.003 175.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 22.6 m -121.33 141.52 41.45 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.175 0 N-CA-C 107.14 -1.429 . . . . 65.400000000000006 107.14 175.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.0 t -92.85 116.81 34.81 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.614 0 N-CA-C 107.463 -1.31 . . . . 72.530000000000001 107.463 177.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.417 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 82.5 tttt -77.62 -21.76 51.8 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.109 -0.95 . . . . 73.510000000000005 109.214 -176.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.417 ' HB2' ' O ' ' A' ' 52' ' ' LYS . 65.6 ttt180 168.26 131.03 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.51 1.524 . . . . 74.209999999999994 109.536 163.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 175.88 152.69 9.72 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 121.044 -0.598 . . . . 75.420000000000002 112.032 178.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -69.84 -9.28 25.7 Favored 'Trans proline' 0 C--N 1.36 1.147 0 C-N-CA 123.795 2.997 . . . . 71.049999999999997 112.489 177.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -60.94 -42.64 98.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.795 -0.639 . . . . 74.420000000000002 110.656 -178.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -164.47 -58.99 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 109.254 -0.647 . . . . 64.420000000000002 109.254 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.45 32.82 36.91 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.692 -0.766 . . . . 75.219999999999999 111.614 -178.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -144.11 -164.74 1.96 Allowed 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 108.109 -1.071 . . . . 75.420000000000002 108.109 -177.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -115.48 138.56 50.89 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 120.769 0.319 . . . . 74.519999999999996 110.311 177.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -130.33 147.5 52.05 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.647 -0.706 . . . . 74.420000000000002 110.525 -170.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 93.2 mt -105.06 134.52 48.03 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.052 -0.721 . . . . 73.230000000000004 109.052 177.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.4 mp -110.78 114.37 27.68 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.221 -0.659 . . . . 75.530000000000001 109.221 178.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -131.76 4.66 4.22 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.828 -1.175 . . . . 74.340000000000003 107.828 172.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -83.56 124.79 75.05 Favored Pre-proline 0 N--CA 1.441 -0.911 0 N-CA-C 106.838 -1.542 . . . . 73.299999999999997 106.838 178.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.445 ' O ' ' HG3' ' A' ' 93' ' ' ARG . 1.2 Cg_endo -45.81 -46.23 15.74 Favored 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 123.291 2.661 . . . . 75.430000000000007 112.912 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 32.1 m -136.37 117.53 14.45 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 109.546 -0.539 . . . . 75.530000000000001 109.546 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 20.4 m -113.37 113.28 25.01 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 107.967 -1.123 . . . . 65.310000000000002 107.967 177.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.5 m -97.79 131.04 44.66 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.197 0.523 . . . . 75.239999999999995 110.756 -176.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.418 ' HB3' ' HB2' ' A' ' 80' ' ' LEU . . . -97.57 110.59 23.12 Favored 'General case' 0 N--CA 1.428 -1.526 0 CA-C-N 115.849 -0.614 . . . . 53.520000000000003 110.52 -178.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -136.47 -143.09 4.57 Favored Glycine 0 N--CA 1.437 -1.254 0 N-CA-C 108.703 -1.759 . . . . 64.230000000000004 108.703 178.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.516 ' O ' ' HD3' ' A' ' 72' ' ' ARG . 4.7 tmt_? -161.19 12.23 0.09 Allowed 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 122.128 0.965 . . . . 75.040000000000006 109.63 176.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 34.5 m170 -99.45 157.7 33.52 Favored Pre-proline 0 N--CA 1.433 -1.283 0 N-CA-C 108.03 -1.1 . . . . 72.540000000000006 108.03 -178.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_exo -56.48 -21.2 36.63 Favored 'Trans proline' 0 N--CA 1.478 0.582 0 C-N-CA 122.969 2.446 . . . . 75.409999999999997 113.88 -178.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.62 -1.68 43.21 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 112.253 0.464 . . . . 74.0 112.253 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 16.0 m -83.14 146.79 28.45 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 108.248 -1.019 . . . . 64.400000000000006 108.248 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -61.26 -60.03 4.38 Favored 'General case' 0 C--N 1.322 -0.618 0 O-C-N 123.273 0.358 . . . . 74.349999999999994 110.968 -176.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 38.2 pt -122.77 157.89 27.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-O 120.746 0.307 . . . . 73.310000000000002 110.194 176.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -97.07 126.54 42.3 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.017 -1.105 . . . . 74.25 108.017 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.418 ' HB2' ' HB3' ' A' ' 70' ' ' ALA . 1.2 tm? -108.71 -90.25 0.46 Allowed 'General case' 0 N--CA 1.418 -2.055 0 CA-C-O 121.153 0.501 . . . . 73.329999999999998 111.711 -175.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -96.81 118.04 32.38 Favored 'General case' 0 C--N 1.262 -3.211 0 CA-C-O 121.658 0.742 . . . . 74.230000000000004 109.238 -176.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -94.22 -40.25 10.1 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-N 114.412 -1.267 . . . . 74.510000000000005 112.273 -175.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 8.2 p -80.74 -31.66 12.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-N 115.63 -0.714 . . . . 72.109999999999999 110.423 -174.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 5.1 p -133.97 73.68 1.51 Allowed 'General case' 0 C--N 1.294 -1.829 0 CA-C-O 122.242 1.02 . . . . 74.310000000000002 109.291 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.8 p -82.31 124.65 39.44 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 N-CA-C 114.55 1.315 . . . . 75.409999999999997 114.55 -169.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 51.0 m -96.54 139.5 32.55 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 105.514 -2.032 . . . . 63.329999999999998 105.514 167.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 8.8 ptp85 -56.69 -39.3 73.58 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 121.678 0.751 . . . . 75.239999999999995 112.045 -176.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 23.1 mmt180 -133.06 103.22 5.92 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 106.026 -1.842 . . . . 64.400000000000006 106.026 173.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 12.9 t60 -84.73 -69.92 0.61 Allowed 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.267 0.556 . . . . 73.010000000000005 110.341 -173.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -144.62 170.69 15.59 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.971 -0.752 . . . . 61.530000000000001 108.971 -176.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -144.45 128.19 17.24 Favored 'General case' 0 N--CA 1.419 -2.008 0 CA-C-O 121.317 0.58 . . . . 74.129999999999995 109.649 178.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -107.34 117.34 33.83 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.661 -1.237 . . . . 73.209999999999994 107.661 -177.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.445 ' HG3' ' O ' ' A' ' 66' ' ' PRO . 40.3 ttp85 -126.17 140.98 52.13 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-O 121.527 0.68 . . . . 73.329999999999998 111.053 -177.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.9 pp -115.16 126.76 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.967 0 N-CA-C 106.865 -1.532 . . . . 74.540000000000006 106.865 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -118.43 146.25 44.59 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 108.698 -0.852 . . . . 73.040000000000006 108.698 -174.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.35 -29.52 4.03 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 114.267 1.21 . . . . 72.230000000000004 114.267 -177.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -96.7 -40.57 3.82 Favored Glycine 0 N--CA 1.432 -1.577 0 C-N-CA 120.755 -0.736 . . . . 72.439999999999998 114.088 177.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -150.65 171.02 17.79 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 117.417 0.608 . . . . 74.140000000000001 111.26 -172.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -105.46 128.6 53.63 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.109 -1.071 . . . . 75.239999999999995 108.109 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -132.5 135.18 45.83 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 120.321 -0.551 . . . . 71.310000000000002 111.596 -177.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.5 p -117.68 122.7 70.43 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 N-CA-C 109.166 -0.679 . . . . 74.109999999999999 109.166 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.3 m -119.95 137.63 53.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 112.694 0.627 . . . . 70.209999999999994 112.694 -177.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -83.26 126.33 32.55 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.622 -1.251 . . . . 75.540000000000006 107.622 171.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 8.2 p -105.33 1.8 10.32 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 CA-C-O 121.734 0.778 . . . . 75.129999999999995 110.518 -177.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 136.47 42.22 0.11 Allowed Glycine 0 N--CA 1.441 -0.976 0 C-N-CA 119.701 -1.238 . . . . 70.310000000000002 113.698 175.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 67.6 p -73.85 124.85 26.9 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-N 117.176 0.488 . . . . 53.329999999999998 109.706 178.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 51.1 tp -78.15 -26.01 47.58 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.447 0.642 . . . . 74.150000000000006 109.327 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -76.66 -23.54 53.26 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.505 -0.77 . . . . 74.329999999999998 110.388 178.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 94.93 132.56 6.86 Favored Glycine 0 N--CA 1.431 -1.634 0 CA-C-N 115.464 -0.789 . . . . 63.310000000000002 112.802 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 79.7 m -109.18 119.82 40.68 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.381 -0.97 . . . . 74.519999999999996 108.381 175.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -125.2 141.54 52.03 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 109.285 -0.635 . . . . 74.340000000000003 109.285 -175.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 28.3 m -98.86 111.45 28.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 N-CA-C 108.687 -0.857 . . . . 73.420000000000002 108.687 175.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 65.89 -76.99 0.04 OUTLIER 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 125.449 1.5 . . . . 70.430000000000007 109.007 -172.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -147.1 10.48 1.01 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.208 1.003 . . . . 74.099999999999994 109.916 177.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -100.58 122.0 51.05 Favored Pre-proline 0 C--O 1.242 0.664 0 CA-C-O 119.648 -0.215 . . . . 70.430000000000007 110.592 -176.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -69.91 112.99 3.25 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.527 2.151 . . . . 73.420000000000002 110.238 174.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -138.44 120.19 15.26 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 109.501 -0.555 . . . . 72.049999999999997 109.501 -177.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -86.08 -21.99 27.39 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 119.914 -0.714 . . . . 75.239999999999995 109.146 176.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -136.67 136.38 39.03 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 106.475 -1.676 . . . . 73.510000000000005 106.475 169.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.95 151.07 40.53 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 109.761 -0.459 . . . . 75.040000000000006 109.761 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.2 p -79.3 123.83 36.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 105.153 -2.166 . . . . 72.239999999999995 105.153 170.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 34.8 ttp -73.54 115.23 12.69 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 121.463 0.649 . . . . 74.120000000000005 110.452 -170.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -103.86 136.96 42.56 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 114.192 -1.367 . . . . 72.409999999999997 109.976 -172.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 40.7 p -88.45 122.27 31.75 Favored 'General case' 0 N--CA 1.411 -2.421 0 CA-C-N 115.047 -0.979 . . . . 74.150000000000006 109.506 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 120.82 -29.09 5.94 Favored Glycine 0 N--CA 1.438 -1.181 0 C-N-CA 120.816 -0.707 . . . . 73.400000000000006 112.306 177.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -93.22 164.08 13.37 Favored 'General case' 0 C--O 1.248 1.002 0 N-CA-C 109.101 -0.703 . . . . 62.399999999999999 109.101 -175.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -108.93 134.86 51.03 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-O 121.989 0.9 . . . . 70.340000000000003 112.052 -176.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 66.4 mt -97.88 121.12 48.08 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 N-CA-C 108.23 -1.026 . . . . 75.230000000000004 108.23 -178.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -89.66 112.54 23.82 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 107.98 -1.119 . . . . 73.230000000000004 107.98 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.405 HG13 ' HB2' ' A' ' 133' ' ' PHE . 6.2 pt -100.99 97.15 5.37 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.572 0 N-CA-C 108.002 -1.11 . . . . 72.140000000000001 108.002 177.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 67.6 -109.52 2.95 Favored Glycine 0 N--CA 1.427 -1.919 0 N-CA-C 109.84 -1.304 . . . . 75.340000000000003 109.84 -173.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -104.72 -17.55 14.59 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 109.237 -0.653 . . . . 75.319999999999993 109.237 176.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.405 ' HB2' HG13 ' A' ' 130' ' ' ILE . 55.1 m-85 -82.92 165.7 19.52 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.659 -0.7 . . . . 71.409999999999997 111.04 -173.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 13.1 ptt180 -126.87 122.1 33.69 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 121.719 0.771 . . . . 74.530000000000001 112.294 -170.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 7.8 tt -125.04 142.16 51.67 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.328 -1.36 . . . . 73.420000000000002 107.328 177.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.408 HG23 ' HB2' ' A' ' 52' ' ' LYS . 18.8 t -122.65 131.6 72.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 107.916 -1.142 . . . . 62.140000000000001 107.916 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -102.67 128.88 49.19 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.534 -1.284 . . . . 75.140000000000001 107.534 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -124.75 164.34 20.17 Favored 'General case' 0 C--O 1.253 1.25 0 CA-C-O 121.946 0.879 . . . . 75.120000000000005 111.42 -176.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -72.07 119.84 16.83 Favored 'General case' 0 N--CA 1.416 -2.169 0 CA-C-N 114.446 -1.252 . . . . 75.230000000000004 108.522 176.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.406 ' H ' ' HG3' ' A' ' 43' ' ' PRO . . . -75.64 -160.19 8.78 Favored Glycine 0 N--CA 1.42 -2.425 0 CA-C-N 115.346 -0.843 . . . . 74.310000000000002 111.64 178.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -76.78 125.96 8.49 Favored 'Trans proline' 0 N--CA 1.425 -2.531 0 C-N-CA 121.892 1.728 . . . . 73.25 113.829 -176.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -109.59 102.92 11.72 Favored 'General case' 0 C--N 1.28 -2.422 0 N-CA-C 102.552 -3.129 . . . . 71.140000000000001 102.552 166.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 . . . . . 0 C--N 1.291 -1.936 0 N-CA-C 107.966 -1.124 . . . . 75.530000000000001 107.966 -169.167 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.6 mmt . . . . . 0 CA--C 1.499 -0.982 0 CA-C-O 120.818 0.342 . . . . 74.409999999999997 111.413 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.4 m -76.73 -42.77 40.0 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 105.867 -1.901 . . . . 75.329999999999998 105.867 171.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 16.5 t70 56.57 84.3 0.09 Allowed 'General case' 0 C--O 1.244 0.804 0 CA-C-N 113.593 -1.64 . . . . 72.040000000000006 110.568 178.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 33.5 p30 -90.7 170.53 10.06 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 114.878 -1.056 . . . . 73.219999999999999 111.302 -175.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -101.49 149.44 24.07 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.376 0.608 . . . . 74.239999999999995 110.302 177.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -121.29 95.89 0.58 Allowed Glycine 0 N--CA 1.421 -2.338 0 N-CA-C 108.729 -1.748 . . . . 75.019999999999996 108.729 176.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.5 p -99.29 124.54 44.56 Favored Pre-proline 0 C--N 1.291 -1.939 0 N-CA-C 110.571 -0.159 . . . . 72.530000000000001 110.571 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -66.41 134.87 37.45 Favored 'Trans proline' 0 C--O 1.242 0.708 0 C-N-CA 122.46 2.107 . . . . 64.420000000000002 110.016 175.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -92.36 129.66 40.26 Favored Pre-proline 0 C--N 1.294 -1.834 0 N-CA-C 109.821 -0.437 . . . . 72.510000000000005 109.821 -179.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -54.48 148.02 45.04 Favored 'Trans proline' 0 C--O 1.251 1.15 0 C-N-CA 123.683 2.922 . . . . 54.450000000000003 114.003 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -128.3 153.22 47.23 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 115.002 -0.999 . . . . 74.319999999999993 108.655 -178.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.8 p -126.27 136.38 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.805 0 N-CA-C 109.079 -0.711 . . . . 74.439999999999998 109.079 178.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -92.24 136.1 33.47 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.85 -1.167 . . . . 75.420000000000002 107.85 176.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.3 p -78.93 88.49 4.73 Favored 'General case' 0 N--CA 1.427 -1.623 0 CA-C-O 122.239 1.018 . . . . 75.010000000000005 110.948 -177.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.6 m -97.29 103.93 15.91 Favored 'General case' 0 N--CA 1.417 -2.103 0 CA-C-N 114.844 -1.071 . . . . 73.319999999999993 108.349 -177.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.8 m -111.72 154.68 24.64 Favored 'General case' 0 N--CA 1.417 -2.119 0 CA-C-N 115.832 -0.622 . . . . 63.43 109.818 -175.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 66.3 t -87.02 123.41 39.85 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 CA-C-N 115.577 -0.738 . . . . 74.329999999999998 109.267 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -100.01 107.63 19.62 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 109.854 -0.424 . . . . 73.25 109.854 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 19.0 mtp180 -103.11 163.04 12.47 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.905 -0.589 . . . . 73.400000000000006 110.752 178.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -118.12 79.22 1.34 Allowed 'General case' 0 N--CA 1.432 -1.348 0 CA-C-O 121.828 0.823 . . . . 70.400000000000006 109.114 175.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -93.16 -29.82 15.55 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.137 -0.938 . . . . 71.230000000000004 110.79 -178.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 91.1 mt -82.36 84.06 7.27 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 121.779 0.799 . . . . 74.109999999999999 112.721 -176.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.2 tt -155.45 121.75 5.21 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 103.988 -2.597 . . . . 75.099999999999994 103.988 176.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -117.15 -35.75 3.97 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 114.359 1.244 . . . . 75.510000000000005 114.359 -174.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -162.59 164.9 26.52 Favored 'General case' 0 CA--C 1.513 -0.459 0 C-N-CA 119.893 -0.723 . . . . 75.450000000000003 112.254 -176.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 84.8 mtp -139.13 19.07 2.61 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.349 -0.982 . . . . 74.120000000000005 108.349 176.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.33 112.2 8.19 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 114.794 -1.094 . . . . 73.120000000000005 110.504 -177.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 40.4 m -139.44 141.14 37.47 Favored 'General case' 0 N--CA 1.422 -1.863 0 CA-C-N 115.453 -0.794 . . . . 70.109999999999999 109.064 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.8 p -77.73 132.67 38.24 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 123.275 0.63 . . . . 74.319999999999993 109.892 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 25.4 p -82.27 148.89 28.12 Favored 'General case' 0 C--O 1.257 1.491 0 CA-C-O 120.504 0.192 . . . . 74.030000000000001 111.428 -179.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -62.18 124.7 34.33 Favored Glycine 0 N--CA 1.438 -1.233 0 N-CA-C 110.971 -0.852 . . . . 71.349999999999994 110.971 177.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 28.4 m -86.02 128.84 34.94 Favored 'General case' 0 N--CA 1.414 -2.262 0 N-CA-C 109.794 -0.447 . . . . 70.230000000000004 109.794 -177.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.17 114.25 45.3 Favored Pre-proline 0 C--N 1.302 -1.459 0 CA-C-N 114.746 -1.115 . . . . 75.400000000000006 108.713 -179.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -77.94 107.79 2.41 Favored 'Trans proline' 0 N--CA 1.441 -1.589 0 C-N-CA 122.165 1.91 . . . . 65.400000000000006 113.792 -176.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -101.21 -37.37 8.57 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 106.519 -1.66 . . . . 73.439999999999998 106.519 172.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.0 m -75.72 79.51 2.67 Favored 'General case' 0 N--CA 1.423 -1.825 0 CA-C-N 114.411 -1.268 . . . . 61.210000000000001 110.156 177.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 93.1 m -98.64 -27.99 13.75 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.691 -0.686 . . . . 74.019999999999996 109.55 176.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.81 69.87 1.37 Allowed Glycine 0 N--CA 1.431 -1.696 0 CA-C-N 115.888 -0.596 . . . . 75.319999999999993 112.516 177.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.28 -25.04 63.76 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 123.321 0.648 . . . . 53.109999999999999 111.929 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -79.56 -30.08 41.54 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 116.342 -0.39 . . . . 72.120000000000005 111.523 178.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -84.78 -37.46 20.78 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-O 121.182 0.515 . . . . 74.340000000000003 111.872 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.4 HD21 ' O ' ' A' ' 43' ' ' PRO . 6.6 tt -73.65 121.03 84.17 Favored Pre-proline 0 C--N 1.308 -1.224 0 CA-C-N 115.287 -0.869 . . . . 63.340000000000003 109.515 -177.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.4 ' O ' HD21 ' A' ' 42' ' ' LEU . 30.6 Cg_exo -63.73 142.29 82.56 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 122.939 2.426 . . . . 62.240000000000002 112.061 178.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.19 97.89 3.05 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.448 0.642 . . . . 71.230000000000004 111.343 -177.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -148.27 89.9 0.14 Allowed Glycine 0 N--CA 1.432 -1.622 0 N-CA-C 109.044 -1.623 . . . . 74.219999999999999 109.044 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.0 m -89.33 164.73 14.78 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 121.64 0.734 . . . . 75.109999999999999 112.658 -173.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.495 ' HB2' ' O ' ' A' ' 138' ' ' LEU . . . -131.93 165.42 23.95 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 107.94 -1.133 . . . . 72.040000000000006 107.94 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -127.6 154.8 44.79 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 120.647 -0.421 . . . . 72.099999999999994 111.802 -176.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.428 ' HB2' HD12 ' A' ' 135' ' ' LEU . 2.8 pp -126.23 144.13 50.89 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 115.829 -0.623 . . . . 71.340000000000003 109.974 177.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.406 HG13 ' CB ' ' A' ' 60' ' ' ARG . 1.8 m -128.02 138.99 53.12 Favored 'Isoleucine or valine' 0 C--O 1.252 1.207 0 N-CA-C 109.348 -0.612 . . . . 74.120000000000005 109.348 178.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 93.8 t -93.62 115.98 33.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 109.792 -0.447 . . . . 73.109999999999999 109.792 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -69.38 -38.17 77.88 Favored 'General case' 0 CA--C 1.506 -0.748 0 O-C-N 123.273 0.358 . . . . 73.299999999999997 110.506 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 42.6 ttt180 -168.84 135.49 1.83 Allowed 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.352 -0.84 . . . . 71.519999999999996 109.655 178.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 149.24 145.54 4.15 Favored Glycine 0 N--CA 1.416 -2.639 0 N-CA-C 110.862 -0.895 . . . . 75.109999999999999 110.862 177.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -67.63 -9.16 24.53 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.796 2.331 . . . . 72.040000000000006 112.105 177.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.44 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 87.9 m-20 -51.25 -46.8 62.48 Favored 'General case' 0 C--O 1.21 -1.009 0 C-N-CA 124.674 1.19 . . . . 74.519999999999996 110.333 175.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -172.79 -176.78 1.53 Allowed 'General case' 0 C--O 1.215 -0.714 0 N-CA-C 107.632 -1.247 . . . . 73.299999999999997 107.632 178.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -161.8 41.9 0.39 Allowed Glycine 0 C--N 1.29 -1.987 0 N-CA-C 109.938 -1.265 . . . . 65.430000000000007 109.938 -178.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -159.46 -166.39 1.78 Allowed 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 107.863 -1.162 . . . . 75.329999999999998 107.863 -176.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.406 ' CB ' HG13 ' A' ' 50' ' ' VAL . 19.6 ptt180 -115.71 135.03 54.44 Favored 'General case' 0 N--CA 1.433 -1.317 0 O-C-N 123.934 0.771 . . . . 73.25 109.294 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -126.75 121.77 32.93 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 120.772 0.32 . . . . 75.030000000000001 111.152 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 44.2 tp -88.04 119.32 28.3 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 106.913 -1.514 . . . . 74.209999999999994 106.913 177.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -79.66 114.8 18.87 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 120.57 -0.452 . . . . 74.030000000000001 110.137 -177.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -95.91 -20.82 18.47 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.663 0.744 . . . . 71.109999999999999 110.368 -176.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -97.22 139.66 21.6 Favored Pre-proline 0 C--N 1.304 -1.409 0 CA-C-N 114.91 -1.041 . . . . 74.150000000000006 112.098 -175.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.401 ' HA ' ' CG2' ' A' ' 94' ' ' ILE . 29.9 Cg_endo -64.42 -24.53 64.08 Favored 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 123.488 2.792 . . . . 75.140000000000001 114.347 -177.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.8 m -135.25 103.93 5.7 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 121.445 0.641 . . . . 72.219999999999999 109.972 178.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 17.0 m -103.13 121.69 43.16 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 115.456 -0.793 . . . . 74.230000000000004 109.658 -178.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.6 m -97.8 119.86 37.16 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 109.933 -0.395 . . . . 74.340000000000003 109.933 -177.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.82 133.84 42.56 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 121.217 0.532 . . . . 75.200000000000003 109.851 178.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -170.13 -152.71 8.18 Favored Glycine 0 N--CA 1.424 -2.139 0 N-CA-C 108.456 -1.857 . . . . 70.120000000000005 108.456 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.5 ttt180 -90.37 -38.77 13.1 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 118.765 -1.174 . . . . 75.319999999999993 111.901 -178.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -176.73 -56.22 0.0 OUTLIER Pre-proline 0 CA--C 1.569 1.677 0 N-CA-C 114.679 1.362 . . . . 73.219999999999999 114.679 -178.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -49.88 -41.65 46.73 Favored 'Trans proline' 0 C--N 1.388 2.641 0 C-N-CA 123.325 2.683 . . . . 74.329999999999998 116.697 -167.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.416 ' OE2' ' HB2' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -126.17 7.97 7.23 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 122.415 1.102 . . . . 73.230000000000004 108.34 178.31 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.5 m -82.72 121.28 26.67 Favored 'General case' 0 N--CA 1.4 -2.941 0 CA-C-N 114.082 -1.417 . . . . 73.040000000000006 108.524 -175.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -66.3 -31.63 72.54 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.777 0.799 . . . . 73.540000000000006 109.633 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.44 141.17 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.391 0 N-CA-C 106.322 -1.733 . . . . 73.349999999999994 106.322 172.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -97.47 117.73 32.37 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 120.959 0.409 . . . . 63.399999999999999 111.746 -176.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.44 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 5.9 mp -102.51 179.06 4.41 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 107.891 -1.151 . . . . 53.409999999999997 107.891 178.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -163.99 84.24 0.45 Allowed 'General case' 0 N--CA 1.442 -0.841 0 CA-C-O 121.791 0.805 . . . . 74.140000000000001 110.671 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.451 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 11.2 t70 -97.48 165.0 12.21 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 105.458 -2.052 . . . . 73.540000000000006 105.458 170.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.8 p -69.39 -27.22 33.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 CA-C-N 119.08 0.855 . . . . 72.010000000000005 110.615 -178.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.448 ' HB ' ' ND2' ' A' ' 108' ' ' ASN . 4.2 m -119.45 36.82 4.36 Favored 'General case' 0 CA--C 1.556 1.187 0 CA-C-O 121.855 0.835 . . . . 75.409999999999997 108.756 -179.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.451 ' HB ' ' HB3' ' A' ' 82' ' ' ASP . 11.8 p -81.75 140.14 16.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 108.958 -0.756 . . . . 65.140000000000001 108.958 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 26.3 m -121.34 147.33 45.84 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 110.016 -0.365 . . . . 75.230000000000004 110.016 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.416 ' HB2' ' OE2' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -59.76 132.19 53.21 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 107.222 -1.399 . . . . 75.209999999999994 107.222 170.683 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 42.1 mtm180 58.8 74.17 0.45 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.568 0.699 . . . . 75.209999999999994 109.758 -169.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -100.13 -58.55 1.89 Allowed 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 108.181 -1.044 . . . . 72.439999999999998 108.181 -177.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -136.58 135.93 38.81 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.507 -0.924 . . . . 55.149999999999999 108.507 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -108.3 126.76 53.2 Favored 'General case' 0 C--N 1.278 -2.503 0 N-CA-C 107.88 -1.155 . . . . 74.409999999999997 107.88 178.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -104.51 112.68 25.84 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.525 -0.917 . . . . 60.420000000000002 108.525 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 35.2 ttt180 -116.65 147.55 41.82 Favored 'General case' 0 C--N 1.275 -2.657 0 N-CA-C 108.331 -0.989 . . . . 74.030000000000001 108.331 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.401 ' CG2' ' HA ' ' A' ' 66' ' ' PRO . 6.7 tt -114.62 137.67 47.25 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.341 0 N-CA-C 108.436 -0.95 . . . . 74.310000000000002 108.436 177.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -118.31 147.48 43.42 Favored 'General case' 0 N--CA 1.419 -2.003 0 N-CA-C 105.942 -1.873 . . . . 74.209999999999994 105.942 177.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -42.48 -19.13 0.01 OUTLIER 'General case' 0 CA--C 1.559 1.326 0 N-CA-C 116.719 2.118 . . . . 73.219999999999999 116.719 -174.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -119.14 -29.1 1.86 Allowed Glycine 0 N--CA 1.43 -1.73 0 C-N-CA 120.751 -0.738 . . . . 60.009999999999998 113.527 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -161.24 177.57 10.08 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-N 118.089 0.944 . . . . 71.219999999999999 109.765 -174.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -103.47 138.67 39.87 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 113.596 0.962 . . . . 72.420000000000002 113.596 -173.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -112.93 116.82 30.59 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.273 -1.01 . . . . 62.439999999999998 108.273 178.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 59.3 t -119.4 119.52 60.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 108.752 -0.832 . . . . 75.349999999999994 108.752 -178.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.6 m -111.4 131.79 61.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-O 121.417 0.627 . . . . 71.540000000000006 111.276 -179.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -91.29 113.29 25.52 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.125 -0.943 . . . . 74.049999999999997 109.486 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 19.1 m -114.79 9.88 7.72 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 CA-C-O 121.463 0.649 . . . . 74.030000000000001 109.954 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -127.75 53.29 0.8 Allowed Glycine 0 N--CA 1.431 -1.641 0 N-CA-C 110.367 -1.093 . . . . 50.439999999999998 110.367 179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.4 m -61.42 -7.61 3.24 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 124.42 1.088 . . . . 75.349999999999994 113.059 -177.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 69.0 tp -58.15 -44.76 88.03 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 107.996 -1.112 . . . . 75.329999999999998 107.996 174.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.529 ' OD1' ' HA2' ' A' ' 131' ' ' GLY . 52.3 t-20 -98.9 -53.1 3.37 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 106.409 -1.7 . . . . 72.340000000000003 106.409 175.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 94.96 135.87 8.24 Favored Glycine 0 N--CA 1.432 -1.604 0 CA-C-N 115.037 -0.983 . . . . 62.509999999999998 112.716 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 26.9 m -91.94 123.65 35.47 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 108.211 -1.033 . . . . 71.319999999999993 108.211 173.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -102.29 133.87 46.49 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-O 120.994 0.426 . . . . 74.200000000000003 110.277 -177.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.6 p -105.23 115.74 47.67 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 N-CA-C 106.536 -1.653 . . . . 75.430000000000007 106.536 173.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 12.2 m120 64.73 -78.41 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 124.737 1.215 . . . . 74.25 110.767 -173.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 -140.18 -3.75 1.37 Allowed 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 123.703 0.801 . . . . 71.319999999999993 110.44 -176.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -118.03 130.21 24.87 Favored Pre-proline 0 C--N 1.325 -0.462 0 C-N-CA 120.688 -0.405 . . . . 75.439999999999998 111.711 -170.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -79.64 117.3 3.65 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.394 2.063 . . . . 74.340000000000003 111.104 177.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 36.9 mmt180 -118.76 153.84 33.78 Favored 'General case' 0 C--N 1.308 -1.238 0 O-C-N 121.762 -0.586 . . . . 75.019999999999996 109.868 -177.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -84.73 -25.39 28.36 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.71 0.767 . . . . 74.319999999999993 109.123 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -157.56 139.17 13.9 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 107.539 -1.282 . . . . 61.219999999999999 107.539 175.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -140.62 149.25 42.07 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-O 121.033 0.444 . . . . 73.430000000000007 110.973 178.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 41.1 t -104.52 105.04 17.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 105.294 -2.113 . . . . 72.219999999999999 105.294 175.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 65.7 mtp -103.25 151.35 22.77 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 113.488 0.921 . . . . 75.129999999999995 113.488 -171.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -113.96 153.33 29.49 Favored 'General case' 0 N--CA 1.418 -2.049 0 CA-C-N 113.813 -1.539 . . . . 74.150000000000006 108.269 -177.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.7 p -77.71 129.36 35.42 Favored 'General case' 0 N--CA 1.417 -2.093 0 CA-C-O 121.532 0.682 . . . . 64.129999999999995 111.646 -176.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 111.82 8.64 22.12 Favored Glycine 0 N--CA 1.442 -0.91 0 N-CA-C 110.539 -1.025 . . . . 52.210000000000001 110.539 -177.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -109.89 169.34 8.78 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-O 120.445 0.164 . . . . 73.25 110.989 -175.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.402 ' OE2' ' HD2' ' A' ' 134' ' ' ARG . 38.2 tt0 -108.73 139.97 42.8 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 113.299 0.851 . . . . 74.409999999999997 113.299 -172.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 58.4 mt -125.31 131.23 72.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 124.436 1.094 . . . . 74.209999999999994 109.704 -176.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -113.94 124.05 51.22 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 121.404 0.621 . . . . 73.239999999999995 110.069 173.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 27.7 mt -108.5 100.07 9.98 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 N-CA-C 107.311 -1.366 . . . . 75.430000000000007 107.311 -177.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.529 ' HA2' ' OD1' ' A' ' 108' ' ' ASN . . . 71.04 -100.6 0.87 Allowed Glycine 0 N--CA 1.425 -2.06 0 O-C-N 124.25 0.969 . . . . 72.140000000000001 110.788 -177.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -114.6 -9.81 12.59 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-O 121.16 0.505 . . . . 74.129999999999995 110.685 177.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -104.27 142.61 34.23 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 118.993 -1.083 . . . . 74.439999999999998 112.32 -171.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.402 ' HD2' ' OE2' ' A' ' 127' ' ' GLU . 11.9 ttp180 -106.79 128.78 54.53 Favored 'General case' 0 C--O 1.248 0.992 0 N-CA-C 113.792 1.034 . . . . 72.319999999999993 113.792 -167.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.428 HD12 ' HB2' ' A' ' 49' ' ' LEU . 38.8 tp -123.94 145.04 49.42 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 126.449 1.9 . . . . 62.509999999999998 109.551 -174.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.405 ' CG1' HG23 ' A' ' 50' ' ' VAL . 7.3 p -123.17 135.24 63.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 108.84 -0.8 . . . . 73.340000000000003 108.84 171.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -112.11 118.41 35.3 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.499 -0.926 . . . . 74.420000000000002 108.499 -174.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.495 ' O ' ' HB2' ' A' ' 47' ' ' ALA . 4.5 mp -120.88 164.42 16.69 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 120.891 0.377 . . . . 72.310000000000002 111.089 -175.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -75.25 145.74 41.68 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.298 -0.63 . . . . 55.100000000000001 109.298 177.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -103.7 -178.62 25.79 Favored Glycine 0 N--CA 1.429 -1.789 0 C-N-CA 120.608 -0.806 . . . . 64.439999999999998 111.638 -178.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -70.64 149.0 60.59 Favored 'Trans proline' 0 C--O 1.242 0.686 0 C-N-CA 122.628 2.219 . . . . 60.130000000000003 112.515 -179.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -82.2 113.54 20.1 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 106.258 -1.756 . . . . 74.209999999999994 106.258 173.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 . . . . . 0 C--N 1.289 -2.034 0 N-CA-C 109.595 -0.52 . . . . 74.439999999999998 109.595 -174.876 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 CA--C 1.509 -0.616 0 N-CA-C 109.069 -0.715 . . . . 75.329999999999998 109.069 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.8 m -82.1 -28.25 32.4 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 107.458 -1.312 . . . . 74.109999999999999 107.458 174.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -151.52 137.11 17.83 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 105.716 -1.957 . . . . 73.200000000000003 105.716 174.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -100.75 163.08 12.49 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 111.724 0.268 . . . . 70.0 111.724 -174.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 51.6 t30 54.41 84.1 0.07 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.823 1.249 . . . . 75.200000000000003 111.459 -178.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -108.48 175.63 19.69 Favored Glycine 0 N--CA 1.426 -1.992 0 N-CA-C 110.258 -1.137 . . . . 74.140000000000001 110.258 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.1 m -68.98 130.92 91.15 Favored Pre-proline 0 C--N 1.3 -1.578 0 N-CA-C 108.294 -1.002 . . . . 74.239999999999995 108.294 178.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.553 ' O ' ' HD3' ' A' ' 10' ' ' PRO . 10.7 Cg_endo -53.46 149.86 29.02 Favored 'Trans proline' 0 C--N 1.358 1.059 0 C-N-CA 123.22 2.614 . . . . 72.400000000000006 111.814 -179.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -85.74 105.11 6.29 Favored Pre-proline 0 N--CA 1.422 -1.831 0 N-CA-C 107.741 -1.207 . . . . 74.239999999999995 107.741 178.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.553 ' HD3' ' O ' ' A' ' 8' ' ' PRO . 86.8 Cg_endo -103.26 155.0 0.25 Allowed 'Trans proline' 0 N--CA 1.437 -1.823 0 C-N-CA 122.596 2.197 . . . . 74.450000000000003 112.981 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -80.73 72.47 7.69 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 122.452 1.12 . . . . 75.530000000000001 109.412 173.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.8 p -62.02 142.48 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 CA-C-N 113.454 -1.703 . . . . 75.209999999999994 109.998 -177.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.05 137.59 51.39 Favored 'General case' 0 N--CA 1.423 -1.779 0 C-N-CA 119.72 -0.792 . . . . 73.540000000000006 110.16 179.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.4 m -129.53 90.99 3.08 Favored 'General case' 0 C--N 1.274 -2.674 0 N-CA-C 107.495 -1.298 . . . . 72.219999999999999 107.495 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 94.3 m -69.28 97.0 0.9 Allowed 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 115.066 -0.97 . . . . 72.209999999999994 111.183 -177.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 25.3 t -136.51 112.9 9.94 Favored 'General case' 0 N--CA 1.419 -2.005 0 N-CA-C 105.741 -1.948 . . . . 71.230000000000004 105.741 178.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.7 m -102.76 -173.27 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 CA-C-N 116.051 -0.522 . . . . 75.010000000000005 111.22 -174.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -81.09 134.59 35.68 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 116.232 -0.44 . . . . 74.010000000000005 110.523 178.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -77.07 102.45 6.51 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.908 -0.587 . . . . 74.420000000000002 109.584 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.02 91.79 5.51 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.26 0.552 . . . . 74.030000000000001 110.781 -177.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -71.6 -36.85 70.95 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.02 -0.991 . . . . 73.25 110.667 -178.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.4 tt 76.61 120.52 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.469 1.107 . . . . 62.299999999999997 110.348 -178.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -70.99 127.7 33.47 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 107.521 -1.288 . . . . 73.25 107.521 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.6 167.06 4.7 Favored 'General case' 0 C--N 1.313 -0.998 0 O-C-N 124.023 0.827 . . . . 75.239999999999995 113.045 -176.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -72.89 -167.6 0.39 Allowed 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.03 -0.986 . . . . 72.510000000000005 112.761 -171.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 83.6 mtp -84.4 101.95 12.39 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.072 -1.084 . . . . 75.019999999999996 108.072 176.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -69.02 161.52 28.81 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.991 -0.744 . . . . 71.349999999999994 108.991 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.6 t -81.13 171.56 14.77 Favored 'General case' 0 N--CA 1.42 -1.939 0 N-CA-C 107.878 -1.156 . . . . 73.140000000000001 107.878 176.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 20.4 m -89.46 -165.09 1.26 Allowed 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.215 -1.032 . . . . 73.010000000000005 108.215 178.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 38.8 m -62.41 125.52 24.18 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 108.814 -0.81 . . . . 73.340000000000003 108.814 175.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.17 -104.24 0.28 Allowed Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 120.975 -0.631 . . . . 72.310000000000002 113.498 -175.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.0 t -91.07 150.54 21.37 Favored 'General case' 0 N--CA 1.428 -1.572 0 CA-C-O 121.306 0.574 . . . . 64.25 110.895 -176.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -90.4 113.06 56.2 Favored Pre-proline 0 N--CA 1.43 -1.435 0 N-CA-C 108.244 -1.021 . . . . 72.049999999999997 108.244 176.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -64.7 118.88 5.82 Favored 'Trans proline' 0 C--O 1.25 1.091 0 C-N-CA 122.703 2.269 . . . . 74.420000000000002 111.406 -179.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.95 122.75 23.94 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.526 -0.761 . . . . 62.219999999999999 111.652 -175.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.0 t -90.62 99.57 12.58 Favored 'General case' 0 N--CA 1.421 -1.906 0 N-CA-C 108.114 -1.069 . . . . 65.430000000000007 108.114 176.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.4 p -95.04 18.49 12.0 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 115.434 -0.803 . . . . 74.230000000000004 111.215 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.47 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . 99.31 95.92 2.09 Favored Glycine 0 N--CA 1.439 -1.144 0 C-N-CA 120.925 -0.655 . . . . 73.209999999999994 111.488 179.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.23 -27.22 67.8 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 122.498 0.319 . . . . 71.349999999999994 111.744 -176.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -83.12 -16.9 44.97 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.004 0.431 . . . . 74.219999999999999 110.933 179.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -83.32 -33.32 25.94 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 108.706 -0.849 . . . . 73.129999999999995 108.706 176.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 38' ' ' GLY . 89.0 mt -65.77 149.1 97.82 Favored Pre-proline 0 C--O 1.247 0.959 0 CA-C-N 115.23 -0.895 . . . . 75.530000000000001 109.249 176.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -61.99 156.78 47.4 Favored 'Trans proline' 0 C--O 1.25 1.087 0 C-N-CA 122.644 2.229 . . . . 74.150000000000006 112.447 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -78.73 102.88 8.31 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 115.683 -0.69 . . . . 61.119999999999997 109.863 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -166.45 46.15 0.26 Allowed Glycine 0 C--N 1.292 -1.872 0 N-CA-C 108.122 -1.991 . . . . 54.329999999999998 108.122 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.3 m -91.14 167.84 12.06 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 114.252 -0.974 . . . . 60.299999999999997 110.033 -176.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -102.19 166.84 10.37 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 109.907 -0.405 . . . . 72.530000000000001 109.907 -179.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -134.35 152.64 51.92 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.841 -0.8 . . . . 74.040000000000006 108.841 176.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.403 ' O ' HD12 ' A' ' 49' ' ' LEU . 4.4 pp -109.27 134.63 51.54 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 108.772 -0.825 . . . . 72.349999999999994 108.772 178.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 94.1 t -117.08 117.81 56.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 CA-C-N 116.032 -0.531 . . . . 75.25 109.604 -177.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.447 HG22 ' HB2' ' A' ' 57' ' ' ALA . 15.6 t -93.15 118.96 40.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 107.711 -1.218 . . . . 72.540000000000006 107.711 178.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -75.99 -42.35 48.49 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 115.664 -0.698 . . . . 64.340000000000003 109.156 -178.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 62.3 ttt180 -177.34 157.64 1.35 Allowed 'General case' 0 C--O 1.245 0.865 0 CA-C-N 115.047 -0.979 . . . . 72.120000000000005 108.921 -177.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 124.88 142.85 5.97 Favored Glycine 0 C--O 1.202 -1.866 0 CA-C-O 119.201 -0.777 . . . . 65.340000000000003 111.563 176.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.556 ' HD2' ' CE1' ' A' ' 133' ' ' PHE . 9.3 Cg_endo -51.62 -7.4 0.2 Allowed 'Trans proline' 0 N--CA 1.499 1.828 0 C-N-CA 124.963 3.775 . . . . 75.329999999999998 115.311 177.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.475 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -56.64 -51.59 68.14 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 108.225 -1.028 . . . . 74.430000000000007 108.225 175.079 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.447 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -179.5 -171.51 0.19 Allowed 'General case' 0 C--O 1.214 -0.783 0 N-CA-C 106.585 -1.635 . . . . 71.540000000000006 106.585 -178.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -166.96 56.4 0.23 Allowed Glycine 0 C--N 1.291 -1.932 0 N-CA-C 110.416 -1.073 . . . . 75.510000000000005 110.416 -177.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -163.04 -171.01 2.5 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.595 -1.261 . . . . 74.400000000000006 107.595 -178.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 18.4 ptp180 -136.66 138.26 40.92 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.618 -0.882 . . . . 74.319999999999993 108.618 178.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -142.0 148.23 38.22 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 120.128 -0.629 . . . . 73.349999999999994 111.686 176.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.1 tt -84.06 133.97 34.63 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 113.943 -1.481 . . . . 73.230000000000004 107.519 -177.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.5 mp -87.51 112.92 22.73 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 108.501 -0.926 . . . . 73.319999999999993 108.501 178.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -125.12 18.02 8.4 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 122.42 1.105 . . . . 71.439999999999998 108.136 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -119.2 149.31 46.96 Favored Pre-proline 0 C--N 1.296 -1.717 0 CA-C-N 113.874 -1.512 . . . . 74.409999999999997 108.257 -176.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -63.68 -35.23 59.44 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 122.409 2.073 . . . . 75.310000000000002 112.582 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' A' ' 92' ' ' PHE . 44.1 m -137.53 123.06 19.68 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 116.516 -0.311 . . . . 71.420000000000002 111.133 179.127 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.446 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 31.3 m -98.12 116.89 31.27 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 106.566 -1.642 . . . . 72.219999999999999 106.566 171.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.491 ' HB ' ' NE2' ' A' ' 73' ' ' HIS . 0.1 OUTLIER -104.86 102.6 12.13 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-O 121.23 0.538 . . . . 74.230000000000004 112.102 -174.37 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -105.87 117.74 34.8 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.088 0.47 . . . . 70.25 110.173 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 172.41 -163.75 35.93 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.949 -1.26 . . . . 74.120000000000005 109.949 -179.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.7 ptp180 -110.96 21.45 16.44 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 122.045 0.926 . . . . 70.349999999999994 109.561 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.491 ' NE2' ' HB ' ' A' ' 69' ' ' THR . 12.1 p-80 -84.95 163.67 45.06 Favored Pre-proline 0 C--N 1.299 -1.599 0 CA-C-N 114.672 -1.149 . . . . 72.310000000000002 109.799 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -51.01 -40.42 58.89 Favored 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 123.602 2.868 . . . . 72.120000000000005 115.693 -174.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -97.13 30.21 2.85 Favored 'General case' 0 C--N 1.318 -0.801 0 O-C-N 121.515 -0.741 . . . . 73.209999999999994 112.873 -176.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.0 p -56.91 116.9 3.47 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.268 -0.424 . . . . 75.540000000000006 111.208 178.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -67.23 -49.79 63.14 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 106.301 -1.741 . . . . 74.310000000000002 106.301 173.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 30.4 pt -134.28 138.26 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 CA-C-N 113.606 -1.634 . . . . 74.239999999999995 107.236 174.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -104.09 117.54 34.51 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 108.676 -0.861 . . . . 62.25 108.676 177.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 2.1 pt? -75.38 111.58 10.81 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.369 -0.975 . . . . 61.109999999999999 108.369 177.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -85.59 73.6 10.43 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 118.954 -1.099 . . . . 74.099999999999994 112.752 -173.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -119.85 150.8 39.87 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 115.031 -0.986 . . . . 73.519999999999996 108.901 170.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.0 p -73.38 -20.17 18.36 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 C-N-CA 122.921 0.488 . . . . 74.430000000000007 112.281 -176.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.449 ' HB ' ' ND2' ' A' ' 108' ' ' ASN . 1.3 m -89.53 6.68 39.95 Favored 'General case' 0 CA--C 1.557 1.25 0 CA-C-O 121.057 0.455 . . . . 74.409999999999997 111.943 -172.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.4 t -82.27 137.16 21.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 109.409 -0.589 . . . . 62.409999999999997 109.409 -178.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 15.3 p -86.01 -71.1 0.56 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.989 0.423 . . . . 62.109999999999999 112.104 -178.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 21.2 tpp180 -150.19 -66.96 0.2 Allowed 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 106.953 -1.499 . . . . 74.340000000000003 106.953 -178.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.47 ' HA ' ' HD1' ' A' ' 73' ' ' HIS . 48.0 mtt180 -96.56 167.81 10.92 Favored 'General case' 0 CA--C 1.486 -1.516 0 N-CA-C 106.228 -1.768 . . . . 71.400000000000006 106.228 171.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -151.49 -70.72 0.17 Allowed 'General case' 0 C--N 1.292 -1.934 0 C-N-CA 118.921 -1.112 . . . . 73.129999999999995 109.753 -177.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -133.45 104.05 6.23 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-O 121.155 0.502 . . . . 73.140000000000001 109.908 -178.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.415 ' OE1' ' HD3' ' A' ' 88' ' ' ARG . 3.0 mp0 -104.01 132.24 50.45 Favored 'General case' 0 N--CA 1.419 -1.983 0 C-N-CA 119.738 -0.785 . . . . 73.219999999999999 109.961 176.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.446 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 29.9 m-85 -97.1 112.22 24.1 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 105.287 -2.116 . . . . 73.340000000000003 105.287 175.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 72.8 mtt180 -118.3 115.31 24.46 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 106.63 -1.619 . . . . 74.5 106.63 -175.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.9 pp -115.48 143.03 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.927 0 C-N-CA 119.58 -0.848 . . . . 74.239999999999995 111.734 -172.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -117.71 146.77 43.52 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 105.219 -2.141 . . . . 64.209999999999994 105.219 175.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -49.01 -32.97 10.19 Favored 'General case' 0 C--N 1.315 -0.912 0 O-C-N 123.575 0.547 . . . . 71.510000000000005 112.453 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -85.35 -48.27 4.86 Favored Glycine 0 N--CA 1.433 -1.538 0 C-N-CA 120.733 -0.746 . . . . 64.439999999999998 112.749 179.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -133.2 131.55 40.5 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-O 121.682 0.753 . . . . 75.140000000000001 112.581 -177.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -99.74 124.55 45.12 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.209 -1.034 . . . . 72.219999999999999 108.209 -178.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -129.19 136.54 50.28 Favored 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 113.829 1.048 . . . . 64.530000000000001 113.829 -176.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.2 p -110.84 118.9 58.36 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 CA-C-N 114.73 -1.123 . . . . 65.120000000000005 108.884 175.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.8 m -120.37 120.8 63.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 N-CA-C 113.166 0.802 . . . . 71.340000000000003 113.166 -177.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.422 ' HB3' ' HB2' ' A' ' 118' ' ' ASN . 4.6 t70 -84.76 122.7 29.49 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 109.164 -0.68 . . . . 63.420000000000002 109.164 169.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 26.8 m -114.53 -1.12 9.48 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 CA-C-N 115.625 -0.716 . . . . 62.140000000000001 109.47 177.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.433 ' C ' ' H ' ' A' ' 107' ' ' LEU . . . -112.85 59.95 0.36 Allowed Glycine 0 N--CA 1.434 -1.486 0 N-CA-C 110.619 -0.993 . . . . 65.430000000000007 110.619 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 19.1 m -72.41 19.25 0.08 Allowed 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 123.671 0.788 . . . . 71.219999999999999 112.913 -175.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.433 ' H ' ' C ' ' A' ' 105' ' ' GLY . 6.2 mp -75.58 -33.61 60.6 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 109.58 -0.526 . . . . 75.219999999999999 109.58 178.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.449 ' ND2' ' HB ' ' A' ' 84' ' ' THR . 10.0 m120 -80.25 -24.27 40.25 Favored 'General case' 0 CA--C 1.5 -0.962 0 CA-C-N 116.15 -0.477 . . . . 71.030000000000001 110.54 176.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 86.59 82.58 1.15 Allowed Glycine 0 N--CA 1.428 -1.889 0 N-CA-C 109.956 -1.258 . . . . 71.120000000000005 109.956 -177.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 64.7 m -87.18 119.51 27.49 Favored 'General case' 0 N--CA 1.42 -1.938 0 CA-C-O 121.305 0.574 . . . . 70.540000000000006 109.803 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -116.66 134.07 55.26 Favored 'General case' 0 N--CA 1.425 -1.688 0 N-CA-C 107.54 -1.282 . . . . 73.120000000000005 107.54 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.443 HG11 ' O ' ' A' ' 117' ' ' ARG . 7.4 p -117.68 132.23 68.09 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.713 0 N-CA-C 107.264 -1.384 . . . . 72.430000000000007 107.264 175.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 64.93 26.33 12.79 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 107.837 -1.171 . . . . 64.439999999999998 107.837 -175.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.429 ' HG2' ' OE1' ' A' ' 129' ' ' GLN . 16.9 mtt-85 70.27 7.48 6.24 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 126.638 1.975 . . . . 73.310000000000002 111.698 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -106.69 144.62 29.42 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 109.831 -0.433 . . . . 74.299999999999997 109.831 -176.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -68.11 91.74 0.38 Allowed 'Trans proline' 0 C--N 1.356 0.93 0 C-N-CA 122.223 1.949 . . . . 72.340000000000003 112.402 176.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.443 ' O ' HG11 ' A' ' 112' ' ' VAL . 5.2 ptt180 -154.61 116.55 4.19 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 125.034 1.333 . . . . 73.450000000000003 108.881 174.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.422 ' HB2' ' HB3' ' A' ' 103' ' ' ASP . 23.5 p-10 -83.74 -30.99 26.24 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 114.888 -1.051 . . . . 72.349999999999994 113.125 -174.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -105.53 138.26 42.01 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.675 -0.81 . . . . 71.409999999999997 110.929 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -140.46 149.36 42.46 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 113.394 0.887 . . . . 71.030000000000001 113.394 178.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.7 p -91.34 135.76 26.09 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 N-CA-C 106.67 -1.604 . . . . 75.400000000000006 106.67 173.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 23.2 ttt -39.45 102.52 0.02 OUTLIER 'General case' 0 C--O 1.247 0.954 0 N-CA-C 114.001 1.111 . . . . 74.439999999999998 114.001 178.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -123.23 123.39 40.66 Favored 'General case' 0 N--CA 1.424 -1.77 0 N-CA-C 105.605 -1.998 . . . . 74.209999999999994 105.605 173.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 7.3 t -81.92 129.06 34.65 Favored 'General case' 0 C--N 1.291 -1.959 0 C-N-CA 120.565 -0.454 . . . . 74.430000000000007 110.363 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 100.36 18.54 21.19 Favored Glycine 0 N--CA 1.433 -1.532 0 CA-C-N 115.55 -0.75 . . . . 64.420000000000002 112.18 177.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -110.77 150.05 29.64 Favored 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 119.581 -0.848 . . . . 72.049999999999997 109.501 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -110.48 132.26 54.34 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.558 0.694 . . . . 74.430000000000007 112.519 -174.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 66.2 mt -108.42 118.43 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.591 0 CA-C-N 114.68 -1.146 . . . . 75.120000000000005 107.991 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.429 ' OE1' ' HG2' ' A' ' 114' ' ' ARG . 54.6 mt-30 -109.54 112.61 24.81 Favored 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 109.221 -0.659 . . . . 74.400000000000006 109.221 178.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.432 ' O ' HG13 ' A' ' 130' ' ' ILE . 23.4 pt -95.09 96.94 6.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 108.771 -0.825 . . . . 75.549999999999997 108.771 177.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 61.67 -85.31 0.03 OUTLIER Glycine 0 CA--C 1.528 0.853 0 CA-C-N 115.35 -0.841 . . . . 54.420000000000002 112.897 -176.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.486 ' HE3' ' CZ ' ' A' ' 133' ' ' PHE . 48.2 mtmt -113.66 -13.38 12.71 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 123.175 0.59 . . . . 74.400000000000006 111.237 -175.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.556 ' CE1' ' HD2' ' A' ' 55' ' ' PRO . 19.3 m-85 -107.3 154.07 21.81 Favored 'General case' 0 CA--C 1.501 -0.923 0 C-N-CA 119.748 -0.781 . . . . 74.219999999999999 112.227 -169.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 74.2 mtp180 -119.27 122.57 42.21 Favored 'General case' 0 C--O 1.248 0.987 0 CA-C-O 121.603 0.716 . . . . 64.329999999999998 112.623 -172.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 56.9 tp -123.95 131.21 53.54 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 114.466 -1.243 . . . . 74.209999999999994 107.841 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.7 t -115.58 138.76 44.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 N-CA-C 108.17 -1.048 . . . . 74.109999999999999 108.17 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -111.13 117.0 32.06 Favored 'General case' 0 C--N 1.309 -1.152 0 N-CA-C 109.302 -0.629 . . . . 74.530000000000001 109.302 -176.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -123.69 158.99 30.33 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.861 -0.422 . . . . 70.519999999999996 109.861 -177.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -79.91 140.67 36.62 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.049 -1.463 . . . . 64.340000000000003 107.049 172.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -97.96 -143.2 14.39 Favored Glycine 0 C--N 1.292 -1.861 0 C-N-CA 120.329 -0.939 . . . . 52.149999999999999 112.232 -176.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -64.91 120.43 7.67 Favored 'Trans proline' 0 N--CA 1.44 -1.668 0 C-N-CA 122.259 1.973 . . . . 73.010000000000005 113.662 -177.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -104.27 103.89 13.71 Favored 'General case' 0 C--N 1.279 -2.484 0 N-CA-C 106.744 -1.576 . . . . 55.130000000000003 106.744 175.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 . . . . . 0 C--N 1.291 -1.946 0 N-CA-C 108.109 -1.071 . . . . 70.25 108.109 -176.51 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.0 mtt . . . . . 0 N--CA 1.474 0.772 0 N-CA-C 109.572 -0.529 . . . . 71.420000000000002 109.572 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.6 p -77.02 -27.33 54.53 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 107.675 -1.231 . . . . 74.319999999999993 107.675 173.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -88.03 144.8 26.32 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 106.613 -1.625 . . . . 73.109999999999999 106.613 172.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -168.12 172.18 8.92 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.52 -0.918 . . . . 74.540000000000006 108.52 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -134.67 66.36 1.54 Allowed 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.848 -1.167 . . . . 74.530000000000001 107.848 173.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -94.05 76.62 1.03 Allowed Glycine 0 N--CA 1.426 -1.969 0 CA-C-N 113.987 -1.46 . . . . 71.120000000000005 110.863 -178.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.3 p -77.25 123.88 87.07 Favored Pre-proline 0 C--N 1.291 -1.978 0 CA-C-N 115.332 -0.434 . . . . 73.310000000000002 110.396 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -65.6 146.35 84.28 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 121.617 1.545 . . . . 75.530000000000001 110.384 177.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -68.6 122.57 85.18 Favored Pre-proline 0 C--N 1.302 -1.494 0 N-CA-C 109.733 -0.469 . . . . 72.519999999999996 109.733 -174.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -50.23 159.27 1.98 Allowed 'Trans proline' 0 C--N 1.37 1.686 0 C-N-CA 124.281 3.321 . . . . 73.400000000000006 112.624 -178.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 53.3 tp60 -51.14 107.0 0.15 Allowed 'General case' 0 C--O 1.242 0.7 0 C-N-CA 123.666 0.786 . . . . 73.219999999999999 112.418 -174.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.4 p -84.57 146.73 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 107.539 -1.282 . . . . 72.400000000000006 107.539 175.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -104.76 121.48 43.71 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 107.414 -1.328 . . . . 73.319999999999993 107.414 -178.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.4 m -132.94 120.33 21.3 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.96 -0.755 . . . . 52.210000000000001 108.96 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.9 t -115.08 133.01 56.41 Favored 'General case' 0 N--CA 1.412 -2.355 0 CA-C-O 121.666 0.746 . . . . 74.319999999999993 109.562 -177.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 21.0 m -92.88 127.81 38.52 Favored 'General case' 0 C--N 1.283 -2.321 0 N-CA-C 108.169 -1.049 . . . . 75.239999999999995 108.169 178.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.5 m -116.85 167.28 10.12 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.329 0 N-CA-C 108.496 -0.928 . . . . 74.109999999999999 108.496 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -81.21 116.2 20.98 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 109.305 -0.628 . . . . 72.019999999999996 109.305 177.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -56.47 112.08 1.16 Allowed 'General case' 0 C--O 1.241 0.626 0 CA-C-O 121.658 0.742 . . . . 74.239999999999995 112.094 177.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -117.96 63.67 0.75 Allowed 'General case' 0 N--CA 1.418 -2.055 0 CA-C-O 121.975 0.893 . . . . 64.450000000000003 109.381 178.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -80.96 -30.9 35.08 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 114.009 -1.451 . . . . 75.209999999999994 109.348 176.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . 0.293 0.9 OUTLIER 47.41 78.63 0.07 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.468 1.507 . . . . 74.409999999999997 112.981 -176.473 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.4 pp -104.11 158.53 16.37 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.18 -0.918 . . . . 75.010000000000005 111.371 -178.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 6.6 mtpm? -112.7 121.17 43.96 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.746 -0.835 . . . . 73.340000000000003 108.746 -178.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -91.13 155.3 18.73 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.295 -0.631 . . . . 72.040000000000006 109.295 -178.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.62 159.97 16.89 Favored 'General case' 0 C--O 1.25 1.122 0 CA-C-O 120.669 0.271 . . . . 72.230000000000004 110.754 -176.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -163.25 157.02 19.79 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 107.032 -1.47 . . . . 73.140000000000001 107.032 -177.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.8 m -78.7 -45.47 21.22 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 119.907 -0.717 . . . . 72.239999999999995 110.03 177.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 44.8 m -82.37 75.58 9.28 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-O 121.381 0.61 . . . . 73.400000000000006 111.362 178.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.1 t 178.93 170.06 0.89 Allowed 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 106.106 -1.813 . . . . 74.519999999999996 106.106 176.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.39 104.51 2.82 Favored Glycine 0 N--CA 1.43 -1.763 0 N-CA-C 110.268 -1.133 . . . . 74.439999999999998 110.268 -176.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 8.9 t -88.04 138.55 31.35 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.443 0.64 . . . . 73.239999999999995 111.106 -177.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -90.7 145.18 31.62 Favored Pre-proline 0 C--N 1.3 -1.572 0 N-CA-C 107.958 -1.127 . . . . 73.230000000000004 107.958 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -63.93 103.04 0.39 Allowed 'Trans proline' 0 C--O 1.246 0.884 0 C-N-CA 121.829 1.686 . . . . 74.239999999999995 111.098 178.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -92.81 98.98 11.74 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 115.001 -1.0 . . . . 74.409999999999997 108.842 -178.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.3 m 75.26 -12.99 0.9 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.179 1.392 . . . . 75.540000000000006 112.463 -178.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 52.2 m -70.99 114.45 9.06 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-O 121.595 0.712 . . . . 71.319999999999993 109.119 175.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 106.73 -32.73 7.0 Favored Glycine 0 N--CA 1.421 -2.325 0 N-CA-C 109.01 -1.636 . . . . 71.439999999999998 109.01 -175.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.96 -25.93 56.35 Favored 'General case' 0 CA--C 1.499 -1.016 0 CA-C-N 115.028 -0.586 . . . . 73.420000000000002 110.12 -175.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.04 -37.22 85.31 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 115.333 -0.849 . . . . 72.140000000000001 109.982 -178.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -77.11 -25.09 51.77 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.749 -0.66 . . . . 75.310000000000002 110.542 177.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.9 tm? 64.01 88.53 0.11 Allowed Pre-proline 0 C--O 1.24 0.553 0 N-CA-C 104.097 -2.557 . . . . 63.409999999999997 104.097 -166.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -88.62 160.21 6.43 Favored 'Trans proline' 0 N--CA 1.432 -2.121 0 C-N-CA 122.436 2.091 . . . . 73.109999999999999 114.726 -164.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -84.11 93.47 8.13 Favored 'General case' 0 N--CA 1.407 -2.615 0 N-CA-C 103.483 -2.784 . . . . 64.209999999999994 103.483 167.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -139.74 77.05 0.32 Allowed Glycine 0 N--CA 1.413 -2.86 0 CA-C-N 115.313 -0.858 . . . . 73.439999999999998 111.572 -173.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 42.6 m -90.85 166.69 12.94 Favored 'General case' 0 N--CA 1.407 -2.598 0 N-CA-C 107.975 -1.12 . . . . 74.109999999999999 107.975 177.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -91.59 154.38 19.1 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 109.763 -0.458 . . . . 64.319999999999993 109.763 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -131.31 148.51 52.69 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.721 -0.844 . . . . 74.439999999999998 108.721 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.436 ' HB2' HD22 ' A' ' 135' ' ' LEU . 4.4 pp -112.66 138.59 49.23 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 109.511 -0.552 . . . . 71.109999999999999 109.511 178.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 38.7 t -114.54 120.0 63.04 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 108.087 -1.079 . . . . 63.140000000000001 108.087 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 26.3 t -93.2 115.6 32.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 107.523 -1.288 . . . . 74.430000000000007 107.523 178.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -85.38 -40.16 16.79 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.117 -0.947 . . . . 63.310000000000002 109.991 -176.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 36.9 mmt180 -144.32 153.67 42.24 Favored 'General case' 0 CA--C 1.495 -1.17 0 CA-C-N 115.589 -0.732 . . . . 75.120000000000005 110.185 -177.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 131.89 140.23 4.49 Favored Glycine 0 N--CA 1.426 -2.022 0 O-C-N 124.185 0.928 . . . . 65.319999999999993 111.57 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.422 ' HB2' ' O ' ' A' ' 81' ' ' ASP . 14.1 Cg_exo -69.08 -14.95 39.2 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 122.533 2.156 . . . . 74.530000000000001 111.508 175.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.55 ' HA ' ' H ' ' A' ' 81' ' ' ASP . 4.7 p-10 -61.72 -48.77 79.24 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.417 1.087 . . . . 73.450000000000003 111.162 178.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -166.89 171.09 11.6 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.756 -0.831 . . . . 63.210000000000001 108.756 -176.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -155.05 30.28 0.65 Allowed Glycine 0 C--N 1.303 -1.287 0 N-CA-C 110.042 -1.223 . . . . 72.409999999999997 110.042 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -132.78 -168.51 2.08 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 109.261 -0.644 . . . . 73.420000000000002 109.261 -177.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -135.02 137.18 42.71 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 109.187 -0.671 . . . . 75.030000000000001 109.187 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.426 ' CE2' HD11 ' A' ' 49' ' ' LEU . 53.0 p90 -135.28 148.42 49.53 Favored 'General case' 0 C--N 1.293 -1.885 0 C-N-CA 120.044 -0.662 . . . . 73.219999999999999 110.579 178.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 36.2 tp -86.69 122.83 31.15 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 124.241 0.963 . . . . 74.430000000000007 108.459 -178.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.4 mp -83.99 114.56 21.8 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.103 0.478 . . . . 73.049999999999997 111.408 -176.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -129.49 7.03 5.28 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.11 -0.95 . . . . 75.109999999999999 108.576 172.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.523 ' OE1' ' HA ' ' A' ' 68' ' ' THR . 8.4 tt0 -88.87 123.52 67.42 Favored Pre-proline 0 N--CA 1.421 -1.888 0 CA-C-N 114.377 -1.283 . . . . 73.299999999999997 107.952 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -51.54 -44.93 40.81 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 123.437 2.758 . . . . 74.439999999999998 112.049 -177.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 91.2 m -136.15 99.38 4.11 Favored 'General case' 0 N--CA 1.425 -1.681 0 N-CA-C 109.026 -0.731 . . . . 72.219999999999999 109.026 174.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.523 ' HA ' ' OE1' ' A' ' 65' ' ' GLN . 16.9 m -77.7 116.45 18.25 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 107.196 -1.409 . . . . 64.040000000000006 107.196 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.492 HG22 ' CE1' ' A' ' 73' ' ' HIS . 2.3 m -92.81 92.54 7.98 Favored 'General case' 0 N--CA 1.419 -1.987 0 CA-C-O 121.152 0.501 . . . . 72.120000000000005 110.435 -171.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.94 131.87 44.01 Favored 'General case' 0 C--O 1.246 0.893 0 CA-C-N 115.723 -0.671 . . . . 73.310000000000002 111.007 -178.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 155.75 -137.66 5.66 Favored Glycine 0 CA--C 1.472 -2.635 0 N-CA-C 107.442 -2.263 . . . . 71.040000000000006 107.442 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -103.51 -83.33 0.49 Allowed 'General case' 0 N--CA 1.418 -2.074 0 N-CA-C 107.538 -1.282 . . . . 74.420000000000002 107.538 170.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.492 ' CE1' HG22 ' A' ' 69' ' ' THR . 31.6 m80 67.03 161.32 0.14 Allowed Pre-proline 0 N--CA 1.475 0.824 0 C-N-CA 123.994 0.918 . . . . 61.109999999999999 110.86 178.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -67.34 -22.01 46.55 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 121.903 1.736 . . . . 73.430000000000007 110.098 167.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -120.82 78.34 1.38 Allowed 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 108.519 -0.919 . . . . 74.140000000000001 108.519 -177.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.0 m -79.9 109.88 14.74 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-N 115.834 -0.621 . . . . 63.420000000000002 109.464 178.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.468 ' CG ' HE22 ' A' ' 65' ' ' GLN . 35.3 t70 -69.76 -43.11 72.91 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 106.936 -1.505 . . . . 44.350000000000001 106.936 173.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.86 147.17 23.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 N-CA-C 104.753 -2.314 . . . . 74.340000000000003 104.753 170.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -116.83 127.48 54.35 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-O 122.009 0.909 . . . . 74.239999999999995 112.347 -173.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.521 ' HA ' ' CB ' ' A' ' 56' ' ' ASN . 8.7 mp -84.8 102.35 12.98 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 115.163 -0.926 . . . . 74.239999999999995 108.932 174.147 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.55 ' H ' ' HA ' ' A' ' 56' ' ' ASN . 37.1 t70 -80.64 64.79 5.55 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 122.836 1.303 . . . . 74.109999999999999 110.975 -178.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -131.91 146.28 52.01 Favored 'General case' 0 C--N 1.283 -2.307 0 CA-C-N 113.89 -1.504 . . . . 62.340000000000003 108.436 175.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 28.3 m -81.92 2.06 3.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 113.729 1.011 . . . . 74.420000000000002 113.729 -174.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.72 12.55 25.67 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 121.816 0.817 . . . . 74.219999999999999 109.298 -179.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 98.8 t -83.08 132.01 32.38 Favored 'Isoleucine or valine' 0 C--O 1.244 0.789 0 CA-C-N 115.28 -0.873 . . . . 74.230000000000004 111.844 -177.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 7.6 m -103.73 165.42 11.05 Favored 'General case' 0 C--O 1.25 1.121 0 CA-C-N 115.1 -0.955 . . . . 65.450000000000003 110.252 -177.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.427 ' O ' ' HD2' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -74.13 132.69 42.5 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 107.405 -1.331 . . . . 75.099999999999994 107.405 169.11 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.42 ' O ' HG22 ' A' ' 104' ' ' VAL . 9.2 mmm180 61.72 83.54 0.15 Allowed 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 106.412 -1.699 . . . . 73.140000000000001 106.412 -168.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 12.5 t60 -104.87 -73.58 0.67 Allowed 'General case' 0 N--CA 1.428 -1.557 0 CA-C-N 115.366 -0.834 . . . . 73.420000000000002 110.149 -174.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -121.71 108.87 14.04 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.633 -0.877 . . . . 74.340000000000003 108.633 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -99.72 126.1 45.71 Favored 'General case' 0 C--N 1.28 -2.42 0 C-N-CA 119.373 -0.931 . . . . 74.150000000000006 109.678 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.461 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 58.5 m-85 -107.12 112.62 25.62 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 105.955 -1.868 . . . . 75.030000000000001 105.955 176.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.421 ' NH1' HG22 ' A' ' 102' ' ' VAL . 99.2 mtt180 -112.7 133.05 54.91 Favored 'General case' 0 C--N 1.277 -2.547 0 N-CA-C 109.035 -0.728 . . . . 75.030000000000001 109.035 -174.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 18.9 pt -116.76 138.14 48.35 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.429 0 C-N-CA 119.332 -0.947 . . . . 64.420000000000002 108.842 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -121.28 146.33 46.94 Favored 'General case' 0 C--N 1.266 -3.046 0 N-CA-C 106.207 -1.775 . . . . 74.230000000000004 106.207 174.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -60.08 -17.19 37.82 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.202 0.525 . . . . 73.040000000000006 112.288 177.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -91.31 -36.73 6.47 Favored Glycine 0 N--CA 1.439 -1.155 0 C-N-CA 121.415 -0.421 . . . . 61.299999999999997 113.081 178.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -169.18 161.69 10.36 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 109.46 -0.57 . . . . 75.0 109.46 -178.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.418 ' HB2' ' HB2' ' A' ' 122' ' ' MET . 59.2 m-85 -97.05 139.16 33.47 Favored 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 122.919 0.488 . . . . 64.439999999999998 110.997 -177.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -125.35 135.34 52.34 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 123.157 0.583 . . . . 75.040000000000006 111.148 -176.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.9 p -115.02 125.4 72.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 121.972 -0.455 . . . . 75.150000000000006 110.485 177.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.421 HG22 ' NH1' ' A' ' 93' ' ' ARG . 96.0 t -119.33 125.46 74.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-O 121.041 0.448 . . . . 75.409999999999997 111.2 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -104.99 122.14 45.24 Favored 'General case' 0 CA--C 1.489 -1.372 0 CA-C-N 115.907 -0.588 . . . . 72.239999999999995 110.624 176.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.42 HG22 ' O ' ' A' ' 88' ' ' ARG . 0.9 OUTLIER -131.51 11.08 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.433 0 CA-C-N 114.976 -1.011 . . . . 72.25 109.675 173.165 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -110.22 44.94 1.4 Allowed Glycine 0 N--CA 1.438 -1.197 0 N-CA-C 109.23 -1.548 . . . . 74.439999999999998 109.23 178.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.4 m -67.58 -3.29 8.41 Favored 'General case' 0 C--N 1.31 -1.109 0 C-N-CA 124.92 1.288 . . . . 74.409999999999997 112.498 -175.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 33.7 tp -68.21 -40.26 82.17 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 107.798 -1.186 . . . . 72.219999999999999 107.798 174.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -89.59 -40.97 12.26 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 107.835 -1.172 . . . . 71.209999999999994 107.835 175.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 96.36 92.96 1.81 Allowed Glycine 0 N--CA 1.44 -1.086 0 CA-C-N 115.347 -0.842 . . . . 54.509999999999998 113.377 176.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 24.2 m -88.87 119.56 29.48 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.259 -1.015 . . . . 64.010000000000005 108.259 175.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.449 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 41.9 m-85 -112.6 134.83 53.93 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 108.008 -1.108 . . . . 75.219999999999999 108.008 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.3 p -109.03 136.27 45.42 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.444 0 N-CA-C 107.848 -1.167 . . . . 75.310000000000002 107.848 179.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.601 ' O ' ' HD2' ' A' ' 114' ' ' ARG . 20.5 m120 70.64 -81.46 0.03 OUTLIER 'General case' 0 CA--C 1.501 -0.904 0 N-CA-C 107.429 -1.323 . . . . 74.120000000000005 107.429 -172.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.601 ' HD2' ' O ' ' A' ' 113' ' ' ASN . 26.4 mmm180 -154.97 12.8 0.38 Allowed 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 107.648 -1.241 . . . . 75.239999999999995 107.648 173.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -123.64 146.07 49.1 Favored Pre-proline 0 N--CA 1.464 0.274 0 N-CA-C 113.089 0.774 . . . . 73.329999999999998 113.089 -168.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -77.5 119.29 4.84 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.658 2.239 . . . . 71.299999999999997 109.809 175.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 14.8 mmm180 -136.1 148.29 48.2 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 109.391 -0.596 . . . . 75.439999999999998 109.391 -177.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -86.87 -40.54 14.79 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.534 -0.913 . . . . 74.219999999999999 108.534 173.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -142.58 137.38 30.05 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 107.663 -1.236 . . . . 72.109999999999999 107.663 172.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 24.0 tm0? -142.43 147.01 35.45 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.261 -1.014 . . . . 75.430000000000007 108.261 177.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.5 p -84.63 112.83 22.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-O 121.071 0.462 . . . . 63.350000000000001 109.758 177.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.418 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 64.2 mtt -54.22 142.16 26.98 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.873 1.064 . . . . 74.129999999999995 113.873 -171.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -122.13 135.38 54.79 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 115.209 -0.905 . . . . 75.420000000000002 109.068 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 6.7 t -79.89 132.53 36.1 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.855 -0.611 . . . . 54.240000000000002 111.538 -178.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 95.46 16.7 39.04 Favored Glycine 0 CA--C 1.488 -1.607 0 CA-C-N 115.685 -0.689 . . . . 73.040000000000006 111.855 176.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -124.92 -170.99 2.26 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.892 -0.781 . . . . 50.5 108.892 -177.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -133.59 150.83 51.62 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 113.641 0.978 . . . . 74.219999999999999 113.641 -172.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 67.5 mt -113.13 126.98 70.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 107.818 -1.178 . . . . 61.210000000000001 107.818 176.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.449 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 14.5 tp60 -102.11 111.94 24.41 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 107.306 -1.368 . . . . 72.510000000000005 107.306 -178.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.401 HG13 ' HB2' ' A' ' 133' ' ' PHE . 14.7 pt -102.35 98.46 6.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 CA-C-O 121.344 0.593 . . . . 71.219999999999999 109.784 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 66.11 -89.74 0.13 Allowed Glycine 0 N--CA 1.438 -1.205 0 CA-C-N 115.208 -0.906 . . . . 60.100000000000001 111.793 -176.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -126.33 -1.04 6.97 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 122.846 0.458 . . . . 73.120000000000005 110.123 -178.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.401 ' HB2' HG13 ' A' ' 130' ' ' ILE . 11.5 m-85 -108.85 156.33 19.78 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.44 -0.948 . . . . 75.439999999999998 108.44 -174.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -124.78 136.0 53.45 Favored 'General case' 0 C--O 1.249 1.05 0 CA-C-O 121.81 0.814 . . . . 74.420000000000002 112.642 -174.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.436 HD22 ' HB2' ' A' ' 49' ' ' LEU . 5.0 tt -124.2 139.82 53.55 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 114.086 -1.415 . . . . 75.129999999999995 107.603 -178.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 9.4 p -113.11 139.25 39.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 109.386 -0.598 . . . . 63.299999999999997 109.386 178.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -116.05 121.37 42.0 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 120.587 0.232 . . . . 73.439999999999998 111.011 -174.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -128.81 143.13 50.83 Favored 'General case' 0 C--O 1.217 -0.643 0 CA-C-O 120.856 0.36 . . . . 74.540000000000006 111.209 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -103.41 44.17 1.03 Allowed 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 105.744 -1.947 . . . . 72.129999999999995 105.744 172.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -60.08 -64.97 3.7 Favored Glycine 0 C--N 1.31 -0.881 0 CA-C-N 112.532 -2.122 . . . . 70.549999999999997 117.691 -168.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -76.76 120.96 5.69 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 CA-C-N 119.9 1.85 . . . . 70.400000000000006 114.116 -171.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -110.68 103.52 12.09 Favored 'General case' 0 C--N 1.286 -2.196 0 N-CA-C 107.955 -1.128 . . . . 70.219999999999999 107.955 174.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 . . . . . 0 N--CA 1.404 -2.729 0 CA-C-O 119.191 -0.433 . . . . 74.340000000000003 110.054 179.34 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.0 mtt . . . . . 0 C--O 1.244 0.766 0 N-CA-C 106.489 -1.671 . . . . 74.409999999999997 106.489 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.0 p -66.65 -44.2 82.53 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 106.807 -1.553 . . . . 75.140000000000001 106.807 169.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 67.57 3.39 3.36 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.744 1.617 . . . . 74.439999999999998 113.652 173.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 22.1 p-10 -100.23 103.83 15.3 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-O 121.98 0.895 . . . . 74.409999999999997 109.841 178.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -86.71 112.98 22.18 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 107.944 -1.132 . . . . 64.140000000000001 107.944 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -64.2 107.7 1.92 Allowed Glycine 0 N--CA 1.44 -1.083 0 O-C-N 123.854 0.722 . . . . 63.200000000000003 111.347 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.7 t -96.11 135.1 22.9 Favored Pre-proline 0 N--CA 1.427 -1.586 0 N-CA-C 109.62 -0.511 . . . . 73.200000000000003 109.62 -177.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -63.64 134.43 44.16 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 121.903 1.736 . . . . 75.409999999999997 109.588 174.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -102.95 141.73 23.08 Favored Pre-proline 0 C--N 1.284 -2.266 0 N-CA-C 109.087 -0.708 . . . . 75.230000000000004 109.087 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -38.69 115.1 0.2 Allowed 'Trans proline' 0 C--N 1.368 1.562 0 C-N-CA 124.334 3.356 . . . . 74.010000000000005 113.056 -176.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -64.83 122.45 16.96 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.83 -1.077 . . . . 65.409999999999997 110.848 -178.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.1 p -86.22 119.61 34.68 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 CA-C-N 115.305 -0.862 . . . . 72.319999999999993 111.221 -177.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -121.6 140.8 51.79 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 107.262 -1.385 . . . . 75.310000000000002 107.262 178.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.0 t -85.17 136.57 33.48 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 108.606 -0.887 . . . . 64.310000000000002 108.606 -178.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.8 p -93.52 16.35 13.83 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 121.695 0.76 . . . . 74.400000000000006 110.452 -179.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 18.3 m -79.5 97.28 6.37 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 115.295 -0.866 . . . . 64.230000000000004 112.004 -177.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.8 m -126.38 142.92 41.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 107.922 -1.14 . . . . 74.329999999999998 107.922 174.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -83.85 154.03 23.69 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.421 -0.585 . . . . 70.549999999999997 109.421 -176.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.551 ' HB2' ' OD1' ' A' ' 21' ' ' ASP . 19.9 mtm180 -112.5 -163.29 0.84 Allowed 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 108.4 -0.963 . . . . 74.230000000000004 108.4 -177.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -87.67 40.97 0.96 Allowed 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 109.347 -0.612 . . . . 74.120000000000005 109.347 175.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.551 ' OD1' ' HB2' ' A' ' 19' ' ' ARG . 2.6 m-20 -55.17 -44.92 75.65 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 124.871 1.268 . . . . 71.219999999999999 111.861 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 94.8 mt -90.52 103.9 16.54 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.328 -0.99 . . . . 74.409999999999997 108.328 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.7 tt -63.0 121.74 14.31 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 108.143 -1.058 . . . . 73.420000000000002 108.143 -178.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 15.2 ptmm? -74.68 -176.56 2.86 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-N 116.055 -0.521 . . . . 72.349999999999994 111.089 -178.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -83.13 148.93 27.19 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.389 -0.967 . . . . 71.230000000000004 108.389 175.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 58.5 ttp -82.88 116.91 22.39 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.005 0.431 . . . . 73.129999999999995 109.901 -177.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -85.59 168.87 14.06 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 108.968 -0.753 . . . . 75.099999999999994 108.968 175.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.5 m -50.91 -34.0 26.6 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 113.738 1.014 . . . . 75.129999999999995 113.738 -173.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.7 m 55.77 49.53 16.01 Favored 'General case' 0 C--N 1.351 0.663 0 CA-C-O 121.728 0.775 . . . . 74.519999999999996 108.99 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 23.5 m -58.35 114.85 2.62 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-N 113.845 -1.525 . . . . 74.510000000000005 112.461 -173.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -86.25 96.04 2.09 Favored Glycine 0 N--CA 1.42 -2.376 0 N-CA-C 107.609 -2.196 . . . . 74.329999999999998 107.609 172.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 32.2 p -66.13 151.3 47.23 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 122.033 0.133 . . . . 74.340000000000003 110.708 -176.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.75 122.11 69.23 Favored Pre-proline 0 N--CA 1.443 -0.784 0 N-CA-C 107.973 -1.121 . . . . 72.409999999999997 107.973 177.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -45.74 109.47 0.19 Allowed 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 123.72 2.947 . . . . 74.019999999999996 113.276 -174.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -106.22 97.15 7.0 Favored 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 106.332 -1.729 . . . . 63.439999999999998 106.332 176.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.4 t -107.23 140.37 40.21 Favored 'General case' 0 N--CA 1.415 -2.208 0 CA-C-N 115.663 -0.699 . . . . 73.510000000000005 111.236 -173.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 25.2 m -90.14 -19.64 24.03 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 107.36 -1.348 . . . . 74.439999999999998 107.36 175.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 160.18 97.63 0.12 Allowed Glycine 0 N--CA 1.44 -1.087 0 N-CA-C 109.749 -1.34 . . . . 73.549999999999997 109.749 -179.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.82 -23.52 67.31 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 122.745 0.418 . . . . 75.040000000000006 112.096 -176.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -62.94 -11.25 17.39 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.872 -0.604 . . . . 74.409999999999997 112.025 177.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.415 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 7.2 t30 -61.45 -32.03 72.0 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 123.523 0.729 . . . . 71.299999999999997 109.967 173.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 6.0 tt -112.63 91.93 18.62 Favored Pre-proline 0 CA--C 1.557 1.214 0 N-CA-C 108.206 -1.035 . . . . 73.25 108.206 -178.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.415 ' HD3' ' O ' ' A' ' 41' ' ' ASN . 73.9 Cg_endo -97.15 5.42 1.55 Allowed 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.652 2.235 . . . . 65.409999999999997 113.299 -177.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -108.74 23.34 14.68 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.748 0.785 . . . . 73.5 110.362 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -145.71 30.19 1.69 Allowed Glycine 0 C--N 1.296 -1.663 0 N-CA-C 109.996 -1.242 . . . . 45.409999999999997 109.996 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 12.9 m -101.53 162.93 12.54 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 108.2 -1.037 . . . . 74.329999999999998 108.2 -179.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -137.97 164.54 28.77 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.398 -0.593 . . . . 65.239999999999995 109.398 -177.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.6 pp -134.89 160.01 39.63 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 120.825 0.345 . . . . 74.120000000000005 111.827 -177.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.6 pp -128.45 146.71 50.72 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 116.512 -0.313 . . . . 74.409999999999997 110.44 178.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 47.7 t -126.65 122.34 60.59 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 N-CA-C 108.314 -0.995 . . . . 74.0 108.314 178.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 19.6 t -93.35 118.1 38.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 N-CA-C 108.669 -0.863 . . . . 73.120000000000005 108.669 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -89.52 -31.81 17.47 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 116.079 -0.51 . . . . 63.399999999999999 111.047 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 27.9 tpt180 -156.99 129.3 7.4 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.308 -0.405 . . . . 72.439999999999998 110.147 178.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 139.71 136.05 3.32 Favored Glycine 0 N--CA 1.422 -2.277 0 CA-C-N 115.743 -0.662 . . . . 71.25 112.542 176.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -59.98 -9.07 9.07 Favored 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 124.226 3.284 . . . . 74.430000000000007 111.894 175.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.573 ' ND2' ' HB2' ' A' ' 80' ' ' LEU . 20.6 t-20 -35.16 -50.75 0.53 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 127.764 2.426 . . . . 72.129999999999995 109.245 168.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -169.67 -58.14 0.02 OUTLIER 'General case' 0 CA--C 1.504 -0.793 0 CA-C-N 115.511 -0.768 . . . . 64.310000000000002 108.963 176.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.08 30.12 55.8 Favored Glycine 0 C--N 1.318 -0.42 0 N-CA-C 110.342 -1.103 . . . . 72.420000000000002 110.342 -177.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -142.58 -175.53 4.51 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 108.727 -0.842 . . . . 54.240000000000002 108.727 -176.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 16.6 ptt-85 -135.54 137.13 41.74 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.191 -0.67 . . . . 71.230000000000004 109.191 178.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -156.51 154.7 30.75 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.59 -0.277 . . . . 71.349999999999994 111.074 -179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.1 tt -96.19 139.72 31.93 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.495 -0.775 . . . . 71.219999999999999 110.424 -178.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.2 mp -110.39 126.94 54.81 Favored 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 123.996 0.918 . . . . 60.420000000000002 108.87 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -139.04 24.08 2.56 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 121.769 0.795 . . . . 74.530000000000001 109.957 177.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -90.44 146.81 35.22 Favored Pre-proline 0 C--N 1.315 -0.92 0 N-CA-C 108.132 -1.062 . . . . 75.409999999999997 108.132 178.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -56.71 -45.42 36.94 Favored 'Trans proline' 0 C--N 1.361 1.228 0 C-N-CA 122.956 2.437 . . . . 74.109999999999999 111.664 -177.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 90.2 m -136.1 97.41 3.6 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 115.054 -0.975 . . . . 75.140000000000001 110.238 177.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 21.7 m -88.07 114.15 24.41 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.359 -1.348 . . . . 63.329999999999998 107.359 177.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.2 m -100.25 120.14 39.45 Favored 'General case' 0 C--O 1.25 1.131 0 C-N-CA 120.622 -0.431 . . . . 74.129999999999995 110.65 -176.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.447 ' CB ' HD22 ' A' ' 80' ' ' LEU . . . -98.01 129.72 44.87 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 123.99 0.916 . . . . 73.150000000000006 110.734 -177.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.456 ' O ' ' HA ' ' A' ' 79' ' ' PHE . . . -178.43 -106.22 0.2 Allowed Glycine 0 C--O 1.242 0.65 0 N-CA-C 110.439 -1.064 . . . . 75.299999999999997 110.439 178.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.426 ' HG2' HG21 ' A' ' 85' ' ' VAL . 18.0 mmm180 -131.38 -81.91 0.52 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.152 0.581 . . . . 74.239999999999995 110.218 174.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.42 ' HB3' ' HD3' ' A' ' 74' ' ' PRO . 10.8 t60 -150.78 -61.29 0.02 OUTLIER Pre-proline 0 CA--C 1.553 1.08 0 CA-C-O 118.867 -0.587 . . . . 52.100000000000001 111.838 -177.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.42 ' HD3' ' HB3' ' A' ' 73' ' ' HIS . 83.3 Cg_exo -50.28 -37.89 50.76 Favored 'Trans proline' 0 C--N 1.374 1.899 0 C-N-CA 122.514 2.142 . . . . 62.420000000000002 114.781 179.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.579 ' OE2' ' HD2' ' A' ' 87' ' ' ARG . 45.5 mt-10 -109.42 2.62 20.72 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 112.657 0.614 . . . . 75.010000000000005 112.657 -177.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 36.1 p -148.88 -175.31 4.9 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.119 -1.033 . . . . 75.010000000000005 113.023 -171.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -102.79 -42.29 5.91 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.684 0.754 . . . . 64.400000000000006 110.055 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 21.5 pt -118.91 153.17 21.19 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 115.747 -0.66 . . . . 71.329999999999998 111.087 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.456 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 40.7 p90 -105.83 129.26 54.04 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.036 -0.727 . . . . 73.420000000000002 109.036 177.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.573 ' HB2' ' ND2' ' A' ' 56' ' ' ASN . 1.4 pt? -156.2 6.27 0.19 Allowed 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 113.773 1.027 . . . . 45.210000000000001 113.773 -175.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -122.62 128.53 50.79 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 118.996 -1.081 . . . . 73.140000000000001 108.337 173.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -127.6 -4.11 5.96 Favored 'General case' 0 C--N 1.286 -2.159 0 CA-C-N 115.018 -0.992 . . . . 74.519999999999996 111.538 -176.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.403 ' C ' ' HG1' ' A' ' 84' ' ' THR . 13.1 p -87.36 -37.52 11.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 C-N-CA 119.043 -1.063 . . . . 75.510000000000005 109.374 -174.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.403 ' HG1' ' C ' ' A' ' 83' ' ' VAL . 23.3 m -171.8 81.98 0.07 Allowed 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.08 -1.082 . . . . 70.049999999999997 108.08 -178.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.426 HG21 ' HG2' ' A' ' 72' ' ' ARG . 8.9 p -82.91 104.56 11.72 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.366 0 C-N-CA 116.535 -2.066 . . . . 73.030000000000001 109.647 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 58.2 m -76.75 -44.77 31.76 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 113.972 -1.467 . . . . 72.519999999999996 112.212 -175.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.579 ' HD2' ' OE2' ' A' ' 75' ' ' GLU . 13.7 mmt180 -166.15 -167.04 0.98 Allowed 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 105.083 -2.191 . . . . 74.209999999999994 105.083 -176.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.78 126.61 20.62 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 106.55 -1.648 . . . . 74.109999999999999 106.55 166.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.402 ' NE2' ' HB ' ' A' ' 130' ' ' ILE . 40.6 t60 -92.83 -49.56 6.0 Favored 'General case' 0 C--N 1.284 -2.269 0 CA-C-N 115.501 -0.772 . . . . 62.340000000000003 111.845 -164.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -139.66 142.65 36.97 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 120.296 -0.562 . . . . 72.450000000000003 110.362 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -117.23 127.3 53.96 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 109.136 -0.69 . . . . 73.299999999999997 109.136 176.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -108.72 112.28 24.5 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 106.827 -1.546 . . . . 72.340000000000003 106.827 176.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 20.0 mtm180 -123.74 124.67 43.23 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 109.426 -0.583 . . . . 73.239999999999995 109.426 -177.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.488 ' O ' HD11 ' A' ' 94' ' ' ILE . 2.8 pp -115.47 122.48 69.41 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.222 0 CA-C-O 121.76 0.79 . . . . 75.099999999999994 112.041 -175.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -119.08 145.65 45.74 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 107.018 -1.475 . . . . 71.230000000000004 107.018 177.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -54.81 -29.7 55.32 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 122.641 0.377 . . . . 61.130000000000003 111.937 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -80.45 -46.69 7.27 Favored Glycine 0 N--CA 1.43 -1.706 0 CA-C-O 119.692 -0.504 . . . . 64.540000000000006 112.34 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -144.99 142.76 30.08 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 117.211 0.505 . . . . 74.430000000000007 110.472 -179.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -95.67 114.79 26.57 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 106.64 -1.615 . . . . 72.140000000000001 106.64 176.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -119.61 116.25 25.64 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.332 0.587 . . . . 73.129999999999995 112.343 -170.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 5.6 p -105.88 124.44 61.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 108.265 -1.013 . . . . 74.150000000000006 108.265 172.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 33.8 t -111.66 115.01 48.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 CA-C-N 115.869 -0.605 . . . . 72.030000000000001 109.435 -176.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.56 ' HB3' ' CB ' ' A' ' 110' ' ' THR . 4.9 m-20 -85.41 109.69 18.61 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 114.796 -1.093 . . . . 74.430000000000007 108.855 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 12.3 m -118.3 16.83 7.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 111.95 0.352 . . . . 73.109999999999999 111.95 -176.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -114.22 48.43 0.94 Allowed Glycine 0 C--O 1.241 0.589 0 N-CA-C 110.771 -0.932 . . . . 64.010000000000005 110.771 177.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 6.9 m -65.52 -22.58 66.73 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 124.126 0.97 . . . . 75.010000000000005 112.425 -175.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -58.77 -42.14 88.26 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.209 0.528 . . . . 74.329999999999998 110.296 177.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -76.94 -52.9 8.59 Favored 'General case' 0 CA--C 1.485 -1.554 0 N-CA-C 106.456 -1.683 . . . . 73.019999999999996 106.456 175.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 123.91 103.0 1.55 Allowed Glycine 0 N--CA 1.406 -3.31 0 CA-C-N 113.892 -1.504 . . . . 70.329999999999998 110.116 -177.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.56 ' CB ' ' HB3' ' A' ' 103' ' ' ASP . 1.5 p -92.82 119.16 31.88 Favored 'General case' 0 N--CA 1.409 -2.525 0 N-CA-C 107.501 -1.296 . . . . 72.200000000000003 107.501 175.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.411 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 65.6 m-85 -121.99 139.44 53.68 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-O 121.554 0.692 . . . . 73.510000000000005 112.506 -172.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.678 ' HB ' ' NE ' ' A' ' 117' ' ' ARG . 7.1 p -104.87 111.71 35.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 106.333 -1.728 . . . . 71.310000000000002 106.333 170.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 46.7 m-80 54.23 35.7 23.28 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.922 0.489 . . . . 72.299999999999997 111.295 -177.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 49.2 mtm-85 83.81 3.09 0.88 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.676 1.59 . . . . 74.310000000000002 115.257 178.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -110.47 139.5 21.6 Favored Pre-proline 0 C--N 1.314 -0.957 0 C-N-CA 119.645 -0.822 . . . . 70.099999999999994 110.069 175.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.27 142.32 97.92 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 122.869 2.38 . . . . 74.200000000000003 113.767 -175.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.678 ' NE ' ' HB ' ' A' ' 112' ' ' VAL . 13.1 ptt180 -147.14 163.94 34.72 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.842 -0.617 . . . . 75.030000000000001 111.744 176.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.431 ' HA ' ' HB2' ' A' ' 103' ' ' ASP . 11.1 m120 -124.75 -17.86 5.78 Favored 'General case' 0 CA--C 1.513 -0.452 0 O-C-N 124.094 0.871 . . . . 75.209999999999994 111.959 173.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -155.42 138.28 15.33 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.162 -0.681 . . . . 74.140000000000001 109.162 174.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 21.6 tm0? -141.47 149.28 40.75 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.174 -1.047 . . . . 71.140000000000001 108.174 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.3 p -101.83 113.76 39.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 109.389 -0.597 . . . . 74.439999999999998 109.389 176.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -32.91 116.95 0.24 Allowed 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 115.796 1.776 . . . . 74.409999999999997 115.796 -172.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -118.3 145.48 45.04 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 106.795 -1.557 . . . . 65.010000000000005 106.795 172.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 15.0 t -89.46 130.94 35.72 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 119.766 -0.774 . . . . 74.099999999999994 109.856 -178.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 94.27 19.02 34.27 Favored Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 110.88 -0.888 . . . . 74.409999999999997 110.88 -178.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -96.66 142.13 29.07 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 108.538 -0.912 . . . . 71.109999999999999 108.538 -178.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -109.5 127.32 54.36 Favored 'General case' 0 N--CA 1.422 -1.867 0 CA-C-O 122.086 0.946 . . . . 62.409999999999997 111.127 179.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.512 HG12 ' NH2' ' A' ' 117' ' ' ARG . 25.6 mt -106.7 125.65 62.61 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.285 0 CA-C-N 114.477 -1.238 . . . . 73.319999999999993 108.043 -177.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.411 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 51.0 tt0 -105.42 111.9 24.79 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 107.313 -1.365 . . . . 73.099999999999994 107.313 172.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.435 HD11 ' ND2' ' A' ' 56' ' ' ASN . 17.3 pt -102.05 101.0 11.51 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 N-CA-C 108.593 -0.892 . . . . 75.450000000000003 108.593 177.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 73.62 -90.99 0.65 Allowed Glycine 0 N--CA 1.419 -2.463 0 CA-C-N 114.866 -1.061 . . . . 63.240000000000002 110.757 -177.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 45.0 tttp -131.88 3.53 4.1 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 121.117 0.484 . . . . 75.129999999999995 110.345 -176.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -101.61 144.35 30.45 Favored 'General case' 0 C--N 1.311 -1.069 0 O-C-N 121.918 -0.489 . . . . 74.239999999999995 109.743 -176.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -106.85 121.04 43.62 Favored 'General case' 0 C--O 1.247 0.95 0 N-CA-C 107.711 -1.218 . . . . 75.349999999999994 107.711 -177.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 42.9 tp -123.89 142.42 51.15 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 114.993 -1.003 . . . . 73.349999999999994 108.362 -176.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 11.1 p -117.09 130.51 71.88 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 N-CA-C 107.553 -1.277 . . . . 71.5 107.553 174.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -111.47 130.27 55.77 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 116.233 -0.44 . . . . 71.319999999999993 110.055 -173.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -127.94 170.16 13.16 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.92 -0.77 . . . . 64.239999999999995 108.92 -178.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -89.53 164.61 14.72 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 109.031 -0.729 . . . . 53.329999999999998 109.031 176.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -82.87 142.96 21.96 Favored Glycine 0 N--CA 1.435 -1.394 0 N-CA-C 109.723 -1.351 . . . . 63.450000000000003 109.723 177.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -75.23 119.65 5.67 Favored 'Trans proline' 0 N--CA 1.444 -1.423 0 CA-C-N 119.608 1.704 . . . . 63.329999999999998 111.377 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -109.24 110.04 21.13 Favored 'General case' 0 C--N 1.283 -2.308 0 N-CA-C 108.529 -0.915 . . . . 71.450000000000003 108.529 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.426 -1.642 0 CA-C-N 115.941 -0.572 . . . . 74.400000000000006 111.403 -178.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.9 mtt . . . . . 0 N--CA 1.474 0.734 0 N-CA-C 109.603 -0.517 . . . . 74.140000000000001 109.603 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.3 p -82.42 -48.24 11.34 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 107.698 -1.223 . . . . 64.120000000000005 107.698 173.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -103.26 124.45 48.65 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 106.585 -1.635 . . . . 74.540000000000006 106.585 174.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -111.93 148.74 33.07 Favored 'General case' 0 C--N 1.287 -2.129 0 C-N-CA 120.832 -0.347 . . . . 74.519999999999996 110.655 -177.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -92.23 113.45 25.73 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 116.092 -0.504 . . . . 74.340000000000003 110.187 -178.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -119.95 101.1 0.81 Allowed Glycine 0 N--CA 1.425 -2.045 0 N-CA-C 111.107 -0.797 . . . . 64.25 111.107 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.2 m -78.78 124.03 85.15 Favored Pre-proline 0 C--N 1.306 -1.29 0 N-CA-C 108.555 -0.906 . . . . 73.530000000000001 108.555 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -60.49 128.02 24.65 Favored 'Trans proline' 0 C--O 1.252 1.19 0 C-N-CA 122.363 2.042 . . . . 74.200000000000003 111.601 178.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -100.98 131.67 23.02 Favored Pre-proline 0 C--N 1.299 -1.604 0 CA-C-N 115.919 -0.582 . . . . 72.510000000000005 110.188 -178.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -65.1 127.18 17.85 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 121.982 1.788 . . . . 74.340000000000003 111.225 178.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -82.12 104.91 12.8 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.844 -1.169 . . . . 64.209999999999994 107.844 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 23.5 t -111.83 148.95 14.65 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 N-CA-C 107.459 -1.311 . . . . 73.129999999999995 107.459 -178.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -82.47 121.57 26.93 Favored 'General case' 0 N--CA 1.408 -2.533 0 N-CA-C 106.143 -1.799 . . . . 64.010000000000005 106.143 170.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 58.4 m -60.53 104.28 0.32 Allowed 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.78 -0.645 . . . . 75.519999999999996 109.642 -177.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 18.2 m -81.25 94.64 6.75 Favored 'General case' 0 N--CA 1.415 -2.189 0 CA-C-N 114.781 -1.1 . . . . 73.310000000000002 110.586 -174.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 21.2 m -134.35 83.68 2.05 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 114.697 -1.138 . . . . 72.209999999999994 108.221 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 39.4 t -108.51 113.69 44.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 108.453 -0.943 . . . . 62.210000000000001 108.453 -178.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -109.89 164.03 12.97 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 108.725 -0.843 . . . . 72.150000000000006 108.725 178.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.424 ' C ' ' H ' ' A' ' 21' ' ' ASP . 7.3 mpt_? -113.38 175.51 5.42 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 109.418 -0.586 . . . . 75.510000000000005 109.418 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.79 34.21 0.18 Allowed 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 123.567 0.747 . . . . 55.520000000000003 111.77 -177.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.424 ' H ' ' C ' ' A' ' 19' ' ' ARG . 25.0 m-20 -71.34 -32.72 68.88 Favored 'General case' 0 CA--C 1.504 -0.793 0 C-N-CA 124.072 0.949 . . . . 73.239999999999995 110.015 -176.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -74.22 99.09 3.33 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.347 -0.842 . . . . 75.010000000000005 110.214 -177.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 91.3 mt -94.85 166.53 11.93 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.789 -0.641 . . . . 75.230000000000004 110.014 -179.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -74.24 105.69 5.54 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 106.506 -1.665 . . . . 74.340000000000003 106.506 175.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -75.51 132.68 40.92 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.762 -0.458 . . . . 74.120000000000005 109.762 178.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -90.29 127.1 36.06 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.786 -0.643 . . . . 74.430000000000007 110.309 -176.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -99.75 169.15 9.45 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 115.582 -0.736 . . . . 73.140000000000001 109.871 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 16.7 p -142.04 150.85 41.81 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.927 -0.768 . . . . 62.009999999999998 108.927 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.6 m -102.67 169.62 8.52 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 109.841 -0.429 . . . . 74.310000000000002 109.841 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.8 t -130.02 143.24 50.69 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 109.839 -0.43 . . . . 72.239999999999995 109.839 -179.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -90.18 -170.48 43.88 Favored Glycine 0 N--CA 1.441 -1.03 0 N-CA-C 111.695 -0.562 . . . . 72.150000000000006 111.695 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 24.9 m -83.77 149.93 26.13 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 122.809 0.444 . . . . 73.430000000000007 110.621 -178.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -89.82 120.87 69.41 Favored Pre-proline 0 C--N 1.311 -1.069 0 N-CA-C 109.432 -0.581 . . . . 75.109999999999999 109.432 176.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -72.74 127.57 12.46 Favored 'Trans proline' 0 C--O 1.238 0.488 0 C-N-CA 122.651 2.234 . . . . 74.420000000000002 111.622 177.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -91.64 90.87 7.76 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.299 -1.0 . . . . 63.310000000000002 108.299 176.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.2 m -57.52 114.62 2.32 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 115.111 -0.949 . . . . 65.099999999999994 112.202 -176.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.3 t -148.54 155.88 41.71 Favored 'General case' 0 N--CA 1.42 -1.942 0 N-CA-C 106.396 -1.705 . . . . 72.0 106.396 178.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 126.47 99.15 1.1 Allowed Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 110.718 -0.953 . . . . 71.540000000000006 110.718 -177.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.4 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . . . -71.01 -34.2 71.1 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 121.212 0.529 . . . . 54.520000000000003 111.329 -175.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.37 -34.36 23.61 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.408 -0.815 . . . . 73.450000000000003 110.588 -178.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -77.58 -43.08 32.94 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.832 -1.076 . . . . 74.319999999999993 112.059 -174.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.423 ' HB2' ' CG ' ' A' ' 66' ' ' PRO . 86.2 mt -84.54 150.34 56.58 Favored Pre-proline 0 C--N 1.302 -1.484 0 O-C-N 122.257 -0.277 . . . . 71.329999999999998 110.696 -176.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -61.24 130.46 32.32 Favored 'Trans proline' 0 N--CA 1.482 0.849 0 C-N-CA 123.807 3.005 . . . . 54.310000000000002 113.057 -178.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -99.81 -171.09 1.99 Allowed 'General case' 0 C--O 1.245 0.841 0 CA-C-O 121.277 0.56 . . . . 73.409999999999997 111.069 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 128.47 53.97 0.12 Allowed Glycine 0 CA--C 1.488 -1.65 0 N-CA-C 107.877 -2.089 . . . . 34.539999999999999 107.877 -177.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 10.1 m -89.47 152.12 21.63 Favored 'General case' 0 N--CA 1.422 -1.832 0 CA-C-O 121.684 0.754 . . . . 75.109999999999999 112.374 -166.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.413 ' HB3' ' O ' ' A' ' 138' ' ' LEU . . . -112.32 -164.38 0.91 Allowed 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 114.114 -1.403 . . . . 62.32 107.434 178.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.7 pp -131.07 155.4 46.98 Favored 'General case' 0 N--CA 1.438 -1.051 0 C-N-CA 120.277 -0.569 . . . . 75.140000000000001 111.96 -177.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.6 pp -132.1 141.29 49.12 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 115.771 -0.649 . . . . 74.209999999999994 109.985 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 59.8 t -119.07 126.04 75.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 109.655 -0.498 . . . . 74.209999999999994 109.655 -177.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.5 t -93.17 115.87 32.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 107.553 -1.277 . . . . 73.430000000000007 107.553 176.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.402 ' HE3' ' CG2' ' A' ' 136' ' ' VAL . 94.5 mttt -66.02 -43.93 86.23 Favored 'General case' 0 CA--C 1.496 -1.125 0 CA-C-N 115.105 -0.952 . . . . 73.0 109.088 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 30.0 tpt180 -168.9 135.13 1.75 Allowed 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.067 -1.457 . . . . 65.439999999999998 107.067 179.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.43 135.73 2.02 Favored Glycine 0 N--CA 1.42 -2.393 0 N-CA-C 109.267 -1.533 . . . . 72.310000000000002 109.267 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.542 ' HB2' ' O ' ' A' ' 81' ' ' ASP . 15.0 Cg_exo -67.52 -10.95 30.43 Favored 'Trans proline' 0 CA--C 1.53 0.307 0 C-N-CA 122.372 2.048 . . . . 73.409999999999997 112.723 -176.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.541 ' HA ' ' N ' ' A' ' 81' ' ' ASP . 29.5 p-10 -53.92 -42.36 68.67 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.708 0.803 . . . . 73.450000000000003 110.673 178.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -168.17 -47.18 0.02 OUTLIER 'General case' 0 N--CA 1.444 -0.732 0 O-C-N 123.411 0.444 . . . . 64.129999999999995 110.769 178.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.28 64.73 2.86 Favored Glycine 0 C--O 1.239 0.466 0 N-CA-C 110.727 -0.949 . . . . 74.219999999999999 110.727 -176.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -166.45 -178.49 4.49 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 107.449 -1.315 . . . . 72.5 107.449 -177.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 13.3 ptt180 -112.64 144.97 41.22 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 109.199 -0.667 . . . . 75.25 109.199 175.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -132.33 154.31 49.86 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 116.372 -0.377 . . . . 70.319999999999993 110.553 -177.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.1 tt -111.48 140.27 46.22 Favored 'General case' 0 C--N 1.28 -2.439 0 N-CA-C 103.544 -2.762 . . . . 71.450000000000003 103.544 173.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.8 mp -70.38 113.74 7.82 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 118.555 -1.258 . . . . 72.010000000000005 109.115 -176.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -72.36 -60.59 2.16 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 114.081 -1.418 . . . . 62.43 109.632 -173.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -103.02 132.92 20.66 Favored Pre-proline 0 N--CA 1.419 -1.992 0 CA-C-N 115.168 -0.924 . . . . 72.109999999999999 109.39 -178.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.423 ' CG ' ' HB2' ' A' ' 42' ' ' LEU . 5.8 Cg_exo -37.6 -46.94 1.89 Allowed 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 124.9 3.733 . . . . 75.219999999999999 113.515 175.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 87.3 m -106.61 96.44 6.45 Favored 'General case' 0 N--CA 1.423 -1.817 0 N-CA-C 108.189 -1.041 . . . . 64.340000000000003 108.189 173.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.428 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 22.3 m -89.16 114.61 25.92 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 108.404 -0.961 . . . . 74.010000000000005 108.404 -179.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.4 t -96.85 120.08 36.53 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.583 0.706 . . . . 72.329999999999998 109.86 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -110.28 148.94 30.92 Favored 'General case' 0 N--CA 1.428 -1.569 0 CA-C-N 115.837 -0.62 . . . . 62.530000000000001 110.579 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 147.71 -137.82 6.78 Favored Glycine 0 CA--C 1.466 -2.994 0 N-CA-C 107.389 -2.285 . . . . 65.0 107.389 -178.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.296 4.5 ptt85 -110.94 -88.94 0.5 Allowed 'General case' 0 C--N 1.284 -2.268 0 CA-C-O 118.428 -0.796 . . . . 75.109999999999999 111.857 174.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.443 ' HB3' ' HD2' ' A' ' 74' ' ' PRO . 32.7 m170 60.63 173.74 0.05 OUTLIER Pre-proline 0 CA--C 1.559 1.298 0 CA-C-N 118.598 0.635 . . . . 73.209999999999994 110.879 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.443 ' HD2' ' HB3' ' A' ' 73' ' ' HIS . 28.4 Cg_endo -66.77 -21.74 50.75 Favored 'Trans proline' 0 CA--C 1.545 1.026 0 C-N-CA 121.394 1.396 . . . . 74.25 111.81 169.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -134.33 92.96 2.99 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-O 121.337 0.589 . . . . 73.420000000000002 110.363 -176.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 13.1 m -77.38 117.32 18.76 Favored 'General case' 0 C--N 1.279 -2.494 0 N-CA-C 107.084 -1.45 . . . . 73.319999999999993 107.084 172.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -70.99 -35.06 71.96 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 108.522 -0.918 . . . . 73.400000000000006 108.522 -178.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.7 pp -130.15 162.47 37.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 106.14 -1.8 . . . . 74.150000000000006 106.14 165.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -101.33 136.64 40.85 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 113.974 1.102 . . . . 74.420000000000002 113.974 -170.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.451 ' HA ' ' HB2' ' A' ' 56' ' ' ASN . 94.4 mt -128.91 150.18 50.47 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 106.971 -1.492 . . . . 73.239999999999995 106.971 175.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.542 ' O ' ' HB2' ' A' ' 55' ' ' PRO . 16.9 t70 -156.93 94.59 1.44 Allowed 'General case' 0 C--N 1.288 -2.071 0 O-C-N 124.0 0.812 . . . . 72.519999999999996 109.425 -177.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.447 ' O ' HG11 ' A' ' 85' ' ' VAL . 14.1 t70 -157.82 152.92 25.62 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 107.802 -1.185 . . . . 72.030000000000001 107.802 175.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.6 p -61.31 -27.5 41.99 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.061 0 C-N-CA 122.893 0.477 . . . . 74.349999999999994 112.202 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 17.6 p -96.77 21.85 8.96 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 113.88 1.067 . . . . 72.430000000000007 113.88 -177.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.447 HG11 ' O ' ' A' ' 82' ' ' ASP . 13.9 p -82.06 124.74 39.45 Favored 'Isoleucine or valine' 0 C--O 1.249 1.038 0 CA-C-O 122.044 0.925 . . . . 74.239999999999995 110.266 179.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 16.2 m -80.9 163.32 23.45 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.805 -0.813 . . . . 70.549999999999997 108.805 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.49 -43.21 97.26 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 119.677 -0.809 . . . . 73.120000000000005 108.931 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -110.4 110.81 21.72 Favored 'General case' 0 N--CA 1.419 -2.02 0 N-CA-C 102.565 -3.124 . . . . 74.319999999999993 102.565 176.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 14.6 t60 -110.62 -85.88 0.55 Allowed 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 117.878 -1.529 . . . . 73.25 112.398 -172.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -126.6 123.82 38.51 Favored 'General case' 0 C--N 1.292 -1.932 0 C-N-CA 120.167 -0.613 . . . . 55.009999999999998 109.722 -175.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -110.04 127.53 54.89 Favored 'General case' 0 C--N 1.275 -2.642 0 C-N-CA 118.938 -1.105 . . . . 71.439999999999998 110.419 177.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.428 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 53.0 m-85 -103.41 113.64 27.3 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 114.61 -1.177 . . . . 75.409999999999997 108.116 -176.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 48.6 mtm180 -108.78 122.6 47.5 Favored 'General case' 0 C--N 1.288 -2.109 0 N-CA-C 109.632 -0.507 . . . . 74.450000000000003 109.632 178.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.2 116.95 54.09 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.495 0 N-CA-C 106.888 -1.523 . . . . 74.319999999999993 106.888 175.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -117.8 146.06 44.09 Favored 'General case' 0 C--N 1.278 -2.533 0 CA-C-N 113.575 -1.648 . . . . 74.140000000000001 106.6 178.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -56.1 -22.02 25.68 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 112.396 0.517 . . . . 72.230000000000004 112.396 -177.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -95.95 -33.6 6.28 Favored Glycine 0 N--CA 1.435 -1.368 0 C-N-CA 121.042 -0.599 . . . . 60.119999999999997 113.611 178.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -148.16 144.3 27.67 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 117.494 0.647 . . . . 73.519999999999996 111.687 -176.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.476 ' HB3' ' SD ' ' A' ' 122' ' ' MET . 5.1 m-85 -106.67 114.3 28.32 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 106.986 -1.487 . . . . 74.299999999999997 106.986 176.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -132.37 135.12 45.92 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.43 -0.794 . . . . 70.129999999999995 111.901 -176.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.5 p -114.53 119.53 61.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 109.066 -0.716 . . . . 75.299999999999997 109.066 176.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 50.0 t -110.83 114.09 46.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 108.168 -1.049 . . . . 73.409999999999997 108.168 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -105.43 127.44 52.99 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-O 121.235 0.54 . . . . 63.350000000000001 110.556 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 28.7 m -116.67 12.61 7.55 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.176 0 CA-C-N 115.052 -0.976 . . . . 62.240000000000002 109.51 174.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -100.89 52.5 0.92 Allowed Glycine 0 N--CA 1.437 -1.284 0 N-CA-C 110.596 -1.001 . . . . 60.140000000000001 110.596 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.5 m -60.96 -17.16 50.06 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.201 1.4 . . . . 74.040000000000006 112.331 -176.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 82.6 mt -58.3 -39.9 80.56 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.698 0.761 . . . . 75.239999999999995 109.395 174.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -90.64 -48.99 6.73 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 106.706 -1.59 . . . . 73.530000000000001 106.706 176.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.66 94.0 1.24 Allowed Glycine 0 N--CA 1.442 -0.948 0 CA-C-N 114.767 -1.106 . . . . 63.140000000000001 113.982 175.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 42.0 m -93.72 120.09 33.55 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 109.208 -0.664 . . . . 72.420000000000002 109.208 175.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -135.65 168.74 18.7 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 107.923 -1.14 . . . . 74.010000000000005 107.923 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 52.5 t -106.84 141.67 21.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 107.932 -1.136 . . . . 74.319999999999993 107.932 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -51.48 -38.11 52.25 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 123.88 0.872 . . . . 74.329999999999998 111.563 178.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 53.5 ttt180 -84.06 -36.46 23.04 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 116.072 -0.513 . . . . 75.329999999999998 111.343 176.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 21.3 tp10 -124.2 114.21 27.73 Favored Pre-proline 0 C--N 1.306 -1.295 0 N-CA-C 112.125 0.417 . . . . 72.150000000000006 112.125 -169.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -78.75 38.82 0.74 Allowed 'Trans proline' 0 CA--C 1.547 1.146 0 C-N-CA 123.409 2.739 . . . . 64.140000000000001 113.206 -178.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 64.8 mtm180 -109.45 145.06 36.81 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 116.197 -0.456 . . . . 74.219999999999999 110.286 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -71.28 -38.64 71.82 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 123.941 0.776 . . . . 70.25 110.992 -172.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -115.04 136.9 52.62 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 107.13 -1.433 . . . . 71.409999999999997 107.13 173.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 -142.58 150.85 40.88 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 114.518 1.303 . . . . 72.140000000000001 114.518 -177.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.1 p -79.88 128.82 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.915 0 N-CA-C 105.252 -2.129 . . . . 73.120000000000005 105.252 167.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.476 ' SD ' ' HB3' ' A' ' 99' ' ' PHE . 59.4 mtt -60.59 136.68 58.13 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 123.29 0.636 . . . . 74.319999999999993 112.095 -171.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.416 HE21 ' HB2' ' A' ' 126' ' ' ASP . 0.2 OUTLIER -108.39 125.06 51.31 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 105.435 -2.061 . . . . 74.329999999999998 105.435 178.065 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 21.7 p -78.89 115.39 18.55 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.222 0.534 . . . . 75.310000000000002 111.507 -176.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 101.53 13.77 31.77 Favored Glycine 0 N--CA 1.432 -1.606 0 C-N-CA 120.758 -0.734 . . . . 63.200000000000003 112.505 179.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.416 ' HB2' HE21 ' A' ' 123' ' ' GLN . 8.1 t70 -116.6 176.33 5.16 Favored 'General case' 0 C--O 1.248 0.986 0 C-N-CA 119.531 -0.868 . . . . 64.530000000000001 109.476 178.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.531 ' OE1' ' HD3' ' A' ' 134' ' ' ARG . 40.6 tt0 -110.48 135.11 51.65 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-O 121.296 0.57 . . . . 72.430000000000007 109.984 -171.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 67.4 mt -103.37 122.95 56.55 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.406 0 N-CA-C 107.889 -1.152 . . . . 75.409999999999997 107.889 178.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -97.32 112.45 24.26 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 115.913 -0.585 . . . . 74.049999999999997 109.454 -179.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.1 pt -102.01 98.21 6.57 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.343 0 N-CA-C 107.549 -1.278 . . . . 74.209999999999994 107.549 175.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 75.08 -113.86 4.12 Favored Glycine 0 N--CA 1.421 -2.315 0 N-CA-C 108.198 -1.961 . . . . 70.120000000000005 108.198 -172.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -124.66 6.27 8.19 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 120.971 0.415 . . . . 72.329999999999998 110.397 175.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -98.78 151.64 20.57 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 109.224 -0.658 . . . . 74.340000000000003 109.224 174.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.531 ' HD3' ' OE1' ' A' ' 127' ' ' GLU . 77.9 mtt-85 -117.85 132.5 56.42 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 115.104 1.52 . . . . 74.439999999999998 115.104 -164.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 5.6 tt -124.3 136.33 54.03 Favored 'General case' 0 C--O 1.195 -1.773 0 CA-C-N 114.008 -1.451 . . . . 75.0 107.466 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.402 ' CG2' ' HE3' ' A' ' 52' ' ' LYS . 25.9 t -112.58 137.63 44.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.941 -0.763 . . . . 61.539999999999999 108.941 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -107.26 117.36 33.86 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 110.014 -0.365 . . . . 71.25 110.014 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.413 ' O ' ' HB3' ' A' ' 47' ' ' ALA . 2.5 mm? -117.34 143.87 45.5 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.35 0.595 . . . . 72.439999999999998 110.976 -177.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -97.57 91.27 5.35 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.415 -0.957 . . . . 65.329999999999998 108.415 177.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -107.16 -72.28 0.79 Allowed Glycine 0 N--CA 1.43 -1.727 0 CA-C-N 115.358 -0.837 . . . . 42.109999999999999 111.176 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -75.87 128.79 11.06 Favored 'Trans proline' 0 N--CA 1.446 -1.28 0 C-N-CA 121.935 1.757 . . . . 72.109999999999999 112.441 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -110.75 111.5 22.72 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 107.59 -1.263 . . . . 54.130000000000003 107.59 174.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 . . . . . 0 N--CA 1.425 -1.712 0 N-CA-C 108.619 -0.882 . . . . 63.420000000000002 108.619 -178.365 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 ppp? . . . . . 0 N--CA 1.466 0.37 0 N-CA-C 112.662 0.616 . . . . 65.420000000000002 112.662 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.2 m -74.67 -29.98 61.42 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-O 120.981 0.419 . . . . 74.129999999999995 109.914 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.0 t70 66.17 101.79 0.04 OUTLIER 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 122.492 1.139 . . . . 72.129999999999995 113.357 178.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -118.67 138.02 52.9 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 114.118 -1.401 . . . . 74.329999999999998 108.198 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -150.93 156.67 41.67 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 109.317 -0.623 . . . . 72.200000000000003 109.317 -174.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -73.85 106.15 1.96 Allowed Glycine 0 N--CA 1.436 -1.305 0 N-CA-C 110.66 -0.976 . . . . 72.010000000000005 110.66 178.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.1 t -98.02 126.73 39.28 Favored Pre-proline 0 C--N 1.296 -1.721 0 N-CA-C 110.122 -0.325 . . . . 72.209999999999994 110.122 -179.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -66.3 128.37 19.25 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.388 2.059 . . . . 71.540000000000006 111.205 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -90.77 131.68 36.93 Favored Pre-proline 0 C--N 1.294 -1.808 0 N-CA-C 108.898 -0.779 . . . . 71.010000000000005 108.898 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_exo -49.14 129.36 21.77 Favored 'Trans proline' 0 C--O 1.239 0.541 0 C-N-CA 123.508 2.805 . . . . 75.530000000000001 114.707 -174.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -110.18 107.95 17.93 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.007 -1.849 . . . . 73.450000000000003 106.007 174.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.6 p -114.65 107.49 23.0 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 CA-C-O 122.01 0.91 . . . . 70.510000000000005 111.7 -175.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -139.57 140.95 37.2 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 105.676 -1.972 . . . . 65.420000000000002 105.676 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 67.8 m -150.71 95.57 2.24 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 109.897 -0.408 . . . . 71.340000000000003 109.897 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.9 p -113.33 104.18 12.06 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-O 121.363 0.601 . . . . 74.0 111.547 177.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 39.9 t -164.9 115.2 1.14 Allowed 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 107.498 -1.297 . . . . 72.530000000000001 107.498 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.8 p -141.69 144.73 25.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 N-CA-C 109.792 -0.447 . . . . 73.319999999999993 109.792 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -128.98 158.1 39.8 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.364 -0.976 . . . . 73.230000000000004 108.364 175.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 16.3 ptt85 -127.4 138.11 52.91 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.416 0.627 . . . . 75.430000000000007 112.235 -176.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -99.94 42.06 1.13 Allowed 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.705 -0.679 . . . . 64.510000000000005 110.529 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -69.99 -15.76 63.08 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 116.373 -0.376 . . . . 72.010000000000005 111.983 -178.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.414 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 45.4 tp -79.15 156.89 28.05 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 107.653 -1.24 . . . . 74.409999999999997 107.653 175.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.414 ' HB2' ' O ' ' A' ' 22' ' ' LEU . 9.7 mp 75.55 34.69 0.58 Allowed 'General case' 0 N--CA 1.483 1.212 0 CA-C-O 122.057 0.932 . . . . 73.129999999999995 110.515 -177.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -87.99 115.72 25.65 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.588 -1.187 . . . . 72.219999999999999 108.363 177.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -106.39 -177.95 3.51 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.549 -0.75 . . . . 73.310000000000002 109.374 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -144.73 139.76 28.11 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.817 -0.808 . . . . 75.109999999999999 108.817 178.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -78.07 135.14 37.67 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 108.939 -0.763 . . . . 74.150000000000006 108.939 177.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.5 m -79.07 155.73 28.66 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.326 -0.852 . . . . 71.430000000000007 111.999 -172.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 14.5 m -94.22 148.93 21.71 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 115.473 -0.785 . . . . 71.310000000000002 109.168 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.0 t -109.42 -177.51 3.31 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.222 -1.399 . . . . 70.549999999999997 107.222 177.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -116.31 178.7 17.52 Favored Glycine 0 C--N 1.304 -1.206 0 C-N-CA 120.504 -0.855 . . . . 70.140000000000001 111.145 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.3 m -76.69 138.24 39.88 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 109.897 -0.408 . . . . 73.019999999999996 109.897 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -78.49 143.32 63.6 Favored Pre-proline 0 C--N 1.304 -1.403 0 N-CA-C 108.734 -0.839 . . . . 73.409999999999997 108.734 177.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -63.11 110.15 1.1 Allowed 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.038 1.825 . . . . 75.439999999999998 110.186 177.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -158.22 116.78 3.07 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 115.001 -0.999 . . . . 72.219999999999999 108.489 -177.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.3 p -80.01 144.91 32.84 Favored 'General case' 0 N--CA 1.422 -1.842 0 O-C-N 123.85 0.719 . . . . 71.549999999999997 109.207 176.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.6 t -109.91 157.53 19.14 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-O 121.102 0.477 . . . . 75.140000000000001 110.11 -177.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -133.83 50.79 0.86 Allowed Glycine 0 N--CA 1.409 -3.106 0 N-CA-C 108.287 -1.925 . . . . 71.209999999999994 108.287 174.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.17 -29.51 70.85 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 123.373 0.669 . . . . 73.409999999999997 111.07 -178.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -72.14 -15.11 61.97 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 116.219 -0.446 . . . . 74.209999999999994 111.559 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -71.25 -29.93 65.71 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.91 0.862 . . . . 72.209999999999994 109.11 177.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -84.27 151.63 59.98 Favored Pre-proline 0 N--CA 1.422 -1.854 0 N-CA-C 107.516 -1.291 . . . . 73.329999999999998 107.516 177.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -68.11 176.53 5.33 Favored 'Trans proline' 0 C--O 1.253 1.245 0 C-N-CA 122.006 1.804 . . . . 64.239999999999995 111.647 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.401 ' HB2' ' HB2' ' A' ' 143' ' ' GLU . . . -69.44 108.5 3.78 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.858 0.837 . . . . 65.239999999999995 110.99 -178.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.476 ' HA2' ' O ' ' A' ' 141' ' ' PRO . . . -158.52 48.83 0.42 Allowed Glycine 0 CA--C 1.48 -2.154 0 N-CA-C 106.015 -2.834 . . . . 73.040000000000006 106.015 178.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 13.6 m -89.98 164.79 14.4 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 113.56 -1.32 . . . . 70.420000000000002 111.264 -169.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -92.91 164.58 13.26 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 116.015 -0.539 . . . . 74.439999999999998 109.773 -179.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -133.83 155.91 48.99 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 110.261 -0.274 . . . . 75.239999999999995 110.261 -178.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.468 HD23 ' O ' ' A' ' 61' ' ' PHE . 2.7 pt? -108.79 132.77 53.66 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 107.065 -1.457 . . . . 75.439999999999998 107.065 176.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.8 t -117.68 114.66 46.13 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 N-CA-C 108.661 -0.866 . . . . 73.510000000000005 108.661 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.461 HG12 ' OD1' ' A' ' 56' ' ' ASN . 61.9 t -92.9 116.03 33.09 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 N-CA-C 107.722 -1.214 . . . . 70.219999999999999 107.722 177.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.434 ' HB3' ' HZ1' ' A' ' 52' ' ' LYS . 2.4 mmmp? -82.56 -39.12 22.75 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.381 -0.827 . . . . 71.219999999999999 108.831 -178.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.437 ' O ' ' HB3' ' A' ' 133' ' ' PHE . 72.8 ttt180 -147.86 115.65 6.4 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 115.196 -0.911 . . . . 75.400000000000006 108.94 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 175.74 134.18 1.88 Allowed Glycine 0 N--CA 1.438 -1.174 0 C-N-CA 120.127 -1.035 . . . . 72.219999999999999 113.433 176.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.55 -9.25 25.7 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 123.957 3.105 . . . . 64.510000000000005 111.897 175.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.461 ' OD1' HG12 ' A' ' 51' ' ' VAL . 13.2 p30 -48.54 -46.05 38.26 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.488 1.115 . . . . 72.349999999999994 111.495 177.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -171.34 -40.53 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 125.203 1.401 . . . . 75.150000000000006 107.381 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 64.6 46.35 90.34 Favored Glycine 0 CA--C 1.495 -1.192 0 N-CA-C 110.191 -1.163 . . . . 71.099999999999994 110.191 -178.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -143.11 -178.01 5.63 Favored 'General case' 0 N--CA 1.424 -1.775 0 N-CA-C 108.513 -0.921 . . . . 75.420000000000002 108.513 -173.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.403 ' HA ' ' O ' ' A' ' 49' ' ' LEU . 11.2 ptt180 -141.49 131.94 25.27 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 123.416 0.447 . . . . 75.530000000000001 109.969 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.468 ' O ' HD23 ' A' ' 49' ' ' LEU . 30.7 p90 -154.36 154.96 34.19 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 112.415 0.524 . . . . 71.540000000000006 112.415 -177.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.2 tt -81.08 139.69 35.54 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.019 -0.991 . . . . 72.230000000000004 110.874 -176.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -101.71 115.77 31.27 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 110.253 -0.277 . . . . 72.420000000000002 110.253 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -111.31 -4.45 14.93 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 122.393 1.092 . . . . 72.129999999999995 108.392 177.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -78.73 123.6 85.31 Favored Pre-proline 0 C--N 1.314 -0.959 0 CA-C-N 114.587 -1.188 . . . . 74.120000000000005 109.98 -175.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.02 -27.71 85.08 Favored 'Trans proline' 0 C--N 1.361 1.225 0 C-N-CA 122.878 2.385 . . . . 73.430000000000007 111.308 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 91.8 m -134.93 116.63 14.94 Favored 'General case' 0 N--CA 1.408 -2.535 0 N-CA-C 107.13 -1.433 . . . . 71.310000000000002 107.13 173.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 88.9 m -105.24 114.4 28.56 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 108.969 -0.752 . . . . 73.420000000000002 108.969 -179.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 28.3 p -82.67 130.24 35.09 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 115.35 -0.841 . . . . 74.219999999999999 111.577 -178.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -108.58 115.5 30.21 Favored 'General case' 0 C--O 1.252 1.212 0 CA-C-O 121.385 0.612 . . . . 70.109999999999999 110.947 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 165.74 -158.5 31.41 Favored Glycine 0 CA--C 1.487 -1.691 0 N-CA-C 106.046 -2.822 . . . . 74.040000000000006 106.046 -179.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.8 ttp180 -159.32 78.18 0.72 Allowed 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 119.093 1.446 . . . . 75.239999999999995 111.417 174.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.416 ' HB3' ' HD3' ' A' ' 74' ' ' PRO . 13.0 t60 -175.53 -77.98 0.0 OUTLIER Pre-proline 0 CA--C 1.556 1.176 0 N-CA-C 113.392 0.886 . . . . 74.329999999999998 113.392 175.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.416 ' HD3' ' HB3' ' A' ' 73' ' ' HIS . 48.2 Cg_endo -66.71 -41.87 10.14 Favored 'Trans proline' 0 C--N 1.394 2.966 0 CA-C-N 120.839 1.335 . . . . 75.420000000000002 113.372 -169.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -166.71 114.54 0.85 Allowed 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 102.582 -3.118 . . . . 52.350000000000001 102.582 -178.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 19.7 m -136.33 103.07 5.17 Favored 'General case' 0 C--N 1.26 -3.319 0 CA-C-N 115.888 -0.597 . . . . 73.120000000000005 109.647 -178.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -74.07 -31.98 63.07 Favored 'General case' 0 CA--C 1.493 -1.227 0 CA-C-N 115.218 -0.901 . . . . 75.219999999999999 109.363 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 39.0 pt -119.75 137.82 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.871 0 N-CA-C 107.086 -1.45 . . . . 75.319999999999993 107.086 170.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -85.73 124.14 31.91 Favored 'General case' 0 C--N 1.284 -2.272 0 N-CA-C 108.145 -1.057 . . . . 73.140000000000001 108.145 179.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.414 ' HA ' ' HB2' ' A' ' 56' ' ' ASN . 35.4 tp -122.02 155.58 35.3 Favored 'General case' 0 N--CA 1.414 -2.248 0 CA-C-N 115.929 -0.578 . . . . 74.439999999999998 109.712 -174.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.419 ' CB ' ' HA ' ' A' ' 56' ' ' ASN . 9.8 t70 -168.94 150.32 4.57 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 104.583 -2.376 . . . . 64.230000000000004 104.583 178.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -169.41 164.28 10.61 Favored 'General case' 0 C--N 1.26 -3.298 0 N-CA-C 106.647 -1.612 . . . . 73.230000000000004 106.647 -176.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.8 m -63.2 -23.72 34.05 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 O-C-N 123.309 0.381 . . . . 73.319999999999993 111.367 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.507 ' HB ' ' HB2' ' A' ' 108' ' ' ASN . 45.8 m -144.2 70.77 1.3 Allowed 'General case' 0 N--CA 1.423 -1.793 0 CA-C-O 122.39 1.091 . . . . 72.109999999999999 109.802 175.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.5 p -95.84 140.19 17.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 114.499 -1.228 . . . . 74.049999999999997 110.466 -177.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 24.1 t -92.72 159.95 15.19 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 110.054 -0.35 . . . . 75.400000000000006 110.054 178.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 4.5 tpp180 -57.88 -47.97 81.19 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.864 0.865 . . . . 71.439999999999998 109.024 177.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -119.08 86.93 2.64 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 104.685 -2.339 . . . . 75.519999999999996 104.685 174.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 25.5 t60 -81.39 -52.49 7.22 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.962 -0.563 . . . . 71.140000000000001 111.204 -172.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.97 160.6 42.16 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 120.02 -0.672 . . . . 72.239999999999995 110.239 -177.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -131.18 127.22 37.51 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 108.345 -0.983 . . . . 75.310000000000002 108.345 174.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -106.74 123.91 48.84 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 109.692 -0.484 . . . . 74.219999999999999 109.692 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -113.74 136.33 52.97 Favored 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 107.858 -1.164 . . . . 74.319999999999993 107.858 177.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 12.5 tt -116.1 131.44 68.6 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.236 0 C-N-CA 119.522 -0.871 . . . . 75.030000000000001 109.844 -178.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -109.4 145.97 35.23 Favored 'General case' 0 C--N 1.282 -2.359 0 N-CA-C 105.171 -2.159 . . . . 73.540000000000006 105.171 175.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -54.75 -22.94 15.66 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 113.226 0.825 . . . . 75.140000000000001 113.226 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -117.07 5.73 17.82 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 120.321 -0.943 . . . . 61.310000000000002 114.094 177.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -162.44 148.49 12.86 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 118.778 1.289 . . . . 62.299999999999997 111.642 -177.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -117.79 114.51 23.39 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.491 -0.929 . . . . 73.340000000000003 108.491 -176.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -132.25 135.13 46.06 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 119.638 -0.825 . . . . 61.409999999999997 112.498 -177.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.2 p -121.83 131.36 73.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-N 115.883 -0.599 . . . . 71.409999999999997 110.243 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.2 m -106.37 134.77 47.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-O 120.905 0.383 . . . . 70.120000000000005 110.907 178.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -90.0 108.95 20.03 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.283 -1.377 . . . . 74.439999999999998 107.283 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 21.2 m -113.52 11.7 8.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-N 115.942 -0.572 . . . . 74.439999999999998 111.29 -178.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -144.15 63.17 0.48 Allowed Glycine 0 N--CA 1.432 -1.584 0 N-CA-C 109.444 -1.462 . . . . 73.5 109.444 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 13.3 m -74.93 61.35 1.03 Allowed 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 123.549 0.74 . . . . 64.230000000000004 112.722 -173.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 85.4 mt -89.09 -49.11 6.95 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.467 -0.938 . . . . 74.230000000000004 108.467 176.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.507 ' HB2' ' HB ' ' A' ' 84' ' ' THR . 53.6 t30 -114.74 -33.0 5.64 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.592 -0.731 . . . . 74.310000000000002 109.506 -179.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 102.68 138.89 10.2 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.568 -0.825 . . . . 71.109999999999999 114.79 171.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.2 m -97.24 138.16 35.15 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.251 -1.018 . . . . 74.340000000000003 108.251 174.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.485 ' CE2' ' HB3' ' A' ' 116' ' ' PRO . 52.8 m-85 -130.89 151.91 50.8 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 109.321 -0.622 . . . . 72.329999999999998 109.321 -177.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.413 HG13 HE21 ' A' ' 120' ' ' GLN . 8.6 p -128.8 118.53 47.36 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 N-CA-C 108.017 -1.105 . . . . 73.209999999999994 108.017 168.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 48.82 51.8 15.25 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 116.21 -0.45 . . . . 75.230000000000004 111.563 -175.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 70.5 mtp180 74.42 -17.48 0.47 Allowed 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 124.763 1.225 . . . . 74.430000000000007 114.192 -179.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -76.07 115.04 43.17 Favored Pre-proline 0 C--O 1.247 0.952 0 CA-C-N 117.79 0.268 . . . . 63.539999999999999 111.23 -177.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.485 ' HB3' ' CE2' ' A' ' 111' ' ' TYR . 36.3 Cg_endo -91.8 102.9 0.22 Allowed 'Trans proline' 0 N--CA 1.443 -1.469 0 C-N-CA 123.141 2.561 . . . . 73.519999999999996 112.202 178.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 25.5 mtp180 -130.34 161.35 31.49 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 122.107 -0.37 . . . . 62.530000000000001 110.561 176.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -84.95 -8.94 58.55 Favored 'General case' 0 CA--C 1.496 -1.134 0 N-CA-C 113.434 0.902 . . . . 73.420000000000002 113.434 -177.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -153.42 137.9 16.77 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 105.432 -2.062 . . . . 72.420000000000002 105.432 170.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.413 HE21 HG13 ' A' ' 112' ' ' VAL . 9.0 mm100 -141.34 149.21 40.87 Favored 'General case' 0 CA--C 1.472 -2.033 0 N-CA-C 114.451 1.278 . . . . 73.219999999999999 114.451 -178.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 25.5 t -88.33 122.88 40.38 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.261 0 N-CA-C 105.878 -1.897 . . . . 72.230000000000004 105.878 174.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 52.8 mtt -70.91 139.34 50.69 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 120.85 0.357 . . . . 75.25 110.808 -178.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 60.6 tp60 -104.75 131.48 52.15 Favored 'General case' 0 N--CA 1.425 -1.723 0 N-CA-C 108.896 -0.779 . . . . 72.230000000000004 108.896 -177.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -78.51 115.6 18.33 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 115.735 -0.666 . . . . 74.200000000000003 111.177 -178.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 98.84 8.8 53.81 Favored Glycine 0 N--CA 1.438 -1.227 0 CA-C-N 115.617 -0.72 . . . . 71.439999999999998 111.687 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -125.58 -176.55 3.63 Favored 'General case' 0 C--O 1.245 0.816 0 N-CA-C 112.193 0.442 . . . . 74.120000000000005 112.193 -178.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.406 ' HG2' HG21 ' A' ' 136' ' ' VAL . 43.0 mt-10 -108.55 132.21 54.08 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 113.755 1.02 . . . . 72.340000000000003 113.755 -170.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.7 mp -114.1 120.09 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.991 0 N-CA-C 105.959 -1.867 . . . . 75.439999999999998 105.959 175.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.406 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 51.1 tt0 -103.7 122.31 44.79 Favored 'General case' 0 C--N 1.282 -2.329 0 CA-C-O 121.223 0.535 . . . . 71.140000000000001 110.264 -177.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.3 pp -103.28 98.85 7.32 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.182 0 CA-C-N 115.309 -0.86 . . . . 72.409999999999997 109.979 178.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 78.82 -106.6 2.38 Favored Glycine 0 N--CA 1.421 -2.351 0 N-CA-C 109.838 -1.305 . . . . 51.350000000000001 109.838 -176.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -111.35 -12.92 13.99 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 122.419 0.288 . . . . 74.409999999999997 111.464 177.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.437 ' HB3' ' O ' ' A' ' 53' ' ' ARG . 79.6 m-85 -97.77 151.15 20.47 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 112.605 0.594 . . . . 74.439999999999998 112.605 -172.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 20.0 mtp180 -112.49 128.3 56.29 Favored 'General case' 0 C--O 1.252 1.21 0 CA-C-O 121.949 0.881 . . . . 73.140000000000001 112.577 -168.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 5.0 tt -120.98 136.41 54.98 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 114.056 -1.429 . . . . 75.049999999999997 107.735 -178.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.406 HG21 ' HG2' ' A' ' 127' ' ' GLU . 22.0 t -109.01 127.98 65.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 106.985 -1.487 . . . . 61.020000000000003 106.985 176.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -105.67 122.86 46.93 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 109.147 -0.686 . . . . 64.530000000000001 109.147 -177.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.8 mp -130.51 159.04 38.27 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.857 -0.423 . . . . 73.530000000000001 109.857 -178.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -79.26 133.07 36.66 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 107.15 -1.426 . . . . 63.219999999999999 107.15 173.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -91.85 -160.92 36.53 Favored Glycine 0 N--CA 1.435 -1.414 0 C-N-CA 120.514 -0.851 . . . . 65.209999999999994 113.736 -173.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.476 ' O ' ' HA2' ' A' ' 45' ' ' GLY . 86.9 Cg_endo -81.45 158.88 19.64 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.992 2.462 . . . . 61.329999999999998 113.945 -175.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -107.12 107.63 18.7 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 108.075 -1.083 . . . . 72.439999999999998 108.075 176.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.401 ' HB2' ' HB2' ' A' ' 44' ' ' ALA . 13.5 mm-40 . . . . . 0 N--CA 1.426 -1.67 0 C-N-CA 123.049 0.54 . . . . 64.329999999999998 110.769 -176.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.0 mmm . . . . . 0 C--O 1.244 0.805 0 CA-C-O 119.965 -0.064 . . . . 73.5 111.022 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.8 p -66.88 -49.22 66.33 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 106.904 -1.517 . . . . 65.0 106.904 171.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -96.97 148.55 22.85 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 104.77 -2.308 . . . . 73.239999999999995 104.77 167.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -144.39 152.49 40.76 Favored 'General case' 0 C--N 1.292 -1.932 0 O-C-N 122.081 -0.387 . . . . 75.319999999999993 110.404 -176.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -153.16 94.88 1.89 Allowed 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.351 0.596 . . . . 73.219999999999999 110.044 -177.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -146.37 86.79 0.17 Allowed Glycine 0 N--CA 1.425 -2.062 0 N-CA-C 108.665 -1.774 . . . . 74.109999999999999 108.665 178.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.6 m -78.83 122.8 85.11 Favored Pre-proline 0 C--N 1.305 -1.339 0 CA-C-N 115.755 -0.223 . . . . 72.140000000000001 111.414 -174.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -69.22 138.43 39.52 Favored 'Trans proline' 0 C--O 1.25 1.095 0 C-N-CA 122.93 2.42 . . . . 74.439999999999998 110.804 172.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.4 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 8.4 pt-20 -95.52 137.83 21.94 Favored Pre-proline 0 C--O 1.251 1.183 0 C-N-CA 118.864 -1.134 . . . . 65.109999999999999 109.788 176.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 9' ' ' GLU . 5.3 Cg_exo -75.72 127.2 10.02 Favored 'Trans proline' 0 N--CA 1.439 -1.714 0 C-N-CA 122.242 1.961 . . . . 70.150000000000006 109.982 175.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -68.11 123.41 20.59 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 109.023 -0.732 . . . . 74.299999999999997 109.023 178.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.2 t -92.09 94.7 4.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 107.659 -1.237 . . . . 74.129999999999995 107.659 175.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.439 ' OE2' HG21 ' A' ' 15' ' ' THR . 0.4 OUTLIER -70.23 127.05 31.44 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 106.504 -1.665 . . . . 75.140000000000001 106.504 -179.123 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.6 m -100.48 -24.64 14.43 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 113.329 0.863 . . . . 74.329999999999998 113.329 -169.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.439 HG21 ' OE2' ' A' ' 13' ' ' GLU 0.313 14.0 t -83.63 72.14 10.33 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-O 123.896 1.808 . . . . 73.239999999999995 112.936 -174.314 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 57.3 m -139.37 138.55 36.69 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 104.521 -2.4 . . . . 73.319999999999993 104.521 174.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.1 t 71.19 110.13 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.244 0.805 0 N-CA-C 107.35 -1.352 . . . . 73.219999999999999 107.35 -170.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -125.26 139.4 53.75 Favored 'General case' 0 C--N 1.288 -2.074 0 CA-C-N 116.045 -0.525 . . . . 73.049999999999997 110.985 -174.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 60.0 mtt85 -111.52 102.23 10.59 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 107.862 -1.162 . . . . 72.450000000000003 107.862 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.16 86.28 7.05 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.284 0.564 . . . . 73.129999999999995 110.098 -178.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -81.88 -39.73 23.43 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.326 -0.99 . . . . 73.099999999999994 108.326 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 66.4 tp -79.81 100.78 8.14 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-N 114.928 -1.033 . . . . 71.530000000000001 109.997 177.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -117.73 142.49 47.2 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 103.033 -2.951 . . . . 74.219999999999999 103.033 174.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -64.21 133.9 53.74 Favored 'General case' 0 C--O 1.244 0.808 0 N-CA-C 113.577 0.954 . . . . 75.230000000000004 113.577 -176.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -70.26 162.33 28.66 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 113.709 -1.587 . . . . 73.219999999999999 110.57 -177.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 59.8 ttp -83.0 93.46 7.57 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-O 121.306 0.574 . . . . 74.040000000000006 109.718 178.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.558 ' HG2' ' H ' ' A' ' 28' ' ' SER . 22.4 tt0 -100.13 -157.62 0.62 Allowed 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 106.677 -1.601 . . . . 72.109999999999999 106.677 -179.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.558 ' H ' ' HG2' ' A' ' 27' ' ' GLU . 14.5 m -59.07 133.29 55.96 Favored 'General case' 0 C--O 1.248 1.016 0 CA-C-N 118.049 0.386 . . . . 75.420000000000002 109.988 179.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 45.7 m -75.53 131.91 40.37 Favored 'General case' 0 N--CA 1.419 -1.995 0 CA-C-O 121.554 0.692 . . . . 63.520000000000003 110.3 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.3 t -90.02 122.21 32.81 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 114.888 -1.051 . . . . 71.329999999999998 110.004 -176.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -77.85 -33.3 42.23 Favored Glycine 0 CA--C 1.488 -1.603 0 N-CA-C 109.25 -1.54 . . . . 62.240000000000002 109.25 178.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.48 ' CG2' ' HA ' ' A' ' 98' ' ' GLU . 35.2 m -71.85 142.87 49.58 Favored 'General case' 0 N--CA 1.408 -2.552 0 N-CA-C 107.588 -1.264 . . . . 74.109999999999999 107.588 174.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -83.79 114.43 53.85 Favored Pre-proline 0 C--N 1.308 -1.196 0 N-CA-C 111.525 0.195 . . . . 74.430000000000007 111.525 -173.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -62.03 122.47 10.99 Favored 'Trans proline' 0 C--O 1.245 0.844 0 C-N-CA 121.842 1.694 . . . . 73.209999999999994 110.24 179.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -79.6 23.36 0.42 Allowed 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.384 0.612 . . . . 71.200000000000003 112.384 -174.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.5 m -75.95 -30.02 58.51 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-O 121.262 0.553 . . . . 73.510000000000005 109.795 178.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 11.6 t -162.42 127.16 3.23 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 107.51 -1.293 . . . . 75.409999999999997 107.51 177.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.68 68.55 1.61 Allowed Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.823 -0.703 . . . . 72.5 111.399 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.42 -34.54 76.19 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 120.709 0.29 . . . . 73.329999999999998 110.852 -178.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -60.21 -10.3 4.38 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 124.611 1.165 . . . . 73.219999999999999 113.936 -178.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -63.04 -14.98 54.79 Favored 'General case' 0 C--N 1.28 -2.429 0 C-N-CA 125.042 1.337 . . . . 75.420000000000002 111.634 178.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.427 HD23 ' C ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -43.39 139.38 2.53 Favored Pre-proline 0 CA--C 1.555 1.147 0 N-CA-C 114.959 1.466 . . . . 75.219999999999999 114.959 -178.296 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -77.14 -18.34 14.42 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 122.645 2.23 . . . . 74.310000000000002 112.585 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.427 ' C ' HD23 ' A' ' 42' ' ' LEU . . . -162.93 129.14 3.36 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 107.702 -1.221 . . . . 74.409999999999997 107.702 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.71 -28.55 60.92 Favored Glycine 0 CA--C 1.495 -1.167 0 N-CA-C 111.06 -0.816 . . . . 53.329999999999998 111.06 178.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.7 m -129.67 146.1 51.48 Favored 'General case' 0 N--CA 1.414 -2.229 0 N-CA-C 107.266 -1.383 . . . . 52.420000000000002 107.266 177.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.83 175.1 10.67 Favored 'General case' 0 C--N 1.282 -2.362 0 N-CA-C 106.875 -1.528 . . . . 62.310000000000002 106.875 -178.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.8 pp -133.82 154.26 51.14 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 112.885 0.698 . . . . 75.030000000000001 112.885 -175.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.596 ' O ' ' HA ' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -118.94 140.9 49.22 Favored 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 108.312 -0.995 . . . . 73.409999999999997 108.312 175.575 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.8 t -121.3 114.32 42.8 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 108.566 -0.901 . . . . 75.239999999999995 108.566 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 78.5 t -93.8 115.54 32.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 107.592 -1.262 . . . . 63.310000000000002 107.592 175.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 51.7 tttm -90.38 -24.1 20.89 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.771 -0.649 . . . . 74.239999999999995 110.505 -173.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.402 ' O ' ' HB3' ' A' ' 133' ' ' PHE . 30.8 ttp-105 -146.69 119.3 8.54 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 106.878 -1.527 . . . . 74.340000000000003 106.878 176.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 143.15 116.86 1.18 Allowed Glycine 0 N--CA 1.417 -2.575 0 C-N-CA 120.176 -1.011 . . . . 74.299999999999997 112.181 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.424 ' HB2' ' HB3' ' A' ' 81' ' ' ASP . 27.8 Cg_exo -65.44 -10.81 27.59 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 123.423 2.749 . . . . 72.25 111.089 178.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.503 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 2.2 m-20 -48.38 -36.16 14.07 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 126.295 1.838 . . . . 75.439999999999998 110.212 174.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -152.16 -62.09 0.16 Allowed 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 107.978 -1.119 . . . . 71.430000000000007 107.978 175.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.61 23.83 75.36 Favored Glycine 0 CA--C 1.508 -0.363 0 CA-C-N 115.596 -0.729 . . . . 72.120000000000005 112.958 177.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -157.25 -179.43 8.19 Favored 'General case' 0 N--CA 1.428 -1.525 0 N-CA-C 108.478 -0.934 . . . . 62.399999999999999 108.478 -176.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.596 ' HA ' ' O ' ' A' ' 49' ' ' LEU . 9.8 ptp85 -111.1 133.87 53.14 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 124.04 0.838 . . . . 73.019999999999996 109.515 175.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -141.51 153.05 44.67 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.556 -0.535 . . . . 75.219999999999999 109.556 173.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.0 pp -94.41 140.4 29.86 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 112.114 0.413 . . . . 64.510000000000005 112.114 -177.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -78.6 114.94 17.95 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.646 -0.706 . . . . 72.420000000000002 109.918 178.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -146.47 16.83 1.31 Allowed 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 123.267 1.508 . . . . 71.239999999999995 107.596 175.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -126.49 104.34 24.71 Favored Pre-proline 0 C--N 1.301 -1.535 0 CA-C-N 114.352 -1.295 . . . . 74.420000000000002 108.029 178.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -45.92 -47.43 14.19 Favored 'Trans proline' 0 C--N 1.369 1.614 0 C-N-CA 124.133 3.222 . . . . 62.350000000000001 114.279 -174.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 50.3 m -113.24 97.33 6.42 Favored 'General case' 0 N--CA 1.424 -1.769 0 CA-C-O 121.319 0.58 . . . . 72.409999999999997 110.467 178.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.405 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 93.1 m -109.03 114.14 27.62 Favored 'General case' 0 N--CA 1.424 -1.771 0 N-CA-C 108.695 -0.854 . . . . 74.109999999999999 108.695 177.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 41.6 m -105.01 131.44 52.52 Favored 'General case' 0 N--CA 1.421 -1.895 0 CA-C-O 121.037 0.446 . . . . 75.230000000000004 109.904 -175.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -103.78 130.41 51.31 Favored 'General case' 0 N--CA 1.419 -1.981 0 N-CA-C 107.905 -1.146 . . . . 74.530000000000001 107.905 176.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -170.39 -140.86 3.11 Favored Glycine 0 N--CA 1.425 -2.058 0 N-CA-C 110.672 -0.971 . . . . 73.209999999999994 110.672 -178.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 27.1 ttm-85 -79.84 -59.12 2.86 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 120.469 -0.492 . . . . 75.129999999999995 109.854 -176.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 28.2 t-80 175.22 -47.76 0.0 OUTLIER Pre-proline 0 CA--C 1.562 1.431 0 O-C-N 124.203 0.939 . . . . 73.439999999999998 113.167 177.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -57.55 -27.9 78.71 Favored 'Trans proline' 0 C--N 1.384 2.421 0 C-N-CA 122.065 1.844 . . . . 74.310000000000002 114.13 -174.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -125.12 26.47 6.94 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 109.697 -0.483 . . . . 72.129999999999995 109.697 -177.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.3 m -145.01 140.37 28.1 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 122.298 -0.252 . . . . 71.25 110.558 -175.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -69.03 -42.36 76.49 Favored 'General case' 0 C--O 1.242 0.708 0 C-N-CA 120.191 -0.604 . . . . 75.209999999999994 110.394 178.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 21.0 pt -100.86 144.32 12.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 CA-C-N 115.118 -0.946 . . . . 75.340000000000003 109.934 178.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -100.61 117.73 35.32 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.106 0.479 . . . . 75.230000000000004 109.969 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.503 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 6.9 mp -98.71 122.9 42.52 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 120.842 0.353 . . . . 72.230000000000004 111.917 -178.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.424 ' HB3' ' HB2' ' A' ' 55' ' ' PRO . 24.3 t70 -99.83 73.78 1.79 Allowed 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 106.01 -1.848 . . . . 72.129999999999995 106.01 168.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.406 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 13.2 t70 -81.56 -175.87 5.74 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.141 -1.391 . . . . 72.430000000000007 107.718 -177.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.8 p -88.94 -23.64 6.23 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 N-CA-C 108.182 -1.044 . . . . 72.340000000000003 108.182 178.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 17.7 m -154.35 84.69 1.12 Allowed 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 116.033 -0.531 . . . . 74.219999999999999 110.069 176.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.406 ' HB ' ' HB3' ' A' ' 82' ' ' ASP . 7.4 p -108.7 136.28 44.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.912 -0.586 . . . . 72.219999999999999 110.03 -178.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 23.7 p -90.99 -81.98 0.3 Allowed 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.575 0.703 . . . . 73.430000000000007 111.616 -178.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -162.72 -34.09 0.04 OUTLIER 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 125.203 1.401 . . . . 72.310000000000002 108.333 -179.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 11.5 mmt180 -125.69 101.09 6.72 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 105.033 -2.21 . . . . 71.310000000000002 105.033 174.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 18.4 t60 -95.79 -60.61 1.61 Allowed 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.657 -0.868 . . . . 71.0 108.657 -173.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -145.57 144.31 30.43 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 115.771 -0.649 . . . . 72.5 110.055 -178.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -104.34 127.99 52.09 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 115.653 -0.703 . . . . 73.439999999999998 109.164 176.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.405 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 95.5 m-85 -104.68 112.02 24.96 Favored 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 107.061 -1.459 . . . . 74.340000000000003 107.061 174.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -104.4 122.1 44.79 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-N 114.528 -1.214 . . . . 74.219999999999999 110.259 -177.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.8 116.03 50.86 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.654 0 N-CA-C 105.978 -1.86 . . . . 73.209999999999994 105.978 171.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.491 ' C ' ' H ' ' A' ' 97' ' ' GLY . 52.5 t30 -114.08 148.05 37.73 Favored 'General case' 0 C--N 1.276 -2.6 0 N-CA-C 106.343 -1.725 . . . . 72.319999999999993 106.343 -178.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -52.59 24.52 0.0 OUTLIER 'General case' 0 CA--C 1.578 2.04 0 C-N-CA 126.847 2.059 . . . . 72.310000000000002 115.296 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.491 ' H ' ' C ' ' A' ' 95' ' ' ASN . . . -168.29 -43.66 0.03 OUTLIER Glycine 0 N--CA 1.426 -2.006 0 N-CA-C 110.123 -1.191 . . . . 63.420000000000002 110.123 -178.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.48 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 43.8 mt-10 -120.23 143.66 48.16 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 113.035 0.754 . . . . 73.430000000000007 113.035 -175.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.472 ' HB3' ' SD ' ' A' ' 122' ' ' MET . 84.1 m-85 -105.12 121.5 43.93 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 105.522 -2.029 . . . . 75.319999999999993 105.522 173.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -127.75 136.3 51.33 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 112.701 0.63 . . . . 74.230000000000004 112.701 -174.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.2 p -115.19 118.85 60.08 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 N-CA-C 108.836 -0.801 . . . . 72.400000000000006 108.836 177.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 42.7 t -120.27 129.99 74.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-N 116.282 -0.417 . . . . 71.129999999999995 110.21 -177.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.574 ' OD2' ' HB3' ' A' ' 106' ' ' SER . 10.9 t70 -83.37 130.26 35.04 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 107.239 -1.393 . . . . 73.349999999999994 107.239 172.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.0 m -124.01 13.57 4.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 112.946 0.721 . . . . 72.140000000000001 112.946 -177.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 152.94 26.61 0.04 OUTLIER Glycine 0 N--CA 1.438 -1.209 0 C-N-CA 118.59 -1.767 . . . . 44.5 114.42 178.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.574 ' HB3' ' OD2' ' A' ' 103' ' ' ASP . 32.7 t -79.8 131.57 35.93 Favored 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 108.075 -1.083 . . . . 75.420000000000002 108.075 175.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -76.07 -18.46 59.19 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.517 0.675 . . . . 73.310000000000002 110.171 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -88.9 -37.03 15.61 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 115.186 -0.915 . . . . 72.239999999999995 109.16 178.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 92.22 121.04 2.77 Favored Glycine 0 C--N 1.306 -1.11 0 CA-C-N 114.86 -1.064 . . . . 61.310000000000002 112.589 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 24.0 m -85.23 120.15 26.41 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 109.147 -0.686 . . . . 64.129999999999995 109.147 176.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -139.12 163.09 33.35 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.719 -0.474 . . . . 72.129999999999995 109.719 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.48 ' HB ' ' HB3' ' A' ' 115' ' ' GLU . 23.9 t -100.36 141.49 17.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 106.511 -1.663 . . . . 65.349999999999994 106.511 177.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -60.05 -25.07 65.07 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-O 120.969 0.414 . . . . 73.219999999999999 111.419 -175.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 81.8 mtt85 -106.58 -9.28 16.64 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.387 -0.37 . . . . 65.219999999999999 111.773 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.519 ' HG2' ' NE2' ' A' ' 120' ' ' GLN . 9.5 tp10 -133.16 112.9 13.33 Favored Pre-proline 0 C--O 1.252 1.231 0 C-N-CA 119.983 -0.687 . . . . 73.329999999999998 110.858 -172.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -75.25 60.61 5.66 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.516 2.811 . . . . 63.219999999999999 111.77 177.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.433 ' HB3' ' O ' ' A' ' 119' ' ' ALA . 28.4 mmm-85 -128.92 131.86 47.6 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.919 -1.141 . . . . 73.140000000000001 107.919 -179.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 31.4 p-10 -83.62 -18.35 38.46 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-O 121.96 0.886 . . . . 74.140000000000001 109.67 177.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.433 ' O ' ' HB3' ' A' ' 117' ' ' ARG . . . -128.98 133.85 47.94 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 106.551 -1.648 . . . . 74.319999999999993 106.551 165.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.519 ' NE2' ' HG2' ' A' ' 115' ' ' GLU . 5.0 tp60 -144.59 150.77 38.02 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 123.655 0.597 . . . . 64.109999999999999 112.171 -177.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.457 ' O ' ' HG3' ' A' ' 120' ' ' GLN . 7.3 p -79.65 130.62 35.78 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 N-CA-C 106.195 -1.78 . . . . 74.099999999999994 106.195 168.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.472 ' SD ' ' HB3' ' A' ' 99' ' ' PHE . 65.2 mtt -66.92 156.2 36.46 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 112.7 0.63 . . . . 71.310000000000002 112.7 -173.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -132.67 134.6 45.04 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.374 -1.343 . . . . 74.439999999999998 107.374 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 7.6 t -79.68 128.23 33.16 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 109.122 -0.696 . . . . 72.340000000000003 109.122 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 93.46 20.75 31.27 Favored Glycine 0 N--CA 1.421 -2.3 0 C-N-CA 120.229 -0.986 . . . . 74.340000000000003 111.298 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -123.4 172.9 8.34 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.235 -1.394 . . . . 72.299999999999997 107.235 178.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -129.05 125.68 37.8 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-O 121.383 0.611 . . . . 73.109999999999999 110.826 -173.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 59.4 mt -109.49 130.77 61.95 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 CA-C-N 115.015 -0.993 . . . . 75.349999999999994 108.641 -175.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -98.43 112.64 24.59 Favored 'General case' 0 N--CA 1.423 -1.816 0 N-CA-C 108.659 -0.867 . . . . 61.340000000000003 108.659 178.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 18.8 pt -90.92 98.36 8.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-O 121.727 0.775 . . . . 71.409999999999997 109.577 -178.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 75.28 -82.0 0.92 Allowed Glycine 0 N--CA 1.426 -2.027 0 CA-C-N 114.571 -1.195 . . . . 54.310000000000002 110.123 -176.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -136.1 -11.03 1.98 Allowed 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 109.917 -0.401 . . . . 65.150000000000006 109.917 176.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.402 ' HB3' ' O ' ' A' ' 53' ' ' ARG . 89.3 m-85 -94.5 157.08 16.16 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 113.185 0.809 . . . . 74.5 113.185 -172.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 45.9 ttt180 -99.66 120.58 39.92 Favored 'General case' 0 C--O 1.245 0.867 0 CA-C-N 115.66 -0.7 . . . . 72.120000000000005 111.452 -167.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.5 tt -125.23 129.21 49.62 Favored 'General case' 0 C--O 1.218 -0.586 0 C-N-CA 123.973 0.909 . . . . 72.209999999999994 109.721 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 40.6 t -107.83 128.05 63.41 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 N-CA-C 107.606 -1.257 . . . . 74.209999999999994 107.606 177.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -102.28 125.76 49.07 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 109.729 -0.471 . . . . 72.329999999999998 109.729 -178.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 84.2 mt -138.73 138.18 37.45 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.533 0.682 . . . . 73.450000000000003 111.282 -176.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -80.19 90.92 5.51 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 108.18 -1.045 . . . . 72.040000000000006 108.18 174.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -65.6 -79.83 0.18 Allowed Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 115.388 -0.823 . . . . 62.310000000000002 111.409 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -81.45 120.95 3.7 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 C-N-CA 121.608 1.539 . . . . 73.200000000000003 111.968 177.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -91.05 104.13 16.75 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 107.212 -1.403 . . . . 74.409999999999997 107.212 176.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 . . . . . 0 C--N 1.289 -2.037 0 N-CA-C 108.013 -1.106 . . . . 74.400000000000006 108.013 -173.218 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.2 mtt . . . . . 0 CA--C 1.491 -1.293 0 N-CA-C 107.883 -1.155 . . . . 73.140000000000001 107.883 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.5 t -76.64 -37.86 55.62 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 109.357 -0.609 . . . . 73.540000000000006 109.357 178.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . 0.31 5.1 p-10 37.81 76.25 0.06 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.209 1.404 . . . . 63.0 113.465 -178.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -76.25 95.19 3.68 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 114.311 -1.313 . . . . 72.25 110.603 -177.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -101.91 136.41 41.8 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 114.95 -1.023 . . . . 74.299999999999997 109.769 177.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 159.87 138.11 2.38 Favored Glycine 0 N--CA 1.429 -1.775 0 C-N-CA 120.893 -0.67 . . . . 65.129999999999995 111.986 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.9 t -105.61 132.96 20.43 Favored Pre-proline 0 N--CA 1.427 -1.58 0 N-CA-C 109.12 -0.696 . . . . 64.450000000000003 109.12 178.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -66.84 132.28 28.01 Favored 'Trans proline' 0 C--O 1.243 0.762 0 C-N-CA 122.232 1.955 . . . . 73.430000000000007 110.342 176.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -80.89 146.45 59.61 Favored Pre-proline 0 C--N 1.306 -1.324 0 CA-C-N 116.587 -0.279 . . . . 75.430000000000007 110.501 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -62.01 139.07 77.03 Favored 'Trans proline' 0 C--O 1.243 0.765 0 C-N-CA 122.403 2.069 . . . . 65.430000000000007 110.983 178.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -84.52 137.43 33.34 Favored 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 108.154 -1.054 . . . . 74.310000000000002 108.154 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.4 m -74.44 85.34 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 CA-C-O 122.55 1.166 . . . . 73.310000000000002 111.277 178.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -92.85 137.54 32.27 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 114.737 -1.119 . . . . 73.209999999999994 108.568 -178.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.0 p -72.48 130.19 40.09 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 116.458 -0.337 . . . . 64.329999999999998 111.019 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.2 t -77.73 -8.19 57.61 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-O 122.601 1.191 . . . . 74.430000000000007 108.276 176.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.9 m -76.8 100.13 5.38 Favored 'General case' 0 N--CA 1.412 -2.367 0 CA-C-N 113.702 -1.59 . . . . 73.430000000000007 107.073 174.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.6 m -81.95 91.66 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.673 0 CA-C-O 122.392 1.091 . . . . 75.349999999999994 111.245 -178.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -83.04 116.81 22.45 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 106.672 -1.603 . . . . 73.150000000000006 106.672 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.428 ' O ' ' HA ' ' A' ' 141' ' ' PRO . 98.9 mtt180 -59.24 103.94 0.22 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.719 0.771 . . . . 73.010000000000005 112.446 -175.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -126.17 69.87 1.22 Allowed 'General case' 0 N--CA 1.42 -1.961 0 N-CA-C 108.49 -0.93 . . . . 75.120000000000005 108.49 177.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.445 ' HB3' ' HB2' ' A' ' 142' ' ' ALA . 18.2 t70 -63.77 -41.88 97.88 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 114.859 -1.064 . . . . 52.140000000000001 109.625 177.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 54.2 tp 54.86 95.23 0.02 OUTLIER 'General case' 0 C--O 1.242 0.681 0 O-C-N 124.48 1.113 . . . . 73.150000000000006 112.247 178.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.422 HD13 ' O ' ' A' ' 23' ' ' LEU . 4.6 pp -82.02 129.02 34.67 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 115.897 -0.592 . . . . 72.420000000000002 109.974 178.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -121.02 63.45 0.87 Allowed 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 122.531 1.158 . . . . 75.239999999999995 109.688 176.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -75.73 119.13 19.32 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 106.466 -1.679 . . . . 71.120000000000005 106.466 179.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 53.0 ttm -66.44 131.55 46.31 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 109.42 -0.585 . . . . 74.430000000000007 109.42 -179.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -44.76 96.03 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.134 1.374 . . . . 74.099999999999994 112.636 -178.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.6 m -122.55 67.35 0.95 Allowed 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 107.722 -1.214 . . . . 74.329999999999998 107.722 178.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 44.6 t -144.01 142.06 30.48 Favored 'General case' 0 N--CA 1.414 -2.264 0 CA-C-N 114.754 -1.112 . . . . 75.420000000000002 108.908 -174.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.4 m -124.79 16.76 8.68 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.2 -1.037 . . . . 74.340000000000003 108.2 177.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 71.49 53.78 9.65 Favored Glycine 0 N--CA 1.44 -1.097 0 CA-C-N 114.945 -1.025 . . . . 73.430000000000007 111.5 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 52.6 p -90.1 153.9 20.19 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 109.314 -0.625 . . . . 65.209999999999994 109.314 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -74.24 112.74 18.3 Favored Pre-proline 0 C--O 1.245 0.835 0 N-CA-C 109.443 -0.577 . . . . 74.310000000000002 109.443 178.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -80.78 108.72 2.13 Favored 'Trans proline' 0 N--CA 1.439 -1.677 0 C-N-CA 122.218 1.946 . . . . 73.030000000000001 113.272 -177.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -89.66 -25.25 21.34 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 107.127 -1.434 . . . . 71.150000000000006 107.127 173.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 45.8 m -74.71 158.34 33.73 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 114.808 -1.087 . . . . 71.150000000000006 109.422 174.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.3 t -141.71 152.37 43.79 Favored 'General case' 0 N--CA 1.421 -1.883 0 N-CA-C 109.088 -0.708 . . . . 73.299999999999997 109.088 -178.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -153.41 16.16 0.66 Allowed Glycine 0 N--CA 1.42 -2.381 0 CA-C-N 115.946 -0.57 . . . . 72.030000000000001 112.063 178.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -56.62 -40.1 74.77 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 117.403 0.602 . . . . 72.349999999999994 112.365 -178.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -83.9 -23.19 31.32 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-O 121.139 0.495 . . . . 63.409999999999997 111.321 178.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -83.88 -39.06 20.34 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 116.062 -0.517 . . . . 74.510000000000005 111.612 -175.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -83.04 134.37 46.5 Favored Pre-proline 0 C--N 1.294 -1.822 0 N-CA-C 105.726 -1.953 . . . . 74.239999999999995 105.726 178.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -60.87 -176.75 0.15 Allowed 'Trans proline' 0 CA--C 1.545 1.05 0 C-N-CA 122.62 2.213 . . . . 74.099999999999994 112.377 177.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.529 ' O ' ' HA ' ' A' ' 142' ' ' ALA . . . -79.8 88.62 5.23 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.465 -0.772 . . . . 72.510000000000005 109.416 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -82.08 67.95 3.59 Favored Glycine 0 CA--C 1.483 -1.958 0 N-CA-C 109.566 -1.413 . . . . 71.120000000000005 109.566 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.7 p -89.12 152.69 21.49 Favored 'General case' 0 C--N 1.279 -2.474 0 CA-C-N 114.461 -0.87 . . . . 73.540000000000006 111.446 -177.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.92 167.2 20.67 Favored 'General case' 0 C--N 1.284 -2.268 0 CA-C-N 115.166 -0.924 . . . . 75.310000000000002 109.891 -175.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -128.89 138.87 52.26 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.387 0.613 . . . . 72.209999999999994 110.688 -177.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.7 pp -127.91 149.09 50.47 Favored 'General case' 0 C--N 1.282 -2.354 0 CA-C-N 115.671 -0.695 . . . . 74.219999999999999 110.028 178.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.425 HG12 ' CB ' ' A' ' 60' ' ' ARG . 27.2 m -125.87 140.13 49.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 N-CA-C 109.802 -0.444 . . . . 71.409999999999997 109.802 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.4 t -104.19 116.49 48.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 106.484 -1.673 . . . . 71.310000000000002 106.484 175.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -103.59 -25.04 13.34 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 120.264 -0.574 . . . . 74.299999999999997 112.184 -175.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.417 ' O ' ' HA ' ' A' ' 133' ' ' PHE . 24.9 tpt180 -141.35 115.48 9.3 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 120.213 -0.595 . . . . 74.420000000000002 110.957 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 138.15 139.35 3.84 Favored Glycine 0 N--CA 1.433 -1.517 0 C-N-CA 119.796 -1.193 . . . . 75.140000000000001 113.414 173.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -52.49 -8.06 0.36 Allowed 'Trans proline' 0 N--CA 1.506 2.26 0 C-N-CA 125.056 3.837 . . . . 73.340000000000003 115.402 176.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.429 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 37.2 t30 -58.94 -51.42 70.14 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.579 0.752 . . . . 74.310000000000002 109.565 177.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -173.81 -177.39 1.38 Allowed 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.941 -0.763 . . . . 63.299999999999997 108.941 -177.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -164.22 53.87 0.28 Allowed Glycine 0 N--CA 1.425 -2.07 0 N-CA-C 109.512 -1.435 . . . . 51.119999999999997 109.512 178.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -153.69 -176.98 6.07 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 108.523 -0.917 . . . . 63.340000000000003 108.523 -177.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.425 ' CB ' HG12 ' A' ' 50' ' ' VAL . 0.4 OUTLIER -108.55 139.2 43.65 Favored 'General case' 0 C--N 1.309 -1.192 0 O-C-N 123.885 0.741 . . . . 73.219999999999999 109.049 178.8 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -128.49 129.04 45.49 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 110.093 -0.336 . . . . 70.439999999999998 110.093 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -97.09 116.25 28.95 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 105.945 -1.872 . . . . 74.109999999999999 105.945 175.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -99.99 115.65 30.2 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 112.811 0.671 . . . . 74.219999999999999 112.811 -174.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -109.02 -5.88 15.87 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 105.956 -1.868 . . . . 74.5 105.956 168.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -66.1 112.54 9.3 Favored Pre-proline 0 N--CA 1.443 -0.787 0 CA-C-N 112.937 -1.938 . . . . 73.510000000000005 109.124 176.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -62.04 -30.83 83.47 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.663 2.242 . . . . 74.219999999999999 113.003 -177.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 85.5 m -137.17 111.07 8.21 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-O 121.024 0.44 . . . . 75.430000000000007 111.825 -178.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 55.5 m -110.14 114.08 27.3 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 108.624 -0.88 . . . . 73.010000000000005 108.624 176.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.5 p -93.33 140.82 29.13 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 122.091 -0.38 . . . . 74.310000000000002 111.048 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -116.08 140.06 49.66 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 109.473 -0.566 . . . . 72.409999999999997 109.473 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 170.01 -148.71 12.02 Favored Glycine 0 N--CA 1.421 -2.316 0 C-N-CA 120.254 -0.974 . . . . 71.109999999999999 112.372 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.427 ' HB2' ' HA ' ' A' ' 87' ' ' ARG . 56.5 ttt180 -51.47 -75.19 0.03 OUTLIER 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 125.541 1.537 . . . . 75.140000000000001 113.915 -175.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.434 ' HB3' ' CD ' ' A' ' 74' ' ' PRO . 7.9 t60 -172.12 -76.65 0.0 OUTLIER Pre-proline 0 CA--C 1.56 1.347 0 CA-C-O 118.798 -0.62 . . . . 72.329999999999998 110.798 -178.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.434 ' CD ' ' HB3' ' A' ' 73' ' ' HIS . 49.8 Cg_endo -68.55 -24.84 35.47 Favored 'Trans proline' 0 C--N 1.389 2.701 0 CA-C-N 121.135 1.441 . . . . 72.010000000000005 111.136 178.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.407 ' HB3' ' CZ ' ' A' ' 88' ' ' ARG . 34.9 mt-10 -89.0 15.6 8.35 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 114.119 -1.4 . . . . 75.120000000000005 111.526 -173.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.1 p -153.44 166.85 31.37 Favored 'General case' 0 N--CA 1.421 -1.907 0 CA-C-N 116.682 -0.236 . . . . 75.319999999999993 110.751 -178.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -79.98 -46.37 16.78 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.344 -0.984 . . . . 64.099999999999994 108.344 177.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 34.5 pt -104.91 143.57 16.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 108.747 -0.834 . . . . 75.219999999999999 108.747 175.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 33.7 p90 -115.27 117.64 31.04 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 121.495 0.664 . . . . 75.329999999999998 112.49 -174.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.544 HD22 ' CE2' ' A' ' 133' ' ' PHE . 4.5 mp -90.18 111.94 23.27 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.876 -1.157 . . . . 75.340000000000003 107.876 178.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -84.29 10.34 10.74 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-O 121.702 0.763 . . . . 74.349999999999994 112.697 -173.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -77.55 146.02 36.56 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 108.995 -0.743 . . . . 74.25 108.995 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.5 p -67.87 -22.14 27.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-O 121.256 0.55 . . . . 74.400000000000006 111.828 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -96.07 23.16 6.72 Favored 'General case' 0 CA--C 1.557 1.239 0 CA-C-O 121.185 0.516 . . . . 74.340000000000003 110.751 -176.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.2 p -81.94 140.84 15.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 O-C-N 121.921 -0.487 . . . . 72.230000000000004 110.297 -178.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 19.6 m -83.03 156.33 23.44 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.549 -0.908 . . . . 64.239999999999995 108.549 175.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.427 ' HA ' ' HB2' ' A' ' 72' ' ' ARG . 36.5 mtp-105 -63.06 -54.64 34.91 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-O 121.332 0.586 . . . . 74.319999999999993 109.539 -178.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.407 ' CZ ' ' HB3' ' A' ' 75' ' ' GLU . 13.1 mmt180 -117.22 112.55 20.96 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 105.347 -2.094 . . . . 75.040000000000006 105.347 175.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 11.3 t60 -98.13 -76.74 0.52 Allowed 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.16 0.505 . . . . 71.239999999999995 110.534 -174.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.37 167.49 23.45 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.553 -0.717 . . . . 61.409999999999997 110.543 -176.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -127.87 128.19 44.76 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 115.811 -0.631 . . . . 74.019999999999996 109.507 177.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -104.69 120.24 40.88 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.423 -0.954 . . . . 74.230000000000004 108.423 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 78.9 mtt180 -119.25 141.8 48.61 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-O 121.553 0.692 . . . . 75.209999999999994 111.288 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.64 119.79 62.86 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 104.359 -2.46 . . . . 73.430000000000007 104.359 171.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.537 ' C ' ' H ' ' A' ' 97' ' ' GLY . 51.4 t-20 -111.4 147.08 35.98 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 115.299 -0.864 . . . . 74.519999999999996 109.16 -170.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -63.43 31.8 0.01 OUTLIER 'General case' 0 CA--C 1.581 2.136 0 C-N-CA 125.853 1.661 . . . . 75.310000000000002 111.869 176.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.537 ' H ' ' C ' ' A' ' 95' ' ' ASN . . . -171.1 -38.32 0.03 OUTLIER Glycine 0 N--CA 1.428 -1.887 0 N-CA-C 111.46 -0.656 . . . . 72.450000000000003 111.46 -179.05 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -133.11 177.41 7.69 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-O 121.509 0.671 . . . . 73.519999999999996 111.201 -177.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.418 ' HB3' ' HB3' ' A' ' 122' ' ' MET . 87.7 m-85 -122.63 121.33 36.17 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 104.418 -2.438 . . . . 74.409999999999997 104.418 171.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -131.14 127.27 37.71 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 120.661 -0.416 . . . . 64.439999999999998 111.445 -169.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 5.5 p -126.12 119.27 53.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-O 121.526 0.679 . . . . 73.329999999999998 109.472 176.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 23.3 m -119.51 136.6 56.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-N 115.425 -0.807 . . . . 75.209999999999994 112.04 -176.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -83.11 132.34 35.1 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 106.542 -1.651 . . . . 73.540000000000006 106.542 174.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 30.5 m -104.09 8.06 9.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 C-N-CA 119.653 -0.819 . . . . 73.340000000000003 112.285 -179.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 127.89 52.04 0.14 Allowed Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.593 -0.813 . . . . 63.530000000000001 112.447 179.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 14.2 m -80.87 126.18 31.04 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 112.319 0.488 . . . . 73.140000000000001 112.319 -176.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.0 mp -82.47 -22.06 35.33 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 107.493 -1.299 . . . . 74.310000000000002 107.493 173.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.498 ' OD1' ' HA3' ' A' ' 131' ' ' GLY . 22.8 t-20 -75.12 -30.52 60.87 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.372 -1.286 . . . . 74.310000000000002 109.989 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 92.07 117.94 2.36 Favored Glycine 0 C--O 1.221 -0.698 0 N-CA-C 114.566 0.587 . . . . 62.329999999999998 114.566 174.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 88.4 m -99.34 119.81 38.56 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-O 120.966 0.412 . . . . 70.230000000000004 110.093 178.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -115.19 134.78 54.84 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 109.411 -0.588 . . . . 73.219999999999999 109.411 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 5.4 p -113.09 121.16 64.78 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.582 0 N-CA-C 106.557 -1.645 . . . . 74.439999999999998 106.557 171.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 17.6 m120 58.9 26.27 14.7 Favored 'General case' 0 N--CA 1.48 1.05 0 O-C-N 123.163 0.289 . . . . 74.430000000000007 110.266 -175.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 80.38 6.29 1.62 Allowed 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.982 1.313 . . . . 73.349999999999994 113.467 -177.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -100.83 121.47 52.43 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 109.315 -0.624 . . . . 73.409999999999997 109.315 176.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.415 ' HA ' ' O ' ' A' ' 110' ' ' THR . 57.3 Cg_endo -78.14 126.42 7.78 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 121.993 1.795 . . . . 75.329999999999998 111.157 177.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -150.18 -176.96 5.67 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 109.908 -0.404 . . . . 72.439999999999998 109.908 177.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -96.12 -57.37 2.36 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 123.189 0.306 . . . . 73.129999999999995 111.795 -177.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -117.92 139.72 50.73 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 109.629 -0.508 . . . . 62.240000000000002 109.629 -177.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 54.7 tp60 -139.25 140.73 37.77 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 116.207 -0.451 . . . . 73.239999999999995 110.472 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 59.5 t -80.25 114.22 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 104.936 -2.246 . . . . 64.420000000000002 104.936 170.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.472 ' HE2' ' CD1' ' A' ' 137' ' ' PHE . 16.6 ttt -63.36 123.01 17.62 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.973 -0.751 . . . . 74.109999999999999 108.973 -173.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -104.57 136.8 43.45 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-O 121.333 0.587 . . . . 74.420000000000002 111.457 -171.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 14.4 p -79.37 118.55 21.37 Favored 'General case' 0 N--CA 1.416 -2.158 0 CA-C-N 114.891 -1.049 . . . . 74.099999999999994 111.079 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 107.07 -13.33 40.86 Favored Glycine 0 N--CA 1.44 -1.057 0 CA-C-N 115.715 -0.675 . . . . 62.229999999999997 112.219 177.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -99.35 172.95 7.01 Favored 'General case' 0 C--O 1.25 1.088 0 N-CA-C 113.564 0.95 . . . . 74.530000000000001 113.564 -175.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.514 ' OE1' ' HD3' ' A' ' 134' ' ' ARG . 17.1 pt-20 -108.97 140.47 42.42 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 114.528 -1.214 . . . . 73.129999999999995 111.333 -174.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 71.9 mt -123.31 119.28 57.08 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 N-CA-C 106.765 -1.568 . . . . 74.209999999999994 106.765 177.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -115.75 121.88 43.79 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 109.278 -0.638 . . . . 72.439999999999998 109.278 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.503 ' O ' ' HD2' ' A' ' 133' ' ' PHE . 18.5 pt -103.83 98.68 7.13 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.171 0 N-CA-C 108.271 -1.011 . . . . 74.340000000000003 108.271 176.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.498 ' HA3' ' OD1' ' A' ' 108' ' ' ASN . . . 62.97 -95.01 0.12 Allowed Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.273 -0.876 . . . . 75.299999999999997 113.667 -178.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 3.8 ttmp? -101.72 -22.28 14.45 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 123.27 0.628 . . . . 74.150000000000006 109.891 -177.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.544 ' CE2' HD22 ' A' ' 80' ' ' LEU . 5.5 m-85 -92.17 112.14 23.96 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.617 -0.72 . . . . 73.439999999999998 110.038 -170.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.514 ' HD3' ' OE1' ' A' ' 127' ' ' GLU . 13.4 ttm180 -104.52 124.95 50.2 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 120.395 -0.522 . . . . 74.400000000000006 109.943 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.8 tt -124.25 140.33 53.07 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.547 -1.206 . . . . 74.329999999999998 108.604 -177.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 8.9 p -116.35 136.52 53.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 109.036 -0.727 . . . . 74.030000000000001 109.036 175.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.472 ' CD1' ' HE2' ' A' ' 122' ' ' MET . 80.5 t80 -108.42 122.13 46.37 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.26 -0.427 . . . . 74.310000000000002 111.757 -173.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -121.83 150.23 42.21 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.119 -0.697 . . . . 75.209999999999994 109.119 178.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -129.4 148.64 51.34 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 109.691 -0.485 . . . . 75.549999999999997 109.691 178.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -169.21 -70.52 0.03 OUTLIER Glycine 0 C--N 1.303 -1.253 0 C-N-CA 120.019 -1.086 . . . . 61.140000000000001 112.708 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.428 ' HA ' ' O ' ' A' ' 19' ' ' ARG . 10.5 Cg_endo -56.12 102.7 0.1 Allowed 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 123.451 2.767 . . . . 71.019999999999996 116.344 -177.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.529 ' HA ' ' O ' ' A' ' 44' ' ' ALA . . . -111.78 103.37 11.63 Favored 'General case' 0 C--N 1.267 -3.0 0 CA-C-N 113.207 -1.815 . . . . 72.420000000000002 106.417 174.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.402 ' HG3' ' HD2' ' A' ' 19' ' ' ARG . 41.1 tt0 . . . . . 0 C--N 1.291 -1.96 0 O-C-N 123.292 0.37 . . . . 72.340000000000003 110.518 -174.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.4 ttm . . . . . 0 N--CA 1.472 0.639 0 N-CA-C 109.437 -0.579 . . . . 73.349999999999994 109.437 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.9 t -79.7 -37.08 36.53 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 106.297 -1.742 . . . . 75.0 106.297 173.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -75.34 145.21 41.91 Favored 'General case' 0 C--O 1.254 1.318 0 N-CA-C 105.965 -1.865 . . . . 75.319999999999993 105.965 170.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 57.3 64.03 1.72 Allowed 'General case' 0 C--O 1.242 0.678 0 CA-C-O 122.787 1.279 . . . . 72.430000000000007 108.028 -176.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -69.38 167.24 16.95 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 113.1 -1.864 . . . . 74.519999999999996 110.52 -174.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -58.07 149.5 34.45 Favored Glycine 0 C--O 1.239 0.449 0 N-CA-C 112.518 -0.233 . . . . 73.099999999999994 112.518 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 60.5 m -67.46 124.83 90.13 Favored Pre-proline 0 C--N 1.311 -1.105 0 C-N-CA 122.763 0.425 . . . . 75.219999999999999 111.108 -177.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -67.7 151.82 78.54 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.491 2.794 . . . . 72.200000000000003 111.28 176.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -69.97 111.87 10.55 Favored Pre-proline 0 C--N 1.315 -0.895 0 N-CA-C 105.6 -2.0 . . . . 70.120000000000005 105.6 170.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -53.61 109.9 0.43 Allowed 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 123.187 2.592 . . . . 74.209999999999994 114.507 -170.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -90.11 107.86 19.39 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 114.585 -1.188 . . . . 64.120000000000005 108.635 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 46.9 t -89.69 94.02 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.528 0 N-CA-C 108.526 -0.916 . . . . 75.400000000000006 108.526 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -70.01 134.39 48.25 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 114.877 -1.056 . . . . 73.329999999999998 109.486 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 28.5 m -65.87 112.26 3.69 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-O 121.522 0.677 . . . . 73.140000000000001 112.046 -176.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 86.9 m -43.61 125.23 3.93 Favored 'General case' 0 N--CA 1.42 -1.93 0 C-N-CA 127.08 2.152 . . . . 74.219999999999999 114.598 -178.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.8 t -118.32 99.85 7.11 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 113.441 -1.709 . . . . 55.32 108.243 176.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.3 m -129.57 170.9 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 CA-C-O 120.745 0.307 . . . . 74.200000000000003 111.024 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -98.49 95.47 7.33 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 121.191 0.519 . . . . 71.409999999999997 110.499 177.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 41.8 ttm-85 65.75 95.77 0.05 Allowed 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 125.098 1.359 . . . . 74.329999999999998 112.562 178.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -86.63 -4.27 59.15 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.541 0.686 . . . . 55.420000000000002 110.458 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -64.92 -49.49 70.19 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.476 -1.238 . . . . 72.420000000000002 108.646 178.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 68.0 tp -150.34 112.08 4.52 Favored 'General case' 0 N--CA 1.425 -1.684 0 CA-C-N 114.364 -1.289 . . . . 75.519999999999996 108.619 -176.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -104.08 118.73 37.35 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.431 -1.322 . . . . 75.140000000000001 107.431 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -95.61 130.77 42.36 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.447 -0.575 . . . . 71.430000000000007 109.447 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -71.64 93.52 1.25 Allowed 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.856 -0.794 . . . . 75.209999999999994 108.856 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 54.1 mtt -80.33 109.16 14.55 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 108.331 -0.989 . . . . 74.310000000000002 108.331 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -114.36 140.73 48.41 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.11 0.481 . . . . 73.099999999999994 111.182 -178.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.4 p -93.75 104.35 16.44 Favored 'General case' 0 N--CA 1.414 -2.248 0 CA-C-N 115.809 -0.632 . . . . 74.120000000000005 110.926 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.8 t -75.94 -18.71 59.23 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.143 -1.058 . . . . 74.140000000000001 108.143 177.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.5 t -161.15 132.64 5.57 Favored 'General case' 0 N--CA 1.415 -2.204 0 N-CA-C 104.587 -2.375 . . . . 75.209999999999994 104.587 177.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 142.74 -152.31 23.78 Favored Glycine 0 N--CA 1.438 -1.202 0 C-N-CA 119.753 -1.213 . . . . 74.219999999999999 112.025 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.7 t -110.7 148.88 31.35 Favored 'General case' 0 N--CA 1.433 -1.275 0 CA-C-O 121.088 0.471 . . . . 74.510000000000005 110.778 -177.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -91.43 119.05 68.74 Favored Pre-proline 0 C--N 1.31 -1.139 0 CA-C-N 115.766 -0.652 . . . . 74.109999999999999 109.973 178.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -69.87 117.2 4.95 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.42 2.08 . . . . 61.520000000000003 111.535 178.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -143.92 30.4 1.31 Allowed 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.176 -1.046 . . . . 65.420000000000002 108.176 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.9 p -78.2 1.05 22.73 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.844 -1.071 . . . . 72.140000000000001 112.891 -176.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.0 t -76.18 -178.7 4.61 Favored 'General case' 0 CA--C 1.557 1.247 0 N-CA-C 109.793 -0.447 . . . . 72.129999999999995 109.793 178.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -79.53 74.39 2.25 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.977 -0.154 . . . . 73.010000000000005 113.454 -175.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.49 -34.21 63.02 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.252 0.548 . . . . 74.409999999999997 110.206 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -77.21 -23.39 51.42 Favored 'General case' 0 C--O 1.245 0.844 0 CA-C-O 121.487 0.66 . . . . 75.540000000000006 109.55 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -75.7 -34.85 60.43 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.137 -0.938 . . . . 53.329999999999998 109.325 177.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 31.3 tp 69.47 116.98 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 125.509 1.523 . . . . 74.400000000000006 109.517 -177.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -56.2 111.14 0.69 Allowed 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 122.576 2.184 . . . . 74.109999999999999 113.628 -176.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -115.37 152.98 31.85 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 108.163 -1.051 . . . . 51.310000000000002 108.163 177.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.4 32.45 31.07 Favored Glycine 0 CA--C 1.504 -0.62 0 N-CA-C 109.793 -1.323 . . . . 74.540000000000006 109.793 -176.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 16.2 m -90.63 168.51 11.73 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 114.344 -0.928 . . . . 73.439999999999998 110.427 -177.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -95.52 177.18 5.9 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.995 -0.742 . . . . 74.319999999999993 108.995 178.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.98 160.25 38.29 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.619 0.6 . . . . 75.109999999999999 112.619 -174.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.416 ' O ' HD13 ' A' ' 49' ' ' LEU . 3.0 pp -131.61 144.11 50.82 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 115.463 -0.789 . . . . 74.25 110.06 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.7 t -124.73 139.61 50.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 N-CA-C 108.411 -0.959 . . . . 75.049999999999997 108.411 -178.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.1 t -92.29 116.39 33.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-O 121.565 0.698 . . . . 50.420000000000002 109.195 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -76.71 -45.93 27.51 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 114.43 -1.259 . . . . 73.519999999999996 108.598 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.405 ' O ' ' HB3' ' A' ' 133' ' ' PHE . 2.6 tpm_? -151.65 111.3 4.0 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.283 -1.006 . . . . 72.209999999999994 108.283 -176.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 161.4 118.27 0.47 Allowed Glycine 0 N--CA 1.432 -1.568 0 C-N-CA 118.851 -1.642 . . . . 75.140000000000001 114.769 176.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -63.77 -7.62 13.47 Favored 'Trans proline' 0 C--N 1.366 1.498 0 C-N-CA 123.745 2.963 . . . . 73.010000000000005 112.161 176.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.543 ' OD1' ' HG ' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -44.2 -42.01 6.19 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.657 1.183 . . . . 74.239999999999995 107.812 172.218 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -154.2 -64.55 0.14 Allowed 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.426 -0.806 . . . . 74.519999999999996 109.163 176.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.09 34.9 28.73 Favored Glycine 0 C--O 1.226 -0.39 0 C-N-CA 121.003 -0.618 . . . . 60.43 111.639 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -149.79 -164.7 2.08 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.999 -1.112 . . . . 75.230000000000004 107.999 -177.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 17.0 ptt180 -126.39 152.93 45.65 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 106.733 -1.581 . . . . 72.230000000000004 106.733 177.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.412 ' CZ ' HD11 ' A' ' 49' ' ' LEU . 51.1 p90 -156.5 149.46 24.0 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-O 121.509 0.671 . . . . 75.319999999999993 112.639 173.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 41.8 tp -87.03 140.31 29.69 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 113.784 -1.553 . . . . 73.0 107.474 178.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -78.38 114.69 17.51 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 119.709 -0.796 . . . . 73.510000000000005 110.148 177.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -127.39 -2.46 6.23 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 121.982 0.896 . . . . 75.019999999999996 109.799 178.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 6.3 pm0 -111.48 114.15 52.99 Favored Pre-proline 0 N--CA 1.42 -1.929 0 CA-C-N 115.155 -0.929 . . . . 72.019999999999996 109.466 178.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.424 ' HA ' ' CG1' ' A' ' 94' ' ' ILE . 9.6 Cg_endo -49.95 -34.9 39.05 Favored 'Trans proline' 0 C--N 1.371 1.756 0 C-N-CA 124.437 3.425 . . . . 63.32 115.62 -173.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 92.4 m -133.62 105.46 6.87 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-O 121.262 0.553 . . . . 73.0 109.846 177.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.491 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 3.5 m -102.19 113.13 26.14 Favored 'General case' 0 N--CA 1.422 -1.863 0 N-CA-C 108.235 -1.024 . . . . 74.310000000000002 108.235 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.412 ' HB ' ' HA ' ' A' ' 76' ' ' SER . 57.4 m -93.61 141.43 28.49 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 108.685 -0.858 . . . . 74.129999999999995 108.685 177.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -120.91 126.67 50.59 Favored 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 108.92 -0.77 . . . . 75.129999999999995 108.92 177.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -176.03 -140.8 3.59 Favored Glycine 0 N--CA 1.425 -2.091 0 C-N-CA 120.613 -0.803 . . . . 53.43 112.081 -177.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 22.8 ttm180 -114.15 -25.91 8.29 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.245 0.545 . . . . 72.409999999999997 111.837 -174.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.428 ' NE2' ' HG2' ' A' ' 87' ' ' ARG . 25.3 m-70 -99.54 157.41 34.03 Favored Pre-proline 0 C--N 1.305 -1.342 0 CA-C-N 116.386 -0.37 . . . . 70.219999999999999 110.101 -172.126 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -51.94 -21.38 11.98 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 124.089 3.193 . . . . 73.450000000000003 114.387 -178.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -60.51 -21.88 62.94 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.389 0.614 . . . . 65.439999999999998 110.045 176.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.412 ' HA ' ' HB ' ' A' ' 69' ' ' THR . 34.4 m -86.94 139.36 30.69 Favored 'General case' 0 N--CA 1.421 -1.9 0 CA-C-N 115.376 -0.829 . . . . 73.400000000000006 109.042 175.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -80.12 -30.68 39.08 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.204 0.526 . . . . 71.219999999999999 109.678 -179.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.95 136.49 60.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 109.244 -0.651 . . . . 72.430000000000007 109.244 175.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -103.11 117.73 35.21 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 115.809 -0.632 . . . . 74.439999999999998 109.54 -176.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.543 ' HG ' ' OD1' ' A' ' 56' ' ' ASN . 5.5 mp -70.02 115.94 9.82 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.851 -1.166 . . . . 71.0 107.851 175.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.418 ' H ' ' HA ' ' A' ' 56' ' ' ASN . 24.4 t0 -88.44 61.59 6.21 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 122.68 1.229 . . . . 74.25 110.459 177.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -111.29 156.04 22.11 Favored 'General case' 0 C--N 1.286 -2.189 0 CA-C-N 113.136 -1.847 . . . . 71.129999999999995 107.872 174.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.9 p -74.42 -25.61 19.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 111.914 0.338 . . . . 74.450000000000003 111.914 -177.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.8 m -116.2 72.04 0.8 Allowed 'General case' 0 CA--C 1.548 0.904 0 CA-C-O 121.977 0.894 . . . . 73.040000000000006 110.829 -177.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 47.7 t -112.65 139.53 37.12 Favored 'Isoleucine or valine' 0 C--O 1.249 1.074 0 CA-C-N 115.766 -0.652 . . . . 73.319999999999993 110.844 -178.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 42.6 t -83.71 179.44 7.6 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.621 -0.881 . . . . 73.109999999999999 108.621 178.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.428 ' HG2' ' NE2' ' A' ' 73' ' ' HIS . 93.4 mtt180 -78.4 -54.09 6.56 Favored 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 105.854 -1.906 . . . . 70.120000000000005 105.854 175.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 5.6 ptm180 -105.32 100.37 9.95 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 106.105 -1.813 . . . . 74.450000000000003 106.105 171.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 11.0 t60 -99.59 -59.32 1.74 Allowed 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.959 -0.756 . . . . 75.109999999999999 108.959 -174.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -136.81 152.7 50.58 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.479 -0.934 . . . . 75.310000000000002 108.479 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -135.54 128.26 30.97 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 109.554 -0.535 . . . . 75.239999999999995 109.554 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.491 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 67.8 m-85 -101.81 115.98 31.71 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 107.762 -1.199 . . . . 74.109999999999999 107.762 179.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 18.8 mmt180 -108.33 140.0 42.23 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 109.319 -0.622 . . . . 74.129999999999995 109.319 178.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.424 ' CG1' ' HA ' ' A' ' 66' ' ' PRO . 2.6 pp -115.98 116.91 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.192 0 N-CA-C 106.965 -1.494 . . . . 74.109999999999999 106.965 172.071 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.53 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 46.6 t-20 -108.97 146.13 34.35 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 107.26 -1.385 . . . . 73.340000000000003 107.26 -174.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -59.49 -16.46 24.38 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 124.449 1.099 . . . . 74.409999999999997 111.551 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -87.42 -47.11 4.73 Favored Glycine 0 N--CA 1.431 -1.675 0 N-CA-C 111.594 -0.602 . . . . 72.310000000000002 111.594 176.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.53 ' O ' ' HB3' ' A' ' 95' ' ' ASN . 26.2 tt0 -173.36 169.15 4.51 Favored 'General case' 0 C--O 1.218 -0.573 0 N-CA-C 105.856 -1.905 . . . . 62.030000000000001 105.856 -179.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.401 ' CD1' ' HB ' ' A' ' 94' ' ' ILE . 10.1 m-85 -104.49 131.71 51.56 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 119.262 0.937 . . . . 73.420000000000002 110.479 -173.038 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -131.7 138.13 48.55 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 122.566 1.174 . . . . 72.239999999999995 113.226 -178.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 44.3 t -102.57 129.79 53.57 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.258 0 N-CA-C 106.945 -1.502 . . . . 75.439999999999998 106.945 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.4 t -118.73 136.0 57.34 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 C-N-CA 120.926 -0.31 . . . . 73.530000000000001 110.283 -177.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -82.67 110.59 17.87 Favored 'General case' 0 N--CA 1.437 -1.109 0 N-CA-C 106.536 -1.653 . . . . 73.010000000000005 106.536 170.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 30.0 m -100.51 7.04 9.42 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 CA-C-N 114.935 -1.029 . . . . 75.230000000000004 111.518 -173.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 134.51 52.18 0.07 OUTLIER Glycine 0 N--CA 1.425 -2.084 0 C-N-CA 119.815 -1.183 . . . . 73.209999999999994 112.054 178.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 50.4 m -59.11 128.24 36.2 Favored 'General case' 0 C--O 1.25 1.131 0 N-CA-C 109.667 -0.494 . . . . 65.120000000000005 109.667 176.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.83 -51.15 63.68 Favored 'General case' 0 C--O 1.217 -0.609 0 N-CA-C 108.62 -0.882 . . . . 73.310000000000002 108.62 -178.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.412 ' OD1' ' HA2' ' A' ' 131' ' ' GLY . 7.9 p30 -91.61 -45.66 8.36 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 112.281 0.475 . . . . 63.520000000000003 112.281 177.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 143.71 139.56 3.53 Favored Glycine 0 C--O 1.219 -0.82 0 C-N-CA 119.506 -1.331 . . . . 71.099999999999994 114.063 174.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 59.8 m -105.26 120.14 40.82 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 108.908 -0.775 . . . . 73.400000000000006 108.908 174.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -122.04 137.91 54.63 Favored 'General case' 0 C--O 1.198 -1.645 0 CA-C-N 115.649 -0.705 . . . . 74.510000000000005 109.715 -174.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.402 HG21 ' HG3' ' A' ' 120' ' ' GLN . 59.6 t -99.18 117.08 43.76 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.485 0 N-CA-C 106.708 -1.59 . . . . 71.510000000000005 106.708 177.088 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 68.58 -71.07 0.12 Allowed 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 125.341 1.457 . . . . 73.030000000000001 108.877 -172.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 55.9 ttp85 -157.67 6.79 0.14 Allowed 'General case' 0 CA--C 1.553 1.073 0 CA-C-O 121.339 0.59 . . . . 72.450000000000003 109.775 172.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -114.8 131.74 23.29 Favored Pre-proline 0 N--CA 1.449 -0.476 0 O-C-N 121.845 -0.535 . . . . 75.209999999999994 110.026 -174.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -68.87 131.38 22.39 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.203 1.935 . . . . 62.219999999999999 112.241 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 -122.27 145.07 48.57 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 106.767 -1.568 . . . . 71.019999999999996 106.767 176.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -78.76 -46.54 18.65 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.989 -1.115 . . . . 75.120000000000005 107.989 178.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -138.35 143.48 39.9 Favored 'General case' 0 N--CA 1.421 -1.891 0 N-CA-C 106.609 -1.626 . . . . 71.209999999999994 106.609 175.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.402 ' HG3' HG21 ' A' ' 112' ' ' VAL . 22.1 tm0? -129.69 141.86 50.82 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 107.345 -1.354 . . . . 75.040000000000006 107.345 -176.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.3 p -103.15 119.05 51.06 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.297 0 N-CA-C 108.554 -0.906 . . . . 74.099999999999994 108.554 178.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.548 ' HB3' ' CE1' ' A' ' 137' ' ' PHE . 64.9 mtt -41.84 111.93 0.28 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.217 1.007 . . . . 74.230000000000004 112.588 -170.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -114.83 136.3 53.24 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-N 114.929 -1.032 . . . . 75.319999999999993 109.619 -170.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.423 ' HB ' ' HB2' ' A' ' 139' ' ' ALA . 14.6 t -79.4 127.59 32.29 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 121.666 0.746 . . . . 71.239999999999995 112.778 -176.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 80.97 33.51 29.47 Favored Glycine 0 N--CA 1.428 -1.849 0 CA-C-N 115.124 -0.943 . . . . 54.329999999999998 111.958 173.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -137.2 155.78 49.13 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.427 -0.953 . . . . 74.420000000000002 108.427 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -118.8 135.57 54.46 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-O 121.97 0.891 . . . . 74.510000000000005 113.206 -175.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 64.6 mt -111.35 130.4 64.92 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 CA-C-N 114.386 -1.279 . . . . 74.120000000000005 108.706 -177.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -91.9 111.49 23.05 Favored 'General case' 0 N--CA 1.417 -2.109 0 N-CA-C 107.707 -1.22 . . . . 73.540000000000006 107.707 175.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 10.9 pt -93.97 98.84 8.65 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 N-CA-C 107.911 -1.144 . . . . 74.209999999999994 107.911 177.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.412 ' HA2' ' OD1' ' A' ' 108' ' ' ASN . . . 79.58 -104.07 2.14 Favored Glycine 0 N--CA 1.412 -2.907 0 N-CA-C 109.363 -1.495 . . . . 65.409999999999997 109.363 -174.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -123.68 5.3 8.86 Favored 'General case' 0 C--N 1.298 -1.63 0 N-CA-C 109.965 -0.383 . . . . 75.530000000000001 109.965 178.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.405 ' HB3' ' O ' ' A' ' 53' ' ' ARG . 35.2 m-85 -113.03 152.71 29.16 Favored 'General case' 0 C--O 1.211 -0.954 0 CA-C-N 116.375 -0.375 . . . . 74.239999999999995 110.625 -177.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 66.4 mtp85 -113.61 128.31 56.39 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.52 0.676 . . . . 73.310000000000002 112.611 -170.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 45.1 tp -119.43 132.6 55.84 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 124.92 1.288 . . . . 74.310000000000002 108.552 -177.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 9.9 p -108.17 132.36 56.13 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 108.765 -0.828 . . . . 74.420000000000002 108.765 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.548 ' CE1' ' HB3' ' A' ' 122' ' ' MET . 39.8 t80 -109.04 131.38 55.13 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 121.077 -0.249 . . . . 73.120000000000005 110.948 -175.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.4 mp -124.44 124.18 41.76 Favored 'General case' 0 C--O 1.244 0.79 0 CA-C-O 121.131 0.491 . . . . 74.319999999999993 109.927 177.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.423 ' HB2' ' HB ' ' A' ' 124' ' ' THR . . . -94.64 82.91 4.0 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-O 121.536 0.684 . . . . 73.120000000000005 111.072 -177.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -127.12 96.87 0.46 Allowed Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 109.021 -1.631 . . . . 71.030000000000001 109.021 177.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -50.12 117.37 3.07 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 123.159 2.573 . . . . 74.420000000000002 113.271 -176.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -109.95 105.89 15.22 Favored 'General case' 0 C--N 1.276 -2.63 0 CA-C-N 114.266 -1.334 . . . . 75.120000000000005 109.82 178.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 . . . . . 0 C--N 1.291 -1.937 0 N-CA-C 105.747 -1.946 . . . . 75.019999999999996 105.747 177.574 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.9 mtt . . . . . 0 CA--C 1.516 -0.346 0 N-CA-C 108.221 -1.029 . . . . 74.540000000000006 108.221 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.0 t -82.22 -31.48 30.27 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 106.685 -1.598 . . . . 73.200000000000003 106.685 172.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -71.39 148.66 46.75 Favored 'General case' 0 C--O 1.247 0.933 0 CA-C-N 114.459 -1.246 . . . . 74.519999999999996 108.286 174.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -93.92 127.03 39.47 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 109.295 -0.632 . . . . 74.230000000000004 109.295 177.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -148.25 166.52 27.7 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 116.325 -0.398 . . . . 64.430000000000007 110.464 -179.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 161.23 176.47 33.37 Favored Glycine 0 N--CA 1.431 -1.688 0 N-CA-C 110.733 -0.947 . . . . 64.510000000000005 110.733 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.3 p -92.2 124.62 59.2 Favored Pre-proline 0 C--N 1.292 -1.9 0 CA-C-N 116.624 0.212 . . . . 74.349999999999994 110.909 -178.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -63.83 128.92 23.22 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.314 2.01 . . . . 73.030000000000001 110.326 176.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -86.4 130.55 49.08 Favored Pre-proline 0 C--N 1.299 -1.615 0 CA-C-N 116.32 -0.4 . . . . 74.420000000000002 111.856 -174.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -65.15 145.33 84.28 Favored 'Trans proline' 0 C--O 1.247 0.934 0 C-N-CA 122.632 2.221 . . . . 74.319999999999993 111.377 178.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -57.8 128.34 36.58 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-N 115.685 -0.689 . . . . 72.409999999999997 112.483 -178.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.4 m -73.53 76.25 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 CA-C-O 122.66 1.219 . . . . 62.43 109.903 173.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -88.83 122.59 32.37 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-N 114.231 -1.35 . . . . 74.200000000000003 111.033 -174.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.6 t -145.27 89.29 1.93 Allowed 'General case' 0 N--CA 1.407 -2.597 0 CA-C-O 122.583 1.182 . . . . 70.219999999999999 107.944 174.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 28.6 m -92.5 105.82 17.92 Favored 'General case' 0 N--CA 1.415 -2.212 0 CA-C-N 114.79 -1.096 . . . . 62.140000000000001 109.444 -177.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.9 m -72.32 113.99 9.95 Favored 'General case' 0 N--CA 1.418 -2.075 0 CA-C-N 115.065 -0.97 . . . . 63.039999999999999 109.029 177.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.1 m -65.7 133.41 30.83 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-O 121.125 0.488 . . . . 75.319999999999993 110.506 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -88.32 129.22 35.44 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 115.099 -0.955 . . . . 75.310000000000002 109.853 -177.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 -89.13 144.74 25.91 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 112.935 0.717 . . . . 75.230000000000004 112.935 -177.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.04 16.57 0.72 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.346 -0.843 . . . . 74.120000000000005 111.217 177.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -88.94 -17.1 30.21 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.812 -1.181 . . . . 63.439999999999998 107.812 176.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 65.94 72.85 0.39 Allowed 'General case' 0 CA--C 1.506 -0.738 0 CA-C-N 114.491 -1.231 . . . . 73.439999999999998 112.762 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.4 tt -116.15 113.45 23.11 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 105.331 -2.1 . . . . 74.230000000000004 105.331 175.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.52 101.55 11.74 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 120.964 0.411 . . . . 64.140000000000001 110.239 -177.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -56.11 122.69 12.27 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.977 -1.01 . . . . 75.420000000000002 111.603 -179.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 65.5 mtt -93.05 -1.42 56.57 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 115.812 -0.631 . . . . 73.140000000000001 109.979 175.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -67.05 148.11 52.33 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.972 -1.013 . . . . 75.450000000000003 108.803 175.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.1 t -69.56 170.41 10.74 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 121.2 0.524 . . . . 53.229999999999997 111.13 -174.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 26.3 p -67.2 142.35 57.01 Favored 'General case' 0 N--CA 1.427 -1.624 0 CA-C-N 115.418 -0.81 . . . . 71.25 112.387 -174.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.1 t -133.76 112.54 11.45 Favored 'General case' 0 N--CA 1.414 -2.245 0 N-CA-C 108.881 -0.785 . . . . 71.400000000000006 108.881 177.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 129.69 -57.33 0.72 Allowed Glycine 0 N--CA 1.432 -1.572 0 N-CA-C 110.829 -0.908 . . . . 73.209999999999994 110.829 -178.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 15.6 m -91.81 138.38 31.6 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.112 -0.699 . . . . 75.430000000000007 109.112 179.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -89.7 117.61 68.28 Favored Pre-proline 0 C--N 1.313 -1.013 0 N-CA-C 109.755 -0.461 . . . . 73.530000000000001 109.755 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -65.69 120.75 7.99 Favored 'Trans proline' 0 C--O 1.236 0.419 0 C-N-CA 122.736 2.291 . . . . 73.299999999999997 111.532 178.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -93.25 100.99 13.25 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 109.088 -0.708 . . . . 73.540000000000006 109.088 178.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.7 m -101.8 163.38 12.28 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.879 -0.785 . . . . 65.230000000000004 108.879 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 13.3 t -156.61 -177.7 6.8 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 108.08 -1.081 . . . . 72.530000000000001 108.08 178.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.18 107.44 0.53 Allowed Glycine 0 N--CA 1.427 -1.908 0 C-N-CA 120.406 -0.902 . . . . 62.219999999999999 111.949 -175.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.0 -33.69 61.86 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 121.089 0.471 . . . . 72.010000000000005 110.14 178.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -74.89 -11.87 60.23 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.399 0.619 . . . . 73.319999999999993 110.367 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -76.09 -27.41 57.16 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.292 -0.867 . . . . 73.519999999999996 109.74 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 96.1 mt -102.91 147.75 34.56 Favored Pre-proline 0 N--CA 1.419 -2.016 0 CA-C-N 115.222 -0.899 . . . . 74.329999999999998 109.678 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -63.21 162.42 26.68 Favored 'Trans proline' 0 C--O 1.251 1.154 0 C-N-CA 122.652 2.235 . . . . 72.510000000000005 111.437 175.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -47.26 106.9 0.1 Allowed 'General case' 0 C--O 1.238 0.494 0 C-N-CA 124.802 1.241 . . . . 71.420000000000002 112.987 -176.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -148.83 46.69 0.67 Allowed Glycine 0 CA--C 1.484 -1.851 0 N-CA-C 107.261 -2.336 . . . . 75.439999999999998 107.261 177.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 20.2 m -90.89 167.08 12.7 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 114.107 -1.046 . . . . 72.430000000000007 110.609 -174.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -127.4 171.13 11.81 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.137 -1.431 . . . . 65.329999999999998 107.137 177.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -134.04 145.5 49.48 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 120.039 -0.664 . . . . 72.420000000000002 111.109 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.453 ' O ' ' HA ' ' A' ' 60' ' ' ARG . 4.1 pp -110.56 132.72 53.94 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 115.217 -0.901 . . . . 75.209999999999994 108.934 176.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 51.5 t -116.67 113.88 44.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 108.509 -0.923 . . . . 64.209999999999994 108.509 179.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 36.3 t -96.21 115.61 35.94 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 N-CA-C 109.033 -0.729 . . . . 72.439999999999998 109.033 -179.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -86.14 -32.86 21.06 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.377 0.608 . . . . 75.120000000000005 110.183 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.438 ' O ' ' HB3' ' A' ' 133' ' ' PHE . 10.1 tpt180 -147.55 131.08 16.75 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 106.535 -1.654 . . . . 73.209999999999994 106.535 179.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 145.14 110.74 0.7 Allowed Glycine 0 C--N 1.298 -1.555 0 N-CA-C 111.376 -0.689 . . . . 72.549999999999997 111.376 -178.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -58.36 -20.7 49.42 Favored 'Trans proline' 0 C--N 1.358 1.052 0 C-N-CA 123.403 2.735 . . . . 72.329999999999998 113.689 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -48.0 -35.9 11.77 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.225 1.01 . . . . 74.319999999999993 111.82 175.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -152.21 -72.04 0.15 Allowed 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 109.241 -0.651 . . . . 73.109999999999999 109.241 176.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.96 36.64 35.37 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.652 -0.704 . . . . 64.129999999999995 111.752 -179.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -158.38 -171.61 3.54 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 107.672 -1.232 . . . . 70.340000000000003 107.672 -178.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.453 ' HA ' ' O ' ' A' ' 49' ' ' LEU . 36.6 ptt180 -113.37 133.02 55.38 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 109.546 -0.539 . . . . 74.420000000000002 109.546 178.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -135.57 134.7 39.65 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 116.483 -0.326 . . . . 75.400000000000006 110.681 -176.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.5 mp -91.57 130.16 37.43 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.921 -0.581 . . . . 74.510000000000005 109.438 178.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -71.34 121.34 18.34 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.546 0.689 . . . . 75.409999999999997 110.761 -177.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -123.78 -24.95 4.37 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.206 -1.361 . . . . 72.010000000000005 111.383 -175.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -92.27 141.34 24.87 Favored Pre-proline 0 C--N 1.295 -1.781 0 CA-C-N 115.021 -0.99 . . . . 74.549999999999997 111.032 -174.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.68 -34.29 32.47 Favored 'Trans proline' 0 C--O 1.242 0.709 0 C-N-CA 123.075 2.516 . . . . 62.439999999999998 112.798 -176.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 39.5 m -132.61 99.71 4.72 Favored 'General case' 0 N--CA 1.415 -2.187 0 N-CA-C 107.57 -1.27 . . . . 73.540000000000006 107.57 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.464 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 6.1 m -90.74 112.92 24.89 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.506 -0.924 . . . . 73.329999999999998 108.506 179.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 51.7 m -94.04 119.94 33.6 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 109.296 -0.631 . . . . 75.310000000000002 109.296 177.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -109.69 120.31 42.1 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 108.59 -0.893 . . . . 63.119999999999997 108.59 178.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 175.29 -147.09 8.69 Favored Glycine 0 C--N 1.289 -2.067 0 N-CA-C 109.221 -1.552 . . . . 74.420000000000002 109.221 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.504 ' HD3' ' O ' ' A' ' 80' ' ' LEU . 10.2 tpt180 -134.32 66.16 1.55 Allowed 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 108.424 -0.954 . . . . 73.409999999999997 108.424 179.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 30.1 m170 -126.87 166.01 25.05 Favored Pre-proline 0 C--N 1.303 -1.414 0 N-CA-C 107.568 -1.271 . . . . 75.310000000000002 107.568 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -61.13 -32.94 91.71 Favored 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 121.755 1.637 . . . . 72.340000000000003 109.986 172.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 -97.82 72.3 2.25 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-O 122.35 1.071 . . . . 71.400000000000006 109.898 177.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 48.9 m -142.62 125.92 16.55 Favored 'General case' 0 C--N 1.277 -2.545 0 CA-C-N 114.087 -1.415 . . . . 72.219999999999999 107.557 174.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -69.48 -50.66 43.27 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 107.774 -1.195 . . . . 62.32 107.774 -179.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 30.1 pt -109.09 123.59 65.09 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.222 0 N-CA-C 107.083 -1.451 . . . . 74.099999999999994 107.083 172.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -108.04 116.91 32.82 Favored 'General case' 0 C--N 1.28 -2.455 0 CA-C-O 122.177 0.989 . . . . 74.409999999999997 111.524 -177.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.504 ' O ' ' HD3' ' A' ' 72' ' ' ARG . 6.3 mp -79.89 135.28 36.4 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 113.835 -1.53 . . . . 51.009999999999998 109.272 -177.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -134.13 23.79 3.85 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 105.472 -2.047 . . . . 73.319999999999993 105.472 179.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -78.44 179.19 7.17 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 111.796 -2.456 . . . . 72.219999999999999 109.906 -175.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.9 p -83.34 1.59 3.91 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-O 122.073 0.94 . . . . 74.040000000000006 110.13 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 12.0 p -109.89 14.32 23.18 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 115.932 -0.576 . . . . 71.540000000000006 111.778 -175.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.2 m -81.83 139.09 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.634 0 CA-C-O 121.346 0.593 . . . . 74.200000000000003 111.915 -174.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 13.0 p -130.98 -81.44 0.53 Allowed 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.24 -0.891 . . . . 72.140000000000001 111.367 -179.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 20.0 tpp85 -156.33 -92.39 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.002 -1.11 . . . . 75.219999999999999 108.002 178.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.411 ' HB3' HG21 ' A' ' 104' ' ' VAL . 5.4 mpt_? -85.65 107.06 17.37 Favored 'General case' 0 CA--C 1.493 -1.243 0 N-CA-C 105.168 -2.16 . . . . 74.340000000000003 105.168 171.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -91.53 -75.58 0.47 Allowed 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 120.287 -0.565 . . . . 65.340000000000003 110.255 -174.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -144.51 155.0 43.48 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.991 -0.744 . . . . 74.409999999999997 108.991 -178.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -140.34 128.2 21.93 Favored 'General case' 0 C--N 1.287 -2.131 0 C-N-CA 119.994 -0.682 . . . . 73.040000000000006 109.326 179.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.464 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 42.3 m-85 -97.55 113.09 24.73 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 106.887 -1.523 . . . . 74.340000000000003 106.887 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 46.1 mtt-85 -112.56 152.12 29.23 Favored 'General case' 0 C--N 1.269 -2.913 0 C-N-CA 120.527 -0.469 . . . . 74.329999999999998 109.922 179.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.43 116.12 51.69 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.3 0 CA-C-O 123.111 1.434 . . . . 75.109999999999999 108.177 177.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -97.64 96.44 8.28 Favored 'General case' 0 N--CA 1.42 -1.928 0 CA-C-N 113.256 -1.793 . . . . 71.109999999999999 109.8 -173.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 43.45 13.6 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 127.477 2.311 . . . . 55.530000000000001 116.667 175.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 158.48 -13.15 0.23 Allowed Glycine 0 N--CA 1.417 -2.599 0 C-N-CA 120.234 -0.984 . . . . 75.099999999999994 113.606 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -146.36 152.82 39.71 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 118.05 -1.46 . . . . 73.239999999999995 110.513 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -89.99 138.46 31.49 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.377 0.608 . . . . 75.340000000000003 110.851 -176.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -128.07 125.36 39.13 Favored 'General case' 0 C--N 1.28 -2.417 0 N-CA-C 107.61 -1.256 . . . . 74.430000000000007 107.61 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.5 p -103.07 118.55 50.18 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-O 121.602 0.715 . . . . 75.409999999999997 109.862 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 29.9 m -119.96 137.67 53.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-N 115.033 -0.985 . . . . 75.430000000000007 111.686 -179.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -83.23 122.96 29.1 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 104.742 -2.318 . . . . 72.200000000000003 104.742 171.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.411 HG21 ' HB3' ' A' ' 88' ' ' ARG . 16.8 m -106.15 9.59 9.37 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 N-CA-C 112.816 0.673 . . . . 73.329999999999998 112.816 -172.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -126.41 -45.96 0.22 Allowed Glycine 0 N--CA 1.43 -1.701 0 C-N-CA 119.018 -1.563 . . . . 55.340000000000003 112.96 -179.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 21.7 m 67.18 9.97 7.35 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.205 1.402 . . . . 73.319999999999993 110.659 -175.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 94.4 mt -74.92 -48.6 23.75 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 114.663 -1.153 . . . . 75.25 109.292 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -83.36 -50.34 8.44 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 108.643 -0.873 . . . . 71.430000000000007 108.643 175.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.01 76.99 1.32 Allowed Glycine 0 N--CA 1.431 -1.646 0 N-CA-C 109.486 -1.446 . . . . 75.299999999999997 109.486 -175.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 32.1 m -73.09 135.35 44.78 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 109.671 -0.492 . . . . 74.219999999999999 109.671 -179.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -102.18 133.2 47.43 Favored 'General case' 0 N--CA 1.422 -1.838 0 N-CA-C 106.925 -1.509 . . . . 74.25 106.925 178.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.429 HG22 HG12 ' A' ' 128' ' ' ILE . 7.5 p -128.41 137.29 57.8 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.179 0 N-CA-C 107.57 -1.27 . . . . 72.209999999999994 107.57 -175.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 60.61 21.95 11.78 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 108.149 -1.056 . . . . 75.519999999999996 108.149 -171.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 64.1 mtp180 54.7 37.38 28.18 Favored 'General case' 0 C--N 1.352 0.704 0 CA-C-N 114.412 -1.267 . . . . 73.019999999999996 112.582 -172.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -132.63 149.5 73.2 Favored Pre-proline 0 C--N 1.312 -1.061 0 N-CA-C 108.298 -1.001 . . . . 73.450000000000003 108.298 174.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -76.28 87.65 1.41 Allowed 'Trans proline' 0 N--CA 1.443 -1.476 0 C-N-CA 121.49 1.46 . . . . 65.420000000000002 110.554 174.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -120.14 149.73 41.76 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.758 -1.201 . . . . 74.030000000000001 107.758 178.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -89.27 -28.9 19.6 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 109.467 -0.568 . . . . 74.239999999999995 109.467 179.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -140.92 140.36 34.47 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 115.413 -0.812 . . . . 74.329999999999998 109.514 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.5 142.23 37.3 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.737 -1.208 . . . . 64.340000000000003 107.737 174.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 11.3 p -98.07 135.84 31.22 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.232 0 N-CA-C 109.641 -0.503 . . . . 74.549999999999997 109.641 -177.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 48.6 ttp -31.58 108.99 0.05 Allowed 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 125.97 1.708 . . . . 73.230000000000004 112.24 -177.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -133.06 138.71 46.84 Favored 'General case' 0 N--CA 1.419 -2.015 0 N-CA-C 106.763 -1.569 . . . . 70.129999999999995 106.763 179.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 12.3 t -80.06 131.37 35.76 Favored 'General case' 0 N--CA 1.423 -1.823 0 N-CA-C 109.12 -0.696 . . . . 63.32 109.12 -179.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 91.39 18.14 46.87 Favored Glycine 0 N--CA 1.438 -1.176 0 C-N-CA 120.314 -0.946 . . . . 71.450000000000003 111.125 178.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -81.51 140.64 34.44 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 106.657 -1.609 . . . . 75.530000000000001 106.657 178.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -124.77 120.88 33.03 Favored 'General case' 0 C--N 1.277 -2.552 0 CA-C-O 122.41 1.1 . . . . 61.329999999999998 110.576 -179.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.429 HG12 HG22 ' A' ' 112' ' ' VAL . 61.0 mt -103.66 128.49 56.81 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.095 0 CA-C-N 113.885 -1.507 . . . . 72.450000000000003 108.908 -174.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -120.6 124.82 46.22 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 109.793 -0.447 . . . . 74.430000000000007 109.793 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.403 HG13 ' HB2' ' A' ' 133' ' ' PHE . 22.0 pt -109.76 98.24 6.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 108.404 -0.961 . . . . 73.239999999999995 108.404 173.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 70.4 -82.81 0.36 Allowed Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.074 -0.966 . . . . 34.329999999999998 111.615 -175.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -130.77 -12.79 3.75 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 123.104 0.562 . . . . 75.109999999999999 110.182 179.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.438 ' HB3' ' O ' ' A' ' 53' ' ' ARG . 42.3 m-85 -85.63 131.74 34.29 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.852 -0.795 . . . . 72.019999999999996 108.852 -176.039 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 21.4 ptt180 -118.33 135.05 54.54 Favored 'General case' 0 C--O 1.258 1.541 0 CA-C-O 121.993 0.902 . . . . 75.219999999999999 112.821 -175.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 5.2 tt -120.04 133.23 55.59 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 113.473 -1.694 . . . . 71.530000000000001 107.302 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 40.7 t -107.91 120.75 59.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 107.318 -1.364 . . . . 70.439999999999998 107.318 177.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -102.48 121.9 43.26 Favored 'General case' 0 C--N 1.288 -2.078 0 CA-C-N 115.7 -0.682 . . . . 73.5 109.497 -176.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -121.52 159.52 26.18 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 109.606 -0.516 . . . . 72.420000000000002 109.606 -178.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -72.0 148.78 45.58 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 106.772 -1.566 . . . . 63.32 106.772 172.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -113.86 -140.62 7.57 Favored Glycine 0 C--N 1.29 -1.983 0 C-N-CA 119.546 -1.311 . . . . 53.409999999999997 112.874 -173.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -77.92 118.41 4.43 Favored 'Trans proline' 0 N--CA 1.435 -1.915 0 C-N-CA 122.57 2.18 . . . . 73.109999999999999 113.061 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -109.95 104.54 13.47 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 105.972 -1.862 . . . . 72.109999999999999 105.972 173.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 . . . . . 0 C--N 1.296 -1.723 0 N-CA-C 109.185 -0.672 . . . . 73.010000000000005 109.185 -174.643 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.3 ptm . . . . . 0 C--O 1.222 -0.379 0 CA-C-O 121.409 0.623 . . . . 74.030000000000001 111.117 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.2 m -83.2 -36.26 24.79 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.138 0.494 . . . . 74.430000000000007 111.001 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -102.27 126.79 49.37 Favored 'General case' 0 CA--C 1.489 -1.377 0 CA-C-N 116.121 -0.491 . . . . 71.310000000000002 112.19 -174.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -82.97 92.89 7.43 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 105.423 -2.066 . . . . 73.219999999999999 105.423 171.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -104.18 163.69 12.23 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 114.969 -1.014 . . . . 75.230000000000004 112.131 -170.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -179.59 -165.18 33.24 Favored Glycine 0 N--CA 1.428 -1.876 0 N-CA-C 107.67 -2.172 . . . . 74.439999999999998 107.67 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.8 p -77.29 124.26 87.02 Favored Pre-proline 0 C--N 1.3 -1.55 0 CA-C-N 118.212 1.006 . . . . 71.120000000000005 109.667 179.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -61.21 148.12 93.76 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 123.175 2.583 . . . . 74.200000000000003 112.855 -175.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -69.77 117.62 55.23 Favored Pre-proline 0 C--O 1.247 0.925 0 N-CA-C 109.556 -0.535 . . . . 72.420000000000002 109.556 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -82.24 142.53 12.11 Favored 'Trans proline' 0 N--CA 1.444 -1.44 0 C-N-CA 122.738 2.292 . . . . 75.230000000000004 112.63 -176.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -70.55 134.35 47.59 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-N 115.456 -0.793 . . . . 75.019999999999996 109.801 178.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.7 t -73.86 89.22 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 CA-C-N 115.483 -0.78 . . . . 62.329999999999998 109.591 -179.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -72.96 124.41 25.39 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 114.546 -1.206 . . . . 73.340000000000003 108.95 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.4 m -67.29 98.32 0.61 Allowed 'General case' 0 N--CA 1.427 -1.621 0 CA-C-N 115.709 -0.678 . . . . 74.530000000000001 109.844 -179.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.1 t -79.3 75.05 5.88 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 123.037 1.398 . . . . 75.299999999999997 110.394 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.8 m -155.69 164.05 39.1 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 106.452 -1.684 . . . . 74.230000000000004 106.452 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.7 m -73.34 136.55 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.591 0 N-CA-C 108.863 -0.792 . . . . 72.540000000000006 108.863 175.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -129.28 -178.28 4.59 Favored 'General case' 0 C--N 1.277 -2.583 0 N-CA-C 106.902 -1.518 . . . . 73.510000000000005 106.902 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.409 ' C ' ' H ' ' A' ' 21' ' ' ASP . 28.8 mmm180 -81.87 160.74 23.39 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 109.548 -0.538 . . . . 74.140000000000001 109.548 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.0 27.17 1.4 Allowed 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.748 0.785 . . . . 61.439999999999998 109.381 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.409 ' H ' ' C ' ' A' ' 19' ' ' ARG . 31.6 t70 -58.78 -50.31 74.43 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 125.13 1.372 . . . . 74.409999999999997 110.375 -179.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 60.8 tp -157.52 101.86 1.87 Allowed 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.597 -0.728 . . . . 75.219999999999999 109.099 177.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 91.9 mt -93.55 158.42 15.71 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.662 -0.866 . . . . 74.120000000000005 108.662 177.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.455 ' HD2' ' N ' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -94.08 140.6 29.53 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 120.65 -0.42 . . . . 74.129999999999995 110.436 -177.135 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -60.7 121.88 13.37 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 114.673 1.361 . . . . 74.099999999999994 114.673 -177.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 11.1 tmm? -90.32 125.31 35.48 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 106.214 -1.773 . . . . 73.219999999999999 106.214 172.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -140.08 150.95 44.96 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.795 -1.187 . . . . 75.420000000000002 107.795 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.3 p -145.52 -37.6 0.27 Allowed 'General case' 0 C--N 1.293 -1.861 0 O-C-N 123.644 0.59 . . . . 54.140000000000001 109.422 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.4 m 60.82 23.16 13.16 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 124.397 1.079 . . . . 70.349999999999994 110.154 -179.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.4 m -98.19 114.26 26.44 Favored 'General case' 0 N--CA 1.411 -2.42 0 CA-C-N 114.566 -1.197 . . . . 73.349999999999994 109.025 -178.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.31 72.5 2.63 Favored Glycine 0 N--CA 1.438 -1.202 0 N-CA-C 109.494 -1.442 . . . . 50.039999999999999 109.494 177.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 10.6 t -69.57 140.15 53.78 Favored 'General case' 0 N--CA 1.426 -1.663 0 CA-C-N 115.004 -0.598 . . . . 73.230000000000004 110.536 -177.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.3 139.19 64.15 Favored Pre-proline 0 C--N 1.303 -1.431 0 CA-C-N 114.901 -1.045 . . . . 71.439999999999998 109.601 -178.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -68.5 136.75 37.45 Favored 'Trans proline' 0 N--CA 1.446 -1.292 0 C-N-CA 121.675 1.584 . . . . 74.530000000000001 109.569 175.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.82 -48.97 78.2 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-O 120.669 0.271 . . . . 72.25 110.324 -179.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.4 m 66.27 -0.11 1.55 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.925 1.29 . . . . 71.219999999999999 112.247 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 13.1 p -94.66 140.13 30.3 Favored 'General case' 0 N--CA 1.423 -1.812 0 CA-C-O 120.994 0.426 . . . . 73.230000000000004 111.5 -177.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 97.83 -8.68 63.64 Favored Glycine 0 N--CA 1.438 -1.22 0 CA-C-N 115.958 -0.565 . . . . 74.409999999999997 111.823 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.14 -21.21 62.22 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.03 0.443 . . . . 65.129999999999995 110.526 -178.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -68.75 -11.17 60.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.652 -0.704 . . . . 75.209999999999994 111.971 178.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -61.56 -30.25 70.54 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.778 0.799 . . . . 75.430000000000007 109.033 174.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.566 ' HG ' ' O ' ' A' ' 44' ' ' ALA . 46.3 tp -117.57 95.0 46.93 Favored Pre-proline 0 N--CA 1.413 -2.295 0 CA-C-N 114.861 -1.063 . . . . 74.530000000000001 108.768 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.441 ' HA ' ' OE1' ' A' ' 96' ' ' GLU . 83.1 Cg_endo -97.2 23.11 0.32 Allowed 'Trans proline' 0 C--O 1.239 0.55 0 C-N-CA 123.425 2.75 . . . . 65.530000000000001 110.318 178.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.566 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -143.11 173.09 11.88 Favored 'General case' 0 N--CA 1.422 -1.84 0 N-CA-C 106.06 -1.829 . . . . 74.239999999999995 106.06 -178.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 111.47 58.13 0.47 Allowed Glycine 0 C--N 1.28 -2.582 0 N-CA-C 109.605 -1.398 . . . . 75.150000000000006 109.605 -176.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.555 ' HB3' ' O ' ' A' ' 63' ' ' LEU . 4.8 m -90.0 154.64 19.67 Favored 'General case' 0 N--CA 1.41 -2.448 0 CA-C-N 114.446 -0.877 . . . . 73.200000000000003 108.892 -177.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -116.26 175.89 5.35 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.303 -0.999 . . . . 64.329999999999998 108.303 -178.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -130.27 159.66 36.23 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 121.327 0.584 . . . . 65.140000000000001 111.348 -175.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.401 ' O ' HD13 ' A' ' 49' ' ' LEU . 1.7 pp -122.17 147.63 45.93 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 115.356 -0.838 . . . . 74.340000000000003 110.097 177.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.469 ' CG2' ' HB ' ' A' ' 136' ' ' VAL . 24.6 m -123.28 134.05 67.37 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 108.603 -0.888 . . . . 73.430000000000007 108.603 175.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.407 HG22 ' HB1' ' A' ' 57' ' ' ALA . 48.5 t -92.54 115.69 32.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 106.457 -1.683 . . . . 71.400000000000006 106.457 176.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -73.96 -39.98 63.35 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 114.524 -1.217 . . . . 74.540000000000006 108.417 -176.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 31.7 tpt180 -168.31 138.51 2.55 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 107.157 -1.423 . . . . 72.049999999999997 107.157 177.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 139.28 127.67 2.47 Favored Glycine 0 N--CA 1.425 -2.077 0 C-N-CA 119.724 -1.227 . . . . 45.030000000000001 114.382 178.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.499 ' HD2' ' CE2' ' A' ' 133' ' ' PHE . 80.3 Cg_exo -54.0 -8.74 1.04 Allowed 'Trans proline' 0 C--N 1.368 1.553 0 C-N-CA 125.237 3.958 . . . . 74.219999999999999 114.117 173.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.464 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 4.3 t-20 -40.99 -45.44 2.6 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.717 1.207 . . . . 64.400000000000006 109.792 170.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.407 ' HB1' HG22 ' A' ' 51' ' ' VAL . . . -162.95 -48.55 0.04 OUTLIER 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 115.989 -0.551 . . . . 74.040000000000006 109.601 176.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 67.82 48.52 54.7 Favored Glycine 0 C--N 1.324 -0.134 0 N-CA-C 111.225 -0.75 . . . . 62.130000000000003 111.225 -179.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -161.64 -173.02 3.56 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.25 -1.018 . . . . 74.150000000000006 108.25 -178.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 19.1 ptp180 -140.5 135.41 31.89 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.777 -0.824 . . . . 75.400000000000006 108.777 175.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -156.46 155.42 32.01 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 120.743 0.306 . . . . 73.010000000000005 111.609 -176.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 14.7 tp -79.87 139.7 37.05 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.035 -0.984 . . . . 71.049999999999997 108.642 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.555 ' O ' ' HB3' ' A' ' 46' ' ' SER . 94.3 mt -95.17 114.09 25.84 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 120.138 -0.625 . . . . 74.120000000000005 109.623 177.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -96.86 -28.87 14.03 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 121.561 0.696 . . . . 75.230000000000004 109.786 177.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -74.77 115.8 47.65 Favored Pre-proline 0 C--N 1.309 -1.157 0 CA-C-N 114.086 -1.416 . . . . 74.329999999999998 109.621 -177.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.443 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 15.2 Cg_endo -57.93 -28.25 82.12 Favored 'Trans proline' 0 C--N 1.363 1.307 0 C-N-CA 123.045 2.497 . . . . 74.010000000000005 112.402 -176.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 90.8 m -136.46 109.86 7.91 Favored 'General case' 0 N--CA 1.418 -2.055 0 N-CA-C 108.874 -0.787 . . . . 64.349999999999994 108.874 174.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 23.4 m -105.64 114.32 28.41 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.296 -1.002 . . . . 73.329999999999998 108.296 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.444 HG22 ' HG2' ' A' ' 91' ' ' GLU . 65.6 p -91.96 133.77 35.4 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 109.802 -0.444 . . . . 75.299999999999997 109.802 -178.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -127.28 133.53 50.15 Favored 'General case' 0 C--O 1.243 0.724 0 O-C-N 122.249 -0.282 . . . . 63.229999999999997 111.118 -179.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 161.41 -105.29 0.26 Allowed Glycine 0 N--CA 1.437 -1.282 0 C-N-CA 119.894 -1.146 . . . . 63.329999999999998 114.044 175.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 66.8 ttt180 -91.19 99.54 12.52 Favored 'General case' 0 N--CA 1.42 -1.938 0 N-CA-C 107.991 -1.114 . . . . 75.549999999999997 107.991 -174.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -12.63 -68.48 0.02 OUTLIER Pre-proline 0 N--CA 1.5 2.056 0 C-N-CA 127.758 2.423 . . . . 75.230000000000004 115.306 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -66.32 -21.9 53.69 Favored 'Trans proline' 0 C--N 1.387 2.563 0 C-N-CA 122.082 1.855 . . . . 70.209999999999994 114.43 -177.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -112.86 18.29 18.29 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.428 0.632 . . . . 71.310000000000002 110.631 -175.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 40.0 m -144.35 165.71 27.14 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.365 -0.976 . . . . 72.120000000000005 108.365 178.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -81.37 -57.13 3.63 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 109.185 -0.672 . . . . 72.549999999999997 109.185 176.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 49.4 pt -106.78 166.94 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 CA-C-O 121.604 0.716 . . . . 72.230000000000004 110.712 177.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -123.27 137.02 54.96 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-N 114.954 -1.021 . . . . 74.450000000000003 109.211 -175.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.464 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 2.5 pt? -114.11 121.79 44.87 Favored 'General case' 0 N--CA 1.406 -2.664 0 N-CA-C 105.933 -1.877 . . . . 54.109999999999999 105.933 170.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -80.72 78.19 7.51 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 122.018 0.913 . . . . 72.230000000000004 110.411 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.459 ' OD2' HG21 ' A' ' 84' ' ' THR . 17.3 t70 -117.58 -167.31 1.3 Allowed 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 114.244 -1.344 . . . . 72.530000000000001 108.252 177.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.457 ' H ' ' CG ' ' A' ' 82' ' ' ASP . 11.0 p -129.65 -19.36 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 CA-C-N 118.241 0.473 . . . . 75.400000000000006 111.225 -177.104 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.459 HG21 ' OD2' ' A' ' 82' ' ' ASP . 12.3 t -99.12 20.99 12.43 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.52 0.676 . . . . 74.510000000000005 110.497 -177.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.7 p -81.24 111.02 17.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 108.607 -0.886 . . . . 71.239999999999995 108.607 178.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.8 m -76.51 -89.83 0.03 OUTLIER 'General case' 0 CA--C 1.562 1.412 0 N-CA-C 113.478 0.918 . . . . 75.140000000000001 113.478 -172.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -84.09 -48.25 10.07 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 106.802 -1.555 . . . . 75.430000000000007 106.802 177.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -162.55 176.42 10.42 Favored 'General case' 0 C--N 1.274 -2.717 0 N-CA-C 100.269 -3.974 . . . . 74.540000000000006 100.269 170.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 21.3 t60 -96.27 -74.18 0.57 Allowed 'General case' 0 C--N 1.276 -2.617 0 C-N-CA 116.443 -2.103 . . . . 72.540000000000006 111.979 -170.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.15 163.66 34.68 Favored 'General case' 0 C--N 1.294 -1.809 0 C-N-CA 120.012 -0.675 . . . . 75.5 110.474 -174.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.444 ' HG2' HG22 ' A' ' 69' ' ' THR . 52.1 mt-10 -116.21 127.35 54.69 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.624 -0.88 . . . . 75.540000000000006 108.624 175.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -100.51 112.89 25.31 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 107.595 -1.261 . . . . 74.510000000000005 107.595 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 60.0 mtp180 -103.3 112.93 26.03 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 106.89 -1.522 . . . . 73.310000000000002 106.89 -179.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.443 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -120.14 111.43 32.4 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.328 0 N-CA-C 106.954 -1.499 . . . . 74.019999999999996 106.954 -179.756 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -122.33 147.23 46.51 Favored 'General case' 0 N--CA 1.393 -3.302 0 CA-C-N 114.469 -1.241 . . . . 71.25 111.004 176.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.441 ' OE1' ' HA ' ' A' ' 43' ' ' PRO . 0.7 OUTLIER -61.27 -30.35 70.41 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 107.58 -1.267 . . . . 74.109999999999999 107.58 175.572 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -69.58 -61.39 4.45 Favored Glycine 0 N--CA 1.429 -1.824 0 CA-C-N 113.442 -1.708 . . . . 62.0 111.304 175.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -147.2 146.63 29.9 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.962 0.381 . . . . 74.049999999999997 110.972 -179.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -104.39 116.22 31.74 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.002 -0.74 . . . . 74.439999999999998 109.002 -178.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -133.16 135.4 45.12 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 113.503 0.927 . . . . 72.140000000000001 113.503 -177.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.7 p -116.31 119.07 60.83 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.295 0 N-CA-C 108.959 -0.756 . . . . 62.409999999999997 108.959 176.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.6 p -120.84 131.75 72.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 112.591 0.589 . . . . 72.239999999999995 112.591 -177.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -83.06 136.67 34.4 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 108.596 -0.89 . . . . 71.409999999999997 108.596 172.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.6 m -89.57 -16.95 8.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-O 121.189 0.518 . . . . 73.400000000000006 111.872 -176.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 142.28 53.06 0.04 OUTLIER Glycine 0 N--CA 1.424 -2.136 0 N-CA-C 109.746 -1.341 . . . . 64.319999999999993 109.746 -173.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.6 t -154.7 28.6 0.43 Allowed 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 106.462 -1.681 . . . . 53.0 106.462 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 32.9 tp -62.64 -11.52 17.52 Favored 'General case' 0 C--N 1.356 0.882 0 C-N-CA 125.794 1.637 . . . . 72.340000000000003 111.57 -174.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -60.45 -26.76 67.0 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 115.156 -0.929 . . . . 75.530000000000001 109.472 173.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -123.54 3.45 9.45 Favored Glycine 0 N--CA 1.429 -1.785 0 C-N-CA 120.975 -0.631 . . . . 65.319999999999993 113.69 178.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.7 m -102.31 118.69 37.41 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 118.79 1.295 . . . . 73.310000000000002 109.757 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -139.16 137.32 35.98 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.483 -0.562 . . . . 64.530000000000001 109.483 -178.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.2 p -103.14 119.18 51.24 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 106.348 -1.723 . . . . 71.420000000000002 106.348 170.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 18.9 m120 70.63 -78.01 0.05 Allowed 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 108.479 -0.934 . . . . 73.329999999999998 108.479 -171.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -152.31 2.16 0.34 Allowed 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.253 -0.885 . . . . 74.310000000000002 108.862 174.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -101.19 119.01 59.04 Favored Pre-proline 0 N--CA 1.438 -1.033 0 O-C-N 122.022 -0.424 . . . . 75.230000000000004 110.976 -171.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -81.02 90.99 1.17 Allowed 'Trans proline' 0 N--CA 1.43 -2.226 0 C-N-CA 121.777 1.651 . . . . 74.340000000000003 109.538 174.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.03 -94.62 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.662 -0.699 . . . . 74.120000000000005 109.594 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 7.4 t30 167.83 -60.44 0.01 OUTLIER 'General case' 0 CA--C 1.489 -1.39 0 N-CA-C 104.431 -2.433 . . . . 72.140000000000001 104.431 175.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -123.91 138.71 54.44 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 106.313 -1.736 . . . . 64.439999999999998 106.313 171.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 55.1 tp60 -140.45 150.52 43.92 Favored 'General case' 0 C--N 1.278 -2.526 0 N-CA-C 109.868 -0.419 . . . . 71.219999999999999 109.868 -176.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 97.4 t -77.89 118.75 25.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 105.485 -2.043 . . . . 75.519999999999996 105.485 171.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.416 ' HE2' ' CD1' ' A' ' 137' ' ' PHE . 21.1 ttt -75.48 113.21 12.63 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 114.919 -1.037 . . . . 74.319999999999993 108.409 -173.079 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -104.95 139.21 40.0 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.755 -0.657 . . . . 72.230000000000004 111.526 -171.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 3.5 t -79.0 131.99 36.49 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 114.932 -1.031 . . . . 75.319999999999993 110.56 -179.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 97.66 11.05 52.02 Favored Glycine 0 N--CA 1.434 -1.485 0 CA-C-N 115.604 -0.726 . . . . 53.200000000000003 112.14 177.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -124.2 173.1 8.55 Favored 'General case' 0 C--O 1.253 1.284 0 N-CA-C 108.228 -1.027 . . . . 72.530000000000001 108.228 178.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.584 ' OE2' ' HD3' ' A' ' 134' ' ' ARG . 36.9 tt0 -123.82 123.77 41.2 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 121.337 0.589 . . . . 72.030000000000001 109.665 -172.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 67.6 mt -105.18 130.37 56.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 108.645 -0.872 . . . . 73.430000000000007 108.645 -177.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -98.3 118.83 35.84 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 109.142 -0.688 . . . . 72.150000000000006 109.142 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 17.0 pt -120.06 109.04 24.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 CA-C-O 121.915 0.865 . . . . 75.129999999999995 110.002 -177.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 81.98 -124.34 6.43 Favored Glycine 0 N--CA 1.416 -2.666 0 N-CA-C 109.198 -1.561 . . . . 75.329999999999998 109.198 -178.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -102.23 -4.03 26.38 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 108.916 -0.772 . . . . 74.140000000000001 108.916 176.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.499 ' CE2' ' HD2' ' A' ' 55' ' ' PRO . 45.2 m-85 -115.82 -179.96 3.8 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.254 -0.43 . . . . 72.239999999999995 111.599 -172.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.584 ' HD3' ' OE2' ' A' ' 127' ' ' GLU . 10.4 ptp180 -137.86 140.83 40.64 Favored 'General case' 0 C--O 1.247 0.932 0 N-CA-C 113.515 0.932 . . . . 74.019999999999996 113.515 -172.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 29.5 tp -123.86 133.15 53.83 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.21 -1.359 . . . . 73.25 108.751 -175.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.469 ' HB ' ' CG2' ' A' ' 50' ' ' VAL . 25.7 t -107.81 132.29 55.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 107.689 -1.226 . . . . 74.049999999999997 107.689 178.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.416 ' CD1' ' HE2' ' A' ' 122' ' ' MET . 73.9 t80 -104.18 123.83 48.02 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 120.617 0.246 . . . . 74.049999999999997 110.55 -176.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -126.41 138.58 53.56 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-O 121.809 0.814 . . . . 63.439999999999998 111.462 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -106.53 91.9 3.89 Favored 'General case' 0 C--N 1.278 -2.509 0 N-CA-C 107.163 -1.421 . . . . 72.510000000000005 107.163 172.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -93.63 -127.2 4.58 Favored Glycine 0 CA--C 1.497 -1.039 0 N-CA-C 110.47 -1.052 . . . . 41.25 110.47 -177.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -65.22 122.2 9.86 Favored 'Trans proline' 0 N--CA 1.445 -1.33 0 C-N-CA 121.588 1.525 . . . . 63.509999999999998 109.031 175.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -75.46 106.92 7.25 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 123.949 0.781 . . . . 62.25 110.413 -176.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 51.3 mt-10 . . . . . 0 N--CA 1.396 -3.14 0 CA-C-O 117.936 -1.031 . . . . 72.230000000000004 108.359 176.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 pmm? . . . . . 0 N--CA 1.472 0.666 0 N-CA-C 111.538 0.199 . . . . 62.420000000000002 111.538 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.1 m -67.44 -42.59 82.87 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 107.76 -1.2 . . . . 74.409999999999997 107.76 175.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 51.9 64.21 1.94 Allowed 'General case' 0 C--O 1.239 0.548 0 C-N-CA 124.861 1.265 . . . . 73.530000000000001 113.388 176.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 29.2 t30 -134.46 100.86 4.78 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 114.713 -1.131 . . . . 75.439999999999998 108.715 178.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -81.86 92.13 6.65 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.724 -0.843 . . . . 65.510000000000005 108.724 178.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -107.61 56.21 0.49 Allowed Glycine 0 N--CA 1.429 -1.811 0 C-N-CA 120.806 -0.711 . . . . 62.530000000000001 112.184 -176.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.6 m -92.59 123.21 62.54 Favored Pre-proline 0 C--N 1.303 -1.445 0 N-CA-C 109.239 -0.652 . . . . 61.32 109.239 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -67.07 128.55 18.84 Favored 'Trans proline' 0 C--O 1.243 0.744 0 C-N-CA 122.537 2.158 . . . . 73.310000000000002 111.037 175.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -85.89 144.98 40.17 Favored Pre-proline 0 C--N 1.294 -1.82 0 CA-C-N 116.137 -0.483 . . . . 71.340000000000003 109.942 -179.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -72.85 117.3 5.06 Favored 'Trans proline' 0 N--CA 1.446 -1.3 0 C-N-CA 122.207 1.938 . . . . 74.430000000000007 112.683 -177.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -100.75 136.85 39.96 Favored 'General case' 0 C--N 1.282 -2.364 0 CA-C-N 115.03 -0.986 . . . . 74.340000000000003 108.768 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.1 p -127.37 122.89 60.63 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 CA-C-O 121.72 0.771 . . . . 75.230000000000004 110.809 178.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -122.63 133.17 54.53 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 108.205 -1.035 . . . . 71.439999999999998 108.205 177.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.4 t -163.9 99.66 0.87 Allowed 'General case' 0 N--CA 1.42 -1.958 0 CA-C-O 122.054 0.931 . . . . 71.140000000000001 109.367 -178.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 21.0 m -84.44 79.26 9.63 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 108.532 -0.914 . . . . 72.310000000000002 108.532 178.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.9 p -125.47 84.45 2.28 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 115.108 -0.951 . . . . 73.25 111.53 -176.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 50.4 t -129.64 141.71 45.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 108.024 -1.102 . . . . 73.299999999999997 108.024 -178.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -100.07 78.24 2.07 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.733 0.778 . . . . 74.109999999999999 109.583 175.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 21.7 ttp180 -111.16 8.98 21.88 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 115.146 -0.934 . . . . 74.310000000000002 108.605 -179.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 60.76 33.87 20.01 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 114.984 -1.007 . . . . 73.310000000000002 109.202 -177.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -49.81 -44.49 49.19 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.41 1.884 . . . . 72.219999999999999 110.101 -177.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 56.3 tp -148.47 84.67 1.49 Allowed 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 106.444 -1.687 . . . . 65.120000000000005 106.444 172.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -138.99 101.35 4.27 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.819 -0.808 . . . . 64.510000000000005 108.819 -176.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -105.23 166.75 10.19 Favored 'General case' 0 C--N 1.288 -2.098 0 CA-C-N 115.468 -0.787 . . . . 73.319999999999993 109.076 178.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 67.68 76.72 0.27 Allowed 'General case' 0 C--O 1.237 0.412 0 O-C-N 124.595 1.185 . . . . 70.230000000000004 108.844 -174.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 25.6 ptt? -119.88 154.07 34.91 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.949 -0.76 . . . . 64.219999999999999 108.949 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -69.2 110.57 4.64 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 123.663 0.602 . . . . 72.129999999999995 110.036 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.7 m -141.96 149.82 40.6 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.424 -0.954 . . . . 73.25 108.424 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.516 ' CB ' ' HA ' ' A' ' 61' ' ' PHE . 60.9 p -107.73 127.87 54.06 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 120.967 0.413 . . . . 72.150000000000006 111.211 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.1 m -155.22 100.77 2.18 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.102 -1.444 . . . . 75.109999999999999 107.102 178.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -84.55 173.48 49.58 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 111.442 -0.663 . . . . 73.409999999999997 111.442 -177.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.6 m -108.09 114.63 28.67 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.901 -0.777 . . . . 72.140000000000001 108.901 -179.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.19 117.36 53.67 Favored Pre-proline 0 C--N 1.305 -1.337 0 O-C-N 123.726 0.641 . . . . 75.400000000000006 110.967 -177.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -66.9 132.65 28.92 Favored 'Trans proline' 0 C--O 1.246 0.9 0 C-N-CA 122.648 2.232 . . . . 62.299999999999997 110.451 175.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -79.7 102.87 9.23 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 107.431 -1.322 . . . . 74.030000000000001 107.431 177.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 65.9 m -147.03 155.67 42.41 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-N 116.293 -0.412 . . . . 75.109999999999999 109.906 -175.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 17.7 m -88.11 -8.47 55.41 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.753 -0.832 . . . . 73.099999999999994 108.753 178.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -49.37 113.53 1.78 Allowed Glycine 0 N--CA 1.419 -2.451 0 C-N-CA 125.453 1.501 . . . . 60.109999999999999 113.107 176.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.487 ' O ' ' HD3' ' A' ' 43' ' ' PRO . . . -55.89 -24.09 35.18 Favored 'General case' 0 C--N 1.277 -2.569 0 CA-C-N 113.074 -1.563 . . . . 75.219999999999999 113.035 -178.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -66.36 -14.7 62.48 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 122.988 0.515 . . . . 75.140000000000001 112.022 178.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -83.0 -13.55 55.73 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.01 0.433 . . . . 55.0 110.938 176.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -77.74 -50.09 2.0 Favored Pre-proline 0 CA--C 1.57 1.726 0 N-CA-C 113.884 1.068 . . . . 72.409999999999997 113.884 -177.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.487 ' HD3' ' O ' ' A' ' 39' ' ' ALA . 8.0 Cg_exo -73.56 98.02 1.01 Allowed 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 121.657 1.571 . . . . 75.209999999999994 112.348 -178.181 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -87.37 66.97 9.35 Favored 'General case' 0 C--O 1.249 1.047 0 CA-C-O 122.42 1.105 . . . . 61.009999999999998 111.302 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -112.61 70.45 0.22 Allowed Glycine 0 CA--C 1.477 -2.294 0 N-CA-C 106.084 -2.806 . . . . 64.510000000000005 106.084 175.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 25.0 m -88.74 163.0 15.93 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-O 121.835 0.826 . . . . 63.409999999999997 112.405 -167.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.501 ' HA ' ' N ' ' A' ' 140' ' ' GLY . . . -129.48 171.14 12.86 Favored 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 107.604 -1.258 . . . . 54.219999999999999 107.604 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.7 pp -133.71 143.87 48.78 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 112.314 0.487 . . . . 71.329999999999998 112.314 -175.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.515 HD23 ' O ' ' A' ' 61' ' ' PHE . 2.4 pt? -109.75 132.01 54.54 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.91 -1.145 . . . . 71.239999999999995 107.91 178.044 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 23.5 t -119.04 126.37 75.3 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 109.111 -0.7 . . . . 75.230000000000004 109.111 -176.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 15.4 t -92.77 118.35 38.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.761 0 N-CA-C 107.234 -1.395 . . . . 74.340000000000003 107.234 177.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.45 ' HB2' ' HG3' ' A' ' 134' ' ' ARG . 31.8 mmmt -70.68 -38.22 73.72 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 108.72 -0.844 . . . . 75.25 108.72 -179.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.436 ' HA ' ' HE ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -174.3 133.74 0.41 Allowed 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.011 -0.995 . . . . 71.540000000000006 108.805 178.076 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -177.91 158.26 23.15 Favored Glycine 0 N--CA 1.43 -1.715 0 N-CA-C 108.648 -1.781 . . . . 53.109999999999999 108.648 176.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -68.42 -25.47 35.66 Favored 'Trans proline' 0 N--CA 1.48 0.73 0 C-N-CA 122.292 1.995 . . . . 74.230000000000004 110.477 176.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.459 ' CB ' ' HA ' ' A' ' 80' ' ' LEU . 9.7 p30 -58.55 -58.64 7.66 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 113.91 -1.495 . . . . 73.329999999999998 111.9 177.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -162.96 -179.75 6.98 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 108.761 -0.829 . . . . 63.329999999999998 108.761 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -155.31 36.04 0.65 Allowed Glycine 0 C--N 1.3 -1.46 0 N-CA-C 109.97 -1.252 . . . . 71.420000000000002 109.97 178.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -140.04 -171.25 3.14 Favored 'General case' 0 N--CA 1.424 -1.763 0 N-CA-C 108.851 -0.796 . . . . 71.310000000000002 108.851 -175.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 23.7 ptt180 -112.62 146.02 39.35 Favored 'General case' 0 C--N 1.294 -1.839 0 O-C-N 123.578 0.549 . . . . 75.329999999999998 110.577 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.516 ' HA ' ' CB ' ' A' ' 29' ' ' SER . 93.5 m-85 -129.45 131.64 46.78 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.885 -0.598 . . . . 75.010000000000005 109.613 178.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 53.8 tp -90.45 129.38 36.64 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.033 -0.728 . . . . 75.450000000000003 109.033 178.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -79.75 113.84 18.21 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 119.855 -0.738 . . . . 75.120000000000005 110.379 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -112.2 -24.99 9.52 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 122.186 0.994 . . . . 75.409999999999997 108.506 174.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -92.39 127.55 48.25 Favored Pre-proline 0 C--N 1.306 -1.291 0 CA-C-N 114.305 -1.316 . . . . 75.349999999999994 110.171 -174.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.473 ' O ' ' HA ' ' A' ' 93' ' ' ARG . 10.4 Cg_endo -57.78 -41.79 66.21 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 122.852 2.368 . . . . 53.310000000000002 112.783 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 32.0 m -118.34 109.35 16.18 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 109.386 -0.598 . . . . 73.299999999999997 109.386 178.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 64.1 m -106.32 115.39 30.13 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 115.913 -0.585 . . . . 73.129999999999995 109.594 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.7 m -86.49 120.61 28.0 Favored 'General case' 0 C--O 1.25 1.127 0 CA-C-N 116.184 -0.462 . . . . 74.340000000000003 109.942 -177.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -101.99 112.98 25.82 Favored 'General case' 0 C--O 1.252 1.232 0 CA-C-O 120.88 0.372 . . . . 64.439999999999998 110.445 179.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 170.4 -173.19 44.3 Favored Glycine 0 N--CA 1.426 -1.993 0 N-CA-C 110.07 -1.212 . . . . 53.530000000000001 110.07 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -119.26 95.42 4.8 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 105.808 -1.923 . . . . 64.400000000000006 105.808 178.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 8.7 m80 -134.65 178.26 1.85 Allowed Pre-proline 0 C--N 1.287 -2.127 0 N-CA-C 106.289 -1.745 . . . . 73.109999999999999 106.289 -177.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -64.21 -21.54 67.38 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 121.45 1.434 . . . . 74.519999999999996 109.732 167.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -116.66 78.79 1.24 Allowed 'General case' 0 N--CA 1.434 -1.24 0 C-N-CA 123.958 0.903 . . . . 72.400000000000006 109.754 178.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 74.2 m -104.58 118.45 36.61 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-N 115.467 -0.788 . . . . 70.209999999999994 109.482 172.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -78.01 -43.43 29.5 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 108.694 -0.854 . . . . 75.25 108.694 177.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.8 pp -120.5 166.49 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 N-CA-C 107.786 -1.191 . . . . 74.340000000000003 107.786 171.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -107.53 135.96 48.12 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 115.161 1.541 . . . . 71.129999999999995 115.161 -168.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.459 ' HA ' ' CB ' ' A' ' 56' ' ' ASN . 4.0 mm? -125.08 153.41 42.97 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 104.429 -2.434 . . . . 74.109999999999999 104.429 171.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -144.72 -14.86 0.55 Allowed 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 118.793 -1.163 . . . . 73.019999999999996 112.557 -175.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -72.89 161.49 30.65 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 123.579 0.751 . . . . 71.310000000000002 110.747 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.3 p -77.12 -16.32 14.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-O 122.202 1.001 . . . . 74.450000000000003 110.377 -176.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -82.93 11.45 6.11 Favored 'General case' 0 N--CA 1.42 -1.928 0 CA-C-N 114.768 -1.106 . . . . 71.420000000000002 112.973 -179.206 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.0 p -83.3 139.74 17.28 Favored 'Isoleucine or valine' 0 C--O 1.244 0.783 0 CA-C-O 121.068 0.461 . . . . 63.140000000000001 109.833 176.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 28.4 t -105.37 157.11 17.56 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.446 -0.946 . . . . 72.299999999999997 108.446 179.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -69.98 110.69 5.2 Favored 'General case' 0 C--O 1.249 1.035 0 N-CA-C 106.839 -1.541 . . . . 73.209999999999994 106.839 174.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 59.4 mtt180 60.49 78.15 0.29 Allowed 'General case' 0 C--N 1.316 -0.867 0 O-C-N 124.536 1.147 . . . . 73.420000000000002 107.964 -166.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 45.0 t60 -77.29 -43.06 34.54 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 113.554 -1.657 . . . . 74.420000000000002 108.46 -176.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -150.67 159.19 44.69 Favored 'General case' 0 N--CA 1.422 -1.838 0 N-CA-C 107.251 -1.389 . . . . 74.450000000000003 107.251 178.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -136.73 127.86 27.9 Favored 'General case' 0 C--N 1.283 -2.311 0 N-CA-C 107.615 -1.254 . . . . 74.340000000000003 107.615 176.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -110.28 124.48 51.72 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.955 -0.757 . . . . 74.310000000000002 108.955 -177.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.473 ' HA ' ' O ' ' A' ' 66' ' ' PRO . 42.7 mtp85 -119.09 138.18 53.06 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-O 121.317 0.58 . . . . 74.450000000000003 112.449 175.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.46 ' O ' HD13 ' A' ' 94' ' ' ILE . 2.8 pp -116.02 116.47 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.152 0 N-CA-C 106.664 -1.606 . . . . 72.239999999999995 106.664 173.266 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -118.68 147.49 43.74 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 115.452 -0.794 . . . . 72.040000000000006 110.666 -173.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -45.82 -32.22 2.48 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.896 1.278 . . . . 72.409999999999997 112.385 178.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -78.72 -59.19 2.87 Favored Glycine 0 N--CA 1.436 -1.355 0 N-CA-C 111.488 -0.645 . . . . 74.150000000000006 111.488 175.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -158.28 173.77 16.18 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 123.777 0.831 . . . . 75.219999999999999 109.304 -175.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -102.68 134.73 45.57 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.068 -1.086 . . . . 72.230000000000004 108.068 -178.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -132.31 135.73 46.41 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 114.117 1.154 . . . . 74.329999999999998 114.117 -177.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 6.9 p -110.98 127.62 67.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 CA-C-N 114.532 -1.213 . . . . 72.140000000000001 107.973 177.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.6 p -119.09 130.3 74.04 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 C-N-CA 120.347 -0.541 . . . . 75.549999999999997 111.779 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -81.37 106.22 13.17 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 105.533 -2.025 . . . . 63.210000000000001 105.533 174.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.6 m -104.35 13.86 7.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 112.761 0.652 . . . . 62.100000000000001 112.761 -175.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 114.02 73.82 0.61 Allowed Glycine 0 CA--C 1.489 -1.544 0 C-N-CA 120.537 -0.84 . . . . 53.240000000000002 111.239 178.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 14.0 p -91.76 138.23 31.72 Favored 'General case' 0 N--CA 1.416 -2.154 0 CA-C-N 115.337 -0.432 . . . . 75.310000000000002 110.218 -177.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 5.8 tt -82.75 -47.55 11.83 Favored 'General case' 0 C--N 1.315 -0.935 0 N-CA-C 108.016 -1.105 . . . . 71.430000000000007 108.016 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.433 ' OD1' ' HA3' ' A' ' 131' ' ' GLY . 11.6 t-20 -68.42 -32.64 72.82 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.679 -0.691 . . . . 72.450000000000003 109.901 179.207 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 130' ' ' ILE . . . 112.53 131.68 5.63 Favored Glycine 0 C--O 1.223 -0.573 0 CA-C-N 116.093 -0.503 . . . . 52.399999999999999 112.233 179.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -109.16 122.03 46.43 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 123.389 0.676 . . . . 73.510000000000005 109.717 176.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -123.76 133.06 53.91 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 108.616 -0.883 . . . . 71.200000000000003 108.616 178.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 45.4 t -121.35 117.45 52.77 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 N-CA-C 106.128 -1.804 . . . . 72.409999999999997 106.128 177.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.461 ' HB2' HH21 ' A' ' 117' ' ' ARG . 20.3 m120 66.88 24.74 9.66 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 108.556 -0.905 . . . . 74.140000000000001 108.556 -172.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.524 ' HG2' ' OE1' ' A' ' 129' ' ' GLN . 96.2 mtt180 75.77 2.84 3.77 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 126.001 1.72 . . . . 74.150000000000006 112.833 -178.156 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 55.0 mm-40 -104.97 129.49 24.75 Favored Pre-proline 0 C--N 1.311 -1.071 0 N-CA-C 109.11 -0.7 . . . . 72.329999999999998 109.11 178.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -71.56 124.76 10.57 Favored 'Trans proline' 0 C--O 1.247 0.957 0 C-N-CA 122.116 1.878 . . . . 64.030000000000001 108.881 174.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.461 HH21 ' HB2' ' A' ' 113' ' ' ASN . 47.4 mtt180 -119.98 -158.78 0.75 Allowed 'General case' 0 C--N 1.31 -1.113 0 O-C-N 121.951 -0.468 . . . . 73.209999999999994 111.24 -172.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -121.74 -45.24 2.29 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 108.104 -1.073 . . . . 73.0 108.104 174.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -156.7 138.87 14.61 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 107.28 -1.378 . . . . 63.329999999999998 107.28 171.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 53.8 tp60 -141.73 150.85 42.33 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 110.437 -0.209 . . . . 74.439999999999998 110.437 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 78.7 t -78.87 127.96 38.7 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 107.24 -1.393 . . . . 71.239999999999995 107.24 174.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 82.0 mtp -71.68 120.02 16.67 Favored 'General case' 0 CA--C 1.497 -1.085 0 CA-C-N 115.757 -0.656 . . . . 72.120000000000005 109.28 -175.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 14.2 tp60 -105.39 130.17 53.55 Favored 'General case' 0 N--CA 1.415 -2.182 0 N-CA-C 108.362 -0.977 . . . . 74.049999999999997 108.362 -177.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 18.9 p -78.35 123.54 27.1 Favored 'General case' 0 N--CA 1.424 -1.769 0 CA-C-O 121.1 0.476 . . . . 75.450000000000003 110.606 -177.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 123.62 -17.61 7.77 Favored Glycine 0 N--CA 1.416 -2.664 0 CA-C-N 115.432 -0.803 . . . . 63.140000000000001 111.791 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -104.32 -169.73 1.67 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 120.133 -0.627 . . . . 64.299999999999997 110.941 -176.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -136.97 136.11 38.25 Favored 'General case' 0 C--O 1.25 1.123 0 CA-C-O 121.829 0.823 . . . . 75.120000000000005 112.141 -171.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 74.4 mt -110.29 130.59 63.29 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 C-N-CA 125.418 1.487 . . . . 71.219999999999999 107.926 -179.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.524 ' OE1' ' HG2' ' A' ' 114' ' ' ARG . 52.0 mt-30 -109.74 133.46 53.11 Favored 'General case' 0 C--N 1.29 -2.02 0 C-N-CA 120.347 -0.541 . . . . 74.349999999999994 110.713 -178.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.439 ' HA ' ' O ' ' A' ' 109' ' ' GLY . 0.2 OUTLIER -107.44 97.71 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.963 0 N-CA-C 106.783 -1.562 . . . . 74.420000000000002 106.783 171.859 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.433 ' HA3' ' OD1' ' A' ' 108' ' ' ASN . . . 70.78 -115.25 5.77 Favored Glycine 0 N--CA 1.427 -1.95 0 N-CA-C 108.81 -1.716 . . . . 65.450000000000003 108.81 -170.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -112.3 2.31 16.48 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.074 0.464 . . . . 64.099999999999994 110.689 176.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -85.78 140.19 30.68 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 106.402 -1.703 . . . . 75.310000000000002 106.402 177.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.45 ' HG3' ' HB2' ' A' ' 52' ' ' LYS . 15.3 ptm180 -116.75 131.63 56.9 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.043 -1.063 . . . . 74.540000000000006 113.856 -168.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 34.3 tp -122.58 121.5 36.63 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 114.032 -1.44 . . . . 74.420000000000002 108.715 -177.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 10.7 p -106.66 137.54 36.75 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.15 0 N-CA-C 108.863 -0.791 . . . . 74.319999999999993 108.863 -178.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -114.33 115.67 27.74 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 110.293 -0.262 . . . . 70.010000000000005 110.293 -173.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -121.47 163.62 18.5 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 109.065 -0.717 . . . . 75.549999999999997 109.065 -178.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -75.3 147.03 40.53 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 109.461 -0.57 . . . . 62.009999999999998 109.461 177.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.501 ' N ' ' HA ' ' A' ' 47' ' ' ALA . . . -104.39 -149.88 20.22 Favored Glycine 0 N--CA 1.426 -2.013 0 C-N-CA 120.551 -0.833 . . . . 72.450000000000003 111.403 -176.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -95.76 164.76 1.4 Allowed 'Trans proline' 0 N--CA 1.427 -2.391 0 C-N-CA 122.529 2.152 . . . . 74.409999999999997 112.693 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -92.91 112.6 24.61 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 106.77 -1.567 . . . . 75.450000000000003 106.77 174.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 . . . . . 0 N--CA 1.426 -1.643 0 CA-C-O 118.557 -0.735 . . . . 73.409999999999997 109.46 -175.609 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 CA--C 1.508 -0.647 0 N-CA-C 109.283 -0.636 . . . . 73.25 109.283 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.4 m -69.19 -47.67 64.24 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.649 -0.5 . . . . 71.010000000000005 109.649 179.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.7 t70 67.03 174.2 0.25 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.333 1.453 . . . . 72.230000000000004 110.604 178.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -130.16 -5.35 4.39 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 121.705 -0.622 . . . . 72.010000000000005 110.715 -178.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 58.6 t30 61.81 95.29 0.04 OUTLIER 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.911 1.284 . . . . 74.409999999999997 109.816 -174.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -56.63 100.03 0.1 Allowed Glycine 0 CA--C 1.506 -0.484 0 O-C-N 123.679 0.612 . . . . 64.120000000000005 112.965 -178.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.7 m -119.05 130.95 24.56 Favored Pre-proline 0 C--N 1.304 -1.375 0 N-CA-C 109.438 -0.579 . . . . 75.040000000000006 109.438 -176.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.91 127.38 16.85 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 121.667 1.578 . . . . 72.209999999999994 110.13 175.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -97.12 113.99 63.98 Favored Pre-proline 0 C--N 1.301 -1.518 0 N-CA-C 109.053 -0.721 . . . . 72.129999999999995 109.053 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -62.26 136.32 59.29 Favored 'Trans proline' 0 C--O 1.237 0.457 0 C-N-CA 123.342 2.694 . . . . 74.329999999999998 113.867 -173.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.0 tm0? -126.95 109.26 11.75 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 107.145 -1.428 . . . . 71.129999999999995 107.145 178.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.7 p -94.14 132.91 36.9 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 109.297 -0.631 . . . . 70.219999999999999 109.297 178.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -114.43 139.25 49.66 Favored 'General case' 0 N--CA 1.424 -1.727 0 N-CA-C 109.083 -0.71 . . . . 74.340000000000003 109.083 -178.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.0 m -100.86 118.41 36.87 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.735 -0.839 . . . . 74.129999999999995 108.735 -177.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 40.0 p -116.17 103.83 10.92 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 121.352 0.596 . . . . 73.109999999999999 111.843 -178.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.6 p -112.42 138.77 48.68 Favored 'General case' 0 N--CA 1.42 -1.932 0 N-CA-C 107.42 -1.326 . . . . 61.130000000000003 107.42 176.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.1 m -120.76 135.56 60.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 CA-C-O 121.372 0.606 . . . . 74.099999999999994 111.9 -177.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -155.54 135.88 13.17 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 106.401 -1.703 . . . . 74.099999999999994 106.401 177.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.32 -164.44 1.02 Allowed 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.867 -0.79 . . . . 73.239999999999995 108.867 -173.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.84 80.83 8.04 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 106.188 -1.782 . . . . 74.409999999999997 106.188 170.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -91.15 -2.35 57.56 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 114.439 -1.255 . . . . 73.409999999999997 113.997 -171.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 58.2 tp -93.08 99.63 12.2 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 119.938 -0.705 . . . . 74.540000000000006 111.416 179.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 53.5 tp -97.08 145.54 25.88 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 108.084 -1.08 . . . . 73.230000000000004 108.084 176.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.99 177.24 8.5 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.961 -0.755 . . . . 75.25 108.961 -178.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.73 -177.53 4.47 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.558 -0.534 . . . . 72.150000000000006 109.558 179.124 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.31 157.64 28.77 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.846 -1.168 . . . . 71.230000000000004 107.846 177.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -92.45 174.6 7.2 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 121.262 0.554 . . . . 71.530000000000001 111.473 177.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.9 m -107.28 -176.71 3.15 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 106.753 -1.573 . . . . 72.219999999999999 106.753 177.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.6 t -126.33 139.36 53.35 Favored 'General case' 0 N--CA 1.428 -1.543 0 C-N-CA 120.181 -0.608 . . . . 73.439999999999998 109.549 -178.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.2 t -132.89 128.17 35.99 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.652 -0.87 . . . . 74.230000000000004 108.652 177.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -123.01 114.11 2.33 Favored Glycine 0 N--CA 1.435 -1.375 0 N-CA-C 111.419 -0.673 . . . . 54.340000000000003 111.419 -177.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.9 p -67.87 154.81 40.76 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 123.243 0.617 . . . . 73.430000000000007 112.294 -177.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -83.87 130.9 53.4 Favored Pre-proline 0 C--N 1.312 -1.061 0 CA-C-N 116.139 -0.482 . . . . 75.299999999999997 109.918 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -75.94 109.05 2.82 Favored 'Trans proline' 0 N--CA 1.443 -1.442 0 C-N-CA 122.162 1.908 . . . . 65.049999999999997 110.543 176.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -102.8 116.99 33.66 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.623 -0.717 . . . . 75.400000000000006 109.367 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.0 t -138.1 124.62 20.77 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.029 0.442 . . . . 65.019999999999996 109.88 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.503 ' O ' ' HG2' ' A' ' 40' ' ' GLU . 91.0 m -127.65 158.25 38.07 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.099 -1.075 . . . . 55.5 108.099 179.181 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -81.32 -48.47 5.96 Favored Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 119.83 -1.176 . . . . 75.400000000000006 110.978 177.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -56.11 -19.76 14.56 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 124.526 1.13 . . . . 75.549999999999997 113.856 -178.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.503 ' HG2' ' O ' ' A' ' 37' ' ' THR . 11.6 pt-20 -65.67 -29.34 69.88 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.705 0.631 . . . . 70.019999999999996 112.705 -175.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -83.07 -16.47 46.82 Favored 'General case' 0 CA--C 1.505 -0.773 0 C-N-CA 119.183 -1.007 . . . . 74.439999999999998 110.004 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 tm? 75.92 104.97 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 125.723 1.609 . . . . 74.329999999999998 110.371 -179.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.421 ' HA ' ' O ' ' A' ' 139' ' ' ALA . 88.6 Cg_endo -79.96 173.03 13.23 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.779 2.319 . . . . 73.049999999999997 112.721 -179.392 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -140.1 -167.46 2.31 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.75 -0.463 . . . . 75.25 109.75 -177.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -82.21 -12.48 80.7 Favored Glycine 0 CA--C 1.508 -0.376 0 N-CA-C 111.446 -0.662 . . . . 71.409999999999997 111.446 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.5 m -112.32 153.82 26.64 Favored 'General case' 0 N--CA 1.424 -1.761 0 N-CA-C 108.707 -0.849 . . . . 75.140000000000001 108.707 177.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.418 ' O ' ' HG ' ' A' ' 62' ' ' LEU . . . -153.43 146.4 24.51 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 108.756 -0.831 . . . . 70.239999999999995 108.756 -178.062 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -130.23 160.12 34.8 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 109.484 -0.561 . . . . 75.299999999999997 109.484 -178.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.415 HD13 ' CZ ' ' A' ' 61' ' ' PHE . 3.7 pp -133.93 147.77 51.12 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 116.349 -0.387 . . . . 75.5 110.672 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.471 HG12 ' HB3' ' A' ' 60' ' ' ARG . 27.9 m -117.03 129.24 73.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 108.961 -0.755 . . . . 64.219999999999999 108.961 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.5 t -97.79 118.79 44.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 N-CA-C 107.754 -1.202 . . . . 71.340000000000003 107.754 176.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -110.81 -13.56 14.13 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.827 -0.624 . . . . 74.400000000000006 112.626 -173.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 16.6 tpp180 -150.1 125.94 10.45 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.86 -0.793 . . . . 71.140000000000001 108.86 176.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 139.9 135.76 3.28 Favored Glycine 0 C--O 1.206 -1.622 0 C-N-CA 120.722 -0.751 . . . . 65.230000000000004 112.472 176.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.517 ' HD2' ' CE1' ' A' ' 133' ' ' PHE . 39.2 Cg_exo -67.71 -8.66 23.06 Favored 'Trans proline' 0 N--CA 1.484 0.939 0 C-N-CA 123.134 2.556 . . . . 75.430000000000007 112.951 174.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -66.02 -40.13 90.81 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.203 -0.453 . . . . 73.540000000000006 110.667 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -169.26 173.56 6.61 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 109.252 -0.647 . . . . 73.439999999999998 109.252 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.93 43.61 0.41 Allowed Glycine 0 CA--C 1.487 -1.707 0 N-CA-C 108.997 -1.641 . . . . 74.030000000000001 108.997 178.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -147.15 -173.18 4.18 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.722 -0.844 . . . . 75.439999999999998 108.722 -174.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.471 ' HB3' HG12 ' A' ' 50' ' ' VAL . 14.1 ptt180 -121.69 141.48 51.11 Favored 'General case' 0 N--CA 1.434 -1.233 0 O-C-N 123.687 0.617 . . . . 75.299999999999997 110.116 179.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.415 ' CZ ' HD13 ' A' ' 49' ' ' LEU . 52.6 p90 -149.39 152.45 35.77 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 109.042 -0.725 . . . . 74.099999999999994 109.042 175.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 47' ' ' ALA . 9.2 tt -99.43 140.51 33.51 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 123.622 0.576 . . . . 71.409999999999997 109.621 -176.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 84.3 mt -81.13 114.26 19.85 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 121.279 0.562 . . . . 73.319999999999993 110.955 -176.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -122.25 -36.78 2.91 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.253 -1.017 . . . . 74.129999999999995 108.253 174.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.5 pm0 -64.46 130.18 94.54 Favored Pre-proline 0 N--CA 1.436 -1.148 0 CA-C-N 114.965 -1.016 . . . . 74.219999999999999 110.031 175.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.47 -30.64 91.22 Favored 'Trans proline' 0 N--CA 1.479 0.663 0 C-N-CA 123.846 3.031 . . . . 75.120000000000005 113.477 -173.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 90.0 m -135.92 116.14 13.47 Favored 'General case' 0 N--CA 1.416 -2.158 0 CA-C-N 115.929 -0.578 . . . . 75.219999999999999 109.801 178.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.473 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 11.9 m -100.65 115.36 30.02 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 106.717 -1.586 . . . . 72.420000000000002 106.717 176.322 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.7 p -96.82 108.8 21.54 Favored 'General case' 0 N--CA 1.425 -1.679 0 CA-C-O 121.414 0.626 . . . . 74.299999999999997 112.169 -176.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.4 ' O ' ' HB3' ' A' ' 89' ' ' HIS . . . -102.32 92.55 4.76 Favored 'General case' 0 N--CA 1.425 -1.71 0 N-CA-C 107.836 -1.172 . . . . 71.540000000000006 107.836 174.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.613 ' O ' ' HA ' ' A' ' 88' ' ' ARG . . . 99.97 102.01 2.42 Favored Glycine 0 N--CA 1.428 -1.871 0 N-CA-C 110.5 -1.04 . . . . 71.239999999999995 110.5 -178.19 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.3 mmt85 -155.14 -61.1 0.11 Allowed 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 124.866 1.266 . . . . 72.420000000000002 108.488 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.413 ' HB3' ' HD2' ' A' ' 74' ' ' PRO . 94.4 m-70 -146.2 177.21 1.85 Allowed Pre-proline 0 C--N 1.295 -1.786 0 N-CA-C 106.751 -1.574 . . . . 72.030000000000001 106.751 -178.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.413 ' HD2' ' HB3' ' A' ' 73' ' ' HIS . 6.3 Cg_endo -54.24 -30.69 62.97 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 121.88 1.72 . . . . 74.439999999999998 110.508 170.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -107.79 72.58 0.86 Allowed 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 115.16 -0.927 . . . . 74.120000000000005 109.678 178.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.423 ' HB2' ' O ' ' A' ' 78' ' ' ILE . 41.5 m -91.01 -174.82 4.13 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.502 -1.296 . . . . 75.439999999999998 107.502 173.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -60.9 -44.33 97.29 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 108.32 -0.992 . . . . 72.340000000000003 108.32 177.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.423 ' O ' ' HB2' ' A' ' 76' ' ' SER . 36.8 pt -128.02 143.59 40.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 105.582 -2.007 . . . . 73.409999999999997 105.582 170.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -99.48 126.45 45.41 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 118.568 -1.253 . . . . 75.219999999999999 112.113 -175.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.5 mp -85.46 89.6 7.74 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 106.361 -1.718 . . . . 74.310000000000002 106.361 175.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -45.27 -58.73 3.07 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.552 -1.204 . . . . 75.519999999999996 113.542 -173.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -162.84 -167.05 1.42 Allowed 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 106.69 -1.596 . . . . 54.219999999999999 106.69 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 83.2 t 74.3 -41.95 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.246 1.418 . . . . 72.349999999999994 112.58 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.533 ' HB ' ' CZ ' ' A' ' 133' ' ' PHE . 56.6 m -154.04 71.96 0.87 Allowed 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.358 0.599 . . . . 61.43 110.331 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.3 p -114.45 109.03 27.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 O-C-N 121.617 -0.677 . . . . 75.420000000000002 112.401 176.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 36.0 t -97.74 170.29 9.09 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.699 -0.852 . . . . 73.430000000000007 108.699 174.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 60.0 ttt180 -78.39 -8.23 58.23 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 122.952 1.358 . . . . 74.439999999999998 109.381 -179.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.613 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -170.61 125.65 0.72 Allowed 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 104.154 -2.536 . . . . 74.530000000000001 104.154 173.047 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.4 ' HB3' ' O ' ' A' ' 70' ' ' ALA . 11.7 t60 -128.46 -76.97 0.56 Allowed 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 118.939 -1.105 . . . . 74.519999999999996 112.914 -172.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -127.7 119.26 25.44 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-O 121.272 0.558 . . . . 73.310000000000002 109.605 -176.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -114.03 128.01 56.2 Favored 'General case' 0 C--N 1.276 -2.594 0 C-N-CA 120.02 -0.672 . . . . 65.530000000000001 110.439 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.473 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 56.2 m-85 -97.41 121.21 39.05 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 107.991 -1.114 . . . . 75.140000000000001 107.991 -178.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 34.3 mmt-85 -104.91 129.13 53.36 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.437 -0.949 . . . . 71.420000000000002 108.437 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 11.4 pt -115.88 130.96 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.201 0 C-N-CA 118.504 -1.279 . . . . 73.019999999999996 108.022 173.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.435 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 56.0 t-20 -120.03 145.47 46.79 Favored 'General case' 0 C--N 1.269 -2.93 0 N-CA-C 106.547 -1.649 . . . . 74.109999999999999 106.547 -175.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -59.7 -20.27 55.26 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-O 121.357 0.598 . . . . 64.530000000000001 110.267 174.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -77.61 -61.81 2.52 Favored Glycine 0 N--CA 1.423 -2.172 0 CA-C-N 115.488 -0.778 . . . . 63.549999999999997 111.604 174.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.435 ' O ' ' HB3' ' A' ' 95' ' ' ASN . 27.3 tt0 -157.4 -178.11 7.1 Favored 'General case' 0 CA--C 1.552 1.023 0 CA-C-N 117.475 0.637 . . . . 74.0 109.346 -176.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.633 ' HB3' ' SD ' ' A' ' 122' ' ' MET . 81.5 m-85 -109.71 130.05 55.55 Favored 'General case' 0 C--N 1.311 -1.091 0 O-C-N 121.963 -0.46 . . . . 72.099999999999994 110.52 -176.183 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -132.53 135.84 46.23 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-O 120.633 0.254 . . . . 74.400000000000006 111.464 -175.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 8.9 p -114.56 129.62 70.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 O-C-N 121.845 -0.534 . . . . 74.420000000000002 110.073 176.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 59.4 t -118.92 128.97 75.72 Favored 'Isoleucine or valine' 0 C--O 1.248 0.98 0 CA-C-N 116.313 -0.403 . . . . 75.25 111.321 -177.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -83.95 117.96 23.7 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.637 -0.71 . . . . 63.210000000000001 109.215 173.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.416 ' O ' ' HG2' ' A' ' 88' ' ' ARG . 17.8 m -118.2 8.0 6.9 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.35 0 N-CA-C 108.258 -1.016 . . . . 73.239999999999995 108.258 176.02 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.436 ' HA2' ' O ' ' A' ' 88' ' ' ARG . . . -91.2 -66.15 1.16 Allowed Glycine 0 N--CA 1.404 -3.446 0 CA-C-N 114.578 -1.192 . . . . 72.439999999999998 111.091 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 14.0 m 60.07 1.46 0.34 Allowed 'General case' 0 CA--C 1.566 1.573 0 C-N-CA 124.252 1.021 . . . . 74.299999999999997 112.282 -179.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.419 ' H ' ' C ' ' A' ' 105' ' ' GLY . 49.1 tp -72.98 -50.82 21.01 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.099 0.959 . . . . 70.310000000000002 109.656 -177.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -99.23 -35.44 9.97 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.114 -0.948 . . . . 73.5 109.397 176.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 104.05 133.84 7.98 Favored Glycine 0 N--CA 1.427 -1.964 0 N-CA-C 110.584 -1.006 . . . . 73.129999999999995 110.584 -178.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 97.7 m -101.87 119.62 39.08 Favored 'General case' 0 C--N 1.281 -2.374 0 N-CA-C 108.847 -0.797 . . . . 75.099999999999994 108.847 178.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 116' ' ' PRO . 3.9 m-85 -111.32 132.48 54.36 Favored 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 106.487 -1.671 . . . . 74.019999999999996 106.487 -177.229 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.7 p -131.16 131.92 63.51 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.776 0 C-N-CA 119.953 -0.699 . . . . 73.140000000000001 110.696 178.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 66.56 -72.46 0.08 Allowed 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 125.506 1.523 . . . . 73.010000000000005 110.841 -177.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -154.59 4.26 0.24 Allowed 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.902 -0.59 . . . . 75.040000000000006 109.489 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -132.98 134.72 24.78 Favored Pre-proline 0 C--O 1.237 0.43 0 O-C-N 121.319 -0.863 . . . . 74.439999999999998 112.487 -174.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.417 ' HA ' ' HA ' ' A' ' 111' ' ' TYR . 2.9 Cg_exo -77.23 116.01 4.07 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 122.332 2.021 . . . . 75.230000000000004 108.702 170.144 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.437 HH11 ' HG3' ' A' ' 120' ' ' GLN . 7.0 ptp180 -144.06 151.41 39.61 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.112 -1.07 . . . . 74.299999999999997 108.112 -178.299 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -76.22 -42.19 46.86 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 112.529 0.566 . . . . 74.349999999999994 112.529 -174.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -125.84 140.61 52.52 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 109.331 -0.618 . . . . 75.540000000000006 109.331 179.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.437 ' HG3' HH11 ' A' ' 117' ' ' ARG . 1.6 tm0? -138.94 149.85 45.23 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 116.41 -0.359 . . . . 71.420000000000002 110.561 -178.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 81.1 t -104.5 117.68 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 N-CA-C 105.743 -1.947 . . . . 75.319999999999993 105.743 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.633 ' SD ' ' HB3' ' A' ' 99' ' ' PHE . 66.7 mtt -59.86 128.67 38.04 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 113.87 1.063 . . . . 72.530000000000001 113.87 -169.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -112.07 137.73 49.71 Favored 'General case' 0 N--CA 1.418 -2.044 0 N-CA-C 107.079 -1.452 . . . . 74.329999999999998 107.079 178.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.8 t -79.37 129.76 34.78 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-O 121.368 0.604 . . . . 62.509999999999998 110.826 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 83.79 38.21 10.79 Favored Glycine 0 N--CA 1.424 -2.118 0 N-CA-C 110.014 -1.234 . . . . 71.109999999999999 110.014 -178.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -125.25 166.81 15.82 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.722 -0.391 . . . . 74.319999999999993 110.985 -177.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 19.1 tp10 -107.47 120.56 42.51 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 123.405 0.682 . . . . 75.030000000000001 109.181 -172.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 61.6 mt -114.96 117.6 56.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 108.006 -1.109 . . . . 72.25 108.006 179.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -116.49 111.8 20.49 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.255 0.55 . . . . 73.209999999999994 109.787 -175.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 25.6 pt -101.71 98.36 6.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-O 121.83 0.824 . . . . 74.239999999999995 109.384 179.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 70.36 -100.09 0.78 Allowed Glycine 0 N--CA 1.435 -1.386 0 N-CA-C 110.384 -1.087 . . . . 70.120000000000005 110.384 -175.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -115.18 0.35 13.53 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 120.938 0.399 . . . . 75.019999999999996 110.603 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.533 ' CZ ' ' HB ' ' A' ' 84' ' ' THR . 9.7 m-30 -93.27 141.15 28.76 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.035 -0.728 . . . . 74.409999999999997 109.035 -176.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 41.0 mtm180 -121.81 122.55 39.73 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.889 0.852 . . . . 75.049999999999997 111.193 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.8 tt -124.72 131.1 53.48 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 113.744 -1.571 . . . . 74.420000000000002 108.77 -176.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 57.5 t -108.09 128.41 63.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 108.697 -0.853 . . . . 73.120000000000005 108.697 178.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -100.78 130.05 46.75 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.953 -0.567 . . . . 74.340000000000003 110.438 -176.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.4 mp -130.66 130.45 43.93 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.692 -0.484 . . . . 75.409999999999997 109.692 179.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.421 ' O ' ' HA ' ' A' ' 43' ' ' PRO . . . -122.38 117.67 26.6 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 108.07 -1.085 . . . . 74.129999999999995 108.07 177.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -174.04 -60.11 0.05 OUTLIER Glycine 0 C--N 1.294 -1.786 0 C-N-CA 120.125 -1.036 . . . . 73.319999999999993 112.673 -176.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -61.88 123.36 12.47 Favored 'Trans proline' 0 C--N 1.358 1.045 0 C-N-CA 121.917 1.744 . . . . 73.420000000000002 110.895 176.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -96.88 109.5 22.2 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 115.304 -0.862 . . . . 62.43 111.065 -175.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 . . . . . 0 N--CA 1.408 -2.542 0 N-CA-C 108.16 -1.052 . . . . 71.140000000000001 108.16 177.123 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ptt? . . . . . 0 C--O 1.237 0.431 0 CA-C-O 122.09 0.948 . . . . 73.349999999999994 110.527 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.9 t -82.24 -49.15 10.42 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 115.278 -0.874 . . . . 74.349999999999994 111.974 -174.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -107.29 139.03 42.39 Favored 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 120.675 -0.41 . . . . 75.129999999999995 109.908 -176.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -95.58 120.05 35.14 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.3 0.571 . . . . 71.540000000000006 111.928 -176.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -118.03 145.49 44.74 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.277 -1.379 . . . . 74.0 107.277 175.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 93.11 45.65 3.51 Favored Glycine 0 N--CA 1.431 -1.682 0 N-CA-C 109.631 -1.388 . . . . 73.049999999999997 109.631 -175.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 55.9 m -92.28 122.91 63.86 Favored Pre-proline 0 N--CA 1.416 -2.141 0 N-CA-C 107.833 -1.173 . . . . 73.510000000000005 107.833 178.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.56 128.95 19.02 Favored 'Trans proline' 0 N--CA 1.448 -1.205 0 C-N-CA 122.211 1.941 . . . . 71.030000000000001 111.272 177.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -73.67 109.73 7.32 Favored Pre-proline 0 C--N 1.315 -0.9 0 N-CA-C 107.168 -1.419 . . . . 71.420000000000002 107.168 173.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -73.24 132.84 18.48 Favored 'Trans proline' 0 N--CA 1.443 -1.465 0 C-N-CA 122.186 1.924 . . . . 73.439999999999998 113.016 -171.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -110.27 116.73 32.0 Favored 'General case' 0 N--CA 1.422 -1.837 0 CA-C-N 115.573 -0.74 . . . . 64.340000000000003 109.323 175.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.9 p -86.01 88.84 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.519 0 CA-C-O 122.542 1.163 . . . . 72.439999999999998 110.062 178.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -125.52 120.35 30.66 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 106.667 -1.605 . . . . 60.310000000000002 106.667 178.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.5 m -113.4 98.98 7.43 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-O 121.321 0.581 . . . . 64.239999999999995 111.281 -175.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.5 m -105.85 -11.58 16.18 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 122.557 1.17 . . . . 74.150000000000006 108.459 175.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.2 t -83.26 91.83 7.36 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 114.218 -1.355 . . . . 74.519999999999996 108.24 176.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 59.8 t -134.41 130.51 53.98 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 N-CA-C 107.721 -1.215 . . . . 73.010000000000005 107.721 -178.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -127.92 144.63 51.1 Favored 'General case' 0 N--CA 1.424 -1.753 0 C-N-CA 119.826 -0.75 . . . . 72.439999999999998 111.445 179.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 85.1 mtt180 -100.0 41.62 1.15 Allowed 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.384 -1.339 . . . . 75.310000000000002 107.384 -177.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 69.49 18.77 7.73 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.784 1.234 . . . . 73.150000000000006 110.234 -174.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -49.85 -49.23 49.9 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.704 1.202 . . . . 74.349999999999994 111.941 -178.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.436 HD22 ' H ' ' A' ' 22' ' ' LEU . 1.7 pt? -111.11 27.38 9.73 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.384 0.611 . . . . 75.140000000000001 111.033 -177.196 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.6 tt -110.27 97.07 6.63 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 107.447 -1.316 . . . . 75.420000000000002 107.447 178.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.491 ' HG3' ' H ' ' A' ' 25' ' ' GLU . 0.1 OUTLIER -128.83 -71.68 0.63 Allowed 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.832 -0.622 . . . . 74.099999999999994 112.349 -177.501 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.491 ' H ' ' HG3' ' A' ' 24' ' ' LYS . 39.4 mt-10 -126.9 90.33 3.14 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.918 -0.771 . . . . 72.219999999999999 108.918 -177.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 70.6 mtm -93.07 133.06 36.62 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 116.269 -0.423 . . . . 74.010000000000005 111.025 -177.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -78.77 103.99 9.08 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.415 -0.811 . . . . 75.010000000000005 109.642 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.3 p -79.66 89.22 5.14 Favored 'General case' 0 N--CA 1.423 -1.809 0 CA-C-N 115.67 -0.695 . . . . 75.200000000000003 110.663 179.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 29.6 t 69.88 96.34 0.07 Allowed 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 114.908 -1.042 . . . . 73.400000000000006 110.219 -177.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.1 t -120.19 127.62 52.62 Favored 'General case' 0 N--CA 1.424 -1.743 0 N-CA-C 109.045 -0.724 . . . . 73.349999999999994 109.045 177.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -152.45 -141.28 3.27 Favored Glycine 0 N--CA 1.416 -2.637 0 N-CA-C 111.012 -0.835 . . . . 73.519999999999996 111.012 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.3 t -110.43 151.57 27.34 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 109.623 -0.51 . . . . 75.200000000000003 109.623 -178.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.65 114.16 47.85 Favored Pre-proline 0 C--N 1.31 -1.137 0 N-CA-C 108.982 -0.747 . . . . 53.109999999999999 108.982 177.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -79.85 114.65 3.2 Favored 'Trans proline' 0 N--CA 1.445 -1.376 0 C-N-CA 121.929 1.753 . . . . 72.25 111.81 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -96.98 111.64 23.76 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.401 -0.818 . . . . 75.510000000000005 109.541 179.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.7 m -77.45 104.87 8.22 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 115.759 -0.655 . . . . 64.530000000000001 109.316 -179.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 20.6 m -86.16 83.13 7.81 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-O 121.819 0.819 . . . . 74.340000000000003 108.965 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -135.66 43.96 1.21 Allowed Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 108.343 -1.903 . . . . 75.510000000000005 108.343 177.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.87 -20.9 66.18 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 124.096 0.958 . . . . 62.109999999999999 111.839 -174.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -62.13 -36.65 82.44 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.352 0.596 . . . . 72.319999999999993 109.655 177.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -73.19 -28.55 62.26 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.142 -0.935 . . . . 74.109999999999999 111.211 -178.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -89.47 111.49 45.93 Favored Pre-proline 0 C--N 1.316 -0.867 0 CA-C-N 116.653 -0.248 . . . . 75.329999999999998 110.55 -178.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -82.48 -0.15 10.02 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.635 2.223 . . . . 75.140000000000001 111.587 178.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -144.48 110.28 5.34 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 108.217 -1.031 . . . . 65.540000000000006 108.217 177.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -122.52 47.93 0.99 Allowed Glycine 0 C--N 1.3 -1.441 0 N-CA-C 110.473 -1.051 . . . . 70.450000000000003 110.473 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.9 m -132.83 158.11 43.33 Favored 'General case' 0 N--CA 1.426 -1.635 0 N-CA-C 109.312 -0.625 . . . . 74.540000000000006 109.312 179.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -162.31 167.45 23.84 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.013 -1.477 . . . . 74.409999999999997 107.013 -177.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -134.55 158.26 44.43 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 109.231 -0.655 . . . . 74.340000000000003 109.231 178.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.4 pp -114.45 136.49 52.95 Favored 'General case' 0 N--CA 1.412 -2.337 0 N-CA-C 108.179 -1.045 . . . . 72.450000000000003 108.179 175.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 60.8 t -121.67 124.99 72.83 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.397 0 N-CA-C 107.895 -1.15 . . . . 74.310000000000002 107.895 -179.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.404 HG12 ' OD1' ' A' ' 56' ' ' ASN . 42.0 t -92.65 115.57 31.82 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 N-CA-C 107.446 -1.316 . . . . 75.409999999999997 107.446 177.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -85.12 -36.57 21.03 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-N 114.491 -1.231 . . . . 71.340000000000003 110.513 -174.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.461 ' O ' ' HB3' ' A' ' 133' ' ' PHE . 16.1 tpp180 -155.3 121.33 5.14 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 120.143 -0.623 . . . . 75.340000000000003 110.906 -178.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.416 ' HA2' ' CD1' ' A' ' 133' ' ' PHE . . . 162.08 141.97 3.27 Favored Glycine 0 C--O 1.194 -2.361 0 O-C-N 124.038 0.837 . . . . 73.109999999999999 111.102 176.017 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.407 ' HB2' ' OD2' ' A' ' 81' ' ' ASP . 17.0 Cg_exo -68.64 -10.07 27.99 Favored 'Trans proline' 0 N--CA 1.477 0.527 0 C-N-CA 122.45 2.1 . . . . 60.210000000000001 111.603 177.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.465 ' HA ' ' N ' ' A' ' 81' ' ' ASP . 4.4 p30 -59.35 -53.88 53.2 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 115.134 -0.939 . . . . 71.310000000000002 109.775 175.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -164.29 174.49 11.06 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-N 115.809 -0.632 . . . . 64.239999999999995 109.471 -179.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -163.45 54.36 0.29 Allowed Glycine 0 C--N 1.289 -2.083 0 N-CA-C 108.531 -1.828 . . . . 62.25 108.531 179.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -150.04 178.42 8.96 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 108.184 -1.043 . . . . 71.439999999999998 108.184 -175.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -102.36 137.81 40.11 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 108.147 -1.057 . . . . 75.329999999999998 108.147 179.151 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -132.43 129.89 39.87 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.095 -0.706 . . . . 75.439999999999998 109.095 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 52.4 tp -88.88 128.05 35.66 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 116.34 -0.391 . . . . 75.349999999999994 110.897 -176.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -77.73 115.47 17.51 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 108.267 -1.012 . . . . 71.120000000000005 108.267 176.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -143.14 -53.09 0.38 Allowed 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 115.029 -0.987 . . . . 72.510000000000005 109.348 -177.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -69.63 121.31 82.01 Favored Pre-proline 0 C--N 1.312 -1.061 0 N-CA-C 108.505 -0.924 . . . . 72.129999999999995 108.505 177.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -42.07 -51.37 4.74 Favored 'Trans proline' 0 C--N 1.372 1.795 0 C-N-CA 124.745 3.63 . . . . 61.130000000000003 113.958 -173.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.5 m -102.97 99.88 9.8 Favored 'General case' 0 N--CA 1.415 -2.205 0 CA-C-N 116.144 -0.48 . . . . 70.239999999999995 109.844 179.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 86.2 m -98.14 114.05 26.13 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.422 -1.325 . . . . 72.209999999999994 107.422 175.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.7 m -105.58 133.92 49.54 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 112.925 0.713 . . . . 73.230000000000004 112.925 -171.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -108.63 117.5 34.34 Favored 'General case' 0 C--O 1.253 1.243 0 N-CA-C 108.386 -0.968 . . . . 64.129999999999995 108.386 175.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -158.68 -179.83 33.82 Favored Glycine 0 N--CA 1.438 -1.209 0 C-N-CA 120.158 -1.02 . . . . 74.319999999999993 111.188 -177.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.6 ttp180 -90.21 8.5 32.75 Favored 'General case' 0 CA--C 1.553 1.064 0 CA-C-O 121.949 0.881 . . . . 64.310000000000002 110.089 -176.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 60.8 m-70 -88.94 146.54 36.84 Favored Pre-proline 0 C--N 1.298 -1.64 0 N-CA-C 108.805 -0.813 . . . . 72.299999999999997 108.805 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -66.83 -28.73 42.8 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 121.729 1.619 . . . . 73.219999999999999 109.534 174.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -90.69 65.57 5.94 Favored 'General case' 0 N--CA 1.423 -1.819 0 CA-C-N 114.385 -1.28 . . . . 74.420000000000002 109.236 177.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.6 p -121.35 -174.76 2.92 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 106.066 -1.828 . . . . 72.340000000000003 106.066 175.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -100.67 -41.09 7.06 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 119.374 -0.931 . . . . 75.150000000000006 108.956 178.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 41.7 pt -114.78 150.58 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.618 0 N-CA-C 106.99 -1.485 . . . . 73.400000000000006 106.99 170.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -87.51 136.18 33.05 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 109.441 -0.577 . . . . 75.310000000000002 109.441 -179.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 50.4 tp -125.26 122.7 37.7 Favored 'General case' 0 N--CA 1.413 -2.319 0 CA-C-O 121.832 0.825 . . . . 75.420000000000002 111.043 -175.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.465 ' N ' ' HA ' ' A' ' 56' ' ' ASN . 33.9 t70 -142.59 108.5 5.17 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 114.561 -1.2 . . . . 71.540000000000006 108.304 176.078 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -137.04 161.84 34.96 Favored 'General case' 0 C--N 1.264 -3.137 0 CA-C-N 113.116 -1.856 . . . . 75.420000000000002 107.934 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.7 m -80.43 -15.46 12.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-O 121.441 0.639 . . . . 73.239999999999995 112.095 -177.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.495 ' OG1' ' HB3' ' A' ' 108' ' ' ASN . 3.1 p -128.54 45.73 2.73 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 122.261 1.029 . . . . 62.049999999999997 108.5 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.8 p -81.21 139.68 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 CA-C-N 113.672 -1.604 . . . . 64.209999999999994 110.789 -173.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 24.4 t -101.28 163.09 12.45 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 107.26 -1.385 . . . . 62.130000000000003 107.26 177.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 26.4 ttm180 -60.91 -43.3 98.73 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 108.946 -0.761 . . . . 71.420000000000002 108.946 179.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.0 133.23 54.37 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 105.434 -2.061 . . . . 74.230000000000004 105.434 175.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 21.1 t60 -113.19 -68.63 0.92 Allowed 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.232 -0.987 . . . . 74.209999999999994 111.273 -174.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.37 153.65 40.75 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 116.295 -0.412 . . . . 74.409999999999997 109.889 -176.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -117.59 127.34 53.87 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 108.299 -1.0 . . . . 71.510000000000005 108.299 178.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -100.51 115.58 30.45 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 107.744 -1.206 . . . . 74.400000000000006 107.744 178.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 61.9 mtp85 -106.85 123.13 47.71 Favored 'General case' 0 C--N 1.285 -2.238 0 N-CA-C 108.566 -0.902 . . . . 74.150000000000006 108.566 -176.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.3 tp -115.67 116.08 51.31 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 CA-C-O 121.639 0.733 . . . . 73.340000000000003 109.91 -176.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -118.71 143.81 46.64 Favored 'General case' 0 N--CA 1.41 -2.455 0 N-CA-C 103.986 -2.598 . . . . 63.32 103.986 175.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -70.91 -9.33 57.57 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 121.235 0.54 . . . . 73.150000000000006 111.658 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -80.86 -55.7 3.27 Favored Glycine 0 N--CA 1.433 -1.56 0 N-CA-C 111.025 -0.83 . . . . 70.239999999999995 111.025 171.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -148.89 166.24 29.13 Favored 'General case' 0 C--N 1.348 0.526 0 C-N-CA 122.801 0.44 . . . . 72.310000000000002 110.479 -178.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.463 ' HB2' ' HB2' ' A' ' 122' ' ' MET . 8.0 m-85 -111.03 128.74 55.96 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.947 -1.131 . . . . 72.030000000000001 107.947 -175.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -130.23 136.16 48.91 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.524 0.202 . . . . 73.299999999999997 110.89 -173.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.4 p -125.74 126.83 70.78 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-O 121.04 0.447 . . . . 75.430000000000007 110.165 175.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 51.9 t -119.21 133.41 66.14 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 CA-C-N 115.781 -0.645 . . . . 64.530000000000001 109.826 -178.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -82.9 131.53 35.19 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 107.18 -1.415 . . . . 71.209999999999994 107.18 173.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.4 m -111.97 20.22 6.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-O 121.086 0.469 . . . . 74.420000000000002 112.152 -177.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 120.06 54.85 0.25 Allowed Glycine 0 N--CA 1.433 -1.563 0 C-N-CA 119.981 -1.104 . . . . 75.010000000000005 114.367 174.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 77.7 p -78.86 145.77 34.02 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 117.253 0.526 . . . . 72.409999999999997 109.819 177.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 98.1 mt -80.19 -31.2 38.79 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 121.514 0.673 . . . . 71.219999999999999 109.931 178.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.495 ' HB3' ' OG1' ' A' ' 84' ' ' THR . 23.4 p30 -85.29 -24.52 27.68 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.01 -0.996 . . . . 75.109999999999999 112.841 -177.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 88.5 105.57 1.0 Allowed Glycine 0 N--CA 1.433 -1.502 0 C-N-CA 120.865 -0.683 . . . . 74.549999999999997 111.763 -179.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.6 m -75.63 123.94 26.38 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.794 -0.817 . . . . 74.010000000000005 108.794 176.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -136.97 153.71 50.62 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 109.796 -0.446 . . . . 74.219999999999999 109.796 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 31.1 t -98.07 142.63 14.18 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.006 0 N-CA-C 106.526 -1.657 . . . . 73.319999999999993 106.526 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 33.6 p-10 -55.21 -25.21 31.62 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 112.573 0.583 . . . . 73.439999999999998 112.573 -175.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 33.5 mtm105 -100.9 -32.51 10.62 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.369 -0.378 . . . . 75.340000000000003 111.809 177.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -130.65 125.29 21.41 Favored Pre-proline 0 C--N 1.316 -0.848 0 C-N-CA 121.078 -0.249 . . . . 63.149999999999999 111.589 -169.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.15 39.47 0.73 Allowed 'Trans proline' 0 CA--C 1.554 1.507 0 C-N-CA 122.838 2.359 . . . . 74.219999999999999 112.043 178.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.416 ' HB3' ' O ' ' A' ' 119' ' ' ALA . 31.1 mmt180 -90.51 131.33 36.31 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 123.537 0.735 . . . . 74.129999999999995 110.262 -177.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -78.64 -38.61 39.24 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.141 0.496 . . . . 75.430000000000007 110.021 174.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.416 ' O ' ' HB3' ' A' ' 117' ' ' ARG . . . -105.47 137.93 42.49 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 105.398 -2.075 . . . . 70.450000000000003 105.398 170.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -139.47 140.22 37.21 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-O 121.256 0.551 . . . . 74.530000000000001 111.932 -172.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 48.1 t -85.61 118.27 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 104.846 -2.279 . . . . 65.019999999999996 104.846 169.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.463 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 12.6 mmt -58.26 150.04 22.78 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 114.506 1.299 . . . . 73.540000000000006 114.506 -173.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -125.67 129.53 49.75 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 105.09 -2.189 . . . . 73.109999999999999 105.09 172.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 45.9 p -83.07 123.57 29.61 Favored 'General case' 0 C--N 1.283 -2.297 0 C-N-CA 121.002 -0.279 . . . . 75.200000000000003 110.676 -174.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 92.4 38.55 5.59 Favored Glycine 0 CA--C 1.497 -1.071 0 N-CA-C 109.528 -1.429 . . . . 75.25 109.528 -175.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -139.56 170.35 16.07 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 107.437 -1.32 . . . . 54.32 107.437 -176.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -140.52 139.75 35.13 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 122.285 1.04 . . . . 73.129999999999995 113.261 -174.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 60.0 mt -112.33 131.63 63.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-N 114.417 -1.265 . . . . 74.409999999999997 109.987 -175.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -93.76 112.53 24.42 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-O 121.843 0.83 . . . . 72.099999999999994 110.257 -178.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.9 pt -95.34 98.54 8.03 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 N-CA-C 107.641 -1.244 . . . . 71.099999999999994 107.641 176.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 76.06 -98.95 1.24 Allowed Glycine 0 N--CA 1.428 -1.885 0 N-CA-C 110.476 -1.05 . . . . 73.129999999999995 110.476 -176.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -127.64 10.19 6.59 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.197 0.523 . . . . 71.430000000000007 109.839 178.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.461 ' HB3' ' O ' ' A' ' 53' ' ' ARG . 57.4 m-85 -119.92 157.17 29.33 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.952 -0.567 . . . . 75.040000000000006 109.697 -175.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 20.1 ptp180 -125.77 131.33 52.52 Favored 'General case' 0 C--O 1.256 1.398 0 N-CA-C 114.087 1.143 . . . . 75.420000000000002 114.087 -170.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.5 tt -114.71 134.35 55.16 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 114.072 -1.422 . . . . 75.340000000000003 108.213 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 38.2 t -107.54 139.14 30.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 108.824 -0.806 . . . . 73.430000000000007 108.824 -176.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -115.84 126.3 53.8 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 109.883 -0.414 . . . . 75.140000000000001 109.883 -179.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 66.5 mt -132.69 137.57 46.97 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.63 -0.259 . . . . 74.439999999999998 110.749 -177.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -103.31 41.1 1.3 Allowed 'General case' 0 N--CA 1.482 1.141 0 CA-C-O 122.142 0.972 . . . . 75.319999999999993 108.719 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -75.81 -50.09 8.24 Favored Glycine 0 C--N 1.294 -1.759 0 CA-C-N 113.834 -1.53 . . . . 73.129999999999995 116.19 -174.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -74.64 121.9 7.01 Favored 'Trans proline' 0 C--N 1.368 1.588 0 CA-C-N 120.214 2.007 . . . . 73.319999999999993 115.407 -170.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -110.38 126.98 54.84 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 105.882 -1.896 . . . . 74.319999999999993 105.882 173.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.425 -1.691 0 CA-C-O 118.199 -0.905 . . . . 75.140000000000001 112.311 -177.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 mmt . . . . . 0 CA--C 1.491 -1.31 0 N-CA-C 107.613 -1.254 . . . . 74.439999999999998 107.613 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.2 p -68.92 -30.62 69.12 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 108.725 -0.842 . . . . 72.319999999999993 108.725 177.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.7 t70 72.66 -50.85 0.7 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.243 1.817 . . . . 72.200000000000003 112.739 169.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -85.35 104.87 15.57 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.38 -0.6 . . . . 53.409999999999997 109.38 176.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -161.6 151.44 16.82 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 106.878 -1.527 . . . . 74.329999999999998 106.878 178.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -89.4 166.28 33.13 Favored Glycine 0 N--CA 1.429 -1.792 0 C-N-CA 119.766 -1.207 . . . . 73.329999999999998 110.398 178.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.2 p -84.65 133.32 44.3 Favored Pre-proline 0 N--CA 1.421 -1.907 0 N-CA-C 109.165 -0.68 . . . . 73.120000000000005 109.165 177.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -66.2 127.49 17.63 Favored 'Trans proline' 0 N--CA 1.448 -1.157 0 N-CA-C 107.923 -1.607 . . . . 61.039999999999999 107.923 174.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -95.89 118.08 66.03 Favored Pre-proline 0 C--N 1.288 -2.07 0 N-CA-C 112.926 0.713 . . . . 75.040000000000006 112.926 -174.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -66.13 140.58 60.05 Favored 'Trans proline' 0 C--O 1.245 0.862 0 C-N-CA 122.644 2.23 . . . . 62.25 108.948 173.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -149.23 98.69 2.84 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-O 122.075 0.94 . . . . 62.130000000000003 109.161 -176.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 49.2 t -69.4 118.24 13.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 114.06 -1.427 . . . . 74.319999999999993 112.259 -172.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -95.7 135.96 36.71 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 107.308 -1.367 . . . . 73.25 107.308 173.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.5 t -152.17 151.92 31.63 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-O 121.302 0.573 . . . . 74.120000000000005 110.756 -175.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.8 m -122.13 81.52 1.84 Allowed 'General case' 0 N--CA 1.41 -2.458 0 N-CA-C 107.805 -1.183 . . . . 73.109999999999999 107.805 173.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.7 m -82.36 99.33 9.32 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 115.551 -0.75 . . . . 61.149999999999999 109.224 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.9 p -138.06 136.61 44.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 108.659 -0.867 . . . . 73.120000000000005 108.659 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -94.1 163.99 13.25 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 109.073 -0.714 . . . . 74.340000000000003 109.073 -178.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.5 mtm180 -103.21 132.67 49.29 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 109.519 -0.549 . . . . 75.209999999999994 109.519 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.9 93.37 7.49 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 107.119 -1.437 . . . . 70.549999999999997 107.119 172.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -79.84 -53.22 6.99 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.972 -0.558 . . . . 65.439999999999998 109.95 -176.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 56.84 64.08 1.76 Allowed 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 115.416 -0.811 . . . . 75.209999999999994 111.082 -176.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 85.2 mt -88.08 140.58 29.34 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 115.421 -0.809 . . . . 74.140000000000001 109.315 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.45 32.59 5.45 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 121.87 0.843 . . . . 72.409999999999997 109.295 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -72.79 104.11 3.88 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 114.591 -1.186 . . . . 75.010000000000005 108.736 -178.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 57.7 mtt -123.17 119.78 31.25 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.982 -1.118 . . . . 73.420000000000002 107.982 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -136.76 160.44 38.85 Favored 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 120.206 -0.597 . . . . 71.239999999999995 111.569 175.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.405 ' O ' ' HB1' ' A' ' 139' ' ' ALA . 32.8 t -139.65 74.23 1.46 Allowed 'General case' 0 N--CA 1.407 -2.578 0 N-CA-C 106.386 -1.709 . . . . 75.099999999999994 106.386 172.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.2 t -72.89 88.11 1.34 Allowed 'General case' 0 N--CA 1.424 -1.754 0 CA-C-O 121.955 0.883 . . . . 73.439999999999998 108.964 177.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.2 p -133.51 126.72 31.67 Favored 'General case' 0 N--CA 1.414 -2.239 0 CA-C-N 114.172 -1.376 . . . . 74.219999999999999 107.939 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -78.83 64.77 3.6 Favored Glycine 0 C--N 1.323 -0.182 0 N-CA-C 111.217 -0.753 . . . . 71.049999999999997 111.217 179.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 8.8 m -98.85 142.67 30.08 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 123.377 0.671 . . . . 73.409999999999997 109.681 -176.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -73.74 113.12 19.87 Favored Pre-proline 0 N--CA 1.436 -1.139 0 N-CA-C 106.634 -1.617 . . . . 63.310000000000002 106.634 173.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -86.78 177.48 4.13 Favored 'Trans proline' 0 N--CA 1.436 -1.872 0 C-N-CA 121.845 1.697 . . . . 75.549999999999997 113.554 -173.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -154.75 170.6 21.22 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 105.906 -1.887 . . . . 74.219999999999999 105.906 176.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.7 m -65.94 95.98 0.29 Allowed 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 121.584 0.707 . . . . 71.120000000000005 109.526 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 25.7 m -76.28 99.61 4.83 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 115.314 -0.857 . . . . 72.230000000000004 110.464 -175.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 62.78 56.63 20.03 Favored Glycine 0 C--O 1.214 -1.125 0 CA-C-N 115.493 -0.776 . . . . 71.219999999999999 111.664 -178.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.74 -37.1 82.99 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 123.058 0.543 . . . . 74.109999999999999 111.587 -176.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -83.07 -20.32 35.15 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.124 -0.489 . . . . 65.0 111.307 -179.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -83.61 -36.36 23.95 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.325 -0.991 . . . . 64.439999999999998 108.325 177.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 52.15 77.69 0.44 Allowed Pre-proline 0 N--CA 1.44 -0.947 0 C-N-CA 127.297 2.239 . . . . 75.239999999999995 111.509 -178.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -85.41 -72.35 0.01 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.406 0 C-N-CA 122.474 2.116 . . . . 74.200000000000003 109.87 175.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -150.85 102.78 3.02 Favored 'General case' 0 N--CA 1.424 -1.748 0 N-CA-C 107.43 -1.322 . . . . 72.530000000000001 107.43 176.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -103.0 33.34 6.66 Favored Glycine 0 C--N 1.306 -1.108 0 N-CA-C 110.409 -1.076 . . . . 70.219999999999999 110.409 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 18.8 m -134.07 166.82 21.85 Favored 'General case' 0 N--CA 1.419 -2.016 0 N-CA-C 108.761 -0.829 . . . . 75.209999999999994 108.761 -179.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.507 ' HB3' ' CZ ' ' A' ' 137' ' ' PHE . . . -151.15 -170.9 3.79 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 107.939 -1.134 . . . . 73.340000000000003 107.939 178.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.22 152.25 41.47 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 120.366 -0.533 . . . . 74.430000000000007 111.399 -176.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.0 pp -127.78 145.01 51.06 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 115.555 -0.748 . . . . 72.549999999999997 110.922 178.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.3 m -131.28 142.34 43.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 109.394 -0.595 . . . . 61.219999999999999 109.394 178.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 76.5 t -93.82 115.93 33.83 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 N-CA-C 107.878 -1.156 . . . . 74.209999999999994 107.878 176.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.5 tmtm? -82.16 -38.81 24.13 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.756 -0.831 . . . . 74.319999999999993 108.756 -175.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.45 ' O ' ' HB3' ' A' ' 133' ' ' PHE . 13.8 tpp180 -142.41 117.3 9.92 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 108.181 -1.044 . . . . 75.329999999999998 108.181 -178.105 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 148.42 125.18 1.46 Allowed Glycine 0 N--CA 1.427 -1.955 0 C-N-CA 119.784 -1.198 . . . . 72.420000000000002 114.057 177.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -67.54 -8.92 23.67 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 123.768 2.979 . . . . 74.340000000000003 110.509 174.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.566 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 2.1 m-20 -51.18 -26.5 6.95 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 126.852 2.061 . . . . 73.120000000000005 111.215 177.241 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -166.88 -62.16 0.03 OUTLIER 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 123.45 0.7 . . . . 73.120000000000005 109.403 176.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 61.3 44.82 97.59 Favored Glycine 0 C--N 1.336 0.557 0 CA-C-N 115.741 -0.663 . . . . 72.420000000000002 111.85 -179.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -151.62 -171.68 4.0 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 108.927 -0.768 . . . . 74.430000000000007 108.927 -176.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.8 ptt180 -119.93 138.51 53.4 Favored 'General case' 0 C--N 1.312 -1.064 0 O-C-N 124.002 0.814 . . . . 72.430000000000007 109.221 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -138.54 129.43 26.68 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-O 120.896 0.379 . . . . 74.140000000000001 110.807 179.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 65.3 tp -91.45 129.59 37.41 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 107.505 -1.294 . . . . 74.450000000000003 107.505 176.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 79.7 mt -72.16 120.15 17.35 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 113.018 0.748 . . . . 74.409999999999997 113.018 -176.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -146.29 -39.99 0.21 Allowed 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.884 -1.053 . . . . 73.349999999999994 110.56 175.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -61.28 113.89 9.26 Favored Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 123.888 0.875 . . . . 74.510000000000005 110.297 173.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.556 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 8.4 Cg_endo -53.8 -41.31 75.51 Favored 'Trans proline' 0 C--N 1.361 1.185 0 C-N-CA 122.983 2.455 . . . . 71.0 113.253 -175.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 50.2 m -119.82 105.89 11.55 Favored 'General case' 0 N--CA 1.423 -1.8 0 CA-C-O 121.21 0.528 . . . . 73.329999999999998 109.79 178.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.433 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 40.1 m -107.01 113.8 27.5 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 107.259 -1.386 . . . . 61.539999999999999 107.259 174.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.4 p -98.04 133.64 42.23 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 116.002 -0.544 . . . . 71.040000000000006 112.369 -175.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -115.21 120.29 39.22 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 115.574 -0.739 . . . . 72.519999999999996 109.135 176.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.42 ' HA2' ' CG2' ' A' ' 85' ' ' VAL . . . 167.63 -160.44 34.05 Favored Glycine 0 N--CA 1.422 -2.254 0 N-CA-C 110.051 -1.22 . . . . 73.5 110.051 178.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.475 ' O ' ' HG2' ' A' ' 87' ' ' ARG . 18.6 tpt180 -132.42 89.56 2.67 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 109.445 -0.576 . . . . 75.120000000000005 109.445 174.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.52 ' CD2' ' H ' ' A' ' 88' ' ' ARG . 5.1 p80 -161.59 165.76 15.93 Favored Pre-proline 0 C--N 1.304 -1.402 0 N-CA-C 107.686 -1.227 . . . . 63.520000000000003 107.686 177.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.487 ' HD2' ' HB2' ' A' ' 73' ' ' HIS . 3.1 Cg_endo -47.89 -35.44 24.61 Favored 'Trans proline' 0 C--N 1.359 1.101 0 C-N-CA 123.317 2.678 . . . . 72.329999999999998 115.7 -175.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -99.33 14.6 29.06 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 119.237 -0.985 . . . . 64.530000000000001 113.52 -175.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 24.0 m -73.2 133.24 43.96 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.635 -0.506 . . . . 75.340000000000003 109.635 176.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -80.19 -56.02 4.51 Favored 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 108.441 -0.948 . . . . 74.530000000000001 108.441 176.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 32.4 pt -97.69 134.46 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 N-CA-C 109.117 -0.697 . . . . 73.409999999999997 109.117 177.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -104.42 116.87 32.88 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 121.764 0.792 . . . . 73.030000000000001 110.529 -177.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.566 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 7.0 mp -82.02 106.53 14.01 Favored 'General case' 0 N--CA 1.422 -1.831 0 CA-C-N 114.817 -1.083 . . . . 74.519999999999996 111.09 -177.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -85.0 69.49 10.82 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 122.432 1.111 . . . . 75.340000000000003 109.743 176.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -148.62 164.26 34.82 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 113.94 -1.482 . . . . 70.319999999999993 108.279 176.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.1 p -94.69 -6.65 10.15 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-O 121.083 0.468 . . . . 74.409999999999997 111.516 -176.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.7 m -91.96 13.45 18.58 Favored 'General case' 0 CA--C 1.548 0.899 0 O-C-N 121.491 -0.755 . . . . 74.430000000000007 110.267 -177.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.42 ' CG2' ' HA2' ' A' ' 71' ' ' GLY . 10.6 p -102.77 133.11 47.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-O 121.258 0.551 . . . . 74.109999999999999 111.312 -178.269 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 18.3 m -102.05 169.95 8.42 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 108.94 -0.763 . . . . 51.420000000000002 108.94 176.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.475 ' HG2' ' O ' ' A' ' 72' ' ' ARG . 63.1 mtm180 -75.27 134.7 41.04 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 106.674 -1.602 . . . . 72.540000000000006 106.674 173.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.52 ' H ' ' CD2' ' A' ' 73' ' ' HIS 0.36 0.0 OUTLIER 50.38 71.76 0.39 Allowed 'General case' 0 C--O 1.22 -0.497 0 CA-C-O 122.654 1.216 . . . . 74.340000000000003 111.096 -171.507 . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 11.4 t60 -95.39 -60.14 1.73 Allowed 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 113.828 -1.533 . . . . 72.209999999999994 109.846 -173.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -130.94 127.47 38.52 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 109.215 -0.661 . . . . 63.240000000000002 109.215 -179.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -109.75 127.19 54.46 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 109.049 -0.723 . . . . 75.329999999999998 109.049 177.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.433 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 97.5 m-85 -104.09 112.62 25.69 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 107.651 -1.241 . . . . 74.140000000000001 107.651 177.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 27.5 mtp85 -108.48 113.59 26.74 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 115.368 -0.833 . . . . 75.420000000000002 109.072 -177.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.556 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -128.48 124.22 61.38 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.522 0 CA-C-O 122.085 0.945 . . . . 75.099999999999994 110.077 -177.778 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -110.52 147.71 33.6 Favored 'General case' 0 C--N 1.269 -2.906 0 N-CA-C 106.765 -1.568 . . . . 63.409999999999997 106.765 177.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -42.42 -26.57 0.12 Allowed 'General case' 0 CA--C 1.56 1.354 0 N-CA-C 114.234 1.198 . . . . 73.219999999999999 114.234 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -128.77 23.85 4.96 Favored Glycine 0 N--CA 1.437 -1.249 0 C-N-CA 120.617 -0.802 . . . . 42.310000000000002 113.513 179.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -165.44 144.25 6.32 Favored 'General case' 0 C--O 1.213 -0.868 0 CA-C-N 117.852 0.826 . . . . 73.040000000000006 110.84 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.457 ' HB2' ' SD ' ' A' ' 122' ' ' MET . 1.3 p90 -132.15 115.83 16.23 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-O 121.873 0.844 . . . . 74.019999999999996 112.085 -177.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -129.9 135.24 48.12 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.468 -0.787 . . . . 72.540000000000006 111.559 -172.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.6 p -116.5 128.38 73.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 109.561 -0.533 . . . . 74.450000000000003 109.561 178.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 58.6 t -118.82 130.61 73.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-N 116.325 -0.398 . . . . 71.420000000000002 110.943 -175.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -101.31 115.24 30.04 Favored 'General case' 0 CA--C 1.496 -1.127 0 CA-C-O 121.074 0.464 . . . . 75.439999999999998 109.802 176.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.454 HG22 ' O ' ' A' ' 88' ' ' ARG . 5.3 m -122.42 -1.64 7.22 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 CA-C-O 121.671 0.748 . . . . 74.209999999999994 111.459 178.233 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -100.22 39.83 2.62 Favored Glycine 0 N--CA 1.429 -1.771 0 N-CA-C 109.401 -1.48 . . . . 61.310000000000002 109.401 176.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 11.4 m -63.45 4.52 0.23 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.042 1.737 . . . . 64.129999999999995 113.479 -176.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -68.95 -41.09 78.48 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 106.693 -1.595 . . . . 73.349999999999994 106.693 171.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -110.18 -41.19 4.49 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.071 -1.422 . . . . 71.319999999999993 108.355 177.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 92.65 131.53 5.67 Favored Glycine 0 N--CA 1.438 -1.202 0 N-CA-C 115.71 1.044 . . . . 74.200000000000003 115.71 173.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 18.6 m -94.65 135.59 35.94 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 105.941 -1.874 . . . . 74.319999999999993 105.941 169.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -117.69 134.42 54.92 Favored 'General case' 0 C--N 1.294 -1.833 0 C-N-CA 120.013 -0.675 . . . . 73.109999999999999 109.659 -177.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 22.3 m -100.43 110.56 27.75 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.935 0 N-CA-C 106.973 -1.491 . . . . 73.409999999999997 106.973 172.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 66.96 -79.72 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 125.843 1.657 . . . . 71.209999999999994 108.944 -171.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 51.9 mtp180 -148.11 13.8 1.0 Allowed 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 124.652 1.181 . . . . 73.129999999999995 109.147 176.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -102.51 113.74 65.72 Favored Pre-proline 0 N--CA 1.439 -1.005 0 CA-C-N 115.327 -0.851 . . . . 71.219999999999999 110.39 -175.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -84.26 94.8 0.72 Allowed 'Trans proline' 0 N--CA 1.446 -1.283 0 C-N-CA 122.444 2.096 . . . . 73.439999999999998 109.182 173.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -121.28 146.22 47.05 Favored 'General case' 0 CA--C 1.502 -0.885 0 CA-C-N 116.397 -0.365 . . . . 72.329999999999998 111.191 -174.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -66.05 -42.22 89.79 Favored 'General case' 0 C--N 1.319 -0.719 0 O-C-N 124.145 0.903 . . . . 75.450000000000003 110.73 -177.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -149.64 138.89 21.34 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 108.363 -0.977 . . . . 73.319999999999993 108.363 175.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 6.0 tp60 -140.98 150.49 43.15 Favored 'General case' 0 C--N 1.292 -1.935 0 C-N-CA 122.821 0.448 . . . . 75.349999999999994 110.117 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 64.1 t -79.82 134.03 28.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 105.508 -2.034 . . . . 72.430000000000007 105.508 173.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.457 ' SD ' ' HB2' ' A' ' 99' ' ' PHE . 64.7 mtt -61.0 126.33 26.97 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 109.61 -0.515 . . . . 65.030000000000001 109.61 -176.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -104.95 130.35 53.15 Favored 'General case' 0 N--CA 1.418 -2.061 0 CA-C-O 121.346 0.594 . . . . 55.229999999999997 110.098 -178.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 18.6 p -78.3 131.9 37.24 Favored 'General case' 0 N--CA 1.416 -2.167 0 CA-C-N 114.782 -1.099 . . . . 75.540000000000006 109.479 -177.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 85.0 22.88 51.4 Favored Glycine 0 N--CA 1.431 -1.671 0 N-CA-C 110.647 -0.981 . . . . 74.5 110.647 179.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -123.61 171.16 9.76 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 120.165 -0.614 . . . . 71.0 109.749 -178.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -118.84 121.42 39.99 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 123.412 0.685 . . . . 74.439999999999998 110.393 -170.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 64.1 mt -106.15 118.2 53.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 N-CA-C 109.614 -0.513 . . . . 74.420000000000002 109.614 -178.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -95.14 114.17 25.94 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 109.455 -0.572 . . . . 74.430000000000007 109.455 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 9.8 pt -99.9 97.58 6.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 CA-C-O 122.215 1.007 . . . . 73.400000000000006 109.101 178.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 73.15 -87.35 0.58 Allowed Glycine 0 N--CA 1.435 -1.42 0 CA-C-N 114.498 -1.228 . . . . 62.450000000000003 111.088 -177.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -120.1 -33.03 4.03 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 120.974 0.416 . . . . 74.409999999999997 110.513 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.45 ' HB3' ' O ' ' A' ' 53' ' ' ARG . 77.9 m-85 -95.5 161.21 14.16 Favored 'General case' 0 CA--C 1.496 -1.125 0 CA-C-N 116.293 -0.412 . . . . 72.530000000000001 110.95 -173.109 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 27.9 ptt180 -131.42 141.5 49.85 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 114.155 1.168 . . . . 54.439999999999998 114.155 -171.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.4 tt -117.69 140.03 50.22 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 112.935 -1.939 . . . . 71.540000000000006 107.48 -177.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 7.7 p -115.93 131.56 68.02 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 CA-C-O 121.046 0.451 . . . . 74.239999999999995 109.787 179.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.507 ' CZ ' ' HB3' ' A' ' 47' ' ' ALA . 71.4 t80 -102.91 119.0 38.07 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.53 -0.759 . . . . 74.340000000000003 109.057 -175.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.46 ' O ' ' HB2' ' A' ' 47' ' ' ALA . 2.5 mm? -114.68 147.1 40.11 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 120.966 0.412 . . . . 74.439999999999998 111.282 -175.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.405 ' HB1' ' O ' ' A' ' 28' ' ' SER . . . -81.94 118.23 22.79 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 107.827 -1.175 . . . . 74.530000000000001 107.827 175.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -93.57 -135.92 7.74 Favored Glycine 0 N--CA 1.427 -1.913 0 C-N-CA 120.64 -0.791 . . . . 60.439999999999998 111.874 -177.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -78.82 129.41 9.07 Favored 'Trans proline' 0 N--CA 1.441 -1.617 0 C-N-CA 122.492 2.128 . . . . 61.409999999999997 112.305 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -92.84 102.3 14.68 Favored 'General case' 0 N--CA 1.42 -1.953 0 N-CA-C 104.835 -2.283 . . . . 74.25 104.835 172.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 . . . . . 0 C--N 1.277 -2.571 0 N-CA-C 108.745 -0.835 . . . . 73.430000000000007 108.745 -170.284 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.516 -0.346 0 N-CA-C 108.835 -0.802 . . . . 74.400000000000006 108.835 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.1 t -82.97 -37.58 23.87 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 110.693 -0.114 . . . . 54.200000000000003 110.693 -178.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 56.81 42.05 27.16 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-O 121.967 0.889 . . . . 75.340000000000003 111.465 -177.18 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 30.6 p-10 -101.88 -4.05 26.88 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.517 -0.765 . . . . 64.349999999999994 109.79 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -106.37 86.26 2.32 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 108.647 -0.872 . . . . 74.549999999999997 108.647 176.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -143.69 108.98 0.53 Allowed Glycine 0 N--CA 1.428 -1.85 0 N-CA-C 109.892 -1.283 . . . . 74.109999999999999 109.892 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.7 t -94.07 125.01 54.36 Favored Pre-proline 0 C--N 1.301 -1.537 0 CA-C-O 120.801 0.334 . . . . 75.219999999999999 110.969 -177.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -66.22 144.73 76.01 Favored 'Trans proline' 0 C--O 1.244 0.809 0 C-N-CA 122.22 1.947 . . . . 71.140000000000001 109.59 174.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -89.81 138.68 27.79 Favored Pre-proline 0 C--N 1.29 -2.011 0 C-N-CA 121.361 -0.136 . . . . 74.420000000000002 110.638 -177.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -74.64 103.78 1.77 Allowed 'Trans proline' 0 N--CA 1.44 -1.668 0 C-N-CA 121.24 1.293 . . . . 75.400000000000006 109.163 172.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -92.94 119.65 32.45 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 115.373 -0.831 . . . . 63.509999999999998 111.513 -174.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.9 p -88.64 136.86 22.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 CA-C-N 115.812 -0.631 . . . . 74.329999999999998 109.449 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -77.53 134.92 38.18 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 108.542 -0.91 . . . . 64.519999999999996 108.542 178.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.8 m -134.1 71.55 1.46 Allowed 'General case' 0 C--N 1.294 -1.829 0 CA-C-O 121.396 0.617 . . . . 73.430000000000007 110.241 -178.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.8 t 167.43 137.11 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 126.596 1.958 . . . . 73.430000000000007 106.638 176.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 53.4 m -152.16 37.22 0.55 Allowed 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 108.069 -1.086 . . . . 75.200000000000003 108.069 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.8 t -65.1 119.02 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 CA-C-N 114.554 -1.203 . . . . 72.120000000000005 108.424 178.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -74.39 99.16 3.45 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.989 0.9 . . . . 75.150000000000006 110.593 -179.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 74.1 mtp180 -110.28 153.17 25.23 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 114.476 -1.238 . . . . 75.099999999999994 110.752 -175.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -146.84 89.33 1.81 Allowed 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 104.901 -2.259 . . . . 75.519999999999996 104.901 174.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.415 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 46.0 m-20 -67.56 -53.81 25.22 Favored 'General case' 0 CA--C 1.502 -0.895 0 CA-C-N 115.788 -0.642 . . . . 73.420000000000002 111.468 -171.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.415 ' HB2' ' O ' ' A' ' 21' ' ' ASP . 1.4 tm? 177.95 109.7 0.03 OUTLIER 'General case' 0 C--O 1.236 0.355 0 O-C-N 123.752 0.658 . . . . 74.049999999999997 109.596 175.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.497 HD23 ' O ' ' A' ' 23' ' ' LEU 0.274 0.0 OUTLIER -145.01 90.19 2.03 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 122.187 0.994 . . . . 73.310000000000002 109.289 172.49 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.89 175.47 6.79 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.074 -0.967 . . . . 65.239999999999995 113.435 -172.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -82.2 106.44 14.09 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-O 121.456 0.646 . . . . 75.400000000000006 109.616 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 46.3 tpp -129.01 133.0 47.58 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 109.053 -0.721 . . . . 64.310000000000002 109.053 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -84.8 143.31 29.18 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.888 -1.153 . . . . 71.310000000000002 107.888 176.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.9 t -98.62 148.01 24.24 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 108.058 -1.09 . . . . 71.420000000000002 108.058 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 28.7 m -84.44 90.12 7.54 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 121.583 0.706 . . . . 74.400000000000006 110.178 179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 60.1 m -119.35 101.0 7.65 Favored 'General case' 0 N--CA 1.422 -1.832 0 N-CA-C 108.262 -1.014 . . . . 74.409999999999997 108.262 177.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -103.39 -146.35 16.62 Favored Glycine 0 N--CA 1.426 -2.001 0 C-N-CA 120.694 -0.765 . . . . 74.519999999999996 111.361 -179.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 24.0 m -110.68 148.83 31.45 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 108.363 -0.977 . . . . 75.109999999999999 108.363 179.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -90.51 112.6 53.89 Favored Pre-proline 0 N--CA 1.439 -0.984 0 N-CA-C 108.405 -0.961 . . . . 75.319999999999993 108.405 175.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -79.31 135.88 12.29 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.386 2.057 . . . . 72.239999999999995 111.3 178.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -112.67 122.83 48.82 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.689 -0.856 . . . . 71.439999999999998 108.689 177.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 27.0 t -104.04 96.61 6.78 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 109.177 -0.675 . . . . 74.439999999999998 109.177 -177.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.4 m -105.88 145.03 31.78 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.712 -0.847 . . . . 72.129999999999995 108.712 -178.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -146.23 64.35 0.44 Allowed Glycine 0 N--CA 1.44 -1.041 0 N-CA-C 108.742 -1.743 . . . . 75.219999999999999 108.742 179.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.96 -30.37 61.63 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.944 1.09 . . . . 71.299999999999997 113.944 -171.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -66.87 -34.28 77.44 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.982 0.42 . . . . 63.340000000000003 111.043 -178.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -84.15 -43.59 14.84 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-N 116.339 -0.391 . . . . 73.25 110.395 177.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 58.0 tp 56.95 73.83 0.75 Allowed Pre-proline 0 C--O 1.252 1.222 0 CA-C-N 114.402 -1.272 . . . . 73.549999999999997 110.833 -174.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -63.83 137.58 58.98 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.706 2.271 . . . . 75.349999999999994 110.834 177.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -84.26 143.93 29.25 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 109.332 -0.618 . . . . 62.140000000000001 109.332 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 177.57 110.67 0.28 Allowed Glycine 0 N--CA 1.413 -2.835 0 N-CA-C 109.333 -1.507 . . . . 63.509999999999998 109.333 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.8 m -100.17 164.49 11.94 Favored 'General case' 0 C--N 1.279 -2.494 0 N-CA-C 108.815 -0.809 . . . . 74.310000000000002 108.815 178.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -124.64 132.88 53.39 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.751 -0.463 . . . . 72.209999999999994 109.751 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -115.81 140.79 48.88 Favored 'General case' 0 C--N 1.29 -2.008 0 C-N-CA 120.312 -0.555 . . . . 75.5 110.837 179.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.424 ' O ' HD13 ' A' ' 49' ' ' LEU . 3.1 pp -120.39 140.01 51.96 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 115.542 -0.753 . . . . 74.230000000000004 110.352 178.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 47.4 t -117.75 126.51 74.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 108.581 -0.896 . . . . 64.519999999999996 108.581 179.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 53.2 t -93.1 115.56 32.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 108.942 -0.762 . . . . 75.510000000000005 108.942 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -82.56 -46.31 13.52 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.38 -0.97 . . . . 72.530000000000001 108.38 176.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -147.84 149.1 31.67 Favored 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 106.968 -1.494 . . . . 75.030000000000001 106.968 179.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 144.99 145.67 4.34 Favored Glycine 0 N--CA 1.425 -2.045 0 N-CA-C 110.527 -1.029 . . . . 73.420000000000002 110.527 -178.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.417 ' HB2' ' H ' ' A' ' 82' ' ' ASP . 13.8 Cg_exo -67.93 -9.18 24.81 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.419 2.746 . . . . 71.319999999999993 113.359 -177.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.437 ' HB2' ' HA ' ' A' ' 80' ' ' LEU . 5.6 t-20 -42.87 -60.3 1.65 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.098 0.959 . . . . 75.540000000000006 111.451 175.356 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 174.37 -64.19 0.01 OUTLIER 'General case' 0 CA--C 1.504 -0.827 0 C-N-CA 124.814 1.245 . . . . 74.409999999999997 107.991 -178.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 116.83 52.91 0.34 Allowed Glycine 0 N--CA 1.441 -0.969 0 N-CA-C 110.023 -1.231 . . . . 62.299999999999997 110.023 -176.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -139.9 -174.3 3.87 Favored 'General case' 0 N--CA 1.434 -1.275 0 N-CA-C 108.881 -0.785 . . . . 71.129999999999995 108.881 -176.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 34.9 ptt180 -122.05 134.65 54.78 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.486 -0.931 . . . . 64.230000000000004 108.486 177.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -127.13 139.5 52.93 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 109.85 -0.426 . . . . 72.439999999999998 109.85 -177.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 58.3 tp -101.98 112.05 24.54 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 108.22 -1.03 . . . . 65.430000000000007 108.22 178.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -94.68 116.75 29.12 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.324 0.583 . . . . 75.129999999999995 110.469 -176.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -121.81 8.24 9.96 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.448 -1.315 . . . . 75.530000000000001 107.448 176.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -93.05 115.96 65.77 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 114.139 -1.391 . . . . 71.439999999999998 109.684 178.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -50.52 -43.56 44.32 Favored 'Trans proline' 0 C--N 1.361 1.215 0 C-N-CA 123.541 2.827 . . . . 74.010000000000005 113.917 -174.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 31.9 m -106.85 102.77 12.11 Favored 'General case' 0 N--CA 1.423 -1.812 0 N-CA-C 109.63 -0.508 . . . . 74.340000000000003 109.63 177.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 79.4 m -108.79 114.05 27.5 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 107.444 -1.317 . . . . 74.129999999999995 107.444 176.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 14.5 t -117.61 128.79 55.28 Favored 'General case' 0 C--N 1.296 -1.761 0 C-N-CA 119.221 -0.992 . . . . 71.219999999999999 110.693 -175.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' A' ' 78' ' ' ILE . . . -115.08 106.44 14.12 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 115.504 -0.771 . . . . 65.109999999999999 109.576 -176.211 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.46 73.11 1.28 Allowed Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 109.314 -1.515 . . . . 75.129999999999995 109.314 -175.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.528 ' HA ' ' O ' ' A' ' 87' ' ' ARG . 1.1 tmm_? -145.07 85.55 1.75 Allowed 'General case' 0 N--CA 1.423 -1.805 0 N-CA-C 107.294 -1.372 . . . . 74.510000000000005 107.294 -178.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.551 ' CG ' ' HD2' ' A' ' 74' ' ' PRO . 1.3 t-80 68.3 170.71 0.1 Allowed Pre-proline 0 CA--C 1.575 1.935 0 O-C-N 124.545 1.153 . . . . 74.5 109.075 177.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.551 ' HD2' ' CG ' ' A' ' 73' ' ' HIS . 96.3 Cg_exo -48.38 -39.63 35.83 Favored 'Trans proline' 0 C--N 1.369 1.645 0 C-N-CA 121.981 1.787 . . . . 65.519999999999996 112.789 175.322 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.9 pm0 -92.07 58.27 3.3 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 122.202 1.001 . . . . 73.409999999999997 111.636 178.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 66.2 m -65.28 150.47 48.19 Favored 'General case' 0 C--O 1.244 0.783 0 CA-C-N 115.143 -0.935 . . . . 75.420000000000002 108.997 175.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -68.97 -45.2 71.29 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 107.434 -1.321 . . . . 71.150000000000006 107.434 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.492 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 46.1 pt -139.97 143.82 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 N-CA-C 108.135 -1.061 . . . . 75.099999999999994 108.135 171.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -102.47 130.8 49.38 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 119.251 -0.98 . . . . 63.409999999999997 108.403 172.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.437 ' HA ' ' HB2' ' A' ' 56' ' ' ASN . 30.8 tp -108.53 -26.15 10.57 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-O 122.552 1.168 . . . . 74.540000000000006 109.786 -174.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -138.23 134.09 34.0 Favored 'General case' 0 C--N 1.266 -3.022 0 N-CA-C 105.854 -1.906 . . . . 72.0 105.854 177.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.417 ' H ' ' HB2' ' A' ' 55' ' ' PRO . 33.1 t70 -117.79 -15.49 10.07 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 115.534 -0.757 . . . . 74.239999999999995 111.21 -177.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.4 m -91.3 -21.91 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.812 0 N-CA-C 108.087 -1.079 . . . . 73.120000000000005 108.087 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 22.4 m -138.34 83.51 1.97 Allowed 'General case' 0 N--CA 1.414 -2.24 0 CA-C-N 114.56 -1.2 . . . . 72.239999999999995 108.375 174.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.8 p -112.16 139.88 34.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 108.48 -0.933 . . . . 75.319999999999993 108.48 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 15.5 m -124.44 168.83 12.52 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 109.582 -0.525 . . . . 75.120000000000005 109.582 -177.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.528 ' O ' ' HA ' ' A' ' 72' ' ' ARG . 20.5 mtp180 -68.56 -31.59 70.91 Favored 'General case' 0 C--O 1.212 -0.897 0 CA-C-O 121.042 0.449 . . . . 74.319999999999993 110.074 175.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.82 101.7 3.79 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 106.277 -1.749 . . . . 73.120000000000005 106.277 170.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.497 ' O ' HG22 ' A' ' 104' ' ' VAL . 19.0 t60 -98.74 -71.7 0.68 Allowed 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 114.466 -1.243 . . . . 75.030000000000001 111.075 -174.343 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -144.75 160.69 40.83 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 107.738 -1.208 . . . . 74.030000000000001 107.738 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -146.19 139.46 25.89 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.907 -0.717 . . . . 74.420000000000002 110.262 -177.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -115.61 123.0 47.32 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.898 -0.778 . . . . 73.510000000000005 108.898 -177.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 52.8 mtm-85 -107.8 123.65 48.89 Favored 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 107.831 -1.174 . . . . 72.349999999999994 107.831 176.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.3 pp -115.42 116.08 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.128 0 C-N-CA 118.684 -1.207 . . . . 74.510000000000005 108.38 177.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.528 ' ND2' ' HG2' ' A' ' 96' ' ' GLU . 4.9 t30 -120.09 147.05 45.34 Favored 'General case' 0 C--N 1.28 -2.424 0 CA-C-N 114.121 -1.399 . . . . 61.539999999999999 107.55 -179.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.528 ' HG2' ' ND2' ' A' ' 95' ' ' ASN . 8.8 pt-20 -29.12 -36.6 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 126.898 2.079 . . . . 72.239999999999995 115.908 -177.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -131.95 3.04 5.24 Favored Glycine 0 CA--C 1.504 -0.6 0 C-N-CA 119.387 -1.387 . . . . 65.239999999999995 113.28 -175.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -148.05 118.2 7.28 Favored 'General case' 0 N--CA 1.411 -2.399 0 CA-C-O 122.401 1.096 . . . . 72.510000000000005 111.098 -177.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.507 ' HD1' ' SD ' ' A' ' 122' ' ' MET . 71.0 m-85 -107.09 115.83 30.86 Favored 'General case' 0 C--N 1.275 -2.663 0 CA-C-N 114.423 -1.262 . . . . 73.549999999999997 107.62 -179.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -110.18 135.92 50.2 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 113.612 0.967 . . . . 53.119999999999997 113.612 -173.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.5 p -116.33 117.64 56.15 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.116 0 CA-C-N 114.377 -1.283 . . . . 75.140000000000001 107.709 173.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 39.7 t -120.86 125.36 73.96 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 CA-C-N 115.831 -0.622 . . . . 73.519999999999996 110.768 -177.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.445 ' HB2' ' HB ' ' A' ' 110' ' ' THR . 18.0 t0 -92.45 115.46 28.11 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 102.333 -3.21 . . . . 74.019999999999996 102.333 168.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.497 HG22 ' O ' ' A' ' 89' ' ' HIS . 19.2 m -59.67 -23.35 25.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 113.278 0.844 . . . . 73.439999999999998 113.278 -169.165 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -152.76 16.06 0.72 Allowed Glycine 0 C--N 1.305 -1.176 0 C-N-CA 117.8 -2.143 . . . . 74.420000000000002 113.796 178.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 50.3 m 57.17 36.6 27.7 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 122.824 1.297 . . . . 34.329999999999998 107.514 -175.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 49.5 tp -73.66 -47.43 39.93 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 112.828 -1.987 . . . . 75.099999999999994 112.761 -168.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -107.4 -11.52 15.51 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 119.2 -1.0 . . . . 70.420000000000002 109.791 179.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 97.5 65.12 0.89 Allowed Glycine 0 N--CA 1.433 -1.53 0 C-N-CA 120.413 -0.899 . . . . 61.32 113.247 173.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.445 ' HB ' ' HB2' ' A' ' 103' ' ' ASP . 18.9 m -85.24 119.66 25.87 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.683 -0.858 . . . . 64.200000000000003 108.683 174.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.412 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 2.1 m-85 -116.91 140.87 48.95 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.419 -0.956 . . . . 64.239999999999995 108.419 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.5 p -99.58 116.46 42.81 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 N-CA-C 108.197 -1.038 . . . . 74.340000000000003 108.197 176.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 71.17 -73.53 0.1 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.131 0.972 . . . . 74.329999999999998 109.476 -175.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 48.5 ttp180 -161.3 14.37 0.1 Allowed 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 107.538 -1.282 . . . . 74.109999999999999 107.538 172.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -102.27 116.36 63.13 Favored Pre-proline 0 N--CA 1.429 -1.479 0 CA-C-N 115.513 -0.767 . . . . 72.109999999999999 108.94 -172.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -76.24 103.67 1.78 Allowed 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.85 2.367 . . . . 74.5 111.195 178.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 15.1 mmt180 -130.79 157.23 43.43 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 109.348 -0.612 . . . . 74.239999999999995 109.348 -179.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 50.8 m-20 -76.88 -42.57 39.37 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.487 -1.301 . . . . 70.120000000000005 107.487 178.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -147.87 146.04 28.92 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 114.561 -1.2 . . . . 73.209999999999994 108.886 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -138.58 138.17 37.67 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 108.545 -0.909 . . . . 74.25 108.545 178.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 39.0 t -94.82 95.46 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.527 0 C-N-CA 119.477 -0.889 . . . . 71.340000000000003 108.61 177.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.507 ' SD ' ' HD1' ' A' ' 99' ' ' PHE . 25.5 ptt? 44.56 139.02 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 119.087 2.995 . . . . 72.230000000000004 119.087 177.188 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -132.97 122.81 24.81 Favored 'General case' 0 N--CA 1.401 -2.92 1 N-CA-C 99.815 -4.143 . . . . 73.010000000000005 99.815 166.308 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 13.1 t -108.04 127.39 53.74 Favored 'General case' 0 C--N 1.288 -2.077 0 C-N-CA 118.606 -1.238 . . . . 74.519999999999996 112.034 -171.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 83.84 22.35 55.69 Favored Glycine 0 N--CA 1.424 -2.113 0 N-CA-C 109.993 -1.243 . . . . 73.030000000000001 109.993 -179.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -122.76 -175.88 3.26 Favored 'General case' 0 C--O 1.249 1.053 0 N-CA-C 108.36 -0.978 . . . . 74.319999999999993 108.36 -177.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.455 ' OE2' ' HD3' ' A' ' 134' ' ' ARG . 40.0 mt-10 -116.65 130.98 57.05 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 121.784 0.802 . . . . 73.310000000000002 111.492 -175.027 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 66.0 mt -100.47 126.43 54.07 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 N-CA-C 107.151 -1.426 . . . . 74.400000000000006 107.151 176.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.412 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 34.4 tt0 -93.43 112.65 24.61 Favored 'General case' 0 C--N 1.282 -2.334 0 N-CA-C 108.339 -0.986 . . . . 73.049999999999997 108.339 -178.281 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.451 HG13 ' HB2' ' A' ' 133' ' ' PHE . 19.2 pt -101.92 97.95 6.27 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.07 0 N-CA-C 108.747 -0.834 . . . . 72.420000000000002 108.747 179.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 70.13 -98.86 0.66 Allowed Glycine 0 N--CA 1.432 -1.575 0 N-CA-C 109.738 -1.345 . . . . 62.340000000000003 109.738 -176.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -122.71 5.08 9.48 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 120.707 0.289 . . . . 73.340000000000003 110.72 177.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.451 ' HB2' HG13 ' A' ' 130' ' ' ILE . 27.1 m-85 -104.72 171.38 7.35 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 108.784 -0.821 . . . . 74.5 108.784 -179.372 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.455 ' HD3' ' OE2' ' A' ' 127' ' ' GLU . 14.0 ptp180 -130.67 132.67 45.55 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.73 0.776 . . . . 71.439999999999998 112.057 -179.201 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 48.9 tp -117.48 143.46 46.02 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 114.167 -1.379 . . . . 74.540000000000006 107.411 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 34.2 t -106.72 129.95 59.41 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 N-CA-C 106.553 -1.647 . . . . 71.310000000000002 106.553 177.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -121.64 119.89 33.17 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 120.964 0.411 . . . . 73.239999999999995 111.188 -174.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.4 mp -117.53 116.68 27.6 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 107.873 -1.158 . . . . 75.510000000000005 107.873 177.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -122.1 122.87 40.24 Favored 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 121.02 -0.272 . . . . 72.439999999999998 110.382 -175.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.483 ' N ' ' HD2' ' A' ' 141' ' ' PRO . . . 152.48 -52.72 0.48 Allowed Glycine 0 C--N 1.306 -1.095 0 C-N-CA 118.376 -1.868 . . . . 73.049999999999997 115.353 178.181 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.483 ' HD2' ' N ' ' A' ' 140' ' ' GLY . 5.2 Cg_endo -46.1 125.7 8.85 Favored 'Trans proline' 0 C--N 1.374 1.904 0 C-N-CA 123.489 2.793 . . . . 74.239999999999995 114.672 -177.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -91.54 120.76 32.63 Favored 'General case' 0 N--CA 1.425 -1.681 0 CA-C-N 114.809 -1.087 . . . . 71.25 108.6 179.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.282 -2.343 0 N-CA-C 105.858 -1.904 . . . . 75.409999999999997 105.858 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.8 ttt . . . . . 0 CA--C 1.504 -0.798 0 N-CA-C 110.096 -0.335 . . . . 73.409999999999997 110.096 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.4 t -83.45 -50.22 8.51 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 107.518 -1.29 . . . . 73.310000000000002 107.518 174.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.9 t70 57.48 19.13 4.99 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 126.073 1.749 . . . . 75.420000000000002 111.761 176.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -124.46 145.35 49.57 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 108.828 -0.804 . . . . 71.219999999999999 108.828 -178.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -121.67 102.87 8.49 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 107.655 -1.239 . . . . 74.209999999999994 107.655 174.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -82.13 105.52 2.58 Favored Glycine 0 C--N 1.303 -1.292 0 N-CA-C 111.178 -0.769 . . . . 73.049999999999997 111.178 -177.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.5 t -83.18 135.32 44.66 Favored Pre-proline 0 C--N 1.302 -1.463 0 N-CA-C 109.035 -0.728 . . . . 73.540000000000006 109.035 -178.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -66.75 150.15 83.51 Favored 'Trans proline' 0 C--O 1.236 0.419 0 C-N-CA 122.574 2.182 . . . . 74.120000000000005 112.072 -178.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.402 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 0.7 OUTLIER -79.79 112.19 27.51 Favored Pre-proline 0 C--N 1.316 -0.885 0 N-CA-C 109.598 -0.519 . . . . 75.319999999999993 109.598 176.983 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 9' ' ' GLU . 16.5 Cg_exo -65.23 118.09 5.15 Favored 'Trans proline' 0 C--O 1.246 0.921 0 C-N-CA 122.465 2.11 . . . . 73.340000000000003 112.256 -175.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.417 ' HA ' ' OE1' ' A' ' 11' ' ' GLN . 5.0 tp60 -93.39 81.02 4.39 Favored 'General case' 0 N--CA 1.42 -1.95 0 CA-C-O 122.115 0.96 . . . . 74.239999999999995 109.814 177.59 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.4 t -104.53 120.05 54.33 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 N-CA-C 106.634 -1.617 . . . . 75.049999999999997 106.634 177.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.63 140.95 51.72 Favored 'General case' 0 N--CA 1.433 -1.317 0 CA-C-O 120.943 0.401 . . . . 74.420000000000002 111.044 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.7 m -113.2 88.28 2.8 Favored 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 109.217 -0.661 . . . . 73.019999999999996 109.217 -179.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 42.7 m -100.29 95.06 6.53 Favored 'General case' 0 N--CA 1.411 -2.406 0 N-CA-C 108.901 -0.777 . . . . 73.430000000000007 108.901 178.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.0 t -101.19 98.06 8.51 Favored 'General case' 0 N--CA 1.42 -1.946 0 N-CA-C 108.135 -1.061 . . . . 62.030000000000001 108.135 -178.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 23.5 t -95.33 97.72 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 N-CA-C 109.162 -0.681 . . . . 74.030000000000001 109.162 -178.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -88.73 128.68 35.62 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 108.335 -0.987 . . . . 72.340000000000003 108.335 175.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 18.8 mtm180 -109.68 159.99 16.67 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 109.238 -0.653 . . . . 74.099999999999994 109.238 -173.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -99.62 86.01 3.25 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.782 -1.192 . . . . 75.420000000000002 107.782 174.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -93.35 -40.37 10.43 Favored 'General case' 0 CA--C 1.494 -1.194 0 CA-C-N 115.545 -0.752 . . . . 72.319999999999993 110.484 -178.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.9 pp -73.73 155.28 39.09 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-O 121.351 0.596 . . . . 73.230000000000004 111.9 -178.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 95.8 mt -136.56 -178.02 4.99 Favored 'General case' 0 C--N 1.294 -1.804 0 N-CA-C 106.76 -1.57 . . . . 75.040000000000006 106.76 178.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -76.8 104.25 7.2 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 121.344 0.592 . . . . 73.439999999999998 109.763 177.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -83.18 103.66 12.76 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.843 -0.799 . . . . 71.010000000000005 108.843 178.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 49.8 mtt -85.93 96.06 9.68 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 115.219 -0.901 . . . . 73.400000000000006 109.886 -175.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -111.89 118.56 35.85 Favored 'General case' 0 N--CA 1.426 -1.671 0 C-N-CA 119.883 -0.727 . . . . 65.420000000000002 109.186 175.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.7 t -122.06 128.48 51.42 Favored 'General case' 0 N--CA 1.408 -2.534 0 N-CA-C 105.392 -2.077 . . . . 74.540000000000006 105.392 176.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 58.8 p -140.94 -178.52 5.59 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 120.264 -0.574 . . . . 73.219999999999999 111.494 -175.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 23.5 m -74.95 127.69 33.81 Favored 'General case' 0 N--CA 1.425 -1.699 0 N-CA-C 108.188 -1.042 . . . . 72.140000000000001 108.188 177.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.05 -42.14 1.97 Allowed Glycine 0 N--CA 1.44 -1.099 0 N-CA-C 111.007 -0.837 . . . . 62.109999999999999 111.007 -179.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.9 p -78.52 161.14 27.26 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 122.405 0.282 . . . . 75.230000000000004 110.597 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.24 126.56 92.4 Favored Pre-proline 0 N--CA 1.432 -1.371 0 N-CA-C 107.299 -1.371 . . . . 65.329999999999998 107.299 173.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -62.32 126.43 18.51 Favored 'Trans proline' 0 C--O 1.256 1.418 0 C-N-CA 122.334 2.023 . . . . 74.120000000000005 112.899 -176.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -69.86 95.41 0.91 Allowed 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 106.903 -1.517 . . . . 75.450000000000003 106.903 174.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.8 p -121.24 152.55 38.72 Favored 'General case' 0 N--CA 1.408 -2.571 0 CA-C-N 115.004 -0.998 . . . . 74.439999999999998 111.682 -171.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.5 t -79.75 176.59 9.58 Favored 'General case' 0 N--CA 1.425 -1.693 0 CA-C-N 115.382 -0.826 . . . . 53.100000000000001 108.908 177.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -83.25 96.21 1.9 Allowed Glycine 0 N--CA 1.419 -2.434 0 N-CA-C 109.749 -1.34 . . . . 73.400000000000006 109.749 -179.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -56.5 -34.43 66.96 Favored 'General case' 0 C--N 1.293 -1.875 0 C-N-CA 125.15 1.38 . . . . 63.240000000000002 112.159 -176.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.8 pm0 -68.47 -13.9 62.63 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.676 -0.693 . . . . 75.439999999999998 112.444 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -83.14 -14.09 54.27 Favored 'General case' 0 C--N 1.319 -0.729 0 O-C-N 122.018 -0.426 . . . . 74.420000000000002 111.703 -179.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.3 mp -67.84 116.39 37.66 Favored Pre-proline 0 C--N 1.319 -0.757 0 CA-C-N 115.919 -0.582 . . . . 72.230000000000004 109.757 178.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -68.82 -28.25 30.28 Favored 'Trans proline' 0 N--CA 1.475 0.397 0 C-N-CA 122.512 2.141 . . . . 74.219999999999999 112.107 -177.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -104.76 23.4 13.48 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.978 0.894 . . . . 73.099999999999994 109.037 179.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -107.63 7.01 36.11 Favored Glycine 0 N--CA 1.433 -1.516 0 CA-C-N 114.644 -1.162 . . . . 74.430000000000007 112.186 -178.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.438 ' HB2' ' O ' ' A' ' 141' ' ' PRO . 8.7 m -90.19 152.96 20.85 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 121.464 0.65 . . . . 64.239999999999995 109.5 -178.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -153.73 164.15 38.81 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.234 -1.025 . . . . 64.510000000000005 108.234 -177.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -130.12 142.13 50.62 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.402 0.62 . . . . 73.400000000000006 111.471 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.41 ' O ' HD11 ' A' ' 49' ' ' LEU . 4.2 pp -109.78 133.25 53.36 Favored 'General case' 0 N--CA 1.423 -1.825 0 N-CA-C 107.736 -1.209 . . . . 73.25 107.736 175.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 48.1 t -119.08 117.46 54.31 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 N-CA-C 109.69 -0.485 . . . . 65.109999999999999 109.69 -176.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 57.3 t -93.04 114.45 29.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 106.016 -1.846 . . . . 73.310000000000002 106.016 175.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -93.39 -33.11 13.99 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.389 -0.597 . . . . 75.409999999999997 109.389 -176.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.465 ' O ' ' HB3' ' A' ' 133' ' ' PHE . 60.5 mtt180 -138.53 123.19 18.63 Favored 'General case' 0 CA--C 1.487 -1.444 0 N-CA-C 108.559 -0.904 . . . . 74.319999999999993 108.559 177.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.407 ' HA2' ' HD2' ' A' ' 55' ' ' PRO . . . 146.98 116.33 0.94 Allowed Glycine 0 N--CA 1.415 -2.761 0 C-N-CA 120.911 -0.662 . . . . 71.329999999999998 112.525 179.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.407 ' HD2' ' HA2' ' A' ' 54' ' ' GLY . 11.9 Cg_endo -59.55 -9.22 8.54 Favored 'Trans proline' 0 C--N 1.37 1.689 0 C-N-CA 124.058 3.172 . . . . 73.239999999999995 112.269 176.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.436 ' HA ' ' N ' ' A' ' 81' ' ' ASP . 2.3 m-20 -45.99 -49.42 16.03 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 125.39 1.476 . . . . 74.140000000000001 108.901 172.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -149.37 -58.65 0.21 Allowed 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 115.407 -0.815 . . . . 73.140000000000001 109.54 -179.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.21 31.71 63.56 Favored Glycine 0 CA--C 1.507 -0.465 0 N-CA-C 110.099 -1.2 . . . . 73.310000000000002 110.099 -176.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -152.93 176.05 12.27 Favored 'General case' 0 N--CA 1.42 -1.952 0 N-CA-C 108.834 -0.802 . . . . 73.209999999999994 108.834 -175.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -109.17 153.44 23.76 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.888 -0.597 . . . . 74.430000000000007 109.557 177.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -143.64 134.24 24.96 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 108.141 -1.059 . . . . 73.549999999999997 108.141 -179.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -104.21 135.81 44.98 Favored 'General case' 0 N--CA 1.428 -1.539 0 CA-C-O 120.877 0.37 . . . . 75.239999999999995 110.571 178.146 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 81.6 mt -82.6 115.07 21.4 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.684 -0.689 . . . . 72.030000000000001 109.471 -178.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -126.63 9.18 7.05 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 107.582 -1.266 . . . . 73.150000000000006 107.582 176.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -131.19 147.51 66.54 Favored Pre-proline 0 C--N 1.295 -1.781 0 CA-C-N 113.571 -1.649 . . . . 73.019999999999996 107.621 -175.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -57.42 -53.52 4.6 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 122.759 2.306 . . . . 75.25 114.859 -175.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 85.0 m -131.67 109.78 10.44 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.224 0.535 . . . . 73.219999999999999 112.365 -177.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 41.4 m -98.55 118.07 34.42 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.309 -0.997 . . . . 72.540000000000006 108.309 175.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.492 ' OG1' ' HG2' ' A' ' 88' ' ' ARG . 12.5 t -102.59 147.79 26.35 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 119.308 -0.957 . . . . 74.430000000000007 110.697 179.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -108.1 132.67 53.34 Favored 'General case' 0 N--CA 1.424 -1.726 0 CA-C-N 115.437 -0.801 . . . . 71.129999999999995 109.509 179.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.534 ' O ' ' HA ' ' A' ' 79' ' ' PHE . . . -161.53 -146.05 4.51 Favored Glycine 0 N--CA 1.428 -1.852 0 N-CA-C 108.645 -1.782 . . . . 64.400000000000006 108.645 176.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 18.2 ttp85 -164.76 58.76 0.13 Allowed 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.166 -1.05 . . . . 74.519999999999996 108.166 173.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 70.1 m80 -139.38 165.24 33.11 Favored Pre-proline 0 C--N 1.279 -2.499 0 N-CA-C 106.738 -1.579 . . . . 71.200000000000003 106.738 179.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 99.5 Cg_exo -48.99 -33.43 26.16 Favored 'Trans proline' 0 C--N 1.358 1.055 0 C-N-CA 122.715 2.277 . . . . 71.439999999999998 112.556 177.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -106.71 74.39 1.0 Allowed 'General case' 0 N--CA 1.432 -1.347 0 CA-C-O 122.016 0.912 . . . . 73.140000000000001 109.855 176.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 37.7 m -146.1 123.42 11.6 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 113.957 -1.474 . . . . 53.240000000000002 108.159 174.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -65.21 -52.1 56.8 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-O 120.605 0.241 . . . . 75.349999999999994 110.83 -178.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 41.8 pt -123.61 178.78 3.15 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 109.627 -0.509 . . . . 73.299999999999997 109.627 175.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.534 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 97.2 m-85 -122.89 136.98 55.06 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 112.623 0.601 . . . . 75.010000000000005 112.623 -172.101 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -117.92 132.23 56.43 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.187 -1.412 . . . . 74.329999999999998 107.187 167.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.436 ' N ' ' HA ' ' A' ' 56' ' ' ASN . 38.1 t70 -127.98 70.21 1.34 Allowed 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 122.437 1.113 . . . . 63.009999999999998 109.439 -175.183 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -122.92 -163.56 1.11 Allowed 'General case' 0 C--N 1.284 -2.273 0 CA-C-N 113.668 -1.606 . . . . 72.310000000000002 108.542 176.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 44.7 t -65.27 -38.03 81.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 C-N-CA 123.389 0.676 . . . . 75.329999999999998 112.133 -176.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 26.2 m -121.95 93.5 4.01 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.868 0.842 . . . . 74.430000000000007 112.75 -175.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 6.0 p -111.63 128.89 67.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 CA-C-N 114.91 -1.041 . . . . 64.010000000000005 110.793 -178.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 8.9 m -112.64 -170.4 1.66 Allowed 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.232 -0.655 . . . . 65.310000000000002 109.232 178.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -78.98 -76.05 0.21 Allowed 'General case' 0 C--O 1.217 -0.609 0 N-CA-C 109.982 -0.377 . . . . 71.209999999999994 109.982 177.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.492 ' HG2' ' OG1' ' A' ' 69' ' ' THR . 1.5 tmm_? -101.48 82.58 2.32 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 105.386 -2.079 . . . . 75.25 105.386 174.521 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 67.1 t60 -87.37 -70.76 0.6 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.219 -0.901 . . . . 75.420000000000002 112.49 -170.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -110.86 147.57 34.27 Favored 'General case' 0 CA--C 1.483 -1.631 0 N-CA-C 108.793 -0.818 . . . . 73.420000000000002 108.793 -177.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -128.3 127.81 43.44 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-O 121.201 0.524 . . . . 75.230000000000004 110.412 178.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -105.81 113.13 26.5 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 105.602 -1.999 . . . . 75.420000000000002 105.602 177.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 71.7 mtp180 -118.45 147.32 43.72 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 121.864 0.84 . . . . 73.409999999999997 112.961 -172.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.53 117.12 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.321 0 N-CA-C 103.428 -2.804 . . . . 74.409999999999997 103.428 170.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 32.1 t-20 -118.36 147.25 43.71 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 108.161 -1.052 . . . . 72.019999999999996 108.161 -173.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.63 -20.09 53.62 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 113.195 0.813 . . . . 65.099999999999994 113.195 -179.104 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -78.82 -49.86 6.27 Favored Glycine 0 N--CA 1.423 -2.18 0 N-CA-C 111.14 -0.784 . . . . 71.030000000000001 111.14 173.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -177.77 -172.94 0.37 Allowed 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 107.363 -1.347 . . . . 74.319999999999993 107.363 -177.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.428 ' CB ' ' HB3' ' A' ' 122' ' ' MET . 89.9 m-85 -89.84 138.68 31.28 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 118.919 0.781 . . . . 70.549999999999997 109.393 -178.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -131.9 135.19 46.46 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 116.274 -0.421 . . . . 74.299999999999997 110.431 -174.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.6 p -128.95 117.71 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 108.934 -0.765 . . . . 74.450000000000003 108.934 174.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 19.4 m -121.09 135.55 60.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 CA-C-N 115.307 -0.86 . . . . 74.0 112.051 -178.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -99.07 107.38 19.77 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 106.093 -1.817 . . . . 75.120000000000005 106.093 170.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.4 m -94.21 9.35 5.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-O 121.402 0.62 . . . . 72.049999999999997 111.224 -176.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -90.04 -42.41 5.32 Favored Glycine 0 N--CA 1.428 -1.844 0 N-CA-C 108.159 -1.976 . . . . 73.420000000000002 108.159 172.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 39.7 m 70.23 -37.82 0.39 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.739 2.016 . . . . 60.399999999999999 114.348 174.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -58.66 -42.51 88.6 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 123.111 0.564 . . . . 75.120000000000005 111.658 177.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -86.05 -52.09 5.92 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.894 -0.78 . . . . 72.329999999999998 108.894 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 77.31 103.28 0.17 Allowed Glycine 0 N--CA 1.434 -1.456 0 CA-C-N 115.33 -0.85 . . . . 73.349999999999994 114.545 177.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 89.3 m -76.21 120.01 20.91 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 106.414 -1.698 . . . . 73.25 106.414 169.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -114.3 171.98 7.29 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.883 0.849 . . . . 73.319999999999993 111.591 -171.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 21.9 t -98.53 142.74 14.19 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.122 0 N-CA-C 104.758 -2.312 . . . . 74.140000000000001 104.758 173.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -40.03 -36.84 0.52 Allowed 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 114.204 1.187 . . . . 73.040000000000006 114.204 -176.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -118.56 -13.0 9.7 Favored 'General case' 0 C--O 1.222 -0.387 0 N-CA-C 112.386 0.513 . . . . 75.140000000000001 112.386 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -114.43 107.42 51.28 Favored Pre-proline 0 C--N 1.315 -0.933 0 N-CA-C 111.892 0.33 . . . . 74.409999999999997 111.892 -178.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -83.65 101.35 0.92 Allowed 'Trans proline' 0 N--CA 1.44 -1.665 0 C-N-CA 122.4 2.067 . . . . 62.439999999999998 110.739 176.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.573 ' HD2' ' OE1' ' A' ' 120' ' ' GLN . 15.5 ptp180 -153.63 152.94 31.42 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.884 -1.154 . . . . 72.310000000000002 107.884 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -81.16 -26.96 35.64 Favored 'General case' 0 C--N 1.313 -1.022 0 N-CA-C 112.425 0.528 . . . . 74.5 112.425 -175.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -129.38 139.04 51.82 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 109.273 -0.64 . . . . 62.210000000000001 109.273 178.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.573 ' OE1' ' HD2' ' A' ' 117' ' ' ARG . 51.8 tp60 -140.45 149.48 42.62 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.491 -0.777 . . . . 64.400000000000006 109.925 -176.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.4 p -79.47 121.4 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 105.764 -1.939 . . . . 70.519999999999996 105.764 169.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.515 ' HE3' ' CD1' ' A' ' 137' ' ' PHE . 10.9 ttt -71.35 115.02 10.02 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 121.575 0.702 . . . . 75.129999999999995 109.159 -170.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 21.5 tp60 -104.76 135.13 46.71 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.254 -0.885 . . . . 74.420000000000002 108.776 -173.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.1 t -78.86 131.33 36.41 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-O 121.049 0.452 . . . . 73.0 110.256 178.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 89.14 24.76 30.84 Favored Glycine 0 N--CA 1.426 -2.012 0 N-CA-C 111.024 -0.83 . . . . 71.409999999999997 111.024 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -116.49 169.45 9.32 Favored 'General case' 0 C--O 1.251 1.139 0 N-CA-C 109.16 -0.682 . . . . 70.340000000000003 109.16 -178.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -114.07 121.22 43.16 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.819 -1.178 . . . . 65.510000000000005 107.819 -174.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 65.2 mt -107.93 131.43 58.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 C-N-CA 123.93 0.892 . . . . 64.439999999999998 110.577 -175.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -101.13 111.87 24.2 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.803 -0.635 . . . . 75.519999999999996 109.296 -177.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 5.1 pt -103.1 98.14 6.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 CA-C-O 121.575 0.702 . . . . 74.519999999999996 109.808 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 71.88 -100.4 0.92 Allowed Glycine 0 N--CA 1.44 -1.088 0 N-CA-C 109.228 -1.549 . . . . 75.549999999999997 109.228 -174.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -124.41 5.7 8.36 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 108.953 -0.758 . . . . 74.219999999999999 108.953 175.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.465 ' HB3' ' O ' ' A' ' 53' ' ' ARG . 63.0 m-85 -103.19 173.54 6.26 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 115.408 -0.815 . . . . 75.430000000000007 110.563 -175.201 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 34.2 ttt180 -132.26 125.21 30.53 Favored 'General case' 0 C--O 1.255 1.365 0 C-N-CA 119.698 -0.801 . . . . 75.129999999999995 112.988 -165.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 5.9 tt -124.57 139.7 53.63 Favored 'General case' 0 C--O 1.21 -0.984 0 C-N-CA 124.792 1.237 . . . . 71.310000000000002 109.495 -178.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 8.6 t -109.95 136.39 46.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 107.088 -1.449 . . . . 75.25 107.088 176.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.515 ' CD1' ' HE3' ' A' ' 122' ' ' MET . 73.5 t80 -115.06 126.8 55.12 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 120.195 -0.602 . . . . 71.549999999999997 110.983 179.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.0 mp -133.35 133.07 42.01 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.961 -0.385 . . . . 75.530000000000001 109.961 178.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -93.44 141.42 28.48 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 105.102 -2.184 . . . . 73.25 105.102 170.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 177.15 -52.44 0.1 Allowed Glycine 0 C--N 1.289 -2.057 0 C-N-CA 118.273 -1.917 . . . . 44.130000000000003 114.307 -174.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.438 ' O ' ' HB2' ' A' ' 46' ' ' SER . 33.2 Cg_exo -58.89 112.0 1.07 Allowed 'Trans proline' 0 C--N 1.368 1.565 0 CA-C-N 119.906 1.853 . . . . 74.329999999999998 112.194 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -109.98 104.5 13.41 Favored 'General case' 0 C--N 1.264 -3.133 0 N-CA-C 106.452 -1.685 . . . . 63.439999999999998 106.452 177.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 . . . . . 0 N--CA 1.407 -2.584 0 CA-C-O 118.164 -0.922 . . . . 71.010000000000005 111.327 -171.908 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 CA--C 1.505 -0.772 0 N-CA-C 109.931 -0.396 . . . . 75.230000000000004 109.931 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.6 m -79.35 -31.6 43.05 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 108.166 -1.05 . . . . 72.239999999999995 108.166 177.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -110.03 142.91 40.8 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 114.449 -1.251 . . . . 75.230000000000004 107.989 175.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -68.86 106.52 2.73 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 109.695 -0.484 . . . . 74.099999999999994 109.695 179.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -67.36 110.45 3.57 Favored 'General case' 0 C--O 1.245 0.843 0 CA-C-N 114.95 -1.023 . . . . 73.200000000000003 110.785 -175.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.38 104.51 3.18 Favored Glycine 0 N--CA 1.437 -1.282 0 N-CA-C 111.145 -0.782 . . . . 65.120000000000005 111.145 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 50.3 m -101.63 124.44 40.68 Favored Pre-proline 0 C--N 1.301 -1.521 0 N-CA-C 109.838 -0.43 . . . . 75.510000000000005 109.838 -178.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -66.33 145.23 77.06 Favored 'Trans proline' 0 C--O 1.247 0.926 0 C-N-CA 121.837 1.691 . . . . 74.409999999999997 110.007 175.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -69.76 138.71 88.18 Favored Pre-proline 0 C--N 1.3 -1.548 0 CA-C-N 116.336 -0.393 . . . . 75.150000000000006 109.996 -175.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.32 134.3 60.61 Favored 'Trans proline' 0 C--O 1.252 1.185 0 C-N-CA 122.845 2.363 . . . . 74.219999999999999 113.098 -174.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 73.84 80.33 0.12 Allowed 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 125.903 1.681 . . . . 63.43 110.705 -176.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.5 p -103.38 136.57 35.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-N 114.754 -1.112 . . . . 64.310000000000002 109.189 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.28 131.54 36.04 Favored 'General case' 0 N--CA 1.42 -1.969 0 CA-C-O 120.941 0.401 . . . . 72.310000000000002 109.939 179.06 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.9 t -82.84 147.36 28.39 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 109.012 -0.736 . . . . 64.140000000000001 109.012 176.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.0 t -85.06 114.37 22.16 Favored 'General case' 0 N--CA 1.407 -2.577 0 CA-C-O 121.761 0.791 . . . . 61.329999999999998 109.311 178.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 37.4 m -138.68 85.45 2.08 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 115.131 -0.94 . . . . 75.439999999999998 108.754 175.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.1 p -145.54 157.71 12.92 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 N-CA-C 106.934 -1.506 . . . . 73.019999999999996 106.934 -176.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -72.14 135.12 46.09 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-O 121.894 0.854 . . . . 63.219999999999999 111.544 179.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -115.65 -155.47 0.58 Allowed 'General case' 0 C--N 1.283 -2.326 0 N-CA-C 106.471 -1.677 . . . . 74.239999999999995 106.471 -174.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.0 71.18 9.04 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 107.269 -1.382 . . . . 74.439999999999998 107.269 171.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -79.17 -24.89 42.94 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.564 -1.198 . . . . 73.129999999999995 111.362 -176.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.2 tm? 64.21 93.85 0.06 Allowed 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 125.046 1.338 . . . . 72.109999999999999 111.591 177.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 66.3 tp -113.95 92.55 4.01 Favored 'General case' 0 C--N 1.292 -1.935 0 N-CA-C 107.588 -1.264 . . . . 73.329999999999998 107.588 175.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 6.8 mmtm -147.16 100.62 3.31 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.991 -1.004 . . . . 74.120000000000005 109.623 -179.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -138.98 164.26 30.21 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 109.628 -0.508 . . . . 71.209999999999994 109.628 176.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 51.2 tpp -56.33 124.56 18.45 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.092 0.87 . . . . 63.399999999999999 111.188 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -104.56 -165.98 1.19 Allowed 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 109.247 -0.649 . . . . 74.219999999999999 109.247 178.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 32.0 t -63.39 118.63 8.34 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 109.231 -0.655 . . . . 71.230000000000004 109.231 177.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 43.8 m -84.27 149.77 25.87 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 109.255 -0.646 . . . . 75.409999999999997 109.255 179.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 22.3 m -58.21 124.34 19.1 Favored 'General case' 0 C--O 1.245 0.828 0 O-C-N 123.503 0.502 . . . . 75.430000000000007 109.819 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -66.98 117.23 8.93 Favored Glycine 0 N--CA 1.439 -1.164 0 CA-C-N 115.786 -0.643 . . . . 64.239999999999995 111.638 -177.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.6 m -83.98 133.62 34.68 Favored 'General case' 0 N--CA 1.419 -1.991 0 N-CA-C 109.262 -0.644 . . . . 71.329999999999998 109.262 -179.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.07 126.67 92.86 Favored Pre-proline 0 N--CA 1.439 -0.994 0 N-CA-C 107.841 -1.17 . . . . 71.319999999999993 107.841 174.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -61.1 141.22 93.22 Favored 'Trans proline' 0 C--O 1.242 0.68 0 C-N-CA 122.377 2.052 . . . . 72.420000000000002 111.631 -178.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -91.02 63.33 5.11 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 116.374 -0.375 . . . . 75.129999999999995 110.405 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.5 m 53.65 74.22 0.33 Allowed 'General case' 0 C--N 1.347 0.471 0 CA-C-O 121.985 0.898 . . . . 63.039999999999999 110.297 -177.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.1 t -143.55 159.64 42.06 Favored 'General case' 0 N--CA 1.41 -2.454 0 CA-C-N 115.698 -0.683 . . . . 72.120000000000005 109.607 -172.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 129.61 131.56 3.37 Favored Glycine 0 N--CA 1.433 -1.509 0 N-CA-C 110.626 -0.989 . . . . 62.310000000000002 110.626 -179.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.57 -24.47 58.92 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.739 0.78 . . . . 73.310000000000002 110.759 -176.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.402 ' CD ' ' H ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -83.15 -39.71 20.69 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 114.829 -1.078 . . . . 72.319999999999993 111.113 -178.357 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -82.86 -37.55 24.19 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 116.277 -0.419 . . . . 75.219999999999999 111.662 -177.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.7 mp -84.17 145.9 47.0 Favored Pre-proline 0 C--N 1.312 -1.034 0 C-N-CA 120.43 -0.508 . . . . 73.409999999999997 112.004 -177.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -79.53 39.41 0.82 Allowed 'Trans proline' 0 C--N 1.359 1.123 0 C-N-CA 123.921 3.08 . . . . 73.439999999999998 113.67 -175.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -116.52 111.97 20.71 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 120.677 0.275 . . . . 73.299999999999997 110.526 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -83.64 -25.37 46.72 Favored Glycine 0 C--N 1.316 -0.556 0 N-CA-C 109.401 -1.48 . . . . 63.200000000000003 109.401 174.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.9 m -132.75 151.49 51.98 Favored 'General case' 0 N--CA 1.421 -1.895 0 N-CA-C 104.926 -2.25 . . . . 53.329999999999998 104.926 175.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.417 ' HB2' ' CZ ' ' A' ' 137' ' ' PHE . . . -142.88 164.81 29.09 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 108.497 -0.927 . . . . 64.010000000000005 108.497 -178.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -119.44 150.43 40.22 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 120.32 -0.552 . . . . 73.439999999999998 111.677 -174.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.476 ' O ' HD12 ' A' ' 49' ' ' LEU . 2.8 pp -109.77 138.95 45.4 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 115.312 -0.858 . . . . 73.430000000000007 109.325 176.108 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.432 ' O ' HD12 ' A' ' 135' ' ' LEU . 29.8 m -112.66 131.79 63.21 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 N-CA-C 108.093 -1.077 . . . . 71.239999999999995 108.093 177.062 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 37.1 t -92.05 114.34 28.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 N-CA-C 104.442 -2.429 . . . . 73.409999999999997 104.442 175.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 50.5 tttp -84.72 -32.46 23.49 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 108.328 -0.99 . . . . 73.5 108.328 -173.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.445 ' HA ' ' NE ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -170.44 108.9 0.35 Allowed 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 107.721 -1.215 . . . . 73.200000000000003 107.721 174.213 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -168.86 117.75 0.74 Allowed Glycine 0 N--CA 1.424 -2.111 0 C-N-CA 120.465 -0.874 . . . . 64.510000000000005 111.099 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -51.6 -12.77 1.16 Allowed 'Trans proline' 0 CA--C 1.555 1.532 0 C-N-CA 124.423 3.415 . . . . 75.299999999999997 116.127 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.462 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 31.3 p30 -71.67 -29.48 64.66 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 122.115 -0.365 . . . . 74.450000000000003 111.6 179.426 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -163.47 -148.88 0.13 Allowed 'General case' 0 C--O 1.24 0.576 0 N-CA-C 108.57 -0.9 . . . . 71.450000000000003 108.57 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 169.23 53.57 0.03 OUTLIER Glycine 0 CA--C 1.488 -1.608 0 N-CA-C 110.489 -1.044 . . . . 71.450000000000003 110.489 177.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -154.57 -170.24 3.47 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 108.303 -0.999 . . . . 54.439999999999998 108.303 -176.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 27.3 ptt180 -131.23 135.69 47.58 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 107.835 -1.172 . . . . 73.329999999999998 107.835 175.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -143.73 141.66 30.58 Favored 'General case' 0 C--N 1.291 -1.969 0 C-N-CA 120.518 -0.473 . . . . 74.319999999999993 111.226 178.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 28.3 tp -75.98 129.85 37.53 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 114.784 -1.098 . . . . 72.239999999999995 109.224 -178.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 81.9 mt -86.87 114.5 23.57 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 108.485 -0.932 . . . . 75.140000000000001 108.485 176.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -150.0 37.21 0.7 Allowed 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 103.761 -2.681 . . . . 73.409999999999997 103.761 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -133.98 128.64 19.74 Favored Pre-proline 0 C--N 1.297 -1.689 0 CA-C-N 113.486 -1.688 . . . . 73.340000000000003 107.768 -174.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -45.65 -55.41 3.58 Favored 'Trans proline' 0 C--N 1.362 1.237 0 C-N-CA 123.937 3.091 . . . . 75.340000000000003 113.562 -174.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 57.9 m -137.16 98.75 3.81 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 121.713 0.768 . . . . 75.329999999999998 112.963 179.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.411 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 90.1 m -80.57 112.83 18.29 Favored 'General case' 0 N--CA 1.417 -2.093 0 N-CA-C 106.42 -1.696 . . . . 75.120000000000005 106.42 174.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.411 ' HB ' ' HA ' ' A' ' 76' ' ' SER . 27.1 m -108.64 128.02 54.48 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 116.36 -0.382 . . . . 70.439999999999998 110.333 -175.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -105.0 120.02 40.45 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 108.873 -0.788 . . . . 72.239999999999995 108.873 177.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 158.39 -127.34 1.86 Allowed Glycine 0 N--CA 1.431 -1.664 0 N-CA-C 110.649 -0.98 . . . . 62.149999999999999 110.649 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.495 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 41.1 ttm180 -154.23 84.27 1.13 Allowed 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 121.436 0.636 . . . . 75.219999999999999 110.18 179.187 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 11.2 m170 -137.3 167.18 21.87 Favored Pre-proline 0 C--N 1.288 -2.088 0 N-CA-C 107.616 -1.253 . . . . 72.349999999999994 107.616 175.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -60.07 -21.56 65.98 Favored 'Trans proline' 0 C--N 1.358 1.069 0 C-N-CA 122.308 2.005 . . . . 74.239999999999995 111.024 174.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -112.53 78.72 1.15 Allowed 'General case' 0 N--CA 1.424 -1.758 0 N-CA-C 107.963 -1.125 . . . . 72.519999999999996 107.963 177.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.411 ' HA ' ' HB ' ' A' ' 69' ' ' THR . 55.4 m -139.35 151.53 46.44 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 115.108 -0.951 . . . . 72.430000000000007 110.525 177.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -104.36 -46.85 4.28 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 109.018 -0.734 . . . . 74.349999999999994 109.018 -178.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 33.8 pt -133.31 156.01 41.36 Favored 'Isoleucine or valine' 0 C--O 1.245 0.865 0 CA-C-N 115.58 -0.736 . . . . 70.230000000000004 109.685 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -120.29 135.45 55.0 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.583 -0.895 . . . . 74.450000000000003 108.583 178.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 4.5 mp -75.42 106.01 6.74 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 122.849 0.46 . . . . 73.510000000000005 110.94 -178.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -86.26 63.51 8.05 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 122.718 1.246 . . . . 61.210000000000001 109.913 177.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -143.66 167.58 21.93 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 113.726 -1.579 . . . . 65.329999999999998 107.301 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.1 m -66.4 -33.87 66.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 117.801 0.273 . . . . 71.310000000000002 111.375 178.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 11.7 p -90.63 72.22 6.79 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-O 121.603 0.716 . . . . 75.530000000000001 112.425 179.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 6.9 p -113.58 113.41 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 CA-C-N 114.872 -1.058 . . . . 74.230000000000004 111.257 177.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 7.0 m -92.83 148.23 22.2 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 105.281 -2.118 . . . . 61.520000000000003 105.281 171.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.495 ' HB2' ' O ' ' A' ' 72' ' ' ARG . 9.1 ptm180 -73.47 -21.92 60.31 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 118.421 -1.312 . . . . 74.049999999999997 110.481 -179.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 26.8 ptt180 -122.24 97.77 5.63 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 106.526 -1.657 . . . . 74.129999999999995 106.526 165.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 8.6 t60 -109.66 -52.29 2.79 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.923 -0.711 . . . . 74.450000000000003 110.941 -173.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -144.96 131.94 20.28 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 120.188 -0.605 . . . . 71.219999999999999 110.104 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -114.91 126.81 55.22 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 108.794 -0.817 . . . . 74.019999999999996 108.794 177.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.411 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 79.8 m-85 -113.61 113.45 25.08 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 107.72 -1.215 . . . . 74.310000000000002 107.72 -179.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 51.5 mtm180 -115.25 152.64 32.33 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-O 121.116 0.484 . . . . 74.420000000000002 110.977 -175.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.49 ' O ' HD11 ' A' ' 94' ' ' ILE . 2.9 pp -113.83 117.07 54.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 CA-C-O 122.414 1.102 . . . . 73.439999999999998 108.459 175.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 38.1 t-20 -103.05 147.65 26.7 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 106.893 -1.521 . . . . 74.099999999999994 106.893 -173.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -49.81 -32.94 15.2 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 112.505 0.557 . . . . 72.450000000000003 112.505 -177.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -94.19 -40.72 4.47 Favored Glycine 0 N--CA 1.422 -2.296 0 C-N-CA 120.265 -0.969 . . . . 72.349999999999994 113.371 -179.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -149.32 178.47 8.74 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 121.872 0.844 . . . . 73.120000000000005 112.574 -173.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.428 ' HB3' ' HE3' ' A' ' 122' ' ' MET . 89.4 m-85 -93.35 127.18 38.85 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 107.455 -1.313 . . . . 74.530000000000001 107.455 177.272 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -123.03 130.78 53.23 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 120.858 0.361 . . . . 73.420000000000002 111.973 -171.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 9.0 p -121.54 131.05 73.97 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 109.139 -0.689 . . . . 75.049999999999997 109.139 175.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.7 m -117.76 128.02 75.0 Favored 'Isoleucine or valine' 0 C--O 1.259 1.578 0 CA-C-O 121.569 0.699 . . . . 71.430000000000007 111.02 178.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -83.79 114.5 21.66 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.679 -1.146 . . . . 71.239999999999995 110.065 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 23.4 m -122.35 3.18 5.99 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 CA-C-O 121.923 0.868 . . . . 75.019999999999996 108.903 173.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -109.17 53.26 0.6 Allowed Glycine 0 N--CA 1.427 -1.955 0 CA-C-N 114.596 -1.184 . . . . 75.219999999999999 110.36 -178.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.2 p -64.85 -2.85 2.83 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.455 1.102 . . . . 72.319999999999993 112.107 -178.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -62.83 -35.64 80.59 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 108.454 -0.943 . . . . 73.140000000000001 108.454 174.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -114.49 -45.93 2.99 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.237 -1.023 . . . . 74.030000000000001 108.237 177.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 94.37 120.97 3.35 Favored Glycine 0 N--CA 1.435 -1.419 0 CA-C-N 115.012 -0.994 . . . . 71.129999999999995 111.398 -178.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.4 m -79.56 119.53 22.66 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.999 -0.741 . . . . 73.25 108.999 176.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -103.4 134.42 46.8 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.967 -0.753 . . . . 74.099999999999994 108.967 178.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.402 HG13 ' HG2' ' A' ' 120' ' ' GLN . 61.9 t -115.91 117.93 57.15 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.359 0 N-CA-C 105.923 -1.88 . . . . 73.140000000000001 105.923 175.053 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 59.46 31.67 21.2 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-O 122.286 1.041 . . . . 72.209999999999994 108.392 -175.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 44.4 mtp180 74.39 5.03 4.56 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.127 1.371 . . . . 74.349999999999994 114.304 -178.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -103.05 134.95 19.5 Favored Pre-proline 0 C--N 1.309 -1.167 0 O-C-N 121.705 -0.622 . . . . 74.510000000000005 109.671 177.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -69.72 119.28 6.26 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.086 1.857 . . . . 74.230000000000004 110.096 177.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -123.35 129.98 52.07 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.715 -0.846 . . . . 70.010000000000005 108.715 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -69.64 -42.11 74.73 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 121.363 0.602 . . . . 74.230000000000004 109.904 178.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -144.61 138.39 27.38 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 105.814 -1.921 . . . . 75.530000000000001 105.814 173.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.402 ' HG2' HG13 ' A' ' 112' ' ' VAL . 57.8 tp60 -141.44 148.9 40.28 Favored 'General case' 0 C--N 1.282 -2.369 0 CA-C-O 120.732 0.301 . . . . 74.239999999999995 110.405 -177.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 89.1 t -80.46 120.88 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.669 0 N-CA-C 104.997 -2.223 . . . . 74.109999999999999 104.997 169.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.428 ' HE3' ' HB3' ' A' ' 99' ' ' PHE . 76.8 mtm -60.37 138.64 57.94 Favored 'General case' 0 CA--C 1.499 -0.985 0 CA-C-O 121.249 0.547 . . . . 74.230000000000004 111.339 -176.349 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 8.4 tp60 -103.79 123.48 47.15 Favored 'General case' 0 N--CA 1.417 -2.1 0 CA-C-N 115.146 -0.934 . . . . 73.540000000000006 108.483 -168.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 21.4 p -83.23 117.67 23.1 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.848 -0.615 . . . . 73.129999999999995 109.953 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 95.68 13.52 50.34 Favored Glycine 0 N--CA 1.436 -1.359 0 N-CA-C 111.631 -0.588 . . . . 71.219999999999999 111.631 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -132.5 -175.42 3.75 Favored 'General case' 0 C--O 1.248 0.976 0 N-CA-C 109.186 -0.672 . . . . 73.329999999999998 109.186 -177.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -112.03 149.05 32.59 Favored 'General case' 0 C--O 1.251 1.15 0 N-CA-C 114.997 1.48 . . . . 73.010000000000005 114.997 -171.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.3 mm -121.79 117.69 53.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 105.983 -1.858 . . . . 72.430000000000007 105.983 174.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -120.35 116.78 26.19 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 107.357 -1.349 . . . . 73.219999999999999 107.357 -177.238 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.0 tt -128.79 108.92 18.02 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.226 0 CA-C-O 121.417 0.627 . . . . 74.030000000000001 110.589 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 70.67 -103.98 1.3 Allowed Glycine 0 C--N 1.314 -0.669 0 N-CA-C 110.439 -1.064 . . . . 73.239999999999995 110.439 -177.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -120.09 6.56 10.79 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.056 -0.72 . . . . 74.439999999999998 109.056 173.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.462 ' CE2' HD23 ' A' ' 80' ' ' LEU . 56.3 m-85 -91.43 106.56 18.58 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 108.965 -0.754 . . . . 74.420000000000002 108.965 -177.081 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 14.5 ptt180 -96.41 120.95 37.65 Favored 'General case' 0 N--CA 1.432 -1.375 0 CA-C-O 122.168 0.985 . . . . 72.319999999999993 110.203 177.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.432 HD12 ' O ' ' A' ' 50' ' ' VAL . 25.3 tp -124.51 142.98 50.92 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 113.643 -1.617 . . . . 73.450000000000003 108.378 -174.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 29.8 t -124.5 134.89 65.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 107.499 -1.297 . . . . 71.099999999999994 107.499 176.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.417 ' CZ ' ' HB2' ' A' ' 47' ' ' ALA . 64.1 t80 -108.32 120.34 42.09 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.057 -0.72 . . . . 74.239999999999995 109.057 -176.097 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -121.85 144.04 49.06 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.6 0.714 . . . . 70.430000000000007 112.337 -175.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -91.82 80.27 5.27 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 106.533 -1.654 . . . . 63.310000000000002 106.533 172.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -77.61 -71.69 1.19 Allowed Glycine 0 C--N 1.301 -1.414 0 CA-C-N 114.791 -1.095 . . . . 73.510000000000005 113.778 -174.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -65.26 133.12 33.93 Favored 'Trans proline' 0 N--CA 1.445 -1.326 0 C-N-CA 122.139 1.892 . . . . 72.430000000000007 113.023 -177.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -109.36 103.92 12.93 Favored 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 104.825 -2.287 . . . . 74.200000000000003 104.825 170.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 . . . . . 0 C--N 1.289 -2.038 0 CA-C-O 118.543 -0.741 . . . . 74.310000000000002 109.026 -173.021 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 CA--C 1.499 -0.99 0 N-CA-C 109.37 -0.604 . . . . 75.549999999999997 109.37 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.9 t -81.37 -38.39 26.69 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 106.971 -1.492 . . . . 71.329999999999998 106.971 177.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -88.29 155.26 19.83 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 106.796 -1.557 . . . . 74.549999999999997 106.796 175.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -155.68 153.02 29.34 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 120.58 -0.448 . . . . 75.25 111.457 -178.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -131.19 144.54 51.43 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 107.143 -1.429 . . . . 60.539999999999999 107.143 176.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -136.82 -133.28 3.16 Favored Glycine 0 N--CA 1.425 -2.064 0 C-N-CA 120.233 -0.984 . . . . 71.230000000000004 112.997 -176.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.8 t -85.09 143.22 39.36 Favored Pre-proline 0 C--N 1.302 -1.474 0 C-N-CA 122.599 0.36 . . . . 62.240000000000002 111.223 -176.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -66.73 150.34 83.51 Favored 'Trans proline' 0 C--O 1.249 1.037 0 C-N-CA 122.601 2.201 . . . . 72.430000000000007 110.385 171.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.9 mp0 -76.94 128.34 81.62 Favored Pre-proline 0 C--O 1.245 0.861 0 N-CA-C 109.612 -0.514 . . . . 74.299999999999997 109.612 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -63.05 150.43 88.66 Favored 'Trans proline' 0 C--O 1.25 1.079 0 C-N-CA 122.817 2.344 . . . . 74.420000000000002 111.191 175.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -92.77 173.89 7.53 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-O 121.028 0.442 . . . . 72.299999999999997 110.698 -175.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.5 m -121.18 169.57 12.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-N 115.698 -0.683 . . . . 72.400000000000006 110.779 -178.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -78.49 140.94 38.55 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 109.594 -0.521 . . . . 75.230000000000004 109.594 178.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.1 t -111.47 148.52 32.96 Favored 'General case' 0 N--CA 1.422 -1.833 0 CA-C-O 121.079 0.466 . . . . 75.209999999999994 110.311 -178.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.6 p -100.51 8.79 43.29 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 112.282 0.475 . . . . 72.030000000000001 112.282 178.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.4 p -78.94 32.54 0.21 Allowed 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.421 0.689 . . . . 73.150000000000006 112.621 -177.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.9 m -112.44 132.43 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 N-CA-C 108.45 -0.945 . . . . 75.400000000000006 108.45 178.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -87.76 141.09 28.87 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 118.712 -1.195 . . . . 74.239999999999995 109.872 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -86.04 132.34 34.07 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 107.288 -1.375 . . . . 75.439999999999998 107.288 175.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.31 90.28 0.92 Allowed 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.797 0.808 . . . . 74.319999999999993 112.201 -176.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -100.12 -33.66 10.37 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 115.105 -0.952 . . . . 70.299999999999997 110.522 175.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 62.1 tp -79.14 88.73 4.85 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.272 0.558 . . . . 75.349999999999994 109.779 178.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 91.4 mt -113.84 129.84 56.54 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.795 -0.817 . . . . 73.010000000000005 108.795 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.462 ' HZ2' ' HB2' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -104.95 -10.45 17.25 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 120.238 -0.585 . . . . 75.310000000000002 112.322 -176.905 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -80.91 120.46 24.76 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 118.494 -1.283 . . . . 74.120000000000005 112.254 -177.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 21.5 ptt? -102.02 120.36 40.29 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.202 -1.407 . . . . 71.230000000000004 107.202 175.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -71.69 136.47 47.25 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 112.871 0.693 . . . . 73.519999999999996 112.871 -175.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.1 m -93.1 88.06 5.95 Favored 'General case' 0 N--CA 1.42 -1.965 0 N-CA-C 105.617 -1.994 . . . . 71.219999999999999 105.617 170.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.0 t -61.18 130.49 46.54 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 114.887 -1.051 . . . . 73.230000000000004 110.601 -173.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.1 t -125.2 120.73 32.12 Favored 'General case' 0 N--CA 1.425 -1.694 0 CA-C-O 121.552 0.691 . . . . 74.019999999999996 110.963 -178.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -104.6 71.62 0.25 Allowed Glycine 0 N--CA 1.438 -1.192 0 N-CA-C 108.772 -1.731 . . . . 75.319999999999993 108.772 174.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.6 m -67.22 137.01 55.87 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 123.724 0.81 . . . . 71.219999999999999 112.176 -172.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -85.75 140.45 35.53 Favored Pre-proline 0 C--N 1.308 -1.199 0 N-CA-C 108.419 -0.956 . . . . 71.510000000000005 108.419 176.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -73.55 105.69 2.04 Favored 'Trans proline' 0 N--CA 1.446 -1.27 0 C-N-CA 121.684 1.589 . . . . 72.299999999999997 111.831 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -92.51 70.11 4.99 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.429 -0.952 . . . . 65.319999999999993 108.429 177.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.6 t -144.39 143.72 31.07 Favored 'General case' 0 N--CA 1.423 -1.806 0 N-CA-C 107.678 -1.23 . . . . 74.099999999999994 107.678 -177.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 13.2 m 65.7 75.9 0.34 Allowed 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 124.52 1.128 . . . . 72.120000000000005 109.785 -178.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 136.98 -34.59 2.19 Favored Glycine 0 N--CA 1.432 -1.596 0 CA-C-N 114.22 -1.355 . . . . 75.049999999999997 110.121 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.93 -46.74 33.66 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 121.753 0.787 . . . . 73.540000000000006 110.237 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.88 -11.67 56.61 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.35 -0.841 . . . . 71.219999999999999 109.895 -178.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.531 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 47.6 t30 -62.72 -29.16 70.46 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.857 -1.065 . . . . 75.439999999999998 110.781 -179.121 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -107.81 89.14 5.03 Favored Pre-proline 0 N--CA 1.44 -0.96 0 CA-C-N 116.508 -0.314 . . . . 75.150000000000006 110.511 177.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.531 ' HD3' ' O ' ' A' ' 41' ' ' ASN . 63.7 Cg_endo -100.63 17.09 0.35 Allowed 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 122.726 2.284 . . . . 73.319999999999993 111.498 178.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -153.39 154.07 33.76 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 107.699 -1.222 . . . . 55.009999999999998 107.699 -179.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.84 30.21 56.27 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 109.178 -1.569 . . . . 72.25 109.178 -174.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.5 m -90.67 165.89 13.46 Favored 'General case' 0 N--CA 1.425 -1.692 0 CA-C-N 114.548 -0.826 . . . . 74.329999999999998 111.192 -174.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -90.86 163.42 14.41 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 108.104 -1.073 . . . . 63.350000000000001 108.104 175.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.412 ' HB3' ' HG ' ' A' ' 62' ' ' LEU . 2.5 pt? -133.93 159.96 39.14 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.453 0.644 . . . . 73.329999999999998 110.733 -177.253 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -122.97 132.84 54.33 Favored 'General case' 0 C--N 1.278 -2.528 0 CA-C-N 115.018 -0.992 . . . . 75.209999999999994 108.806 176.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.4 m -110.01 116.35 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.019 0 N-CA-C 107.14 -1.43 . . . . 74.329999999999998 107.14 175.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.1 t -93.03 115.62 32.25 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.467 0 N-CA-C 107.88 -1.156 . . . . 75.540000000000006 107.88 -176.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -72.66 -38.6 67.59 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.584 -1.265 . . . . 73.299999999999997 107.584 -177.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 50.9 ttt180 -176.18 111.22 0.1 Allowed 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 106.359 -1.719 . . . . 74.230000000000004 106.359 174.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.458 ' HA2' ' HB3' ' A' ' 133' ' ' PHE . . . -122.84 166.17 15.33 Favored Glycine 0 N--CA 1.418 -2.53 0 N-CA-C 111.412 -0.675 . . . . 62.340000000000003 111.412 -177.307 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -69.09 -23.73 33.55 Favored 'Trans proline' 0 C--N 1.322 -0.847 0 C-N-CA 122.954 2.436 . . . . 64.319999999999993 111.481 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -98.87 -52.03 3.7 Favored 'General case' 0 N--CA 1.426 -1.63 0 CA-C-N 114.595 -1.184 . . . . 73.120000000000005 111.322 -177.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -144.25 -173.08 3.92 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-O 120.808 0.337 . . . . 72.540000000000006 110.496 -173.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.38 46.02 0.41 Allowed Glycine 0 N--CA 1.435 -1.399 0 N-CA-C 109.114 -1.594 . . . . 53.340000000000003 109.114 178.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -133.67 -169.87 2.38 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.888 -0.782 . . . . 74.329999999999998 108.888 -175.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -125.84 135.26 51.76 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 110.462 -0.199 . . . . 73.519999999999996 110.462 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -156.26 149.3 24.2 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 112.947 0.721 . . . . 72.140000000000001 112.947 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.412 ' HG ' ' HB3' ' A' ' 48' ' ' LEU . 6.8 mp -93.06 141.98 27.8 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 124.581 1.152 . . . . 74.109999999999999 109.73 177.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -74.49 115.3 13.86 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.592 -0.443 . . . . 75.129999999999995 110.065 176.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -113.13 8.97 18.46 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 108.606 -0.887 . . . . 71.409999999999997 108.606 -179.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -136.69 134.4 19.45 Favored Pre-proline 0 C--N 1.3 -1.571 0 N-CA-C 112.258 0.466 . . . . 71.209999999999994 112.258 -167.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -52.43 -62.49 0.35 Allowed 'Trans proline' 0 C--N 1.371 1.721 0 C-N-CA 124.538 3.492 . . . . 75.230000000000004 113.853 -177.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 94.7 m -116.49 110.64 18.87 Favored 'General case' 0 N--CA 1.422 -1.831 0 N-CA-C 109.354 -0.61 . . . . 75.409999999999997 109.354 178.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.411 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 91.2 m -109.56 113.63 26.58 Favored 'General case' 0 C--N 1.283 -2.314 0 N-CA-C 109.045 -0.724 . . . . 71.420000000000002 109.045 177.107 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.8 t -95.75 132.83 40.56 Favored 'General case' 0 C--O 1.256 1.424 0 N-CA-C 109.381 -0.6 . . . . 73.209999999999994 109.381 -178.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -127.88 124.92 38.65 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 115.739 -0.664 . . . . 61.520000000000003 110.282 -177.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.79 33.46 15.7 Favored Glycine 0 C--N 1.3 -1.445 0 C-N-CA 119.092 -1.527 . . . . 75.140000000000001 111.913 177.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.631 ' HA ' ' O ' ' A' ' 87' ' ' ARG . 2.1 tmt_? -123.73 87.66 2.78 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 105.993 -1.854 . . . . 74.519999999999996 105.993 176.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 20.3 m170 66.05 171.2 0.1 OUTLIER Pre-proline 0 CA--C 1.552 1.033 0 O-C-N 124.106 0.879 . . . . 72.219999999999999 109.795 -175.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -65.47 -20.18 60.91 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 121.686 1.591 . . . . 75.549999999999997 109.33 170.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -75.78 7.77 3.6 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 126.027 1.731 . . . . 74.239999999999995 112.381 -177.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 10.1 p -84.73 175.23 9.31 Favored 'General case' 0 C--N 1.322 -0.607 0 O-C-N 121.973 -0.454 . . . . 64.420000000000002 110.526 177.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -62.85 -56.74 14.71 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 108.791 -0.818 . . . . 73.230000000000004 108.791 -178.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.65 123.55 64.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 106.3 -1.741 . . . . 75.099999999999994 106.3 172.457 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -99.38 121.57 41.3 Favored 'General case' 0 C--N 1.29 -2.015 0 C-N-CA 119.829 -0.748 . . . . 72.540000000000006 112.872 -171.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.6 mp -69.09 128.95 38.46 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 107.418 -1.327 . . . . 75.439999999999998 107.418 170.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -116.06 24.04 11.74 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-O 122.46 1.124 . . . . 64.430000000000007 110.093 -175.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -103.84 -164.85 1.1 Allowed 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.745 -0.782 . . . . 74.019999999999996 109.889 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.7 p -92.19 -6.74 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.319 0 CA-C-O 121.339 0.59 . . . . 74.430000000000007 111.779 -174.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 7.4 m -87.45 12.87 11.15 Favored 'General case' 0 CA--C 1.555 1.139 0 CA-C-O 121.666 0.746 . . . . 72.329999999999998 110.543 -177.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 87.7 t -81.59 104.77 10.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-O 121.993 0.901 . . . . 75.430000000000007 110.83 -177.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 16.8 m -86.64 42.52 1.01 Allowed 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 124.388 1.075 . . . . 72.340000000000003 112.096 -176.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.631 ' O ' ' HA ' ' A' ' 72' ' ' ARG . 82.7 mtm180 72.65 -48.22 0.68 Allowed 'General case' 0 N--CA 1.513 2.724 0 C-N-CA 124.496 1.118 . . . . 71.329999999999998 110.39 -175.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -139.73 120.3 14.16 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 103.113 -2.921 . . . . 75.150000000000006 103.113 171.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 54.8 t60 -110.19 -71.45 0.76 Allowed 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 117.664 -1.614 . . . . 73.420000000000002 113.76 -174.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -117.85 143.24 46.47 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.974 -0.691 . . . . 74.109999999999999 111.911 -173.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.4 mm-40 -121.65 127.53 50.91 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.087 -1.079 . . . . 72.120000000000005 108.087 177.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.411 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 91.6 m-85 -103.67 113.47 27.01 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 106.628 -1.619 . . . . 73.319999999999993 106.628 175.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 89.5 mtt-85 -120.52 146.12 46.61 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 121.185 0.517 . . . . 75.319999999999993 110.795 -174.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 5.6 tt -115.87 130.93 69.72 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 N-CA-C 108.737 -0.838 . . . . 73.25 108.737 175.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -118.68 146.31 44.8 Favored 'General case' 0 C--N 1.282 -2.335 0 N-CA-C 106.166 -1.79 . . . . 64.409999999999997 106.166 178.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.97 -10.29 20.6 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 112.886 0.699 . . . . 72.209999999999994 112.886 -176.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -103.81 -41.85 2.07 Favored Glycine 0 N--CA 1.436 -1.361 0 CA-C-N 116.424 -0.353 . . . . 74.439999999999998 112.661 175.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -141.44 162.9 34.36 Favored 'General case' 0 C--O 1.216 -0.684 0 CA-C-O 121.277 0.56 . . . . 73.129999999999995 111.724 -176.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -108.2 121.19 44.36 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 106.674 -1.602 . . . . 74.109999999999999 106.674 173.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -125.52 135.55 52.39 Favored 'General case' 0 CA--C 1.49 -1.328 0 CA-C-O 122.087 0.946 . . . . 74.040000000000006 113.162 -176.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 6.0 p -108.28 119.38 57.76 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.333 0 CA-C-N 114.12 -1.4 . . . . 72.510000000000005 108.269 176.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 29.5 m -119.0 131.72 70.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 C-N-CA 120.595 -0.442 . . . . 62.350000000000001 109.852 -177.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -105.16 116.41 31.91 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.025 -1.472 . . . . 74.120000000000005 107.025 176.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.3 m -89.9 0.93 7.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-O 120.911 0.386 . . . . 71.010000000000005 111.025 -174.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -126.46 36.06 2.77 Favored Glycine 0 N--CA 1.429 -1.783 0 N-CA-C 108.673 -1.771 . . . . 65.219999999999999 108.673 175.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.7 p -68.8 7.35 0.68 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 113.826 1.047 . . . . 62.119999999999997 113.826 -175.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 78.3 mt -70.8 -21.51 62.47 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 108.885 -0.783 . . . . 73.129999999999995 108.885 176.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -77.23 -7.42 55.89 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.723 -0.671 . . . . 71.129999999999995 110.039 177.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 88.84 78.14 1.3 Allowed Glycine 0 N--CA 1.439 -1.126 0 N-CA-C 111.795 -0.522 . . . . 72.340000000000003 111.795 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 11.1 m -81.7 123.95 29.18 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 109.005 -0.739 . . . . 63.210000000000001 109.005 178.276 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -115.38 134.77 54.79 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 120.033 -0.667 . . . . 74.239999999999995 110.891 -176.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 29.1 m -112.68 110.37 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.135 0 N-CA-C 106.876 -1.527 . . . . 64.200000000000003 106.876 169.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 62.5 t30 58.18 36.66 25.97 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 125.355 1.462 . . . . 74.099999999999994 109.708 -177.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 52.8 mtp180 81.74 -0.62 1.57 Allowed 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 126.753 2.021 . . . . 74.540000000000006 113.545 -178.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -92.42 115.79 65.36 Favored Pre-proline 0 C--N 1.313 -1.004 0 N-CA-C 109.372 -0.603 . . . . 72.219999999999999 109.372 178.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.454 ' HA ' ' O ' ' A' ' 110' ' ' THR . 36.4 Cg_endo -66.34 121.5 8.8 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.905 2.403 . . . . 74.310000000000002 112.182 -179.024 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 8.8 mmm180 -136.1 163.73 29.66 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 120.833 0.349 . . . . 72.299999999999997 110.144 -177.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -98.94 -45.9 5.81 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.114 -1.069 . . . . 74.239999999999995 108.114 176.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -139.86 142.26 36.58 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 107.263 -1.384 . . . . 63.439999999999998 107.263 -179.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -134.68 141.06 46.44 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-O 121.316 0.579 . . . . 73.239999999999995 111.126 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.3 p -90.73 134.81 28.35 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 106.337 -1.727 . . . . 75.340000000000003 106.337 177.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 20.9 ptt? -41.01 123.84 2.06 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 122.143 0.973 . . . . 54.520000000000003 112.847 -177.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -127.01 124.71 40.03 Favored 'General case' 0 N--CA 1.413 -2.325 0 N-CA-C 106.17 -1.789 . . . . 73.109999999999999 106.17 177.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 31.1 p -78.48 124.45 28.15 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 116.138 -0.483 . . . . 75.200000000000003 111.821 -172.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 92.67 1.38 68.32 Favored Glycine 0 N--CA 1.44 -1.089 0 CA-C-N 115.207 -0.906 . . . . 51.210000000000001 110.894 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -90.41 151.54 21.38 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 108.312 -0.995 . . . . 73.129999999999995 108.312 -177.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -113.31 129.3 56.57 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 112.264 0.468 . . . . 75.430000000000007 112.264 -175.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 61.9 mt -95.27 115.78 35.09 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.164 0 N-CA-C 105.9 -1.889 . . . . 75.329999999999998 105.9 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -118.26 119.37 34.46 Favored 'General case' 0 N--CA 1.418 -2.059 0 CA-C-N 115.124 -0.944 . . . . 75.519999999999996 110.12 -172.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 7.5 pt -123.32 125.53 71.93 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 CA-C-N 114.962 -1.017 . . . . 75.530000000000001 109.222 179.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 68.5 -102.11 0.84 Allowed Glycine 0 N--CA 1.434 -1.499 0 N-CA-C 108.746 -1.741 . . . . 72.420000000000002 108.746 -171.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -137.32 18.76 2.94 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.947 -0.761 . . . . 73.239999999999995 108.947 174.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.458 ' HB3' ' HA2' ' A' ' 54' ' ' GLY . 81.6 m-85 -93.03 150.13 20.74 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.679 -0.692 . . . . 75.040000000000006 110.225 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 75.6 mtt180 -123.81 122.9 39.25 Favored 'General case' 0 C--O 1.252 1.206 0 CA-C-O 121.498 0.666 . . . . 64.439999999999998 111.47 -172.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 5.5 tt -123.67 129.99 51.96 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 106.682 -1.599 . . . . 73.5 106.682 177.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 12.2 t -108.14 128.73 63.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 N-CA-C 108.297 -1.001 . . . . 73.129999999999995 108.297 -178.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -105.92 129.38 54.08 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 120.71 -0.396 . . . . 75.129999999999995 110.408 -176.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -132.65 169.22 16.97 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.872 0.368 . . . . 74.230000000000004 110.263 -177.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -91.72 139.0 31.1 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 107.728 -1.212 . . . . 65.239999999999995 107.728 174.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -102.95 171.17 20.54 Favored Glycine 0 N--CA 1.439 -1.162 0 C-N-CA 120.119 -1.038 . . . . 71.530000000000001 113.005 -175.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -80.49 164.68 21.15 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 122.583 2.189 . . . . 72.019999999999996 111.586 177.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -109.27 125.56 52.42 Favored 'General case' 0 N--CA 1.425 -1.714 0 N-CA-C 108.638 -0.875 . . . . 73.120000000000005 108.638 178.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 . . . . . 0 N--CA 1.428 -1.55 0 O-C-N 123.403 0.439 . . . . 74.239999999999995 110.557 177.359 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.4 ptt? . . . . . 0 N--CA 1.451 -0.384 0 CA-C-O 121.659 0.742 . . . . 71.120000000000005 110.959 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.4 m -83.41 -23.92 32.15 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.559 -0.746 . . . . 74.400000000000006 109.505 176.257 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -42.71 128.35 4.09 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 126.373 1.869 . . . . 74.109999999999999 113.984 -176.346 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -134.57 145.45 48.7 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 106.837 -1.542 . . . . 73.319999999999993 106.837 174.118 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -85.07 92.87 8.47 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.899 -0.778 . . . . 75.099999999999994 108.899 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -78.74 158.81 45.36 Favored Glycine 0 N--CA 1.431 -1.671 0 N-CA-C 110.786 -0.925 . . . . 62.149999999999999 110.786 179.187 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.5 m -75.14 125.28 89.31 Favored Pre-proline 0 C--N 1.299 -1.624 0 N-CA-C 109.987 -0.375 . . . . 71.340000000000003 109.987 -178.894 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -63.92 127.73 20.2 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 121.628 1.552 . . . . 74.430000000000007 109.121 175.158 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.429 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -89.99 144.12 30.94 Favored Pre-proline 0 C--N 1.298 -1.641 0 N-CA-C 112.489 0.552 . . . . 65.310000000000002 112.489 -176.844 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 9' ' ' GLU . 4.1 Cg_exo -76.66 141.67 22.25 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.373 2.049 . . . . 60.439999999999998 111.722 178.282 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -81.51 118.31 22.63 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.498 -0.927 . . . . 75.450000000000003 108.498 179.386 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.2 p -75.62 118.62 22.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 109.521 -0.548 . . . . 73.239999999999995 109.521 178.764 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -81.55 120.92 25.65 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 109.704 -0.48 . . . . 75.450000000000003 109.704 -179.078 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.0 t -129.6 117.44 20.4 Favored 'General case' 0 N--CA 1.414 -2.262 0 CA-C-N 115.496 -0.774 . . . . 73.319999999999993 110.19 -178.495 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.9 p -95.5 101.15 12.84 Favored 'General case' 0 N--CA 1.425 -1.688 0 CA-C-N 115.856 -0.611 . . . . 73.200000000000003 110.978 179.867 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.4 t -81.16 103.18 10.78 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 108.97 -0.752 . . . . 74.319999999999993 108.97 178.702 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 42.6 t -91.77 136.43 24.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 N-CA-C 107.75 -1.204 . . . . 74.099999999999994 107.75 179.0 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -69.86 106.95 3.34 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.809 -0.812 . . . . 74.239999999999995 108.809 177.957 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 -85.09 129.89 34.71 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 115.649 -0.705 . . . . 72.530000000000001 109.716 -178.84 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.07 55.53 2.17 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 122.081 0.943 . . . . 71.319999999999993 109.787 178.846 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -78.41 -44.49 24.69 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 114.709 -1.132 . . . . 75.340000000000003 110.344 -177.499 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 57.8 tp 64.13 102.81 0.03 OUTLIER 'General case' 0 C--O 1.259 1.602 0 C-N-CA 125.361 1.464 . . . . 73.430000000000007 114.301 175.705 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 60.6 tp -89.51 132.19 35.17 Favored 'General case' 0 N--CA 1.423 -1.812 0 N-CA-C 107.051 -1.463 . . . . 72.129999999999995 107.051 172.677 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.68 174.61 5.79 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 109.223 -0.658 . . . . 74.120000000000005 109.223 -177.304 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -71.3 130.89 42.52 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.018 0.437 . . . . 71.530000000000001 110.784 -176.165 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 88.3 mtp -81.48 92.82 6.54 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.542 -0.754 . . . . 74.430000000000007 109.913 -179.006 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -82.9 169.92 15.53 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.538 -0.755 . . . . 74.140000000000001 111.108 -179.925 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.6 m -85.0 -177.38 6.55 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.955 -0.566 . . . . 70.319999999999993 111.112 -179.068 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.2 m -64.46 158.55 23.59 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 123.622 0.769 . . . . 73.200000000000003 111.958 -175.907 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.6 p -62.92 -43.52 98.57 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 114.757 1.392 . . . . 72.310000000000002 114.757 -177.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -165.4 -179.28 39.09 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 119.891 -1.147 . . . . 75.049999999999997 112.05 -178.809 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.5 t -104.26 132.64 50.29 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 120.929 0.395 . . . . 70.120000000000005 110.138 179.67 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -92.0 126.07 54.62 Favored Pre-proline 0 C--N 1.301 -1.503 0 CA-C-N 115.778 -0.646 . . . . 74.230000000000004 109.813 179.407 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -86.15 -178.93 2.99 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.048 1.832 . . . . 51.340000000000003 111.008 177.726 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.38 103.41 7.29 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.482 -0.562 . . . . 73.030000000000001 109.482 178.725 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.7 t -84.62 96.98 9.36 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 108.807 -0.812 . . . . 73.340000000000003 108.807 -178.449 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.4 t -111.45 152.33 27.54 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 108.378 -0.971 . . . . 73.430000000000007 108.378 -179.328 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.15 51.81 0.68 Allowed Glycine 0 C--N 1.31 -0.866 0 C-N-CA 120.795 -0.717 . . . . 72.040000000000006 111.448 -177.898 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.1 -24.69 63.25 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.099 0.476 . . . . 74.340000000000003 110.931 -177.167 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -68.42 -11.93 60.41 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.372 -0.831 . . . . 75.239999999999995 112.458 -179.545 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -76.15 -43.03 44.78 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.544 -0.462 . . . . 71.329999999999998 110.448 -178.714 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.7 tm? 67.75 116.5 0.03 OUTLIER Pre-proline 0 CA--C 1.564 1.518 0 C-N-CA 124.98 1.312 . . . . 72.439999999999998 111.088 -179.9 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -89.49 115.48 0.66 Allowed 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.668 2.245 . . . . 74.25 111.716 177.555 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.55 82.01 8.13 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.383 0.611 . . . . 74.150000000000006 111.125 -179.463 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.401 ' O ' HD12 ' A' ' 94' ' ' ILE . . . -171.34 93.61 0.1 Allowed Glycine 0 CA--C 1.48 -2.106 0 N-CA-C 107.275 -2.33 . . . . 71.109999999999999 107.275 178.182 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.3 m -90.15 153.22 20.68 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-O 122.055 0.931 . . . . 71.409999999999997 112.311 -166.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.27 166.56 22.2 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 107.878 -1.156 . . . . 74.150000000000006 107.878 179.149 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.45 148.32 50.58 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.163 0.506 . . . . 72.340000000000003 112.093 -179.434 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.436 HD22 HD11 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -123.51 140.3 53.15 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.72 -0.845 . . . . 75.299999999999997 108.72 176.336 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 35.7 t -126.43 133.5 68.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 N-CA-C 108.249 -1.019 . . . . 73.319999999999993 108.249 -179.05 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 35.1 t -92.22 115.23 30.7 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.077 0 N-CA-C 106.328 -1.73 . . . . 63.109999999999999 106.328 177.522 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -86.02 -31.62 21.91 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 114.992 -1.004 . . . . 74.409999999999997 109.888 -172.488 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.476 ' O ' ' HB3' ' A' ' 133' ' ' PHE . 53.5 ttt180 -159.3 139.66 12.17 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.438 -0.578 . . . . 74.430000000000007 109.438 -179.218 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 132.68 148.83 6.08 Favored Glycine 0 N--CA 1.435 -1.387 0 C-N-CA 120.423 -0.894 . . . . 73.319999999999993 114.292 176.737 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -65.59 -8.62 19.79 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 124.126 3.217 . . . . 73.219999999999999 112.418 174.132 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -49.06 -56.67 8.33 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.139 0.976 . . . . 74.25 108.724 174.543 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -179.41 -172.09 0.22 Allowed 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.702 1.201 . . . . 70.140000000000001 107.968 179.729 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -154.23 30.45 0.71 Allowed Glycine 0 CA--C 1.483 -1.915 0 N-CA-C 107.809 -2.116 . . . . 72.25 107.809 178.019 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -116.88 -179.75 3.78 Favored 'General case' 0 N--CA 1.412 -2.369 0 CA-C-N 113.676 -1.262 . . . . 64.230000000000004 108.814 -175.328 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 7.6 ptt180 -138.12 131.01 29.83 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 108.312 -0.996 . . . . 70.129999999999995 108.312 -179.801 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -122.02 148.44 44.83 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 116.354 -0.385 . . . . 74.349999999999994 110.852 -172.711 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.1 tt -98.76 117.36 33.07 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.367 -0.975 . . . . 73.329999999999998 108.367 178.497 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 94.0 mt -90.76 115.58 27.95 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.656 -0.702 . . . . 74.140000000000001 109.585 179.802 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -121.37 -34.03 3.54 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 107.667 -1.235 . . . . 73.540000000000006 107.667 177.913 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 15.5 pm0 -64.99 130.15 94.76 Favored Pre-proline 0 N--CA 1.436 -1.159 0 CA-C-N 113.987 -1.461 . . . . 74.019999999999996 109.95 175.971 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -61.5 -33.06 88.55 Favored 'Trans proline' 0 C--O 1.244 0.811 0 C-N-CA 123.299 2.666 . . . . 73.109999999999999 114.269 -175.968 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.7 m -111.97 120.38 41.71 Favored 'General case' 0 N--CA 1.435 -1.183 0 O-C-N 122.177 -0.327 . . . . 72.230000000000004 110.825 -178.061 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.451 ' HB ' ' HB3' ' A' ' 92' ' ' PHE . 41.4 m -118.74 114.1 22.18 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.841 -0.799 . . . . 53.43 108.841 176.181 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 36.7 m -102.0 127.56 48.82 Favored 'General case' 0 C--N 1.312 -1.054 0 O-C-N 121.658 -0.651 . . . . 74.310000000000002 111.245 -179.462 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -106.1 125.2 50.7 Favored 'General case' 0 C--O 1.248 0.985 0 CA-C-N 115.652 -0.703 . . . . 43.210000000000001 109.153 177.985 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 167.43 -151.1 18.4 Favored Glycine 0 CA--C 1.49 -1.513 0 N-CA-C 110.624 -0.99 . . . . 74.230000000000004 110.624 179.866 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -130.54 83.72 2.14 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 122.573 1.178 . . . . 75.409999999999997 111.311 179.45 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 31.3 m80 -146.83 174.72 3.17 Favored Pre-proline 0 C--N 1.293 -1.874 0 N-CA-C 106.999 -1.482 . . . . 75.319999999999993 106.999 178.452 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -66.49 -22.25 51.99 Favored 'Trans proline' 0 C--N 1.354 0.848 0 N-CA-C 107.544 -1.752 . . . . 73.540000000000006 107.544 164.733 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -89.64 68.42 7.64 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 113.854 -1.521 . . . . 71.140000000000001 108.164 176.511 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 53.6 m -139.33 113.41 8.76 Favored 'General case' 0 C--N 1.275 -2.646 0 CA-C-N 114.395 -1.275 . . . . 72.239999999999995 107.56 175.54 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -71.84 -35.6 69.91 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.909 -1.041 . . . . 71.319999999999993 109.38 -174.669 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.41 160.56 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.252 0 N-CA-C 106.667 -1.605 . . . . 72.409999999999997 106.667 175.348 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -107.02 135.92 47.77 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-O 121.33 0.586 . . . . 75.319999999999993 111.861 -175.385 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.0 mp -125.66 137.85 53.88 Favored 'General case' 0 N--CA 1.424 -1.77 0 N-CA-C 108.061 -1.088 . . . . 70.439999999999998 108.061 179.05 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -140.37 75.76 1.52 Allowed 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.376 -1.342 . . . . 74.310000000000002 107.376 179.543 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.412 ' OD2' ' HA3' ' A' ' 131' ' ' GLY . 18.6 t70 -120.35 159.9 24.12 Favored 'General case' 0 C--N 1.275 -2.651 0 CA-C-N 113.34 -1.755 . . . . 73.230000000000004 108.209 179.761 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 10.2 p -71.45 -27.25 28.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 CA-C-O 121.176 0.513 . . . . 71.25 111.076 -178.46 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.5 p -113.04 14.7 19.65 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 113.437 0.902 . . . . 72.439999999999998 113.437 -176.809 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.8 p -82.61 120.43 34.02 Favored 'Isoleucine or valine' 0 C--O 1.253 1.261 0 C-N-CA 118.792 -1.163 . . . . 74.329999999999998 108.878 173.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 9.1 t -80.62 -172.4 3.59 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 115.208 -0.906 . . . . 70.129999999999995 111.602 -173.616 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 18.8 ttp180 -62.29 -51.69 66.66 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.109 0.963 . . . . 74.209999999999994 110.988 -179.584 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -134.06 97.61 3.91 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 104.608 -2.367 . . . . 73.140000000000001 104.608 177.532 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -88.76 -55.29 3.76 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 116.049 -0.523 . . . . 73.420000000000002 111.301 -168.299 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.79 151.13 36.63 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 120.278 -0.569 . . . . 75.450000000000003 110.532 -177.231 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -120.74 128.06 52.58 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 107.428 -1.323 . . . . 73.329999999999998 107.428 174.521 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.546 ' CE2' ' HB ' ' A' ' 94' ' ' ILE . 69.8 t80 -104.49 127.77 52.27 Favored 'General case' 0 C--N 1.277 -2.553 0 N-CA-C 108.888 -0.782 . . . . 74.150000000000006 108.888 178.03 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 -109.83 122.21 46.99 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 107.137 -1.431 . . . . 75.409999999999997 107.137 -179.689 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.546 ' HB ' ' CE2' ' A' ' 92' ' ' PHE . 0.0 OUTLIER -116.05 125.93 73.34 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.246 0 CA-C-O 121.777 0.799 . . . . 71.310000000000002 110.824 -177.789 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.413 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 20.7 t-20 -118.42 145.77 44.96 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 105.507 -2.035 . . . . 73.540000000000006 105.507 174.651 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -61.92 -19.14 62.38 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 112.526 0.565 . . . . 71.209999999999994 112.526 -175.19 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -104.58 -31.89 4.39 Favored Glycine 0 N--CA 1.431 -1.635 0 C-N-CA 120.72 -0.752 . . . . 75.519999999999996 113.178 178.492 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.413 ' O ' ' HB3' ' A' ' 95' ' ' ASN . 8.8 pt-20 -143.06 155.71 44.68 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 117.363 0.582 . . . . 75.439999999999998 111.604 -174.7 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -127.35 128.67 46.28 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 110.099 -0.334 . . . . 74.329999999999998 110.099 -173.813 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -128.19 135.35 49.6 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 110.262 -0.273 . . . . 70.329999999999998 110.262 -178.531 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 14.6 p -120.7 129.73 75.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 108.919 -0.771 . . . . 74.340000000000003 108.919 174.844 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 25.4 m -115.85 129.73 71.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 CA-C-O 121.445 0.64 . . . . 73.409999999999997 111.185 179.635 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -86.55 121.34 28.95 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 114.977 -1.01 . . . . 73.310000000000002 109.067 179.231 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 18.5 m -118.44 -1.16 8.81 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 CA-C-N 115.546 -0.752 . . . . 73.340000000000003 110.009 179.055 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -111.83 52.04 0.66 Allowed Glycine 0 N--CA 1.427 -1.956 0 N-CA-C 109.73 -1.348 . . . . 71.510000000000005 109.73 178.62 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 14.2 m -62.91 -4.92 2.43 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.538 1.135 . . . . 74.140000000000001 112.192 -177.633 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 81.2 mt -61.99 -30.2 70.77 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 124.253 1.021 . . . . 65.329999999999998 109.244 174.707 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -125.71 -40.41 2.06 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.131 -0.94 . . . . 75.409999999999997 108.771 179.251 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.74 132.21 5.14 Favored Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.349 -0.841 . . . . 74.109999999999999 113.312 178.333 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 28.9 m -81.56 136.26 35.58 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.312 -0.996 . . . . 65.329999999999998 108.312 173.353 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -114.43 134.17 55.19 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 108.268 -1.012 . . . . 75.109999999999999 108.268 -177.595 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 60.0 t -120.76 111.04 30.23 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 N-CA-C 106.926 -1.509 . . . . 75.409999999999997 106.926 176.784 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 42.7 t-20 44.08 70.36 0.33 Allowed 'General case' 0 C--O 1.241 0.634 0 O-C-N 125.143 1.527 . . . . 72.420000000000002 111.59 -176.114 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 73.98 -26.62 0.19 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.503 1.521 . . . . 75.219999999999999 113.388 177.362 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -90.77 118.1 68.41 Favored Pre-proline 0 C--N 1.311 -1.07 0 N-CA-C 112.343 0.497 . . . . 75.329999999999998 112.343 -175.68 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -63.38 128.24 22.05 Favored 'Trans proline' 0 C--O 1.247 0.965 0 C-N-CA 122.295 1.997 . . . . 75.310000000000002 108.584 172.299 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 3.1 mmp_? -123.04 145.23 48.71 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 116.991 -0.095 . . . . 75.120000000000005 110.81 -175.356 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -95.33 -36.66 11.31 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 108.181 -1.044 . . . . 72.010000000000005 108.181 172.11 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -149.19 139.49 22.33 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 105.89 -1.893 . . . . 75.409999999999997 105.89 174.308 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 7.7 tp60 -140.09 148.55 41.91 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 110.32 -0.252 . . . . 73.230000000000004 110.32 -178.714 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 67.4 t -93.11 123.12 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 N-CA-C 105.124 -2.176 . . . . 75.209999999999994 105.124 173.239 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 83.5 mmm -78.7 143.94 35.77 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 114.204 1.187 . . . . 75.030000000000001 114.204 -173.338 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -121.89 137.14 54.9 Favored 'General case' 0 N--CA 1.419 -1.99 0 CA-C-N 113.823 -1.535 . . . . 72.129999999999995 108.852 -177.581 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 7.1 t -79.54 126.69 31.2 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 109.024 -0.732 . . . . 74.409999999999997 109.024 178.502 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 95.74 19.33 29.65 Favored Glycine 0 N--CA 1.434 -1.454 0 C-N-CA 120.747 -0.739 . . . . 75.319999999999993 111.578 -179.175 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -118.93 160.91 21.08 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.816 -0.809 . . . . 72.310000000000002 108.816 178.246 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.442 ' OE1' ' HD2' ' A' ' 134' ' ' ARG . 44.0 tt0 -115.4 131.49 56.91 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.494 0.664 . . . . 73.299999999999997 111.495 -172.183 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.409 ' N ' HD13 ' A' ' 128' ' ' ILE . 3.5 mp -105.35 131.44 54.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 107.681 -1.229 . . . . 72.049999999999997 107.681 -176.728 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -102.26 113.21 26.3 Favored 'General case' 0 N--CA 1.425 -1.702 0 C-N-CA 119.178 -1.009 . . . . 74.010000000000005 108.375 177.849 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 8.0 pt -100.73 98.14 6.56 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.361 0 CA-C-N 114.743 -1.117 . . . . 74.310000000000002 108.549 178.826 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.412 ' HA3' ' OD2' ' A' ' 82' ' ' ASP . . . 77.73 -110.96 3.15 Favored Glycine 0 N--CA 1.426 -2.029 0 CA-C-N 113.976 -1.466 . . . . 65.230000000000004 109.522 -174.923 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.453 ' HZ2' ' HB3' ' A' ' 132' ' ' LYS . 7.8 mtpm? -104.87 -19.88 13.74 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 116.918 0.359 . . . . 73.109999999999999 110.083 175.0 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.476 ' HB3' ' O ' ' A' ' 53' ' ' ARG . 57.4 m-85 -97.77 161.76 13.6 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-O 120.856 0.36 . . . . 63.219999999999999 111.571 -171.181 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.442 ' HD2' ' OE1' ' A' ' 127' ' ' GLU . 70.3 mtm180 -121.0 140.55 51.75 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 113.817 1.043 . . . . 74.040000000000006 113.817 -169.023 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.436 HD11 HD22 ' A' ' 49' ' ' LEU . 47.6 tp -121.41 136.47 54.96 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 113.734 -1.575 . . . . 74.409999999999997 108.25 -177.325 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 10.7 p -111.21 132.4 59.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 C-N-CA 120.195 -0.602 . . . . 74.430000000000007 109.541 177.666 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -111.29 129.68 55.9 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.162 -0.472 . . . . 74.329999999999998 111.445 -176.368 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -129.45 148.82 51.4 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.308 -0.627 . . . . 75.019999999999996 109.308 176.799 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -95.36 137.83 33.89 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.286 -1.005 . . . . 73.439999999999998 108.286 175.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -120.23 -127.99 3.59 Favored Glycine 0 N--CA 1.435 -1.433 0 C-N-CA 119.509 -1.329 . . . . 72.430000000000007 114.339 -173.895 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -70.22 135.0 28.3 Favored 'Trans proline' 0 C--O 1.235 0.367 0 C-N-CA 123.305 2.67 . . . . 64.329999999999998 114.94 -172.491 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -110.7 117.64 34.02 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.755 -1.202 . . . . 73.129999999999995 107.755 175.529 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 . . . . . 0 C--N 1.317 -0.811 0 N-CA-C 109.66 -0.496 . . . . 73.400000000000006 109.66 -179.242 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.522 -0.109 0 N-CA-C 106.012 -1.847 . . . . 64.040000000000006 106.012 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.6 m -51.75 -42.3 62.23 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.226 0.61 . . . . 73.129999999999995 112.342 -179.066 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -157.25 109.04 2.38 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 108.813 -0.81 . . . . 64.519999999999996 108.813 177.594 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -141.26 141.66 33.96 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.774 -0.824 . . . . 72.109999999999999 108.774 177.804 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -154.19 130.92 10.77 Favored 'General case' 0 C--N 1.287 -2.145 0 N-CA-C 107.582 -1.266 . . . . 72.310000000000002 107.582 179.555 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.87 80.4 0.57 Allowed Glycine 0 CA--C 1.503 -0.709 0 N-CA-C 109.132 -1.587 . . . . 73.239999999999995 109.132 175.688 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.8 m -78.67 124.52 85.17 Favored Pre-proline 0 N--CA 1.418 -2.042 0 C-N-CA 123.675 0.79 . . . . 73.239999999999995 111.289 -169.963 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -66.36 134.73 37.08 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 122.485 2.123 . . . . 54.520000000000003 109.573 174.545 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.3 135.71 79.16 Favored Pre-proline 0 C--N 1.303 -1.444 0 C-N-CA 119.976 -0.69 . . . . 64.129999999999995 110.67 177.093 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -60.27 121.61 10.05 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 122.204 1.936 . . . . 73.310000000000002 111.82 -178.225 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -79.63 108.53 13.25 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 106.631 -1.618 . . . . 74.319999999999993 106.631 178.636 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.8 m -63.95 126.14 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.305 0 CA-C-O 121.66 0.743 . . . . 75.010000000000005 112.44 -174.008 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -88.08 141.16 28.79 Favored 'General case' 0 N--CA 1.425 -1.678 0 CA-C-N 114.953 -1.021 . . . . 73.140000000000001 109.755 178.826 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.8 t -138.65 141.78 39.06 Favored 'General case' 0 C--N 1.285 -2.231 0 N-CA-C 108.156 -1.054 . . . . 73.409999999999997 108.156 179.027 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.8 t -105.23 124.95 50.4 Favored 'General case' 0 N--CA 1.406 -2.644 0 N-CA-C 108.171 -1.048 . . . . 72.120000000000005 108.171 -179.829 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.0 m -143.03 93.53 2.51 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-N 115.691 -0.686 . . . . 64.349999999999994 110.319 -178.811 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.3 p -156.63 137.21 4.6 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 N-CA-C 108.629 -0.878 . . . . 75.030000000000001 108.629 179.333 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -167.02 174.9 7.97 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.739 -0.467 . . . . 75.510000000000005 109.739 -178.904 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -102.98 111.37 23.67 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 120.841 0.353 . . . . 72.319999999999993 110.341 178.068 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -109.37 17.87 21.02 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 109.542 -0.54 . . . . 63.399999999999999 109.542 -179.801 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -69.07 -54.92 12.54 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.122 -0.945 . . . . 74.340000000000003 111.338 -176.05 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.2 tm? 52.87 93.02 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 O-C-N 124.385 1.053 . . . . 73.340000000000003 109.357 -174.624 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 86.8 mt -71.31 110.1 5.73 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.961 -0.563 . . . . 74.129999999999995 111.391 -176.148 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.36 -173.76 4.12 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 106.211 -1.774 . . . . 73.319999999999993 106.211 176.32 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -80.59 150.64 29.43 Favored 'General case' 0 N--CA 1.433 -1.306 0 C-N-CA 118.897 -1.121 . . . . 74.530000000000001 109.528 178.181 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -67.29 164.8 17.6 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 123.408 0.683 . . . . 74.409999999999997 111.081 -178.737 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -83.91 93.22 7.98 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.837 -0.801 . . . . 74.450000000000003 108.837 176.849 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.1 m -80.82 -33.93 34.31 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 109.062 -0.718 . . . . 64.030000000000001 109.062 177.821 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.4 m 66.39 111.4 0.04 OUTLIER 'General case' 0 C--O 1.242 0.664 0 C-N-CA 125.5 1.52 . . . . 61.030000000000001 112.606 178.726 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.9 t -82.34 145.6 29.84 Favored 'General case' 0 N--CA 1.423 -1.78 0 N-CA-C 107.513 -1.292 . . . . 74.319999999999993 107.513 174.755 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -100.53 85.94 0.62 Allowed Glycine 0 N--CA 1.431 -1.634 0 C-N-CA 120.552 -0.832 . . . . 74.25 111.815 -177.173 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.9 m -71.36 118.72 14.52 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.871 -0.788 . . . . 73.230000000000004 108.871 178.582 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.98 140.46 46.56 Favored Pre-proline 0 C--N 1.293 -1.891 0 CA-C-N 115.92 -0.582 . . . . 64.430000000000007 110.097 -177.73 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -49.99 146.03 17.93 Favored 'Trans proline' 0 C--O 1.246 0.907 0 C-N-CA 123.37 2.713 . . . . 74.310000000000002 111.782 177.511 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . 81.06 -15.04 0.77 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.59 1.556 . . . . 74.150000000000006 111.775 -177.25 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.6 m -94.75 109.1 21.09 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 106.701 -1.592 . . . . 71.150000000000006 106.701 174.569 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.6 t -169.99 170.65 7.49 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 108.603 -0.888 . . . . 71.310000000000002 108.603 -174.489 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 165.05 -55.66 0.26 Allowed Glycine 0 N--CA 1.427 -1.915 0 N-CA-C 112.1 -0.4 . . . . 72.230000000000004 112.1 176.085 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.66 -32.7 70.07 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 112.503 0.557 . . . . 63.409999999999997 112.503 -172.531 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.4 ' H ' ' CD ' ' A' ' 40' ' ' GLU . 0.3 OUTLIER -83.67 -11.97 56.52 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 121.05 0.453 . . . . 73.150000000000006 110.919 179.251 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -83.46 -18.06 39.9 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-O 121.051 0.453 . . . . 70.439999999999998 110.077 177.846 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -109.81 100.46 42.92 Favored Pre-proline 0 N--CA 1.435 -1.198 0 CA-C-N 115.836 -0.62 . . . . 71.420000000000002 110.387 177.789 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -65.2 -33.8 47.96 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 121.948 1.765 . . . . 72.219999999999999 109.977 176.863 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -143.06 108.3 5.0 Favored 'General case' 0 N--CA 1.425 -1.697 0 N-CA-C 107.124 -1.435 . . . . 74.319999999999993 107.124 175.658 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 166.43 -19.26 0.1 OUTLIER Glycine 0 C--N 1.302 -1.348 0 N-CA-C 111.05 -0.82 . . . . 54.32 111.05 -175.527 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.2 m -89.65 152.74 21.21 Favored 'General case' 0 N--CA 1.428 -1.526 0 N-CA-C 107.228 -1.397 . . . . 63.439999999999998 107.228 176.347 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.481 ' HB3' ' CZ ' ' A' ' 137' ' ' PHE . . . -97.64 178.54 5.13 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 110.201 -0.296 . . . . 65.540000000000006 110.201 -176.991 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -134.16 158.03 44.71 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.121 0.486 . . . . 73.340000000000003 111.507 -175.524 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.6 pp -121.34 140.26 52.33 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 115.354 -0.839 . . . . 74.299999999999997 109.023 174.869 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.432 HG13 ' CB ' ' A' ' 60' ' ' ARG . 33.1 m -115.52 138.51 45.66 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 CA-C-O 121.043 0.449 . . . . 62.549999999999997 109.834 179.611 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.0 t -93.61 115.62 32.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 107.818 -1.178 . . . . 74.209999999999994 107.818 179.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -88.56 -36.2 16.49 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.241 0.543 . . . . 72.219999999999999 109.551 -179.411 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.425 ' O ' ' HB3' ' A' ' 133' ' ' PHE . 37.6 ttm180 -149.84 125.5 10.36 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.309 -0.997 . . . . 74.400000000000006 108.309 -179.879 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 153.94 121.85 0.83 Allowed Glycine 0 N--CA 1.418 -2.539 0 C-N-CA 120.959 -0.639 . . . . 52.219999999999999 111.662 179.821 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -55.85 -9.04 2.58 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 124.522 3.481 . . . . 64.430000000000007 113.876 178.802 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.432 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 7.2 t30 -51.86 -38.39 55.82 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 124.106 0.962 . . . . 73.230000000000004 110.786 176.01 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -178.57 -59.87 0.01 OUTLIER 'General case' 0 C--N 1.354 0.764 0 CA-C-N 116.318 -0.401 . . . . 74.329999999999998 111.735 179.738 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.55 54.07 4.12 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 109.515 -1.434 . . . . 74.310000000000002 109.515 -173.837 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -154.63 -171.52 3.88 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 107.926 -1.138 . . . . 64.409999999999997 107.926 -175.752 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.432 ' CB ' HG13 ' A' ' 50' ' ' VAL . 18.7 ptp180 -110.15 140.2 44.5 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 109.875 -0.417 . . . . 72.040000000000006 109.875 -178.368 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -135.24 119.02 17.2 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 120.673 0.273 . . . . 74.329999999999998 110.891 179.765 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.0 tt -86.55 139.56 30.73 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 107.073 -1.454 . . . . 75.239999999999995 107.073 174.724 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 87.8 mt -71.19 114.07 8.87 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 119.923 -0.711 . . . . 75.319999999999993 109.385 -176.433 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -117.45 -32.26 4.98 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 114.793 -1.094 . . . . 71.319999999999993 110.989 -172.655 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -96.97 132.25 26.22 Favored Pre-proline 0 C--N 1.303 -1.454 0 N-CA-C 107.686 -1.227 . . . . 73.530000000000001 107.686 178.653 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.406 ' HA ' ' CG1' ' A' ' 94' ' ' ILE . 10.5 Cg_endo -53.45 -26.48 36.09 Favored 'Trans proline' 0 C--N 1.371 1.748 0 C-N-CA 124.034 3.156 . . . . 73.319999999999993 113.411 -176.207 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 51.8 m -133.39 98.09 4.14 Favored 'General case' 0 N--CA 1.407 -2.586 0 N-CA-C 108.404 -0.961 . . . . 75.019999999999996 108.404 174.282 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 98.2 m -88.75 115.4 26.26 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 114.868 -1.06 . . . . 74.0 108.469 -178.685 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.6 t -107.78 121.51 44.87 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-O 121.554 0.693 . . . . 74.239999999999995 111.369 -177.277 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -104.7 115.32 30.12 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 114.868 -1.06 . . . . 74.030000000000001 109.022 179.185 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.736 ' O ' ' HA ' ' A' ' 88' ' ' ARG . . . 90.64 85.33 1.39 Allowed Glycine 0 CA--C 1.475 -2.446 0 N-CA-C 107.798 -2.121 . . . . 73.329999999999998 107.798 -177.375 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.401 ' HG2' ' O ' ' A' ' 75' ' ' GLU . 23.5 tpt180 -177.57 142.79 0.33 Allowed 'General case' 0 N--CA 1.407 -2.59 0 N-CA-C 102.243 -3.243 . . . . 73.310000000000002 102.243 -171.513 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -109.16 -60.55 0.04 OUTLIER Pre-proline 0 C--N 1.274 -2.705 0 N-CA-C 115.316 1.599 . . . . 73.420000000000002 115.316 -177.701 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_exo -66.67 -40.63 12.82 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 121.871 1.714 . . . . 73.109999999999999 113.862 -173.249 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.401 ' O ' ' HG2' ' A' ' 72' ' ' ARG . 38.7 tt0 -130.42 75.55 1.66 Allowed 'General case' 0 N--CA 1.422 -1.87 0 N-CA-C 107.378 -1.341 . . . . 71.120000000000005 107.378 -177.309 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.4 p -112.24 170.44 8.16 Favored 'General case' 0 C--N 1.285 -2.231 0 N-CA-C 113.365 0.876 . . . . 73.510000000000005 113.365 -171.689 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -112.14 -55.71 2.48 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 107.166 -1.42 . . . . 72.150000000000006 107.166 173.857 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 24.2 pt -125.43 152.28 32.05 Favored 'Isoleucine or valine' 0 C--O 1.25 1.12 0 CA-C-N 115.539 -0.755 . . . . 74.010000000000005 109.422 174.797 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.432 ' O ' ' HA ' ' A' ' 56' ' ' ASN . 87.8 m-85 -112.89 117.53 32.38 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 112.293 0.479 . . . . 72.219999999999999 112.293 -173.131 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.2 mp -74.12 107.39 6.28 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 108.743 -0.836 . . . . 72.430000000000007 108.743 170.1 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -82.04 1.4 35.95 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 123.993 0.917 . . . . 64.409999999999997 110.976 -178.02 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -98.4 164.44 12.28 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.55 -0.75 . . . . 70.340000000000003 109.857 -177.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.2 p -69.92 -18.8 22.2 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.134 0 C-N-CA 123.35 0.66 . . . . 75.230000000000004 111.64 -178.769 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 13.3 p -73.05 11.44 0.7 Allowed 'General case' 0 CA--C 1.555 1.15 0 N-CA-C 113.698 0.999 . . . . 75.140000000000001 113.698 -178.807 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.6 p -82.58 125.0 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 CA-C-O 121.436 0.636 . . . . 73.209999999999994 111.931 -177.187 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 41.9 t -84.68 169.34 14.41 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.343 -0.984 . . . . 64.329999999999998 108.343 174.624 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 52.3 mtm-85 -56.76 -40.76 76.4 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 108.946 -0.761 . . . . 73.230000000000004 108.946 175.87 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.736 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -146.07 129.45 16.82 Favored 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 105.754 -1.943 . . . . 72.0 105.754 165.392 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 30.1 t60 -108.74 -74.04 0.67 Allowed 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 113.213 0.819 . . . . 72.409999999999997 113.213 -171.088 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -117.29 119.39 35.0 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 121.652 -0.655 . . . . 65.400000000000006 109.756 -177.443 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -109.69 127.18 54.4 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 108.277 -1.009 . . . . 73.120000000000005 108.277 -179.608 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -112.33 112.8 24.63 Favored 'General case' 0 N--CA 1.425 -1.693 0 N-CA-C 107.619 -1.252 . . . . 74.219999999999999 107.619 -178.763 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 30.8 ttm-85 -101.91 143.32 31.94 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 107.819 -1.178 . . . . 72.519999999999996 107.819 179.791 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.406 ' CG1' ' HA ' ' A' ' 66' ' ' PRO . 2.6 pp -115.53 140.46 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.479 0 N-CA-C 107.578 -1.267 . . . . 71.450000000000003 107.578 175.298 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.505 ' C ' ' H ' ' A' ' 97' ' ' GLY . 40.0 t-20 -118.44 147.08 43.95 Favored 'General case' 0 C--N 1.268 -2.972 0 N-CA-C 104.541 -2.392 . . . . 70.099999999999994 104.541 -178.807 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -59.84 26.5 0.01 OUTLIER 'General case' 0 CA--C 1.574 1.881 0 N-CA-C 114.62 1.341 . . . . 75.25 114.62 -176.945 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.505 ' H ' ' C ' ' A' ' 95' ' ' ASN . . . -169.16 -38.31 0.03 OUTLIER Glycine 0 N--CA 1.426 -2.011 0 N-CA-C 111.074 -0.81 . . . . 71.129999999999995 111.074 -179.445 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -127.61 170.9 12.14 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.95 0.405 . . . . 73.409999999999997 111.283 -176.392 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -116.89 129.3 55.98 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 116.276 -0.42 . . . . 73.409999999999997 110.101 -179.912 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -122.07 119.52 31.64 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.907 -0.405 . . . . 74.019999999999996 109.907 -176.845 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.469 HG13 ' SD ' ' A' ' 122' ' ' MET . 27.9 m -121.93 128.92 75.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 C-N-CA 119.835 -0.746 . . . . 74.299999999999997 110.944 178.371 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 29.4 m -119.84 137.46 53.65 Favored 'Isoleucine or valine' 0 C--O 1.252 1.234 0 N-CA-C 112.76 0.652 . . . . 73.120000000000005 112.76 -178.243 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -92.68 108.37 19.93 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.485 -0.78 . . . . 72.319999999999993 110.228 174.98 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.3 m -114.56 5.46 7.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 CA-C-O 121.86 0.838 . . . . 75.310000000000002 109.709 177.417 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -105.86 36.32 4.48 Favored Glycine 0 N--CA 1.431 -1.676 0 N-CA-C 109.725 -1.35 . . . . 71.099999999999994 109.725 179.351 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 14.0 m -65.01 5.47 0.34 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.736 1.615 . . . . 74.239999999999995 113.158 -176.689 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.4 mp -69.37 -34.27 74.3 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 107.505 -1.295 . . . . 71.329999999999998 107.505 172.918 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -119.01 -40.06 2.87 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 107.293 -1.373 . . . . 75.519999999999996 107.293 174.1 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 104.96 141.89 11.08 Favored Glycine 0 N--CA 1.44 -1.08 0 CA-C-N 115.79 -0.641 . . . . 74.540000000000006 113.485 176.108 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 27.6 m -108.52 125.45 51.82 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 107.362 -1.347 . . . . 73.430000000000007 107.362 173.205 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -103.64 134.52 46.85 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.56 -0.533 . . . . 73.299999999999997 109.56 -176.684 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.2 p -125.77 127.51 71.42 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.428 0 N-CA-C 106.973 -1.491 . . . . 73.420000000000002 106.973 175.391 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 18.4 m120 64.71 22.6 12.62 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 109.108 -0.701 . . . . 70.239999999999995 109.108 -174.842 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 18.3 mmm180 76.54 5.41 3.53 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.729 1.212 . . . . 75.209999999999994 112.779 -175.291 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -112.41 130.07 23.73 Favored Pre-proline 0 C--N 1.315 -0.924 0 N-CA-C 110.386 -0.227 . . . . 71.400000000000006 110.386 -179.4 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -74.85 110.48 3.12 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 121.823 1.682 . . . . 74.510000000000005 109.772 175.858 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 43.2 ttt180 -126.83 154.64 44.07 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.508 -1.293 . . . . 75.310000000000002 107.508 -176.235 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -81.2 -50.52 9.48 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.271 -0.572 . . . . 75.319999999999993 110.664 -175.182 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -130.18 140.16 50.77 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 108.406 -0.961 . . . . 64.439999999999998 108.406 178.875 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 55.2 tp60 -139.72 148.03 41.74 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 109.692 -0.485 . . . . 75.140000000000001 109.692 -179.926 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 98.8 t -88.17 117.29 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 N-CA-C 105.195 -2.15 . . . . 74.420000000000002 105.195 167.86 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.469 ' SD ' HG13 ' A' ' 101' ' ' VAL . 4.6 tpt -55.89 116.73 3.13 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 124.071 0.948 . . . . 70.310000000000002 111.468 -171.74 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -105.26 129.83 53.53 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.662 -0.699 . . . . 75.230000000000004 109.6 -174.336 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 7.0 t -79.61 129.16 34.22 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 121.628 0.728 . . . . 54.450000000000003 112.571 -175.217 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 108.18 -11.43 37.03 Favored Glycine 0 N--CA 1.423 -2.17 0 CA-C-N 115.249 -0.887 . . . . 62.530000000000001 111.638 178.196 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -102.35 172.59 6.8 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 112.867 0.692 . . . . 74.430000000000007 112.867 -177.344 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -108.32 142.52 38.5 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-N 115.056 -0.974 . . . . 74.099999999999994 112.115 -172.891 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.4 mp -124.1 113.17 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.922 0 N-CA-C 105.74 -1.948 . . . . 74.040000000000006 105.74 178.216 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.427 ' HA ' ' O ' ' A' ' 133' ' ' PHE . 66.4 mt-30 -102.95 119.64 39.21 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 109.667 -0.494 . . . . 73.439999999999998 109.667 -177.056 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 20.9 pt -91.41 99.72 10.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 N-CA-C 107.999 -1.112 . . . . 74.310000000000002 107.999 176.884 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 79.19 -94.03 1.34 Allowed Glycine 0 N--CA 1.422 -2.299 0 N-CA-C 108.755 -1.738 . . . . 72.230000000000004 108.755 -174.376 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -137.54 15.94 2.94 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.205 0.526 . . . . 74.209999999999994 110.306 177.128 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.427 ' O ' ' HA ' ' A' ' 129' ' ' GLN . 53.1 m-85 -103.52 131.3 50.76 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 109.664 -0.495 . . . . 75.299999999999997 109.664 -179.868 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 48.7 ttt180 -95.27 121.76 37.26 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-O 121.631 0.729 . . . . 70.049999999999997 111.708 -169.214 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 9.5 mp -121.96 143.87 49.21 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 107.668 -1.234 . . . . 74.530000000000001 107.668 175.672 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 6.3 p -126.95 130.67 71.37 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.435 0 C-N-CA 120.633 -0.427 . . . . 71.200000000000003 110.318 179.342 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.481 ' CZ ' ' HB3' ' A' ' 47' ' ' ALA . 90.7 t80 -97.22 125.21 41.61 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.585 -0.734 . . . . 74.319999999999993 110.115 -176.759 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -128.56 144.24 51.11 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.385 0.612 . . . . 74.140000000000001 110.785 -179.752 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -87.01 86.21 7.3 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 106.996 -1.483 . . . . 73.340000000000003 106.996 171.926 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -75.27 -174.09 34.18 Favored Glycine 0 N--CA 1.439 -1.121 0 CA-C-N 114.983 -1.008 . . . . 52.409999999999997 113.945 -174.719 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -71.11 140.21 37.2 Favored 'Trans proline' 0 N--CA 1.447 -1.218 0 C-N-CA 122.716 2.278 . . . . 74.120000000000005 112.801 -179.14 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -99.72 103.97 15.66 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 107.827 -1.175 . . . . 73.010000000000005 107.827 176.916 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 . . . . . 0 C--N 1.304 -1.405 0 N-CA-C 108.736 -0.838 . . . . 62.240000000000002 108.736 -178.969 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.2 ttp . . . . . 0 CA--C 1.507 -0.684 0 N-CA-C 109.511 -0.551 . . . . 74.420000000000002 109.511 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.0 m -81.0 -48.97 11.51 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.256 -1.016 . . . . 54.130000000000003 108.256 175.965 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -157.08 132.43 9.15 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 107.86 -1.163 . . . . 63.149999999999999 107.86 -178.931 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -102.95 148.19 25.99 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.395 -0.594 . . . . 73.109999999999999 109.395 -179.408 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -117.8 102.37 9.05 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 121.178 0.513 . . . . 72.439999999999998 111.278 -176.282 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -138.12 55.23 0.68 Allowed Glycine 0 N--CA 1.438 -1.229 0 N-CA-C 109.916 -1.273 . . . . 61.310000000000002 109.916 179.398 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.3 t -64.8 127.98 93.14 Favored Pre-proline 0 N--CA 1.439 -0.987 0 CA-C-N 115.191 -0.504 . . . . 74.010000000000005 109.834 -177.907 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -61.1 127.65 22.86 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.198 1.932 . . . . 73.319999999999993 111.212 179.849 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -101.74 115.69 64.5 Favored Pre-proline 0 C--N 1.302 -1.496 0 N-CA-C 109.505 -0.554 . . . . 75.109999999999999 109.505 179.606 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -73.03 128.87 13.53 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.744 2.296 . . . . 72.219999999999999 113.894 -176.59 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -106.69 108.04 19.36 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 106.057 -1.831 . . . . 74.010000000000005 106.057 176.369 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.2 p -124.54 135.48 63.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 N-CA-C 109.396 -0.594 . . . . 70.239999999999995 109.396 -179.314 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -105.92 130.77 53.8 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.121 0.486 . . . . 74.040000000000006 110.825 -178.98 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 95.6 m -151.63 106.43 3.25 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.238 -1.023 . . . . 64.310000000000002 108.238 174.693 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 17.1 p -96.99 122.98 40.58 Favored 'General case' 0 N--CA 1.412 -2.327 0 CA-C-O 121.422 0.63 . . . . 72.200000000000003 110.506 -178.049 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 27.5 t -80.66 108.78 14.6 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 114.747 -1.115 . . . . 74.030000000000001 110.336 -177.331 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 91.5 t -81.96 131.78 33.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 108.416 -0.957 . . . . 74.439999999999998 108.416 178.497 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -98.89 158.53 15.58 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 110.036 -0.357 . . . . 74.129999999999995 110.036 179.148 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -124.98 159.58 30.92 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 108.512 -0.921 . . . . 75.109999999999999 108.512 -178.789 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -84.97 83.5 8.03 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.354 -0.98 . . . . 74.349999999999994 108.354 174.208 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -77.33 -27.77 52.9 Favored 'General case' 0 CA--C 1.487 -1.45 0 CA-C-N 114.739 -1.119 . . . . 74.239999999999995 111.309 -175.041 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -135.47 139.24 43.91 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 116.053 -0.521 . . . . 75.329999999999998 109.613 -179.019 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.443 HD12 ' O ' ' A' ' 23' ' ' LEU . 4.0 pp -166.88 132.28 2.16 Favored 'General case' 0 N--CA 1.436 -1.17 0 O-C-N 124.232 0.957 . . . . 74.120000000000005 110.002 178.614 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.5 162.74 27.58 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 106.094 -1.817 . . . . 74.030000000000001 106.094 178.715 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -142.78 148.39 37.09 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 120.177 -0.609 . . . . 74.329999999999998 112.28 -179.281 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 48.7 ttm 66.53 84.55 0.15 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.658 1.224 . . . . 71.420000000000002 110.095 -175.955 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -138.58 106.37 5.64 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-N 114.927 -1.033 . . . . 72.129999999999995 109.359 -179.194 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.5 p -138.2 137.25 37.4 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 115.464 -0.789 . . . . 54.219999999999999 109.957 178.291 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 16.5 m -61.45 119.34 8.37 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 108.944 -0.762 . . . . 71.129999999999995 108.944 176.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 18.6 m -88.77 107.16 18.82 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 108.283 -1.006 . . . . 74.549999999999997 108.283 -177.68 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -83.15 62.04 4.69 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 121.017 -0.611 . . . . 73.010000000000005 114.179 -174.536 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 26.4 m -93.52 116.75 29.28 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 107.694 -1.224 . . . . 71.209999999999994 107.694 174.447 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -90.92 114.73 62.45 Favored Pre-proline 0 C--N 1.281 -2.393 0 CA-C-N 116.226 -0.443 . . . . 74.120000000000005 109.829 -178.751 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -68.12 119.32 6.33 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 121.75 1.633 . . . . 73.010000000000005 110.813 177.581 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -126.16 137.13 53.54 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 115.706 -0.679 . . . . 62.119999999999997 109.293 -177.716 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.8 m -57.51 -46.35 83.88 Favored 'General case' 0 N--CA 1.438 -1.068 0 O-C-N 123.984 0.803 . . . . 73.299999999999997 110.709 177.831 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 20.5 m 56.53 40.78 29.34 Favored 'General case' 0 CA--C 1.554 1.129 0 CA-C-O 123.192 1.473 . . . . 75.310000000000002 108.635 -179.241 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -111.43 33.27 5.91 Favored Glycine 0 N--CA 1.431 -1.671 0 CA-C-N 114.518 -1.219 . . . . 72.310000000000002 111.813 -176.34 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.1 -45.11 94.93 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-O 121.634 0.731 . . . . 73.209999999999994 109.767 179.657 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -71.91 -11.14 60.65 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 114.932 -1.031 . . . . 72.340000000000003 112.694 -177.734 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -72.62 -17.74 61.65 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 108.858 -0.793 . . . . 73.319999999999993 108.858 -177.863 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 50.1 tp -60.09 125.12 80.3 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-N 115.605 -0.725 . . . . 74.209999999999994 109.333 177.374 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -66.19 171.38 10.35 Favored 'Trans proline' 0 C--O 1.245 0.868 0 C-N-CA 122.644 2.229 . . . . 73.219999999999999 112.592 178.509 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.83 152.41 44.59 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.566 -0.743 . . . . 72.430000000000007 110.743 -179.726 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 105.43 37.97 2.53 Favored Glycine 0 N--CA 1.439 -1.149 0 N-CA-C 111.149 -0.78 . . . . 73.200000000000003 111.149 -176.723 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.454 ' O ' ' HA ' ' A' ' 141' ' ' PRO . 10.8 m -90.53 159.77 16.31 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.342 -0.614 . . . . 55.049999999999997 109.342 -178.282 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -113.98 178.38 4.3 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 117.741 0.246 . . . . 73.450000000000003 111.064 -176.261 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.5 pp -132.36 158.94 40.64 Favored 'General case' 0 C--O 1.244 0.788 0 N-CA-C 112.909 0.707 . . . . 70.349999999999994 112.909 -173.389 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.4 pp -119.24 147.74 43.91 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.58 -0.736 . . . . 74.040000000000006 109.817 176.914 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 25.3 t -130.23 149.86 34.02 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 C-N-CA 123.606 0.763 . . . . 70.150000000000006 109.284 -175.577 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.54 118.05 33.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-O 122.375 1.083 . . . . 74.319999999999993 111.05 179.475 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -95.6 -39.05 10.12 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-N 115.244 -0.889 . . . . 74.450000000000003 108.785 174.016 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -154.04 89.17 1.28 Allowed 'General case' 0 C--O 1.215 -0.748 0 N-CA-C 109.051 -0.722 . . . . 63.450000000000003 109.051 176.211 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 20.87 54.04 0.01 OUTLIER Glycine 0 N--CA 1.508 3.495 0 N-CA-C 119.842 2.697 . . . . 72.519999999999996 119.842 177.44 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.91 -40.37 2.69 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 CA-C-N 120.821 2.31 . . . . 72.129999999999995 113.89 -178.783 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.592 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 15.6 m120 -134.17 -84.42 0.43 Allowed 'General case' 0 C--O 1.209 -1.055 0 CA-C-O 121.183 0.516 . . . . 62.420000000000002 112.079 -171.504 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.64 -6.82 26.59 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.528 0.566 . . . . 73.239999999999995 112.528 -173.825 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.24 40.57 99.2 Favored Glycine 0 CA--C 1.523 0.579 0 C-N-CA 120.756 -0.735 . . . . 71.109999999999999 112.256 -178.199 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -157.09 -163.7 1.45 Allowed 'General case' 0 C--O 1.254 1.331 0 N-CA-C 108.886 -0.783 . . . . 44.520000000000003 108.886 -177.122 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -132.34 139.49 48.17 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 108.354 -0.98 . . . . 72.340000000000003 108.354 176.134 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -156.46 154.5 30.5 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.057 0.456 . . . . 73.150000000000006 111.786 179.477 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 31.2 tp -80.08 139.49 36.87 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 114.55 -1.204 . . . . 75.340000000000003 109.172 179.655 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.9 mp -82.77 114.38 21.06 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 106.52 -1.659 . . . . 74.230000000000004 106.52 173.704 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -112.42 3.8 17.14 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 116.132 -0.486 . . . . 74.219999999999999 110.233 -175.012 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -121.82 141.11 33.21 Favored Pre-proline 0 C--N 1.301 -1.541 0 N-CA-C 107.741 -1.207 . . . . 75.319999999999993 107.741 -179.391 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -55.08 -49.89 14.99 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.167 2.578 . . . . 63.109999999999999 111.924 -177.413 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 92' ' ' PHE . 44.3 m -121.08 108.54 13.94 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-N 115.509 -0.769 . . . . 74.239999999999995 110.455 178.924 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.419 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 4.7 m -91.66 114.81 27.44 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.264 -1.013 . . . . 75.430000000000007 108.264 179.116 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 16.7 p -90.79 122.76 33.8 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 116.742 -0.208 . . . . 75.340000000000003 110.693 -179.774 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.433 ' HA ' ' O ' ' A' ' 78' ' ' ILE . . . -109.5 121.84 46.08 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 109.877 -0.416 . . . . 71.209999999999994 109.877 178.178 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -164.6 -136.22 1.96 Allowed Glycine 0 N--CA 1.432 -1.604 0 N-CA-C 111.117 -0.793 . . . . 70.439999999999998 111.117 178.52 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.443 ' NH2' ' HA ' ' A' ' 81' ' ' ASP . 4.2 tpp180 -159.57 84.65 0.77 Allowed 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.025 -1.472 . . . . 75.25 107.025 176.992 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -179.97 151.18 0.57 Allowed Pre-proline 0 C--N 1.296 -1.756 0 N-CA-C 104.745 -2.317 . . . . 75.439999999999998 104.745 -177.514 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.44 -22.15 70.52 Favored 'Trans proline' 0 N--CA 1.48 0.709 0 C-N-CA 122.41 2.073 . . . . 74.120000000000005 113.211 -178.149 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -79.54 -18.34 52.03 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.431 -0.35 . . . . 71.219999999999999 111.064 -179.148 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.0 m -88.42 131.86 34.69 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 107.162 -1.422 . . . . 73.010000000000005 107.162 176.167 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -70.84 -50.38 36.02 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 120.956 -0.297 . . . . 63.310000000000002 111.451 -176.851 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.433 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 39.2 pt -112.37 154.55 13.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 C-N-CA 120.133 -0.627 . . . . 65.299999999999997 109.883 178.991 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -116.58 136.05 53.3 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 116.399 -0.364 . . . . 72.450000000000003 110.501 -179.023 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.592 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 1.5 pt? -84.99 139.92 31.44 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 106.647 -1.612 . . . . 73.329999999999998 106.647 171.553 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.443 ' HA ' ' NH2' ' A' ' 72' ' ' ARG . 19.8 t70 -106.56 58.0 0.64 Allowed 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 118.415 -1.314 . . . . 70.239999999999995 112.583 -172.098 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -104.07 151.19 23.55 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 106.641 -1.615 . . . . 72.25 106.641 171.476 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.4 m -74.38 -12.45 15.14 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 N-CA-C 112.284 0.476 . . . . 72.329999999999998 112.284 -178.621 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -113.42 51.52 0.84 Allowed 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 106.956 -1.498 . . . . 72.329999999999998 106.956 179.16 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.422 ' CG2' ' HB2' ' A' ' 72' ' ' ARG . 7.6 p -82.24 135.59 24.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 115.469 -0.787 . . . . 73.540000000000006 113.004 -173.038 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 8.0 m -101.75 144.21 30.72 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.625 -0.716 . . . . 74.439999999999998 110.93 -177.925 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -67.39 120.79 14.47 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 106.172 -1.788 . . . . 74.409999999999997 106.172 170.569 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 58.1 81.35 0.15 Allowed 'General case' 0 N--CA 1.466 0.357 0 O-C-N 123.9 0.75 . . . . 73.420000000000002 110.396 -172.421 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 19.1 t60 -98.81 -35.65 10.06 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 109.398 -0.593 . . . . 72.349999999999994 109.398 -178.626 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -149.22 136.27 19.83 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 120.335 -0.546 . . . . 73.040000000000006 110.031 -179.447 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -112.89 126.98 56.05 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 108.313 -0.995 . . . . 75.150000000000006 108.313 173.989 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.435 ' O ' ' HA ' ' A' ' 67' ' ' THR . 86.1 m-85 -105.37 122.39 45.88 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.049 -1.093 . . . . 73.409999999999997 108.049 179.058 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.43 ' HB3' ' HB3' ' A' ' 100' ' ' GLU . 51.4 ttt180 -113.06 119.16 36.89 Favored 'General case' 0 C--N 1.281 -2.385 0 N-CA-C 108.34 -0.985 . . . . 71.510000000000005 108.34 179.569 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.79 116.43 52.38 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 N-CA-C 107.48 -1.304 . . . . 74.329999999999998 107.48 179.553 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 27.4 t30 -101.88 145.55 29.06 Favored 'General case' 0 C--N 1.275 -2.634 0 CA-C-N 113.758 -1.565 . . . . 75.120000000000005 106.864 -179.787 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -42.88 -29.5 0.33 Allowed 'General case' 0 C--N 1.313 -0.995 0 C-N-CA 125.049 1.34 . . . . 73.120000000000005 113.668 -178.388 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -138.7 29.52 2.57 Favored Glycine 0 N--CA 1.43 -1.72 0 C-N-CA 120.373 -0.918 . . . . 75.239999999999995 112.75 177.331 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -165.07 152.99 11.49 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 117.883 0.841 . . . . 64.239999999999995 110.989 -179.866 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -124.96 126.87 46.16 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.845 -0.428 . . . . 74.129999999999995 109.845 -176.549 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.43 ' HB3' ' HB3' ' A' ' 93' ' ' ARG . 37.3 tt0 -132.26 135.19 46.09 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 122.568 0.347 . . . . 73.129999999999995 110.269 -175.992 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.7 p -128.7 129.01 68.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 O-C-N 121.946 -0.472 . . . . 73.340000000000003 110.908 177.608 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 97.5 t -119.47 124.53 73.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 116.008 -0.542 . . . . 72.239999999999995 110.816 179.722 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -83.6 125.16 31.52 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 123.2 0.6 . . . . 74.450000000000003 110.272 174.725 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.8 t -118.72 7.6 6.79 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 N-CA-C 107.936 -1.135 . . . . 71.519999999999996 107.936 178.393 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -116.7 45.56 1.27 Allowed Glycine 0 N--CA 1.441 -1.009 0 N-CA-C 110.498 -1.041 . . . . 62.530000000000001 110.498 -178.873 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 12.3 m -63.72 -12.62 36.29 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 123.977 0.911 . . . . 74.129999999999995 111.61 -177.538 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 92.0 mt -61.35 -35.84 78.55 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.8 0.84 . . . . 75.200000000000003 109.892 174.748 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -93.69 -37.59 11.75 Favored 'General case' 0 CA--C 1.496 -1.118 0 N-CA-C 108.327 -0.99 . . . . 74.439999999999998 108.327 178.257 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 93.65 88.63 1.62 Allowed Glycine 0 N--CA 1.432 -1.614 0 CA-C-N 114.943 -1.026 . . . . 74.019999999999996 111.499 -179.99 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 55.1 m -82.3 120.62 25.63 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 109.37 -0.604 . . . . 71.450000000000003 109.37 177.634 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.448 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 37.4 m-85 -106.2 134.93 48.56 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 107.818 -1.178 . . . . 74.120000000000005 107.818 -179.927 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 23.8 t -105.88 121.33 58.09 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.235 0 N-CA-C 106.8 -1.556 . . . . 72.239999999999995 106.8 177.898 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 61.96 25.51 15.32 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.704 1.202 . . . . 54.140000000000001 109.809 -175.102 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 65.6 mtp180 75.08 14.53 3.1 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.248 1.819 . . . . 71.010000000000005 112.363 -178.523 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 25.1 tp10 -110.76 123.94 34.29 Favored Pre-proline 0 C--N 1.307 -1.279 0 N-CA-C 108.039 -1.097 . . . . 71.310000000000002 108.039 174.798 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -57.21 103.83 0.14 Allowed 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.226 1.951 . . . . 72.310000000000002 110.762 176.073 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? -143.41 111.07 5.92 Favored 'General case' 0 N--CA 1.414 -2.229 0 N-CA-C 105.391 -2.077 . . . . 71.140000000000001 105.391 -176.697 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -81.21 -23.73 37.92 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 120.553 -0.459 . . . . 72.409999999999997 111.638 -173.856 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -130.77 137.05 49.28 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.264 -1.384 . . . . 73.219999999999999 107.264 172.286 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.43 145.85 37.55 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 108.229 -1.026 . . . . 75.129999999999995 108.229 -178.734 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 44.9 t -95.53 103.45 14.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 104.955 -2.239 . . . . 72.430000000000007 104.955 174.694 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 24.7 mtt -58.11 129.44 41.97 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 116.296 1.962 . . . . 73.230000000000004 116.296 -168.927 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.461 HE21 ' CA ' ' A' ' 123' ' ' GLN . 0.0 OUTLIER -106.99 153.3 22.78 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 112.715 -2.039 . . . . 64.239999999999995 107.334 176.418 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 9.5 t -76.75 115.58 16.65 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 122.367 1.079 . . . . 74.349999999999994 109.575 -178.571 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 113.46 3.74 23.85 Favored Glycine 0 N--CA 1.426 -2.016 0 CA-C-N 114.865 -1.062 . . . . 62.520000000000003 110.821 -176.057 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -62.31 133.98 55.86 Favored 'General case' 0 CA--C 1.491 -1.305 0 CA-C-O 121.258 0.551 . . . . 75.209999999999994 111.283 178.991 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -114.33 127.66 55.97 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 115.032 -0.986 . . . . 74.120000000000005 110.32 -178.378 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.438 ' O ' ' HA ' ' A' ' 134' ' ' ARG . 65.4 mt -97.67 118.94 45.02 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.234 0 N-CA-C 108.039 -1.097 . . . . 73.209999999999994 108.039 177.086 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.448 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 48.9 tp60 -103.39 112.71 25.73 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 115.326 -0.852 . . . . 74.400000000000006 109.148 -177.086 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.409 HG13 ' HB2' ' A' ' 133' ' ' PHE . 14.0 pt -124.34 97.9 4.91 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 108.426 -0.953 . . . . 74.040000000000006 108.426 174.25 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 68.46 -108.65 2.54 Favored Glycine 0 N--CA 1.435 -1.4 0 CA-C-N 114.865 -1.061 . . . . 73.340000000000003 110.62 -175.663 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -108.34 -1.86 19.66 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 120.769 0.318 . . . . 73.430000000000007 111.004 177.638 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.409 ' HB2' HG13 ' A' ' 130' ' ' ILE . 71.0 m-85 -93.54 147.55 22.88 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.724 0.297 . . . . 73.430000000000007 110.984 -177.902 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.438 ' HA ' ' O ' ' A' ' 128' ' ' ILE . 84.1 mtt180 -133.74 129.65 36.98 Favored 'General case' 0 C--O 1.257 1.453 0 CA-C-N 115.785 -0.643 . . . . 75.519999999999996 111.829 -178.979 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.477 HD12 ' N ' ' A' ' 136' ' ' VAL . 3.4 tm? -109.39 144.68 37.27 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 106.185 -1.783 . . . . 74.030000000000001 106.185 172.628 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.477 ' N ' HD12 ' A' ' 135' ' ' LEU . 12.9 p -130.09 128.03 64.1 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.704 0 N-CA-C 109.377 -0.601 . . . . 72.329999999999998 109.377 -178.82 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -110.69 129.88 55.71 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.656 -0.702 . . . . 71.430000000000007 109.569 -176.871 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.3 mp -127.7 140.66 51.94 Favored 'General case' 0 C--O 1.253 1.25 0 CA-C-O 121.363 0.601 . . . . 74.420000000000002 110.804 -179.455 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -86.73 87.88 7.55 Favored 'General case' 0 N--CA 1.422 -1.852 0 CA-C-N 115.339 -0.846 . . . . 74.310000000000002 109.363 179.08 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -120.27 84.13 0.37 Allowed Glycine 0 C--N 1.292 -1.884 0 N-CA-C 107.536 -2.226 . . . . 53.420000000000002 107.536 174.517 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.454 ' HA ' ' O ' ' A' ' 46' ' ' SER . 14.9 Cg_endo -59.42 120.03 7.62 Favored 'Trans proline' 0 N--CA 1.445 -1.376 0 C-N-CA 122.541 2.16 . . . . 73.299999999999997 114.775 -172.049 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -86.83 104.65 16.38 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 106.613 -1.625 . . . . 75.099999999999994 106.613 173.754 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 . . . . . 0 C--N 1.284 -2.271 0 N-CA-C 107.098 -1.445 . . . . 65.409999999999997 107.098 -175.75 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.422 ' HG3' ' H ' ' A' ' 2' ' ' SER . 22.7 ptt? . . . . . 0 N--CA 1.473 0.694 0 CA-C-O 119.394 -0.336 . . . . 71.239999999999995 111.566 . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.422 ' H ' ' HG3' ' A' ' 1' ' ' MET . 15.2 m -77.84 -38.03 47.1 Favored 'General case' 0 C--O 1.244 0.778 0 N-CA-C 105.262 -2.125 . . . . 65.519999999999996 105.262 170.897 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -73.13 146.97 45.3 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 112.917 -1.947 . . . . 62.43 107.616 173.493 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -79.2 -29.41 42.83 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.432 -0.951 . . . . 71.310000000000002 108.432 179.459 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 56.0 t30 68.03 88.88 0.11 Allowed 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 114.249 -1.341 . . . . 75.530000000000001 112.224 176.616 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 88.61 130.11 3.52 Favored Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 120.884 -0.674 . . . . 72.209999999999994 112.189 178.599 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.5 m -111.48 124.69 32.0 Favored Pre-proline 0 C--N 1.302 -1.496 0 N-CA-C 109.777 -0.453 . . . . 74.310000000000002 109.777 179.272 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -66.14 142.24 66.71 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.925 2.417 . . . . 73.549999999999997 112.098 177.736 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -121.75 146.82 46.71 Favored Pre-proline 0 C--N 1.296 -1.721 0 N-CA-C 108.113 -1.069 . . . . 72.0 108.113 178.465 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -61.44 155.14 54.31 Favored 'Trans proline' 0 C--O 1.251 1.164 0 C-N-CA 122.548 2.165 . . . . 64.049999999999997 111.97 178.053 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -66.66 150.86 48.45 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.731 -0.668 . . . . 75.409999999999997 109.934 179.548 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.2 p -88.4 129.09 40.15 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.353 0 CA-C-N 116.114 -0.494 . . . . 74.230000000000004 110.386 179.978 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -78.25 140.74 38.87 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 116.035 -0.529 . . . . 72.409999999999997 110.24 -178.862 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.8 t -101.67 142.23 33.32 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.285 -1.006 . . . . 74.340000000000003 108.285 177.01 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.9 t -157.35 158.43 35.96 Favored 'General case' 0 N--CA 1.422 -1.847 0 N-CA-C 107.555 -1.276 . . . . 74.200000000000003 107.555 -179.004 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.7 t -98.64 101.54 12.99 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.246 -1.02 . . . . 75.040000000000006 108.246 179.788 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.8 p -126.04 97.84 4.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-O 122.339 1.066 . . . . 74.040000000000006 113.299 -176.79 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -161.42 145.08 12.81 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 114.24 -1.345 . . . . 75.129999999999995 109.652 177.338 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 54.0 mtm180 -148.57 -173.66 4.4 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 107.883 -1.154 . . . . 75.239999999999995 107.883 -178.035 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -84.79 57.8 4.59 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 106.947 -1.501 . . . . 71.310000000000002 106.947 171.193 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -83.01 -23.55 33.23 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 113.911 -1.495 . . . . 73.239999999999995 110.688 -172.766 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.4 tt -72.73 140.84 48.06 Favored 'General case' 0 C--O 1.245 0.83 0 CA-C-N 115.063 -0.971 . . . . 62.439999999999998 109.507 -177.713 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.1 pp -115.37 165.47 12.94 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 116.383 -0.371 . . . . 74.450000000000003 111.877 -177.037 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -80.16 128.53 33.62 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.217 -1.031 . . . . 75.030000000000001 108.217 -179.578 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.9 168.87 9.84 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-O 121.175 0.512 . . . . 63.329999999999998 111.471 -176.017 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 83.5 mtp -120.8 176.04 5.73 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.873 -0.603 . . . . 73.430000000000007 109.755 179.652 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -87.67 153.53 21.3 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.871 -1.159 . . . . 70.219999999999999 107.871 177.836 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.3 m -103.22 159.92 15.12 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 121.009 -0.276 . . . . 71.109999999999999 110.328 -177.862 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 14.3 m -69.65 132.73 46.64 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 116.62 -0.264 . . . . 61.229999999999997 110.404 179.354 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.9 t -89.38 105.93 18.12 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-O 122.081 0.943 . . . . 75.549999999999997 109.147 177.103 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -89.61 141.26 16.03 Favored Glycine 0 N--CA 1.436 -1.308 0 CA-C-N 115.319 -0.855 . . . . 71.25 111.492 -176.828 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.8 p -87.03 157.5 19.42 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 110.138 -0.319 . . . . 74.239999999999995 110.138 178.722 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.4 116.98 64.59 Favored Pre-proline 0 C--N 1.31 -1.142 0 O-C-N 122.975 0.172 . . . . 54.32 111.25 -178.181 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -78.26 120.48 4.93 Favored 'Trans proline' 0 C--O 1.243 0.729 0 C-N-CA 122.563 2.175 . . . . 72.510000000000005 109.379 174.742 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -114.56 110.13 19.33 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 120.449 -0.5 . . . . 73.450000000000003 111.348 -179.228 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 69.8 m -77.28 135.72 38.45 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 109.28 -0.637 . . . . 73.430000000000007 109.28 175.699 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.5 m -64.77 158.38 25.02 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 115.537 -0.756 . . . . 73.310000000000002 110.323 -178.426 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -70.66 83.4 0.37 Allowed Glycine 0 N--CA 1.436 -1.315 0 N-CA-C 114.172 0.429 . . . . 73.329999999999998 114.172 -176.377 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.37 -52.98 21.89 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 109.114 -0.699 . . . . 75.420000000000002 109.114 175.931 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.414 ' CD ' ' H ' ' A' ' 40' ' ' GLU . 0.8 OUTLIER -63.86 -11.4 27.24 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.477 1.511 . . . . 75.540000000000006 111.995 179.291 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -72.92 -13.46 61.26 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 123.865 0.866 . . . . 73.420000000000002 112.256 178.31 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -58.78 154.69 35.25 Favored Pre-proline 0 CA--C 1.549 0.927 0 O-C-N 123.223 0.327 . . . . 63.329999999999998 110.684 179.824 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -61.61 165.54 13.37 Favored 'Trans proline' 0 C--O 1.247 0.966 0 C-N-CA 122.292 1.994 . . . . 64.439999999999998 112.025 177.576 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -86.27 151.81 23.29 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 116.125 -0.489 . . . . 65.340000000000003 109.911 -178.941 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.63 74.29 1.24 Allowed Glycine 0 N--CA 1.433 -1.537 0 N-CA-C 109.404 -1.479 . . . . 74.420000000000002 109.404 -176.568 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 65.8 m -89.94 165.15 14.25 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.481 0.658 . . . . 72.129999999999995 111.606 -175.94 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -119.18 163.78 16.56 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 108.329 -0.989 . . . . 73.140000000000001 108.329 179.707 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -135.17 156.29 49.25 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 120.814 0.34 . . . . 72.150000000000006 111.186 -177.821 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -114.76 132.8 56.33 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.675 -0.861 . . . . 64.109999999999999 108.675 174.307 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 24.8 t -116.03 134.02 60.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.566 -0.901 . . . . 75.540000000000006 108.566 -178.872 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 24.4 t -92.74 121.5 43.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-O 121.018 0.437 . . . . 74.420000000000002 110.158 -177.893 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -94.43 -41.59 9.31 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.698 -0.683 . . . . 73.230000000000004 110.306 177.964 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -153.14 123.88 7.31 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 109.299 -0.63 . . . . 74.140000000000001 109.299 -176.505 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 151.53 130.32 1.64 Allowed Glycine 0 N--CA 1.427 -1.918 0 N-CA-C 111.261 -0.735 . . . . 72.540000000000006 111.261 178.277 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -61.47 -8.62 11.16 Favored 'Trans proline' 0 N--CA 1.481 0.761 0 C-N-CA 123.534 2.823 . . . . 73.230000000000004 113.433 178.051 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.489 ' CB ' ' HA ' ' A' ' 80' ' ' LEU . 5.1 p-10 -56.06 -41.04 74.46 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.28 0.632 . . . . 72.140000000000001 110.611 177.475 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -178.75 -168.99 0.15 Allowed 'General case' 0 C--O 1.217 -0.64 0 C-N-CA 123.936 0.894 . . . . 53.350000000000001 109.093 -179.145 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -159.48 28.95 0.39 Allowed Glycine 0 C--N 1.312 -0.775 0 N-CA-C 110.184 -1.167 . . . . 54.509999999999998 110.184 179.122 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -130.19 -166.23 1.65 Allowed 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.295 -1.002 . . . . 74.219999999999999 108.295 -175.471 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.96 139.96 53.52 Favored 'General case' 0 N--CA 1.412 -2.335 0 N-CA-C 108.771 -0.826 . . . . 73.510000000000005 108.771 178.382 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -118.94 121.78 40.73 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 109.835 -0.432 . . . . 74.239999999999995 109.835 -177.992 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 47.7 tp -91.25 133.98 34.95 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.541 -0.911 . . . . 75.310000000000002 108.541 178.521 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 7.0 mp -83.27 114.93 21.73 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 120.394 -0.523 . . . . 64.329999999999998 111.219 -179.721 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -120.24 18.35 12.27 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.148 -1.056 . . . . 75.439999999999998 108.148 174.56 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -133.94 142.99 45.53 Favored Pre-proline 0 N--CA 1.438 -1.03 0 CA-C-N 113.881 -1.509 . . . . 75.299999999999997 108.045 178.374 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -63.16 -31.26 75.17 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.898 2.398 . . . . 71.310000000000002 113.683 -177.371 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 41.2 m -136.49 120.75 17.93 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.82 -0.55 . . . . 74.010000000000005 110.0 179.417 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.478 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 9.2 m -102.99 119.85 39.58 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 106.471 -1.677 . . . . 72.310000000000002 106.471 176.645 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.405 HG22 ' HA ' ' A' ' 76' ' ' SER . 7.9 t -101.47 131.86 47.37 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 109.08 -0.711 . . . . 73.120000000000005 109.08 -176.604 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -127.5 119.47 26.13 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-O 120.845 0.355 . . . . 74.439999999999998 111.826 -174.577 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 60.3 44.81 97.12 Favored Glycine 0 CA--C 1.496 -1.133 0 CA-C-N 115.707 -0.678 . . . . 74.540000000000006 111.641 178.15 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.409 ' HA ' ' HA ' ' A' ' 88' ' ' ARG . 46.9 ttt180 -137.9 -31.1 0.79 Allowed 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 120.592 -0.443 . . . . 75.299999999999997 111.507 -173.619 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 32.3 m-70 -128.78 160.29 63.89 Favored Pre-proline 0 C--N 1.303 -1.434 0 N-CA-C 107.815 -1.18 . . . . 75.25 107.815 179.837 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -64.32 -25.4 64.22 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 121.303 1.335 . . . . 74.310000000000002 110.195 172.479 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -99.08 29.46 3.86 Favored 'General case' 0 C--O 1.243 0.756 0 CA-C-N 115.401 -0.818 . . . . 74.340000000000003 111.58 179.422 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.405 ' HA ' HG22 ' A' ' 69' ' ' THR . 70.2 m -54.43 136.53 44.01 Favored 'General case' 0 C--O 1.244 0.814 0 CA-C-O 120.898 0.38 . . . . 75.439999999999998 111.158 178.765 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -61.27 -43.91 98.1 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 115.025 -0.989 . . . . 63.43 109.911 -177.347 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 48.4 pt -124.93 156.72 33.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 CA-C-N 115.167 -0.924 . . . . 75.099999999999994 108.649 176.766 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -106.73 136.18 46.98 Favored 'General case' 0 C--N 1.284 -2.25 0 CA-C-N 115.846 -0.615 . . . . 74.209999999999994 110.026 -179.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.489 ' HA ' ' CB ' ' A' ' 56' ' ' ASN . 94.2 mt -107.38 171.74 7.21 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 108.67 -0.863 . . . . 75.400000000000006 108.67 -179.471 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -66.16 122.52 17.62 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 121.971 0.891 . . . . 71.450000000000003 110.213 -178.996 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -67.16 -16.54 64.37 Favored 'General case' 0 C--N 1.278 -2.535 0 CA-C-N 113.888 -1.505 . . . . 55.219999999999999 114.52 -174.784 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.3 t -90.8 -24.66 5.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-O 121.825 0.822 . . . . 74.200000000000003 109.183 -179.283 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 11.2 p -103.26 -3.34 25.8 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.702 -0.681 . . . . 64.430000000000007 112.816 -179.628 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.7 p -81.47 121.56 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 N-CA-C 107.971 -1.122 . . . . 72.540000000000006 107.971 179.254 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 27.0 p -115.03 46.31 1.46 Allowed 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 112.122 0.415 . . . . 64.420000000000002 112.122 -175.026 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 68.6 mtt180 67.52 108.12 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.883 0.873 . . . . 72.209999999999994 110.928 -178.998 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.413 ' O ' HG22 ' A' ' 104' ' ' VAL . 93.7 mtt180 63.71 78.11 0.3 Allowed 'General case' 0 CA--C 1.506 -0.725 0 N-CA-C 108.815 -0.809 . . . . 74.200000000000003 108.815 178.669 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 41.1 t60 -85.34 -67.27 0.81 Allowed 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 118.701 -1.2 . . . . 74.400000000000006 113.905 -172.522 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -137.8 156.45 47.94 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 118.324 -1.351 . . . . 74.340000000000003 113.589 -173.284 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -127.1 127.76 45.15 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 114.358 -1.292 . . . . 71.109999999999999 108.104 175.172 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.478 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 79.1 m-85 -108.69 112.72 25.18 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 106.085 -1.82 . . . . 75.420000000000002 106.085 174.865 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -117.08 144.4 44.7 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 121.64 0.733 . . . . 73.140000000000001 111.535 -173.396 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.441 ' O ' HD11 ' A' ' 94' ' ' ILE . 2.8 pp -116.17 116.4 52.18 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.64 0 N-CA-C 104.119 -2.549 . . . . 74.109999999999999 104.119 167.347 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.587 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 46.6 t-20 -108.09 145.03 34.65 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 107.734 -1.209 . . . . 72.420000000000002 107.734 -172.647 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -54.66 -26.75 35.17 Favored 'General case' 0 C--N 1.311 -1.078 0 O-C-N 123.645 0.591 . . . . 74.120000000000005 111.076 178.692 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -72.7 -63.35 2.9 Favored Glycine 0 N--CA 1.43 -1.759 0 N-CA-C 110.816 -0.914 . . . . 74.409999999999997 110.816 173.785 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.587 ' O ' ' HB3' ' A' ' 95' ' ' ASN . 44.2 mt-10 -159.26 168.36 26.66 Favored 'General case' 0 C--O 1.212 -0.893 0 N-CA-C 106.202 -1.777 . . . . 73.230000000000004 106.202 -178.38 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.435 ' HB2' ' CB ' ' A' ' 122' ' ' MET . 9.3 m-85 -91.31 134.84 34.25 Favored 'General case' 0 C--N 1.295 -1.767 0 C-N-CA 119.414 -0.914 . . . . 74.530000000000001 109.534 -177.379 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -132.2 136.22 46.87 Favored 'General case' 0 CA--C 1.501 -0.904 0 N-CA-C 113.218 0.821 . . . . 75.319999999999993 113.218 -175.858 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 90.1 t -111.01 119.91 60.6 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.077 0 N-CA-C 108.11 -1.07 . . . . 65.150000000000006 108.11 176.629 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 35.3 t -119.2 116.63 51.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 116.367 -0.379 . . . . 74.450000000000003 110.012 -176.733 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -104.26 108.93 20.55 Favored 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 107.551 -1.277 . . . . 75.120000000000005 107.551 175.97 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.413 HG22 ' O ' ' A' ' 88' ' ' ARG . 26.3 m -92.13 -9.56 10.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-O 121.128 0.489 . . . . 64.439999999999998 110.995 -177.886 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.41 ' C ' ' H ' ' A' ' 107' ' ' LEU . . . -92.16 27.33 10.49 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 109.759 -1.336 . . . . 72.409999999999997 109.759 176.049 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.432 ' HA ' ' OG1' ' A' ' 110' ' ' THR . 1.1 p -69.52 10.03 0.41 Allowed 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 125.532 1.533 . . . . 74.340000000000003 113.282 -177.455 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.422 ' O ' HD23 ' A' ' 107' ' ' LEU . 6.0 tt -68.22 -24.78 64.96 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 106.251 -1.759 . . . . 72.140000000000001 106.251 172.994 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -78.07 -1.84 34.37 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 115.054 -0.975 . . . . 62.450000000000003 110.657 177.393 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 77.28 56.44 3.97 Favored Glycine 0 N--CA 1.439 -1.123 0 N-CA-C 110.471 -1.052 . . . . 71.329999999999998 110.471 -178.203 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.432 ' OG1' ' HA ' ' A' ' 106' ' ' SER . 17.9 m -72.89 121.42 19.98 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-O 121.606 0.717 . . . . 64.340000000000003 111.507 -176.692 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -102.13 133.27 47.25 Favored 'General case' 0 N--CA 1.416 -2.158 0 N-CA-C 106.199 -1.778 . . . . 72.340000000000003 106.199 175.449 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 25.9 t -125.17 128.78 73.12 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.063 0 N-CA-C 105.537 -2.023 . . . . 74.319999999999993 105.537 179.822 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 63.55 27.24 14.97 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 107.841 -1.17 . . . . 73.319999999999993 107.841 -173.658 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 67.72 9.31 7.0 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 124.899 1.279 . . . . 73.510000000000005 112.254 -175.226 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.569 ' OE1' ' HD2' ' A' ' 116' ' ' PRO . 9.2 tp10 -111.51 126.38 28.68 Favored Pre-proline 0 C--N 1.305 -1.359 0 N-CA-C 108.452 -0.944 . . . . 75.120000000000005 108.452 -178.826 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.569 ' HD2' ' OE1' ' A' ' 115' ' ' GLU . 32.9 Cg_exo -53.75 113.24 1.23 Allowed 'Trans proline' 0 C--O 1.25 1.099 0 C-N-CA 121.967 1.778 . . . . 74.5 109.309 173.105 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 12.5 tpp85 -160.13 143.31 13.77 Favored 'General case' 0 N--CA 1.425 -1.704 0 N-CA-C 108.508 -0.923 . . . . 75.25 108.508 -173.349 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -87.98 -41.57 13.05 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.448 -0.575 . . . . 75.530000000000001 109.448 -179.062 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -132.72 139.34 47.58 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.399 -0.963 . . . . 53.340000000000003 108.399 177.429 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.07 148.83 47.01 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 107.249 -1.389 . . . . 73.420000000000002 107.249 -176.744 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 8.7 p -84.58 134.33 27.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 108.518 -0.919 . . . . 74.209999999999994 108.518 179.876 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.435 ' CB ' ' HB2' ' A' ' 99' ' ' PHE . 1.5 tmt? -50.24 124.39 10.27 Favored 'General case' 0 C--N 1.313 -1.008 0 O-C-N 123.739 0.649 . . . . 72.030000000000001 112.671 -175.489 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -129.85 151.09 50.8 Favored 'General case' 0 N--CA 1.424 -1.761 0 CA-C-N 115.148 -0.933 . . . . 74.120000000000005 108.817 173.461 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 6.6 p -78.53 115.17 18.05 Favored 'General case' 0 C--N 1.283 -2.306 0 CA-C-N 115.738 -0.665 . . . . 71.530000000000001 109.636 177.681 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 95.16 33.55 6.52 Favored Glycine 0 N--CA 1.437 -1.271 0 N-CA-C 110.334 -1.107 . . . . 73.239999999999995 110.334 -178.234 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -91.48 150.59 21.16 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 107.125 -1.435 . . . . 72.329999999999998 107.125 -179.79 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -137.85 123.13 19.38 Favored 'General case' 0 C--N 1.29 -2.003 0 CA-C-O 122.093 0.949 . . . . 53.119999999999997 111.069 -177.082 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 58.9 mt -101.92 126.09 55.96 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.22 0 CA-C-N 114.162 -1.381 . . . . 74.5 108.46 -176.727 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -119.69 112.78 19.72 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 109.412 -0.588 . . . . 65.510000000000005 109.412 177.94 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 23.1 pt -105.64 97.48 5.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-N 115.139 -0.937 . . . . 61.140000000000001 109.981 -178.826 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 69.36 -72.6 0.45 Allowed Glycine 0 CA--C 1.526 0.747 0 CA-C-N 115.438 -0.801 . . . . 72.420000000000002 113.69 178.502 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -132.15 -12.71 3.19 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 123.096 0.558 . . . . 75.150000000000006 110.256 -176.076 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -107.72 156.31 19.24 Favored 'General case' 0 C--N 1.321 -0.656 0 O-C-N 121.76 -0.588 . . . . 72.510000000000005 112.023 -171.29 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 50.4 mtp180 -131.32 127.02 36.81 Favored 'General case' 0 C--O 1.251 1.14 0 CA-C-O 121.616 0.722 . . . . 74.25 111.791 -174.745 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 58.6 tp -122.06 135.17 54.79 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 114.531 -1.213 . . . . 72.129999999999995 107.748 -179.693 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 14.9 p -112.06 138.63 40.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 N-CA-C 109.326 -0.62 . . . . 73.140000000000001 109.326 -179.737 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -116.25 129.79 56.46 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 109.334 -0.617 . . . . 74.450000000000003 109.334 -177.359 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 58.4 mt -135.66 172.5 12.92 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.306 -0.627 . . . . 64.430000000000007 109.306 -177.078 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -91.11 146.56 23.74 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 107.639 -1.245 . . . . 73.129999999999995 107.639 175.694 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -96.58 -127.53 5.52 Favored Glycine 0 N--CA 1.429 -1.772 0 C-N-CA 120.374 -0.917 . . . . 71.439999999999998 111.68 -176.705 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -71.33 128.29 14.42 Favored 'Trans proline' 0 N--CA 1.444 -1.412 0 C-N-CA 122.192 1.928 . . . . 74.510000000000005 112.03 179.973 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -78.75 112.72 16.16 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.367 -1.345 . . . . 75.219999999999999 107.367 177.313 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 . . . . . 0 C--N 1.283 -2.298 0 N-CA-C 109.057 -0.72 . . . . 72.219999999999999 109.057 -175.694 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.7 ttt . . . . . 0 N--CA 1.456 -0.157 0 N-CA-C 108.516 -0.92 . . . . 74.150000000000006 108.516 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.3 p -82.38 -39.11 23.17 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.135 0.493 . . . . 62.009999999999998 111.821 -177.087 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -120.53 175.16 6.13 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.806 -0.634 . . . . 63.210000000000001 110.566 -172.444 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -126.54 171.33 11.17 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 107.927 -1.138 . . . . 74.340000000000003 107.927 179.187 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -105.69 167.06 10.02 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 107.402 -1.332 . . . . 74.430000000000007 107.402 173.198 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -133.15 -166.1 11.33 Favored Glycine 0 N--CA 1.424 -2.118 0 C-N-CA 119.908 -1.139 . . . . 73.530000000000001 111.656 -178.001 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.3 t -100.76 143.57 26.83 Favored Pre-proline 0 N--CA 1.417 -2.104 0 N-CA-C 108.169 -1.048 . . . . 62.310000000000002 108.169 -179.765 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -58.45 128.03 26.89 Favored 'Trans proline' 0 C--O 1.245 0.858 0 C-N-CA 122.409 2.072 . . . . 75.319999999999993 110.658 177.67 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -82.97 126.85 71.61 Favored Pre-proline 0 C--N 1.295 -1.793 0 CA-C-N 115.836 -0.62 . . . . 74.099999999999994 110.668 -176.535 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.76 151.33 28.12 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.298 1.999 . . . . 74.25 111.277 178.9 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -118.68 110.44 17.3 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.755 0.788 . . . . 73.340000000000003 111.467 179.671 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.9 p -90.23 158.02 2.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 107.283 -1.377 . . . . 64.519999999999996 107.283 177.654 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -92.28 133.32 35.94 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 120.059 -0.656 . . . . 70.140000000000001 111.527 -179.325 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.5 m -106.26 91.78 3.86 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 104.899 -2.26 . . . . 75.239999999999995 104.899 171.569 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 14.9 t -83.13 -175.19 5.71 Favored 'General case' 0 N--CA 1.413 -2.309 0 CA-C-O 121.607 0.718 . . . . 72.409999999999997 111.916 -169.005 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.1 m -81.8 40.35 0.6 Allowed 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 124.952 1.301 . . . . 75.420000000000002 111.65 -173.312 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.7 p -78.81 0.25 3.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 122.613 1.197 . . . . 74.040000000000006 110.589 -177.59 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -99.21 153.29 19.05 Favored 'General case' 0 C--N 1.273 -2.736 0 CA-C-N 114.534 -1.212 . . . . 74.219999999999999 109.255 -179.951 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 15.0 mmt180 -91.82 145.03 24.89 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 116.159 -0.473 . . . . 73.230000000000004 110.595 -179.422 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -91.59 95.16 9.77 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 106.193 -1.781 . . . . 73.230000000000004 106.193 172.417 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -78.45 -41.97 31.26 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 121.472 0.653 . . . . 74.319999999999993 109.572 -174.448 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -89.95 93.94 9.61 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 107.579 -1.267 . . . . 74.299999999999997 107.579 177.004 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 96.0 mt -81.94 111.87 18.52 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 107.466 -1.309 . . . . 72.5 107.466 176.497 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . 0.251 0.0 OUTLIER -70.28 -20.86 63.01 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 113.888 1.069 . . . . 73.430000000000007 113.888 -173.999 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 34.66 69.92 0.14 Allowed 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 125.239 1.415 . . . . 73.120000000000005 113.093 177.212 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 47.3 ttm -114.01 89.77 3.17 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-N 115.277 -0.874 . . . . 72.099999999999994 112.22 -173.124 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -137.78 119.1 14.66 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 106.165 -1.791 . . . . 65.340000000000003 106.165 174.656 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 45.8 m -142.02 148.45 38.52 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 109.745 -0.465 . . . . 75.310000000000002 109.745 -179.339 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 35.9 m -75.22 130.91 39.94 Favored 'General case' 0 N--CA 1.427 -1.579 0 O-C-N 123.624 0.578 . . . . 74.430000000000007 111.028 -177.595 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.1 t -134.24 164.27 27.75 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 107.636 -1.246 . . . . 73.010000000000005 107.636 -179.488 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -162.52 141.59 7.31 Favored Glycine 0 N--CA 1.425 -2.044 0 N-CA-C 110.946 -0.862 . . . . 51.509999999999998 110.946 179.828 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 33.9 m -110.18 129.08 55.77 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 108.254 -1.017 . . . . 62.240000000000002 108.254 175.909 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -90.76 129.17 45.5 Favored Pre-proline 0 C--N 1.288 -2.079 0 N-CA-C 109.284 -0.635 . . . . 73.25 109.284 -178.963 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -63.03 121.06 8.79 Favored 'Trans proline' 0 C--O 1.241 0.665 0 C-N-CA 122.28 1.986 . . . . 74.140000000000001 110.408 176.412 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -87.64 133.94 33.73 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 116.303 -0.408 . . . . 74.019999999999996 110.361 -178.042 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 77.8 p -149.47 142.7 25.09 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.803 -0.181 . . . . 74.25 111.044 179.735 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.0 t -168.83 115.52 0.63 Allowed 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 123.828 0.851 . . . . 73.540000000000006 109.895 172.963 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -132.41 105.85 0.62 Allowed Glycine 0 N--CA 1.419 -2.499 0 CA-C-N 115.121 -0.945 . . . . 70.329999999999998 110.995 -178.245 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.22 -26.69 67.91 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 123.416 0.686 . . . . 51.520000000000003 112.367 -179.027 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -70.11 -12.55 61.68 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.389 0.614 . . . . 75.049999999999997 111.037 -177.065 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -73.07 -26.15 61.16 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.38 -0.827 . . . . 74.209999999999994 109.661 177.01 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 62.9 tp -98.66 116.4 65.4 Favored Pre-proline 0 C--N 1.318 -0.794 0 CA-C-N 115.175 -0.921 . . . . 74.140000000000001 108.796 -178.966 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_exo -54.33 -61.54 0.4 Allowed 'Trans proline' 0 C--N 1.358 1.04 0 C-N-CA 123.228 2.618 . . . . 73.549999999999997 112.783 -178.953 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -95.42 81.25 3.56 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 121.371 0.605 . . . . 64.239999999999995 109.696 177.439 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -97.92 39.41 2.78 Favored Glycine 0 CA--C 1.497 -1.073 0 N-CA-C 109.682 -1.367 . . . . 61.25 109.682 177.78 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.0 m -100.39 156.81 17.05 Favored 'General case' 0 N--CA 1.416 -2.158 0 N-CA-C 108.988 -0.745 . . . . 64.219999999999999 108.988 -178.111 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.484 ' HB1' ' CE1' ' A' ' 137' ' ' PHE . . . -140.63 162.88 34.34 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 106.273 -1.751 . . . . 75.310000000000002 106.273 176.927 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.3 pp -134.31 142.39 47.25 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 118.246 -1.382 . . . . 74.549999999999997 111.836 179.436 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.474 ' O ' HD13 ' A' ' 49' ' ' LEU . 2.2 pp -109.38 140.81 42.61 Favored 'General case' 0 N--CA 1.424 -1.754 0 CA-C-N 115.453 -0.794 . . . . 74.120000000000005 110.266 179.51 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 45.2 t -123.6 113.5 37.6 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 N-CA-C 106.299 -1.741 . . . . 74.120000000000005 106.299 174.12 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 42.1 t -96.28 115.59 35.99 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.115 0 C-N-CA 118.915 -1.114 . . . . 74.219999999999999 108.49 179.476 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -68.99 -38.71 79.45 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 114.728 -1.123 . . . . 74.319999999999993 109.528 -176.559 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 26.4 ttm180 -177.25 142.3 0.35 Allowed 'General case' 0 C--O 1.244 0.773 0 CA-C-N 115.699 -0.682 . . . . 71.510000000000005 109.812 -179.95 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 143.31 165.91 10.94 Favored Glycine 0 N--CA 1.436 -1.36 0 CA-C-N 116.232 -0.44 . . . . 73.420000000000002 112.435 177.266 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -67.53 -8.21 21.55 Favored 'Trans proline' 0 N--CA 1.486 1.044 0 C-N-CA 123.659 2.906 . . . . 74.129999999999995 112.949 178.258 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.53 ' HA ' ' CB ' ' A' ' 80' ' ' LEU . 26.3 t-20 -65.15 -54.13 34.51 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.925 -0.58 . . . . 73.239999999999995 109.898 178.564 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -172.56 -176.51 1.54 Allowed 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.897 0.879 . . . . 74.310000000000002 108.822 -179.692 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -158.46 46.28 0.45 Allowed Glycine 0 CA--C 1.494 -1.235 0 N-CA-C 110.155 -1.178 . . . . 74.450000000000003 110.155 179.588 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -162.62 -173.83 3.71 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.157 -1.423 . . . . 72.030000000000001 107.157 -177.797 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.51 132.24 37.06 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 120.673 0.273 . . . . 72.510000000000005 110.46 177.73 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -156.75 155.03 30.92 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 116.002 -0.545 . . . . 75.209999999999994 110.425 -178.346 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -79.13 139.74 37.97 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 122.063 0.935 . . . . 73.25 113.056 -178.062 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 75.3 mt -99.84 133.49 44.13 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 104.87 -2.27 . . . . 71.010000000000005 104.87 172.089 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -147.28 78.52 1.48 Allowed 'General case' 0 C--N 1.296 -1.737 0 CA-C-O 121.568 0.699 . . . . 72.430000000000007 111.449 -178.638 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -147.9 149.69 33.78 Favored Pre-proline 0 C--N 1.306 -1.299 0 N-CA-C 106.918 -1.512 . . . . 72.230000000000004 106.918 174.679 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -58.54 -40.65 72.21 Favored 'Trans proline' 0 C--N 1.366 1.455 0 C-N-CA 122.612 2.208 . . . . 74.430000000000007 110.301 -179.682 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 33.9 m -128.58 100.06 5.61 Favored 'General case' 0 N--CA 1.414 -2.264 0 CA-C-N 114.519 -1.219 . . . . 74.319999999999993 108.322 175.547 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 57.8 m -95.32 113.87 25.59 Favored 'General case' 0 N--CA 1.423 -1.807 0 N-CA-C 107.121 -1.437 . . . . 74.540000000000006 107.121 179.762 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.1 t -108.98 135.77 49.61 Favored 'General case' 0 C--N 1.283 -2.318 0 C-N-CA 120.033 -0.667 . . . . 72.439999999999998 110.717 -174.416 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -119.9 131.7 55.31 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 108.97 -0.752 . . . . 74.549999999999997 108.97 179.466 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 178.73 -122.92 0.83 Allowed Glycine 0 N--CA 1.411 -2.985 0 C-N-CA 120.641 -0.79 . . . . 72.340000000000003 111.145 179.153 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 18.7 tpt180 -146.94 14.92 1.18 Allowed 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 109.658 -0.497 . . . . 74.329999999999998 109.658 -176.078 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.404 ' HB3' ' HB3' ' A' ' 87' ' ' ARG . 38.0 p-80 -98.3 156.34 35.9 Favored Pre-proline 0 C--N 1.318 -0.765 0 N-CA-C 108.253 -1.017 . . . . 64.340000000000003 108.253 179.893 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -49.02 -30.71 18.7 Favored 'Trans proline' 0 N--CA 1.488 1.15 0 C-N-CA 123.907 3.071 . . . . 72.040000000000006 115.766 -174.831 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -93.27 12.76 23.48 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 113.298 0.851 . . . . 71.439999999999998 113.298 -177.439 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 24.2 m -65.76 135.78 55.36 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.632 -0.877 . . . . 73.239999999999995 108.632 176.738 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -68.65 -46.12 70.02 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 107.716 -1.216 . . . . 74.040000000000006 107.716 179.055 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.82 135.35 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 CA-C-N 113.631 -1.622 . . . . 73.400000000000006 109.226 176.929 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -103.86 117.49 34.47 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 115.83 -0.623 . . . . 75.340000000000003 109.373 178.873 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.53 ' CB ' ' HA ' ' A' ' 56' ' ' ASN . 0.9 OUTLIER -86.94 119.89 27.63 Favored 'General case' 0 N--CA 1.418 -2.062 0 N-CA-C 107.548 -1.279 . . . . 75.340000000000003 107.548 174.418 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -84.95 60.57 6.31 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 122.38 1.086 . . . . 72.349999999999994 111.918 -176.109 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -93.04 -175.33 3.83 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 106.311 -1.737 . . . . 70.230000000000004 106.311 171.71 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.6 p -126.99 -6.98 4.65 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 CA-C-O 121.861 0.839 . . . . 75.109999999999999 109.987 -179.029 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 5.8 m -115.22 15.58 16.98 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 122.303 1.049 . . . . 64.120000000000005 108.249 179.376 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.7 p -84.34 138.56 18.96 Favored 'Isoleucine or valine' 0 C--O 1.248 1.011 0 CA-C-N 115.005 -0.998 . . . . 70.439999999999998 110.796 -179.851 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 19.6 m -77.03 166.57 23.14 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.944 -0.571 . . . . 73.030000000000001 110.2 178.37 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.404 ' HB3' ' HB3' ' A' ' 73' ' ' HIS . 18.4 mmt180 -63.12 -37.75 88.43 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 121.317 0.58 . . . . 75.25 109.884 178.495 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.1 119.71 29.36 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 106.517 -1.66 . . . . 72.219999999999999 106.517 167.831 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 9.1 t60 -106.62 -63.11 1.31 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.683 -0.488 . . . . 63.030000000000001 109.683 -175.814 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -134.74 119.43 18.22 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.246 -1.02 . . . . 73.129999999999995 108.246 -179.858 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -104.92 128.04 53.0 Favored 'General case' 0 C--N 1.287 -2.123 0 C-N-CA 119.883 -0.727 . . . . 75.420000000000002 109.368 179.34 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -105.58 119.72 39.82 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 107.673 -1.232 . . . . 65.129999999999995 107.673 -176.366 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -118.59 148.96 42.14 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 109.388 -0.597 . . . . 74.400000000000006 109.388 -178.944 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 4.3 tp -115.58 127.63 73.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 CA-C-O 121.769 0.795 . . . . 74.540000000000006 109.651 -179.83 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -108.17 146.63 32.45 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 106.19 -1.781 . . . . 75.349999999999994 106.19 -179.67 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -54.93 -18.24 4.72 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 113.53 0.937 . . . . 73.340000000000003 113.53 -177.718 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -108.06 -44.51 1.18 Allowed Glycine 0 N--CA 1.431 -1.647 0 C-N-CA 121.377 -0.44 . . . . 64.25 113.037 177.666 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -133.88 175.57 9.34 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-O 121.615 0.721 . . . . 75.099999999999994 111.935 -174.687 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -104.68 137.45 42.48 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 106.508 -1.664 . . . . 73.400000000000006 106.508 174.785 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -130.54 130.05 43.61 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 118.28 0.491 . . . . 74.209999999999994 110.039 -178.226 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 6.9 p -117.29 127.64 74.77 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-O 120.926 0.393 . . . . 72.420000000000002 110.35 -179.636 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 30.9 m -118.88 121.38 66.72 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 CA-C-O 121.497 0.665 . . . . 73.129999999999995 111.873 178.544 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -83.41 124.42 30.65 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.281 -0.872 . . . . 61.219999999999999 110.506 175.473 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 6.7 m -125.89 17.42 3.99 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.227 0 CA-C-N 114.837 -1.074 . . . . 64.450000000000003 109.849 176.739 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -127.5 46.92 1.05 Allowed Glycine 0 N--CA 1.443 -0.865 0 N-CA-C 108.866 -1.694 . . . . 75.319999999999993 108.866 177.495 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.7 m -59.52 -23.49 62.87 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 124.359 1.064 . . . . 73.239999999999995 113.643 -173.039 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 85.1 mt -77.62 -21.31 52.49 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.054 -0.658 . . . . 73.519999999999996 112.0 -179.33 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -81.72 -36.0 29.13 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 107.378 -1.341 . . . . 71.519999999999996 107.378 176.008 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 103.78 88.24 2.04 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 114.635 -1.166 . . . . 75.420000000000002 113.995 176.793 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 27.9 m -99.59 120.12 39.16 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.655 -0.868 . . . . 74.219999999999999 108.655 175.211 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -127.2 152.35 47.49 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 108.792 -0.818 . . . . 74.340000000000003 108.792 -177.726 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 74.7 t -106.32 113.41 42.93 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.111 0 N-CA-C 107.215 -1.402 . . . . 73.319999999999993 107.215 175.525 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 67.07 -73.59 0.08 Allowed 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 126.427 1.891 . . . . 73.239999999999995 109.862 -174.592 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -141.13 -12.56 0.94 Allowed 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 123.235 0.614 . . . . 75.430000000000007 111.106 177.099 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -106.78 140.72 21.64 Favored Pre-proline 0 C--N 1.321 -0.646 0 N-CA-C 112.503 0.557 . . . . 73.010000000000005 112.503 -169.787 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -71.27 93.27 0.65 Allowed 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.695 2.263 . . . . 63.119999999999997 112.777 178.562 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 12.6 mmt85 -110.54 100.51 9.31 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 106.464 -1.68 . . . . 74.329999999999998 106.464 176.032 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -75.85 -31.88 59.51 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 119.896 -0.721 . . . . 72.120000000000005 110.612 -176.101 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -124.35 136.13 53.86 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 105.265 -2.124 . . . . 73.109999999999999 105.265 167.854 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 55.7 tp60 -142.54 148.82 38.22 Favored 'General case' 0 C--N 1.283 -2.285 0 C-N-CA 120.922 -0.311 . . . . 72.349999999999994 110.928 -178.063 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.0 p -79.58 114.62 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.662 0 N-CA-C 103.893 -2.632 . . . . 75.239999999999995 103.893 167.126 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.509 ' HE1' ' CD1' ' A' ' 137' ' ' PHE . 9.7 ttt -68.52 120.35 14.43 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 115.033 -0.985 . . . . 75.420000000000002 111.079 -166.771 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 30.1 tp60 -104.25 124.9 49.98 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.252 -0.886 . . . . 73.510000000000005 110.325 -172.69 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.2 t -78.94 131.69 36.45 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 114.913 -1.04 . . . . 71.140000000000001 108.577 177.458 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 110.0 -9.73 31.73 Favored Glycine 0 N--CA 1.437 -1.266 0 CA-C-N 115.995 -0.548 . . . . 74.239999999999995 112.316 178.856 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -113.82 169.9 8.66 Favored 'General case' 0 C--O 1.25 1.118 0 N-CA-C 108.806 -0.813 . . . . 74.219999999999999 108.806 -177.357 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -110.63 144.98 38.69 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.791 0.805 . . . . 71.299999999999997 111.747 -178.25 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 65.2 mt -106.55 124.78 62.28 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 N-CA-C 107.367 -1.346 . . . . 61.130000000000003 107.367 177.139 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 58.2 tp60 -97.73 116.55 30.17 Favored 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 108.899 -0.778 . . . . 73.409999999999997 108.899 -176.896 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.1 pt -115.41 97.71 5.95 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.301 0 CA-C-O 122.177 0.989 . . . . 72.409999999999997 109.565 177.904 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 68.85 -116.55 7.4 Favored Glycine 0 N--CA 1.429 -1.786 0 CA-C-N 114.454 -1.248 . . . . 73.010000000000005 111.4 -175.697 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 17.9 tppt? -94.14 -22.14 18.65 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.239 0.542 . . . . 74.510000000000005 110.588 179.64 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -101.34 161.17 13.82 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 116.24 -0.437 . . . . 73.430000000000007 112.121 -174.919 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 9.8 ptp85 -137.28 144.37 42.66 Favored 'General case' 0 C--O 1.245 0.847 0 N-CA-C 113.419 0.896 . . . . 75.540000000000006 113.419 -172.984 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.8 tt -121.99 138.57 54.37 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 106.915 -1.513 . . . . 75.120000000000005 106.915 -179.247 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 27.7 t -106.83 130.49 58.68 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 N-CA-C 106.772 -1.566 . . . . 71.430000000000007 106.772 179.401 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.509 ' CD1' ' HE1' ' A' ' 122' ' ' MET . 86.4 t80 -104.37 128.19 52.16 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 112.086 0.402 . . . . 74.340000000000003 112.086 -174.78 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -128.57 151.13 49.8 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 108.211 -1.033 . . . . 73.430000000000007 108.211 173.882 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -62.81 149.54 43.89 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.892 -0.781 . . . . 43.520000000000003 108.892 175.47 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.437 ' N ' ' HA ' ' A' ' 47' ' ' ALA . . . -69.42 169.32 44.27 Favored Glycine 0 N--CA 1.434 -1.485 0 C-N-CA 120.88 -0.676 . . . . 54.310000000000002 113.405 -175.499 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -55.05 139.74 80.04 Favored 'Trans proline' 0 C--O 1.241 0.637 0 C-N-CA 123.25 2.633 . . . . 75.099999999999994 111.734 -179.881 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -82.17 103.45 11.78 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 108.566 -0.902 . . . . 72.530000000000001 108.566 179.23 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 . . . . . 0 C--N 1.298 -1.642 0 N-CA-C 108.035 -1.098 . . . . 74.510000000000005 108.035 -178.046 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ptt? . . . . . 0 N--CA 1.481 1.081 0 N-CA-C 112.007 0.373 . . . . 73.299999999999997 112.007 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.4 m -77.51 -49.14 15.34 Favored 'General case' 0 C--O 1.243 0.755 0 N-CA-C 106.933 -1.506 . . . . 75.340000000000003 106.933 176.344 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -97.69 143.54 28.24 Favored 'General case' 0 N--CA 1.422 -1.841 0 N-CA-C 104.884 -2.265 . . . . 75.430000000000007 104.884 169.977 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -134.07 125.18 27.49 Favored 'General case' 0 C--N 1.287 -2.126 0 C-N-CA 120.999 -0.28 . . . . 63.450000000000003 110.288 -177.669 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -67.57 154.54 41.2 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.478 -0.783 . . . . 72.400000000000006 109.019 175.089 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -81.95 149.12 27.83 Favored Glycine 0 N--CA 1.421 -2.307 0 N-CA-C 110.736 -0.945 . . . . 74.319999999999993 110.736 179.289 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.3 m -63.28 139.61 97.58 Favored Pre-proline 0 C--N 1.303 -1.425 0 N-CA-C 107.452 -1.314 . . . . 75.239999999999995 107.452 176.568 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -51.14 137.02 45.94 Favored 'Trans proline' 0 C--O 1.25 1.1 0 C-N-CA 122.326 2.017 . . . . 74.549999999999997 110.36 177.845 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -68.58 143.68 95.46 Favored Pre-proline 0 C--N 1.307 -1.254 0 CA-C-N 116.129 -0.487 . . . . 75.329999999999998 110.183 -174.565 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -36.94 114.78 0.13 Allowed 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 124.823 3.682 . . . . 62.240000000000002 113.784 -177.079 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -102.27 156.58 17.48 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.104 -1.443 . . . . 75.319999999999993 107.104 -178.895 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.4 m -90.26 148.36 4.6 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 CA-C-O 120.895 0.378 . . . . 73.209999999999994 110.222 177.533 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -103.5 141.52 35.85 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.14 -1.059 . . . . 52.240000000000002 108.14 177.315 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.5 t -68.92 152.7 44.94 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.705 -0.85 . . . . 72.239999999999995 108.705 179.007 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.9 t -145.11 105.45 4.08 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-O 121.748 0.785 . . . . 74.450000000000003 112.039 -176.88 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.6 t -94.21 96.03 9.33 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 105.589 -2.004 . . . . 75.530000000000001 105.589 174.982 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.1 p -103.49 127.83 57.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 CA-C-O 121.986 0.898 . . . . 72.340000000000003 112.209 -173.0 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -114.08 130.18 56.58 Favored 'General case' 0 N--CA 1.425 -1.713 0 N-CA-C 106.875 -1.528 . . . . 73.439999999999998 106.875 177.92 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -94.57 172.72 8.01 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 108.954 -0.758 . . . . 74.519999999999996 108.954 179.863 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.48 78.45 3.99 Favored 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 108.714 -0.847 . . . . 75.030000000000001 108.714 175.738 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -92.6 -24.37 18.72 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.03 -0.986 . . . . 71.129999999999995 110.129 -177.432 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -70.04 137.31 51.18 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.661 -0.699 . . . . 65.540000000000006 109.429 -177.985 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -136.57 176.19 8.92 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.054 -1.091 . . . . 75.209999999999994 108.054 179.926 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -78.18 135.1 37.56 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 113.47 0.915 . . . . 73.230000000000004 113.47 -176.898 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -130.59 143.86 51.03 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 106.244 -1.762 . . . . 64.010000000000005 106.244 177.227 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 22.5 ptt? -95.7 173.19 7.6 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.746 -0.381 . . . . 74.5 110.737 -176.462 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -82.86 171.01 14.36 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.678 -0.692 . . . . 75.230000000000004 110.734 179.512 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.5 m -85.93 143.55 28.13 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 116.004 -0.544 . . . . 75.310000000000002 109.586 178.177 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 16.4 m -72.44 162.02 30.04 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.631 0.729 . . . . 72.349999999999994 112.069 -176.359 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 82.5 m -149.65 126.02 10.83 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.309 -0.997 . . . . 74.439999999999998 108.309 176.744 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -87.06 174.45 45.69 Favored Glycine 0 N--CA 1.432 -1.584 0 C-N-CA 120.778 -0.725 . . . . 74.430000000000007 111.374 178.757 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 10.0 t -97.52 157.09 16.2 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.792 -0.818 . . . . 75.140000000000001 108.792 -178.239 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.43 132.2 56.26 Favored Pre-proline 0 C--N 1.307 -1.27 0 N-CA-C 109.21 -0.663 . . . . 71.420000000000002 109.21 179.358 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -79.41 160.94 25.69 Favored 'Trans proline' 0 C--O 1.252 1.214 0 C-N-CA 122.503 2.135 . . . . 73.010000000000005 112.18 -179.324 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.1 117.28 5.8 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.399 -0.593 . . . . 74.439999999999998 109.399 178.474 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.2 m -127.04 109.1 11.53 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.408 -0.96 . . . . 73.140000000000001 108.408 -177.904 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.51 ' OG1' ' HG2' ' A' ' 66' ' ' PRO . 15.3 t -153.25 -177.51 6.37 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 109.03 -0.73 . . . . 72.5 109.03 -177.167 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -162.07 117.01 0.74 Allowed Glycine 0 N--CA 1.437 -1.239 0 N-CA-C 111.001 -0.84 . . . . 43.5 111.001 -178.285 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.8 -27.09 68.95 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 123.778 0.831 . . . . 75.340000000000003 112.382 -177.524 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -64.15 -13.17 46.39 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 113.157 0.799 . . . . 75.230000000000004 113.157 -177.527 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -76.69 -14.88 59.92 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-O 121.021 0.439 . . . . 65.430000000000007 110.533 179.72 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 73.5 mt -120.12 145.34 39.81 Favored Pre-proline 0 N--CA 1.414 -2.251 0 N-CA-C 109.074 -0.713 . . . . 70.439999999999998 109.074 -177.675 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -65.88 131.79 28.38 Favored 'Trans proline' 0 C--O 1.251 1.163 0 C-N-CA 121.726 1.617 . . . . 74.230000000000004 109.276 173.726 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.18 131.49 41.37 Favored 'General case' 0 C--O 1.248 0.99 0 CA-C-O 121.566 0.698 . . . . 72.129999999999995 112.861 -176.022 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -165.02 101.65 0.19 Allowed Glycine 0 N--CA 1.426 -2.015 0 N-CA-C 107.29 -2.324 . . . . 74.340000000000003 107.29 -179.479 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.2 m -103.09 155.26 18.52 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-O 121.179 0.514 . . . . 75.409999999999997 111.155 -174.726 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.3 151.37 37.41 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.145 -1.428 . . . . 75.450000000000003 107.145 177.705 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.401 ' HB3' ' HG ' ' A' ' 62' ' ' LEU . 2.6 pt? -123.03 151.38 41.98 Favored 'General case' 0 CA--C 1.493 -1.243 0 CA-C-O 121.576 0.703 . . . . 73.430000000000007 111.392 -175.041 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -129.74 132.72 46.68 Favored 'General case' 0 C--N 1.276 -2.595 0 CA-C-N 115.259 -0.882 . . . . 71.310000000000002 108.651 175.23 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 23.5 m -104.37 141.41 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 N-CA-C 108.749 -0.834 . . . . 75.310000000000002 108.749 -178.222 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.9 t -92.92 114.97 30.68 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 N-CA-C 107.591 -1.263 . . . . 65.209999999999994 107.591 178.558 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.9 tmtm? -73.23 -44.34 59.69 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 106.157 -1.794 . . . . 73.219999999999999 106.157 -178.723 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 35.1 ttm180 -165.16 128.0 2.21 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 106.59 -1.633 . . . . 74.340000000000003 106.59 176.815 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 158.52 133.84 1.61 Allowed Glycine 0 N--CA 1.42 -2.414 0 C-N-CA 120.183 -1.008 . . . . 75.510000000000005 111.924 -179.697 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -59.62 -7.83 6.3 Favored 'Trans proline' 0 N--CA 1.484 0.963 0 C-N-CA 124.201 3.267 . . . . 65.510000000000005 114.116 178.612 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -44.16 -48.16 9.16 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.565 1.146 . . . . 75.239999999999995 111.379 175.349 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -165.29 -48.14 0.03 OUTLIER 'General case' 0 CA--C 1.51 -0.581 0 CA-C-O 121.329 0.585 . . . . 75.219999999999999 109.979 -179.348 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.12 25.58 57.24 Favored Glycine 0 C--O 1.225 -0.441 0 N-CA-C 110.528 -1.029 . . . . 73.519999999999996 110.528 -177.847 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -146.84 -157.32 0.8 Allowed 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.704 -1.221 . . . . 74.299999999999997 107.704 -177.494 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.54 141.39 50.99 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 108.251 -1.018 . . . . 73.140000000000001 108.251 177.309 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -140.6 153.69 46.17 Favored 'General case' 0 C--N 1.291 -1.955 0 C-N-CA 120.544 -0.462 . . . . 74.420000000000002 109.99 178.064 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.401 ' HG ' ' HB3' ' A' ' 48' ' ' LEU . 8.4 mp -103.68 140.61 37.36 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 115.728 -0.669 . . . . 75.129999999999995 109.605 -179.177 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 88.1 mt -72.14 114.13 9.92 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.085 -1.08 . . . . 73.400000000000006 108.085 175.388 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -117.91 4.8 12.15 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.588 -0.893 . . . . 71.010000000000005 108.588 -179.633 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.484 ' HB2' ' OG1' ' A' ' 68' ' ' THR . 1.0 OUTLIER -122.13 131.81 24.35 Favored Pre-proline 0 N--CA 1.437 -1.075 0 CA-C-N 115.893 -0.594 . . . . 64.239999999999995 109.726 -174.9 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.51 ' HG2' ' OG1' ' A' ' 37' ' ' THR . 2.8 Cg_exo -54.52 -40.15 84.92 Favored 'Trans proline' 0 C--N 1.36 1.142 0 C-N-CA 123.302 2.668 . . . . 71.340000000000003 110.904 177.822 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 97.6 m -126.34 103.28 7.56 Favored 'General case' 0 N--CA 1.42 -1.941 0 CA-C-N 114.964 -1.016 . . . . 52.350000000000001 108.716 175.829 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.484 ' OG1' ' HB2' ' A' ' 65' ' ' GLN . 38.3 m -107.24 113.07 26.25 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 108.1 -1.074 . . . . 74.349999999999994 108.1 179.047 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.1 m -105.2 121.05 43.03 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 120.469 -0.492 . . . . 73.219999999999999 109.898 -178.57 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.414 ' HB1' HD12 ' A' ' 80' ' ' LEU . . . -95.68 124.08 39.54 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 109.074 -0.713 . . . . 74.519999999999996 109.074 -179.878 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 79' ' ' PHE . . . -159.62 -179.01 34.14 Favored Glycine 0 N--CA 1.437 -1.248 0 C-N-CA 120.237 -0.983 . . . . 74.450000000000003 112.401 179.85 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.69 ' NH1' ' HA ' ' A' ' 81' ' ' ASP . 25.3 tpt180 -112.99 84.89 2.07 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.602 -0.888 . . . . 74.519999999999996 108.602 177.641 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -177.73 147.85 0.66 Allowed Pre-proline 0 C--N 1.314 -0.936 0 C-N-CA 125.509 1.524 . . . . 73.209999999999994 106.936 178.43 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -56.7 -40.47 84.09 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.787 2.325 . . . . 72.010000000000005 112.487 179.389 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -87.9 64.8 8.04 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-O 122.684 1.23 . . . . 70.439999999999998 112.467 177.855 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 19.6 m -133.59 159.9 39.08 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 104.684 -2.339 . . . . 71.040000000000006 104.684 172.601 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -64.96 -42.58 94.47 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 118.972 0.805 . . . . 71.510000000000005 109.592 -178.532 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.95 138.5 43.76 Favored 'Isoleucine or valine' 0 C--O 1.251 1.133 0 N-CA-C 106.944 -1.502 . . . . 75.409999999999997 106.944 171.735 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.422 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 53.5 p90 -107.62 125.34 51.22 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.734 -0.786 . . . . 74.420000000000002 111.813 -179.601 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.446 ' O ' ' HD3' ' A' ' 72' ' ' ARG . 5.3 mp -80.51 135.83 36.18 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.76 -1.2 . . . . 75.140000000000001 107.76 178.685 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.69 ' HA ' ' NH1' ' A' ' 72' ' ' ARG . 25.5 t70 -92.13 39.81 1.03 Allowed 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.682 0.753 . . . . 74.420000000000002 111.878 -174.648 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -123.5 151.36 42.88 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.928 -0.767 . . . . 54.030000000000001 108.928 178.511 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 33.3 m -90.26 -5.89 10.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 113.015 0.746 . . . . 73.099999999999994 113.015 -174.963 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.2 t -83.65 -13.1 54.99 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-O 121.816 0.817 . . . . 73.140000000000001 108.987 178.424 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 51.3 t -82.83 134.49 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 CA-C-N 114.906 -1.043 . . . . 75.450000000000003 110.023 -175.998 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.524 ' OG ' HD23 ' A' ' 107' ' ' LEU . 58.3 m -82.74 -174.01 4.98 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 116.155 -0.475 . . . . 75.140000000000001 111.534 -179.949 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -56.05 -50.49 70.81 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 108.204 -1.035 . . . . 75.310000000000002 108.204 175.099 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 59.0 mtt180 -126.74 115.78 19.92 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 105.597 -2.001 . . . . 72.439999999999998 105.597 174.376 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 11.0 t60 -100.02 -51.34 3.72 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 121.656 0.741 . . . . 75.430000000000007 109.812 -177.149 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -145.51 145.01 30.89 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 108.416 -0.957 . . . . 62.130000000000003 108.416 -179.786 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -121.89 127.86 50.93 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-O 121.699 0.761 . . . . 74.140000000000001 109.75 178.453 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -107.82 113.69 27.1 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 107.39 -1.337 . . . . 62.399999999999999 107.39 -178.27 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 41.9 mtp180 -117.52 147.57 42.65 Favored 'General case' 0 C--N 1.283 -2.29 0 C-N-CA 119.936 -0.706 . . . . 72.510000000000005 110.277 -179.033 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.44 122.56 70.07 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.132 0 N-CA-C 106.872 -1.529 . . . . 74.409999999999997 106.872 175.977 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -108.47 146.8 32.61 Favored 'General case' 0 C--N 1.275 -2.669 0 N-CA-C 107.434 -1.321 . . . . 74.409999999999997 107.434 -178.641 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -51.12 -22.83 2.72 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 123.769 0.827 . . . . 74.340000000000003 112.581 179.828 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -91.73 -51.33 2.51 Favored Glycine 0 N--CA 1.432 -1.618 0 C-N-CA 121.046 -0.597 . . . . 75.219999999999999 112.693 175.322 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -149.95 175.21 11.88 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 117.496 0.648 . . . . 65.099999999999994 112.387 -175.223 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.414 ' HB2' ' CB ' ' A' ' 122' ' ' MET . 63.1 m-85 -99.0 132.08 44.57 Favored 'General case' 0 C--O 1.247 0.951 0 N-CA-C 108.318 -0.993 . . . . 72.530000000000001 108.318 176.407 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -131.89 128.75 39.24 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 121.038 0.447 . . . . 74.400000000000006 111.196 -175.964 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 5.3 p -116.46 122.19 69.26 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-O 121.244 0.545 . . . . 74.230000000000004 110.507 177.804 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.7 m -119.53 136.96 55.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-N 115.736 -0.665 . . . . 75.219999999999999 109.999 177.833 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.416 ' OD2' ' HA ' ' A' ' 118' ' ' ASN . 1.4 p30 -86.39 143.12 27.98 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 118.727 -1.189 . . . . 72.230000000000004 108.345 175.409 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 15.7 m -127.68 12.31 3.29 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 CA-C-O 122.033 0.92 . . . . 74.030000000000001 109.298 176.773 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -161.67 67.69 0.24 Allowed Glycine 0 N--CA 1.427 -1.926 0 CA-C-N 114.569 -1.196 . . . . 73.409999999999997 110.965 -179.729 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.405 ' HB2' ' OD1' ' A' ' 103' ' ' ASP . 22.1 t -88.99 80.44 7.05 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 122.045 -0.68 . . . . 75.450000000000003 109.438 178.425 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.524 HD23 ' OG ' ' A' ' 86' ' ' SER . 1.9 mm? -81.03 -51.95 7.95 Favored 'General case' 0 CA--C 1.501 -0.908 0 C-N-CA 120.143 -0.623 . . . . 75.409999999999997 109.609 179.324 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -100.04 2.91 43.79 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.667 -0.697 . . . . 74.109999999999999 109.288 -175.869 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 100.93 130.72 7.15 Favored Glycine 0 N--CA 1.427 -1.955 0 CA-C-N 115.483 -0.781 . . . . 71.109999999999999 112.296 -178.662 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.425 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 26.9 m -105.68 119.52 39.35 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 106.764 -1.569 . . . . 73.340000000000003 106.764 172.79 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -125.67 144.23 50.69 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 120.843 0.354 . . . . 75.109999999999999 111.32 -173.736 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 5.2 p -121.81 111.74 32.15 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 N-CA-C 106.378 -1.712 . . . . 75.150000000000006 106.378 169.655 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 56.51 41.79 28.21 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.219 0.533 . . . . 73.019999999999996 111.228 -176.642 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 74.77 4.55 4.36 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.643 1.177 . . . . 75.239999999999995 112.782 179.749 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -97.27 115.6 65.77 Favored Pre-proline 0 C--N 1.315 -0.908 0 N-CA-C 110.008 -0.367 . . . . 75.120000000000005 110.008 178.261 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.425 ' HA ' ' O ' ' A' ' 110' ' ' THR . 41.8 Cg_endo -78.2 95.68 1.08 Allowed 'Trans proline' 0 N--CA 1.449 -1.122 0 C-N-CA 121.986 1.79 . . . . 70.219999999999999 110.688 176.866 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 27.8 mmm180 -114.23 146.32 40.56 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.601 -1.259 . . . . 75.150000000000006 107.601 -177.583 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.416 ' HA ' ' OD2' ' A' ' 103' ' ' ASP . 2.7 t-20 -84.17 -38.58 20.46 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.568 0.699 . . . . 73.150000000000006 110.46 -177.801 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -130.73 139.0 50.25 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 108.322 -0.992 . . . . 62.119999999999997 108.322 177.038 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 5.6 tp60 -139.81 145.45 38.18 Favored 'General case' 0 N--CA 1.425 -1.703 0 CA-C-O 121.299 0.571 . . . . 63.310000000000002 111.505 179.536 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 60.7 t -92.11 134.24 30.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 106.049 -1.834 . . . . 60.310000000000002 106.049 175.433 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.414 ' CB ' ' HB2' ' A' ' 99' ' ' PHE . 17.0 tmm? -39.36 127.09 1.81 Allowed 'General case' 0 N--CA 1.483 1.188 0 O-C-N 124.443 1.089 . . . . 74.120000000000005 113.366 -177.632 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -128.79 124.1 34.59 Favored 'General case' 0 N--CA 1.417 -2.088 0 N-CA-C 105.982 -1.859 . . . . 75.200000000000003 105.982 177.844 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 4.9 t -92.87 130.86 38.32 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 121.56 0.695 . . . . 72.120000000000005 112.221 -173.874 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 94.64 3.03 62.86 Favored Glycine 0 N--CA 1.438 -1.201 0 CA-C-N 115.24 -0.891 . . . . 63.119999999999997 111.393 177.784 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -106.43 168.02 9.44 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.533 -0.333 . . . . 75.400000000000006 111.157 -177.579 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -108.73 131.64 54.74 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.291 0.567 . . . . 72.439999999999998 111.88 -172.71 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 61.9 mt -119.05 113.22 40.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-N 115.344 -0.843 . . . . 65.319999999999993 109.211 179.816 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -95.32 112.75 24.41 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 109.098 -0.705 . . . . 75.019999999999996 109.098 177.425 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.5 pt -100.98 103.42 14.81 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 CA-C-O 122.127 0.965 . . . . 73.209999999999994 108.741 176.083 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 80.3 -104.96 2.31 Favored Glycine 0 N--CA 1.413 -2.86 0 CA-C-N 114.678 -1.146 . . . . 74.549999999999997 110.765 179.822 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -119.92 1.2 10.94 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 121.158 0.504 . . . . 72.040000000000006 110.954 -176.786 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -127.97 160.06 33.06 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 116.265 -0.425 . . . . 74.040000000000006 110.883 -178.114 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 11.1 ptp180 -129.59 139.16 51.55 Favored 'General case' 0 C--O 1.252 1.224 0 N-CA-C 114.818 1.414 . . . . 72.430000000000007 114.818 -169.517 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 8.2 mp -121.86 144.23 48.96 Favored 'General case' 0 N--CA 1.424 -1.747 0 CA-C-N 113.406 -1.724 . . . . 73.519999999999996 108.596 179.052 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 58.3 t -107.37 124.16 63.1 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.141 0 N-CA-C 106.907 -1.516 . . . . 73.409999999999997 106.907 179.433 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -100.33 130.33 46.42 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.92 -0.4 . . . . 75.439999999999998 109.92 -173.12 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -126.55 151.72 47.52 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 121.1 0.476 . . . . 74.140000000000001 109.774 -179.847 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -69.58 135.98 50.69 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.108 -1.441 . . . . 71.239999999999995 107.108 172.766 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -82.98 -177.25 51.92 Favored Glycine 0 N--CA 1.439 -1.131 0 C-N-CA 120.102 -1.047 . . . . 54.329999999999998 112.603 -174.907 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -73.66 123.41 8.53 Favored 'Trans proline' 0 N--CA 1.439 -1.732 0 C-N-CA 122.204 1.936 . . . . 63.420000000000002 109.715 175.922 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -96.6 107.79 20.28 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 108.93 -0.767 . . . . 72.0 108.93 -178.715 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 . . . . . 0 C--N 1.292 -1.916 0 N-CA-C 107.465 -1.309 . . . . 72.129999999999995 107.465 -179.273 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.4 ppp? . . . . . 0 C--O 1.239 0.535 0 N-CA-C 111.7 0.259 . . . . 74.450000000000003 111.7 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.6 p -65.24 -40.05 93.52 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 121.35 0.595 . . . . 74.409999999999997 111.951 -177.937 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -135.16 146.56 48.87 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 115.416 -0.811 . . . . 75.040000000000006 110.702 -174.004 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -123.3 87.21 2.71 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 122.52 1.153 . . . . 75.340000000000003 110.197 178.018 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -112.75 119.62 38.68 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 114.779 -1.101 . . . . 71.430000000000007 110.751 -179.227 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 154.51 115.86 0.56 Allowed Glycine 0 C--N 1.294 -1.759 0 N-CA-C 109.849 -1.3 . . . . 72.439999999999998 109.849 -178.692 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.3 m -82.65 124.8 77.1 Favored Pre-proline 0 C--N 1.299 -1.626 0 N-CA-C 109.236 -0.653 . . . . 73.109999999999999 109.236 -179.024 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.17 128.05 28.17 Favored 'Trans proline' 0 C--N 1.36 1.159 0 C-N-CA 122.331 2.02 . . . . 73.329999999999998 109.718 175.852 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -75.4 120.27 80.88 Favored Pre-proline 0 C--N 1.308 -1.229 0 CA-C-N 116.063 -0.517 . . . . 65.219999999999999 111.992 -173.141 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -82.16 129.55 6.07 Favored 'Trans proline' 0 N--CA 1.443 -1.487 0 C-N-CA 122.238 1.959 . . . . 75.230000000000004 110.321 175.935 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -89.21 119.58 29.83 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.624 -0.88 . . . . 74.310000000000002 108.624 179.381 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.9 m -91.77 166.82 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 116.32 -0.4 . . . . 72.439999999999998 111.389 -175.586 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -96.49 141.13 30.14 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 108.823 -0.806 . . . . 75.209999999999994 108.823 176.119 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 50.3 m -120.06 102.33 8.46 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-O 121.301 0.572 . . . . 73.010000000000005 109.911 178.89 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.9 m -123.9 141.49 51.99 Favored 'General case' 0 N--CA 1.408 -2.545 0 N-CA-C 105.644 -1.984 . . . . 74.319999999999993 105.644 177.533 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.3 t -132.17 146.4 52.0 Favored 'General case' 0 C--N 1.271 -2.805 0 N-CA-C 108.709 -0.848 . . . . 64.140000000000001 108.709 -177.888 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.7 m -86.12 138.88 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-O 121.11 0.481 . . . . 72.150000000000006 110.092 179.707 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -86.81 154.62 20.77 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 109.212 -0.662 . . . . 75.209999999999994 109.212 178.408 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 31.4 mmm180 -90.97 110.4 21.66 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 109.242 -0.651 . . . . 74.310000000000002 109.242 179.174 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.54 95.07 8.19 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.495 0.664 . . . . 74.510000000000005 110.594 -178.876 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -82.2 -33.7 29.28 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.642 -0.874 . . . . 74.530000000000001 108.642 176.417 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 59.6 tp 62.84 90.66 0.08 Allowed 'General case' 0 CA--C 1.508 -0.656 0 CA-C-N 114.139 -1.391 . . . . 71.409999999999997 109.609 -176.94 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.5 mp -76.75 114.59 15.68 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.386 -0.824 . . . . 62.350000000000001 108.847 -179.336 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -72.85 158.99 34.45 Favored 'General case' 0 C--O 1.25 1.128 0 CA-C-N 115.98 -0.555 . . . . 75.099999999999994 111.792 -175.825 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.18 174.02 6.06 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.44 -0.8 . . . . 75.409999999999997 111.12 178.556 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 16.0 tpt -134.15 122.74 23.29 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.269 -0.641 . . . . 61.439999999999998 109.269 177.929 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.84 177.82 5.97 Favored 'General case' 0 C--O 1.256 1.439 0 CA-C-O 120.946 0.403 . . . . 74.239999999999995 111.017 -179.847 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.1 t -145.68 129.87 17.57 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 107.888 -1.153 . . . . 63.039999999999999 107.888 -179.896 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.0 t -70.93 134.57 47.33 Favored 'General case' 0 N--CA 1.434 -1.231 0 O-C-N 123.73 0.644 . . . . 75.510000000000005 109.528 -179.87 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.3 t -132.16 157.59 43.89 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 108.472 -0.936 . . . . 74.439999999999998 108.472 179.512 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -75.96 85.13 0.89 Allowed Glycine 0 N--CA 1.438 -1.218 0 N-CA-C 111.363 -0.695 . . . . 63.149999999999999 111.363 179.131 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.6 t -82.04 158.93 23.6 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 109.34 -0.615 . . . . 72.519999999999996 109.34 179.306 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -87.21 129.21 52.55 Favored Pre-proline 0 C--N 1.304 -1.394 0 N-CA-C 110.358 -0.238 . . . . 74.340000000000003 110.358 -178.294 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -72.74 157.26 52.31 Favored 'Trans proline' 0 C--O 1.238 0.51 0 C-N-CA 121.999 1.799 . . . . 75.319999999999993 110.291 176.79 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -72.25 109.42 5.98 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.126 0.489 . . . . 71.25 110.8 -178.56 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.5 t -83.98 158.77 21.4 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.89 -0.595 . . . . 70.549999999999997 109.602 179.211 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -75.52 164.02 26.78 Favored 'General case' 0 N--CA 1.418 -2.072 0 N-CA-C 109.001 -0.74 . . . . 72.349999999999994 109.001 173.037 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -134.38 108.04 0.7 Allowed Glycine 0 N--CA 1.419 -2.446 0 C-N-CA 120.716 -0.754 . . . . 65.319999999999993 111.615 -176.943 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.94 -40.52 93.58 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 121.508 0.67 . . . . 63.539999999999999 110.603 178.679 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -64.21 -14.68 57.0 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.955 -1.02 . . . . 64.439999999999998 113.199 -179.394 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -77.26 -27.25 53.14 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-N 116.839 -0.164 . . . . 73.150000000000006 111.161 179.673 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -86.14 113.93 54.57 Favored Pre-proline 0 N--CA 1.437 -1.105 0 N-CA-C 109.624 -0.509 . . . . 74.400000000000006 109.624 -179.24 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -76.89 -68.48 0.02 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 121.558 1.505 . . . . 71.400000000000006 109.753 177.61 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -132.99 98.33 4.26 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 109.134 -0.691 . . . . 63.140000000000001 109.134 176.77 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -142.85 39.39 1.34 Allowed Glycine 0 C--N 1.289 -2.058 0 N-CA-C 106.635 -2.586 . . . . 55.130000000000003 106.635 177.996 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.7 m -90.88 167.42 12.45 Favored 'General case' 0 N--CA 1.414 -2.226 0 CA-C-N 113.058 -1.571 . . . . 74.109999999999999 111.383 -171.549 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.66 157.4 44.93 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 106.775 -1.565 . . . . 75.299999999999997 106.775 176.394 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.4 pp -134.63 151.97 51.44 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 119.632 -0.827 . . . . 61.130000000000003 111.787 -178.822 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -126.79 136.76 52.82 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.734 -0.666 . . . . 74.439999999999998 109.565 -179.6 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.431 ' CG2' ' HB ' ' A' ' 136' ' ' VAL . 33.5 m -114.24 128.97 71.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 109.202 -0.666 . . . . 71.420000000000002 109.202 175.475 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.6 t -95.14 125.57 47.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 109.439 -0.578 . . . . 72.420000000000002 109.439 -177.2 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -96.66 -34.07 11.52 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.879 -0.6 . . . . 75.030000000000001 110.078 176.17 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.44 ' O ' ' HB3' ' A' ' 133' ' ' PHE . 30.9 tpt180 -165.46 121.51 1.37 Allowed 'General case' 0 CA--C 1.496 -1.133 0 N-CA-C 108.992 -0.744 . . . . 75.140000000000001 108.992 175.938 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -163.19 164.88 36.3 Favored Glycine 0 N--CA 1.415 -2.714 0 N-CA-C 108.218 -1.953 . . . . 53.119999999999997 108.218 177.353 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.402 ' HB2' ' HB3' ' A' ' 82' ' ' ASP . 14.3 Cg_exo -68.82 -20.81 39.05 Favored 'Trans proline' 0 C--O 1.238 0.518 0 C-N-CA 122.385 2.057 . . . . 72.030000000000001 111.397 179.997 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.405 ' HB3' ' CA ' ' A' ' 80' ' ' LEU . 21.8 p-10 -68.52 -59.34 3.22 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 114.761 -1.109 . . . . 72.030000000000001 112.387 -178.651 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -175.75 -153.52 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 108.18 -1.044 . . . . 73.200000000000003 108.18 -173.096 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.03 54.05 0.35 Allowed Glycine 0 N--CA 1.428 -1.888 0 N-CA-C 107.708 -2.157 . . . . 73.150000000000006 107.708 178.677 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -135.91 -167.41 2.03 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 108.52 -0.918 . . . . 62.229999999999997 108.52 -173.93 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 17.7 ptp180 -116.12 144.95 43.47 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 120.546 0.213 . . . . 74.049999999999997 110.502 -177.95 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -136.81 140.48 42.5 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 108.516 -0.92 . . . . 74.420000000000002 108.516 179.97 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.1 tt -117.97 136.29 53.6 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 109.072 -0.714 . . . . 74.340000000000003 109.072 177.979 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -93.36 115.27 27.84 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.853 -0.425 . . . . 72.340000000000003 109.853 -178.889 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -109.6 13.41 23.89 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 122.439 1.114 . . . . 74.349999999999994 108.569 179.082 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -123.93 144.49 45.14 Favored Pre-proline 0 C--N 1.309 -1.172 0 CA-C-N 115.307 -0.861 . . . . 71.239999999999995 109.927 -177.628 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.531 ' HA ' ' CD1' ' A' ' 94' ' ' ILE . 10.1 Cg_endo -55.34 -54.98 3.5 Favored 'Trans proline' 0 C--N 1.358 1.037 0 C-N-CA 123.468 2.779 . . . . 73.430000000000007 113.851 -177.773 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 42.6 m -113.41 108.61 17.44 Favored 'General case' 0 N--CA 1.425 -1.676 0 N-CA-C 109.581 -0.525 . . . . 74.200000000000003 109.581 -178.718 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 24.8 m -103.23 114.16 28.22 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 108.982 -0.748 . . . . 73.140000000000001 108.982 175.899 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.6 p -98.51 115.25 28.16 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 121.794 0.806 . . . . 74.420000000000002 111.814 -179.555 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.63 134.87 41.89 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 106.901 -1.518 . . . . 70.400000000000006 106.901 175.685 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 82.57 73.56 1.22 Allowed Glycine 0 C--N 1.3 -1.436 0 C-N-CA 119.702 -1.237 . . . . 71.209999999999994 110.327 -175.183 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 56.9 ttt180 -158.35 106.61 1.95 Allowed 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 105.206 -2.146 . . . . 75.129999999999995 105.206 -178.472 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 19.0 m-70 -52.01 -68.37 0.42 Allowed Pre-proline 0 CA--C 1.55 0.959 0 N-CA-C 116.069 1.877 . . . . 75.239999999999995 116.069 -169.999 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -66.97 -40.15 12.51 Favored 'Trans proline' 0 C--N 1.359 1.093 0 C-N-CA 121.286 1.324 . . . . 73.200000000000003 114.101 -176.18 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -125.77 75.58 1.51 Allowed 'General case' 0 C--N 1.32 -0.675 0 O-C-N 122.293 -0.254 . . . . 72.349999999999994 110.521 -175.588 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 18.0 p -78.31 123.17 26.66 Favored 'General case' 0 C--N 1.28 -2.454 0 C-N-CA 119.11 -1.036 . . . . 73.239999999999995 109.093 176.391 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -67.09 -55.56 13.76 Favored 'General case' 0 CA--C 1.485 -1.537 0 N-CA-C 107.365 -1.346 . . . . 73.219999999999999 107.365 175.696 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 45.4 pt -125.67 148.0 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.847 0 CA-C-N 115.047 -0.979 . . . . 65.239999999999995 108.427 173.998 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -97.51 136.22 38.24 Favored 'General case' 0 C--N 1.276 -2.592 0 CA-C-N 115.321 -0.854 . . . . 75.200000000000003 108.929 177.151 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.405 ' CA ' ' HB3' ' A' ' 56' ' ' ASN . 58.1 tp -144.21 -88.62 0.12 Allowed 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.799 -0.815 . . . . 74.239999999999995 108.799 -175.158 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -76.34 96.93 4.1 Favored 'General case' 0 C--N 1.261 -3.242 0 N-CA-C 108.36 -0.978 . . . . 74.040000000000006 108.36 171.478 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.402 ' HB3' ' HB2' ' A' ' 55' ' ' PRO . 14.6 t70 -81.09 -54.96 5.09 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.269 -0.878 . . . . 54.340000000000003 110.206 -179.077 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.9 t -85.11 -39.91 14.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 CA-C-N 114.882 -1.054 . . . . 75.319999999999993 109.123 -178.994 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.6 p -87.47 32.78 0.7 Allowed 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 124.386 1.075 . . . . 61.020000000000003 111.395 -178.328 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.9 p -81.3 139.87 17.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 CA-C-N 115.171 -0.922 . . . . 71.140000000000001 112.137 -171.909 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 23.3 t -128.52 -176.86 3.95 Favored 'General case' 0 N--CA 1.424 -1.767 0 N-CA-C 107.625 -1.25 . . . . 75.450000000000003 107.625 175.88 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -100.77 120.41 40.07 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 123.446 0.699 . . . . 74.340000000000003 109.227 -177.94 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 64.49 32.92 11.42 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 108.419 -0.956 . . . . 73.530000000000001 108.419 -176.372 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 67.4 t60 -46.79 -66.45 0.4 Allowed 'General case' 0 C--O 1.241 0.641 0 C-N-CA 124.759 1.224 . . . . 75.219999999999999 112.429 -175.317 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.465 ' HA ' ' HA ' ' A' ' 103' ' ' ASP . . . -141.05 141.34 34.3 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 121.147 -0.221 . . . . 54.43 110.776 -178.129 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -116.32 127.75 54.96 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.33 0.586 . . . . 75.400000000000006 110.791 177.495 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -105.11 112.64 25.84 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 105.611 -1.996 . . . . 72.409999999999997 105.611 174.302 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -124.38 150.09 45.94 Favored 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 120.49 -0.484 . . . . 75.420000000000002 109.742 -176.522 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.531 ' CD1' ' HA ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -116.95 139.1 45.32 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.063 0 C-N-CA 118.985 -1.086 . . . . 72.510000000000005 108.444 172.233 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -119.22 145.33 46.14 Favored 'General case' 0 C--N 1.27 -2.884 0 N-CA-C 105.793 -1.929 . . . . 75.519999999999996 105.793 176.696 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.94 -20.15 8.33 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 114.038 1.125 . . . . 75.439999999999998 114.038 -173.457 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -106.46 -31.95 3.84 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 119.953 -1.118 . . . . 74.200000000000003 114.16 177.789 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -145.33 147.34 32.21 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-N 117.65 0.725 . . . . 73.400000000000006 109.803 -175.026 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.407 ' HB2' ' HB3' ' A' ' 122' ' ' MET . 30.5 m-85 -94.9 129.88 41.73 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 106.974 -1.491 . . . . 74.239999999999995 106.974 176.4 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -132.3 129.26 39.32 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 119.535 -0.866 . . . . 74.439999999999998 111.76 -175.061 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 61.4 t -114.11 118.1 57.44 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 107.842 -1.17 . . . . 73.340000000000003 107.842 177.552 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 30.8 m -121.06 130.82 74.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 CA-C-N 115.934 -0.576 . . . . 75.310000000000002 109.991 178.9 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.465 ' HA ' ' HA ' ' A' ' 90' ' ' ALA . 0.7 OUTLIER -97.0 138.78 34.0 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 117.326 -1.75 . . . . 74.319999999999993 108.406 170.718 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.8 m -124.18 -2.46 6.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 112.183 0.438 . . . . 61.409999999999997 112.183 179.948 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -89.86 -44.9 4.69 Favored Glycine 0 CA--C 1.509 -0.319 0 N-CA-C 109.752 -1.339 . . . . 65.099999999999994 109.752 175.97 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 14.2 m 58.79 29.2 18.41 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 114.414 1.264 . . . . 72.200000000000003 114.414 174.013 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 49.3 tp -85.32 -48.21 9.28 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 120.109 -0.636 . . . . 72.519999999999996 112.541 -177.659 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -87.64 -19.45 27.71 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 119.448 -0.901 . . . . 62.310000000000002 111.315 -176.247 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 97.34 127.97 5.81 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 120.418 -0.896 . . . . 74.310000000000002 113.666 176.855 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.406 HG21 ' HB3' ' A' ' 103' ' ' ASP . 5.7 p -109.47 134.33 52.01 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 123.281 0.632 . . . . 74.120000000000005 111.335 -179.407 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.438 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 26.6 m-85 -138.78 147.47 42.63 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 107.583 -1.265 . . . . 74.340000000000003 107.583 178.435 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.6 p -123.19 125.81 72.52 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 N-CA-C 106.088 -1.819 . . . . 74.310000000000002 106.088 171.271 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 17.6 m120 62.93 22.15 13.28 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.068 0.547 . . . . 72.040000000000006 109.796 -175.952 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 40.8 mtp180 75.05 12.25 3.46 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.334 1.453 . . . . 75.109999999999999 112.396 -177.126 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -102.85 118.27 58.68 Favored Pre-proline 0 C--N 1.31 -1.115 0 N-CA-C 105.983 -1.858 . . . . 74.409999999999997 105.983 176.27 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -46.66 119.61 3.37 Favored 'Trans proline' 0 C--N 1.362 1.273 0 C-N-CA 123.767 2.978 . . . . 74.340000000000003 112.508 -178.122 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 12.0 tpt180 -153.25 118.91 5.3 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 109.936 -0.394 . . . . 75.439999999999998 109.936 -173.627 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -81.63 -38.76 25.47 Favored 'General case' 0 C--N 1.317 -0.839 0 O-C-N 123.521 0.513 . . . . 72.239999999999995 112.103 -179.085 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -125.4 139.46 53.64 Favored 'General case' 0 N--CA 1.437 -1.119 0 C-N-CA 120.444 -0.502 . . . . 73.439999999999998 110.171 -178.857 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -139.36 137.95 36.18 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 109.044 -0.725 . . . . 75.340000000000003 109.044 175.66 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.2 t -111.83 97.72 6.11 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 CA-C-N 115.404 -0.816 . . . . 73.209999999999994 108.91 -177.828 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.407 ' HB3' ' HB2' ' A' ' 99' ' ' PHE . 26.3 ptt? 41.5 98.11 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 127.118 2.167 . . . . 70.319999999999993 116.293 179.091 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 52.1 tp60 -121.69 122.34 39.36 Favored 'General case' 0 N--CA 1.385 -3.706 0 N-CA-C 101.28 -3.6 . . . . 74.439999999999998 101.28 174.52 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 14.9 t -110.29 127.74 55.17 Favored 'General case' 0 C--N 1.29 -2.003 0 C-N-CA 119.194 -1.003 . . . . 74.430000000000007 110.666 -172.404 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 87.62 16.9 59.35 Favored Glycine 0 N--CA 1.425 -2.077 0 N-CA-C 110.218 -1.153 . . . . 74.450000000000003 110.218 -178.334 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -112.61 162.15 16.01 Favored 'General case' 0 CA--C 1.484 -1.589 0 N-CA-C 112.527 0.565 . . . . 73.150000000000006 112.527 -179.68 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -107.58 122.58 46.96 Favored 'General case' 0 N--CA 1.421 -1.878 0 CA-C-N 114.761 -1.109 . . . . 71.430000000000007 111.049 -172.148 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 68.7 mt -101.37 129.87 51.79 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 N-CA-C 106.967 -1.494 . . . . 72.540000000000006 106.967 176.499 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.438 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 34.6 tt0 -110.76 125.46 53.56 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 109.2 -0.667 . . . . 72.439999999999998 109.2 -179.659 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -112.5 109.87 30.13 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 N-CA-C 108.6 -0.889 . . . . 74.420000000000002 108.6 177.667 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 71.21 -82.37 0.45 Allowed Glycine 0 C--N 1.308 -0.991 0 CA-C-N 115.735 -0.666 . . . . 52.109999999999999 112.094 -176.995 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -146.14 8.16 1.07 Allowed 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.771 -0.826 . . . . 74.420000000000002 108.771 179.118 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.44 ' HB3' ' O ' ' A' ' 53' ' ' ARG . 35.4 m-85 -104.7 150.83 24.39 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.781 -0.822 . . . . 73.510000000000005 108.781 -175.429 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.34 130.74 55.51 Favored 'General case' 0 C--O 1.258 1.505 0 C-N-CA 119.05 -1.06 . . . . 74.420000000000002 112.931 -177.701 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.7 tt -123.79 137.99 54.58 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 125.808 1.643 . . . . 70.549999999999997 107.287 -177.245 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.431 ' HB ' ' CG2' ' A' ' 50' ' ' VAL . 60.8 t -108.81 127.15 65.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 108.677 -0.86 . . . . 70.409999999999997 108.677 177.021 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -102.47 130.4 49.27 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 116.209 -0.45 . . . . 65.409999999999997 110.558 -175.071 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -125.34 148.94 48.53 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 109.239 -0.652 . . . . 75.430000000000007 109.239 178.843 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -81.33 135.23 35.68 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.433 -0.951 . . . . 74.420000000000002 108.433 176.739 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.49 153.71 52.66 Favored Glycine 0 N--CA 1.437 -1.281 0 C-N-CA 120.933 -0.651 . . . . 74.209999999999994 111.518 -178.03 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -68.01 137.56 41.43 Favored 'Trans proline' 0 N--CA 1.445 -1.336 0 C-N-CA 122.401 2.068 . . . . 73.299999999999997 113.002 -177.809 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -82.47 103.64 12.17 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 107.478 -1.304 . . . . 71.120000000000005 107.478 176.934 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 . . . . . 0 C--N 1.284 -2.269 0 N-CA-C 107.273 -1.381 . . . . 71.200000000000003 107.273 -175.771 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.0 mtp . . . . . 0 C--O 1.241 0.64 0 CA-C-O 120.755 0.312 . . . . 71.030000000000001 110.429 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.0 p -73.45 -49.53 26.38 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-N 116.484 -0.325 . . . . 74.030000000000001 110.264 -178.333 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 44.22 71.74 0.23 Allowed 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.958 1.303 . . . . 74.25 112.38 -179.806 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 49.7 t-20 -117.9 119.77 35.86 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 107.245 -1.391 . . . . 54.509999999999998 107.245 -179.803 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -94.38 112.08 23.85 Favored 'General case' 0 C--N 1.286 -2.152 0 N-CA-C 109.16 -0.682 . . . . 60.210000000000001 109.16 -177.131 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.85 123.97 8.07 Favored Glycine 0 N--CA 1.435 -1.424 0 N-CA-C 110.905 -0.878 . . . . 73.310000000000002 110.905 -178.966 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.0 p -94.42 126.13 49.29 Favored Pre-proline 0 C--N 1.299 -1.606 0 CA-C-N 116.687 0.244 . . . . 73.25 111.2 -179.099 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.477 ' O ' ' HD3' ' A' ' 10' ' ' PRO . 24.1 Cg_exo -65.39 129.76 23.49 Favored 'Trans proline' 0 C--O 1.245 0.83 0 C-N-CA 121.954 1.769 . . . . 73.549999999999997 110.309 175.748 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -103.64 95.8 7.92 Favored Pre-proline 0 C--N 1.315 -0.933 0 N-CA-C 108.23 -1.026 . . . . 71.200000000000003 108.23 178.672 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' A' ' 8' ' ' PRO . 90.9 Cg_endo -92.8 179.14 1.23 Allowed 'Trans proline' 0 N--CA 1.445 -1.366 0 C-N-CA 122.823 2.349 . . . . 73.200000000000003 113.298 -174.469 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 67.96 84.79 0.15 Allowed 'General case' 0 CA--C 1.509 -0.621 0 C-N-CA 125.285 1.434 . . . . 73.140000000000001 112.14 -179.159 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 24.5 t -113.62 78.03 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 108.503 -0.925 . . . . 74.409999999999997 108.503 178.543 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -140.01 131.23 26.57 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.057 -1.09 . . . . 75.310000000000002 108.057 177.816 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.0 m -143.98 76.67 1.52 Allowed 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 106.551 -1.648 . . . . 73.099999999999994 106.551 172.93 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.1 m -99.59 90.33 4.45 Favored 'General case' 0 N--CA 1.413 -2.299 0 CA-C-N 115.406 -0.815 . . . . 74.230000000000004 110.013 -177.907 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.7 m -125.02 70.31 1.15 Allowed 'General case' 0 N--CA 1.415 -2.194 0 N-CA-C 107.148 -1.427 . . . . 71.340000000000003 107.148 175.698 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.8 m -104.13 152.57 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 CA-C-N 114.876 -1.056 . . . . 65.109999999999999 109.575 -176.966 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 59.25 74.29 0.45 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.713 1.258 . . . . 74.409999999999997 109.649 -176.849 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 15.9 mtm-85 -107.42 142.29 37.48 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.196 -1.038 . . . . 73.010000000000005 108.196 -176.908 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -90.89 79.46 5.91 Favored 'General case' 0 N--CA 1.416 -2.156 0 N-CA-C 107.686 -1.228 . . . . 74.150000000000006 107.686 173.912 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -59.57 -50.55 73.46 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-N 115.191 -0.913 . . . . 74.430000000000007 109.073 -179.793 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 62.8 tp -145.53 119.92 9.64 Favored 'General case' 0 N--CA 1.427 -1.597 0 N-CA-C 107.898 -1.149 . . . . 75.340000000000003 107.898 174.629 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.8 tt -109.62 98.85 8.14 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 106.361 -1.718 . . . . 72.109999999999999 106.361 175.991 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -140.64 88.83 2.22 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.801 -1.185 . . . . 65.200000000000003 107.801 179.878 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -78.03 145.4 35.93 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 114.826 -1.079 . . . . 64.450000000000003 111.973 -175.648 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -69.3 125.15 25.8 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 114.874 -1.057 . . . . 75.420000000000002 108.483 177.749 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -116.39 -68.66 0.9 Allowed 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.787 -1.19 . . . . 64.200000000000003 107.787 -178.225 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 49.9 m -101.52 93.93 5.63 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 108.941 -0.763 . . . . 75.5 108.941 177.187 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.9 p -82.14 -23.64 35.5 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 121.441 0.639 . . . . 74.430000000000007 110.707 -179.671 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.3 m -104.81 168.31 9.15 Favored 'General case' 0 N--CA 1.425 -1.71 0 N-CA-C 107.357 -1.349 . . . . 75.329999999999998 107.357 179.558 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -87.21 67.49 3.33 Favored Glycine 0 C--N 1.315 -0.588 0 C-N-CA 120.972 -0.633 . . . . 71.310000000000002 112.149 -178.237 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.0 p -91.72 147.61 22.86 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 122.405 0.282 . . . . 74.319999999999993 111.047 179.402 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.69 120.7 78.47 Favored Pre-proline 0 C--N 1.31 -1.112 0 N-CA-C 108.712 -0.847 . . . . 64.010000000000005 108.712 177.648 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -74.82 127.42 10.8 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 122.232 1.955 . . . . 72.409999999999997 112.713 -177.59 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -140.0 79.15 1.7 Allowed 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.617 -0.883 . . . . 55.310000000000002 108.617 176.856 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.6 m -148.19 162.25 39.82 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.823 -0.806 . . . . 71.549999999999997 108.823 -178.533 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.2 t -129.22 162.41 27.91 Favored 'General case' 0 N--CA 1.421 -1.896 0 CA-C-O 120.861 0.362 . . . . 71.519999999999996 110.114 -179.957 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -156.99 33.21 0.56 Allowed Glycine 0 N--CA 1.433 -1.517 0 N-CA-C 109.92 -1.272 . . . . 72.239999999999995 109.92 179.436 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.94 -22.82 65.92 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 123.235 0.614 . . . . 70.200000000000003 111.285 -176.852 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -84.53 -27.03 27.64 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.992 -0.549 . . . . 71.409999999999997 110.351 175.725 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.442 HD21 HD22 ' A' ' 42' ' ' LEU . 9.1 t30 -81.13 -43.1 19.9 Favored 'General case' 0 CA--C 1.504 -0.806 0 CA-C-N 116.046 -0.525 . . . . 71.040000000000006 110.21 -175.314 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.442 HD22 HD21 ' A' ' 41' ' ' ASN . 3.5 mm? -89.06 144.31 32.5 Favored Pre-proline 0 N--CA 1.427 -1.578 0 N-CA-C 107.659 -1.237 . . . . 74.510000000000005 107.659 175.749 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -60.39 108.55 0.53 Allowed 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 121.827 1.685 . . . . 73.25 109.856 175.468 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.89 141.93 54.53 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.149 -0.932 . . . . 74.230000000000004 113.051 -175.587 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -155.35 67.69 0.3 Allowed Glycine 0 N--CA 1.433 -1.504 0 N-CA-C 108.132 -1.987 . . . . 73.310000000000002 108.132 177.812 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.518 ' O ' ' HA ' ' A' ' 141' ' ' PRO . 16.3 m -90.7 162.05 15.09 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 115.1 -0.55 . . . . 74.150000000000006 111.166 -173.993 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -136.77 177.6 7.73 Favored 'General case' 0 C--O 1.253 1.278 0 N-CA-C 107.816 -1.179 . . . . 64.219999999999999 107.816 176.482 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -118.54 146.67 44.38 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 120.171 -0.612 . . . . 73.230000000000004 112.536 -172.471 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -124.38 132.95 53.54 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.161 -1.051 . . . . 74.329999999999998 108.161 177.501 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 26.0 t -125.9 144.75 34.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 108.849 -0.797 . . . . 74.420000000000002 108.849 -176.823 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 57.7 t -92.46 127.73 44.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 108.624 -0.88 . . . . 74.140000000000001 108.624 179.795 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -94.45 -38.33 10.99 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.655 -0.702 . . . . 70.0 110.142 -179.604 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 5.5 tpm_? -160.51 114.14 2.11 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.625 -0.716 . . . . 75.319999999999993 110.125 -175.094 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 158.32 125.64 0.84 Allowed Glycine 0 N--CA 1.426 -1.968 0 O-C-N 124.106 0.879 . . . . 73.099999999999994 111.189 176.845 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.559 ' HD2' ' CZ ' ' A' ' 133' ' ' PHE . 50.4 Cg_exo -59.76 -10.63 12.32 Favored 'Trans proline' 0 N--CA 1.489 1.261 0 C-N-CA 123.291 2.661 . . . . 71.549999999999997 113.646 177.599 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.555 ' HB2' ' O ' ' A' ' 79' ' ' PHE . 4.3 p-10 -52.44 -36.41 54.48 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.297 1.039 . . . . 73.230000000000004 110.046 179.59 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -171.93 -162.28 0.21 Allowed 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.513 1.125 . . . . 62.450000000000003 108.123 -179.681 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 172.58 62.64 0.05 OUTLIER Glycine 0 CA--C 1.491 -1.408 0 N-CA-C 110.205 -1.158 . . . . 65.209999999999994 110.205 -179.266 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -163.53 -176.4 4.68 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 107.329 -1.36 . . . . 75.049999999999997 107.329 -176.762 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -103.54 136.06 43.97 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 124.013 0.821 . . . . 75.430000000000007 109.374 176.687 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -121.76 149.93 42.59 Favored 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 108.664 -0.865 . . . . 74.409999999999997 108.664 178.161 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 38.6 tp -114.55 135.81 53.71 Favored 'General case' 0 C--N 1.285 -2.212 0 N-CA-C 106.294 -1.743 . . . . 74.340000000000003 106.294 178.122 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 94.7 mt -79.73 112.94 17.49 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 118.519 -1.272 . . . . 72.209999999999994 109.575 179.064 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -121.02 -0.59 9.99 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-O 121.58 0.705 . . . . 70.230000000000004 109.397 178.973 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -115.63 138.71 24.02 Favored Pre-proline 0 C--N 1.303 -1.431 0 N-CA-C 108.532 -0.914 . . . . 74.319999999999993 108.532 -177.693 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -63.33 -30.92 73.57 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.367 2.044 . . . . 74.329999999999998 112.055 -179.801 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 40.9 m -136.73 114.92 11.6 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 109.892 -0.41 . . . . 74.439999999999998 109.892 177.571 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 24.7 m -110.66 114.11 27.25 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 109.029 -0.73 . . . . 74.219999999999999 109.029 179.318 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 49.4 p -93.27 124.85 37.54 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.118 0.485 . . . . 70.140000000000001 111.633 -179.384 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -109.15 126.45 53.25 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 109.1 -0.704 . . . . 64.349999999999994 109.1 176.498 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -173.94 -171.92 38.78 Favored Glycine 0 N--CA 1.43 -1.706 0 C-N-CA 120.377 -0.916 . . . . 64.099999999999994 111.323 178.538 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -109.69 88.04 2.65 Favored 'General case' 0 N--CA 1.423 -1.777 0 N-CA-C 107.294 -1.373 . . . . 72.239999999999995 107.294 179.467 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 9.8 t-160 -164.18 133.19 2.86 Favored Pre-proline 0 C--N 1.279 -2.476 0 N-CA-C 105.185 -2.154 . . . . 72.329999999999998 105.185 -179.872 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -51.06 -37.06 56.72 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 123.16 2.573 . . . . 61.109999999999999 112.933 -178.917 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -102.07 70.13 1.19 Allowed 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 122.569 1.176 . . . . 74.430000000000007 111.828 179.298 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 31.1 m -126.25 169.28 13.04 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 113.29 -1.777 . . . . 74.340000000000003 106.673 174.582 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -79.38 -38.53 34.7 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 119.872 -0.731 . . . . 60.43 110.579 -178.29 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 39.0 pt -136.73 171.06 17.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 108.591 -0.892 . . . . 73.430000000000007 108.591 173.125 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.555 ' O ' ' HB2' ' A' ' 56' ' ' ASN . 98.0 m-85 -105.25 137.23 43.37 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 112.448 0.536 . . . . 75.030000000000001 112.448 -175.807 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.465 ' HA ' ' HB2' ' A' ' 56' ' ' ASN . 1.7 tt -146.96 104.8 3.73 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 104.658 -2.349 . . . . 74.120000000000005 104.658 177.16 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -115.78 13.5 16.15 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 114.378 1.251 . . . . 64.120000000000005 114.378 -171.252 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.509 ' OD2' ' HB ' ' A' ' 85' ' ' VAL 0.292 3.1 p30 -31.76 -88.72 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.378 0 N-CA-C 115.785 1.772 . . . . 71.239999999999995 115.785 -174.744 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.483 ' H ' ' CG ' ' A' ' 82' ' ' ASP . 7.5 p -163.99 -46.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 C-N-CA 123.13 0.572 . . . . 74.510000000000005 110.732 178.25 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 18.0 m -110.12 27.41 9.64 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 123.337 1.541 . . . . 63.109999999999999 109.007 -177.41 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.509 ' HB ' ' OD2' ' A' ' 82' ' ' ASP . 6.3 p -82.25 138.96 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.935 0 CA-C-N 113.48 -1.691 . . . . 74.329999999999998 109.177 178.333 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 20.2 m -87.59 178.01 6.9 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 115.629 -0.714 . . . . 74.200000000000003 110.186 -179.318 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 45.5 mtm180 -64.84 -46.1 83.31 Favored 'General case' 0 C--O 1.221 -0.414 0 N-CA-C 109.964 -0.384 . . . . 73.450000000000003 109.964 178.095 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.56 112.12 17.08 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 104.985 -2.228 . . . . 74.310000000000002 104.985 163.774 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.414 ' CE1' ' HA3' ' A' ' 105' ' ' GLY . 27.2 t60 -104.64 -54.8 2.45 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 115.483 -0.781 . . . . 73.109999999999999 110.916 -170.702 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -120.01 129.67 54.37 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 108.827 -0.805 . . . . 73.200000000000003 108.827 -178.808 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -106.49 127.0 52.96 Favored 'General case' 0 C--N 1.287 -2.142 0 C-N-CA 120.159 -0.616 . . . . 75.230000000000004 109.987 178.478 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -106.94 113.07 26.33 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 106.355 -1.72 . . . . 74.519999999999996 106.355 176.784 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -128.92 150.97 50.14 Favored 'General case' 0 C--N 1.282 -2.35 0 C-N-CA 119.658 -0.817 . . . . 75.420000000000002 111.963 -176.578 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.445 HD12 ' CD2' ' A' ' 99' ' ' PHE . 4.0 tp -115.62 120.14 63.88 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 CA-C-N 114.919 -1.037 . . . . 75.150000000000006 109.252 -179.828 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -101.24 146.72 27.16 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 107.266 -1.383 . . . . 63.210000000000001 107.266 178.409 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.41 -14.21 7.16 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.436 0.532 . . . . 74.340000000000003 112.436 179.866 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -86.29 -64.85 1.44 Allowed Glycine 0 N--CA 1.42 -2.414 0 N-CA-C 110.95 -0.86 . . . . 75.129999999999995 110.95 171.427 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -146.45 177.89 8.69 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 117.306 0.553 . . . . 74.219999999999999 111.348 -175.15 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.445 ' CD2' HD12 ' A' ' 94' ' ' ILE . 89.7 m-85 -90.93 130.59 36.85 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.724 -1.213 . . . . 72.239999999999995 107.724 176.693 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -132.29 135.29 46.12 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 120.53 -0.468 . . . . 73.439999999999998 110.78 -176.63 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 5.0 p -120.91 119.69 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.095 0 CA-C-O 121.599 0.714 . . . . 71.219999999999999 109.765 179.671 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 30.5 m -119.35 128.26 75.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-N 115.228 -0.896 . . . . 74.049999999999997 111.004 -178.089 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -91.73 132.45 36.38 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 115.682 -0.69 . . . . 75.129999999999995 109.754 176.153 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 26.8 m -115.02 11.52 7.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 CA-C-O 121.274 0.559 . . . . 70.140000000000001 110.781 175.096 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.414 ' HA3' ' CE1' ' A' ' 89' ' ' HIS . . . -122.99 56.09 0.67 Allowed Glycine 0 C--O 1.247 0.928 0 N-CA-C 109.651 -1.38 . . . . 75.209999999999994 109.651 179.17 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 12.5 m -68.9 -8.56 45.29 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 113.288 0.847 . . . . 72.530000000000001 113.288 -171.773 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.6 tt -71.31 -37.78 71.78 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 107.551 -1.278 . . . . 74.409999999999997 107.551 176.829 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -84.97 -42.31 15.04 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.527 -1.286 . . . . 72.409999999999997 107.527 176.746 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 88.38 122.73 1.94 Allowed Glycine 0 N--CA 1.439 -1.16 0 CA-C-N 114.971 -1.013 . . . . 64.420000000000002 114.965 174.35 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 31.5 m -100.85 140.33 35.3 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.066 -1.087 . . . . 64.129999999999995 108.066 172.781 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -127.41 168.41 14.89 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.732 0.777 . . . . 74.209999999999994 111.186 -174.69 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 13.7 p -122.81 143.66 34.94 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 N-CA-C 105.846 -1.909 . . . . 75.129999999999995 105.846 174.173 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -19.05 90.91 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 126.322 1.849 . . . . 74.299999999999997 113.874 -176.944 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 67.04 2.1 2.6 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 127.982 2.513 . . . . 71.519999999999996 115.392 175.209 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -124.86 142.31 40.61 Favored Pre-proline 0 C--N 1.312 -1.044 0 O-C-N 121.45 -0.781 . . . . 75.140000000000001 112.169 -178.822 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -79.04 98.91 1.22 Allowed 'Trans proline' 0 C--O 1.246 0.899 0 C-N-CA 122.766 2.311 . . . . 75.439999999999998 114.493 -175.998 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 65.5 mtp180 -140.2 119.91 13.35 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.417 -0.957 . . . . 74.200000000000003 108.417 174.3 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -85.92 -23.31 27.03 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 124.103 0.877 . . . . 72.299999999999997 109.92 -175.688 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -125.1 138.36 54.17 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 107.183 -1.414 . . . . 61.310000000000002 107.183 174.177 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -141.47 149.84 41.46 Favored 'General case' 0 C--N 1.288 -2.072 0 CA-C-N 116.045 -0.525 . . . . 73.239999999999995 110.899 -177.119 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.3 p -85.66 122.66 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.684 0 N-CA-C 103.372 -2.825 . . . . 73.510000000000005 103.372 170.187 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.45 ' HE3' ' CD1' ' A' ' 137' ' ' PHE . 12.3 ttt -65.69 113.3 4.17 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.426 0.631 . . . . 71.540000000000006 109.923 -168.806 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -103.64 133.92 47.84 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 115.148 -0.933 . . . . 74.329999999999998 109.944 -171.252 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.4 ' CB ' ' HB3' ' A' ' 139' ' ' ALA . 41.1 p -83.15 129.54 35.03 Favored 'General case' 0 N--CA 1.412 -2.336 0 CA-C-N 115.463 -0.789 . . . . 70.319999999999993 110.53 -177.732 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 107.75 -9.55 37.6 Favored Glycine 0 N--CA 1.416 -2.674 0 CA-C-N 115.689 -0.687 . . . . 74.129999999999995 111.654 177.239 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -116.26 176.18 5.22 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 118.504 -1.278 . . . . 70.310000000000002 112.592 -175.82 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -109.16 128.22 54.84 Favored 'General case' 0 N--CA 1.428 -1.575 0 C-N-CA 125.318 1.447 . . . . 73.140000000000001 110.348 -174.521 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 68.6 mt -115.97 130.3 70.91 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 N-CA-C 107.194 -1.409 . . . . 75.129999999999995 107.194 179.253 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -104.29 111.5 24.16 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 119.945 -0.702 . . . . 74.209999999999994 109.833 -177.682 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.8 pp -95.17 113.71 30.16 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 CA-C-N 115.567 -0.742 . . . . 75.010000000000005 110.812 179.68 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 72.28 -89.25 0.51 Allowed Glycine 0 N--CA 1.437 -1.262 0 N-CA-C 109.648 -1.381 . . . . 71.120000000000005 109.648 -174.033 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -142.3 3.8 1.56 Allowed 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 109.435 -0.58 . . . . 71.329999999999998 109.435 177.128 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.559 ' CZ ' ' HD2' ' A' ' 55' ' ' PRO . 21.7 m-85 -102.52 150.37 23.46 Favored 'General case' 0 CA--C 1.513 -0.47 0 O-C-N 122.026 -0.422 . . . . 74.310000000000002 110.42 -176.807 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -104.6 122.93 46.64 Favored 'General case' 0 C--O 1.252 1.231 0 CA-C-O 121.505 0.669 . . . . 73.209999999999994 112.331 -174.219 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 31.1 tp -117.78 138.47 52.03 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 114.546 -1.207 . . . . 75.200000000000003 107.828 179.729 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 10.2 p -115.08 138.75 44.37 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 N-CA-C 108.683 -0.858 . . . . 71.019999999999996 108.683 177.639 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.45 ' CD1' ' HE3' ' A' ' 122' ' ' MET . 42.3 t80 -114.5 123.4 49.29 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.776 -0.824 . . . . 73.230000000000004 108.776 -177.937 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -114.62 148.24 38.38 Favored 'General case' 0 C--O 1.253 1.259 0 CA-C-O 121.111 0.481 . . . . 74.5 111.549 -175.649 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.4 ' HB3' ' CB ' ' A' ' 124' ' ' THR . . . -85.18 99.31 11.0 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-N 115.491 -0.777 . . . . 73.129999999999995 109.731 177.768 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -140.09 77.17 0.32 Allowed Glycine 0 C--N 1.281 -2.526 0 N-CA-C 107.817 -2.113 . . . . 74.549999999999997 107.817 175.002 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.518 ' HA ' ' O ' ' A' ' 46' ' ' SER . 14.9 Cg_endo -59.13 113.56 1.64 Allowed 'Trans proline' 0 CA--C 1.498 -1.323 0 C-N-CA 122.674 2.249 . . . . 74.430000000000007 113.799 -173.759 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -103.51 104.59 14.68 Favored 'General case' 0 C--N 1.269 -2.895 0 CA-C-N 113.616 -1.629 . . . . 74.439999999999998 108.706 -179.981 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 . . . . . 0 N--CA 1.402 -2.87 0 N-CA-C 107.019 -1.475 . . . . 71.329999999999998 107.019 -179.944 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.1 mtt . . . . . 0 N--CA 1.469 0.497 0 N-CA-C 109.478 -0.564 . . . . 73.430000000000007 109.478 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.4 m -76.66 -28.74 56.1 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 107.66 -1.237 . . . . 65.010000000000005 107.66 173.983 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -82.15 142.03 32.57 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 113.669 -1.605 . . . . 75.109999999999999 107.747 174.946 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -169.48 167.37 9.9 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.623 -0.51 . . . . 74.329999999999998 109.623 176.927 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -163.3 128.94 3.14 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.292 -1.003 . . . . 71.329999999999998 108.292 176.075 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -92.02 156.5 23.67 Favored Glycine 0 N--CA 1.427 -1.92 0 C-N-CA 120.619 -0.8 . . . . 53.530000000000001 111.435 179.94 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.0 m -82.7 129.71 61.24 Favored Pre-proline 0 C--N 1.294 -1.823 0 N-CA-C 109.106 -0.702 . . . . 74.420000000000002 109.106 179.131 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -66.61 127.9 18.07 Favored 'Trans proline' 0 N--CA 1.447 -1.233 0 C-N-CA 121.553 1.502 . . . . 75.420000000000002 109.321 173.295 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -83.34 136.73 42.79 Favored Pre-proline 0 C--N 1.295 -1.794 0 N-CA-C 108.524 -0.917 . . . . 75.219999999999999 108.524 179.132 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_exo -70.41 116.02 4.44 Favored 'Trans proline' 0 N--CA 1.441 -1.578 0 C-N-CA 121.426 1.417 . . . . 72.030000000000001 109.611 176.209 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 25.7 mp0 -66.96 124.22 22.4 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.429 -0.952 . . . . 72.129999999999995 108.429 179.128 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.6 m -53.36 126.51 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 O-C-N 124.279 0.987 . . . . 72.340000000000003 110.526 -178.621 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -70.23 139.37 52.23 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-N 115.539 -0.755 . . . . 53.32 110.826 -177.147 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 64.4 m -144.56 138.88 27.8 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 107.881 -1.155 . . . . 64.400000000000006 107.881 179.162 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 21.1 m -116.56 126.83 53.86 Favored 'General case' 0 N--CA 1.414 -2.243 0 N-CA-C 108.771 -0.826 . . . . 71.140000000000001 108.771 -177.025 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.4 t -60.88 -54.13 48.86 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 121.811 0.815 . . . . 73.510000000000005 110.036 179.696 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.9 m -141.5 133.3 28.09 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.906 0 CA-C-N 113.982 -1.463 . . . . 74.409999999999997 109.964 177.927 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -72.73 112.51 8.84 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 108.24 -1.022 . . . . 75.219999999999999 108.24 175.105 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 52.2 mtt180 -102.54 110.08 21.91 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 115.496 -0.775 . . . . 75.129999999999995 109.396 -177.9 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.49 67.26 7.58 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 121.181 0.515 . . . . 73.030000000000001 109.8 178.315 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -65.61 -43.94 88.06 Favored 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 108.723 -0.843 . . . . 72.340000000000003 108.723 177.721 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 94.2 mt 55.06 47.36 22.16 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 124.35 1.031 . . . . 74.340000000000003 112.235 171.623 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -96.56 104.74 16.75 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.665 -1.235 . . . . 75.129999999999995 107.665 179.725 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.73 135.86 42.55 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.833 -0.803 . . . . 73.129999999999995 108.833 178.709 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -107.27 151.44 25.46 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-O 121.074 0.464 . . . . 74.430000000000007 110.866 -179.944 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 21.5 ptp -150.98 136.42 17.8 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 106.422 -1.695 . . . . 75.439999999999998 106.422 176.122 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -72.86 87.44 1.3 Allowed 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 122.165 0.983 . . . . 72.439999999999998 112.586 -178.491 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.9 t -116.44 122.54 45.07 Favored 'General case' 0 N--CA 1.419 -1.996 0 CA-C-N 114.121 -1.4 . . . . 74.0 108.835 -177.074 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.6 t -118.83 103.52 9.7 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.566 -1.272 . . . . 74.129999999999995 107.566 177.455 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 24.4 p -101.7 111.9 24.3 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.833 -0.621 . . . . 74.519999999999996 110.505 -177.376 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -117.06 114.9 3.11 Favored Glycine 0 N--CA 1.43 -1.766 0 C-N-CA 120.724 -0.75 . . . . 71.540000000000006 111.341 -179.701 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 14.4 t -111.1 163.09 14.23 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.01 -1.107 . . . . 73.319999999999993 108.01 178.61 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -85.14 118.15 70.24 Favored Pre-proline 0 C--N 1.307 -1.247 0 N-CA-C 110.272 -0.27 . . . . 71.120000000000005 110.272 -179.589 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -73.93 145.33 35.77 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.287 1.991 . . . . 54.25 111.584 -179.569 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -90.24 87.99 7.05 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 121.352 0.596 . . . . 74.200000000000003 109.743 178.965 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.9 m -97.74 18.96 14.48 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 121.971 0.891 . . . . 73.319999999999993 110.031 179.889 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.9 p -93.83 152.77 18.67 Favored 'General case' 0 N--CA 1.419 -2.008 0 CA-C-N 114.884 -1.053 . . . . 63.310000000000002 110.394 179.739 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 115.17 -9.21 20.67 Favored Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.673 -0.775 . . . . 70.019999999999996 112.253 179.705 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.95 -28.64 60.66 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.323 0.582 . . . . 74.150000000000006 110.126 179.309 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -64.05 -11.59 30.91 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.835 0.854 . . . . 75.349999999999994 112.355 178.725 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -75.5 -13.89 60.39 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 112.959 0.725 . . . . 74.109999999999999 112.959 -179.238 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.9 pp -59.57 149.78 69.11 Favored Pre-proline 0 CA--C 1.551 0.989 0 N-CA-C 111.719 0.266 . . . . 70.109999999999999 111.719 179.649 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -67.68 -75.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.156 1.904 . . . . 75.319999999999993 112.504 179.667 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -171.03 167.68 7.15 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 108.751 -0.833 . . . . 71.519999999999996 108.751 179.728 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 138.15 59.14 0.05 OUTLIER Glycine 0 CA--C 1.494 -1.272 0 N-CA-C 109.718 -1.353 . . . . 64.310000000000002 109.718 -178.553 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.1 m -91.19 163.57 14.21 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 121.711 0.767 . . . . 63.32 112.327 -173.746 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.557 ' HA ' ' N ' ' A' ' 140' ' ' GLY . . . -126.71 165.95 18.29 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 106.981 -1.489 . . . . 74.099999999999994 106.981 176.625 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.1 pp -129.91 150.66 51.1 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 113.087 0.773 . . . . 74.209999999999994 113.087 -173.83 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.5 HD12 ' CE1' ' A' ' 61' ' ' PHE . 4.4 pp -119.46 147.73 44.07 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.614 -0.721 . . . . 75.530000000000001 109.774 178.044 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.9 t -124.87 125.58 69.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 107.745 -1.205 . . . . 74.329999999999998 107.745 179.221 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.0 t -93.02 118.1 37.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 108.394 -0.965 . . . . 74.040000000000006 108.394 178.632 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -83.77 -34.12 24.86 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.354 0.597 . . . . 73.319999999999993 110.02 -178.428 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -155.55 125.94 6.76 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.269 -0.878 . . . . 74.519999999999996 108.783 176.283 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 155.44 109.52 0.32 Allowed Glycine 0 N--CA 1.415 -2.727 0 N-CA-C 111.649 -0.58 . . . . 74.200000000000003 111.649 -179.545 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -58.5 -8.58 5.6 Favored 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 124.47 3.446 . . . . 73.049999999999997 112.808 177.997 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 50.5 m-20 -52.34 -37.28 55.59 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.213 1.405 . . . . 71.420000000000002 109.229 174.306 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -159.97 -63.45 0.07 Allowed 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.659 -0.701 . . . . 72.519999999999996 109.873 -179.872 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.89 34.27 59.21 Favored Glycine 0 C--O 1.223 -0.553 0 CA-C-N 115.981 -0.554 . . . . 74.450000000000003 111.93 -179.861 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -149.42 -173.86 4.51 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 108.15 -1.056 . . . . 63.549999999999997 108.15 -178.159 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.2 ptt180 -119.79 150.1 40.96 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 108.454 -0.943 . . . . 75.109999999999999 108.454 175.777 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.5 ' CE1' HD12 ' A' ' 49' ' ' LEU . 52.0 p90 -157.23 151.72 25.25 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.598 -0.519 . . . . 72.239999999999995 109.598 173.031 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.2 pp -88.11 140.85 29.07 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 108.886 -0.783 . . . . 63.109999999999999 108.886 176.05 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 90.9 mt -71.58 113.04 8.21 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.672 -0.862 . . . . 74.310000000000002 108.672 179.667 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -110.67 -33.48 6.55 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 114.71 -1.132 . . . . 43.340000000000003 109.542 -178.967 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -79.23 122.27 84.01 Favored Pre-proline 0 C--N 1.308 -1.207 0 N-CA-C 107.22 -1.4 . . . . 74.310000000000002 107.22 179.728 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -51.55 -31.77 41.16 Favored 'Trans proline' 0 C--N 1.367 1.552 0 C-N-CA 123.509 2.806 . . . . 61.420000000000002 112.634 -176.8 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.4 m -134.5 97.05 3.71 Favored 'General case' 0 N--CA 1.417 -2.098 0 N-CA-C 107.904 -1.147 . . . . 64.230000000000004 107.904 173.404 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 86.0 m -91.73 118.46 30.69 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.963 -1.125 . . . . 71.549999999999997 107.963 -179.277 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 27.6 m -108.41 121.04 44.12 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-O 121.775 0.797 . . . . 72.049999999999997 111.919 -176.478 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.459 ' O ' ' HB3' ' A' ' 89' ' ' HIS . . . -98.16 103.3 15.23 Favored 'General case' 0 N--CA 1.416 -2.168 0 N-CA-C 106.876 -1.527 . . . . 64.299999999999997 106.876 174.232 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 111.07 69.86 0.59 Allowed Glycine 0 N--CA 1.429 -1.795 0 C-N-CA 119.76 -1.21 . . . . 54.350000000000001 111.224 -177.9 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -151.0 61.11 0.92 Allowed 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 104.093 -2.558 . . . . 71.040000000000006 104.093 177.993 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 16.5 t60 -37.95 -43.97 1.74 Allowed Pre-proline 0 CA--C 1.578 2.021 0 N-CA-C 116.559 2.059 . . . . 73.409999999999997 116.559 -167.338 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -60.15 -40.25 61.92 Favored 'Trans proline' 0 C--N 1.374 1.921 0 CA-C-N 121.559 1.593 . . . . 62.109999999999999 113.207 175.405 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -149.84 88.03 1.52 Allowed 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 108.946 -0.761 . . . . 74.120000000000005 108.946 -179.078 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 53.4 m -101.61 152.17 21.13 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 116.439 -0.346 . . . . 74.209999999999994 110.425 179.577 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -72.22 -43.8 63.88 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 106.136 -1.801 . . . . 74.129999999999995 106.136 171.103 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 30.0 pt -131.68 130.26 61.95 Favored 'Isoleucine or valine' 0 C--O 1.245 0.868 0 CA-C-N 114.407 -1.27 . . . . 75.140000000000001 108.507 171.802 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -90.73 116.99 29.02 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 116.314 -0.403 . . . . 73.239999999999995 109.978 -177.063 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 97.2 mt -66.86 172.33 4.48 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.318 0.58 . . . . 73.450000000000003 111.251 -179.859 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -73.87 -12.16 60.59 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.792 -0.64 . . . . 60.030000000000001 110.732 179.04 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.417 ' HA ' HG22 ' A' ' 85' ' ' VAL . 1.6 m-20 54.05 78.4 0.16 Allowed 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 115.085 -0.962 . . . . 73.230000000000004 113.369 -176.74 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 44.2 t -93.06 -37.04 8.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 106.92 -1.511 . . . . 71.329999999999998 106.92 173.727 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 76.1 m -179.55 84.37 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 127.971 2.508 . . . . 73.310000000000002 105.473 -178.616 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.417 HG22 ' HA ' ' A' ' 82' ' ' ASP . 78.8 t -103.34 136.18 37.33 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.192 0 CA-C-N 115.204 -0.907 . . . . 73.219999999999999 109.726 -176.662 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 23.3 t -74.3 180.0 4.23 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 115.147 -0.933 . . . . 75.409999999999997 111.04 -176.096 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 -68.15 -34.19 75.88 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 107.615 -1.254 . . . . 75.019999999999996 107.615 178.841 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.469 ' O ' HG21 ' A' ' 104' ' ' VAL . 0.2 OUTLIER -139.45 125.66 20.08 Favored 'General case' 0 CA--C 1.495 -1.145 0 N-CA-C 101.236 -3.616 . . . . 74.510000000000005 101.236 167.572 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.459 ' HB3' ' O ' ' A' ' 70' ' ' ALA . 6.7 t60 -100.65 -79.32 0.5 Allowed 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 118.619 -1.233 . . . . 73.510000000000005 112.403 -173.996 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -120.07 107.81 13.51 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.152 0.501 . . . . 73.019999999999996 109.772 -178.867 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -95.5 127.89 41.91 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 109.027 -0.731 . . . . 74.040000000000006 109.027 178.909 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -112.74 112.27 23.66 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 107.321 -1.363 . . . . 74.219999999999999 107.321 176.737 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 54.7 ttp180 -103.59 124.19 48.35 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.325 -0.991 . . . . 75.310000000000002 108.325 178.42 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.36 117.02 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.319 0 CA-C-O 122.122 0.963 . . . . 62.229999999999997 109.443 -173.243 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 -118.41 144.69 45.75 Favored 'General case' 0 C--N 1.28 -2.415 0 N-CA-C 103.174 -2.899 . . . . 62.549999999999997 103.174 172.142 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.09 -16.07 63.63 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 121.067 0.46 . . . . 70.219999999999999 112.196 -177.627 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -90.07 -45.19 4.54 Favored Glycine 0 N--CA 1.431 -1.688 0 CA-C-N 115.534 -0.757 . . . . 74.150000000000006 112.695 174.883 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -136.41 140.88 43.51 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 121.297 0.57 . . . . 64.310000000000002 110.96 -176.977 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -112.54 125.95 54.81 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 107.177 -1.416 . . . . 75.239999999999995 107.177 179.561 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -132.39 137.78 47.46 Favored 'General case' 0 C--N 1.309 -1.178 0 C-N-CA 120.051 -0.659 . . . . 74.540000000000006 112.179 -179.051 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.8 p -115.85 125.95 73.18 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 CA-C-N 115.211 -0.904 . . . . 64.340000000000003 109.551 179.518 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 46.3 t -112.97 115.52 50.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 CA-C-N 115.951 -0.568 . . . . 74.420000000000002 109.697 -179.28 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -95.95 107.5 19.78 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 121.644 0.735 . . . . 75.349999999999994 110.048 177.034 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.469 HG21 ' O ' ' A' ' 88' ' ' ARG . 1.3 m -114.0 16.02 8.07 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.277 0 CA-C-N 115.075 -0.966 . . . . 74.25 109.659 175.5 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -122.35 45.43 1.21 Allowed Glycine 0 N--CA 1.438 -1.189 0 N-CA-C 109.119 -1.593 . . . . 73.219999999999999 109.119 176.265 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.5 p -69.68 -13.65 62.41 Favored 'General case' 0 C--O 1.249 1.037 0 C-N-CA 124.702 1.201 . . . . 71.549999999999997 112.973 -175.427 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 49.9 tp -67.73 -43.84 79.03 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 108.212 -1.033 . . . . 73.450000000000003 108.212 175.442 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -74.77 -47.68 29.68 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 107.123 -1.436 . . . . 72.340000000000003 107.123 173.065 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 100.31 96.02 2.18 Favored Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 115.16 0.824 . . . . 63.329999999999998 115.16 175.01 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 51.7 m -91.2 120.11 31.85 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.359 -0.978 . . . . 71.310000000000002 108.359 173.044 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.444 ' HB3' ' HA ' ' A' ' 114' ' ' ARG . 59.9 m-85 -102.35 134.58 45.42 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 108.574 -0.898 . . . . 74.239999999999995 108.574 178.774 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 34.5 t -117.62 121.95 68.68 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 N-CA-C 105.415 -2.069 . . . . 75.200000000000003 105.415 176.131 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.447 ' HA ' ' OD1' ' A' ' 126' ' ' ASP . 14.2 m120 67.52 18.19 10.0 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 107.211 -1.403 . . . . 75.200000000000003 107.211 -172.672 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.444 ' HA ' ' HB3' ' A' ' 111' ' ' TYR 0.344 44.7 mtt85 68.79 12.67 8.73 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 113.626 -1.625 . . . . 74.209999999999994 114.207 -173.354 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -97.85 135.96 21.32 Favored Pre-proline 0 N--CA 1.442 -0.865 0 N-CA-C 107.866 -1.161 . . . . 74.450000000000003 107.866 174.681 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -68.61 115.81 4.1 Favored 'Trans proline' 0 C--O 1.24 0.605 0 C-N-CA 121.864 1.71 . . . . 72.140000000000001 109.12 172.787 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 37.9 mmt180 -134.76 131.11 37.17 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 107.97 -1.122 . . . . 75.239999999999995 107.97 -178.285 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -77.85 -29.49 50.5 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.823 0.821 . . . . 73.109999999999999 109.092 176.682 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -144.35 137.52 27.18 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 107.132 -1.432 . . . . 71.439999999999998 107.132 171.343 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -142.06 150.42 41.21 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 109.66 -0.496 . . . . 74.420000000000002 109.66 177.96 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 48.5 t -80.62 112.66 18.93 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.156 0 N-CA-C 105.107 -2.183 . . . . 75.120000000000005 105.107 173.414 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.408 ' HG2' ' CE2' ' A' ' 137' ' ' PHE . 22.1 ttt -64.27 122.54 16.91 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.183 -0.917 . . . . 73.400000000000006 109.325 -171.817 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 56.1 tp60 -104.73 125.91 51.28 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.766 -0.652 . . . . 72.400000000000006 111.145 -171.182 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 10.5 p -79.31 116.38 19.52 Favored 'General case' 0 N--CA 1.434 -1.232 0 C-N-CA 123.271 0.628 . . . . 74.530000000000001 109.945 178.793 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 115.33 7.11 17.06 Favored Glycine 0 N--CA 1.435 -1.38 0 C-N-CA 120.547 -0.835 . . . . 60.340000000000003 112.881 178.178 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.447 ' OD1' ' HA ' ' A' ' 113' ' ' ASN . 8.0 t70 -128.63 -165.7 1.54 Allowed 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.584 -0.895 . . . . 65.120000000000005 108.584 -179.606 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -128.99 149.86 50.64 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.773 0.797 . . . . 72.519999999999996 113.133 -172.294 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 65.8 mt -124.02 129.9 74.04 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 107.912 -1.144 . . . . 72.349999999999994 107.912 -178.188 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -117.91 112.77 20.77 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 109.616 -0.512 . . . . 75.540000000000006 109.616 -177.125 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.415 HD12 ' H ' ' A' ' 130' ' ' ILE . 0.2 OUTLIER -94.19 105.69 17.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 109.367 -0.605 . . . . 75.150000000000006 109.367 178.708 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 71.07 -104.26 1.38 Allowed Glycine 0 N--CA 1.433 -1.53 0 N-CA-C 110.297 -1.121 . . . . 73.239999999999995 110.297 -176.633 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 42.8 mtpt -123.72 14.58 9.38 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 120.996 0.427 . . . . 72.109999999999999 109.927 177.67 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -101.04 132.12 46.62 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.915 -0.402 . . . . 64.540000000000006 109.915 -179.11 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 17.8 ptt180 -96.98 121.43 38.85 Favored 'General case' 0 C--O 1.254 1.341 0 CA-C-O 121.726 0.774 . . . . 74.010000000000005 112.234 -176.773 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.4 tt -125.19 142.99 51.16 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 114.466 -1.243 . . . . 72.140000000000001 107.715 178.415 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 10.0 p -119.2 140.27 43.72 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 N-CA-C 108.661 -0.866 . . . . 74.439999999999998 108.661 177.671 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.408 ' CE2' ' HG2' ' A' ' 122' ' ' MET . 59.6 t80 -120.2 118.0 29.36 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 120.976 0.417 . . . . 73.420000000000002 110.482 -176.4 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -118.61 173.92 6.57 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 109.401 -0.592 . . . . 75.329999999999998 109.401 -176.626 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -71.1 149.89 46.02 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.629 -1.249 . . . . 74.430000000000007 107.629 172.804 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.557 ' N ' ' HA ' ' A' ' 47' ' ' ALA . . . -96.34 -160.52 32.41 Favored Glycine 0 C--N 1.287 -2.163 0 C-N-CA 120.46 -0.876 . . . . 64.400000000000006 111.478 -176.844 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -69.52 121.95 8.69 Favored 'Trans proline' 0 N--CA 1.434 -1.995 0 C-N-CA 121.823 1.682 . . . . 74.430000000000007 110.895 179.634 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -85.62 103.41 14.42 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 105.579 -2.008 . . . . 72.349999999999994 105.579 177.596 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 . . . . . 0 N--CA 1.42 -1.973 0 N-CA-C 108.141 -1.059 . . . . 72.209999999999994 108.141 -171.357 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.514 -0.42 0 N-CA-C 108.921 -0.77 . . . . 65.530000000000001 108.921 . . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.4 t -83.31 -49.93 8.88 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.4 -0.592 . . . . 75.040000000000006 109.4 -179.526 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . 0.288 0.6 OUTLIER 36.01 79.7 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 116.17 1.915 . . . . 63.299999999999997 116.17 179.486 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -163.84 171.5 15.35 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.549 -1.278 . . . . 75.439999999999998 107.549 178.327 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -107.19 105.84 16.02 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 108.843 -0.799 . . . . 75.219999999999999 108.843 177.891 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -152.68 32.89 0.82 Allowed Glycine 0 C--N 1.29 -1.995 0 N-CA-C 109.815 -1.314 . . . . 71.510000000000005 109.815 178.492 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.8 p -75.76 129.69 80.73 Favored Pre-proline 0 N--CA 1.424 -1.756 0 CA-C-N 115.007 -0.596 . . . . 74.109999999999999 110.381 -177.381 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -55.49 133.03 55.69 Favored 'Trans proline' 0 C--O 1.241 0.658 0 C-N-CA 123.137 2.558 . . . . 71.510000000000005 112.587 -178.592 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -96.59 125.49 46.89 Favored Pre-proline 0 N--CA 1.431 -1.383 0 N-CA-C 107.974 -1.121 . . . . 75.010000000000005 107.974 175.987 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -55.42 136.01 71.8 Favored 'Trans proline' 0 C--O 1.245 0.835 0 C-N-CA 122.958 2.438 . . . . 75.209999999999994 112.157 -178.496 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -72.31 108.84 5.65 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.162 -0.681 . . . . 75.340000000000003 109.162 -178.885 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 36.2 t -87.88 115.82 28.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 109.657 -0.497 . . . . 75.099999999999994 109.657 -176.812 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -135.01 121.77 20.9 Favored 'General case' 0 N--CA 1.424 -1.77 0 N-CA-C 108.376 -0.972 . . . . 74.5 108.376 177.085 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.4 t -78.57 -25.07 45.26 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.215 0.531 . . . . 71.349999999999994 109.799 178.914 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.8 m 68.31 12.32 8.7 Favored 'General case' 0 CA--C 1.564 1.485 0 C-N-CA 124.426 1.09 . . . . 74.129999999999995 110.751 177.375 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.2 t -146.34 111.18 5.26 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 107.33 -1.359 . . . . 75.340000000000003 107.33 -179.452 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 46.5 t -106.9 123.78 62.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 N-CA-C 109.809 -0.441 . . . . 72.310000000000002 109.809 -176.458 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -89.23 131.4 35.36 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.434 -0.95 . . . . 74.329999999999998 108.434 176.506 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -118.4 138.48 52.42 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 110.054 -0.35 . . . . 74.450000000000003 110.054 179.718 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -97.08 74.1 2.55 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 105.995 -1.854 . . . . 65.319999999999993 105.995 171.865 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -73.48 -45.5 53.72 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 114.326 -1.306 . . . . 74.409999999999997 111.872 -169.323 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -117.56 114.49 23.5 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-O 120.965 0.412 . . . . 73.239999999999995 110.259 -179.928 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.3 tt -83.38 113.23 20.59 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.801 -1.185 . . . . 75.540000000000006 107.801 179.539 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.438 ' C ' ' HD3' ' A' ' 24' ' ' LYS . 0.7 OUTLIER -76.52 110.79 11.36 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 107.765 -1.198 . . . . 62.329999999999998 107.765 179.015 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -116.61 178.83 4.19 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 116.108 -0.496 . . . . 74.230000000000004 109.839 -179.246 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -165.24 169.6 15.77 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 105.862 -1.903 . . . . 72.400000000000006 105.862 -179.464 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.44 ' HG3' ' O ' ' A' ' 29' ' ' SER . 10.2 tp10 -139.06 141.11 38.22 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 118.59 0.632 . . . . 75.439999999999998 110.8 -177.684 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.3 p -104.28 -26.34 12.53 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 115.709 -0.678 . . . . 75.400000000000006 110.394 179.733 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.44 ' O ' ' HG3' ' A' ' 27' ' ' GLU . 23.3 m -88.6 175.26 7.63 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 107.89 -1.152 . . . . 71.340000000000003 107.89 176.745 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.2 t -169.26 176.02 5.37 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 109.106 -0.702 . . . . 60.549999999999997 109.106 178.189 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.51 109.43 2.94 Favored Glycine 0 N--CA 1.436 -1.331 0 N-CA-C 110.432 -1.067 . . . . 72.510000000000005 110.432 179.424 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.7 p -75.36 118.57 18.4 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-O 121.149 0.499 . . . . 75.25 110.544 179.838 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -89.73 122.52 67.99 Favored Pre-proline 0 C--N 1.308 -1.216 0 CA-C-N 115.939 -0.573 . . . . 72.349999999999994 110.255 -177.4 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -91.63 -176.77 0.88 Allowed 'Trans proline' 0 N--CA 1.441 -1.595 0 C-N-CA 122.087 1.858 . . . . 74.219999999999999 110.667 175.419 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -94.12 -3.78 50.46 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 109.14 -0.689 . . . . 72.030000000000001 109.14 177.133 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.8 m -86.45 88.41 7.63 Favored 'General case' 0 N--CA 1.421 -1.876 0 CA-C-N 115.202 -0.908 . . . . 75.450000000000003 112.448 -177.83 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 18.0 m -88.38 111.95 22.33 Favored 'General case' 0 N--CA 1.417 -2.078 0 N-CA-C 105.215 -2.142 . . . . 71.200000000000003 105.215 170.804 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.0 65.79 0.79 Allowed Glycine 0 N--CA 1.425 -2.079 0 N-CA-C 109.164 -1.575 . . . . 51.130000000000003 109.164 -173.344 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.85 -28.91 69.32 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 122.525 0.33 . . . . 73.040000000000006 110.691 -177.902 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.539 ' HA ' ' O ' ' A' ' 96' ' ' GLU . 1.6 pm0 -70.45 -11.89 61.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.39 0.614 . . . . 70.409999999999997 112.471 179.733 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -84.19 -14.41 50.16 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 116.014 -0.539 . . . . 75.409999999999997 111.349 176.293 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.3 mp -106.15 109.01 62.8 Favored Pre-proline 0 N--CA 1.435 -1.207 0 CA-C-N 116.331 -0.395 . . . . 74.120000000000005 111.97 -176.514 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -66.62 -24.68 47.97 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.029 1.82 . . . . 61.32 110.451 174.942 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -95.92 24.58 5.36 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.066 -0.97 . . . . 74.319999999999993 109.933 178.977 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -89.71 70.29 2.37 Favored Glycine 0 CA--C 1.489 -1.582 0 N-CA-C 107.212 -2.355 . . . . 74.150000000000006 107.212 176.198 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.6 p -88.78 152.74 21.59 Favored 'General case' 0 C--N 1.28 -2.429 0 N-CA-C 114.294 1.22 . . . . 74.450000000000003 114.294 -170.302 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -122.43 178.36 5.0 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 106.386 -1.709 . . . . 65.230000000000004 106.386 176.223 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -133.03 146.65 51.92 Favored 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 118.78 -1.168 . . . . 70.239999999999995 111.86 -176.742 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -109.49 131.73 54.79 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 107.365 -1.346 . . . . 74.439999999999998 107.365 176.959 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.4 t -114.07 118.49 58.56 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 N-CA-C 107.969 -1.122 . . . . 74.430000000000007 107.969 -179.077 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 6.5 t -92.86 116.19 33.42 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.151 0 N-CA-C 107.433 -1.321 . . . . 75.140000000000001 107.433 -179.44 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -74.4 -35.12 63.45 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.724 -0.843 . . . . 73.310000000000002 108.724 -178.943 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.515 ' O ' ' HB3' ' A' ' 133' ' ' PHE . 76.7 ttt180 -170.3 126.97 0.81 Allowed 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 103.578 -2.749 . . . . 75.129999999999995 103.578 176.084 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.478 ' HA2' ' HB3' ' A' ' 133' ' ' PHE . . . -151.35 174.15 30.6 Favored Glycine 0 N--CA 1.421 -2.321 0 C-N-CA 118.293 -1.908 . . . . 74.329999999999998 114.825 -174.745 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -68.65 -39.95 8.21 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 123.321 2.681 . . . . 61.409999999999997 111.748 -179.753 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -79.86 -56.26 4.4 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.609 -0.723 . . . . 75.129999999999995 110.449 -179.374 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -158.91 -160.99 0.91 Allowed 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 108.737 -0.838 . . . . 73.439999999999998 108.737 -175.801 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -152.06 46.81 0.58 Allowed Glycine 0 N--CA 1.43 -1.721 0 N-CA-C 107.384 -2.286 . . . . 70.439999999999998 107.384 -178.711 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -133.69 -172.78 3.05 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 107.384 -1.339 . . . . 65.430000000000007 107.384 -175.641 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 37.2 ptt180 -116.64 139.87 50.04 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 119.811 -0.756 . . . . 73.549999999999997 110.798 179.793 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -126.71 153.94 44.78 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.923 -0.769 . . . . 73.310000000000002 108.923 -177.239 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.0 mp -110.23 140.57 44.23 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.68 -0.859 . . . . 75.25 108.68 178.613 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -71.24 115.59 10.57 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 109.019 -0.734 . . . . 74.430000000000007 109.019 177.719 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -135.83 -26.46 1.2 Allowed 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 115.282 -0.872 . . . . 74.120000000000005 111.44 -175.32 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -108.83 125.88 30.67 Favored Pre-proline 0 C--N 1.311 -1.071 0 N-CA-C 108.49 -0.93 . . . . 75.400000000000006 108.49 179.244 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -41.41 -58.02 1.23 Allowed 'Trans proline' 0 C--N 1.37 1.676 0 C-N-CA 124.57 3.514 . . . . 73.420000000000002 114.738 -176.791 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 26.1 m -109.73 115.95 30.81 Favored 'General case' 0 N--CA 1.434 -1.271 0 C-N-CA 120.158 -0.617 . . . . 74.140000000000001 109.555 178.777 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 87.5 m -116.8 116.16 26.94 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.124 -1.435 . . . . 74.140000000000001 107.124 176.302 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.6 t -110.06 125.21 52.72 Favored 'General case' 0 N--CA 1.434 -1.235 0 C-N-CA 118.853 -1.139 . . . . 72.030000000000001 111.245 -175.576 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -100.22 110.0 22.25 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 115.161 -0.927 . . . . 53.350000000000001 109.142 179.5 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -178.96 -144.04 5.56 Favored Glycine 0 CA--C 1.468 -2.85 0 N-CA-C 109.005 -1.638 . . . . 52.530000000000001 109.005 -179.729 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 21.4 ttt180 -112.75 -89.8 0.52 Allowed 'General case' 0 N--CA 1.404 -2.763 0 C-N-CA 119.322 -0.951 . . . . 72.329999999999998 111.141 178.098 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 35.6 m170 59.97 156.96 0.1 Allowed Pre-proline 0 CA--C 1.547 0.859 0 CA-C-O 121.507 0.67 . . . . 74.540000000000006 111.576 -172.931 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -66.97 -25.55 44.52 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 121.248 1.299 . . . . 73.230000000000004 108.823 168.549 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -111.71 70.94 0.73 Allowed 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 114.355 -1.293 . . . . 54.509999999999998 108.378 -177.443 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.3 m -73.76 134.01 43.37 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.7 -0.682 . . . . 74.200000000000003 110.452 -178.948 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -78.8 -49.6 12.72 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 107.355 -1.35 . . . . 73.150000000000006 107.355 173.899 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 39.7 pt -125.43 141.84 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 N-CA-C 106.155 -1.795 . . . . 73.329999999999998 106.155 169.253 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -95.1 121.83 37.14 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-O 121.588 0.708 . . . . 61.109999999999999 111.903 -174.45 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.0 mp -88.25 118.1 27.61 Favored 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 107.777 -1.194 . . . . 72.400000000000006 107.777 172.411 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -96.65 -6.03 37.58 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.364 -1.289 . . . . 71.5 113.047 -165.699 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -78.75 -170.3 2.08 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 115.98 -0.554 . . . . 65.109999999999999 110.479 -177.554 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.8 p -122.36 7.83 5.61 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.42 0 CA-C-O 121.341 0.591 . . . . 73.430000000000007 111.63 -176.263 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 8.2 t -120.51 20.25 11.86 Favored 'General case' 0 C--N 1.308 -1.235 0 O-C-N 121.197 -0.94 . . . . 72.319999999999993 108.907 -179.775 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 86' ' ' SER . 6.1 p -81.42 131.27 34.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-N 114.496 -1.229 . . . . 61.509999999999998 111.737 -176.089 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.465 ' O ' HG23 ' A' ' 85' ' ' VAL . 44.7 t -70.34 157.03 38.48 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 114.629 -1.169 . . . . 70.510000000000005 108.103 175.653 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -52.58 -41.83 63.96 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.563 0.696 . . . . 74.439999999999998 110.398 179.209 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -138.0 130.81 29.82 Favored 'General case' 0 CA--C 1.488 -1.423 0 N-CA-C 103.786 -2.672 . . . . 75.530000000000001 103.786 168.299 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 37.7 t60 -107.71 -63.64 1.29 Allowed 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 119.45 -0.9 . . . . 71.430000000000007 110.588 -176.477 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -136.22 125.7 25.13 Favored 'General case' 0 C--N 1.292 -1.902 0 C-N-CA 120.08 -0.648 . . . . 75.150000000000006 110.036 -177.505 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -97.67 127.22 43.47 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 107.573 -1.269 . . . . 74.420000000000002 107.573 175.722 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -106.01 112.96 26.22 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.569 -1.271 . . . . 74.409999999999997 107.569 179.352 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -113.86 126.98 55.79 Favored 'General case' 0 C--N 1.277 -2.551 0 N-CA-C 108.524 -0.917 . . . . 73.439999999999998 108.524 -178.676 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.5 116.81 53.63 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 CA-C-O 122.048 0.928 . . . . 75.409999999999997 109.98 -178.357 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -108.7 145.75 34.57 Favored 'General case' 0 N--CA 1.419 -2.021 0 N-CA-C 106.0 -1.852 . . . . 73.439999999999998 106.0 174.506 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.539 ' O ' ' HA ' ' A' ' 40' ' ' GLU . 10.0 pt-20 -50.62 -28.03 8.0 Favored 'General case' 0 C--N 1.308 -1.197 0 O-C-N 124.059 0.85 . . . . 73.409999999999997 112.078 179.599 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.408 ' HA2' ' CB ' ' A' ' 40' ' ' GLU . . . -85.03 -51.35 3.8 Favored Glycine 0 N--CA 1.426 -2.027 0 C-N-CA 120.617 -0.801 . . . . 74.150000000000006 112.728 179.026 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -144.06 153.44 42.19 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-O 121.073 0.463 . . . . 75.329999999999998 111.087 -173.831 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -95.46 123.85 39.2 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.216 -1.031 . . . . 74.230000000000004 108.216 177.125 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -115.93 134.29 55.13 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.786 -0.45 . . . . 73.099999999999994 109.786 -178.407 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.6 p -125.33 126.2 70.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 109.272 -0.64 . . . . 74.329999999999998 109.272 177.437 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.7 t -114.56 123.68 70.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 CA-C-N 116.01 -0.541 . . . . 72.439999999999998 110.274 -179.35 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -89.5 115.91 27.27 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 121.567 0.699 . . . . 62.219999999999999 110.288 176.958 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 13.9 m -118.42 11.34 7.0 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.373 0 N-CA-C 108.184 -1.043 . . . . 62.130000000000003 108.184 173.94 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -110.17 34.57 5.34 Favored Glycine 0 N--CA 1.421 -2.335 0 N-CA-C 109.862 -1.295 . . . . 74.409999999999997 109.862 178.879 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.4 m -63.15 -9.73 12.11 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.947 1.299 . . . . 65.230000000000004 110.299 179.893 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 49.8 tp -58.27 -37.92 75.95 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 125.217 1.407 . . . . 64.439999999999998 107.825 174.707 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -110.15 -41.2 4.49 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 115.316 -0.856 . . . . 55.240000000000002 109.297 176.684 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 107.99 123.67 4.96 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 120.628 -0.796 . . . . 71.409999999999997 114.749 174.052 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 87.1 m -109.17 120.18 41.75 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.267 -1.012 . . . . 74.129999999999995 108.267 173.61 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . 0.25 40.5 p90 -123.48 135.81 54.25 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 114.407 1.262 . . . . 75.319999999999993 114.407 -177.83 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 18.2 m -105.09 136.33 39.35 Favored 'Isoleucine or valine' 0 C--O 1.257 1.448 0 CA-C-N 114.657 -1.156 . . . . 73.230000000000004 108.291 -179.994 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 12.6 m120 62.06 -83.02 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 124.685 1.194 . . . . 64.329999999999998 108.744 -169.549 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 27.5 mmm180 -139.74 -12.67 1.13 Allowed 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 124.052 0.941 . . . . 73.540000000000006 110.843 177.654 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -110.5 131.08 22.24 Favored Pre-proline 0 C--O 1.245 0.821 0 N-CA-C 113.891 1.071 . . . . 71.450000000000003 113.891 -168.205 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -65.14 136.05 46.21 Favored 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 122.748 2.299 . . . . 71.409999999999997 110.17 175.282 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -131.35 164.06 26.49 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.645 -0.502 . . . . 64.150000000000006 109.645 -178.156 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -93.48 -56.03 3.07 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 108.911 -0.774 . . . . 72.439999999999998 108.911 176.733 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -130.99 139.74 50.04 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 108.778 -0.823 . . . . 74.329999999999998 108.778 179.572 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -138.88 149.94 45.42 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-O 121.536 0.684 . . . . 74.340000000000003 112.828 -178.453 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 39.7 t -92.34 105.08 16.29 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.101 0 N-CA-C 104.107 -2.553 . . . . 74.219999999999999 104.107 172.328 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 9.6 tpt -50.38 120.47 4.61 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 125.065 1.346 . . . . 72.120000000000005 110.297 -171.561 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -104.92 132.07 51.62 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 121.26 0.552 . . . . 74.310000000000002 111.577 -172.083 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.2 p -79.16 115.77 19.03 Favored 'General case' 0 N--CA 1.424 -1.73 0 CA-C-N 115.014 -0.994 . . . . 75.209999999999994 110.756 -179.201 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 119.82 -7.01 12.18 Favored Glycine 0 N--CA 1.429 -1.788 0 C-N-CA 121.033 -0.604 . . . . 65.239999999999995 112.823 177.768 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -106.8 157.9 17.39 Favored 'General case' 0 C--O 1.247 0.932 0 C-N-CA 119.944 -0.702 . . . . 64.140000000000001 111.637 -177.731 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -114.51 121.36 43.28 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-O 122.153 0.978 . . . . 73.349999999999994 109.081 177.587 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 71.6 mt -111.79 130.42 65.42 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.358 0 CA-C-N 113.968 -1.469 . . . . 74.230000000000004 109.962 -170.586 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.482 ' HG3' ' O ' ' A' ' 133' ' ' PHE . 42.8 tt0 -97.36 124.85 41.66 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.99 -0.684 . . . . 74.5 111.438 178.028 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 11.8 pt -105.55 101.95 13.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 114.504 -1.226 . . . . 74.530000000000001 108.481 178.355 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 72.44 -101.76 1.11 Allowed Glycine 0 N--CA 1.437 -1.278 0 N-CA-C 110.273 -1.131 . . . . 74.439999999999998 110.273 -176.559 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 32.8 mmmt -126.0 9.75 7.51 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.23 0.538 . . . . 75.409999999999997 110.307 178.6 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.515 ' HB3' ' O ' ' A' ' 53' ' ' ARG . 78.5 m-85 -114.36 158.04 22.03 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 108.901 -0.777 . . . . 73.439999999999998 108.901 -179.013 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 51.4 ttp180 -127.49 135.61 50.62 Favored 'General case' 0 C--O 1.249 1.063 0 C-N-CA 118.567 -1.253 . . . . 74.030000000000001 112.731 -176.105 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 5.7 tt -122.16 132.11 54.29 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 114.191 -1.368 . . . . 71.299999999999997 107.465 -178.268 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 9.6 p -111.12 135.17 51.11 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 N-CA-C 108.631 -0.878 . . . . 55.310000000000002 108.631 178.294 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -113.84 121.41 43.93 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 109.631 -0.507 . . . . 72.140000000000001 109.631 -175.918 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -123.27 165.98 16.04 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 109.396 -0.594 . . . . 75.409999999999997 109.396 -177.983 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -71.16 130.3 41.13 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 107.522 -1.288 . . . . 74.439999999999998 107.522 174.167 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -116.99 -174.19 17.01 Favored Glycine 0 N--CA 1.418 -2.564 0 C-N-CA 120.115 -1.04 . . . . 64.340000000000003 112.952 -173.485 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -79.33 129.0 8.38 Favored 'Trans proline' 0 N--CA 1.428 -2.381 0 C-N-CA 122.5 2.133 . . . . 70.409999999999997 112.156 -179.626 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -95.17 104.3 16.17 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 105.57 -2.011 . . . . 64.430000000000007 105.57 172.762 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 . . . . . 0 C--N 1.303 -1.428 0 CA-C-O 118.491 -0.766 . . . . 74.209999999999994 110.653 -173.025 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 t30 . . . . . 0 C--O 1.233 0.208 0 CA-C-O 121.202 0.525 . . . . 72.530000000000001 111.077 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.01 25.75 27.01 Favored Glycine 0 N--CA 1.439 -1.134 0 C-N-CA 120.894 -0.67 . . . . 45.109999999999999 111.648 -178.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 61.7 m -87.28 123.51 69.76 Favored Pre-proline 0 N--CA 1.433 -1.278 0 N-CA-C 108.872 -0.788 . . . . 64.109999999999999 108.872 177.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -68.25 127.49 15.91 Favored 'Trans proline' 0 N--CA 1.448 -1.182 0 C-N-CA 121.659 1.573 . . . . 75.209999999999994 110.437 174.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -100.94 139.13 20.27 Favored Pre-proline 0 C--N 1.296 -1.736 0 N-CA-C 108.787 -0.82 . . . . 74.230000000000004 108.787 177.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -75.51 118.03 5.0 Favored 'Trans proline' 0 N--CA 1.441 -1.579 0 C-N-CA 121.845 1.697 . . . . 73.129999999999995 111.335 -177.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -76.82 173.74 11.34 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 108.953 -0.758 . . . . 71.400000000000006 108.953 177.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 45.1 t 61.21 81.09 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 108.189 -1.041 . . . . 64.219999999999999 108.189 -173.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -74.73 132.27 41.51 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 115.309 -0.86 . . . . 73.439999999999998 110.067 -176.217 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.9 t -124.21 108.71 12.57 Favored 'General case' 0 N--CA 1.407 -2.609 0 CA-C-O 121.794 0.807 . . . . 71.329999999999998 109.67 -178.008 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 15.2 t -112.61 -3.78 14.26 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 122.331 1.062 . . . . 65.129999999999995 108.361 176.128 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.6 p -92.07 35.88 0.98 Allowed 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 114.417 -1.265 . . . . 75.439999999999998 109.157 179.388 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.9 m . . . . . 0 N--CA 1.427 -1.612 0 CA-C-N 114.36 -1.291 . . . . 74.150000000000006 111.248 -177.027 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.471 0 N-CA-C 113.866 0.306 . . . . 62.450000000000003 113.866 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 9.0 m -113.69 153.79 28.37 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 109.715 -0.476 . . . . 54.219999999999999 109.715 -177.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.81 174.0 10.94 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.856 -0.794 . . . . 62.229999999999997 108.856 -178.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.5 pp -135.28 160.14 39.34 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 119.22 -0.992 . . . . 53.5 112.256 -177.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.9 pp -137.75 149.28 46.31 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 109.003 -0.739 . . . . 75.140000000000001 109.003 175.173 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 22.6 m -121.33 141.52 41.45 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.175 0 N-CA-C 107.14 -1.429 . . . . 64.010000000000005 107.14 175.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.0 t -92.85 116.81 34.81 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.614 0 N-CA-C 107.463 -1.31 . . . . 72.530000000000001 107.463 177.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.483 ' HB2' HG23 ' A' ' 136' ' ' VAL . 82.5 tttt -77.62 -21.76 51.8 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.109 -0.95 . . . . 64.409999999999997 109.214 -176.224 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.422 ' HB2' ' O ' ' A' ' 52' ' ' LYS . 65.6 ttt180 168.26 131.03 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.51 1.524 . . . . 73.120000000000005 109.536 163.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 175.88 152.69 9.72 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 121.044 -0.598 . . . . 42.240000000000002 112.032 178.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -69.84 -9.28 25.7 Favored 'Trans proline' 0 C--N 1.36 1.147 0 C-N-CA 123.795 2.997 . . . . 71.049999999999997 112.489 177.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -60.94 -42.64 98.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.795 -0.639 . . . . 73.209999999999994 110.656 -178.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -164.47 -58.99 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 109.254 -0.647 . . . . 64.420000000000002 109.254 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.45 32.82 36.91 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.692 -0.766 . . . . 65.140000000000001 111.614 -178.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -144.11 -164.74 1.96 Allowed 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 108.109 -1.071 . . . . 75.420000000000002 108.109 -177.015 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -115.48 138.56 50.89 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 120.769 0.319 . . . . 63.539999999999999 110.311 177.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -130.33 147.5 52.05 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.647 -0.706 . . . . 74.420000000000002 110.525 -170.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 93.2 mt -105.06 134.52 48.03 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.052 -0.721 . . . . 71.510000000000005 109.052 177.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.4 mp -110.78 114.37 27.68 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.221 -0.659 . . . . 75.530000000000001 109.221 178.009 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -131.76 4.66 4.22 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.828 -1.175 . . . . 64.25 107.828 172.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -83.56 124.79 75.05 Favored Pre-proline 0 N--CA 1.441 -0.911 0 N-CA-C 106.838 -1.542 . . . . 60.039999999999999 106.838 178.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.454 ' O ' ' HG3' ' A' ' 93' ' ' ARG . 1.2 Cg_endo -45.81 -46.23 15.74 Favored 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 123.291 2.661 . . . . 75.430000000000007 112.912 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 32.1 m -136.37 117.53 14.45 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 109.546 -0.539 . . . . 75.530000000000001 109.546 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 20.4 m -113.37 113.28 25.01 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 107.967 -1.123 . . . . 65.310000000000002 107.967 177.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.5 m -97.79 131.04 44.66 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.197 0.523 . . . . 32.509999999999998 110.756 -176.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.456 ' HB1' ' HB2' ' A' ' 80' ' ' LEU . . . -97.57 110.59 23.12 Favored 'General case' 0 N--CA 1.428 -1.526 0 CA-C-N 115.849 -0.614 . . . . 33.030000000000001 110.52 -178.209 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -136.47 -143.09 4.57 Favored Glycine 0 N--CA 1.437 -1.254 0 N-CA-C 108.703 -1.759 . . . . 64.230000000000004 108.703 178.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.521 ' O ' ' HD3' ' A' ' 72' ' ' ARG . 4.7 tmt_? -161.19 12.23 0.09 Allowed 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 122.128 0.965 . . . . 73.409999999999997 109.63 176.33 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 34.5 m170 -99.45 157.7 33.52 Favored Pre-proline 0 N--CA 1.433 -1.283 0 N-CA-C 108.03 -1.1 . . . . 72.540000000000006 108.03 -178.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_exo -56.48 -21.2 36.63 Favored 'Trans proline' 0 N--CA 1.478 0.582 0 C-N-CA 122.969 2.446 . . . . 64.140000000000001 113.88 -178.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.62 -1.68 43.21 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 112.253 0.464 . . . . 74.0 112.253 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 16.0 m -83.14 146.79 28.45 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 108.248 -1.019 . . . . 64.400000000000006 108.248 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -61.26 -60.03 4.38 Favored 'General case' 0 C--N 1.322 -0.618 0 O-C-N 123.273 0.358 . . . . 74.349999999999994 110.968 -176.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 38.2 pt -122.77 157.89 27.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-O 120.746 0.307 . . . . 64.439999999999998 110.194 176.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -97.07 126.54 42.3 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.017 -1.105 . . . . 71.209999999999994 108.017 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.456 ' HB2' ' HB1' ' A' ' 70' ' ' ALA . 1.2 tm? -108.71 -90.25 0.46 Allowed 'General case' 0 N--CA 1.418 -2.055 0 CA-C-O 121.153 0.501 . . . . 62.340000000000003 111.711 -175.428 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -96.81 118.04 32.38 Favored 'General case' 0 C--N 1.262 -3.211 0 CA-C-O 121.658 0.742 . . . . 74.230000000000004 109.238 -176.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -94.22 -40.25 10.1 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-N 114.412 -1.267 . . . . 63.119999999999997 112.273 -175.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 8.2 p -80.74 -31.66 12.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-N 115.63 -0.714 . . . . 45.299999999999997 110.423 -174.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 5.1 p -133.97 73.68 1.51 Allowed 'General case' 0 C--N 1.294 -1.829 0 CA-C-O 122.242 1.02 . . . . 71.340000000000003 109.291 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.402 HG12 ' H ' ' A' ' 85' ' ' VAL . 2.8 p -82.31 124.65 39.44 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 N-CA-C 114.55 1.315 . . . . 75.409999999999997 114.55 -169.351 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 51.0 m -96.54 139.5 32.55 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 105.514 -2.032 . . . . 63.329999999999998 105.514 167.071 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 8.8 ptp85 -56.69 -39.3 73.58 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 121.678 0.751 . . . . 73.340000000000003 112.045 -176.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.451 ' HB3' HG13 ' A' ' 104' ' ' VAL . 23.1 mmt180 -133.06 103.22 5.92 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 106.026 -1.842 . . . . 64.209999999999994 106.026 173.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 12.9 t60 -84.73 -69.92 0.61 Allowed 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.267 0.556 . . . . 73.010000000000005 110.341 -173.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -144.62 170.69 15.59 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.971 -0.752 . . . . 61.420000000000002 108.971 -176.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -144.45 128.19 17.24 Favored 'General case' 0 N--CA 1.419 -2.008 0 CA-C-O 121.317 0.58 . . . . 73.340000000000003 109.649 178.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -107.34 117.34 33.83 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.661 -1.237 . . . . 73.209999999999994 107.661 -177.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.454 ' HG3' ' O ' ' A' ' 66' ' ' PRO . 40.3 ttp85 -126.17 140.98 52.13 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-O 121.527 0.68 . . . . 61.310000000000002 111.053 -177.36 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.404 HD12 ' O ' ' A' ' 94' ' ' ILE . 2.9 pp -115.16 126.76 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.967 0 N-CA-C 106.865 -1.532 . . . . 74.540000000000006 106.865 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -118.43 146.25 44.59 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 108.698 -0.852 . . . . 73.040000000000006 108.698 -174.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.35 -29.52 4.03 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 114.267 1.21 . . . . 72.230000000000004 114.267 -177.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -96.7 -40.57 3.82 Favored Glycine 0 N--CA 1.432 -1.577 0 C-N-CA 120.755 -0.736 . . . . 71.230000000000004 114.088 177.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -150.65 171.02 17.79 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 117.417 0.608 . . . . 73.120000000000005 111.26 -172.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -105.46 128.6 53.63 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.109 -1.071 . . . . 75.239999999999995 108.109 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -132.5 135.18 45.83 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 120.321 -0.551 . . . . 71.310000000000002 111.596 -177.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.5 p -117.68 122.7 70.43 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 N-CA-C 109.166 -0.679 . . . . 74.109999999999999 109.166 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.3 m -119.95 137.63 53.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 112.694 0.627 . . . . 70.209999999999994 112.694 -177.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -83.26 126.33 32.55 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.622 -1.251 . . . . 75.540000000000006 107.622 171.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.451 HG13 ' HB3' ' A' ' 88' ' ' ARG . 8.2 p -105.33 1.8 10.32 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 CA-C-O 121.734 0.778 . . . . 75.129999999999995 110.518 -177.059 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 136.47 42.22 0.11 Allowed Glycine 0 N--CA 1.441 -0.976 0 C-N-CA 119.701 -1.238 . . . . 70.310000000000002 113.698 175.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 67.6 p -73.85 124.85 26.9 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-N 117.176 0.488 . . . . 53.329999999999998 109.706 178.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 51.1 tp -78.15 -26.01 47.58 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.447 0.642 . . . . 73.439999999999998 109.327 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -76.66 -23.54 53.26 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.505 -0.77 . . . . 44.109999999999999 110.388 178.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 94.93 132.56 6.86 Favored Glycine 0 N--CA 1.431 -1.634 0 CA-C-N 115.464 -0.789 . . . . 63.310000000000002 112.802 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 79.7 m -109.18 119.82 40.68 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.381 -0.97 . . . . 74.519999999999996 108.381 175.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -125.2 141.54 52.03 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 109.285 -0.635 . . . . 64.319999999999993 109.285 -175.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.474 HG21 ' HG3' ' A' ' 120' ' ' GLN . 28.3 m -98.86 111.45 28.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 N-CA-C 108.687 -0.857 . . . . 62.039999999999999 108.687 175.066 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 65.89 -76.99 0.04 OUTLIER 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 125.449 1.5 . . . . 70.430000000000007 109.007 -172.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -147.1 10.48 1.01 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.208 1.003 . . . . 62.140000000000001 109.916 177.007 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -100.58 122.0 51.05 Favored Pre-proline 0 C--O 1.242 0.664 0 CA-C-O 119.648 -0.215 . . . . 70.430000000000007 110.592 -176.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -69.91 112.99 3.25 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.527 2.151 . . . . 73.420000000000002 110.238 174.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -138.44 120.19 15.26 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 109.501 -0.555 . . . . 72.049999999999997 109.501 -177.136 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -86.08 -21.99 27.39 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 119.914 -0.714 . . . . 75.239999999999995 109.146 176.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -136.67 136.38 39.03 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 106.475 -1.676 . . . . 73.510000000000005 106.475 169.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.474 ' HG3' HG21 ' A' ' 112' ' ' VAL . 0.0 OUTLIER -142.95 151.07 40.53 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 109.761 -0.459 . . . . 74.310000000000002 109.761 -179.872 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.2 p -79.3 123.83 36.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 105.153 -2.166 . . . . 63.229999999999997 105.153 170.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 34.8 ttp -73.54 115.23 12.69 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 121.463 0.649 . . . . 74.120000000000005 110.452 -170.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -103.86 136.96 42.56 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 114.192 -1.367 . . . . 72.409999999999997 109.976 -172.247 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 40.7 p -88.45 122.27 31.75 Favored 'General case' 0 N--CA 1.411 -2.421 0 CA-C-N 115.047 -0.979 . . . . 63.350000000000001 109.506 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 120.82 -29.09 5.94 Favored Glycine 0 N--CA 1.438 -1.181 0 C-N-CA 120.816 -0.707 . . . . 73.400000000000006 112.306 177.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -93.22 164.08 13.37 Favored 'General case' 0 C--O 1.248 1.002 0 N-CA-C 109.101 -0.703 . . . . 62.399999999999999 109.101 -175.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -108.93 134.86 51.03 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-O 121.989 0.9 . . . . 62.210000000000001 112.052 -176.115 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 66.4 mt -97.88 121.12 48.08 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 N-CA-C 108.23 -1.026 . . . . 65.340000000000003 108.23 -178.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -89.66 112.54 23.82 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 107.98 -1.119 . . . . 73.230000000000004 107.98 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.442 HG13 ' HB2' ' A' ' 133' ' ' PHE . 6.2 pt -100.99 97.15 5.37 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.572 0 N-CA-C 108.002 -1.11 . . . . 72.129999999999995 108.002 177.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 67.6 -109.52 2.95 Favored Glycine 0 N--CA 1.427 -1.919 0 N-CA-C 109.84 -1.304 . . . . 65.450000000000003 109.84 -173.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -104.72 -17.55 14.59 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 109.237 -0.653 . . . . 73.109999999999999 109.237 176.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.442 ' HB2' HG13 ' A' ' 130' ' ' ILE . 55.1 m-85 -82.92 165.7 19.52 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.659 -0.7 . . . . 71.409999999999997 111.04 -173.024 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.402 ' HG3' ' HB3' ' A' ' 52' ' ' LYS . 13.1 ptt180 -126.87 122.1 33.69 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 121.719 0.771 . . . . 74.230000000000004 112.294 -170.326 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 7.8 tt -125.04 142.16 51.67 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.328 -1.36 . . . . 73.420000000000002 107.328 177.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.483 HG23 ' HB2' ' A' ' 52' ' ' LYS . 18.8 t -122.65 131.6 72.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 107.916 -1.142 . . . . 62.100000000000001 107.916 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -102.67 128.88 49.19 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.534 -1.284 . . . . 62.020000000000003 107.534 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -124.75 164.34 20.17 Favored 'General case' 0 C--O 1.253 1.25 0 CA-C-O 121.946 0.879 . . . . 72.400000000000006 111.42 -176.185 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -72.07 119.84 16.83 Favored 'General case' 0 N--CA 1.416 -2.169 0 CA-C-N 114.446 -1.252 . . . . 75.230000000000004 108.522 176.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -75.64 -160.19 8.78 Favored Glycine 0 N--CA 1.42 -2.425 0 CA-C-N 115.346 -0.843 . . . . 60.420000000000002 111.64 178.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo . . . . . 0 N--CA 1.425 -2.531 0 C-N-CA 121.892 1.728 . . . . 73.25 113.829 -176.151 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 10.0 p30 . . . . . 0 C--O 1.251 1.149 0 CA-C-O 121.376 0.608 . . . . 74.239999999999995 110.302 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -121.29 95.89 0.58 Allowed Glycine 0 N--CA 1.421 -2.338 0 N-CA-C 108.729 -1.748 . . . . 74.140000000000001 108.729 176.397 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.41 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 7.5 p -99.29 124.54 44.56 Favored Pre-proline 0 C--N 1.291 -1.939 0 N-CA-C 110.571 -0.159 . . . . 72.530000000000001 110.571 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 7' ' ' THR . 24.3 Cg_exo -66.41 134.87 37.45 Favored 'Trans proline' 0 C--O 1.242 0.708 0 C-N-CA 122.46 2.107 . . . . 64.420000000000002 110.016 175.075 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.428 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 43.7 mt-10 -92.36 129.66 40.26 Favored Pre-proline 0 C--N 1.294 -1.834 0 N-CA-C 109.821 -0.437 . . . . 72.510000000000005 109.821 -179.08 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 9' ' ' GLU . 71.0 Cg_exo -54.48 148.02 45.04 Favored 'Trans proline' 0 C--O 1.251 1.15 0 C-N-CA 123.683 2.922 . . . . 42.140000000000001 114.003 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -128.3 153.22 47.23 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 115.002 -0.999 . . . . 74.319999999999993 108.655 -178.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.8 p -126.27 136.38 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.805 0 N-CA-C 109.079 -0.711 . . . . 74.0 109.079 178.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -92.24 136.1 33.47 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.85 -1.167 . . . . 75.420000000000002 107.85 176.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.3 p -78.93 88.49 4.73 Favored 'General case' 0 N--CA 1.427 -1.623 0 CA-C-O 122.239 1.018 . . . . 71.099999999999994 110.948 -177.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.6 m -97.29 103.93 15.91 Favored 'General case' 0 N--CA 1.417 -2.103 0 CA-C-N 114.844 -1.071 . . . . 73.239999999999995 108.349 -177.185 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.8 m -111.72 154.68 24.64 Favored 'General case' 0 N--CA 1.417 -2.119 0 CA-C-N 115.832 -0.622 . . . . 63.43 109.818 -175.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 66.3 t . . . . . 0 C--N 1.291 -1.973 0 CA-C-N 115.577 -0.738 . . . . 72.239999999999995 109.267 179.376 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.622 0 N-CA-C 109.044 -1.623 . . . . 54.420000000000002 109.044 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.0 m -89.33 164.73 14.78 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 121.64 0.734 . . . . 75.109999999999999 112.658 -173.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.507 ' HB1' ' O ' ' A' ' 138' ' ' LEU . . . -131.93 165.42 23.95 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 107.94 -1.133 . . . . 61.299999999999997 107.94 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -127.6 154.8 44.79 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 120.647 -0.421 . . . . 72.099999999999994 111.802 -176.274 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.464 ' HB2' HD11 ' A' ' 135' ' ' LEU . 2.8 pp -126.23 144.13 50.89 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 115.829 -0.623 . . . . 61.310000000000002 109.974 177.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.494 HG12 ' HB3' ' A' ' 60' ' ' ARG . 1.8 m -128.02 138.99 53.12 Favored 'Isoleucine or valine' 0 C--O 1.252 1.207 0 N-CA-C 109.348 -0.612 . . . . 63.130000000000003 109.348 178.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.499 HG21 ' HB3' ' A' ' 57' ' ' ALA . 93.8 t -93.62 115.98 33.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 109.792 -0.447 . . . . 70.150000000000006 109.792 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -69.38 -38.17 77.88 Favored 'General case' 0 CA--C 1.506 -0.748 0 O-C-N 123.273 0.358 . . . . 63.210000000000001 110.506 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 42.6 ttt180 -168.84 135.49 1.83 Allowed 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.352 -0.84 . . . . 71.519999999999996 109.655 178.172 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 149.24 145.54 4.15 Favored Glycine 0 N--CA 1.416 -2.639 0 N-CA-C 110.862 -0.895 . . . . 75.109999999999999 110.862 177.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -67.63 -9.16 24.53 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.796 2.331 . . . . 61.219999999999999 112.105 177.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.436 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 87.9 m-20 -51.25 -46.8 62.48 Favored 'General case' 0 C--O 1.21 -1.009 0 C-N-CA 124.674 1.19 . . . . 74.519999999999996 110.333 175.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.499 ' HB3' HG21 ' A' ' 51' ' ' VAL . . . -172.79 -176.78 1.53 Allowed 'General case' 0 C--O 1.215 -0.714 0 N-CA-C 107.632 -1.247 . . . . 62.299999999999997 107.632 178.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -161.8 41.9 0.39 Allowed Glycine 0 C--N 1.29 -1.987 0 N-CA-C 109.938 -1.265 . . . . 65.430000000000007 109.938 -178.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -159.46 -166.39 1.78 Allowed 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 107.863 -1.162 . . . . 63.420000000000002 107.863 -176.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.494 ' HB3' HG12 ' A' ' 50' ' ' VAL . 19.6 ptt180 -115.71 135.03 54.44 Favored 'General case' 0 N--CA 1.433 -1.317 0 O-C-N 123.934 0.771 . . . . 73.25 109.294 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -126.75 121.77 32.93 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 120.772 0.32 . . . . 75.030000000000001 111.152 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 44.2 tp -88.04 119.32 28.3 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 106.913 -1.514 . . . . 60.32 106.913 177.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -79.66 114.8 18.87 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 120.57 -0.452 . . . . 72.400000000000006 110.137 -177.18 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -95.91 -20.82 18.47 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.663 0.744 . . . . 63.009999999999998 110.368 -176.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -97.22 139.66 21.6 Favored Pre-proline 0 C--N 1.304 -1.409 0 CA-C-N 114.91 -1.041 . . . . 74.150000000000006 112.098 -175.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.443 ' HA ' ' CG2' ' A' ' 94' ' ' ILE . 29.9 Cg_endo -64.42 -24.53 64.08 Favored 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 123.488 2.792 . . . . 74.430000000000007 114.347 -177.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.8 m -135.25 103.93 5.7 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 121.445 0.641 . . . . 72.219999999999999 109.972 178.185 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 17.0 m -103.13 121.69 43.16 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 115.456 -0.793 . . . . 74.230000000000004 109.658 -178.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.6 m -97.8 119.86 37.16 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 109.933 -0.395 . . . . 74.340000000000003 109.933 -177.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.82 133.84 42.56 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 121.217 0.532 . . . . 75.200000000000003 109.851 178.098 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -170.13 -152.71 8.18 Favored Glycine 0 N--CA 1.424 -2.139 0 N-CA-C 108.456 -1.857 . . . . 70.120000000000005 108.456 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.5 ttt180 -90.37 -38.77 13.1 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 118.765 -1.174 . . . . 61.43 111.901 -178.178 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -176.73 -56.22 0.0 OUTLIER Pre-proline 0 CA--C 1.569 1.677 0 N-CA-C 114.679 1.362 . . . . 73.219999999999999 114.679 -178.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -49.88 -41.65 46.73 Favored 'Trans proline' 0 C--N 1.388 2.641 0 C-N-CA 123.325 2.683 . . . . 71.409999999999997 116.697 -167.17 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.406 ' OE2' ' HB2' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -126.17 7.97 7.23 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 122.415 1.102 . . . . 72.129999999999995 108.34 178.31 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.5 m -82.72 121.28 26.67 Favored 'General case' 0 N--CA 1.4 -2.941 0 CA-C-N 114.082 -1.417 . . . . 73.040000000000006 108.524 -175.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -66.3 -31.63 72.54 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.777 0.799 . . . . 73.540000000000006 109.633 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.463 HD13 ' H ' ' A' ' 78' ' ' ILE . 0.2 OUTLIER -127.44 141.17 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.391 0 N-CA-C 106.322 -1.733 . . . . 73.129999999999995 106.322 172.269 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -97.47 117.73 32.37 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 120.959 0.409 . . . . 63.399999999999999 111.746 -176.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 5.9 mp -102.51 179.06 4.41 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 107.891 -1.151 . . . . 45.340000000000003 107.891 178.539 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.419 ' H ' ' HA ' ' A' ' 56' ' ' ASN . 15.4 t70 -163.99 84.24 0.45 Allowed 'General case' 0 N--CA 1.442 -0.841 0 CA-C-O 121.791 0.805 . . . . 74.140000000000001 110.671 178.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.495 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 11.2 t70 -97.48 165.0 12.21 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 105.458 -2.052 . . . . 73.129999999999995 105.458 170.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.8 p -69.39 -27.22 33.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 CA-C-N 119.08 0.855 . . . . 61.200000000000003 110.615 -178.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.465 ' HB ' ' ND2' ' A' ' 108' ' ' ASN . 4.2 m -119.45 36.82 4.36 Favored 'General case' 0 CA--C 1.556 1.187 0 CA-C-O 121.855 0.835 . . . . 75.409999999999997 108.756 -179.306 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.495 ' HB ' ' HB3' ' A' ' 82' ' ' ASP . 11.8 p -81.75 140.14 16.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 108.958 -0.756 . . . . 65.140000000000001 108.958 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 26.3 m -121.34 147.33 45.84 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 110.016 -0.365 . . . . 75.230000000000004 110.016 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.406 ' HB2' ' OE2' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -59.76 132.19 53.21 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 107.222 -1.399 . . . . 70.420000000000002 107.222 170.683 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 42.1 mtm180 58.8 74.17 0.45 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.568 0.699 . . . . 75.209999999999994 109.758 -169.114 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -100.13 -58.55 1.89 Allowed 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 108.181 -1.044 . . . . 62.109999999999999 108.181 -177.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -136.58 135.93 38.81 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.507 -0.924 . . . . 55.149999999999999 108.507 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -108.3 126.76 53.2 Favored 'General case' 0 C--N 1.278 -2.503 0 N-CA-C 107.88 -1.155 . . . . 74.409999999999997 107.88 178.267 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -104.51 112.68 25.84 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.525 -0.917 . . . . 60.420000000000002 108.525 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 35.2 ttt180 -116.65 147.55 41.82 Favored 'General case' 0 C--N 1.275 -2.657 0 N-CA-C 108.331 -0.989 . . . . 74.030000000000001 108.331 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.443 ' CG2' ' HA ' ' A' ' 66' ' ' PRO . 6.7 tt -114.62 137.67 47.25 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.341 0 N-CA-C 108.436 -0.95 . . . . 62.030000000000001 108.436 177.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -118.31 147.48 43.42 Favored 'General case' 0 N--CA 1.419 -2.003 0 N-CA-C 105.942 -1.873 . . . . 74.209999999999994 105.942 177.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -42.48 -19.13 0.01 OUTLIER 'General case' 0 CA--C 1.559 1.326 0 N-CA-C 116.719 2.118 . . . . 73.219999999999999 116.719 -174.462 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -119.14 -29.1 1.86 Allowed Glycine 0 N--CA 1.43 -1.73 0 C-N-CA 120.751 -0.738 . . . . 53.030000000000001 113.527 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -161.24 177.57 10.08 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-N 118.089 0.944 . . . . 34.420000000000002 109.765 -174.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -103.47 138.67 39.87 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 113.596 0.962 . . . . 72.420000000000002 113.596 -173.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -112.93 116.82 30.59 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.273 -1.01 . . . . 62.439999999999998 108.273 178.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 59.3 t -119.4 119.52 60.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 108.752 -0.832 . . . . 72.310000000000002 108.752 -178.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.6 m -111.4 131.79 61.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-O 121.417 0.627 . . . . 71.030000000000001 111.276 -179.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -91.29 113.29 25.52 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.125 -0.943 . . . . 74.049999999999997 109.486 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 19.1 m -114.79 9.88 7.72 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 CA-C-O 121.463 0.649 . . . . 74.030000000000001 109.954 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -127.75 53.29 0.8 Allowed Glycine 0 N--CA 1.431 -1.641 0 N-CA-C 110.367 -1.093 . . . . 45.340000000000003 110.367 179.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.4 m -61.42 -7.61 3.24 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 124.42 1.088 . . . . 75.349999999999994 113.059 -177.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 69.0 tp -58.15 -44.76 88.03 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 107.996 -1.112 . . . . 72.510000000000005 107.996 174.151 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.543 ' OD1' ' HA2' ' A' ' 131' ' ' GLY . 52.3 t-20 -98.9 -53.1 3.37 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 106.409 -1.7 . . . . 64.430000000000007 106.409 175.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 94.96 135.87 8.24 Favored Glycine 0 N--CA 1.432 -1.604 0 CA-C-N 115.037 -0.983 . . . . 62.509999999999998 112.716 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 26.9 m -91.94 123.65 35.47 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 108.211 -1.033 . . . . 64.439999999999998 108.211 173.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -102.29 133.87 46.49 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-O 120.994 0.426 . . . . 74.200000000000003 110.277 -177.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.6 p -105.23 115.74 47.67 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 N-CA-C 106.536 -1.653 . . . . 75.430000000000007 106.536 173.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 12.2 m120 64.73 -78.41 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 124.737 1.215 . . . . 73.329999999999998 110.767 -173.168 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 -140.18 -3.75 1.37 Allowed 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 123.703 0.801 . . . . 63.140000000000001 110.44 -176.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -118.03 130.21 24.87 Favored Pre-proline 0 C--N 1.325 -0.462 0 C-N-CA 120.688 -0.405 . . . . 75.439999999999998 111.711 -170.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -79.64 117.3 3.65 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.394 2.063 . . . . 74.340000000000003 111.104 177.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 36.9 mmt180 -118.76 153.84 33.78 Favored 'General case' 0 C--N 1.308 -1.238 0 O-C-N 121.762 -0.586 . . . . 75.019999999999996 109.868 -177.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -84.73 -25.39 28.36 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.71 0.767 . . . . 74.319999999999993 109.123 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -157.56 139.17 13.9 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 107.539 -1.282 . . . . 41.520000000000003 107.539 175.132 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -140.62 149.25 42.07 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-O 121.033 0.444 . . . . 73.030000000000001 110.973 178.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 41.1 t -104.52 105.04 17.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 105.294 -2.113 . . . . 72.219999999999999 105.294 175.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 65.7 mtp -103.25 151.35 22.77 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 113.488 0.921 . . . . 64.329999999999998 113.488 -171.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -113.96 153.33 29.49 Favored 'General case' 0 N--CA 1.418 -2.049 0 CA-C-N 113.813 -1.539 . . . . 72.409999999999997 108.269 -177.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.7 p -77.71 129.36 35.42 Favored 'General case' 0 N--CA 1.417 -2.093 0 CA-C-O 121.532 0.682 . . . . 41.340000000000003 111.646 -176.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 111.82 8.64 22.12 Favored Glycine 0 N--CA 1.442 -0.91 0 N-CA-C 110.539 -1.025 . . . . 34.409999999999997 110.539 -177.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -109.89 169.34 8.78 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-O 120.445 0.164 . . . . 62.130000000000003 110.989 -175.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.405 ' OE2' ' HD2' ' A' ' 134' ' ' ARG . 38.2 tt0 -108.73 139.97 42.8 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 113.299 0.851 . . . . 63.520000000000003 113.299 -172.289 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 58.4 mt -125.31 131.23 72.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 124.436 1.094 . . . . 74.150000000000006 109.704 -176.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -113.94 124.05 51.22 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 121.404 0.621 . . . . 73.239999999999995 110.069 173.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 27.7 mt -108.5 100.07 9.98 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 N-CA-C 107.311 -1.366 . . . . 63.329999999999998 107.311 -177.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.543 ' HA2' ' OD1' ' A' ' 108' ' ' ASN . . . 71.04 -100.6 0.87 Allowed Glycine 0 N--CA 1.425 -2.06 0 O-C-N 124.25 0.969 . . . . 62.219999999999999 110.788 -177.08 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -114.6 -9.81 12.59 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-O 121.16 0.505 . . . . 74.129999999999995 110.685 177.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -104.27 142.61 34.23 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 118.993 -1.083 . . . . 74.439999999999998 112.32 -171.13 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.405 ' HD2' ' OE2' ' A' ' 127' ' ' GLU . 11.9 ttp180 -106.79 128.78 54.53 Favored 'General case' 0 C--O 1.248 0.992 0 N-CA-C 113.792 1.034 . . . . 72.319999999999993 113.792 -167.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.464 HD11 ' HB2' ' A' ' 49' ' ' LEU . 38.8 tp -123.94 145.04 49.42 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 126.449 1.9 . . . . 62.509999999999998 109.551 -174.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.419 ' CG1' HG22 ' A' ' 50' ' ' VAL . 7.3 p -123.17 135.24 63.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 108.84 -0.8 . . . . 72.340000000000003 108.84 171.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -112.11 118.41 35.3 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.499 -0.926 . . . . 74.420000000000002 108.499 -174.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.507 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 4.5 mp -120.88 164.42 16.69 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 120.891 0.377 . . . . 72.310000000000002 111.089 -175.073 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -75.25 145.74 41.68 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.298 -0.63 . . . . 54.25 109.298 177.029 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -103.7 -178.62 25.79 Favored Glycine 0 N--CA 1.429 -1.789 0 C-N-CA 120.608 -0.806 . . . . 64.439999999999998 111.638 -178.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo . . . . . 0 C--O 1.242 0.686 0 C-N-CA 122.628 2.219 . . . . 55.32 112.515 -179.394 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 51.6 t30 . . . . . 0 N--CA 1.478 0.951 0 CA-C-O 121.266 0.555 . . . . 75.200000000000003 111.459 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -108.48 175.63 19.69 Favored Glycine 0 N--CA 1.426 -1.992 0 N-CA-C 110.258 -1.137 . . . . 74.140000000000001 110.258 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.1 m -68.98 130.92 91.15 Favored Pre-proline 0 C--N 1.3 -1.578 0 N-CA-C 108.294 -1.002 . . . . 74.239999999999995 108.294 178.043 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.538 ' O ' ' HD3' ' A' ' 10' ' ' PRO . 10.7 Cg_endo -53.46 149.86 29.02 Favored 'Trans proline' 0 C--N 1.358 1.059 0 C-N-CA 123.22 2.614 . . . . 53.219999999999999 111.814 -179.32 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -85.74 105.11 6.29 Favored Pre-proline 0 N--CA 1.422 -1.831 0 N-CA-C 107.741 -1.207 . . . . 74.239999999999995 107.741 178.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.538 ' HD3' ' O ' ' A' ' 8' ' ' PRO . 86.8 Cg_endo -103.26 155.0 0.25 Allowed 'Trans proline' 0 N--CA 1.437 -1.823 0 C-N-CA 122.596 2.197 . . . . 74.450000000000003 112.981 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -80.73 72.47 7.69 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 122.452 1.12 . . . . 74.409999999999997 109.412 173.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.8 p -62.02 142.48 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 CA-C-N 113.454 -1.703 . . . . 75.209999999999994 109.998 -177.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.05 137.59 51.39 Favored 'General case' 0 N--CA 1.423 -1.779 0 C-N-CA 119.72 -0.792 . . . . 72.120000000000005 110.16 179.027 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.4 m -129.53 90.99 3.08 Favored 'General case' 0 C--N 1.274 -2.674 0 N-CA-C 107.495 -1.298 . . . . 72.219999999999999 107.495 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 94.3 m -69.28 97.0 0.9 Allowed 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 115.066 -0.97 . . . . 72.209999999999994 111.183 -177.154 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 25.3 t -136.51 112.9 9.94 Favored 'General case' 0 N--CA 1.419 -2.005 0 N-CA-C 105.741 -1.948 . . . . 63.539999999999999 105.741 178.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.7 m . . . . . 0 C--N 1.292 -1.913 0 CA-C-N 116.051 -0.522 . . . . 45.039999999999999 111.22 -174.382 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.689 0 N-CA-C 108.122 -1.991 . . . . 54.329999999999998 108.122 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.3 m -91.14 167.84 12.06 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 114.252 -0.974 . . . . 60.299999999999997 110.033 -176.249 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -102.19 166.84 10.37 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 109.907 -0.405 . . . . 72.530000000000001 109.907 -179.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -134.35 152.64 51.92 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.841 -0.8 . . . . 74.040000000000006 108.841 176.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.421 ' HB2' HD11 ' A' ' 135' ' ' LEU . 4.4 pp -109.27 134.63 51.54 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 108.772 -0.825 . . . . 72.349999999999994 108.772 178.363 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 94.1 t -117.08 117.81 56.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 CA-C-N 116.032 -0.531 . . . . 73.239999999999995 109.604 -177.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.566 HG21 ' HB3' ' A' ' 57' ' ' ALA . 15.6 t -93.15 118.96 40.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 107.711 -1.218 . . . . 72.540000000000006 107.711 178.311 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -75.99 -42.35 48.49 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 115.664 -0.698 . . . . 64.340000000000003 109.156 -178.293 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 62.3 ttt180 -177.34 157.64 1.35 Allowed 'General case' 0 C--O 1.245 0.865 0 CA-C-N 115.047 -0.979 . . . . 71.299999999999997 108.921 -177.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 124.88 142.85 5.97 Favored Glycine 0 C--O 1.202 -1.866 0 CA-C-O 119.201 -0.777 . . . . 65.340000000000003 111.563 176.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.568 ' HD2' ' CE1' ' A' ' 133' ' ' PHE . 9.3 Cg_endo -51.62 -7.4 0.2 Allowed 'Trans proline' 0 N--CA 1.499 1.828 0 C-N-CA 124.963 3.775 . . . . 74.349999999999994 115.311 177.204 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.606 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -56.64 -51.59 68.14 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 108.225 -1.028 . . . . 74.430000000000007 108.225 175.079 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.566 ' HB3' HG21 ' A' ' 51' ' ' VAL . . . -179.5 -171.51 0.19 Allowed 'General case' 0 C--O 1.214 -0.783 0 N-CA-C 106.585 -1.635 . . . . 71.540000000000006 106.585 -178.507 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -166.96 56.4 0.23 Allowed Glycine 0 C--N 1.291 -1.932 0 N-CA-C 110.416 -1.073 . . . . 54.020000000000003 110.416 -177.473 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -163.04 -171.01 2.5 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.595 -1.261 . . . . 71.439999999999998 107.595 -178.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 18.4 ptp180 -136.66 138.26 40.92 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.618 -0.882 . . . . 54.329999999999998 108.618 178.019 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -142.0 148.23 38.22 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 120.128 -0.629 . . . . 73.349999999999994 111.686 176.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.1 tt -84.06 133.97 34.63 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 113.943 -1.481 . . . . 73.230000000000004 107.519 -177.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.5 mp -87.51 112.92 22.73 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 108.501 -0.926 . . . . 63.119999999999997 108.501 178.316 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -125.12 18.02 8.4 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 122.42 1.105 . . . . 62.350000000000001 108.136 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -119.2 149.31 46.96 Favored Pre-proline 0 C--N 1.296 -1.717 0 CA-C-N 113.874 -1.512 . . . . 74.409999999999997 108.257 -176.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -63.68 -35.23 59.44 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 122.409 2.073 . . . . 72.519999999999996 112.582 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 92' ' ' PHE . 44.1 m -137.53 123.06 19.68 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 116.516 -0.311 . . . . 70.439999999999998 111.133 179.127 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.469 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 31.3 m -98.12 116.89 31.27 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 106.566 -1.642 . . . . 72.219999999999999 106.566 171.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.505 ' HB ' ' NE2' ' A' ' 73' ' ' HIS . 0.1 OUTLIER -104.86 102.6 12.13 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-O 121.23 0.538 . . . . 71.340000000000003 112.102 -174.37 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -105.87 117.74 34.8 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.088 0.47 . . . . 54.039999999999999 110.173 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 172.41 -163.75 35.93 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.949 -1.26 . . . . 73.209999999999994 109.949 -179.043 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.7 ptp180 -110.96 21.45 16.44 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 122.045 0.926 . . . . 42.439999999999998 109.561 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.522 ' HD1' ' HA ' ' A' ' 88' ' ' ARG . 12.1 p-80 -84.95 163.67 45.06 Favored Pre-proline 0 C--N 1.299 -1.599 0 CA-C-N 114.672 -1.149 . . . . 72.310000000000002 109.799 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -51.01 -40.42 58.89 Favored 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 123.602 2.868 . . . . 43.340000000000003 115.693 -174.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -97.13 30.21 2.85 Favored 'General case' 0 C--N 1.318 -0.801 0 O-C-N 121.515 -0.741 . . . . 72.409999999999997 112.873 -176.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.0 p -56.91 116.9 3.47 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.268 -0.424 . . . . 75.540000000000006 111.208 178.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -67.23 -49.79 63.14 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 106.301 -1.741 . . . . 74.310000000000002 106.301 173.22 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 30.4 pt -134.28 138.26 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 CA-C-N 113.606 -1.634 . . . . 63.5 107.236 174.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -104.09 117.54 34.51 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 108.676 -0.861 . . . . 62.25 108.676 177.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.606 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 2.1 pt? -75.38 111.58 10.81 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.369 -0.975 . . . . 61.109999999999999 108.369 177.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -85.59 73.6 10.43 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 118.954 -1.099 . . . . 74.099999999999994 112.752 -173.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -119.85 150.8 39.87 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 115.031 -0.986 . . . . 73.519999999999996 108.901 170.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.0 p -73.38 -20.17 18.36 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 C-N-CA 122.921 0.488 . . . . 71.340000000000003 112.281 -176.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.448 ' HB ' ' ND2' ' A' ' 108' ' ' ASN . 1.3 m -89.53 6.68 39.95 Favored 'General case' 0 CA--C 1.557 1.25 0 CA-C-O 121.057 0.455 . . . . 74.409999999999997 111.943 -172.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.464 HG13 ' HD2' ' A' ' 89' ' ' HIS . 48.4 t -82.27 137.16 21.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 109.409 -0.589 . . . . 62.409999999999997 109.409 -178.513 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 15.3 p -86.01 -71.1 0.56 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.989 0.423 . . . . 62.109999999999999 112.104 -178.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 21.2 tpp180 -150.19 -66.96 0.2 Allowed 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 106.953 -1.499 . . . . 74.340000000000003 106.953 -178.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.522 ' HA ' ' HD1' ' A' ' 73' ' ' HIS . 48.0 mtt180 -96.56 167.81 10.92 Favored 'General case' 0 CA--C 1.486 -1.516 0 N-CA-C 106.228 -1.768 . . . . 71.400000000000006 106.228 171.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.464 ' HD2' HG13 ' A' ' 85' ' ' VAL . 57.1 t-80 -151.49 -70.72 0.17 Allowed 'General case' 0 C--N 1.292 -1.934 0 C-N-CA 118.921 -1.112 . . . . 73.129999999999995 109.753 -177.18 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -133.45 104.05 6.23 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-O 121.155 0.502 . . . . 73.140000000000001 109.908 -178.157 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.424 ' OE1' ' HD3' ' A' ' 88' ' ' ARG . 3.0 mp0 -104.01 132.24 50.45 Favored 'General case' 0 N--CA 1.419 -1.983 0 C-N-CA 119.738 -0.785 . . . . 73.200000000000003 109.961 176.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.469 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 29.9 m-85 -97.1 112.22 24.1 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 105.287 -2.116 . . . . 71.209999999999994 105.287 175.257 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 72.8 mtt180 -118.3 115.31 24.46 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 106.63 -1.619 . . . . 74.5 106.63 -175.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.9 pp -115.48 143.03 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.927 0 C-N-CA 119.58 -0.848 . . . . 71.340000000000003 111.734 -172.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -117.71 146.77 43.52 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 105.219 -2.141 . . . . 53.43 105.219 175.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -49.01 -32.97 10.19 Favored 'General case' 0 C--N 1.315 -0.912 0 O-C-N 123.575 0.547 . . . . 71.510000000000005 112.453 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -85.35 -48.27 4.86 Favored Glycine 0 N--CA 1.433 -1.538 0 C-N-CA 120.733 -0.746 . . . . 64.430000000000007 112.749 179.239 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -133.2 131.55 40.5 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-O 121.682 0.753 . . . . 51.039999999999999 112.581 -177.293 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -99.74 124.55 45.12 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.209 -1.034 . . . . 72.219999999999999 108.209 -178.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -129.19 136.54 50.28 Favored 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 113.829 1.048 . . . . 60.149999999999999 113.829 -176.026 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.2 p -110.84 118.9 58.36 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 CA-C-N 114.73 -1.123 . . . . 65.120000000000005 108.884 175.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.8 m -120.37 120.8 63.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 N-CA-C 113.166 0.802 . . . . 61.520000000000003 113.166 -177.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.488 ' HB3' ' HB2' ' A' ' 118' ' ' ASN . 4.6 t70 -84.76 122.7 29.49 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 109.164 -0.68 . . . . 63.420000000000002 109.164 169.443 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 26.8 m -114.53 -1.12 9.48 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 CA-C-N 115.625 -0.716 . . . . 62.140000000000001 109.47 177.027 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -112.85 59.95 0.36 Allowed Glycine 0 N--CA 1.434 -1.486 0 N-CA-C 110.619 -0.993 . . . . 65.430000000000007 110.619 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 19.1 m -72.41 19.25 0.08 Allowed 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 123.671 0.788 . . . . 71.219999999999999 112.913 -175.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.2 mp -75.58 -33.61 60.6 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 109.58 -0.526 . . . . 75.219999999999999 109.58 178.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.448 ' ND2' ' HB ' ' A' ' 84' ' ' THR . 10.0 m120 -80.25 -24.27 40.25 Favored 'General case' 0 CA--C 1.5 -0.962 0 CA-C-N 116.15 -0.477 . . . . 71.030000000000001 110.54 176.454 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 86.59 82.58 1.15 Allowed Glycine 0 N--CA 1.428 -1.889 0 N-CA-C 109.956 -1.258 . . . . 70.430000000000007 109.956 -177.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 64.7 m -87.18 119.51 27.49 Favored 'General case' 0 N--CA 1.42 -1.938 0 CA-C-O 121.305 0.574 . . . . 62.530000000000001 109.803 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -116.66 134.07 55.26 Favored 'General case' 0 N--CA 1.425 -1.688 0 N-CA-C 107.54 -1.282 . . . . 73.120000000000005 107.54 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.458 HG12 ' O ' ' A' ' 117' ' ' ARG . 7.4 p -117.68 132.23 68.09 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.713 0 N-CA-C 107.264 -1.384 . . . . 72.430000000000007 107.264 175.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 64.93 26.33 12.79 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 107.837 -1.171 . . . . 63.130000000000003 107.837 -175.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.452 ' HG2' HH11 ' A' ' 114' ' ' ARG . 16.9 mtt-85 70.27 7.48 6.24 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 126.638 1.975 . . . . 73.310000000000002 111.698 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -106.69 144.62 29.42 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 109.831 -0.433 . . . . 71.140000000000001 109.831 -176.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -68.11 91.74 0.38 Allowed 'Trans proline' 0 C--N 1.356 0.93 0 C-N-CA 122.223 1.949 . . . . 72.340000000000003 112.402 176.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.458 ' O ' HG12 ' A' ' 112' ' ' VAL . 5.2 ptt180 -154.61 116.55 4.19 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 125.034 1.333 . . . . 72.299999999999997 108.881 174.191 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.488 ' HB2' ' HB3' ' A' ' 103' ' ' ASP . 23.5 p-10 -83.74 -30.99 26.24 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 114.888 -1.051 . . . . 62.219999999999999 113.125 -174.613 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -105.53 138.26 42.01 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.675 -0.81 . . . . 71.409999999999997 110.929 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -140.46 149.36 42.46 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 113.394 0.887 . . . . 71.030000000000001 113.394 178.137 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.7 p -91.34 135.76 26.09 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 N-CA-C 106.67 -1.604 . . . . 74.340000000000003 106.67 173.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 23.2 ttt -39.45 102.52 0.02 OUTLIER 'General case' 0 C--O 1.247 0.954 0 N-CA-C 114.001 1.111 . . . . 61.219999999999999 114.001 178.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -123.23 123.39 40.66 Favored 'General case' 0 N--CA 1.424 -1.77 0 N-CA-C 105.605 -1.998 . . . . 74.209999999999994 105.605 173.015 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 7.3 t -81.92 129.06 34.65 Favored 'General case' 0 C--N 1.291 -1.959 0 C-N-CA 120.565 -0.454 . . . . 74.430000000000007 110.363 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 100.36 18.54 21.19 Favored Glycine 0 N--CA 1.433 -1.532 0 CA-C-N 115.55 -0.75 . . . . 64.420000000000002 112.18 177.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -110.77 150.05 29.64 Favored 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 119.581 -0.848 . . . . 72.049999999999997 109.501 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -110.48 132.26 54.34 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.558 0.694 . . . . 74.239999999999995 112.519 -174.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 66.2 mt -108.42 118.43 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.591 0 CA-C-N 114.68 -1.146 . . . . 75.120000000000005 107.991 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.425 ' OE1' ' HG2' ' A' ' 114' ' ' ARG . 54.6 mt-30 -109.54 112.61 24.81 Favored 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 109.221 -0.659 . . . . 73.5 109.221 178.11 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.432 ' O ' HG13 ' A' ' 130' ' ' ILE . 23.4 pt -95.09 96.94 6.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 108.771 -0.825 . . . . 75.549999999999997 108.771 177.303 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 61.67 -85.31 0.03 OUTLIER Glycine 0 CA--C 1.528 0.853 0 CA-C-N 115.35 -0.841 . . . . 54.140000000000001 112.897 -176.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.503 ' HE3' ' CZ ' ' A' ' 133' ' ' PHE . 48.2 mtmt -113.66 -13.38 12.71 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 123.175 0.59 . . . . 32.009999999999998 111.237 -175.51 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.568 ' CE1' ' HD2' ' A' ' 55' ' ' PRO . 19.3 m-85 -107.3 154.07 21.81 Favored 'General case' 0 CA--C 1.501 -0.923 0 C-N-CA 119.748 -0.781 . . . . 74.219999999999999 112.227 -169.59 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 74.2 mtp180 -119.27 122.57 42.21 Favored 'General case' 0 C--O 1.248 0.987 0 CA-C-O 121.603 0.716 . . . . 64.329999999999998 112.623 -172.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.421 HD11 ' HB2' ' A' ' 49' ' ' LEU . 56.9 tp -123.95 131.21 53.54 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 114.466 -1.243 . . . . 73.239999999999995 107.841 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.7 t -115.58 138.76 44.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 N-CA-C 108.17 -1.048 . . . . 71.200000000000003 108.17 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -111.13 117.0 32.06 Favored 'General case' 0 C--N 1.309 -1.152 0 N-CA-C 109.302 -0.629 . . . . 74.530000000000001 109.302 -176.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -123.69 158.99 30.33 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.861 -0.422 . . . . 70.519999999999996 109.861 -177.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -79.91 140.67 36.62 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.049 -1.463 . . . . 61.140000000000001 107.049 172.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -97.96 -143.2 14.39 Favored Glycine 0 C--N 1.292 -1.861 0 C-N-CA 120.329 -0.939 . . . . 52.149999999999999 112.232 -176.1 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo . . . . . 0 N--CA 1.44 -1.668 0 C-N-CA 122.259 1.973 . . . . 70.299999999999997 113.662 -177.484 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 . . . . . 0 N--CA 1.439 -0.994 0 N-CA-C 107.848 -1.167 . . . . 72.209999999999994 107.848 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -94.05 76.62 1.03 Allowed Glycine 0 N--CA 1.426 -1.969 0 CA-C-N 113.987 -1.46 . . . . 54.420000000000002 110.863 -178.333 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.3 p -77.25 123.88 87.07 Favored Pre-proline 0 C--N 1.291 -1.978 0 CA-C-N 115.332 -0.434 . . . . 73.310000000000002 110.396 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -65.6 146.35 84.28 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 121.617 1.545 . . . . 75.530000000000001 110.384 177.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -68.6 122.57 85.18 Favored Pre-proline 0 C--N 1.302 -1.494 0 N-CA-C 109.733 -0.469 . . . . 72.519999999999996 109.733 -174.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -50.23 159.27 1.98 Allowed 'Trans proline' 0 C--N 1.37 1.686 0 C-N-CA 124.281 3.321 . . . . 73.400000000000006 112.624 -178.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 53.3 tp60 -51.14 107.0 0.15 Allowed 'General case' 0 C--O 1.242 0.7 0 C-N-CA 123.666 0.786 . . . . 73.219999999999999 112.418 -174.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.4 p -84.57 146.73 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 107.539 -1.282 . . . . 65.219999999999999 107.539 175.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -104.76 121.48 43.71 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 107.414 -1.328 . . . . 73.319999999999993 107.414 -178.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.4 m -132.94 120.33 21.3 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.96 -0.755 . . . . 52.210000000000001 108.96 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.9 t -115.08 133.01 56.41 Favored 'General case' 0 N--CA 1.412 -2.355 0 CA-C-O 121.666 0.746 . . . . 72.109999999999999 109.562 -177.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 21.0 m -92.88 127.81 38.52 Favored 'General case' 0 C--N 1.283 -2.321 0 N-CA-C 108.169 -1.049 . . . . 75.239999999999995 108.169 178.182 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.5 m . . . . . 0 C--N 1.282 -2.329 0 N-CA-C 108.496 -0.928 . . . . 72.109999999999999 108.496 178.799 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.413 -2.86 0 N-CA-C 111.572 -0.611 . . . . 31.420000000000002 111.572 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 42.6 m -90.85 166.69 12.94 Favored 'General case' 0 N--CA 1.407 -2.598 0 N-CA-C 107.975 -1.12 . . . . 74.109999999999999 107.975 177.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -91.59 154.38 19.1 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 109.763 -0.458 . . . . 64.319999999999993 109.763 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.4 ' H ' HD23 ' A' ' 48' ' ' LEU . 2.4 pt? -131.31 148.51 52.69 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.721 -0.844 . . . . 72.200000000000003 108.721 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.562 ' HB2' HD21 ' A' ' 135' ' ' LEU . 4.4 pp -112.66 138.59 49.23 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 109.511 -0.552 . . . . 60.229999999999997 109.511 178.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 38.7 t -114.54 120.0 63.04 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 108.087 -1.079 . . . . 63.140000000000001 108.087 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 26.3 t -93.2 115.6 32.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 107.523 -1.288 . . . . 74.430000000000007 107.523 178.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -85.38 -40.16 16.79 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.117 -0.947 . . . . 63.310000000000002 109.991 -176.02 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 36.9 mmt180 -144.32 153.67 42.24 Favored 'General case' 0 CA--C 1.495 -1.17 0 CA-C-N 115.589 -0.732 . . . . 75.120000000000005 110.185 -177.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 131.89 140.23 4.49 Favored Glycine 0 N--CA 1.426 -2.022 0 O-C-N 124.185 0.928 . . . . 43.219999999999999 111.57 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.442 ' HB2' ' O ' ' A' ' 81' ' ' ASP . 14.1 Cg_exo -69.08 -14.95 39.2 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 122.533 2.156 . . . . 61.420000000000002 111.508 175.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.557 ' HA ' ' H ' ' A' ' 81' ' ' ASP . 4.7 p-10 -61.72 -48.77 79.24 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.417 1.087 . . . . 73.450000000000003 111.162 178.188 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -166.89 171.09 11.6 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.756 -0.831 . . . . 34.130000000000003 108.756 -176.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -155.05 30.28 0.65 Allowed Glycine 0 C--N 1.303 -1.287 0 N-CA-C 110.042 -1.223 . . . . 43.109999999999999 110.042 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -132.78 -168.51 2.08 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 109.261 -0.644 . . . . 65.329999999999998 109.261 -177.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.415 ' HA ' ' O ' ' A' ' 49' ' ' LEU . 19.8 ptp180 -135.02 137.18 42.71 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 109.187 -0.671 . . . . 75.030000000000001 109.187 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.437 ' CE2' HD11 ' A' ' 49' ' ' LEU . 53.0 p90 -135.28 148.42 49.53 Favored 'General case' 0 C--N 1.293 -1.885 0 C-N-CA 120.044 -0.662 . . . . 73.219999999999999 110.579 178.211 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 36.2 tp -86.69 122.83 31.15 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 124.241 0.963 . . . . 74.430000000000007 108.459 -178.025 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.4 mp -83.99 114.56 21.8 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.103 0.478 . . . . 73.049999999999997 111.408 -176.186 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -129.49 7.03 5.28 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.11 -0.95 . . . . 75.109999999999999 108.576 172.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.671 ' NE2' ' HA ' ' A' ' 68' ' ' THR . 55.2 tt0 -88.87 123.52 67.42 Favored Pre-proline 0 N--CA 1.421 -1.888 0 CA-C-N 114.377 -1.283 . . . . 73.299999999999997 107.952 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -51.54 -44.93 40.81 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 123.437 2.758 . . . . 64.540000000000006 112.049 -177.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 91.2 m -136.15 99.38 4.11 Favored 'General case' 0 N--CA 1.425 -1.681 0 N-CA-C 109.026 -0.731 . . . . 70.030000000000001 109.026 174.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.671 ' HA ' ' NE2' ' A' ' 65' ' ' GLN . 16.9 m -77.7 116.45 18.25 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 107.196 -1.409 . . . . 64.040000000000006 107.196 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.503 HG22 ' CE1' ' A' ' 73' ' ' HIS . 2.3 m -92.81 92.54 7.98 Favored 'General case' 0 N--CA 1.419 -1.987 0 CA-C-O 121.152 0.501 . . . . 63.32 110.435 -171.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.464 ' HB2' HD11 ' A' ' 78' ' ' ILE . . . -97.94 131.87 44.01 Favored 'General case' 0 C--O 1.246 0.893 0 CA-C-N 115.723 -0.671 . . . . 73.230000000000004 111.007 -178.458 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 155.75 -137.66 5.66 Favored Glycine 0 CA--C 1.472 -2.635 0 N-CA-C 107.442 -2.263 . . . . 71.040000000000006 107.442 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -103.51 -83.33 0.49 Allowed 'General case' 0 N--CA 1.418 -2.074 0 N-CA-C 107.538 -1.282 . . . . 74.420000000000002 107.538 170.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.503 ' CE1' HG22 ' A' ' 69' ' ' THR . 31.6 m80 67.03 161.32 0.14 Allowed Pre-proline 0 N--CA 1.475 0.824 0 C-N-CA 123.994 0.918 . . . . 54.100000000000001 110.86 178.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -67.34 -22.01 46.55 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 121.903 1.736 . . . . 71.530000000000001 110.098 167.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -120.82 78.34 1.38 Allowed 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 108.519 -0.919 . . . . 74.140000000000001 108.519 -177.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.0 m -79.9 109.88 14.74 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-N 115.834 -0.621 . . . . 63.420000000000002 109.464 178.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -69.76 -43.11 72.91 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 106.936 -1.505 . . . . 44.229999999999997 106.936 173.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.464 HD11 ' HB2' ' A' ' 70' ' ' ALA . 0.2 OUTLIER -140.86 147.17 23.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 N-CA-C 104.753 -2.314 . . . . 74.340000000000003 104.753 170.519 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -116.83 127.48 54.35 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-O 122.009 0.909 . . . . 74.239999999999995 112.347 -173.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.552 ' HA ' ' CB ' ' A' ' 56' ' ' ASN . 8.7 mp -84.8 102.35 12.98 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 115.163 -0.926 . . . . 74.219999999999999 108.932 174.147 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.557 ' H ' ' HA ' ' A' ' 56' ' ' ASN . 37.1 t70 -80.64 64.79 5.55 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 122.836 1.303 . . . . 74.109999999999999 110.975 -178.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -131.91 146.28 52.01 Favored 'General case' 0 C--N 1.283 -2.307 0 CA-C-N 113.89 -1.504 . . . . 52.310000000000002 108.436 175.127 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 28.3 m -81.92 2.06 3.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 113.729 1.011 . . . . 41.32 113.729 -174.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.72 12.55 25.67 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 121.816 0.817 . . . . 74.109999999999999 109.298 -179.26 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 98.8 t -83.08 132.01 32.38 Favored 'Isoleucine or valine' 0 C--O 1.244 0.789 0 CA-C-N 115.28 -0.873 . . . . 52.109999999999999 111.844 -177.161 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 7.6 m -103.73 165.42 11.05 Favored 'General case' 0 C--O 1.25 1.121 0 CA-C-N 115.1 -0.955 . . . . 65.450000000000003 110.252 -177.198 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.438 ' O ' ' HD2' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -74.13 132.69 42.5 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 107.405 -1.331 . . . . 64.25 107.405 169.11 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.442 ' H ' ' CD2' ' A' ' 73' ' ' HIS . 9.2 mmm180 61.72 83.54 0.15 Allowed 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 106.412 -1.699 . . . . 71.200000000000003 106.412 -168.677 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 12.5 t60 -104.87 -73.58 0.67 Allowed 'General case' 0 N--CA 1.428 -1.557 0 CA-C-N 115.366 -0.834 . . . . 73.120000000000005 110.149 -174.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.444 ' O ' ' HB3' ' A' ' 70' ' ' ALA . . . -121.71 108.87 14.04 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.633 -0.877 . . . . 74.340000000000003 108.633 -179.358 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -99.72 126.1 45.71 Favored 'General case' 0 C--N 1.28 -2.42 0 C-N-CA 119.373 -0.931 . . . . 72.349999999999994 109.678 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.486 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 58.5 m-85 -107.12 112.62 25.62 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 105.955 -1.868 . . . . 75.030000000000001 105.955 176.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.432 ' NH1' HG21 ' A' ' 102' ' ' VAL . 99.2 mtt180 -112.7 133.05 54.91 Favored 'General case' 0 C--N 1.277 -2.547 0 N-CA-C 109.035 -0.728 . . . . 74.349999999999994 109.035 -174.599 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 18.9 pt -116.76 138.14 48.35 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.429 0 C-N-CA 119.332 -0.947 . . . . 64.420000000000002 108.842 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -121.28 146.33 46.94 Favored 'General case' 0 C--N 1.266 -3.046 0 N-CA-C 106.207 -1.775 . . . . 74.230000000000004 106.207 174.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -60.08 -17.19 37.82 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.202 0.525 . . . . 73.040000000000006 112.288 177.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -91.31 -36.73 6.47 Favored Glycine 0 N--CA 1.439 -1.155 0 C-N-CA 121.415 -0.421 . . . . 61.299999999999997 113.081 178.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -169.18 161.69 10.36 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 109.46 -0.57 . . . . 75.0 109.46 -178.103 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.497 ' HB2' ' HB2' ' A' ' 122' ' ' MET . 59.2 m-85 -97.05 139.16 33.47 Favored 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 122.919 0.488 . . . . 51.530000000000001 110.997 -177.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -125.35 135.34 52.34 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 123.157 0.583 . . . . 74.310000000000002 111.148 -176.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.9 p -115.02 125.4 72.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 121.972 -0.455 . . . . 73.409999999999997 110.485 177.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.432 HG21 ' NH1' ' A' ' 93' ' ' ARG . 96.0 t -119.33 125.46 74.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-O 121.041 0.448 . . . . 72.230000000000004 111.2 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.435 ' HB2' ' HB ' ' A' ' 110' ' ' THR . 12.9 t70 -104.99 122.14 45.24 Favored 'General case' 0 CA--C 1.489 -1.372 0 CA-C-N 115.907 -0.588 . . . . 52.5 110.624 176.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 88' ' ' ARG . 0.9 OUTLIER -131.51 11.08 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.433 0 CA-C-N 114.976 -1.011 . . . . 71.400000000000006 109.675 173.165 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -110.22 44.94 1.4 Allowed Glycine 0 N--CA 1.438 -1.197 0 N-CA-C 109.23 -1.548 . . . . 74.439999999999998 109.23 178.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.4 m -67.58 -3.29 8.41 Favored 'General case' 0 C--N 1.31 -1.109 0 C-N-CA 124.92 1.288 . . . . 74.409999999999997 112.498 -175.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 33.7 tp -68.21 -40.26 82.17 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 107.798 -1.186 . . . . 71.349999999999994 107.798 174.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -89.59 -40.97 12.26 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 107.835 -1.172 . . . . 71.209999999999994 107.835 175.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 96.36 92.96 1.81 Allowed Glycine 0 N--CA 1.44 -1.086 0 CA-C-N 115.347 -0.842 . . . . 54.340000000000003 113.377 176.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.435 ' HB ' ' HB2' ' A' ' 103' ' ' ASP . 24.2 m -88.87 119.56 29.48 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.259 -1.015 . . . . 64.010000000000005 108.259 175.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.478 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 41.9 m-85 -112.6 134.83 53.93 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 108.008 -1.108 . . . . 73.409999999999997 108.008 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.3 p -109.03 136.27 45.42 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.444 0 N-CA-C 107.848 -1.167 . . . . 73.329999999999998 107.848 179.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.607 ' O ' ' HD2' ' A' ' 114' ' ' ARG . 45.1 m-80 70.64 -81.46 0.03 OUTLIER 'General case' 0 CA--C 1.501 -0.904 0 N-CA-C 107.429 -1.323 . . . . 73.209999999999994 107.429 -172.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.607 ' HD2' ' O ' ' A' ' 113' ' ' ASN . 26.4 mmm180 -154.97 12.8 0.38 Allowed 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 107.648 -1.241 . . . . 71.120000000000005 107.648 173.62 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.426 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . 35.9 mt-10 -123.64 146.07 49.1 Favored Pre-proline 0 N--CA 1.464 0.274 0 N-CA-C 113.089 0.774 . . . . 64.150000000000006 113.089 -168.373 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 115' ' ' GLU . 4.9 Cg_exo -77.5 119.29 4.84 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.658 2.239 . . . . 71.299999999999997 109.809 175.068 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 14.8 mmm180 -136.1 148.29 48.2 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 109.391 -0.596 . . . . 64.430000000000007 109.391 -177.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -86.87 -40.54 14.79 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.534 -0.913 . . . . 63.409999999999997 108.534 173.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -142.58 137.38 30.05 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 107.663 -1.236 . . . . 64.540000000000006 107.663 172.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 24.0 tm0? -142.43 147.01 35.45 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.261 -1.014 . . . . 74.25 108.261 177.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.5 p -84.63 112.83 22.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-O 121.071 0.462 . . . . 63.350000000000001 109.758 177.07 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.497 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 64.2 mtt -54.22 142.16 26.98 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.873 1.064 . . . . 74.129999999999995 113.873 -171.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -122.13 135.38 54.79 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 115.209 -0.905 . . . . 72.439999999999998 109.068 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 6.7 t -79.89 132.53 36.1 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.855 -0.611 . . . . 54.240000000000002 111.538 -178.04 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 95.46 16.7 39.04 Favored Glycine 0 CA--C 1.488 -1.607 0 CA-C-N 115.685 -0.689 . . . . 72.510000000000005 111.855 176.001 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -124.92 -170.99 2.26 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.892 -0.781 . . . . 50.5 108.892 -177.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -133.59 150.83 51.62 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 113.641 0.978 . . . . 63.219999999999999 113.641 -172.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 67.5 mt -113.13 126.98 70.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 107.818 -1.178 . . . . 52.25 107.818 176.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.478 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 14.5 tp60 -102.11 111.94 24.41 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 107.306 -1.368 . . . . 72.409999999999997 107.306 -178.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.446 HG13 ' HB2' ' A' ' 133' ' ' PHE . 14.7 pt -102.35 98.46 6.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 CA-C-O 121.344 0.593 . . . . 71.219999999999999 109.784 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 66.11 -89.74 0.13 Allowed Glycine 0 N--CA 1.438 -1.205 0 CA-C-N 115.208 -0.906 . . . . 60.100000000000001 111.793 -176.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -126.33 -1.04 6.97 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 122.846 0.458 . . . . 73.120000000000005 110.123 -178.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.446 ' HB2' HG13 ' A' ' 130' ' ' ILE . 11.5 m-85 -108.85 156.33 19.78 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.44 -0.948 . . . . 75.439999999999998 108.44 -174.557 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -124.78 136.0 53.45 Favored 'General case' 0 C--O 1.249 1.05 0 CA-C-O 121.81 0.814 . . . . 73.209999999999994 112.642 -174.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.562 HD21 ' HB2' ' A' ' 49' ' ' LEU . 5.0 tt -124.2 139.82 53.55 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 114.086 -1.415 . . . . 75.129999999999995 107.603 -178.746 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 9.4 p -113.11 139.25 39.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 109.386 -0.598 . . . . 52.329999999999998 109.386 178.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -116.05 121.37 42.0 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 120.587 0.232 . . . . 73.439999999999998 111.011 -174.061 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -128.81 143.13 50.83 Favored 'General case' 0 C--O 1.217 -0.643 0 CA-C-O 120.856 0.36 . . . . 74.510000000000005 111.209 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -103.41 44.17 1.03 Allowed 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 105.744 -1.947 . . . . 72.129999999999995 105.744 172.008 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -60.08 -64.97 3.7 Favored Glycine 0 C--N 1.31 -0.881 0 CA-C-N 112.532 -2.122 . . . . 34.32 117.691 -168.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo . . . . . 0 N--CA 1.45 -1.044 0 CA-C-N 119.9 1.85 . . . . 70.400000000000006 114.116 -171.359 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 19.2 m120 . . . . . 0 CA--C 1.493 -1.246 0 N-CA-C 107.944 -1.132 . . . . 64.140000000000001 107.944 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -64.2 107.7 1.92 Allowed Glycine 0 N--CA 1.44 -1.083 0 O-C-N 123.854 0.722 . . . . 63.200000000000003 111.347 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.7 t -96.11 135.1 22.9 Favored Pre-proline 0 N--CA 1.427 -1.586 0 N-CA-C 109.62 -0.511 . . . . 63.340000000000003 109.62 -177.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -63.64 134.43 44.16 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 121.903 1.736 . . . . 71.319999999999993 109.588 174.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -102.95 141.73 23.08 Favored Pre-proline 0 C--N 1.284 -2.266 0 N-CA-C 109.087 -0.708 . . . . 72.409999999999997 109.087 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -38.69 115.1 0.2 Allowed 'Trans proline' 0 C--N 1.368 1.562 0 C-N-CA 124.334 3.356 . . . . 74.010000000000005 113.056 -176.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -64.83 122.45 16.96 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.83 -1.077 . . . . 65.409999999999997 110.848 -178.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.1 p -86.22 119.61 34.68 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 CA-C-N 115.305 -0.862 . . . . 62.43 111.221 -177.393 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -121.6 140.8 51.79 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 107.262 -1.385 . . . . 75.310000000000002 107.262 178.071 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.0 t -85.17 136.57 33.48 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 108.606 -0.887 . . . . 64.310000000000002 108.606 -178.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.8 p -93.52 16.35 13.83 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 121.695 0.76 . . . . 74.400000000000006 110.452 -179.15 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 18.3 m -79.5 97.28 6.37 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 115.295 -0.866 . . . . 62.439999999999998 112.004 -177.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.8 m . . . . . 0 C--N 1.305 -1.332 0 N-CA-C 107.922 -1.14 . . . . 74.329999999999998 107.922 174.133 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.033 0 N-CA-C 109.996 -1.242 . . . . 44.340000000000003 109.996 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 12.9 m -101.53 162.93 12.54 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 108.2 -1.037 . . . . 74.329999999999998 108.2 -179.291 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -137.97 164.54 28.77 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.398 -0.593 . . . . 54.310000000000002 109.398 -177.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.6 pp -134.89 160.01 39.63 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 120.825 0.345 . . . . 74.120000000000005 111.827 -177.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.447 ' HB2' HD11 ' A' ' 135' ' ' LEU . 3.6 pp -128.45 146.71 50.72 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 116.512 -0.313 . . . . 51.109999999999999 110.44 178.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 47.7 t -126.65 122.34 60.59 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 N-CA-C 108.314 -0.995 . . . . 72.340000000000003 108.314 178.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.542 HG21 ' HB3' ' A' ' 57' ' ' ALA . 19.6 t -93.35 118.1 38.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 N-CA-C 108.669 -0.863 . . . . 71.420000000000002 108.669 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -89.52 -31.81 17.47 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 116.079 -0.51 . . . . 63.399999999999999 111.047 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 27.9 tpt180 -156.99 129.3 7.4 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.308 -0.405 . . . . 51.439999999999998 110.147 178.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 139.71 136.05 3.32 Favored Glycine 0 N--CA 1.422 -2.277 0 CA-C-N 115.743 -0.662 . . . . 50.25 112.542 176.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.403 ' HD2' ' CE1' ' A' ' 133' ' ' PHE . 51.6 Cg_exo -59.98 -9.07 9.07 Favored 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 124.226 3.284 . . . . 74.430000000000007 111.894 175.644 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.462 HD21 HG21 ' A' ' 51' ' ' VAL . 2.8 t30 -35.16 -50.75 0.53 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 127.764 2.426 . . . . 72.129999999999995 109.245 168.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.542 ' HB3' HG21 ' A' ' 51' ' ' VAL . . . -169.67 -58.14 0.02 OUTLIER 'General case' 0 CA--C 1.504 -0.793 0 CA-C-N 115.511 -0.768 . . . . 64.310000000000002 108.963 176.582 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.08 30.12 55.8 Favored Glycine 0 C--N 1.318 -0.42 0 N-CA-C 110.342 -1.103 . . . . 71.129999999999995 110.342 -177.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -142.58 -175.53 4.51 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 108.727 -0.842 . . . . 54.240000000000002 108.727 -176.36 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 16.6 ptt-85 -135.54 137.13 41.74 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.191 -0.67 . . . . 71.230000000000004 109.191 178.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -156.51 154.7 30.75 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.59 -0.277 . . . . 70.140000000000001 111.074 -179.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.1 tt -96.19 139.72 31.93 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.495 -0.775 . . . . 71.219999999999999 110.424 -178.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.2 mp -110.39 126.94 54.81 Favored 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 123.996 0.918 . . . . 60.420000000000002 108.87 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -139.04 24.08 2.56 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 121.769 0.795 . . . . 74.239999999999995 109.957 177.047 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -90.44 146.81 35.22 Favored Pre-proline 0 C--N 1.315 -0.92 0 N-CA-C 108.132 -1.062 . . . . 74.400000000000006 108.132 178.193 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -56.71 -45.42 36.94 Favored 'Trans proline' 0 C--N 1.361 1.228 0 C-N-CA 122.956 2.437 . . . . 74.109999999999999 111.664 -177.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.42 HG23 ' HG2' ' A' ' 93' ' ' ARG . 90.2 m -136.1 97.41 3.6 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 115.054 -0.975 . . . . 75.140000000000001 110.238 177.364 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 21.7 m -88.07 114.15 24.41 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.359 -1.348 . . . . 63.329999999999998 107.359 177.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.403 ' O ' ' HB2' ' A' ' 76' ' ' SER . 17.2 m -100.25 120.14 39.45 Favored 'General case' 0 C--O 1.25 1.131 0 C-N-CA 120.622 -0.431 . . . . 74.129999999999995 110.65 -176.582 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.629 ' HB1' HD21 ' A' ' 80' ' ' LEU . . . -98.01 129.72 44.87 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 123.99 0.916 . . . . 53.450000000000003 110.734 -177.589 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 79' ' ' PHE . . . -178.43 -106.22 0.2 Allowed Glycine 0 C--O 1.242 0.65 0 N-CA-C 110.439 -1.064 . . . . 53.549999999999997 110.439 178.331 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.492 ' HG2' HG21 ' A' ' 85' ' ' VAL . 18.0 mmm180 -131.38 -81.91 0.52 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.152 0.581 . . . . 74.239999999999995 110.218 174.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.503 ' HB3' ' HD3' ' A' ' 74' ' ' PRO . 10.8 t60 -150.78 -61.29 0.02 OUTLIER Pre-proline 0 CA--C 1.553 1.08 0 CA-C-O 118.867 -0.587 . . . . 52.100000000000001 111.838 -177.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.503 ' HD3' ' HB3' ' A' ' 73' ' ' HIS . 83.3 Cg_exo -50.28 -37.89 50.76 Favored 'Trans proline' 0 C--N 1.374 1.899 0 C-N-CA 122.514 2.142 . . . . 55.539999999999999 114.781 179.063 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.596 ' OE2' ' HD2' ' A' ' 87' ' ' ARG . 45.5 mt-10 -109.42 2.62 20.72 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 112.657 0.614 . . . . 75.010000000000005 112.657 -177.13 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.403 ' HB2' ' O ' ' A' ' 69' ' ' THR . 36.1 p -148.88 -175.31 4.9 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.119 -1.033 . . . . 75.010000000000005 113.023 -171.621 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -102.79 -42.29 5.91 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.684 0.754 . . . . 64.400000000000006 110.055 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 21.5 pt -118.91 153.17 21.19 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 115.747 -0.66 . . . . 64.239999999999995 111.087 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.472 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 40.7 p90 -105.83 129.26 54.04 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.036 -0.727 . . . . 73.420000000000002 109.036 177.296 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.629 HD21 ' HB1' ' A' ' 70' ' ' ALA . 1.4 pt? -156.2 6.27 0.19 Allowed 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 113.773 1.027 . . . . 42.119999999999997 113.773 -175.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -122.62 128.53 50.79 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 118.996 -1.081 . . . . 71.420000000000002 108.337 173.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -127.6 -4.11 5.96 Favored 'General case' 0 C--N 1.286 -2.159 0 CA-C-N 115.018 -0.992 . . . . 74.519999999999996 111.538 -176.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.1 p -87.36 -37.52 11.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 C-N-CA 119.043 -1.063 . . . . 75.510000000000005 109.374 -174.268 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.3 m -171.8 81.98 0.07 Allowed 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.08 -1.082 . . . . 70.049999999999997 108.08 -178.19 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.492 HG21 ' HG2' ' A' ' 72' ' ' ARG . 8.9 p -82.91 104.56 11.72 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.366 0 C-N-CA 116.535 -2.066 . . . . 63.240000000000002 109.647 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 58.2 m -76.75 -44.77 31.76 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 113.972 -1.467 . . . . 72.519999999999996 112.212 -175.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.596 ' HD2' ' OE2' ' A' ' 75' ' ' GLU . 13.7 mmt180 -166.15 -167.04 0.98 Allowed 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 105.083 -2.191 . . . . 73.510000000000005 105.083 -176.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.537 ' H ' ' HD3' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -52.78 126.61 20.62 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 106.55 -1.648 . . . . 74.109999999999999 106.55 166.431 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.405 ' NE2' ' HB ' ' A' ' 130' ' ' ILE . 40.6 t60 -92.83 -49.56 6.0 Favored 'General case' 0 C--N 1.284 -2.269 0 CA-C-N 115.501 -0.772 . . . . 62.340000000000003 111.845 -164.189 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -139.66 142.65 36.97 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 120.296 -0.562 . . . . 61.439999999999998 110.362 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -117.23 127.3 53.96 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 109.136 -0.69 . . . . 73.299999999999997 109.136 176.171 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -108.72 112.28 24.5 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 106.827 -1.546 . . . . 72.340000000000003 106.827 176.206 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.42 ' HG2' HG23 ' A' ' 67' ' ' THR . 20.0 mtm180 -123.74 124.67 43.23 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 109.426 -0.583 . . . . 64.430000000000007 109.426 -177.383 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.492 ' O ' HD12 ' A' ' 94' ' ' ILE . 2.8 pp -115.47 122.48 69.41 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.222 0 CA-C-O 121.76 0.79 . . . . 50.450000000000003 112.041 -175.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -119.08 145.65 45.74 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 107.018 -1.475 . . . . 54.32 107.018 177.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -54.81 -29.7 55.32 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 122.641 0.377 . . . . 61.130000000000003 111.937 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -80.45 -46.69 7.27 Favored Glycine 0 N--CA 1.43 -1.706 0 CA-C-O 119.692 -0.504 . . . . 32.229999999999997 112.34 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -144.99 142.76 30.08 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 117.211 0.505 . . . . 74.430000000000007 110.472 -179.033 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -95.67 114.79 26.57 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 106.64 -1.615 . . . . 72.140000000000001 106.64 176.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -119.61 116.25 25.64 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.332 0.587 . . . . 73.129999999999995 112.343 -170.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 5.6 p -105.88 124.44 61.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 108.265 -1.013 . . . . 71.510000000000005 108.265 172.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.487 HG12 HG13 ' A' ' 104' ' ' VAL . 33.8 t -111.66 115.01 48.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 CA-C-N 115.869 -0.605 . . . . 72.030000000000001 109.435 -176.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.577 ' HB3' ' CB ' ' A' ' 110' ' ' THR . 4.9 m-20 -85.41 109.69 18.61 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 114.796 -1.093 . . . . 74.430000000000007 108.855 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.487 HG13 HG12 ' A' ' 102' ' ' VAL . 12.3 m -118.3 16.83 7.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 111.95 0.352 . . . . 73.109999999999999 111.95 -176.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -114.22 48.43 0.94 Allowed Glycine 0 C--O 1.241 0.589 0 N-CA-C 110.771 -0.932 . . . . 54.420000000000002 110.771 177.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 6.9 m -65.52 -22.58 66.73 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 124.126 0.97 . . . . 73.109999999999999 112.425 -175.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -58.77 -42.14 88.26 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.209 0.528 . . . . 70.200000000000003 110.296 177.09 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -76.94 -52.9 8.59 Favored 'General case' 0 CA--C 1.485 -1.554 0 N-CA-C 106.456 -1.683 . . . . 64.140000000000001 106.456 175.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 123.91 103.0 1.55 Allowed Glycine 0 N--CA 1.406 -3.31 0 CA-C-N 113.892 -1.504 . . . . 42.5 110.116 -177.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.577 ' CB ' ' HB3' ' A' ' 103' ' ' ASP . 1.5 p -92.82 119.16 31.88 Favored 'General case' 0 N--CA 1.409 -2.525 0 N-CA-C 107.501 -1.296 . . . . 62.340000000000003 107.501 175.244 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.434 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 65.6 m-85 -121.99 139.44 53.68 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-O 121.554 0.692 . . . . 63.450000000000003 112.506 -172.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.697 ' HB ' ' NE ' ' A' ' 117' ' ' ARG . 7.1 p -104.87 111.71 35.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 106.333 -1.728 . . . . 65.530000000000001 106.333 170.202 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 25.8 m120 54.23 35.7 23.28 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.922 0.489 . . . . 61.100000000000001 111.295 -177.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 49.2 mtm-85 83.81 3.09 0.88 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.676 1.59 . . . . 74.310000000000002 115.257 178.39 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -110.47 139.5 21.6 Favored Pre-proline 0 C--N 1.314 -0.957 0 C-N-CA 119.645 -0.822 . . . . 43.439999999999998 110.069 175.142 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.27 142.32 97.92 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 122.869 2.38 . . . . 74.200000000000003 113.767 -175.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.697 ' NE ' ' HB ' ' A' ' 112' ' ' VAL . 13.1 ptt180 -147.14 163.94 34.72 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.842 -0.617 . . . . 75.030000000000001 111.744 176.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.433 ' HA ' ' HB2' ' A' ' 103' ' ' ASP . 11.1 m120 -124.75 -17.86 5.78 Favored 'General case' 0 CA--C 1.513 -0.452 0 O-C-N 124.094 0.871 . . . . 75.209999999999994 111.959 173.396 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -155.42 138.28 15.33 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.162 -0.681 . . . . 73.310000000000002 109.162 174.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 21.6 tm0? -141.47 149.28 40.75 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.174 -1.047 . . . . 65.040000000000006 108.174 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.3 p -101.83 113.76 39.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 109.389 -0.597 . . . . 74.439999999999998 109.389 176.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -32.91 116.95 0.24 Allowed 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 115.796 1.776 . . . . 73.310000000000002 115.796 -172.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -118.3 145.48 45.04 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 106.795 -1.557 . . . . 65.010000000000005 106.795 172.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 15.0 t -89.46 130.94 35.72 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 119.766 -0.774 . . . . 74.099999999999994 109.856 -178.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 94.27 19.02 34.27 Favored Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 110.88 -0.888 . . . . 64.420000000000002 110.88 -178.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -96.66 142.13 29.07 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 108.538 -0.912 . . . . 42.439999999999998 108.538 -178.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -109.5 127.32 54.36 Favored 'General case' 0 N--CA 1.422 -1.867 0 CA-C-O 122.086 0.946 . . . . 45.119999999999997 111.127 179.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.511 HG12 ' NH2' ' A' ' 117' ' ' ARG . 25.6 mt -106.7 125.65 62.61 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.285 0 CA-C-N 114.477 -1.238 . . . . 53.310000000000002 108.043 -177.048 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.434 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 51.0 tt0 -105.42 111.9 24.79 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 107.313 -1.365 . . . . 73.099999999999994 107.313 172.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.405 ' HB ' ' NE2' ' A' ' 89' ' ' HIS . 17.3 pt -102.05 101.0 11.51 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 N-CA-C 108.593 -0.892 . . . . 75.450000000000003 108.593 177.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 73.62 -90.99 0.65 Allowed Glycine 0 N--CA 1.419 -2.463 0 CA-C-N 114.866 -1.061 . . . . 63.240000000000002 110.757 -177.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 45.0 tttp -131.88 3.53 4.1 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 121.117 0.484 . . . . 75.129999999999995 110.345 -176.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.403 ' CE1' ' HD2' ' A' ' 55' ' ' PRO . 34.5 m-85 -101.61 144.35 30.45 Favored 'General case' 0 C--N 1.311 -1.069 0 O-C-N 121.918 -0.489 . . . . 73.019999999999996 109.743 -176.026 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -106.85 121.04 43.62 Favored 'General case' 0 C--O 1.247 0.95 0 N-CA-C 107.711 -1.218 . . . . 75.349999999999994 107.711 -177.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.447 HD11 ' HB2' ' A' ' 49' ' ' LEU . 42.9 tp -123.89 142.42 51.15 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 114.993 -1.003 . . . . 72.310000000000002 108.362 -176.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 11.1 p -117.09 130.51 71.88 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 N-CA-C 107.553 -1.277 . . . . 71.5 107.553 174.454 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -111.47 130.27 55.77 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 116.233 -0.44 . . . . 71.319999999999993 110.055 -173.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -127.94 170.16 13.16 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.92 -0.77 . . . . 63.340000000000003 108.92 -178.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -89.53 164.61 14.72 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 109.031 -0.729 . . . . 53.329999999999998 109.031 176.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -82.87 142.96 21.96 Favored Glycine 0 N--CA 1.435 -1.394 0 N-CA-C 109.723 -1.351 . . . . 53.399999999999999 109.723 177.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo . . . . . 0 N--CA 1.444 -1.423 0 CA-C-N 119.608 1.704 . . . . 63.329999999999998 111.377 179.987 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 . . . . . 0 CA--C 1.501 -0.927 0 CA-C-O 120.971 0.415 . . . . 74.340000000000003 110.187 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -119.95 101.1 0.81 Allowed Glycine 0 N--CA 1.425 -2.045 0 N-CA-C 111.107 -0.797 . . . . 64.25 111.107 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.2 m -78.78 124.03 85.15 Favored Pre-proline 0 C--N 1.306 -1.29 0 N-CA-C 108.555 -0.906 . . . . 73.140000000000001 108.555 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -60.49 128.02 24.65 Favored 'Trans proline' 0 C--O 1.252 1.19 0 C-N-CA 122.363 2.042 . . . . 74.200000000000003 111.601 178.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -100.98 131.67 23.02 Favored Pre-proline 0 C--N 1.299 -1.604 0 CA-C-N 115.919 -0.582 . . . . 72.510000000000005 110.188 -178.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -65.1 127.18 17.85 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 121.982 1.788 . . . . 74.340000000000003 111.225 178.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -82.12 104.91 12.8 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.844 -1.169 . . . . 64.209999999999994 107.844 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 23.5 t -111.83 148.95 14.65 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 N-CA-C 107.459 -1.311 . . . . 63.229999999999997 107.459 -178.064 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -82.47 121.57 26.93 Favored 'General case' 0 N--CA 1.408 -2.533 0 N-CA-C 106.143 -1.799 . . . . 63.32 106.143 170.306 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 58.4 m -60.53 104.28 0.32 Allowed 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.78 -0.645 . . . . 71.349999999999994 109.642 -177.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 18.2 m -81.25 94.64 6.75 Favored 'General case' 0 N--CA 1.415 -2.189 0 CA-C-N 114.781 -1.1 . . . . 73.310000000000002 110.586 -174.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 21.2 m -134.35 83.68 2.05 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 114.697 -1.138 . . . . 62.340000000000003 108.221 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 39.4 t . . . . . 0 C--N 1.301 -1.533 0 N-CA-C 108.453 -0.943 . . . . 62.210000000000001 108.453 -178.275 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.488 -1.65 0 N-CA-C 107.877 -2.089 . . . . 24.32 107.877 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.402 ' HB3' ' HB2' ' A' ' 63' ' ' LEU . 10.1 m -89.47 152.12 21.63 Favored 'General case' 0 N--CA 1.422 -1.832 0 CA-C-O 121.684 0.754 . . . . 73.439999999999998 112.374 -166.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.414 ' HB1' ' O ' ' A' ' 138' ' ' LEU . . . -112.32 -164.38 0.91 Allowed 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 114.114 -1.403 . . . . 51.140000000000001 107.434 178.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.7 pp -131.07 155.4 46.98 Favored 'General case' 0 N--CA 1.438 -1.051 0 C-N-CA 120.277 -0.569 . . . . 63.310000000000002 111.96 -177.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.42 ' HB2' HD21 ' A' ' 135' ' ' LEU . 3.6 pp -132.1 141.29 49.12 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 115.771 -0.649 . . . . 74.209999999999994 109.985 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 59.8 t -119.07 126.04 75.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 109.655 -0.498 . . . . 74.140000000000001 109.655 -177.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.5 t -93.17 115.87 32.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 107.553 -1.277 . . . . 70.010000000000005 107.553 176.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.412 ' HE3' ' CG2' ' A' ' 136' ' ' VAL . 94.5 mttt -66.02 -43.93 86.23 Favored 'General case' 0 CA--C 1.496 -1.125 0 CA-C-N 115.105 -0.952 . . . . 71.409999999999997 109.088 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.412 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 30.0 tpt180 -168.9 135.13 1.75 Allowed 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.067 -1.457 . . . . 65.439999999999998 107.067 179.018 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.447 ' HA2' ' HD3' ' A' ' 55' ' ' PRO . . . 172.43 135.73 2.02 Favored Glycine 0 N--CA 1.42 -2.393 0 N-CA-C 109.267 -1.533 . . . . 72.310000000000002 109.267 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.542 ' HB2' ' O ' ' A' ' 81' ' ' ASP . 15.0 Cg_exo -67.52 -10.95 30.43 Favored 'Trans proline' 0 CA--C 1.53 0.307 0 C-N-CA 122.372 2.048 . . . . 61.539999999999999 112.723 -176.601 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.543 ' HA ' ' N ' ' A' ' 81' ' ' ASP . 29.5 p-10 -53.92 -42.36 68.67 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.708 0.803 . . . . 73.450000000000003 110.673 178.409 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -168.17 -47.18 0.02 OUTLIER 'General case' 0 N--CA 1.444 -0.732 0 O-C-N 123.411 0.444 . . . . 64.129999999999995 110.769 178.206 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.28 64.73 2.86 Favored Glycine 0 C--O 1.239 0.466 0 N-CA-C 110.727 -0.949 . . . . 74.219999999999999 110.727 -176.288 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -166.45 -178.49 4.49 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 107.449 -1.315 . . . . 72.5 107.449 -177.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 13.3 ptt180 -112.64 144.97 41.22 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 109.199 -0.667 . . . . 64.420000000000002 109.199 175.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -132.33 154.31 49.86 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 116.372 -0.377 . . . . 70.319999999999993 110.553 -177.151 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.1 tt -111.48 140.27 46.22 Favored 'General case' 0 C--N 1.28 -2.439 0 N-CA-C 103.544 -2.762 . . . . 71.450000000000003 103.544 173.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.402 ' HB2' ' HB3' ' A' ' 46' ' ' SER . 6.8 mp -70.38 113.74 7.82 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 118.555 -1.258 . . . . 72.010000000000005 109.115 -176.349 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -72.36 -60.59 2.16 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 114.081 -1.418 . . . . 62.43 109.632 -173.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.466 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 53.7 tt0 -103.02 132.92 20.66 Favored Pre-proline 0 N--CA 1.419 -1.992 0 CA-C-N 115.168 -0.924 . . . . 63.240000000000002 109.39 -178.564 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.466 ' HD2' ' HA ' ' A' ' 65' ' ' GLN . 5.8 Cg_exo -37.6 -46.94 1.89 Allowed 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 124.9 3.733 . . . . 75.219999999999999 113.515 175.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.452 HG23 ' HG2' ' A' ' 93' ' ' ARG . 87.3 m -106.61 96.44 6.45 Favored 'General case' 0 N--CA 1.423 -1.817 0 N-CA-C 108.189 -1.041 . . . . 64.340000000000003 108.189 173.102 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.451 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 22.3 m -89.16 114.61 25.92 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 108.404 -0.961 . . . . 60.030000000000001 108.404 -179.069 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.4 t -96.85 120.08 36.53 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.583 0.706 . . . . 72.329999999999998 109.86 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -110.28 148.94 30.92 Favored 'General case' 0 N--CA 1.428 -1.569 0 CA-C-N 115.837 -0.62 . . . . 62.530000000000001 110.579 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 147.71 -137.82 6.78 Favored Glycine 0 CA--C 1.466 -2.994 0 N-CA-C 107.389 -2.285 . . . . 64.450000000000003 107.389 -178.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.296 4.5 ptt85 -110.94 -88.94 0.5 Allowed 'General case' 0 C--N 1.284 -2.268 0 CA-C-O 118.428 -0.796 . . . . 75.109999999999999 111.857 174.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.471 ' HB3' ' HD2' ' A' ' 74' ' ' PRO . 32.7 m170 60.63 173.74 0.05 OUTLIER Pre-proline 0 CA--C 1.559 1.298 0 CA-C-N 118.598 0.635 . . . . 73.209999999999994 110.879 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.471 ' HD2' ' HB3' ' A' ' 73' ' ' HIS . 28.4 Cg_endo -66.77 -21.74 50.75 Favored 'Trans proline' 0 CA--C 1.545 1.026 0 C-N-CA 121.394 1.396 . . . . 65.299999999999997 111.81 169.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -134.33 92.96 2.99 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-O 121.337 0.589 . . . . 73.420000000000002 110.363 -176.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 13.1 m -77.38 117.32 18.76 Favored 'General case' 0 C--N 1.279 -2.494 0 N-CA-C 107.084 -1.45 . . . . 73.129999999999995 107.084 172.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -70.99 -35.06 71.96 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 108.522 -0.918 . . . . 73.400000000000006 108.522 -178.102 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.7 pp -130.15 162.47 37.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 106.14 -1.8 . . . . 74.150000000000006 106.14 165.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -101.33 136.64 40.85 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 113.974 1.102 . . . . 74.420000000000002 113.974 -170.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.53 ' HA ' ' HB2' ' A' ' 56' ' ' ASN . 94.4 mt -128.91 150.18 50.47 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 106.971 -1.492 . . . . 73.239999999999995 106.971 175.536 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.543 ' N ' ' HA ' ' A' ' 56' ' ' ASN . 16.9 t70 -156.93 94.59 1.44 Allowed 'General case' 0 C--N 1.288 -2.071 0 O-C-N 124.0 0.812 . . . . 72.519999999999996 109.425 -177.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.448 ' O ' HG12 ' A' ' 85' ' ' VAL . 14.1 t70 -157.82 152.92 25.62 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 107.802 -1.185 . . . . 72.030000000000001 107.802 175.542 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.6 p -61.31 -27.5 41.99 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.061 0 C-N-CA 122.893 0.477 . . . . 63.43 112.202 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 17.6 p -96.77 21.85 8.96 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 113.88 1.067 . . . . 72.430000000000007 113.88 -177.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.448 HG12 ' O ' ' A' ' 82' ' ' ASP . 13.9 p -82.06 124.74 39.45 Favored 'Isoleucine or valine' 0 C--O 1.249 1.038 0 CA-C-O 122.044 0.925 . . . . 74.239999999999995 110.266 179.021 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 16.2 m -80.9 163.32 23.45 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.805 -0.813 . . . . 70.549999999999997 108.805 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.49 -43.21 97.26 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 119.677 -0.809 . . . . 70.140000000000001 108.931 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -110.4 110.81 21.72 Favored 'General case' 0 N--CA 1.419 -2.02 0 N-CA-C 102.565 -3.124 . . . . 74.319999999999993 102.565 176.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 14.6 t60 -110.62 -85.88 0.55 Allowed 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 117.878 -1.529 . . . . 73.25 112.398 -172.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.414 ' HA ' ' HA ' ' A' ' 103' ' ' ASP . . . -126.6 123.82 38.51 Favored 'General case' 0 C--N 1.292 -1.932 0 C-N-CA 120.167 -0.613 . . . . 42.240000000000002 109.722 -175.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -110.04 127.53 54.89 Favored 'General case' 0 C--N 1.275 -2.642 0 C-N-CA 118.938 -1.105 . . . . 55.409999999999997 110.419 177.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.451 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 53.0 m-85 -103.41 113.64 27.3 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 114.61 -1.177 . . . . 74.430000000000007 108.116 -176.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.452 ' HG2' HG23 ' A' ' 67' ' ' THR . 48.6 mtm180 -108.78 122.6 47.5 Favored 'General case' 0 C--N 1.288 -2.109 0 N-CA-C 109.632 -0.507 . . . . 74.450000000000003 109.632 178.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.412 ' CG2' ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -115.2 116.95 54.09 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.495 0 N-CA-C 106.888 -1.523 . . . . 74.319999999999993 106.888 175.919 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -117.8 146.06 44.09 Favored 'General case' 0 C--N 1.278 -2.533 0 CA-C-N 113.575 -1.648 . . . . 74.140000000000001 106.6 178.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -56.1 -22.02 25.68 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 112.396 0.517 . . . . 72.230000000000004 112.396 -177.246 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -95.95 -33.6 6.28 Favored Glycine 0 N--CA 1.435 -1.368 0 C-N-CA 121.042 -0.599 . . . . 60.119999999999997 113.611 178.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -148.16 144.3 27.67 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 117.494 0.647 . . . . 73.519999999999996 111.687 -176.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.487 ' HB3' ' SD ' ' A' ' 122' ' ' MET . 5.1 m-85 -106.67 114.3 28.32 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 106.986 -1.487 . . . . 74.299999999999997 106.986 176.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -132.37 135.12 45.92 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.43 -0.794 . . . . 63.140000000000001 111.901 -176.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.5 p -114.53 119.53 61.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 109.066 -0.716 . . . . 72.129999999999995 109.066 176.118 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 50.0 t -110.83 114.09 46.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 108.168 -1.049 . . . . 60.140000000000001 108.168 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.414 ' HA ' ' HA ' ' A' ' 90' ' ' ALA . 19.5 t70 -105.43 127.44 52.99 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-O 121.235 0.54 . . . . 63.350000000000001 110.556 179.301 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 28.7 m -116.67 12.61 7.55 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.176 0 CA-C-N 115.052 -0.976 . . . . 62.240000000000002 109.51 174.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -100.89 52.5 0.92 Allowed Glycine 0 N--CA 1.437 -1.284 0 N-CA-C 110.596 -1.001 . . . . 60.140000000000001 110.596 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.5 m -60.96 -17.16 50.06 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.201 1.4 . . . . 74.040000000000006 112.331 -176.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 82.6 mt -58.3 -39.9 80.56 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.698 0.761 . . . . 74.209999999999994 109.395 174.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -90.64 -48.99 6.73 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 106.706 -1.59 . . . . 73.530000000000001 106.706 176.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.66 94.0 1.24 Allowed Glycine 0 N--CA 1.442 -0.948 0 CA-C-N 114.767 -1.106 . . . . 53.039999999999999 113.982 175.131 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 42.0 m -93.72 120.09 33.55 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 109.208 -0.664 . . . . 71.049999999999997 109.208 175.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -135.65 168.74 18.7 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 107.923 -1.14 . . . . 65.530000000000001 107.923 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.417 HG12 ' H ' ' A' ' 114' ' ' ARG . 52.5 t -106.84 141.67 21.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 107.932 -1.136 . . . . 72.420000000000002 107.932 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -51.48 -38.11 52.25 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 123.88 0.872 . . . . 74.329999999999998 111.563 178.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.417 ' H ' HG12 ' A' ' 112' ' ' VAL . 53.5 ttt180 -84.06 -36.46 23.04 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 116.072 -0.513 . . . . 73.099999999999994 111.343 176.495 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 21.3 tp10 -124.2 114.21 27.73 Favored Pre-proline 0 C--N 1.306 -1.295 0 N-CA-C 112.125 0.417 . . . . 72.150000000000006 112.125 -169.094 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -78.75 38.82 0.74 Allowed 'Trans proline' 0 CA--C 1.547 1.146 0 C-N-CA 123.409 2.739 . . . . 63.329999999999998 113.206 -178.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 64.8 mtm180 -109.45 145.06 36.81 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 116.197 -0.456 . . . . 71.040000000000006 110.286 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -71.28 -38.64 71.82 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 123.941 0.776 . . . . 70.25 110.992 -172.503 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -115.04 136.9 52.62 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 107.13 -1.433 . . . . 61.020000000000003 107.13 173.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 -142.58 150.85 40.88 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 114.518 1.303 . . . . 72.140000000000001 114.518 -177.279 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.1 p -79.88 128.82 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.915 0 N-CA-C 105.252 -2.129 . . . . 63.32 105.252 167.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.487 ' SD ' ' HB3' ' A' ' 99' ' ' PHE . 59.4 mtt -60.59 136.68 58.13 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 123.29 0.636 . . . . 74.319999999999993 112.095 -171.041 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.39 125.06 51.31 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 105.435 -2.061 . . . . 74.329999999999998 105.435 178.065 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 21.7 p -78.89 115.39 18.55 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.222 0.534 . . . . 53.329999999999998 111.507 -176.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 101.53 13.77 31.77 Favored Glycine 0 N--CA 1.432 -1.606 0 C-N-CA 120.758 -0.734 . . . . 63.200000000000003 112.505 179.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -116.6 176.33 5.16 Favored 'General case' 0 C--O 1.248 0.986 0 C-N-CA 119.531 -0.868 . . . . 52.310000000000002 109.476 178.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.54 ' OE1' ' HD3' ' A' ' 134' ' ' ARG . 40.6 tt0 -110.48 135.11 51.65 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-O 121.296 0.57 . . . . 72.430000000000007 109.984 -171.078 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 67.4 mt -103.37 122.95 56.55 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.406 0 N-CA-C 107.889 -1.152 . . . . 70.239999999999995 107.889 178.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -97.32 112.45 24.26 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 115.913 -0.585 . . . . 74.049999999999997 109.454 -179.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.1 pt -102.01 98.21 6.57 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.343 0 N-CA-C 107.549 -1.278 . . . . 74.209999999999994 107.549 175.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 75.08 -113.86 4.12 Favored Glycine 0 N--CA 1.421 -2.315 0 N-CA-C 108.198 -1.961 . . . . 70.120000000000005 108.198 -172.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -124.66 6.27 8.19 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 120.971 0.415 . . . . 72.329999999999998 110.397 175.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.412 ' HB2' ' O ' ' A' ' 53' ' ' ARG . 9.4 p90 -98.78 151.64 20.57 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 109.224 -0.658 . . . . 74.340000000000003 109.224 174.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.54 ' HD3' ' OE1' ' A' ' 127' ' ' GLU . 77.9 mtt-85 -117.85 132.5 56.42 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 115.104 1.52 . . . . 74.439999999999998 115.104 -164.307 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.42 HD21 ' HB2' ' A' ' 49' ' ' LEU . 5.6 tt -124.3 136.33 54.03 Favored 'General case' 0 C--O 1.195 -1.773 0 CA-C-N 114.008 -1.451 . . . . 75.0 107.466 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.412 ' CG2' ' HE3' ' A' ' 52' ' ' LYS . 25.9 t -112.58 137.63 44.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.941 -0.763 . . . . 61.539999999999999 108.941 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -107.26 117.36 33.86 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 110.014 -0.365 . . . . 71.25 110.014 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.414 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 2.5 mm? -117.34 143.87 45.5 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.35 0.595 . . . . 72.439999999999998 110.976 -177.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -97.57 91.27 5.35 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.415 -0.957 . . . . 65.329999999999998 108.415 177.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -107.16 -72.28 0.79 Allowed Glycine 0 N--CA 1.43 -1.727 0 CA-C-N 115.358 -0.837 . . . . 42.109999999999999 111.176 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo . . . . . 0 N--CA 1.446 -1.28 0 C-N-CA 121.935 1.757 . . . . 64.030000000000001 112.441 179.717 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 55.7 t30 . . . . . 0 N--CA 1.45 -0.455 0 N-CA-C 109.317 -0.623 . . . . 72.200000000000003 109.317 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -73.85 106.15 1.96 Allowed Glycine 0 N--CA 1.436 -1.305 0 N-CA-C 110.66 -0.976 . . . . 63.450000000000003 110.66 178.31 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.1 t -98.02 126.73 39.28 Favored Pre-proline 0 C--N 1.296 -1.721 0 N-CA-C 110.122 -0.325 . . . . 72.209999999999994 110.122 -179.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -66.3 128.37 19.25 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.388 2.059 . . . . 71.540000000000006 111.205 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -90.77 131.68 36.93 Favored Pre-proline 0 C--N 1.294 -1.808 0 N-CA-C 108.898 -0.779 . . . . 71.010000000000005 108.898 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_exo -49.14 129.36 21.77 Favored 'Trans proline' 0 C--O 1.239 0.541 0 C-N-CA 123.508 2.805 . . . . 34.399999999999999 114.707 -174.262 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -110.18 107.95 17.93 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.007 -1.849 . . . . 71.409999999999997 106.007 174.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.6 p -114.65 107.49 23.0 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 CA-C-O 122.01 0.91 . . . . 53.030000000000001 111.7 -175.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -139.57 140.95 37.2 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 105.676 -1.972 . . . . 60.32 105.676 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 67.8 m -150.71 95.57 2.24 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 109.897 -0.408 . . . . 64.25 109.897 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.9 p -113.33 104.18 12.06 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-O 121.363 0.601 . . . . 74.0 111.547 177.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 39.9 t -164.9 115.2 1.14 Allowed 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 107.498 -1.297 . . . . 63.109999999999999 107.498 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.8 p . . . . . 0 C--N 1.309 -1.194 0 N-CA-C 109.792 -0.447 . . . . 73.319999999999993 109.792 179.589 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.48 ' HA2' ' O ' ' A' ' 141' ' ' PRO . . . . . . . . 0 CA--C 1.48 -2.154 0 N-CA-C 106.015 -2.834 . . . . 44.130000000000003 106.015 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 13.6 m -89.98 164.79 14.4 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 113.56 -1.32 . . . . 61.240000000000002 111.264 -169.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -92.91 164.58 13.26 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 116.015 -0.539 . . . . 74.439999999999998 109.773 -179.031 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -133.83 155.91 48.99 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 110.261 -0.274 . . . . 75.239999999999995 110.261 -178.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.473 HD23 ' O ' ' A' ' 61' ' ' PHE . 2.7 pt? -108.79 132.77 53.66 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 107.065 -1.457 . . . . 72.310000000000002 107.065 176.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.8 t -117.68 114.66 46.13 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 N-CA-C 108.661 -0.866 . . . . 65.299999999999997 108.661 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.47 HG11 ' OD1' ' A' ' 56' ' ' ASN . 61.9 t -92.9 116.03 33.09 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 N-CA-C 107.722 -1.214 . . . . 64.109999999999999 107.722 177.526 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.4 mmmp? -82.56 -39.12 22.75 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.381 -0.827 . . . . 62.119999999999997 108.831 -178.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.43 ' O ' ' HB3' ' A' ' 133' ' ' PHE . 72.8 ttt180 -147.86 115.65 6.4 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 115.196 -0.911 . . . . 75.400000000000006 108.94 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 175.74 134.18 1.88 Allowed Glycine 0 N--CA 1.438 -1.174 0 C-N-CA 120.127 -1.035 . . . . 72.219999999999999 113.433 176.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.55 -9.25 25.7 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 123.957 3.105 . . . . 64.510000000000005 111.897 175.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.49 ' HB2' ' HA ' ' A' ' 80' ' ' LEU . 13.2 p30 -48.54 -46.05 38.26 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.488 1.115 . . . . 54.43 111.495 177.676 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -171.34 -40.53 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 125.203 1.401 . . . . 75.150000000000006 107.381 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 64.6 46.35 90.34 Favored Glycine 0 CA--C 1.495 -1.192 0 N-CA-C 110.191 -1.163 . . . . 71.099999999999994 110.191 -178.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -143.11 -178.01 5.63 Favored 'General case' 0 N--CA 1.424 -1.775 0 N-CA-C 108.513 -0.921 . . . . 75.420000000000002 108.513 -173.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.445 ' HA ' ' O ' ' A' ' 49' ' ' LEU . 11.2 ptt180 -141.49 131.94 25.27 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 123.416 0.447 . . . . 73.329999999999998 109.969 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.473 ' O ' HD23 ' A' ' 49' ' ' LEU . 30.7 p90 -154.36 154.96 34.19 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 112.415 0.524 . . . . 71.540000000000006 112.415 -177.054 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.2 tt -81.08 139.69 35.54 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.019 -0.991 . . . . 64.140000000000001 110.874 -176.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -101.71 115.77 31.27 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 110.253 -0.277 . . . . 60.409999999999997 110.253 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -111.31 -4.45 14.93 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 122.393 1.092 . . . . 72.040000000000006 108.392 177.014 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.416 HE21 ' HB3' ' A' ' 77' ' ' ASP . 1.0 OUTLIER -78.73 123.6 85.31 Favored Pre-proline 0 C--N 1.314 -0.959 0 CA-C-N 114.587 -1.188 . . . . 74.120000000000005 109.98 -175.875 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.02 -27.71 85.08 Favored 'Trans proline' 0 C--N 1.361 1.225 0 C-N-CA 122.878 2.385 . . . . 73.310000000000002 111.308 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 91.8 m -134.93 116.63 14.94 Favored 'General case' 0 N--CA 1.408 -2.535 0 N-CA-C 107.13 -1.433 . . . . 71.310000000000002 107.13 173.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.423 HG23 ' HB2' ' A' ' 77' ' ' ASP . 88.9 m -105.24 114.4 28.56 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 108.969 -0.752 . . . . 72.299999999999997 108.969 -179.189 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 28.3 p -82.67 130.24 35.09 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 115.35 -0.841 . . . . 43.530000000000001 111.577 -178.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -108.58 115.5 30.21 Favored 'General case' 0 C--O 1.252 1.212 0 CA-C-O 121.385 0.612 . . . . 70.109999999999999 110.947 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 165.74 -158.5 31.41 Favored Glycine 0 CA--C 1.487 -1.691 0 N-CA-C 106.046 -2.822 . . . . 55.439999999999998 106.046 -179.159 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.8 ttp180 -159.32 78.18 0.72 Allowed 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 119.093 1.446 . . . . 75.239999999999995 111.417 174.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.48 ' HB3' ' HD3' ' A' ' 74' ' ' PRO . 13.0 t60 -175.53 -77.98 0.0 OUTLIER Pre-proline 0 CA--C 1.556 1.176 0 N-CA-C 113.392 0.886 . . . . 73.510000000000005 113.392 175.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.48 ' HD3' ' HB3' ' A' ' 73' ' ' HIS . 48.2 Cg_endo -66.71 -41.87 10.14 Favored 'Trans proline' 0 C--N 1.394 2.966 0 CA-C-N 120.839 1.335 . . . . 75.420000000000002 113.372 -169.552 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -166.71 114.54 0.85 Allowed 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 102.582 -3.118 . . . . 44.520000000000003 102.582 -178.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 19.7 m -136.33 103.07 5.17 Favored 'General case' 0 C--N 1.26 -3.319 0 CA-C-N 115.888 -0.597 . . . . 61.119999999999997 109.647 -178.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.423 ' HB2' HG23 ' A' ' 68' ' ' THR . 42.1 m-20 -74.07 -31.98 63.07 Favored 'General case' 0 CA--C 1.493 -1.227 0 CA-C-N 115.218 -0.901 . . . . 75.219999999999999 109.363 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 39.0 pt -119.75 137.82 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.871 0 N-CA-C 107.086 -1.45 . . . . 71.409999999999997 107.086 170.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -85.73 124.14 31.91 Favored 'General case' 0 C--N 1.284 -2.272 0 N-CA-C 108.145 -1.057 . . . . 73.140000000000001 108.145 179.102 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.49 ' HA ' ' HB2' ' A' ' 56' ' ' ASN . 35.4 tp -122.02 155.58 35.3 Favored 'General case' 0 N--CA 1.414 -2.248 0 CA-C-N 115.929 -0.578 . . . . 61.350000000000001 109.712 -174.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.41 ' CB ' ' HA ' ' A' ' 56' ' ' ASN . 9.8 t70 -168.94 150.32 4.57 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 104.583 -2.376 . . . . 60.409999999999997 104.583 178.134 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.425 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 20.8 t70 -169.41 164.28 10.61 Favored 'General case' 0 C--N 1.26 -3.298 0 N-CA-C 106.647 -1.612 . . . . 73.230000000000004 106.647 -176.255 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.8 m -63.2 -23.72 34.05 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 O-C-N 123.309 0.381 . . . . 45.140000000000001 111.367 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.572 ' HB ' ' HB2' ' A' ' 108' ' ' ASN . 45.8 m -144.2 70.77 1.3 Allowed 'General case' 0 N--CA 1.423 -1.793 0 CA-C-O 122.39 1.091 . . . . 72.109999999999999 109.802 175.475 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.425 ' HB ' ' HB3' ' A' ' 82' ' ' ASP . 12.5 p -95.84 140.19 17.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 114.499 -1.228 . . . . 74.049999999999997 110.466 -177.46 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 24.1 t -92.72 159.95 15.19 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 110.054 -0.35 . . . . 75.400000000000006 110.054 178.228 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 4.5 tpp180 -57.88 -47.97 81.19 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.864 0.865 . . . . 71.439999999999998 109.024 177.66 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -119.08 86.93 2.64 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 104.685 -2.339 . . . . 75.519999999999996 104.685 174.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 25.5 t60 -81.39 -52.49 7.22 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.962 -0.563 . . . . 64.120000000000005 111.204 -172.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.97 160.6 42.16 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 120.02 -0.672 . . . . 72.239999999999995 110.239 -177.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -131.18 127.22 37.51 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 108.345 -0.983 . . . . 75.310000000000002 108.345 174.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.42 ' HB3' ' HB ' ' A' ' 68' ' ' THR . 57.5 t80 -106.74 123.91 48.84 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 109.692 -0.484 . . . . 52.100000000000001 109.692 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -113.74 136.33 52.97 Favored 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 107.858 -1.164 . . . . 74.230000000000004 107.858 177.219 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 12.5 tt -116.1 131.44 68.6 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.236 0 C-N-CA 119.522 -0.871 . . . . 74.340000000000003 109.844 -178.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -109.4 145.97 35.23 Favored 'General case' 0 C--N 1.282 -2.359 0 N-CA-C 105.171 -2.159 . . . . 70.439999999999998 105.171 175.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -54.75 -22.94 15.66 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 113.226 0.825 . . . . 75.140000000000001 113.226 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -117.07 5.73 17.82 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 120.321 -0.943 . . . . 54.049999999999997 114.094 177.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -162.44 148.49 12.86 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 118.778 1.289 . . . . 62.219999999999999 111.642 -177.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -117.79 114.51 23.39 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.491 -0.929 . . . . 73.340000000000003 108.491 -176.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -132.25 135.13 46.06 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 119.638 -0.825 . . . . 61.409999999999997 112.498 -177.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.2 p -121.83 131.36 73.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-N 115.883 -0.599 . . . . 54.340000000000003 110.243 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.2 m -106.37 134.77 47.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-O 120.905 0.383 . . . . 70.120000000000005 110.907 178.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -90.0 108.95 20.03 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.283 -1.377 . . . . 53.420000000000002 107.283 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 21.2 m -113.52 11.7 8.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-N 115.942 -0.572 . . . . 74.439999999999998 111.29 -178.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -144.15 63.17 0.48 Allowed Glycine 0 N--CA 1.432 -1.584 0 N-CA-C 109.444 -1.462 . . . . 73.5 109.444 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 13.3 m -74.93 61.35 1.03 Allowed 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 123.549 0.74 . . . . 64.230000000000004 112.722 -173.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 85.4 mt -89.09 -49.11 6.95 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.467 -0.938 . . . . 72.319999999999993 108.467 176.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.572 ' HB2' ' HB ' ' A' ' 84' ' ' THR . 53.6 t30 -114.74 -33.0 5.64 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.592 -0.731 . . . . 74.310000000000002 109.506 -179.085 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 102.68 138.89 10.2 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.568 -0.825 . . . . 71.109999999999999 114.79 171.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.2 m -97.24 138.16 35.15 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.251 -1.018 . . . . 74.340000000000003 108.251 174.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.49 ' CE2' ' HB3' ' A' ' 116' ' ' PRO . 52.8 m-85 -130.89 151.91 50.8 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 109.321 -0.622 . . . . 72.329999999999998 109.321 -177.144 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.431 HG12 ' HG3' ' A' ' 120' ' ' GLN . 8.6 p -128.8 118.53 47.36 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 N-CA-C 108.017 -1.105 . . . . 64.349999999999994 108.017 168.09 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 48.82 51.8 15.25 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 116.21 -0.45 . . . . 75.230000000000004 111.563 -175.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 70.5 mtp180 74.42 -17.48 0.47 Allowed 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 124.763 1.225 . . . . 74.430000000000007 114.192 -179.27 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -76.07 115.04 43.17 Favored Pre-proline 0 C--O 1.247 0.952 0 CA-C-N 117.79 0.268 . . . . 63.130000000000003 111.23 -177.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.49 ' HB3' ' CE2' ' A' ' 111' ' ' TYR . 36.3 Cg_endo -91.8 102.9 0.22 Allowed 'Trans proline' 0 N--CA 1.443 -1.469 0 C-N-CA 123.141 2.561 . . . . 73.519999999999996 112.202 178.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.419 ' HB2' ' HG2' ' A' ' 120' ' ' GLN . 25.5 mtp180 -130.34 161.35 31.49 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 122.107 -0.37 . . . . 62.420000000000002 110.561 176.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -84.95 -8.94 58.55 Favored 'General case' 0 CA--C 1.496 -1.134 0 N-CA-C 113.434 0.902 . . . . 73.420000000000002 113.434 -177.219 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -153.42 137.9 16.77 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 105.432 -2.062 . . . . 71.400000000000006 105.432 170.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.466 ' NE2' ' HA ' ' A' ' 120' ' ' GLN . 15.2 mm-40 -141.34 149.21 40.87 Favored 'General case' 0 CA--C 1.472 -2.033 0 N-CA-C 114.451 1.278 . . . . 73.219999999999999 114.451 -178.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 25.5 t -88.33 122.88 40.38 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.261 0 N-CA-C 105.878 -1.897 . . . . 71.340000000000003 105.878 174.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 52.8 mtt -70.91 139.34 50.69 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 120.85 0.357 . . . . 75.25 110.808 -178.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 60.6 tp60 -104.75 131.48 52.15 Favored 'General case' 0 N--CA 1.425 -1.723 0 N-CA-C 108.896 -0.779 . . . . 70.450000000000003 108.896 -177.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -78.51 115.6 18.33 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 115.735 -0.666 . . . . 53.329999999999998 111.177 -178.736 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 98.84 8.8 53.81 Favored Glycine 0 N--CA 1.438 -1.227 0 CA-C-N 115.617 -0.72 . . . . 62.109999999999999 111.687 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -125.58 -176.55 3.63 Favored 'General case' 0 C--O 1.245 0.816 0 N-CA-C 112.193 0.442 . . . . 74.120000000000005 112.193 -178.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.453 ' HG2' HG22 ' A' ' 136' ' ' VAL . 43.0 mt-10 -108.55 132.21 54.08 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 113.755 1.02 . . . . 70.230000000000004 113.755 -170.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.7 mp -114.1 120.09 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.991 0 N-CA-C 105.959 -1.867 . . . . 75.439999999999998 105.959 175.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.428 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 51.1 tt0 -103.7 122.31 44.79 Favored 'General case' 0 C--N 1.282 -2.329 0 CA-C-O 121.223 0.535 . . . . 64.510000000000005 110.264 -177.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.3 pp -103.28 98.85 7.32 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.182 0 CA-C-N 115.309 -0.86 . . . . 61.310000000000002 109.979 178.019 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 78.82 -106.6 2.38 Favored Glycine 0 N--CA 1.421 -2.351 0 N-CA-C 109.838 -1.305 . . . . 50.409999999999997 109.838 -176.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -111.35 -12.92 13.99 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 122.419 0.288 . . . . 74.340000000000003 111.464 177.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.43 ' HB3' ' O ' ' A' ' 53' ' ' ARG . 79.6 m-85 -97.77 151.15 20.47 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 112.605 0.594 . . . . 73.439999999999998 112.605 -172.557 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 20.0 mtp180 -112.49 128.3 56.29 Favored 'General case' 0 C--O 1.252 1.21 0 CA-C-O 121.949 0.881 . . . . 72.109999999999999 112.577 -168.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.425 HD11 HD12 ' A' ' 49' ' ' LEU . 5.0 tt -120.98 136.41 54.98 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 114.056 -1.429 . . . . 70.329999999999998 107.735 -178.244 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.453 HG22 ' HG2' ' A' ' 127' ' ' GLU . 22.0 t -109.01 127.98 65.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 106.985 -1.487 . . . . 61.020000000000003 106.985 176.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -105.67 122.86 46.93 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 109.147 -0.686 . . . . 53.399999999999999 109.147 -177.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.8 mp -130.51 159.04 38.27 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.857 -0.423 . . . . 64.329999999999998 109.857 -178.12 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -79.26 133.07 36.66 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 107.15 -1.426 . . . . 63.219999999999999 107.15 173.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -91.85 -160.92 36.53 Favored Glycine 0 N--CA 1.435 -1.414 0 C-N-CA 120.514 -0.851 . . . . 65.209999999999994 113.736 -173.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.48 ' O ' ' HA2' ' A' ' 45' ' ' GLY . 86.9 Cg_endo . . . . . 0 N--CA 1.452 -0.935 0 C-N-CA 122.992 2.462 . . . . 61.329999999999998 113.945 -175.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 42.9 t30 . . . . . 0 C--O 1.247 0.947 0 CA-C-O 121.351 0.596 . . . . 72.549999999999997 110.044 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -146.37 86.79 0.17 Allowed Glycine 0 N--CA 1.425 -2.062 0 N-CA-C 108.665 -1.774 . . . . 74.109999999999999 108.665 178.006 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.6 m -78.83 122.8 85.11 Favored Pre-proline 0 C--N 1.305 -1.339 0 CA-C-N 115.755 -0.223 . . . . 72.140000000000001 111.414 -174.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -69.22 138.43 39.52 Favored 'Trans proline' 0 C--O 1.25 1.095 0 C-N-CA 122.93 2.42 . . . . 73.420000000000002 110.804 172.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.433 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 8.4 pt-20 -95.52 137.83 21.94 Favored Pre-proline 0 C--O 1.251 1.183 0 C-N-CA 118.864 -1.134 . . . . 62.329999999999998 109.788 176.165 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 9' ' ' GLU . 5.3 Cg_exo -75.72 127.2 10.02 Favored 'Trans proline' 0 N--CA 1.439 -1.714 0 C-N-CA 122.242 1.961 . . . . 65.439999999999998 109.982 175.615 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -68.11 123.41 20.59 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 109.023 -0.732 . . . . 63.039999999999999 109.023 178.037 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.2 t -92.09 94.7 4.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 107.659 -1.237 . . . . 73.450000000000003 107.659 175.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.441 ' OE2' HG22 ' A' ' 15' ' ' THR . 0.4 OUTLIER -70.23 127.05 31.44 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 106.504 -1.665 . . . . 75.140000000000001 106.504 -179.123 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.6 m -100.48 -24.64 14.43 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 113.329 0.863 . . . . 73.230000000000004 113.329 -169.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.441 HG22 ' OE2' ' A' ' 13' ' ' GLU 0.313 14.0 t -83.63 72.14 10.33 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-O 123.896 1.808 . . . . 72.409999999999997 112.936 -174.314 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 57.3 m -139.37 138.55 36.69 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 104.521 -2.4 . . . . 73.319999999999993 104.521 174.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.1 t . . . . . 0 C--O 1.244 0.805 0 N-CA-C 107.35 -1.352 . . . . 72.030000000000001 107.35 -170.084 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.167 0 N-CA-C 111.06 -0.816 . . . . 52.409999999999997 111.06 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.7 m -129.67 146.1 51.48 Favored 'General case' 0 N--CA 1.414 -2.229 0 N-CA-C 107.266 -1.383 . . . . 52.420000000000002 107.266 177.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.83 175.1 10.67 Favored 'General case' 0 C--N 1.282 -2.362 0 N-CA-C 106.875 -1.528 . . . . 62.310000000000002 106.875 -178.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.8 pp -133.82 154.26 51.14 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 112.885 0.698 . . . . 75.030000000000001 112.885 -175.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.608 ' O ' ' HA ' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -118.94 140.9 49.22 Favored 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 108.312 -0.995 . . . . 73.409999999999997 108.312 175.575 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.4 HG22 ' HB3' ' A' ' 60' ' ' ARG . 27.8 t -121.3 114.32 42.8 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 108.566 -0.901 . . . . 71.219999999999999 108.566 -179.461 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.409 HG21 ' HB3' ' A' ' 57' ' ' ALA . 78.5 t -93.8 115.54 32.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 107.592 -1.262 . . . . 63.310000000000002 107.592 175.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 51.7 tttm -90.38 -24.1 20.89 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.771 -0.649 . . . . 65.219999999999999 110.505 -173.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 30.8 ttp-105 -146.69 119.3 8.54 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 106.878 -1.527 . . . . 74.340000000000003 106.878 176.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 143.15 116.86 1.18 Allowed Glycine 0 N--CA 1.417 -2.575 0 C-N-CA 120.176 -1.011 . . . . 74.299999999999997 112.181 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.501 ' HB2' ' HB3' ' A' ' 81' ' ' ASP . 27.8 Cg_exo -65.44 -10.81 27.59 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 123.423 2.749 . . . . 61.399999999999999 111.089 178.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.52 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 2.2 m-20 -48.38 -36.16 14.07 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 126.295 1.838 . . . . 61.130000000000003 110.212 174.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.409 ' HB3' HG21 ' A' ' 51' ' ' VAL . . . -152.16 -62.09 0.16 Allowed 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 107.978 -1.119 . . . . 55.310000000000002 107.978 175.327 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.61 23.83 75.36 Favored Glycine 0 CA--C 1.508 -0.363 0 CA-C-N 115.596 -0.729 . . . . 72.120000000000005 112.958 177.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -157.25 -179.43 8.19 Favored 'General case' 0 N--CA 1.428 -1.525 0 N-CA-C 108.478 -0.934 . . . . 52.130000000000003 108.478 -176.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.608 ' HA ' ' O ' ' A' ' 49' ' ' LEU . 9.8 ptp85 -111.1 133.87 53.14 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 124.04 0.838 . . . . 73.019999999999996 109.515 175.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -141.51 153.05 44.67 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.556 -0.535 . . . . 71.420000000000002 109.556 173.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.0 pp -94.41 140.4 29.86 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 112.114 0.413 . . . . 64.510000000000005 112.114 -177.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -78.6 114.94 17.95 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.646 -0.706 . . . . 65.230000000000004 109.918 178.015 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -146.47 16.83 1.31 Allowed 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 123.267 1.508 . . . . 63.520000000000003 107.596 175.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.452 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 28.4 tt0 -126.49 104.34 24.71 Favored Pre-proline 0 C--N 1.301 -1.535 0 CA-C-N 114.352 -1.295 . . . . 71.109999999999999 108.029 178.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.452 ' HD2' ' HA ' ' A' ' 65' ' ' GLN . 2.0 Cg_endo -45.92 -47.43 14.19 Favored 'Trans proline' 0 C--N 1.369 1.614 0 C-N-CA 124.133 3.222 . . . . 62.350000000000001 114.279 -174.484 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 50.3 m -113.24 97.33 6.42 Favored 'General case' 0 N--CA 1.424 -1.769 0 CA-C-O 121.319 0.58 . . . . 63.109999999999999 110.467 178.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.49 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 93.1 m -109.03 114.14 27.62 Favored 'General case' 0 N--CA 1.424 -1.771 0 N-CA-C 108.695 -0.854 . . . . 63.310000000000002 108.695 177.524 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 41.6 m -105.01 131.44 52.52 Favored 'General case' 0 N--CA 1.421 -1.895 0 CA-C-O 121.037 0.446 . . . . 75.230000000000004 109.904 -175.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -103.78 130.41 51.31 Favored 'General case' 0 N--CA 1.419 -1.981 0 N-CA-C 107.905 -1.146 . . . . 74.530000000000001 107.905 176.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -170.39 -140.86 3.11 Favored Glycine 0 N--CA 1.425 -2.058 0 N-CA-C 110.672 -0.971 . . . . 62.009999999999998 110.672 -178.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 27.1 ttm-85 -79.84 -59.12 2.86 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 120.469 -0.492 . . . . 75.129999999999995 109.854 -176.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 77.8 t60 175.22 -47.76 0.0 OUTLIER Pre-proline 0 CA--C 1.562 1.431 0 O-C-N 124.203 0.939 . . . . 70.239999999999995 113.167 177.157 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -57.55 -27.9 78.71 Favored 'Trans proline' 0 C--N 1.384 2.421 0 C-N-CA 122.065 1.844 . . . . 55.439999999999998 114.13 -174.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.412 ' CD ' HH21 ' A' ' 87' ' ' ARG . 41.8 mt-10 -125.12 26.47 6.94 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 109.697 -0.483 . . . . 70.340000000000003 109.697 -177.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.3 m -145.01 140.37 28.1 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 122.298 -0.252 . . . . 64.230000000000004 110.558 -175.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -69.03 -42.36 76.49 Favored 'General case' 0 C--O 1.242 0.708 0 C-N-CA 120.191 -0.604 . . . . 65.319999999999993 110.394 178.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 21.0 pt -100.86 144.32 12.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 CA-C-N 115.118 -0.946 . . . . 71.420000000000002 109.934 178.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -100.61 117.73 35.32 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.106 0.479 . . . . 75.230000000000004 109.969 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.52 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 6.9 mp -98.71 122.9 42.52 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 120.842 0.353 . . . . 72.230000000000004 111.917 -178.051 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.501 ' HB3' ' HB2' ' A' ' 55' ' ' PRO . 24.3 t70 -99.83 73.78 1.79 Allowed 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 106.01 -1.848 . . . . 72.129999999999995 106.01 168.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.468 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 13.2 t70 -81.56 -175.87 5.74 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.141 -1.391 . . . . 72.430000000000007 107.718 -177.372 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.8 p -88.94 -23.64 6.23 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 N-CA-C 108.182 -1.044 . . . . 72.340000000000003 108.182 178.387 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 17.7 m -154.35 84.69 1.12 Allowed 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 116.033 -0.531 . . . . 74.219999999999999 110.069 176.069 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.468 ' HB ' ' HB3' ' A' ' 82' ' ' ASP . 7.4 p -108.7 136.28 44.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.912 -0.586 . . . . 71.420000000000002 110.03 -178.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 23.7 p -90.99 -81.98 0.3 Allowed 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.575 0.703 . . . . 73.430000000000007 111.616 -178.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.412 HH21 ' CD ' ' A' ' 75' ' ' GLU . 16.5 ptm180 -162.72 -34.09 0.04 OUTLIER 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 125.203 1.401 . . . . 72.310000000000002 108.333 -179.189 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 11.5 mmt180 -125.69 101.09 6.72 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 105.033 -2.21 . . . . 71.310000000000002 105.033 174.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 18.4 t60 -95.79 -60.61 1.61 Allowed 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.657 -0.868 . . . . 52.340000000000003 108.657 -173.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -145.57 144.31 30.43 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 115.771 -0.649 . . . . 64.219999999999999 110.055 -178.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -104.34 127.99 52.09 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 115.653 -0.703 . . . . 71.530000000000001 109.164 176.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.49 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 95.5 m-85 -104.68 112.02 24.96 Favored 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 107.061 -1.459 . . . . 74.340000000000003 107.061 174.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -104.4 122.1 44.79 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-N 114.528 -1.214 . . . . 74.219999999999999 110.259 -177.316 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.8 116.03 50.86 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.654 0 N-CA-C 105.978 -1.86 . . . . 73.209999999999994 105.978 171.013 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.467 ' C ' ' H ' ' A' ' 97' ' ' GLY . 52.5 t30 -114.08 148.05 37.73 Favored 'General case' 0 C--N 1.276 -2.6 0 N-CA-C 106.343 -1.725 . . . . 72.319999999999993 106.343 -178.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -52.59 24.52 0.0 OUTLIER 'General case' 0 CA--C 1.578 2.04 0 C-N-CA 126.847 2.059 . . . . 72.310000000000002 115.296 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.467 ' H ' ' C ' ' A' ' 95' ' ' ASN . . . -168.29 -43.66 0.03 OUTLIER Glycine 0 N--CA 1.426 -2.006 0 N-CA-C 110.123 -1.191 . . . . 63.420000000000002 110.123 -178.13 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -120.23 143.66 48.16 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 113.035 0.754 . . . . 73.430000000000007 113.035 -175.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.479 ' HB3' ' SD ' ' A' ' 122' ' ' MET . 84.1 m-85 -105.12 121.5 43.93 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 105.522 -2.029 . . . . 75.319999999999993 105.522 173.384 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -127.75 136.3 51.33 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 112.701 0.63 . . . . 74.230000000000004 112.701 -174.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 119' ' ' ALA . 7.2 p -115.19 118.85 60.08 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 N-CA-C 108.836 -0.801 . . . . 72.340000000000003 108.836 177.393 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 42.7 t -120.27 129.99 74.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-N 116.282 -0.417 . . . . 71.129999999999995 110.21 -177.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.596 ' OD2' ' HB3' ' A' ' 106' ' ' SER . 10.9 t70 -83.37 130.26 35.04 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 107.239 -1.393 . . . . 61.020000000000003 107.239 172.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.0 m -124.01 13.57 4.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 112.946 0.721 . . . . 72.140000000000001 112.946 -177.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 152.94 26.61 0.04 OUTLIER Glycine 0 N--CA 1.438 -1.209 0 C-N-CA 118.59 -1.767 . . . . 34.310000000000002 114.42 178.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.596 ' HB3' ' OD2' ' A' ' 103' ' ' ASP . 32.7 t -79.8 131.57 35.93 Favored 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 108.075 -1.083 . . . . 44.030000000000001 108.075 175.521 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -76.07 -18.46 59.19 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.517 0.675 . . . . 64.239999999999995 110.171 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -88.9 -37.03 15.61 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 115.186 -0.915 . . . . 72.239999999999995 109.16 178.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 92.22 121.04 2.77 Favored Glycine 0 C--N 1.306 -1.11 0 CA-C-N 114.86 -1.064 . . . . 61.310000000000002 112.589 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.401 HG23 ' HA ' ' A' ' 130' ' ' ILE . 24.0 m -85.23 120.15 26.41 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 109.147 -0.686 . . . . 60.509999999999998 109.147 176.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -139.12 163.09 33.35 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.719 -0.474 . . . . 63.310000000000002 109.719 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.527 ' HB ' ' HB3' ' A' ' 115' ' ' GLU . 23.9 t -100.36 141.49 17.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 106.511 -1.663 . . . . 65.349999999999994 106.511 177.581 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -60.05 -25.07 65.07 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-O 120.969 0.414 . . . . 73.129999999999995 111.419 -175.128 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 81.8 mtt85 -106.58 -9.28 16.64 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.387 -0.37 . . . . 65.219999999999999 111.773 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.527 ' HB3' ' HB ' ' A' ' 112' ' ' VAL . 9.5 tp10 -133.16 112.9 13.33 Favored Pre-proline 0 C--O 1.252 1.231 0 C-N-CA 119.983 -0.687 . . . . 73.329999999999998 110.858 -172.318 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -75.25 60.61 5.66 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.516 2.811 . . . . 63.219999999999999 111.77 177.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.443 ' HB3' ' O ' ' A' ' 119' ' ' ALA . 28.4 mmm-85 -128.92 131.86 47.6 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.919 -1.141 . . . . 73.120000000000005 107.919 -179.301 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 31.4 p-10 -83.62 -18.35 38.46 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-O 121.96 0.886 . . . . 74.140000000000001 109.67 177.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.443 ' O ' ' HB3' ' A' ' 117' ' ' ARG . . . -128.98 133.85 47.94 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 106.551 -1.648 . . . . 74.319999999999993 106.551 165.539 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.523 ' NE2' ' HG2' ' A' ' 115' ' ' GLU . 5.0 tp60 -144.59 150.77 38.02 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 123.655 0.597 . . . . 63.030000000000001 112.171 -177.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.464 ' O ' ' HG3' ' A' ' 120' ' ' GLN . 7.3 p -79.65 130.62 35.78 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 N-CA-C 106.195 -1.78 . . . . 74.099999999999994 106.195 168.744 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.479 ' SD ' ' HB3' ' A' ' 99' ' ' PHE . 65.2 mtt -66.92 156.2 36.46 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 112.7 0.63 . . . . 62.350000000000001 112.7 -173.131 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -132.67 134.6 45.04 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.374 -1.343 . . . . 74.439999999999998 107.374 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 7.6 t -79.68 128.23 33.16 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 109.122 -0.696 . . . . 72.340000000000003 109.122 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 93.46 20.75 31.27 Favored Glycine 0 N--CA 1.421 -2.3 0 C-N-CA 120.229 -0.986 . . . . 54.530000000000001 111.298 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -123.4 172.9 8.34 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.235 -1.394 . . . . 72.299999999999997 107.235 178.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -129.05 125.68 37.8 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-O 121.383 0.611 . . . . 73.109999999999999 110.826 -173.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 59.4 mt -109.49 130.77 61.95 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 CA-C-N 115.015 -0.993 . . . . 73.25 108.641 -175.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -98.43 112.64 24.59 Favored 'General case' 0 N--CA 1.423 -1.816 0 N-CA-C 108.659 -0.867 . . . . 61.340000000000003 108.659 178.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.401 ' HA ' HG23 ' A' ' 110' ' ' THR . 18.8 pt -90.92 98.36 8.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-O 121.727 0.775 . . . . 71.409999999999997 109.577 -178.667 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 75.28 -82.0 0.92 Allowed Glycine 0 N--CA 1.426 -2.027 0 CA-C-N 114.571 -1.195 . . . . 54.310000000000002 110.123 -176.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -136.1 -11.03 1.98 Allowed 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 109.917 -0.401 . . . . 65.150000000000006 109.917 176.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -94.5 157.08 16.16 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 113.185 0.809 . . . . 74.010000000000005 113.185 -172.327 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 45.9 ttt180 -99.66 120.58 39.92 Favored 'General case' 0 C--O 1.245 0.867 0 CA-C-N 115.66 -0.7 . . . . 72.120000000000005 111.452 -167.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.5 tt -125.23 129.21 49.62 Favored 'General case' 0 C--O 1.218 -0.586 0 C-N-CA 123.973 0.909 . . . . 72.209999999999994 109.721 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 40.6 t -107.83 128.05 63.41 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 N-CA-C 107.606 -1.257 . . . . 74.209999999999994 107.606 177.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -102.28 125.76 49.07 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 109.729 -0.471 . . . . 62.530000000000001 109.729 -178.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 84.2 mt -138.73 138.18 37.45 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.533 0.682 . . . . 73.450000000000003 111.282 -176.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -80.19 90.92 5.51 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 108.18 -1.045 . . . . 72.040000000000006 108.18 174.09 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -65.6 -79.83 0.18 Allowed Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 115.388 -0.823 . . . . 30.219999999999999 111.409 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo . . . . . 0 N--CA 1.437 -1.849 0 C-N-CA 121.608 1.539 . . . . 73.200000000000003 111.968 177.685 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 . . . . . 0 N--CA 1.441 -0.879 0 N-CA-C 109.769 -0.456 . . . . 74.299999999999997 109.769 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 159.87 138.11 2.38 Favored Glycine 0 N--CA 1.429 -1.775 0 C-N-CA 120.893 -0.67 . . . . 40.130000000000003 111.986 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.9 t -105.61 132.96 20.43 Favored Pre-proline 0 N--CA 1.427 -1.58 0 N-CA-C 109.12 -0.696 . . . . 64.450000000000003 109.12 178.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -66.84 132.28 28.01 Favored 'Trans proline' 0 C--O 1.243 0.762 0 C-N-CA 122.232 1.955 . . . . 73.430000000000007 110.342 176.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -80.89 146.45 59.61 Favored Pre-proline 0 C--N 1.306 -1.324 0 CA-C-N 116.587 -0.279 . . . . 61.210000000000001 110.501 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -62.01 139.07 77.03 Favored 'Trans proline' 0 C--O 1.243 0.765 0 C-N-CA 122.403 2.069 . . . . 64.420000000000002 110.983 178.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -84.52 137.43 33.34 Favored 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 108.154 -1.054 . . . . 71.140000000000001 108.154 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.4 m -74.44 85.34 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 CA-C-O 122.55 1.166 . . . . 73.310000000000002 111.277 178.303 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -92.85 137.54 32.27 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 114.737 -1.119 . . . . 73.209999999999994 108.568 -178.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.0 p -72.48 130.19 40.09 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 116.458 -0.337 . . . . 64.329999999999998 111.019 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.2 t -77.73 -8.19 57.61 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-O 122.601 1.191 . . . . 74.430000000000007 108.276 176.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.9 m -76.8 100.13 5.38 Favored 'General case' 0 N--CA 1.412 -2.367 0 CA-C-N 113.702 -1.59 . . . . 73.430000000000007 107.073 174.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.6 m . . . . . 0 N--CA 1.426 -1.673 0 CA-C-O 122.392 1.091 . . . . 63.299999999999997 111.245 -178.744 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.483 -1.958 0 N-CA-C 109.566 -1.413 . . . . 62.240000000000002 109.566 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.7 p -89.12 152.69 21.49 Favored 'General case' 0 C--N 1.279 -2.474 0 CA-C-N 114.461 -0.87 . . . . 73.540000000000006 111.446 -177.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.92 167.2 20.67 Favored 'General case' 0 C--N 1.284 -2.268 0 CA-C-N 115.166 -0.924 . . . . 75.310000000000002 109.891 -175.247 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.417 HD23 ' H ' ' A' ' 48' ' ' LEU . 2.2 pt? -128.89 138.87 52.26 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.387 0.613 . . . . 70.310000000000002 110.688 -177.063 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.7 pp -127.91 149.09 50.47 Favored 'General case' 0 C--N 1.282 -2.354 0 CA-C-N 115.671 -0.695 . . . . 74.219999999999999 110.028 178.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.44 HG12 ' CB ' ' A' ' 60' ' ' ARG . 27.2 m -125.87 140.13 49.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 N-CA-C 109.802 -0.444 . . . . 55.420000000000002 109.802 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.4 t -104.19 116.49 48.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 106.484 -1.673 . . . . 71.310000000000002 106.484 175.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -103.59 -25.04 13.34 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 120.264 -0.574 . . . . 64.25 112.184 -175.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.431 ' O ' ' HA ' ' A' ' 133' ' ' PHE . 24.9 tpt180 -141.35 115.48 9.3 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 120.213 -0.595 . . . . 71.120000000000005 110.957 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 138.15 139.35 3.84 Favored Glycine 0 N--CA 1.433 -1.517 0 C-N-CA 119.796 -1.193 . . . . 75.140000000000001 113.414 173.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -52.49 -8.06 0.36 Allowed 'Trans proline' 0 N--CA 1.506 2.26 0 C-N-CA 125.056 3.837 . . . . 64.150000000000006 115.402 176.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.474 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 37.2 t30 -58.94 -51.42 70.14 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.579 0.752 . . . . 60.119999999999997 109.565 177.143 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -173.81 -177.39 1.38 Allowed 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.941 -0.763 . . . . 63.299999999999997 108.941 -177.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -164.22 53.87 0.28 Allowed Glycine 0 N--CA 1.425 -2.07 0 N-CA-C 109.512 -1.435 . . . . 51.119999999999997 109.512 178.29 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -153.69 -176.98 6.07 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 108.523 -0.917 . . . . 63.340000000000003 108.523 -177.428 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.44 ' CB ' HG12 ' A' ' 50' ' ' VAL . 0.4 OUTLIER -108.55 139.2 43.65 Favored 'General case' 0 C--N 1.309 -1.192 0 O-C-N 123.885 0.741 . . . . 71.219999999999999 109.049 178.8 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -128.49 129.04 45.49 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 110.093 -0.336 . . . . 65.329999999999998 110.093 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -97.09 116.25 28.95 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 105.945 -1.872 . . . . 61.310000000000002 105.945 175.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -99.99 115.65 30.2 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 112.811 0.671 . . . . 74.219999999999999 112.811 -174.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -109.02 -5.88 15.87 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 105.956 -1.868 . . . . 72.409999999999997 105.956 168.219 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -66.1 112.54 9.3 Favored Pre-proline 0 N--CA 1.443 -0.787 0 CA-C-N 112.937 -1.938 . . . . 72.310000000000002 109.124 176.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -62.04 -30.83 83.47 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.663 2.242 . . . . 74.219999999999999 113.003 -177.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 85.5 m -137.17 111.07 8.21 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-O 121.024 0.44 . . . . 72.409999999999997 111.825 -178.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 55.5 m -110.14 114.08 27.3 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 108.624 -0.88 . . . . 70.439999999999998 108.624 176.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.5 p -93.33 140.82 29.13 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 122.091 -0.38 . . . . 74.310000000000002 111.048 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -116.08 140.06 49.66 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 109.473 -0.566 . . . . 62.119999999999997 109.473 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 170.01 -148.71 12.02 Favored Glycine 0 N--CA 1.421 -2.316 0 C-N-CA 120.254 -0.974 . . . . 71.109999999999999 112.372 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.464 ' HB2' ' HA ' ' A' ' 87' ' ' ARG . 56.5 ttt180 -51.47 -75.19 0.03 OUTLIER 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 125.541 1.537 . . . . 75.140000000000001 113.915 -175.277 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.46 ' HB3' ' CD ' ' A' ' 74' ' ' PRO . 7.9 t60 -172.12 -76.65 0.0 OUTLIER Pre-proline 0 CA--C 1.56 1.347 0 CA-C-O 118.798 -0.62 . . . . 71.200000000000003 110.798 -178.324 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.46 ' CD ' ' HB3' ' A' ' 73' ' ' HIS . 49.8 Cg_endo -68.55 -24.84 35.47 Favored 'Trans proline' 0 C--N 1.389 2.701 0 CA-C-N 121.135 1.441 . . . . 62.240000000000002 111.136 178.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.42 ' OE2' ' HD3' ' A' ' 72' ' ' ARG . 34.9 mt-10 -89.0 15.6 8.35 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 114.119 -1.4 . . . . 75.120000000000005 111.526 -173.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.1 p -153.44 166.85 31.37 Favored 'General case' 0 N--CA 1.421 -1.907 0 CA-C-N 116.682 -0.236 . . . . 75.319999999999993 110.751 -178.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -79.98 -46.37 16.78 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.344 -0.984 . . . . 64.099999999999994 108.344 177.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 34.5 pt -104.91 143.57 16.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 108.747 -0.834 . . . . 74.299999999999997 108.747 175.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.417 ' HB3' ' HA ' ' A' ' 73' ' ' HIS . 33.7 p90 -115.27 117.64 31.04 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 121.495 0.664 . . . . 75.329999999999998 112.49 -174.531 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.554 HD23 ' CE2' ' A' ' 133' ' ' PHE . 4.5 mp -90.18 111.94 23.27 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.876 -1.157 . . . . 75.340000000000003 107.876 178.461 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -84.29 10.34 10.74 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-O 121.702 0.763 . . . . 74.349999999999994 112.697 -173.139 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -77.55 146.02 36.56 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 108.995 -0.743 . . . . 74.25 108.995 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.5 p -67.87 -22.14 27.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-O 121.256 0.55 . . . . 64.319999999999993 111.828 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -96.07 23.16 6.72 Favored 'General case' 0 CA--C 1.557 1.239 0 CA-C-O 121.185 0.516 . . . . 74.030000000000001 110.751 -176.155 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.431 HG21 ' HB2' ' A' ' 80' ' ' LEU . 13.2 p -81.94 140.84 15.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 O-C-N 121.921 -0.487 . . . . 72.230000000000004 110.297 -178.22 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 19.6 m -83.03 156.33 23.44 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.549 -0.908 . . . . 62.229999999999997 108.549 175.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.464 ' HA ' ' HB2' ' A' ' 72' ' ' ARG . 36.5 mtp-105 -63.06 -54.64 34.91 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-O 121.332 0.586 . . . . 74.319999999999993 109.539 -178.073 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.402 ' CZ ' ' HB3' ' A' ' 75' ' ' GLU . 13.1 mmt180 -117.22 112.55 20.96 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 105.347 -2.094 . . . . 73.409999999999997 105.347 175.463 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.411 ' CE1' ' HB3' ' A' ' 108' ' ' ASN . 11.3 t60 -98.13 -76.74 0.52 Allowed 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.16 0.505 . . . . 71.239999999999995 110.534 -174.384 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.37 167.49 23.45 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.553 -0.717 . . . . 42.310000000000002 110.543 -176.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -127.87 128.19 44.76 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 115.811 -0.631 . . . . 74.019999999999996 109.507 177.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -104.69 120.24 40.88 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.423 -0.954 . . . . 73.430000000000007 108.423 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 78.9 mtt180 -119.25 141.8 48.61 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-O 121.553 0.692 . . . . 72.209999999999994 111.288 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.64 119.79 62.86 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 104.359 -2.46 . . . . 63.109999999999999 104.359 171.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.494 ' C ' ' H ' ' A' ' 97' ' ' GLY . 51.4 t-20 -111.4 147.08 35.98 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 115.299 -0.864 . . . . 54.210000000000001 109.16 -170.226 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -63.43 31.8 0.01 OUTLIER 'General case' 0 CA--C 1.581 2.136 0 C-N-CA 125.853 1.661 . . . . 70.510000000000005 111.869 176.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.494 ' H ' ' C ' ' A' ' 95' ' ' ASN . . . -171.1 -38.32 0.03 OUTLIER Glycine 0 N--CA 1.428 -1.887 0 N-CA-C 111.46 -0.656 . . . . 34.509999999999998 111.46 -179.05 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -133.11 177.41 7.69 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-O 121.509 0.671 . . . . 73.519999999999996 111.201 -177.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.486 ' HB3' ' HB3' ' A' ' 122' ' ' MET . 87.7 m-85 -122.63 121.33 36.17 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 104.418 -2.438 . . . . 74.409999999999997 104.418 171.361 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -131.14 127.27 37.71 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 120.661 -0.416 . . . . 54.439999999999998 111.445 -169.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 5.5 p -126.12 119.27 53.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-O 121.526 0.679 . . . . 62.200000000000003 109.472 176.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 23.3 m -119.51 136.6 56.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-N 115.425 -0.807 . . . . 75.209999999999994 112.04 -176.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -83.11 132.34 35.1 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 106.542 -1.651 . . . . 73.540000000000006 106.542 174.441 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 30.5 m -104.09 8.06 9.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 C-N-CA 119.653 -0.819 . . . . 73.340000000000003 112.285 -179.155 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 127.89 52.04 0.14 Allowed Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.593 -0.813 . . . . 63.530000000000001 112.447 179.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 14.2 m -80.87 126.18 31.04 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 112.319 0.488 . . . . 71.329999999999998 112.319 -176.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.0 mp -82.47 -22.06 35.33 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 107.493 -1.299 . . . . 73.409999999999997 107.493 173.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.496 ' OD1' ' HA3' ' A' ' 131' ' ' GLY . 22.8 t-20 -75.12 -30.52 60.87 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.372 -1.286 . . . . 74.310000000000002 109.989 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 92.07 117.94 2.36 Favored Glycine 0 C--O 1.221 -0.698 0 N-CA-C 114.566 0.587 . . . . 43.109999999999999 114.566 174.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 88.4 m -99.34 119.81 38.56 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-O 120.966 0.412 . . . . 54.130000000000003 110.093 178.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -115.19 134.78 54.84 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 109.411 -0.588 . . . . 73.219999999999999 109.411 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 5.4 p -113.09 121.16 64.78 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.582 0 N-CA-C 106.557 -1.645 . . . . 72.25 106.557 171.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 17.6 m120 58.9 26.27 14.7 Favored 'General case' 0 N--CA 1.48 1.05 0 O-C-N 123.163 0.289 . . . . 74.430000000000007 110.266 -175.067 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 80.38 6.29 1.62 Allowed 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.982 1.313 . . . . 73.349999999999994 113.467 -177.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -100.83 121.47 52.43 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 109.315 -0.624 . . . . 73.409999999999997 109.315 176.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.429 ' HA ' ' O ' ' A' ' 110' ' ' THR . 57.3 Cg_endo -78.14 126.42 7.78 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 121.993 1.795 . . . . 75.329999999999998 111.157 177.284 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -150.18 -176.96 5.67 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 109.908 -0.404 . . . . 72.239999999999995 109.908 177.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -96.12 -57.37 2.36 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 123.189 0.306 . . . . 45.420000000000002 111.795 -177.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -117.92 139.72 50.73 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 109.629 -0.508 . . . . 62.240000000000002 109.629 -177.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 54.7 tp60 -139.25 140.73 37.77 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 116.207 -0.451 . . . . 72.140000000000001 110.472 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 59.5 t -80.25 114.22 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 104.936 -2.246 . . . . 64.420000000000002 104.936 170.154 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.486 ' HB3' ' HB3' ' A' ' 99' ' ' PHE . 16.6 ttt -63.36 123.01 17.62 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.973 -0.751 . . . . 73.319999999999993 108.973 -173.143 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -104.57 136.8 43.45 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-O 121.333 0.587 . . . . 70.239999999999995 111.457 -171.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 14.4 p -79.37 118.55 21.37 Favored 'General case' 0 N--CA 1.416 -2.158 0 CA-C-N 114.891 -1.049 . . . . 74.099999999999994 111.079 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 107.07 -13.33 40.86 Favored Glycine 0 N--CA 1.44 -1.057 0 CA-C-N 115.715 -0.675 . . . . 62.229999999999997 112.219 177.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -99.35 172.95 7.01 Favored 'General case' 0 C--O 1.25 1.088 0 N-CA-C 113.564 0.95 . . . . 74.530000000000001 113.564 -175.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.52 ' OE1' ' HD3' ' A' ' 134' ' ' ARG . 17.1 pt-20 -108.97 140.47 42.42 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 114.528 -1.214 . . . . 73.129999999999995 111.333 -174.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 71.9 mt -123.31 119.28 57.08 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 N-CA-C 106.765 -1.568 . . . . 74.209999999999994 106.765 177.045 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -115.75 121.88 43.79 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 109.278 -0.638 . . . . 72.129999999999995 109.278 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.503 ' O ' ' HD2' ' A' ' 133' ' ' PHE . 18.5 pt -103.83 98.68 7.13 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.171 0 N-CA-C 108.271 -1.011 . . . . 74.340000000000003 108.271 176.439 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.496 ' HA3' ' OD1' ' A' ' 108' ' ' ASN . . . 62.97 -95.01 0.12 Allowed Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.273 -0.876 . . . . 75.299999999999997 113.667 -178.193 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 3.8 ttmp? -101.72 -22.28 14.45 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 123.27 0.628 . . . . 74.150000000000006 109.891 -177.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.554 ' CE2' HD23 ' A' ' 80' ' ' LEU . 5.5 m-85 -92.17 112.14 23.96 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.617 -0.72 . . . . 71.329999999999998 110.038 -170.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.52 ' HD3' ' OE1' ' A' ' 127' ' ' GLU . 13.4 ttm180 -104.52 124.95 50.2 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 120.395 -0.522 . . . . 74.400000000000006 109.943 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.8 tt -124.25 140.33 53.07 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.547 -1.206 . . . . 63.409999999999997 108.604 -177.117 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 8.9 p -116.35 136.52 53.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 109.036 -0.727 . . . . 62.420000000000002 109.036 175.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -108.42 122.13 46.37 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.26 -0.427 . . . . 74.310000000000002 111.757 -173.229 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -121.83 150.23 42.21 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.119 -0.697 . . . . 75.209999999999994 109.119 178.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -129.4 148.64 51.34 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 109.691 -0.485 . . . . 75.549999999999997 109.691 178.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -169.21 -70.52 0.03 OUTLIER Glycine 0 C--N 1.303 -1.253 0 C-N-CA 120.019 -1.086 . . . . 41.420000000000002 112.708 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo . . . . . 0 C--N 1.357 0.988 0 C-N-CA 123.451 2.767 . . . . 61.439999999999998 116.344 -177.07 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 50.3 t30 . . . . . 0 CA--C 1.541 0.63 0 N-CA-C 110.52 -0.178 . . . . 71.299999999999997 110.52 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -58.07 149.5 34.45 Favored Glycine 0 C--O 1.239 0.449 0 N-CA-C 112.518 -0.233 . . . . 73.099999999999994 112.518 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 60.5 m -67.46 124.83 90.13 Favored Pre-proline 0 C--N 1.311 -1.105 0 C-N-CA 122.763 0.425 . . . . 63.149999999999999 111.108 -177.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -67.7 151.82 78.54 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.491 2.794 . . . . 72.200000000000003 111.28 176.147 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -69.97 111.87 10.55 Favored Pre-proline 0 C--N 1.315 -0.895 0 N-CA-C 105.6 -2.0 . . . . 63.229999999999997 105.6 170.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -53.61 109.9 0.43 Allowed 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 123.187 2.592 . . . . 74.209999999999994 114.507 -170.238 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -90.11 107.86 19.39 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 114.585 -1.188 . . . . 62.509999999999998 108.635 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 46.9 t -89.69 94.02 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.528 0 N-CA-C 108.526 -0.916 . . . . 75.400000000000006 108.526 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -70.01 134.39 48.25 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 114.877 -1.056 . . . . 73.329999999999998 109.486 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 28.5 m -65.87 112.26 3.69 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-O 121.522 0.677 . . . . 73.140000000000001 112.046 -176.045 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.509 HG23 ' HB2' ' A' ' 98' ' ' GLU . 86.9 m -43.61 125.23 3.93 Favored 'General case' 0 N--CA 1.42 -1.93 0 C-N-CA 127.08 2.152 . . . . 55.350000000000001 114.598 -178.409 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.8 t -118.32 99.85 7.11 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 113.441 -1.709 . . . . 55.32 108.243 176.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.3 m . . . . . 0 CA--C 1.516 -0.349 0 CA-C-O 120.745 0.307 . . . . 71.530000000000001 111.024 -179.178 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.62 0 N-CA-C 109.793 -1.323 . . . . 74.540000000000006 109.793 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 16.2 m -90.63 168.51 11.73 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 114.344 -0.928 . . . . 62.100000000000001 110.427 -177.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.575 ' HB1' ' HA ' ' A' ' 139' ' ' ALA . . . -95.52 177.18 5.9 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.995 -0.742 . . . . 64.409999999999997 108.995 178.286 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.98 160.25 38.29 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.619 0.6 . . . . 73.430000000000007 112.619 -174.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.492 HD13 HD11 ' A' ' 135' ' ' LEU . 3.0 pp -131.61 144.11 50.82 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 115.463 -0.789 . . . . 73.450000000000003 110.06 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.7 t -124.73 139.61 50.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 N-CA-C 108.411 -0.959 . . . . 73.120000000000005 108.411 -178.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.435 HG21 ' HB3' ' A' ' 57' ' ' ALA . 48.1 t -92.29 116.39 33.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-O 121.565 0.698 . . . . 50.310000000000002 109.195 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -76.71 -45.93 27.51 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 114.43 -1.259 . . . . 73.239999999999995 108.598 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.6 tpm_? -151.65 111.3 4.0 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.283 -1.006 . . . . 72.209999999999994 108.283 -176.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 161.4 118.27 0.47 Allowed Glycine 0 N--CA 1.432 -1.568 0 C-N-CA 118.851 -1.642 . . . . 75.129999999999995 114.769 176.238 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -63.77 -7.62 13.47 Favored 'Trans proline' 0 C--N 1.366 1.498 0 C-N-CA 123.745 2.963 . . . . 73.010000000000005 112.161 176.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.558 ' OD1' ' HG ' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -44.2 -42.01 6.19 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.657 1.183 . . . . 74.239999999999995 107.812 172.218 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.435 ' HB3' HG21 ' A' ' 51' ' ' VAL . . . -154.2 -64.55 0.14 Allowed 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.426 -0.806 . . . . 74.519999999999996 109.163 176.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.09 34.9 28.73 Favored Glycine 0 C--O 1.226 -0.39 0 C-N-CA 121.003 -0.618 . . . . 60.43 111.639 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -149.79 -164.7 2.08 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.999 -1.112 . . . . 75.230000000000004 107.999 -177.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 17.0 ptt180 -126.39 152.93 45.65 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 106.733 -1.581 . . . . 63.350000000000001 106.733 177.01 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.45 ' CZ ' HD11 ' A' ' 49' ' ' LEU . 51.1 p90 -156.5 149.46 24.0 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-O 121.509 0.671 . . . . 75.219999999999999 112.639 173.254 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 41.8 tp -87.03 140.31 29.69 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 113.784 -1.553 . . . . 71.040000000000006 107.474 178.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -78.38 114.69 17.51 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 119.709 -0.796 . . . . 73.510000000000005 110.148 177.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -127.39 -2.46 6.23 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 121.982 0.896 . . . . 64.349999999999994 109.799 178.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.426 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 6.3 pm0 -111.48 114.15 52.99 Favored Pre-proline 0 N--CA 1.42 -1.929 0 CA-C-N 115.155 -0.929 . . . . 72.019999999999996 109.466 178.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.499 ' HA ' HG13 ' A' ' 94' ' ' ILE . 9.6 Cg_endo -49.95 -34.9 39.05 Favored 'Trans proline' 0 C--N 1.371 1.756 0 C-N-CA 124.437 3.425 . . . . 63.020000000000003 115.62 -173.334 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 92.4 m -133.62 105.46 6.87 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-O 121.262 0.553 . . . . 73.0 109.846 177.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.521 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 3.5 m -102.19 113.13 26.14 Favored 'General case' 0 N--CA 1.422 -1.863 0 N-CA-C 108.235 -1.024 . . . . 71.430000000000007 108.235 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.465 ' HB ' ' HA ' ' A' ' 76' ' ' SER . 57.4 m -93.61 141.43 28.49 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 108.685 -0.858 . . . . 65.319999999999993 108.685 177.616 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.508 ' HB1' HD11 ' A' ' 80' ' ' LEU . . . -120.91 126.67 50.59 Favored 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 108.92 -0.77 . . . . 75.129999999999995 108.92 177.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -176.03 -140.8 3.59 Favored Glycine 0 N--CA 1.425 -2.091 0 C-N-CA 120.613 -0.803 . . . . 53.43 112.081 -177.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 22.8 ttm180 -114.15 -25.91 8.29 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.245 0.545 . . . . 72.409999999999997 111.837 -174.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.421 ' NE2' ' HG2' ' A' ' 87' ' ' ARG . 25.3 m-70 -99.54 157.41 34.03 Favored Pre-proline 0 C--N 1.305 -1.342 0 CA-C-N 116.386 -0.37 . . . . 70.219999999999999 110.101 -172.126 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -51.94 -21.38 11.98 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 124.089 3.193 . . . . 73.450000000000003 114.387 -178.135 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -60.51 -21.88 62.94 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.389 0.614 . . . . 61.310000000000002 110.045 176.004 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.465 ' HA ' ' HB ' ' A' ' 69' ' ' THR . 34.4 m -86.94 139.36 30.69 Favored 'General case' 0 N--CA 1.421 -1.9 0 CA-C-N 115.376 -0.829 . . . . 73.400000000000006 109.042 175.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -80.12 -30.68 39.08 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.204 0.526 . . . . 71.219999999999999 109.678 -179.004 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.453 ' H ' HD13 ' A' ' 78' ' ' ILE . 0.2 OUTLIER -126.95 136.49 60.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 109.244 -0.651 . . . . 63.100000000000001 109.244 175.39 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -103.11 117.73 35.21 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 115.809 -0.632 . . . . 74.439999999999998 109.54 -176.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.558 ' HG ' ' OD1' ' A' ' 56' ' ' ASN . 5.5 mp -70.02 115.94 9.82 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.851 -1.166 . . . . 70.409999999999997 107.851 175.483 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -88.44 61.59 6.21 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 122.68 1.229 . . . . 73.109999999999999 110.459 177.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -111.29 156.04 22.11 Favored 'General case' 0 C--N 1.286 -2.189 0 CA-C-N 113.136 -1.847 . . . . 71.129999999999995 107.872 174.208 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.9 p -74.42 -25.61 19.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 111.914 0.338 . . . . 74.450000000000003 111.914 -177.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.8 m -116.2 72.04 0.8 Allowed 'General case' 0 CA--C 1.548 0.904 0 CA-C-O 121.977 0.894 . . . . 64.140000000000001 110.829 -177.126 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 47.7 t -112.65 139.53 37.12 Favored 'Isoleucine or valine' 0 C--O 1.249 1.074 0 CA-C-N 115.766 -0.652 . . . . 73.319999999999993 110.844 -178.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 42.6 t -83.71 179.44 7.6 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.621 -0.881 . . . . 62.039999999999999 108.621 178.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.421 ' HG2' ' NE2' ' A' ' 73' ' ' HIS . 93.4 mtt180 -78.4 -54.09 6.56 Favored 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 105.854 -1.906 . . . . 65.230000000000004 105.854 175.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 5.6 ptm180 -105.32 100.37 9.95 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 106.105 -1.813 . . . . 74.450000000000003 106.105 171.14 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 11.0 t60 -99.59 -59.32 1.74 Allowed 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.959 -0.756 . . . . 74.400000000000006 108.959 -174.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -136.81 152.7 50.58 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.479 -0.934 . . . . 60.149999999999999 108.479 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -135.54 128.26 30.97 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 109.554 -0.535 . . . . 70.519999999999996 109.554 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.521 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 67.8 m-85 -101.81 115.98 31.71 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 107.762 -1.199 . . . . 74.109999999999999 107.762 179.27 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 18.8 mmt180 -108.33 140.0 42.23 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 109.319 -0.622 . . . . 74.129999999999995 109.319 178.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.499 HG13 ' HA ' ' A' ' 66' ' ' PRO . 2.6 pp -115.98 116.91 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.192 0 N-CA-C 106.965 -1.494 . . . . 74.109999999999999 106.965 172.071 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.538 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 46.6 t-20 -108.97 146.13 34.35 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 107.26 -1.385 . . . . 73.340000000000003 107.26 -174.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -59.49 -16.46 24.38 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 124.449 1.099 . . . . 74.409999999999997 111.551 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -87.42 -47.11 4.73 Favored Glycine 0 N--CA 1.431 -1.675 0 N-CA-C 111.594 -0.602 . . . . 72.310000000000002 111.594 176.093 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.538 ' O ' ' HB3' ' A' ' 95' ' ' ASN . 26.2 tt0 -173.36 169.15 4.51 Favored 'General case' 0 C--O 1.218 -0.573 0 N-CA-C 105.856 -1.905 . . . . 53.140000000000001 105.856 -179.037 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -104.49 131.71 51.56 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 119.262 0.937 . . . . 73.420000000000002 110.479 -173.038 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -131.7 138.13 48.55 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 122.566 1.174 . . . . 60.409999999999997 113.226 -178.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 44.3 t -102.57 129.79 53.57 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.258 0 N-CA-C 106.945 -1.502 . . . . 60.229999999999997 106.945 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.4 t -118.73 136.0 57.34 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 C-N-CA 120.926 -0.31 . . . . 72.239999999999995 110.283 -177.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -82.67 110.59 17.87 Favored 'General case' 0 N--CA 1.437 -1.109 0 N-CA-C 106.536 -1.653 . . . . 73.010000000000005 106.536 170.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 30.0 m -100.51 7.04 9.42 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 CA-C-N 114.935 -1.029 . . . . 75.230000000000004 111.518 -173.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 134.51 52.18 0.07 OUTLIER Glycine 0 N--CA 1.425 -2.084 0 C-N-CA 119.815 -1.183 . . . . 73.209999999999994 112.054 178.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 50.4 m -59.11 128.24 36.2 Favored 'General case' 0 C--O 1.25 1.131 0 N-CA-C 109.667 -0.494 . . . . 61.210000000000001 109.667 176.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.83 -51.15 63.68 Favored 'General case' 0 C--O 1.217 -0.609 0 N-CA-C 108.62 -0.882 . . . . 65.319999999999993 108.62 -178.618 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.435 ' OD1' ' HA2' ' A' ' 131' ' ' GLY . 7.9 p30 -91.61 -45.66 8.36 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 112.281 0.475 . . . . 63.520000000000003 112.281 177.157 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 143.71 139.56 3.53 Favored Glycine 0 C--O 1.219 -0.82 0 C-N-CA 119.506 -1.331 . . . . 32.450000000000003 114.063 174.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 59.8 m -105.26 120.14 40.82 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 108.908 -0.775 . . . . 44.100000000000001 108.908 174.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -122.04 137.91 54.63 Favored 'General case' 0 C--O 1.198 -1.645 0 CA-C-N 115.649 -0.705 . . . . 73.109999999999999 109.715 -174.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.541 HG21 ' HG3' ' A' ' 120' ' ' GLN . 59.6 t -99.18 117.08 43.76 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.485 0 N-CA-C 106.708 -1.59 . . . . 51.420000000000002 106.708 177.088 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 68.58 -71.07 0.12 Allowed 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 125.341 1.457 . . . . 73.030000000000001 108.877 -172.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 55.9 ttp85 -157.67 6.79 0.14 Allowed 'General case' 0 CA--C 1.553 1.073 0 CA-C-O 121.339 0.59 . . . . 72.450000000000003 109.775 172.307 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -114.8 131.74 23.29 Favored Pre-proline 0 N--CA 1.449 -0.476 0 O-C-N 121.845 -0.535 . . . . 73.439999999999998 110.026 -174.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -68.87 131.38 22.39 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.203 1.935 . . . . 62.219999999999999 112.241 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 -122.27 145.07 48.57 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 106.767 -1.568 . . . . 65.409999999999997 106.767 176.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -78.76 -46.54 18.65 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.989 -1.115 . . . . 75.120000000000005 107.989 178.276 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -138.35 143.48 39.9 Favored 'General case' 0 N--CA 1.421 -1.891 0 N-CA-C 106.609 -1.626 . . . . 34.539999999999999 106.609 175.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.541 ' HG3' HG21 ' A' ' 112' ' ' VAL . 22.1 tm0? -129.69 141.86 50.82 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 107.345 -1.354 . . . . 75.040000000000006 107.345 -176.32 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.3 p -103.15 119.05 51.06 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.297 0 N-CA-C 108.554 -0.906 . . . . 71.439999999999998 108.554 178.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.558 ' HB3' ' CE1' ' A' ' 137' ' ' PHE . 64.9 mtt -41.84 111.93 0.28 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.217 1.007 . . . . 74.230000000000004 112.588 -170.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -114.83 136.3 53.24 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-N 114.929 -1.032 . . . . 75.319999999999993 109.619 -170.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.703 ' HB ' ' HB3' ' A' ' 139' ' ' ALA . 14.6 t -79.4 127.59 32.29 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 121.666 0.746 . . . . 63.539999999999999 112.778 -176.063 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 80.97 33.51 29.47 Favored Glycine 0 N--CA 1.428 -1.849 0 CA-C-N 115.124 -0.943 . . . . 52.32 111.958 173.254 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -137.2 155.78 49.13 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.427 -0.953 . . . . 71.420000000000002 108.427 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -118.8 135.57 54.46 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-O 121.97 0.891 . . . . 73.230000000000004 113.206 -175.436 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 64.6 mt -111.35 130.4 64.92 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 CA-C-N 114.386 -1.279 . . . . 73.219999999999999 108.706 -177.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -91.9 111.49 23.05 Favored 'General case' 0 N--CA 1.417 -2.109 0 N-CA-C 107.707 -1.22 . . . . 73.540000000000006 107.707 175.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 10.9 pt -93.97 98.84 8.65 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 N-CA-C 107.911 -1.144 . . . . 70.409999999999997 107.911 177.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.435 ' HA2' ' OD1' ' A' ' 108' ' ' ASN . . . 79.58 -104.07 2.14 Favored Glycine 0 N--CA 1.412 -2.907 0 N-CA-C 109.363 -1.495 . . . . 65.409999999999997 109.363 -174.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -123.68 5.3 8.86 Favored 'General case' 0 C--N 1.298 -1.63 0 N-CA-C 109.965 -0.383 . . . . 74.040000000000006 109.965 178.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -113.03 152.71 29.16 Favored 'General case' 0 C--O 1.211 -0.954 0 CA-C-N 116.375 -0.375 . . . . 74.239999999999995 110.625 -177.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 66.4 mtp85 -113.61 128.31 56.39 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.52 0.676 . . . . 64.010000000000005 112.611 -170.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.492 HD11 HD13 ' A' ' 49' ' ' LEU . 45.1 tp -119.43 132.6 55.84 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 124.92 1.288 . . . . 74.310000000000002 108.552 -177.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 9.9 p -108.17 132.36 56.13 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 108.765 -0.828 . . . . 72.439999999999998 108.765 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' PHE . . . . . 0.558 ' CE1' ' HB3' ' A' ' 122' ' ' MET . 39.8 t80 -109.04 131.38 55.13 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 121.077 -0.249 . . . . 73.120000000000005 110.948 -175.442 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.4 mp -124.44 124.18 41.76 Favored 'General case' 0 C--O 1.244 0.79 0 CA-C-O 121.131 0.491 . . . . 71.530000000000001 109.927 177.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.703 ' HB3' ' HB ' ' A' ' 124' ' ' THR . . . -94.64 82.91 4.0 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-O 121.536 0.684 . . . . 73.120000000000005 111.072 -177.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -127.12 96.87 0.46 Allowed Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 109.021 -1.631 . . . . 71.030000000000001 109.021 177.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo . . . . . 0 C--N 1.355 0.881 0 C-N-CA 123.159 2.573 . . . . 74.030000000000001 113.271 -176.917 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.6 p30 . . . . . 0 C--O 1.245 0.866 0 CA-C-O 120.812 0.339 . . . . 64.430000000000007 110.464 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 161.23 176.47 33.37 Favored Glycine 0 N--CA 1.431 -1.688 0 N-CA-C 110.733 -0.947 . . . . 64.510000000000005 110.733 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.3 p -92.2 124.62 59.2 Favored Pre-proline 0 C--N 1.292 -1.9 0 CA-C-N 116.624 0.212 . . . . 71.099999999999994 110.909 -178.235 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -63.83 128.92 23.22 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.314 2.01 . . . . 72.129999999999995 110.326 176.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -86.4 130.55 49.08 Favored Pre-proline 0 C--N 1.299 -1.615 0 CA-C-N 116.32 -0.4 . . . . 74.420000000000002 111.856 -174.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -65.15 145.33 84.28 Favored 'Trans proline' 0 C--O 1.247 0.934 0 C-N-CA 122.632 2.221 . . . . 74.319999999999993 111.377 178.355 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -57.8 128.34 36.58 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-N 115.685 -0.689 . . . . 72.409999999999997 112.483 -178.033 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.4 m -73.53 76.25 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 CA-C-O 122.66 1.219 . . . . 31.239999999999998 109.903 173.34 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -88.83 122.59 32.37 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-N 114.231 -1.35 . . . . 74.200000000000003 111.033 -174.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.6 t -145.27 89.29 1.93 Allowed 'General case' 0 N--CA 1.407 -2.597 0 CA-C-O 122.583 1.182 . . . . 70.219999999999999 107.944 174.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 28.6 m -92.5 105.82 17.92 Favored 'General case' 0 N--CA 1.415 -2.212 0 CA-C-N 114.79 -1.096 . . . . 62.140000000000001 109.444 -177.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.9 m -72.32 113.99 9.95 Favored 'General case' 0 N--CA 1.418 -2.075 0 CA-C-N 115.065 -0.97 . . . . 63.039999999999999 109.029 177.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.1 m . . . . . 0 C--N 1.312 -1.029 0 CA-C-O 121.125 0.488 . . . . 74.140000000000001 110.506 179.556 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.484 -1.851 0 N-CA-C 107.261 -2.336 . . . . 52.109999999999999 107.261 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 20.2 m -90.89 167.08 12.7 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 114.107 -1.046 . . . . 53.219999999999999 110.609 -174.426 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -127.4 171.13 11.81 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.137 -1.431 . . . . 65.329999999999998 107.137 177.566 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -134.04 145.5 49.48 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 120.039 -0.664 . . . . 71.530000000000001 111.109 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.479 ' O ' ' HA ' ' A' ' 60' ' ' ARG . 4.1 pp -110.56 132.72 53.94 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 115.217 -0.901 . . . . 75.209999999999994 108.934 176.538 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 51.5 t -116.67 113.88 44.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 108.509 -0.923 . . . . 62.030000000000001 108.509 179.124 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 36.3 t -96.21 115.61 35.94 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 N-CA-C 109.033 -0.729 . . . . 71.329999999999998 109.033 -179.268 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -86.14 -32.86 21.06 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.377 0.608 . . . . 63.549999999999997 110.183 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.438 ' O ' ' HB3' ' A' ' 133' ' ' PHE . 10.1 tpt180 -147.55 131.08 16.75 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 106.535 -1.654 . . . . 73.209999999999994 106.535 179.493 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.426 ' HA2' ' HD2' ' A' ' 55' ' ' PRO . . . 145.14 110.74 0.7 Allowed Glycine 0 C--N 1.298 -1.555 0 N-CA-C 111.376 -0.689 . . . . 65.120000000000005 111.376 -178.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.426 ' HD2' ' HA2' ' A' ' 54' ' ' GLY . 14.3 Cg_endo -58.36 -20.7 49.42 Favored 'Trans proline' 0 C--N 1.358 1.052 0 C-N-CA 123.403 2.735 . . . . 70.140000000000001 113.689 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.448 ' HB3' ' HG ' ' A' ' 80' ' ' LEU . 7.6 p30 -48.0 -35.9 11.77 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.225 1.01 . . . . 74.319999999999993 111.82 175.188 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -152.21 -72.04 0.15 Allowed 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 109.241 -0.651 . . . . 73.109999999999999 109.241 176.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.96 36.64 35.37 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.652 -0.704 . . . . 64.129999999999995 111.752 -179.041 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -158.38 -171.61 3.54 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 107.672 -1.232 . . . . 70.340000000000003 107.672 -178.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.479 ' HA ' ' O ' ' A' ' 49' ' ' LEU . 36.6 ptt180 -113.37 133.02 55.38 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 109.546 -0.539 . . . . 74.420000000000002 109.546 178.363 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -135.57 134.7 39.65 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 116.483 -0.326 . . . . 75.400000000000006 110.681 -176.135 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.5 mp -91.57 130.16 37.43 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.921 -0.581 . . . . 73.109999999999999 109.438 178.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -71.34 121.34 18.34 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.546 0.689 . . . . 74.409999999999997 110.761 -177.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -123.78 -24.95 4.37 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.206 -1.361 . . . . 72.010000000000005 111.383 -175.136 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.446 ' H ' ' CD ' ' A' ' 65' ' ' GLN . 0.2 OUTLIER -92.27 141.34 24.87 Favored Pre-proline 0 C--N 1.295 -1.781 0 CA-C-N 115.021 -0.99 . . . . 73.340000000000003 111.032 -174.684 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.525 ' HA ' HG22 ' A' ' 94' ' ' ILE . 37.2 Cg_endo -66.68 -34.29 32.47 Favored 'Trans proline' 0 C--O 1.242 0.709 0 C-N-CA 123.075 2.516 . . . . 51.100000000000001 112.798 -176.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 39.5 m -132.61 99.71 4.72 Favored 'General case' 0 N--CA 1.415 -2.187 0 N-CA-C 107.57 -1.27 . . . . 73.540000000000006 107.57 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.516 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 6.1 m -90.74 112.92 24.89 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.506 -0.924 . . . . 62.130000000000003 108.506 179.415 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 51.7 m -94.04 119.94 33.6 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 109.296 -0.631 . . . . 75.310000000000002 109.296 177.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -109.69 120.31 42.1 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 108.59 -0.893 . . . . 63.119999999999997 108.59 178.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 175.29 -147.09 8.69 Favored Glycine 0 C--N 1.289 -2.067 0 N-CA-C 109.221 -1.552 . . . . 42.530000000000001 109.221 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.499 ' HD3' ' O ' ' A' ' 80' ' ' LEU . 10.2 tpt180 -134.32 66.16 1.55 Allowed 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 108.424 -0.954 . . . . 73.409999999999997 108.424 179.176 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 30.1 m170 -126.87 166.01 25.05 Favored Pre-proline 0 C--N 1.303 -1.414 0 N-CA-C 107.568 -1.271 . . . . 75.310000000000002 107.568 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -61.13 -32.94 91.71 Favored 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 121.755 1.637 . . . . 72.319999999999993 109.986 172.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 -97.82 72.3 2.25 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-O 122.35 1.071 . . . . 61.039999999999999 109.898 177.277 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 48.9 m -142.62 125.92 16.55 Favored 'General case' 0 C--N 1.277 -2.545 0 CA-C-N 114.087 -1.415 . . . . 72.219999999999999 107.557 174.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -69.48 -50.66 43.27 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 107.774 -1.195 . . . . 62.32 107.774 -179.487 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 30.1 pt -109.09 123.59 65.09 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.222 0 N-CA-C 107.083 -1.451 . . . . 74.099999999999994 107.083 172.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -108.04 116.91 32.82 Favored 'General case' 0 C--N 1.28 -2.455 0 CA-C-O 122.177 0.989 . . . . 74.409999999999997 111.524 -177.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.499 ' O ' ' HD3' ' A' ' 72' ' ' ARG . 6.3 mp -79.89 135.28 36.4 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 113.835 -1.53 . . . . 51.009999999999998 109.272 -177.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -134.13 23.79 3.85 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 105.472 -2.047 . . . . 73.319999999999993 105.472 179.256 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -78.44 179.19 7.17 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 111.796 -2.456 . . . . 72.219999999999999 109.906 -175.405 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.9 p -83.34 1.59 3.91 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-O 122.073 0.94 . . . . 55.329999999999998 110.13 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 12.0 p -109.89 14.32 23.18 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 115.932 -0.576 . . . . 65.310000000000002 111.778 -175.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.2 m -81.83 139.09 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.634 0 CA-C-O 121.346 0.593 . . . . 70.109999999999999 111.915 -174.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 13.0 p -130.98 -81.44 0.53 Allowed 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.24 -0.891 . . . . 72.140000000000001 111.367 -179.321 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.447 ' HG3' ' HD2' ' A' ' 88' ' ' ARG . 20.0 tpp85 -156.33 -92.39 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.002 -1.11 . . . . 50.530000000000001 108.002 178.056 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.571 ' HB3' HG23 ' A' ' 104' ' ' VAL . 5.4 mpt_? -85.65 107.06 17.37 Favored 'General case' 0 CA--C 1.493 -1.243 0 N-CA-C 105.168 -2.16 . . . . 73.530000000000001 105.168 171.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -91.53 -75.58 0.47 Allowed 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 120.287 -0.565 . . . . 65.340000000000003 110.255 -174.015 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -144.51 155.0 43.48 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.991 -0.744 . . . . 64.540000000000006 108.991 -178.119 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -140.34 128.2 21.93 Favored 'General case' 0 C--N 1.287 -2.131 0 C-N-CA 119.994 -0.682 . . . . 73.040000000000006 109.326 179.165 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.516 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 42.3 m-85 -97.55 113.09 24.73 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 106.887 -1.523 . . . . 70.409999999999997 106.887 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.428 HH11 ' HD3' ' A' ' 93' ' ' ARG . 46.1 mtt-85 -112.56 152.12 29.23 Favored 'General case' 0 C--N 1.269 -2.913 0 C-N-CA 120.527 -0.469 . . . . 73.340000000000003 109.922 179.394 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.525 HG22 ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -113.43 116.12 51.69 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.3 0 CA-C-O 123.111 1.434 . . . . 75.109999999999999 108.177 177.842 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -97.64 96.44 8.28 Favored 'General case' 0 N--CA 1.42 -1.928 0 CA-C-N 113.256 -1.793 . . . . 71.040000000000006 109.8 -173.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 43.45 13.6 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 127.477 2.311 . . . . 55.530000000000001 116.667 175.013 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 158.48 -13.15 0.23 Allowed Glycine 0 N--CA 1.417 -2.599 0 C-N-CA 120.234 -0.984 . . . . 63.030000000000001 113.606 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -146.36 152.82 39.71 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 118.05 -1.46 . . . . 63.43 110.513 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.414 ' CD2' ' HB ' ' A' ' 94' ' ' ILE . 89.8 m-85 -89.99 138.46 31.49 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.377 0.608 . . . . 75.340000000000003 110.851 -176.106 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -128.07 125.36 39.13 Favored 'General case' 0 C--N 1.28 -2.417 0 N-CA-C 107.61 -1.256 . . . . 70.200000000000003 107.61 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.5 p -103.07 118.55 50.18 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-O 121.602 0.715 . . . . 75.409999999999997 109.862 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 29.9 m -119.96 137.67 53.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-N 115.033 -0.985 . . . . 62.509999999999998 111.686 -179.367 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -83.23 122.96 29.1 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 104.742 -2.318 . . . . 72.200000000000003 104.742 171.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.571 HG23 ' HB3' ' A' ' 88' ' ' ARG . 16.8 m -106.15 9.59 9.37 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 N-CA-C 112.816 0.673 . . . . 62.509999999999998 112.816 -172.111 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -126.41 -45.96 0.22 Allowed Glycine 0 N--CA 1.43 -1.701 0 C-N-CA 119.018 -1.563 . . . . 55.340000000000003 112.96 -179.053 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 21.7 m 67.18 9.97 7.35 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.205 1.402 . . . . 71.329999999999998 110.659 -175.37 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 94.4 mt -74.92 -48.6 23.75 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 114.663 -1.153 . . . . 75.25 109.292 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -83.36 -50.34 8.44 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 108.643 -0.873 . . . . 65.400000000000006 108.643 175.094 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.01 76.99 1.32 Allowed Glycine 0 N--CA 1.431 -1.646 0 N-CA-C 109.486 -1.446 . . . . 55.109999999999999 109.486 -175.268 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 32.1 m -73.09 135.35 44.78 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 109.671 -0.492 . . . . 74.219999999999999 109.671 -179.015 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -102.18 133.2 47.43 Favored 'General case' 0 N--CA 1.422 -1.838 0 N-CA-C 106.925 -1.509 . . . . 74.25 106.925 178.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.47 HG23 HG12 ' A' ' 128' ' ' ILE . 7.5 p -128.41 137.29 57.8 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.179 0 N-CA-C 107.57 -1.27 . . . . 72.209999999999994 107.57 -175.627 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 60.61 21.95 11.78 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 108.149 -1.056 . . . . 75.519999999999996 108.149 -171.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 64.1 mtp180 54.7 37.38 28.18 Favored 'General case' 0 C--N 1.352 0.704 0 CA-C-N 114.412 -1.267 . . . . 73.019999999999996 112.582 -172.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -132.63 149.5 73.2 Favored Pre-proline 0 C--N 1.312 -1.061 0 N-CA-C 108.298 -1.001 . . . . 45.329999999999998 108.298 174.592 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -76.28 87.65 1.41 Allowed 'Trans proline' 0 N--CA 1.443 -1.476 0 C-N-CA 121.49 1.46 . . . . 52.25 110.554 174.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -120.14 149.73 41.76 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.758 -1.201 . . . . 74.030000000000001 107.758 178.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -89.27 -28.9 19.6 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 109.467 -0.568 . . . . 74.239999999999995 109.467 179.225 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -140.92 140.36 34.47 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 115.413 -0.812 . . . . 74.329999999999998 109.514 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.5 142.23 37.3 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.737 -1.208 . . . . 64.340000000000003 107.737 174.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 11.3 p -98.07 135.84 31.22 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.232 0 N-CA-C 109.641 -0.503 . . . . 73.239999999999995 109.641 -177.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 48.6 ttp -31.58 108.99 0.05 Allowed 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 125.97 1.708 . . . . 63.119999999999997 112.24 -177.583 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -133.06 138.71 46.84 Favored 'General case' 0 N--CA 1.419 -2.015 0 N-CA-C 106.763 -1.569 . . . . 65.120000000000005 106.763 179.05 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 12.3 t -80.06 131.37 35.76 Favored 'General case' 0 N--CA 1.423 -1.823 0 N-CA-C 109.12 -0.696 . . . . 63.32 109.12 -179.266 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 91.39 18.14 46.87 Favored Glycine 0 N--CA 1.438 -1.176 0 C-N-CA 120.314 -0.946 . . . . 71.450000000000003 111.125 178.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -81.51 140.64 34.44 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 106.657 -1.609 . . . . 75.530000000000001 106.657 178.493 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -124.77 120.88 33.03 Favored 'General case' 0 C--N 1.277 -2.552 0 CA-C-O 122.41 1.1 . . . . 55.420000000000002 110.576 -179.401 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.47 HG12 HG23 ' A' ' 112' ' ' VAL . 61.0 mt -103.66 128.49 56.81 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.095 0 CA-C-N 113.885 -1.507 . . . . 72.450000000000003 108.908 -174.548 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -120.6 124.82 46.22 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 109.793 -0.447 . . . . 63.119999999999997 109.793 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.464 HG13 ' HB2' ' A' ' 133' ' ' PHE . 22.0 pt -109.76 98.24 6.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 108.404 -0.961 . . . . 62.399999999999999 108.404 173.479 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 70.4 -82.81 0.36 Allowed Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.074 -0.966 . . . . 34.329999999999998 111.615 -175.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -130.77 -12.79 3.75 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 123.104 0.562 . . . . 73.430000000000007 110.182 179.171 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.464 ' HB2' HG13 ' A' ' 130' ' ' ILE . 42.3 m-85 -85.63 131.74 34.29 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.852 -0.795 . . . . 71.310000000000002 108.852 -176.039 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 21.4 ptt180 -118.33 135.05 54.54 Favored 'General case' 0 C--O 1.258 1.541 0 CA-C-O 121.993 0.902 . . . . 62.509999999999998 112.821 -175.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 5.2 tt -120.04 133.23 55.59 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 113.473 -1.694 . . . . 55.109999999999999 107.302 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 40.7 t -107.91 120.75 59.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 107.318 -1.364 . . . . 63.310000000000002 107.318 177.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -102.48 121.9 43.26 Favored 'General case' 0 C--N 1.288 -2.078 0 CA-C-N 115.7 -0.682 . . . . 73.5 109.497 -176.17 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -121.52 159.52 26.18 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 109.606 -0.516 . . . . 60.109999999999999 109.606 -178.298 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -72.0 148.78 45.58 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 106.772 -1.566 . . . . 63.009999999999998 106.772 172.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -113.86 -140.62 7.57 Favored Glycine 0 C--N 1.29 -1.983 0 C-N-CA 119.546 -1.311 . . . . 35.240000000000002 112.874 -173.458 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 N--CA 1.435 -1.915 0 C-N-CA 122.57 2.18 . . . . 73.109999999999999 113.061 -179.303 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.7 p30 . . . . . 0 N--CA 1.437 -1.111 0 CA-C-O 121.046 0.45 . . . . 74.25 112.131 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -179.59 -165.18 33.24 Favored Glycine 0 N--CA 1.428 -1.876 0 N-CA-C 107.67 -2.172 . . . . 74.439999999999998 107.67 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.8 p -77.29 124.26 87.02 Favored Pre-proline 0 C--N 1.3 -1.55 0 CA-C-N 118.212 1.006 . . . . 71.120000000000005 109.667 179.091 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -61.21 148.12 93.76 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 123.175 2.583 . . . . 74.200000000000003 112.855 -175.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -69.77 117.62 55.23 Favored Pre-proline 0 C--O 1.247 0.925 0 N-CA-C 109.556 -0.535 . . . . 71.120000000000005 109.556 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -82.24 142.53 12.11 Favored 'Trans proline' 0 N--CA 1.444 -1.44 0 C-N-CA 122.738 2.292 . . . . 74.219999999999999 112.63 -176.532 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -70.55 134.35 47.59 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-N 115.456 -0.793 . . . . 63.100000000000001 109.801 178.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.7 t -73.86 89.22 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 CA-C-N 115.483 -0.78 . . . . 54.43 109.591 -179.441 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -72.96 124.41 25.39 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 114.546 -1.206 . . . . 71.530000000000001 108.95 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.4 m -67.29 98.32 0.61 Allowed 'General case' 0 N--CA 1.427 -1.621 0 CA-C-N 115.709 -0.678 . . . . 51.240000000000002 109.844 -179.014 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.1 t -79.3 75.05 5.88 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 123.037 1.398 . . . . 75.030000000000001 110.394 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.8 m -155.69 164.05 39.1 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 106.452 -1.684 . . . . 71.140000000000001 106.452 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.7 m . . . . . 0 N--CA 1.427 -1.591 0 N-CA-C 108.863 -0.792 . . . . 72.540000000000006 108.863 175.648 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.485 -1.829 0 N-CA-C 109.605 -1.398 . . . . 51.32 109.605 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.568 ' HB3' ' O ' ' A' ' 63' ' ' LEU . 4.8 m -90.0 154.64 19.67 Favored 'General case' 0 N--CA 1.41 -2.448 0 CA-C-N 114.446 -0.877 . . . . 64.310000000000002 108.892 -177.444 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -116.26 175.89 5.35 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.303 -0.999 . . . . 64.329999999999998 108.303 -178.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -130.27 159.66 36.23 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 121.327 0.584 . . . . 65.140000000000001 111.348 -175.108 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.44 HD22 HD21 ' A' ' 135' ' ' LEU . 1.7 pp -122.17 147.63 45.93 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 115.356 -0.838 . . . . 73.420000000000002 110.097 177.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.483 ' CG2' ' HB ' ' A' ' 136' ' ' VAL . 24.6 m -123.28 134.05 67.37 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 108.603 -0.888 . . . . 73.430000000000007 108.603 175.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.463 HG21 ' HB3' ' A' ' 57' ' ' ALA . 48.5 t -92.54 115.69 32.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 106.457 -1.683 . . . . 63.240000000000002 106.457 176.744 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.402 ' HB3' ' HG3' ' A' ' 134' ' ' ARG . 76.9 tttt -73.96 -39.98 63.35 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 114.524 -1.217 . . . . 71.0 108.417 -176.118 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 31.7 tpt180 -168.31 138.51 2.55 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 107.157 -1.423 . . . . 65.209999999999994 107.157 177.098 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 139.28 127.67 2.47 Favored Glycine 0 N--CA 1.425 -2.077 0 C-N-CA 119.724 -1.227 . . . . 45.030000000000001 114.382 178.49 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.508 ' HD2' ' CE2' ' A' ' 133' ' ' PHE . 80.3 Cg_exo -54.0 -8.74 1.04 Allowed 'Trans proline' 0 C--N 1.368 1.553 0 C-N-CA 125.237 3.958 . . . . 74.219999999999999 114.117 173.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.541 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 1.5 t30 -40.99 -45.44 2.6 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.717 1.207 . . . . 52.240000000000002 109.792 170.592 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.463 ' HB3' HG21 ' A' ' 51' ' ' VAL . . . -162.95 -48.55 0.04 OUTLIER 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 115.989 -0.551 . . . . 74.040000000000006 109.601 176.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 67.82 48.52 54.7 Favored Glycine 0 C--N 1.324 -0.134 0 N-CA-C 111.225 -0.75 . . . . 62.130000000000003 111.225 -179.111 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -161.64 -173.02 3.56 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.25 -1.018 . . . . 54.409999999999997 108.25 -178.072 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.464 ' HB2' HG12 ' A' ' 50' ' ' VAL . 19.1 ptp180 -140.5 135.41 31.89 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.777 -0.824 . . . . 72.340000000000003 108.777 175.738 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -156.46 155.42 32.01 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 120.743 0.306 . . . . 73.010000000000005 111.609 -176.193 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 14.7 tp -79.87 139.7 37.05 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.035 -0.984 . . . . 64.200000000000003 108.642 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.568 ' O ' ' HB3' ' A' ' 46' ' ' SER . 94.3 mt -95.17 114.09 25.84 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 120.138 -0.625 . . . . 74.120000000000005 109.623 177.026 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -96.86 -28.87 14.03 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 121.561 0.696 . . . . 75.230000000000004 109.786 177.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -74.77 115.8 47.65 Favored Pre-proline 0 C--N 1.309 -1.157 0 CA-C-N 114.086 -1.416 . . . . 74.329999999999998 109.621 -177.009 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.467 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 15.2 Cg_endo -57.93 -28.25 82.12 Favored 'Trans proline' 0 C--N 1.363 1.307 0 C-N-CA 123.045 2.497 . . . . 74.010000000000005 112.402 -176.506 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 90.8 m -136.46 109.86 7.91 Favored 'General case' 0 N--CA 1.418 -2.055 0 N-CA-C 108.874 -0.787 . . . . 62.350000000000001 108.874 174.049 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 23.4 m -105.64 114.32 28.41 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.296 -1.002 . . . . 73.329999999999998 108.296 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.495 HG22 ' HG2' ' A' ' 91' ' ' GLU . 65.6 p -91.96 133.77 35.4 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 109.802 -0.444 . . . . 71.120000000000005 109.802 -178.718 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -127.28 133.53 50.15 Favored 'General case' 0 C--O 1.243 0.724 0 O-C-N 122.249 -0.282 . . . . 63.229999999999997 111.118 -179.156 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 161.41 -105.29 0.26 Allowed Glycine 0 N--CA 1.437 -1.282 0 C-N-CA 119.894 -1.146 . . . . 63.329999999999998 114.044 175.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 66.8 ttt180 -91.19 99.54 12.52 Favored 'General case' 0 N--CA 1.42 -1.938 0 N-CA-C 107.991 -1.114 . . . . 75.549999999999997 107.991 -174.575 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 23.1 m80 -12.63 -68.48 0.02 OUTLIER Pre-proline 0 N--CA 1.5 2.056 0 C-N-CA 127.758 2.423 . . . . 73.430000000000007 115.306 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -66.32 -21.9 53.69 Favored 'Trans proline' 0 C--N 1.387 2.563 0 C-N-CA 122.082 1.855 . . . . 64.329999999999998 114.43 -177.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -112.86 18.29 18.29 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.428 0.632 . . . . 71.310000000000002 110.631 -175.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 40.0 m -144.35 165.71 27.14 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.365 -0.976 . . . . 71.409999999999997 108.365 178.274 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -81.37 -57.13 3.63 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 109.185 -0.672 . . . . 54.520000000000003 109.185 176.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 49.4 pt -106.78 166.94 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 CA-C-O 121.604 0.716 . . . . 71.329999999999998 110.712 177.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -123.27 137.02 54.96 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-N 114.954 -1.021 . . . . 74.450000000000003 109.211 -175.52 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.541 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 2.5 pt? -114.11 121.79 44.87 Favored 'General case' 0 N--CA 1.406 -2.664 0 N-CA-C 105.933 -1.877 . . . . 54.109999999999999 105.933 170.434 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -80.72 78.19 7.51 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 122.018 0.913 . . . . 72.230000000000004 110.411 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.462 ' OD2' HG22 ' A' ' 84' ' ' THR . 17.3 t70 -117.58 -167.31 1.3 Allowed 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 114.244 -1.344 . . . . 72.530000000000001 108.252 177.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.41 ' H ' ' CG ' ' A' ' 82' ' ' ASP . 11.0 p -129.65 -19.36 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 CA-C-N 118.241 0.473 . . . . 70.329999999999998 111.225 -177.104 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.462 HG22 ' OD2' ' A' ' 82' ' ' ASP . 12.3 t -99.12 20.99 12.43 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.52 0.676 . . . . 74.310000000000002 110.497 -177.556 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.7 p -81.24 111.02 17.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 108.607 -0.886 . . . . 71.239999999999995 108.607 178.083 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.8 m -76.51 -89.83 0.03 OUTLIER 'General case' 0 CA--C 1.562 1.412 0 N-CA-C 113.478 0.918 . . . . 75.140000000000001 113.478 -172.155 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -84.09 -48.25 10.07 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 106.802 -1.555 . . . . 75.430000000000007 106.802 177.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -162.55 176.42 10.42 Favored 'General case' 0 C--N 1.274 -2.717 0 N-CA-C 100.269 -3.974 . . . . 74.540000000000006 100.269 170.446 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 21.3 t60 -96.27 -74.18 0.57 Allowed 'General case' 0 C--N 1.276 -2.617 0 C-N-CA 116.443 -2.103 . . . . 62.520000000000003 111.979 -170.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.15 163.66 34.68 Favored 'General case' 0 C--N 1.294 -1.809 0 C-N-CA 120.012 -0.675 . . . . 54.130000000000003 110.474 -174.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.495 ' HG2' HG22 ' A' ' 69' ' ' THR . 52.1 mt-10 -116.21 127.35 54.69 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.624 -0.88 . . . . 75.540000000000006 108.624 175.61 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -100.51 112.89 25.31 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 107.595 -1.261 . . . . 74.510000000000005 107.595 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 60.0 mtp180 -103.3 112.93 26.03 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 106.89 -1.522 . . . . 62.130000000000003 106.89 -179.033 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.467 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -120.14 111.43 32.4 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.328 0 N-CA-C 106.954 -1.499 . . . . 74.019999999999996 106.954 -179.756 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -122.33 147.23 46.51 Favored 'General case' 0 N--CA 1.393 -3.302 0 CA-C-N 114.469 -1.241 . . . . 71.25 111.004 176.32 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.27 -30.35 70.41 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 107.58 -1.267 . . . . 74.109999999999999 107.58 175.572 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -69.58 -61.39 4.45 Favored Glycine 0 N--CA 1.429 -1.824 0 CA-C-N 113.442 -1.708 . . . . 62.0 111.304 175.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -147.2 146.63 29.9 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.962 0.381 . . . . 55.240000000000002 110.972 -179.312 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -104.39 116.22 31.74 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.002 -0.74 . . . . 74.439999999999998 109.002 -178.203 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -133.16 135.4 45.12 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 113.503 0.927 . . . . 72.140000000000001 113.503 -177.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.7 p -116.31 119.07 60.83 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.295 0 N-CA-C 108.959 -0.756 . . . . 52.229999999999997 108.959 176.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.6 p -120.84 131.75 72.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 112.591 0.589 . . . . 72.239999999999995 112.591 -177.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -83.06 136.67 34.4 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 108.596 -0.89 . . . . 71.409999999999997 108.596 172.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.6 m -89.57 -16.95 8.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-O 121.189 0.518 . . . . 73.400000000000006 111.872 -176.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 142.28 53.06 0.04 OUTLIER Glycine 0 N--CA 1.424 -2.136 0 N-CA-C 109.746 -1.341 . . . . 51.130000000000003 109.746 -173.21 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.6 t -154.7 28.6 0.43 Allowed 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 106.462 -1.681 . . . . 53.0 106.462 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 32.9 tp -62.64 -11.52 17.52 Favored 'General case' 0 C--N 1.356 0.882 0 C-N-CA 125.794 1.637 . . . . 72.340000000000003 111.57 -174.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -60.45 -26.76 67.0 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 115.156 -0.929 . . . . 75.530000000000001 109.472 173.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -123.54 3.45 9.45 Favored Glycine 0 N--CA 1.429 -1.785 0 C-N-CA 120.975 -0.631 . . . . 65.109999999999999 113.69 178.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.7 m -102.31 118.69 37.41 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 118.79 1.295 . . . . 63.439999999999998 109.757 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -139.16 137.32 35.98 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.483 -0.562 . . . . 64.530000000000001 109.483 -178.682 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.2 p -103.14 119.18 51.24 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 106.348 -1.723 . . . . 61.119999999999997 106.348 170.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 18.9 m120 70.63 -78.01 0.05 Allowed 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 108.479 -0.934 . . . . 73.329999999999998 108.479 -171.244 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -152.31 2.16 0.34 Allowed 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.253 -0.885 . . . . 73.140000000000001 108.862 174.039 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -101.19 119.01 59.04 Favored Pre-proline 0 N--CA 1.438 -1.033 0 O-C-N 122.022 -0.424 . . . . 75.230000000000004 110.976 -171.141 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -81.02 90.99 1.17 Allowed 'Trans proline' 0 N--CA 1.43 -2.226 0 C-N-CA 121.777 1.651 . . . . 62.329999999999998 109.538 174.275 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.03 -94.62 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.662 -0.699 . . . . 73.25 109.594 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 7.4 t30 167.83 -60.44 0.01 OUTLIER 'General case' 0 CA--C 1.489 -1.39 0 N-CA-C 104.431 -2.433 . . . . 70.019999999999996 104.431 175.071 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -123.91 138.71 54.44 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 106.313 -1.736 . . . . 61.100000000000001 106.313 171.034 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 55.1 tp60 -140.45 150.52 43.92 Favored 'General case' 0 C--N 1.278 -2.526 0 N-CA-C 109.868 -0.419 . . . . 71.219999999999999 109.868 -176.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 97.4 t -77.89 118.75 25.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 105.485 -2.043 . . . . 75.519999999999996 105.485 171.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 21.1 ttt -75.48 113.21 12.63 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 114.919 -1.037 . . . . 72.140000000000001 108.409 -173.079 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.4 ' HA ' ' OE1' ' A' ' 123' ' ' GLN . 5.7 tp60 -104.95 139.21 40.0 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.755 -0.657 . . . . 72.230000000000004 111.526 -171.136 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 3.5 t -79.0 131.99 36.49 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 114.932 -1.031 . . . . 74.299999999999997 110.56 -179.472 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 97.66 11.05 52.02 Favored Glycine 0 N--CA 1.434 -1.485 0 CA-C-N 115.604 -0.726 . . . . 53.200000000000003 112.14 177.381 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -124.2 173.1 8.55 Favored 'General case' 0 C--O 1.253 1.284 0 N-CA-C 108.228 -1.027 . . . . 72.530000000000001 108.228 178.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.592 ' OE2' ' HD3' ' A' ' 134' ' ' ARG . 36.9 tt0 -123.82 123.77 41.2 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 121.337 0.589 . . . . 72.030000000000001 109.665 -172.728 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 67.6 mt -105.18 130.37 56.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 108.645 -0.872 . . . . 73.430000000000007 108.645 -177.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -98.3 118.83 35.84 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 109.142 -0.688 . . . . 63.009999999999998 109.142 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 17.0 pt -120.06 109.04 24.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 CA-C-O 121.915 0.865 . . . . 64.209999999999994 110.002 -177.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 81.98 -124.34 6.43 Favored Glycine 0 N--CA 1.416 -2.666 0 N-CA-C 109.198 -1.561 . . . . 52.539999999999999 109.198 -178.22 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -102.23 -4.03 26.38 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 108.916 -0.772 . . . . 74.140000000000001 108.916 176.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.508 ' CE2' ' HD2' ' A' ' 55' ' ' PRO . 45.2 m-85 -115.82 -179.96 3.8 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.254 -0.43 . . . . 72.239999999999995 111.599 -172.49 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.592 ' HD3' ' OE2' ' A' ' 127' ' ' GLU . 10.4 ptp180 -137.86 140.83 40.64 Favored 'General case' 0 C--O 1.247 0.932 0 N-CA-C 113.515 0.932 . . . . 71.310000000000002 113.515 -172.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.44 HD21 HD22 ' A' ' 49' ' ' LEU . 29.5 tp -123.86 133.15 53.83 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.21 -1.359 . . . . 73.25 108.751 -175.807 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.483 ' HB ' ' CG2' ' A' ' 50' ' ' VAL . 25.7 t -107.81 132.29 55.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 107.689 -1.226 . . . . 74.049999999999997 107.689 178.403 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -104.18 123.83 48.02 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 120.617 0.246 . . . . 73.129999999999995 110.55 -176.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -126.41 138.58 53.56 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-O 121.809 0.814 . . . . 63.439999999999998 111.462 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -106.53 91.9 3.89 Favored 'General case' 0 C--N 1.278 -2.509 0 N-CA-C 107.163 -1.421 . . . . 53.409999999999997 107.163 172.202 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -93.63 -127.2 4.58 Favored Glycine 0 CA--C 1.497 -1.039 0 N-CA-C 110.47 -1.052 . . . . 31.239999999999998 110.47 -177.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo . . . . . 0 N--CA 1.445 -1.33 0 C-N-CA 121.588 1.525 . . . . 63.509999999999998 109.031 175.955 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.7 t30 . . . . . 0 N--CA 1.44 -0.947 0 N-CA-C 108.724 -0.843 . . . . 65.510000000000005 108.724 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -107.61 56.21 0.49 Allowed Glycine 0 N--CA 1.429 -1.811 0 C-N-CA 120.806 -0.711 . . . . 52.509999999999998 112.184 -176.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.6 m -92.59 123.21 62.54 Favored Pre-proline 0 C--N 1.303 -1.445 0 N-CA-C 109.239 -0.652 . . . . 61.32 109.239 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -67.07 128.55 18.84 Favored 'Trans proline' 0 C--O 1.243 0.744 0 C-N-CA 122.537 2.158 . . . . 73.310000000000002 111.037 175.059 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -85.89 144.98 40.17 Favored Pre-proline 0 C--N 1.294 -1.82 0 CA-C-N 116.137 -0.483 . . . . 65.200000000000003 109.942 -179.383 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -72.85 117.3 5.06 Favored 'Trans proline' 0 N--CA 1.446 -1.3 0 C-N-CA 122.207 1.938 . . . . 62.310000000000002 112.683 -177.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -100.75 136.85 39.96 Favored 'General case' 0 C--N 1.282 -2.364 0 CA-C-N 115.03 -0.986 . . . . 74.340000000000003 108.768 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.1 p -127.37 122.89 60.63 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 CA-C-O 121.72 0.771 . . . . 75.230000000000004 110.809 178.435 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -122.63 133.17 54.53 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 108.205 -1.035 . . . . 63.539999999999999 108.205 177.206 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.4 t -163.9 99.66 0.87 Allowed 'General case' 0 N--CA 1.42 -1.958 0 CA-C-O 122.054 0.931 . . . . 71.140000000000001 109.367 -178.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 21.0 m -84.44 79.26 9.63 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 108.532 -0.914 . . . . 53.130000000000003 108.532 178.433 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.9 p -125.47 84.45 2.28 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 115.108 -0.951 . . . . 73.25 111.53 -176.354 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 50.4 t . . . . . 0 C--N 1.308 -1.21 0 N-CA-C 108.024 -1.102 . . . . 62.329999999999998 108.024 -178.585 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.477 -2.294 0 N-CA-C 106.084 -2.806 . . . . 64.510000000000005 106.084 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 25.0 m -88.74 163.0 15.93 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-O 121.835 0.826 . . . . 35.229999999999997 112.405 -167.564 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.509 ' HA ' ' N ' ' A' ' 140' ' ' GLY . . . -129.48 171.14 12.86 Favored 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 107.604 -1.258 . . . . 54.219999999999999 107.604 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.7 pp -133.71 143.87 48.78 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 112.314 0.487 . . . . 64.150000000000006 112.314 -175.432 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.521 HD23 ' H ' ' A' ' 49' ' ' LEU . 2.4 pt? -109.75 132.01 54.54 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.91 -1.145 . . . . 71.239999999999995 107.91 178.044 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 23.5 t -119.04 126.37 75.3 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 109.111 -0.7 . . . . 75.230000000000004 109.111 -176.229 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.436 HG22 HD13 ' A' ' 135' ' ' LEU . 15.4 t -92.77 118.35 38.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.761 0 N-CA-C 107.234 -1.395 . . . . 74.340000000000003 107.234 177.545 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.524 ' HB2' ' HG3' ' A' ' 134' ' ' ARG . 31.8 mmmt -70.68 -38.22 73.72 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 108.72 -0.844 . . . . 75.25 108.72 -179.058 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.547 ' HA ' ' HE ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -174.3 133.74 0.41 Allowed 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.011 -0.995 . . . . 63.020000000000003 108.805 178.076 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -177.91 158.26 23.15 Favored Glycine 0 N--CA 1.43 -1.715 0 N-CA-C 108.648 -1.781 . . . . 53.109999999999999 108.648 176.026 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -68.42 -25.47 35.66 Favored 'Trans proline' 0 N--CA 1.48 0.73 0 C-N-CA 122.292 1.995 . . . . 72.209999999999994 110.477 176.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.457 ' CB ' ' HA ' ' A' ' 80' ' ' LEU . 9.7 p30 -58.55 -58.64 7.66 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 113.91 -1.495 . . . . 73.329999999999998 111.9 177.733 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -162.96 -179.75 6.98 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 108.761 -0.829 . . . . 53.140000000000001 108.761 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -155.31 36.04 0.65 Allowed Glycine 0 C--N 1.3 -1.46 0 N-CA-C 109.97 -1.252 . . . . 71.019999999999996 109.97 178.345 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -140.04 -171.25 3.14 Favored 'General case' 0 N--CA 1.424 -1.763 0 N-CA-C 108.851 -0.796 . . . . 71.310000000000002 108.851 -175.379 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 23.7 ptt180 -112.62 146.02 39.35 Favored 'General case' 0 C--N 1.294 -1.839 0 O-C-N 123.578 0.549 . . . . 75.329999999999998 110.577 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.516 ' O ' HD23 ' A' ' 49' ' ' LEU . 93.5 m-85 -129.45 131.64 46.78 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.885 -0.598 . . . . 72.349999999999994 109.613 178.368 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 53.8 tp -90.45 129.38 36.64 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.033 -0.728 . . . . 75.450000000000003 109.033 178.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -79.75 113.84 18.21 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 119.855 -0.738 . . . . 75.120000000000005 110.379 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -112.2 -24.99 9.52 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 122.186 0.994 . . . . 75.409999999999997 108.506 174.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -92.39 127.55 48.25 Favored Pre-proline 0 C--N 1.306 -1.291 0 CA-C-N 114.305 -1.316 . . . . 75.349999999999994 110.171 -174.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.461 ' O ' ' HA ' ' A' ' 93' ' ' ARG . 10.4 Cg_endo -57.78 -41.79 66.21 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 122.852 2.368 . . . . 53.310000000000002 112.783 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 32.0 m -118.34 109.35 16.18 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 109.386 -0.598 . . . . 73.299999999999997 109.386 178.218 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.418 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 64.1 m -106.32 115.39 30.13 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 115.913 -0.585 . . . . 72.420000000000002 109.594 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.7 m -86.49 120.61 28.0 Favored 'General case' 0 C--O 1.25 1.127 0 CA-C-N 116.184 -0.462 . . . . 74.340000000000003 109.942 -177.416 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -101.99 112.98 25.82 Favored 'General case' 0 C--O 1.252 1.232 0 CA-C-O 120.88 0.372 . . . . 61.210000000000001 110.445 179.066 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 170.4 -173.19 44.3 Favored Glycine 0 N--CA 1.426 -1.993 0 N-CA-C 110.07 -1.212 . . . . 52.240000000000002 110.07 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -119.26 95.42 4.8 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 105.808 -1.923 . . . . 64.400000000000006 105.808 178.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 8.7 m80 -134.65 178.26 1.85 Allowed Pre-proline 0 C--N 1.287 -2.127 0 N-CA-C 106.289 -1.745 . . . . 73.109999999999999 106.289 -177.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -64.21 -21.54 67.38 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 121.45 1.434 . . . . 74.519999999999996 109.732 167.556 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -116.66 78.79 1.24 Allowed 'General case' 0 N--CA 1.434 -1.24 0 C-N-CA 123.958 0.903 . . . . 72.400000000000006 109.754 178.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 74.2 m -104.58 118.45 36.61 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-N 115.467 -0.788 . . . . 70.209999999999994 109.482 172.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -78.01 -43.43 29.5 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 108.694 -0.854 . . . . 75.25 108.694 177.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.8 pp -120.5 166.49 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 N-CA-C 107.786 -1.191 . . . . 53.240000000000002 107.786 171.095 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -107.53 135.96 48.12 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 115.161 1.541 . . . . 51.119999999999997 115.161 -168.534 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.457 ' HA ' ' CB ' ' A' ' 56' ' ' ASN . 4.0 mm? -125.08 153.41 42.97 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 104.429 -2.434 . . . . 63.030000000000001 104.429 171.512 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -144.72 -14.86 0.55 Allowed 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 118.793 -1.163 . . . . 73.019999999999996 112.557 -175.367 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -72.89 161.49 30.65 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 123.579 0.751 . . . . 71.150000000000006 110.747 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.3 p -77.12 -16.32 14.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-O 122.202 1.001 . . . . 53.0 110.377 -176.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -82.93 11.45 6.11 Favored 'General case' 0 N--CA 1.42 -1.928 0 CA-C-N 114.768 -1.106 . . . . 54.009999999999998 112.973 -179.206 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.0 p -83.3 139.74 17.28 Favored 'Isoleucine or valine' 0 C--O 1.244 0.783 0 CA-C-O 121.068 0.461 . . . . 61.240000000000002 109.833 176.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 28.4 t -105.37 157.11 17.56 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.446 -0.946 . . . . 72.299999999999997 108.446 179.29 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -69.98 110.69 5.2 Favored 'General case' 0 C--O 1.249 1.035 0 N-CA-C 106.839 -1.541 . . . . 73.209999999999994 106.839 174.086 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 59.4 mtt180 60.49 78.15 0.29 Allowed 'General case' 0 C--N 1.316 -0.867 0 O-C-N 124.536 1.147 . . . . 70.120000000000005 107.964 -166.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 45.0 t60 -77.29 -43.06 34.54 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 113.554 -1.657 . . . . 74.420000000000002 108.46 -176.606 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -150.67 159.19 44.69 Favored 'General case' 0 N--CA 1.422 -1.838 0 N-CA-C 107.251 -1.389 . . . . 51.439999999999998 107.251 178.42 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -136.73 127.86 27.9 Favored 'General case' 0 C--N 1.283 -2.311 0 N-CA-C 107.615 -1.254 . . . . 74.340000000000003 107.615 176.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.418 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 91.9 m-85 -110.28 124.48 51.72 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.955 -0.757 . . . . 60.450000000000003 108.955 -177.409 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' A' ' 66' ' ' PRO . 42.7 mtp85 -119.09 138.18 53.06 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-O 121.317 0.58 . . . . 64.439999999999998 112.449 175.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.466 ' O ' HD12 ' A' ' 94' ' ' ILE . 2.8 pp -116.02 116.47 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.152 0 N-CA-C 106.664 -1.606 . . . . 64.430000000000007 106.664 173.266 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -118.68 147.49 43.74 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 115.452 -0.794 . . . . 72.040000000000006 110.666 -173.056 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -45.82 -32.22 2.48 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.896 1.278 . . . . 72.409999999999997 112.385 178.243 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -78.72 -59.19 2.87 Favored Glycine 0 N--CA 1.436 -1.355 0 N-CA-C 111.488 -0.645 . . . . 74.150000000000006 111.488 175.747 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -158.28 173.77 16.18 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 123.777 0.831 . . . . 61.240000000000002 109.304 -175.454 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -102.68 134.73 45.57 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.068 -1.086 . . . . 65.430000000000007 108.068 -178.324 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -132.31 135.73 46.41 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 114.117 1.154 . . . . 74.329999999999998 114.117 -177.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 6.9 p -110.98 127.62 67.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 CA-C-N 114.532 -1.213 . . . . 72.140000000000001 107.973 177.104 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.6 p -119.09 130.3 74.04 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 C-N-CA 120.347 -0.541 . . . . 73.540000000000006 111.779 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -81.37 106.22 13.17 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 105.533 -2.025 . . . . 63.210000000000001 105.533 174.535 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.6 m -104.35 13.86 7.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 112.761 0.652 . . . . 44.240000000000002 112.761 -175.636 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 114.02 73.82 0.61 Allowed Glycine 0 CA--C 1.489 -1.544 0 C-N-CA 120.537 -0.84 . . . . 53.240000000000002 111.239 178.441 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 14.0 p -91.76 138.23 31.72 Favored 'General case' 0 N--CA 1.416 -2.154 0 CA-C-N 115.337 -0.432 . . . . 52.140000000000001 110.218 -177.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 5.8 tt -82.75 -47.55 11.83 Favored 'General case' 0 C--N 1.315 -0.935 0 N-CA-C 108.016 -1.105 . . . . 40.219999999999999 108.016 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.463 ' OD1' ' HA3' ' A' ' 131' ' ' GLY . 11.6 t-20 -68.42 -32.64 72.82 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.679 -0.691 . . . . 72.299999999999997 109.901 179.207 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.428 ' O ' ' HA ' ' A' ' 130' ' ' ILE . . . 112.53 131.68 5.63 Favored Glycine 0 C--O 1.223 -0.573 0 CA-C-N 116.093 -0.503 . . . . 24.210000000000001 112.233 179.064 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -109.16 122.03 46.43 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 123.389 0.676 . . . . 54.100000000000001 109.717 176.64 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -123.76 133.06 53.91 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 108.616 -0.883 . . . . 51.240000000000002 108.616 178.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 45.4 t -121.35 117.45 52.77 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 N-CA-C 106.128 -1.804 . . . . 64.219999999999999 106.128 177.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.495 ' HB2' HH21 ' A' ' 117' ' ' ARG . 20.3 m120 66.88 24.74 9.66 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 108.556 -0.905 . . . . 65.340000000000003 108.556 -172.576 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.528 ' HG2' ' OE1' ' A' ' 129' ' ' GLN . 96.2 mtt180 75.77 2.84 3.77 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 126.001 1.72 . . . . 63.149999999999999 112.833 -178.156 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 55.0 mm-40 -104.97 129.49 24.75 Favored Pre-proline 0 C--N 1.311 -1.071 0 N-CA-C 109.11 -0.7 . . . . 72.329999999999998 109.11 178.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -71.56 124.76 10.57 Favored 'Trans proline' 0 C--O 1.247 0.957 0 C-N-CA 122.116 1.878 . . . . 60.0 108.881 174.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.495 HH21 ' HB2' ' A' ' 113' ' ' ASN . 47.4 mtt180 -119.98 -158.78 0.75 Allowed 'General case' 0 C--N 1.31 -1.113 0 O-C-N 121.951 -0.468 . . . . 73.209999999999994 111.24 -172.41 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -121.74 -45.24 2.29 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 108.104 -1.073 . . . . 71.349999999999994 108.104 174.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -156.7 138.87 14.61 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 107.28 -1.378 . . . . 60.200000000000003 107.28 171.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 53.8 tp60 -141.73 150.85 42.33 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 110.437 -0.209 . . . . 74.439999999999998 110.437 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 78.7 t -78.87 127.96 38.7 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 107.24 -1.393 . . . . 71.239999999999995 107.24 174.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 82.0 mtp -71.68 120.02 16.67 Favored 'General case' 0 CA--C 1.497 -1.085 0 CA-C-N 115.757 -0.656 . . . . 60.210000000000001 109.28 -175.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 14.2 tp60 -105.39 130.17 53.55 Favored 'General case' 0 N--CA 1.415 -2.182 0 N-CA-C 108.362 -0.977 . . . . 62.229999999999997 108.362 -177.415 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 18.9 p -78.35 123.54 27.1 Favored 'General case' 0 N--CA 1.424 -1.769 0 CA-C-O 121.1 0.476 . . . . 71.349999999999994 110.606 -177.303 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 123.62 -17.61 7.77 Favored Glycine 0 N--CA 1.416 -2.664 0 CA-C-N 115.432 -0.803 . . . . 63.140000000000001 111.791 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -104.32 -169.73 1.67 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 120.133 -0.627 . . . . 63.439999999999998 110.941 -176.16 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -136.97 136.11 38.25 Favored 'General case' 0 C--O 1.25 1.123 0 CA-C-O 121.829 0.823 . . . . 75.120000000000005 112.141 -171.382 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 74.4 mt -110.29 130.59 63.29 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 C-N-CA 125.418 1.487 . . . . 64.109999999999999 107.926 -179.034 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.528 ' OE1' ' HG2' ' A' ' 114' ' ' ARG . 52.0 mt-30 -109.74 133.46 53.11 Favored 'General case' 0 C--N 1.29 -2.02 0 C-N-CA 120.347 -0.541 . . . . 72.329999999999998 110.713 -178.522 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.528 HD13 ' H ' ' A' ' 130' ' ' ILE . 0.2 OUTLIER -107.44 97.71 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.963 0 N-CA-C 106.783 -1.562 . . . . 53.32 106.783 171.859 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.463 ' HA3' ' OD1' ' A' ' 108' ' ' ASN . . . 70.78 -115.25 5.77 Favored Glycine 0 N--CA 1.427 -1.95 0 N-CA-C 108.81 -1.716 . . . . 41.219999999999999 108.81 -170.71 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -112.3 2.31 16.48 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.074 0.464 . . . . 52.240000000000002 110.689 176.028 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -85.78 140.19 30.68 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 106.402 -1.703 . . . . 72.329999999999998 106.402 177.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.524 ' HG3' ' HB2' ' A' ' 52' ' ' LYS . 15.3 ptm180 -116.75 131.63 56.9 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.043 -1.063 . . . . 74.540000000000006 113.856 -168.224 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.488 HD21 HD12 ' A' ' 49' ' ' LEU . 34.3 tp -122.58 121.5 36.63 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 114.032 -1.44 . . . . 74.420000000000002 108.715 -177.784 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 10.7 p -106.66 137.54 36.75 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.15 0 N-CA-C 108.863 -0.791 . . . . 74.319999999999993 108.863 -178.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -114.33 115.67 27.74 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 110.293 -0.262 . . . . 70.010000000000005 110.293 -173.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -121.47 163.62 18.5 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 109.065 -0.717 . . . . 74.329999999999998 109.065 -178.343 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -75.3 147.03 40.53 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 109.461 -0.57 . . . . 61.310000000000002 109.461 177.571 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.509 ' N ' ' HA ' ' A' ' 47' ' ' ALA . . . -104.39 -149.88 20.22 Favored Glycine 0 N--CA 1.426 -2.013 0 C-N-CA 120.551 -0.833 . . . . 72.010000000000005 111.403 -176.237 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo . . . . . 0 N--CA 1.427 -2.391 0 C-N-CA 122.529 2.152 . . . . 62.509999999999998 112.693 179.505 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 58.6 t30 . . . . . 0 C--O 1.237 0.439 0 N-CA-C 109.816 -0.438 . . . . 71.109999999999999 109.816 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -56.63 100.03 0.1 Allowed Glycine 0 CA--C 1.506 -0.484 0 O-C-N 123.679 0.612 . . . . 64.120000000000005 112.965 -178.364 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.7 m -119.05 130.95 24.56 Favored Pre-proline 0 C--N 1.304 -1.375 0 N-CA-C 109.438 -0.579 . . . . 75.040000000000006 109.438 -176.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.91 127.38 16.85 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 121.667 1.578 . . . . 72.209999999999994 110.13 175.212 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -97.12 113.99 63.98 Favored Pre-proline 0 C--N 1.301 -1.518 0 N-CA-C 109.053 -0.721 . . . . 72.129999999999995 109.053 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -62.26 136.32 59.29 Favored 'Trans proline' 0 C--O 1.237 0.457 0 C-N-CA 123.342 2.694 . . . . 74.329999999999998 113.867 -173.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.0 tm0? -126.95 109.26 11.75 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 107.145 -1.428 . . . . 70.140000000000001 107.145 178.084 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.7 p -94.14 132.91 36.9 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 109.297 -0.631 . . . . 70.219999999999999 109.297 178.497 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -114.43 139.25 49.66 Favored 'General case' 0 N--CA 1.424 -1.727 0 N-CA-C 109.083 -0.71 . . . . 74.340000000000003 109.083 -178.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.0 m -100.86 118.41 36.87 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.735 -0.839 . . . . 74.129999999999995 108.735 -177.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 40.0 p -116.17 103.83 10.92 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 121.352 0.596 . . . . 73.109999999999999 111.843 -178.284 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.6 p -112.42 138.77 48.68 Favored 'General case' 0 N--CA 1.42 -1.932 0 N-CA-C 107.42 -1.326 . . . . 61.130000000000003 107.42 176.255 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.1 m . . . . . 0 C--N 1.3 -1.581 0 CA-C-O 121.372 0.606 . . . . 74.099999999999994 111.9 -177.7 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.376 0 N-CA-C 111.446 -0.662 . . . . 71.409999999999997 111.446 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.402 ' HB2' ' O ' ' A' ' 141' ' ' PRO . 15.5 m -112.32 153.82 26.64 Favored 'General case' 0 N--CA 1.424 -1.761 0 N-CA-C 108.707 -0.849 . . . . 75.140000000000001 108.707 177.298 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.439 ' O ' ' HG ' ' A' ' 62' ' ' LEU . . . -153.43 146.4 24.51 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 108.756 -0.831 . . . . 51.100000000000001 108.756 -178.062 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.43 ' HA ' ' HA ' ' A' ' 62' ' ' LEU . 2.4 pt? -130.23 160.12 34.8 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 109.484 -0.561 . . . . 72.120000000000005 109.484 -178.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.423 HD11 ' CZ ' ' A' ' 61' ' ' PHE . 3.7 pp -133.93 147.77 51.12 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 116.349 -0.387 . . . . 64.430000000000007 110.672 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.555 HG12 ' HB3' ' A' ' 60' ' ' ARG . 27.9 m -117.03 129.24 73.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 108.961 -0.755 . . . . 53.219999999999999 108.961 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.5 t -97.79 118.79 44.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 N-CA-C 107.754 -1.202 . . . . 45.130000000000003 107.754 176.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -110.81 -13.56 14.13 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.827 -0.624 . . . . 74.340000000000003 112.626 -173.044 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 16.6 tpp180 -150.1 125.94 10.45 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.86 -0.793 . . . . 71.129999999999995 108.86 176.388 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 139.9 135.76 3.28 Favored Glycine 0 C--O 1.206 -1.622 0 C-N-CA 120.722 -0.751 . . . . 54.539999999999999 112.472 176.595 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.543 ' HD2' ' CE1' ' A' ' 133' ' ' PHE . 39.2 Cg_exo -67.71 -8.66 23.06 Favored 'Trans proline' 0 N--CA 1.484 0.939 0 C-N-CA 123.134 2.556 . . . . 75.430000000000007 112.951 174.355 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -66.02 -40.13 90.81 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.203 -0.453 . . . . 73.540000000000006 110.667 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -169.26 173.56 6.61 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 109.252 -0.647 . . . . 63.310000000000002 109.252 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.93 43.61 0.41 Allowed Glycine 0 CA--C 1.487 -1.707 0 N-CA-C 108.997 -1.641 . . . . 44.200000000000003 108.997 178.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -147.15 -173.18 4.18 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.722 -0.844 . . . . 70.329999999999998 108.722 -174.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.555 ' HB3' HG12 ' A' ' 50' ' ' VAL . 14.1 ptt180 -121.69 141.48 51.11 Favored 'General case' 0 N--CA 1.434 -1.233 0 O-C-N 123.687 0.617 . . . . 73.409999999999997 110.116 179.251 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.423 ' CZ ' HD11 ' A' ' 49' ' ' LEU . 52.6 p90 -149.39 152.45 35.77 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 109.042 -0.725 . . . . 74.099999999999994 109.042 175.632 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 47' ' ' ALA . 9.2 tt -99.43 140.51 33.51 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 123.622 0.576 . . . . 63.229999999999997 109.621 -176.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 84.3 mt -81.13 114.26 19.85 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 121.279 0.562 . . . . 62.399999999999999 110.955 -176.447 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -122.25 -36.78 2.91 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.253 -1.017 . . . . 74.129999999999995 108.253 174.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.5 pm0 -64.46 130.18 94.54 Favored Pre-proline 0 N--CA 1.436 -1.148 0 CA-C-N 114.965 -1.016 . . . . 74.219999999999999 110.031 175.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.504 ' HA ' HG12 ' A' ' 94' ' ' ILE . 19.5 Cg_endo -60.47 -30.64 91.22 Favored 'Trans proline' 0 N--CA 1.479 0.663 0 C-N-CA 123.846 3.031 . . . . 75.120000000000005 113.477 -173.572 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 90.0 m -135.92 116.14 13.47 Favored 'General case' 0 N--CA 1.416 -2.158 0 CA-C-N 115.929 -0.578 . . . . 75.219999999999999 109.801 178.385 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.481 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 11.9 m -100.65 115.36 30.02 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 106.717 -1.586 . . . . 72.420000000000002 106.717 176.322 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.7 p -96.82 108.8 21.54 Favored 'General case' 0 N--CA 1.425 -1.679 0 CA-C-O 121.414 0.626 . . . . 72.430000000000007 112.169 -176.039 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.416 ' O ' ' HB3' ' A' ' 89' ' ' HIS . . . -102.32 92.55 4.76 Favored 'General case' 0 N--CA 1.425 -1.71 0 N-CA-C 107.836 -1.172 . . . . 71.540000000000006 107.836 174.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.587 ' O ' ' HA ' ' A' ' 88' ' ' ARG . . . 99.97 102.01 2.42 Favored Glycine 0 N--CA 1.428 -1.871 0 N-CA-C 110.5 -1.04 . . . . 42.100000000000001 110.5 -178.19 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.3 mmt85 -155.14 -61.1 0.11 Allowed 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 124.866 1.266 . . . . 72.420000000000002 108.488 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.465 ' HB3' ' HD2' ' A' ' 74' ' ' PRO . 94.4 m-70 -146.2 177.21 1.85 Allowed Pre-proline 0 C--N 1.295 -1.786 0 N-CA-C 106.751 -1.574 . . . . 63.420000000000002 106.751 -178.202 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 73' ' ' HIS . 6.3 Cg_endo -54.24 -30.69 62.97 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 121.88 1.72 . . . . 74.439999999999998 110.508 170.243 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -107.79 72.58 0.86 Allowed 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 115.16 -0.927 . . . . 63.140000000000001 109.678 178.055 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.444 ' HB2' ' O ' ' A' ' 78' ' ' ILE . 41.5 m -91.01 -174.82 4.13 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.502 -1.296 . . . . 64.120000000000005 107.502 173.604 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -60.9 -44.33 97.29 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 108.32 -0.992 . . . . 72.340000000000003 108.32 177.032 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.444 ' O ' ' HB2' ' A' ' 76' ' ' SER . 36.8 pt -128.02 143.59 40.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 105.582 -2.007 . . . . 63.210000000000001 105.582 170.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -99.48 126.45 45.41 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 118.568 -1.253 . . . . 75.219999999999999 112.113 -175.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.5 mp -85.46 89.6 7.74 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 106.361 -1.718 . . . . 74.310000000000002 106.361 175.195 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -45.27 -58.73 3.07 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.552 -1.204 . . . . 74.010000000000005 113.542 -173.618 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -162.84 -167.05 1.42 Allowed 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 106.69 -1.596 . . . . 54.219999999999999 106.69 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 83.2 t 74.3 -41.95 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.246 1.418 . . . . 72.349999999999994 112.58 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.541 ' HB ' ' CZ ' ' A' ' 133' ' ' PHE . 56.6 m -154.04 71.96 0.87 Allowed 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.358 0.599 . . . . 54.109999999999999 110.331 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.3 p -114.45 109.03 27.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 O-C-N 121.617 -0.677 . . . . 75.420000000000002 112.401 176.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 36.0 t -97.74 170.29 9.09 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.699 -0.852 . . . . 73.430000000000007 108.699 174.439 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 60.0 ttt180 -78.39 -8.23 58.23 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 122.952 1.358 . . . . 72.299999999999997 109.381 -179.49 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.587 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -170.61 125.65 0.72 Allowed 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 104.154 -2.536 . . . . 72.150000000000006 104.154 173.047 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.416 ' HB3' ' O ' ' A' ' 70' ' ' ALA . 11.7 t60 -128.46 -76.97 0.56 Allowed 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 118.939 -1.105 . . . . 74.519999999999996 112.914 -172.585 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -127.7 119.26 25.44 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-O 121.272 0.558 . . . . 72.129999999999995 109.605 -176.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -114.03 128.01 56.2 Favored 'General case' 0 C--N 1.276 -2.594 0 C-N-CA 120.02 -0.672 . . . . 62.219999999999999 110.439 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.481 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 56.2 m-85 -97.41 121.21 39.05 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 107.991 -1.114 . . . . 65.409999999999997 107.991 -178.571 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 34.3 mmt-85 -104.91 129.13 53.36 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.437 -0.949 . . . . 71.219999999999999 108.437 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.504 HG12 ' HA ' ' A' ' 66' ' ' PRO . 11.4 pt -115.88 130.96 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.201 0 C-N-CA 118.504 -1.279 . . . . 72.030000000000001 108.022 173.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.437 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 56.0 t-20 -120.03 145.47 46.79 Favored 'General case' 0 C--N 1.269 -2.93 0 N-CA-C 106.547 -1.649 . . . . 74.109999999999999 106.547 -175.732 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -59.7 -20.27 55.26 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-O 121.357 0.598 . . . . 64.530000000000001 110.267 174.04 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -77.61 -61.81 2.52 Favored Glycine 0 N--CA 1.423 -2.172 0 CA-C-N 115.488 -0.778 . . . . 63.549999999999997 111.604 174.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.437 ' O ' ' HB3' ' A' ' 95' ' ' ASN . 27.3 tt0 -157.4 -178.11 7.1 Favored 'General case' 0 CA--C 1.552 1.023 0 CA-C-N 117.475 0.637 . . . . 74.0 109.346 -176.48 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.638 ' HB3' ' SD ' ' A' ' 122' ' ' MET . 81.5 m-85 -109.71 130.05 55.55 Favored 'General case' 0 C--N 1.311 -1.091 0 O-C-N 121.963 -0.46 . . . . 72.099999999999994 110.52 -176.183 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -132.53 135.84 46.23 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-O 120.633 0.254 . . . . 74.400000000000006 111.464 -175.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 8.9 p -114.56 129.62 70.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 O-C-N 121.845 -0.534 . . . . 33.32 110.073 176.499 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 59.4 t -118.92 128.97 75.72 Favored 'Isoleucine or valine' 0 C--O 1.248 0.98 0 CA-C-N 116.313 -0.403 . . . . 75.25 111.321 -177.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -83.95 117.96 23.7 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.637 -0.71 . . . . 62.219999999999999 109.215 173.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.423 ' O ' ' HG2' ' A' ' 88' ' ' ARG . 17.8 m -118.2 8.0 6.9 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.35 0 N-CA-C 108.258 -1.016 . . . . 73.239999999999995 108.258 176.02 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.448 ' HA2' ' O ' ' A' ' 88' ' ' ARG . . . -91.2 -66.15 1.16 Allowed Glycine 0 N--CA 1.404 -3.446 0 CA-C-N 114.578 -1.192 . . . . 63.340000000000003 111.091 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 14.0 m 60.07 1.46 0.34 Allowed 'General case' 0 CA--C 1.566 1.573 0 C-N-CA 124.252 1.021 . . . . 62.409999999999997 112.282 -179.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 49.1 tp -72.98 -50.82 21.01 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.099 0.959 . . . . 70.310000000000002 109.656 -177.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -99.23 -35.44 9.97 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.114 -0.948 . . . . 64.230000000000004 109.397 176.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 104.05 133.84 7.98 Favored Glycine 0 N--CA 1.427 -1.964 0 N-CA-C 110.584 -1.006 . . . . 33.32 110.584 -178.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 97.7 m -101.87 119.62 39.08 Favored 'General case' 0 C--N 1.281 -2.374 0 N-CA-C 108.847 -0.797 . . . . 75.099999999999994 108.847 178.464 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 116' ' ' PRO . 3.9 m-85 -111.32 132.48 54.36 Favored 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 106.487 -1.671 . . . . 73.510000000000005 106.487 -177.229 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.471 HG11 ' HG3' ' A' ' 120' ' ' GLN . 7.7 p -131.16 131.92 63.51 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.776 0 C-N-CA 119.953 -0.699 . . . . 73.140000000000001 110.696 178.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 66.56 -72.46 0.08 Allowed 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 125.506 1.523 . . . . 73.010000000000005 110.841 -177.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 114' ' ' ARG . 6.7 tpt180 -154.59 4.26 0.24 Allowed 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.902 -0.59 . . . . 61.109999999999999 109.489 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.432 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . 43.8 mt-10 -132.98 134.72 24.78 Favored Pre-proline 0 C--O 1.237 0.43 0 O-C-N 121.319 -0.863 . . . . 64.400000000000006 112.487 -174.491 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 115' ' ' GLU . 2.9 Cg_exo -77.23 116.01 4.07 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 122.332 2.021 . . . . 52.240000000000002 108.702 170.144 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.45 HH11 ' HG3' ' A' ' 120' ' ' GLN . 7.0 ptp180 -144.06 151.41 39.61 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.112 -1.07 . . . . 74.239999999999995 108.112 -178.299 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -76.22 -42.19 46.86 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 112.529 0.566 . . . . 74.349999999999994 112.529 -174.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -125.84 140.61 52.52 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 109.331 -0.618 . . . . 75.540000000000006 109.331 179.217 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.471 ' HG3' HG11 ' A' ' 112' ' ' VAL . 1.6 tm0? -138.94 149.85 45.23 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 116.41 -0.359 . . . . 71.420000000000002 110.561 -178.34 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 81.1 t -104.5 117.68 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 N-CA-C 105.743 -1.947 . . . . 75.319999999999993 105.743 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.638 ' SD ' ' HB3' ' A' ' 99' ' ' PHE . 66.7 mtt -59.86 128.67 38.04 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 113.87 1.063 . . . . 65.120000000000005 113.87 -169.285 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -112.07 137.73 49.71 Favored 'General case' 0 N--CA 1.418 -2.044 0 N-CA-C 107.079 -1.452 . . . . 74.329999999999998 107.079 178.07 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.489 ' HB ' ' HB3' ' A' ' 139' ' ' ALA . 1.8 t -79.37 129.76 34.78 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-O 121.368 0.604 . . . . 60.420000000000002 110.826 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 83.79 38.21 10.79 Favored Glycine 0 N--CA 1.424 -2.118 0 N-CA-C 110.014 -1.234 . . . . 71.109999999999999 110.014 -178.486 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -125.25 166.81 15.82 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.722 -0.391 . . . . 73.349999999999994 110.985 -177.286 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 19.1 tp10 -107.47 120.56 42.51 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 123.405 0.682 . . . . 75.030000000000001 109.181 -172.295 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 61.6 mt -114.96 117.6 56.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 108.006 -1.109 . . . . 72.019999999999996 108.006 179.023 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -116.49 111.8 20.49 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.255 0.55 . . . . 73.209999999999994 109.787 -175.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.413 HG13 ' HB2' ' A' ' 133' ' ' PHE . 25.6 pt -101.71 98.36 6.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-O 121.83 0.824 . . . . 74.239999999999995 109.384 179.055 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 70.36 -100.09 0.78 Allowed Glycine 0 N--CA 1.435 -1.386 0 N-CA-C 110.384 -1.087 . . . . 63.32 110.384 -175.574 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -115.18 0.35 13.53 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 120.938 0.399 . . . . 75.019999999999996 110.603 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.543 ' CE1' ' HD2' ' A' ' 55' ' ' PRO . 9.7 m-30 -93.27 141.15 28.76 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.035 -0.728 . . . . 72.510000000000005 109.035 -176.708 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 41.0 mtm180 -121.81 122.55 39.73 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.889 0.852 . . . . 74.329999999999998 111.193 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.8 tt -124.72 131.1 53.48 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 113.744 -1.571 . . . . 70.200000000000003 108.77 -176.492 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 57.5 t -108.09 128.41 63.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 108.697 -0.853 . . . . 73.120000000000005 108.697 178.424 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -100.78 130.05 46.75 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.953 -0.567 . . . . 73.230000000000004 110.438 -176.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.4 mp -130.66 130.45 43.93 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.692 -0.484 . . . . 74.120000000000005 109.692 179.13 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.489 ' HB3' ' HB ' ' A' ' 124' ' ' THR . . . -122.38 117.67 26.6 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 108.07 -1.085 . . . . 73.209999999999994 108.07 177.37 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -174.04 -60.11 0.05 OUTLIER Glycine 0 C--N 1.294 -1.786 0 C-N-CA 120.125 -1.036 . . . . 73.319999999999993 112.673 -176.625 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.402 ' O ' ' HB2' ' A' ' 46' ' ' SER . 33.2 Cg_exo . . . . . 0 C--N 1.358 1.045 0 C-N-CA 121.917 1.744 . . . . 63.299999999999997 110.895 176.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 . . . . . 0 CA--C 1.493 -1.221 0 N-CA-C 107.277 -1.379 . . . . 74.0 107.277 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 93.11 45.65 3.51 Favored Glycine 0 N--CA 1.431 -1.682 0 N-CA-C 109.631 -1.388 . . . . 73.049999999999997 109.631 -175.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 55.9 m -92.28 122.91 63.86 Favored Pre-proline 0 N--CA 1.416 -2.141 0 N-CA-C 107.833 -1.173 . . . . 73.510000000000005 107.833 178.324 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.56 128.95 19.02 Favored 'Trans proline' 0 N--CA 1.448 -1.205 0 C-N-CA 122.211 1.941 . . . . 71.030000000000001 111.272 177.485 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -73.67 109.73 7.32 Favored Pre-proline 0 C--N 1.315 -0.9 0 N-CA-C 107.168 -1.419 . . . . 71.019999999999996 107.168 173.406 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -73.24 132.84 18.48 Favored 'Trans proline' 0 N--CA 1.443 -1.465 0 C-N-CA 122.186 1.924 . . . . 73.439999999999998 113.016 -171.263 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 23.8 pt20 -110.27 116.73 32.0 Favored 'General case' 0 N--CA 1.422 -1.837 0 CA-C-N 115.573 -0.74 . . . . 64.340000000000003 109.323 175.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.9 p -86.01 88.84 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.519 0 CA-C-O 122.542 1.163 . . . . 72.439999999999998 110.062 178.064 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -125.52 120.35 30.66 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 106.667 -1.605 . . . . 55.409999999999997 106.667 178.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.5 m -113.4 98.98 7.43 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-O 121.321 0.581 . . . . 60.450000000000003 111.281 -175.596 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.5 m -105.85 -11.58 16.18 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 122.557 1.17 . . . . 74.150000000000006 108.459 175.014 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.2 t -83.26 91.83 7.36 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 114.218 -1.355 . . . . 74.519999999999996 108.24 176.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 59.8 t . . . . . 0 C--N 1.311 -1.087 0 N-CA-C 107.721 -1.215 . . . . 65.430000000000007 107.721 -178.502 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.257 0 N-CA-C 110.473 -1.051 . . . . 70.450000000000003 110.473 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.9 m -132.83 158.11 43.33 Favored 'General case' 0 N--CA 1.426 -1.635 0 N-CA-C 109.312 -0.625 . . . . 74.530000000000001 109.312 179.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -162.31 167.45 23.84 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.013 -1.477 . . . . 55.43 107.013 -177.122 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.405 HD22 ' HD3' ' A' ' 141' ' ' PRO . 2.1 pt? -134.55 158.26 44.43 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 109.231 -0.655 . . . . 72.0 109.231 178.314 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.422 ' HB2' HD21 ' A' ' 135' ' ' LEU . 4.4 pp -114.45 136.49 52.95 Favored 'General case' 0 N--CA 1.412 -2.337 0 N-CA-C 108.179 -1.045 . . . . 62.119999999999997 108.179 175.225 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 60.8 t -121.67 124.99 72.83 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.397 0 N-CA-C 107.895 -1.15 . . . . 74.310000000000002 107.895 -179.061 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.415 HG11 ' OD1' ' A' ' 56' ' ' ASN . 42.0 t -92.65 115.57 31.82 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 N-CA-C 107.446 -1.316 . . . . 61.149999999999999 107.446 177.671 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -85.12 -36.57 21.03 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-N 114.491 -1.231 . . . . 65.340000000000003 110.513 -174.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.459 ' O ' ' HB3' ' A' ' 133' ' ' PHE . 16.1 tpp180 -155.3 121.33 5.14 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 120.143 -0.623 . . . . 75.340000000000003 110.906 -178.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.421 ' HA2' ' CD1' ' A' ' 133' ' ' PHE . . . 162.08 141.97 3.27 Favored Glycine 0 C--O 1.194 -2.361 0 O-C-N 124.038 0.837 . . . . 55.049999999999997 111.102 176.017 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.434 ' HB2' ' OD2' ' A' ' 81' ' ' ASP . 17.0 Cg_exo -68.64 -10.07 27.99 Favored 'Trans proline' 0 N--CA 1.477 0.527 0 C-N-CA 122.45 2.1 . . . . 54.210000000000001 111.603 177.582 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.493 ' HB3' ' H ' ' A' ' 81' ' ' ASP . 4.4 p30 -59.35 -53.88 53.2 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 115.134 -0.939 . . . . 71.310000000000002 109.775 175.665 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -164.29 174.49 11.06 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-N 115.809 -0.632 . . . . 64.239999999999995 109.471 -179.378 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -163.45 54.36 0.29 Allowed Glycine 0 C--N 1.289 -2.083 0 N-CA-C 108.531 -1.828 . . . . 62.25 108.531 179.287 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -150.04 178.42 8.96 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 108.184 -1.043 . . . . 64.439999999999998 108.184 -175.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -102.36 137.81 40.11 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 108.147 -1.057 . . . . 63.409999999999997 108.147 179.151 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -132.43 129.89 39.87 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.095 -0.706 . . . . 72.310000000000002 109.095 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 52.4 tp -88.88 128.05 35.66 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 116.34 -0.391 . . . . 75.219999999999999 110.897 -176.027 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -77.73 115.47 17.51 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 108.267 -1.012 . . . . 63.210000000000001 108.267 176.033 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -143.14 -53.09 0.38 Allowed 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 115.029 -0.987 . . . . 72.510000000000005 109.348 -177.355 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.416 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 25.4 tt0 -69.63 121.31 82.01 Favored Pre-proline 0 C--N 1.312 -1.061 0 N-CA-C 108.505 -0.924 . . . . 72.129999999999995 108.505 177.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 65' ' ' GLN . 1.0 OUTLIER -42.07 -51.37 4.74 Favored 'Trans proline' 0 C--N 1.372 1.795 0 C-N-CA 124.745 3.63 . . . . 61.130000000000003 113.958 -173.997 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.5 m -102.97 99.88 9.8 Favored 'General case' 0 N--CA 1.415 -2.205 0 CA-C-N 116.144 -0.48 . . . . 54.25 109.844 179.163 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.447 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 86.2 m -98.14 114.05 26.13 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.422 -1.325 . . . . 72.209999999999994 107.422 175.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.7 m -105.58 133.92 49.54 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 112.925 0.713 . . . . 53.450000000000003 112.925 -171.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -108.63 117.5 34.34 Favored 'General case' 0 C--O 1.253 1.243 0 N-CA-C 108.386 -0.968 . . . . 64.109999999999999 108.386 175.056 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -158.68 -179.83 33.82 Favored Glycine 0 N--CA 1.438 -1.209 0 C-N-CA 120.158 -1.02 . . . . 62.109999999999999 111.188 -177.069 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.6 ttp180 -90.21 8.5 32.75 Favored 'General case' 0 CA--C 1.553 1.064 0 CA-C-O 121.949 0.881 . . . . 43.100000000000001 110.089 -176.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 60.8 m-70 -88.94 146.54 36.84 Favored Pre-proline 0 C--N 1.298 -1.64 0 N-CA-C 108.805 -0.813 . . . . 72.299999999999997 108.805 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -66.83 -28.73 42.8 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 121.729 1.619 . . . . 72.099999999999994 109.534 174.001 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -90.69 65.57 5.94 Favored 'General case' 0 N--CA 1.423 -1.819 0 CA-C-N 114.385 -1.28 . . . . 74.310000000000002 109.236 177.539 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.6 p -121.35 -174.76 2.92 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 106.066 -1.828 . . . . 71.450000000000003 106.066 175.082 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -100.67 -41.09 7.06 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 119.374 -0.931 . . . . 75.150000000000006 108.956 178.087 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 41.7 pt -114.78 150.58 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.618 0 N-CA-C 106.99 -1.485 . . . . 71.430000000000007 106.99 170.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -87.51 136.18 33.05 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 109.441 -0.577 . . . . 62.240000000000002 109.441 -179.384 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.462 ' HA ' ' HB2' ' A' ' 56' ' ' ASN . 50.4 tp -125.26 122.7 37.7 Favored 'General case' 0 N--CA 1.413 -2.319 0 CA-C-O 121.832 0.825 . . . . 74.099999999999994 111.043 -175.613 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.493 ' H ' ' HB3' ' A' ' 56' ' ' ASN . 33.9 t70 -142.59 108.5 5.17 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 114.561 -1.2 . . . . 71.540000000000006 108.304 176.078 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -137.04 161.84 34.96 Favored 'General case' 0 C--N 1.264 -3.137 0 CA-C-N 113.116 -1.856 . . . . 71.510000000000005 107.934 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.7 m -80.43 -15.46 12.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-O 121.441 0.639 . . . . 72.530000000000001 112.095 -177.09 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.505 ' OG1' ' HB3' ' A' ' 108' ' ' ASN . 3.1 p -128.54 45.73 2.73 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 122.261 1.029 . . . . 53.140000000000001 108.5 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.8 p -81.21 139.68 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 CA-C-N 113.672 -1.604 . . . . 62.439999999999998 110.789 -173.507 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 24.4 t -101.28 163.09 12.45 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 107.26 -1.385 . . . . 55.210000000000001 107.26 177.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 26.4 ttm180 -60.91 -43.3 98.73 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 108.946 -0.761 . . . . 70.329999999999998 108.946 179.196 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.495 ' HD3' ' H ' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -123.0 133.23 54.37 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 105.434 -2.061 . . . . 74.230000000000004 105.434 175.522 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 21.1 t60 -113.19 -68.63 0.92 Allowed 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.232 -0.987 . . . . 74.209999999999994 111.273 -174.089 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.37 153.65 40.75 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 116.295 -0.412 . . . . 74.409999999999997 109.889 -176.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -117.59 127.34 53.87 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 108.299 -1.0 . . . . 62.030000000000001 108.299 178.695 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.447 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 93.5 m-85 -100.51 115.58 30.45 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 107.744 -1.206 . . . . 72.049999999999997 107.744 178.833 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 61.9 mtp85 -106.85 123.13 47.71 Favored 'General case' 0 C--N 1.285 -2.238 0 N-CA-C 108.566 -0.902 . . . . 74.150000000000006 108.566 -176.37 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.3 tp -115.67 116.08 51.31 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 CA-C-O 121.639 0.733 . . . . 73.340000000000003 109.91 -176.465 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -118.71 143.81 46.64 Favored 'General case' 0 N--CA 1.41 -2.455 0 N-CA-C 103.986 -2.598 . . . . 63.32 103.986 175.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -70.91 -9.33 57.57 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 121.235 0.54 . . . . 73.150000000000006 111.658 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -80.86 -55.7 3.27 Favored Glycine 0 N--CA 1.433 -1.56 0 N-CA-C 111.025 -0.83 . . . . 51.219999999999999 111.025 171.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -148.89 166.24 29.13 Favored 'General case' 0 C--N 1.348 0.526 0 C-N-CA 122.801 0.44 . . . . 62.420000000000002 110.479 -178.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.531 ' HB2' ' HB2' ' A' ' 122' ' ' MET . 8.0 m-85 -111.03 128.74 55.96 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.947 -1.131 . . . . 72.030000000000001 107.947 -175.483 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -130.23 136.16 48.91 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.524 0.202 . . . . 71.510000000000005 110.89 -173.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.4 p -125.74 126.83 70.78 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-O 121.04 0.447 . . . . 71.140000000000001 110.165 175.655 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 51.9 t -119.21 133.41 66.14 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 CA-C-N 115.781 -0.645 . . . . 64.439999999999998 109.826 -178.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -82.9 131.53 35.19 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 107.18 -1.415 . . . . 54.109999999999999 107.18 173.032 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.402 HG23 ' HG2' ' A' ' 88' ' ' ARG . 17.4 m -111.97 20.22 6.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-O 121.086 0.469 . . . . 74.420000000000002 112.152 -177.388 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 120.06 54.85 0.25 Allowed Glycine 0 N--CA 1.433 -1.563 0 C-N-CA 119.981 -1.104 . . . . 61.329999999999998 114.367 174.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 77.7 p -78.86 145.77 34.02 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 117.253 0.526 . . . . 72.409999999999997 109.819 177.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 98.1 mt -80.19 -31.2 38.79 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 121.514 0.673 . . . . 63.539999999999999 109.931 178.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.505 ' HB3' ' OG1' ' A' ' 84' ' ' THR . 23.4 p30 -85.29 -24.52 27.68 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.01 -0.996 . . . . 63.210000000000001 112.841 -177.757 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 88.5 105.57 1.0 Allowed Glycine 0 N--CA 1.433 -1.502 0 C-N-CA 120.865 -0.683 . . . . 64.049999999999997 111.763 -179.059 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.6 m -75.63 123.94 26.38 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.794 -0.817 . . . . 73.409999999999997 108.794 176.004 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -136.97 153.71 50.62 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 109.796 -0.446 . . . . 71.25 109.796 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 31.1 t -98.07 142.63 14.18 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.006 0 N-CA-C 106.526 -1.657 . . . . 63.439999999999998 106.526 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 33.6 p-10 -55.21 -25.21 31.62 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 112.573 0.583 . . . . 73.319999999999993 112.573 -175.351 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 33.5 mtm105 -100.9 -32.51 10.62 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.369 -0.378 . . . . 71.239999999999995 111.809 177.556 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -130.65 125.29 21.41 Favored Pre-proline 0 C--N 1.316 -0.848 0 C-N-CA 121.078 -0.249 . . . . 63.149999999999999 111.589 -169.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.15 39.47 0.73 Allowed 'Trans proline' 0 CA--C 1.554 1.507 0 C-N-CA 122.838 2.359 . . . . 74.219999999999999 112.043 178.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.431 ' HB3' ' O ' ' A' ' 119' ' ' ALA . 31.1 mmt180 -90.51 131.33 36.31 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 123.537 0.735 . . . . 72.510000000000005 110.262 -177.491 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -78.64 -38.61 39.24 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.141 0.496 . . . . 43.240000000000002 110.021 174.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.431 ' O ' ' HB3' ' A' ' 117' ' ' ARG . . . -105.47 137.93 42.49 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 105.398 -2.075 . . . . 31.23 105.398 170.297 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -139.47 140.22 37.21 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-O 121.256 0.551 . . . . 51.119999999999997 111.932 -172.341 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 48.1 t -85.61 118.27 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 104.846 -2.279 . . . . 64.450000000000003 104.846 169.367 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.531 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 12.6 mmt -58.26 150.04 22.78 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 114.506 1.299 . . . . 63.240000000000002 114.506 -173.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -125.67 129.53 49.75 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 105.09 -2.189 . . . . 72.420000000000002 105.09 172.11 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 45.9 p -83.07 123.57 29.61 Favored 'General case' 0 C--N 1.283 -2.297 0 C-N-CA 121.002 -0.279 . . . . 75.109999999999999 110.676 -174.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 92.4 38.55 5.59 Favored Glycine 0 CA--C 1.497 -1.071 0 N-CA-C 109.528 -1.429 . . . . 75.25 109.528 -175.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -139.56 170.35 16.07 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 107.437 -1.32 . . . . 54.32 107.437 -176.149 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -140.52 139.75 35.13 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 122.285 1.04 . . . . 73.129999999999995 113.261 -174.413 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 60.0 mt -112.33 131.63 63.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-N 114.417 -1.265 . . . . 64.310000000000002 109.987 -175.247 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -93.76 112.53 24.42 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-O 121.843 0.83 . . . . 72.099999999999994 110.257 -178.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.9 pt -95.34 98.54 8.03 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 N-CA-C 107.641 -1.244 . . . . 71.099999999999994 107.641 176.286 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 76.06 -98.95 1.24 Allowed Glycine 0 N--CA 1.428 -1.885 0 N-CA-C 110.476 -1.05 . . . . 73.129999999999995 110.476 -176.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -127.64 10.19 6.59 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.197 0.523 . . . . 71.409999999999997 109.839 178.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.459 ' HB3' ' O ' ' A' ' 53' ' ' ARG . 57.4 m-85 -119.92 157.17 29.33 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.952 -0.567 . . . . 72.230000000000004 109.697 -175.404 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 20.1 ptp180 -125.77 131.33 52.52 Favored 'General case' 0 C--O 1.256 1.398 0 N-CA-C 114.087 1.143 . . . . 71.420000000000002 114.087 -170.436 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.422 HD21 ' HB2' ' A' ' 49' ' ' LEU . 6.5 tt -114.71 134.35 55.16 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 114.072 -1.422 . . . . 75.340000000000003 108.213 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 38.2 t -107.54 139.14 30.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 108.824 -0.806 . . . . 73.430000000000007 108.824 -176.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -115.84 126.3 53.8 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 109.883 -0.414 . . . . 75.140000000000001 109.883 -179.049 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 66.5 mt -132.69 137.57 46.97 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.63 -0.259 . . . . 71.099999999999994 110.749 -177.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -103.31 41.1 1.3 Allowed 'General case' 0 N--CA 1.482 1.141 0 CA-C-O 122.142 0.972 . . . . 62.119999999999997 108.719 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -75.81 -50.09 8.24 Favored Glycine 0 C--N 1.294 -1.759 0 CA-C-N 113.834 -1.53 . . . . 73.129999999999995 116.19 -174.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.405 ' HD3' HD22 ' A' ' 48' ' ' LEU . 5.8 Cg_exo . . . . . 0 C--N 1.368 1.588 0 CA-C-N 120.214 2.007 . . . . 73.319999999999993 115.407 -170.278 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 . . . . . 0 CA--C 1.492 -1.251 0 N-CA-C 106.878 -1.527 . . . . 73.230000000000004 106.878 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -89.4 166.28 33.13 Favored Glycine 0 N--CA 1.429 -1.792 0 C-N-CA 119.766 -1.207 . . . . 72.209999999999994 110.398 178.501 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.2 p -84.65 133.32 44.3 Favored Pre-proline 0 N--CA 1.421 -1.907 0 N-CA-C 109.165 -0.68 . . . . 70.129999999999995 109.165 177.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -66.2 127.49 17.63 Favored 'Trans proline' 0 N--CA 1.448 -1.157 0 N-CA-C 107.923 -1.607 . . . . 61.039999999999999 107.923 174.427 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -95.89 118.08 66.03 Favored Pre-proline 0 C--N 1.288 -2.07 0 N-CA-C 112.926 0.713 . . . . 75.040000000000006 112.926 -174.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -66.13 140.58 60.05 Favored 'Trans proline' 0 C--O 1.245 0.862 0 C-N-CA 122.644 2.23 . . . . 62.25 108.948 173.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -149.23 98.69 2.84 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-O 122.075 0.94 . . . . 62.130000000000003 109.161 -176.587 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 49.2 t -69.4 118.24 13.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 114.06 -1.427 . . . . 74.209999999999994 112.259 -172.488 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -95.7 135.96 36.71 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 107.308 -1.367 . . . . 73.120000000000005 107.308 173.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.5 t -152.17 151.92 31.63 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-O 121.302 0.573 . . . . 73.439999999999998 110.756 -175.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.8 m -122.13 81.52 1.84 Allowed 'General case' 0 N--CA 1.41 -2.458 0 N-CA-C 107.805 -1.183 . . . . 73.109999999999999 107.805 173.575 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.7 m -82.36 99.33 9.32 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 115.551 -0.75 . . . . 61.140000000000001 109.224 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.9 p . . . . . 0 C--N 1.304 -1.374 0 N-CA-C 108.659 -0.867 . . . . 71.439999999999998 108.659 -179.713 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.002 0 N-CA-C 110.409 -1.076 . . . . 70.219999999999999 110.409 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 18.8 m -134.07 166.82 21.85 Favored 'General case' 0 N--CA 1.419 -2.016 0 N-CA-C 108.761 -0.829 . . . . 73.120000000000005 108.761 -179.402 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.518 ' HB3' ' CZ ' ' A' ' 137' ' ' PHE . . . -151.15 -170.9 3.79 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 107.939 -1.134 . . . . 41.409999999999997 107.939 178.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.412 ' H ' HD13 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -123.22 152.25 41.47 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 120.366 -0.533 . . . . 72.420000000000002 111.399 -176.991 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.441 ' HB2' HD21 ' A' ' 135' ' ' LEU . 2.0 pp -127.78 145.01 51.06 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 115.555 -0.748 . . . . 72.549999999999997 110.922 178.566 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.3 m -131.28 142.34 43.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 109.394 -0.595 . . . . 61.219999999999999 109.394 178.335 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.508 HG21 ' HB3' ' A' ' 57' ' ' ALA . 76.5 t -93.82 115.93 33.83 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 N-CA-C 107.878 -1.156 . . . . 74.209999999999994 107.878 176.802 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.5 tmtm? -82.16 -38.81 24.13 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.756 -0.831 . . . . 40.020000000000003 108.756 -175.167 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.446 ' O ' ' HB3' ' A' ' 133' ' ' PHE . 13.8 tpp180 -142.41 117.3 9.92 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 108.181 -1.044 . . . . 72.140000000000001 108.181 -178.105 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 148.42 125.18 1.46 Allowed Glycine 0 N--CA 1.427 -1.955 0 C-N-CA 119.784 -1.198 . . . . 72.420000000000002 114.057 177.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -67.54 -8.92 23.67 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 123.768 2.979 . . . . 71.329999999999998 110.509 174.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.575 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 2.1 m-20 -51.18 -26.5 6.95 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 126.852 2.061 . . . . 72.129999999999995 111.215 177.241 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.508 ' HB3' HG21 ' A' ' 51' ' ' VAL . . . -166.88 -62.16 0.03 OUTLIER 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 123.45 0.7 . . . . 73.120000000000005 109.403 176.269 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 61.3 44.82 97.59 Favored Glycine 0 C--N 1.336 0.557 0 CA-C-N 115.741 -0.663 . . . . 45.420000000000002 111.85 -179.096 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -151.62 -171.68 4.0 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 108.927 -0.768 . . . . 74.430000000000007 108.927 -176.097 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.8 ptt180 -119.93 138.51 53.4 Favored 'General case' 0 C--N 1.312 -1.064 0 O-C-N 124.002 0.814 . . . . 62.43 109.221 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -138.54 129.43 26.68 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-O 120.896 0.379 . . . . 73.430000000000007 110.807 179.357 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 65.3 tp -91.45 129.59 37.41 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 107.505 -1.294 . . . . 74.450000000000003 107.505 176.482 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 79.7 mt -72.16 120.15 17.35 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 113.018 0.748 . . . . 72.099999999999994 113.018 -176.693 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -146.29 -39.99 0.21 Allowed 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.884 -1.053 . . . . 73.349999999999994 110.56 175.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -61.28 113.89 9.26 Favored Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 123.888 0.875 . . . . 74.409999999999997 110.297 173.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.566 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 8.4 Cg_endo -53.8 -41.31 75.51 Favored 'Trans proline' 0 C--N 1.361 1.185 0 C-N-CA 122.983 2.455 . . . . 71.0 113.253 -175.752 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 50.2 m -119.82 105.89 11.55 Favored 'General case' 0 N--CA 1.423 -1.8 0 CA-C-O 121.21 0.528 . . . . 72.030000000000001 109.79 178.076 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.485 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 40.1 m -107.01 113.8 27.5 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 107.259 -1.386 . . . . 61.539999999999999 107.259 174.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.4 p -98.04 133.64 42.23 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 116.002 -0.544 . . . . 71.040000000000006 112.369 -175.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -115.21 120.29 39.22 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 115.574 -0.739 . . . . 72.519999999999996 109.135 176.311 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.428 ' HA2' ' CG2' ' A' ' 85' ' ' VAL . . . 167.63 -160.44 34.05 Favored Glycine 0 N--CA 1.422 -2.254 0 N-CA-C 110.051 -1.22 . . . . 73.5 110.051 178.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.49 ' O ' ' HG2' ' A' ' 87' ' ' ARG . 18.6 tpt180 -132.42 89.56 2.67 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 109.445 -0.576 . . . . 62.219999999999999 109.445 174.449 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.559 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 23.4 p-80 -161.59 165.76 15.93 Favored Pre-proline 0 C--N 1.304 -1.402 0 N-CA-C 107.686 -1.227 . . . . 63.520000000000003 107.686 177.779 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.559 ' HD2' ' HB2' ' A' ' 73' ' ' HIS . 3.1 Cg_endo -47.89 -35.44 24.61 Favored 'Trans proline' 0 C--N 1.359 1.101 0 C-N-CA 123.317 2.678 . . . . 72.329999999999998 115.7 -175.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -99.33 14.6 29.06 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 119.237 -0.985 . . . . 62.030000000000001 113.52 -175.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 24.0 m -73.2 133.24 43.96 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.635 -0.506 . . . . 75.340000000000003 109.635 176.083 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -80.19 -56.02 4.51 Favored 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 108.441 -0.948 . . . . 72.310000000000002 108.441 176.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 32.4 pt -97.69 134.46 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 N-CA-C 109.117 -0.697 . . . . 44.530000000000001 109.117 177.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -104.42 116.87 32.88 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 121.764 0.792 . . . . 73.030000000000001 110.529 -177.415 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.575 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 7.0 mp -82.02 106.53 14.01 Favored 'General case' 0 N--CA 1.422 -1.831 0 CA-C-N 114.817 -1.083 . . . . 74.519999999999996 111.09 -177.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -85.0 69.49 10.82 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 122.432 1.111 . . . . 75.340000000000003 109.743 176.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -148.62 164.26 34.82 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 113.94 -1.482 . . . . 70.319999999999993 108.279 176.257 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.1 p -94.69 -6.65 10.15 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-O 121.083 0.468 . . . . 63.32 111.516 -176.356 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.7 m -91.96 13.45 18.58 Favored 'General case' 0 CA--C 1.548 0.899 0 O-C-N 121.491 -0.755 . . . . 74.430000000000007 110.267 -177.574 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.428 ' CG2' ' HA2' ' A' ' 71' ' ' GLY . 10.6 p -102.77 133.11 47.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-O 121.258 0.551 . . . . 70.340000000000003 111.312 -178.269 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 18.3 m -102.05 169.95 8.42 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 108.94 -0.763 . . . . 51.420000000000002 108.94 176.622 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.49 ' HG2' ' O ' ' A' ' 72' ' ' ARG . 63.1 mtm180 -75.27 134.7 41.04 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 106.674 -1.602 . . . . 72.540000000000006 106.674 173.667 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.497 ' H ' ' CE1' ' A' ' 73' ' ' HIS 0.36 0.0 OUTLIER 50.38 71.76 0.39 Allowed 'General case' 0 C--O 1.22 -0.497 0 CA-C-O 122.654 1.216 . . . . 74.340000000000003 111.096 -171.507 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.453 ' HA ' ' HA3' ' A' ' 105' ' ' GLY . 11.4 t60 -95.39 -60.14 1.73 Allowed 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 113.828 -1.533 . . . . 72.209999999999994 109.846 -173.366 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -130.94 127.47 38.52 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 109.215 -0.661 . . . . 63.240000000000002 109.215 -179.146 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -109.75 127.19 54.46 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 109.049 -0.723 . . . . 72.540000000000006 109.049 177.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.485 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 97.5 m-85 -104.09 112.62 25.69 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 107.651 -1.241 . . . . 74.140000000000001 107.651 177.552 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 27.5 mtp85 -108.48 113.59 26.74 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 115.368 -0.833 . . . . 75.420000000000002 109.072 -177.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.566 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -128.48 124.22 61.38 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.522 0 CA-C-O 122.085 0.945 . . . . 64.120000000000005 110.077 -177.778 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -110.52 147.71 33.6 Favored 'General case' 0 C--N 1.269 -2.906 0 N-CA-C 106.765 -1.568 . . . . 63.409999999999997 106.765 177.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -42.42 -26.57 0.12 Allowed 'General case' 0 CA--C 1.56 1.354 0 N-CA-C 114.234 1.198 . . . . 73.219999999999999 114.234 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -128.77 23.85 4.96 Favored Glycine 0 N--CA 1.437 -1.249 0 C-N-CA 120.617 -0.802 . . . . 13.23 113.513 179.047 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -165.44 144.25 6.32 Favored 'General case' 0 C--O 1.213 -0.868 0 CA-C-N 117.852 0.826 . . . . 73.040000000000006 110.84 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.479 ' HB2' ' SD ' ' A' ' 122' ' ' MET . 1.3 p90 -132.15 115.83 16.23 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-O 121.873 0.844 . . . . 72.109999999999999 112.085 -177.621 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -129.9 135.24 48.12 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.468 -0.787 . . . . 64.430000000000007 111.559 -172.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.6 p -116.5 128.38 73.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 109.561 -0.533 . . . . 73.040000000000006 109.561 178.323 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 58.6 t -118.82 130.61 73.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-N 116.325 -0.398 . . . . 62.32 110.943 -175.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -101.31 115.24 30.04 Favored 'General case' 0 CA--C 1.496 -1.127 0 CA-C-O 121.074 0.464 . . . . 75.439999999999998 109.802 176.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 88' ' ' ARG . 5.3 m -122.42 -1.64 7.22 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 CA-C-O 121.671 0.748 . . . . 61.329999999999998 111.459 178.233 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.453 ' HA3' ' HA ' ' A' ' 89' ' ' HIS . . . -100.22 39.83 2.62 Favored Glycine 0 N--CA 1.429 -1.771 0 N-CA-C 109.401 -1.48 . . . . 54.439999999999998 109.401 176.849 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 11.4 m -63.45 4.52 0.23 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.042 1.737 . . . . 54.340000000000003 113.479 -176.011 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -68.95 -41.09 78.48 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 106.693 -1.595 . . . . 71.400000000000006 106.693 171.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -110.18 -41.19 4.49 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.071 -1.422 . . . . 70.120000000000005 108.355 177.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 92.65 131.53 5.67 Favored Glycine 0 N--CA 1.438 -1.202 0 N-CA-C 115.71 1.044 . . . . 74.200000000000003 115.71 173.106 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 18.6 m -94.65 135.59 35.94 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 105.941 -1.874 . . . . 70.329999999999998 105.941 169.132 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -117.69 134.42 54.92 Favored 'General case' 0 C--N 1.294 -1.833 0 C-N-CA 120.013 -0.675 . . . . 70.230000000000004 109.659 -177.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.474 HG23 ' HB2' ' A' ' 115' ' ' GLU . 22.3 m -100.43 110.56 27.75 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.935 0 N-CA-C 106.973 -1.491 . . . . 73.409999999999997 106.973 172.263 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 66.96 -79.72 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 125.843 1.657 . . . . 44.25 108.944 -171.053 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 51.9 mtp180 -148.11 13.8 1.0 Allowed 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 124.652 1.181 . . . . 73.129999999999995 109.147 176.694 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.474 ' HB2' HG23 ' A' ' 112' ' ' VAL . 32.4 mm-40 -102.51 113.74 65.72 Favored Pre-proline 0 N--CA 1.439 -1.005 0 CA-C-N 115.327 -0.851 . . . . 71.219999999999999 110.39 -175.544 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -84.26 94.8 0.72 Allowed 'Trans proline' 0 N--CA 1.446 -1.283 0 C-N-CA 122.444 2.096 . . . . 70.310000000000002 109.182 173.179 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -121.28 146.22 47.05 Favored 'General case' 0 CA--C 1.502 -0.885 0 CA-C-N 116.397 -0.365 . . . . 72.329999999999998 111.191 -174.622 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -66.05 -42.22 89.79 Favored 'General case' 0 C--N 1.319 -0.719 0 O-C-N 124.145 0.903 . . . . 73.109999999999999 110.73 -177.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -149.64 138.89 21.34 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 108.363 -0.977 . . . . 32.32 108.363 175.089 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.468 ' HG2' HG21 ' A' ' 112' ' ' VAL . 6.0 tp60 -140.98 150.49 43.15 Favored 'General case' 0 C--N 1.292 -1.935 0 C-N-CA 122.821 0.448 . . . . 75.349999999999994 110.117 -179.436 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 64.1 t -79.82 134.03 28.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 105.508 -2.034 . . . . 70.120000000000005 105.508 173.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.479 ' SD ' ' HB2' ' A' ' 99' ' ' PHE . 64.7 mtt -61.0 126.33 26.97 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 109.61 -0.515 . . . . 63.450000000000003 109.61 -176.72 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -104.95 130.35 53.15 Favored 'General case' 0 N--CA 1.418 -2.061 0 CA-C-O 121.346 0.594 . . . . 55.229999999999997 110.098 -178.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 18.6 p -78.3 131.9 37.24 Favored 'General case' 0 N--CA 1.416 -2.167 0 CA-C-N 114.782 -1.099 . . . . 74.140000000000001 109.479 -177.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 85.0 22.88 51.4 Favored Glycine 0 N--CA 1.431 -1.671 0 N-CA-C 110.647 -0.981 . . . . 74.5 110.647 179.328 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -123.61 171.16 9.76 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 120.165 -0.614 . . . . 71.0 109.749 -178.33 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -118.84 121.42 39.99 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 123.412 0.685 . . . . 74.439999999999998 110.393 -170.455 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 64.1 mt -106.15 118.2 53.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 N-CA-C 109.614 -0.513 . . . . 74.420000000000002 109.614 -178.523 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -95.14 114.17 25.94 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 109.455 -0.572 . . . . 74.430000000000007 109.455 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 9.8 pt -99.9 97.58 6.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 CA-C-O 122.215 1.007 . . . . 73.400000000000006 109.101 178.35 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 73.15 -87.35 0.58 Allowed Glycine 0 N--CA 1.435 -1.42 0 CA-C-N 114.498 -1.228 . . . . 43.25 111.088 -177.295 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -120.1 -33.03 4.03 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 120.974 0.416 . . . . 73.120000000000005 110.513 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.446 ' HB3' ' O ' ' A' ' 53' ' ' ARG . 77.9 m-85 -95.5 161.21 14.16 Favored 'General case' 0 CA--C 1.496 -1.125 0 CA-C-N 116.293 -0.412 . . . . 62.109999999999999 110.95 -173.109 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 27.9 ptt180 -131.42 141.5 49.85 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 114.155 1.168 . . . . 52.450000000000003 114.155 -171.595 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.441 HD21 ' HB2' ' A' ' 49' ' ' LEU . 3.4 tt -117.69 140.03 50.22 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 112.935 -1.939 . . . . 71.540000000000006 107.48 -177.63 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 7.7 p -115.93 131.56 68.02 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 CA-C-O 121.046 0.451 . . . . 74.239999999999995 109.787 179.198 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' PHE . . . . . 0.518 ' CZ ' ' HB3' ' A' ' 47' ' ' ALA . 71.4 t80 -102.91 119.0 38.07 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.53 -0.759 . . . . 74.340000000000003 109.057 -175.804 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.47 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 2.5 mm? -114.68 147.1 40.11 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 120.966 0.412 . . . . 64.109999999999999 111.282 -175.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -81.94 118.23 22.79 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 107.827 -1.175 . . . . 74.530000000000001 107.827 175.416 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -93.57 -135.92 7.74 Favored Glycine 0 N--CA 1.427 -1.913 0 C-N-CA 120.64 -0.791 . . . . 50.240000000000002 111.874 -177.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo . . . . . 0 N--CA 1.441 -1.617 0 C-N-CA 122.492 2.128 . . . . 61.310000000000002 112.305 179.691 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.6 t30 . . . . . 0 N--CA 1.437 -1.098 0 N-CA-C 108.647 -0.872 . . . . 62.140000000000001 108.647 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -143.69 108.98 0.53 Allowed Glycine 0 N--CA 1.428 -1.85 0 N-CA-C 109.892 -1.283 . . . . 65.409999999999997 109.892 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.401 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 8.7 t -94.07 125.01 54.36 Favored Pre-proline 0 C--N 1.301 -1.537 0 CA-C-O 120.801 0.334 . . . . 75.219999999999999 110.969 -177.215 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 7' ' ' THR . 22.7 Cg_exo -66.22 144.73 76.01 Favored 'Trans proline' 0 C--O 1.244 0.809 0 C-N-CA 122.22 1.947 . . . . 44.240000000000002 109.59 174.504 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -89.81 138.68 27.79 Favored Pre-proline 0 C--N 1.29 -2.011 0 C-N-CA 121.361 -0.136 . . . . 74.420000000000002 110.638 -177.128 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -74.64 103.78 1.77 Allowed 'Trans proline' 0 N--CA 1.44 -1.668 0 C-N-CA 121.24 1.293 . . . . 75.019999999999996 109.163 172.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -92.94 119.65 32.45 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 115.373 -0.831 . . . . 55.219999999999999 111.513 -174.658 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.9 p -88.64 136.86 22.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 CA-C-N 115.812 -0.631 . . . . 63.420000000000002 109.449 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -77.53 134.92 38.18 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 108.542 -0.91 . . . . 61.210000000000001 108.542 178.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.8 m -134.1 71.55 1.46 Allowed 'General case' 0 C--N 1.294 -1.829 0 CA-C-O 121.396 0.617 . . . . 53.310000000000002 110.241 -178.527 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.8 t 167.43 137.11 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 126.596 1.958 . . . . 73.430000000000007 106.638 176.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 53.4 m -152.16 37.22 0.55 Allowed 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 108.069 -1.086 . . . . 75.200000000000003 108.069 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.8 t . . . . . 0 N--CA 1.438 -1.072 0 CA-C-N 114.554 -1.203 . . . . 72.120000000000005 108.424 178.75 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.413 -2.835 0 N-CA-C 109.333 -1.507 . . . . 63.509999999999998 109.333 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.8 m -100.17 164.49 11.94 Favored 'General case' 0 C--N 1.279 -2.494 0 N-CA-C 108.815 -0.809 . . . . 74.310000000000002 108.815 178.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -124.64 132.88 53.39 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.751 -0.463 . . . . 61.350000000000001 109.751 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.436 HD23 ' H ' ' A' ' 48' ' ' LEU . 2.1 pt? -115.81 140.79 48.88 Favored 'General case' 0 C--N 1.29 -2.008 0 C-N-CA 120.312 -0.555 . . . . 75.5 110.837 179.02 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.427 ' O ' HD12 ' A' ' 49' ' ' LEU . 3.1 pp -120.39 140.01 51.96 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 115.542 -0.753 . . . . 74.230000000000004 110.352 178.371 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.401 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 47.4 t -117.75 126.51 74.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 108.581 -0.896 . . . . 64.519999999999996 108.581 179.403 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 53.2 t -93.1 115.56 32.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 108.942 -0.762 . . . . 64.099999999999994 108.942 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.42 ' HB2' ' HG3' ' A' ' 134' ' ' ARG . 72.7 mmtt -82.56 -46.31 13.52 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.38 -0.97 . . . . 72.5 108.38 176.449 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -147.84 149.1 31.67 Favored 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 106.968 -1.494 . . . . 75.030000000000001 106.968 179.223 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 144.99 145.67 4.34 Favored Glycine 0 N--CA 1.425 -2.045 0 N-CA-C 110.527 -1.029 . . . . 54.409999999999997 110.527 -178.284 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.502 ' HB2' ' H ' ' A' ' 82' ' ' ASP . 13.8 Cg_exo -67.93 -9.18 24.81 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.419 2.746 . . . . 71.319999999999993 113.359 -177.355 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.502 ' HB2' ' HA ' ' A' ' 80' ' ' LEU . 5.6 t-20 -42.87 -60.3 1.65 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.098 0.959 . . . . 75.540000000000006 111.451 175.356 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 174.37 -64.19 0.01 OUTLIER 'General case' 0 CA--C 1.504 -0.827 0 C-N-CA 124.814 1.245 . . . . 74.409999999999997 107.991 -178.033 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 116.83 52.91 0.34 Allowed Glycine 0 N--CA 1.441 -0.969 0 N-CA-C 110.023 -1.231 . . . . 62.299999999999997 110.023 -176.558 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -139.9 -174.3 3.87 Favored 'General case' 0 N--CA 1.434 -1.275 0 N-CA-C 108.881 -0.785 . . . . 71.129999999999995 108.881 -176.003 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 34.9 ptt180 -122.05 134.65 54.78 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.486 -0.931 . . . . 55.25 108.486 177.565 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -127.13 139.5 52.93 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 109.85 -0.426 . . . . 72.439999999999998 109.85 -177.291 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 58.3 tp -101.98 112.05 24.54 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 108.22 -1.03 . . . . 65.430000000000007 108.22 178.248 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -94.68 116.75 29.12 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.324 0.583 . . . . 54.140000000000001 110.469 -176.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -121.81 8.24 9.96 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.448 -1.315 . . . . 75.530000000000001 107.448 176.287 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.4 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 2.9 pt20 -93.05 115.96 65.77 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 114.139 -1.391 . . . . 71.439999999999998 109.684 178.304 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 65' ' ' GLN . 7.1 Cg_endo -50.52 -43.56 44.32 Favored 'Trans proline' 0 C--N 1.361 1.215 0 C-N-CA 123.541 2.827 . . . . 73.450000000000003 113.917 -174.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 31.9 m -106.85 102.77 12.11 Favored 'General case' 0 N--CA 1.423 -1.812 0 N-CA-C 109.63 -0.508 . . . . 74.120000000000005 109.63 177.461 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.419 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 79.4 m -108.79 114.05 27.5 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 107.444 -1.317 . . . . 74.129999999999995 107.444 176.567 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 14.5 t -117.61 128.79 55.28 Favored 'General case' 0 C--N 1.296 -1.761 0 C-N-CA 119.221 -0.992 . . . . 71.219999999999999 110.693 -175.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.508 ' HA ' ' O ' ' A' ' 78' ' ' ILE . . . -115.08 106.44 14.12 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 115.504 -0.771 . . . . 44.009999999999998 109.576 -176.211 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.46 73.11 1.28 Allowed Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 109.314 -1.515 . . . . 75.129999999999995 109.314 -175.079 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.531 ' HA ' ' O ' ' A' ' 87' ' ' ARG . 1.1 tmm_? -145.07 85.55 1.75 Allowed 'General case' 0 N--CA 1.423 -1.805 0 N-CA-C 107.294 -1.372 . . . . 73.409999999999997 107.294 -178.421 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.568 ' CG ' ' HD2' ' A' ' 74' ' ' PRO . 1.3 t-80 68.3 170.71 0.1 Allowed Pre-proline 0 CA--C 1.575 1.935 0 O-C-N 124.545 1.153 . . . . 74.5 109.075 177.439 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.568 ' HD2' ' CG ' ' A' ' 73' ' ' HIS . 96.3 Cg_exo -48.38 -39.63 35.83 Favored 'Trans proline' 0 C--N 1.369 1.645 0 C-N-CA 121.981 1.787 . . . . 55.32 112.789 175.322 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.9 pm0 -92.07 58.27 3.3 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 122.202 1.001 . . . . 73.409999999999997 111.636 178.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 66.2 m -65.28 150.47 48.19 Favored 'General case' 0 C--O 1.244 0.783 0 CA-C-N 115.143 -0.935 . . . . 75.420000000000002 108.997 175.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -68.97 -45.2 71.29 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 107.434 -1.321 . . . . 71.150000000000006 107.434 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.508 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 46.1 pt -139.97 143.82 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 N-CA-C 108.135 -1.061 . . . . 74.140000000000001 108.135 171.498 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -102.47 130.8 49.38 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 119.251 -0.98 . . . . 63.310000000000002 108.403 172.516 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.502 ' HA ' ' HB2' ' A' ' 56' ' ' ASN . 30.8 tp -108.53 -26.15 10.57 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-O 122.552 1.168 . . . . 74.540000000000006 109.786 -174.11 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -138.23 134.09 34.0 Favored 'General case' 0 C--N 1.266 -3.022 0 N-CA-C 105.854 -1.906 . . . . 72.0 105.854 177.554 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.502 ' H ' ' HB2' ' A' ' 55' ' ' PRO . 33.1 t70 -117.79 -15.49 10.07 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 115.534 -0.757 . . . . 62.229999999999997 111.21 -177.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.4 m -91.3 -21.91 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.812 0 N-CA-C 108.087 -1.079 . . . . 73.120000000000005 108.087 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 22.4 m -138.34 83.51 1.97 Allowed 'General case' 0 N--CA 1.414 -2.24 0 CA-C-N 114.56 -1.2 . . . . 72.239999999999995 108.375 174.613 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.8 p -112.16 139.88 34.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 108.48 -0.933 . . . . 65.129999999999995 108.48 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 15.5 m -124.44 168.83 12.52 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 109.582 -0.525 . . . . 62.200000000000003 109.582 -177.682 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.531 ' O ' ' HA ' ' A' ' 72' ' ' ARG . 20.5 mtp180 -68.56 -31.59 70.91 Favored 'General case' 0 C--O 1.212 -0.897 0 CA-C-O 121.042 0.449 . . . . 71.510000000000005 110.074 175.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.412 ' HG2' HG21 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -143.82 101.7 3.79 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 106.277 -1.749 . . . . 73.120000000000005 106.277 170.781 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.515 ' O ' HG22 ' A' ' 104' ' ' VAL . 19.0 t60 -98.74 -71.7 0.68 Allowed 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 114.466 -1.243 . . . . 75.030000000000001 111.075 -174.343 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -144.75 160.69 40.83 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 107.738 -1.208 . . . . 73.400000000000006 107.738 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -146.19 139.46 25.89 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.907 -0.717 . . . . 74.420000000000002 110.262 -177.531 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.419 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 78.1 m-85 -115.61 123.0 47.32 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.898 -0.778 . . . . 73.510000000000005 108.898 -177.839 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 52.8 mtm-85 -107.8 123.65 48.89 Favored 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 107.831 -1.174 . . . . 72.349999999999994 107.831 176.605 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.3 pp -115.42 116.08 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.128 0 C-N-CA 118.684 -1.207 . . . . 72.120000000000005 108.38 177.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.546 ' ND2' ' HG2' ' A' ' 96' ' ' GLU . 4.9 t30 -120.09 147.05 45.34 Favored 'General case' 0 C--N 1.28 -2.424 0 CA-C-N 114.121 -1.399 . . . . 61.539999999999999 107.55 -179.582 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.546 ' HG2' ' ND2' ' A' ' 95' ' ' ASN . 8.8 pt-20 -29.12 -36.6 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 126.898 2.079 . . . . 72.239999999999995 115.908 -177.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -131.95 3.04 5.24 Favored Glycine 0 CA--C 1.504 -0.6 0 C-N-CA 119.387 -1.387 . . . . 45.340000000000003 113.28 -175.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -148.05 118.2 7.28 Favored 'General case' 0 N--CA 1.411 -2.399 0 CA-C-O 122.401 1.096 . . . . 72.510000000000005 111.098 -177.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.509 ' HD1' ' SD ' ' A' ' 122' ' ' MET . 71.0 m-85 -107.09 115.83 30.86 Favored 'General case' 0 C--N 1.275 -2.663 0 CA-C-N 114.423 -1.262 . . . . 73.549999999999997 107.62 -179.432 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -110.18 135.92 50.2 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 113.612 0.967 . . . . 53.119999999999997 113.612 -173.273 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.5 p -116.33 117.64 56.15 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.116 0 CA-C-N 114.377 -1.283 . . . . 75.140000000000001 107.709 173.525 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 39.7 t -120.86 125.36 73.96 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 CA-C-N 115.831 -0.622 . . . . 73.519999999999996 110.768 -177.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.459 ' HB2' ' HB ' ' A' ' 110' ' ' THR . 18.0 t0 -92.45 115.46 28.11 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 102.333 -3.21 . . . . 74.019999999999996 102.333 168.407 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 89' ' ' HIS . 19.2 m -59.67 -23.35 25.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 113.278 0.844 . . . . 73.439999999999998 113.278 -169.165 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -152.76 16.06 0.72 Allowed Glycine 0 C--N 1.305 -1.176 0 C-N-CA 117.8 -2.143 . . . . 74.420000000000002 113.796 178.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 50.3 m 57.17 36.6 27.7 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 122.824 1.297 . . . . 34.329999999999998 107.514 -175.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 49.5 tp -73.66 -47.43 39.93 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 112.828 -1.987 . . . . 74.340000000000003 112.761 -168.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -107.4 -11.52 15.51 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 119.2 -1.0 . . . . 70.420000000000002 109.791 179.487 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 97.5 65.12 0.89 Allowed Glycine 0 N--CA 1.433 -1.53 0 C-N-CA 120.413 -0.899 . . . . 61.32 113.247 173.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.459 ' HB ' ' HB2' ' A' ' 103' ' ' ASP . 18.9 m -85.24 119.66 25.87 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.683 -0.858 . . . . 64.200000000000003 108.683 174.52 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.45 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 2.1 m-85 -116.91 140.87 48.95 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.419 -0.956 . . . . 64.239999999999995 108.419 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.5 p -99.58 116.46 42.81 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 N-CA-C 108.197 -1.038 . . . . 65.129999999999995 108.197 176.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 71.17 -73.53 0.1 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.131 0.972 . . . . 74.329999999999998 109.476 -175.309 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 48.5 ttp180 -161.3 14.37 0.1 Allowed 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 107.538 -1.282 . . . . 72.0 107.538 172.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.446 ' HG3' ' HE ' ' A' ' 117' ' ' ARG . 15.3 tp10 -102.27 116.36 63.13 Favored Pre-proline 0 N--CA 1.429 -1.479 0 CA-C-N 115.513 -0.767 . . . . 72.109999999999999 108.94 -172.504 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -76.24 103.67 1.78 Allowed 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.85 2.367 . . . . 71.310000000000002 111.195 178.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.446 ' HE ' ' HG3' ' A' ' 115' ' ' GLU . 15.1 mmt180 -130.79 157.23 43.43 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 109.348 -0.612 . . . . 74.239999999999995 109.348 -179.153 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 50.8 m-20 -76.88 -42.57 39.37 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.487 -1.301 . . . . 63.439999999999998 107.487 178.635 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -147.87 146.04 28.92 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 114.561 -1.2 . . . . 73.209999999999994 108.886 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -138.58 138.17 37.67 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 108.545 -0.909 . . . . 74.25 108.545 178.526 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 39.0 t -94.82 95.46 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.527 0 C-N-CA 119.477 -0.889 . . . . 71.340000000000003 108.61 177.565 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.509 ' SD ' ' HD1' ' A' ' 99' ' ' PHE . 25.5 ptt? 44.56 139.02 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 119.087 2.995 . . . . 72.230000000000004 119.087 177.188 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -132.97 122.81 24.81 Favored 'General case' 0 N--CA 1.401 -2.92 1 N-CA-C 99.815 -4.143 . . . . 73.010000000000005 99.815 166.308 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 13.1 t -108.04 127.39 53.74 Favored 'General case' 0 C--N 1.288 -2.077 0 C-N-CA 118.606 -1.238 . . . . 54.229999999999997 112.034 -171.588 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 83.84 22.35 55.69 Favored Glycine 0 N--CA 1.424 -2.113 0 N-CA-C 109.993 -1.243 . . . . 64.0 109.993 -179.212 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -122.76 -175.88 3.26 Favored 'General case' 0 C--O 1.249 1.053 0 N-CA-C 108.36 -0.978 . . . . 72.510000000000005 108.36 -177.381 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.469 ' OE2' ' HD3' ' A' ' 134' ' ' ARG . 40.0 mt-10 -116.65 130.98 57.05 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 121.784 0.802 . . . . 72.150000000000006 111.492 -175.027 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 66.0 mt -100.47 126.43 54.07 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 N-CA-C 107.151 -1.426 . . . . 74.019999999999996 107.151 176.472 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.45 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 34.4 tt0 -93.43 112.65 24.61 Favored 'General case' 0 C--N 1.282 -2.334 0 N-CA-C 108.339 -0.986 . . . . 65.439999999999998 108.339 -178.281 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.52 HG13 ' HB2' ' A' ' 133' ' ' PHE . 19.2 pt -101.92 97.95 6.27 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.07 0 N-CA-C 108.747 -0.834 . . . . 72.420000000000002 108.747 179.374 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 70.13 -98.86 0.66 Allowed Glycine 0 N--CA 1.432 -1.575 0 N-CA-C 109.738 -1.345 . . . . 62.200000000000003 109.738 -176.226 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -122.71 5.08 9.48 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 120.707 0.289 . . . . 62.299999999999997 110.72 177.605 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.52 ' HB2' HG13 ' A' ' 130' ' ' ILE . 27.1 m-85 -104.72 171.38 7.35 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 108.784 -0.821 . . . . 72.340000000000003 108.784 -179.372 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.469 ' HD3' ' OE2' ' A' ' 127' ' ' GLU . 14.0 ptp180 -130.67 132.67 45.55 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.73 0.776 . . . . 70.420000000000002 112.057 -179.201 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.403 HD11 ' HB2' ' A' ' 49' ' ' LEU . 48.9 tp -117.48 143.46 46.02 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 114.167 -1.379 . . . . 74.540000000000006 107.411 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.401 ' HB ' ' HB ' ' A' ' 50' ' ' VAL . 34.2 t -106.72 129.95 59.41 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 N-CA-C 106.553 -1.647 . . . . 71.310000000000002 106.553 177.695 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' PHE . . . . . 0.401 ' CE2' ' HB2' ' A' ' 139' ' ' ALA . 70.8 t80 -121.64 119.89 33.17 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 120.964 0.411 . . . . 71.030000000000001 111.188 -174.09 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.4 mp -117.53 116.68 27.6 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 107.873 -1.158 . . . . 75.510000000000005 107.873 177.404 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.401 ' HB2' ' CE2' ' A' ' 137' ' ' PHE . . . -122.1 122.87 40.24 Favored 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 121.02 -0.272 . . . . 33.43 110.382 -175.792 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.483 ' N ' ' HD2' ' A' ' 141' ' ' PRO . . . 152.48 -52.72 0.48 Allowed Glycine 0 C--N 1.306 -1.095 0 C-N-CA 118.376 -1.868 . . . . 63.539999999999999 115.353 178.181 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.483 ' HD2' ' N ' ' A' ' 140' ' ' GLY . 5.2 Cg_endo . . . . . 0 C--N 1.374 1.904 0 C-N-CA 123.489 2.793 . . . . 65.540000000000006 114.672 -177.242 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.506 -0.732 0 N-CA-C 107.655 -1.239 . . . . 74.209999999999994 107.655 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -82.13 105.52 2.58 Favored Glycine 0 C--N 1.303 -1.292 0 N-CA-C 111.178 -0.769 . . . . 73.049999999999997 111.178 -177.614 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.5 t -83.18 135.32 44.66 Favored Pre-proline 0 C--N 1.302 -1.463 0 N-CA-C 109.035 -0.728 . . . . 64.439999999999998 109.035 -178.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -66.75 150.15 83.51 Favored 'Trans proline' 0 C--O 1.236 0.419 0 C-N-CA 122.574 2.182 . . . . 74.120000000000005 112.072 -178.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.412 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 0.7 OUTLIER -79.79 112.19 27.51 Favored Pre-proline 0 C--N 1.316 -0.885 0 N-CA-C 109.598 -0.519 . . . . 75.140000000000001 109.598 176.983 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 9' ' ' GLU . 16.5 Cg_exo -65.23 118.09 5.15 Favored 'Trans proline' 0 C--O 1.246 0.921 0 C-N-CA 122.465 2.11 . . . . 72.549999999999997 112.256 -175.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.476 ' HA ' ' OE1' ' A' ' 11' ' ' GLN . 5.0 tp60 -93.39 81.02 4.39 Favored 'General case' 0 N--CA 1.42 -1.95 0 CA-C-O 122.115 0.96 . . . . 74.239999999999995 109.814 177.59 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.4 t -104.53 120.05 54.33 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 N-CA-C 106.634 -1.617 . . . . 74.310000000000002 106.634 177.172 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.63 140.95 51.72 Favored 'General case' 0 N--CA 1.433 -1.317 0 CA-C-O 120.943 0.401 . . . . 74.420000000000002 111.044 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.7 m -113.2 88.28 2.8 Favored 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 109.217 -0.661 . . . . 65.409999999999997 109.217 -179.455 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 42.7 m -100.29 95.06 6.53 Favored 'General case' 0 N--CA 1.411 -2.406 0 N-CA-C 108.901 -0.777 . . . . 73.430000000000007 108.901 178.231 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.0 t -101.19 98.06 8.51 Favored 'General case' 0 N--CA 1.42 -1.946 0 N-CA-C 108.135 -1.061 . . . . 52.140000000000001 108.135 -178.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 23.5 t . . . . . 0 N--CA 1.429 -1.477 0 N-CA-C 109.162 -0.681 . . . . 51.039999999999999 109.162 -178.614 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.516 0 N-CA-C 112.186 -0.365 . . . . 74.430000000000007 112.186 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.446 ' HB2' ' O ' ' A' ' 141' ' ' PRO . 8.7 m -90.19 152.96 20.85 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 121.464 0.65 . . . . 64.239999999999995 109.5 -178.834 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -153.73 164.15 38.81 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.234 -1.025 . . . . 64.510000000000005 108.234 -177.085 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 62' ' ' LEU . 2.5 pt? -130.12 142.13 50.62 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.402 0.62 . . . . 73.400000000000006 111.471 -179.315 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.42 ' O ' HD12 ' A' ' 49' ' ' LEU . 4.2 pp -109.78 133.25 53.36 Favored 'General case' 0 N--CA 1.423 -1.825 0 N-CA-C 107.736 -1.209 . . . . 73.25 107.736 175.275 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 48.1 t -119.08 117.46 54.31 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 N-CA-C 109.69 -0.485 . . . . 65.109999999999999 109.69 -176.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 57.3 t -93.04 114.45 29.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 106.016 -1.846 . . . . 34.229999999999997 106.016 175.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -93.39 -33.11 13.99 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.389 -0.597 . . . . 74.150000000000006 109.389 -176.104 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.472 ' O ' ' HB3' ' A' ' 133' ' ' PHE . 60.5 mtt180 -138.53 123.19 18.63 Favored 'General case' 0 CA--C 1.487 -1.444 0 N-CA-C 108.559 -0.904 . . . . 74.319999999999993 108.559 177.757 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.4 ' HA2' ' CD1' ' A' ' 133' ' ' PHE . . . 146.98 116.33 0.94 Allowed Glycine 0 N--CA 1.415 -2.761 0 C-N-CA 120.911 -0.662 . . . . 71.329999999999998 112.525 179.638 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.4 ' HD2' ' HA2' ' A' ' 54' ' ' GLY . 11.9 Cg_endo -59.55 -9.22 8.54 Favored 'Trans proline' 0 C--N 1.37 1.689 0 C-N-CA 124.058 3.172 . . . . 71.5 112.269 176.651 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.428 ' HA ' ' N ' ' A' ' 81' ' ' ASP . 2.3 m-20 -45.99 -49.42 16.03 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 125.39 1.476 . . . . 74.140000000000001 108.901 172.428 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -149.37 -58.65 0.21 Allowed 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 115.407 -0.815 . . . . 63.210000000000001 109.54 -179.352 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.21 31.71 63.56 Favored Glycine 0 CA--C 1.507 -0.465 0 N-CA-C 110.099 -1.2 . . . . 73.310000000000002 110.099 -176.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -152.93 176.05 12.27 Favored 'General case' 0 N--CA 1.42 -1.952 0 N-CA-C 108.834 -0.802 . . . . 44.43 108.834 -175.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -109.17 153.44 23.76 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.888 -0.597 . . . . 74.430000000000007 109.557 177.392 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -143.64 134.24 24.96 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 108.141 -1.059 . . . . 73.549999999999997 108.141 -179.043 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 48' ' ' LEU . 0.8 OUTLIER -104.21 135.81 44.98 Favored 'General case' 0 N--CA 1.428 -1.539 0 CA-C-O 120.877 0.37 . . . . 73.430000000000007 110.571 178.146 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 81.6 mt -82.6 115.07 21.4 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.684 -0.689 . . . . 51.439999999999998 109.471 -178.027 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -126.63 9.18 7.05 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 107.582 -1.266 . . . . 73.150000000000006 107.582 176.282 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -131.19 147.51 66.54 Favored Pre-proline 0 C--N 1.295 -1.781 0 CA-C-N 113.571 -1.649 . . . . 64.019999999999996 107.621 -175.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -57.42 -53.52 4.6 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 122.759 2.306 . . . . 71.0 114.859 -175.106 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 85.0 m -131.67 109.78 10.44 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.224 0.535 . . . . 73.019999999999996 112.365 -177.002 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 41.4 m -98.55 118.07 34.42 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.309 -0.997 . . . . 72.540000000000006 108.309 175.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.501 ' OG1' ' HG2' ' A' ' 88' ' ' ARG . 12.5 t -102.59 147.79 26.35 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 119.308 -0.957 . . . . 74.239999999999995 110.697 179.561 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -108.1 132.67 53.34 Favored 'General case' 0 N--CA 1.424 -1.726 0 CA-C-N 115.437 -0.801 . . . . 63.229999999999997 109.509 179.192 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.543 ' O ' ' HA ' ' A' ' 79' ' ' PHE . . . -161.53 -146.05 4.51 Favored Glycine 0 N--CA 1.428 -1.852 0 N-CA-C 108.645 -1.782 . . . . 64.400000000000006 108.645 176.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 18.2 ttp85 -164.76 58.76 0.13 Allowed 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.166 -1.05 . . . . 74.450000000000003 108.166 173.227 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 70.1 m80 -139.38 165.24 33.11 Favored Pre-proline 0 C--N 1.279 -2.499 0 N-CA-C 106.738 -1.579 . . . . 64.040000000000006 106.738 179.201 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 99.5 Cg_exo -48.99 -33.43 26.16 Favored 'Trans proline' 0 C--N 1.358 1.055 0 C-N-CA 122.715 2.277 . . . . 65.010000000000005 112.556 177.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -106.71 74.39 1.0 Allowed 'General case' 0 N--CA 1.432 -1.347 0 CA-C-O 122.016 0.912 . . . . 61.039999999999999 109.855 176.106 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 37.7 m -146.1 123.42 11.6 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 113.957 -1.474 . . . . 34.039999999999999 108.159 174.6 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -65.21 -52.1 56.8 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-O 120.605 0.241 . . . . 75.349999999999994 110.83 -178.235 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 41.8 pt -123.61 178.78 3.15 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 109.627 -0.509 . . . . 65.140000000000001 109.627 175.237 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.543 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 97.2 m-85 -122.89 136.98 55.06 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 112.623 0.601 . . . . 75.010000000000005 112.623 -172.101 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -117.92 132.23 56.43 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.187 -1.412 . . . . 71.25 107.187 167.427 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.428 ' N ' ' HA ' ' A' ' 56' ' ' ASN . 38.1 t70 -127.98 70.21 1.34 Allowed 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 122.437 1.113 . . . . 52.439999999999998 109.439 -175.183 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -122.92 -163.56 1.11 Allowed 'General case' 0 C--N 1.284 -2.273 0 CA-C-N 113.668 -1.606 . . . . 72.310000000000002 108.542 176.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 44.7 t -65.27 -38.03 81.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 C-N-CA 123.389 0.676 . . . . 64.219999999999999 112.133 -176.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 26.2 m -121.95 93.5 4.01 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.868 0.842 . . . . 74.430000000000007 112.75 -175.468 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 6.0 p -111.63 128.89 67.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 CA-C-N 114.91 -1.041 . . . . 35.43 110.793 -178.193 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.423 ' HB2' ' HB2' ' A' ' 89' ' ' HIS . 8.9 m -112.64 -170.4 1.66 Allowed 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.232 -0.655 . . . . 65.310000000000002 109.232 178.179 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -78.98 -76.05 0.21 Allowed 'General case' 0 C--O 1.217 -0.609 0 N-CA-C 109.982 -0.377 . . . . 71.209999999999994 109.982 177.126 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.501 ' HG2' ' OG1' ' A' ' 69' ' ' THR . 1.5 tmm_? -101.48 82.58 2.32 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 105.386 -2.079 . . . . 52.229999999999997 105.386 174.521 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.423 ' HB2' ' HB2' ' A' ' 86' ' ' SER . 67.1 t60 -87.37 -70.76 0.6 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.219 -0.901 . . . . 75.420000000000002 112.49 -170.789 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -110.86 147.57 34.27 Favored 'General case' 0 CA--C 1.483 -1.631 0 N-CA-C 108.793 -0.818 . . . . 72.230000000000004 108.793 -177.216 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -128.3 127.81 43.44 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-O 121.201 0.524 . . . . 75.230000000000004 110.412 178.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.532 ' HD1' ' HE3' ' A' ' 122' ' ' MET . 83.7 m-85 -105.81 113.13 26.5 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 105.602 -1.999 . . . . 75.420000000000002 105.602 177.837 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 71.7 mtp180 -118.45 147.32 43.72 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 121.864 0.84 . . . . 71.400000000000006 112.961 -172.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.53 117.12 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.321 0 N-CA-C 103.428 -2.804 . . . . 73.319999999999993 103.428 170.368 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 32.1 t-20 -118.36 147.25 43.71 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 108.161 -1.052 . . . . 72.019999999999996 108.161 -173.577 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.63 -20.09 53.62 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 113.195 0.813 . . . . 64.140000000000001 113.195 -179.104 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -78.82 -49.86 6.27 Favored Glycine 0 N--CA 1.423 -2.18 0 N-CA-C 111.14 -0.784 . . . . 71.030000000000001 111.14 173.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.411 ' HG2' ' H ' ' A' ' 99' ' ' PHE . 28.6 tt0 -177.77 -172.94 0.37 Allowed 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 107.363 -1.347 . . . . 74.319999999999993 107.363 -177.253 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.445 ' CB ' ' HB3' ' A' ' 122' ' ' MET . 89.9 m-85 -89.84 138.68 31.28 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 118.919 0.781 . . . . 70.549999999999997 109.393 -178.581 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -131.9 135.19 46.46 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 116.274 -0.421 . . . . 74.299999999999997 110.431 -174.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.6 p -128.95 117.71 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 108.934 -0.765 . . . . 71.230000000000004 108.934 174.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 19.4 m -121.09 135.55 60.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 CA-C-N 115.307 -0.86 . . . . 74.0 112.051 -178.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -99.07 107.38 19.77 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 106.093 -1.817 . . . . 75.120000000000005 106.093 170.222 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.4 m -94.21 9.35 5.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-O 121.402 0.62 . . . . 72.049999999999997 111.224 -176.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -90.04 -42.41 5.32 Favored Glycine 0 N--CA 1.428 -1.844 0 N-CA-C 108.159 -1.976 . . . . 73.420000000000002 108.159 172.034 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 39.7 m 70.23 -37.82 0.39 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.739 2.016 . . . . 53.219999999999999 114.348 174.284 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -58.66 -42.51 88.6 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 123.111 0.564 . . . . 65.120000000000005 111.658 177.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -86.05 -52.09 5.92 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.894 -0.78 . . . . 72.329999999999998 108.894 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 77.31 103.28 0.17 Allowed Glycine 0 N--CA 1.434 -1.456 0 CA-C-N 115.33 -0.85 . . . . 70.400000000000006 114.545 177.181 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 89.3 m -76.21 120.01 20.91 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 106.414 -1.698 . . . . 61.200000000000003 106.414 169.506 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -114.3 171.98 7.29 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.883 0.849 . . . . 72.010000000000005 111.591 -171.618 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.44 ' HB ' ' HB2' ' A' ' 115' ' ' GLU . 21.9 t -98.53 142.74 14.19 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.122 0 N-CA-C 104.758 -2.312 . . . . 64.030000000000001 104.758 173.328 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -40.03 -36.84 0.52 Allowed 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 114.204 1.187 . . . . 71.239999999999995 114.204 -176.119 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -118.56 -13.0 9.7 Favored 'General case' 0 C--O 1.222 -0.387 0 N-CA-C 112.386 0.513 . . . . 74.340000000000003 112.386 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.44 ' HB2' ' HB ' ' A' ' 112' ' ' VAL . 64.0 mm-40 -114.43 107.42 51.28 Favored Pre-proline 0 C--N 1.315 -0.933 0 N-CA-C 111.892 0.33 . . . . 62.43 111.892 -178.045 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -83.65 101.35 0.92 Allowed 'Trans proline' 0 N--CA 1.44 -1.665 0 C-N-CA 122.4 2.067 . . . . 62.439999999999998 110.739 176.529 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.584 ' HD2' ' OE1' ' A' ' 120' ' ' GLN . 15.5 ptp180 -153.63 152.94 31.42 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.884 -1.154 . . . . 52.310000000000002 107.884 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -81.16 -26.96 35.64 Favored 'General case' 0 C--N 1.313 -1.022 0 N-CA-C 112.425 0.528 . . . . 61.039999999999999 112.425 -175.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -129.38 139.04 51.82 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 109.273 -0.64 . . . . 25.199999999999999 109.273 178.104 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.584 ' OE1' ' HD2' ' A' ' 117' ' ' ARG . 51.8 tp60 -140.45 149.48 42.62 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.491 -0.777 . . . . 64.400000000000006 109.925 -176.849 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.4 p -79.47 121.4 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 105.764 -1.939 . . . . 63.439999999999998 105.764 169.705 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.532 ' HE3' ' HD1' ' A' ' 92' ' ' PHE . 10.9 ttt -71.35 115.02 10.02 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 121.575 0.702 . . . . 75.129999999999995 109.159 -170.457 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 21.5 tp60 -104.76 135.13 46.71 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.254 -0.885 . . . . 74.420000000000002 108.776 -173.036 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.1 t -78.86 131.33 36.41 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-O 121.049 0.452 . . . . 52.119999999999997 110.256 178.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 89.14 24.76 30.84 Favored Glycine 0 N--CA 1.426 -2.012 0 N-CA-C 111.024 -0.83 . . . . 71.409999999999997 111.024 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -116.49 169.45 9.32 Favored 'General case' 0 C--O 1.251 1.139 0 N-CA-C 109.16 -0.682 . . . . 64.040000000000006 109.16 -178.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.424 ' CD ' ' HE ' ' A' ' 134' ' ' ARG . 13.7 tp10 -114.07 121.22 43.16 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.819 -1.178 . . . . 65.510000000000005 107.819 -174.401 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 65.2 mt -107.93 131.43 58.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 C-N-CA 123.93 0.892 . . . . 64.439999999999998 110.577 -175.143 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -101.13 111.87 24.2 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.803 -0.635 . . . . 61.43 109.296 -177.574 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 5.1 pt -103.1 98.14 6.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 CA-C-O 121.575 0.702 . . . . 62.25 109.808 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 71.88 -100.4 0.92 Allowed Glycine 0 N--CA 1.44 -1.088 0 N-CA-C 109.228 -1.549 . . . . 75.549999999999997 109.228 -174.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -124.41 5.7 8.36 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 108.953 -0.758 . . . . 74.219999999999999 108.953 175.342 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.472 ' HB3' ' O ' ' A' ' 53' ' ' ARG . 63.0 m-85 -103.19 173.54 6.26 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 115.408 -0.815 . . . . 71.349999999999994 110.563 -175.201 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.424 ' HE ' ' CD ' ' A' ' 127' ' ' GLU . 34.2 ttt180 -132.26 125.21 30.53 Favored 'General case' 0 C--O 1.255 1.365 0 C-N-CA 119.698 -0.801 . . . . 75.129999999999995 112.988 -165.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 5.9 tt -124.57 139.7 53.63 Favored 'General case' 0 C--O 1.21 -0.984 0 C-N-CA 124.792 1.237 . . . . 71.310000000000002 109.495 -178.211 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 8.6 t -109.95 136.39 46.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 107.088 -1.449 . . . . 75.25 107.088 176.485 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -115.06 126.8 55.12 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 120.195 -0.602 . . . . 71.549999999999997 110.983 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.0 mp -133.35 133.07 42.01 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.961 -0.385 . . . . 72.510000000000005 109.961 178.759 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -93.44 141.42 28.48 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 105.102 -2.184 . . . . 61.340000000000003 105.102 170.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 177.15 -52.44 0.1 Allowed Glycine 0 C--N 1.289 -2.057 0 C-N-CA 118.273 -1.917 . . . . 44.130000000000003 114.307 -174.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.446 ' O ' ' HB2' ' A' ' 46' ' ' SER . 33.2 Cg_exo . . . . . 0 C--N 1.368 1.565 0 CA-C-N 119.906 1.853 . . . . 71.319999999999993 112.194 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 45.3 t30 . . . . . 0 C--O 1.245 0.843 0 CA-C-O 120.644 0.259 . . . . 73.200000000000003 110.785 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.38 104.51 3.18 Favored Glycine 0 N--CA 1.437 -1.282 0 N-CA-C 111.145 -0.782 . . . . 44.109999999999999 111.145 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 50.3 m -101.63 124.44 40.68 Favored Pre-proline 0 C--N 1.301 -1.521 0 N-CA-C 109.838 -0.43 . . . . 75.510000000000005 109.838 -178.668 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -66.33 145.23 77.06 Favored 'Trans proline' 0 C--O 1.247 0.926 0 C-N-CA 121.837 1.691 . . . . 74.409999999999997 110.007 175.42 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -69.76 138.71 88.18 Favored Pre-proline 0 C--N 1.3 -1.548 0 CA-C-N 116.336 -0.393 . . . . 75.150000000000006 109.996 -175.345 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.32 134.3 60.61 Favored 'Trans proline' 0 C--O 1.252 1.185 0 C-N-CA 122.845 2.363 . . . . 74.219999999999999 113.098 -174.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 73.84 80.33 0.12 Allowed 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 125.903 1.681 . . . . 63.43 110.705 -176.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.5 p -103.38 136.57 35.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-N 114.754 -1.112 . . . . 64.310000000000002 109.189 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.28 131.54 36.04 Favored 'General case' 0 N--CA 1.42 -1.969 0 CA-C-O 120.941 0.401 . . . . 72.310000000000002 109.939 179.06 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.9 t -82.84 147.36 28.39 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 109.012 -0.736 . . . . 53.119999999999997 109.012 176.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.0 t -85.06 114.37 22.16 Favored 'General case' 0 N--CA 1.407 -2.577 0 CA-C-O 121.761 0.791 . . . . 61.329999999999998 109.311 178.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 37.4 m -138.68 85.45 2.08 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 115.131 -0.94 . . . . 63.219999999999999 108.754 175.433 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.1 p . . . . . 0 C--N 1.298 -1.635 0 N-CA-C 106.934 -1.506 . . . . 73.019999999999996 106.934 -176.402 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 109.401 -1.48 . . . . 63.200000000000003 109.401 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.9 m -132.75 151.49 51.98 Favored 'General case' 0 N--CA 1.421 -1.895 0 N-CA-C 104.926 -2.25 . . . . 51.310000000000002 104.926 175.351 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.412 ' HB3' ' CZ ' ' A' ' 137' ' ' PHE . . . -142.88 164.81 29.09 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 108.497 -0.927 . . . . 51.229999999999997 108.497 -178.055 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.514 HD12 ' HD3' ' A' ' 141' ' ' PRO . 0.0 OUTLIER -119.44 150.43 40.22 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 120.32 -0.552 . . . . 73.439999999999998 111.677 -174.544 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.476 ' O ' HD12 ' A' ' 49' ' ' LEU . 2.8 pp -109.77 138.95 45.4 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 115.312 -0.858 . . . . 73.430000000000007 109.325 176.108 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.42 HG12 ' HB3' ' A' ' 60' ' ' ARG . 29.8 m -112.66 131.79 63.21 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 N-CA-C 108.093 -1.077 . . . . 61.43 108.093 177.062 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 37.1 t -92.05 114.34 28.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 N-CA-C 104.442 -2.429 . . . . 65.200000000000003 104.442 175.611 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 50.5 tttp -84.72 -32.46 23.49 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 108.328 -0.99 . . . . 62.439999999999998 108.328 -173.547 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.492 ' HA ' ' NE ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -170.44 108.9 0.35 Allowed 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 107.721 -1.215 . . . . 72.129999999999995 107.721 174.213 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -168.86 117.75 0.74 Allowed Glycine 0 N--CA 1.424 -2.111 0 C-N-CA 120.465 -0.874 . . . . 64.430000000000007 111.099 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.417 ' HB2' ' HB2' ' A' ' 82' ' ' ASP . 85.9 Cg_exo -51.6 -12.77 1.16 Allowed 'Trans proline' 0 CA--C 1.555 1.532 0 C-N-CA 124.423 3.415 . . . . 75.239999999999995 116.127 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.484 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 31.3 p30 -71.67 -29.48 64.66 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 122.115 -0.365 . . . . 73.420000000000002 111.6 179.426 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -163.47 -148.88 0.13 Allowed 'General case' 0 C--O 1.24 0.576 0 N-CA-C 108.57 -0.9 . . . . 71.450000000000003 108.57 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 169.23 53.57 0.03 OUTLIER Glycine 0 CA--C 1.488 -1.608 0 N-CA-C 110.489 -1.044 . . . . 71.450000000000003 110.489 177.016 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -154.57 -170.24 3.47 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 108.303 -0.999 . . . . 52.439999999999998 108.303 -176.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.42 ' HB3' HG12 ' A' ' 50' ' ' VAL . 27.3 ptt180 -131.23 135.69 47.58 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 107.835 -1.172 . . . . 65.540000000000006 107.835 175.389 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -143.73 141.66 30.58 Favored 'General case' 0 C--N 1.291 -1.969 0 C-N-CA 120.518 -0.473 . . . . 74.120000000000005 111.226 178.372 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 28.3 tp -75.98 129.85 37.53 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 114.784 -1.098 . . . . 55.210000000000001 109.224 -178.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 81.9 mt -86.87 114.5 23.57 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 108.485 -0.932 . . . . 72.230000000000004 108.485 176.008 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -150.0 37.21 0.7 Allowed 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 103.761 -2.681 . . . . 73.409999999999997 103.761 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -133.98 128.64 19.74 Favored Pre-proline 0 C--N 1.297 -1.689 0 CA-C-N 113.486 -1.688 . . . . 73.340000000000003 107.768 -174.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -45.65 -55.41 3.58 Favored 'Trans proline' 0 C--N 1.362 1.237 0 C-N-CA 123.937 3.091 . . . . 75.340000000000003 113.562 -174.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.429 HG23 ' HG2' ' A' ' 93' ' ' ARG . 57.9 m -137.16 98.75 3.81 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 121.713 0.768 . . . . 71.239999999999995 112.963 179.426 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.444 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 90.1 m -80.57 112.83 18.29 Favored 'General case' 0 N--CA 1.417 -2.093 0 N-CA-C 106.42 -1.696 . . . . 75.120000000000005 106.42 174.701 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.441 ' HB ' ' HA ' ' A' ' 76' ' ' SER . 27.1 m -108.64 128.02 54.48 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 116.36 -0.382 . . . . 70.439999999999998 110.333 -175.069 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -105.0 120.02 40.45 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 108.873 -0.788 . . . . 72.239999999999995 108.873 177.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 158.39 -127.34 1.86 Allowed Glycine 0 N--CA 1.431 -1.664 0 N-CA-C 110.649 -0.98 . . . . 42.340000000000003 110.649 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.508 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 41.1 ttm180 -154.23 84.27 1.13 Allowed 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 121.436 0.636 . . . . 74.239999999999995 110.18 179.187 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 21.1 m-70 -137.3 167.18 21.87 Favored Pre-proline 0 C--N 1.288 -2.088 0 N-CA-C 107.616 -1.253 . . . . 72.349999999999994 107.616 175.097 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -60.07 -21.56 65.98 Favored 'Trans proline' 0 C--N 1.358 1.069 0 C-N-CA 122.308 2.005 . . . . 74.239999999999995 111.024 174.281 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -112.53 78.72 1.15 Allowed 'General case' 0 N--CA 1.424 -1.758 0 N-CA-C 107.963 -1.125 . . . . 72.519999999999996 107.963 177.17 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.441 ' HA ' ' HB ' ' A' ' 69' ' ' THR . 55.4 m -139.35 151.53 46.44 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 115.108 -0.951 . . . . 63.030000000000001 110.525 177.455 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -104.36 -46.85 4.28 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 109.018 -0.734 . . . . 73.230000000000004 109.018 -178.126 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 33.8 pt -133.31 156.01 41.36 Favored 'Isoleucine or valine' 0 C--O 1.245 0.865 0 CA-C-N 115.58 -0.736 . . . . 70.230000000000004 109.685 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -120.29 135.45 55.0 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.583 -0.895 . . . . 74.450000000000003 108.583 178.652 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.484 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 4.5 mp -75.42 106.01 6.74 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 122.849 0.46 . . . . 61.200000000000003 110.94 -178.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -86.26 63.51 8.05 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 122.718 1.246 . . . . 61.210000000000001 109.913 177.505 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.417 ' HB2' ' HB2' ' A' ' 55' ' ' PRO . 21.6 t70 -143.66 167.58 21.93 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 113.726 -1.579 . . . . 65.319999999999993 107.301 178.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.1 m -66.4 -33.87 66.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 117.801 0.273 . . . . 71.219999999999999 111.375 178.25 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 11.7 p -90.63 72.22 6.79 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-O 121.603 0.716 . . . . 75.530000000000001 112.425 179.433 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 6.9 p -113.58 113.41 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 CA-C-N 114.872 -1.058 . . . . 54.130000000000003 111.257 177.151 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 7.0 m -92.83 148.23 22.2 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 105.281 -2.118 . . . . 61.520000000000003 105.281 171.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.508 ' HB2' ' O ' ' A' ' 72' ' ' ARG . 9.1 ptm180 -73.47 -21.92 60.31 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 118.421 -1.312 . . . . 74.049999999999997 110.481 -179.57 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 26.8 ptt180 -122.24 97.77 5.63 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 106.526 -1.657 . . . . 72.310000000000002 106.526 165.215 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 8.6 t60 -109.66 -52.29 2.79 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.923 -0.711 . . . . 74.450000000000003 110.941 -173.556 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -144.96 131.94 20.28 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 120.188 -0.605 . . . . 71.219999999999999 110.104 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -114.91 126.81 55.22 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 108.794 -0.817 . . . . 74.019999999999996 108.794 177.014 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.444 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 79.8 m-85 -113.61 113.45 25.08 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 107.72 -1.215 . . . . 74.310000000000002 107.72 -179.543 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.429 ' HG2' HG23 ' A' ' 67' ' ' THR . 51.5 mtm180 -115.25 152.64 32.33 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-O 121.116 0.484 . . . . 74.420000000000002 110.977 -175.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.492 ' O ' HD12 ' A' ' 94' ' ' ILE . 2.9 pp -113.83 117.07 54.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 CA-C-O 122.414 1.102 . . . . 73.439999999999998 108.459 175.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 38.1 t-20 -103.05 147.65 26.7 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 106.893 -1.521 . . . . 74.099999999999994 106.893 -173.06 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -49.81 -32.94 15.2 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 112.505 0.557 . . . . 71.319999999999993 112.505 -177.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -94.19 -40.72 4.47 Favored Glycine 0 N--CA 1.422 -2.296 0 C-N-CA 120.265 -0.969 . . . . 72.349999999999994 113.371 -179.198 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -149.32 178.47 8.74 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 121.872 0.844 . . . . 73.120000000000005 112.574 -173.412 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -93.35 127.18 38.85 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 107.455 -1.313 . . . . 74.510000000000005 107.455 177.272 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -123.03 130.78 53.23 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 120.858 0.361 . . . . 73.420000000000002 111.973 -171.333 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 9.0 p -121.54 131.05 73.97 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 109.139 -0.689 . . . . 75.049999999999997 109.139 175.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.7 m -117.76 128.02 75.0 Favored 'Isoleucine or valine' 0 C--O 1.259 1.578 0 CA-C-O 121.569 0.699 . . . . 71.430000000000007 111.02 178.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -83.79 114.5 21.66 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.679 -1.146 . . . . 54.25 110.065 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 23.4 m -122.35 3.18 5.99 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 CA-C-O 121.923 0.868 . . . . 75.019999999999996 108.903 173.003 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -109.17 53.26 0.6 Allowed Glycine 0 N--CA 1.427 -1.955 0 CA-C-N 114.596 -1.184 . . . . 75.219999999999999 110.36 -178.695 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.2 p -64.85 -2.85 2.83 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.455 1.102 . . . . 53.420000000000002 112.107 -178.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.412 ' H ' HD22 ' A' ' 107' ' ' LEU . 2.9 mm? -62.83 -35.64 80.59 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 108.454 -0.943 . . . . 64.25 108.454 174.449 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -114.49 -45.93 2.99 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.237 -1.023 . . . . 64.310000000000002 108.237 177.38 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 94.37 120.97 3.35 Favored Glycine 0 N--CA 1.435 -1.419 0 CA-C-N 115.012 -0.994 . . . . 63.299999999999997 111.398 -178.681 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.4 m -79.56 119.53 22.66 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.999 -0.741 . . . . 72.239999999999995 108.999 176.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -103.4 134.42 46.8 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.967 -0.753 . . . . 74.099999999999994 108.967 178.181 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.468 HG11 ' HG2' ' A' ' 120' ' ' GLN . 61.9 t -115.91 117.93 57.15 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.359 0 N-CA-C 105.923 -1.88 . . . . 71.040000000000006 105.923 175.053 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 59.46 31.67 21.2 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-O 122.286 1.041 . . . . 55.310000000000002 108.392 -175.515 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 44.4 mtp180 74.39 5.03 4.56 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.127 1.371 . . . . 74.349999999999994 114.304 -178.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -103.05 134.95 19.5 Favored Pre-proline 0 C--N 1.309 -1.167 0 O-C-N 121.705 -0.622 . . . . 73.450000000000003 109.671 177.161 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -69.72 119.28 6.26 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.086 1.857 . . . . 74.230000000000004 110.096 177.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -123.35 129.98 52.07 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.715 -0.846 . . . . 70.010000000000005 108.715 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -69.64 -42.11 74.73 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 121.363 0.602 . . . . 43.109999999999999 109.904 178.329 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -144.61 138.39 27.38 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 105.814 -1.921 . . . . 75.530000000000001 105.814 173.634 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.468 ' HG2' HG11 ' A' ' 112' ' ' VAL . 57.8 tp60 -141.44 148.9 40.28 Favored 'General case' 0 C--N 1.282 -2.369 0 CA-C-O 120.732 0.301 . . . . 74.239999999999995 110.405 -177.71 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 89.1 t -80.46 120.88 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.669 0 N-CA-C 104.997 -2.223 . . . . 63.43 104.997 169.376 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 76.8 mtm -60.37 138.64 57.94 Favored 'General case' 0 CA--C 1.499 -0.985 0 CA-C-O 121.249 0.547 . . . . 74.230000000000004 111.339 -176.349 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 8.4 tp60 -103.79 123.48 47.15 Favored 'General case' 0 N--CA 1.417 -2.1 0 CA-C-N 115.146 -0.934 . . . . 72.329999999999998 108.483 -168.865 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 21.4 p -83.23 117.67 23.1 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.848 -0.615 . . . . 72.530000000000001 109.953 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 95.68 13.52 50.34 Favored Glycine 0 N--CA 1.436 -1.359 0 N-CA-C 111.631 -0.588 . . . . 71.219999999999999 111.631 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -132.5 -175.42 3.75 Favored 'General case' 0 C--O 1.248 0.976 0 N-CA-C 109.186 -0.672 . . . . 73.329999999999998 109.186 -177.617 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -112.03 149.05 32.59 Favored 'General case' 0 C--O 1.251 1.15 0 N-CA-C 114.997 1.48 . . . . 65.150000000000006 114.997 -171.215 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.409 ' HB ' ' HB3' ' A' ' 135' ' ' LEU . 37.3 mm -121.79 117.69 53.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 105.983 -1.858 . . . . 62.350000000000001 105.983 174.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -120.35 116.78 26.19 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 107.357 -1.349 . . . . 63.350000000000001 107.357 -177.238 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.0 tt -128.79 108.92 18.02 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.226 0 CA-C-O 121.417 0.627 . . . . 74.030000000000001 110.589 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 70.67 -103.98 1.3 Allowed Glycine 0 C--N 1.314 -0.669 0 N-CA-C 110.439 -1.064 . . . . 51.149999999999999 110.439 -177.239 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -120.09 6.56 10.79 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.056 -0.72 . . . . 72.420000000000002 109.056 173.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.472 ' CE2' HD23 ' A' ' 80' ' ' LEU . 56.3 m-85 -91.43 106.56 18.58 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 108.965 -0.754 . . . . 74.420000000000002 108.965 -177.081 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 14.5 ptt180 -96.41 120.95 37.65 Favored 'General case' 0 N--CA 1.432 -1.375 0 CA-C-O 122.168 0.985 . . . . 71.450000000000003 110.203 177.185 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.417 HD12 ' O ' ' A' ' 50' ' ' VAL . 25.3 tp -124.51 142.98 50.92 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 113.643 -1.617 . . . . 73.450000000000003 108.378 -174.577 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 29.8 t -124.5 134.89 65.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 107.499 -1.297 . . . . 71.099999999999994 107.499 176.256 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' PHE . . . . . 0.412 ' CZ ' ' HB3' ' A' ' 47' ' ' ALA . 64.1 t80 -108.32 120.34 42.09 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.057 -0.72 . . . . 74.239999999999995 109.057 -176.097 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -121.85 144.04 49.06 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.6 0.714 . . . . 70.430000000000007 112.337 -175.453 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -91.82 80.27 5.27 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 106.533 -1.654 . . . . 62.229999999999997 106.533 172.38 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -77.61 -71.69 1.19 Allowed Glycine 0 C--N 1.301 -1.414 0 CA-C-N 114.791 -1.095 . . . . 70.400000000000006 113.778 -174.464 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.514 ' HD3' HD12 ' A' ' 48' ' ' LEU . 19.7 Cg_exo . . . . . 0 N--CA 1.445 -1.326 0 C-N-CA 122.139 1.892 . . . . 72.430000000000007 113.023 -177.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 48.3 t30 . . . . . 0 C--O 1.244 0.8 0 N-CA-C 107.143 -1.429 . . . . 60.539999999999999 107.143 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -136.82 -133.28 3.16 Favored Glycine 0 N--CA 1.425 -2.064 0 C-N-CA 120.233 -0.984 . . . . 32.119999999999997 112.997 -176.318 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.8 t -85.09 143.22 39.36 Favored Pre-proline 0 C--N 1.302 -1.474 0 C-N-CA 122.599 0.36 . . . . 50.450000000000003 111.223 -176.187 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -66.73 150.34 83.51 Favored 'Trans proline' 0 C--O 1.249 1.037 0 C-N-CA 122.601 2.201 . . . . 72.430000000000007 110.385 171.112 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.9 mp0 -76.94 128.34 81.62 Favored Pre-proline 0 C--O 1.245 0.861 0 N-CA-C 109.612 -0.514 . . . . 74.299999999999997 109.612 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -63.05 150.43 88.66 Favored 'Trans proline' 0 C--O 1.25 1.079 0 C-N-CA 122.817 2.344 . . . . 63.32 111.191 175.411 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -92.77 173.89 7.53 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-O 121.028 0.442 . . . . 64.109999999999999 110.698 -175.668 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.5 m -121.18 169.57 12.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-N 115.698 -0.683 . . . . 63.509999999999998 110.779 -178.687 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -78.49 140.94 38.55 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 109.594 -0.521 . . . . 65.329999999999998 109.594 178.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.1 t -111.47 148.52 32.96 Favored 'General case' 0 N--CA 1.422 -1.833 0 CA-C-O 121.079 0.466 . . . . 51.25 110.311 -178.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.6 p -100.51 8.79 43.29 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 112.282 0.475 . . . . 72.030000000000001 112.282 178.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.4 p -78.94 32.54 0.21 Allowed 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.421 0.689 . . . . 73.150000000000006 112.621 -177.417 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.9 m . . . . . 0 N--CA 1.431 -1.42 0 N-CA-C 108.45 -0.945 . . . . 75.400000000000006 108.45 178.74 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.693 0 N-CA-C 109.178 -1.569 . . . . 62.509999999999998 109.178 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.5 m -90.67 165.89 13.46 Favored 'General case' 0 N--CA 1.425 -1.692 0 CA-C-N 114.548 -0.826 . . . . 74.329999999999998 111.192 -174.694 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -90.86 163.42 14.41 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 108.104 -1.073 . . . . 63.350000000000001 108.104 175.59 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.45 ' HB3' ' HG ' ' A' ' 62' ' ' LEU . 2.5 pt? -133.93 159.96 39.14 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.453 0.644 . . . . 63.299999999999997 110.733 -177.253 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.417 ' HB2' HD21 ' A' ' 135' ' ' LEU . 1.1 pt? -122.97 132.84 54.33 Favored 'General case' 0 C--N 1.278 -2.528 0 CA-C-N 115.018 -0.992 . . . . 75.209999999999994 108.806 176.673 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.4 m -110.01 116.35 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.019 0 N-CA-C 107.14 -1.43 . . . . 74.329999999999998 107.14 175.423 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.1 t -93.03 115.62 32.25 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.467 0 N-CA-C 107.88 -1.156 . . . . 75.540000000000006 107.88 -176.21 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -72.66 -38.6 67.59 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.584 -1.265 . . . . 73.299999999999997 107.584 -177.217 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 50.9 ttt180 -176.18 111.22 0.1 Allowed 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 106.359 -1.719 . . . . 72.329999999999998 106.359 174.257 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.49 ' HA2' ' HB3' ' A' ' 133' ' ' PHE . . . -122.84 166.17 15.33 Favored Glycine 0 N--CA 1.418 -2.53 0 N-CA-C 111.412 -0.675 . . . . 61.240000000000002 111.412 -177.307 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -69.09 -23.73 33.55 Favored 'Trans proline' 0 C--N 1.322 -0.847 0 C-N-CA 122.954 2.436 . . . . 64.319999999999993 111.481 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -98.87 -52.03 3.7 Favored 'General case' 0 N--CA 1.426 -1.63 0 CA-C-N 114.595 -1.184 . . . . 73.120000000000005 111.322 -177.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -144.25 -173.08 3.92 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-O 120.808 0.337 . . . . 72.540000000000006 110.496 -173.534 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.38 46.02 0.41 Allowed Glycine 0 N--CA 1.435 -1.399 0 N-CA-C 109.114 -1.594 . . . . 32.450000000000003 109.114 178.372 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -133.67 -169.87 2.38 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.888 -0.782 . . . . 74.329999999999998 108.888 -175.186 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -125.84 135.26 51.76 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 110.462 -0.199 . . . . 65.430000000000007 110.462 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -156.26 149.3 24.2 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 112.947 0.721 . . . . 72.140000000000001 112.947 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.45 ' HG ' ' HB3' ' A' ' 48' ' ' LEU . 6.8 mp -93.06 141.98 27.8 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 124.581 1.152 . . . . 72.349999999999994 109.73 177.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -74.49 115.3 13.86 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.592 -0.443 . . . . 73.549999999999997 110.065 176.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -113.13 8.97 18.46 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 108.606 -0.887 . . . . 71.409999999999997 108.606 -179.454 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -136.69 134.4 19.45 Favored Pre-proline 0 C--N 1.3 -1.571 0 N-CA-C 112.258 0.466 . . . . 71.209999999999994 112.258 -167.292 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.444 ' HA ' ' CG2' ' A' ' 94' ' ' ILE . 9.7 Cg_endo -52.43 -62.49 0.35 Allowed 'Trans proline' 0 C--N 1.371 1.721 0 C-N-CA 124.538 3.492 . . . . 75.230000000000004 113.853 -177.619 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 94.7 m -116.49 110.64 18.87 Favored 'General case' 0 N--CA 1.422 -1.831 0 N-CA-C 109.354 -0.61 . . . . 75.409999999999997 109.354 178.728 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.452 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 91.2 m -109.56 113.63 26.58 Favored 'General case' 0 C--N 1.283 -2.314 0 N-CA-C 109.045 -0.724 . . . . 65.439999999999998 109.045 177.107 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.8 t -95.75 132.83 40.56 Favored 'General case' 0 C--O 1.256 1.424 0 N-CA-C 109.381 -0.6 . . . . 73.209999999999994 109.381 -178.699 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -127.88 124.92 38.65 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 115.739 -0.664 . . . . 51.119999999999997 110.282 -177.479 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.79 33.46 15.7 Favored Glycine 0 C--N 1.3 -1.445 0 C-N-CA 119.092 -1.527 . . . . 75.140000000000001 111.913 177.396 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.645 ' HA ' ' O ' ' A' ' 87' ' ' ARG . 2.1 tmt_? -123.73 87.66 2.78 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 105.993 -1.854 . . . . 74.519999999999996 105.993 176.603 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 20.3 m170 66.05 171.2 0.1 OUTLIER Pre-proline 0 CA--C 1.552 1.033 0 O-C-N 124.106 0.879 . . . . 72.219999999999999 109.795 -175.068 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -65.47 -20.18 60.91 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 121.686 1.591 . . . . 71.310000000000002 109.33 170.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -75.78 7.77 3.6 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 126.027 1.731 . . . . 74.239999999999995 112.381 -177.466 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 10.1 p -84.73 175.23 9.31 Favored 'General case' 0 C--N 1.322 -0.607 0 O-C-N 121.973 -0.454 . . . . 50.399999999999999 110.526 177.273 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -62.85 -56.74 14.71 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 108.791 -0.818 . . . . 73.230000000000004 108.791 -178.004 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.482 HD13 ' H ' ' A' ' 78' ' ' ILE . 0.2 OUTLIER -125.65 123.55 64.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 106.3 -1.741 . . . . 74.349999999999994 106.3 172.457 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -99.38 121.57 41.3 Favored 'General case' 0 C--N 1.29 -2.015 0 C-N-CA 119.829 -0.748 . . . . 72.540000000000006 112.872 -171.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.6 mp -69.09 128.95 38.46 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 107.418 -1.327 . . . . 75.439999999999998 107.418 170.54 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -116.06 24.04 11.74 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-O 122.46 1.124 . . . . 64.430000000000007 110.093 -175.003 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -103.84 -164.85 1.1 Allowed 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.745 -0.782 . . . . 74.019999999999996 109.889 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.7 p -92.19 -6.74 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.319 0 CA-C-O 121.339 0.59 . . . . 74.430000000000007 111.779 -174.711 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 7.4 m -87.45 12.87 11.15 Favored 'General case' 0 CA--C 1.555 1.139 0 CA-C-O 121.666 0.746 . . . . 72.329999999999998 110.543 -177.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 87.7 t -81.59 104.77 10.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-O 121.993 0.901 . . . . 73.150000000000006 110.83 -177.106 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 16.8 m -86.64 42.52 1.01 Allowed 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 124.388 1.075 . . . . 61.43 112.096 -176.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.645 ' O ' ' HA ' ' A' ' 72' ' ' ARG . 82.7 mtm180 72.65 -48.22 0.68 Allowed 'General case' 0 N--CA 1.513 2.724 0 C-N-CA 124.496 1.118 . . . . 54.420000000000002 110.39 -175.822 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -139.73 120.3 14.16 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 103.113 -2.921 . . . . 75.150000000000006 103.113 171.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 54.8 t60 -110.19 -71.45 0.76 Allowed 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 117.664 -1.614 . . . . 44.140000000000001 113.76 -174.025 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -117.85 143.24 46.47 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.974 -0.691 . . . . 74.109999999999999 111.911 -173.262 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.4 mm-40 -121.65 127.53 50.91 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.087 -1.079 . . . . 72.120000000000005 108.087 177.266 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.452 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 91.6 m-85 -103.67 113.47 27.01 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 106.628 -1.619 . . . . 71.430000000000007 106.628 175.391 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 89.5 mtt-85 -120.52 146.12 46.61 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 121.185 0.517 . . . . 73.519999999999996 110.795 -174.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.444 ' CG2' ' HA ' ' A' ' 66' ' ' PRO . 5.6 tt -115.87 130.93 69.72 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 N-CA-C 108.737 -0.838 . . . . 70.340000000000003 108.737 175.492 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.406 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 14.8 t-20 -118.68 146.31 44.8 Favored 'General case' 0 C--N 1.282 -2.335 0 N-CA-C 106.166 -1.79 . . . . 61.409999999999997 106.166 178.455 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.97 -10.29 20.6 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 112.886 0.699 . . . . 72.209999999999994 112.886 -176.565 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -103.81 -41.85 2.07 Favored Glycine 0 N--CA 1.436 -1.361 0 CA-C-N 116.424 -0.353 . . . . 74.439999999999998 112.661 175.67 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.406 ' O ' ' HB3' ' A' ' 95' ' ' ASN . 67.7 mm-40 -141.44 162.9 34.36 Favored 'General case' 0 C--O 1.216 -0.684 0 CA-C-O 121.277 0.56 . . . . 73.129999999999995 111.724 -176.5 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -108.2 121.19 44.36 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 106.674 -1.602 . . . . 74.109999999999999 106.674 173.192 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -125.52 135.55 52.39 Favored 'General case' 0 CA--C 1.49 -1.328 0 CA-C-O 122.087 0.946 . . . . 73.120000000000005 113.162 -176.63 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 6.0 p -108.28 119.38 57.76 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.333 0 CA-C-N 114.12 -1.4 . . . . 71.540000000000006 108.269 176.088 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.417 HG12 ' HB1' ' A' ' 119' ' ' ALA . 29.5 m -119.0 131.72 70.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 C-N-CA 120.595 -0.442 . . . . 62.310000000000002 109.852 -177.792 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -105.16 116.41 31.91 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.025 -1.472 . . . . 74.120000000000005 107.025 176.383 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.3 m -89.9 0.93 7.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-O 120.911 0.386 . . . . 71.010000000000005 111.025 -174.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -126.46 36.06 2.77 Favored Glycine 0 N--CA 1.429 -1.783 0 N-CA-C 108.673 -1.771 . . . . 54.340000000000003 108.673 175.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.7 p -68.8 7.35 0.68 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 113.826 1.047 . . . . 62.119999999999997 113.826 -175.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 78.3 mt -70.8 -21.51 62.47 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 108.885 -0.783 . . . . 61.149999999999999 108.885 176.571 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -77.23 -7.42 55.89 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.723 -0.671 . . . . 65.120000000000005 110.039 177.314 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 88.84 78.14 1.3 Allowed Glycine 0 N--CA 1.439 -1.126 0 N-CA-C 111.795 -0.522 . . . . 72.340000000000003 111.795 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.49 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 11.1 m -81.7 123.95 29.18 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 109.005 -0.739 . . . . 63.210000000000001 109.005 178.276 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -115.38 134.77 54.79 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 120.033 -0.667 . . . . 63.229999999999997 110.891 -176.13 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 29.1 m -112.68 110.37 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.135 0 N-CA-C 106.876 -1.527 . . . . 23.23 106.876 169.547 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 62.5 t30 58.18 36.66 25.97 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 125.355 1.462 . . . . 74.099999999999994 109.708 -177.065 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 52.8 mtp180 81.74 -0.62 1.57 Allowed 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 126.753 2.021 . . . . 74.329999999999998 113.545 -178.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -92.42 115.79 65.36 Favored Pre-proline 0 C--N 1.313 -1.004 0 N-CA-C 109.372 -0.603 . . . . 72.219999999999999 109.372 178.556 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.49 ' HA ' ' O ' ' A' ' 110' ' ' THR . 36.4 Cg_endo -66.34 121.5 8.8 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.905 2.403 . . . . 74.310000000000002 112.182 -179.024 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 8.8 mmm180 -136.1 163.73 29.66 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 120.833 0.349 . . . . 70.430000000000007 110.144 -177.376 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -98.94 -45.9 5.81 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.114 -1.069 . . . . 63.539999999999999 108.114 176.343 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.417 ' HB1' HG12 ' A' ' 102' ' ' VAL . . . -139.86 142.26 36.58 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 107.263 -1.384 . . . . 63.439999999999998 107.263 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -134.68 141.06 46.44 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-O 121.316 0.579 . . . . 72.129999999999995 111.126 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.3 p -90.73 134.81 28.35 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 106.337 -1.727 . . . . 61.43 106.337 177.088 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 20.9 ptt? -41.01 123.84 2.06 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 122.143 0.973 . . . . 53.140000000000001 112.847 -177.373 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -127.01 124.71 40.03 Favored 'General case' 0 N--CA 1.413 -2.325 0 N-CA-C 106.17 -1.789 . . . . 73.109999999999999 106.17 177.101 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 31.1 p -78.48 124.45 28.15 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 116.138 -0.483 . . . . 75.200000000000003 111.821 -172.783 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 92.67 1.38 68.32 Favored Glycine 0 N--CA 1.44 -1.089 0 CA-C-N 115.207 -0.906 . . . . 42.25 110.894 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -90.41 151.54 21.38 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 108.312 -0.995 . . . . 73.129999999999995 108.312 -177.735 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.422 ' HG2' HG22 ' A' ' 136' ' ' VAL . 39.8 mt-10 -113.31 129.3 56.57 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 112.264 0.468 . . . . 75.430000000000007 112.264 -175.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 61.9 mt -95.27 115.78 35.09 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.164 0 N-CA-C 105.9 -1.889 . . . . 75.329999999999998 105.9 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.413 ' HA ' ' O ' ' A' ' 133' ' ' PHE . 76.5 mt-30 -118.26 119.37 34.46 Favored 'General case' 0 N--CA 1.418 -2.059 0 CA-C-N 115.124 -0.944 . . . . 62.450000000000003 110.12 -172.696 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 7.5 pt -123.32 125.53 71.93 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 CA-C-N 114.962 -1.017 . . . . 75.530000000000001 109.222 179.033 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 68.5 -102.11 0.84 Allowed Glycine 0 N--CA 1.434 -1.499 0 N-CA-C 108.746 -1.741 . . . . 72.420000000000002 108.746 -171.246 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -137.32 18.76 2.94 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.947 -0.761 . . . . 61.119999999999997 108.947 174.122 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.49 ' HB3' ' HA2' ' A' ' 54' ' ' GLY . 81.6 m-85 -93.03 150.13 20.74 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.679 -0.692 . . . . 75.040000000000006 110.225 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 75.6 mtt180 -123.81 122.9 39.25 Favored 'General case' 0 C--O 1.252 1.206 0 CA-C-O 121.498 0.666 . . . . 64.439999999999998 111.47 -172.494 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.417 HD21 ' HB2' ' A' ' 49' ' ' LEU . 5.5 tt -123.67 129.99 51.96 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 106.682 -1.599 . . . . 73.5 106.682 177.592 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.422 HG22 ' HG2' ' A' ' 127' ' ' GLU . 12.2 t -108.14 128.73 63.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 N-CA-C 108.297 -1.001 . . . . 64.349999999999994 108.297 -178.484 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -105.92 129.38 54.08 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 120.71 -0.396 . . . . 73.519999999999996 110.408 -176.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -132.65 169.22 16.97 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.872 0.368 . . . . 74.230000000000004 110.263 -177.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -91.72 139.0 31.1 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 107.728 -1.212 . . . . 65.239999999999995 107.728 174.361 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -102.95 171.17 20.54 Favored Glycine 0 N--CA 1.439 -1.162 0 C-N-CA 120.119 -1.038 . . . . 71.530000000000001 113.005 -175.114 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo . . . . . 0 N--CA 1.451 -0.994 0 C-N-CA 122.583 2.189 . . . . 72.019999999999996 111.586 177.868 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 54.9 t30 . . . . . 0 N--CA 1.441 -0.888 0 N-CA-C 108.899 -0.778 . . . . 75.099999999999994 108.899 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -78.74 158.81 45.36 Favored Glycine 0 N--CA 1.431 -1.671 0 N-CA-C 110.786 -0.925 . . . . 54.200000000000003 110.786 179.187 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.5 m -75.14 125.28 89.31 Favored Pre-proline 0 C--N 1.299 -1.624 0 N-CA-C 109.987 -0.375 . . . . 63.240000000000002 109.987 -178.894 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -63.92 127.73 20.2 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 121.628 1.552 . . . . 74.0 109.121 175.158 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.434 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -89.99 144.12 30.94 Favored Pre-proline 0 C--N 1.298 -1.641 0 N-CA-C 112.489 0.552 . . . . 65.310000000000002 112.489 -176.844 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 9' ' ' GLU . 4.1 Cg_exo -76.66 141.67 22.25 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.373 2.049 . . . . 53.520000000000003 111.722 178.282 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -81.51 118.31 22.63 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.498 -0.927 . . . . 72.239999999999995 108.498 179.386 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.2 p -75.62 118.62 22.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 109.521 -0.548 . . . . 61.009999999999998 109.521 178.764 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -81.55 120.92 25.65 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 109.704 -0.48 . . . . 73.25 109.704 -179.078 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.0 t -129.6 117.44 20.4 Favored 'General case' 0 N--CA 1.414 -2.262 0 CA-C-N 115.496 -0.774 . . . . 73.319999999999993 110.19 -178.495 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.9 p -95.5 101.15 12.84 Favored 'General case' 0 N--CA 1.425 -1.688 0 CA-C-N 115.856 -0.611 . . . . 71.439999999999998 110.978 179.867 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.4 t -81.16 103.18 10.78 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 108.97 -0.752 . . . . 62.43 108.97 178.702 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 42.6 t . . . . . 0 C--N 1.294 -1.827 0 N-CA-C 107.75 -1.204 . . . . 72.230000000000004 107.75 179.0 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.412 ' O ' HD11 ' A' ' 94' ' ' ILE . . . . . . . . 0 CA--C 1.48 -2.106 0 N-CA-C 107.275 -2.33 . . . . 71.109999999999999 107.275 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.3 m -90.15 153.22 20.68 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-O 122.055 0.931 . . . . 63.130000000000003 112.311 -166.989 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.27 166.56 22.2 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 107.878 -1.156 . . . . 74.150000000000006 107.878 179.149 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.45 148.32 50.58 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.163 0.506 . . . . 72.340000000000003 112.093 -179.434 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.564 HD23 HD11 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -123.51 140.3 53.15 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.72 -0.845 . . . . 74.120000000000005 108.72 176.336 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.401 ' O ' HD12 ' A' ' 135' ' ' LEU . 35.7 t -126.43 133.5 68.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 N-CA-C 108.249 -1.019 . . . . 72.400000000000006 108.249 -179.05 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.433 HG21 ' HB3' ' A' ' 57' ' ' ALA . 35.1 t -92.22 115.23 30.7 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.077 0 N-CA-C 106.328 -1.73 . . . . 61.530000000000001 106.328 177.522 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -86.02 -31.62 21.91 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 114.992 -1.004 . . . . 74.409999999999997 109.888 -172.488 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.487 ' O ' ' HB3' ' A' ' 133' ' ' PHE . 53.5 ttt180 -159.3 139.66 12.17 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.438 -0.578 . . . . 72.019999999999996 109.438 -179.218 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.409 ' HA2' ' HD3' ' A' ' 55' ' ' PRO . . . 132.68 148.83 6.08 Favored Glycine 0 N--CA 1.435 -1.387 0 C-N-CA 120.423 -0.894 . . . . 43.329999999999998 114.292 176.737 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.409 ' HD3' ' HA2' ' A' ' 54' ' ' GLY . 31.2 Cg_exo -65.59 -8.62 19.79 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 124.126 3.217 . . . . 61.409999999999997 112.418 174.132 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.403 HD21 ' HB2' ' A' ' 133' ' ' PHE . 81.5 m-20 -49.06 -56.67 8.33 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.139 0.976 . . . . 74.25 108.724 174.543 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.433 ' HB3' HG21 ' A' ' 51' ' ' VAL . . . -179.41 -172.09 0.22 Allowed 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.702 1.201 . . . . 70.140000000000001 107.968 179.729 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -154.23 30.45 0.71 Allowed Glycine 0 CA--C 1.483 -1.915 0 N-CA-C 107.809 -2.116 . . . . 72.25 107.809 178.019 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -116.88 -179.75 3.78 Favored 'General case' 0 N--CA 1.412 -2.369 0 CA-C-N 113.676 -1.262 . . . . 63.329999999999998 108.814 -175.328 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 7.6 ptt180 -138.12 131.01 29.83 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 108.312 -0.996 . . . . 63.140000000000001 108.312 -179.801 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -122.02 148.44 44.83 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 116.354 -0.385 . . . . 74.349999999999994 110.852 -172.711 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.1 tt -98.76 117.36 33.07 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.367 -0.975 . . . . 72.230000000000004 108.367 178.497 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 94.0 mt -90.76 115.58 27.95 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.656 -0.702 . . . . 74.140000000000001 109.585 179.802 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -121.37 -34.03 3.54 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 107.667 -1.235 . . . . 64.120000000000005 107.667 177.913 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 15.5 pm0 -64.99 130.15 94.76 Favored Pre-proline 0 N--CA 1.436 -1.159 0 CA-C-N 113.987 -1.461 . . . . 74.019999999999996 109.95 175.971 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -61.5 -33.06 88.55 Favored 'Trans proline' 0 C--O 1.244 0.811 0 C-N-CA 123.299 2.666 . . . . 63.340000000000003 114.269 -175.968 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.7 m -111.97 120.38 41.71 Favored 'General case' 0 N--CA 1.435 -1.183 0 O-C-N 122.177 -0.327 . . . . 72.230000000000004 110.825 -178.061 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.488 ' HB ' ' HB3' ' A' ' 92' ' ' PHE . 41.4 m -118.74 114.1 22.18 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.841 -0.799 . . . . 44.149999999999999 108.841 176.181 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 36.7 m -102.0 127.56 48.82 Favored 'General case' 0 C--N 1.312 -1.054 0 O-C-N 121.658 -0.651 . . . . 63.509999999999998 111.245 -179.462 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -106.1 125.2 50.7 Favored 'General case' 0 C--O 1.248 0.985 0 CA-C-N 115.652 -0.703 . . . . 43.210000000000001 109.153 177.985 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 167.43 -151.1 18.4 Favored Glycine 0 CA--C 1.49 -1.513 0 N-CA-C 110.624 -0.99 . . . . 74.230000000000004 110.624 179.866 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.406 ' HG2' ' HA ' ' A' ' 87' ' ' ARG . 11.6 ptp180 -130.54 83.72 2.14 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 122.573 1.178 . . . . 75.409999999999997 111.311 179.45 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 31.3 m80 -146.83 174.72 3.17 Favored Pre-proline 0 C--N 1.293 -1.874 0 N-CA-C 106.999 -1.482 . . . . 75.319999999999993 106.999 178.452 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -66.49 -22.25 51.99 Favored 'Trans proline' 0 C--N 1.354 0.848 0 N-CA-C 107.544 -1.752 . . . . 73.540000000000006 107.544 164.733 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -89.64 68.42 7.64 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 113.854 -1.521 . . . . 71.140000000000001 108.164 176.511 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 53.6 m -139.33 113.41 8.76 Favored 'General case' 0 C--N 1.275 -2.646 0 CA-C-N 114.395 -1.275 . . . . 62.109999999999999 107.56 175.54 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -71.84 -35.6 69.91 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.909 -1.041 . . . . 71.319999999999993 109.38 -174.669 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.484 HD13 ' H ' ' A' ' 78' ' ' ILE . 0.2 OUTLIER -128.41 160.56 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.252 0 N-CA-C 106.667 -1.605 . . . . 71.349999999999994 106.667 175.348 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -107.02 135.92 47.77 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-O 121.33 0.586 . . . . 75.319999999999993 111.861 -175.385 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.0 mp -125.66 137.85 53.88 Favored 'General case' 0 N--CA 1.424 -1.77 0 N-CA-C 108.061 -1.088 . . . . 70.439999999999998 108.061 179.05 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -140.37 75.76 1.52 Allowed 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.376 -1.342 . . . . 54.219999999999999 107.376 179.543 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.432 ' OD2' ' HA3' ' A' ' 131' ' ' GLY . 18.6 t70 -120.35 159.9 24.12 Favored 'General case' 0 C--N 1.275 -2.651 0 CA-C-N 113.34 -1.755 . . . . 72.150000000000006 108.209 179.761 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 10.2 p -71.45 -27.25 28.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 CA-C-O 121.176 0.513 . . . . 71.25 111.076 -178.46 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.5 p -113.04 14.7 19.65 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 113.437 0.902 . . . . 72.439999999999998 113.437 -176.809 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.8 p -82.61 120.43 34.02 Favored 'Isoleucine or valine' 0 C--O 1.253 1.261 0 C-N-CA 118.792 -1.163 . . . . 73.549999999999997 108.878 173.996 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 9.1 t -80.62 -172.4 3.59 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 115.208 -0.906 . . . . 70.129999999999995 111.602 -173.616 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.406 ' HA ' ' HG2' ' A' ' 72' ' ' ARG . 18.8 ttp180 -62.29 -51.69 66.66 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.109 0.963 . . . . 73.329999999999998 110.988 -179.584 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -134.06 97.61 3.91 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 104.608 -2.367 . . . . 55.409999999999997 104.608 177.532 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.42 ' HA ' ' HA3' ' A' ' 105' ' ' GLY . 5.9 t60 -88.76 -55.29 3.76 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 116.049 -0.523 . . . . 73.420000000000002 111.301 -168.299 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.79 151.13 36.63 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 120.278 -0.569 . . . . 75.450000000000003 110.532 -177.231 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -120.74 128.06 52.58 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 107.428 -1.323 . . . . 73.329999999999998 107.428 174.521 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.549 ' CE2' ' HB ' ' A' ' 94' ' ' ILE . 69.8 t80 -104.49 127.77 52.27 Favored 'General case' 0 C--N 1.277 -2.553 0 N-CA-C 108.888 -0.782 . . . . 74.150000000000006 108.888 178.03 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 -109.83 122.21 46.99 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 107.137 -1.431 . . . . 75.409999999999997 107.137 -179.689 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.549 ' HB ' ' CE2' ' A' ' 92' ' ' PHE . 0.0 OUTLIER -116.05 125.93 73.34 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.246 0 CA-C-O 121.777 0.799 . . . . 65.230000000000004 110.824 -177.789 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.416 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 20.7 t-20 -118.42 145.77 44.96 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 105.507 -2.035 . . . . 64.239999999999995 105.507 174.651 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -61.92 -19.14 62.38 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 112.526 0.565 . . . . 71.209999999999994 112.526 -175.19 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -104.58 -31.89 4.39 Favored Glycine 0 N--CA 1.431 -1.635 0 C-N-CA 120.72 -0.752 . . . . 64.150000000000006 113.178 178.492 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.416 ' O ' ' HB3' ' A' ' 95' ' ' ASN . 8.8 pt-20 -143.06 155.71 44.68 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 117.363 0.582 . . . . 75.439999999999998 111.604 -174.7 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.439 ' HB2' ' HB2' ' A' ' 122' ' ' MET . 57.7 m-85 -127.35 128.67 46.28 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 110.099 -0.334 . . . . 73.109999999999999 110.099 -173.813 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -128.19 135.35 49.6 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 110.262 -0.273 . . . . 70.329999999999998 110.262 -178.531 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 14.6 p -120.7 129.73 75.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 108.919 -0.771 . . . . 55.439999999999998 108.919 174.844 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 25.4 m -115.85 129.73 71.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 CA-C-O 121.445 0.64 . . . . 71.430000000000007 111.185 179.635 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -86.55 121.34 28.95 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 114.977 -1.01 . . . . 73.310000000000002 109.067 179.231 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 18.5 m -118.44 -1.16 8.81 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 CA-C-N 115.546 -0.752 . . . . 73.340000000000003 110.009 179.055 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.42 ' HA3' ' HA ' ' A' ' 89' ' ' HIS . . . -111.83 52.04 0.66 Allowed Glycine 0 N--CA 1.427 -1.956 0 N-CA-C 109.73 -1.348 . . . . 71.409999999999997 109.73 178.62 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 14.2 m -62.91 -4.92 2.43 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.538 1.135 . . . . 74.140000000000001 112.192 -177.633 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 81.2 mt -61.99 -30.2 70.77 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 124.253 1.021 . . . . 61.200000000000003 109.244 174.707 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -125.71 -40.41 2.06 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.131 -0.94 . . . . 74.299999999999997 108.771 179.251 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.74 132.21 5.14 Favored Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.349 -0.841 . . . . 72.129999999999995 113.312 178.333 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 28.9 m -81.56 136.26 35.58 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.312 -0.996 . . . . 65.329999999999998 108.312 173.353 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.427 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 18.6 m-85 -114.43 134.17 55.19 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 108.268 -1.012 . . . . 75.109999999999999 108.268 -177.595 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 60.0 t -120.76 111.04 30.23 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 N-CA-C 106.926 -1.509 . . . . 65.049999999999997 106.926 176.784 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 42.7 t-20 44.08 70.36 0.33 Allowed 'General case' 0 C--O 1.241 0.634 0 O-C-N 125.143 1.527 . . . . 72.420000000000002 111.59 -176.114 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 73.98 -26.62 0.19 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.503 1.521 . . . . 75.219999999999999 113.388 177.362 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -90.77 118.1 68.41 Favored Pre-proline 0 C--N 1.311 -1.07 0 N-CA-C 112.343 0.497 . . . . 75.329999999999998 112.343 -175.68 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -63.38 128.24 22.05 Favored 'Trans proline' 0 C--O 1.247 0.965 0 C-N-CA 122.295 1.997 . . . . 71.299999999999997 108.584 172.299 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 3.1 mmp_? -123.04 145.23 48.71 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 116.991 -0.095 . . . . 75.120000000000005 110.81 -175.356 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -95.33 -36.66 11.31 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 108.181 -1.044 . . . . 72.010000000000005 108.181 172.11 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -149.19 139.49 22.33 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 105.89 -1.893 . . . . 75.409999999999997 105.89 174.308 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 7.7 tp60 -140.09 148.55 41.91 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 110.32 -0.252 . . . . 73.200000000000003 110.32 -178.714 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 67.4 t -93.11 123.12 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 N-CA-C 105.124 -2.176 . . . . 72.129999999999995 105.124 173.239 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.439 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 83.5 mmm -78.7 143.94 35.77 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 114.204 1.187 . . . . 55.140000000000001 114.204 -173.338 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -121.89 137.14 54.9 Favored 'General case' 0 N--CA 1.419 -1.99 0 CA-C-N 113.823 -1.535 . . . . 72.129999999999995 108.852 -177.581 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 7.1 t -79.54 126.69 31.2 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 109.024 -0.732 . . . . 74.409999999999997 109.024 178.502 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 95.74 19.33 29.65 Favored Glycine 0 N--CA 1.434 -1.454 0 C-N-CA 120.747 -0.739 . . . . 74.5 111.578 -179.175 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -118.93 160.91 21.08 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.816 -0.809 . . . . 72.310000000000002 108.816 178.246 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.447 ' OE1' ' HD2' ' A' ' 134' ' ' ARG . 44.0 tt0 -115.4 131.49 56.91 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.494 0.664 . . . . 73.299999999999997 111.495 -172.183 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.412 ' N ' HD12 ' A' ' 128' ' ' ILE . 3.5 mp -105.35 131.44 54.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 107.681 -1.229 . . . . 62.409999999999997 107.681 -176.728 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.427 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 60.1 tt0 -102.26 113.21 26.3 Favored 'General case' 0 N--CA 1.425 -1.702 0 C-N-CA 119.178 -1.009 . . . . 64.319999999999993 108.375 177.849 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 8.0 pt -100.73 98.14 6.56 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.361 0 CA-C-N 114.743 -1.117 . . . . 73.230000000000004 108.549 178.826 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.432 ' HA3' ' OD2' ' A' ' 82' ' ' ASP . . . 77.73 -110.96 3.15 Favored Glycine 0 N--CA 1.426 -2.029 0 CA-C-N 113.976 -1.466 . . . . 61.310000000000002 109.522 -174.923 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.403 ' NZ ' ' HB3' ' A' ' 132' ' ' LYS . 7.8 mtpm? -104.87 -19.88 13.74 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 116.918 0.359 . . . . 73.109999999999999 110.083 175.0 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.487 ' HB3' ' O ' ' A' ' 53' ' ' ARG . 57.4 m-85 -97.77 161.76 13.6 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-O 120.856 0.36 . . . . 61.240000000000002 111.571 -171.181 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.447 ' HD2' ' OE1' ' A' ' 127' ' ' GLU . 70.3 mtm180 -121.0 140.55 51.75 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 113.817 1.043 . . . . 73.510000000000005 113.817 -169.023 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.564 HD11 HD23 ' A' ' 49' ' ' LEU . 47.6 tp -121.41 136.47 54.96 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 113.734 -1.575 . . . . 64.299999999999997 108.25 -177.325 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 10.7 p -111.21 132.4 59.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 C-N-CA 120.195 -0.602 . . . . 74.430000000000007 109.541 177.666 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -111.29 129.68 55.9 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.162 -0.472 . . . . 60.130000000000003 111.445 -176.368 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -129.45 148.82 51.4 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.308 -0.627 . . . . 72.519999999999996 109.308 176.799 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -95.36 137.83 33.89 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.286 -1.005 . . . . 73.439999999999998 108.286 175.986 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -120.23 -127.99 3.59 Favored Glycine 0 N--CA 1.435 -1.433 0 C-N-CA 119.509 -1.329 . . . . 72.430000000000007 114.339 -173.895 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo . . . . . 0 C--O 1.235 0.367 0 C-N-CA 123.305 2.67 . . . . 61.350000000000001 114.94 -172.491 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 41.9 t30 . . . . . 0 N--CA 1.434 -1.253 0 N-CA-C 107.582 -1.266 . . . . 62.409999999999997 107.582 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.87 80.4 0.57 Allowed Glycine 0 CA--C 1.503 -0.709 0 N-CA-C 109.132 -1.587 . . . . 73.239999999999995 109.132 175.688 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.8 m -78.67 124.52 85.17 Favored Pre-proline 0 N--CA 1.418 -2.042 0 C-N-CA 123.675 0.79 . . . . 73.239999999999995 111.289 -169.963 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -66.36 134.73 37.08 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 122.485 2.123 . . . . 31.149999999999999 109.573 174.545 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.414 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -73.3 135.71 79.16 Favored Pre-proline 0 C--N 1.303 -1.444 0 C-N-CA 119.976 -0.69 . . . . 62.350000000000001 110.67 177.093 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 9' ' ' GLU . 38.8 Cg_exo -60.27 121.61 10.05 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 122.204 1.936 . . . . 54.509999999999998 111.82 -178.225 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -79.63 108.53 13.25 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 106.631 -1.618 . . . . 73.540000000000006 106.631 178.636 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.8 m -63.95 126.14 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.305 0 CA-C-O 121.66 0.743 . . . . 60.149999999999999 112.44 -174.008 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -88.08 141.16 28.79 Favored 'General case' 0 N--CA 1.425 -1.678 0 CA-C-N 114.953 -1.021 . . . . 73.140000000000001 109.755 178.826 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.8 t -138.65 141.78 39.06 Favored 'General case' 0 C--N 1.285 -2.231 0 N-CA-C 108.156 -1.054 . . . . 51.310000000000002 108.156 179.027 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.8 t -105.23 124.95 50.4 Favored 'General case' 0 N--CA 1.406 -2.644 0 N-CA-C 108.171 -1.048 . . . . 71.439999999999998 108.171 -179.829 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.0 m -143.03 93.53 2.51 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-N 115.691 -0.686 . . . . 64.349999999999994 110.319 -178.811 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 C--N 1.312 -1.048 0 N-CA-C 108.629 -0.878 . . . . 75.030000000000001 108.629 179.333 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.644 0 N-CA-C 111.05 -0.82 . . . . 44.32 111.05 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.2 m -89.65 152.74 21.21 Favored 'General case' 0 N--CA 1.428 -1.526 0 N-CA-C 107.228 -1.397 . . . . 63.439999999999998 107.228 176.347 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.485 ' HB3' ' CZ ' ' A' ' 137' ' ' PHE . . . -97.64 178.54 5.13 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 110.201 -0.296 . . . . 65.540000000000006 110.201 -176.991 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -134.16 158.03 44.71 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.121 0.486 . . . . 73.340000000000003 111.507 -175.524 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.6 pp -121.34 140.26 52.33 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 115.354 -0.839 . . . . 71.230000000000004 109.023 174.869 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.446 HG12 ' CB ' ' A' ' 60' ' ' ARG . 33.1 m -115.52 138.51 45.66 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 CA-C-O 121.043 0.449 . . . . 52.310000000000002 109.834 179.611 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.0 t -93.61 115.62 32.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 107.818 -1.178 . . . . 74.209999999999994 107.818 179.943 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -88.56 -36.2 16.49 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.241 0.543 . . . . 72.219999999999999 109.551 -179.411 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.424 ' O ' ' HB3' ' A' ' 133' ' ' PHE . 37.6 ttm180 -149.84 125.5 10.36 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.309 -0.997 . . . . 72.319999999999993 108.309 -179.879 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 153.94 121.85 0.83 Allowed Glycine 0 N--CA 1.418 -2.539 0 C-N-CA 120.959 -0.639 . . . . 33.520000000000003 111.662 179.821 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -55.85 -9.04 2.58 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 124.522 3.481 . . . . 52.109999999999999 113.876 178.802 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.445 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 7.2 t30 -51.86 -38.39 55.82 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 124.106 0.962 . . . . 63.350000000000001 110.786 176.01 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -178.57 -59.87 0.01 OUTLIER 'General case' 0 C--N 1.354 0.764 0 CA-C-N 116.318 -0.401 . . . . 73.209999999999994 111.735 179.738 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.55 54.07 4.12 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 109.515 -1.434 . . . . 74.310000000000002 109.515 -173.837 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -154.63 -171.52 3.88 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 107.926 -1.138 . . . . 53.0 107.926 -175.752 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.446 ' CB ' HG12 ' A' ' 50' ' ' VAL . 18.7 ptp180 -110.15 140.2 44.5 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 109.875 -0.417 . . . . 72.040000000000006 109.875 -178.368 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -135.24 119.02 17.2 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 120.673 0.273 . . . . 73.420000000000002 110.891 179.765 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.0 tt -86.55 139.56 30.73 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 107.073 -1.454 . . . . 75.239999999999995 107.073 174.724 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 87.8 mt -71.19 114.07 8.87 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 119.923 -0.711 . . . . 74.239999999999995 109.385 -176.433 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -117.45 -32.26 4.98 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 114.793 -1.094 . . . . 53.43 110.989 -172.655 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -96.97 132.25 26.22 Favored Pre-proline 0 C--N 1.303 -1.454 0 N-CA-C 107.686 -1.227 . . . . 73.239999999999995 107.686 178.653 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.454 ' HA ' HG13 ' A' ' 94' ' ' ILE . 10.5 Cg_endo -53.45 -26.48 36.09 Favored 'Trans proline' 0 C--N 1.371 1.748 0 C-N-CA 124.034 3.156 . . . . 43.439999999999998 113.411 -176.207 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 51.8 m -133.39 98.09 4.14 Favored 'General case' 0 N--CA 1.407 -2.586 0 N-CA-C 108.404 -0.961 . . . . 70.329999999999998 108.404 174.282 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 98.2 m -88.75 115.4 26.26 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 114.868 -1.06 . . . . 74.0 108.469 -178.685 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.6 t -107.78 121.51 44.87 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-O 121.554 0.693 . . . . 61.409999999999997 111.369 -177.277 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -104.7 115.32 30.12 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 114.868 -1.06 . . . . 44.399999999999999 109.022 179.185 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.725 ' O ' ' HA ' ' A' ' 88' ' ' ARG . . . 90.64 85.33 1.39 Allowed Glycine 0 CA--C 1.475 -2.446 0 N-CA-C 107.798 -2.121 . . . . 73.329999999999998 107.798 -177.375 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.416 ' HG2' ' O ' ' A' ' 75' ' ' GLU . 23.5 tpt180 -177.57 142.79 0.33 Allowed 'General case' 0 N--CA 1.407 -2.59 0 N-CA-C 102.243 -3.243 . . . . 63.009999999999998 102.243 -171.513 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -109.16 -60.55 0.04 OUTLIER Pre-proline 0 C--N 1.274 -2.705 0 N-CA-C 115.316 1.599 . . . . 73.420000000000002 115.316 -177.701 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_exo -66.67 -40.63 12.82 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 121.871 1.714 . . . . 65.109999999999999 113.862 -173.249 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.416 ' O ' ' HG2' ' A' ' 72' ' ' ARG . 38.7 tt0 -130.42 75.55 1.66 Allowed 'General case' 0 N--CA 1.422 -1.87 0 N-CA-C 107.378 -1.341 . . . . 41.340000000000003 107.378 -177.309 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.4 p -112.24 170.44 8.16 Favored 'General case' 0 C--N 1.285 -2.231 0 N-CA-C 113.365 0.876 . . . . 72.510000000000005 113.365 -171.689 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -112.14 -55.71 2.48 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 107.166 -1.42 . . . . 51.240000000000002 107.166 173.857 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 24.2 pt -125.43 152.28 32.05 Favored 'Isoleucine or valine' 0 C--O 1.25 1.12 0 CA-C-N 115.539 -0.755 . . . . 71.129999999999995 109.422 174.797 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.445 ' O ' ' HA ' ' A' ' 56' ' ' ASN . 87.8 m-85 -112.89 117.53 32.38 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 112.293 0.479 . . . . 71.400000000000006 112.293 -173.131 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.2 mp -74.12 107.39 6.28 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 108.743 -0.836 . . . . 72.430000000000007 108.743 170.1 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -82.04 1.4 35.95 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 123.993 0.917 . . . . 64.409999999999997 110.976 -178.02 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -98.4 164.44 12.28 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.55 -0.75 . . . . 62.149999999999999 109.857 -177.949 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.2 p -69.92 -18.8 22.2 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.134 0 C-N-CA 123.35 0.66 . . . . 63.549999999999997 111.64 -178.769 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 13.3 p -73.05 11.44 0.7 Allowed 'General case' 0 CA--C 1.555 1.15 0 N-CA-C 113.698 0.999 . . . . 74.230000000000004 113.698 -178.807 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.6 p -82.58 125.0 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 CA-C-O 121.436 0.636 . . . . 64.0 111.931 -177.187 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 41.9 t -84.68 169.34 14.41 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.343 -0.984 . . . . 43.420000000000002 108.343 174.624 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 52.3 mtm-85 -56.76 -40.76 76.4 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 108.946 -0.761 . . . . 73.230000000000004 108.946 175.87 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.725 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -146.07 129.45 16.82 Favored 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 105.754 -1.943 . . . . 64.510000000000005 105.754 165.392 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.401 ' HA ' ' HA3' ' A' ' 105' ' ' GLY . 30.1 t60 -108.74 -74.04 0.67 Allowed 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 113.213 0.819 . . . . 70.239999999999995 113.213 -171.088 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -117.29 119.39 35.0 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 121.652 -0.655 . . . . 61.009999999999998 109.756 -177.443 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -109.69 127.18 54.4 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 108.277 -1.009 . . . . 72.209999999999994 108.277 -179.608 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -112.33 112.8 24.63 Favored 'General case' 0 N--CA 1.425 -1.693 0 N-CA-C 107.619 -1.252 . . . . 74.219999999999999 107.619 -178.763 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 30.8 ttm-85 -101.91 143.32 31.94 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 107.819 -1.178 . . . . 71.129999999999995 107.819 179.791 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.454 HG13 ' HA ' ' A' ' 66' ' ' PRO . 2.6 pp -115.53 140.46 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.479 0 N-CA-C 107.578 -1.267 . . . . 71.450000000000003 107.578 175.298 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.455 ' C ' ' H ' ' A' ' 97' ' ' GLY . 40.0 t-20 -118.44 147.08 43.95 Favored 'General case' 0 C--N 1.268 -2.972 0 N-CA-C 104.541 -2.392 . . . . 55.130000000000003 104.541 -178.807 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -59.84 26.5 0.01 OUTLIER 'General case' 0 CA--C 1.574 1.881 0 N-CA-C 114.62 1.341 . . . . 64.349999999999994 114.62 -176.945 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.455 ' H ' ' C ' ' A' ' 95' ' ' ASN . . . -169.16 -38.31 0.03 OUTLIER Glycine 0 N--CA 1.426 -2.011 0 N-CA-C 111.074 -0.81 . . . . 71.129999999999995 111.074 -179.445 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -127.61 170.9 12.14 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.95 0.405 . . . . 73.409999999999997 111.283 -176.392 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -116.89 129.3 55.98 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 116.276 -0.42 . . . . 71.120000000000005 110.101 -179.912 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -122.07 119.52 31.64 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.907 -0.405 . . . . 74.019999999999996 109.907 -176.845 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.496 HG11 ' SD ' ' A' ' 122' ' ' MET . 27.9 m -121.93 128.92 75.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 C-N-CA 119.835 -0.746 . . . . 74.299999999999997 110.944 178.371 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 29.4 m -119.84 137.46 53.65 Favored 'Isoleucine or valine' 0 C--O 1.252 1.234 0 N-CA-C 112.76 0.652 . . . . 62.420000000000002 112.76 -178.243 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -92.68 108.37 19.93 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.485 -0.78 . . . . 72.319999999999993 110.228 174.98 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.3 m -114.56 5.46 7.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 CA-C-O 121.86 0.838 . . . . 53.310000000000002 109.709 177.417 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.401 ' HA3' ' HA ' ' A' ' 89' ' ' HIS . . . -105.86 36.32 4.48 Favored Glycine 0 N--CA 1.431 -1.676 0 N-CA-C 109.725 -1.35 . . . . 42.43 109.725 179.351 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 14.0 m -65.01 5.47 0.34 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.736 1.615 . . . . 74.239999999999995 113.158 -176.689 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.4 mp -69.37 -34.27 74.3 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 107.505 -1.295 . . . . 71.329999999999998 107.505 172.918 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -119.01 -40.06 2.87 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 107.293 -1.373 . . . . 75.519999999999996 107.293 174.1 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 104.96 141.89 11.08 Favored Glycine 0 N--CA 1.44 -1.08 0 CA-C-N 115.79 -0.641 . . . . 74.099999999999994 113.485 176.108 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 27.6 m -108.52 125.45 51.82 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 107.362 -1.347 . . . . 51.140000000000001 107.362 173.205 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -103.64 134.52 46.85 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.56 -0.533 . . . . 73.299999999999997 109.56 -176.684 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.421 HG21 ' HG2' ' A' ' 120' ' ' GLN . 7.2 p -125.77 127.51 71.42 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.428 0 N-CA-C 106.973 -1.491 . . . . 70.450000000000003 106.973 175.391 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 18.4 m120 64.71 22.6 12.62 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 109.108 -0.701 . . . . 63.219999999999999 109.108 -174.842 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 18.3 mmm180 76.54 5.41 3.53 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.729 1.212 . . . . 72.25 112.779 -175.291 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -112.41 130.07 23.73 Favored Pre-proline 0 C--N 1.315 -0.924 0 N-CA-C 110.386 -0.227 . . . . 71.400000000000006 110.386 -179.4 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -74.85 110.48 3.12 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 121.823 1.682 . . . . 74.510000000000005 109.772 175.858 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 43.2 ttt180 -126.83 154.64 44.07 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.508 -1.293 . . . . 75.310000000000002 107.508 -176.235 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -81.2 -50.52 9.48 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.271 -0.572 . . . . 75.319999999999993 110.664 -175.182 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -130.18 140.16 50.77 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 108.406 -0.961 . . . . 64.439999999999998 108.406 178.875 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.421 ' HG2' HG21 ' A' ' 112' ' ' VAL . 55.2 tp60 -139.72 148.03 41.74 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 109.692 -0.485 . . . . 70.0 109.692 -179.926 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 98.8 t -88.17 117.29 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 N-CA-C 105.195 -2.15 . . . . 74.420000000000002 105.195 167.86 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.496 ' SD ' HG11 ' A' ' 101' ' ' VAL . 4.6 tpt -55.89 116.73 3.13 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 124.071 0.948 . . . . 70.310000000000002 111.468 -171.74 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -105.26 129.83 53.53 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.662 -0.699 . . . . 63.549999999999997 109.6 -174.336 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 7.0 t -79.61 129.16 34.22 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 121.628 0.728 . . . . 54.450000000000003 112.571 -175.217 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 108.18 -11.43 37.03 Favored Glycine 0 N--CA 1.423 -2.17 0 CA-C-N 115.249 -0.887 . . . . 62.530000000000001 111.638 178.196 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -102.35 172.59 6.8 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 112.867 0.692 . . . . 73.310000000000002 112.867 -177.344 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -108.32 142.52 38.5 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-N 115.056 -0.974 . . . . 74.099999999999994 112.115 -172.891 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.4 mp -124.1 113.17 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.922 0 N-CA-C 105.74 -1.948 . . . . 74.040000000000006 105.74 178.216 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.428 ' HA ' ' O ' ' A' ' 133' ' ' PHE . 66.4 mt-30 -102.95 119.64 39.21 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 109.667 -0.494 . . . . 72.439999999999998 109.667 -177.056 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 20.9 pt -91.41 99.72 10.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 N-CA-C 107.999 -1.112 . . . . 74.310000000000002 107.999 176.884 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 79.19 -94.03 1.34 Allowed Glycine 0 N--CA 1.422 -2.299 0 N-CA-C 108.755 -1.738 . . . . 72.230000000000004 108.755 -174.376 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -137.54 15.94 2.94 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.205 0.526 . . . . 64.310000000000002 110.306 177.128 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.428 ' O ' ' HA ' ' A' ' 129' ' ' GLN . 53.1 m-85 -103.52 131.3 50.76 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 109.664 -0.495 . . . . 75.299999999999997 109.664 -179.868 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 48.7 ttt180 -95.27 121.76 37.26 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-O 121.631 0.729 . . . . 55.549999999999997 111.708 -169.214 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 9.5 mp -121.96 143.87 49.21 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 107.668 -1.234 . . . . 63.119999999999997 107.668 175.672 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 6.3 p -126.95 130.67 71.37 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.435 0 C-N-CA 120.633 -0.427 . . . . 71.200000000000003 110.318 179.342 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 137' ' ' PHE . . . . . 0.485 ' CZ ' ' HB3' ' A' ' 47' ' ' ALA . 90.7 t80 -97.22 125.21 41.61 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.585 -0.734 . . . . 74.319999999999993 110.115 -176.759 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -128.56 144.24 51.11 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.385 0.612 . . . . 52.219999999999999 110.785 -179.752 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -87.01 86.21 7.3 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 106.996 -1.483 . . . . 73.340000000000003 106.996 171.926 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -75.27 -174.09 34.18 Favored Glycine 0 N--CA 1.439 -1.121 0 CA-C-N 114.983 -1.008 . . . . 52.409999999999997 113.945 -174.719 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo . . . . . 0 N--CA 1.447 -1.218 0 C-N-CA 122.716 2.278 . . . . 74.120000000000005 112.801 -179.14 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 . . . . . 0 CA--C 1.506 -0.716 0 CA-C-O 121.178 0.513 . . . . 55.219999999999999 111.278 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -138.12 55.23 0.68 Allowed Glycine 0 N--CA 1.438 -1.229 0 N-CA-C 109.916 -1.273 . . . . 61.310000000000002 109.916 179.398 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.427 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 11.3 t -64.8 127.98 93.14 Favored Pre-proline 0 N--CA 1.439 -0.987 0 CA-C-N 115.191 -0.504 . . . . 74.010000000000005 109.834 -177.907 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 7' ' ' THR . 31.4 Cg_exo -61.1 127.65 22.86 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.198 1.932 . . . . 43.520000000000003 111.212 179.849 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -101.74 115.69 64.5 Favored Pre-proline 0 C--N 1.302 -1.496 0 N-CA-C 109.505 -0.554 . . . . 65.439999999999998 109.505 179.606 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -73.03 128.87 13.53 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.744 2.296 . . . . 72.219999999999999 113.894 -176.59 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -106.69 108.04 19.36 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 106.057 -1.831 . . . . 74.010000000000005 106.057 176.369 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.2 p -124.54 135.48 63.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 N-CA-C 109.396 -0.594 . . . . 33.43 109.396 -179.314 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -105.92 130.77 53.8 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.121 0.486 . . . . 74.040000000000006 110.825 -178.98 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 95.6 m -151.63 106.43 3.25 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.238 -1.023 . . . . 51.350000000000001 108.238 174.693 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 17.1 p -96.99 122.98 40.58 Favored 'General case' 0 N--CA 1.412 -2.327 0 CA-C-O 121.422 0.63 . . . . 55.240000000000002 110.506 -178.049 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 27.5 t -80.66 108.78 14.6 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 114.747 -1.115 . . . . 74.030000000000001 110.336 -177.331 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 91.5 t . . . . . 0 C--N 1.306 -1.302 0 N-CA-C 108.416 -0.957 . . . . 72.430000000000007 108.416 178.497 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.149 0 N-CA-C 111.149 -0.78 . . . . 45.119999999999997 111.149 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.5 ' O ' ' HA ' ' A' ' 141' ' ' PRO . 10.8 m -90.53 159.77 16.31 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.342 -0.614 . . . . 51.520000000000003 109.342 -178.282 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -113.98 178.38 4.3 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 117.741 0.246 . . . . 73.450000000000003 111.064 -176.261 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.5 pp -132.36 158.94 40.64 Favored 'General case' 0 C--O 1.244 0.788 0 N-CA-C 112.909 0.707 . . . . 61.310000000000002 112.909 -173.389 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.4 pp -119.24 147.74 43.91 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.58 -0.736 . . . . 74.040000000000006 109.817 176.914 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 25.3 t -130.23 149.86 34.02 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 C-N-CA 123.606 0.763 . . . . 51.549999999999997 109.284 -175.577 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.489 HG23 ' HD2' ' A' ' 55' ' ' PRO . 3.5 p -88.54 118.05 33.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-O 122.375 1.083 . . . . 74.319999999999993 111.05 179.475 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -95.6 -39.05 10.12 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-N 115.244 -0.889 . . . . 64.239999999999995 108.785 174.016 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -154.04 89.17 1.28 Allowed 'General case' 0 C--O 1.215 -0.748 0 N-CA-C 109.051 -0.722 . . . . 63.450000000000003 109.051 176.211 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 20.87 54.04 0.01 OUTLIER Glycine 0 N--CA 1.508 3.495 0 N-CA-C 119.842 2.697 . . . . 62.409999999999997 119.842 177.44 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.489 ' HD2' HG23 ' A' ' 51' ' ' VAL . 74.0 Cg_endo -71.91 -40.37 2.69 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 CA-C-N 120.821 2.31 . . . . 63.439999999999998 113.89 -178.783 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.565 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 17.1 m-80 -134.17 -84.42 0.43 Allowed 'General case' 0 C--O 1.209 -1.055 0 CA-C-O 121.183 0.516 . . . . 62.420000000000002 112.079 -171.504 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.64 -6.82 26.59 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.528 0.566 . . . . 73.239999999999995 112.528 -173.825 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.24 40.57 99.2 Favored Glycine 0 CA--C 1.523 0.579 0 C-N-CA 120.756 -0.735 . . . . 61.0 112.256 -178.199 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -157.09 -163.7 1.45 Allowed 'General case' 0 C--O 1.254 1.331 0 N-CA-C 108.886 -0.783 . . . . 44.520000000000003 108.886 -177.122 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -132.34 139.49 48.17 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 108.354 -0.98 . . . . 72.129999999999995 108.354 176.134 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -156.46 154.5 30.5 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.057 0.456 . . . . 71.340000000000003 111.786 179.477 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 31.2 tp -80.08 139.49 36.87 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 114.55 -1.204 . . . . 73.340000000000003 109.172 179.655 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.9 mp -82.77 114.38 21.06 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 106.52 -1.659 . . . . 74.230000000000004 106.52 173.704 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -112.42 3.8 17.14 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 116.132 -0.486 . . . . 74.219999999999999 110.233 -175.012 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -121.82 141.11 33.21 Favored Pre-proline 0 C--N 1.301 -1.541 0 N-CA-C 107.741 -1.207 . . . . 63.25 107.741 -179.391 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -55.08 -49.89 14.99 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.167 2.578 . . . . 51.200000000000003 111.924 -177.413 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' A' ' 92' ' ' PHE . 44.3 m -121.08 108.54 13.94 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-N 115.509 -0.769 . . . . 74.239999999999995 110.455 178.924 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.436 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 4.7 m -91.66 114.81 27.44 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.264 -1.013 . . . . 75.430000000000007 108.264 179.116 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 16.7 p -90.79 122.76 33.8 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 116.742 -0.208 . . . . 75.340000000000003 110.693 -179.774 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.441 ' HA ' ' O ' ' A' ' 78' ' ' ILE . . . -109.5 121.84 46.08 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 109.877 -0.416 . . . . 71.209999999999994 109.877 178.178 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -164.6 -136.22 1.96 Allowed Glycine 0 N--CA 1.432 -1.604 0 N-CA-C 111.117 -0.793 . . . . 70.439999999999998 111.117 178.52 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.463 ' NH2' ' HA ' ' A' ' 81' ' ' ASP . 4.2 tpp180 -159.57 84.65 0.77 Allowed 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.025 -1.472 . . . . 75.25 107.025 176.992 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -179.97 151.18 0.57 Allowed Pre-proline 0 C--N 1.296 -1.756 0 N-CA-C 104.745 -2.317 . . . . 75.439999999999998 104.745 -177.514 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.44 -22.15 70.52 Favored 'Trans proline' 0 N--CA 1.48 0.709 0 C-N-CA 122.41 2.073 . . . . 74.120000000000005 113.211 -178.149 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -79.54 -18.34 52.03 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.431 -0.35 . . . . 71.219999999999999 111.064 -179.148 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.0 m -88.42 131.86 34.69 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 107.162 -1.422 . . . . 65.230000000000004 107.162 176.167 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -70.84 -50.38 36.02 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 120.956 -0.297 . . . . 63.310000000000002 111.451 -176.851 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.441 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 39.2 pt -112.37 154.55 13.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 C-N-CA 120.133 -0.627 . . . . 55.530000000000001 109.883 178.991 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -116.58 136.05 53.3 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 116.399 -0.364 . . . . 72.450000000000003 110.501 -179.023 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.565 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 1.5 pt? -84.99 139.92 31.44 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 106.647 -1.612 . . . . 63.329999999999998 106.647 171.553 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.463 ' HA ' ' NH2' ' A' ' 72' ' ' ARG . 19.8 t70 -106.56 58.0 0.64 Allowed 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 118.415 -1.314 . . . . 52.329999999999998 112.583 -172.098 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -104.07 151.19 23.55 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 106.641 -1.615 . . . . 72.25 106.641 171.476 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.4 m -74.38 -12.45 15.14 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 N-CA-C 112.284 0.476 . . . . 72.329999999999998 112.284 -178.621 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -113.42 51.52 0.84 Allowed 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 106.956 -1.498 . . . . 72.329999999999998 106.956 179.16 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.47 HG23 ' HG ' ' A' ' 80' ' ' LEU . 7.6 p -82.24 135.59 24.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 115.469 -0.787 . . . . 73.540000000000006 113.004 -173.038 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 8.0 m -101.75 144.21 30.72 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.625 -0.716 . . . . 74.439999999999998 110.93 -177.925 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -67.39 120.79 14.47 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 106.172 -1.788 . . . . 74.409999999999997 106.172 170.569 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 58.1 81.35 0.15 Allowed 'General case' 0 N--CA 1.466 0.357 0 O-C-N 123.9 0.75 . . . . 73.319999999999993 110.396 -172.421 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 19.1 t60 -98.81 -35.65 10.06 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 109.398 -0.593 . . . . 72.340000000000003 109.398 -178.626 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -149.22 136.27 19.83 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 120.335 -0.546 . . . . 73.040000000000006 110.031 -179.447 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -112.89 126.98 56.05 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 108.313 -0.995 . . . . 75.150000000000006 108.313 173.989 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.452 ' O ' ' HA ' ' A' ' 67' ' ' THR . 86.1 m-85 -105.37 122.39 45.88 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.049 -1.093 . . . . 72.129999999999995 108.049 179.058 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.467 ' HB3' ' HB3' ' A' ' 100' ' ' GLU . 51.4 ttt180 -113.06 119.16 36.89 Favored 'General case' 0 C--N 1.281 -2.385 0 N-CA-C 108.34 -0.985 . . . . 61.509999999999998 108.34 179.569 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.79 116.43 52.38 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 N-CA-C 107.48 -1.304 . . . . 74.329999999999998 107.48 179.553 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.41 ' OD1' ' HG2' ' A' ' 96' ' ' GLU . 27.4 t30 -101.88 145.55 29.06 Favored 'General case' 0 C--N 1.275 -2.634 0 CA-C-N 113.758 -1.565 . . . . 75.120000000000005 106.864 -179.787 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.41 ' HG2' ' OD1' ' A' ' 95' ' ' ASN . 9.6 pt-20 -42.88 -29.5 0.33 Allowed 'General case' 0 C--N 1.313 -0.995 0 C-N-CA 125.049 1.34 . . . . 73.120000000000005 113.668 -178.388 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -138.7 29.52 2.57 Favored Glycine 0 N--CA 1.43 -1.72 0 C-N-CA 120.373 -0.918 . . . . 75.239999999999995 112.75 177.331 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.405 ' HB3' HD22 ' A' ' 95' ' ' ASN . 8.2 tp10 -165.07 152.99 11.49 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 117.883 0.841 . . . . 64.239999999999995 110.989 -179.866 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -124.96 126.87 46.16 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.845 -0.428 . . . . 72.239999999999995 109.845 -176.549 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.467 ' HB3' ' HB3' ' A' ' 93' ' ' ARG . 37.3 tt0 -132.26 135.19 46.09 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 122.568 0.347 . . . . 73.129999999999995 110.269 -175.992 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.7 p -128.7 129.01 68.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 O-C-N 121.946 -0.472 . . . . 70.349999999999994 110.908 177.608 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 97.5 t -119.47 124.53 73.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 116.008 -0.542 . . . . 72.239999999999995 110.816 179.722 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -83.6 125.16 31.52 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 123.2 0.6 . . . . 60.329999999999998 110.272 174.725 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.8 t -118.72 7.6 6.79 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 N-CA-C 107.936 -1.135 . . . . 63.100000000000001 107.936 178.393 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -116.7 45.56 1.27 Allowed Glycine 0 N--CA 1.441 -1.009 0 N-CA-C 110.498 -1.041 . . . . 23.32 110.498 -178.873 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 12.3 m -63.72 -12.62 36.29 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 123.977 0.911 . . . . 74.129999999999995 111.61 -177.538 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 92.0 mt -61.35 -35.84 78.55 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.8 0.84 . . . . 74.129999999999995 109.892 174.748 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -93.69 -37.59 11.75 Favored 'General case' 0 CA--C 1.496 -1.118 0 N-CA-C 108.327 -0.99 . . . . 64.340000000000003 108.327 178.257 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 93.65 88.63 1.62 Allowed Glycine 0 N--CA 1.432 -1.614 0 CA-C-N 114.943 -1.026 . . . . 74.019999999999996 111.499 -179.99 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 55.1 m -82.3 120.62 25.63 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 109.37 -0.604 . . . . 70.409999999999997 109.37 177.634 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.476 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 37.4 m-85 -106.2 134.93 48.56 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 107.818 -1.178 . . . . 73.310000000000002 107.818 -179.927 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 23.8 t -105.88 121.33 58.09 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.235 0 N-CA-C 106.8 -1.556 . . . . 72.239999999999995 106.8 177.898 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 61.96 25.51 15.32 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.704 1.202 . . . . 54.140000000000001 109.809 -175.102 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 65.6 mtp180 75.08 14.53 3.1 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.248 1.819 . . . . 61.210000000000001 112.363 -178.523 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 25.1 tp10 -110.76 123.94 34.29 Favored Pre-proline 0 C--N 1.307 -1.279 0 N-CA-C 108.039 -1.097 . . . . 71.310000000000002 108.039 174.798 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -57.21 103.83 0.14 Allowed 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.226 1.951 . . . . 65.439999999999998 110.762 176.073 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.408 ' HE ' ' HA ' ' A' ' 117' ' ' ARG . 1.6 tpm_? -143.41 111.07 5.92 Favored 'General case' 0 N--CA 1.414 -2.229 0 N-CA-C 105.391 -2.077 . . . . 63.25 105.391 -176.697 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -81.21 -23.73 37.92 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 120.553 -0.459 . . . . 72.409999999999997 111.638 -173.856 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -130.77 137.05 49.28 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.264 -1.384 . . . . 73.219999999999999 107.264 172.286 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.401 ' HG2' ' HG2' ' A' ' 117' ' ' ARG . 0.0 OUTLIER -140.43 145.85 37.55 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 108.229 -1.026 . . . . 74.200000000000003 108.229 -178.734 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 44.9 t -95.53 103.45 14.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 104.955 -2.239 . . . . 72.430000000000007 104.955 174.694 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 24.7 mtt -58.11 129.44 41.97 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 116.296 1.962 . . . . 54.240000000000002 116.296 -168.927 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.99 153.3 22.78 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 112.715 -2.039 . . . . 64.239999999999995 107.334 176.418 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 9.5 t -76.75 115.58 16.65 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 122.367 1.079 . . . . 64.230000000000004 109.575 -178.571 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 113.46 3.74 23.85 Favored Glycine 0 N--CA 1.426 -2.016 0 CA-C-N 114.865 -1.062 . . . . 61.340000000000003 110.821 -176.057 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -62.31 133.98 55.86 Favored 'General case' 0 CA--C 1.491 -1.305 0 CA-C-O 121.258 0.551 . . . . 75.209999999999994 111.283 178.991 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -114.33 127.66 55.97 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 115.032 -0.986 . . . . 72.120000000000005 110.32 -178.378 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.461 ' HB ' ' HB3' ' A' ' 135' ' ' LEU . 65.4 mt -97.67 118.94 45.02 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.234 0 N-CA-C 108.039 -1.097 . . . . 65.230000000000004 108.039 177.086 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.476 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 48.9 tp60 -103.39 112.71 25.73 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 115.326 -0.852 . . . . 74.400000000000006 109.148 -177.086 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.455 HG13 ' HB2' ' A' ' 133' ' ' PHE . 14.0 pt -124.34 97.9 4.91 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 108.426 -0.953 . . . . 71.430000000000007 108.426 174.25 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 68.46 -108.65 2.54 Favored Glycine 0 N--CA 1.435 -1.4 0 CA-C-N 114.865 -1.061 . . . . 50.210000000000001 110.62 -175.663 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -108.34 -1.86 19.66 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 120.769 0.318 . . . . 73.430000000000007 111.004 177.638 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.455 ' HB2' HG13 ' A' ' 130' ' ' ILE . 71.0 m-85 -93.54 147.55 22.88 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.724 0.297 . . . . 73.430000000000007 110.984 -177.902 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.421 ' HA ' ' O ' ' A' ' 128' ' ' ILE . 84.1 mtt180 -133.74 129.65 36.98 Favored 'General case' 0 C--O 1.257 1.453 0 CA-C-N 115.785 -0.643 . . . . 71.200000000000003 111.829 -178.979 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.486 HD13 ' N ' ' A' ' 136' ' ' VAL . 3.4 tm? -109.39 144.68 37.27 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 106.185 -1.783 . . . . 74.030000000000001 106.185 172.628 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.486 ' N ' HD13 ' A' ' 135' ' ' LEU . 12.9 p -130.09 128.03 64.1 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.704 0 N-CA-C 109.377 -0.601 . . . . 72.329999999999998 109.377 -178.82 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -110.69 129.88 55.71 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.656 -0.702 . . . . 71.430000000000007 109.569 -176.871 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.3 mp -127.7 140.66 51.94 Favored 'General case' 0 C--O 1.253 1.25 0 CA-C-O 121.363 0.601 . . . . 62.009999999999998 110.804 -179.455 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -86.73 87.88 7.55 Favored 'General case' 0 N--CA 1.422 -1.852 0 CA-C-N 115.339 -0.846 . . . . 74.310000000000002 109.363 179.08 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -120.27 84.13 0.37 Allowed Glycine 0 C--N 1.292 -1.884 0 N-CA-C 107.536 -2.226 . . . . 40.5 107.536 174.517 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.5 ' HA ' ' O ' ' A' ' 46' ' ' SER . 14.9 Cg_endo . . . . . 0 N--CA 1.445 -1.376 0 C-N-CA 122.541 2.16 . . . . 73.299999999999997 114.775 -172.049 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 56.0 t30 . . . . . 0 N--CA 1.468 0.466 0 N-CA-C 112.224 0.453 . . . . 75.530000000000001 112.224 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 88.61 130.11 3.52 Favored Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 120.884 -0.674 . . . . 72.209999999999994 112.189 178.599 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.5 m -111.48 124.69 32.0 Favored Pre-proline 0 C--N 1.302 -1.496 0 N-CA-C 109.777 -0.453 . . . . 74.310000000000002 109.777 179.272 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -66.14 142.24 66.71 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.925 2.417 . . . . 73.549999999999997 112.098 177.736 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -121.75 146.82 46.71 Favored Pre-proline 0 C--N 1.296 -1.721 0 N-CA-C 108.113 -1.069 . . . . 72.0 108.113 178.465 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -61.44 155.14 54.31 Favored 'Trans proline' 0 C--O 1.251 1.164 0 C-N-CA 122.548 2.165 . . . . 50.409999999999997 111.97 178.053 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -66.66 150.86 48.45 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.731 -0.668 . . . . 63.439999999999998 109.934 179.548 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.2 p -88.4 129.09 40.15 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.353 0 CA-C-N 116.114 -0.494 . . . . 52.130000000000003 110.386 179.978 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -78.25 140.74 38.87 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 116.035 -0.529 . . . . 72.109999999999999 110.24 -178.862 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.8 t -101.67 142.23 33.32 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.285 -1.006 . . . . 74.340000000000003 108.285 177.01 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.9 t -157.35 158.43 35.96 Favored 'General case' 0 N--CA 1.422 -1.847 0 N-CA-C 107.555 -1.276 . . . . 74.200000000000003 107.555 -179.004 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.7 t -98.64 101.54 12.99 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.246 -1.02 . . . . 75.040000000000006 108.246 179.788 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.8 p . . . . . 0 C--N 1.315 -0.92 0 CA-C-O 122.339 1.066 . . . . 52.340000000000003 113.299 -176.79 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.537 0 N-CA-C 109.404 -1.479 . . . . 74.420000000000002 109.404 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 65.8 m -89.94 165.15 14.25 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.481 0.658 . . . . 54.299999999999997 111.606 -175.94 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -119.18 163.78 16.56 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 108.329 -0.989 . . . . 73.140000000000001 108.329 179.707 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -135.17 156.29 49.25 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 120.814 0.34 . . . . 60.130000000000003 111.186 -177.821 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.418 ' H ' HD23 ' A' ' 49' ' ' LEU . 1.4 pt? -114.76 132.8 56.33 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.675 -0.861 . . . . 60.509999999999998 108.675 174.307 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 24.8 t -116.03 134.02 60.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.566 -0.901 . . . . 75.540000000000006 108.566 -178.872 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.488 HG21 ' HB3' ' A' ' 57' ' ' ALA . 24.4 t -92.74 121.5 43.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-O 121.018 0.437 . . . . 51.520000000000003 110.158 -177.893 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -94.43 -41.59 9.31 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.698 -0.683 . . . . 63.420000000000002 110.306 177.964 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -153.14 123.88 7.31 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 109.299 -0.63 . . . . 62.100000000000001 109.299 -176.505 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 151.53 130.32 1.64 Allowed Glycine 0 N--CA 1.427 -1.918 0 N-CA-C 111.261 -0.735 . . . . 53.009999999999998 111.261 178.277 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -61.47 -8.62 11.16 Favored 'Trans proline' 0 N--CA 1.481 0.761 0 C-N-CA 123.534 2.823 . . . . 70.5 113.433 178.051 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.511 ' HB2' ' HA ' ' A' ' 80' ' ' LEU . 5.1 p-10 -56.06 -41.04 74.46 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.28 0.632 . . . . 72.140000000000001 110.611 177.475 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.488 ' HB3' HG21 ' A' ' 51' ' ' VAL . . . -178.75 -168.99 0.15 Allowed 'General case' 0 C--O 1.217 -0.64 0 C-N-CA 123.936 0.894 . . . . 43.329999999999998 109.093 -179.145 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -159.48 28.95 0.39 Allowed Glycine 0 C--N 1.312 -0.775 0 N-CA-C 110.184 -1.167 . . . . 54.509999999999998 110.184 179.122 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -130.19 -166.23 1.65 Allowed 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.295 -1.002 . . . . 72.310000000000002 108.295 -175.471 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.457 ' H ' ' NE ' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -122.96 139.96 53.52 Favored 'General case' 0 N--CA 1.412 -2.335 0 N-CA-C 108.771 -0.826 . . . . 73.510000000000005 108.771 178.382 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -118.94 121.78 40.73 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 109.835 -0.432 . . . . 74.239999999999995 109.835 -177.992 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 47.7 tp -91.25 133.98 34.95 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.541 -0.911 . . . . 75.310000000000002 108.541 178.521 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 7.0 mp -83.27 114.93 21.73 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 120.394 -0.523 . . . . 64.319999999999993 111.219 -179.721 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -120.24 18.35 12.27 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.148 -1.056 . . . . 75.439999999999998 108.148 174.56 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -133.94 142.99 45.53 Favored Pre-proline 0 N--CA 1.438 -1.03 0 CA-C-N 113.881 -1.509 . . . . 75.299999999999997 108.045 178.374 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.424 ' HA ' HG13 ' A' ' 94' ' ' ILE . 26.0 Cg_endo -63.16 -31.26 75.17 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.898 2.398 . . . . 63.329999999999998 113.683 -177.371 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 41.2 m -136.49 120.75 17.93 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.82 -0.55 . . . . 72.019999999999996 110.0 179.417 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.503 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 9.2 m -102.99 119.85 39.58 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 106.471 -1.677 . . . . 72.310000000000002 106.471 176.645 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.46 HG23 ' HA ' ' A' ' 76' ' ' SER . 7.9 t -101.47 131.86 47.37 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 109.08 -0.711 . . . . 73.120000000000005 109.08 -176.604 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -127.5 119.47 26.13 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-O 120.845 0.355 . . . . 74.439999999999998 111.826 -174.577 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 60.3 44.81 97.12 Favored Glycine 0 CA--C 1.496 -1.133 0 CA-C-N 115.707 -0.678 . . . . 74.540000000000006 111.641 178.15 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 46.9 ttt180 -137.9 -31.1 0.79 Allowed 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 120.592 -0.443 . . . . 74.310000000000002 111.507 -173.619 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 49.8 m80 -128.78 160.29 63.89 Favored Pre-proline 0 C--N 1.303 -1.434 0 N-CA-C 107.815 -1.18 . . . . 74.510000000000005 107.815 179.837 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -64.32 -25.4 64.22 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 121.303 1.335 . . . . 74.310000000000002 110.195 172.479 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -99.08 29.46 3.86 Favored 'General case' 0 C--O 1.243 0.756 0 CA-C-N 115.401 -0.818 . . . . 74.340000000000003 111.58 179.422 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.46 ' HA ' HG23 ' A' ' 69' ' ' THR . 70.2 m -54.43 136.53 44.01 Favored 'General case' 0 C--O 1.244 0.814 0 CA-C-O 120.898 0.38 . . . . 75.109999999999999 111.158 178.765 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -61.27 -43.91 98.1 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 115.025 -0.989 . . . . 62.530000000000001 109.911 -177.347 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 48.4 pt -124.93 156.72 33.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 CA-C-N 115.167 -0.924 . . . . 63.43 108.649 176.766 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -106.73 136.18 46.98 Favored 'General case' 0 C--N 1.284 -2.25 0 CA-C-N 115.846 -0.615 . . . . 74.209999999999994 110.026 -179.913 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.511 ' HA ' ' HB2' ' A' ' 56' ' ' ASN . 94.2 mt -107.38 171.74 7.21 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 108.67 -0.863 . . . . 75.400000000000006 108.67 -179.471 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -66.16 122.52 17.62 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 121.971 0.891 . . . . 71.329999999999998 110.213 -178.996 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.406 ' HA ' HG12 ' A' ' 85' ' ' VAL . 17.2 m-20 -67.16 -16.54 64.37 Favored 'General case' 0 C--N 1.278 -2.535 0 CA-C-N 113.888 -1.505 . . . . 55.219999999999999 114.52 -174.784 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.3 t -90.8 -24.66 5.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-O 121.825 0.822 . . . . 61.100000000000001 109.183 -179.283 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 11.2 p -103.26 -3.34 25.8 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.702 -0.681 . . . . 64.430000000000007 112.816 -179.628 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.406 HG12 ' HA ' ' A' ' 82' ' ' ASP . 10.7 p -81.47 121.56 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 N-CA-C 107.971 -1.122 . . . . 71.209999999999994 107.971 179.254 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 27.0 p -115.03 46.31 1.46 Allowed 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 112.122 0.415 . . . . 64.420000000000002 112.122 -175.026 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 87' ' ' ARG . 68.6 mtt180 67.52 108.12 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.883 0.873 . . . . 72.209999999999994 110.928 -178.998 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.42 ' O ' HG23 ' A' ' 104' ' ' VAL . 93.7 mtt180 63.71 78.11 0.3 Allowed 'General case' 0 CA--C 1.506 -0.725 0 N-CA-C 108.815 -0.809 . . . . 63.210000000000001 108.815 178.669 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 41.1 t60 -85.34 -67.27 0.81 Allowed 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 118.701 -1.2 . . . . 74.400000000000006 113.905 -172.522 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -137.8 156.45 47.94 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 118.324 -1.351 . . . . 74.340000000000003 113.589 -173.284 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -127.1 127.76 45.15 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 114.358 -1.292 . . . . 71.109999999999999 108.104 175.172 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.503 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 79.1 m-85 -108.69 112.72 25.18 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 106.085 -1.82 . . . . 75.230000000000004 106.085 174.865 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -117.08 144.4 44.7 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 121.64 0.733 . . . . 71.209999999999994 111.535 -173.396 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.445 ' O ' HD12 ' A' ' 94' ' ' ILE . 2.8 pp -116.17 116.4 52.18 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.64 0 N-CA-C 104.119 -2.549 . . . . 74.109999999999999 104.119 167.347 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.593 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 46.6 t-20 -108.09 145.03 34.65 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 107.734 -1.209 . . . . 72.420000000000002 107.734 -172.647 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -54.66 -26.75 35.17 Favored 'General case' 0 C--N 1.311 -1.078 0 O-C-N 123.645 0.591 . . . . 74.120000000000005 111.076 178.692 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -72.7 -63.35 2.9 Favored Glycine 0 N--CA 1.43 -1.759 0 N-CA-C 110.816 -0.914 . . . . 74.409999999999997 110.816 173.785 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.593 ' O ' ' HB3' ' A' ' 95' ' ' ASN . 44.2 mt-10 -159.26 168.36 26.66 Favored 'General case' 0 C--O 1.212 -0.893 0 N-CA-C 106.202 -1.777 . . . . 73.230000000000004 106.202 -178.38 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.454 ' HB2' ' CB ' ' A' ' 122' ' ' MET . 9.3 m-85 -91.31 134.84 34.25 Favored 'General case' 0 C--N 1.295 -1.767 0 C-N-CA 119.414 -0.914 . . . . 74.530000000000001 109.534 -177.379 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -132.2 136.22 46.87 Favored 'General case' 0 CA--C 1.501 -0.904 0 N-CA-C 113.218 0.821 . . . . 72.040000000000006 113.218 -175.858 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 90.1 t -111.01 119.91 60.6 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.077 0 N-CA-C 108.11 -1.07 . . . . 65.150000000000006 108.11 176.629 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 35.3 t -119.2 116.63 51.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 116.367 -0.379 . . . . 70.540000000000006 110.012 -176.733 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -104.26 108.93 20.55 Favored 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 107.551 -1.277 . . . . 65.340000000000003 107.551 175.97 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 88' ' ' ARG . 26.3 m -92.13 -9.56 10.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-O 121.128 0.489 . . . . 44.350000000000001 110.995 -177.886 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -92.16 27.33 10.49 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 109.759 -1.336 . . . . 71.540000000000006 109.759 176.049 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.42 ' HA ' ' OG1' ' A' ' 110' ' ' THR . 1.1 p -69.52 10.03 0.41 Allowed 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 125.532 1.533 . . . . 74.340000000000003 113.282 -177.455 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.427 HD23 ' O ' ' A' ' 107' ' ' LEU . 6.0 tt -68.22 -24.78 64.96 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 106.251 -1.759 . . . . 72.140000000000001 106.251 172.994 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -78.07 -1.84 34.37 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 115.054 -0.975 . . . . 62.140000000000001 110.657 177.393 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 77.28 56.44 3.97 Favored Glycine 0 N--CA 1.439 -1.123 0 N-CA-C 110.471 -1.052 . . . . 71.329999999999998 110.471 -178.203 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.42 ' OG1' ' HA ' ' A' ' 106' ' ' SER . 17.9 m -72.89 121.42 19.98 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-O 121.606 0.717 . . . . 53.350000000000001 111.507 -176.692 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -102.13 133.27 47.25 Favored 'General case' 0 N--CA 1.416 -2.158 0 N-CA-C 106.199 -1.778 . . . . 72.340000000000003 106.199 175.449 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.442 HG13 HG12 ' A' ' 128' ' ' ILE . 25.9 t -125.17 128.78 73.12 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.063 0 N-CA-C 105.537 -2.023 . . . . 74.120000000000005 105.537 179.822 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 63.55 27.24 14.97 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 107.841 -1.17 . . . . 73.319999999999993 107.841 -173.658 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 67.72 9.31 7.0 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 124.899 1.279 . . . . 73.510000000000005 112.254 -175.226 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.572 ' OE1' ' HD2' ' A' ' 116' ' ' PRO . 9.2 tp10 -111.51 126.38 28.68 Favored Pre-proline 0 C--N 1.305 -1.359 0 N-CA-C 108.452 -0.944 . . . . 75.120000000000005 108.452 -178.826 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.572 ' HD2' ' OE1' ' A' ' 115' ' ' GLU . 32.9 Cg_exo -53.75 113.24 1.23 Allowed 'Trans proline' 0 C--O 1.25 1.099 0 C-N-CA 121.967 1.778 . . . . 74.420000000000002 109.309 173.105 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 12.5 tpp85 -160.13 143.31 13.77 Favored 'General case' 0 N--CA 1.425 -1.704 0 N-CA-C 108.508 -0.923 . . . . 74.319999999999993 108.508 -173.349 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -87.98 -41.57 13.05 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.448 -0.575 . . . . 74.129999999999995 109.448 -179.062 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -132.72 139.34 47.58 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.399 -0.963 . . . . 31.43 108.399 177.429 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.07 148.83 47.01 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 107.249 -1.389 . . . . 73.420000000000002 107.249 -176.744 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 8.7 p -84.58 134.33 27.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 108.518 -0.919 . . . . 74.209999999999994 108.518 179.876 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.454 ' CB ' ' HB2' ' A' ' 99' ' ' PHE . 1.5 tmt? -50.24 124.39 10.27 Favored 'General case' 0 C--N 1.313 -1.008 0 O-C-N 123.739 0.649 . . . . 72.030000000000001 112.671 -175.489 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -129.85 151.09 50.8 Favored 'General case' 0 N--CA 1.424 -1.761 0 CA-C-N 115.148 -0.933 . . . . 72.219999999999999 108.817 173.461 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 6.6 p -78.53 115.17 18.05 Favored 'General case' 0 C--N 1.283 -2.306 0 CA-C-N 115.738 -0.665 . . . . 71.530000000000001 109.636 177.681 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 95.16 33.55 6.52 Favored Glycine 0 N--CA 1.437 -1.271 0 N-CA-C 110.334 -1.107 . . . . 73.239999999999995 110.334 -178.234 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -91.48 150.59 21.16 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 107.125 -1.435 . . . . 72.329999999999998 107.125 -179.79 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -137.85 123.13 19.38 Favored 'General case' 0 C--N 1.29 -2.003 0 CA-C-O 122.093 0.949 . . . . 53.119999999999997 111.069 -177.082 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.442 HG12 HG13 ' A' ' 112' ' ' VAL . 58.9 mt -101.92 126.09 55.96 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.22 0 CA-C-N 114.162 -1.381 . . . . 70.420000000000002 108.46 -176.727 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.423 ' HA ' ' O ' ' A' ' 133' ' ' PHE . 29.8 tt0 -119.69 112.78 19.72 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 109.412 -0.588 . . . . 63.310000000000002 109.412 177.94 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 23.1 pt -105.64 97.48 5.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-N 115.139 -0.937 . . . . 55.520000000000003 109.981 -178.826 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 69.36 -72.6 0.45 Allowed Glycine 0 CA--C 1.526 0.747 0 CA-C-N 115.438 -0.801 . . . . 62.229999999999997 113.69 178.502 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -132.15 -12.71 3.19 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 123.096 0.558 . . . . 71.120000000000005 110.256 -176.076 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.423 ' O ' ' HA ' ' A' ' 129' ' ' GLN . 19.5 m-85 -107.72 156.31 19.24 Favored 'General case' 0 C--N 1.321 -0.656 0 O-C-N 121.76 -0.588 . . . . 72.510000000000005 112.023 -171.29 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 134' ' ' ARG . 50.4 mtp180 -131.32 127.02 36.81 Favored 'General case' 0 C--O 1.251 1.14 0 CA-C-O 121.616 0.722 . . . . 73.0 111.791 -174.745 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 58.6 tp -122.06 135.17 54.79 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 114.531 -1.213 . . . . 72.129999999999995 107.748 -179.693 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 14.9 p -112.06 138.63 40.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 N-CA-C 109.326 -0.62 . . . . 65.219999999999999 109.326 -179.737 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -116.25 129.79 56.46 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 109.334 -0.617 . . . . 64.439999999999998 109.334 -177.359 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 58.4 mt -135.66 172.5 12.92 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.306 -0.627 . . . . 64.430000000000007 109.306 -177.078 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -91.11 146.56 23.74 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 107.639 -1.245 . . . . 73.129999999999995 107.639 175.694 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.406 ' HA3' ' HD3' ' A' ' 141' ' ' PRO . . . -96.58 -127.53 5.52 Favored Glycine 0 N--CA 1.429 -1.772 0 C-N-CA 120.374 -0.917 . . . . 71.409999999999997 111.68 -176.705 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.406 ' HD3' ' HA3' ' A' ' 140' ' ' GLY . 6.6 Cg_exo . . . . . 0 N--CA 1.444 -1.412 0 C-N-CA 122.192 1.928 . . . . 64.120000000000005 112.03 179.973 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 . . . . . 0 C--O 1.247 0.928 0 N-CA-C 107.402 -1.332 . . . . 74.430000000000007 107.402 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -133.15 -166.1 11.33 Favored Glycine 0 N--CA 1.424 -2.118 0 C-N-CA 119.908 -1.139 . . . . 73.530000000000001 111.656 -178.001 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.3 t -100.76 143.57 26.83 Favored Pre-proline 0 N--CA 1.417 -2.104 0 N-CA-C 108.169 -1.048 . . . . 62.310000000000002 108.169 -179.765 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -58.45 128.03 26.89 Favored 'Trans proline' 0 C--O 1.245 0.858 0 C-N-CA 122.409 2.072 . . . . 64.230000000000004 110.658 177.67 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -82.97 126.85 71.61 Favored Pre-proline 0 C--N 1.295 -1.793 0 CA-C-N 115.836 -0.62 . . . . 74.099999999999994 110.668 -176.535 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.76 151.33 28.12 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.298 1.999 . . . . 41.119999999999997 111.277 178.9 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -118.68 110.44 17.3 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.755 0.788 . . . . 73.340000000000003 111.467 179.671 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.9 p -90.23 158.02 2.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 107.283 -1.377 . . . . 64.519999999999996 107.283 177.654 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -92.28 133.32 35.94 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 120.059 -0.656 . . . . 61.140000000000001 111.527 -179.325 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.5 m -106.26 91.78 3.86 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 104.899 -2.26 . . . . 65.230000000000004 104.899 171.569 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 14.9 t -83.13 -175.19 5.71 Favored 'General case' 0 N--CA 1.413 -2.309 0 CA-C-O 121.607 0.718 . . . . 72.409999999999997 111.916 -169.005 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.1 m -81.8 40.35 0.6 Allowed 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 124.952 1.301 . . . . 71.099999999999994 111.65 -173.312 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.7 p . . . . . 0 C--N 1.323 -0.561 0 CA-C-O 122.613 1.197 . . . . 72.430000000000007 110.589 -177.59 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.073 0 N-CA-C 109.682 -1.367 . . . . 61.25 109.682 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.0 m -100.39 156.81 17.05 Favored 'General case' 0 N--CA 1.416 -2.158 0 N-CA-C 108.988 -0.745 . . . . 64.219999999999999 108.988 -178.111 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.514 ' HB1' ' CE1' ' A' ' 137' ' ' PHE . . . -140.63 162.88 34.34 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 106.273 -1.751 . . . . 52.240000000000002 106.273 176.927 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.3 pp -134.31 142.39 47.25 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 118.246 -1.382 . . . . 64.140000000000001 111.836 179.436 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.479 ' O ' HD12 ' A' ' 49' ' ' LEU . 2.2 pp -109.38 140.81 42.61 Favored 'General case' 0 N--CA 1.424 -1.754 0 CA-C-N 115.453 -0.794 . . . . 71.409999999999997 110.266 179.51 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 45.2 t -123.6 113.5 37.6 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 N-CA-C 106.299 -1.741 . . . . 74.120000000000005 106.299 174.12 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.455 HG21 ' HB3' ' A' ' 57' ' ' ALA . 42.1 t -96.28 115.59 35.99 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.115 0 C-N-CA 118.915 -1.114 . . . . 72.409999999999997 108.49 179.476 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -68.99 -38.71 79.45 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 114.728 -1.123 . . . . 61.530000000000001 109.528 -176.559 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 26.4 ttm180 -177.25 142.3 0.35 Allowed 'General case' 0 C--O 1.244 0.773 0 CA-C-N 115.699 -0.682 . . . . 70.239999999999995 109.812 -179.95 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 143.31 165.91 10.94 Favored Glycine 0 N--CA 1.436 -1.36 0 CA-C-N 116.232 -0.44 . . . . 30.199999999999999 112.435 177.266 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -67.53 -8.21 21.55 Favored 'Trans proline' 0 N--CA 1.486 1.044 0 C-N-CA 123.659 2.906 . . . . 65.150000000000006 112.949 178.258 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.544 ' HA ' ' CB ' ' A' ' 80' ' ' LEU . 26.3 t-20 -65.15 -54.13 34.51 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.925 -0.58 . . . . 54.240000000000002 109.898 178.564 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.455 ' HB3' HG21 ' A' ' 51' ' ' VAL . . . -172.56 -176.51 1.54 Allowed 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.897 0.879 . . . . 70.349999999999994 108.822 -179.692 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -158.46 46.28 0.45 Allowed Glycine 0 CA--C 1.494 -1.235 0 N-CA-C 110.155 -1.178 . . . . 74.450000000000003 110.155 179.588 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -162.62 -173.83 3.71 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.157 -1.423 . . . . 72.030000000000001 107.157 -177.797 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.51 132.24 37.06 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 120.673 0.273 . . . . 72.239999999999995 110.46 177.73 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -156.75 155.03 30.92 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 116.002 -0.545 . . . . 75.209999999999994 110.425 -178.346 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.486 HD23 ' H ' ' A' ' 62' ' ' LEU . 2.7 pt? -79.13 139.74 37.97 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 122.063 0.935 . . . . 64.340000000000003 113.056 -178.062 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.461 HD11 HD23 ' A' ' 49' ' ' LEU . 75.3 mt -99.84 133.49 44.13 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 104.87 -2.27 . . . . 41.229999999999997 104.87 172.089 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -147.28 78.52 1.48 Allowed 'General case' 0 C--N 1.296 -1.737 0 CA-C-O 121.568 0.699 . . . . 72.430000000000007 111.449 -178.638 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -147.9 149.69 33.78 Favored Pre-proline 0 C--N 1.306 -1.299 0 N-CA-C 106.918 -1.512 . . . . 63.210000000000001 106.918 174.679 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -58.54 -40.65 72.21 Favored 'Trans proline' 0 C--N 1.366 1.455 0 C-N-CA 122.612 2.208 . . . . 73.430000000000007 110.301 -179.682 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 33.9 m -128.58 100.06 5.61 Favored 'General case' 0 N--CA 1.414 -2.264 0 CA-C-N 114.519 -1.219 . . . . 74.319999999999993 108.322 175.547 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 57.8 m -95.32 113.87 25.59 Favored 'General case' 0 N--CA 1.423 -1.807 0 N-CA-C 107.121 -1.437 . . . . 74.540000000000006 107.121 179.762 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.1 t -108.98 135.77 49.61 Favored 'General case' 0 C--N 1.283 -2.318 0 C-N-CA 120.033 -0.667 . . . . 70.519999999999996 110.717 -174.416 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -119.9 131.7 55.31 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 108.97 -0.752 . . . . 51.140000000000001 108.97 179.466 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 178.73 -122.92 0.83 Allowed Glycine 0 N--CA 1.411 -2.985 0 C-N-CA 120.641 -0.79 . . . . 72.340000000000003 111.145 179.153 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 18.7 tpt180 -146.94 14.92 1.18 Allowed 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 109.658 -0.497 . . . . 74.329999999999998 109.658 -176.078 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.439 ' HB3' ' HB3' ' A' ' 87' ' ' ARG . 38.0 p-80 -98.3 156.34 35.9 Favored Pre-proline 0 C--N 1.318 -0.765 0 N-CA-C 108.253 -1.017 . . . . 64.340000000000003 108.253 179.893 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -49.02 -30.71 18.7 Favored 'Trans proline' 0 N--CA 1.488 1.15 0 C-N-CA 123.907 3.071 . . . . 62.329999999999998 115.766 -174.831 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -93.27 12.76 23.48 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 113.298 0.851 . . . . 71.439999999999998 113.298 -177.439 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 24.2 m -65.76 135.78 55.36 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.632 -0.877 . . . . 73.239999999999995 108.632 176.738 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -68.65 -46.12 70.02 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 107.716 -1.216 . . . . 74.040000000000006 107.716 179.055 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.476 HD13 ' H ' ' A' ' 78' ' ' ILE . 0.2 OUTLIER -125.82 135.35 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 CA-C-N 113.631 -1.622 . . . . 64.519999999999996 109.226 176.929 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -103.86 117.49 34.47 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 115.83 -0.623 . . . . 75.340000000000003 109.373 178.873 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.544 ' CB ' ' HA ' ' A' ' 56' ' ' ASN . 0.9 OUTLIER -86.94 119.89 27.63 Favored 'General case' 0 N--CA 1.418 -2.062 0 N-CA-C 107.548 -1.279 . . . . 75.340000000000003 107.548 174.418 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -84.95 60.57 6.31 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 122.38 1.086 . . . . 61.030000000000001 111.918 -176.109 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -93.04 -175.33 3.83 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 106.311 -1.737 . . . . 70.230000000000004 106.311 171.71 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.6 p -126.99 -6.98 4.65 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 CA-C-O 121.861 0.839 . . . . 73.299999999999997 109.987 -179.029 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 5.8 m -115.22 15.58 16.98 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 122.303 1.049 . . . . 64.120000000000005 108.249 179.376 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.7 p -84.34 138.56 18.96 Favored 'Isoleucine or valine' 0 C--O 1.248 1.011 0 CA-C-N 115.005 -0.998 . . . . 70.439999999999998 110.796 -179.851 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 19.6 m -77.03 166.57 23.14 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.944 -0.571 . . . . 73.030000000000001 110.2 178.37 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.439 ' HB3' ' HB3' ' A' ' 73' ' ' HIS . 18.4 mmt180 -63.12 -37.75 88.43 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 121.317 0.58 . . . . 75.25 109.884 178.495 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.1 119.71 29.36 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 106.517 -1.66 . . . . 71.329999999999998 106.517 167.831 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 9.1 t60 -106.62 -63.11 1.31 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.683 -0.488 . . . . 63.030000000000001 109.683 -175.814 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -134.74 119.43 18.22 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.246 -1.02 . . . . 73.129999999999995 108.246 -179.858 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -104.92 128.04 53.0 Favored 'General case' 0 C--N 1.287 -2.123 0 C-N-CA 119.883 -0.727 . . . . 75.420000000000002 109.368 179.34 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -105.58 119.72 39.82 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 107.673 -1.232 . . . . 65.129999999999995 107.673 -176.366 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -118.59 148.96 42.14 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 109.388 -0.597 . . . . 74.400000000000006 109.388 -178.944 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 4.3 tp -115.58 127.63 73.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 CA-C-O 121.769 0.795 . . . . 74.540000000000006 109.651 -179.83 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -108.17 146.63 32.45 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 106.19 -1.781 . . . . 75.349999999999994 106.19 -179.67 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -54.93 -18.24 4.72 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 113.53 0.937 . . . . 63.229999999999997 113.53 -177.718 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -108.06 -44.51 1.18 Allowed Glycine 0 N--CA 1.431 -1.647 0 C-N-CA 121.377 -0.44 . . . . 52.020000000000003 113.037 177.666 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -133.88 175.57 9.34 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-O 121.615 0.721 . . . . 75.099999999999994 111.935 -174.687 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.412 ' HB2' ' HB3' ' A' ' 122' ' ' MET . 91.4 m-85 -104.68 137.45 42.48 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 106.508 -1.664 . . . . 73.400000000000006 106.508 174.785 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -130.54 130.05 43.61 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 118.28 0.491 . . . . 74.209999999999994 110.039 -178.226 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 6.9 p -117.29 127.64 74.77 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-O 120.926 0.393 . . . . 64.420000000000002 110.35 -179.636 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 30.9 m -118.88 121.38 66.72 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 CA-C-O 121.497 0.665 . . . . 72.340000000000003 111.873 178.544 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -83.41 124.42 30.65 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.281 -0.872 . . . . 61.219999999999999 110.506 175.473 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 6.7 m -125.89 17.42 3.99 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.227 0 CA-C-N 114.837 -1.074 . . . . 60.350000000000001 109.849 176.739 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -127.5 46.92 1.05 Allowed Glycine 0 N--CA 1.443 -0.865 0 N-CA-C 108.866 -1.694 . . . . 63.229999999999997 108.866 177.495 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.7 m -59.52 -23.49 62.87 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 124.359 1.064 . . . . 73.239999999999995 113.643 -173.039 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 85.1 mt -77.62 -21.31 52.49 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.054 -0.658 . . . . 65.349999999999994 112.0 -179.33 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -81.72 -36.0 29.13 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 107.378 -1.341 . . . . 64.329999999999998 107.378 176.008 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 103.78 88.24 2.04 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 114.635 -1.166 . . . . 75.420000000000002 113.995 176.793 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 27.9 m -99.59 120.12 39.16 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.655 -0.868 . . . . 63.329999999999998 108.655 175.211 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.405 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 29.9 m-85 -127.2 152.35 47.49 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 108.792 -0.818 . . . . 74.340000000000003 108.792 -177.726 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 74.7 t -106.32 113.41 42.93 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.111 0 N-CA-C 107.215 -1.402 . . . . 73.319999999999993 107.215 175.525 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 67.07 -73.59 0.08 Allowed 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 126.427 1.891 . . . . 73.239999999999995 109.862 -174.592 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -141.13 -12.56 0.94 Allowed 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 123.235 0.614 . . . . 75.430000000000007 111.106 177.099 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -106.78 140.72 21.64 Favored Pre-proline 0 C--N 1.321 -0.646 0 N-CA-C 112.503 0.557 . . . . 73.010000000000005 112.503 -169.787 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -71.27 93.27 0.65 Allowed 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.695 2.263 . . . . 52.240000000000002 112.777 178.562 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 12.6 mmt85 -110.54 100.51 9.31 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 106.464 -1.68 . . . . 74.329999999999998 106.464 176.032 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -75.85 -31.88 59.51 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 119.896 -0.721 . . . . 72.120000000000005 110.612 -176.101 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -124.35 136.13 53.86 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 105.265 -2.124 . . . . 73.109999999999999 105.265 167.854 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 55.7 tp60 -142.54 148.82 38.22 Favored 'General case' 0 C--N 1.283 -2.285 0 C-N-CA 120.922 -0.311 . . . . 65.430000000000007 110.928 -178.063 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.0 p -79.58 114.62 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.662 0 N-CA-C 103.893 -2.632 . . . . 75.239999999999995 103.893 167.126 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.412 ' HB3' ' HB2' ' A' ' 99' ' ' PHE . 9.7 ttt -68.52 120.35 14.43 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 115.033 -0.985 . . . . 51.039999999999999 111.079 -166.771 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 30.1 tp60 -104.25 124.9 49.98 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.252 -0.886 . . . . 73.230000000000004 110.325 -172.69 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.2 t -78.94 131.69 36.45 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 114.913 -1.04 . . . . 63.109999999999999 108.577 177.458 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 110.0 -9.73 31.73 Favored Glycine 0 N--CA 1.437 -1.266 0 CA-C-N 115.995 -0.548 . . . . 72.25 112.316 178.856 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -113.82 169.9 8.66 Favored 'General case' 0 C--O 1.25 1.118 0 N-CA-C 108.806 -0.813 . . . . 70.010000000000005 108.806 -177.357 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -110.63 144.98 38.69 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.791 0.805 . . . . 65.329999999999998 111.747 -178.25 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 65.2 mt -106.55 124.78 62.28 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 N-CA-C 107.367 -1.346 . . . . 52.32 107.367 177.139 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.405 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 58.2 tp60 -97.73 116.55 30.17 Favored 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 108.899 -0.778 . . . . 73.409999999999997 108.899 -176.896 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.1 pt -115.41 97.71 5.95 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.301 0 CA-C-O 122.177 0.989 . . . . 72.409999999999997 109.565 177.904 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 68.85 -116.55 7.4 Favored Glycine 0 N--CA 1.429 -1.786 0 CA-C-N 114.454 -1.248 . . . . 73.010000000000005 111.4 -175.697 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 17.9 tppt? -94.14 -22.14 18.65 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.239 0.542 . . . . 54.200000000000003 110.588 179.64 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -101.34 161.17 13.82 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 116.24 -0.437 . . . . 73.430000000000007 112.121 -174.919 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 9.8 ptp85 -137.28 144.37 42.66 Favored 'General case' 0 C--O 1.245 0.847 0 N-CA-C 113.419 0.896 . . . . 75.540000000000006 113.419 -172.984 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.8 tt -121.99 138.57 54.37 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 106.915 -1.513 . . . . 75.120000000000005 106.915 -179.247 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 27.7 t -106.83 130.49 58.68 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 N-CA-C 106.772 -1.566 . . . . 61.229999999999997 106.772 179.401 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 137' ' ' PHE . . . . . 0.514 ' CE1' ' HB1' ' A' ' 47' ' ' ALA . 86.4 t80 -104.37 128.19 52.16 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 112.086 0.402 . . . . 74.340000000000003 112.086 -174.78 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -128.57 151.13 49.8 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 108.211 -1.033 . . . . 73.430000000000007 108.211 173.882 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -62.81 149.54 43.89 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.892 -0.781 . . . . 43.520000000000003 108.892 175.47 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.419 ' N ' ' HA ' ' A' ' 47' ' ' ALA . . . -69.42 169.32 44.27 Favored Glycine 0 N--CA 1.434 -1.485 0 C-N-CA 120.88 -0.676 . . . . 54.310000000000002 113.405 -175.499 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo . . . . . 0 C--O 1.241 0.637 0 C-N-CA 123.25 2.633 . . . . 74.019999999999996 111.734 -179.881 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.0 p30 . . . . . 0 C--O 1.251 1.141 0 N-CA-C 109.019 -0.734 . . . . 72.400000000000006 109.019 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -81.95 149.12 27.83 Favored Glycine 0 N--CA 1.421 -2.307 0 N-CA-C 110.736 -0.945 . . . . 74.319999999999993 110.736 179.289 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.3 m -63.28 139.61 97.58 Favored Pre-proline 0 C--N 1.303 -1.425 0 N-CA-C 107.452 -1.314 . . . . 75.239999999999995 107.452 176.568 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -51.14 137.02 45.94 Favored 'Trans proline' 0 C--O 1.25 1.1 0 C-N-CA 122.326 2.017 . . . . 71.209999999999994 110.36 177.845 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -68.58 143.68 95.46 Favored Pre-proline 0 C--N 1.307 -1.254 0 CA-C-N 116.129 -0.487 . . . . 75.329999999999998 110.183 -174.565 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -36.94 114.78 0.13 Allowed 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 124.823 3.682 . . . . 62.240000000000002 113.784 -177.079 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -102.27 156.58 17.48 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.104 -1.443 . . . . 75.319999999999993 107.104 -178.895 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.4 m -90.26 148.36 4.6 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 CA-C-O 120.895 0.378 . . . . 70.530000000000001 110.222 177.533 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -103.5 141.52 35.85 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.14 -1.059 . . . . 44.439999999999998 108.14 177.315 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.5 t -68.92 152.7 44.94 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.705 -0.85 . . . . 63.25 108.705 179.007 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.9 t -145.11 105.45 4.08 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-O 121.748 0.785 . . . . 74.450000000000003 112.039 -176.88 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.6 t -94.21 96.03 9.33 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 105.589 -2.004 . . . . 75.530000000000001 105.589 174.982 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.1 p . . . . . 0 C--N 1.301 -1.511 0 CA-C-O 121.986 0.898 . . . . 72.340000000000003 112.209 -173.0 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.426 -2.015 0 N-CA-C 107.29 -2.324 . . . . 72.5 107.29 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.2 m -103.09 155.26 18.52 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-O 121.179 0.514 . . . . 54.32 111.155 -174.726 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.421 ' HA ' ' N ' ' A' ' 140' ' ' GLY . . . -146.3 151.37 37.41 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.145 -1.428 . . . . 75.450000000000003 107.145 177.705 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.447 HD23 ' H ' ' A' ' 48' ' ' LEU . 2.6 pt? -123.03 151.38 41.98 Favored 'General case' 0 CA--C 1.493 -1.243 0 CA-C-O 121.576 0.703 . . . . 71.200000000000003 111.392 -175.041 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.401 ' HB3' ' CD2' ' A' ' 137' ' ' PHE . 0.9 OUTLIER -129.74 132.72 46.68 Favored 'General case' 0 C--N 1.276 -2.595 0 CA-C-N 115.259 -0.882 . . . . 71.310000000000002 108.651 175.23 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.422 HG12 ' HB3' ' A' ' 60' ' ' ARG . 23.5 m -104.37 141.41 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 N-CA-C 108.749 -0.834 . . . . 65.129999999999995 108.749 -178.222 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.454 ' HA ' ' HG ' ' A' ' 135' ' ' LEU . 39.9 t -92.92 114.97 30.68 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 N-CA-C 107.591 -1.263 . . . . 65.209999999999994 107.591 178.558 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.9 tmtm? -73.23 -44.34 59.69 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 106.157 -1.794 . . . . 61.130000000000003 106.157 -178.723 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.416 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 35.1 ttm180 -165.16 128.0 2.21 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 106.59 -1.633 . . . . 74.340000000000003 106.59 176.815 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 158.52 133.84 1.61 Allowed Glycine 0 N--CA 1.42 -2.414 0 C-N-CA 120.183 -1.008 . . . . 54.119999999999997 111.924 -179.697 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.422 ' HB2' ' HB2' ' A' ' 82' ' ' ASP . 52.2 Cg_exo -59.62 -7.83 6.3 Favored 'Trans proline' 0 N--CA 1.484 0.963 0 C-N-CA 124.201 3.267 . . . . 60.200000000000003 114.116 178.612 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -44.16 -48.16 9.16 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.565 1.146 . . . . 75.239999999999995 111.379 175.349 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -165.29 -48.14 0.03 OUTLIER 'General case' 0 CA--C 1.51 -0.581 0 CA-C-O 121.329 0.585 . . . . 33.25 109.979 -179.348 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.12 25.58 57.24 Favored Glycine 0 C--O 1.225 -0.441 0 N-CA-C 110.528 -1.029 . . . . 60.009999999999998 110.528 -177.847 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -146.84 -157.32 0.8 Allowed 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.704 -1.221 . . . . 74.299999999999997 107.704 -177.494 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.454 ' HD3' ' H ' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -129.54 141.39 50.99 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 108.251 -1.018 . . . . 72.329999999999998 108.251 177.309 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -140.6 153.69 46.17 Favored 'General case' 0 C--N 1.291 -1.955 0 C-N-CA 120.544 -0.462 . . . . 74.420000000000002 109.99 178.064 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.432 ' HG ' ' HB3' ' A' ' 48' ' ' LEU . 8.4 mp -103.68 140.61 37.36 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 115.728 -0.669 . . . . 75.129999999999995 109.605 -179.177 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 88.1 mt -72.14 114.13 9.92 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.085 -1.08 . . . . 73.209999999999994 108.085 175.388 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -117.91 4.8 12.15 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.588 -0.893 . . . . 71.010000000000005 108.588 -179.633 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.494 ' HB2' ' OG1' ' A' ' 68' ' ' THR . 1.0 OUTLIER -122.13 131.81 24.35 Favored Pre-proline 0 N--CA 1.437 -1.075 0 CA-C-N 115.893 -0.594 . . . . 54.329999999999998 109.726 -174.9 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.415 ' HA ' ' CG2' ' A' ' 94' ' ' ILE . 2.8 Cg_exo -54.52 -40.15 84.92 Favored 'Trans proline' 0 C--N 1.36 1.142 0 C-N-CA 123.302 2.668 . . . . 71.340000000000003 110.904 177.822 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 97.6 m -126.34 103.28 7.56 Favored 'General case' 0 N--CA 1.42 -1.941 0 CA-C-N 114.964 -1.016 . . . . 52.25 108.716 175.829 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.494 ' OG1' ' HB2' ' A' ' 65' ' ' GLN . 38.3 m -107.24 113.07 26.25 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 108.1 -1.074 . . . . 61.409999999999997 108.1 179.047 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.1 m -105.2 121.05 43.03 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 120.469 -0.492 . . . . 73.219999999999999 109.898 -178.57 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.583 ' HB1' HD11 ' A' ' 80' ' ' LEU . . . -95.68 124.08 39.54 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 109.074 -0.713 . . . . 74.519999999999996 109.074 -179.878 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.445 ' O ' ' HA ' ' A' ' 79' ' ' PHE . . . -159.62 -179.01 34.14 Favored Glycine 0 N--CA 1.437 -1.248 0 C-N-CA 120.237 -0.983 . . . . 74.450000000000003 112.401 179.85 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.71 ' NH1' ' HA ' ' A' ' 81' ' ' ASP . 25.3 tpt180 -112.99 84.89 2.07 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.602 -0.888 . . . . 74.519999999999996 108.602 177.641 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -177.73 147.85 0.66 Allowed Pre-proline 0 C--N 1.314 -0.936 0 C-N-CA 125.509 1.524 . . . . 73.109999999999999 106.936 178.43 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -56.7 -40.47 84.09 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.787 2.325 . . . . 63.340000000000003 112.487 179.389 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -87.9 64.8 8.04 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-O 122.684 1.23 . . . . 70.439999999999998 112.467 177.855 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 19.6 m -133.59 159.9 39.08 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 104.684 -2.339 . . . . 71.040000000000006 104.684 172.601 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -64.96 -42.58 94.47 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 118.972 0.805 . . . . 71.510000000000005 109.592 -178.532 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.95 138.5 43.76 Favored 'Isoleucine or valine' 0 C--O 1.251 1.133 0 N-CA-C 106.944 -1.502 . . . . 73.109999999999999 106.944 171.735 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.445 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 53.5 p90 -107.62 125.34 51.22 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.734 -0.786 . . . . 74.420000000000002 111.813 -179.601 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.583 HD11 ' HB1' ' A' ' 70' ' ' ALA . 5.3 mp -80.51 135.83 36.18 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.76 -1.2 . . . . 75.140000000000001 107.76 178.685 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.71 ' HA ' ' NH1' ' A' ' 72' ' ' ARG . 25.5 t70 -92.13 39.81 1.03 Allowed 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.682 0.753 . . . . 74.420000000000002 111.878 -174.648 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.422 ' HB2' ' HB2' ' A' ' 55' ' ' PRO . 12.0 t70 -123.5 151.36 42.88 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.928 -0.767 . . . . 32.409999999999997 108.928 178.511 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 33.3 m -90.26 -5.89 10.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 113.015 0.746 . . . . 73.099999999999994 113.015 -174.963 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.2 t -83.65 -13.1 54.99 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-O 121.816 0.817 . . . . 71.329999999999998 108.987 178.424 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.44 HG13 ' HB2' ' A' ' 89' ' ' HIS . 51.3 t -82.83 134.49 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 CA-C-N 114.906 -1.043 . . . . 75.299999999999997 110.023 -175.998 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.534 ' OG ' HD21 ' A' ' 107' ' ' LEU . 58.3 m -82.74 -174.01 4.98 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 116.155 -0.475 . . . . 73.010000000000005 111.534 -179.949 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -56.05 -50.49 70.81 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 108.204 -1.035 . . . . 75.310000000000002 108.204 175.099 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 59.0 mtt180 -126.74 115.78 19.92 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 105.597 -2.001 . . . . 72.409999999999997 105.597 174.376 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.44 ' HB2' HG13 ' A' ' 85' ' ' VAL . 11.0 t60 -100.02 -51.34 3.72 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 121.656 0.741 . . . . 61.229999999999997 109.812 -177.149 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -145.51 145.01 30.89 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 108.416 -0.957 . . . . 61.140000000000001 108.416 -179.786 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -121.89 127.86 50.93 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-O 121.699 0.761 . . . . 63.409999999999997 109.75 178.453 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -107.82 113.69 27.1 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 107.39 -1.337 . . . . 61.149999999999999 107.39 -178.27 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 41.9 mtp180 -117.52 147.57 42.65 Favored 'General case' 0 C--N 1.283 -2.29 0 C-N-CA 119.936 -0.706 . . . . 72.510000000000005 110.277 -179.033 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.415 ' CG2' ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -116.44 122.56 70.07 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.132 0 N-CA-C 106.872 -1.529 . . . . 72.430000000000007 106.872 175.977 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -108.47 146.8 32.61 Favored 'General case' 0 C--N 1.275 -2.669 0 N-CA-C 107.434 -1.321 . . . . 74.340000000000003 107.434 -178.641 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -51.12 -22.83 2.72 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 123.769 0.827 . . . . 65.310000000000002 112.581 179.828 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -91.73 -51.33 2.51 Favored Glycine 0 N--CA 1.432 -1.618 0 C-N-CA 121.046 -0.597 . . . . 33.329999999999998 112.693 175.322 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -149.95 175.21 11.88 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 117.496 0.648 . . . . 61.310000000000002 112.387 -175.223 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.521 ' HB2' ' HB2' ' A' ' 122' ' ' MET . 63.1 m-85 -99.0 132.08 44.57 Favored 'General case' 0 C--O 1.247 0.951 0 N-CA-C 108.318 -0.993 . . . . 64.540000000000006 108.318 176.407 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -131.89 128.75 39.24 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 121.038 0.447 . . . . 74.400000000000006 111.196 -175.964 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 5.3 p -116.46 122.19 69.26 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-O 121.244 0.545 . . . . 74.230000000000004 110.507 177.804 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.7 m -119.53 136.96 55.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-N 115.736 -0.665 . . . . 75.219999999999999 109.999 177.833 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.432 ' OD2' ' HA ' ' A' ' 118' ' ' ASN . 1.4 p30 -86.39 143.12 27.98 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 118.727 -1.189 . . . . 72.230000000000004 108.345 175.409 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 15.7 m -127.68 12.31 3.29 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 CA-C-O 122.033 0.92 . . . . 74.030000000000001 109.298 176.773 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -161.67 67.69 0.24 Allowed Glycine 0 N--CA 1.427 -1.926 0 CA-C-N 114.569 -1.196 . . . . 73.409999999999997 110.965 -179.729 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.43 ' HB2' ' OD1' ' A' ' 103' ' ' ASP . 22.1 t -88.99 80.44 7.05 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 122.045 -0.68 . . . . 75.450000000000003 109.438 178.425 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.534 HD21 ' OG ' ' A' ' 86' ' ' SER . 1.9 mm? -81.03 -51.95 7.95 Favored 'General case' 0 CA--C 1.501 -0.908 0 C-N-CA 120.143 -0.623 . . . . 75.329999999999998 109.609 179.324 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -100.04 2.91 43.79 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.667 -0.697 . . . . 74.109999999999999 109.288 -175.869 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 100.93 130.72 7.15 Favored Glycine 0 N--CA 1.427 -1.955 0 CA-C-N 115.483 -0.781 . . . . 55.140000000000001 112.296 -178.662 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.442 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 26.9 m -105.68 119.52 39.35 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 106.764 -1.569 . . . . 62.119999999999997 106.764 172.79 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -125.67 144.23 50.69 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 120.843 0.354 . . . . 75.109999999999999 111.32 -173.736 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 5.2 p -121.81 111.74 32.15 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 N-CA-C 106.378 -1.712 . . . . 72.25 106.378 169.655 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 56.51 41.79 28.21 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.219 0.533 . . . . 73.019999999999996 111.228 -176.642 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 74.77 4.55 4.36 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.643 1.177 . . . . 75.239999999999995 112.782 179.749 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -97.27 115.6 65.77 Favored Pre-proline 0 C--N 1.315 -0.908 0 N-CA-C 110.008 -0.367 . . . . 75.120000000000005 110.008 178.261 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.442 ' HA ' ' O ' ' A' ' 110' ' ' THR . 41.8 Cg_endo -78.2 95.68 1.08 Allowed 'Trans proline' 0 N--CA 1.449 -1.122 0 C-N-CA 121.986 1.79 . . . . 70.219999999999999 110.688 176.866 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 27.8 mmm180 -114.23 146.32 40.56 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.601 -1.259 . . . . 54.149999999999999 107.601 -177.583 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.432 ' HA ' ' OD2' ' A' ' 103' ' ' ASP . 2.7 t-20 -84.17 -38.58 20.46 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.568 0.699 . . . . 72.420000000000002 110.46 -177.801 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -130.73 139.0 50.25 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 108.322 -0.992 . . . . 50.219999999999999 108.322 177.038 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.412 ' HA ' ' OE1' ' A' ' 120' ' ' GLN . 5.6 tp60 -139.81 145.45 38.18 Favored 'General case' 0 N--CA 1.425 -1.703 0 CA-C-O 121.299 0.571 . . . . 61.130000000000003 111.505 179.536 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 60.7 t -92.11 134.24 30.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 106.049 -1.834 . . . . 60.310000000000002 106.049 175.433 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.521 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 17.0 tmm? -39.36 127.09 1.81 Allowed 'General case' 0 N--CA 1.483 1.188 0 O-C-N 124.443 1.089 . . . . 74.120000000000005 113.366 -177.632 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -128.79 124.1 34.59 Favored 'General case' 0 N--CA 1.417 -2.088 0 N-CA-C 105.982 -1.859 . . . . 74.430000000000007 105.982 177.844 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 4.9 t -92.87 130.86 38.32 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 121.56 0.695 . . . . 54.329999999999998 112.221 -173.874 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 94.64 3.03 62.86 Favored Glycine 0 N--CA 1.438 -1.201 0 CA-C-N 115.24 -0.891 . . . . 63.119999999999997 111.393 177.784 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -106.43 168.02 9.44 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.533 -0.333 . . . . 75.400000000000006 111.157 -177.579 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -108.73 131.64 54.74 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.291 0.567 . . . . 72.439999999999998 111.88 -172.71 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 61.9 mt -119.05 113.22 40.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-N 115.344 -0.843 . . . . 62.130000000000003 109.211 179.816 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -95.32 112.75 24.41 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 109.098 -0.705 . . . . 74.030000000000001 109.098 177.425 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.5 pt -100.98 103.42 14.81 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 CA-C-O 122.127 0.965 . . . . 72.219999999999999 108.741 176.083 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 80.3 -104.96 2.31 Favored Glycine 0 N--CA 1.413 -2.86 0 CA-C-N 114.678 -1.146 . . . . 74.549999999999997 110.765 179.822 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -119.92 1.2 10.94 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 121.158 0.504 . . . . 53.509999999999998 110.954 -176.786 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.416 ' HB2' ' O ' ' A' ' 53' ' ' ARG . 20.1 p90 -127.97 160.06 33.06 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 116.265 -0.425 . . . . 74.040000000000006 110.883 -178.114 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 11.1 ptp180 -129.59 139.16 51.55 Favored 'General case' 0 C--O 1.252 1.224 0 N-CA-C 114.818 1.414 . . . . 71.109999999999999 114.818 -169.517 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.454 ' HG ' ' HA ' ' A' ' 51' ' ' VAL . 8.2 mp -121.86 144.23 48.96 Favored 'General case' 0 N--CA 1.424 -1.747 0 CA-C-N 113.406 -1.724 . . . . 73.5 108.596 179.052 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 58.3 t -107.37 124.16 63.1 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.141 0 N-CA-C 106.907 -1.516 . . . . 73.409999999999997 106.907 179.433 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 137' ' ' PHE . . . . . 0.401 ' CD2' ' HB3' ' A' ' 49' ' ' LEU . 6.4 t80 -100.33 130.33 46.42 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.92 -0.4 . . . . 75.439999999999998 109.92 -173.12 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -126.55 151.72 47.52 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 121.1 0.476 . . . . 70.420000000000002 109.774 -179.847 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -69.58 135.98 50.69 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.108 -1.441 . . . . 71.239999999999995 107.108 172.766 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.421 ' N ' ' HA ' ' A' ' 47' ' ' ALA . . . -82.98 -177.25 51.92 Favored Glycine 0 N--CA 1.439 -1.131 0 C-N-CA 120.102 -1.047 . . . . 54.329999999999998 112.603 -174.907 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo . . . . . 0 N--CA 1.439 -1.732 0 C-N-CA 122.204 1.936 . . . . 55.340000000000003 109.715 175.922 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 18.1 m120 . . . . . 0 CA--C 1.501 -0.932 0 CA-C-O 121.061 0.457 . . . . 64.129999999999995 110.751 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 154.51 115.86 0.56 Allowed Glycine 0 C--N 1.294 -1.759 0 N-CA-C 109.849 -1.3 . . . . 72.439999999999998 109.849 -178.692 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.3 m -82.65 124.8 77.1 Favored Pre-proline 0 C--N 1.299 -1.626 0 N-CA-C 109.236 -0.653 . . . . 73.109999999999999 109.236 -179.024 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.17 128.05 28.17 Favored 'Trans proline' 0 C--N 1.36 1.159 0 C-N-CA 122.331 2.02 . . . . 73.329999999999998 109.718 175.852 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -75.4 120.27 80.88 Favored Pre-proline 0 C--N 1.308 -1.229 0 CA-C-N 116.063 -0.517 . . . . 65.219999999999999 111.992 -173.141 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -82.16 129.55 6.07 Favored 'Trans proline' 0 N--CA 1.443 -1.487 0 C-N-CA 122.238 1.959 . . . . 75.230000000000004 110.321 175.935 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -89.21 119.58 29.83 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.624 -0.88 . . . . 74.310000000000002 108.624 179.381 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.9 m -91.77 166.82 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 116.32 -0.4 . . . . 62.240000000000002 111.389 -175.586 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -96.49 141.13 30.14 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 108.823 -0.806 . . . . 75.209999999999994 108.823 176.119 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 50.3 m -120.06 102.33 8.46 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-O 121.301 0.572 . . . . 62.43 109.911 178.89 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.9 m -123.9 141.49 51.99 Favored 'General case' 0 N--CA 1.408 -2.545 0 N-CA-C 105.644 -1.984 . . . . 71.5 105.644 177.533 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.3 t -132.17 146.4 52.0 Favored 'General case' 0 C--N 1.271 -2.805 0 N-CA-C 108.709 -0.848 . . . . 44.200000000000003 108.709 -177.888 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.7 m . . . . . 0 N--CA 1.43 -1.441 0 CA-C-O 121.11 0.481 . . . . 72.150000000000006 110.092 179.707 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.482 -2.023 0 N-CA-C 106.635 -2.586 . . . . 55.130000000000003 106.635 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.7 m -90.88 167.42 12.45 Favored 'General case' 0 N--CA 1.414 -2.226 0 CA-C-N 113.058 -1.571 . . . . 74.109999999999999 111.383 -171.549 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.66 157.4 44.93 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 106.775 -1.565 . . . . 75.299999999999997 106.775 176.394 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.4 pp -134.63 151.97 51.44 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 119.632 -0.827 . . . . 51.130000000000003 111.787 -178.822 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -126.79 136.76 52.82 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.734 -0.666 . . . . 71.430000000000007 109.565 -179.6 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.445 ' CG2' ' HB ' ' A' ' 136' ' ' VAL . 33.5 m -114.24 128.97 71.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 109.202 -0.666 . . . . 61.030000000000001 109.202 175.475 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.6 t -95.14 125.57 47.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 109.439 -0.578 . . . . 72.420000000000002 109.439 -177.2 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -96.66 -34.07 11.52 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.879 -0.6 . . . . 72.299999999999997 110.078 176.17 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.449 ' O ' ' HB3' ' A' ' 133' ' ' PHE . 30.9 tpt180 -165.46 121.51 1.37 Allowed 'General case' 0 CA--C 1.496 -1.133 0 N-CA-C 108.992 -0.744 . . . . 74.530000000000001 108.992 175.938 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -163.19 164.88 36.3 Favored Glycine 0 N--CA 1.415 -2.714 0 N-CA-C 108.218 -1.953 . . . . 53.119999999999997 108.218 177.353 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.483 ' HB2' ' HB3' ' A' ' 82' ' ' ASP . 14.3 Cg_exo -68.82 -20.81 39.05 Favored 'Trans proline' 0 C--O 1.238 0.518 0 C-N-CA 122.385 2.057 . . . . 60.100000000000001 111.397 179.997 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.419 ' HB3' ' CA ' ' A' ' 80' ' ' LEU . 21.8 p-10 -68.52 -59.34 3.22 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 114.761 -1.109 . . . . 72.030000000000001 112.387 -178.651 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -175.75 -153.52 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 108.18 -1.044 . . . . 73.200000000000003 108.18 -173.096 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.03 54.05 0.35 Allowed Glycine 0 N--CA 1.428 -1.888 0 N-CA-C 107.708 -2.157 . . . . 22.41 107.708 178.677 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -135.91 -167.41 2.03 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 108.52 -0.918 . . . . 62.229999999999997 108.52 -173.93 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 17.7 ptp180 -116.12 144.95 43.47 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 120.546 0.213 . . . . 62.399999999999999 110.502 -177.95 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -136.81 140.48 42.5 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 108.516 -0.92 . . . . 64.420000000000002 108.516 179.97 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.1 tt -117.97 136.29 53.6 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 109.072 -0.714 . . . . 74.340000000000003 109.072 177.979 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.441 HD12 HG21 ' A' ' 68' ' ' THR . 1.2 mm? -93.36 115.27 27.84 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.853 -0.425 . . . . 72.340000000000003 109.853 -178.889 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -109.6 13.41 23.89 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 122.439 1.114 . . . . 74.349999999999994 108.569 179.082 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -123.93 144.49 45.14 Favored Pre-proline 0 C--N 1.309 -1.172 0 CA-C-N 115.307 -0.861 . . . . 71.239999999999995 109.927 -177.628 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.557 ' HA ' ' CD1' ' A' ' 94' ' ' ILE . 10.1 Cg_endo -55.34 -54.98 3.5 Favored 'Trans proline' 0 C--N 1.358 1.037 0 C-N-CA 123.468 2.779 . . . . 73.430000000000007 113.851 -177.773 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 42.6 m -113.41 108.61 17.44 Favored 'General case' 0 N--CA 1.425 -1.676 0 N-CA-C 109.581 -0.525 . . . . 64.099999999999994 109.581 -178.718 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.441 HG21 HD12 ' A' ' 63' ' ' LEU . 24.8 m -103.23 114.16 28.22 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 108.982 -0.748 . . . . 60.5 108.982 175.899 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.6 p -98.51 115.25 28.16 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 121.794 0.806 . . . . 74.420000000000002 111.814 -179.555 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.63 134.87 41.89 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 106.901 -1.518 . . . . 70.400000000000006 106.901 175.685 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.418 ' HA3' ' HB3' ' A' ' 89' ' ' HIS . . . 82.57 73.56 1.22 Allowed Glycine 0 C--N 1.3 -1.436 0 C-N-CA 119.702 -1.237 . . . . 71.209999999999994 110.327 -175.183 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 56.9 ttt180 -158.35 106.61 1.95 Allowed 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 105.206 -2.146 . . . . 72.019999999999996 105.206 -178.472 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 19.0 m-70 -52.01 -68.37 0.42 Allowed Pre-proline 0 CA--C 1.55 0.959 0 N-CA-C 116.069 1.877 . . . . 61.030000000000001 116.069 -169.999 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -66.97 -40.15 12.51 Favored 'Trans proline' 0 C--N 1.359 1.093 0 C-N-CA 121.286 1.324 . . . . 73.200000000000003 114.101 -176.18 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -125.77 75.58 1.51 Allowed 'General case' 0 C--N 1.32 -0.675 0 O-C-N 122.293 -0.254 . . . . 72.349999999999994 110.521 -175.588 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 18.0 p -78.31 123.17 26.66 Favored 'General case' 0 C--N 1.28 -2.454 0 C-N-CA 119.11 -1.036 . . . . 73.239999999999995 109.093 176.391 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -67.09 -55.56 13.76 Favored 'General case' 0 CA--C 1.485 -1.537 0 N-CA-C 107.365 -1.346 . . . . 73.219999999999999 107.365 175.696 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 45.4 pt -125.67 148.0 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.847 0 CA-C-N 115.047 -0.979 . . . . 62.119999999999997 108.427 173.998 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -97.51 136.22 38.24 Favored 'General case' 0 C--N 1.276 -2.592 0 CA-C-N 115.321 -0.854 . . . . 75.200000000000003 108.929 177.151 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.419 ' CA ' ' HB3' ' A' ' 56' ' ' ASN . 58.1 tp -144.21 -88.62 0.12 Allowed 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.799 -0.815 . . . . 62.530000000000001 108.799 -175.158 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -76.34 96.93 4.1 Favored 'General case' 0 C--N 1.261 -3.242 0 N-CA-C 108.36 -0.978 . . . . 74.040000000000006 108.36 171.478 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.483 ' HB3' ' HB2' ' A' ' 55' ' ' PRO . 14.6 t70 -81.09 -54.96 5.09 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.269 -0.878 . . . . 54.340000000000003 110.206 -179.077 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.9 t -85.11 -39.91 14.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 CA-C-N 114.882 -1.054 . . . . 74.219999999999999 109.123 -178.994 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.6 p -87.47 32.78 0.7 Allowed 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 124.386 1.075 . . . . 60.439999999999998 111.395 -178.328 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.9 p -81.3 139.87 17.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 CA-C-N 115.171 -0.922 . . . . 70.430000000000007 112.137 -171.909 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 23.3 t -128.52 -176.86 3.95 Favored 'General case' 0 N--CA 1.424 -1.767 0 N-CA-C 107.625 -1.25 . . . . 74.230000000000004 107.625 175.88 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -100.77 120.41 40.07 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 123.446 0.699 . . . . 73.340000000000003 109.227 -177.94 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 88' ' ' ARG . 11.0 mmm180 64.49 32.92 11.42 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 108.419 -0.956 . . . . 62.409999999999997 108.419 -176.372 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.418 ' HB3' ' HA3' ' A' ' 71' ' ' GLY . 67.4 t60 -46.79 -66.45 0.4 Allowed 'General case' 0 C--O 1.241 0.641 0 C-N-CA 124.759 1.224 . . . . 75.219999999999999 112.429 -175.317 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.537 ' HA ' ' HA ' ' A' ' 103' ' ' ASP . . . -141.05 141.34 34.3 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 121.147 -0.221 . . . . 54.43 110.776 -178.129 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -116.32 127.75 54.96 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.33 0.586 . . . . 63.219999999999999 110.791 177.495 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.419 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 41.5 m-85 -105.11 112.64 25.84 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 105.611 -1.996 . . . . 72.409999999999997 105.611 174.302 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -124.38 150.09 45.94 Favored 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 120.49 -0.484 . . . . 73.209999999999994 109.742 -176.522 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.557 ' CD1' ' HA ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -116.95 139.1 45.32 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.063 0 C-N-CA 118.985 -1.086 . . . . 72.310000000000002 108.444 172.233 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -119.22 145.33 46.14 Favored 'General case' 0 C--N 1.27 -2.884 0 N-CA-C 105.793 -1.929 . . . . 74.540000000000006 105.793 176.696 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.94 -20.15 8.33 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 114.038 1.125 . . . . 44.439999999999998 114.038 -173.457 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -106.46 -31.95 3.84 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 119.953 -1.118 . . . . 73.109999999999999 114.16 177.789 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -145.33 147.34 32.21 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-N 117.65 0.725 . . . . 62.009999999999998 109.803 -175.026 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.456 ' HB2' ' HB3' ' A' ' 122' ' ' MET . 30.5 m-85 -94.9 129.88 41.73 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 106.974 -1.491 . . . . 52.229999999999997 106.974 176.4 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -132.3 129.26 39.32 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 119.535 -0.866 . . . . 74.439999999999998 111.76 -175.061 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 61.4 t -114.11 118.1 57.44 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 107.842 -1.17 . . . . 73.340000000000003 107.842 177.552 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 30.8 m -121.06 130.82 74.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 CA-C-N 115.934 -0.576 . . . . 72.120000000000005 109.991 178.9 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.537 ' HA ' ' HA ' ' A' ' 90' ' ' ALA . 0.7 OUTLIER -97.0 138.78 34.0 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 117.326 -1.75 . . . . 74.319999999999993 108.406 170.718 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.8 m -124.18 -2.46 6.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 112.183 0.438 . . . . 61.409999999999997 112.183 179.948 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -89.86 -44.9 4.69 Favored Glycine 0 CA--C 1.509 -0.319 0 N-CA-C 109.752 -1.339 . . . . 65.099999999999994 109.752 175.97 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 14.2 m 58.79 29.2 18.41 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 114.414 1.264 . . . . 72.200000000000003 114.414 174.013 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 49.3 tp -85.32 -48.21 9.28 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 120.109 -0.636 . . . . 72.209999999999994 112.541 -177.659 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -87.64 -19.45 27.71 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 119.448 -0.901 . . . . 62.140000000000001 111.315 -176.247 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 97.34 127.97 5.81 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 120.418 -0.896 . . . . 74.310000000000002 113.666 176.855 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.458 HG21 ' HB3' ' A' ' 103' ' ' ASP . 5.7 p -109.47 134.33 52.01 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 123.281 0.632 . . . . 71.129999999999995 111.335 -179.407 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.462 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 26.6 m-85 -138.78 147.47 42.63 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 107.583 -1.265 . . . . 74.340000000000003 107.583 178.435 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.416 HG11 HE21 ' A' ' 120' ' ' GLN . 12.6 p -123.19 125.81 72.52 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 N-CA-C 106.088 -1.819 . . . . 74.310000000000002 106.088 171.271 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 17.6 m120 62.93 22.15 13.28 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.068 0.547 . . . . 71.219999999999999 109.796 -175.952 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 40.8 mtp180 75.05 12.25 3.46 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.334 1.453 . . . . 73.299999999999997 112.396 -177.126 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -102.85 118.27 58.68 Favored Pre-proline 0 C--N 1.31 -1.115 0 N-CA-C 105.983 -1.858 . . . . 72.230000000000004 105.983 176.27 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -46.66 119.61 3.37 Favored 'Trans proline' 0 C--N 1.362 1.273 0 C-N-CA 123.767 2.978 . . . . 74.340000000000003 112.508 -178.122 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 12.0 tpt180 -153.25 118.91 5.3 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 109.936 -0.394 . . . . 73.310000000000002 109.936 -173.627 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -81.63 -38.76 25.47 Favored 'General case' 0 C--N 1.317 -0.839 0 O-C-N 123.521 0.513 . . . . 72.239999999999995 112.103 -179.085 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -125.4 139.46 53.64 Favored 'General case' 0 N--CA 1.437 -1.119 0 C-N-CA 120.444 -0.502 . . . . 73.439999999999998 110.171 -178.857 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.416 HE21 HG11 ' A' ' 112' ' ' VAL . 6.6 tp-100 -139.36 137.95 36.18 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 109.044 -0.725 . . . . 75.340000000000003 109.044 175.66 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.2 t -111.83 97.72 6.11 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 CA-C-N 115.404 -0.816 . . . . 73.209999999999994 108.91 -177.828 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.456 ' HB3' ' HB2' ' A' ' 99' ' ' PHE . 26.3 ptt? 41.5 98.11 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 127.118 2.167 . . . . 70.319999999999993 116.293 179.091 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.458 ' HG3' ' HB2' ' A' ' 126' ' ' ASP . 52.1 tp60 -121.69 122.34 39.36 Favored 'General case' 0 N--CA 1.385 -3.706 0 N-CA-C 101.28 -3.6 . . . . 64.310000000000002 101.28 174.52 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 14.9 t -110.29 127.74 55.17 Favored 'General case' 0 C--N 1.29 -2.003 0 C-N-CA 119.194 -1.003 . . . . 62.119999999999997 110.666 -172.404 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 87.62 16.9 59.35 Favored Glycine 0 N--CA 1.425 -2.077 0 N-CA-C 110.218 -1.153 . . . . 41.340000000000003 110.218 -178.334 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.458 ' HB2' ' HG3' ' A' ' 123' ' ' GLN . 6.1 m-20 -112.61 162.15 16.01 Favored 'General case' 0 CA--C 1.484 -1.589 0 N-CA-C 112.527 0.565 . . . . 72.219999999999999 112.527 -179.68 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -107.58 122.58 46.96 Favored 'General case' 0 N--CA 1.421 -1.878 0 CA-C-N 114.761 -1.109 . . . . 63.43 111.049 -172.148 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 68.7 mt -101.37 129.87 51.79 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 N-CA-C 106.967 -1.494 . . . . 62.509999999999998 106.967 176.499 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.462 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 34.6 tt0 -110.76 125.46 53.56 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 109.2 -0.667 . . . . 72.439999999999998 109.2 -179.659 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.505 HD13 ' H ' ' A' ' 130' ' ' ILE . 0.2 OUTLIER -112.5 109.87 30.13 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 N-CA-C 108.6 -0.889 . . . . 74.420000000000002 108.6 177.667 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 71.21 -82.37 0.45 Allowed Glycine 0 C--N 1.308 -0.991 0 CA-C-N 115.735 -0.666 . . . . 41.109999999999999 112.094 -176.995 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -146.14 8.16 1.07 Allowed 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.771 -0.826 . . . . 73.200000000000003 108.771 179.118 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.449 ' HB3' ' O ' ' A' ' 53' ' ' ARG . 35.4 m-85 -104.7 150.83 24.39 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.781 -0.822 . . . . 62.350000000000001 108.781 -175.429 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.34 130.74 55.51 Favored 'General case' 0 C--O 1.258 1.505 0 C-N-CA 119.05 -1.06 . . . . 74.140000000000001 112.931 -177.701 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.7 tt -123.79 137.99 54.58 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 125.808 1.643 . . . . 65.329999999999998 107.287 -177.245 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.445 ' HB ' ' CG2' ' A' ' 50' ' ' VAL . 60.8 t -108.81 127.15 65.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 108.677 -0.86 . . . . 51.0 108.677 177.021 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -102.47 130.4 49.27 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 116.209 -0.45 . . . . 65.409999999999997 110.558 -175.071 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -125.34 148.94 48.53 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 109.239 -0.652 . . . . 71.420000000000002 109.239 178.843 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -81.33 135.23 35.68 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.433 -0.951 . . . . 73.140000000000001 108.433 176.739 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.49 153.71 52.66 Favored Glycine 0 N--CA 1.437 -1.281 0 C-N-CA 120.933 -0.651 . . . . 74.209999999999994 111.518 -178.03 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo . . . . . 0 N--CA 1.445 -1.336 0 C-N-CA 122.401 2.068 . . . . 45.119999999999997 113.002 -177.809 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 . . . . . 0 N--CA 1.437 -1.079 0 N-CA-C 109.16 -0.682 . . . . 60.210000000000001 109.16 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.85 123.97 8.07 Favored Glycine 0 N--CA 1.435 -1.424 0 N-CA-C 110.905 -0.878 . . . . 73.310000000000002 110.905 -178.966 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.0 p -94.42 126.13 49.29 Favored Pre-proline 0 C--N 1.299 -1.606 0 CA-C-N 116.687 0.244 . . . . 44.219999999999999 111.2 -179.099 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.493 ' O ' ' HD3' ' A' ' 10' ' ' PRO . 24.1 Cg_exo -65.39 129.76 23.49 Favored 'Trans proline' 0 C--O 1.245 0.83 0 C-N-CA 121.954 1.769 . . . . 73.549999999999997 110.309 175.748 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -103.64 95.8 7.92 Favored Pre-proline 0 C--N 1.315 -0.933 0 N-CA-C 108.23 -1.026 . . . . 71.200000000000003 108.23 178.672 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.493 ' HD3' ' O ' ' A' ' 8' ' ' PRO . 90.9 Cg_endo -92.8 179.14 1.23 Allowed 'Trans proline' 0 N--CA 1.445 -1.366 0 C-N-CA 122.823 2.349 . . . . 51.43 113.298 -174.469 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 67.96 84.79 0.15 Allowed 'General case' 0 CA--C 1.509 -0.621 0 C-N-CA 125.285 1.434 . . . . 71.019999999999996 112.14 -179.159 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 24.5 t -113.62 78.03 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 108.503 -0.925 . . . . 74.409999999999997 108.503 178.543 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -140.01 131.23 26.57 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.057 -1.09 . . . . 75.310000000000002 108.057 177.816 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.0 m -143.98 76.67 1.52 Allowed 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 106.551 -1.648 . . . . 73.099999999999994 106.551 172.93 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.1 m -99.59 90.33 4.45 Favored 'General case' 0 N--CA 1.413 -2.299 0 CA-C-N 115.406 -0.815 . . . . 74.040000000000006 110.013 -177.907 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.7 m -125.02 70.31 1.15 Allowed 'General case' 0 N--CA 1.415 -2.194 0 N-CA-C 107.148 -1.427 . . . . 71.340000000000003 107.148 175.698 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.8 m . . . . . 0 N--CA 1.428 -1.562 0 CA-C-N 114.876 -1.056 . . . . 65.109999999999999 109.575 -176.966 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.504 0 N-CA-C 108.132 -1.987 . . . . 70.120000000000005 108.132 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.568 ' O ' ' HA ' ' A' ' 141' ' ' PRO . 16.3 m -90.7 162.05 15.09 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 115.1 -0.55 . . . . 54.32 111.166 -173.993 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -136.77 177.6 7.73 Favored 'General case' 0 C--O 1.253 1.278 0 N-CA-C 107.816 -1.179 . . . . 64.219999999999999 107.816 176.482 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.447 ' H ' HD23 ' A' ' 48' ' ' LEU . 2.1 pt? -118.54 146.67 44.38 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 120.171 -0.612 . . . . 71.340000000000003 112.536 -172.471 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.425 HD23 ' H ' ' A' ' 49' ' ' LEU . 1.4 pt? -124.38 132.95 53.54 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.161 -1.051 . . . . 74.329999999999998 108.161 177.501 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 26.0 t -125.9 144.75 34.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 108.849 -0.797 . . . . 74.420000000000002 108.849 -176.823 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.423 HG21 ' HB3' ' A' ' 57' ' ' ALA . 57.7 t -92.46 127.73 44.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 108.624 -0.88 . . . . 42.420000000000002 108.624 179.795 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -94.45 -38.33 10.99 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.655 -0.702 . . . . 64.349999999999994 110.142 -179.604 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 5.5 tpm_? -160.51 114.14 2.11 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.625 -0.716 . . . . 75.319999999999993 110.125 -175.094 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 158.32 125.64 0.84 Allowed Glycine 0 N--CA 1.426 -1.968 0 O-C-N 124.106 0.879 . . . . 73.099999999999994 111.189 176.845 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.569 ' HD2' ' CZ ' ' A' ' 133' ' ' PHE . 50.4 Cg_exo -59.76 -10.63 12.32 Favored 'Trans proline' 0 N--CA 1.489 1.261 0 C-N-CA 123.291 2.661 . . . . 71.549999999999997 113.646 177.599 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.595 ' HB2' ' HA ' ' A' ' 80' ' ' LEU . 4.3 p-10 -52.44 -36.41 54.48 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.297 1.039 . . . . 73.230000000000004 110.046 179.59 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.423 ' HB3' HG21 ' A' ' 51' ' ' VAL . . . -171.93 -162.28 0.21 Allowed 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.513 1.125 . . . . 62.130000000000003 108.123 -179.681 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 172.58 62.64 0.05 OUTLIER Glycine 0 CA--C 1.491 -1.408 0 N-CA-C 110.205 -1.158 . . . . 65.209999999999994 110.205 -179.266 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -163.53 -176.4 4.68 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 107.329 -1.36 . . . . 75.049999999999997 107.329 -176.762 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -103.54 136.06 43.97 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 124.013 0.821 . . . . 74.439999999999998 109.374 176.687 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -121.76 149.93 42.59 Favored 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 108.664 -0.865 . . . . 74.409999999999997 108.664 178.161 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 38.6 tp -114.55 135.81 53.71 Favored 'General case' 0 C--N 1.285 -2.212 0 N-CA-C 106.294 -1.743 . . . . 74.099999999999994 106.294 178.122 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 94.7 mt -79.73 112.94 17.49 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 118.519 -1.272 . . . . 53.210000000000001 109.575 179.064 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -121.02 -0.59 9.99 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-O 121.58 0.705 . . . . 70.230000000000004 109.397 178.973 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -115.63 138.71 24.02 Favored Pre-proline 0 C--N 1.303 -1.431 0 N-CA-C 108.532 -0.914 . . . . 74.319999999999993 108.532 -177.693 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -63.33 -30.92 73.57 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.367 2.044 . . . . 74.329999999999998 112.055 -179.801 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 40.9 m -136.73 114.92 11.6 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 109.892 -0.41 . . . . 62.229999999999997 109.892 177.571 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 24.7 m -110.66 114.11 27.25 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 109.029 -0.73 . . . . 63.119999999999997 109.029 179.318 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 49.4 p -93.27 124.85 37.54 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.118 0.485 . . . . 70.140000000000001 111.633 -179.384 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -109.15 126.45 53.25 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 109.1 -0.704 . . . . 64.349999999999994 109.1 176.498 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -173.94 -171.92 38.78 Favored Glycine 0 N--CA 1.43 -1.706 0 C-N-CA 120.377 -0.916 . . . . 61.439999999999998 111.323 178.538 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -109.69 88.04 2.65 Favored 'General case' 0 N--CA 1.423 -1.777 0 N-CA-C 107.294 -1.373 . . . . 63.329999999999998 107.294 179.467 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 34.6 t60 -164.18 133.19 2.86 Favored Pre-proline 0 C--N 1.279 -2.476 0 N-CA-C 105.185 -2.154 . . . . 72.329999999999998 105.185 -179.872 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -51.06 -37.06 56.72 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 123.16 2.573 . . . . 61.109999999999999 112.933 -178.917 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -102.07 70.13 1.19 Allowed 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 122.569 1.176 . . . . 65.420000000000002 111.828 179.298 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 31.1 m -126.25 169.28 13.04 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 113.29 -1.777 . . . . 53.140000000000001 106.673 174.582 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -79.38 -38.53 34.7 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 119.872 -0.731 . . . . 53.439999999999998 110.579 -178.29 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 39.0 pt -136.73 171.06 17.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 108.591 -0.892 . . . . 52.310000000000002 108.591 173.125 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.53 ' O ' ' HB2' ' A' ' 56' ' ' ASN . 98.0 m-85 -105.25 137.23 43.37 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 112.448 0.536 . . . . 72.200000000000003 112.448 -175.807 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.595 ' HA ' ' HB2' ' A' ' 56' ' ' ASN . 1.7 tt -146.96 104.8 3.73 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 104.658 -2.349 . . . . 64.129999999999995 104.658 177.16 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -115.78 13.5 16.15 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 114.378 1.251 . . . . 64.120000000000005 114.378 -171.252 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.517 ' OD2' ' HB ' ' A' ' 85' ' ' VAL 0.292 3.1 p30 -31.76 -88.72 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.378 0 N-CA-C 115.785 1.772 . . . . 71.239999999999995 115.785 -174.744 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.428 ' H ' ' CG ' ' A' ' 82' ' ' ASP . 7.5 p -163.99 -46.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 C-N-CA 123.13 0.572 . . . . 70.299999999999997 110.732 178.25 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.407 ' HB ' ' CG ' ' A' ' 108' ' ' ASN . 18.0 m -110.12 27.41 9.64 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 123.337 1.541 . . . . 63.109999999999999 109.007 -177.41 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.517 ' HB ' ' OD2' ' A' ' 82' ' ' ASP . 6.3 p -82.25 138.96 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.935 0 CA-C-N 113.48 -1.691 . . . . 72.439999999999998 109.177 178.333 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 20.2 m -87.59 178.01 6.9 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 115.629 -0.714 . . . . 74.200000000000003 110.186 -179.318 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 45.5 mtm180 -64.84 -46.1 83.31 Favored 'General case' 0 C--O 1.221 -0.414 0 N-CA-C 109.964 -0.384 . . . . 72.140000000000001 109.964 178.095 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.56 112.12 17.08 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 104.985 -2.228 . . . . 74.040000000000006 104.985 163.774 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.411 ' CE1' ' HA3' ' A' ' 105' ' ' GLY . 27.2 t60 -104.64 -54.8 2.45 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 115.483 -0.781 . . . . 73.109999999999999 110.916 -170.702 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -120.01 129.67 54.37 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 108.827 -0.805 . . . . 73.200000000000003 108.827 -178.808 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -106.49 127.0 52.96 Favored 'General case' 0 C--N 1.287 -2.142 0 C-N-CA 120.159 -0.616 . . . . 71.209999999999994 109.987 178.478 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -106.94 113.07 26.33 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 106.355 -1.72 . . . . 74.519999999999996 106.355 176.784 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -128.92 150.97 50.14 Favored 'General case' 0 C--N 1.282 -2.35 0 C-N-CA 119.658 -0.817 . . . . 75.420000000000002 111.963 -176.578 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.452 HD13 ' CD2' ' A' ' 99' ' ' PHE . 4.0 tp -115.62 120.14 63.88 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 CA-C-N 114.919 -1.037 . . . . 75.150000000000006 109.252 -179.828 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -101.24 146.72 27.16 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 107.266 -1.383 . . . . 52.32 107.266 178.409 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.41 -14.21 7.16 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.436 0.532 . . . . 74.200000000000003 112.436 179.866 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -86.29 -64.85 1.44 Allowed Glycine 0 N--CA 1.42 -2.414 0 N-CA-C 110.95 -0.86 . . . . 75.129999999999995 110.95 171.427 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -146.45 177.89 8.69 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 117.306 0.553 . . . . 72.430000000000007 111.348 -175.15 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.452 ' CD2' HD13 ' A' ' 94' ' ' ILE . 89.7 m-85 -90.93 130.59 36.85 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.724 -1.213 . . . . 72.239999999999995 107.724 176.693 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -132.29 135.29 46.12 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 120.53 -0.468 . . . . 71.340000000000003 110.78 -176.63 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 5.0 p -120.91 119.69 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.095 0 CA-C-O 121.599 0.714 . . . . 71.219999999999999 109.765 179.671 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 30.5 m -119.35 128.26 75.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-N 115.228 -0.896 . . . . 73.120000000000005 111.004 -178.089 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -91.73 132.45 36.38 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 115.682 -0.69 . . . . 74.420000000000002 109.754 176.153 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 26.8 m -115.02 11.52 7.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 CA-C-O 121.274 0.559 . . . . 64.340000000000003 110.781 175.096 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.411 ' HA3' ' CE1' ' A' ' 89' ' ' HIS . . . -122.99 56.09 0.67 Allowed Glycine 0 C--O 1.247 0.928 0 N-CA-C 109.651 -1.38 . . . . 52.329999999999998 109.651 179.17 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 12.5 m -68.9 -8.56 45.29 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 113.288 0.847 . . . . 72.530000000000001 113.288 -171.773 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.6 tt -71.31 -37.78 71.78 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 107.551 -1.278 . . . . 74.409999999999997 107.551 176.829 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.407 ' CG ' ' HB ' ' A' ' 84' ' ' THR . 59.5 t30 -84.97 -42.31 15.04 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.527 -1.286 . . . . 72.409999999999997 107.527 176.746 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 88.38 122.73 1.94 Allowed Glycine 0 N--CA 1.439 -1.16 0 CA-C-N 114.971 -1.013 . . . . 64.420000000000002 114.965 174.35 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 31.5 m -100.85 140.33 35.3 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.066 -1.087 . . . . 64.129999999999995 108.066 172.781 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -127.41 168.41 14.89 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.732 0.777 . . . . 74.209999999999994 111.186 -174.69 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 13.7 p -122.81 143.66 34.94 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 N-CA-C 105.846 -1.909 . . . . 75.129999999999995 105.846 174.173 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -19.05 90.91 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 126.322 1.849 . . . . 74.299999999999997 113.874 -176.944 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 67.04 2.1 2.6 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 127.982 2.513 . . . . 61.229999999999997 115.392 175.209 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -124.86 142.31 40.61 Favored Pre-proline 0 C--N 1.312 -1.044 0 O-C-N 121.45 -0.781 . . . . 75.140000000000001 112.169 -178.822 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -79.04 98.91 1.22 Allowed 'Trans proline' 0 C--O 1.246 0.899 0 C-N-CA 122.766 2.311 . . . . 75.439999999999998 114.493 -175.998 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 65.5 mtp180 -140.2 119.91 13.35 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.417 -0.957 . . . . 74.200000000000003 108.417 174.3 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -85.92 -23.31 27.03 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 124.103 0.877 . . . . 72.299999999999997 109.92 -175.688 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -125.1 138.36 54.17 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 107.183 -1.414 . . . . 61.310000000000002 107.183 174.177 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -141.47 149.84 41.46 Favored 'General case' 0 C--N 1.288 -2.072 0 CA-C-N 116.045 -0.525 . . . . 72.0 110.899 -177.119 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.3 p -85.66 122.66 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.684 0 N-CA-C 103.372 -2.825 . . . . 62.5 103.372 170.187 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.43 ' HG2' ' CD2' ' A' ' 137' ' ' PHE . 12.3 ttt -65.69 113.3 4.17 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.426 0.631 . . . . 71.540000000000006 109.923 -168.806 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -103.64 133.92 47.84 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 115.148 -0.933 . . . . 74.329999999999998 109.944 -171.252 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.439 ' HB ' ' HB2' ' A' ' 139' ' ' ALA . 41.1 p -83.15 129.54 35.03 Favored 'General case' 0 N--CA 1.412 -2.336 0 CA-C-N 115.463 -0.789 . . . . 70.319999999999993 110.53 -177.732 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 107.75 -9.55 37.6 Favored Glycine 0 N--CA 1.416 -2.674 0 CA-C-N 115.689 -0.687 . . . . 74.129999999999995 111.654 177.239 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -116.26 176.18 5.22 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 118.504 -1.278 . . . . 70.310000000000002 112.592 -175.82 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -109.16 128.22 54.84 Favored 'General case' 0 N--CA 1.428 -1.575 0 C-N-CA 125.318 1.447 . . . . 73.140000000000001 110.348 -174.521 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 68.6 mt -115.97 130.3 70.91 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 N-CA-C 107.194 -1.409 . . . . 75.129999999999995 107.194 179.253 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -104.29 111.5 24.16 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 119.945 -0.702 . . . . 74.209999999999994 109.833 -177.682 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.8 pp -95.17 113.71 30.16 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 CA-C-N 115.567 -0.742 . . . . 65.400000000000006 110.812 179.68 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 72.28 -89.25 0.51 Allowed Glycine 0 N--CA 1.437 -1.262 0 N-CA-C 109.648 -1.381 . . . . 53.299999999999997 109.648 -174.033 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -142.3 3.8 1.56 Allowed 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 109.435 -0.58 . . . . 71.329999999999998 109.435 177.128 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.569 ' CZ ' ' HD2' ' A' ' 55' ' ' PRO . 21.7 m-85 -102.52 150.37 23.46 Favored 'General case' 0 CA--C 1.513 -0.47 0 O-C-N 122.026 -0.422 . . . . 74.310000000000002 110.42 -176.807 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -104.6 122.93 46.64 Favored 'General case' 0 C--O 1.252 1.231 0 CA-C-O 121.505 0.669 . . . . 72.430000000000007 112.331 -174.219 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 31.1 tp -117.78 138.47 52.03 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 114.546 -1.207 . . . . 71.5 107.828 179.729 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 10.2 p -115.08 138.75 44.37 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 N-CA-C 108.683 -0.858 . . . . 71.019999999999996 108.683 177.639 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 137' ' ' PHE . . . . . 0.43 ' CD2' ' HG2' ' A' ' 122' ' ' MET . 42.3 t80 -114.5 123.4 49.29 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.776 -0.824 . . . . 73.230000000000004 108.776 -177.937 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -114.62 148.24 38.38 Favored 'General case' 0 C--O 1.253 1.259 0 CA-C-O 121.111 0.481 . . . . 72.219999999999999 111.549 -175.649 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.439 ' HB2' ' HB ' ' A' ' 124' ' ' THR . . . -85.18 99.31 11.0 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-N 115.491 -0.777 . . . . 73.129999999999995 109.731 177.768 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -140.09 77.17 0.32 Allowed Glycine 0 C--N 1.281 -2.526 0 N-CA-C 107.817 -2.113 . . . . 74.549999999999997 107.817 175.002 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.568 ' HA ' ' O ' ' A' ' 46' ' ' SER . 14.9 Cg_endo . . . . . 0 CA--C 1.498 -1.323 0 C-N-CA 122.674 2.249 . . . . 54.119999999999997 113.799 -173.759 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.4 p30 . . . . . 0 CA--C 1.508 -0.668 0 N-CA-C 108.292 -1.003 . . . . 71.329999999999998 108.292 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -92.02 156.5 23.67 Favored Glycine 0 N--CA 1.427 -1.92 0 C-N-CA 120.619 -0.8 . . . . 53.530000000000001 111.435 179.94 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.0 m -82.7 129.71 61.24 Favored Pre-proline 0 C--N 1.294 -1.823 0 N-CA-C 109.106 -0.702 . . . . 70.230000000000004 109.106 179.131 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -66.61 127.9 18.07 Favored 'Trans proline' 0 N--CA 1.447 -1.233 0 C-N-CA 121.553 1.502 . . . . 75.420000000000002 109.321 173.295 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -83.34 136.73 42.79 Favored Pre-proline 0 C--N 1.295 -1.794 0 N-CA-C 108.524 -0.917 . . . . 75.219999999999999 108.524 179.132 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_exo -70.41 116.02 4.44 Favored 'Trans proline' 0 N--CA 1.441 -1.578 0 C-N-CA 121.426 1.417 . . . . 72.030000000000001 109.611 176.209 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 25.7 mp0 -66.96 124.22 22.4 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.429 -0.952 . . . . 70.510000000000005 108.429 179.128 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.6 m -53.36 126.51 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 O-C-N 124.279 0.987 . . . . 72.340000000000003 110.526 -178.621 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -70.23 139.37 52.23 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-N 115.539 -0.755 . . . . 53.32 110.826 -177.147 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 64.4 m -144.56 138.88 27.8 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 107.881 -1.155 . . . . 60.229999999999997 107.881 179.162 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 21.1 m -116.56 126.83 53.86 Favored 'General case' 0 N--CA 1.414 -2.243 0 N-CA-C 108.771 -0.826 . . . . 71.140000000000001 108.771 -177.025 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.4 t -60.88 -54.13 48.86 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 121.811 0.815 . . . . 72.010000000000005 110.036 179.696 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.9 m . . . . . 0 C--N 1.269 -2.906 0 CA-C-N 113.982 -1.463 . . . . 71.040000000000006 109.964 177.927 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.272 0 N-CA-C 109.718 -1.353 . . . . 64.310000000000002 109.718 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.1 m -91.19 163.57 14.21 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 121.711 0.767 . . . . 63.32 112.327 -173.746 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.587 ' HA ' ' N ' ' A' ' 140' ' ' GLY . . . -126.71 165.95 18.29 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 106.981 -1.489 . . . . 71.239999999999995 106.981 176.625 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.1 pp -129.91 150.66 51.1 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 113.087 0.773 . . . . 74.209999999999994 113.087 -173.83 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.512 HD11 ' CE1' ' A' ' 61' ' ' PHE . 4.4 pp -119.46 147.73 44.07 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.614 -0.721 . . . . 71.0 109.774 178.044 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.9 t -124.87 125.58 69.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 107.745 -1.205 . . . . 74.329999999999998 107.745 179.221 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.0 t -93.02 118.1 37.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 108.394 -0.965 . . . . 74.040000000000006 108.394 178.632 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -83.77 -34.12 24.86 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.354 0.597 . . . . 73.319999999999993 110.02 -178.428 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -155.55 125.94 6.76 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.269 -0.878 . . . . 74.519999999999996 108.783 176.283 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 155.44 109.52 0.32 Allowed Glycine 0 N--CA 1.415 -2.727 0 N-CA-C 111.649 -0.58 . . . . 74.200000000000003 111.649 -179.545 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -58.5 -8.58 5.6 Favored 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 124.47 3.446 . . . . 61.140000000000001 112.808 177.997 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 50.5 m-20 -52.34 -37.28 55.59 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.213 1.405 . . . . 71.420000000000002 109.229 174.306 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -159.97 -63.45 0.07 Allowed 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.659 -0.701 . . . . 53.340000000000003 109.873 -179.872 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.89 34.27 59.21 Favored Glycine 0 C--O 1.223 -0.553 0 CA-C-N 115.981 -0.554 . . . . 74.420000000000002 111.93 -179.861 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -149.42 -173.86 4.51 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 108.15 -1.056 . . . . 63.530000000000001 108.15 -178.159 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.2 ptt180 -119.79 150.1 40.96 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 108.454 -0.943 . . . . 62.140000000000001 108.454 175.777 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.512 ' CE1' HD11 ' A' ' 49' ' ' LEU . 52.0 p90 -157.23 151.72 25.25 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.598 -0.519 . . . . 72.239999999999995 109.598 173.031 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.2 pp -88.11 140.85 29.07 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 108.886 -0.783 . . . . 62.130000000000003 108.886 176.05 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 90.9 mt -71.58 113.04 8.21 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.672 -0.862 . . . . 74.310000000000002 108.672 179.667 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -110.67 -33.48 6.55 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 114.71 -1.132 . . . . 43.340000000000003 109.542 -178.967 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 17.7 mp0 -79.23 122.27 84.01 Favored Pre-proline 0 C--N 1.308 -1.207 0 N-CA-C 107.22 -1.4 . . . . 74.310000000000002 107.22 179.728 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -51.55 -31.77 41.16 Favored 'Trans proline' 0 C--N 1.367 1.552 0 C-N-CA 123.509 2.806 . . . . 44.340000000000003 112.634 -176.8 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.4 m -134.5 97.05 3.71 Favored 'General case' 0 N--CA 1.417 -2.098 0 N-CA-C 107.904 -1.147 . . . . 62.130000000000003 107.904 173.404 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 86.0 m -91.73 118.46 30.69 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.963 -1.125 . . . . 71.549999999999997 107.963 -179.277 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 27.6 m -108.41 121.04 44.12 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-O 121.775 0.797 . . . . 70.510000000000005 111.919 -176.478 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.469 ' O ' ' HB3' ' A' ' 89' ' ' HIS . . . -98.16 103.3 15.23 Favored 'General case' 0 N--CA 1.416 -2.168 0 N-CA-C 106.876 -1.527 . . . . 51.329999999999998 106.876 174.232 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 111.07 69.86 0.59 Allowed Glycine 0 N--CA 1.429 -1.795 0 C-N-CA 119.76 -1.21 . . . . 51.240000000000002 111.224 -177.9 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -151.0 61.11 0.92 Allowed 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 104.093 -2.558 . . . . 71.040000000000006 104.093 177.993 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 16.5 t60 -37.95 -43.97 1.74 Allowed Pre-proline 0 CA--C 1.578 2.021 0 N-CA-C 116.559 2.059 . . . . 73.409999999999997 116.559 -167.338 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -60.15 -40.25 61.92 Favored 'Trans proline' 0 C--N 1.374 1.921 0 CA-C-N 121.559 1.593 . . . . 62.109999999999999 113.207 175.405 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -149.84 88.03 1.52 Allowed 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 108.946 -0.761 . . . . 74.120000000000005 108.946 -179.078 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 53.4 m -101.61 152.17 21.13 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 116.439 -0.346 . . . . 54.229999999999997 110.425 179.577 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -72.22 -43.8 63.88 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 106.136 -1.801 . . . . 74.129999999999995 106.136 171.103 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 30.0 pt -131.68 130.26 61.95 Favored 'Isoleucine or valine' 0 C--O 1.245 0.868 0 CA-C-N 114.407 -1.27 . . . . 75.140000000000001 108.507 171.802 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -90.73 116.99 29.02 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 116.314 -0.403 . . . . 73.239999999999995 109.978 -177.063 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.455 HD21 ' HB1' ' A' ' 70' ' ' ALA . 97.2 mt -66.86 172.33 4.48 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.318 0.58 . . . . 64.400000000000006 111.251 -179.859 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -73.87 -12.16 60.59 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.792 -0.64 . . . . 41.450000000000003 110.732 179.04 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.529 ' HA ' HG23 ' A' ' 85' ' ' VAL . 1.6 m-20 54.05 78.4 0.16 Allowed 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 115.085 -0.962 . . . . 73.230000000000004 113.369 -176.74 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 44.2 t -93.06 -37.04 8.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 106.92 -1.511 . . . . 63.119999999999997 106.92 173.727 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 76.1 m -179.55 84.37 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 127.971 2.508 . . . . 62.119999999999997 105.473 -178.616 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.529 HG23 ' HA ' ' A' ' 82' ' ' ASP . 78.8 t -103.34 136.18 37.33 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.192 0 CA-C-N 115.204 -0.907 . . . . 73.219999999999999 109.726 -176.662 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 23.3 t -74.3 180.0 4.23 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 115.147 -0.933 . . . . 72.319999999999993 111.04 -176.096 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 -68.15 -34.19 75.88 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 107.615 -1.254 . . . . 71.409999999999997 107.615 178.841 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.472 ' O ' HG23 ' A' ' 104' ' ' VAL . 0.2 OUTLIER -139.45 125.66 20.08 Favored 'General case' 0 CA--C 1.495 -1.145 0 N-CA-C 101.236 -3.616 . . . . 74.510000000000005 101.236 167.572 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.469 ' HB3' ' O ' ' A' ' 70' ' ' ALA . 6.7 t60 -100.65 -79.32 0.5 Allowed 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 118.619 -1.233 . . . . 73.510000000000005 112.403 -173.996 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -120.07 107.81 13.51 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.152 0.501 . . . . 73.019999999999996 109.772 -178.867 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -95.5 127.89 41.91 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 109.027 -0.731 . . . . 70.0 109.027 178.909 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -112.74 112.27 23.66 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 107.321 -1.363 . . . . 62.420000000000002 107.321 176.737 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 54.7 ttp180 -103.59 124.19 48.35 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.325 -0.991 . . . . 75.310000000000002 108.325 178.42 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.36 117.02 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.319 0 CA-C-O 122.122 0.963 . . . . 62.009999999999998 109.443 -173.243 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 -118.41 144.69 45.75 Favored 'General case' 0 C--N 1.28 -2.415 0 N-CA-C 103.174 -2.899 . . . . 62.200000000000003 103.174 172.142 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.09 -16.07 63.63 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 121.067 0.46 . . . . 64.129999999999995 112.196 -177.627 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -90.07 -45.19 4.54 Favored Glycine 0 N--CA 1.431 -1.688 0 CA-C-N 115.534 -0.757 . . . . 34.200000000000003 112.695 174.883 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -136.41 140.88 43.51 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 121.297 0.57 . . . . 62.109999999999999 110.96 -176.977 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -112.54 125.95 54.81 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 107.177 -1.416 . . . . 75.239999999999995 107.177 179.561 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -132.39 137.78 47.46 Favored 'General case' 0 C--N 1.309 -1.178 0 C-N-CA 120.051 -0.659 . . . . 74.540000000000006 112.179 -179.051 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.8 p -115.85 125.95 73.18 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 CA-C-N 115.211 -0.904 . . . . 55.539999999999999 109.551 179.518 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 46.3 t -112.97 115.52 50.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 CA-C-N 115.951 -0.568 . . . . 63.420000000000002 109.697 -179.28 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -95.95 107.5 19.78 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 121.644 0.735 . . . . 75.349999999999994 110.048 177.034 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 88' ' ' ARG . 1.3 m -114.0 16.02 8.07 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.277 0 CA-C-N 115.075 -0.966 . . . . 61.340000000000003 109.659 175.5 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -122.35 45.43 1.21 Allowed Glycine 0 N--CA 1.438 -1.189 0 N-CA-C 109.119 -1.593 . . . . 73.219999999999999 109.119 176.265 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.5 p -69.68 -13.65 62.41 Favored 'General case' 0 C--O 1.249 1.037 0 C-N-CA 124.702 1.201 . . . . 61.130000000000003 112.973 -175.427 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 49.9 tp -67.73 -43.84 79.03 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 108.212 -1.033 . . . . 73.319999999999993 108.212 175.442 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -74.77 -47.68 29.68 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 107.123 -1.436 . . . . 72.340000000000003 107.123 173.065 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 100.31 96.02 2.18 Favored Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 115.16 0.824 . . . . 63.299999999999997 115.16 175.01 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.407 HG23 HG22 ' A' ' 130' ' ' ILE . 51.7 m -91.2 120.11 31.85 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.359 -0.978 . . . . 63.219999999999999 108.359 173.044 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.492 ' HB3' ' HA ' ' A' ' 114' ' ' ARG . 59.9 m-85 -102.35 134.58 45.42 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 108.574 -0.898 . . . . 74.239999999999995 108.574 178.774 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 34.5 t -117.62 121.95 68.68 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 N-CA-C 105.415 -2.069 . . . . 75.200000000000003 105.415 176.131 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.483 ' HA ' ' OD1' ' A' ' 126' ' ' ASP . 14.2 m120 67.52 18.19 10.0 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 107.211 -1.403 . . . . 75.200000000000003 107.211 -172.672 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.492 ' HA ' ' HB3' ' A' ' 111' ' ' TYR 0.344 44.7 mtt85 68.79 12.67 8.73 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 113.626 -1.625 . . . . 74.109999999999999 114.207 -173.354 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -97.85 135.96 21.32 Favored Pre-proline 0 N--CA 1.442 -0.865 0 N-CA-C 107.866 -1.161 . . . . 73.340000000000003 107.866 174.681 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -68.61 115.81 4.1 Favored 'Trans proline' 0 C--O 1.24 0.605 0 C-N-CA 121.864 1.71 . . . . 71.040000000000006 109.12 172.787 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 37.9 mmt180 -134.76 131.11 37.17 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 107.97 -1.122 . . . . 75.239999999999995 107.97 -178.285 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -77.85 -29.49 50.5 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.823 0.821 . . . . 73.109999999999999 109.092 176.682 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -144.35 137.52 27.18 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 107.132 -1.432 . . . . 71.439999999999998 107.132 171.343 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -142.06 150.42 41.21 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 109.66 -0.496 . . . . 72.450000000000003 109.66 177.96 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 48.5 t -80.62 112.66 18.93 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.156 0 N-CA-C 105.107 -2.183 . . . . 73.099999999999994 105.107 173.414 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.41 ' HG2' ' CE2' ' A' ' 137' ' ' PHE . 22.1 ttt -64.27 122.54 16.91 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.183 -0.917 . . . . 73.400000000000006 109.325 -171.817 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 56.1 tp60 -104.73 125.91 51.28 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.766 -0.652 . . . . 72.400000000000006 111.145 -171.182 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 10.5 p -79.31 116.38 19.52 Favored 'General case' 0 N--CA 1.434 -1.232 0 C-N-CA 123.271 0.628 . . . . 74.530000000000001 109.945 178.793 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 115.33 7.11 17.06 Favored Glycine 0 N--CA 1.435 -1.38 0 C-N-CA 120.547 -0.835 . . . . 60.340000000000003 112.881 178.178 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.483 ' OD1' ' HA ' ' A' ' 113' ' ' ASN . 8.0 t70 -128.63 -165.7 1.54 Allowed 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.584 -0.895 . . . . 41.109999999999999 108.584 -179.606 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -128.99 149.86 50.64 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.773 0.797 . . . . 72.519999999999996 113.133 -172.294 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 65.8 mt -124.02 129.9 74.04 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 107.912 -1.144 . . . . 63.200000000000003 107.912 -178.188 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -117.91 112.77 20.77 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 109.616 -0.512 . . . . 64.329999999999998 109.616 -177.125 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.596 HD13 ' H ' ' A' ' 130' ' ' ILE . 0.2 OUTLIER -94.19 105.69 17.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 109.367 -0.605 . . . . 75.150000000000006 109.367 178.708 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 71.07 -104.26 1.38 Allowed Glycine 0 N--CA 1.433 -1.53 0 N-CA-C 110.297 -1.121 . . . . 70.349999999999994 110.297 -176.633 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 42.8 mtpt -123.72 14.58 9.38 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 120.996 0.427 . . . . 72.109999999999999 109.927 177.67 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -101.04 132.12 46.62 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.915 -0.402 . . . . 52.409999999999997 109.915 -179.11 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 17.8 ptt180 -96.98 121.43 38.85 Favored 'General case' 0 C--O 1.254 1.341 0 CA-C-O 121.726 0.774 . . . . 73.430000000000007 112.234 -176.773 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.439 HD21 ' HB2' ' A' ' 49' ' ' LEU . 6.4 tt -125.19 142.99 51.16 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 114.466 -1.243 . . . . 65.430000000000007 107.715 178.415 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 10.0 p -119.2 140.27 43.72 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 N-CA-C 108.661 -0.866 . . . . 74.430000000000007 108.661 177.671 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 137' ' ' PHE . . . . . 0.41 ' CE2' ' HG2' ' A' ' 122' ' ' MET . 59.6 t80 -120.2 118.0 29.36 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 120.976 0.417 . . . . 73.420000000000002 110.482 -176.4 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -118.61 173.92 6.57 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 109.401 -0.592 . . . . 75.329999999999998 109.401 -176.626 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -71.1 149.89 46.02 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.629 -1.249 . . . . 73.239999999999995 107.629 172.804 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.587 ' N ' ' HA ' ' A' ' 47' ' ' ALA . . . -96.34 -160.52 32.41 Favored Glycine 0 C--N 1.287 -2.163 0 C-N-CA 120.46 -0.876 . . . . 64.230000000000004 111.478 -176.844 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo . . . . . 0 N--CA 1.434 -1.995 0 C-N-CA 121.823 1.682 . . . . 74.430000000000007 110.895 179.634 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 . . . . . 0 N--CA 1.443 -0.798 0 N-CA-C 108.843 -0.799 . . . . 75.219999999999999 108.843 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -152.68 32.89 0.82 Allowed Glycine 0 C--N 1.29 -1.995 0 N-CA-C 109.815 -1.314 . . . . 71.230000000000004 109.815 178.492 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.41 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 4.8 p -75.76 129.69 80.73 Favored Pre-proline 0 N--CA 1.424 -1.756 0 CA-C-N 115.007 -0.596 . . . . 72.310000000000002 110.381 -177.381 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 7' ' ' THR . 45.8 Cg_exo -55.49 133.03 55.69 Favored 'Trans proline' 0 C--O 1.241 0.658 0 C-N-CA 123.137 2.558 . . . . 35.229999999999997 112.587 -178.592 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -96.59 125.49 46.89 Favored Pre-proline 0 N--CA 1.431 -1.383 0 N-CA-C 107.974 -1.121 . . . . 52.240000000000002 107.974 175.987 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -55.42 136.01 71.8 Favored 'Trans proline' 0 C--O 1.245 0.835 0 C-N-CA 122.958 2.438 . . . . 61.340000000000003 112.157 -178.496 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -72.31 108.84 5.65 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.162 -0.681 . . . . 75.340000000000003 109.162 -178.885 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 36.2 t -87.88 115.82 28.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 109.657 -0.497 . . . . 53.119999999999997 109.657 -176.812 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -135.01 121.77 20.9 Favored 'General case' 0 N--CA 1.424 -1.77 0 N-CA-C 108.376 -0.972 . . . . 71.25 108.376 177.085 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.4 t -78.57 -25.07 45.26 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.215 0.531 . . . . 71.349999999999994 109.799 178.914 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.8 m 68.31 12.32 8.7 Favored 'General case' 0 CA--C 1.564 1.485 0 C-N-CA 124.426 1.09 . . . . 74.129999999999995 110.751 177.375 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.2 t -146.34 111.18 5.26 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 107.33 -1.359 . . . . 50.409999999999997 107.33 -179.452 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 46.5 t . . . . . 0 C--N 1.297 -1.687 0 N-CA-C 109.809 -0.441 . . . . 72.209999999999994 109.809 -176.458 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.489 -1.582 0 N-CA-C 107.212 -2.355 . . . . 74.150000000000006 107.212 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.6 p -88.78 152.74 21.59 Favored 'General case' 0 C--N 1.28 -2.429 0 N-CA-C 114.294 1.22 . . . . 74.450000000000003 114.294 -170.302 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.463 ' HA ' ' H ' ' A' ' 140' ' ' GLY . . . -122.43 178.36 5.0 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 106.386 -1.709 . . . . 62.439999999999998 106.386 176.223 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -133.03 146.65 51.92 Favored 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 118.78 -1.168 . . . . 61.409999999999997 111.86 -176.742 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.44 HD23 ' H ' ' A' ' 49' ' ' LEU . 1.0 OUTLIER -109.49 131.73 54.79 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 107.365 -1.346 . . . . 74.439999999999998 107.365 176.959 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.4 t -114.07 118.49 58.56 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 N-CA-C 107.969 -1.122 . . . . 71.450000000000003 107.969 -179.077 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 6.5 t -92.86 116.19 33.42 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.151 0 N-CA-C 107.433 -1.321 . . . . 51.409999999999997 107.433 -179.44 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -74.4 -35.12 63.45 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.724 -0.843 . . . . 63.439999999999998 108.724 -178.943 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.508 ' O ' ' HB3' ' A' ' 133' ' ' PHE . 76.7 ttt180 -170.3 126.97 0.81 Allowed 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 103.578 -2.749 . . . . 71.140000000000001 103.578 176.084 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.543 ' HA2' ' HB3' ' A' ' 133' ' ' PHE . . . -151.35 174.15 30.6 Favored Glycine 0 N--CA 1.421 -2.321 0 C-N-CA 118.293 -1.908 . . . . 52.509999999999998 114.825 -174.745 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -68.65 -39.95 8.21 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 123.321 2.681 . . . . 54.329999999999998 111.748 -179.753 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -79.86 -56.26 4.4 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.609 -0.723 . . . . 72.349999999999994 110.449 -179.374 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -158.91 -160.99 0.91 Allowed 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 108.737 -0.838 . . . . 73.439999999999998 108.737 -175.801 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -152.06 46.81 0.58 Allowed Glycine 0 N--CA 1.43 -1.721 0 N-CA-C 107.384 -2.286 . . . . 70.439999999999998 107.384 -178.711 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -133.69 -172.78 3.05 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 107.384 -1.339 . . . . 65.430000000000007 107.384 -175.641 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 37.2 ptt180 -116.64 139.87 50.04 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 119.811 -0.756 . . . . 73.340000000000003 110.798 179.793 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -126.71 153.94 44.78 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.923 -0.769 . . . . 71.129999999999995 108.923 -177.239 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.0 mp -110.23 140.57 44.23 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.68 -0.859 . . . . 75.25 108.68 178.613 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -71.24 115.59 10.57 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 109.019 -0.734 . . . . 74.430000000000007 109.019 177.719 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -135.83 -26.46 1.2 Allowed 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 115.282 -0.872 . . . . 74.120000000000005 111.44 -175.32 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -108.83 125.88 30.67 Favored Pre-proline 0 C--N 1.311 -1.071 0 N-CA-C 108.49 -0.93 . . . . 75.400000000000006 108.49 179.244 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -41.41 -58.02 1.23 Allowed 'Trans proline' 0 C--N 1.37 1.676 0 C-N-CA 124.57 3.514 . . . . 73.420000000000002 114.738 -176.791 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 26.1 m -109.73 115.95 30.81 Favored 'General case' 0 N--CA 1.434 -1.271 0 C-N-CA 120.158 -0.617 . . . . 74.140000000000001 109.555 178.777 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 87.5 m -116.8 116.16 26.94 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.124 -1.435 . . . . 61.240000000000002 107.124 176.302 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.6 t -110.06 125.21 52.72 Favored 'General case' 0 N--CA 1.434 -1.235 0 C-N-CA 118.853 -1.139 . . . . 71.109999999999999 111.245 -175.576 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -100.22 110.0 22.25 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 115.161 -0.927 . . . . 43.399999999999999 109.142 179.5 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -178.96 -144.04 5.56 Favored Glycine 0 CA--C 1.468 -2.85 0 N-CA-C 109.005 -1.638 . . . . 23.329999999999998 109.005 -179.729 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 21.4 ttt180 -112.75 -89.8 0.52 Allowed 'General case' 0 N--CA 1.404 -2.763 0 C-N-CA 119.322 -0.951 . . . . 71.049999999999997 111.141 178.098 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 35.6 m170 59.97 156.96 0.1 Allowed Pre-proline 0 CA--C 1.547 0.859 0 CA-C-O 121.507 0.67 . . . . 74.540000000000006 111.576 -172.931 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -66.97 -25.55 44.52 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 121.248 1.299 . . . . 73.230000000000004 108.823 168.549 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -111.71 70.94 0.73 Allowed 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 114.355 -1.293 . . . . 54.509999999999998 108.378 -177.443 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.3 m -73.76 134.01 43.37 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.7 -0.682 . . . . 74.200000000000003 110.452 -178.948 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -78.8 -49.6 12.72 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 107.355 -1.35 . . . . 73.150000000000006 107.355 173.899 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 39.7 pt -125.43 141.84 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 N-CA-C 106.155 -1.795 . . . . 51.43 106.155 169.253 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -95.1 121.83 37.14 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-O 121.588 0.708 . . . . 61.109999999999999 111.903 -174.45 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.0 mp -88.25 118.1 27.61 Favored 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 107.777 -1.194 . . . . 72.400000000000006 107.777 172.411 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -96.65 -6.03 37.58 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.364 -1.289 . . . . 71.5 113.047 -165.699 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -78.75 -170.3 2.08 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 115.98 -0.554 . . . . 65.109999999999999 110.479 -177.554 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.8 p -122.36 7.83 5.61 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.42 0 CA-C-O 121.341 0.591 . . . . 73.430000000000007 111.63 -176.263 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 8.2 t -120.51 20.25 11.86 Favored 'General case' 0 C--N 1.308 -1.235 0 O-C-N 121.197 -0.94 . . . . 72.319999999999993 108.907 -179.775 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.465 HG22 ' O ' ' A' ' 86' ' ' SER . 6.1 p -81.42 131.27 34.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-N 114.496 -1.229 . . . . 61.509999999999998 111.737 -176.089 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.465 ' O ' HG22 ' A' ' 85' ' ' VAL . 44.7 t -70.34 157.03 38.48 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 114.629 -1.169 . . . . 50.140000000000001 108.103 175.653 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -52.58 -41.83 63.96 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.563 0.696 . . . . 70.219999999999999 110.398 179.209 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -138.0 130.81 29.82 Favored 'General case' 0 CA--C 1.488 -1.423 0 N-CA-C 103.786 -2.672 . . . . 75.530000000000001 103.786 168.299 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 37.7 t60 -107.71 -63.64 1.29 Allowed 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 119.45 -0.9 . . . . 71.430000000000007 110.588 -176.477 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -136.22 125.7 25.13 Favored 'General case' 0 C--N 1.292 -1.902 0 C-N-CA 120.08 -0.648 . . . . 75.150000000000006 110.036 -177.505 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -97.67 127.22 43.47 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 107.573 -1.269 . . . . 54.009999999999998 107.573 175.722 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -106.01 112.96 26.22 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.569 -1.271 . . . . 73.329999999999998 107.569 179.352 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -113.86 126.98 55.79 Favored 'General case' 0 C--N 1.277 -2.551 0 N-CA-C 108.524 -0.917 . . . . 65.129999999999995 108.524 -178.676 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.5 116.81 53.63 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 CA-C-O 122.048 0.928 . . . . 75.409999999999997 109.98 -178.357 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -108.7 145.75 34.57 Favored 'General case' 0 N--CA 1.419 -2.021 0 N-CA-C 106.0 -1.852 . . . . 71.430000000000007 106.0 174.506 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -50.62 -28.03 8.0 Favored 'General case' 0 C--N 1.308 -1.197 0 O-C-N 124.059 0.85 . . . . 73.409999999999997 112.078 179.599 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -85.03 -51.35 3.8 Favored Glycine 0 N--CA 1.426 -2.027 0 C-N-CA 120.617 -0.801 . . . . 24.32 112.728 179.026 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -144.06 153.44 42.19 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-O 121.073 0.463 . . . . 75.329999999999998 111.087 -173.831 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.425 ' HB2' ' HB3' ' A' ' 122' ' ' MET . 60.9 m-85 -95.46 123.85 39.2 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.216 -1.031 . . . . 74.230000000000004 108.216 177.125 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -115.93 134.29 55.13 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.786 -0.45 . . . . 73.099999999999994 109.786 -178.407 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.6 p -125.33 126.2 70.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 109.272 -0.64 . . . . 74.329999999999998 109.272 177.437 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.7 t -114.56 123.68 70.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 CA-C-N 116.01 -0.541 . . . . 72.439999999999998 110.274 -179.35 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -89.5 115.91 27.27 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 121.567 0.699 . . . . 62.219999999999999 110.288 176.958 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 13.9 m -118.42 11.34 7.0 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.373 0 N-CA-C 108.184 -1.043 . . . . 62.130000000000003 108.184 173.94 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -110.17 34.57 5.34 Favored Glycine 0 N--CA 1.421 -2.335 0 N-CA-C 109.862 -1.295 . . . . 71.019999999999996 109.862 178.879 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.4 m -63.15 -9.73 12.11 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.947 1.299 . . . . 64.310000000000002 110.299 179.893 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 49.8 tp -58.27 -37.92 75.95 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 125.217 1.407 . . . . 64.439999999999998 107.825 174.707 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -110.15 -41.2 4.49 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 115.316 -0.856 . . . . 55.240000000000002 109.297 176.684 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 107.99 123.67 4.96 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 120.628 -0.796 . . . . 71.409999999999997 114.749 174.052 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 87.1 m -109.17 120.18 41.75 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.267 -1.012 . . . . 71.010000000000005 108.267 173.61 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . 0.25 40.5 p90 -123.48 135.81 54.25 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 114.407 1.262 . . . . 64.519999999999996 114.407 -177.83 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 18.2 m -105.09 136.33 39.35 Favored 'Isoleucine or valine' 0 C--O 1.257 1.448 0 CA-C-N 114.657 -1.156 . . . . 73.230000000000004 108.291 -179.994 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 62.06 -83.02 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 124.685 1.194 . . . . 41.140000000000001 108.744 -169.549 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 27.5 mmm180 -139.74 -12.67 1.13 Allowed 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 124.052 0.941 . . . . 63.32 110.843 177.654 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.459 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . 0.4 OUTLIER -110.5 131.08 22.24 Favored Pre-proline 0 C--O 1.245 0.821 0 N-CA-C 113.891 1.071 . . . . 71.450000000000003 113.891 -168.205 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 115' ' ' GLU . 24.6 Cg_exo -65.14 136.05 46.21 Favored 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 122.748 2.299 . . . . 71.409999999999997 110.17 175.282 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -131.35 164.06 26.49 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.645 -0.502 . . . . 53.340000000000003 109.645 -178.156 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -93.48 -56.03 3.07 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 108.911 -0.774 . . . . 72.439999999999998 108.911 176.733 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -130.99 139.74 50.04 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 108.778 -0.823 . . . . 71.0 108.778 179.572 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -138.88 149.94 45.42 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-O 121.536 0.684 . . . . 71.319999999999993 112.828 -178.453 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 39.7 t -92.34 105.08 16.29 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.101 0 N-CA-C 104.107 -2.553 . . . . 72.409999999999997 104.107 172.328 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.425 ' HB3' ' HB2' ' A' ' 99' ' ' PHE . 9.6 tpt -50.38 120.47 4.61 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 125.065 1.346 . . . . 72.120000000000005 110.297 -171.561 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -104.92 132.07 51.62 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 121.26 0.552 . . . . 74.310000000000002 111.577 -172.083 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.2 p -79.16 115.77 19.03 Favored 'General case' 0 N--CA 1.424 -1.73 0 CA-C-N 115.014 -0.994 . . . . 75.209999999999994 110.756 -179.201 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 119.82 -7.01 12.18 Favored Glycine 0 N--CA 1.429 -1.788 0 C-N-CA 121.033 -0.604 . . . . 65.239999999999995 112.823 177.768 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -106.8 157.9 17.39 Favored 'General case' 0 C--O 1.247 0.932 0 C-N-CA 119.944 -0.702 . . . . 55.039999999999999 111.637 -177.731 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.445 ' HA ' ' HA ' ' A' ' 136' ' ' VAL . 11.0 pt-20 -114.51 121.36 43.28 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-O 122.153 0.978 . . . . 73.349999999999994 109.081 177.587 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 71.6 mt -111.79 130.42 65.42 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.358 0 CA-C-N 113.968 -1.469 . . . . 74.230000000000004 109.962 -170.586 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.49 ' HG3' ' O ' ' A' ' 133' ' ' PHE . 42.8 tt0 -97.36 124.85 41.66 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.99 -0.684 . . . . 74.5 111.438 178.028 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 11.8 pt -105.55 101.95 13.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 114.504 -1.226 . . . . 64.530000000000001 108.481 178.355 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 72.44 -101.76 1.11 Allowed Glycine 0 N--CA 1.437 -1.278 0 N-CA-C 110.273 -1.131 . . . . 74.439999999999998 110.273 -176.559 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 32.8 mmmt -126.0 9.75 7.51 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.23 0.538 . . . . 63.310000000000002 110.307 178.6 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.543 ' HB3' ' HA2' ' A' ' 54' ' ' GLY . 78.5 m-85 -114.36 158.04 22.03 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 108.901 -0.777 . . . . 73.439999999999998 108.901 -179.013 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 51.4 ttp180 -127.49 135.61 50.62 Favored 'General case' 0 C--O 1.249 1.063 0 C-N-CA 118.567 -1.253 . . . . 73.430000000000007 112.731 -176.105 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 5.7 tt -122.16 132.11 54.29 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 114.191 -1.368 . . . . 71.299999999999997 107.465 -178.268 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 127' ' ' GLU . 9.6 p -111.12 135.17 51.11 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 N-CA-C 108.631 -0.878 . . . . 55.140000000000001 108.631 178.294 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -113.84 121.41 43.93 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 109.631 -0.507 . . . . 71.099999999999994 109.631 -175.918 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -123.27 165.98 16.04 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 109.396 -0.594 . . . . 75.409999999999997 109.396 -177.983 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -71.16 130.3 41.13 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 107.522 -1.288 . . . . 74.439999999999998 107.522 174.167 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.463 ' H ' ' HA ' ' A' ' 47' ' ' ALA . . . -116.99 -174.19 17.01 Favored Glycine 0 N--CA 1.418 -2.564 0 C-N-CA 120.115 -1.04 . . . . 64.340000000000003 112.952 -173.485 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo . . . . . 0 N--CA 1.428 -2.381 0 C-N-CA 122.5 2.133 . . . . 54.0 112.156 -179.626 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.8 ptt? . . . . . 0 CA--C 1.514 -0.429 0 CA-C-O 121.521 0.677 . . . . 73.420000000000002 110.678 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.3 p -73.32 -34.86 65.93 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 115.699 -0.682 . . . . 61.340000000000003 111.232 -177.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -93.03 152.5 19.26 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 109.15 -0.685 . . . . 73.200000000000003 109.15 178.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 18.0 m120 73.07 -34.59 0.3 Allowed 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 125.074 1.35 . . . . 54.119999999999997 113.802 176.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -75.73 -23.42 56.05 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 121.202 0.525 . . . . 72.530000000000001 111.077 177.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.01 25.75 27.01 Favored Glycine 0 N--CA 1.439 -1.134 0 C-N-CA 120.894 -0.67 . . . . 45.109999999999999 111.648 -178.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 61.7 m -87.28 123.51 69.76 Favored Pre-proline 0 N--CA 1.433 -1.278 0 N-CA-C 108.872 -0.788 . . . . 64.109999999999999 108.872 177.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -68.25 127.49 15.91 Favored 'Trans proline' 0 N--CA 1.448 -1.182 0 C-N-CA 121.659 1.573 . . . . 75.209999999999994 110.437 174.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -100.94 139.13 20.27 Favored Pre-proline 0 C--N 1.296 -1.736 0 N-CA-C 108.787 -0.82 . . . . 74.230000000000004 108.787 177.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -75.51 118.03 5.0 Favored 'Trans proline' 0 N--CA 1.441 -1.579 0 C-N-CA 121.845 1.697 . . . . 73.129999999999995 111.335 -177.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -76.82 173.74 11.34 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 108.953 -0.758 . . . . 71.400000000000006 108.953 177.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 45.1 t 61.21 81.09 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 108.189 -1.041 . . . . 64.219999999999999 108.189 -173.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -74.73 132.27 41.51 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 115.309 -0.86 . . . . 73.439999999999998 110.067 -176.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.9 t -124.21 108.71 12.57 Favored 'General case' 0 N--CA 1.407 -2.609 0 CA-C-O 121.794 0.807 . . . . 71.329999999999998 109.67 -178.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 15.2 t -112.61 -3.78 14.26 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 122.331 1.062 . . . . 65.129999999999995 108.361 176.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.6 p -92.07 35.88 0.98 Allowed 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 114.417 -1.265 . . . . 75.439999999999998 109.157 179.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.9 m -70.36 158.83 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.612 0 CA-C-N 114.36 -1.291 . . . . 74.150000000000006 111.248 -177.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -136.04 170.67 15.63 Favored 'General case' 0 C--N 1.274 -2.704 0 N-CA-C 106.954 -1.499 . . . . 64.409999999999997 106.954 178.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.8 mpt_? -78.0 129.88 35.82 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 109.44 -0.578 . . . . 63.130000000000003 109.44 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.85 97.28 6.61 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 107.819 -1.178 . . . . 71.519999999999996 107.819 176.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -81.42 -22.14 38.43 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 109.251 -0.648 . . . . 74.319999999999993 109.251 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 58.1 tp 73.19 88.08 0.1 Allowed 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 125.806 1.642 . . . . 74.340000000000003 111.09 -179.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.647 ' H ' HD23 ' A' ' 23' ' ' LEU . 2.2 pt? -86.59 124.04 32.44 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.655 -1.239 . . . . 65.430000000000007 107.655 175.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.4 mtpt -100.46 110.12 22.28 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 120.283 -0.567 . . . . 71.140000000000001 111.487 -176.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -78.83 147.4 33.25 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.729 -0.669 . . . . 74.450000000000003 110.0 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 25.2 ptp -166.76 -179.24 4.68 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.94 -0.763 . . . . 65.109999999999999 108.94 -177.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -143.42 152.52 41.66 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.302 -0.999 . . . . 63.420000000000002 108.302 177.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.0 t -133.18 -30.45 1.33 Allowed 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 110.021 -0.362 . . . . 64.219999999999999 110.021 -179.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 41.9 m -88.87 140.21 29.67 Favored 'General case' 0 N--CA 1.439 -1.006 0 O-C-N 122.159 -0.338 . . . . 54.119999999999997 110.152 -178.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.9 p -67.73 106.9 2.38 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 122.826 0.45 . . . . 72.5 110.965 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -136.09 51.4 0.81 Allowed Glycine 0 N--CA 1.429 -1.789 0 C-N-CA 120.606 -0.807 . . . . 64.519999999999996 113.096 -176.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 47.2 m -85.66 138.98 31.76 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 106.47 -1.678 . . . . 74.409999999999997 106.47 174.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.52 116.05 11.8 Favored Pre-proline 0 C--O 1.241 0.642 0 O-C-N 124.021 0.825 . . . . 61.340000000000003 110.448 -177.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -64.22 115.93 3.44 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.805 2.337 . . . . 72.319999999999993 113.613 -175.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.95 108.97 11.59 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.647 -1.242 . . . . 74.549999999999997 107.647 176.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.2 m 67.73 100.06 0.05 Allowed 'General case' 0 C--O 1.239 0.502 0 O-C-N 124.427 1.079 . . . . 63.340000000000003 111.139 -177.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 23.5 m -79.93 81.47 6.19 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 109.032 -0.729 . . . . 71.120000000000005 109.032 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -150.05 -138.21 2.86 Favored Glycine 0 N--CA 1.425 -2.043 0 N-CA-C 110.804 -0.918 . . . . 74.310000000000002 110.804 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.06 -32.83 72.46 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 123.312 0.645 . . . . 71.310000000000002 112.288 -176.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -82.25 -12.61 57.96 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 112.43 0.53 . . . . 74.010000000000005 112.43 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -83.79 -45.8 12.91 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 108.261 -1.014 . . . . 74.329999999999998 108.261 176.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.4 mp -72.81 157.91 88.04 Favored Pre-proline 0 C--N 1.318 -0.792 0 CA-C-N 114.627 -1.169 . . . . 71.230000000000004 111.131 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.434 ' HG3' ' H ' ' A' ' 140' ' ' GLY . 55.9 Cg_endo -85.76 176.59 5.32 Favored 'Trans proline' 0 C--O 1.24 0.592 0 C-N-CA 122.573 2.182 . . . . 44.409999999999997 112.524 -178.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -115.63 109.79 18.26 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 116.404 -0.362 . . . . 53.229999999999997 110.791 -179.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 84.24 -55.2 5.0 Favored Glycine 0 C--N 1.314 -0.661 0 N-CA-C 113.866 0.306 . . . . 62.450000000000003 113.866 175.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 9.0 m -113.69 153.79 28.37 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 109.715 -0.476 . . . . 54.219999999999999 109.715 -177.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.81 174.0 10.94 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.856 -0.794 . . . . 62.229999999999997 108.856 -178.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.5 pp -135.28 160.14 39.34 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 119.22 -0.992 . . . . 53.5 112.256 -177.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.9 pp -137.75 149.28 46.31 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 109.003 -0.739 . . . . 75.140000000000001 109.003 175.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 22.6 m -121.33 141.52 41.45 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.175 0 N-CA-C 107.14 -1.429 . . . . 64.010000000000005 107.14 175.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.0 t -92.85 116.81 34.81 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.614 0 N-CA-C 107.463 -1.31 . . . . 72.530000000000001 107.463 177.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.483 ' HB2' HG23 ' A' ' 136' ' ' VAL . 82.5 tttt -77.62 -21.76 51.8 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.109 -0.95 . . . . 64.409999999999997 109.214 -176.224 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.422 ' HB2' ' O ' ' A' ' 52' ' ' LYS . 65.6 ttt180 168.26 131.03 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.51 1.524 . . . . 73.120000000000005 109.536 163.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 175.88 152.69 9.72 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 121.044 -0.598 . . . . 42.240000000000002 112.032 178.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -69.84 -9.28 25.7 Favored 'Trans proline' 0 C--N 1.36 1.147 0 C-N-CA 123.795 2.997 . . . . 71.049999999999997 112.489 177.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -60.94 -42.64 98.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.795 -0.639 . . . . 73.209999999999994 110.656 -178.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -164.47 -58.99 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 109.254 -0.647 . . . . 64.420000000000002 109.254 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.45 32.82 36.91 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.692 -0.766 . . . . 65.140000000000001 111.614 -178.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -144.11 -164.74 1.96 Allowed 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 108.109 -1.071 . . . . 75.420000000000002 108.109 -177.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -115.48 138.56 50.89 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 120.769 0.319 . . . . 63.539999999999999 110.311 177.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -130.33 147.5 52.05 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.647 -0.706 . . . . 74.420000000000002 110.525 -170.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 93.2 mt -105.06 134.52 48.03 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.052 -0.721 . . . . 71.510000000000005 109.052 177.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.4 mp -110.78 114.37 27.68 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.221 -0.659 . . . . 75.530000000000001 109.221 178.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -131.76 4.66 4.22 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.828 -1.175 . . . . 64.25 107.828 172.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -83.56 124.79 75.05 Favored Pre-proline 0 N--CA 1.441 -0.911 0 N-CA-C 106.838 -1.542 . . . . 60.039999999999999 106.838 178.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.454 ' O ' ' HG3' ' A' ' 93' ' ' ARG . 1.2 Cg_endo -45.81 -46.23 15.74 Favored 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 123.291 2.661 . . . . 75.430000000000007 112.912 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 32.1 m -136.37 117.53 14.45 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 109.546 -0.539 . . . . 75.530000000000001 109.546 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 20.4 m -113.37 113.28 25.01 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 107.967 -1.123 . . . . 65.310000000000002 107.967 177.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.5 m -97.79 131.04 44.66 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.197 0.523 . . . . 32.509999999999998 110.756 -176.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.456 ' HB1' ' HB2' ' A' ' 80' ' ' LEU . . . -97.57 110.59 23.12 Favored 'General case' 0 N--CA 1.428 -1.526 0 CA-C-N 115.849 -0.614 . . . . 33.030000000000001 110.52 -178.209 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -136.47 -143.09 4.57 Favored Glycine 0 N--CA 1.437 -1.254 0 N-CA-C 108.703 -1.759 . . . . 64.230000000000004 108.703 178.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.521 ' O ' ' HD3' ' A' ' 72' ' ' ARG . 4.7 tmt_? -161.19 12.23 0.09 Allowed 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 122.128 0.965 . . . . 73.409999999999997 109.63 176.33 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 34.5 m170 -99.45 157.7 33.52 Favored Pre-proline 0 N--CA 1.433 -1.283 0 N-CA-C 108.03 -1.1 . . . . 72.540000000000006 108.03 -178.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_exo -56.48 -21.2 36.63 Favored 'Trans proline' 0 N--CA 1.478 0.582 0 C-N-CA 122.969 2.446 . . . . 64.140000000000001 113.88 -178.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.62 -1.68 43.21 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 112.253 0.464 . . . . 74.0 112.253 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 16.0 m -83.14 146.79 28.45 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 108.248 -1.019 . . . . 64.400000000000006 108.248 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -61.26 -60.03 4.38 Favored 'General case' 0 C--N 1.322 -0.618 0 O-C-N 123.273 0.358 . . . . 74.349999999999994 110.968 -176.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 38.2 pt -122.77 157.89 27.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-O 120.746 0.307 . . . . 64.439999999999998 110.194 176.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -97.07 126.54 42.3 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.017 -1.105 . . . . 71.209999999999994 108.017 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.456 ' HB2' ' HB1' ' A' ' 70' ' ' ALA . 1.2 tm? -108.71 -90.25 0.46 Allowed 'General case' 0 N--CA 1.418 -2.055 0 CA-C-O 121.153 0.501 . . . . 62.340000000000003 111.711 -175.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -96.81 118.04 32.38 Favored 'General case' 0 C--N 1.262 -3.211 0 CA-C-O 121.658 0.742 . . . . 74.230000000000004 109.238 -176.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -94.22 -40.25 10.1 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-N 114.412 -1.267 . . . . 63.119999999999997 112.273 -175.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 8.2 p -80.74 -31.66 12.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-N 115.63 -0.714 . . . . 45.299999999999997 110.423 -174.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 5.1 p -133.97 73.68 1.51 Allowed 'General case' 0 C--N 1.294 -1.829 0 CA-C-O 122.242 1.02 . . . . 71.340000000000003 109.291 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.402 HG12 ' H ' ' A' ' 85' ' ' VAL . 2.8 p -82.31 124.65 39.44 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 N-CA-C 114.55 1.315 . . . . 75.409999999999997 114.55 -169.351 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 51.0 m -96.54 139.5 32.55 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 105.514 -2.032 . . . . 63.329999999999998 105.514 167.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 8.8 ptp85 -56.69 -39.3 73.58 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 121.678 0.751 . . . . 73.340000000000003 112.045 -176.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.451 ' HB3' HG13 ' A' ' 104' ' ' VAL . 23.1 mmt180 -133.06 103.22 5.92 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 106.026 -1.842 . . . . 64.209999999999994 106.026 173.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 12.9 t60 -84.73 -69.92 0.61 Allowed 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.267 0.556 . . . . 73.010000000000005 110.341 -173.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -144.62 170.69 15.59 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.971 -0.752 . . . . 61.420000000000002 108.971 -176.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -144.45 128.19 17.24 Favored 'General case' 0 N--CA 1.419 -2.008 0 CA-C-O 121.317 0.58 . . . . 73.340000000000003 109.649 178.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -107.34 117.34 33.83 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.661 -1.237 . . . . 73.209999999999994 107.661 -177.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.454 ' HG3' ' O ' ' A' ' 66' ' ' PRO . 40.3 ttp85 -126.17 140.98 52.13 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-O 121.527 0.68 . . . . 61.310000000000002 111.053 -177.36 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.404 HD12 ' O ' ' A' ' 94' ' ' ILE . 2.9 pp -115.16 126.76 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.967 0 N-CA-C 106.865 -1.532 . . . . 74.540000000000006 106.865 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -118.43 146.25 44.59 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 108.698 -0.852 . . . . 73.040000000000006 108.698 -174.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.35 -29.52 4.03 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 114.267 1.21 . . . . 72.230000000000004 114.267 -177.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -96.7 -40.57 3.82 Favored Glycine 0 N--CA 1.432 -1.577 0 C-N-CA 120.755 -0.736 . . . . 71.230000000000004 114.088 177.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -150.65 171.02 17.79 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 117.417 0.608 . . . . 73.120000000000005 111.26 -172.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -105.46 128.6 53.63 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.109 -1.071 . . . . 75.239999999999995 108.109 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -132.5 135.18 45.83 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 120.321 -0.551 . . . . 71.310000000000002 111.596 -177.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.5 p -117.68 122.7 70.43 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 N-CA-C 109.166 -0.679 . . . . 74.109999999999999 109.166 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.3 m -119.95 137.63 53.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 112.694 0.627 . . . . 70.209999999999994 112.694 -177.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -83.26 126.33 32.55 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.622 -1.251 . . . . 75.540000000000006 107.622 171.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.451 HG13 ' HB3' ' A' ' 88' ' ' ARG . 8.2 p -105.33 1.8 10.32 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 CA-C-O 121.734 0.778 . . . . 75.129999999999995 110.518 -177.059 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 136.47 42.22 0.11 Allowed Glycine 0 N--CA 1.441 -0.976 0 C-N-CA 119.701 -1.238 . . . . 70.310000000000002 113.698 175.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 67.6 p -73.85 124.85 26.9 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-N 117.176 0.488 . . . . 53.329999999999998 109.706 178.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 51.1 tp -78.15 -26.01 47.58 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.447 0.642 . . . . 73.439999999999998 109.327 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -76.66 -23.54 53.26 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.505 -0.77 . . . . 44.109999999999999 110.388 178.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 94.93 132.56 6.86 Favored Glycine 0 N--CA 1.431 -1.634 0 CA-C-N 115.464 -0.789 . . . . 63.310000000000002 112.802 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 79.7 m -109.18 119.82 40.68 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.381 -0.97 . . . . 74.519999999999996 108.381 175.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -125.2 141.54 52.03 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 109.285 -0.635 . . . . 64.319999999999993 109.285 -175.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.474 HG21 ' HG3' ' A' ' 120' ' ' GLN . 28.3 m -98.86 111.45 28.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 N-CA-C 108.687 -0.857 . . . . 62.039999999999999 108.687 175.066 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 65.89 -76.99 0.04 OUTLIER 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 125.449 1.5 . . . . 70.430000000000007 109.007 -172.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -147.1 10.48 1.01 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.208 1.003 . . . . 62.140000000000001 109.916 177.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -100.58 122.0 51.05 Favored Pre-proline 0 C--O 1.242 0.664 0 CA-C-O 119.648 -0.215 . . . . 70.430000000000007 110.592 -176.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -69.91 112.99 3.25 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.527 2.151 . . . . 73.420000000000002 110.238 174.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -138.44 120.19 15.26 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 109.501 -0.555 . . . . 72.049999999999997 109.501 -177.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -86.08 -21.99 27.39 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 119.914 -0.714 . . . . 75.239999999999995 109.146 176.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -136.67 136.38 39.03 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 106.475 -1.676 . . . . 73.510000000000005 106.475 169.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.474 ' HG3' HG21 ' A' ' 112' ' ' VAL . 0.0 OUTLIER -142.95 151.07 40.53 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 109.761 -0.459 . . . . 74.310000000000002 109.761 -179.872 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.2 p -79.3 123.83 36.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 105.153 -2.166 . . . . 63.229999999999997 105.153 170.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 34.8 ttp -73.54 115.23 12.69 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 121.463 0.649 . . . . 74.120000000000005 110.452 -170.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -103.86 136.96 42.56 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 114.192 -1.367 . . . . 72.409999999999997 109.976 -172.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 40.7 p -88.45 122.27 31.75 Favored 'General case' 0 N--CA 1.411 -2.421 0 CA-C-N 115.047 -0.979 . . . . 63.350000000000001 109.506 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 120.82 -29.09 5.94 Favored Glycine 0 N--CA 1.438 -1.181 0 C-N-CA 120.816 -0.707 . . . . 73.400000000000006 112.306 177.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -93.22 164.08 13.37 Favored 'General case' 0 C--O 1.248 1.002 0 N-CA-C 109.101 -0.703 . . . . 62.399999999999999 109.101 -175.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -108.93 134.86 51.03 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-O 121.989 0.9 . . . . 62.210000000000001 112.052 -176.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 66.4 mt -97.88 121.12 48.08 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 N-CA-C 108.23 -1.026 . . . . 65.340000000000003 108.23 -178.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -89.66 112.54 23.82 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 107.98 -1.119 . . . . 73.230000000000004 107.98 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.442 HG13 ' HB2' ' A' ' 133' ' ' PHE . 6.2 pt -100.99 97.15 5.37 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.572 0 N-CA-C 108.002 -1.11 . . . . 72.129999999999995 108.002 177.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 67.6 -109.52 2.95 Favored Glycine 0 N--CA 1.427 -1.919 0 N-CA-C 109.84 -1.304 . . . . 65.450000000000003 109.84 -173.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -104.72 -17.55 14.59 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 109.237 -0.653 . . . . 73.109999999999999 109.237 176.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.442 ' HB2' HG13 ' A' ' 130' ' ' ILE . 55.1 m-85 -82.92 165.7 19.52 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.659 -0.7 . . . . 71.409999999999997 111.04 -173.024 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.402 ' HG3' ' HB3' ' A' ' 52' ' ' LYS . 13.1 ptt180 -126.87 122.1 33.69 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 121.719 0.771 . . . . 74.230000000000004 112.294 -170.326 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 7.8 tt -125.04 142.16 51.67 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.328 -1.36 . . . . 73.420000000000002 107.328 177.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.483 HG23 ' HB2' ' A' ' 52' ' ' LYS . 18.8 t -122.65 131.6 72.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 107.916 -1.142 . . . . 62.100000000000001 107.916 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -102.67 128.88 49.19 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.534 -1.284 . . . . 62.020000000000003 107.534 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -124.75 164.34 20.17 Favored 'General case' 0 C--O 1.253 1.25 0 CA-C-O 121.946 0.879 . . . . 72.400000000000006 111.42 -176.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -72.07 119.84 16.83 Favored 'General case' 0 N--CA 1.416 -2.169 0 CA-C-N 114.446 -1.252 . . . . 75.230000000000004 108.522 176.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.434 ' H ' ' HG3' ' A' ' 43' ' ' PRO . . . -75.64 -160.19 8.78 Favored Glycine 0 N--CA 1.42 -2.425 0 CA-C-N 115.346 -0.843 . . . . 60.420000000000002 111.64 178.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -76.78 125.96 8.49 Favored 'Trans proline' 0 N--CA 1.425 -2.531 0 C-N-CA 121.892 1.728 . . . . 73.25 113.829 -176.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -109.59 102.92 11.72 Favored 'General case' 0 C--N 1.28 -2.422 0 N-CA-C 102.552 -3.129 . . . . 71.140000000000001 102.552 166.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 . . . . . 0 C--N 1.291 -1.936 0 N-CA-C 107.966 -1.124 . . . . 74.010000000000005 107.966 -169.167 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.6 mmt . . . . . 0 CA--C 1.499 -0.982 0 CA-C-O 120.818 0.342 . . . . 52.109999999999999 111.413 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.4 m -76.73 -42.77 40.0 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 105.867 -1.901 . . . . 75.329999999999998 105.867 171.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 16.5 t70 56.57 84.3 0.09 Allowed 'General case' 0 C--O 1.244 0.804 0 CA-C-N 113.593 -1.64 . . . . 72.040000000000006 110.568 178.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 33.5 p30 -90.7 170.53 10.06 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 114.878 -1.056 . . . . 73.219999999999999 111.302 -175.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -101.49 149.44 24.07 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.376 0.608 . . . . 74.239999999999995 110.302 177.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -121.29 95.89 0.58 Allowed Glycine 0 N--CA 1.421 -2.338 0 N-CA-C 108.729 -1.748 . . . . 74.140000000000001 108.729 176.397 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.41 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 7.5 p -99.29 124.54 44.56 Favored Pre-proline 0 C--N 1.291 -1.939 0 N-CA-C 110.571 -0.159 . . . . 72.530000000000001 110.571 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 7' ' ' THR . 24.3 Cg_exo -66.41 134.87 37.45 Favored 'Trans proline' 0 C--O 1.242 0.708 0 C-N-CA 122.46 2.107 . . . . 64.420000000000002 110.016 175.075 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.428 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 43.7 mt-10 -92.36 129.66 40.26 Favored Pre-proline 0 C--N 1.294 -1.834 0 N-CA-C 109.821 -0.437 . . . . 72.510000000000005 109.821 -179.08 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 9' ' ' GLU . 71.0 Cg_exo -54.48 148.02 45.04 Favored 'Trans proline' 0 C--O 1.251 1.15 0 C-N-CA 123.683 2.922 . . . . 42.140000000000001 114.003 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -128.3 153.22 47.23 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 115.002 -0.999 . . . . 74.319999999999993 108.655 -178.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.8 p -126.27 136.38 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.805 0 N-CA-C 109.079 -0.711 . . . . 74.0 109.079 178.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -92.24 136.1 33.47 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.85 -1.167 . . . . 75.420000000000002 107.85 176.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.3 p -78.93 88.49 4.73 Favored 'General case' 0 N--CA 1.427 -1.623 0 CA-C-O 122.239 1.018 . . . . 71.099999999999994 110.948 -177.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.6 m -97.29 103.93 15.91 Favored 'General case' 0 N--CA 1.417 -2.103 0 CA-C-N 114.844 -1.071 . . . . 73.239999999999995 108.349 -177.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.8 m -111.72 154.68 24.64 Favored 'General case' 0 N--CA 1.417 -2.119 0 CA-C-N 115.832 -0.622 . . . . 63.43 109.818 -175.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 66.3 t -87.02 123.41 39.85 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 CA-C-N 115.577 -0.738 . . . . 72.239999999999995 109.267 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -100.01 107.63 19.62 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 109.854 -0.424 . . . . 73.109999999999999 109.854 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 19.0 mtp180 -103.11 163.04 12.47 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.905 -0.589 . . . . 73.400000000000006 110.752 178.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -118.12 79.22 1.34 Allowed 'General case' 0 N--CA 1.432 -1.348 0 CA-C-O 121.828 0.823 . . . . 70.400000000000006 109.114 175.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -93.16 -29.82 15.55 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.137 -0.938 . . . . 71.230000000000004 110.79 -178.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 91.1 mt -82.36 84.06 7.27 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 121.779 0.799 . . . . 74.010000000000005 112.721 -176.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.2 tt -155.45 121.75 5.21 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 103.988 -2.597 . . . . 72.209999999999994 103.988 176.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -117.15 -35.75 3.97 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 114.359 1.244 . . . . 75.510000000000005 114.359 -174.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -162.59 164.9 26.52 Favored 'General case' 0 CA--C 1.513 -0.459 0 C-N-CA 119.893 -0.723 . . . . 72.510000000000005 112.254 -176.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 84.8 mtp -139.13 19.07 2.61 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.349 -0.982 . . . . 74.120000000000005 108.349 176.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.33 112.2 8.19 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 114.794 -1.094 . . . . 73.120000000000005 110.504 -177.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 40.4 m -139.44 141.14 37.47 Favored 'General case' 0 N--CA 1.422 -1.863 0 CA-C-N 115.453 -0.794 . . . . 70.109999999999999 109.064 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.8 p -77.73 132.67 38.24 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 123.275 0.63 . . . . 74.319999999999993 109.892 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 25.4 p -82.27 148.89 28.12 Favored 'General case' 0 C--O 1.257 1.491 0 CA-C-O 120.504 0.192 . . . . 74.030000000000001 111.428 -179.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -62.18 124.7 34.33 Favored Glycine 0 N--CA 1.438 -1.233 0 N-CA-C 110.971 -0.852 . . . . 53.450000000000003 110.971 177.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 28.4 m -86.02 128.84 34.94 Favored 'General case' 0 N--CA 1.414 -2.262 0 N-CA-C 109.794 -0.447 . . . . 53.109999999999999 109.794 -177.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.17 114.25 45.3 Favored Pre-proline 0 C--N 1.302 -1.459 0 CA-C-N 114.746 -1.115 . . . . 75.400000000000006 108.713 -179.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -77.94 107.79 2.41 Favored 'Trans proline' 0 N--CA 1.441 -1.589 0 C-N-CA 122.165 1.91 . . . . 65.400000000000006 113.792 -176.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -101.21 -37.37 8.57 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 106.519 -1.66 . . . . 64.420000000000002 106.519 172.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.0 m -75.72 79.51 2.67 Favored 'General case' 0 N--CA 1.423 -1.825 0 CA-C-N 114.411 -1.268 . . . . 61.210000000000001 110.156 177.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 93.1 m -98.64 -27.99 13.75 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.691 -0.686 . . . . 55.240000000000002 109.55 176.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.81 69.87 1.37 Allowed Glycine 0 N--CA 1.431 -1.696 0 CA-C-N 115.888 -0.596 . . . . 73.25 112.516 177.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.28 -25.04 63.76 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 123.321 0.648 . . . . 35.409999999999997 111.929 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -79.56 -30.08 41.54 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 116.342 -0.39 . . . . 60.229999999999997 111.523 178.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -84.78 -37.46 20.78 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-O 121.182 0.515 . . . . 74.340000000000003 111.872 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.429 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 6.6 tt -73.65 121.03 84.17 Favored Pre-proline 0 C--N 1.308 -1.224 0 CA-C-N 115.287 -0.869 . . . . 63.340000000000003 109.515 -177.378 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 42' ' ' LEU . 30.6 Cg_exo -63.73 142.29 82.56 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 122.939 2.426 . . . . 54.149999999999999 112.061 178.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.19 97.89 3.05 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.448 0.642 . . . . 71.230000000000004 111.343 -177.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -148.27 89.9 0.14 Allowed Glycine 0 N--CA 1.432 -1.622 0 N-CA-C 109.044 -1.623 . . . . 54.420000000000002 109.044 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.0 m -89.33 164.73 14.78 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 121.64 0.734 . . . . 75.109999999999999 112.658 -173.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.507 ' HB1' ' O ' ' A' ' 138' ' ' LEU . . . -131.93 165.42 23.95 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 107.94 -1.133 . . . . 61.299999999999997 107.94 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -127.6 154.8 44.79 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 120.647 -0.421 . . . . 72.099999999999994 111.802 -176.274 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.464 ' HB2' HD11 ' A' ' 135' ' ' LEU . 2.8 pp -126.23 144.13 50.89 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 115.829 -0.623 . . . . 61.310000000000002 109.974 177.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.494 HG12 ' HB3' ' A' ' 60' ' ' ARG . 1.8 m -128.02 138.99 53.12 Favored 'Isoleucine or valine' 0 C--O 1.252 1.207 0 N-CA-C 109.348 -0.612 . . . . 63.130000000000003 109.348 178.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.499 HG21 ' HB3' ' A' ' 57' ' ' ALA . 93.8 t -93.62 115.98 33.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 109.792 -0.447 . . . . 70.150000000000006 109.792 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -69.38 -38.17 77.88 Favored 'General case' 0 CA--C 1.506 -0.748 0 O-C-N 123.273 0.358 . . . . 63.210000000000001 110.506 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 42.6 ttt180 -168.84 135.49 1.83 Allowed 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.352 -0.84 . . . . 71.519999999999996 109.655 178.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 149.24 145.54 4.15 Favored Glycine 0 N--CA 1.416 -2.639 0 N-CA-C 110.862 -0.895 . . . . 75.109999999999999 110.862 177.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -67.63 -9.16 24.53 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.796 2.331 . . . . 61.219999999999999 112.105 177.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.436 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 87.9 m-20 -51.25 -46.8 62.48 Favored 'General case' 0 C--O 1.21 -1.009 0 C-N-CA 124.674 1.19 . . . . 74.519999999999996 110.333 175.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.499 ' HB3' HG21 ' A' ' 51' ' ' VAL . . . -172.79 -176.78 1.53 Allowed 'General case' 0 C--O 1.215 -0.714 0 N-CA-C 107.632 -1.247 . . . . 62.299999999999997 107.632 178.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -161.8 41.9 0.39 Allowed Glycine 0 C--N 1.29 -1.987 0 N-CA-C 109.938 -1.265 . . . . 65.430000000000007 109.938 -178.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -159.46 -166.39 1.78 Allowed 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 107.863 -1.162 . . . . 63.420000000000002 107.863 -176.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.494 ' HB3' HG12 ' A' ' 50' ' ' VAL . 19.6 ptt180 -115.71 135.03 54.44 Favored 'General case' 0 N--CA 1.433 -1.317 0 O-C-N 123.934 0.771 . . . . 73.25 109.294 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -126.75 121.77 32.93 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 120.772 0.32 . . . . 75.030000000000001 111.152 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 44.2 tp -88.04 119.32 28.3 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 106.913 -1.514 . . . . 60.32 106.913 177.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -79.66 114.8 18.87 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 120.57 -0.452 . . . . 72.400000000000006 110.137 -177.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -95.91 -20.82 18.47 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.663 0.744 . . . . 63.009999999999998 110.368 -176.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -97.22 139.66 21.6 Favored Pre-proline 0 C--N 1.304 -1.409 0 CA-C-N 114.91 -1.041 . . . . 74.150000000000006 112.098 -175.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.443 ' HA ' ' CG2' ' A' ' 94' ' ' ILE . 29.9 Cg_endo -64.42 -24.53 64.08 Favored 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 123.488 2.792 . . . . 74.430000000000007 114.347 -177.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.8 m -135.25 103.93 5.7 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 121.445 0.641 . . . . 72.219999999999999 109.972 178.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 17.0 m -103.13 121.69 43.16 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 115.456 -0.793 . . . . 74.230000000000004 109.658 -178.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.6 m -97.8 119.86 37.16 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 109.933 -0.395 . . . . 74.340000000000003 109.933 -177.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.82 133.84 42.56 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 121.217 0.532 . . . . 75.200000000000003 109.851 178.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -170.13 -152.71 8.18 Favored Glycine 0 N--CA 1.424 -2.139 0 N-CA-C 108.456 -1.857 . . . . 70.120000000000005 108.456 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.5 ttt180 -90.37 -38.77 13.1 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 118.765 -1.174 . . . . 61.43 111.901 -178.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -176.73 -56.22 0.0 OUTLIER Pre-proline 0 CA--C 1.569 1.677 0 N-CA-C 114.679 1.362 . . . . 73.219999999999999 114.679 -178.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -49.88 -41.65 46.73 Favored 'Trans proline' 0 C--N 1.388 2.641 0 C-N-CA 123.325 2.683 . . . . 71.409999999999997 116.697 -167.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.406 ' OE2' ' HB2' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -126.17 7.97 7.23 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 122.415 1.102 . . . . 72.129999999999995 108.34 178.31 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.5 m -82.72 121.28 26.67 Favored 'General case' 0 N--CA 1.4 -2.941 0 CA-C-N 114.082 -1.417 . . . . 73.040000000000006 108.524 -175.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -66.3 -31.63 72.54 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.777 0.799 . . . . 73.540000000000006 109.633 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.463 ' H ' HD13 ' A' ' 78' ' ' ILE . 0.2 OUTLIER -127.44 141.17 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.391 0 N-CA-C 106.322 -1.733 . . . . 73.129999999999995 106.322 172.269 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -97.47 117.73 32.37 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 120.959 0.409 . . . . 63.399999999999999 111.746 -176.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 5.9 mp -102.51 179.06 4.41 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 107.891 -1.151 . . . . 45.340000000000003 107.891 178.539 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.419 ' H ' ' HA ' ' A' ' 56' ' ' ASN . 15.4 t70 -163.99 84.24 0.45 Allowed 'General case' 0 N--CA 1.442 -0.841 0 CA-C-O 121.791 0.805 . . . . 74.140000000000001 110.671 178.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.495 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 11.2 t70 -97.48 165.0 12.21 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 105.458 -2.052 . . . . 73.129999999999995 105.458 170.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.8 p -69.39 -27.22 33.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 CA-C-N 119.08 0.855 . . . . 61.200000000000003 110.615 -178.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.465 ' HB ' ' ND2' ' A' ' 108' ' ' ASN . 4.2 m -119.45 36.82 4.36 Favored 'General case' 0 CA--C 1.556 1.187 0 CA-C-O 121.855 0.835 . . . . 75.409999999999997 108.756 -179.306 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.495 ' HB ' ' HB3' ' A' ' 82' ' ' ASP . 11.8 p -81.75 140.14 16.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 108.958 -0.756 . . . . 65.140000000000001 108.958 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 26.3 m -121.34 147.33 45.84 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 110.016 -0.365 . . . . 75.230000000000004 110.016 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.406 ' HB2' ' OE2' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -59.76 132.19 53.21 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 107.222 -1.399 . . . . 70.420000000000002 107.222 170.683 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 42.1 mtm180 58.8 74.17 0.45 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.568 0.699 . . . . 75.209999999999994 109.758 -169.114 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -100.13 -58.55 1.89 Allowed 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 108.181 -1.044 . . . . 62.109999999999999 108.181 -177.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -136.58 135.93 38.81 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.507 -0.924 . . . . 55.149999999999999 108.507 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -108.3 126.76 53.2 Favored 'General case' 0 C--N 1.278 -2.503 0 N-CA-C 107.88 -1.155 . . . . 74.409999999999997 107.88 178.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -104.51 112.68 25.84 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.525 -0.917 . . . . 60.420000000000002 108.525 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 35.2 ttt180 -116.65 147.55 41.82 Favored 'General case' 0 C--N 1.275 -2.657 0 N-CA-C 108.331 -0.989 . . . . 74.030000000000001 108.331 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.443 ' CG2' ' HA ' ' A' ' 66' ' ' PRO . 6.7 tt -114.62 137.67 47.25 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.341 0 N-CA-C 108.436 -0.95 . . . . 62.030000000000001 108.436 177.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -118.31 147.48 43.42 Favored 'General case' 0 N--CA 1.419 -2.003 0 N-CA-C 105.942 -1.873 . . . . 74.209999999999994 105.942 177.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -42.48 -19.13 0.01 OUTLIER 'General case' 0 CA--C 1.559 1.326 0 N-CA-C 116.719 2.118 . . . . 73.219999999999999 116.719 -174.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -119.14 -29.1 1.86 Allowed Glycine 0 N--CA 1.43 -1.73 0 C-N-CA 120.751 -0.738 . . . . 53.030000000000001 113.527 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -161.24 177.57 10.08 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-N 118.089 0.944 . . . . 34.420000000000002 109.765 -174.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -103.47 138.67 39.87 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 113.596 0.962 . . . . 72.420000000000002 113.596 -173.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -112.93 116.82 30.59 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.273 -1.01 . . . . 62.439999999999998 108.273 178.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 59.3 t -119.4 119.52 60.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 108.752 -0.832 . . . . 72.310000000000002 108.752 -178.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.6 m -111.4 131.79 61.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-O 121.417 0.627 . . . . 71.030000000000001 111.276 -179.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -91.29 113.29 25.52 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.125 -0.943 . . . . 74.049999999999997 109.486 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 19.1 m -114.79 9.88 7.72 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 CA-C-O 121.463 0.649 . . . . 74.030000000000001 109.954 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -127.75 53.29 0.8 Allowed Glycine 0 N--CA 1.431 -1.641 0 N-CA-C 110.367 -1.093 . . . . 45.340000000000003 110.367 179.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.4 m -61.42 -7.61 3.24 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 124.42 1.088 . . . . 75.349999999999994 113.059 -177.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 69.0 tp -58.15 -44.76 88.03 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 107.996 -1.112 . . . . 72.510000000000005 107.996 174.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.543 ' OD1' ' HA2' ' A' ' 131' ' ' GLY . 52.3 t-20 -98.9 -53.1 3.37 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 106.409 -1.7 . . . . 64.430000000000007 106.409 175.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 94.96 135.87 8.24 Favored Glycine 0 N--CA 1.432 -1.604 0 CA-C-N 115.037 -0.983 . . . . 62.509999999999998 112.716 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 26.9 m -91.94 123.65 35.47 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 108.211 -1.033 . . . . 64.439999999999998 108.211 173.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -102.29 133.87 46.49 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-O 120.994 0.426 . . . . 74.200000000000003 110.277 -177.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.6 p -105.23 115.74 47.67 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 N-CA-C 106.536 -1.653 . . . . 75.430000000000007 106.536 173.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 12.2 m120 64.73 -78.41 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 124.737 1.215 . . . . 73.329999999999998 110.767 -173.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 -140.18 -3.75 1.37 Allowed 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 123.703 0.801 . . . . 63.140000000000001 110.44 -176.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -118.03 130.21 24.87 Favored Pre-proline 0 C--N 1.325 -0.462 0 C-N-CA 120.688 -0.405 . . . . 75.439999999999998 111.711 -170.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -79.64 117.3 3.65 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.394 2.063 . . . . 74.340000000000003 111.104 177.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 36.9 mmt180 -118.76 153.84 33.78 Favored 'General case' 0 C--N 1.308 -1.238 0 O-C-N 121.762 -0.586 . . . . 75.019999999999996 109.868 -177.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -84.73 -25.39 28.36 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.71 0.767 . . . . 74.319999999999993 109.123 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -157.56 139.17 13.9 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 107.539 -1.282 . . . . 41.520000000000003 107.539 175.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -140.62 149.25 42.07 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-O 121.033 0.444 . . . . 73.030000000000001 110.973 178.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 41.1 t -104.52 105.04 17.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 105.294 -2.113 . . . . 72.219999999999999 105.294 175.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 65.7 mtp -103.25 151.35 22.77 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 113.488 0.921 . . . . 64.329999999999998 113.488 -171.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -113.96 153.33 29.49 Favored 'General case' 0 N--CA 1.418 -2.049 0 CA-C-N 113.813 -1.539 . . . . 72.409999999999997 108.269 -177.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.7 p -77.71 129.36 35.42 Favored 'General case' 0 N--CA 1.417 -2.093 0 CA-C-O 121.532 0.682 . . . . 41.340000000000003 111.646 -176.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 111.82 8.64 22.12 Favored Glycine 0 N--CA 1.442 -0.91 0 N-CA-C 110.539 -1.025 . . . . 34.409999999999997 110.539 -177.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -109.89 169.34 8.78 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-O 120.445 0.164 . . . . 62.130000000000003 110.989 -175.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.405 ' OE2' ' HD2' ' A' ' 134' ' ' ARG . 38.2 tt0 -108.73 139.97 42.8 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 113.299 0.851 . . . . 63.520000000000003 113.299 -172.289 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 58.4 mt -125.31 131.23 72.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 124.436 1.094 . . . . 74.150000000000006 109.704 -176.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -113.94 124.05 51.22 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 121.404 0.621 . . . . 73.239999999999995 110.069 173.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 27.7 mt -108.5 100.07 9.98 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 N-CA-C 107.311 -1.366 . . . . 63.329999999999998 107.311 -177.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.543 ' HA2' ' OD1' ' A' ' 108' ' ' ASN . . . 71.04 -100.6 0.87 Allowed Glycine 0 N--CA 1.425 -2.06 0 O-C-N 124.25 0.969 . . . . 62.219999999999999 110.788 -177.08 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -114.6 -9.81 12.59 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-O 121.16 0.505 . . . . 74.129999999999995 110.685 177.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -104.27 142.61 34.23 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 118.993 -1.083 . . . . 74.439999999999998 112.32 -171.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.405 ' HD2' ' OE2' ' A' ' 127' ' ' GLU . 11.9 ttp180 -106.79 128.78 54.53 Favored 'General case' 0 C--O 1.248 0.992 0 N-CA-C 113.792 1.034 . . . . 72.319999999999993 113.792 -167.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.464 HD11 ' HB2' ' A' ' 49' ' ' LEU . 38.8 tp -123.94 145.04 49.42 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 126.449 1.9 . . . . 62.509999999999998 109.551 -174.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.419 ' CG1' HG22 ' A' ' 50' ' ' VAL . 7.3 p -123.17 135.24 63.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 108.84 -0.8 . . . . 72.340000000000003 108.84 171.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -112.11 118.41 35.3 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.499 -0.926 . . . . 74.420000000000002 108.499 -174.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.507 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 4.5 mp -120.88 164.42 16.69 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 120.891 0.377 . . . . 72.310000000000002 111.089 -175.073 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -75.25 145.74 41.68 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.298 -0.63 . . . . 54.25 109.298 177.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -103.7 -178.62 25.79 Favored Glycine 0 N--CA 1.429 -1.789 0 C-N-CA 120.608 -0.806 . . . . 64.439999999999998 111.638 -178.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -70.64 149.0 60.59 Favored 'Trans proline' 0 C--O 1.242 0.686 0 C-N-CA 122.628 2.219 . . . . 55.32 112.515 -179.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -82.2 113.54 20.1 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 106.258 -1.756 . . . . 74.209999999999994 106.258 173.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 . . . . . 0 C--N 1.289 -2.034 0 N-CA-C 109.595 -0.52 . . . . 74.439999999999998 109.595 -174.876 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 CA--C 1.509 -0.616 0 N-CA-C 109.069 -0.715 . . . . 75.329999999999998 109.069 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.8 m -82.1 -28.25 32.4 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 107.458 -1.312 . . . . 74.109999999999999 107.458 174.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -151.52 137.11 17.83 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 105.716 -1.957 . . . . 73.200000000000003 105.716 174.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -100.75 163.08 12.49 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 111.724 0.268 . . . . 62.100000000000001 111.724 -174.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 51.6 t30 54.41 84.1 0.07 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.823 1.249 . . . . 75.200000000000003 111.459 -178.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -108.48 175.63 19.69 Favored Glycine 0 N--CA 1.426 -1.992 0 N-CA-C 110.258 -1.137 . . . . 74.140000000000001 110.258 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.1 m -68.98 130.92 91.15 Favored Pre-proline 0 C--N 1.3 -1.578 0 N-CA-C 108.294 -1.002 . . . . 74.239999999999995 108.294 178.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.538 ' O ' ' HD3' ' A' ' 10' ' ' PRO . 10.7 Cg_endo -53.46 149.86 29.02 Favored 'Trans proline' 0 C--N 1.358 1.059 0 C-N-CA 123.22 2.614 . . . . 53.219999999999999 111.814 -179.32 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -85.74 105.11 6.29 Favored Pre-proline 0 N--CA 1.422 -1.831 0 N-CA-C 107.741 -1.207 . . . . 74.239999999999995 107.741 178.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.538 ' HD3' ' O ' ' A' ' 8' ' ' PRO . 86.8 Cg_endo -103.26 155.0 0.25 Allowed 'Trans proline' 0 N--CA 1.437 -1.823 0 C-N-CA 122.596 2.197 . . . . 74.450000000000003 112.981 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -80.73 72.47 7.69 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 122.452 1.12 . . . . 74.409999999999997 109.412 173.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.8 p -62.02 142.48 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 CA-C-N 113.454 -1.703 . . . . 75.209999999999994 109.998 -177.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.05 137.59 51.39 Favored 'General case' 0 N--CA 1.423 -1.779 0 C-N-CA 119.72 -0.792 . . . . 72.120000000000005 110.16 179.027 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.4 m -129.53 90.99 3.08 Favored 'General case' 0 C--N 1.274 -2.674 0 N-CA-C 107.495 -1.298 . . . . 72.219999999999999 107.495 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 94.3 m -69.28 97.0 0.9 Allowed 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 115.066 -0.97 . . . . 72.209999999999994 111.183 -177.154 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 25.3 t -136.51 112.9 9.94 Favored 'General case' 0 N--CA 1.419 -2.005 0 N-CA-C 105.741 -1.948 . . . . 63.539999999999999 105.741 178.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.7 m -102.76 -173.27 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 CA-C-N 116.051 -0.522 . . . . 45.039999999999999 111.22 -174.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -81.09 134.59 35.68 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 116.232 -0.44 . . . . 61.340000000000003 110.523 178.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -77.07 102.45 6.51 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.908 -0.587 . . . . 74.420000000000002 109.584 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.02 91.79 5.51 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.26 0.552 . . . . 74.030000000000001 110.781 -177.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -71.6 -36.85 70.95 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.02 -0.991 . . . . 73.25 110.667 -178.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.4 tt 76.61 120.52 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.469 1.107 . . . . 62.299999999999997 110.348 -178.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -70.99 127.7 33.47 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 107.521 -1.288 . . . . 73.25 107.521 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.6 167.06 4.7 Favored 'General case' 0 C--N 1.313 -0.998 0 O-C-N 124.023 0.827 . . . . 71.400000000000006 113.045 -176.432 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -72.89 -167.6 0.39 Allowed 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.03 -0.986 . . . . 72.510000000000005 112.761 -171.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 83.6 mtp -84.4 101.95 12.39 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.072 -1.084 . . . . 54.32 108.072 176.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -69.02 161.52 28.81 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.991 -0.744 . . . . 71.209999999999994 108.991 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.6 t -81.13 171.56 14.77 Favored 'General case' 0 N--CA 1.42 -1.939 0 N-CA-C 107.878 -1.156 . . . . 73.140000000000001 107.878 176.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 20.4 m -89.46 -165.09 1.26 Allowed 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.215 -1.032 . . . . 73.010000000000005 108.215 178.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 38.8 m -62.41 125.52 24.18 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 108.814 -0.81 . . . . 73.340000000000003 108.814 175.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.17 -104.24 0.28 Allowed Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 120.975 -0.631 . . . . 45.140000000000001 113.498 -175.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.0 t -91.07 150.54 21.37 Favored 'General case' 0 N--CA 1.428 -1.572 0 CA-C-O 121.306 0.574 . . . . 64.25 110.895 -176.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -90.4 113.06 56.2 Favored Pre-proline 0 N--CA 1.43 -1.435 0 N-CA-C 108.244 -1.021 . . . . 72.049999999999997 108.244 176.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -64.7 118.88 5.82 Favored 'Trans proline' 0 C--O 1.25 1.091 0 C-N-CA 122.703 2.269 . . . . 71.430000000000007 111.406 -179.171 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.95 122.75 23.94 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.526 -0.761 . . . . 62.219999999999999 111.652 -175.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.0 t -90.62 99.57 12.58 Favored 'General case' 0 N--CA 1.421 -1.906 0 N-CA-C 108.114 -1.069 . . . . 50.409999999999997 108.114 176.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.4 p -95.04 18.49 12.0 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 115.434 -0.803 . . . . 73.150000000000006 111.215 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.48 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . 99.31 95.92 2.09 Favored Glycine 0 N--CA 1.439 -1.144 0 C-N-CA 120.925 -0.655 . . . . 71.340000000000003 111.488 179.178 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.23 -27.22 67.8 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 122.498 0.319 . . . . 53.549999999999997 111.744 -176.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -83.12 -16.9 44.97 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.004 0.431 . . . . 51.109999999999999 110.933 179.135 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -83.32 -33.32 25.94 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 108.706 -0.849 . . . . 73.129999999999995 108.706 176.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 38' ' ' GLY . 89.0 mt -65.77 149.1 97.82 Favored Pre-proline 0 C--O 1.247 0.959 0 CA-C-N 115.23 -0.895 . . . . 75.530000000000001 109.249 176.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -61.99 156.78 47.4 Favored 'Trans proline' 0 C--O 1.25 1.087 0 C-N-CA 122.644 2.229 . . . . 74.150000000000006 112.447 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -78.73 102.88 8.31 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 115.683 -0.69 . . . . 61.119999999999997 109.863 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -166.45 46.15 0.26 Allowed Glycine 0 C--N 1.292 -1.872 0 N-CA-C 108.122 -1.991 . . . . 54.329999999999998 108.122 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.3 m -91.14 167.84 12.06 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 114.252 -0.974 . . . . 60.299999999999997 110.033 -176.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -102.19 166.84 10.37 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 109.907 -0.405 . . . . 72.530000000000001 109.907 -179.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -134.35 152.64 51.92 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.841 -0.8 . . . . 74.040000000000006 108.841 176.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.421 ' HB2' HD11 ' A' ' 135' ' ' LEU . 4.4 pp -109.27 134.63 51.54 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 108.772 -0.825 . . . . 72.349999999999994 108.772 178.363 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 94.1 t -117.08 117.81 56.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 CA-C-N 116.032 -0.531 . . . . 73.239999999999995 109.604 -177.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.566 HG21 ' HB3' ' A' ' 57' ' ' ALA . 15.6 t -93.15 118.96 40.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 107.711 -1.218 . . . . 72.540000000000006 107.711 178.311 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -75.99 -42.35 48.49 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 115.664 -0.698 . . . . 64.340000000000003 109.156 -178.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 62.3 ttt180 -177.34 157.64 1.35 Allowed 'General case' 0 C--O 1.245 0.865 0 CA-C-N 115.047 -0.979 . . . . 71.299999999999997 108.921 -177.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 124.88 142.85 5.97 Favored Glycine 0 C--O 1.202 -1.866 0 CA-C-O 119.201 -0.777 . . . . 65.340000000000003 111.563 176.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.568 ' HD2' ' CE1' ' A' ' 133' ' ' PHE . 9.3 Cg_endo -51.62 -7.4 0.2 Allowed 'Trans proline' 0 N--CA 1.499 1.828 0 C-N-CA 124.963 3.775 . . . . 74.349999999999994 115.311 177.204 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.606 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -56.64 -51.59 68.14 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 108.225 -1.028 . . . . 74.430000000000007 108.225 175.079 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.566 ' HB3' HG21 ' A' ' 51' ' ' VAL . . . -179.5 -171.51 0.19 Allowed 'General case' 0 C--O 1.214 -0.783 0 N-CA-C 106.585 -1.635 . . . . 71.540000000000006 106.585 -178.507 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -166.96 56.4 0.23 Allowed Glycine 0 C--N 1.291 -1.932 0 N-CA-C 110.416 -1.073 . . . . 54.020000000000003 110.416 -177.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -163.04 -171.01 2.5 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.595 -1.261 . . . . 71.439999999999998 107.595 -178.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 18.4 ptp180 -136.66 138.26 40.92 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.618 -0.882 . . . . 54.329999999999998 108.618 178.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -142.0 148.23 38.22 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 120.128 -0.629 . . . . 73.349999999999994 111.686 176.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.1 tt -84.06 133.97 34.63 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 113.943 -1.481 . . . . 73.230000000000004 107.519 -177.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.5 mp -87.51 112.92 22.73 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 108.501 -0.926 . . . . 63.119999999999997 108.501 178.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -125.12 18.02 8.4 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 122.42 1.105 . . . . 62.350000000000001 108.136 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -119.2 149.31 46.96 Favored Pre-proline 0 C--N 1.296 -1.717 0 CA-C-N 113.874 -1.512 . . . . 74.409999999999997 108.257 -176.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -63.68 -35.23 59.44 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 122.409 2.073 . . . . 72.519999999999996 112.582 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 92' ' ' PHE . 44.1 m -137.53 123.06 19.68 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 116.516 -0.311 . . . . 70.439999999999998 111.133 179.127 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.469 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 31.3 m -98.12 116.89 31.27 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 106.566 -1.642 . . . . 72.219999999999999 106.566 171.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.505 ' HB ' ' NE2' ' A' ' 73' ' ' HIS . 0.1 OUTLIER -104.86 102.6 12.13 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-O 121.23 0.538 . . . . 71.340000000000003 112.102 -174.37 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -105.87 117.74 34.8 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.088 0.47 . . . . 54.039999999999999 110.173 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 172.41 -163.75 35.93 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.949 -1.26 . . . . 73.209999999999994 109.949 -179.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.7 ptp180 -110.96 21.45 16.44 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 122.045 0.926 . . . . 42.439999999999998 109.561 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.522 ' HD1' ' HA ' ' A' ' 88' ' ' ARG . 12.1 p-80 -84.95 163.67 45.06 Favored Pre-proline 0 C--N 1.299 -1.599 0 CA-C-N 114.672 -1.149 . . . . 72.310000000000002 109.799 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -51.01 -40.42 58.89 Favored 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 123.602 2.868 . . . . 43.340000000000003 115.693 -174.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -97.13 30.21 2.85 Favored 'General case' 0 C--N 1.318 -0.801 0 O-C-N 121.515 -0.741 . . . . 72.409999999999997 112.873 -176.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.0 p -56.91 116.9 3.47 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.268 -0.424 . . . . 75.540000000000006 111.208 178.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -67.23 -49.79 63.14 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 106.301 -1.741 . . . . 74.310000000000002 106.301 173.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 30.4 pt -134.28 138.26 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 CA-C-N 113.606 -1.634 . . . . 63.5 107.236 174.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -104.09 117.54 34.51 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 108.676 -0.861 . . . . 62.25 108.676 177.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.606 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 2.1 pt? -75.38 111.58 10.81 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.369 -0.975 . . . . 61.109999999999999 108.369 177.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -85.59 73.6 10.43 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 118.954 -1.099 . . . . 74.099999999999994 112.752 -173.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -119.85 150.8 39.87 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 115.031 -0.986 . . . . 73.519999999999996 108.901 170.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.0 p -73.38 -20.17 18.36 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 C-N-CA 122.921 0.488 . . . . 71.340000000000003 112.281 -176.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.448 ' HB ' ' ND2' ' A' ' 108' ' ' ASN . 1.3 m -89.53 6.68 39.95 Favored 'General case' 0 CA--C 1.557 1.25 0 CA-C-O 121.057 0.455 . . . . 74.409999999999997 111.943 -172.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.464 HG13 ' HD2' ' A' ' 89' ' ' HIS . 48.4 t -82.27 137.16 21.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 109.409 -0.589 . . . . 62.409999999999997 109.409 -178.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 15.3 p -86.01 -71.1 0.56 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.989 0.423 . . . . 62.109999999999999 112.104 -178.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 21.2 tpp180 -150.19 -66.96 0.2 Allowed 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 106.953 -1.499 . . . . 74.340000000000003 106.953 -178.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.522 ' HA ' ' HD1' ' A' ' 73' ' ' HIS . 48.0 mtt180 -96.56 167.81 10.92 Favored 'General case' 0 CA--C 1.486 -1.516 0 N-CA-C 106.228 -1.768 . . . . 71.400000000000006 106.228 171.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.464 ' HD2' HG13 ' A' ' 85' ' ' VAL . 57.1 t-80 -151.49 -70.72 0.17 Allowed 'General case' 0 C--N 1.292 -1.934 0 C-N-CA 118.921 -1.112 . . . . 73.129999999999995 109.753 -177.18 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -133.45 104.05 6.23 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-O 121.155 0.502 . . . . 73.140000000000001 109.908 -178.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.424 ' OE1' ' HD3' ' A' ' 88' ' ' ARG . 3.0 mp0 -104.01 132.24 50.45 Favored 'General case' 0 N--CA 1.419 -1.983 0 C-N-CA 119.738 -0.785 . . . . 73.200000000000003 109.961 176.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.469 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 29.9 m-85 -97.1 112.22 24.1 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 105.287 -2.116 . . . . 71.209999999999994 105.287 175.257 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 72.8 mtt180 -118.3 115.31 24.46 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 106.63 -1.619 . . . . 74.5 106.63 -175.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.9 pp -115.48 143.03 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.927 0 C-N-CA 119.58 -0.848 . . . . 71.340000000000003 111.734 -172.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -117.71 146.77 43.52 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 105.219 -2.141 . . . . 53.43 105.219 175.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -49.01 -32.97 10.19 Favored 'General case' 0 C--N 1.315 -0.912 0 O-C-N 123.575 0.547 . . . . 71.510000000000005 112.453 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -85.35 -48.27 4.86 Favored Glycine 0 N--CA 1.433 -1.538 0 C-N-CA 120.733 -0.746 . . . . 64.430000000000007 112.749 179.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -133.2 131.55 40.5 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-O 121.682 0.753 . . . . 51.039999999999999 112.581 -177.293 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -99.74 124.55 45.12 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.209 -1.034 . . . . 72.219999999999999 108.209 -178.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -129.19 136.54 50.28 Favored 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 113.829 1.048 . . . . 60.149999999999999 113.829 -176.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.2 p -110.84 118.9 58.36 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 CA-C-N 114.73 -1.123 . . . . 65.120000000000005 108.884 175.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.8 m -120.37 120.8 63.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 N-CA-C 113.166 0.802 . . . . 61.520000000000003 113.166 -177.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.488 ' HB3' ' HB2' ' A' ' 118' ' ' ASN . 4.6 t70 -84.76 122.7 29.49 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 109.164 -0.68 . . . . 63.420000000000002 109.164 169.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 26.8 m -114.53 -1.12 9.48 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 CA-C-N 115.625 -0.716 . . . . 62.140000000000001 109.47 177.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -112.85 59.95 0.36 Allowed Glycine 0 N--CA 1.434 -1.486 0 N-CA-C 110.619 -0.993 . . . . 65.430000000000007 110.619 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 19.1 m -72.41 19.25 0.08 Allowed 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 123.671 0.788 . . . . 71.219999999999999 112.913 -175.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.2 mp -75.58 -33.61 60.6 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 109.58 -0.526 . . . . 75.219999999999999 109.58 178.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.448 ' ND2' ' HB ' ' A' ' 84' ' ' THR . 10.0 m120 -80.25 -24.27 40.25 Favored 'General case' 0 CA--C 1.5 -0.962 0 CA-C-N 116.15 -0.477 . . . . 71.030000000000001 110.54 176.454 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 86.59 82.58 1.15 Allowed Glycine 0 N--CA 1.428 -1.889 0 N-CA-C 109.956 -1.258 . . . . 70.430000000000007 109.956 -177.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 64.7 m -87.18 119.51 27.49 Favored 'General case' 0 N--CA 1.42 -1.938 0 CA-C-O 121.305 0.574 . . . . 62.530000000000001 109.803 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -116.66 134.07 55.26 Favored 'General case' 0 N--CA 1.425 -1.688 0 N-CA-C 107.54 -1.282 . . . . 73.120000000000005 107.54 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.458 HG12 ' O ' ' A' ' 117' ' ' ARG . 7.4 p -117.68 132.23 68.09 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.713 0 N-CA-C 107.264 -1.384 . . . . 72.430000000000007 107.264 175.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 64.93 26.33 12.79 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 107.837 -1.171 . . . . 63.130000000000003 107.837 -175.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.452 ' HG2' HH11 ' A' ' 114' ' ' ARG . 16.9 mtt-85 70.27 7.48 6.24 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 126.638 1.975 . . . . 73.310000000000002 111.698 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -106.69 144.62 29.42 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 109.831 -0.433 . . . . 71.140000000000001 109.831 -176.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -68.11 91.74 0.38 Allowed 'Trans proline' 0 C--N 1.356 0.93 0 C-N-CA 122.223 1.949 . . . . 72.340000000000003 112.402 176.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.458 ' O ' HG12 ' A' ' 112' ' ' VAL . 5.2 ptt180 -154.61 116.55 4.19 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 125.034 1.333 . . . . 72.299999999999997 108.881 174.191 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.488 ' HB2' ' HB3' ' A' ' 103' ' ' ASP . 23.5 p-10 -83.74 -30.99 26.24 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 114.888 -1.051 . . . . 62.219999999999999 113.125 -174.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -105.53 138.26 42.01 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.675 -0.81 . . . . 71.409999999999997 110.929 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -140.46 149.36 42.46 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 113.394 0.887 . . . . 71.030000000000001 113.394 178.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.7 p -91.34 135.76 26.09 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 N-CA-C 106.67 -1.604 . . . . 74.340000000000003 106.67 173.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 23.2 ttt -39.45 102.52 0.02 OUTLIER 'General case' 0 C--O 1.247 0.954 0 N-CA-C 114.001 1.111 . . . . 61.219999999999999 114.001 178.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -123.23 123.39 40.66 Favored 'General case' 0 N--CA 1.424 -1.77 0 N-CA-C 105.605 -1.998 . . . . 74.209999999999994 105.605 173.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 7.3 t -81.92 129.06 34.65 Favored 'General case' 0 C--N 1.291 -1.959 0 C-N-CA 120.565 -0.454 . . . . 74.430000000000007 110.363 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 100.36 18.54 21.19 Favored Glycine 0 N--CA 1.433 -1.532 0 CA-C-N 115.55 -0.75 . . . . 64.420000000000002 112.18 177.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -110.77 150.05 29.64 Favored 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 119.581 -0.848 . . . . 72.049999999999997 109.501 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -110.48 132.26 54.34 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.558 0.694 . . . . 74.239999999999995 112.519 -174.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 66.2 mt -108.42 118.43 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.591 0 CA-C-N 114.68 -1.146 . . . . 75.120000000000005 107.991 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.425 ' OE1' ' HG2' ' A' ' 114' ' ' ARG . 54.6 mt-30 -109.54 112.61 24.81 Favored 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 109.221 -0.659 . . . . 73.5 109.221 178.11 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.432 ' O ' HG13 ' A' ' 130' ' ' ILE . 23.4 pt -95.09 96.94 6.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 108.771 -0.825 . . . . 75.549999999999997 108.771 177.303 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 61.67 -85.31 0.03 OUTLIER Glycine 0 CA--C 1.528 0.853 0 CA-C-N 115.35 -0.841 . . . . 54.140000000000001 112.897 -176.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.503 ' HE3' ' CZ ' ' A' ' 133' ' ' PHE . 48.2 mtmt -113.66 -13.38 12.71 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 123.175 0.59 . . . . 32.009999999999998 111.237 -175.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.568 ' CE1' ' HD2' ' A' ' 55' ' ' PRO . 19.3 m-85 -107.3 154.07 21.81 Favored 'General case' 0 CA--C 1.501 -0.923 0 C-N-CA 119.748 -0.781 . . . . 74.219999999999999 112.227 -169.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 74.2 mtp180 -119.27 122.57 42.21 Favored 'General case' 0 C--O 1.248 0.987 0 CA-C-O 121.603 0.716 . . . . 64.329999999999998 112.623 -172.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.421 HD11 ' HB2' ' A' ' 49' ' ' LEU . 56.9 tp -123.95 131.21 53.54 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 114.466 -1.243 . . . . 73.239999999999995 107.841 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.7 t -115.58 138.76 44.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 N-CA-C 108.17 -1.048 . . . . 71.200000000000003 108.17 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -111.13 117.0 32.06 Favored 'General case' 0 C--N 1.309 -1.152 0 N-CA-C 109.302 -0.629 . . . . 74.530000000000001 109.302 -176.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -123.69 158.99 30.33 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.861 -0.422 . . . . 70.519999999999996 109.861 -177.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -79.91 140.67 36.62 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.049 -1.463 . . . . 61.140000000000001 107.049 172.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -97.96 -143.2 14.39 Favored Glycine 0 C--N 1.292 -1.861 0 C-N-CA 120.329 -0.939 . . . . 52.149999999999999 112.232 -176.1 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -64.91 120.43 7.67 Favored 'Trans proline' 0 N--CA 1.44 -1.668 0 C-N-CA 122.259 1.973 . . . . 70.299999999999997 113.662 -177.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -104.27 103.89 13.71 Favored 'General case' 0 C--N 1.279 -2.484 0 N-CA-C 106.744 -1.576 . . . . 55.130000000000003 106.744 175.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 . . . . . 0 C--N 1.291 -1.946 0 N-CA-C 108.109 -1.071 . . . . 70.25 108.109 -176.51 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.0 mtt . . . . . 0 N--CA 1.474 0.772 0 N-CA-C 109.572 -0.529 . . . . 55.310000000000002 109.572 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.6 p -77.02 -27.33 54.53 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 107.675 -1.231 . . . . 62.409999999999997 107.675 173.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -88.03 144.8 26.32 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 106.613 -1.625 . . . . 73.109999999999999 106.613 172.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -168.12 172.18 8.92 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.52 -0.918 . . . . 73.530000000000001 108.52 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -134.67 66.36 1.54 Allowed 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.848 -1.167 . . . . 72.209999999999994 107.848 173.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -94.05 76.62 1.03 Allowed Glycine 0 N--CA 1.426 -1.969 0 CA-C-N 113.987 -1.46 . . . . 54.420000000000002 110.863 -178.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.3 p -77.25 123.88 87.07 Favored Pre-proline 0 C--N 1.291 -1.978 0 CA-C-N 115.332 -0.434 . . . . 73.310000000000002 110.396 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -65.6 146.35 84.28 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 121.617 1.545 . . . . 75.530000000000001 110.384 177.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -68.6 122.57 85.18 Favored Pre-proline 0 C--N 1.302 -1.494 0 N-CA-C 109.733 -0.469 . . . . 72.519999999999996 109.733 -174.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -50.23 159.27 1.98 Allowed 'Trans proline' 0 C--N 1.37 1.686 0 C-N-CA 124.281 3.321 . . . . 73.400000000000006 112.624 -178.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 53.3 tp60 -51.14 107.0 0.15 Allowed 'General case' 0 C--O 1.242 0.7 0 C-N-CA 123.666 0.786 . . . . 73.219999999999999 112.418 -174.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.4 p -84.57 146.73 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 107.539 -1.282 . . . . 65.219999999999999 107.539 175.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -104.76 121.48 43.71 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 107.414 -1.328 . . . . 73.319999999999993 107.414 -178.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.4 m -132.94 120.33 21.3 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.96 -0.755 . . . . 52.210000000000001 108.96 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.9 t -115.08 133.01 56.41 Favored 'General case' 0 N--CA 1.412 -2.355 0 CA-C-O 121.666 0.746 . . . . 72.109999999999999 109.562 -177.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 21.0 m -92.88 127.81 38.52 Favored 'General case' 0 C--N 1.283 -2.321 0 N-CA-C 108.169 -1.049 . . . . 75.239999999999995 108.169 178.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.5 m -116.85 167.28 10.12 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.329 0 N-CA-C 108.496 -0.928 . . . . 72.109999999999999 108.496 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -81.21 116.2 20.98 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 109.305 -0.628 . . . . 64.5 109.305 177.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -56.47 112.08 1.16 Allowed 'General case' 0 C--O 1.241 0.626 0 CA-C-O 121.658 0.742 . . . . 71.140000000000001 112.094 177.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -117.96 63.67 0.75 Allowed 'General case' 0 N--CA 1.418 -2.055 0 CA-C-O 121.975 0.893 . . . . 60.039999999999999 109.381 178.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -80.96 -30.9 35.08 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 114.009 -1.451 . . . . 62.219999999999999 109.348 176.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . 0.293 0.9 OUTLIER 47.41 78.63 0.07 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.468 1.507 . . . . 74.340000000000003 112.981 -176.473 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.4 pp -104.11 158.53 16.37 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.18 -0.918 . . . . 75.010000000000005 111.371 -178.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 6.6 mtpm? -112.7 121.17 43.96 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.746 -0.835 . . . . 73.340000000000003 108.746 -178.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -91.13 155.3 18.73 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.295 -0.631 . . . . 72.040000000000006 109.295 -178.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.62 159.97 16.89 Favored 'General case' 0 C--O 1.25 1.122 0 CA-C-O 120.669 0.271 . . . . 72.230000000000004 110.754 -176.354 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -163.25 157.02 19.79 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 107.032 -1.47 . . . . 62.439999999999998 107.032 -177.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.8 m -78.7 -45.47 21.22 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 119.907 -0.717 . . . . 64.140000000000001 110.03 177.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 44.8 m -82.37 75.58 9.28 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-O 121.381 0.61 . . . . 63.409999999999997 111.362 178.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.1 t 178.93 170.06 0.89 Allowed 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 106.106 -1.813 . . . . 72.409999999999997 106.106 176.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.39 104.51 2.82 Favored Glycine 0 N--CA 1.43 -1.763 0 N-CA-C 110.268 -1.133 . . . . 74.439999999999998 110.268 -176.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 8.9 t -88.04 138.55 31.35 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.443 0.64 . . . . 73.239999999999995 111.106 -177.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -90.7 145.18 31.62 Favored Pre-proline 0 C--N 1.3 -1.572 0 N-CA-C 107.958 -1.127 . . . . 72.019999999999996 107.958 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -63.93 103.04 0.39 Allowed 'Trans proline' 0 C--O 1.246 0.884 0 C-N-CA 121.829 1.686 . . . . 74.239999999999995 111.098 178.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -92.81 98.98 11.74 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 115.001 -1.0 . . . . 62.409999999999997 108.842 -178.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.3 m 75.26 -12.99 0.9 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.179 1.392 . . . . 75.540000000000006 112.463 -178.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 52.2 m -70.99 114.45 9.06 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-O 121.595 0.712 . . . . 64.319999999999993 109.119 175.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 106.73 -32.73 7.0 Favored Glycine 0 N--CA 1.421 -2.325 0 N-CA-C 109.01 -1.636 . . . . 54.420000000000002 109.01 -175.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.96 -25.93 56.35 Favored 'General case' 0 CA--C 1.499 -1.016 0 CA-C-N 115.028 -0.586 . . . . 60.549999999999997 110.12 -175.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.04 -37.22 85.31 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 115.333 -0.849 . . . . 72.140000000000001 109.982 -178.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -77.11 -25.09 51.77 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.749 -0.66 . . . . 74.040000000000006 110.542 177.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.9 tm? 64.01 88.53 0.11 Allowed Pre-proline 0 C--O 1.24 0.553 0 N-CA-C 104.097 -2.557 . . . . 63.409999999999997 104.097 -166.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -88.62 160.21 6.43 Favored 'Trans proline' 0 N--CA 1.432 -2.121 0 C-N-CA 122.436 2.091 . . . . 73.109999999999999 114.726 -164.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -84.11 93.47 8.13 Favored 'General case' 0 N--CA 1.407 -2.615 0 N-CA-C 103.483 -2.784 . . . . 64.209999999999994 103.483 167.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -139.74 77.05 0.32 Allowed Glycine 0 N--CA 1.413 -2.86 0 CA-C-N 115.313 -0.858 . . . . 31.420000000000002 111.572 -173.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 42.6 m -90.85 166.69 12.94 Favored 'General case' 0 N--CA 1.407 -2.598 0 N-CA-C 107.975 -1.12 . . . . 74.109999999999999 107.975 177.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -91.59 154.38 19.1 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 109.763 -0.458 . . . . 64.319999999999993 109.763 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.4 ' H ' HD23 ' A' ' 48' ' ' LEU . 2.4 pt? -131.31 148.51 52.69 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.721 -0.844 . . . . 72.200000000000003 108.721 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.562 ' HB2' HD21 ' A' ' 135' ' ' LEU . 4.4 pp -112.66 138.59 49.23 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 109.511 -0.552 . . . . 60.229999999999997 109.511 178.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 38.7 t -114.54 120.0 63.04 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 108.087 -1.079 . . . . 63.140000000000001 108.087 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 26.3 t -93.2 115.6 32.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 107.523 -1.288 . . . . 74.430000000000007 107.523 178.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -85.38 -40.16 16.79 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.117 -0.947 . . . . 63.310000000000002 109.991 -176.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 36.9 mmt180 -144.32 153.67 42.24 Favored 'General case' 0 CA--C 1.495 -1.17 0 CA-C-N 115.589 -0.732 . . . . 75.120000000000005 110.185 -177.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 131.89 140.23 4.49 Favored Glycine 0 N--CA 1.426 -2.022 0 O-C-N 124.185 0.928 . . . . 43.219999999999999 111.57 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.442 ' HB2' ' O ' ' A' ' 81' ' ' ASP . 14.1 Cg_exo -69.08 -14.95 39.2 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 122.533 2.156 . . . . 61.420000000000002 111.508 175.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.557 ' HA ' ' H ' ' A' ' 81' ' ' ASP . 4.7 p-10 -61.72 -48.77 79.24 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.417 1.087 . . . . 73.450000000000003 111.162 178.188 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -166.89 171.09 11.6 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.756 -0.831 . . . . 34.130000000000003 108.756 -176.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -155.05 30.28 0.65 Allowed Glycine 0 C--N 1.303 -1.287 0 N-CA-C 110.042 -1.223 . . . . 43.109999999999999 110.042 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -132.78 -168.51 2.08 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 109.261 -0.644 . . . . 65.329999999999998 109.261 -177.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.415 ' HA ' ' O ' ' A' ' 49' ' ' LEU . 19.8 ptp180 -135.02 137.18 42.71 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 109.187 -0.671 . . . . 75.030000000000001 109.187 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.437 ' CE2' HD11 ' A' ' 49' ' ' LEU . 53.0 p90 -135.28 148.42 49.53 Favored 'General case' 0 C--N 1.293 -1.885 0 C-N-CA 120.044 -0.662 . . . . 73.219999999999999 110.579 178.211 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 36.2 tp -86.69 122.83 31.15 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 124.241 0.963 . . . . 74.430000000000007 108.459 -178.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.4 mp -83.99 114.56 21.8 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.103 0.478 . . . . 73.049999999999997 111.408 -176.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -129.49 7.03 5.28 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.11 -0.95 . . . . 75.109999999999999 108.576 172.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.671 ' NE2' ' HA ' ' A' ' 68' ' ' THR . 55.2 tt0 -88.87 123.52 67.42 Favored Pre-proline 0 N--CA 1.421 -1.888 0 CA-C-N 114.377 -1.283 . . . . 73.299999999999997 107.952 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -51.54 -44.93 40.81 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 123.437 2.758 . . . . 64.540000000000006 112.049 -177.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 91.2 m -136.15 99.38 4.11 Favored 'General case' 0 N--CA 1.425 -1.681 0 N-CA-C 109.026 -0.731 . . . . 70.030000000000001 109.026 174.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.671 ' HA ' ' NE2' ' A' ' 65' ' ' GLN . 16.9 m -77.7 116.45 18.25 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 107.196 -1.409 . . . . 64.040000000000006 107.196 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.503 HG22 ' CE1' ' A' ' 73' ' ' HIS . 2.3 m -92.81 92.54 7.98 Favored 'General case' 0 N--CA 1.419 -1.987 0 CA-C-O 121.152 0.501 . . . . 63.32 110.435 -171.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.464 ' HB2' HD11 ' A' ' 78' ' ' ILE . . . -97.94 131.87 44.01 Favored 'General case' 0 C--O 1.246 0.893 0 CA-C-N 115.723 -0.671 . . . . 73.230000000000004 111.007 -178.458 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 155.75 -137.66 5.66 Favored Glycine 0 CA--C 1.472 -2.635 0 N-CA-C 107.442 -2.263 . . . . 71.040000000000006 107.442 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -103.51 -83.33 0.49 Allowed 'General case' 0 N--CA 1.418 -2.074 0 N-CA-C 107.538 -1.282 . . . . 74.420000000000002 107.538 170.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.503 ' CE1' HG22 ' A' ' 69' ' ' THR . 31.6 m80 67.03 161.32 0.14 Allowed Pre-proline 0 N--CA 1.475 0.824 0 C-N-CA 123.994 0.918 . . . . 54.100000000000001 110.86 178.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -67.34 -22.01 46.55 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 121.903 1.736 . . . . 71.530000000000001 110.098 167.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -120.82 78.34 1.38 Allowed 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 108.519 -0.919 . . . . 74.140000000000001 108.519 -177.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.0 m -79.9 109.88 14.74 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-N 115.834 -0.621 . . . . 63.420000000000002 109.464 178.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -69.76 -43.11 72.91 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 106.936 -1.505 . . . . 44.229999999999997 106.936 173.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.464 HD11 ' HB2' ' A' ' 70' ' ' ALA . 0.2 OUTLIER -140.86 147.17 23.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 N-CA-C 104.753 -2.314 . . . . 74.340000000000003 104.753 170.519 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -116.83 127.48 54.35 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-O 122.009 0.909 . . . . 74.239999999999995 112.347 -173.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.552 ' HA ' ' CB ' ' A' ' 56' ' ' ASN . 8.7 mp -84.8 102.35 12.98 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 115.163 -0.926 . . . . 74.219999999999999 108.932 174.147 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.557 ' H ' ' HA ' ' A' ' 56' ' ' ASN . 37.1 t70 -80.64 64.79 5.55 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 122.836 1.303 . . . . 74.109999999999999 110.975 -178.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -131.91 146.28 52.01 Favored 'General case' 0 C--N 1.283 -2.307 0 CA-C-N 113.89 -1.504 . . . . 52.310000000000002 108.436 175.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 28.3 m -81.92 2.06 3.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 113.729 1.011 . . . . 41.32 113.729 -174.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.72 12.55 25.67 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 121.816 0.817 . . . . 74.109999999999999 109.298 -179.26 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 98.8 t -83.08 132.01 32.38 Favored 'Isoleucine or valine' 0 C--O 1.244 0.789 0 CA-C-N 115.28 -0.873 . . . . 52.109999999999999 111.844 -177.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 7.6 m -103.73 165.42 11.05 Favored 'General case' 0 C--O 1.25 1.121 0 CA-C-N 115.1 -0.955 . . . . 65.450000000000003 110.252 -177.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.438 ' O ' ' HD2' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -74.13 132.69 42.5 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 107.405 -1.331 . . . . 64.25 107.405 169.11 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.442 ' H ' ' CD2' ' A' ' 73' ' ' HIS . 9.2 mmm180 61.72 83.54 0.15 Allowed 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 106.412 -1.699 . . . . 71.200000000000003 106.412 -168.677 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 12.5 t60 -104.87 -73.58 0.67 Allowed 'General case' 0 N--CA 1.428 -1.557 0 CA-C-N 115.366 -0.834 . . . . 73.120000000000005 110.149 -174.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.444 ' O ' ' HB3' ' A' ' 70' ' ' ALA . . . -121.71 108.87 14.04 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.633 -0.877 . . . . 74.340000000000003 108.633 -179.358 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -99.72 126.1 45.71 Favored 'General case' 0 C--N 1.28 -2.42 0 C-N-CA 119.373 -0.931 . . . . 72.349999999999994 109.678 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.486 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 58.5 m-85 -107.12 112.62 25.62 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 105.955 -1.868 . . . . 75.030000000000001 105.955 176.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.432 ' NH1' HG21 ' A' ' 102' ' ' VAL . 99.2 mtt180 -112.7 133.05 54.91 Favored 'General case' 0 C--N 1.277 -2.547 0 N-CA-C 109.035 -0.728 . . . . 74.349999999999994 109.035 -174.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 18.9 pt -116.76 138.14 48.35 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.429 0 C-N-CA 119.332 -0.947 . . . . 64.420000000000002 108.842 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -121.28 146.33 46.94 Favored 'General case' 0 C--N 1.266 -3.046 0 N-CA-C 106.207 -1.775 . . . . 74.230000000000004 106.207 174.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -60.08 -17.19 37.82 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.202 0.525 . . . . 73.040000000000006 112.288 177.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -91.31 -36.73 6.47 Favored Glycine 0 N--CA 1.439 -1.155 0 C-N-CA 121.415 -0.421 . . . . 61.299999999999997 113.081 178.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -169.18 161.69 10.36 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 109.46 -0.57 . . . . 75.0 109.46 -178.103 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.497 ' HB2' ' HB2' ' A' ' 122' ' ' MET . 59.2 m-85 -97.05 139.16 33.47 Favored 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 122.919 0.488 . . . . 51.530000000000001 110.997 -177.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -125.35 135.34 52.34 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 123.157 0.583 . . . . 74.310000000000002 111.148 -176.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.9 p -115.02 125.4 72.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 121.972 -0.455 . . . . 73.409999999999997 110.485 177.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.432 HG21 ' NH1' ' A' ' 93' ' ' ARG . 96.0 t -119.33 125.46 74.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-O 121.041 0.448 . . . . 72.230000000000004 111.2 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.435 ' HB2' ' HB ' ' A' ' 110' ' ' THR . 12.9 t70 -104.99 122.14 45.24 Favored 'General case' 0 CA--C 1.489 -1.372 0 CA-C-N 115.907 -0.588 . . . . 52.5 110.624 176.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 88' ' ' ARG . 0.9 OUTLIER -131.51 11.08 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.433 0 CA-C-N 114.976 -1.011 . . . . 71.400000000000006 109.675 173.165 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -110.22 44.94 1.4 Allowed Glycine 0 N--CA 1.438 -1.197 0 N-CA-C 109.23 -1.548 . . . . 74.439999999999998 109.23 178.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.4 m -67.58 -3.29 8.41 Favored 'General case' 0 C--N 1.31 -1.109 0 C-N-CA 124.92 1.288 . . . . 74.409999999999997 112.498 -175.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 33.7 tp -68.21 -40.26 82.17 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 107.798 -1.186 . . . . 71.349999999999994 107.798 174.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -89.59 -40.97 12.26 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 107.835 -1.172 . . . . 71.209999999999994 107.835 175.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 96.36 92.96 1.81 Allowed Glycine 0 N--CA 1.44 -1.086 0 CA-C-N 115.347 -0.842 . . . . 54.340000000000003 113.377 176.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.435 ' HB ' ' HB2' ' A' ' 103' ' ' ASP . 24.2 m -88.87 119.56 29.48 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.259 -1.015 . . . . 64.010000000000005 108.259 175.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.478 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 41.9 m-85 -112.6 134.83 53.93 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 108.008 -1.108 . . . . 73.409999999999997 108.008 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.3 p -109.03 136.27 45.42 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.444 0 N-CA-C 107.848 -1.167 . . . . 73.329999999999998 107.848 179.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.607 ' O ' ' HD2' ' A' ' 114' ' ' ARG . 45.1 m-80 70.64 -81.46 0.03 OUTLIER 'General case' 0 CA--C 1.501 -0.904 0 N-CA-C 107.429 -1.323 . . . . 73.209999999999994 107.429 -172.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.607 ' HD2' ' O ' ' A' ' 113' ' ' ASN . 26.4 mmm180 -154.97 12.8 0.38 Allowed 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 107.648 -1.241 . . . . 71.120000000000005 107.648 173.62 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.426 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . 35.9 mt-10 -123.64 146.07 49.1 Favored Pre-proline 0 N--CA 1.464 0.274 0 N-CA-C 113.089 0.774 . . . . 64.150000000000006 113.089 -168.373 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 115' ' ' GLU . 4.9 Cg_exo -77.5 119.29 4.84 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.658 2.239 . . . . 71.299999999999997 109.809 175.068 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 14.8 mmm180 -136.1 148.29 48.2 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 109.391 -0.596 . . . . 64.430000000000007 109.391 -177.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -86.87 -40.54 14.79 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.534 -0.913 . . . . 63.409999999999997 108.534 173.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -142.58 137.38 30.05 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 107.663 -1.236 . . . . 64.540000000000006 107.663 172.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 24.0 tm0? -142.43 147.01 35.45 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.261 -1.014 . . . . 74.25 108.261 177.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.5 p -84.63 112.83 22.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-O 121.071 0.462 . . . . 63.350000000000001 109.758 177.07 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.497 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 64.2 mtt -54.22 142.16 26.98 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.873 1.064 . . . . 74.129999999999995 113.873 -171.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -122.13 135.38 54.79 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 115.209 -0.905 . . . . 72.439999999999998 109.068 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 6.7 t -79.89 132.53 36.1 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.855 -0.611 . . . . 54.240000000000002 111.538 -178.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 95.46 16.7 39.04 Favored Glycine 0 CA--C 1.488 -1.607 0 CA-C-N 115.685 -0.689 . . . . 72.510000000000005 111.855 176.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -124.92 -170.99 2.26 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.892 -0.781 . . . . 50.5 108.892 -177.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -133.59 150.83 51.62 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 113.641 0.978 . . . . 63.219999999999999 113.641 -172.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 67.5 mt -113.13 126.98 70.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 107.818 -1.178 . . . . 52.25 107.818 176.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.478 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 14.5 tp60 -102.11 111.94 24.41 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 107.306 -1.368 . . . . 72.409999999999997 107.306 -178.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.446 HG13 ' HB2' ' A' ' 133' ' ' PHE . 14.7 pt -102.35 98.46 6.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 CA-C-O 121.344 0.593 . . . . 71.219999999999999 109.784 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 66.11 -89.74 0.13 Allowed Glycine 0 N--CA 1.438 -1.205 0 CA-C-N 115.208 -0.906 . . . . 60.100000000000001 111.793 -176.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -126.33 -1.04 6.97 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 122.846 0.458 . . . . 73.120000000000005 110.123 -178.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.446 ' HB2' HG13 ' A' ' 130' ' ' ILE . 11.5 m-85 -108.85 156.33 19.78 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.44 -0.948 . . . . 75.439999999999998 108.44 -174.557 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -124.78 136.0 53.45 Favored 'General case' 0 C--O 1.249 1.05 0 CA-C-O 121.81 0.814 . . . . 73.209999999999994 112.642 -174.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.562 HD21 ' HB2' ' A' ' 49' ' ' LEU . 5.0 tt -124.2 139.82 53.55 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 114.086 -1.415 . . . . 75.129999999999995 107.603 -178.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 9.4 p -113.11 139.25 39.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 109.386 -0.598 . . . . 52.329999999999998 109.386 178.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -116.05 121.37 42.0 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 120.587 0.232 . . . . 73.439999999999998 111.011 -174.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -128.81 143.13 50.83 Favored 'General case' 0 C--O 1.217 -0.643 0 CA-C-O 120.856 0.36 . . . . 74.510000000000005 111.209 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -103.41 44.17 1.03 Allowed 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 105.744 -1.947 . . . . 72.129999999999995 105.744 172.008 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -60.08 -64.97 3.7 Favored Glycine 0 C--N 1.31 -0.881 0 CA-C-N 112.532 -2.122 . . . . 34.32 117.691 -168.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -76.76 120.96 5.69 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 CA-C-N 119.9 1.85 . . . . 70.400000000000006 114.116 -171.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -110.68 103.52 12.09 Favored 'General case' 0 C--N 1.286 -2.196 0 N-CA-C 107.955 -1.128 . . . . 70.120000000000005 107.955 174.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 . . . . . 0 N--CA 1.404 -2.729 0 CA-C-O 119.191 -0.433 . . . . 71.030000000000001 110.054 179.34 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.0 mtt . . . . . 0 C--O 1.244 0.766 0 N-CA-C 106.489 -1.671 . . . . 64.299999999999997 106.489 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.0 p -66.65 -44.2 82.53 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 106.807 -1.553 . . . . 75.140000000000001 106.807 169.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 67.57 3.39 3.36 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.744 1.617 . . . . 74.439999999999998 113.652 173.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 22.1 p-10 -100.23 103.83 15.3 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-O 121.98 0.895 . . . . 63.219999999999999 109.841 178.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -86.71 112.98 22.18 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 107.944 -1.132 . . . . 64.140000000000001 107.944 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -64.2 107.7 1.92 Allowed Glycine 0 N--CA 1.44 -1.083 0 O-C-N 123.854 0.722 . . . . 63.200000000000003 111.347 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.7 t -96.11 135.1 22.9 Favored Pre-proline 0 N--CA 1.427 -1.586 0 N-CA-C 109.62 -0.511 . . . . 63.340000000000003 109.62 -177.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -63.64 134.43 44.16 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 121.903 1.736 . . . . 71.319999999999993 109.588 174.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -102.95 141.73 23.08 Favored Pre-proline 0 C--N 1.284 -2.266 0 N-CA-C 109.087 -0.708 . . . . 72.409999999999997 109.087 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -38.69 115.1 0.2 Allowed 'Trans proline' 0 C--N 1.368 1.562 0 C-N-CA 124.334 3.356 . . . . 74.010000000000005 113.056 -176.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -64.83 122.45 16.96 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.83 -1.077 . . . . 65.409999999999997 110.848 -178.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.1 p -86.22 119.61 34.68 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 CA-C-N 115.305 -0.862 . . . . 62.43 111.221 -177.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -121.6 140.8 51.79 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 107.262 -1.385 . . . . 75.310000000000002 107.262 178.071 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.0 t -85.17 136.57 33.48 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 108.606 -0.887 . . . . 64.310000000000002 108.606 -178.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.8 p -93.52 16.35 13.83 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 121.695 0.76 . . . . 74.400000000000006 110.452 -179.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 18.3 m -79.5 97.28 6.37 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 115.295 -0.866 . . . . 62.439999999999998 112.004 -177.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.8 m -126.38 142.92 41.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 107.922 -1.14 . . . . 74.329999999999998 107.922 174.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -83.85 154.03 23.69 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.421 -0.585 . . . . 70.549999999999997 109.421 -176.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.551 ' HB2' ' OD1' ' A' ' 21' ' ' ASP . 19.9 mtm180 -112.5 -163.29 0.84 Allowed 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 108.4 -0.963 . . . . 72.099999999999994 108.4 -177.087 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -87.67 40.97 0.96 Allowed 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 109.347 -0.612 . . . . 71.340000000000003 109.347 175.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.551 ' OD1' ' HB2' ' A' ' 19' ' ' ARG . 2.6 m-20 -55.17 -44.92 75.65 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 124.871 1.268 . . . . 71.219999999999999 111.861 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 94.8 mt -90.52 103.9 16.54 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.328 -0.99 . . . . 74.409999999999997 108.328 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.7 tt -63.0 121.74 14.31 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 108.143 -1.058 . . . . 72.25 108.143 -178.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 15.2 ptmm? -74.68 -176.56 2.86 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-N 116.055 -0.521 . . . . 64.409999999999997 111.089 -178.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -83.13 148.93 27.19 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.389 -0.967 . . . . 71.230000000000004 108.389 175.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 58.5 ttp -82.88 116.91 22.39 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.005 0.431 . . . . 73.129999999999995 109.901 -177.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -85.59 168.87 14.06 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 108.968 -0.753 . . . . 75.099999999999994 108.968 175.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.5 m -50.91 -34.0 26.6 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 113.738 1.014 . . . . 71.430000000000007 113.738 -173.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.7 m 55.77 49.53 16.01 Favored 'General case' 0 C--N 1.351 0.663 0 CA-C-O 121.728 0.775 . . . . 74.519999999999996 108.99 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 23.5 m -58.35 114.85 2.62 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-N 113.845 -1.525 . . . . 63.409999999999997 112.461 -173.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -86.25 96.04 2.09 Favored Glycine 0 N--CA 1.42 -2.376 0 N-CA-C 107.609 -2.196 . . . . 74.329999999999998 107.609 172.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 32.2 p -66.13 151.3 47.23 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 122.033 0.133 . . . . 73.310000000000002 110.708 -176.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.75 122.11 69.23 Favored Pre-proline 0 N--CA 1.443 -0.784 0 N-CA-C 107.973 -1.121 . . . . 72.409999999999997 107.973 177.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -45.74 109.47 0.19 Allowed 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 123.72 2.947 . . . . 74.019999999999996 113.276 -174.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -106.22 97.15 7.0 Favored 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 106.332 -1.729 . . . . 44.439999999999998 106.332 176.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.4 t -107.23 140.37 40.21 Favored 'General case' 0 N--CA 1.415 -2.208 0 CA-C-N 115.663 -0.699 . . . . 73.510000000000005 111.236 -173.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 25.2 m -90.14 -19.64 24.03 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 107.36 -1.348 . . . . 74.439999999999998 107.36 175.051 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 160.18 97.63 0.12 Allowed Glycine 0 N--CA 1.44 -1.087 0 N-CA-C 109.749 -1.34 . . . . 73.549999999999997 109.749 -179.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.82 -23.52 67.31 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 122.745 0.418 . . . . 52.450000000000003 112.096 -176.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -62.94 -11.25 17.39 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.872 -0.604 . . . . 74.409999999999997 112.025 177.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.428 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 7.2 t30 -61.45 -32.03 72.0 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 123.523 0.729 . . . . 71.299999999999997 109.967 173.209 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 6.0 tt -112.63 91.93 18.62 Favored Pre-proline 0 CA--C 1.557 1.214 0 N-CA-C 108.206 -1.035 . . . . 60.119999999999997 108.206 -178.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.428 ' HD3' ' O ' ' A' ' 41' ' ' ASN . 73.9 Cg_endo -97.15 5.42 1.55 Allowed 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.652 2.235 . . . . 60.149999999999999 113.299 -177.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -108.74 23.34 14.68 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.748 0.785 . . . . 54.32 110.362 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -145.71 30.19 1.69 Allowed Glycine 0 C--N 1.296 -1.663 0 N-CA-C 109.996 -1.242 . . . . 44.340000000000003 109.996 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 12.9 m -101.53 162.93 12.54 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 108.2 -1.037 . . . . 74.329999999999998 108.2 -179.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -137.97 164.54 28.77 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.398 -0.593 . . . . 54.310000000000002 109.398 -177.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.6 pp -134.89 160.01 39.63 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 120.825 0.345 . . . . 74.120000000000005 111.827 -177.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.447 ' HB2' HD11 ' A' ' 135' ' ' LEU . 3.6 pp -128.45 146.71 50.72 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 116.512 -0.313 . . . . 51.109999999999999 110.44 178.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 47.7 t -126.65 122.34 60.59 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 N-CA-C 108.314 -0.995 . . . . 72.340000000000003 108.314 178.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.542 HG21 ' HB3' ' A' ' 57' ' ' ALA . 19.6 t -93.35 118.1 38.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 N-CA-C 108.669 -0.863 . . . . 71.420000000000002 108.669 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -89.52 -31.81 17.47 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 116.079 -0.51 . . . . 63.399999999999999 111.047 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 27.9 tpt180 -156.99 129.3 7.4 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.308 -0.405 . . . . 51.439999999999998 110.147 178.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 139.71 136.05 3.32 Favored Glycine 0 N--CA 1.422 -2.277 0 CA-C-N 115.743 -0.662 . . . . 50.25 112.542 176.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.403 ' HD2' ' CE1' ' A' ' 133' ' ' PHE . 51.6 Cg_exo -59.98 -9.07 9.07 Favored 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 124.226 3.284 . . . . 74.430000000000007 111.894 175.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.462 HD21 HG21 ' A' ' 51' ' ' VAL . 2.8 t30 -35.16 -50.75 0.53 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 127.764 2.426 . . . . 72.129999999999995 109.245 168.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.542 ' HB3' HG21 ' A' ' 51' ' ' VAL . . . -169.67 -58.14 0.02 OUTLIER 'General case' 0 CA--C 1.504 -0.793 0 CA-C-N 115.511 -0.768 . . . . 64.310000000000002 108.963 176.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.08 30.12 55.8 Favored Glycine 0 C--N 1.318 -0.42 0 N-CA-C 110.342 -1.103 . . . . 71.129999999999995 110.342 -177.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -142.58 -175.53 4.51 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 108.727 -0.842 . . . . 54.240000000000002 108.727 -176.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 16.6 ptt-85 -135.54 137.13 41.74 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.191 -0.67 . . . . 71.230000000000004 109.191 178.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -156.51 154.7 30.75 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.59 -0.277 . . . . 70.140000000000001 111.074 -179.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.1 tt -96.19 139.72 31.93 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.495 -0.775 . . . . 71.219999999999999 110.424 -178.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.2 mp -110.39 126.94 54.81 Favored 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 123.996 0.918 . . . . 60.420000000000002 108.87 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -139.04 24.08 2.56 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 121.769 0.795 . . . . 74.239999999999995 109.957 177.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -90.44 146.81 35.22 Favored Pre-proline 0 C--N 1.315 -0.92 0 N-CA-C 108.132 -1.062 . . . . 74.400000000000006 108.132 178.193 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -56.71 -45.42 36.94 Favored 'Trans proline' 0 C--N 1.361 1.228 0 C-N-CA 122.956 2.437 . . . . 74.109999999999999 111.664 -177.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.42 HG23 ' HG2' ' A' ' 93' ' ' ARG . 90.2 m -136.1 97.41 3.6 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 115.054 -0.975 . . . . 75.140000000000001 110.238 177.364 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 21.7 m -88.07 114.15 24.41 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.359 -1.348 . . . . 63.329999999999998 107.359 177.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.403 ' O ' ' HB2' ' A' ' 76' ' ' SER . 17.2 m -100.25 120.14 39.45 Favored 'General case' 0 C--O 1.25 1.131 0 C-N-CA 120.622 -0.431 . . . . 74.129999999999995 110.65 -176.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.629 ' HB1' HD21 ' A' ' 80' ' ' LEU . . . -98.01 129.72 44.87 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 123.99 0.916 . . . . 53.450000000000003 110.734 -177.589 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 79' ' ' PHE . . . -178.43 -106.22 0.2 Allowed Glycine 0 C--O 1.242 0.65 0 N-CA-C 110.439 -1.064 . . . . 53.549999999999997 110.439 178.331 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.492 ' HG2' HG21 ' A' ' 85' ' ' VAL . 18.0 mmm180 -131.38 -81.91 0.52 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.152 0.581 . . . . 74.239999999999995 110.218 174.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.503 ' HB3' ' HD3' ' A' ' 74' ' ' PRO . 10.8 t60 -150.78 -61.29 0.02 OUTLIER Pre-proline 0 CA--C 1.553 1.08 0 CA-C-O 118.867 -0.587 . . . . 52.100000000000001 111.838 -177.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.503 ' HD3' ' HB3' ' A' ' 73' ' ' HIS . 83.3 Cg_exo -50.28 -37.89 50.76 Favored 'Trans proline' 0 C--N 1.374 1.899 0 C-N-CA 122.514 2.142 . . . . 55.539999999999999 114.781 179.063 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.596 ' OE2' ' HD2' ' A' ' 87' ' ' ARG . 45.5 mt-10 -109.42 2.62 20.72 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 112.657 0.614 . . . . 75.010000000000005 112.657 -177.13 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.403 ' HB2' ' O ' ' A' ' 69' ' ' THR . 36.1 p -148.88 -175.31 4.9 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.119 -1.033 . . . . 75.010000000000005 113.023 -171.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -102.79 -42.29 5.91 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.684 0.754 . . . . 64.400000000000006 110.055 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 21.5 pt -118.91 153.17 21.19 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 115.747 -0.66 . . . . 64.239999999999995 111.087 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.472 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 40.7 p90 -105.83 129.26 54.04 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.036 -0.727 . . . . 73.420000000000002 109.036 177.296 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.629 HD21 ' HB1' ' A' ' 70' ' ' ALA . 1.4 pt? -156.2 6.27 0.19 Allowed 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 113.773 1.027 . . . . 42.119999999999997 113.773 -175.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -122.62 128.53 50.79 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 118.996 -1.081 . . . . 71.420000000000002 108.337 173.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -127.6 -4.11 5.96 Favored 'General case' 0 C--N 1.286 -2.159 0 CA-C-N 115.018 -0.992 . . . . 74.519999999999996 111.538 -176.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.1 p -87.36 -37.52 11.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 C-N-CA 119.043 -1.063 . . . . 75.510000000000005 109.374 -174.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.3 m -171.8 81.98 0.07 Allowed 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.08 -1.082 . . . . 70.049999999999997 108.08 -178.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.492 HG21 ' HG2' ' A' ' 72' ' ' ARG . 8.9 p -82.91 104.56 11.72 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.366 0 C-N-CA 116.535 -2.066 . . . . 63.240000000000002 109.647 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 58.2 m -76.75 -44.77 31.76 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 113.972 -1.467 . . . . 72.519999999999996 112.212 -175.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.596 ' HD2' ' OE2' ' A' ' 75' ' ' GLU . 13.7 mmt180 -166.15 -167.04 0.98 Allowed 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 105.083 -2.191 . . . . 73.510000000000005 105.083 -176.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.537 ' H ' ' HD3' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -52.78 126.61 20.62 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 106.55 -1.648 . . . . 74.109999999999999 106.55 166.431 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.405 ' NE2' ' HB ' ' A' ' 130' ' ' ILE . 40.6 t60 -92.83 -49.56 6.0 Favored 'General case' 0 C--N 1.284 -2.269 0 CA-C-N 115.501 -0.772 . . . . 62.340000000000003 111.845 -164.189 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -139.66 142.65 36.97 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 120.296 -0.562 . . . . 61.439999999999998 110.362 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -117.23 127.3 53.96 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 109.136 -0.69 . . . . 73.299999999999997 109.136 176.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -108.72 112.28 24.5 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 106.827 -1.546 . . . . 72.340000000000003 106.827 176.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.42 ' HG2' HG23 ' A' ' 67' ' ' THR . 20.0 mtm180 -123.74 124.67 43.23 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 109.426 -0.583 . . . . 64.430000000000007 109.426 -177.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.492 ' O ' HD12 ' A' ' 94' ' ' ILE . 2.8 pp -115.47 122.48 69.41 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.222 0 CA-C-O 121.76 0.79 . . . . 50.450000000000003 112.041 -175.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -119.08 145.65 45.74 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 107.018 -1.475 . . . . 54.32 107.018 177.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -54.81 -29.7 55.32 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 122.641 0.377 . . . . 61.130000000000003 111.937 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -80.45 -46.69 7.27 Favored Glycine 0 N--CA 1.43 -1.706 0 CA-C-O 119.692 -0.504 . . . . 32.229999999999997 112.34 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -144.99 142.76 30.08 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 117.211 0.505 . . . . 74.430000000000007 110.472 -179.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -95.67 114.79 26.57 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 106.64 -1.615 . . . . 72.140000000000001 106.64 176.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -119.61 116.25 25.64 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.332 0.587 . . . . 73.129999999999995 112.343 -170.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 5.6 p -105.88 124.44 61.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 108.265 -1.013 . . . . 71.510000000000005 108.265 172.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.487 HG12 HG13 ' A' ' 104' ' ' VAL . 33.8 t -111.66 115.01 48.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 CA-C-N 115.869 -0.605 . . . . 72.030000000000001 109.435 -176.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.577 ' HB3' ' CB ' ' A' ' 110' ' ' THR . 4.9 m-20 -85.41 109.69 18.61 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 114.796 -1.093 . . . . 74.430000000000007 108.855 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.487 HG13 HG12 ' A' ' 102' ' ' VAL . 12.3 m -118.3 16.83 7.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 111.95 0.352 . . . . 73.109999999999999 111.95 -176.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -114.22 48.43 0.94 Allowed Glycine 0 C--O 1.241 0.589 0 N-CA-C 110.771 -0.932 . . . . 54.420000000000002 110.771 177.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 6.9 m -65.52 -22.58 66.73 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 124.126 0.97 . . . . 73.109999999999999 112.425 -175.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -58.77 -42.14 88.26 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.209 0.528 . . . . 70.200000000000003 110.296 177.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -76.94 -52.9 8.59 Favored 'General case' 0 CA--C 1.485 -1.554 0 N-CA-C 106.456 -1.683 . . . . 64.140000000000001 106.456 175.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 123.91 103.0 1.55 Allowed Glycine 0 N--CA 1.406 -3.31 0 CA-C-N 113.892 -1.504 . . . . 42.5 110.116 -177.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.577 ' CB ' ' HB3' ' A' ' 103' ' ' ASP . 1.5 p -92.82 119.16 31.88 Favored 'General case' 0 N--CA 1.409 -2.525 0 N-CA-C 107.501 -1.296 . . . . 62.340000000000003 107.501 175.244 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.434 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 65.6 m-85 -121.99 139.44 53.68 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-O 121.554 0.692 . . . . 63.450000000000003 112.506 -172.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.697 ' HB ' ' NE ' ' A' ' 117' ' ' ARG . 7.1 p -104.87 111.71 35.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 106.333 -1.728 . . . . 65.530000000000001 106.333 170.202 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 25.8 m120 54.23 35.7 23.28 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.922 0.489 . . . . 61.100000000000001 111.295 -177.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 49.2 mtm-85 83.81 3.09 0.88 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.676 1.59 . . . . 74.310000000000002 115.257 178.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -110.47 139.5 21.6 Favored Pre-proline 0 C--N 1.314 -0.957 0 C-N-CA 119.645 -0.822 . . . . 43.439999999999998 110.069 175.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.27 142.32 97.92 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 122.869 2.38 . . . . 74.200000000000003 113.767 -175.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.697 ' NE ' ' HB ' ' A' ' 112' ' ' VAL . 13.1 ptt180 -147.14 163.94 34.72 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.842 -0.617 . . . . 75.030000000000001 111.744 176.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.433 ' HA ' ' HB2' ' A' ' 103' ' ' ASP . 11.1 m120 -124.75 -17.86 5.78 Favored 'General case' 0 CA--C 1.513 -0.452 0 O-C-N 124.094 0.871 . . . . 75.209999999999994 111.959 173.396 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -155.42 138.28 15.33 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.162 -0.681 . . . . 73.310000000000002 109.162 174.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 21.6 tm0? -141.47 149.28 40.75 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.174 -1.047 . . . . 65.040000000000006 108.174 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.3 p -101.83 113.76 39.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 109.389 -0.597 . . . . 74.439999999999998 109.389 176.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -32.91 116.95 0.24 Allowed 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 115.796 1.776 . . . . 73.310000000000002 115.796 -172.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -118.3 145.48 45.04 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 106.795 -1.557 . . . . 65.010000000000005 106.795 172.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 15.0 t -89.46 130.94 35.72 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 119.766 -0.774 . . . . 74.099999999999994 109.856 -178.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 94.27 19.02 34.27 Favored Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 110.88 -0.888 . . . . 64.420000000000002 110.88 -178.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -96.66 142.13 29.07 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 108.538 -0.912 . . . . 42.439999999999998 108.538 -178.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -109.5 127.32 54.36 Favored 'General case' 0 N--CA 1.422 -1.867 0 CA-C-O 122.086 0.946 . . . . 45.119999999999997 111.127 179.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.511 HG12 ' NH2' ' A' ' 117' ' ' ARG . 25.6 mt -106.7 125.65 62.61 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.285 0 CA-C-N 114.477 -1.238 . . . . 53.310000000000002 108.043 -177.048 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.434 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 51.0 tt0 -105.42 111.9 24.79 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 107.313 -1.365 . . . . 73.099999999999994 107.313 172.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.405 ' HB ' ' NE2' ' A' ' 89' ' ' HIS . 17.3 pt -102.05 101.0 11.51 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 N-CA-C 108.593 -0.892 . . . . 75.450000000000003 108.593 177.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 73.62 -90.99 0.65 Allowed Glycine 0 N--CA 1.419 -2.463 0 CA-C-N 114.866 -1.061 . . . . 63.240000000000002 110.757 -177.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 45.0 tttp -131.88 3.53 4.1 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 121.117 0.484 . . . . 75.129999999999995 110.345 -176.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.403 ' CE1' ' HD2' ' A' ' 55' ' ' PRO . 34.5 m-85 -101.61 144.35 30.45 Favored 'General case' 0 C--N 1.311 -1.069 0 O-C-N 121.918 -0.489 . . . . 73.019999999999996 109.743 -176.026 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -106.85 121.04 43.62 Favored 'General case' 0 C--O 1.247 0.95 0 N-CA-C 107.711 -1.218 . . . . 75.349999999999994 107.711 -177.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.447 HD11 ' HB2' ' A' ' 49' ' ' LEU . 42.9 tp -123.89 142.42 51.15 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 114.993 -1.003 . . . . 72.310000000000002 108.362 -176.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 11.1 p -117.09 130.51 71.88 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 N-CA-C 107.553 -1.277 . . . . 71.5 107.553 174.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -111.47 130.27 55.77 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 116.233 -0.44 . . . . 71.319999999999993 110.055 -173.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -127.94 170.16 13.16 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.92 -0.77 . . . . 63.340000000000003 108.92 -178.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -89.53 164.61 14.72 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 109.031 -0.729 . . . . 53.329999999999998 109.031 176.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -82.87 142.96 21.96 Favored Glycine 0 N--CA 1.435 -1.394 0 N-CA-C 109.723 -1.351 . . . . 53.399999999999999 109.723 177.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -75.23 119.65 5.67 Favored 'Trans proline' 0 N--CA 1.444 -1.423 0 CA-C-N 119.608 1.704 . . . . 63.329999999999998 111.377 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -109.24 110.04 21.13 Favored 'General case' 0 C--N 1.283 -2.308 0 N-CA-C 108.529 -0.915 . . . . 71.450000000000003 108.529 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.426 -1.642 0 CA-C-N 115.941 -0.572 . . . . 72.439999999999998 111.403 -178.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.9 mtt . . . . . 0 N--CA 1.474 0.734 0 N-CA-C 109.603 -0.517 . . . . 64.109999999999999 109.603 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.3 p -82.42 -48.24 11.34 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 107.698 -1.223 . . . . 64.120000000000005 107.698 173.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -103.26 124.45 48.65 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 106.585 -1.635 . . . . 74.540000000000006 106.585 174.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -111.93 148.74 33.07 Favored 'General case' 0 C--N 1.287 -2.129 0 C-N-CA 120.832 -0.347 . . . . 74.519999999999996 110.655 -177.061 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -92.23 113.45 25.73 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 116.092 -0.504 . . . . 74.340000000000003 110.187 -178.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -119.95 101.1 0.81 Allowed Glycine 0 N--CA 1.425 -2.045 0 N-CA-C 111.107 -0.797 . . . . 64.25 111.107 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.2 m -78.78 124.03 85.15 Favored Pre-proline 0 C--N 1.306 -1.29 0 N-CA-C 108.555 -0.906 . . . . 73.140000000000001 108.555 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -60.49 128.02 24.65 Favored 'Trans proline' 0 C--O 1.252 1.19 0 C-N-CA 122.363 2.042 . . . . 74.200000000000003 111.601 178.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -100.98 131.67 23.02 Favored Pre-proline 0 C--N 1.299 -1.604 0 CA-C-N 115.919 -0.582 . . . . 72.510000000000005 110.188 -178.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -65.1 127.18 17.85 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 121.982 1.788 . . . . 74.340000000000003 111.225 178.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -82.12 104.91 12.8 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.844 -1.169 . . . . 64.209999999999994 107.844 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 23.5 t -111.83 148.95 14.65 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 N-CA-C 107.459 -1.311 . . . . 63.229999999999997 107.459 -178.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -82.47 121.57 26.93 Favored 'General case' 0 N--CA 1.408 -2.533 0 N-CA-C 106.143 -1.799 . . . . 63.32 106.143 170.306 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 58.4 m -60.53 104.28 0.32 Allowed 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.78 -0.645 . . . . 71.349999999999994 109.642 -177.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 18.2 m -81.25 94.64 6.75 Favored 'General case' 0 N--CA 1.415 -2.189 0 CA-C-N 114.781 -1.1 . . . . 73.310000000000002 110.586 -174.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 21.2 m -134.35 83.68 2.05 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 114.697 -1.138 . . . . 62.340000000000003 108.221 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 39.4 t -108.51 113.69 44.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 108.453 -0.943 . . . . 62.210000000000001 108.453 -178.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -109.89 164.03 12.97 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 108.725 -0.843 . . . . 72.150000000000006 108.725 178.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.4 ' HD2' ' N ' ' A' ' 19' ' ' ARG . 7.3 mpt_? -113.38 175.51 5.42 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 109.418 -0.586 . . . . 75.400000000000006 109.418 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.79 34.21 0.18 Allowed 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 123.567 0.747 . . . . 55.520000000000003 111.77 -177.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -71.34 -32.72 68.88 Favored 'General case' 0 CA--C 1.504 -0.793 0 C-N-CA 124.072 0.949 . . . . 73.239999999999995 110.015 -176.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -74.22 99.09 3.33 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.347 -0.842 . . . . 65.319999999999993 110.214 -177.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 91.3 mt -94.85 166.53 11.93 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.789 -0.641 . . . . 72.450000000000003 110.014 -179.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -74.24 105.69 5.54 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 106.506 -1.665 . . . . 72.340000000000003 106.506 175.399 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -75.51 132.68 40.92 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.762 -0.458 . . . . 73.049999999999997 109.762 178.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -90.29 127.1 36.06 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.786 -0.643 . . . . 74.430000000000007 110.309 -176.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -99.75 169.15 9.45 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 115.582 -0.736 . . . . 71.450000000000003 109.871 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 16.7 p -142.04 150.85 41.81 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.927 -0.768 . . . . 51.5 108.927 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.6 m -102.67 169.62 8.52 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 109.841 -0.429 . . . . 74.310000000000002 109.841 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.8 t -130.02 143.24 50.69 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 109.839 -0.43 . . . . 63.450000000000003 109.839 -179.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -90.18 -170.48 43.88 Favored Glycine 0 N--CA 1.441 -1.03 0 N-CA-C 111.695 -0.562 . . . . 72.150000000000006 111.695 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 24.9 m -83.77 149.93 26.13 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 122.809 0.444 . . . . 73.430000000000007 110.621 -178.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -89.82 120.87 69.41 Favored Pre-proline 0 C--N 1.311 -1.069 0 N-CA-C 109.432 -0.581 . . . . 31.510000000000002 109.432 176.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -72.74 127.57 12.46 Favored 'Trans proline' 0 C--O 1.238 0.488 0 C-N-CA 122.651 2.234 . . . . 74.420000000000002 111.622 177.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -91.64 90.87 7.76 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.299 -1.0 . . . . 63.310000000000002 108.299 176.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.2 m -57.52 114.62 2.32 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 115.111 -0.949 . . . . 44.140000000000001 112.202 -176.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.3 t -148.54 155.88 41.71 Favored 'General case' 0 N--CA 1.42 -1.942 0 N-CA-C 106.396 -1.705 . . . . 53.0 106.396 178.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 126.47 99.15 1.1 Allowed Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 110.718 -0.953 . . . . 71.540000000000006 110.718 -177.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.01 -34.2 71.1 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 121.212 0.529 . . . . 54.520000000000003 111.329 -175.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.416 ' CD ' ' H ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -84.37 -34.36 23.61 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.408 -0.815 . . . . 73.450000000000003 110.588 -178.704 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -77.58 -43.08 32.94 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.832 -1.076 . . . . 74.150000000000006 112.059 -174.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.447 ' HB2' ' CG ' ' A' ' 66' ' ' PRO . 86.2 mt -84.54 150.34 56.58 Favored Pre-proline 0 C--N 1.302 -1.484 0 O-C-N 122.257 -0.277 . . . . 71.329999999999998 110.696 -176.373 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 42' ' ' LEU . 46.8 Cg_exo -61.24 130.46 32.32 Favored 'Trans proline' 0 N--CA 1.482 0.849 0 C-N-CA 123.807 3.005 . . . . 54.310000000000002 113.057 -178.581 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -99.81 -171.09 1.99 Allowed 'General case' 0 C--O 1.245 0.841 0 CA-C-O 121.277 0.56 . . . . 73.409999999999997 111.069 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 128.47 53.97 0.12 Allowed Glycine 0 CA--C 1.488 -1.65 0 N-CA-C 107.877 -2.089 . . . . 24.32 107.877 -177.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.402 ' HB3' ' HB2' ' A' ' 63' ' ' LEU . 10.1 m -89.47 152.12 21.63 Favored 'General case' 0 N--CA 1.422 -1.832 0 CA-C-O 121.684 0.754 . . . . 73.439999999999998 112.374 -166.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.414 ' HB1' ' O ' ' A' ' 138' ' ' LEU . . . -112.32 -164.38 0.91 Allowed 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 114.114 -1.403 . . . . 51.140000000000001 107.434 178.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.7 pp -131.07 155.4 46.98 Favored 'General case' 0 N--CA 1.438 -1.051 0 C-N-CA 120.277 -0.569 . . . . 63.310000000000002 111.96 -177.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.42 ' HB2' HD21 ' A' ' 135' ' ' LEU . 3.6 pp -132.1 141.29 49.12 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 115.771 -0.649 . . . . 74.209999999999994 109.985 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 59.8 t -119.07 126.04 75.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 109.655 -0.498 . . . . 74.140000000000001 109.655 -177.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.5 t -93.17 115.87 32.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 107.553 -1.277 . . . . 70.010000000000005 107.553 176.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.412 ' HE3' ' CG2' ' A' ' 136' ' ' VAL . 94.5 mttt -66.02 -43.93 86.23 Favored 'General case' 0 CA--C 1.496 -1.125 0 CA-C-N 115.105 -0.952 . . . . 71.409999999999997 109.088 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.412 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 30.0 tpt180 -168.9 135.13 1.75 Allowed 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.067 -1.457 . . . . 65.439999999999998 107.067 179.018 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.447 ' HA2' ' HD3' ' A' ' 55' ' ' PRO . . . 172.43 135.73 2.02 Favored Glycine 0 N--CA 1.42 -2.393 0 N-CA-C 109.267 -1.533 . . . . 72.310000000000002 109.267 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.542 ' HB2' ' O ' ' A' ' 81' ' ' ASP . 15.0 Cg_exo -67.52 -10.95 30.43 Favored 'Trans proline' 0 CA--C 1.53 0.307 0 C-N-CA 122.372 2.048 . . . . 61.539999999999999 112.723 -176.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.543 ' HA ' ' N ' ' A' ' 81' ' ' ASP . 29.5 p-10 -53.92 -42.36 68.67 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.708 0.803 . . . . 73.450000000000003 110.673 178.409 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -168.17 -47.18 0.02 OUTLIER 'General case' 0 N--CA 1.444 -0.732 0 O-C-N 123.411 0.444 . . . . 64.129999999999995 110.769 178.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.28 64.73 2.86 Favored Glycine 0 C--O 1.239 0.466 0 N-CA-C 110.727 -0.949 . . . . 74.219999999999999 110.727 -176.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -166.45 -178.49 4.49 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 107.449 -1.315 . . . . 72.5 107.449 -177.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 13.3 ptt180 -112.64 144.97 41.22 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 109.199 -0.667 . . . . 64.420000000000002 109.199 175.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -132.33 154.31 49.86 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 116.372 -0.377 . . . . 70.319999999999993 110.553 -177.151 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.1 tt -111.48 140.27 46.22 Favored 'General case' 0 C--N 1.28 -2.439 0 N-CA-C 103.544 -2.762 . . . . 71.450000000000003 103.544 173.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.402 ' HB2' ' HB3' ' A' ' 46' ' ' SER . 6.8 mp -70.38 113.74 7.82 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 118.555 -1.258 . . . . 72.010000000000005 109.115 -176.349 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -72.36 -60.59 2.16 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 114.081 -1.418 . . . . 62.43 109.632 -173.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.466 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 7.9 tt0 -103.02 132.92 20.66 Favored Pre-proline 0 N--CA 1.419 -1.992 0 CA-C-N 115.168 -0.924 . . . . 63.240000000000002 109.39 -178.564 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.466 ' HD2' ' HA ' ' A' ' 65' ' ' GLN . 5.8 Cg_exo -37.6 -46.94 1.89 Allowed 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 124.9 3.733 . . . . 75.219999999999999 113.515 175.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.452 HG23 ' HG2' ' A' ' 93' ' ' ARG . 87.3 m -106.61 96.44 6.45 Favored 'General case' 0 N--CA 1.423 -1.817 0 N-CA-C 108.189 -1.041 . . . . 64.340000000000003 108.189 173.102 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.451 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 22.3 m -89.16 114.61 25.92 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 108.404 -0.961 . . . . 60.030000000000001 108.404 -179.069 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.4 t -96.85 120.08 36.53 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.583 0.706 . . . . 72.329999999999998 109.86 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -110.28 148.94 30.92 Favored 'General case' 0 N--CA 1.428 -1.569 0 CA-C-N 115.837 -0.62 . . . . 62.530000000000001 110.579 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 147.71 -137.82 6.78 Favored Glycine 0 CA--C 1.466 -2.994 0 N-CA-C 107.389 -2.285 . . . . 64.450000000000003 107.389 -178.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.296 4.5 ptt85 -110.94 -88.94 0.5 Allowed 'General case' 0 C--N 1.284 -2.268 0 CA-C-O 118.428 -0.796 . . . . 75.109999999999999 111.857 174.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.471 ' HB3' ' HD2' ' A' ' 74' ' ' PRO . 32.7 m170 60.63 173.74 0.05 OUTLIER Pre-proline 0 CA--C 1.559 1.298 0 CA-C-N 118.598 0.635 . . . . 73.209999999999994 110.879 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.471 ' HD2' ' HB3' ' A' ' 73' ' ' HIS . 28.4 Cg_endo -66.77 -21.74 50.75 Favored 'Trans proline' 0 CA--C 1.545 1.026 0 C-N-CA 121.394 1.396 . . . . 65.299999999999997 111.81 169.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -134.33 92.96 2.99 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-O 121.337 0.589 . . . . 73.420000000000002 110.363 -176.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 13.1 m -77.38 117.32 18.76 Favored 'General case' 0 C--N 1.279 -2.494 0 N-CA-C 107.084 -1.45 . . . . 73.129999999999995 107.084 172.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -70.99 -35.06 71.96 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 108.522 -0.918 . . . . 73.400000000000006 108.522 -178.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.7 pp -130.15 162.47 37.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 106.14 -1.8 . . . . 74.150000000000006 106.14 165.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -101.33 136.64 40.85 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 113.974 1.102 . . . . 74.420000000000002 113.974 -170.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.53 ' HA ' ' HB2' ' A' ' 56' ' ' ASN . 94.4 mt -128.91 150.18 50.47 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 106.971 -1.492 . . . . 73.239999999999995 106.971 175.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.543 ' N ' ' HA ' ' A' ' 56' ' ' ASN . 16.9 t70 -156.93 94.59 1.44 Allowed 'General case' 0 C--N 1.288 -2.071 0 O-C-N 124.0 0.812 . . . . 72.519999999999996 109.425 -177.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.448 ' O ' HG12 ' A' ' 85' ' ' VAL . 14.1 t70 -157.82 152.92 25.62 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 107.802 -1.185 . . . . 72.030000000000001 107.802 175.542 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.6 p -61.31 -27.5 41.99 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.061 0 C-N-CA 122.893 0.477 . . . . 63.43 112.202 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 17.6 p -96.77 21.85 8.96 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 113.88 1.067 . . . . 72.430000000000007 113.88 -177.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.448 HG12 ' O ' ' A' ' 82' ' ' ASP . 13.9 p -82.06 124.74 39.45 Favored 'Isoleucine or valine' 0 C--O 1.249 1.038 0 CA-C-O 122.044 0.925 . . . . 74.239999999999995 110.266 179.021 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 16.2 m -80.9 163.32 23.45 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.805 -0.813 . . . . 70.549999999999997 108.805 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.49 -43.21 97.26 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 119.677 -0.809 . . . . 70.140000000000001 108.931 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -110.4 110.81 21.72 Favored 'General case' 0 N--CA 1.419 -2.02 0 N-CA-C 102.565 -3.124 . . . . 74.319999999999993 102.565 176.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 14.6 t60 -110.62 -85.88 0.55 Allowed 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 117.878 -1.529 . . . . 73.25 112.398 -172.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.414 ' HA ' ' HA ' ' A' ' 103' ' ' ASP . . . -126.6 123.82 38.51 Favored 'General case' 0 C--N 1.292 -1.932 0 C-N-CA 120.167 -0.613 . . . . 42.240000000000002 109.722 -175.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -110.04 127.53 54.89 Favored 'General case' 0 C--N 1.275 -2.642 0 C-N-CA 118.938 -1.105 . . . . 55.409999999999997 110.419 177.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.451 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 53.0 m-85 -103.41 113.64 27.3 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 114.61 -1.177 . . . . 74.430000000000007 108.116 -176.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.452 ' HG2' HG23 ' A' ' 67' ' ' THR . 48.6 mtm180 -108.78 122.6 47.5 Favored 'General case' 0 C--N 1.288 -2.109 0 N-CA-C 109.632 -0.507 . . . . 74.450000000000003 109.632 178.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.412 ' CG2' ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -115.2 116.95 54.09 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.495 0 N-CA-C 106.888 -1.523 . . . . 74.319999999999993 106.888 175.919 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -117.8 146.06 44.09 Favored 'General case' 0 C--N 1.278 -2.533 0 CA-C-N 113.575 -1.648 . . . . 74.140000000000001 106.6 178.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -56.1 -22.02 25.68 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 112.396 0.517 . . . . 72.230000000000004 112.396 -177.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -95.95 -33.6 6.28 Favored Glycine 0 N--CA 1.435 -1.368 0 C-N-CA 121.042 -0.599 . . . . 60.119999999999997 113.611 178.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -148.16 144.3 27.67 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 117.494 0.647 . . . . 73.519999999999996 111.687 -176.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.487 ' HB3' ' SD ' ' A' ' 122' ' ' MET . 5.1 m-85 -106.67 114.3 28.32 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 106.986 -1.487 . . . . 74.299999999999997 106.986 176.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -132.37 135.12 45.92 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.43 -0.794 . . . . 63.140000000000001 111.901 -176.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.5 p -114.53 119.53 61.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 109.066 -0.716 . . . . 72.129999999999995 109.066 176.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 50.0 t -110.83 114.09 46.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 108.168 -1.049 . . . . 60.140000000000001 108.168 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.414 ' HA ' ' HA ' ' A' ' 90' ' ' ALA . 19.5 t70 -105.43 127.44 52.99 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-O 121.235 0.54 . . . . 63.350000000000001 110.556 179.301 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 28.7 m -116.67 12.61 7.55 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.176 0 CA-C-N 115.052 -0.976 . . . . 62.240000000000002 109.51 174.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -100.89 52.5 0.92 Allowed Glycine 0 N--CA 1.437 -1.284 0 N-CA-C 110.596 -1.001 . . . . 60.140000000000001 110.596 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.5 m -60.96 -17.16 50.06 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.201 1.4 . . . . 74.040000000000006 112.331 -176.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 82.6 mt -58.3 -39.9 80.56 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.698 0.761 . . . . 74.209999999999994 109.395 174.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -90.64 -48.99 6.73 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 106.706 -1.59 . . . . 73.530000000000001 106.706 176.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.66 94.0 1.24 Allowed Glycine 0 N--CA 1.442 -0.948 0 CA-C-N 114.767 -1.106 . . . . 53.039999999999999 113.982 175.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 42.0 m -93.72 120.09 33.55 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 109.208 -0.664 . . . . 71.049999999999997 109.208 175.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -135.65 168.74 18.7 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 107.923 -1.14 . . . . 65.530000000000001 107.923 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.417 HG12 ' H ' ' A' ' 114' ' ' ARG . 52.5 t -106.84 141.67 21.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 107.932 -1.136 . . . . 72.420000000000002 107.932 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -51.48 -38.11 52.25 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 123.88 0.872 . . . . 74.329999999999998 111.563 178.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.417 ' H ' HG12 ' A' ' 112' ' ' VAL . 53.5 ttt180 -84.06 -36.46 23.04 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 116.072 -0.513 . . . . 73.099999999999994 111.343 176.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 21.3 tp10 -124.2 114.21 27.73 Favored Pre-proline 0 C--N 1.306 -1.295 0 N-CA-C 112.125 0.417 . . . . 72.150000000000006 112.125 -169.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -78.75 38.82 0.74 Allowed 'Trans proline' 0 CA--C 1.547 1.146 0 C-N-CA 123.409 2.739 . . . . 63.329999999999998 113.206 -178.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 64.8 mtm180 -109.45 145.06 36.81 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 116.197 -0.456 . . . . 71.040000000000006 110.286 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -71.28 -38.64 71.82 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 123.941 0.776 . . . . 70.25 110.992 -172.503 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -115.04 136.9 52.62 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 107.13 -1.433 . . . . 61.020000000000003 107.13 173.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 -142.58 150.85 40.88 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 114.518 1.303 . . . . 72.140000000000001 114.518 -177.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.1 p -79.88 128.82 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.915 0 N-CA-C 105.252 -2.129 . . . . 63.32 105.252 167.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.487 ' SD ' ' HB3' ' A' ' 99' ' ' PHE . 59.4 mtt -60.59 136.68 58.13 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 123.29 0.636 . . . . 74.319999999999993 112.095 -171.041 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.39 125.06 51.31 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 105.435 -2.061 . . . . 74.329999999999998 105.435 178.065 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 21.7 p -78.89 115.39 18.55 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.222 0.534 . . . . 53.329999999999998 111.507 -176.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 101.53 13.77 31.77 Favored Glycine 0 N--CA 1.432 -1.606 0 C-N-CA 120.758 -0.734 . . . . 63.200000000000003 112.505 179.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -116.6 176.33 5.16 Favored 'General case' 0 C--O 1.248 0.986 0 C-N-CA 119.531 -0.868 . . . . 52.310000000000002 109.476 178.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.54 ' OE1' ' HD3' ' A' ' 134' ' ' ARG . 40.6 tt0 -110.48 135.11 51.65 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-O 121.296 0.57 . . . . 72.430000000000007 109.984 -171.078 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 67.4 mt -103.37 122.95 56.55 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.406 0 N-CA-C 107.889 -1.152 . . . . 70.239999999999995 107.889 178.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -97.32 112.45 24.26 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 115.913 -0.585 . . . . 74.049999999999997 109.454 -179.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.1 pt -102.01 98.21 6.57 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.343 0 N-CA-C 107.549 -1.278 . . . . 74.209999999999994 107.549 175.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 75.08 -113.86 4.12 Favored Glycine 0 N--CA 1.421 -2.315 0 N-CA-C 108.198 -1.961 . . . . 70.120000000000005 108.198 -172.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -124.66 6.27 8.19 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 120.971 0.415 . . . . 72.329999999999998 110.397 175.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.412 ' HB2' ' O ' ' A' ' 53' ' ' ARG . 9.4 p90 -98.78 151.64 20.57 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 109.224 -0.658 . . . . 74.340000000000003 109.224 174.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.54 ' HD3' ' OE1' ' A' ' 127' ' ' GLU . 77.9 mtt-85 -117.85 132.5 56.42 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 115.104 1.52 . . . . 74.439999999999998 115.104 -164.307 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.42 HD21 ' HB2' ' A' ' 49' ' ' LEU . 5.6 tt -124.3 136.33 54.03 Favored 'General case' 0 C--O 1.195 -1.773 0 CA-C-N 114.008 -1.451 . . . . 75.0 107.466 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.412 ' CG2' ' HE3' ' A' ' 52' ' ' LYS . 25.9 t -112.58 137.63 44.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.941 -0.763 . . . . 61.539999999999999 108.941 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -107.26 117.36 33.86 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 110.014 -0.365 . . . . 71.25 110.014 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.414 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 2.5 mm? -117.34 143.87 45.5 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.35 0.595 . . . . 72.439999999999998 110.976 -177.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -97.57 91.27 5.35 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.415 -0.957 . . . . 65.329999999999998 108.415 177.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -107.16 -72.28 0.79 Allowed Glycine 0 N--CA 1.43 -1.727 0 CA-C-N 115.358 -0.837 . . . . 42.109999999999999 111.176 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -75.87 128.79 11.06 Favored 'Trans proline' 0 N--CA 1.446 -1.28 0 C-N-CA 121.935 1.757 . . . . 64.030000000000001 112.441 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -110.75 111.5 22.72 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 107.59 -1.263 . . . . 54.130000000000003 107.59 174.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 . . . . . 0 N--CA 1.425 -1.712 0 N-CA-C 108.619 -0.882 . . . . 63.119999999999997 108.619 -178.365 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 ppp? . . . . . 0 N--CA 1.466 0.37 0 N-CA-C 112.662 0.616 . . . . 65.420000000000002 112.662 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.2 m -74.67 -29.98 61.42 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-O 120.981 0.419 . . . . 71.129999999999995 109.914 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.0 t70 66.17 101.79 0.04 OUTLIER 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 122.492 1.139 . . . . 64.400000000000006 113.357 178.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -118.67 138.02 52.9 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 114.118 -1.401 . . . . 63.130000000000003 108.198 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -150.93 156.67 41.67 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 109.317 -0.623 . . . . 72.200000000000003 109.317 -174.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -73.85 106.15 1.96 Allowed Glycine 0 N--CA 1.436 -1.305 0 N-CA-C 110.66 -0.976 . . . . 63.450000000000003 110.66 178.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.1 t -98.02 126.73 39.28 Favored Pre-proline 0 C--N 1.296 -1.721 0 N-CA-C 110.122 -0.325 . . . . 72.209999999999994 110.122 -179.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -66.3 128.37 19.25 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.388 2.059 . . . . 71.540000000000006 111.205 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -90.77 131.68 36.93 Favored Pre-proline 0 C--N 1.294 -1.808 0 N-CA-C 108.898 -0.779 . . . . 71.010000000000005 108.898 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_exo -49.14 129.36 21.77 Favored 'Trans proline' 0 C--O 1.239 0.541 0 C-N-CA 123.508 2.805 . . . . 34.399999999999999 114.707 -174.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -110.18 107.95 17.93 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.007 -1.849 . . . . 71.409999999999997 106.007 174.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.6 p -114.65 107.49 23.0 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 CA-C-O 122.01 0.91 . . . . 53.030000000000001 111.7 -175.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -139.57 140.95 37.2 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 105.676 -1.972 . . . . 60.32 105.676 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 67.8 m -150.71 95.57 2.24 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 109.897 -0.408 . . . . 64.25 109.897 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.9 p -113.33 104.18 12.06 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-O 121.363 0.601 . . . . 74.0 111.547 177.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 39.9 t -164.9 115.2 1.14 Allowed 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 107.498 -1.297 . . . . 63.109999999999999 107.498 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.8 p -141.69 144.73 25.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 N-CA-C 109.792 -0.447 . . . . 73.319999999999993 109.792 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -128.98 158.1 39.8 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.364 -0.976 . . . . 73.109999999999999 108.364 175.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 16.3 ptt85 -127.4 138.11 52.91 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.416 0.627 . . . . 75.430000000000007 112.235 -176.063 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -99.94 42.06 1.13 Allowed 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.705 -0.679 . . . . 64.510000000000005 110.529 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -69.99 -15.76 63.08 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 116.373 -0.376 . . . . 65.219999999999999 111.983 -178.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.421 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 45.4 tp -79.15 156.89 28.05 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 107.653 -1.24 . . . . 74.409999999999997 107.653 175.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.421 ' HB2' ' O ' ' A' ' 22' ' ' LEU . 9.7 mp 75.55 34.69 0.58 Allowed 'General case' 0 N--CA 1.483 1.212 0 CA-C-O 122.057 0.932 . . . . 52.119999999999997 110.515 -177.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -87.99 115.72 25.65 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.588 -1.187 . . . . 72.219999999999999 108.363 177.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -106.39 -177.95 3.51 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.549 -0.75 . . . . 71.019999999999996 109.374 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -144.73 139.76 28.11 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.817 -0.808 . . . . 75.040000000000006 108.817 178.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -78.07 135.14 37.67 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 108.939 -0.763 . . . . 62.32 108.939 177.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.5 m -79.07 155.73 28.66 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.326 -0.852 . . . . 71.430000000000007 111.999 -172.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 14.5 m -94.22 148.93 21.71 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 115.473 -0.785 . . . . 71.310000000000002 109.168 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.0 t -109.42 -177.51 3.31 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.222 -1.399 . . . . 70.549999999999997 107.222 177.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -116.31 178.7 17.52 Favored Glycine 0 C--N 1.304 -1.206 0 C-N-CA 120.504 -0.855 . . . . 54.030000000000001 111.145 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.3 m -76.69 138.24 39.88 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 109.897 -0.408 . . . . 73.019999999999996 109.897 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -78.49 143.32 63.6 Favored Pre-proline 0 C--N 1.304 -1.403 0 N-CA-C 108.734 -0.839 . . . . 73.409999999999997 108.734 177.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -63.11 110.15 1.1 Allowed 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.038 1.825 . . . . 73.400000000000006 110.186 177.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -158.22 116.78 3.07 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 115.001 -0.999 . . . . 70.349999999999994 108.489 -177.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.3 p -80.01 144.91 32.84 Favored 'General case' 0 N--CA 1.422 -1.842 0 O-C-N 123.85 0.719 . . . . 71.549999999999997 109.207 176.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.6 t -109.91 157.53 19.14 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-O 121.102 0.477 . . . . 75.140000000000001 110.11 -177.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -133.83 50.79 0.86 Allowed Glycine 0 N--CA 1.409 -3.106 0 N-CA-C 108.287 -1.925 . . . . 64.099999999999994 108.287 174.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.17 -29.51 70.85 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 123.373 0.669 . . . . 73.409999999999997 111.07 -178.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -72.14 -15.11 61.97 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 116.219 -0.446 . . . . 74.209999999999994 111.559 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -71.25 -29.93 65.71 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.91 0.862 . . . . 72.209999999999994 109.11 177.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -84.27 151.63 59.98 Favored Pre-proline 0 N--CA 1.422 -1.854 0 N-CA-C 107.516 -1.291 . . . . 73.329999999999998 107.516 177.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -68.11 176.53 5.33 Favored 'Trans proline' 0 C--O 1.253 1.245 0 C-N-CA 122.006 1.804 . . . . 62.039999999999999 111.647 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.432 ' HB3' ' HB2' ' A' ' 143' ' ' GLU . . . -69.44 108.5 3.78 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.858 0.837 . . . . 52.439999999999998 110.99 -178.538 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.48 ' HA2' ' O ' ' A' ' 141' ' ' PRO . . . -158.52 48.83 0.42 Allowed Glycine 0 CA--C 1.48 -2.154 0 N-CA-C 106.015 -2.834 . . . . 44.130000000000003 106.015 178.327 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 13.6 m -89.98 164.79 14.4 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 113.56 -1.32 . . . . 61.240000000000002 111.264 -169.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -92.91 164.58 13.26 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 116.015 -0.539 . . . . 74.439999999999998 109.773 -179.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -133.83 155.91 48.99 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 110.261 -0.274 . . . . 75.239999999999995 110.261 -178.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.473 HD23 ' O ' ' A' ' 61' ' ' PHE . 2.7 pt? -108.79 132.77 53.66 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 107.065 -1.457 . . . . 72.310000000000002 107.065 176.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.8 t -117.68 114.66 46.13 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 N-CA-C 108.661 -0.866 . . . . 65.299999999999997 108.661 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.47 HG11 ' OD1' ' A' ' 56' ' ' ASN . 61.9 t -92.9 116.03 33.09 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 N-CA-C 107.722 -1.214 . . . . 64.109999999999999 107.722 177.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.4 mmmp? -82.56 -39.12 22.75 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.381 -0.827 . . . . 62.119999999999997 108.831 -178.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.43 ' O ' ' HB3' ' A' ' 133' ' ' PHE . 72.8 ttt180 -147.86 115.65 6.4 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 115.196 -0.911 . . . . 75.400000000000006 108.94 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 175.74 134.18 1.88 Allowed Glycine 0 N--CA 1.438 -1.174 0 C-N-CA 120.127 -1.035 . . . . 72.219999999999999 113.433 176.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.55 -9.25 25.7 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 123.957 3.105 . . . . 64.510000000000005 111.897 175.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.49 ' HB2' ' HA ' ' A' ' 80' ' ' LEU . 13.2 p30 -48.54 -46.05 38.26 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.488 1.115 . . . . 54.43 111.495 177.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -171.34 -40.53 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 125.203 1.401 . . . . 75.150000000000006 107.381 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 64.6 46.35 90.34 Favored Glycine 0 CA--C 1.495 -1.192 0 N-CA-C 110.191 -1.163 . . . . 71.099999999999994 110.191 -178.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -143.11 -178.01 5.63 Favored 'General case' 0 N--CA 1.424 -1.775 0 N-CA-C 108.513 -0.921 . . . . 75.420000000000002 108.513 -173.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.445 ' HA ' ' O ' ' A' ' 49' ' ' LEU . 11.2 ptt180 -141.49 131.94 25.27 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 123.416 0.447 . . . . 73.329999999999998 109.969 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.473 ' O ' HD23 ' A' ' 49' ' ' LEU . 30.7 p90 -154.36 154.96 34.19 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 112.415 0.524 . . . . 71.540000000000006 112.415 -177.054 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.2 tt -81.08 139.69 35.54 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.019 -0.991 . . . . 64.140000000000001 110.874 -176.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -101.71 115.77 31.27 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 110.253 -0.277 . . . . 60.409999999999997 110.253 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -111.31 -4.45 14.93 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 122.393 1.092 . . . . 72.040000000000006 108.392 177.014 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.416 HE21 ' HB3' ' A' ' 77' ' ' ASP . 1.0 OUTLIER -78.73 123.6 85.31 Favored Pre-proline 0 C--N 1.314 -0.959 0 CA-C-N 114.587 -1.188 . . . . 74.120000000000005 109.98 -175.875 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.02 -27.71 85.08 Favored 'Trans proline' 0 C--N 1.361 1.225 0 C-N-CA 122.878 2.385 . . . . 73.310000000000002 111.308 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 91.8 m -134.93 116.63 14.94 Favored 'General case' 0 N--CA 1.408 -2.535 0 N-CA-C 107.13 -1.433 . . . . 71.310000000000002 107.13 173.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.423 HG23 ' HB2' ' A' ' 77' ' ' ASP . 88.9 m -105.24 114.4 28.56 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 108.969 -0.752 . . . . 72.299999999999997 108.969 -179.189 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 28.3 p -82.67 130.24 35.09 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 115.35 -0.841 . . . . 43.530000000000001 111.577 -178.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -108.58 115.5 30.21 Favored 'General case' 0 C--O 1.252 1.212 0 CA-C-O 121.385 0.612 . . . . 70.109999999999999 110.947 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 165.74 -158.5 31.41 Favored Glycine 0 CA--C 1.487 -1.691 0 N-CA-C 106.046 -2.822 . . . . 55.439999999999998 106.046 -179.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.8 ttp180 -159.32 78.18 0.72 Allowed 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 119.093 1.446 . . . . 75.239999999999995 111.417 174.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.48 ' HB3' ' HD3' ' A' ' 74' ' ' PRO . 13.0 t60 -175.53 -77.98 0.0 OUTLIER Pre-proline 0 CA--C 1.556 1.176 0 N-CA-C 113.392 0.886 . . . . 73.510000000000005 113.392 175.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.48 ' HD3' ' HB3' ' A' ' 73' ' ' HIS . 48.2 Cg_endo -66.71 -41.87 10.14 Favored 'Trans proline' 0 C--N 1.394 2.966 0 CA-C-N 120.839 1.335 . . . . 75.420000000000002 113.372 -169.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -166.71 114.54 0.85 Allowed 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 102.582 -3.118 . . . . 44.520000000000003 102.582 -178.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 19.7 m -136.33 103.07 5.17 Favored 'General case' 0 C--N 1.26 -3.319 0 CA-C-N 115.888 -0.597 . . . . 61.119999999999997 109.647 -178.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.423 ' HB2' HG23 ' A' ' 68' ' ' THR . 42.1 m-20 -74.07 -31.98 63.07 Favored 'General case' 0 CA--C 1.493 -1.227 0 CA-C-N 115.218 -0.901 . . . . 75.219999999999999 109.363 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 39.0 pt -119.75 137.82 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.871 0 N-CA-C 107.086 -1.45 . . . . 71.409999999999997 107.086 170.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -85.73 124.14 31.91 Favored 'General case' 0 C--N 1.284 -2.272 0 N-CA-C 108.145 -1.057 . . . . 73.140000000000001 108.145 179.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.49 ' HA ' ' HB2' ' A' ' 56' ' ' ASN . 35.4 tp -122.02 155.58 35.3 Favored 'General case' 0 N--CA 1.414 -2.248 0 CA-C-N 115.929 -0.578 . . . . 61.350000000000001 109.712 -174.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.41 ' CB ' ' HA ' ' A' ' 56' ' ' ASN . 9.8 t70 -168.94 150.32 4.57 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 104.583 -2.376 . . . . 60.409999999999997 104.583 178.134 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.425 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 20.8 t70 -169.41 164.28 10.61 Favored 'General case' 0 C--N 1.26 -3.298 0 N-CA-C 106.647 -1.612 . . . . 73.230000000000004 106.647 -176.255 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.8 m -63.2 -23.72 34.05 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 O-C-N 123.309 0.381 . . . . 45.140000000000001 111.367 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.572 ' HB ' ' HB2' ' A' ' 108' ' ' ASN . 45.8 m -144.2 70.77 1.3 Allowed 'General case' 0 N--CA 1.423 -1.793 0 CA-C-O 122.39 1.091 . . . . 72.109999999999999 109.802 175.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.425 ' HB ' ' HB3' ' A' ' 82' ' ' ASP . 12.5 p -95.84 140.19 17.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 114.499 -1.228 . . . . 74.049999999999997 110.466 -177.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 24.1 t -92.72 159.95 15.19 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 110.054 -0.35 . . . . 75.400000000000006 110.054 178.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 4.5 tpp180 -57.88 -47.97 81.19 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.864 0.865 . . . . 71.439999999999998 109.024 177.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -119.08 86.93 2.64 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 104.685 -2.339 . . . . 75.519999999999996 104.685 174.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 25.5 t60 -81.39 -52.49 7.22 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.962 -0.563 . . . . 64.120000000000005 111.204 -172.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.97 160.6 42.16 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 120.02 -0.672 . . . . 72.239999999999995 110.239 -177.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -131.18 127.22 37.51 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 108.345 -0.983 . . . . 75.310000000000002 108.345 174.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.42 ' HB3' ' HB ' ' A' ' 68' ' ' THR . 57.5 t80 -106.74 123.91 48.84 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 109.692 -0.484 . . . . 52.100000000000001 109.692 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -113.74 136.33 52.97 Favored 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 107.858 -1.164 . . . . 74.230000000000004 107.858 177.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 12.5 tt -116.1 131.44 68.6 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.236 0 C-N-CA 119.522 -0.871 . . . . 74.340000000000003 109.844 -178.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -109.4 145.97 35.23 Favored 'General case' 0 C--N 1.282 -2.359 0 N-CA-C 105.171 -2.159 . . . . 70.439999999999998 105.171 175.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -54.75 -22.94 15.66 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 113.226 0.825 . . . . 75.140000000000001 113.226 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -117.07 5.73 17.82 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 120.321 -0.943 . . . . 54.049999999999997 114.094 177.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -162.44 148.49 12.86 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 118.778 1.289 . . . . 62.219999999999999 111.642 -177.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -117.79 114.51 23.39 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.491 -0.929 . . . . 73.340000000000003 108.491 -176.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -132.25 135.13 46.06 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 119.638 -0.825 . . . . 61.409999999999997 112.498 -177.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.2 p -121.83 131.36 73.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-N 115.883 -0.599 . . . . 54.340000000000003 110.243 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.2 m -106.37 134.77 47.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-O 120.905 0.383 . . . . 70.120000000000005 110.907 178.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -90.0 108.95 20.03 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.283 -1.377 . . . . 53.420000000000002 107.283 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 21.2 m -113.52 11.7 8.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-N 115.942 -0.572 . . . . 74.439999999999998 111.29 -178.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -144.15 63.17 0.48 Allowed Glycine 0 N--CA 1.432 -1.584 0 N-CA-C 109.444 -1.462 . . . . 73.5 109.444 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 13.3 m -74.93 61.35 1.03 Allowed 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 123.549 0.74 . . . . 64.230000000000004 112.722 -173.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 85.4 mt -89.09 -49.11 6.95 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.467 -0.938 . . . . 72.319999999999993 108.467 176.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.572 ' HB2' ' HB ' ' A' ' 84' ' ' THR . 53.6 t30 -114.74 -33.0 5.64 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.592 -0.731 . . . . 74.310000000000002 109.506 -179.085 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 102.68 138.89 10.2 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.568 -0.825 . . . . 71.109999999999999 114.79 171.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.2 m -97.24 138.16 35.15 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.251 -1.018 . . . . 74.340000000000003 108.251 174.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.49 ' CE2' ' HB3' ' A' ' 116' ' ' PRO . 52.8 m-85 -130.89 151.91 50.8 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 109.321 -0.622 . . . . 72.329999999999998 109.321 -177.144 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.431 HG12 ' HG3' ' A' ' 120' ' ' GLN . 8.6 p -128.8 118.53 47.36 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 N-CA-C 108.017 -1.105 . . . . 64.349999999999994 108.017 168.09 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 48.82 51.8 15.25 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 116.21 -0.45 . . . . 75.230000000000004 111.563 -175.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 70.5 mtp180 74.42 -17.48 0.47 Allowed 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 124.763 1.225 . . . . 74.430000000000007 114.192 -179.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -76.07 115.04 43.17 Favored Pre-proline 0 C--O 1.247 0.952 0 CA-C-N 117.79 0.268 . . . . 63.130000000000003 111.23 -177.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.49 ' HB3' ' CE2' ' A' ' 111' ' ' TYR . 36.3 Cg_endo -91.8 102.9 0.22 Allowed 'Trans proline' 0 N--CA 1.443 -1.469 0 C-N-CA 123.141 2.561 . . . . 73.519999999999996 112.202 178.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.419 ' HB2' ' HG2' ' A' ' 120' ' ' GLN . 25.5 mtp180 -130.34 161.35 31.49 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 122.107 -0.37 . . . . 62.420000000000002 110.561 176.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -84.95 -8.94 58.55 Favored 'General case' 0 CA--C 1.496 -1.134 0 N-CA-C 113.434 0.902 . . . . 73.420000000000002 113.434 -177.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -153.42 137.9 16.77 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 105.432 -2.062 . . . . 71.400000000000006 105.432 170.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.466 ' NE2' ' HA ' ' A' ' 120' ' ' GLN . 15.2 mm-40 -141.34 149.21 40.87 Favored 'General case' 0 CA--C 1.472 -2.033 0 N-CA-C 114.451 1.278 . . . . 73.219999999999999 114.451 -178.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 25.5 t -88.33 122.88 40.38 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.261 0 N-CA-C 105.878 -1.897 . . . . 71.340000000000003 105.878 174.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 52.8 mtt -70.91 139.34 50.69 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 120.85 0.357 . . . . 75.25 110.808 -178.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 60.6 tp60 -104.75 131.48 52.15 Favored 'General case' 0 N--CA 1.425 -1.723 0 N-CA-C 108.896 -0.779 . . . . 70.450000000000003 108.896 -177.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -78.51 115.6 18.33 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 115.735 -0.666 . . . . 53.329999999999998 111.177 -178.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 98.84 8.8 53.81 Favored Glycine 0 N--CA 1.438 -1.227 0 CA-C-N 115.617 -0.72 . . . . 62.109999999999999 111.687 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -125.58 -176.55 3.63 Favored 'General case' 0 C--O 1.245 0.816 0 N-CA-C 112.193 0.442 . . . . 74.120000000000005 112.193 -178.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.453 ' HG2' HG22 ' A' ' 136' ' ' VAL . 43.0 mt-10 -108.55 132.21 54.08 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 113.755 1.02 . . . . 70.230000000000004 113.755 -170.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.7 mp -114.1 120.09 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.991 0 N-CA-C 105.959 -1.867 . . . . 75.439999999999998 105.959 175.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.428 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 51.1 tt0 -103.7 122.31 44.79 Favored 'General case' 0 C--N 1.282 -2.329 0 CA-C-O 121.223 0.535 . . . . 64.510000000000005 110.264 -177.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.3 pp -103.28 98.85 7.32 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.182 0 CA-C-N 115.309 -0.86 . . . . 61.310000000000002 109.979 178.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 78.82 -106.6 2.38 Favored Glycine 0 N--CA 1.421 -2.351 0 N-CA-C 109.838 -1.305 . . . . 50.409999999999997 109.838 -176.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -111.35 -12.92 13.99 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 122.419 0.288 . . . . 74.340000000000003 111.464 177.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.43 ' HB3' ' O ' ' A' ' 53' ' ' ARG . 79.6 m-85 -97.77 151.15 20.47 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 112.605 0.594 . . . . 73.439999999999998 112.605 -172.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 20.0 mtp180 -112.49 128.3 56.29 Favored 'General case' 0 C--O 1.252 1.21 0 CA-C-O 121.949 0.881 . . . . 72.109999999999999 112.577 -168.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.425 HD11 HD12 ' A' ' 49' ' ' LEU . 5.0 tt -120.98 136.41 54.98 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 114.056 -1.429 . . . . 70.329999999999998 107.735 -178.244 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.453 HG22 ' HG2' ' A' ' 127' ' ' GLU . 22.0 t -109.01 127.98 65.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 106.985 -1.487 . . . . 61.020000000000003 106.985 176.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -105.67 122.86 46.93 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 109.147 -0.686 . . . . 53.399999999999999 109.147 -177.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.8 mp -130.51 159.04 38.27 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.857 -0.423 . . . . 64.329999999999998 109.857 -178.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -79.26 133.07 36.66 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 107.15 -1.426 . . . . 63.219999999999999 107.15 173.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -91.85 -160.92 36.53 Favored Glycine 0 N--CA 1.435 -1.414 0 C-N-CA 120.514 -0.851 . . . . 65.209999999999994 113.736 -173.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.48 ' O ' ' HA2' ' A' ' 45' ' ' GLY . 86.9 Cg_endo -81.45 158.88 19.64 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.992 2.462 . . . . 61.329999999999998 113.945 -175.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -107.12 107.63 18.7 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 108.075 -1.083 . . . . 72.439999999999998 108.075 176.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.432 ' HB2' ' HB3' ' A' ' 44' ' ' ALA . 13.5 mm-40 . . . . . 0 N--CA 1.426 -1.67 0 C-N-CA 123.049 0.54 . . . . 64.329999999999998 110.769 -176.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.0 mmm . . . . . 0 C--O 1.244 0.805 0 CA-C-O 119.965 -0.064 . . . . 72.209999999999994 111.022 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.8 p -66.88 -49.22 66.33 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 106.904 -1.517 . . . . 63.409999999999997 106.904 171.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -96.97 148.55 22.85 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 104.77 -2.308 . . . . 73.239999999999995 104.77 167.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -144.39 152.49 40.76 Favored 'General case' 0 C--N 1.292 -1.932 0 O-C-N 122.081 -0.387 . . . . 75.319999999999993 110.404 -176.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -153.16 94.88 1.89 Allowed 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.351 0.596 . . . . 72.549999999999997 110.044 -177.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -146.37 86.79 0.17 Allowed Glycine 0 N--CA 1.425 -2.062 0 N-CA-C 108.665 -1.774 . . . . 74.109999999999999 108.665 178.006 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.6 m -78.83 122.8 85.11 Favored Pre-proline 0 C--N 1.305 -1.339 0 CA-C-N 115.755 -0.223 . . . . 72.140000000000001 111.414 -174.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -69.22 138.43 39.52 Favored 'Trans proline' 0 C--O 1.25 1.095 0 C-N-CA 122.93 2.42 . . . . 73.420000000000002 110.804 172.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.433 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 8.4 pt-20 -95.52 137.83 21.94 Favored Pre-proline 0 C--O 1.251 1.183 0 C-N-CA 118.864 -1.134 . . . . 62.329999999999998 109.788 176.165 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 9' ' ' GLU . 5.3 Cg_exo -75.72 127.2 10.02 Favored 'Trans proline' 0 N--CA 1.439 -1.714 0 C-N-CA 122.242 1.961 . . . . 65.439999999999998 109.982 175.615 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -68.11 123.41 20.59 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 109.023 -0.732 . . . . 63.039999999999999 109.023 178.037 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.2 t -92.09 94.7 4.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 107.659 -1.237 . . . . 73.450000000000003 107.659 175.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.441 ' OE2' HG22 ' A' ' 15' ' ' THR . 0.4 OUTLIER -70.23 127.05 31.44 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 106.504 -1.665 . . . . 75.140000000000001 106.504 -179.123 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.6 m -100.48 -24.64 14.43 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 113.329 0.863 . . . . 73.230000000000004 113.329 -169.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.441 HG22 ' OE2' ' A' ' 13' ' ' GLU 0.313 14.0 t -83.63 72.14 10.33 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-O 123.896 1.808 . . . . 72.409999999999997 112.936 -174.314 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 57.3 m -139.37 138.55 36.69 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 104.521 -2.4 . . . . 73.319999999999993 104.521 174.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.1 t 71.19 110.13 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.244 0.805 0 N-CA-C 107.35 -1.352 . . . . 72.030000000000001 107.35 -170.084 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -125.26 139.4 53.75 Favored 'General case' 0 C--N 1.288 -2.074 0 CA-C-N 116.045 -0.525 . . . . 73.049999999999997 110.985 -174.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 60.0 mtt85 -111.52 102.23 10.59 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 107.862 -1.162 . . . . 63.549999999999997 107.862 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.16 86.28 7.05 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.284 0.564 . . . . 73.129999999999995 110.098 -178.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -81.88 -39.73 23.43 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.326 -0.99 . . . . 44.240000000000002 108.326 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 66.4 tp -79.81 100.78 8.14 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-N 114.928 -1.033 . . . . 61.140000000000001 109.997 177.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -117.73 142.49 47.2 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 103.033 -2.951 . . . . 64.019999999999996 103.033 174.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -64.21 133.9 53.74 Favored 'General case' 0 C--O 1.244 0.808 0 N-CA-C 113.577 0.954 . . . . 71.040000000000006 113.577 -176.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -70.26 162.33 28.66 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 113.709 -1.587 . . . . 73.219999999999999 110.57 -177.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 59.8 ttp -83.0 93.46 7.57 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-O 121.306 0.574 . . . . 74.040000000000006 109.718 178.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.6 ' HG2' ' H ' ' A' ' 28' ' ' SER . 22.4 tt0 -100.13 -157.62 0.62 Allowed 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 106.677 -1.601 . . . . 72.109999999999999 106.677 -179.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.6 ' H ' ' HG2' ' A' ' 27' ' ' GLU . 14.5 m -59.07 133.29 55.96 Favored 'General case' 0 C--O 1.248 1.016 0 CA-C-N 118.049 0.386 . . . . 74.340000000000003 109.988 179.144 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 45.7 m -75.53 131.91 40.37 Favored 'General case' 0 N--CA 1.419 -1.995 0 CA-C-O 121.554 0.692 . . . . 52.32 110.3 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.3 t -90.02 122.21 32.81 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 114.888 -1.051 . . . . 71.329999999999998 110.004 -176.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -77.85 -33.3 42.23 Favored Glycine 0 CA--C 1.488 -1.603 0 N-CA-C 109.25 -1.54 . . . . 62.240000000000002 109.25 178.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.48 ' CG2' ' HA ' ' A' ' 98' ' ' GLU . 35.2 m -71.85 142.87 49.58 Favored 'General case' 0 N--CA 1.408 -2.552 0 N-CA-C 107.588 -1.264 . . . . 74.109999999999999 107.588 174.158 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -83.79 114.43 53.85 Favored Pre-proline 0 C--N 1.308 -1.196 0 N-CA-C 111.525 0.195 . . . . 74.430000000000007 111.525 -173.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -62.03 122.47 10.99 Favored 'Trans proline' 0 C--O 1.245 0.844 0 C-N-CA 121.842 1.694 . . . . 72.200000000000003 110.24 179.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -79.6 23.36 0.42 Allowed 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.384 0.612 . . . . 54.520000000000003 112.384 -174.121 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.5 m -75.95 -30.02 58.51 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-O 121.262 0.553 . . . . 73.409999999999997 109.795 178.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 11.6 t -162.42 127.16 3.23 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 107.51 -1.293 . . . . 75.409999999999997 107.51 177.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.68 68.55 1.61 Allowed Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.823 -0.703 . . . . 72.5 111.399 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.42 -34.54 76.19 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 120.709 0.29 . . . . 73.329999999999998 110.852 -178.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -60.21 -10.3 4.38 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 124.611 1.165 . . . . 73.219999999999999 113.936 -178.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -63.04 -14.98 54.79 Favored 'General case' 0 C--N 1.28 -2.429 0 C-N-CA 125.042 1.337 . . . . 75.420000000000002 111.634 178.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.434 ' HB3' ' HA2' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -43.39 139.38 2.53 Favored Pre-proline 0 CA--C 1.555 1.147 0 N-CA-C 114.959 1.466 . . . . 71.209999999999994 114.959 -178.296 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -77.14 -18.34 14.42 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 122.645 2.23 . . . . 50.200000000000003 112.585 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.432 ' C ' HD23 ' A' ' 42' ' ' LEU . . . -162.93 129.14 3.36 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 107.702 -1.221 . . . . 72.150000000000006 107.702 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.71 -28.55 60.92 Favored Glycine 0 CA--C 1.495 -1.167 0 N-CA-C 111.06 -0.816 . . . . 52.409999999999997 111.06 178.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.7 m -129.67 146.1 51.48 Favored 'General case' 0 N--CA 1.414 -2.229 0 N-CA-C 107.266 -1.383 . . . . 52.420000000000002 107.266 177.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.83 175.1 10.67 Favored 'General case' 0 C--N 1.282 -2.362 0 N-CA-C 106.875 -1.528 . . . . 62.310000000000002 106.875 -178.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.8 pp -133.82 154.26 51.14 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 112.885 0.698 . . . . 75.030000000000001 112.885 -175.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.608 ' O ' ' HA ' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -118.94 140.9 49.22 Favored 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 108.312 -0.995 . . . . 73.409999999999997 108.312 175.575 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.4 HG22 ' HB3' ' A' ' 60' ' ' ARG . 27.8 t -121.3 114.32 42.8 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 108.566 -0.901 . . . . 71.219999999999999 108.566 -179.461 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.409 HG21 ' HB3' ' A' ' 57' ' ' ALA . 78.5 t -93.8 115.54 32.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 107.592 -1.262 . . . . 63.310000000000002 107.592 175.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 51.7 tttm -90.38 -24.1 20.89 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.771 -0.649 . . . . 65.219999999999999 110.505 -173.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 30.8 ttp-105 -146.69 119.3 8.54 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 106.878 -1.527 . . . . 74.340000000000003 106.878 176.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 143.15 116.86 1.18 Allowed Glycine 0 N--CA 1.417 -2.575 0 C-N-CA 120.176 -1.011 . . . . 74.299999999999997 112.181 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.501 ' HB2' ' HB3' ' A' ' 81' ' ' ASP . 27.8 Cg_exo -65.44 -10.81 27.59 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 123.423 2.749 . . . . 61.399999999999999 111.089 178.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.52 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 2.2 m-20 -48.38 -36.16 14.07 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 126.295 1.838 . . . . 61.130000000000003 110.212 174.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.409 ' HB3' HG21 ' A' ' 51' ' ' VAL . . . -152.16 -62.09 0.16 Allowed 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 107.978 -1.119 . . . . 55.310000000000002 107.978 175.327 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.61 23.83 75.36 Favored Glycine 0 CA--C 1.508 -0.363 0 CA-C-N 115.596 -0.729 . . . . 72.120000000000005 112.958 177.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -157.25 -179.43 8.19 Favored 'General case' 0 N--CA 1.428 -1.525 0 N-CA-C 108.478 -0.934 . . . . 52.130000000000003 108.478 -176.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.608 ' HA ' ' O ' ' A' ' 49' ' ' LEU . 9.8 ptp85 -111.1 133.87 53.14 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 124.04 0.838 . . . . 73.019999999999996 109.515 175.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -141.51 153.05 44.67 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.556 -0.535 . . . . 71.420000000000002 109.556 173.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.0 pp -94.41 140.4 29.86 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 112.114 0.413 . . . . 64.510000000000005 112.114 -177.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -78.6 114.94 17.95 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.646 -0.706 . . . . 65.230000000000004 109.918 178.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -146.47 16.83 1.31 Allowed 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 123.267 1.508 . . . . 63.520000000000003 107.596 175.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.452 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 28.4 tt0 -126.49 104.34 24.71 Favored Pre-proline 0 C--N 1.301 -1.535 0 CA-C-N 114.352 -1.295 . . . . 71.109999999999999 108.029 178.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.452 ' HD2' ' HA ' ' A' ' 65' ' ' GLN . 2.0 Cg_endo -45.92 -47.43 14.19 Favored 'Trans proline' 0 C--N 1.369 1.614 0 C-N-CA 124.133 3.222 . . . . 62.350000000000001 114.279 -174.484 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 50.3 m -113.24 97.33 6.42 Favored 'General case' 0 N--CA 1.424 -1.769 0 CA-C-O 121.319 0.58 . . . . 63.109999999999999 110.467 178.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.49 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 93.1 m -109.03 114.14 27.62 Favored 'General case' 0 N--CA 1.424 -1.771 0 N-CA-C 108.695 -0.854 . . . . 63.310000000000002 108.695 177.524 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 41.6 m -105.01 131.44 52.52 Favored 'General case' 0 N--CA 1.421 -1.895 0 CA-C-O 121.037 0.446 . . . . 75.230000000000004 109.904 -175.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -103.78 130.41 51.31 Favored 'General case' 0 N--CA 1.419 -1.981 0 N-CA-C 107.905 -1.146 . . . . 74.530000000000001 107.905 176.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -170.39 -140.86 3.11 Favored Glycine 0 N--CA 1.425 -2.058 0 N-CA-C 110.672 -0.971 . . . . 62.009999999999998 110.672 -178.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 27.1 ttm-85 -79.84 -59.12 2.86 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 120.469 -0.492 . . . . 75.129999999999995 109.854 -176.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 77.8 t60 175.22 -47.76 0.0 OUTLIER Pre-proline 0 CA--C 1.562 1.431 0 O-C-N 124.203 0.939 . . . . 70.239999999999995 113.167 177.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -57.55 -27.9 78.71 Favored 'Trans proline' 0 C--N 1.384 2.421 0 C-N-CA 122.065 1.844 . . . . 55.439999999999998 114.13 -174.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.412 ' CD ' HH21 ' A' ' 87' ' ' ARG . 41.8 mt-10 -125.12 26.47 6.94 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 109.697 -0.483 . . . . 70.340000000000003 109.697 -177.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.3 m -145.01 140.37 28.1 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 122.298 -0.252 . . . . 64.230000000000004 110.558 -175.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -69.03 -42.36 76.49 Favored 'General case' 0 C--O 1.242 0.708 0 C-N-CA 120.191 -0.604 . . . . 65.319999999999993 110.394 178.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 21.0 pt -100.86 144.32 12.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 CA-C-N 115.118 -0.946 . . . . 71.420000000000002 109.934 178.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -100.61 117.73 35.32 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.106 0.479 . . . . 75.230000000000004 109.969 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.52 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 6.9 mp -98.71 122.9 42.52 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 120.842 0.353 . . . . 72.230000000000004 111.917 -178.051 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.501 ' HB3' ' HB2' ' A' ' 55' ' ' PRO . 24.3 t70 -99.83 73.78 1.79 Allowed 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 106.01 -1.848 . . . . 72.129999999999995 106.01 168.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.468 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 13.2 t70 -81.56 -175.87 5.74 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.141 -1.391 . . . . 72.430000000000007 107.718 -177.372 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.8 p -88.94 -23.64 6.23 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 N-CA-C 108.182 -1.044 . . . . 72.340000000000003 108.182 178.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 17.7 m -154.35 84.69 1.12 Allowed 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 116.033 -0.531 . . . . 74.219999999999999 110.069 176.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.468 ' HB ' ' HB3' ' A' ' 82' ' ' ASP . 7.4 p -108.7 136.28 44.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.912 -0.586 . . . . 71.420000000000002 110.03 -178.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 23.7 p -90.99 -81.98 0.3 Allowed 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.575 0.703 . . . . 73.430000000000007 111.616 -178.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.412 HH21 ' CD ' ' A' ' 75' ' ' GLU . 16.5 ptm180 -162.72 -34.09 0.04 OUTLIER 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 125.203 1.401 . . . . 72.310000000000002 108.333 -179.189 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 11.5 mmt180 -125.69 101.09 6.72 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 105.033 -2.21 . . . . 71.310000000000002 105.033 174.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 18.4 t60 -95.79 -60.61 1.61 Allowed 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.657 -0.868 . . . . 52.340000000000003 108.657 -173.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -145.57 144.31 30.43 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 115.771 -0.649 . . . . 64.219999999999999 110.055 -178.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -104.34 127.99 52.09 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 115.653 -0.703 . . . . 71.530000000000001 109.164 176.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.49 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 95.5 m-85 -104.68 112.02 24.96 Favored 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 107.061 -1.459 . . . . 74.340000000000003 107.061 174.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -104.4 122.1 44.79 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-N 114.528 -1.214 . . . . 74.219999999999999 110.259 -177.316 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.8 116.03 50.86 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.654 0 N-CA-C 105.978 -1.86 . . . . 73.209999999999994 105.978 171.013 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.467 ' C ' ' H ' ' A' ' 97' ' ' GLY . 52.5 t30 -114.08 148.05 37.73 Favored 'General case' 0 C--N 1.276 -2.6 0 N-CA-C 106.343 -1.725 . . . . 72.319999999999993 106.343 -178.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -52.59 24.52 0.0 OUTLIER 'General case' 0 CA--C 1.578 2.04 0 C-N-CA 126.847 2.059 . . . . 72.310000000000002 115.296 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.467 ' H ' ' C ' ' A' ' 95' ' ' ASN . . . -168.29 -43.66 0.03 OUTLIER Glycine 0 N--CA 1.426 -2.006 0 N-CA-C 110.123 -1.191 . . . . 63.420000000000002 110.123 -178.13 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.48 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 43.8 mt-10 -120.23 143.66 48.16 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 113.035 0.754 . . . . 73.430000000000007 113.035 -175.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.479 ' HB3' ' SD ' ' A' ' 122' ' ' MET . 84.1 m-85 -105.12 121.5 43.93 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 105.522 -2.029 . . . . 75.319999999999993 105.522 173.384 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -127.75 136.3 51.33 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 112.701 0.63 . . . . 74.230000000000004 112.701 -174.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 119' ' ' ALA . 7.2 p -115.19 118.85 60.08 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 N-CA-C 108.836 -0.801 . . . . 72.340000000000003 108.836 177.393 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 42.7 t -120.27 129.99 74.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-N 116.282 -0.417 . . . . 71.129999999999995 110.21 -177.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.596 ' OD2' ' HB3' ' A' ' 106' ' ' SER . 10.9 t70 -83.37 130.26 35.04 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 107.239 -1.393 . . . . 61.020000000000003 107.239 172.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.0 m -124.01 13.57 4.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 112.946 0.721 . . . . 72.140000000000001 112.946 -177.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 152.94 26.61 0.04 OUTLIER Glycine 0 N--CA 1.438 -1.209 0 C-N-CA 118.59 -1.767 . . . . 34.310000000000002 114.42 178.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.596 ' HB3' ' OD2' ' A' ' 103' ' ' ASP . 32.7 t -79.8 131.57 35.93 Favored 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 108.075 -1.083 . . . . 44.030000000000001 108.075 175.521 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -76.07 -18.46 59.19 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.517 0.675 . . . . 64.239999999999995 110.171 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -88.9 -37.03 15.61 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 115.186 -0.915 . . . . 72.239999999999995 109.16 178.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 92.22 121.04 2.77 Favored Glycine 0 C--N 1.306 -1.11 0 CA-C-N 114.86 -1.064 . . . . 61.310000000000002 112.589 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.401 HG23 ' HA ' ' A' ' 130' ' ' ILE . 24.0 m -85.23 120.15 26.41 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 109.147 -0.686 . . . . 60.509999999999998 109.147 176.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -139.12 163.09 33.35 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.719 -0.474 . . . . 63.310000000000002 109.719 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.527 ' HB ' ' HB3' ' A' ' 115' ' ' GLU . 23.9 t -100.36 141.49 17.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 106.511 -1.663 . . . . 65.349999999999994 106.511 177.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -60.05 -25.07 65.07 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-O 120.969 0.414 . . . . 73.129999999999995 111.419 -175.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 81.8 mtt85 -106.58 -9.28 16.64 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.387 -0.37 . . . . 65.219999999999999 111.773 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.527 ' HB3' ' HB ' ' A' ' 112' ' ' VAL . 9.5 tp10 -133.16 112.9 13.33 Favored Pre-proline 0 C--O 1.252 1.231 0 C-N-CA 119.983 -0.687 . . . . 73.329999999999998 110.858 -172.318 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -75.25 60.61 5.66 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.516 2.811 . . . . 63.219999999999999 111.77 177.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.443 ' HB3' ' O ' ' A' ' 119' ' ' ALA . 28.4 mmm-85 -128.92 131.86 47.6 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.919 -1.141 . . . . 73.120000000000005 107.919 -179.301 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 31.4 p-10 -83.62 -18.35 38.46 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-O 121.96 0.886 . . . . 74.140000000000001 109.67 177.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.443 ' O ' ' HB3' ' A' ' 117' ' ' ARG . . . -128.98 133.85 47.94 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 106.551 -1.648 . . . . 74.319999999999993 106.551 165.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.523 ' NE2' ' HG2' ' A' ' 115' ' ' GLU . 5.0 tp60 -144.59 150.77 38.02 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 123.655 0.597 . . . . 63.030000000000001 112.171 -177.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.464 ' O ' ' HG3' ' A' ' 120' ' ' GLN . 7.3 p -79.65 130.62 35.78 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 N-CA-C 106.195 -1.78 . . . . 74.099999999999994 106.195 168.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.479 ' SD ' ' HB3' ' A' ' 99' ' ' PHE . 65.2 mtt -66.92 156.2 36.46 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 112.7 0.63 . . . . 62.350000000000001 112.7 -173.131 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -132.67 134.6 45.04 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.374 -1.343 . . . . 74.439999999999998 107.374 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 7.6 t -79.68 128.23 33.16 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 109.122 -0.696 . . . . 72.340000000000003 109.122 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 93.46 20.75 31.27 Favored Glycine 0 N--CA 1.421 -2.3 0 C-N-CA 120.229 -0.986 . . . . 54.530000000000001 111.298 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -123.4 172.9 8.34 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.235 -1.394 . . . . 72.299999999999997 107.235 178.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -129.05 125.68 37.8 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-O 121.383 0.611 . . . . 73.109999999999999 110.826 -173.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 59.4 mt -109.49 130.77 61.95 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 CA-C-N 115.015 -0.993 . . . . 73.25 108.641 -175.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -98.43 112.64 24.59 Favored 'General case' 0 N--CA 1.423 -1.816 0 N-CA-C 108.659 -0.867 . . . . 61.340000000000003 108.659 178.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.401 ' HA ' HG23 ' A' ' 110' ' ' THR . 18.8 pt -90.92 98.36 8.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-O 121.727 0.775 . . . . 71.409999999999997 109.577 -178.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 75.28 -82.0 0.92 Allowed Glycine 0 N--CA 1.426 -2.027 0 CA-C-N 114.571 -1.195 . . . . 54.310000000000002 110.123 -176.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -136.1 -11.03 1.98 Allowed 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 109.917 -0.401 . . . . 65.150000000000006 109.917 176.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -94.5 157.08 16.16 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 113.185 0.809 . . . . 74.010000000000005 113.185 -172.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 45.9 ttt180 -99.66 120.58 39.92 Favored 'General case' 0 C--O 1.245 0.867 0 CA-C-N 115.66 -0.7 . . . . 72.120000000000005 111.452 -167.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.5 tt -125.23 129.21 49.62 Favored 'General case' 0 C--O 1.218 -0.586 0 C-N-CA 123.973 0.909 . . . . 72.209999999999994 109.721 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 40.6 t -107.83 128.05 63.41 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 N-CA-C 107.606 -1.257 . . . . 74.209999999999994 107.606 177.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -102.28 125.76 49.07 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 109.729 -0.471 . . . . 62.530000000000001 109.729 -178.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 84.2 mt -138.73 138.18 37.45 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.533 0.682 . . . . 73.450000000000003 111.282 -176.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -80.19 90.92 5.51 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 108.18 -1.045 . . . . 72.040000000000006 108.18 174.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -65.6 -79.83 0.18 Allowed Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 115.388 -0.823 . . . . 30.219999999999999 111.409 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -81.45 120.95 3.7 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 C-N-CA 121.608 1.539 . . . . 73.200000000000003 111.968 177.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -91.05 104.13 16.75 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 107.212 -1.403 . . . . 44.229999999999997 107.212 176.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 . . . . . 0 C--N 1.289 -2.037 0 N-CA-C 108.013 -1.106 . . . . 74.400000000000006 108.013 -173.218 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.2 mtt . . . . . 0 CA--C 1.491 -1.293 0 N-CA-C 107.883 -1.155 . . . . 73.140000000000001 107.883 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.5 t -76.64 -37.86 55.62 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 109.357 -0.609 . . . . 73.540000000000006 109.357 178.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . 0.31 5.1 p-10 37.81 76.25 0.06 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.209 1.404 . . . . 63.0 113.465 -178.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -76.25 95.19 3.68 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 114.311 -1.313 . . . . 61.439999999999998 110.603 -177.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -101.91 136.41 41.8 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 114.95 -1.023 . . . . 74.299999999999997 109.769 177.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 159.87 138.11 2.38 Favored Glycine 0 N--CA 1.429 -1.775 0 C-N-CA 120.893 -0.67 . . . . 40.130000000000003 111.986 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.9 t -105.61 132.96 20.43 Favored Pre-proline 0 N--CA 1.427 -1.58 0 N-CA-C 109.12 -0.696 . . . . 64.450000000000003 109.12 178.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -66.84 132.28 28.01 Favored 'Trans proline' 0 C--O 1.243 0.762 0 C-N-CA 122.232 1.955 . . . . 73.430000000000007 110.342 176.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -80.89 146.45 59.61 Favored Pre-proline 0 C--N 1.306 -1.324 0 CA-C-N 116.587 -0.279 . . . . 61.210000000000001 110.501 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -62.01 139.07 77.03 Favored 'Trans proline' 0 C--O 1.243 0.765 0 C-N-CA 122.403 2.069 . . . . 64.420000000000002 110.983 178.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -84.52 137.43 33.34 Favored 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 108.154 -1.054 . . . . 71.140000000000001 108.154 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.4 m -74.44 85.34 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 CA-C-O 122.55 1.166 . . . . 73.310000000000002 111.277 178.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -92.85 137.54 32.27 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 114.737 -1.119 . . . . 73.209999999999994 108.568 -178.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.0 p -72.48 130.19 40.09 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 116.458 -0.337 . . . . 64.329999999999998 111.019 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.2 t -77.73 -8.19 57.61 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-O 122.601 1.191 . . . . 74.430000000000007 108.276 176.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.9 m -76.8 100.13 5.38 Favored 'General case' 0 N--CA 1.412 -2.367 0 CA-C-N 113.702 -1.59 . . . . 73.430000000000007 107.073 174.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.6 m -81.95 91.66 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.673 0 CA-C-O 122.392 1.091 . . . . 63.299999999999997 111.245 -178.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.449 ' CZ ' ' HB3' ' A' ' 141' ' ' PRO . 49.3 t80 -83.04 116.81 22.45 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 106.672 -1.603 . . . . 64.129999999999995 106.672 179.177 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.435 ' O ' ' HA ' ' A' ' 141' ' ' PRO . 98.9 mtt180 -59.24 103.94 0.22 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.719 0.771 . . . . 64.299999999999997 112.446 -175.364 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -126.17 69.87 1.22 Allowed 'General case' 0 N--CA 1.42 -1.961 0 N-CA-C 108.49 -0.93 . . . . 65.319999999999993 108.49 177.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.539 ' HB3' ' HB3' ' A' ' 142' ' ' ALA . 18.2 t70 -63.77 -41.88 97.88 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 114.859 -1.064 . . . . 52.140000000000001 109.625 177.069 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 54.2 tp 54.86 95.23 0.02 OUTLIER 'General case' 0 C--O 1.242 0.681 0 O-C-N 124.48 1.113 . . . . 73.150000000000006 112.247 178.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.427 ' O ' HD12 ' A' ' 23' ' ' LEU . 4.6 pp -82.02 129.02 34.67 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 115.897 -0.592 . . . . 72.420000000000002 109.974 178.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -121.02 63.45 0.87 Allowed 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 122.531 1.158 . . . . 75.239999999999995 109.688 176.106 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -75.73 119.13 19.32 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 106.466 -1.679 . . . . 71.120000000000005 106.466 179.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 53.0 ttm -66.44 131.55 46.31 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 109.42 -0.585 . . . . 74.230000000000004 109.42 -179.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -44.76 96.03 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.134 1.374 . . . . 70.409999999999997 112.636 -178.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.6 m -122.55 67.35 0.95 Allowed 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 107.722 -1.214 . . . . 74.030000000000001 107.722 178.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 44.6 t -144.01 142.06 30.48 Favored 'General case' 0 N--CA 1.414 -2.264 0 CA-C-N 114.754 -1.112 . . . . 75.420000000000002 108.908 -174.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.4 m -124.79 16.76 8.68 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.2 -1.037 . . . . 74.340000000000003 108.2 177.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 71.49 53.78 9.65 Favored Glycine 0 N--CA 1.44 -1.097 0 CA-C-N 114.945 -1.025 . . . . 44.450000000000003 111.5 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 52.6 p -90.1 153.9 20.19 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 109.314 -0.625 . . . . 65.209999999999994 109.314 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.412 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . . . -74.24 112.74 18.3 Favored Pre-proline 0 C--O 1.245 0.835 0 N-CA-C 109.443 -0.577 . . . . 74.310000000000002 109.443 178.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 33' ' ' ALA . 2.0 Cg_endo -80.78 108.72 2.13 Favored 'Trans proline' 0 N--CA 1.439 -1.677 0 C-N-CA 122.218 1.946 . . . . 64.409999999999997 113.272 -177.356 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -89.66 -25.25 21.34 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 107.127 -1.434 . . . . 65.510000000000005 107.127 173.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 45.8 m -74.71 158.34 33.73 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 114.808 -1.087 . . . . 51.229999999999997 109.422 174.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.3 t -141.71 152.37 43.79 Favored 'General case' 0 N--CA 1.421 -1.883 0 N-CA-C 109.088 -0.708 . . . . 73.299999999999997 109.088 -178.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -153.41 16.16 0.66 Allowed Glycine 0 N--CA 1.42 -2.381 0 CA-C-N 115.946 -0.57 . . . . 71.319999999999993 112.063 178.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -56.62 -40.1 74.77 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 117.403 0.602 . . . . 72.349999999999994 112.365 -178.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -83.9 -23.19 31.32 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-O 121.139 0.495 . . . . 62.020000000000003 111.321 178.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -83.88 -39.06 20.34 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 116.062 -0.517 . . . . 74.510000000000005 111.612 -175.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -83.04 134.37 46.5 Favored Pre-proline 0 C--N 1.294 -1.822 0 N-CA-C 105.726 -1.953 . . . . 62.219999999999999 105.726 178.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -60.87 -176.75 0.15 Allowed 'Trans proline' 0 CA--C 1.545 1.05 0 C-N-CA 122.62 2.213 . . . . 74.099999999999994 112.377 177.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.513 ' O ' ' HA ' ' A' ' 142' ' ' ALA . . . -79.8 88.62 5.23 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.465 -0.772 . . . . 72.319999999999993 109.416 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -82.08 67.95 3.59 Favored Glycine 0 CA--C 1.483 -1.958 0 N-CA-C 109.566 -1.413 . . . . 62.240000000000002 109.566 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.7 p -89.12 152.69 21.49 Favored 'General case' 0 C--N 1.279 -2.474 0 CA-C-N 114.461 -0.87 . . . . 73.540000000000006 111.446 -177.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.92 167.2 20.67 Favored 'General case' 0 C--N 1.284 -2.268 0 CA-C-N 115.166 -0.924 . . . . 75.310000000000002 109.891 -175.247 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.417 HD23 ' H ' ' A' ' 48' ' ' LEU . 2.2 pt? -128.89 138.87 52.26 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.387 0.613 . . . . 70.310000000000002 110.688 -177.063 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.7 pp -127.91 149.09 50.47 Favored 'General case' 0 C--N 1.282 -2.354 0 CA-C-N 115.671 -0.695 . . . . 74.219999999999999 110.028 178.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.44 HG12 ' CB ' ' A' ' 60' ' ' ARG . 27.2 m -125.87 140.13 49.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 N-CA-C 109.802 -0.444 . . . . 55.420000000000002 109.802 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.4 t -104.19 116.49 48.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 106.484 -1.673 . . . . 71.310000000000002 106.484 175.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -103.59 -25.04 13.34 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 120.264 -0.574 . . . . 64.25 112.184 -175.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.431 ' O ' ' HA ' ' A' ' 133' ' ' PHE . 24.9 tpt180 -141.35 115.48 9.3 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 120.213 -0.595 . . . . 71.120000000000005 110.957 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 138.15 139.35 3.84 Favored Glycine 0 N--CA 1.433 -1.517 0 C-N-CA 119.796 -1.193 . . . . 75.140000000000001 113.414 173.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -52.49 -8.06 0.36 Allowed 'Trans proline' 0 N--CA 1.506 2.26 0 C-N-CA 125.056 3.837 . . . . 64.150000000000006 115.402 176.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.474 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 37.2 t30 -58.94 -51.42 70.14 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.579 0.752 . . . . 60.119999999999997 109.565 177.143 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -173.81 -177.39 1.38 Allowed 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.941 -0.763 . . . . 63.299999999999997 108.941 -177.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -164.22 53.87 0.28 Allowed Glycine 0 N--CA 1.425 -2.07 0 N-CA-C 109.512 -1.435 . . . . 51.119999999999997 109.512 178.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -153.69 -176.98 6.07 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 108.523 -0.917 . . . . 63.340000000000003 108.523 -177.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.44 ' CB ' HG12 ' A' ' 50' ' ' VAL . 0.4 OUTLIER -108.55 139.2 43.65 Favored 'General case' 0 C--N 1.309 -1.192 0 O-C-N 123.885 0.741 . . . . 71.219999999999999 109.049 178.8 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -128.49 129.04 45.49 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 110.093 -0.336 . . . . 65.329999999999998 110.093 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -97.09 116.25 28.95 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 105.945 -1.872 . . . . 61.310000000000002 105.945 175.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -99.99 115.65 30.2 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 112.811 0.671 . . . . 74.219999999999999 112.811 -174.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -109.02 -5.88 15.87 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 105.956 -1.868 . . . . 72.409999999999997 105.956 168.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -66.1 112.54 9.3 Favored Pre-proline 0 N--CA 1.443 -0.787 0 CA-C-N 112.937 -1.938 . . . . 72.310000000000002 109.124 176.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -62.04 -30.83 83.47 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.663 2.242 . . . . 74.219999999999999 113.003 -177.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 85.5 m -137.17 111.07 8.21 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-O 121.024 0.44 . . . . 72.409999999999997 111.825 -178.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 55.5 m -110.14 114.08 27.3 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 108.624 -0.88 . . . . 70.439999999999998 108.624 176.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.5 p -93.33 140.82 29.13 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 122.091 -0.38 . . . . 74.310000000000002 111.048 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -116.08 140.06 49.66 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 109.473 -0.566 . . . . 62.119999999999997 109.473 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 170.01 -148.71 12.02 Favored Glycine 0 N--CA 1.421 -2.316 0 C-N-CA 120.254 -0.974 . . . . 71.109999999999999 112.372 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.464 ' HB2' ' HA ' ' A' ' 87' ' ' ARG . 56.5 ttt180 -51.47 -75.19 0.03 OUTLIER 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 125.541 1.537 . . . . 75.140000000000001 113.915 -175.277 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.46 ' HB3' ' CD ' ' A' ' 74' ' ' PRO . 7.9 t60 -172.12 -76.65 0.0 OUTLIER Pre-proline 0 CA--C 1.56 1.347 0 CA-C-O 118.798 -0.62 . . . . 71.200000000000003 110.798 -178.324 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.46 ' CD ' ' HB3' ' A' ' 73' ' ' HIS . 49.8 Cg_endo -68.55 -24.84 35.47 Favored 'Trans proline' 0 C--N 1.389 2.701 0 CA-C-N 121.135 1.441 . . . . 62.240000000000002 111.136 178.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.42 ' OE2' ' HD3' ' A' ' 72' ' ' ARG . 34.9 mt-10 -89.0 15.6 8.35 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 114.119 -1.4 . . . . 75.120000000000005 111.526 -173.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.1 p -153.44 166.85 31.37 Favored 'General case' 0 N--CA 1.421 -1.907 0 CA-C-N 116.682 -0.236 . . . . 75.319999999999993 110.751 -178.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -79.98 -46.37 16.78 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.344 -0.984 . . . . 64.099999999999994 108.344 177.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 34.5 pt -104.91 143.57 16.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 108.747 -0.834 . . . . 74.299999999999997 108.747 175.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.417 ' HB3' ' HA ' ' A' ' 73' ' ' HIS . 33.7 p90 -115.27 117.64 31.04 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 121.495 0.664 . . . . 75.329999999999998 112.49 -174.531 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.554 HD23 ' CE2' ' A' ' 133' ' ' PHE . 4.5 mp -90.18 111.94 23.27 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.876 -1.157 . . . . 75.340000000000003 107.876 178.461 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -84.29 10.34 10.74 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-O 121.702 0.763 . . . . 74.349999999999994 112.697 -173.139 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -77.55 146.02 36.56 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 108.995 -0.743 . . . . 74.25 108.995 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.5 p -67.87 -22.14 27.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-O 121.256 0.55 . . . . 64.319999999999993 111.828 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -96.07 23.16 6.72 Favored 'General case' 0 CA--C 1.557 1.239 0 CA-C-O 121.185 0.516 . . . . 74.030000000000001 110.751 -176.155 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.431 HG21 ' HB2' ' A' ' 80' ' ' LEU . 13.2 p -81.94 140.84 15.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 O-C-N 121.921 -0.487 . . . . 72.230000000000004 110.297 -178.22 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 19.6 m -83.03 156.33 23.44 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.549 -0.908 . . . . 62.229999999999997 108.549 175.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.464 ' HA ' ' HB2' ' A' ' 72' ' ' ARG . 36.5 mtp-105 -63.06 -54.64 34.91 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-O 121.332 0.586 . . . . 74.319999999999993 109.539 -178.073 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.402 ' CZ ' ' HB3' ' A' ' 75' ' ' GLU . 13.1 mmt180 -117.22 112.55 20.96 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 105.347 -2.094 . . . . 73.409999999999997 105.347 175.463 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.411 ' CE1' ' HB3' ' A' ' 108' ' ' ASN . 11.3 t60 -98.13 -76.74 0.52 Allowed 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.16 0.505 . . . . 71.239999999999995 110.534 -174.384 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.37 167.49 23.45 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.553 -0.717 . . . . 42.310000000000002 110.543 -176.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -127.87 128.19 44.76 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 115.811 -0.631 . . . . 74.019999999999996 109.507 177.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -104.69 120.24 40.88 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.423 -0.954 . . . . 73.430000000000007 108.423 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 78.9 mtt180 -119.25 141.8 48.61 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-O 121.553 0.692 . . . . 72.209999999999994 111.288 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.64 119.79 62.86 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 104.359 -2.46 . . . . 63.109999999999999 104.359 171.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.494 ' C ' ' H ' ' A' ' 97' ' ' GLY . 51.4 t-20 -111.4 147.08 35.98 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 115.299 -0.864 . . . . 54.210000000000001 109.16 -170.226 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -63.43 31.8 0.01 OUTLIER 'General case' 0 CA--C 1.581 2.136 0 C-N-CA 125.853 1.661 . . . . 70.510000000000005 111.869 176.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.494 ' H ' ' C ' ' A' ' 95' ' ' ASN . . . -171.1 -38.32 0.03 OUTLIER Glycine 0 N--CA 1.428 -1.887 0 N-CA-C 111.46 -0.656 . . . . 34.509999999999998 111.46 -179.05 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -133.11 177.41 7.69 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-O 121.509 0.671 . . . . 73.519999999999996 111.201 -177.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.486 ' HB3' ' HB3' ' A' ' 122' ' ' MET . 87.7 m-85 -122.63 121.33 36.17 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 104.418 -2.438 . . . . 74.409999999999997 104.418 171.361 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -131.14 127.27 37.71 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 120.661 -0.416 . . . . 54.439999999999998 111.445 -169.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 5.5 p -126.12 119.27 53.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-O 121.526 0.679 . . . . 62.200000000000003 109.472 176.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 23.3 m -119.51 136.6 56.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-N 115.425 -0.807 . . . . 75.209999999999994 112.04 -176.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -83.11 132.34 35.1 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 106.542 -1.651 . . . . 73.540000000000006 106.542 174.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 30.5 m -104.09 8.06 9.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 C-N-CA 119.653 -0.819 . . . . 73.340000000000003 112.285 -179.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 127.89 52.04 0.14 Allowed Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.593 -0.813 . . . . 63.530000000000001 112.447 179.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 14.2 m -80.87 126.18 31.04 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 112.319 0.488 . . . . 71.329999999999998 112.319 -176.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.0 mp -82.47 -22.06 35.33 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 107.493 -1.299 . . . . 73.409999999999997 107.493 173.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.496 ' OD1' ' HA3' ' A' ' 131' ' ' GLY . 22.8 t-20 -75.12 -30.52 60.87 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.372 -1.286 . . . . 74.310000000000002 109.989 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 92.07 117.94 2.36 Favored Glycine 0 C--O 1.221 -0.698 0 N-CA-C 114.566 0.587 . . . . 43.109999999999999 114.566 174.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 88.4 m -99.34 119.81 38.56 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-O 120.966 0.412 . . . . 54.130000000000003 110.093 178.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -115.19 134.78 54.84 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 109.411 -0.588 . . . . 73.219999999999999 109.411 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 5.4 p -113.09 121.16 64.78 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.582 0 N-CA-C 106.557 -1.645 . . . . 72.25 106.557 171.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 17.6 m120 58.9 26.27 14.7 Favored 'General case' 0 N--CA 1.48 1.05 0 O-C-N 123.163 0.289 . . . . 74.430000000000007 110.266 -175.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 80.38 6.29 1.62 Allowed 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.982 1.313 . . . . 73.349999999999994 113.467 -177.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -100.83 121.47 52.43 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 109.315 -0.624 . . . . 73.409999999999997 109.315 176.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.429 ' HA ' ' O ' ' A' ' 110' ' ' THR . 57.3 Cg_endo -78.14 126.42 7.78 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 121.993 1.795 . . . . 75.329999999999998 111.157 177.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -150.18 -176.96 5.67 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 109.908 -0.404 . . . . 72.239999999999995 109.908 177.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -96.12 -57.37 2.36 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 123.189 0.306 . . . . 45.420000000000002 111.795 -177.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -117.92 139.72 50.73 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 109.629 -0.508 . . . . 62.240000000000002 109.629 -177.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 54.7 tp60 -139.25 140.73 37.77 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 116.207 -0.451 . . . . 72.140000000000001 110.472 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 59.5 t -80.25 114.22 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 104.936 -2.246 . . . . 64.420000000000002 104.936 170.154 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.486 ' HB3' ' HB3' ' A' ' 99' ' ' PHE . 16.6 ttt -63.36 123.01 17.62 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.973 -0.751 . . . . 73.319999999999993 108.973 -173.143 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -104.57 136.8 43.45 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-O 121.333 0.587 . . . . 70.239999999999995 111.457 -171.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 14.4 p -79.37 118.55 21.37 Favored 'General case' 0 N--CA 1.416 -2.158 0 CA-C-N 114.891 -1.049 . . . . 74.099999999999994 111.079 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 107.07 -13.33 40.86 Favored Glycine 0 N--CA 1.44 -1.057 0 CA-C-N 115.715 -0.675 . . . . 62.229999999999997 112.219 177.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -99.35 172.95 7.01 Favored 'General case' 0 C--O 1.25 1.088 0 N-CA-C 113.564 0.95 . . . . 74.530000000000001 113.564 -175.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.52 ' OE1' ' HD3' ' A' ' 134' ' ' ARG . 17.1 pt-20 -108.97 140.47 42.42 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 114.528 -1.214 . . . . 73.129999999999995 111.333 -174.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 71.9 mt -123.31 119.28 57.08 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 N-CA-C 106.765 -1.568 . . . . 74.209999999999994 106.765 177.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -115.75 121.88 43.79 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 109.278 -0.638 . . . . 72.129999999999995 109.278 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.503 ' O ' ' HD2' ' A' ' 133' ' ' PHE . 18.5 pt -103.83 98.68 7.13 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.171 0 N-CA-C 108.271 -1.011 . . . . 74.340000000000003 108.271 176.439 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.496 ' HA3' ' OD1' ' A' ' 108' ' ' ASN . . . 62.97 -95.01 0.12 Allowed Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.273 -0.876 . . . . 75.299999999999997 113.667 -178.193 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 3.8 ttmp? -101.72 -22.28 14.45 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 123.27 0.628 . . . . 74.150000000000006 109.891 -177.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.554 ' CE2' HD23 ' A' ' 80' ' ' LEU . 5.5 m-85 -92.17 112.14 23.96 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.617 -0.72 . . . . 71.329999999999998 110.038 -170.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.52 ' HD3' ' OE1' ' A' ' 127' ' ' GLU . 13.4 ttm180 -104.52 124.95 50.2 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 120.395 -0.522 . . . . 74.400000000000006 109.943 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.8 tt -124.25 140.33 53.07 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.547 -1.206 . . . . 63.409999999999997 108.604 -177.117 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 8.9 p -116.35 136.52 53.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 109.036 -0.727 . . . . 62.420000000000002 109.036 175.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -108.42 122.13 46.37 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.26 -0.427 . . . . 74.310000000000002 111.757 -173.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -121.83 150.23 42.21 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.119 -0.697 . . . . 75.209999999999994 109.119 178.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -129.4 148.64 51.34 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 109.691 -0.485 . . . . 75.549999999999997 109.691 178.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -169.21 -70.52 0.03 OUTLIER Glycine 0 C--N 1.303 -1.253 0 C-N-CA 120.019 -1.086 . . . . 41.420000000000002 112.708 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.449 ' HB3' ' CZ ' ' A' ' 18' ' ' PHE . 10.5 Cg_endo -56.12 102.7 0.1 Allowed 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 123.451 2.767 . . . . 61.439999999999998 116.344 -177.07 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.539 ' HB3' ' HB3' ' A' ' 21' ' ' ASP . . . -111.78 103.37 11.63 Favored 'General case' 0 C--N 1.267 -3.0 0 CA-C-N 113.207 -1.815 . . . . 72.420000000000002 106.417 174.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.425 ' HG3' ' HD2' ' A' ' 19' ' ' ARG . 41.1 tt0 . . . . . 0 C--N 1.291 -1.96 0 O-C-N 123.292 0.37 . . . . 63.32 110.518 -174.236 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.4 ttm . . . . . 0 N--CA 1.472 0.639 0 N-CA-C 109.437 -0.579 . . . . 73.349999999999994 109.437 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.9 t -79.7 -37.08 36.53 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 106.297 -1.742 . . . . 74.510000000000005 106.297 173.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -75.34 145.21 41.91 Favored 'General case' 0 C--O 1.254 1.318 0 N-CA-C 105.965 -1.865 . . . . 75.319999999999993 105.965 170.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 57.3 64.03 1.72 Allowed 'General case' 0 C--O 1.242 0.678 0 CA-C-O 122.787 1.279 . . . . 54.420000000000002 108.028 -176.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -69.38 167.24 16.95 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 113.1 -1.864 . . . . 71.299999999999997 110.52 -174.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -58.07 149.5 34.45 Favored Glycine 0 C--O 1.239 0.449 0 N-CA-C 112.518 -0.233 . . . . 73.099999999999994 112.518 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 60.5 m -67.46 124.83 90.13 Favored Pre-proline 0 C--N 1.311 -1.105 0 C-N-CA 122.763 0.425 . . . . 63.149999999999999 111.108 -177.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -67.7 151.82 78.54 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.491 2.794 . . . . 72.200000000000003 111.28 176.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -69.97 111.87 10.55 Favored Pre-proline 0 C--N 1.315 -0.895 0 N-CA-C 105.6 -2.0 . . . . 63.229999999999997 105.6 170.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -53.61 109.9 0.43 Allowed 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 123.187 2.592 . . . . 74.209999999999994 114.507 -170.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -90.11 107.86 19.39 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 114.585 -1.188 . . . . 62.509999999999998 108.635 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 46.9 t -89.69 94.02 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.528 0 N-CA-C 108.526 -0.916 . . . . 75.400000000000006 108.526 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -70.01 134.39 48.25 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 114.877 -1.056 . . . . 73.329999999999998 109.486 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 28.5 m -65.87 112.26 3.69 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-O 121.522 0.677 . . . . 73.140000000000001 112.046 -176.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.509 HG23 ' HB2' ' A' ' 98' ' ' GLU . 86.9 m -43.61 125.23 3.93 Favored 'General case' 0 N--CA 1.42 -1.93 0 C-N-CA 127.08 2.152 . . . . 55.350000000000001 114.598 -178.409 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.8 t -118.32 99.85 7.11 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 113.441 -1.709 . . . . 55.32 108.243 176.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.3 m -129.57 170.9 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 CA-C-O 120.745 0.307 . . . . 71.530000000000001 111.024 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -98.49 95.47 7.33 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 121.191 0.519 . . . . 71.409999999999997 110.499 177.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 41.8 ttm-85 65.75 95.77 0.05 Allowed 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 125.098 1.359 . . . . 74.329999999999998 112.562 178.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -86.63 -4.27 59.15 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.541 0.686 . . . . 55.420000000000002 110.458 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -64.92 -49.49 70.19 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.476 -1.238 . . . . 72.420000000000002 108.646 178.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 68.0 tp -150.34 112.08 4.52 Favored 'General case' 0 N--CA 1.425 -1.684 0 CA-C-N 114.364 -1.289 . . . . 74.040000000000006 108.619 -176.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -104.08 118.73 37.35 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.431 -1.322 . . . . 44.25 107.431 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -95.61 130.77 42.36 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.447 -0.575 . . . . 54.520000000000003 109.447 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.454 ' H ' ' CD ' ' A' ' 25' ' ' GLU . 1.6 mp0 -71.64 93.52 1.25 Allowed 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.856 -0.794 . . . . 71.25 108.856 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 54.1 mtt -80.33 109.16 14.55 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 108.331 -0.989 . . . . 74.310000000000002 108.331 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -114.36 140.73 48.41 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.11 0.481 . . . . 73.099999999999994 111.182 -178.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.4 p -93.75 104.35 16.44 Favored 'General case' 0 N--CA 1.414 -2.248 0 CA-C-N 115.809 -0.632 . . . . 74.120000000000005 110.926 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.8 t -75.94 -18.71 59.23 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.143 -1.058 . . . . 74.140000000000001 108.143 177.003 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.5 t -161.15 132.64 5.57 Favored 'General case' 0 N--CA 1.415 -2.204 0 N-CA-C 104.587 -2.375 . . . . 74.140000000000001 104.587 177.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 142.74 -152.31 23.78 Favored Glycine 0 N--CA 1.438 -1.202 0 C-N-CA 119.753 -1.213 . . . . 64.409999999999997 112.025 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.7 t -110.7 148.88 31.35 Favored 'General case' 0 N--CA 1.433 -1.275 0 CA-C-O 121.088 0.471 . . . . 61.539999999999999 110.778 -177.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.409 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . . . -91.43 119.05 68.74 Favored Pre-proline 0 C--N 1.31 -1.139 0 CA-C-N 115.766 -0.652 . . . . 74.109999999999999 109.973 178.288 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 33' ' ' ALA . 13.3 Cg_exo -69.87 117.2 4.95 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.42 2.08 . . . . 61.520000000000003 111.535 178.155 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -143.92 30.4 1.31 Allowed 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.176 -1.046 . . . . 65.420000000000002 108.176 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.9 p -78.2 1.05 22.73 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.844 -1.071 . . . . 65.329999999999998 112.891 -176.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.0 t -76.18 -178.7 4.61 Favored 'General case' 0 CA--C 1.557 1.247 0 N-CA-C 109.793 -0.447 . . . . 62.240000000000002 109.793 178.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -79.53 74.39 2.25 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.977 -0.154 . . . . 73.010000000000005 113.454 -175.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.49 -34.21 63.02 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.252 0.548 . . . . 74.409999999999997 110.206 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -77.21 -23.39 51.42 Favored 'General case' 0 C--O 1.245 0.844 0 CA-C-O 121.487 0.66 . . . . 75.540000000000006 109.55 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -75.7 -34.85 60.43 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.137 -0.938 . . . . 53.329999999999998 109.325 177.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 31.3 tp 69.47 116.98 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 125.509 1.523 . . . . 74.400000000000006 109.517 -177.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -56.2 111.14 0.69 Allowed 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 122.576 2.184 . . . . 74.109999999999999 113.628 -176.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -115.37 152.98 31.85 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 108.163 -1.051 . . . . 24.34 108.163 177.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.4 32.45 31.07 Favored Glycine 0 CA--C 1.504 -0.62 0 N-CA-C 109.793 -1.323 . . . . 74.540000000000006 109.793 -176.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 16.2 m -90.63 168.51 11.73 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 114.344 -0.928 . . . . 62.100000000000001 110.427 -177.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.575 ' HB1' ' HA ' ' A' ' 139' ' ' ALA . . . -95.52 177.18 5.9 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.995 -0.742 . . . . 64.409999999999997 108.995 178.286 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.98 160.25 38.29 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.619 0.6 . . . . 73.430000000000007 112.619 -174.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.492 HD13 HD11 ' A' ' 135' ' ' LEU . 3.0 pp -131.61 144.11 50.82 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 115.463 -0.789 . . . . 73.450000000000003 110.06 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.7 t -124.73 139.61 50.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 N-CA-C 108.411 -0.959 . . . . 73.120000000000005 108.411 -178.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.435 HG21 ' HB3' ' A' ' 57' ' ' ALA . 48.1 t -92.29 116.39 33.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-O 121.565 0.698 . . . . 50.310000000000002 109.195 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -76.71 -45.93 27.51 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 114.43 -1.259 . . . . 73.239999999999995 108.598 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.6 tpm_? -151.65 111.3 4.0 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.283 -1.006 . . . . 72.209999999999994 108.283 -176.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 161.4 118.27 0.47 Allowed Glycine 0 N--CA 1.432 -1.568 0 C-N-CA 118.851 -1.642 . . . . 75.129999999999995 114.769 176.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -63.77 -7.62 13.47 Favored 'Trans proline' 0 C--N 1.366 1.498 0 C-N-CA 123.745 2.963 . . . . 73.010000000000005 112.161 176.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.558 ' OD1' ' HG ' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -44.2 -42.01 6.19 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.657 1.183 . . . . 74.239999999999995 107.812 172.218 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.435 ' HB3' HG21 ' A' ' 51' ' ' VAL . . . -154.2 -64.55 0.14 Allowed 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.426 -0.806 . . . . 74.519999999999996 109.163 176.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.09 34.9 28.73 Favored Glycine 0 C--O 1.226 -0.39 0 C-N-CA 121.003 -0.618 . . . . 60.43 111.639 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -149.79 -164.7 2.08 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.999 -1.112 . . . . 75.230000000000004 107.999 -177.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 17.0 ptt180 -126.39 152.93 45.65 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 106.733 -1.581 . . . . 63.350000000000001 106.733 177.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.45 ' CZ ' HD11 ' A' ' 49' ' ' LEU . 51.1 p90 -156.5 149.46 24.0 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-O 121.509 0.671 . . . . 75.219999999999999 112.639 173.254 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 41.8 tp -87.03 140.31 29.69 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 113.784 -1.553 . . . . 71.040000000000006 107.474 178.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -78.38 114.69 17.51 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 119.709 -0.796 . . . . 73.510000000000005 110.148 177.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -127.39 -2.46 6.23 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 121.982 0.896 . . . . 64.349999999999994 109.799 178.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.426 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 6.3 pm0 -111.48 114.15 52.99 Favored Pre-proline 0 N--CA 1.42 -1.929 0 CA-C-N 115.155 -0.929 . . . . 72.019999999999996 109.466 178.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.499 ' HA ' HG13 ' A' ' 94' ' ' ILE . 9.6 Cg_endo -49.95 -34.9 39.05 Favored 'Trans proline' 0 C--N 1.371 1.756 0 C-N-CA 124.437 3.425 . . . . 63.020000000000003 115.62 -173.334 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 92.4 m -133.62 105.46 6.87 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-O 121.262 0.553 . . . . 73.0 109.846 177.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.521 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 3.5 m -102.19 113.13 26.14 Favored 'General case' 0 N--CA 1.422 -1.863 0 N-CA-C 108.235 -1.024 . . . . 71.430000000000007 108.235 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.465 ' HB ' ' HA ' ' A' ' 76' ' ' SER . 57.4 m -93.61 141.43 28.49 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 108.685 -0.858 . . . . 65.319999999999993 108.685 177.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.508 ' HB1' HD11 ' A' ' 80' ' ' LEU . . . -120.91 126.67 50.59 Favored 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 108.92 -0.77 . . . . 75.129999999999995 108.92 177.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -176.03 -140.8 3.59 Favored Glycine 0 N--CA 1.425 -2.091 0 C-N-CA 120.613 -0.803 . . . . 53.43 112.081 -177.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 22.8 ttm180 -114.15 -25.91 8.29 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.245 0.545 . . . . 72.409999999999997 111.837 -174.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.421 ' NE2' ' HG2' ' A' ' 87' ' ' ARG . 25.3 m-70 -99.54 157.41 34.03 Favored Pre-proline 0 C--N 1.305 -1.342 0 CA-C-N 116.386 -0.37 . . . . 70.219999999999999 110.101 -172.126 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -51.94 -21.38 11.98 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 124.089 3.193 . . . . 73.450000000000003 114.387 -178.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -60.51 -21.88 62.94 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.389 0.614 . . . . 61.310000000000002 110.045 176.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.465 ' HA ' ' HB ' ' A' ' 69' ' ' THR . 34.4 m -86.94 139.36 30.69 Favored 'General case' 0 N--CA 1.421 -1.9 0 CA-C-N 115.376 -0.829 . . . . 73.400000000000006 109.042 175.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -80.12 -30.68 39.08 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.204 0.526 . . . . 71.219999999999999 109.678 -179.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.453 ' H ' HD13 ' A' ' 78' ' ' ILE . 0.2 OUTLIER -126.95 136.49 60.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 109.244 -0.651 . . . . 63.100000000000001 109.244 175.39 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -103.11 117.73 35.21 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 115.809 -0.632 . . . . 74.439999999999998 109.54 -176.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.558 ' HG ' ' OD1' ' A' ' 56' ' ' ASN . 5.5 mp -70.02 115.94 9.82 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.851 -1.166 . . . . 70.409999999999997 107.851 175.483 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -88.44 61.59 6.21 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 122.68 1.229 . . . . 73.109999999999999 110.459 177.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -111.29 156.04 22.11 Favored 'General case' 0 C--N 1.286 -2.189 0 CA-C-N 113.136 -1.847 . . . . 71.129999999999995 107.872 174.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.9 p -74.42 -25.61 19.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 111.914 0.338 . . . . 74.450000000000003 111.914 -177.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.8 m -116.2 72.04 0.8 Allowed 'General case' 0 CA--C 1.548 0.904 0 CA-C-O 121.977 0.894 . . . . 64.140000000000001 110.829 -177.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 47.7 t -112.65 139.53 37.12 Favored 'Isoleucine or valine' 0 C--O 1.249 1.074 0 CA-C-N 115.766 -0.652 . . . . 73.319999999999993 110.844 -178.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 42.6 t -83.71 179.44 7.6 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.621 -0.881 . . . . 62.039999999999999 108.621 178.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.421 ' HG2' ' NE2' ' A' ' 73' ' ' HIS . 93.4 mtt180 -78.4 -54.09 6.56 Favored 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 105.854 -1.906 . . . . 65.230000000000004 105.854 175.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 5.6 ptm180 -105.32 100.37 9.95 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 106.105 -1.813 . . . . 74.450000000000003 106.105 171.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 11.0 t60 -99.59 -59.32 1.74 Allowed 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.959 -0.756 . . . . 74.400000000000006 108.959 -174.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -136.81 152.7 50.58 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.479 -0.934 . . . . 60.149999999999999 108.479 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -135.54 128.26 30.97 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 109.554 -0.535 . . . . 70.519999999999996 109.554 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.521 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 67.8 m-85 -101.81 115.98 31.71 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 107.762 -1.199 . . . . 74.109999999999999 107.762 179.27 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 18.8 mmt180 -108.33 140.0 42.23 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 109.319 -0.622 . . . . 74.129999999999995 109.319 178.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.499 HG13 ' HA ' ' A' ' 66' ' ' PRO . 2.6 pp -115.98 116.91 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.192 0 N-CA-C 106.965 -1.494 . . . . 74.109999999999999 106.965 172.071 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.538 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 46.6 t-20 -108.97 146.13 34.35 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 107.26 -1.385 . . . . 73.340000000000003 107.26 -174.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -59.49 -16.46 24.38 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 124.449 1.099 . . . . 74.409999999999997 111.551 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -87.42 -47.11 4.73 Favored Glycine 0 N--CA 1.431 -1.675 0 N-CA-C 111.594 -0.602 . . . . 72.310000000000002 111.594 176.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.538 ' O ' ' HB3' ' A' ' 95' ' ' ASN . 26.2 tt0 -173.36 169.15 4.51 Favored 'General case' 0 C--O 1.218 -0.573 0 N-CA-C 105.856 -1.905 . . . . 53.140000000000001 105.856 -179.037 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -104.49 131.71 51.56 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 119.262 0.937 . . . . 73.420000000000002 110.479 -173.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -131.7 138.13 48.55 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 122.566 1.174 . . . . 60.409999999999997 113.226 -178.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 44.3 t -102.57 129.79 53.57 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.258 0 N-CA-C 106.945 -1.502 . . . . 60.229999999999997 106.945 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.4 t -118.73 136.0 57.34 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 C-N-CA 120.926 -0.31 . . . . 72.239999999999995 110.283 -177.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -82.67 110.59 17.87 Favored 'General case' 0 N--CA 1.437 -1.109 0 N-CA-C 106.536 -1.653 . . . . 73.010000000000005 106.536 170.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 30.0 m -100.51 7.04 9.42 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 CA-C-N 114.935 -1.029 . . . . 75.230000000000004 111.518 -173.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 134.51 52.18 0.07 OUTLIER Glycine 0 N--CA 1.425 -2.084 0 C-N-CA 119.815 -1.183 . . . . 73.209999999999994 112.054 178.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 50.4 m -59.11 128.24 36.2 Favored 'General case' 0 C--O 1.25 1.131 0 N-CA-C 109.667 -0.494 . . . . 61.210000000000001 109.667 176.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.83 -51.15 63.68 Favored 'General case' 0 C--O 1.217 -0.609 0 N-CA-C 108.62 -0.882 . . . . 65.319999999999993 108.62 -178.618 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.435 ' OD1' ' HA2' ' A' ' 131' ' ' GLY . 7.9 p30 -91.61 -45.66 8.36 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 112.281 0.475 . . . . 63.520000000000003 112.281 177.157 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 143.71 139.56 3.53 Favored Glycine 0 C--O 1.219 -0.82 0 C-N-CA 119.506 -1.331 . . . . 32.450000000000003 114.063 174.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 59.8 m -105.26 120.14 40.82 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 108.908 -0.775 . . . . 44.100000000000001 108.908 174.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -122.04 137.91 54.63 Favored 'General case' 0 C--O 1.198 -1.645 0 CA-C-N 115.649 -0.705 . . . . 73.109999999999999 109.715 -174.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.541 HG21 ' HG3' ' A' ' 120' ' ' GLN . 59.6 t -99.18 117.08 43.76 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.485 0 N-CA-C 106.708 -1.59 . . . . 51.420000000000002 106.708 177.088 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 68.58 -71.07 0.12 Allowed 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 125.341 1.457 . . . . 73.030000000000001 108.877 -172.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 55.9 ttp85 -157.67 6.79 0.14 Allowed 'General case' 0 CA--C 1.553 1.073 0 CA-C-O 121.339 0.59 . . . . 72.450000000000003 109.775 172.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -114.8 131.74 23.29 Favored Pre-proline 0 N--CA 1.449 -0.476 0 O-C-N 121.845 -0.535 . . . . 73.439999999999998 110.026 -174.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -68.87 131.38 22.39 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.203 1.935 . . . . 62.219999999999999 112.241 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 -122.27 145.07 48.57 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 106.767 -1.568 . . . . 65.409999999999997 106.767 176.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -78.76 -46.54 18.65 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.989 -1.115 . . . . 75.120000000000005 107.989 178.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -138.35 143.48 39.9 Favored 'General case' 0 N--CA 1.421 -1.891 0 N-CA-C 106.609 -1.626 . . . . 34.539999999999999 106.609 175.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.541 ' HG3' HG21 ' A' ' 112' ' ' VAL . 22.1 tm0? -129.69 141.86 50.82 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 107.345 -1.354 . . . . 75.040000000000006 107.345 -176.32 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.3 p -103.15 119.05 51.06 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.297 0 N-CA-C 108.554 -0.906 . . . . 71.439999999999998 108.554 178.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.558 ' HB3' ' CE1' ' A' ' 137' ' ' PHE . 64.9 mtt -41.84 111.93 0.28 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.217 1.007 . . . . 74.230000000000004 112.588 -170.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -114.83 136.3 53.24 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-N 114.929 -1.032 . . . . 75.319999999999993 109.619 -170.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.703 ' HB ' ' HB3' ' A' ' 139' ' ' ALA . 14.6 t -79.4 127.59 32.29 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 121.666 0.746 . . . . 63.539999999999999 112.778 -176.063 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 80.97 33.51 29.47 Favored Glycine 0 N--CA 1.428 -1.849 0 CA-C-N 115.124 -0.943 . . . . 52.32 111.958 173.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -137.2 155.78 49.13 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.427 -0.953 . . . . 71.420000000000002 108.427 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -118.8 135.57 54.46 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-O 121.97 0.891 . . . . 73.230000000000004 113.206 -175.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 64.6 mt -111.35 130.4 64.92 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 CA-C-N 114.386 -1.279 . . . . 73.219999999999999 108.706 -177.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -91.9 111.49 23.05 Favored 'General case' 0 N--CA 1.417 -2.109 0 N-CA-C 107.707 -1.22 . . . . 73.540000000000006 107.707 175.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 10.9 pt -93.97 98.84 8.65 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 N-CA-C 107.911 -1.144 . . . . 70.409999999999997 107.911 177.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.435 ' HA2' ' OD1' ' A' ' 108' ' ' ASN . . . 79.58 -104.07 2.14 Favored Glycine 0 N--CA 1.412 -2.907 0 N-CA-C 109.363 -1.495 . . . . 65.409999999999997 109.363 -174.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -123.68 5.3 8.86 Favored 'General case' 0 C--N 1.298 -1.63 0 N-CA-C 109.965 -0.383 . . . . 74.040000000000006 109.965 178.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -113.03 152.71 29.16 Favored 'General case' 0 C--O 1.211 -0.954 0 CA-C-N 116.375 -0.375 . . . . 74.239999999999995 110.625 -177.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 66.4 mtp85 -113.61 128.31 56.39 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.52 0.676 . . . . 64.010000000000005 112.611 -170.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.492 HD11 HD13 ' A' ' 49' ' ' LEU . 45.1 tp -119.43 132.6 55.84 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 124.92 1.288 . . . . 74.310000000000002 108.552 -177.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 9.9 p -108.17 132.36 56.13 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 108.765 -0.828 . . . . 72.439999999999998 108.765 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.558 ' CE1' ' HB3' ' A' ' 122' ' ' MET . 39.8 t80 -109.04 131.38 55.13 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 121.077 -0.249 . . . . 73.120000000000005 110.948 -175.442 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.4 mp -124.44 124.18 41.76 Favored 'General case' 0 C--O 1.244 0.79 0 CA-C-O 121.131 0.491 . . . . 71.530000000000001 109.927 177.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.703 ' HB3' ' HB ' ' A' ' 124' ' ' THR . . . -94.64 82.91 4.0 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-O 121.536 0.684 . . . . 73.120000000000005 111.072 -177.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -127.12 96.87 0.46 Allowed Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 109.021 -1.631 . . . . 71.030000000000001 109.021 177.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -50.12 117.37 3.07 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 123.159 2.573 . . . . 74.030000000000001 113.271 -176.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -109.95 105.89 15.22 Favored 'General case' 0 C--N 1.276 -2.63 0 CA-C-N 114.266 -1.334 . . . . 65.230000000000004 109.82 178.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 . . . . . 0 C--N 1.291 -1.937 0 N-CA-C 105.747 -1.946 . . . . 63.549999999999997 105.747 177.574 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.9 mtt . . . . . 0 CA--C 1.516 -0.346 0 N-CA-C 108.221 -1.029 . . . . 74.010000000000005 108.221 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.0 t -82.22 -31.48 30.27 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 106.685 -1.598 . . . . 73.200000000000003 106.685 172.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -71.39 148.66 46.75 Favored 'General case' 0 C--O 1.247 0.933 0 CA-C-N 114.459 -1.246 . . . . 74.519999999999996 108.286 174.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -93.92 127.03 39.47 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 109.295 -0.632 . . . . 74.230000000000004 109.295 177.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -148.25 166.52 27.7 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 116.325 -0.398 . . . . 64.430000000000007 110.464 -179.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 161.23 176.47 33.37 Favored Glycine 0 N--CA 1.431 -1.688 0 N-CA-C 110.733 -0.947 . . . . 64.510000000000005 110.733 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.3 p -92.2 124.62 59.2 Favored Pre-proline 0 C--N 1.292 -1.9 0 CA-C-N 116.624 0.212 . . . . 71.099999999999994 110.909 -178.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -63.83 128.92 23.22 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.314 2.01 . . . . 72.129999999999995 110.326 176.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -86.4 130.55 49.08 Favored Pre-proline 0 C--N 1.299 -1.615 0 CA-C-N 116.32 -0.4 . . . . 74.420000000000002 111.856 -174.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -65.15 145.33 84.28 Favored 'Trans proline' 0 C--O 1.247 0.934 0 C-N-CA 122.632 2.221 . . . . 74.319999999999993 111.377 178.355 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -57.8 128.34 36.58 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-N 115.685 -0.689 . . . . 72.409999999999997 112.483 -178.033 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.4 m -73.53 76.25 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 CA-C-O 122.66 1.219 . . . . 31.239999999999998 109.903 173.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -88.83 122.59 32.37 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-N 114.231 -1.35 . . . . 74.200000000000003 111.033 -174.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.6 t -145.27 89.29 1.93 Allowed 'General case' 0 N--CA 1.407 -2.597 0 CA-C-O 122.583 1.182 . . . . 70.219999999999999 107.944 174.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 28.6 m -92.5 105.82 17.92 Favored 'General case' 0 N--CA 1.415 -2.212 0 CA-C-N 114.79 -1.096 . . . . 62.140000000000001 109.444 -177.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.9 m -72.32 113.99 9.95 Favored 'General case' 0 N--CA 1.418 -2.075 0 CA-C-N 115.065 -0.97 . . . . 63.039999999999999 109.029 177.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.1 m -65.7 133.41 30.83 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-O 121.125 0.488 . . . . 74.140000000000001 110.506 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -88.32 129.22 35.44 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 115.099 -0.955 . . . . 75.310000000000002 109.853 -177.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 -89.13 144.74 25.91 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 112.935 0.717 . . . . 72.120000000000005 112.935 -177.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.04 16.57 0.72 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.346 -0.843 . . . . 71.530000000000001 111.217 177.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -88.94 -17.1 30.21 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.812 -1.181 . . . . 63.439999999999998 107.812 176.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 65.94 72.85 0.39 Allowed 'General case' 0 CA--C 1.506 -0.738 0 CA-C-N 114.491 -1.231 . . . . 62.43 112.762 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.4 tt -116.15 113.45 23.11 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 105.331 -2.1 . . . . 72.5 105.331 175.097 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.475 ' HD3' ' H ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -102.52 101.55 11.74 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 120.964 0.411 . . . . 63.200000000000003 110.239 -177.96 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -56.11 122.69 12.27 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.977 -1.01 . . . . 75.420000000000002 111.603 -179.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 65.5 mtt -93.05 -1.42 56.57 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 115.812 -0.631 . . . . 73.140000000000001 109.979 175.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -67.05 148.11 52.33 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.972 -1.013 . . . . 75.450000000000003 108.803 175.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.1 t -69.56 170.41 10.74 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 121.2 0.524 . . . . 42.119999999999997 111.13 -174.062 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 26.3 p -67.2 142.35 57.01 Favored 'General case' 0 N--CA 1.427 -1.624 0 CA-C-N 115.418 -0.81 . . . . 71.25 112.387 -174.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.1 t -133.76 112.54 11.45 Favored 'General case' 0 N--CA 1.414 -2.245 0 N-CA-C 108.881 -0.785 . . . . 63.240000000000002 108.881 177.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 129.69 -57.33 0.72 Allowed Glycine 0 N--CA 1.432 -1.572 0 N-CA-C 110.829 -0.908 . . . . 65.219999999999999 110.829 -178.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 15.6 m -91.81 138.38 31.6 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.112 -0.699 . . . . 75.430000000000007 109.112 179.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -89.7 117.61 68.28 Favored Pre-proline 0 C--N 1.313 -1.013 0 N-CA-C 109.755 -0.461 . . . . 73.530000000000001 109.755 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -65.69 120.75 7.99 Favored 'Trans proline' 0 C--O 1.236 0.419 0 C-N-CA 122.736 2.291 . . . . 73.299999999999997 111.532 178.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -93.25 100.99 13.25 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 109.088 -0.708 . . . . 62.140000000000001 109.088 178.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.7 m -101.8 163.38 12.28 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.879 -0.785 . . . . 63.049999999999997 108.879 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 13.3 t -156.61 -177.7 6.8 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 108.08 -1.081 . . . . 72.530000000000001 108.08 178.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.18 107.44 0.53 Allowed Glycine 0 N--CA 1.427 -1.908 0 C-N-CA 120.406 -0.902 . . . . 61.140000000000001 111.949 -175.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.0 -33.69 61.86 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 121.089 0.471 . . . . 62.32 110.14 178.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -74.89 -11.87 60.23 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.399 0.619 . . . . 73.319999999999993 110.367 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -76.09 -27.41 57.16 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.292 -0.867 . . . . 70.200000000000003 109.74 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 96.1 mt -102.91 147.75 34.56 Favored Pre-proline 0 N--CA 1.419 -2.016 0 CA-C-N 115.222 -0.899 . . . . 72.129999999999995 109.678 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -63.21 162.42 26.68 Favored 'Trans proline' 0 C--O 1.251 1.154 0 C-N-CA 122.652 2.235 . . . . 72.510000000000005 111.437 175.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -47.26 106.9 0.1 Allowed 'General case' 0 C--O 1.238 0.494 0 C-N-CA 124.802 1.241 . . . . 22.43 112.987 -176.376 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -148.83 46.69 0.67 Allowed Glycine 0 CA--C 1.484 -1.851 0 N-CA-C 107.261 -2.336 . . . . 52.109999999999999 107.261 177.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 20.2 m -90.89 167.08 12.7 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 114.107 -1.046 . . . . 53.219999999999999 110.609 -174.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -127.4 171.13 11.81 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.137 -1.431 . . . . 65.329999999999998 107.137 177.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -134.04 145.5 49.48 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 120.039 -0.664 . . . . 71.530000000000001 111.109 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.479 ' O ' ' HA ' ' A' ' 60' ' ' ARG . 4.1 pp -110.56 132.72 53.94 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 115.217 -0.901 . . . . 75.209999999999994 108.934 176.538 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 51.5 t -116.67 113.88 44.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 108.509 -0.923 . . . . 62.030000000000001 108.509 179.124 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 36.3 t -96.21 115.61 35.94 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 N-CA-C 109.033 -0.729 . . . . 71.329999999999998 109.033 -179.268 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -86.14 -32.86 21.06 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.377 0.608 . . . . 63.549999999999997 110.183 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.438 ' O ' ' HB3' ' A' ' 133' ' ' PHE . 10.1 tpt180 -147.55 131.08 16.75 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 106.535 -1.654 . . . . 73.209999999999994 106.535 179.493 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.426 ' HA2' ' HD2' ' A' ' 55' ' ' PRO . . . 145.14 110.74 0.7 Allowed Glycine 0 C--N 1.298 -1.555 0 N-CA-C 111.376 -0.689 . . . . 65.120000000000005 111.376 -178.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.426 ' HD2' ' HA2' ' A' ' 54' ' ' GLY . 14.3 Cg_endo -58.36 -20.7 49.42 Favored 'Trans proline' 0 C--N 1.358 1.052 0 C-N-CA 123.403 2.735 . . . . 70.140000000000001 113.689 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.448 ' HB3' ' HG ' ' A' ' 80' ' ' LEU . 7.6 p30 -48.0 -35.9 11.77 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.225 1.01 . . . . 74.319999999999993 111.82 175.188 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -152.21 -72.04 0.15 Allowed 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 109.241 -0.651 . . . . 73.109999999999999 109.241 176.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.96 36.64 35.37 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.652 -0.704 . . . . 64.129999999999995 111.752 -179.041 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -158.38 -171.61 3.54 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 107.672 -1.232 . . . . 70.340000000000003 107.672 -178.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.479 ' HA ' ' O ' ' A' ' 49' ' ' LEU . 36.6 ptt180 -113.37 133.02 55.38 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 109.546 -0.539 . . . . 74.420000000000002 109.546 178.363 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -135.57 134.7 39.65 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 116.483 -0.326 . . . . 75.400000000000006 110.681 -176.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.5 mp -91.57 130.16 37.43 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.921 -0.581 . . . . 73.109999999999999 109.438 178.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -71.34 121.34 18.34 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.546 0.689 . . . . 74.409999999999997 110.761 -177.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -123.78 -24.95 4.37 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.206 -1.361 . . . . 72.010000000000005 111.383 -175.136 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.446 ' H ' ' CD ' ' A' ' 65' ' ' GLN . 0.2 OUTLIER -92.27 141.34 24.87 Favored Pre-proline 0 C--N 1.295 -1.781 0 CA-C-N 115.021 -0.99 . . . . 73.340000000000003 111.032 -174.684 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.525 ' HA ' HG22 ' A' ' 94' ' ' ILE . 37.2 Cg_endo -66.68 -34.29 32.47 Favored 'Trans proline' 0 C--O 1.242 0.709 0 C-N-CA 123.075 2.516 . . . . 51.100000000000001 112.798 -176.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 39.5 m -132.61 99.71 4.72 Favored 'General case' 0 N--CA 1.415 -2.187 0 N-CA-C 107.57 -1.27 . . . . 73.540000000000006 107.57 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.516 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 6.1 m -90.74 112.92 24.89 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.506 -0.924 . . . . 62.130000000000003 108.506 179.415 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 51.7 m -94.04 119.94 33.6 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 109.296 -0.631 . . . . 75.310000000000002 109.296 177.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -109.69 120.31 42.1 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 108.59 -0.893 . . . . 63.119999999999997 108.59 178.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 175.29 -147.09 8.69 Favored Glycine 0 C--N 1.289 -2.067 0 N-CA-C 109.221 -1.552 . . . . 42.530000000000001 109.221 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.499 ' HD3' ' O ' ' A' ' 80' ' ' LEU . 10.2 tpt180 -134.32 66.16 1.55 Allowed 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 108.424 -0.954 . . . . 73.409999999999997 108.424 179.176 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 30.1 m170 -126.87 166.01 25.05 Favored Pre-proline 0 C--N 1.303 -1.414 0 N-CA-C 107.568 -1.271 . . . . 75.310000000000002 107.568 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -61.13 -32.94 91.71 Favored 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 121.755 1.637 . . . . 72.319999999999993 109.986 172.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 -97.82 72.3 2.25 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-O 122.35 1.071 . . . . 61.039999999999999 109.898 177.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 48.9 m -142.62 125.92 16.55 Favored 'General case' 0 C--N 1.277 -2.545 0 CA-C-N 114.087 -1.415 . . . . 72.219999999999999 107.557 174.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -69.48 -50.66 43.27 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 107.774 -1.195 . . . . 62.32 107.774 -179.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 30.1 pt -109.09 123.59 65.09 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.222 0 N-CA-C 107.083 -1.451 . . . . 74.099999999999994 107.083 172.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -108.04 116.91 32.82 Favored 'General case' 0 C--N 1.28 -2.455 0 CA-C-O 122.177 0.989 . . . . 74.409999999999997 111.524 -177.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.499 ' O ' ' HD3' ' A' ' 72' ' ' ARG . 6.3 mp -79.89 135.28 36.4 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 113.835 -1.53 . . . . 51.009999999999998 109.272 -177.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -134.13 23.79 3.85 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 105.472 -2.047 . . . . 73.319999999999993 105.472 179.256 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -78.44 179.19 7.17 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 111.796 -2.456 . . . . 72.219999999999999 109.906 -175.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.9 p -83.34 1.59 3.91 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-O 122.073 0.94 . . . . 55.329999999999998 110.13 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 12.0 p -109.89 14.32 23.18 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 115.932 -0.576 . . . . 65.310000000000002 111.778 -175.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.2 m -81.83 139.09 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.634 0 CA-C-O 121.346 0.593 . . . . 70.109999999999999 111.915 -174.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 13.0 p -130.98 -81.44 0.53 Allowed 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.24 -0.891 . . . . 72.140000000000001 111.367 -179.321 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.447 ' HG3' ' HD2' ' A' ' 88' ' ' ARG . 20.0 tpp85 -156.33 -92.39 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.002 -1.11 . . . . 50.530000000000001 108.002 178.056 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.571 ' HB3' HG23 ' A' ' 104' ' ' VAL . 5.4 mpt_? -85.65 107.06 17.37 Favored 'General case' 0 CA--C 1.493 -1.243 0 N-CA-C 105.168 -2.16 . . . . 73.530000000000001 105.168 171.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -91.53 -75.58 0.47 Allowed 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 120.287 -0.565 . . . . 65.340000000000003 110.255 -174.015 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -144.51 155.0 43.48 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.991 -0.744 . . . . 64.540000000000006 108.991 -178.119 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -140.34 128.2 21.93 Favored 'General case' 0 C--N 1.287 -2.131 0 C-N-CA 119.994 -0.682 . . . . 73.040000000000006 109.326 179.165 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.516 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 42.3 m-85 -97.55 113.09 24.73 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 106.887 -1.523 . . . . 70.409999999999997 106.887 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.428 HH11 ' HD3' ' A' ' 93' ' ' ARG . 46.1 mtt-85 -112.56 152.12 29.23 Favored 'General case' 0 C--N 1.269 -2.913 0 C-N-CA 120.527 -0.469 . . . . 73.340000000000003 109.922 179.394 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.525 HG22 ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -113.43 116.12 51.69 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.3 0 CA-C-O 123.111 1.434 . . . . 75.109999999999999 108.177 177.842 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -97.64 96.44 8.28 Favored 'General case' 0 N--CA 1.42 -1.928 0 CA-C-N 113.256 -1.793 . . . . 71.040000000000006 109.8 -173.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 43.45 13.6 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 127.477 2.311 . . . . 55.530000000000001 116.667 175.013 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 158.48 -13.15 0.23 Allowed Glycine 0 N--CA 1.417 -2.599 0 C-N-CA 120.234 -0.984 . . . . 63.030000000000001 113.606 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -146.36 152.82 39.71 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 118.05 -1.46 . . . . 63.43 110.513 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.414 ' CD2' ' HB ' ' A' ' 94' ' ' ILE . 89.8 m-85 -89.99 138.46 31.49 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.377 0.608 . . . . 75.340000000000003 110.851 -176.106 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -128.07 125.36 39.13 Favored 'General case' 0 C--N 1.28 -2.417 0 N-CA-C 107.61 -1.256 . . . . 70.200000000000003 107.61 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.5 p -103.07 118.55 50.18 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-O 121.602 0.715 . . . . 75.409999999999997 109.862 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 29.9 m -119.96 137.67 53.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-N 115.033 -0.985 . . . . 62.509999999999998 111.686 -179.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -83.23 122.96 29.1 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 104.742 -2.318 . . . . 72.200000000000003 104.742 171.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.571 HG23 ' HB3' ' A' ' 88' ' ' ARG . 16.8 m -106.15 9.59 9.37 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 N-CA-C 112.816 0.673 . . . . 62.509999999999998 112.816 -172.111 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -126.41 -45.96 0.22 Allowed Glycine 0 N--CA 1.43 -1.701 0 C-N-CA 119.018 -1.563 . . . . 55.340000000000003 112.96 -179.053 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 21.7 m 67.18 9.97 7.35 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.205 1.402 . . . . 71.329999999999998 110.659 -175.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 94.4 mt -74.92 -48.6 23.75 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 114.663 -1.153 . . . . 75.25 109.292 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -83.36 -50.34 8.44 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 108.643 -0.873 . . . . 65.400000000000006 108.643 175.094 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.01 76.99 1.32 Allowed Glycine 0 N--CA 1.431 -1.646 0 N-CA-C 109.486 -1.446 . . . . 55.109999999999999 109.486 -175.268 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 32.1 m -73.09 135.35 44.78 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 109.671 -0.492 . . . . 74.219999999999999 109.671 -179.015 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -102.18 133.2 47.43 Favored 'General case' 0 N--CA 1.422 -1.838 0 N-CA-C 106.925 -1.509 . . . . 74.25 106.925 178.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.47 HG23 HG12 ' A' ' 128' ' ' ILE . 7.5 p -128.41 137.29 57.8 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.179 0 N-CA-C 107.57 -1.27 . . . . 72.209999999999994 107.57 -175.627 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 60.61 21.95 11.78 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 108.149 -1.056 . . . . 75.519999999999996 108.149 -171.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 64.1 mtp180 54.7 37.38 28.18 Favored 'General case' 0 C--N 1.352 0.704 0 CA-C-N 114.412 -1.267 . . . . 73.019999999999996 112.582 -172.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -132.63 149.5 73.2 Favored Pre-proline 0 C--N 1.312 -1.061 0 N-CA-C 108.298 -1.001 . . . . 45.329999999999998 108.298 174.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -76.28 87.65 1.41 Allowed 'Trans proline' 0 N--CA 1.443 -1.476 0 C-N-CA 121.49 1.46 . . . . 52.25 110.554 174.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -120.14 149.73 41.76 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.758 -1.201 . . . . 74.030000000000001 107.758 178.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -89.27 -28.9 19.6 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 109.467 -0.568 . . . . 74.239999999999995 109.467 179.225 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -140.92 140.36 34.47 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 115.413 -0.812 . . . . 74.329999999999998 109.514 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.5 142.23 37.3 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.737 -1.208 . . . . 64.340000000000003 107.737 174.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 11.3 p -98.07 135.84 31.22 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.232 0 N-CA-C 109.641 -0.503 . . . . 73.239999999999995 109.641 -177.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 48.6 ttp -31.58 108.99 0.05 Allowed 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 125.97 1.708 . . . . 63.119999999999997 112.24 -177.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -133.06 138.71 46.84 Favored 'General case' 0 N--CA 1.419 -2.015 0 N-CA-C 106.763 -1.569 . . . . 65.120000000000005 106.763 179.05 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 12.3 t -80.06 131.37 35.76 Favored 'General case' 0 N--CA 1.423 -1.823 0 N-CA-C 109.12 -0.696 . . . . 63.32 109.12 -179.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 91.39 18.14 46.87 Favored Glycine 0 N--CA 1.438 -1.176 0 C-N-CA 120.314 -0.946 . . . . 71.450000000000003 111.125 178.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -81.51 140.64 34.44 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 106.657 -1.609 . . . . 75.530000000000001 106.657 178.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -124.77 120.88 33.03 Favored 'General case' 0 C--N 1.277 -2.552 0 CA-C-O 122.41 1.1 . . . . 55.420000000000002 110.576 -179.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.47 HG12 HG23 ' A' ' 112' ' ' VAL . 61.0 mt -103.66 128.49 56.81 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.095 0 CA-C-N 113.885 -1.507 . . . . 72.450000000000003 108.908 -174.548 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -120.6 124.82 46.22 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 109.793 -0.447 . . . . 63.119999999999997 109.793 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.464 HG13 ' HB2' ' A' ' 133' ' ' PHE . 22.0 pt -109.76 98.24 6.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 108.404 -0.961 . . . . 62.399999999999999 108.404 173.479 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 70.4 -82.81 0.36 Allowed Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.074 -0.966 . . . . 34.329999999999998 111.615 -175.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -130.77 -12.79 3.75 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 123.104 0.562 . . . . 73.430000000000007 110.182 179.171 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.464 ' HB2' HG13 ' A' ' 130' ' ' ILE . 42.3 m-85 -85.63 131.74 34.29 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.852 -0.795 . . . . 71.310000000000002 108.852 -176.039 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 21.4 ptt180 -118.33 135.05 54.54 Favored 'General case' 0 C--O 1.258 1.541 0 CA-C-O 121.993 0.902 . . . . 62.509999999999998 112.821 -175.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 5.2 tt -120.04 133.23 55.59 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 113.473 -1.694 . . . . 55.109999999999999 107.302 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 40.7 t -107.91 120.75 59.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 107.318 -1.364 . . . . 63.310000000000002 107.318 177.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -102.48 121.9 43.26 Favored 'General case' 0 C--N 1.288 -2.078 0 CA-C-N 115.7 -0.682 . . . . 73.5 109.497 -176.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -121.52 159.52 26.18 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 109.606 -0.516 . . . . 60.109999999999999 109.606 -178.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -72.0 148.78 45.58 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 106.772 -1.566 . . . . 63.009999999999998 106.772 172.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -113.86 -140.62 7.57 Favored Glycine 0 C--N 1.29 -1.983 0 C-N-CA 119.546 -1.311 . . . . 35.240000000000002 112.874 -173.458 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -77.92 118.41 4.43 Favored 'Trans proline' 0 N--CA 1.435 -1.915 0 C-N-CA 122.57 2.18 . . . . 73.109999999999999 113.061 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -109.95 104.54 13.47 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 105.972 -1.862 . . . . 34.119999999999997 105.972 173.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 . . . . . 0 C--N 1.296 -1.723 0 N-CA-C 109.185 -0.672 . . . . 60.520000000000003 109.185 -174.643 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.3 ptm . . . . . 0 C--O 1.222 -0.379 0 CA-C-O 121.409 0.623 . . . . 74.030000000000001 111.117 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.2 m -83.2 -36.26 24.79 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.138 0.494 . . . . 42.229999999999997 111.001 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -102.27 126.79 49.37 Favored 'General case' 0 CA--C 1.489 -1.377 0 CA-C-N 116.121 -0.491 . . . . 60.420000000000002 112.19 -174.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -82.97 92.89 7.43 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 105.423 -2.066 . . . . 73.219999999999999 105.423 171.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -104.18 163.69 12.23 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 114.969 -1.014 . . . . 74.25 112.131 -170.15 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -179.59 -165.18 33.24 Favored Glycine 0 N--CA 1.428 -1.876 0 N-CA-C 107.67 -2.172 . . . . 74.439999999999998 107.67 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.8 p -77.29 124.26 87.02 Favored Pre-proline 0 C--N 1.3 -1.55 0 CA-C-N 118.212 1.006 . . . . 71.120000000000005 109.667 179.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -61.21 148.12 93.76 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 123.175 2.583 . . . . 74.200000000000003 112.855 -175.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -69.77 117.62 55.23 Favored Pre-proline 0 C--O 1.247 0.925 0 N-CA-C 109.556 -0.535 . . . . 71.120000000000005 109.556 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -82.24 142.53 12.11 Favored 'Trans proline' 0 N--CA 1.444 -1.44 0 C-N-CA 122.738 2.292 . . . . 74.219999999999999 112.63 -176.532 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -70.55 134.35 47.59 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-N 115.456 -0.793 . . . . 63.100000000000001 109.801 178.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.7 t -73.86 89.22 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 CA-C-N 115.483 -0.78 . . . . 54.43 109.591 -179.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -72.96 124.41 25.39 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 114.546 -1.206 . . . . 71.530000000000001 108.95 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.4 m -67.29 98.32 0.61 Allowed 'General case' 0 N--CA 1.427 -1.621 0 CA-C-N 115.709 -0.678 . . . . 51.240000000000002 109.844 -179.014 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.1 t -79.3 75.05 5.88 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 123.037 1.398 . . . . 75.030000000000001 110.394 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.8 m -155.69 164.05 39.1 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 106.452 -1.684 . . . . 71.140000000000001 106.452 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.7 m -73.34 136.55 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.591 0 N-CA-C 108.863 -0.792 . . . . 72.540000000000006 108.863 175.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -129.28 -178.28 4.59 Favored 'General case' 0 C--N 1.277 -2.583 0 N-CA-C 106.902 -1.518 . . . . 73.510000000000005 106.902 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 28.8 mmm180 -81.87 160.74 23.39 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 109.548 -0.538 . . . . 72.400000000000006 109.548 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.0 27.17 1.4 Allowed 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.748 0.785 . . . . 61.439999999999998 109.381 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -58.78 -50.31 74.43 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 125.13 1.372 . . . . 74.409999999999997 110.375 -179.407 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 60.8 tp -157.52 101.86 1.87 Allowed 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.597 -0.728 . . . . 75.219999999999999 109.099 177.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 91.9 mt -93.55 158.42 15.71 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.662 -0.866 . . . . 73.329999999999998 108.662 177.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.464 ' HD2' ' N ' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -94.08 140.6 29.53 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 120.65 -0.42 . . . . 74.129999999999995 110.436 -177.135 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -60.7 121.88 13.37 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 114.673 1.361 . . . . 74.099999999999994 114.673 -177.065 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 11.1 tmm? -90.32 125.31 35.48 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 106.214 -1.773 . . . . 73.219999999999999 106.214 172.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -140.08 150.95 44.96 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.795 -1.187 . . . . 74.219999999999999 107.795 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.3 p -145.52 -37.6 0.27 Allowed 'General case' 0 C--N 1.293 -1.861 0 O-C-N 123.644 0.59 . . . . 54.140000000000001 109.422 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.4 m 60.82 23.16 13.16 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 124.397 1.079 . . . . 54.509999999999998 110.154 -179.099 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.4 m -98.19 114.26 26.44 Favored 'General case' 0 N--CA 1.411 -2.42 0 CA-C-N 114.566 -1.197 . . . . 42.100000000000001 109.025 -178.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.31 72.5 2.63 Favored Glycine 0 N--CA 1.438 -1.202 0 N-CA-C 109.494 -1.442 . . . . 43.210000000000001 109.494 177.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 10.6 t -69.57 140.15 53.78 Favored 'General case' 0 N--CA 1.426 -1.663 0 CA-C-N 115.004 -0.598 . . . . 73.230000000000004 110.536 -177.097 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.3 139.19 64.15 Favored Pre-proline 0 C--N 1.303 -1.431 0 CA-C-N 114.901 -1.045 . . . . 62.200000000000003 109.601 -178.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -68.5 136.75 37.45 Favored 'Trans proline' 0 N--CA 1.446 -1.292 0 C-N-CA 121.675 1.584 . . . . 42.030000000000001 109.569 175.213 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.82 -48.97 78.2 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-O 120.669 0.271 . . . . 54.549999999999997 110.324 -179.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.4 m 66.27 -0.11 1.55 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.925 1.29 . . . . 71.219999999999999 112.247 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 13.1 p -94.66 140.13 30.3 Favored 'General case' 0 N--CA 1.423 -1.812 0 CA-C-O 120.994 0.426 . . . . 54.109999999999999 111.5 -177.487 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 97.83 -8.68 63.64 Favored Glycine 0 N--CA 1.438 -1.22 0 CA-C-N 115.958 -0.565 . . . . 74.409999999999997 111.823 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.14 -21.21 62.22 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.03 0.443 . . . . 53.140000000000001 110.526 -178.116 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -68.75 -11.17 60.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.652 -0.704 . . . . 74.040000000000006 111.971 178.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -61.56 -30.25 70.54 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.778 0.799 . . . . 74.299999999999997 109.033 174.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.568 ' HG ' ' O ' ' A' ' 44' ' ' ALA . 46.3 tp -117.57 95.0 46.93 Favored Pre-proline 0 N--CA 1.413 -2.295 0 CA-C-N 114.861 -1.063 . . . . 73.150000000000006 108.768 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.488 ' HA ' ' OE1' ' A' ' 96' ' ' GLU . 83.1 Cg_endo -97.2 23.11 0.32 Allowed 'Trans proline' 0 C--O 1.239 0.55 0 C-N-CA 123.425 2.75 . . . . 65.530000000000001 110.318 178.292 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.568 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -143.11 173.09 11.88 Favored 'General case' 0 N--CA 1.422 -1.84 0 N-CA-C 106.06 -1.829 . . . . 74.239999999999995 106.06 -178.457 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 111.47 58.13 0.47 Allowed Glycine 0 C--N 1.28 -2.582 0 N-CA-C 109.605 -1.398 . . . . 51.32 109.605 -176.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.568 ' HB3' ' O ' ' A' ' 63' ' ' LEU . 4.8 m -90.0 154.64 19.67 Favored 'General case' 0 N--CA 1.41 -2.448 0 CA-C-N 114.446 -0.877 . . . . 64.310000000000002 108.892 -177.444 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -116.26 175.89 5.35 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.303 -0.999 . . . . 64.329999999999998 108.303 -178.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -130.27 159.66 36.23 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 121.327 0.584 . . . . 65.140000000000001 111.348 -175.108 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.44 HD22 HD21 ' A' ' 135' ' ' LEU . 1.7 pp -122.17 147.63 45.93 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 115.356 -0.838 . . . . 73.420000000000002 110.097 177.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.483 ' CG2' ' HB ' ' A' ' 136' ' ' VAL . 24.6 m -123.28 134.05 67.37 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 108.603 -0.888 . . . . 73.430000000000007 108.603 175.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.463 HG21 ' HB3' ' A' ' 57' ' ' ALA . 48.5 t -92.54 115.69 32.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 106.457 -1.683 . . . . 63.240000000000002 106.457 176.744 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.402 ' HB3' ' HG3' ' A' ' 134' ' ' ARG . 76.9 tttt -73.96 -39.98 63.35 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 114.524 -1.217 . . . . 71.0 108.417 -176.118 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 31.7 tpt180 -168.31 138.51 2.55 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 107.157 -1.423 . . . . 65.209999999999994 107.157 177.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 139.28 127.67 2.47 Favored Glycine 0 N--CA 1.425 -2.077 0 C-N-CA 119.724 -1.227 . . . . 45.030000000000001 114.382 178.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.508 ' HD2' ' CE2' ' A' ' 133' ' ' PHE . 80.3 Cg_exo -54.0 -8.74 1.04 Allowed 'Trans proline' 0 C--N 1.368 1.553 0 C-N-CA 125.237 3.958 . . . . 74.219999999999999 114.117 173.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.541 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 1.5 t30 -40.99 -45.44 2.6 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.717 1.207 . . . . 52.240000000000002 109.792 170.592 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.463 ' HB3' HG21 ' A' ' 51' ' ' VAL . . . -162.95 -48.55 0.04 OUTLIER 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 115.989 -0.551 . . . . 74.040000000000006 109.601 176.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 67.82 48.52 54.7 Favored Glycine 0 C--N 1.324 -0.134 0 N-CA-C 111.225 -0.75 . . . . 62.130000000000003 111.225 -179.111 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -161.64 -173.02 3.56 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.25 -1.018 . . . . 54.409999999999997 108.25 -178.072 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.464 ' HB2' HG12 ' A' ' 50' ' ' VAL . 19.1 ptp180 -140.5 135.41 31.89 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.777 -0.824 . . . . 72.340000000000003 108.777 175.738 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -156.46 155.42 32.01 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 120.743 0.306 . . . . 73.010000000000005 111.609 -176.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 14.7 tp -79.87 139.7 37.05 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.035 -0.984 . . . . 64.200000000000003 108.642 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.568 ' O ' ' HB3' ' A' ' 46' ' ' SER . 94.3 mt -95.17 114.09 25.84 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 120.138 -0.625 . . . . 74.120000000000005 109.623 177.026 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -96.86 -28.87 14.03 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 121.561 0.696 . . . . 75.230000000000004 109.786 177.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -74.77 115.8 47.65 Favored Pre-proline 0 C--N 1.309 -1.157 0 CA-C-N 114.086 -1.416 . . . . 74.329999999999998 109.621 -177.009 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.467 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 15.2 Cg_endo -57.93 -28.25 82.12 Favored 'Trans proline' 0 C--N 1.363 1.307 0 C-N-CA 123.045 2.497 . . . . 74.010000000000005 112.402 -176.506 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 90.8 m -136.46 109.86 7.91 Favored 'General case' 0 N--CA 1.418 -2.055 0 N-CA-C 108.874 -0.787 . . . . 62.350000000000001 108.874 174.049 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 23.4 m -105.64 114.32 28.41 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.296 -1.002 . . . . 73.329999999999998 108.296 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.495 HG22 ' HG2' ' A' ' 91' ' ' GLU . 65.6 p -91.96 133.77 35.4 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 109.802 -0.444 . . . . 71.120000000000005 109.802 -178.718 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -127.28 133.53 50.15 Favored 'General case' 0 C--O 1.243 0.724 0 O-C-N 122.249 -0.282 . . . . 63.229999999999997 111.118 -179.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 161.41 -105.29 0.26 Allowed Glycine 0 N--CA 1.437 -1.282 0 C-N-CA 119.894 -1.146 . . . . 63.329999999999998 114.044 175.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 66.8 ttt180 -91.19 99.54 12.52 Favored 'General case' 0 N--CA 1.42 -1.938 0 N-CA-C 107.991 -1.114 . . . . 75.549999999999997 107.991 -174.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 23.1 m80 -12.63 -68.48 0.02 OUTLIER Pre-proline 0 N--CA 1.5 2.056 0 C-N-CA 127.758 2.423 . . . . 73.430000000000007 115.306 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -66.32 -21.9 53.69 Favored 'Trans proline' 0 C--N 1.387 2.563 0 C-N-CA 122.082 1.855 . . . . 64.329999999999998 114.43 -177.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -112.86 18.29 18.29 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.428 0.632 . . . . 71.310000000000002 110.631 -175.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 40.0 m -144.35 165.71 27.14 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.365 -0.976 . . . . 71.409999999999997 108.365 178.274 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -81.37 -57.13 3.63 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 109.185 -0.672 . . . . 54.520000000000003 109.185 176.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 49.4 pt -106.78 166.94 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 CA-C-O 121.604 0.716 . . . . 71.329999999999998 110.712 177.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -123.27 137.02 54.96 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-N 114.954 -1.021 . . . . 74.450000000000003 109.211 -175.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.541 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 2.5 pt? -114.11 121.79 44.87 Favored 'General case' 0 N--CA 1.406 -2.664 0 N-CA-C 105.933 -1.877 . . . . 54.109999999999999 105.933 170.434 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -80.72 78.19 7.51 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 122.018 0.913 . . . . 72.230000000000004 110.411 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.462 ' OD2' HG22 ' A' ' 84' ' ' THR . 17.3 t70 -117.58 -167.31 1.3 Allowed 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 114.244 -1.344 . . . . 72.530000000000001 108.252 177.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.41 ' H ' ' CG ' ' A' ' 82' ' ' ASP . 11.0 p -129.65 -19.36 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 CA-C-N 118.241 0.473 . . . . 70.329999999999998 111.225 -177.104 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.462 HG22 ' OD2' ' A' ' 82' ' ' ASP . 12.3 t -99.12 20.99 12.43 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.52 0.676 . . . . 74.310000000000002 110.497 -177.556 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.7 p -81.24 111.02 17.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 108.607 -0.886 . . . . 71.239999999999995 108.607 178.083 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.8 m -76.51 -89.83 0.03 OUTLIER 'General case' 0 CA--C 1.562 1.412 0 N-CA-C 113.478 0.918 . . . . 75.140000000000001 113.478 -172.155 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -84.09 -48.25 10.07 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 106.802 -1.555 . . . . 75.430000000000007 106.802 177.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -162.55 176.42 10.42 Favored 'General case' 0 C--N 1.274 -2.717 0 N-CA-C 100.269 -3.974 . . . . 74.540000000000006 100.269 170.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 21.3 t60 -96.27 -74.18 0.57 Allowed 'General case' 0 C--N 1.276 -2.617 0 C-N-CA 116.443 -2.103 . . . . 62.520000000000003 111.979 -170.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.15 163.66 34.68 Favored 'General case' 0 C--N 1.294 -1.809 0 C-N-CA 120.012 -0.675 . . . . 54.130000000000003 110.474 -174.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.495 ' HG2' HG22 ' A' ' 69' ' ' THR . 52.1 mt-10 -116.21 127.35 54.69 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.624 -0.88 . . . . 75.540000000000006 108.624 175.61 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -100.51 112.89 25.31 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 107.595 -1.261 . . . . 74.510000000000005 107.595 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 60.0 mtp180 -103.3 112.93 26.03 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 106.89 -1.522 . . . . 62.130000000000003 106.89 -179.033 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.467 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -120.14 111.43 32.4 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.328 0 N-CA-C 106.954 -1.499 . . . . 74.019999999999996 106.954 -179.756 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -122.33 147.23 46.51 Favored 'General case' 0 N--CA 1.393 -3.302 0 CA-C-N 114.469 -1.241 . . . . 71.25 111.004 176.32 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.488 ' OE1' ' HA ' ' A' ' 43' ' ' PRO . 0.7 OUTLIER -61.27 -30.35 70.41 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 107.58 -1.267 . . . . 74.109999999999999 107.58 175.572 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -69.58 -61.39 4.45 Favored Glycine 0 N--CA 1.429 -1.824 0 CA-C-N 113.442 -1.708 . . . . 62.0 111.304 175.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -147.2 146.63 29.9 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.962 0.381 . . . . 55.240000000000002 110.972 -179.312 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -104.39 116.22 31.74 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.002 -0.74 . . . . 74.439999999999998 109.002 -178.203 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -133.16 135.4 45.12 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 113.503 0.927 . . . . 72.140000000000001 113.503 -177.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.7 p -116.31 119.07 60.83 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.295 0 N-CA-C 108.959 -0.756 . . . . 52.229999999999997 108.959 176.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.6 p -120.84 131.75 72.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 112.591 0.589 . . . . 72.239999999999995 112.591 -177.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -83.06 136.67 34.4 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 108.596 -0.89 . . . . 71.409999999999997 108.596 172.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.6 m -89.57 -16.95 8.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-O 121.189 0.518 . . . . 73.400000000000006 111.872 -176.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 142.28 53.06 0.04 OUTLIER Glycine 0 N--CA 1.424 -2.136 0 N-CA-C 109.746 -1.341 . . . . 51.130000000000003 109.746 -173.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.6 t -154.7 28.6 0.43 Allowed 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 106.462 -1.681 . . . . 53.0 106.462 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 32.9 tp -62.64 -11.52 17.52 Favored 'General case' 0 C--N 1.356 0.882 0 C-N-CA 125.794 1.637 . . . . 72.340000000000003 111.57 -174.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -60.45 -26.76 67.0 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 115.156 -0.929 . . . . 75.530000000000001 109.472 173.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -123.54 3.45 9.45 Favored Glycine 0 N--CA 1.429 -1.785 0 C-N-CA 120.975 -0.631 . . . . 65.109999999999999 113.69 178.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.7 m -102.31 118.69 37.41 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 118.79 1.295 . . . . 63.439999999999998 109.757 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -139.16 137.32 35.98 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.483 -0.562 . . . . 64.530000000000001 109.483 -178.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.2 p -103.14 119.18 51.24 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 106.348 -1.723 . . . . 61.119999999999997 106.348 170.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 18.9 m120 70.63 -78.01 0.05 Allowed 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 108.479 -0.934 . . . . 73.329999999999998 108.479 -171.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -152.31 2.16 0.34 Allowed 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.253 -0.885 . . . . 73.140000000000001 108.862 174.039 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -101.19 119.01 59.04 Favored Pre-proline 0 N--CA 1.438 -1.033 0 O-C-N 122.022 -0.424 . . . . 75.230000000000004 110.976 -171.141 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -81.02 90.99 1.17 Allowed 'Trans proline' 0 N--CA 1.43 -2.226 0 C-N-CA 121.777 1.651 . . . . 62.329999999999998 109.538 174.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.03 -94.62 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.662 -0.699 . . . . 73.25 109.594 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 7.4 t30 167.83 -60.44 0.01 OUTLIER 'General case' 0 CA--C 1.489 -1.39 0 N-CA-C 104.431 -2.433 . . . . 70.019999999999996 104.431 175.071 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -123.91 138.71 54.44 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 106.313 -1.736 . . . . 61.100000000000001 106.313 171.034 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 55.1 tp60 -140.45 150.52 43.92 Favored 'General case' 0 C--N 1.278 -2.526 0 N-CA-C 109.868 -0.419 . . . . 71.219999999999999 109.868 -176.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 97.4 t -77.89 118.75 25.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 105.485 -2.043 . . . . 75.519999999999996 105.485 171.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 21.1 ttt -75.48 113.21 12.63 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 114.919 -1.037 . . . . 72.140000000000001 108.409 -173.079 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.4 ' HA ' ' OE1' ' A' ' 123' ' ' GLN . 5.7 tp60 -104.95 139.21 40.0 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.755 -0.657 . . . . 72.230000000000004 111.526 -171.136 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 3.5 t -79.0 131.99 36.49 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 114.932 -1.031 . . . . 74.299999999999997 110.56 -179.472 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 97.66 11.05 52.02 Favored Glycine 0 N--CA 1.434 -1.485 0 CA-C-N 115.604 -0.726 . . . . 53.200000000000003 112.14 177.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -124.2 173.1 8.55 Favored 'General case' 0 C--O 1.253 1.284 0 N-CA-C 108.228 -1.027 . . . . 72.530000000000001 108.228 178.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.592 ' OE2' ' HD3' ' A' ' 134' ' ' ARG . 36.9 tt0 -123.82 123.77 41.2 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 121.337 0.589 . . . . 72.030000000000001 109.665 -172.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 67.6 mt -105.18 130.37 56.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 108.645 -0.872 . . . . 73.430000000000007 108.645 -177.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -98.3 118.83 35.84 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 109.142 -0.688 . . . . 63.009999999999998 109.142 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 17.0 pt -120.06 109.04 24.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 CA-C-O 121.915 0.865 . . . . 64.209999999999994 110.002 -177.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 81.98 -124.34 6.43 Favored Glycine 0 N--CA 1.416 -2.666 0 N-CA-C 109.198 -1.561 . . . . 52.539999999999999 109.198 -178.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -102.23 -4.03 26.38 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 108.916 -0.772 . . . . 74.140000000000001 108.916 176.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.508 ' CE2' ' HD2' ' A' ' 55' ' ' PRO . 45.2 m-85 -115.82 -179.96 3.8 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.254 -0.43 . . . . 72.239999999999995 111.599 -172.49 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.592 ' HD3' ' OE2' ' A' ' 127' ' ' GLU . 10.4 ptp180 -137.86 140.83 40.64 Favored 'General case' 0 C--O 1.247 0.932 0 N-CA-C 113.515 0.932 . . . . 71.310000000000002 113.515 -172.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.44 HD21 HD22 ' A' ' 49' ' ' LEU . 29.5 tp -123.86 133.15 53.83 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.21 -1.359 . . . . 73.25 108.751 -175.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.483 ' HB ' ' CG2' ' A' ' 50' ' ' VAL . 25.7 t -107.81 132.29 55.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 107.689 -1.226 . . . . 74.049999999999997 107.689 178.403 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -104.18 123.83 48.02 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 120.617 0.246 . . . . 73.129999999999995 110.55 -176.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -126.41 138.58 53.56 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-O 121.809 0.814 . . . . 63.439999999999998 111.462 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -106.53 91.9 3.89 Favored 'General case' 0 C--N 1.278 -2.509 0 N-CA-C 107.163 -1.421 . . . . 53.409999999999997 107.163 172.202 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -93.63 -127.2 4.58 Favored Glycine 0 CA--C 1.497 -1.039 0 N-CA-C 110.47 -1.052 . . . . 31.239999999999998 110.47 -177.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -65.22 122.2 9.86 Favored 'Trans proline' 0 N--CA 1.445 -1.33 0 C-N-CA 121.588 1.525 . . . . 63.509999999999998 109.031 175.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -75.46 106.92 7.25 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 123.949 0.781 . . . . 55.109999999999999 110.413 -176.083 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.401 ' O ' ' HB1' ' A' ' 44' ' ' ALA . 51.3 mt-10 . . . . . 0 N--CA 1.396 -3.14 0 CA-C-O 117.936 -1.031 . . . . 65.299999999999997 108.359 176.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 pmm? . . . . . 0 N--CA 1.472 0.666 0 N-CA-C 111.538 0.199 . . . . 62.420000000000002 111.538 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.1 m -67.44 -42.59 82.87 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 107.76 -1.2 . . . . 74.409999999999997 107.76 175.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 51.9 64.21 1.94 Allowed 'General case' 0 C--O 1.239 0.548 0 C-N-CA 124.861 1.265 . . . . 73.530000000000001 113.388 176.221 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 29.2 t30 -134.46 100.86 4.78 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 114.713 -1.131 . . . . 71.150000000000006 108.715 178.155 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -81.86 92.13 6.65 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.724 -0.843 . . . . 65.510000000000005 108.724 178.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -107.61 56.21 0.49 Allowed Glycine 0 N--CA 1.429 -1.811 0 C-N-CA 120.806 -0.711 . . . . 52.509999999999998 112.184 -176.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.6 m -92.59 123.21 62.54 Favored Pre-proline 0 C--N 1.303 -1.445 0 N-CA-C 109.239 -0.652 . . . . 61.32 109.239 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -67.07 128.55 18.84 Favored 'Trans proline' 0 C--O 1.243 0.744 0 C-N-CA 122.537 2.158 . . . . 73.310000000000002 111.037 175.059 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -85.89 144.98 40.17 Favored Pre-proline 0 C--N 1.294 -1.82 0 CA-C-N 116.137 -0.483 . . . . 65.200000000000003 109.942 -179.383 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -72.85 117.3 5.06 Favored 'Trans proline' 0 N--CA 1.446 -1.3 0 C-N-CA 122.207 1.938 . . . . 62.310000000000002 112.683 -177.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -100.75 136.85 39.96 Favored 'General case' 0 C--N 1.282 -2.364 0 CA-C-N 115.03 -0.986 . . . . 74.340000000000003 108.768 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.1 p -127.37 122.89 60.63 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 CA-C-O 121.72 0.771 . . . . 75.230000000000004 110.809 178.435 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -122.63 133.17 54.53 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 108.205 -1.035 . . . . 63.539999999999999 108.205 177.206 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.4 t -163.9 99.66 0.87 Allowed 'General case' 0 N--CA 1.42 -1.958 0 CA-C-O 122.054 0.931 . . . . 71.140000000000001 109.367 -178.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 21.0 m -84.44 79.26 9.63 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 108.532 -0.914 . . . . 53.130000000000003 108.532 178.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.9 p -125.47 84.45 2.28 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 115.108 -0.951 . . . . 73.25 111.53 -176.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 50.4 t -129.64 141.71 45.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 108.024 -1.102 . . . . 62.329999999999998 108.024 -178.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -100.07 78.24 2.07 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.733 0.778 . . . . 71.030000000000001 109.583 175.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 21.7 ttp180 -111.16 8.98 21.88 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 115.146 -0.934 . . . . 74.310000000000002 108.605 -179.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 60.76 33.87 20.01 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 114.984 -1.007 . . . . 61.100000000000001 109.202 -177.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -49.81 -44.49 49.19 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.41 1.884 . . . . 72.219999999999999 110.101 -177.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 56.3 tp -148.47 84.67 1.49 Allowed 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 106.444 -1.687 . . . . 65.120000000000005 106.444 172.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -138.99 101.35 4.27 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.819 -0.808 . . . . 64.510000000000005 108.819 -176.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -105.23 166.75 10.19 Favored 'General case' 0 C--N 1.288 -2.098 0 CA-C-N 115.468 -0.787 . . . . 63.539999999999999 109.076 178.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 67.68 76.72 0.27 Allowed 'General case' 0 C--O 1.237 0.412 0 O-C-N 124.595 1.185 . . . . 70.230000000000004 108.844 -174.173 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 25.6 ptt? -119.88 154.07 34.91 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.949 -0.76 . . . . 51.329999999999998 108.949 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -69.2 110.57 4.64 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 123.663 0.602 . . . . 64.049999999999997 110.036 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.7 m -141.96 149.82 40.6 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.424 -0.954 . . . . 73.25 108.424 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.525 ' CB ' ' HA ' ' A' ' 61' ' ' PHE . 60.9 p -107.73 127.87 54.06 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 120.967 0.413 . . . . 72.150000000000006 111.211 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.1 m -155.22 100.77 2.18 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.102 -1.444 . . . . 63.299999999999997 107.102 178.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -84.55 173.48 49.58 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 111.442 -0.663 . . . . 61.409999999999997 111.442 -177.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.6 m -108.09 114.63 28.67 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.901 -0.777 . . . . 60.149999999999999 108.901 -179.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.19 117.36 53.67 Favored Pre-proline 0 C--N 1.305 -1.337 0 O-C-N 123.726 0.641 . . . . 75.400000000000006 110.967 -177.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -66.9 132.65 28.92 Favored 'Trans proline' 0 C--O 1.246 0.9 0 C-N-CA 122.648 2.232 . . . . 62.219999999999999 110.451 175.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -79.7 102.87 9.23 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 107.431 -1.322 . . . . 31.210000000000001 107.431 177.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 65.9 m -147.03 155.67 42.41 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-N 116.293 -0.412 . . . . 62.350000000000001 109.906 -175.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 17.7 m -88.11 -8.47 55.41 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.753 -0.832 . . . . 73.099999999999994 108.753 178.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -49.37 113.53 1.78 Allowed Glycine 0 N--CA 1.419 -2.451 0 C-N-CA 125.453 1.501 . . . . 41.32 113.107 176.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.514 ' O ' ' HD3' ' A' ' 43' ' ' PRO . . . -55.89 -24.09 35.18 Favored 'General case' 0 C--N 1.277 -2.569 0 CA-C-N 113.074 -1.563 . . . . 75.219999999999999 113.035 -178.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -66.36 -14.7 62.48 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 122.988 0.515 . . . . 75.140000000000001 112.022 178.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -83.0 -13.55 55.73 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.01 0.433 . . . . 55.0 110.938 176.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -77.74 -50.09 2.0 Favored Pre-proline 0 CA--C 1.57 1.726 0 N-CA-C 113.884 1.068 . . . . 72.409999999999997 113.884 -177.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.514 ' HD3' ' O ' ' A' ' 39' ' ' ALA . 8.0 Cg_exo -73.56 98.02 1.01 Allowed 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 121.657 1.571 . . . . 75.209999999999994 112.348 -178.181 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -87.37 66.97 9.35 Favored 'General case' 0 C--O 1.249 1.047 0 CA-C-O 122.42 1.105 . . . . 55.32 111.302 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -112.61 70.45 0.22 Allowed Glycine 0 CA--C 1.477 -2.294 0 N-CA-C 106.084 -2.806 . . . . 64.510000000000005 106.084 175.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 25.0 m -88.74 163.0 15.93 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-O 121.835 0.826 . . . . 35.229999999999997 112.405 -167.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.509 ' HA ' ' N ' ' A' ' 140' ' ' GLY . . . -129.48 171.14 12.86 Favored 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 107.604 -1.258 . . . . 54.219999999999999 107.604 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.7 pp -133.71 143.87 48.78 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 112.314 0.487 . . . . 64.150000000000006 112.314 -175.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.521 ' H ' HD23 ' A' ' 49' ' ' LEU . 2.4 pt? -109.75 132.01 54.54 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.91 -1.145 . . . . 71.239999999999995 107.91 178.044 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 23.5 t -119.04 126.37 75.3 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 109.111 -0.7 . . . . 75.230000000000004 109.111 -176.229 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.436 HG22 HD13 ' A' ' 135' ' ' LEU . 15.4 t -92.77 118.35 38.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.761 0 N-CA-C 107.234 -1.395 . . . . 74.340000000000003 107.234 177.545 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.524 ' HB2' ' HG3' ' A' ' 134' ' ' ARG . 31.8 mmmt -70.68 -38.22 73.72 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 108.72 -0.844 . . . . 75.25 108.72 -179.058 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.547 ' HE ' ' HA ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -174.3 133.74 0.41 Allowed 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.011 -0.995 . . . . 63.020000000000003 108.805 178.076 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -177.91 158.26 23.15 Favored Glycine 0 N--CA 1.43 -1.715 0 N-CA-C 108.648 -1.781 . . . . 53.109999999999999 108.648 176.026 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -68.42 -25.47 35.66 Favored 'Trans proline' 0 N--CA 1.48 0.73 0 C-N-CA 122.292 1.995 . . . . 72.209999999999994 110.477 176.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.457 ' CB ' ' HA ' ' A' ' 80' ' ' LEU . 9.7 p30 -58.55 -58.64 7.66 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 113.91 -1.495 . . . . 73.329999999999998 111.9 177.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -162.96 -179.75 6.98 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 108.761 -0.829 . . . . 53.140000000000001 108.761 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -155.31 36.04 0.65 Allowed Glycine 0 C--N 1.3 -1.46 0 N-CA-C 109.97 -1.252 . . . . 71.019999999999996 109.97 178.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -140.04 -171.25 3.14 Favored 'General case' 0 N--CA 1.424 -1.763 0 N-CA-C 108.851 -0.796 . . . . 71.310000000000002 108.851 -175.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 23.7 ptt180 -112.62 146.02 39.35 Favored 'General case' 0 C--N 1.294 -1.839 0 O-C-N 123.578 0.549 . . . . 75.329999999999998 110.577 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.525 ' HA ' ' CB ' ' A' ' 29' ' ' SER . 93.5 m-85 -129.45 131.64 46.78 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.885 -0.598 . . . . 72.349999999999994 109.613 178.368 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 53.8 tp -90.45 129.38 36.64 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.033 -0.728 . . . . 75.450000000000003 109.033 178.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -79.75 113.84 18.21 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 119.855 -0.738 . . . . 75.120000000000005 110.379 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -112.2 -24.99 9.52 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 122.186 0.994 . . . . 75.409999999999997 108.506 174.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -92.39 127.55 48.25 Favored Pre-proline 0 C--N 1.306 -1.291 0 CA-C-N 114.305 -1.316 . . . . 75.349999999999994 110.171 -174.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.461 ' O ' ' HA ' ' A' ' 93' ' ' ARG . 10.4 Cg_endo -57.78 -41.79 66.21 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 122.852 2.368 . . . . 53.310000000000002 112.783 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 32.0 m -118.34 109.35 16.18 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 109.386 -0.598 . . . . 73.299999999999997 109.386 178.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.418 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 64.1 m -106.32 115.39 30.13 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 115.913 -0.585 . . . . 72.420000000000002 109.594 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.7 m -86.49 120.61 28.0 Favored 'General case' 0 C--O 1.25 1.127 0 CA-C-N 116.184 -0.462 . . . . 74.340000000000003 109.942 -177.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -101.99 112.98 25.82 Favored 'General case' 0 C--O 1.252 1.232 0 CA-C-O 120.88 0.372 . . . . 61.210000000000001 110.445 179.066 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 170.4 -173.19 44.3 Favored Glycine 0 N--CA 1.426 -1.993 0 N-CA-C 110.07 -1.212 . . . . 52.240000000000002 110.07 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -119.26 95.42 4.8 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 105.808 -1.923 . . . . 64.400000000000006 105.808 178.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 8.7 m80 -134.65 178.26 1.85 Allowed Pre-proline 0 C--N 1.287 -2.127 0 N-CA-C 106.289 -1.745 . . . . 73.109999999999999 106.289 -177.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -64.21 -21.54 67.38 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 121.45 1.434 . . . . 74.519999999999996 109.732 167.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -116.66 78.79 1.24 Allowed 'General case' 0 N--CA 1.434 -1.24 0 C-N-CA 123.958 0.903 . . . . 72.400000000000006 109.754 178.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 74.2 m -104.58 118.45 36.61 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-N 115.467 -0.788 . . . . 70.209999999999994 109.482 172.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -78.01 -43.43 29.5 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 108.694 -0.854 . . . . 75.25 108.694 177.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.8 pp -120.5 166.49 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 N-CA-C 107.786 -1.191 . . . . 53.240000000000002 107.786 171.095 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -107.53 135.96 48.12 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 115.161 1.541 . . . . 51.119999999999997 115.161 -168.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.457 ' HA ' ' CB ' ' A' ' 56' ' ' ASN . 4.0 mm? -125.08 153.41 42.97 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 104.429 -2.434 . . . . 63.030000000000001 104.429 171.512 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -144.72 -14.86 0.55 Allowed 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 118.793 -1.163 . . . . 73.019999999999996 112.557 -175.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -72.89 161.49 30.65 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 123.579 0.751 . . . . 71.150000000000006 110.747 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.3 p -77.12 -16.32 14.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-O 122.202 1.001 . . . . 53.0 110.377 -176.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -82.93 11.45 6.11 Favored 'General case' 0 N--CA 1.42 -1.928 0 CA-C-N 114.768 -1.106 . . . . 54.009999999999998 112.973 -179.206 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.0 p -83.3 139.74 17.28 Favored 'Isoleucine or valine' 0 C--O 1.244 0.783 0 CA-C-O 121.068 0.461 . . . . 61.240000000000002 109.833 176.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 28.4 t -105.37 157.11 17.56 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.446 -0.946 . . . . 72.299999999999997 108.446 179.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -69.98 110.69 5.2 Favored 'General case' 0 C--O 1.249 1.035 0 N-CA-C 106.839 -1.541 . . . . 73.209999999999994 106.839 174.086 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 59.4 mtt180 60.49 78.15 0.29 Allowed 'General case' 0 C--N 1.316 -0.867 0 O-C-N 124.536 1.147 . . . . 70.120000000000005 107.964 -166.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 45.0 t60 -77.29 -43.06 34.54 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 113.554 -1.657 . . . . 74.420000000000002 108.46 -176.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -150.67 159.19 44.69 Favored 'General case' 0 N--CA 1.422 -1.838 0 N-CA-C 107.251 -1.389 . . . . 51.439999999999998 107.251 178.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -136.73 127.86 27.9 Favored 'General case' 0 C--N 1.283 -2.311 0 N-CA-C 107.615 -1.254 . . . . 74.340000000000003 107.615 176.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.418 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 91.9 m-85 -110.28 124.48 51.72 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.955 -0.757 . . . . 60.450000000000003 108.955 -177.409 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' A' ' 66' ' ' PRO . 42.7 mtp85 -119.09 138.18 53.06 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-O 121.317 0.58 . . . . 64.439999999999998 112.449 175.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.466 ' O ' HD12 ' A' ' 94' ' ' ILE . 2.8 pp -116.02 116.47 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.152 0 N-CA-C 106.664 -1.606 . . . . 64.430000000000007 106.664 173.266 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -118.68 147.49 43.74 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 115.452 -0.794 . . . . 72.040000000000006 110.666 -173.056 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -45.82 -32.22 2.48 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.896 1.278 . . . . 72.409999999999997 112.385 178.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -78.72 -59.19 2.87 Favored Glycine 0 N--CA 1.436 -1.355 0 N-CA-C 111.488 -0.645 . . . . 74.150000000000006 111.488 175.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -158.28 173.77 16.18 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 123.777 0.831 . . . . 61.240000000000002 109.304 -175.454 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -102.68 134.73 45.57 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.068 -1.086 . . . . 65.430000000000007 108.068 -178.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -132.31 135.73 46.41 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 114.117 1.154 . . . . 74.329999999999998 114.117 -177.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 6.9 p -110.98 127.62 67.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 CA-C-N 114.532 -1.213 . . . . 72.140000000000001 107.973 177.104 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.6 p -119.09 130.3 74.04 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 C-N-CA 120.347 -0.541 . . . . 73.540000000000006 111.779 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -81.37 106.22 13.17 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 105.533 -2.025 . . . . 63.210000000000001 105.533 174.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.6 m -104.35 13.86 7.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 112.761 0.652 . . . . 44.240000000000002 112.761 -175.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 114.02 73.82 0.61 Allowed Glycine 0 CA--C 1.489 -1.544 0 C-N-CA 120.537 -0.84 . . . . 53.240000000000002 111.239 178.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 14.0 p -91.76 138.23 31.72 Favored 'General case' 0 N--CA 1.416 -2.154 0 CA-C-N 115.337 -0.432 . . . . 52.140000000000001 110.218 -177.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 5.8 tt -82.75 -47.55 11.83 Favored 'General case' 0 C--N 1.315 -0.935 0 N-CA-C 108.016 -1.105 . . . . 40.219999999999999 108.016 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.463 ' OD1' ' HA3' ' A' ' 131' ' ' GLY . 11.6 t-20 -68.42 -32.64 72.82 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.679 -0.691 . . . . 72.299999999999997 109.901 179.207 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.428 ' O ' ' HA ' ' A' ' 130' ' ' ILE . . . 112.53 131.68 5.63 Favored Glycine 0 C--O 1.223 -0.573 0 CA-C-N 116.093 -0.503 . . . . 24.210000000000001 112.233 179.064 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -109.16 122.03 46.43 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 123.389 0.676 . . . . 54.100000000000001 109.717 176.64 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -123.76 133.06 53.91 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 108.616 -0.883 . . . . 51.240000000000002 108.616 178.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 45.4 t -121.35 117.45 52.77 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 N-CA-C 106.128 -1.804 . . . . 64.219999999999999 106.128 177.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.495 ' HB2' HH21 ' A' ' 117' ' ' ARG . 20.3 m120 66.88 24.74 9.66 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 108.556 -0.905 . . . . 65.340000000000003 108.556 -172.576 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.528 ' HG2' ' OE1' ' A' ' 129' ' ' GLN . 96.2 mtt180 75.77 2.84 3.77 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 126.001 1.72 . . . . 63.149999999999999 112.833 -178.156 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 55.0 mm-40 -104.97 129.49 24.75 Favored Pre-proline 0 C--N 1.311 -1.071 0 N-CA-C 109.11 -0.7 . . . . 72.329999999999998 109.11 178.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -71.56 124.76 10.57 Favored 'Trans proline' 0 C--O 1.247 0.957 0 C-N-CA 122.116 1.878 . . . . 60.0 108.881 174.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.495 HH21 ' HB2' ' A' ' 113' ' ' ASN . 47.4 mtt180 -119.98 -158.78 0.75 Allowed 'General case' 0 C--N 1.31 -1.113 0 O-C-N 121.951 -0.468 . . . . 73.209999999999994 111.24 -172.41 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -121.74 -45.24 2.29 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 108.104 -1.073 . . . . 71.349999999999994 108.104 174.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -156.7 138.87 14.61 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 107.28 -1.378 . . . . 60.200000000000003 107.28 171.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 53.8 tp60 -141.73 150.85 42.33 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 110.437 -0.209 . . . . 74.439999999999998 110.437 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 78.7 t -78.87 127.96 38.7 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 107.24 -1.393 . . . . 71.239999999999995 107.24 174.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 82.0 mtp -71.68 120.02 16.67 Favored 'General case' 0 CA--C 1.497 -1.085 0 CA-C-N 115.757 -0.656 . . . . 60.210000000000001 109.28 -175.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 14.2 tp60 -105.39 130.17 53.55 Favored 'General case' 0 N--CA 1.415 -2.182 0 N-CA-C 108.362 -0.977 . . . . 62.229999999999997 108.362 -177.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 18.9 p -78.35 123.54 27.1 Favored 'General case' 0 N--CA 1.424 -1.769 0 CA-C-O 121.1 0.476 . . . . 71.349999999999994 110.606 -177.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 123.62 -17.61 7.77 Favored Glycine 0 N--CA 1.416 -2.664 0 CA-C-N 115.432 -0.803 . . . . 63.140000000000001 111.791 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -104.32 -169.73 1.67 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 120.133 -0.627 . . . . 63.439999999999998 110.941 -176.16 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -136.97 136.11 38.25 Favored 'General case' 0 C--O 1.25 1.123 0 CA-C-O 121.829 0.823 . . . . 75.120000000000005 112.141 -171.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 74.4 mt -110.29 130.59 63.29 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 C-N-CA 125.418 1.487 . . . . 64.109999999999999 107.926 -179.034 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.528 ' OE1' ' HG2' ' A' ' 114' ' ' ARG . 52.0 mt-30 -109.74 133.46 53.11 Favored 'General case' 0 C--N 1.29 -2.02 0 C-N-CA 120.347 -0.541 . . . . 72.329999999999998 110.713 -178.522 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.528 ' H ' HD13 ' A' ' 130' ' ' ILE . 0.2 OUTLIER -107.44 97.71 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.963 0 N-CA-C 106.783 -1.562 . . . . 53.32 106.783 171.859 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.463 ' HA3' ' OD1' ' A' ' 108' ' ' ASN . . . 70.78 -115.25 5.77 Favored Glycine 0 N--CA 1.427 -1.95 0 N-CA-C 108.81 -1.716 . . . . 41.219999999999999 108.81 -170.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -112.3 2.31 16.48 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.074 0.464 . . . . 52.240000000000002 110.689 176.028 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -85.78 140.19 30.68 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 106.402 -1.703 . . . . 72.329999999999998 106.402 177.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.524 ' HG3' ' HB2' ' A' ' 52' ' ' LYS . 15.3 ptm180 -116.75 131.63 56.9 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.043 -1.063 . . . . 74.540000000000006 113.856 -168.224 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.488 HD21 HD12 ' A' ' 49' ' ' LEU . 34.3 tp -122.58 121.5 36.63 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 114.032 -1.44 . . . . 74.420000000000002 108.715 -177.784 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 10.7 p -106.66 137.54 36.75 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.15 0 N-CA-C 108.863 -0.791 . . . . 74.319999999999993 108.863 -178.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -114.33 115.67 27.74 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 110.293 -0.262 . . . . 70.010000000000005 110.293 -173.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -121.47 163.62 18.5 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 109.065 -0.717 . . . . 74.329999999999998 109.065 -178.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -75.3 147.03 40.53 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 109.461 -0.57 . . . . 61.310000000000002 109.461 177.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.509 ' N ' ' HA ' ' A' ' 47' ' ' ALA . . . -104.39 -149.88 20.22 Favored Glycine 0 N--CA 1.426 -2.013 0 C-N-CA 120.551 -0.833 . . . . 72.010000000000005 111.403 -176.237 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -95.76 164.76 1.4 Allowed 'Trans proline' 0 N--CA 1.427 -2.391 0 C-N-CA 122.529 2.152 . . . . 62.509999999999998 112.693 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -92.91 112.6 24.61 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 106.77 -1.567 . . . . 75.450000000000003 106.77 174.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 . . . . . 0 N--CA 1.426 -1.643 0 CA-C-O 118.557 -0.735 . . . . 70.530000000000001 109.46 -175.609 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 CA--C 1.508 -0.647 0 N-CA-C 109.283 -0.636 . . . . 51.130000000000003 109.283 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.4 m -69.19 -47.67 64.24 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.649 -0.5 . . . . 64.409999999999997 109.649 179.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.7 t70 67.03 174.2 0.25 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.333 1.453 . . . . 72.230000000000004 110.604 178.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -130.16 -5.35 4.39 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 121.705 -0.622 . . . . 71.219999999999999 110.715 -178.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 58.6 t30 61.81 95.29 0.04 OUTLIER 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.911 1.284 . . . . 71.109999999999999 109.816 -174.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -56.63 100.03 0.1 Allowed Glycine 0 CA--C 1.506 -0.484 0 O-C-N 123.679 0.612 . . . . 64.120000000000005 112.965 -178.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.7 m -119.05 130.95 24.56 Favored Pre-proline 0 C--N 1.304 -1.375 0 N-CA-C 109.438 -0.579 . . . . 75.040000000000006 109.438 -176.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.91 127.38 16.85 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 121.667 1.578 . . . . 72.209999999999994 110.13 175.212 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -97.12 113.99 63.98 Favored Pre-proline 0 C--N 1.301 -1.518 0 N-CA-C 109.053 -0.721 . . . . 72.129999999999995 109.053 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -62.26 136.32 59.29 Favored 'Trans proline' 0 C--O 1.237 0.457 0 C-N-CA 123.342 2.694 . . . . 74.329999999999998 113.867 -173.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.0 tm0? -126.95 109.26 11.75 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 107.145 -1.428 . . . . 70.140000000000001 107.145 178.084 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.7 p -94.14 132.91 36.9 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 109.297 -0.631 . . . . 70.219999999999999 109.297 178.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -114.43 139.25 49.66 Favored 'General case' 0 N--CA 1.424 -1.727 0 N-CA-C 109.083 -0.71 . . . . 74.340000000000003 109.083 -178.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.0 m -100.86 118.41 36.87 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.735 -0.839 . . . . 74.129999999999995 108.735 -177.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 40.0 p -116.17 103.83 10.92 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 121.352 0.596 . . . . 73.109999999999999 111.843 -178.284 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.6 p -112.42 138.77 48.68 Favored 'General case' 0 N--CA 1.42 -1.932 0 N-CA-C 107.42 -1.326 . . . . 61.130000000000003 107.42 176.255 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.1 m -120.76 135.56 60.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 CA-C-O 121.372 0.606 . . . . 74.099999999999994 111.9 -177.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -155.54 135.88 13.17 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 106.401 -1.703 . . . . 63.32 106.401 177.373 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.32 -164.44 1.02 Allowed 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.867 -0.79 . . . . 73.239999999999995 108.867 -173.598 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.84 80.83 8.04 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 106.188 -1.782 . . . . 74.409999999999997 106.188 170.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -91.15 -2.35 57.56 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 114.439 -1.255 . . . . 73.230000000000004 113.997 -171.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 58.2 tp -93.08 99.63 12.2 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 119.938 -0.705 . . . . 74.540000000000006 111.416 179.016 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 53.5 tp -97.08 145.54 25.88 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 108.084 -1.08 . . . . 72.450000000000003 108.084 176.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.99 177.24 8.5 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.961 -0.755 . . . . 75.25 108.961 -178.644 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.73 -177.53 4.47 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.558 -0.534 . . . . 64.430000000000007 109.558 179.124 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.31 157.64 28.77 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.846 -1.168 . . . . 71.230000000000004 107.846 177.425 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -92.45 174.6 7.2 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 121.262 0.554 . . . . 71.530000000000001 111.473 177.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.9 m -107.28 -176.71 3.15 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 106.753 -1.573 . . . . 72.219999999999999 106.753 177.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.6 t -126.33 139.36 53.35 Favored 'General case' 0 N--CA 1.428 -1.543 0 C-N-CA 120.181 -0.608 . . . . 73.439999999999998 109.549 -178.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.2 t -132.89 128.17 35.99 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.652 -0.87 . . . . 74.230000000000004 108.652 177.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -123.01 114.11 2.33 Favored Glycine 0 N--CA 1.435 -1.375 0 N-CA-C 111.419 -0.673 . . . . 22.34 111.419 -177.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.9 p -67.87 154.81 40.76 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 123.243 0.617 . . . . 73.430000000000007 112.294 -177.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -83.87 130.9 53.4 Favored Pre-proline 0 C--N 1.312 -1.061 0 CA-C-N 116.139 -0.482 . . . . 75.299999999999997 109.918 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -75.94 109.05 2.82 Favored 'Trans proline' 0 N--CA 1.443 -1.442 0 C-N-CA 122.162 1.908 . . . . 54.32 110.543 176.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -102.8 116.99 33.66 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.623 -0.717 . . . . 65.129999999999995 109.367 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.0 t -138.1 124.62 20.77 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.029 0.442 . . . . 65.019999999999996 109.88 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.509 ' O ' ' HG2' ' A' ' 40' ' ' GLU . 91.0 m -127.65 158.25 38.07 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.099 -1.075 . . . . 41.509999999999998 108.099 179.181 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -81.32 -48.47 5.96 Favored Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 119.83 -1.176 . . . . 53.140000000000001 110.978 177.25 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -56.11 -19.76 14.56 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 124.526 1.13 . . . . 75.549999999999997 113.856 -178.101 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.509 ' HG2' ' O ' ' A' ' 37' ' ' THR . 11.6 pt-20 -65.67 -29.34 69.88 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.705 0.631 . . . . 64.340000000000003 112.705 -175.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -83.07 -16.47 46.82 Favored 'General case' 0 CA--C 1.505 -0.773 0 C-N-CA 119.183 -1.007 . . . . 74.340000000000003 110.004 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 tm? 75.92 104.97 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 125.723 1.609 . . . . 74.329999999999998 110.371 -179.09 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -79.96 173.03 13.23 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.779 2.319 . . . . 73.049999999999997 112.721 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -140.1 -167.46 2.31 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.75 -0.463 . . . . 75.25 109.75 -177.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -82.21 -12.48 80.7 Favored Glycine 0 CA--C 1.508 -0.376 0 N-CA-C 111.446 -0.662 . . . . 71.409999999999997 111.446 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.402 ' HB2' ' O ' ' A' ' 141' ' ' PRO . 15.5 m -112.32 153.82 26.64 Favored 'General case' 0 N--CA 1.424 -1.761 0 N-CA-C 108.707 -0.849 . . . . 75.140000000000001 108.707 177.298 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.439 ' O ' ' HG ' ' A' ' 62' ' ' LEU . . . -153.43 146.4 24.51 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 108.756 -0.831 . . . . 51.100000000000001 108.756 -178.062 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.43 ' HA ' ' HA ' ' A' ' 62' ' ' LEU . 2.4 pt? -130.23 160.12 34.8 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 109.484 -0.561 . . . . 72.120000000000005 109.484 -178.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.423 HD11 ' CZ ' ' A' ' 61' ' ' PHE . 3.7 pp -133.93 147.77 51.12 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 116.349 -0.387 . . . . 64.430000000000007 110.672 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.555 HG12 ' HB3' ' A' ' 60' ' ' ARG . 27.9 m -117.03 129.24 73.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 108.961 -0.755 . . . . 53.219999999999999 108.961 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.5 t -97.79 118.79 44.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 N-CA-C 107.754 -1.202 . . . . 45.130000000000003 107.754 176.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -110.81 -13.56 14.13 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.827 -0.624 . . . . 74.340000000000003 112.626 -173.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 16.6 tpp180 -150.1 125.94 10.45 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.86 -0.793 . . . . 71.129999999999995 108.86 176.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 139.9 135.76 3.28 Favored Glycine 0 C--O 1.206 -1.622 0 C-N-CA 120.722 -0.751 . . . . 54.539999999999999 112.472 176.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.543 ' HD2' ' CE1' ' A' ' 133' ' ' PHE . 39.2 Cg_exo -67.71 -8.66 23.06 Favored 'Trans proline' 0 N--CA 1.484 0.939 0 C-N-CA 123.134 2.556 . . . . 75.430000000000007 112.951 174.355 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -66.02 -40.13 90.81 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.203 -0.453 . . . . 73.540000000000006 110.667 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -169.26 173.56 6.61 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 109.252 -0.647 . . . . 63.310000000000002 109.252 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.93 43.61 0.41 Allowed Glycine 0 CA--C 1.487 -1.707 0 N-CA-C 108.997 -1.641 . . . . 44.200000000000003 108.997 178.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -147.15 -173.18 4.18 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.722 -0.844 . . . . 70.329999999999998 108.722 -174.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.555 ' HB3' HG12 ' A' ' 50' ' ' VAL . 14.1 ptt180 -121.69 141.48 51.11 Favored 'General case' 0 N--CA 1.434 -1.233 0 O-C-N 123.687 0.617 . . . . 73.409999999999997 110.116 179.251 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.423 ' CZ ' HD11 ' A' ' 49' ' ' LEU . 52.6 p90 -149.39 152.45 35.77 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 109.042 -0.725 . . . . 74.099999999999994 109.042 175.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 47' ' ' ALA . 9.2 tt -99.43 140.51 33.51 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 123.622 0.576 . . . . 63.229999999999997 109.621 -176.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 84.3 mt -81.13 114.26 19.85 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 121.279 0.562 . . . . 62.399999999999999 110.955 -176.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -122.25 -36.78 2.91 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.253 -1.017 . . . . 74.129999999999995 108.253 174.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.5 pm0 -64.46 130.18 94.54 Favored Pre-proline 0 N--CA 1.436 -1.148 0 CA-C-N 114.965 -1.016 . . . . 74.219999999999999 110.031 175.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.504 ' HA ' HG12 ' A' ' 94' ' ' ILE . 19.5 Cg_endo -60.47 -30.64 91.22 Favored 'Trans proline' 0 N--CA 1.479 0.663 0 C-N-CA 123.846 3.031 . . . . 75.120000000000005 113.477 -173.572 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 90.0 m -135.92 116.14 13.47 Favored 'General case' 0 N--CA 1.416 -2.158 0 CA-C-N 115.929 -0.578 . . . . 75.219999999999999 109.801 178.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.481 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 11.9 m -100.65 115.36 30.02 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 106.717 -1.586 . . . . 72.420000000000002 106.717 176.322 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.7 p -96.82 108.8 21.54 Favored 'General case' 0 N--CA 1.425 -1.679 0 CA-C-O 121.414 0.626 . . . . 72.430000000000007 112.169 -176.039 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.416 ' O ' ' HB3' ' A' ' 89' ' ' HIS . . . -102.32 92.55 4.76 Favored 'General case' 0 N--CA 1.425 -1.71 0 N-CA-C 107.836 -1.172 . . . . 71.540000000000006 107.836 174.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.587 ' O ' ' HA ' ' A' ' 88' ' ' ARG . . . 99.97 102.01 2.42 Favored Glycine 0 N--CA 1.428 -1.871 0 N-CA-C 110.5 -1.04 . . . . 42.100000000000001 110.5 -178.19 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.3 mmt85 -155.14 -61.1 0.11 Allowed 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 124.866 1.266 . . . . 72.420000000000002 108.488 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.465 ' HB3' ' HD2' ' A' ' 74' ' ' PRO . 94.4 m-70 -146.2 177.21 1.85 Allowed Pre-proline 0 C--N 1.295 -1.786 0 N-CA-C 106.751 -1.574 . . . . 63.420000000000002 106.751 -178.202 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 73' ' ' HIS . 6.3 Cg_endo -54.24 -30.69 62.97 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 121.88 1.72 . . . . 74.439999999999998 110.508 170.243 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -107.79 72.58 0.86 Allowed 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 115.16 -0.927 . . . . 63.140000000000001 109.678 178.055 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.444 ' HB2' ' O ' ' A' ' 78' ' ' ILE . 41.5 m -91.01 -174.82 4.13 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.502 -1.296 . . . . 64.120000000000005 107.502 173.604 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -60.9 -44.33 97.29 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 108.32 -0.992 . . . . 72.340000000000003 108.32 177.032 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.444 ' O ' ' HB2' ' A' ' 76' ' ' SER . 36.8 pt -128.02 143.59 40.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 105.582 -2.007 . . . . 63.210000000000001 105.582 170.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -99.48 126.45 45.41 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 118.568 -1.253 . . . . 75.219999999999999 112.113 -175.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.5 mp -85.46 89.6 7.74 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 106.361 -1.718 . . . . 74.310000000000002 106.361 175.195 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -45.27 -58.73 3.07 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.552 -1.204 . . . . 74.010000000000005 113.542 -173.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -162.84 -167.05 1.42 Allowed 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 106.69 -1.596 . . . . 54.219999999999999 106.69 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 83.2 t 74.3 -41.95 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.246 1.418 . . . . 72.349999999999994 112.58 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.541 ' HB ' ' CZ ' ' A' ' 133' ' ' PHE . 56.6 m -154.04 71.96 0.87 Allowed 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.358 0.599 . . . . 54.109999999999999 110.331 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.3 p -114.45 109.03 27.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 O-C-N 121.617 -0.677 . . . . 75.420000000000002 112.401 176.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 36.0 t -97.74 170.29 9.09 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.699 -0.852 . . . . 73.430000000000007 108.699 174.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 60.0 ttt180 -78.39 -8.23 58.23 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 122.952 1.358 . . . . 72.299999999999997 109.381 -179.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.587 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -170.61 125.65 0.72 Allowed 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 104.154 -2.536 . . . . 72.150000000000006 104.154 173.047 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.416 ' HB3' ' O ' ' A' ' 70' ' ' ALA . 11.7 t60 -128.46 -76.97 0.56 Allowed 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 118.939 -1.105 . . . . 74.519999999999996 112.914 -172.585 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -127.7 119.26 25.44 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-O 121.272 0.558 . . . . 72.129999999999995 109.605 -176.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -114.03 128.01 56.2 Favored 'General case' 0 C--N 1.276 -2.594 0 C-N-CA 120.02 -0.672 . . . . 62.219999999999999 110.439 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.481 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 56.2 m-85 -97.41 121.21 39.05 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 107.991 -1.114 . . . . 65.409999999999997 107.991 -178.571 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 34.3 mmt-85 -104.91 129.13 53.36 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.437 -0.949 . . . . 71.219999999999999 108.437 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.504 HG12 ' HA ' ' A' ' 66' ' ' PRO . 11.4 pt -115.88 130.96 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.201 0 C-N-CA 118.504 -1.279 . . . . 72.030000000000001 108.022 173.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.437 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 56.0 t-20 -120.03 145.47 46.79 Favored 'General case' 0 C--N 1.269 -2.93 0 N-CA-C 106.547 -1.649 . . . . 74.109999999999999 106.547 -175.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -59.7 -20.27 55.26 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-O 121.357 0.598 . . . . 64.530000000000001 110.267 174.04 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -77.61 -61.81 2.52 Favored Glycine 0 N--CA 1.423 -2.172 0 CA-C-N 115.488 -0.778 . . . . 63.549999999999997 111.604 174.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.437 ' O ' ' HB3' ' A' ' 95' ' ' ASN . 27.3 tt0 -157.4 -178.11 7.1 Favored 'General case' 0 CA--C 1.552 1.023 0 CA-C-N 117.475 0.637 . . . . 74.0 109.346 -176.48 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.638 ' HB3' ' SD ' ' A' ' 122' ' ' MET . 81.5 m-85 -109.71 130.05 55.55 Favored 'General case' 0 C--N 1.311 -1.091 0 O-C-N 121.963 -0.46 . . . . 72.099999999999994 110.52 -176.183 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -132.53 135.84 46.23 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-O 120.633 0.254 . . . . 74.400000000000006 111.464 -175.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 8.9 p -114.56 129.62 70.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 O-C-N 121.845 -0.534 . . . . 33.32 110.073 176.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 59.4 t -118.92 128.97 75.72 Favored 'Isoleucine or valine' 0 C--O 1.248 0.98 0 CA-C-N 116.313 -0.403 . . . . 75.25 111.321 -177.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -83.95 117.96 23.7 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.637 -0.71 . . . . 62.219999999999999 109.215 173.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.423 ' O ' ' HG2' ' A' ' 88' ' ' ARG . 17.8 m -118.2 8.0 6.9 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.35 0 N-CA-C 108.258 -1.016 . . . . 73.239999999999995 108.258 176.02 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.448 ' HA2' ' O ' ' A' ' 88' ' ' ARG . . . -91.2 -66.15 1.16 Allowed Glycine 0 N--CA 1.404 -3.446 0 CA-C-N 114.578 -1.192 . . . . 63.340000000000003 111.091 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 14.0 m 60.07 1.46 0.34 Allowed 'General case' 0 CA--C 1.566 1.573 0 C-N-CA 124.252 1.021 . . . . 62.409999999999997 112.282 -179.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 49.1 tp -72.98 -50.82 21.01 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.099 0.959 . . . . 70.310000000000002 109.656 -177.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -99.23 -35.44 9.97 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.114 -0.948 . . . . 64.230000000000004 109.397 176.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 104.05 133.84 7.98 Favored Glycine 0 N--CA 1.427 -1.964 0 N-CA-C 110.584 -1.006 . . . . 33.32 110.584 -178.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 97.7 m -101.87 119.62 39.08 Favored 'General case' 0 C--N 1.281 -2.374 0 N-CA-C 108.847 -0.797 . . . . 75.099999999999994 108.847 178.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 116' ' ' PRO . 3.9 m-85 -111.32 132.48 54.36 Favored 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 106.487 -1.671 . . . . 73.510000000000005 106.487 -177.229 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.471 HG11 ' HG3' ' A' ' 120' ' ' GLN . 7.7 p -131.16 131.92 63.51 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.776 0 C-N-CA 119.953 -0.699 . . . . 73.140000000000001 110.696 178.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 66.56 -72.46 0.08 Allowed 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 125.506 1.523 . . . . 73.010000000000005 110.841 -177.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 114' ' ' ARG . 6.7 tpt180 -154.59 4.26 0.24 Allowed 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.902 -0.59 . . . . 61.109999999999999 109.489 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.432 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . 43.8 mt-10 -132.98 134.72 24.78 Favored Pre-proline 0 C--O 1.237 0.43 0 O-C-N 121.319 -0.863 . . . . 64.400000000000006 112.487 -174.491 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 115' ' ' GLU . 2.9 Cg_exo -77.23 116.01 4.07 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 122.332 2.021 . . . . 52.240000000000002 108.702 170.144 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.45 HH11 ' HG3' ' A' ' 120' ' ' GLN . 7.0 ptp180 -144.06 151.41 39.61 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.112 -1.07 . . . . 74.239999999999995 108.112 -178.299 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -76.22 -42.19 46.86 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 112.529 0.566 . . . . 74.349999999999994 112.529 -174.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -125.84 140.61 52.52 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 109.331 -0.618 . . . . 75.540000000000006 109.331 179.217 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.471 ' HG3' HG11 ' A' ' 112' ' ' VAL . 1.6 tm0? -138.94 149.85 45.23 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 116.41 -0.359 . . . . 71.420000000000002 110.561 -178.34 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 81.1 t -104.5 117.68 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 N-CA-C 105.743 -1.947 . . . . 75.319999999999993 105.743 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.638 ' SD ' ' HB3' ' A' ' 99' ' ' PHE . 66.7 mtt -59.86 128.67 38.04 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 113.87 1.063 . . . . 65.120000000000005 113.87 -169.285 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -112.07 137.73 49.71 Favored 'General case' 0 N--CA 1.418 -2.044 0 N-CA-C 107.079 -1.452 . . . . 74.329999999999998 107.079 178.07 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.489 ' HB ' ' HB3' ' A' ' 139' ' ' ALA . 1.8 t -79.37 129.76 34.78 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-O 121.368 0.604 . . . . 60.420000000000002 110.826 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 83.79 38.21 10.79 Favored Glycine 0 N--CA 1.424 -2.118 0 N-CA-C 110.014 -1.234 . . . . 71.109999999999999 110.014 -178.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -125.25 166.81 15.82 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.722 -0.391 . . . . 73.349999999999994 110.985 -177.286 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 19.1 tp10 -107.47 120.56 42.51 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 123.405 0.682 . . . . 75.030000000000001 109.181 -172.295 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 61.6 mt -114.96 117.6 56.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 108.006 -1.109 . . . . 72.019999999999996 108.006 179.023 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -116.49 111.8 20.49 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.255 0.55 . . . . 73.209999999999994 109.787 -175.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.413 HG13 ' HB2' ' A' ' 133' ' ' PHE . 25.6 pt -101.71 98.36 6.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-O 121.83 0.824 . . . . 74.239999999999995 109.384 179.055 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 70.36 -100.09 0.78 Allowed Glycine 0 N--CA 1.435 -1.386 0 N-CA-C 110.384 -1.087 . . . . 63.32 110.384 -175.574 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -115.18 0.35 13.53 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 120.938 0.399 . . . . 75.019999999999996 110.603 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.543 ' CE1' ' HD2' ' A' ' 55' ' ' PRO . 9.7 m-30 -93.27 141.15 28.76 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.035 -0.728 . . . . 72.510000000000005 109.035 -176.708 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 41.0 mtm180 -121.81 122.55 39.73 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.889 0.852 . . . . 74.329999999999998 111.193 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.8 tt -124.72 131.1 53.48 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 113.744 -1.571 . . . . 70.200000000000003 108.77 -176.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 57.5 t -108.09 128.41 63.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 108.697 -0.853 . . . . 73.120000000000005 108.697 178.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -100.78 130.05 46.75 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.953 -0.567 . . . . 73.230000000000004 110.438 -176.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.4 mp -130.66 130.45 43.93 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.692 -0.484 . . . . 74.120000000000005 109.692 179.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.489 ' HB3' ' HB ' ' A' ' 124' ' ' THR . . . -122.38 117.67 26.6 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 108.07 -1.085 . . . . 73.209999999999994 108.07 177.37 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -174.04 -60.11 0.05 OUTLIER Glycine 0 C--N 1.294 -1.786 0 C-N-CA 120.125 -1.036 . . . . 73.319999999999993 112.673 -176.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.402 ' O ' ' HB2' ' A' ' 46' ' ' SER . 33.2 Cg_exo -61.88 123.36 12.47 Favored 'Trans proline' 0 C--N 1.358 1.045 0 C-N-CA 121.917 1.744 . . . . 63.299999999999997 110.895 176.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -96.88 109.5 22.2 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 115.304 -0.862 . . . . 55.130000000000003 111.065 -175.168 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 . . . . . 0 N--CA 1.408 -2.542 0 N-CA-C 108.16 -1.052 . . . . 64.239999999999995 108.16 177.123 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ptt? . . . . . 0 C--O 1.237 0.431 0 CA-C-O 122.09 0.948 . . . . 71.140000000000001 110.527 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.9 t -82.24 -49.15 10.42 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 115.278 -0.874 . . . . 74.349999999999994 111.974 -174.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -107.29 139.03 42.39 Favored 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 120.675 -0.41 . . . . 75.129999999999995 109.908 -176.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -95.58 120.05 35.14 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.3 0.571 . . . . 50.039999999999999 111.928 -176.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -118.03 145.49 44.74 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.277 -1.379 . . . . 74.0 107.277 175.12 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 93.11 45.65 3.51 Favored Glycine 0 N--CA 1.431 -1.682 0 N-CA-C 109.631 -1.388 . . . . 73.049999999999997 109.631 -175.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 55.9 m -92.28 122.91 63.86 Favored Pre-proline 0 N--CA 1.416 -2.141 0 N-CA-C 107.833 -1.173 . . . . 73.510000000000005 107.833 178.324 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.56 128.95 19.02 Favored 'Trans proline' 0 N--CA 1.448 -1.205 0 C-N-CA 122.211 1.941 . . . . 71.030000000000001 111.272 177.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -73.67 109.73 7.32 Favored Pre-proline 0 C--N 1.315 -0.9 0 N-CA-C 107.168 -1.419 . . . . 71.019999999999996 107.168 173.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -73.24 132.84 18.48 Favored 'Trans proline' 0 N--CA 1.443 -1.465 0 C-N-CA 122.186 1.924 . . . . 73.439999999999998 113.016 -171.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 23.8 pt20 -110.27 116.73 32.0 Favored 'General case' 0 N--CA 1.422 -1.837 0 CA-C-N 115.573 -0.74 . . . . 64.340000000000003 109.323 175.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.9 p -86.01 88.84 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.519 0 CA-C-O 122.542 1.163 . . . . 72.439999999999998 110.062 178.064 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -125.52 120.35 30.66 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 106.667 -1.605 . . . . 55.409999999999997 106.667 178.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.5 m -113.4 98.98 7.43 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-O 121.321 0.581 . . . . 60.450000000000003 111.281 -175.596 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.5 m -105.85 -11.58 16.18 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 122.557 1.17 . . . . 74.150000000000006 108.459 175.014 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.2 t -83.26 91.83 7.36 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 114.218 -1.355 . . . . 74.519999999999996 108.24 176.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 59.8 t -134.41 130.51 53.98 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 N-CA-C 107.721 -1.215 . . . . 65.430000000000007 107.721 -178.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -127.92 144.63 51.1 Favored 'General case' 0 N--CA 1.424 -1.753 0 C-N-CA 119.826 -0.75 . . . . 71.030000000000001 111.445 179.266 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 85.1 mtt180 -100.0 41.62 1.15 Allowed 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.384 -1.339 . . . . 74.140000000000001 107.384 -177.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 69.49 18.77 7.73 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.784 1.234 . . . . 73.150000000000006 110.234 -174.225 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -49.85 -49.23 49.9 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.704 1.202 . . . . 74.349999999999994 111.941 -178.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.529 HD23 ' H ' ' A' ' 22' ' ' LEU . 1.7 pt? -111.11 27.38 9.73 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.384 0.611 . . . . 62.049999999999997 111.033 -177.196 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.6 tt -110.27 97.07 6.63 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 107.447 -1.316 . . . . 75.420000000000002 107.447 178.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.522 ' HG3' ' H ' ' A' ' 25' ' ' GLU . 0.1 OUTLIER -128.83 -71.68 0.63 Allowed 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.832 -0.622 . . . . 74.099999999999994 112.349 -177.501 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.522 ' H ' ' HG3' ' A' ' 24' ' ' LYS . 39.4 mt-10 -126.9 90.33 3.14 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.918 -0.771 . . . . 71.150000000000006 108.918 -177.548 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 70.6 mtm -93.07 133.06 36.62 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 116.269 -0.423 . . . . 72.450000000000003 111.025 -177.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -78.77 103.99 9.08 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.415 -0.811 . . . . 65.200000000000003 109.642 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.3 p -79.66 89.22 5.14 Favored 'General case' 0 N--CA 1.423 -1.809 0 CA-C-N 115.67 -0.695 . . . . 71.099999999999994 110.663 179.068 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 29.6 t 69.88 96.34 0.07 Allowed 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 114.908 -1.042 . . . . 73.400000000000006 110.219 -177.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.1 t -120.19 127.62 52.62 Favored 'General case' 0 N--CA 1.424 -1.743 0 N-CA-C 109.045 -0.724 . . . . 61.530000000000001 109.045 177.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -152.45 -141.28 3.27 Favored Glycine 0 N--CA 1.416 -2.637 0 N-CA-C 111.012 -0.835 . . . . 72.340000000000003 111.012 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.3 t -110.43 151.57 27.34 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 109.623 -0.51 . . . . 75.200000000000003 109.623 -178.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.65 114.16 47.85 Favored Pre-proline 0 C--N 1.31 -1.137 0 N-CA-C 108.982 -0.747 . . . . 25.210000000000001 108.982 177.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -79.85 114.65 3.2 Favored 'Trans proline' 0 N--CA 1.445 -1.376 0 C-N-CA 121.929 1.753 . . . . 72.25 111.81 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -96.98 111.64 23.76 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.401 -0.818 . . . . 73.030000000000001 109.541 179.083 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.7 m -77.45 104.87 8.22 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 115.759 -0.655 . . . . 64.530000000000001 109.316 -179.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 20.6 m -86.16 83.13 7.81 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-O 121.819 0.819 . . . . 74.340000000000003 108.965 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -135.66 43.96 1.21 Allowed Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 108.343 -1.903 . . . . 75.510000000000005 108.343 177.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.402 ' HB1' ' HG3' ' A' ' 96' ' ' GLU . . . -63.87 -20.9 66.18 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 124.096 0.958 . . . . 43.119999999999997 111.839 -174.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -62.13 -36.65 82.44 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.352 0.596 . . . . 72.319999999999993 109.655 177.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -73.19 -28.55 62.26 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.142 -0.935 . . . . 74.109999999999999 111.211 -178.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -89.47 111.49 45.93 Favored Pre-proline 0 C--N 1.316 -0.867 0 CA-C-N 116.653 -0.248 . . . . 72.010000000000005 110.55 -178.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -82.48 -0.15 10.02 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.635 2.223 . . . . 75.140000000000001 111.587 178.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -144.48 110.28 5.34 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 108.217 -1.031 . . . . 65.530000000000001 108.217 177.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -122.52 47.93 0.99 Allowed Glycine 0 C--N 1.3 -1.441 0 N-CA-C 110.473 -1.051 . . . . 70.450000000000003 110.473 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.9 m -132.83 158.11 43.33 Favored 'General case' 0 N--CA 1.426 -1.635 0 N-CA-C 109.312 -0.625 . . . . 74.530000000000001 109.312 179.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -162.31 167.45 23.84 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.013 -1.477 . . . . 55.43 107.013 -177.122 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.405 HD22 ' HD3' ' A' ' 141' ' ' PRO . 2.1 pt? -134.55 158.26 44.43 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 109.231 -0.655 . . . . 72.0 109.231 178.314 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.422 ' HB2' HD21 ' A' ' 135' ' ' LEU . 4.4 pp -114.45 136.49 52.95 Favored 'General case' 0 N--CA 1.412 -2.337 0 N-CA-C 108.179 -1.045 . . . . 62.119999999999997 108.179 175.225 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 60.8 t -121.67 124.99 72.83 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.397 0 N-CA-C 107.895 -1.15 . . . . 74.310000000000002 107.895 -179.061 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.415 HG11 ' OD1' ' A' ' 56' ' ' ASN . 42.0 t -92.65 115.57 31.82 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 N-CA-C 107.446 -1.316 . . . . 61.149999999999999 107.446 177.671 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -85.12 -36.57 21.03 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-N 114.491 -1.231 . . . . 65.340000000000003 110.513 -174.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.459 ' O ' ' HB3' ' A' ' 133' ' ' PHE . 16.1 tpp180 -155.3 121.33 5.14 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 120.143 -0.623 . . . . 75.340000000000003 110.906 -178.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.421 ' HA2' ' CD1' ' A' ' 133' ' ' PHE . . . 162.08 141.97 3.27 Favored Glycine 0 C--O 1.194 -2.361 0 O-C-N 124.038 0.837 . . . . 55.049999999999997 111.102 176.017 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.434 ' HB2' ' OD2' ' A' ' 81' ' ' ASP . 17.0 Cg_exo -68.64 -10.07 27.99 Favored 'Trans proline' 0 N--CA 1.477 0.527 0 C-N-CA 122.45 2.1 . . . . 54.210000000000001 111.603 177.582 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.493 ' HB3' ' H ' ' A' ' 81' ' ' ASP . 4.4 p30 -59.35 -53.88 53.2 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 115.134 -0.939 . . . . 71.310000000000002 109.775 175.665 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -164.29 174.49 11.06 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-N 115.809 -0.632 . . . . 64.239999999999995 109.471 -179.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -163.45 54.36 0.29 Allowed Glycine 0 C--N 1.289 -2.083 0 N-CA-C 108.531 -1.828 . . . . 62.25 108.531 179.287 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -150.04 178.42 8.96 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 108.184 -1.043 . . . . 64.439999999999998 108.184 -175.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -102.36 137.81 40.11 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 108.147 -1.057 . . . . 63.409999999999997 108.147 179.151 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -132.43 129.89 39.87 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.095 -0.706 . . . . 72.310000000000002 109.095 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 52.4 tp -88.88 128.05 35.66 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 116.34 -0.391 . . . . 75.219999999999999 110.897 -176.027 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -77.73 115.47 17.51 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 108.267 -1.012 . . . . 63.210000000000001 108.267 176.033 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -143.14 -53.09 0.38 Allowed 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 115.029 -0.987 . . . . 72.510000000000005 109.348 -177.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.416 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 25.4 tt0 -69.63 121.31 82.01 Favored Pre-proline 0 C--N 1.312 -1.061 0 N-CA-C 108.505 -0.924 . . . . 72.129999999999995 108.505 177.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 65' ' ' GLN . 1.0 OUTLIER -42.07 -51.37 4.74 Favored 'Trans proline' 0 C--N 1.372 1.795 0 C-N-CA 124.745 3.63 . . . . 61.130000000000003 113.958 -173.997 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.5 m -102.97 99.88 9.8 Favored 'General case' 0 N--CA 1.415 -2.205 0 CA-C-N 116.144 -0.48 . . . . 54.25 109.844 179.163 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.447 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 86.2 m -98.14 114.05 26.13 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.422 -1.325 . . . . 72.209999999999994 107.422 175.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.7 m -105.58 133.92 49.54 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 112.925 0.713 . . . . 53.450000000000003 112.925 -171.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -108.63 117.5 34.34 Favored 'General case' 0 C--O 1.253 1.243 0 N-CA-C 108.386 -0.968 . . . . 64.109999999999999 108.386 175.056 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -158.68 -179.83 33.82 Favored Glycine 0 N--CA 1.438 -1.209 0 C-N-CA 120.158 -1.02 . . . . 62.109999999999999 111.188 -177.069 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.6 ttp180 -90.21 8.5 32.75 Favored 'General case' 0 CA--C 1.553 1.064 0 CA-C-O 121.949 0.881 . . . . 43.100000000000001 110.089 -176.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 60.8 m-70 -88.94 146.54 36.84 Favored Pre-proline 0 C--N 1.298 -1.64 0 N-CA-C 108.805 -0.813 . . . . 72.299999999999997 108.805 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -66.83 -28.73 42.8 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 121.729 1.619 . . . . 72.099999999999994 109.534 174.001 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -90.69 65.57 5.94 Favored 'General case' 0 N--CA 1.423 -1.819 0 CA-C-N 114.385 -1.28 . . . . 74.310000000000002 109.236 177.539 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.6 p -121.35 -174.76 2.92 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 106.066 -1.828 . . . . 71.450000000000003 106.066 175.082 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -100.67 -41.09 7.06 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 119.374 -0.931 . . . . 75.150000000000006 108.956 178.087 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 41.7 pt -114.78 150.58 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.618 0 N-CA-C 106.99 -1.485 . . . . 71.430000000000007 106.99 170.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -87.51 136.18 33.05 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 109.441 -0.577 . . . . 62.240000000000002 109.441 -179.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.462 ' HA ' ' HB2' ' A' ' 56' ' ' ASN . 50.4 tp -125.26 122.7 37.7 Favored 'General case' 0 N--CA 1.413 -2.319 0 CA-C-O 121.832 0.825 . . . . 74.099999999999994 111.043 -175.613 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.493 ' H ' ' HB3' ' A' ' 56' ' ' ASN . 33.9 t70 -142.59 108.5 5.17 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 114.561 -1.2 . . . . 71.540000000000006 108.304 176.078 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -137.04 161.84 34.96 Favored 'General case' 0 C--N 1.264 -3.137 0 CA-C-N 113.116 -1.856 . . . . 71.510000000000005 107.934 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.7 m -80.43 -15.46 12.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-O 121.441 0.639 . . . . 72.530000000000001 112.095 -177.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.505 ' OG1' ' HB3' ' A' ' 108' ' ' ASN . 3.1 p -128.54 45.73 2.73 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 122.261 1.029 . . . . 53.140000000000001 108.5 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.8 p -81.21 139.68 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 CA-C-N 113.672 -1.604 . . . . 62.439999999999998 110.789 -173.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 24.4 t -101.28 163.09 12.45 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 107.26 -1.385 . . . . 55.210000000000001 107.26 177.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 26.4 ttm180 -60.91 -43.3 98.73 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 108.946 -0.761 . . . . 70.329999999999998 108.946 179.196 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.495 ' H ' ' HD3' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -123.0 133.23 54.37 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 105.434 -2.061 . . . . 74.230000000000004 105.434 175.522 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 21.1 t60 -113.19 -68.63 0.92 Allowed 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.232 -0.987 . . . . 74.209999999999994 111.273 -174.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.37 153.65 40.75 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 116.295 -0.412 . . . . 74.409999999999997 109.889 -176.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -117.59 127.34 53.87 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 108.299 -1.0 . . . . 62.030000000000001 108.299 178.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.447 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 93.5 m-85 -100.51 115.58 30.45 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 107.744 -1.206 . . . . 72.049999999999997 107.744 178.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 61.9 mtp85 -106.85 123.13 47.71 Favored 'General case' 0 C--N 1.285 -2.238 0 N-CA-C 108.566 -0.902 . . . . 74.150000000000006 108.566 -176.37 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.3 tp -115.67 116.08 51.31 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 CA-C-O 121.639 0.733 . . . . 73.340000000000003 109.91 -176.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -118.71 143.81 46.64 Favored 'General case' 0 N--CA 1.41 -2.455 0 N-CA-C 103.986 -2.598 . . . . 63.32 103.986 175.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.402 ' HG3' ' HB1' ' A' ' 39' ' ' ALA . 6.0 pt-20 -70.91 -9.33 57.57 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 121.235 0.54 . . . . 73.150000000000006 111.658 179.154 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -80.86 -55.7 3.27 Favored Glycine 0 N--CA 1.433 -1.56 0 N-CA-C 111.025 -0.83 . . . . 51.219999999999999 111.025 171.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -148.89 166.24 29.13 Favored 'General case' 0 C--N 1.348 0.526 0 C-N-CA 122.801 0.44 . . . . 62.420000000000002 110.479 -178.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.531 ' HB2' ' HB2' ' A' ' 122' ' ' MET . 8.0 m-85 -111.03 128.74 55.96 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.947 -1.131 . . . . 72.030000000000001 107.947 -175.483 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -130.23 136.16 48.91 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.524 0.202 . . . . 71.510000000000005 110.89 -173.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.4 p -125.74 126.83 70.78 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-O 121.04 0.447 . . . . 71.140000000000001 110.165 175.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 51.9 t -119.21 133.41 66.14 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 CA-C-N 115.781 -0.645 . . . . 64.439999999999998 109.826 -178.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -82.9 131.53 35.19 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 107.18 -1.415 . . . . 54.109999999999999 107.18 173.032 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.402 HG23 ' HG2' ' A' ' 88' ' ' ARG . 17.4 m -111.97 20.22 6.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-O 121.086 0.469 . . . . 74.420000000000002 112.152 -177.388 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 120.06 54.85 0.25 Allowed Glycine 0 N--CA 1.433 -1.563 0 C-N-CA 119.981 -1.104 . . . . 61.329999999999998 114.367 174.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 77.7 p -78.86 145.77 34.02 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 117.253 0.526 . . . . 72.409999999999997 109.819 177.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 98.1 mt -80.19 -31.2 38.79 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 121.514 0.673 . . . . 63.539999999999999 109.931 178.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.505 ' HB3' ' OG1' ' A' ' 84' ' ' THR . 23.4 p30 -85.29 -24.52 27.68 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.01 -0.996 . . . . 63.210000000000001 112.841 -177.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 88.5 105.57 1.0 Allowed Glycine 0 N--CA 1.433 -1.502 0 C-N-CA 120.865 -0.683 . . . . 64.049999999999997 111.763 -179.059 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.6 m -75.63 123.94 26.38 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.794 -0.817 . . . . 73.409999999999997 108.794 176.004 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -136.97 153.71 50.62 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 109.796 -0.446 . . . . 71.25 109.796 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 31.1 t -98.07 142.63 14.18 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.006 0 N-CA-C 106.526 -1.657 . . . . 63.439999999999998 106.526 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 33.6 p-10 -55.21 -25.21 31.62 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 112.573 0.583 . . . . 73.319999999999993 112.573 -175.351 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 33.5 mtm105 -100.9 -32.51 10.62 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.369 -0.378 . . . . 71.239999999999995 111.809 177.556 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -130.65 125.29 21.41 Favored Pre-proline 0 C--N 1.316 -0.848 0 C-N-CA 121.078 -0.249 . . . . 63.149999999999999 111.589 -169.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.15 39.47 0.73 Allowed 'Trans proline' 0 CA--C 1.554 1.507 0 C-N-CA 122.838 2.359 . . . . 74.219999999999999 112.043 178.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.431 ' HB3' ' O ' ' A' ' 119' ' ' ALA . 31.1 mmt180 -90.51 131.33 36.31 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 123.537 0.735 . . . . 72.510000000000005 110.262 -177.491 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -78.64 -38.61 39.24 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.141 0.496 . . . . 43.240000000000002 110.021 174.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.431 ' O ' ' HB3' ' A' ' 117' ' ' ARG . . . -105.47 137.93 42.49 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 105.398 -2.075 . . . . 31.23 105.398 170.297 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -139.47 140.22 37.21 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-O 121.256 0.551 . . . . 51.119999999999997 111.932 -172.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 48.1 t -85.61 118.27 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 104.846 -2.279 . . . . 64.450000000000003 104.846 169.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.531 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 12.6 mmt -58.26 150.04 22.78 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 114.506 1.299 . . . . 63.240000000000002 114.506 -173.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -125.67 129.53 49.75 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 105.09 -2.189 . . . . 72.420000000000002 105.09 172.11 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 45.9 p -83.07 123.57 29.61 Favored 'General case' 0 C--N 1.283 -2.297 0 C-N-CA 121.002 -0.279 . . . . 75.109999999999999 110.676 -174.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 92.4 38.55 5.59 Favored Glycine 0 CA--C 1.497 -1.071 0 N-CA-C 109.528 -1.429 . . . . 75.25 109.528 -175.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -139.56 170.35 16.07 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 107.437 -1.32 . . . . 54.32 107.437 -176.149 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -140.52 139.75 35.13 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 122.285 1.04 . . . . 73.129999999999995 113.261 -174.413 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 60.0 mt -112.33 131.63 63.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-N 114.417 -1.265 . . . . 64.310000000000002 109.987 -175.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -93.76 112.53 24.42 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-O 121.843 0.83 . . . . 72.099999999999994 110.257 -178.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.9 pt -95.34 98.54 8.03 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 N-CA-C 107.641 -1.244 . . . . 71.099999999999994 107.641 176.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 76.06 -98.95 1.24 Allowed Glycine 0 N--CA 1.428 -1.885 0 N-CA-C 110.476 -1.05 . . . . 73.129999999999995 110.476 -176.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -127.64 10.19 6.59 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.197 0.523 . . . . 71.409999999999997 109.839 178.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.459 ' HB3' ' O ' ' A' ' 53' ' ' ARG . 57.4 m-85 -119.92 157.17 29.33 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.952 -0.567 . . . . 72.230000000000004 109.697 -175.404 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 20.1 ptp180 -125.77 131.33 52.52 Favored 'General case' 0 C--O 1.256 1.398 0 N-CA-C 114.087 1.143 . . . . 71.420000000000002 114.087 -170.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.422 HD21 ' HB2' ' A' ' 49' ' ' LEU . 6.5 tt -114.71 134.35 55.16 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 114.072 -1.422 . . . . 75.340000000000003 108.213 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 38.2 t -107.54 139.14 30.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 108.824 -0.806 . . . . 73.430000000000007 108.824 -176.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -115.84 126.3 53.8 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 109.883 -0.414 . . . . 75.140000000000001 109.883 -179.049 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 66.5 mt -132.69 137.57 46.97 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.63 -0.259 . . . . 71.099999999999994 110.749 -177.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -103.31 41.1 1.3 Allowed 'General case' 0 N--CA 1.482 1.141 0 CA-C-O 122.142 0.972 . . . . 62.119999999999997 108.719 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -75.81 -50.09 8.24 Favored Glycine 0 C--N 1.294 -1.759 0 CA-C-N 113.834 -1.53 . . . . 73.129999999999995 116.19 -174.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.405 ' HD3' HD22 ' A' ' 48' ' ' LEU . 5.8 Cg_exo -74.64 121.9 7.01 Favored 'Trans proline' 0 C--N 1.368 1.588 0 CA-C-N 120.214 2.007 . . . . 73.319999999999993 115.407 -170.278 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -110.38 126.98 54.84 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 105.882 -1.896 . . . . 74.319999999999993 105.882 173.046 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.425 -1.691 0 CA-C-O 118.199 -0.905 . . . . 73.099999999999994 112.311 -177.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 mmt . . . . . 0 CA--C 1.491 -1.31 0 N-CA-C 107.613 -1.254 . . . . 64.120000000000005 107.613 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.2 p -68.92 -30.62 69.12 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 108.725 -0.842 . . . . 72.319999999999993 108.725 177.006 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.7 t70 72.66 -50.85 0.7 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.243 1.817 . . . . 72.200000000000003 112.739 169.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -85.35 104.87 15.57 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.38 -0.6 . . . . 53.409999999999997 109.38 176.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -161.6 151.44 16.82 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 106.878 -1.527 . . . . 73.230000000000004 106.878 178.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -89.4 166.28 33.13 Favored Glycine 0 N--CA 1.429 -1.792 0 C-N-CA 119.766 -1.207 . . . . 72.209999999999994 110.398 178.501 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.2 p -84.65 133.32 44.3 Favored Pre-proline 0 N--CA 1.421 -1.907 0 N-CA-C 109.165 -0.68 . . . . 70.129999999999995 109.165 177.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -66.2 127.49 17.63 Favored 'Trans proline' 0 N--CA 1.448 -1.157 0 N-CA-C 107.923 -1.607 . . . . 61.039999999999999 107.923 174.427 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -95.89 118.08 66.03 Favored Pre-proline 0 C--N 1.288 -2.07 0 N-CA-C 112.926 0.713 . . . . 75.040000000000006 112.926 -174.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -66.13 140.58 60.05 Favored 'Trans proline' 0 C--O 1.245 0.862 0 C-N-CA 122.644 2.23 . . . . 62.25 108.948 173.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -149.23 98.69 2.84 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-O 122.075 0.94 . . . . 62.130000000000003 109.161 -176.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 49.2 t -69.4 118.24 13.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 114.06 -1.427 . . . . 74.209999999999994 112.259 -172.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -95.7 135.96 36.71 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 107.308 -1.367 . . . . 73.120000000000005 107.308 173.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.5 t -152.17 151.92 31.63 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-O 121.302 0.573 . . . . 73.439999999999998 110.756 -175.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.8 m -122.13 81.52 1.84 Allowed 'General case' 0 N--CA 1.41 -2.458 0 N-CA-C 107.805 -1.183 . . . . 73.109999999999999 107.805 173.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.7 m -82.36 99.33 9.32 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 115.551 -0.75 . . . . 61.140000000000001 109.224 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.9 p -138.06 136.61 44.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 108.659 -0.867 . . . . 71.439999999999998 108.659 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -94.1 163.99 13.25 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 109.073 -0.714 . . . . 71.019999999999996 109.073 -178.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.5 mtm180 -103.21 132.67 49.29 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 109.519 -0.549 . . . . 74.430000000000007 109.519 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.9 93.37 7.49 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 107.119 -1.437 . . . . 70.549999999999997 107.119 172.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -79.84 -53.22 6.99 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.972 -0.558 . . . . 63.200000000000003 109.95 -176.439 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 56.84 64.08 1.76 Allowed 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 115.416 -0.811 . . . . 73.430000000000007 111.082 -176.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 85.2 mt -88.08 140.58 29.34 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 115.421 -0.809 . . . . 74.019999999999996 109.315 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.446 ' HD2' ' H ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -124.45 32.59 5.45 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 121.87 0.843 . . . . 71.329999999999998 109.295 179.811 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -72.79 104.11 3.88 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 114.591 -1.186 . . . . 75.010000000000005 108.736 -178.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 57.7 mtt -123.17 119.78 31.25 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.982 -1.118 . . . . 73.420000000000002 107.982 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -136.76 160.44 38.85 Favored 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 120.206 -0.597 . . . . 71.239999999999995 111.569 175.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.407 ' O ' ' HB3' ' A' ' 139' ' ' ALA . 32.8 t -139.65 74.23 1.46 Allowed 'General case' 0 N--CA 1.407 -2.578 0 N-CA-C 106.386 -1.709 . . . . 75.099999999999994 106.386 172.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.2 t -72.89 88.11 1.34 Allowed 'General case' 0 N--CA 1.424 -1.754 0 CA-C-O 121.955 0.883 . . . . 72.519999999999996 108.964 177.65 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.2 p -133.51 126.72 31.67 Favored 'General case' 0 N--CA 1.414 -2.239 0 CA-C-N 114.172 -1.376 . . . . 74.219999999999999 107.939 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -78.83 64.77 3.6 Favored Glycine 0 C--N 1.323 -0.182 0 N-CA-C 111.217 -0.753 . . . . 54.119999999999997 111.217 179.236 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 8.8 m -98.85 142.67 30.08 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 123.377 0.671 . . . . 65.510000000000005 109.681 -176.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.414 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . . . -73.74 113.12 19.87 Favored Pre-proline 0 N--CA 1.436 -1.139 0 N-CA-C 106.634 -1.617 . . . . 33.329999999999998 106.634 173.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 33' ' ' ALA . 3.4 Cg_endo -86.78 177.48 4.13 Favored 'Trans proline' 0 N--CA 1.436 -1.872 0 C-N-CA 121.845 1.697 . . . . 73.409999999999997 113.554 -173.589 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -154.75 170.6 21.22 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 105.906 -1.887 . . . . 73.209999999999994 105.906 176.266 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.402 ' HB3' ' HB2' ' A' ' 39' ' ' ALA . 11.7 m -65.94 95.98 0.29 Allowed 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 121.584 0.707 . . . . 71.120000000000005 109.526 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 25.7 m -76.28 99.61 4.83 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 115.314 -0.857 . . . . 55.119999999999997 110.464 -175.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.401 ' O ' ' HD3' ' A' ' 43' ' ' PRO . . . 62.78 56.63 20.03 Favored Glycine 0 C--O 1.214 -1.125 0 CA-C-N 115.493 -0.776 . . . . 63.329999999999998 111.664 -178.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.402 ' HB2' ' HB3' ' A' ' 36' ' ' SER . . . -61.74 -37.1 82.99 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 123.058 0.543 . . . . 74.109999999999999 111.587 -176.621 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -83.07 -20.32 35.15 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.124 -0.489 . . . . 65.0 111.307 -179.257 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -83.61 -36.36 23.95 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.325 -0.991 . . . . 43.130000000000003 108.325 177.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 52.15 77.69 0.44 Allowed Pre-proline 0 N--CA 1.44 -0.947 0 C-N-CA 127.297 2.239 . . . . 74.430000000000007 111.509 -178.429 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' A' ' 38' ' ' GLY . 1.8 Cg_endo -85.41 -72.35 0.01 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.406 0 C-N-CA 122.474 2.116 . . . . 72.239999999999995 109.87 175.449 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -150.85 102.78 3.02 Favored 'General case' 0 N--CA 1.424 -1.748 0 N-CA-C 107.43 -1.322 . . . . 61.039999999999999 107.43 176.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -103.0 33.34 6.66 Favored Glycine 0 C--N 1.306 -1.108 0 N-CA-C 110.409 -1.076 . . . . 70.219999999999999 110.409 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 18.8 m -134.07 166.82 21.85 Favored 'General case' 0 N--CA 1.419 -2.016 0 N-CA-C 108.761 -0.829 . . . . 73.120000000000005 108.761 -179.402 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.518 ' HB3' ' CZ ' ' A' ' 137' ' ' PHE . . . -151.15 -170.9 3.79 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 107.939 -1.134 . . . . 41.409999999999997 107.939 178.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.412 ' H ' HD13 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -123.22 152.25 41.47 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 120.366 -0.533 . . . . 72.420000000000002 111.399 -176.991 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.441 ' HB2' HD21 ' A' ' 135' ' ' LEU . 2.0 pp -127.78 145.01 51.06 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 115.555 -0.748 . . . . 72.549999999999997 110.922 178.566 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.3 m -131.28 142.34 43.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 109.394 -0.595 . . . . 61.219999999999999 109.394 178.335 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.508 HG21 ' HB3' ' A' ' 57' ' ' ALA . 76.5 t -93.82 115.93 33.83 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 N-CA-C 107.878 -1.156 . . . . 74.209999999999994 107.878 176.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.5 tmtm? -82.16 -38.81 24.13 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.756 -0.831 . . . . 40.020000000000003 108.756 -175.167 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.446 ' O ' ' HB3' ' A' ' 133' ' ' PHE . 13.8 tpp180 -142.41 117.3 9.92 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 108.181 -1.044 . . . . 72.140000000000001 108.181 -178.105 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 148.42 125.18 1.46 Allowed Glycine 0 N--CA 1.427 -1.955 0 C-N-CA 119.784 -1.198 . . . . 72.420000000000002 114.057 177.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -67.54 -8.92 23.67 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 123.768 2.979 . . . . 71.329999999999998 110.509 174.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.575 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 2.1 m-20 -51.18 -26.5 6.95 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 126.852 2.061 . . . . 72.129999999999995 111.215 177.241 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.508 ' HB3' HG21 ' A' ' 51' ' ' VAL . . . -166.88 -62.16 0.03 OUTLIER 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 123.45 0.7 . . . . 73.120000000000005 109.403 176.269 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 61.3 44.82 97.59 Favored Glycine 0 C--N 1.336 0.557 0 CA-C-N 115.741 -0.663 . . . . 45.420000000000002 111.85 -179.096 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -151.62 -171.68 4.0 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 108.927 -0.768 . . . . 74.430000000000007 108.927 -176.097 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.8 ptt180 -119.93 138.51 53.4 Favored 'General case' 0 C--N 1.312 -1.064 0 O-C-N 124.002 0.814 . . . . 62.43 109.221 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -138.54 129.43 26.68 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-O 120.896 0.379 . . . . 73.430000000000007 110.807 179.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 65.3 tp -91.45 129.59 37.41 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 107.505 -1.294 . . . . 74.450000000000003 107.505 176.482 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 79.7 mt -72.16 120.15 17.35 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 113.018 0.748 . . . . 72.099999999999994 113.018 -176.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -146.29 -39.99 0.21 Allowed 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.884 -1.053 . . . . 73.349999999999994 110.56 175.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -61.28 113.89 9.26 Favored Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 123.888 0.875 . . . . 74.409999999999997 110.297 173.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.566 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 8.4 Cg_endo -53.8 -41.31 75.51 Favored 'Trans proline' 0 C--N 1.361 1.185 0 C-N-CA 122.983 2.455 . . . . 71.0 113.253 -175.752 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 50.2 m -119.82 105.89 11.55 Favored 'General case' 0 N--CA 1.423 -1.8 0 CA-C-O 121.21 0.528 . . . . 72.030000000000001 109.79 178.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.485 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 40.1 m -107.01 113.8 27.5 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 107.259 -1.386 . . . . 61.539999999999999 107.259 174.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.4 p -98.04 133.64 42.23 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 116.002 -0.544 . . . . 71.040000000000006 112.369 -175.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -115.21 120.29 39.22 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 115.574 -0.739 . . . . 72.519999999999996 109.135 176.311 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.428 ' HA2' ' CG2' ' A' ' 85' ' ' VAL . . . 167.63 -160.44 34.05 Favored Glycine 0 N--CA 1.422 -2.254 0 N-CA-C 110.051 -1.22 . . . . 73.5 110.051 178.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.49 ' O ' ' HG2' ' A' ' 87' ' ' ARG . 18.6 tpt180 -132.42 89.56 2.67 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 109.445 -0.576 . . . . 62.219999999999999 109.445 174.449 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.559 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 23.4 p-80 -161.59 165.76 15.93 Favored Pre-proline 0 C--N 1.304 -1.402 0 N-CA-C 107.686 -1.227 . . . . 63.520000000000003 107.686 177.779 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.559 ' HD2' ' HB2' ' A' ' 73' ' ' HIS . 3.1 Cg_endo -47.89 -35.44 24.61 Favored 'Trans proline' 0 C--N 1.359 1.101 0 C-N-CA 123.317 2.678 . . . . 72.329999999999998 115.7 -175.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -99.33 14.6 29.06 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 119.237 -0.985 . . . . 62.030000000000001 113.52 -175.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 24.0 m -73.2 133.24 43.96 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.635 -0.506 . . . . 75.340000000000003 109.635 176.083 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -80.19 -56.02 4.51 Favored 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 108.441 -0.948 . . . . 72.310000000000002 108.441 176.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 32.4 pt -97.69 134.46 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 N-CA-C 109.117 -0.697 . . . . 44.530000000000001 109.117 177.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -104.42 116.87 32.88 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 121.764 0.792 . . . . 73.030000000000001 110.529 -177.415 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.575 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 7.0 mp -82.02 106.53 14.01 Favored 'General case' 0 N--CA 1.422 -1.831 0 CA-C-N 114.817 -1.083 . . . . 74.519999999999996 111.09 -177.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -85.0 69.49 10.82 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 122.432 1.111 . . . . 75.340000000000003 109.743 176.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -148.62 164.26 34.82 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 113.94 -1.482 . . . . 70.319999999999993 108.279 176.257 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.1 p -94.69 -6.65 10.15 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-O 121.083 0.468 . . . . 63.32 111.516 -176.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.7 m -91.96 13.45 18.58 Favored 'General case' 0 CA--C 1.548 0.899 0 O-C-N 121.491 -0.755 . . . . 74.430000000000007 110.267 -177.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.428 ' CG2' ' HA2' ' A' ' 71' ' ' GLY . 10.6 p -102.77 133.11 47.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-O 121.258 0.551 . . . . 70.340000000000003 111.312 -178.269 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 18.3 m -102.05 169.95 8.42 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 108.94 -0.763 . . . . 51.420000000000002 108.94 176.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.49 ' HG2' ' O ' ' A' ' 72' ' ' ARG . 63.1 mtm180 -75.27 134.7 41.04 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 106.674 -1.602 . . . . 72.540000000000006 106.674 173.667 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.497 ' H ' ' CE1' ' A' ' 73' ' ' HIS 0.36 0.0 OUTLIER 50.38 71.76 0.39 Allowed 'General case' 0 C--O 1.22 -0.497 0 CA-C-O 122.654 1.216 . . . . 74.340000000000003 111.096 -171.507 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.453 ' HA ' ' HA3' ' A' ' 105' ' ' GLY . 11.4 t60 -95.39 -60.14 1.73 Allowed 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 113.828 -1.533 . . . . 72.209999999999994 109.846 -173.366 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -130.94 127.47 38.52 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 109.215 -0.661 . . . . 63.240000000000002 109.215 -179.146 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -109.75 127.19 54.46 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 109.049 -0.723 . . . . 72.540000000000006 109.049 177.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.485 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 97.5 m-85 -104.09 112.62 25.69 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 107.651 -1.241 . . . . 74.140000000000001 107.651 177.552 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 27.5 mtp85 -108.48 113.59 26.74 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 115.368 -0.833 . . . . 75.420000000000002 109.072 -177.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.566 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -128.48 124.22 61.38 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.522 0 CA-C-O 122.085 0.945 . . . . 64.120000000000005 110.077 -177.778 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -110.52 147.71 33.6 Favored 'General case' 0 C--N 1.269 -2.906 0 N-CA-C 106.765 -1.568 . . . . 63.409999999999997 106.765 177.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -42.42 -26.57 0.12 Allowed 'General case' 0 CA--C 1.56 1.354 0 N-CA-C 114.234 1.198 . . . . 73.219999999999999 114.234 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -128.77 23.85 4.96 Favored Glycine 0 N--CA 1.437 -1.249 0 C-N-CA 120.617 -0.802 . . . . 13.23 113.513 179.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -165.44 144.25 6.32 Favored 'General case' 0 C--O 1.213 -0.868 0 CA-C-N 117.852 0.826 . . . . 73.040000000000006 110.84 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.479 ' HB2' ' SD ' ' A' ' 122' ' ' MET . 1.3 p90 -132.15 115.83 16.23 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-O 121.873 0.844 . . . . 72.109999999999999 112.085 -177.621 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -129.9 135.24 48.12 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.468 -0.787 . . . . 64.430000000000007 111.559 -172.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.6 p -116.5 128.38 73.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 109.561 -0.533 . . . . 73.040000000000006 109.561 178.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 58.6 t -118.82 130.61 73.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-N 116.325 -0.398 . . . . 62.32 110.943 -175.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -101.31 115.24 30.04 Favored 'General case' 0 CA--C 1.496 -1.127 0 CA-C-O 121.074 0.464 . . . . 75.439999999999998 109.802 176.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 88' ' ' ARG . 5.3 m -122.42 -1.64 7.22 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 CA-C-O 121.671 0.748 . . . . 61.329999999999998 111.459 178.233 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.453 ' HA3' ' HA ' ' A' ' 89' ' ' HIS . . . -100.22 39.83 2.62 Favored Glycine 0 N--CA 1.429 -1.771 0 N-CA-C 109.401 -1.48 . . . . 54.439999999999998 109.401 176.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 11.4 m -63.45 4.52 0.23 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.042 1.737 . . . . 54.340000000000003 113.479 -176.011 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -68.95 -41.09 78.48 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 106.693 -1.595 . . . . 71.400000000000006 106.693 171.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -110.18 -41.19 4.49 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.071 -1.422 . . . . 70.120000000000005 108.355 177.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 92.65 131.53 5.67 Favored Glycine 0 N--CA 1.438 -1.202 0 N-CA-C 115.71 1.044 . . . . 74.200000000000003 115.71 173.106 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 18.6 m -94.65 135.59 35.94 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 105.941 -1.874 . . . . 70.329999999999998 105.941 169.132 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -117.69 134.42 54.92 Favored 'General case' 0 C--N 1.294 -1.833 0 C-N-CA 120.013 -0.675 . . . . 70.230000000000004 109.659 -177.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.474 HG23 ' HB2' ' A' ' 115' ' ' GLU . 22.3 m -100.43 110.56 27.75 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.935 0 N-CA-C 106.973 -1.491 . . . . 73.409999999999997 106.973 172.263 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 66.96 -79.72 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 125.843 1.657 . . . . 44.25 108.944 -171.053 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 51.9 mtp180 -148.11 13.8 1.0 Allowed 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 124.652 1.181 . . . . 73.129999999999995 109.147 176.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.474 ' HB2' HG23 ' A' ' 112' ' ' VAL . 32.4 mm-40 -102.51 113.74 65.72 Favored Pre-proline 0 N--CA 1.439 -1.005 0 CA-C-N 115.327 -0.851 . . . . 71.219999999999999 110.39 -175.544 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -84.26 94.8 0.72 Allowed 'Trans proline' 0 N--CA 1.446 -1.283 0 C-N-CA 122.444 2.096 . . . . 70.310000000000002 109.182 173.179 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -121.28 146.22 47.05 Favored 'General case' 0 CA--C 1.502 -0.885 0 CA-C-N 116.397 -0.365 . . . . 72.329999999999998 111.191 -174.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -66.05 -42.22 89.79 Favored 'General case' 0 C--N 1.319 -0.719 0 O-C-N 124.145 0.903 . . . . 73.109999999999999 110.73 -177.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -149.64 138.89 21.34 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 108.363 -0.977 . . . . 32.32 108.363 175.089 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.468 ' HG2' HG21 ' A' ' 112' ' ' VAL . 6.0 tp60 -140.98 150.49 43.15 Favored 'General case' 0 C--N 1.292 -1.935 0 C-N-CA 122.821 0.448 . . . . 75.349999999999994 110.117 -179.436 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 64.1 t -79.82 134.03 28.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 105.508 -2.034 . . . . 70.120000000000005 105.508 173.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.479 ' SD ' ' HB2' ' A' ' 99' ' ' PHE . 64.7 mtt -61.0 126.33 26.97 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 109.61 -0.515 . . . . 63.450000000000003 109.61 -176.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -104.95 130.35 53.15 Favored 'General case' 0 N--CA 1.418 -2.061 0 CA-C-O 121.346 0.594 . . . . 55.229999999999997 110.098 -178.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 18.6 p -78.3 131.9 37.24 Favored 'General case' 0 N--CA 1.416 -2.167 0 CA-C-N 114.782 -1.099 . . . . 74.140000000000001 109.479 -177.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 85.0 22.88 51.4 Favored Glycine 0 N--CA 1.431 -1.671 0 N-CA-C 110.647 -0.981 . . . . 74.5 110.647 179.328 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -123.61 171.16 9.76 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 120.165 -0.614 . . . . 71.0 109.749 -178.33 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -118.84 121.42 39.99 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 123.412 0.685 . . . . 74.439999999999998 110.393 -170.455 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 64.1 mt -106.15 118.2 53.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 N-CA-C 109.614 -0.513 . . . . 74.420000000000002 109.614 -178.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -95.14 114.17 25.94 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 109.455 -0.572 . . . . 74.430000000000007 109.455 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 9.8 pt -99.9 97.58 6.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 CA-C-O 122.215 1.007 . . . . 73.400000000000006 109.101 178.35 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 73.15 -87.35 0.58 Allowed Glycine 0 N--CA 1.435 -1.42 0 CA-C-N 114.498 -1.228 . . . . 43.25 111.088 -177.295 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -120.1 -33.03 4.03 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 120.974 0.416 . . . . 73.120000000000005 110.513 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.446 ' HB3' ' O ' ' A' ' 53' ' ' ARG . 77.9 m-85 -95.5 161.21 14.16 Favored 'General case' 0 CA--C 1.496 -1.125 0 CA-C-N 116.293 -0.412 . . . . 62.109999999999999 110.95 -173.109 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 27.9 ptt180 -131.42 141.5 49.85 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 114.155 1.168 . . . . 52.450000000000003 114.155 -171.595 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.441 HD21 ' HB2' ' A' ' 49' ' ' LEU . 3.4 tt -117.69 140.03 50.22 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 112.935 -1.939 . . . . 71.540000000000006 107.48 -177.63 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 7.7 p -115.93 131.56 68.02 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 CA-C-O 121.046 0.451 . . . . 74.239999999999995 109.787 179.198 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.518 ' CZ ' ' HB3' ' A' ' 47' ' ' ALA . 71.4 t80 -102.91 119.0 38.07 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.53 -0.759 . . . . 74.340000000000003 109.057 -175.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.47 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 2.5 mm? -114.68 147.1 40.11 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 120.966 0.412 . . . . 64.109999999999999 111.282 -175.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 28' ' ' SER . . . -81.94 118.23 22.79 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 107.827 -1.175 . . . . 74.530000000000001 107.827 175.416 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -93.57 -135.92 7.74 Favored Glycine 0 N--CA 1.427 -1.913 0 C-N-CA 120.64 -0.791 . . . . 50.240000000000002 111.874 -177.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -78.82 129.41 9.07 Favored 'Trans proline' 0 N--CA 1.441 -1.617 0 C-N-CA 122.492 2.128 . . . . 61.310000000000002 112.305 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -92.84 102.3 14.68 Favored 'General case' 0 N--CA 1.42 -1.953 0 N-CA-C 104.835 -2.283 . . . . 45.520000000000003 104.835 172.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 . . . . . 0 C--N 1.277 -2.571 0 N-CA-C 108.745 -0.835 . . . . 73.430000000000007 108.745 -170.284 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.516 -0.346 0 N-CA-C 108.835 -0.802 . . . . 74.400000000000006 108.835 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.1 t -82.97 -37.58 23.87 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 110.693 -0.114 . . . . 43.229999999999997 110.693 -178.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 56.81 42.05 27.16 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-O 121.967 0.889 . . . . 74.549999999999997 111.465 -177.18 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 30.6 p-10 -101.88 -4.05 26.88 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.517 -0.765 . . . . 50.439999999999998 109.79 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -106.37 86.26 2.32 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 108.647 -0.872 . . . . 62.140000000000001 108.647 176.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -143.69 108.98 0.53 Allowed Glycine 0 N--CA 1.428 -1.85 0 N-CA-C 109.892 -1.283 . . . . 65.409999999999997 109.892 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.401 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 8.7 t -94.07 125.01 54.36 Favored Pre-proline 0 C--N 1.301 -1.537 0 CA-C-O 120.801 0.334 . . . . 75.219999999999999 110.969 -177.215 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 7' ' ' THR . 22.7 Cg_exo -66.22 144.73 76.01 Favored 'Trans proline' 0 C--O 1.244 0.809 0 C-N-CA 122.22 1.947 . . . . 44.240000000000002 109.59 174.504 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -89.81 138.68 27.79 Favored Pre-proline 0 C--N 1.29 -2.011 0 C-N-CA 121.361 -0.136 . . . . 74.420000000000002 110.638 -177.128 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -74.64 103.78 1.77 Allowed 'Trans proline' 0 N--CA 1.44 -1.668 0 C-N-CA 121.24 1.293 . . . . 75.019999999999996 109.163 172.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -92.94 119.65 32.45 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 115.373 -0.831 . . . . 55.219999999999999 111.513 -174.658 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.9 p -88.64 136.86 22.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 CA-C-N 115.812 -0.631 . . . . 63.420000000000002 109.449 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -77.53 134.92 38.18 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 108.542 -0.91 . . . . 61.210000000000001 108.542 178.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.8 m -134.1 71.55 1.46 Allowed 'General case' 0 C--N 1.294 -1.829 0 CA-C-O 121.396 0.617 . . . . 53.310000000000002 110.241 -178.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.8 t 167.43 137.11 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 126.596 1.958 . . . . 73.430000000000007 106.638 176.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 53.4 m -152.16 37.22 0.55 Allowed 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 108.069 -1.086 . . . . 75.200000000000003 108.069 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.8 t -65.1 119.02 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 CA-C-N 114.554 -1.203 . . . . 72.120000000000005 108.424 178.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -74.39 99.16 3.45 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.989 0.9 . . . . 72.409999999999997 110.593 -179.329 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 74.1 mtp180 -110.28 153.17 25.23 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 114.476 -1.238 . . . . 75.099999999999994 110.752 -175.273 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -146.84 89.33 1.81 Allowed 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 104.901 -2.259 . . . . 64.129999999999995 104.901 174.239 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.411 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 46.0 m-20 -67.56 -53.81 25.22 Favored 'General case' 0 CA--C 1.502 -0.895 0 CA-C-N 115.788 -0.642 . . . . 73.420000000000002 111.468 -171.464 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.411 ' HB2' ' O ' ' A' ' 21' ' ' ASP . 1.4 tm? 177.95 109.7 0.03 OUTLIER 'General case' 0 C--O 1.236 0.355 0 O-C-N 123.752 0.658 . . . . 52.329999999999998 109.596 175.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.505 ' O ' HD22 ' A' ' 23' ' ' LEU 0.274 0.0 OUTLIER -145.01 90.19 2.03 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 122.187 0.994 . . . . 73.219999999999999 109.289 172.49 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.89 175.47 6.79 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.074 -0.967 . . . . 65.239999999999995 113.435 -172.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -82.2 106.44 14.09 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-O 121.456 0.646 . . . . 70.450000000000003 109.616 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 46.3 tpp -129.01 133.0 47.58 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 109.053 -0.721 . . . . 64.310000000000002 109.053 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -84.8 143.31 29.18 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.888 -1.153 . . . . 71.310000000000002 107.888 176.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.9 t -98.62 148.01 24.24 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 108.058 -1.09 . . . . 71.019999999999996 108.058 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 28.7 m -84.44 90.12 7.54 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 121.583 0.706 . . . . 71.150000000000006 110.178 179.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 60.1 m -119.35 101.0 7.65 Favored 'General case' 0 N--CA 1.422 -1.832 0 N-CA-C 108.262 -1.014 . . . . 74.409999999999997 108.262 177.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -103.39 -146.35 16.62 Favored Glycine 0 N--CA 1.426 -2.001 0 C-N-CA 120.694 -0.765 . . . . 60.109999999999999 111.361 -179.337 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 24.0 m -110.68 148.83 31.45 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 108.363 -0.977 . . . . 75.109999999999999 108.363 179.398 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -90.51 112.6 53.89 Favored Pre-proline 0 N--CA 1.439 -0.984 0 N-CA-C 108.405 -0.961 . . . . 73.549999999999997 108.405 175.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -79.31 135.88 12.29 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.386 2.057 . . . . 72.239999999999995 111.3 178.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -112.67 122.83 48.82 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.689 -0.856 . . . . 61.340000000000003 108.689 177.078 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 27.0 t -104.04 96.61 6.78 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 109.177 -0.675 . . . . 74.439999999999998 109.177 -177.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.4 m -105.88 145.03 31.78 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.712 -0.847 . . . . 63.329999999999998 108.712 -178.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -146.23 64.35 0.44 Allowed Glycine 0 N--CA 1.44 -1.041 0 N-CA-C 108.742 -1.743 . . . . 72.209999999999994 108.742 179.001 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.96 -30.37 61.63 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.944 1.09 . . . . 71.299999999999997 113.944 -171.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -66.87 -34.28 77.44 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.982 0.42 . . . . 63.340000000000003 111.043 -178.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -84.15 -43.59 14.84 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-N 116.339 -0.391 . . . . 73.25 110.395 177.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.407 HD12 ' HB3' ' A' ' 96' ' ' GLU . 58.0 tp 56.95 73.83 0.75 Allowed Pre-proline 0 C--O 1.252 1.222 0 CA-C-N 114.402 -1.272 . . . . 73.409999999999997 110.833 -174.05 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -63.83 137.58 58.98 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.706 2.271 . . . . 75.349999999999994 110.834 177.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -84.26 143.93 29.25 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 109.332 -0.618 . . . . 55.329999999999998 109.332 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 177.57 110.67 0.28 Allowed Glycine 0 N--CA 1.413 -2.835 0 N-CA-C 109.333 -1.507 . . . . 63.509999999999998 109.333 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.8 m -100.17 164.49 11.94 Favored 'General case' 0 C--N 1.279 -2.494 0 N-CA-C 108.815 -0.809 . . . . 74.310000000000002 108.815 178.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -124.64 132.88 53.39 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.751 -0.463 . . . . 61.350000000000001 109.751 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.436 HD23 ' H ' ' A' ' 48' ' ' LEU . 2.1 pt? -115.81 140.79 48.88 Favored 'General case' 0 C--N 1.29 -2.008 0 C-N-CA 120.312 -0.555 . . . . 75.5 110.837 179.02 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.427 ' O ' HD12 ' A' ' 49' ' ' LEU . 3.1 pp -120.39 140.01 51.96 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 115.542 -0.753 . . . . 74.230000000000004 110.352 178.371 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.401 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 47.4 t -117.75 126.51 74.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 108.581 -0.896 . . . . 64.519999999999996 108.581 179.403 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 53.2 t -93.1 115.56 32.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 108.942 -0.762 . . . . 64.099999999999994 108.942 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.42 ' HB2' ' HG3' ' A' ' 134' ' ' ARG . 72.7 mmtt -82.56 -46.31 13.52 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.38 -0.97 . . . . 72.5 108.38 176.449 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -147.84 149.1 31.67 Favored 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 106.968 -1.494 . . . . 75.030000000000001 106.968 179.223 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 144.99 145.67 4.34 Favored Glycine 0 N--CA 1.425 -2.045 0 N-CA-C 110.527 -1.029 . . . . 54.409999999999997 110.527 -178.284 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.502 ' HB2' ' H ' ' A' ' 82' ' ' ASP . 13.8 Cg_exo -67.93 -9.18 24.81 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.419 2.746 . . . . 71.319999999999993 113.359 -177.355 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.502 ' HB2' ' HA ' ' A' ' 80' ' ' LEU . 5.6 t-20 -42.87 -60.3 1.65 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.098 0.959 . . . . 75.540000000000006 111.451 175.356 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 174.37 -64.19 0.01 OUTLIER 'General case' 0 CA--C 1.504 -0.827 0 C-N-CA 124.814 1.245 . . . . 74.409999999999997 107.991 -178.033 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 116.83 52.91 0.34 Allowed Glycine 0 N--CA 1.441 -0.969 0 N-CA-C 110.023 -1.231 . . . . 62.299999999999997 110.023 -176.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -139.9 -174.3 3.87 Favored 'General case' 0 N--CA 1.434 -1.275 0 N-CA-C 108.881 -0.785 . . . . 71.129999999999995 108.881 -176.003 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 34.9 ptt180 -122.05 134.65 54.78 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.486 -0.931 . . . . 55.25 108.486 177.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -127.13 139.5 52.93 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 109.85 -0.426 . . . . 72.439999999999998 109.85 -177.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 58.3 tp -101.98 112.05 24.54 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 108.22 -1.03 . . . . 65.430000000000007 108.22 178.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -94.68 116.75 29.12 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.324 0.583 . . . . 54.140000000000001 110.469 -176.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -121.81 8.24 9.96 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.448 -1.315 . . . . 75.530000000000001 107.448 176.287 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.4 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 2.9 pt20 -93.05 115.96 65.77 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 114.139 -1.391 . . . . 71.439999999999998 109.684 178.304 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 65' ' ' GLN . 7.1 Cg_endo -50.52 -43.56 44.32 Favored 'Trans proline' 0 C--N 1.361 1.215 0 C-N-CA 123.541 2.827 . . . . 73.450000000000003 113.917 -174.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 31.9 m -106.85 102.77 12.11 Favored 'General case' 0 N--CA 1.423 -1.812 0 N-CA-C 109.63 -0.508 . . . . 74.120000000000005 109.63 177.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.419 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 79.4 m -108.79 114.05 27.5 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 107.444 -1.317 . . . . 74.129999999999995 107.444 176.567 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 14.5 t -117.61 128.79 55.28 Favored 'General case' 0 C--N 1.296 -1.761 0 C-N-CA 119.221 -0.992 . . . . 71.219999999999999 110.693 -175.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.508 ' HA ' ' O ' ' A' ' 78' ' ' ILE . . . -115.08 106.44 14.12 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 115.504 -0.771 . . . . 44.009999999999998 109.576 -176.211 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.46 73.11 1.28 Allowed Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 109.314 -1.515 . . . . 75.129999999999995 109.314 -175.079 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.531 ' HA ' ' O ' ' A' ' 87' ' ' ARG . 1.1 tmm_? -145.07 85.55 1.75 Allowed 'General case' 0 N--CA 1.423 -1.805 0 N-CA-C 107.294 -1.372 . . . . 73.409999999999997 107.294 -178.421 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.568 ' CG ' ' HD2' ' A' ' 74' ' ' PRO . 1.3 t-80 68.3 170.71 0.1 Allowed Pre-proline 0 CA--C 1.575 1.935 0 O-C-N 124.545 1.153 . . . . 74.5 109.075 177.439 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.568 ' HD2' ' CG ' ' A' ' 73' ' ' HIS . 96.3 Cg_exo -48.38 -39.63 35.83 Favored 'Trans proline' 0 C--N 1.369 1.645 0 C-N-CA 121.981 1.787 . . . . 55.32 112.789 175.322 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.9 pm0 -92.07 58.27 3.3 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 122.202 1.001 . . . . 73.409999999999997 111.636 178.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 66.2 m -65.28 150.47 48.19 Favored 'General case' 0 C--O 1.244 0.783 0 CA-C-N 115.143 -0.935 . . . . 75.420000000000002 108.997 175.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -68.97 -45.2 71.29 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 107.434 -1.321 . . . . 71.150000000000006 107.434 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.508 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 46.1 pt -139.97 143.82 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 N-CA-C 108.135 -1.061 . . . . 74.140000000000001 108.135 171.498 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -102.47 130.8 49.38 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 119.251 -0.98 . . . . 63.310000000000002 108.403 172.516 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.502 ' HA ' ' HB2' ' A' ' 56' ' ' ASN . 30.8 tp -108.53 -26.15 10.57 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-O 122.552 1.168 . . . . 74.540000000000006 109.786 -174.11 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -138.23 134.09 34.0 Favored 'General case' 0 C--N 1.266 -3.022 0 N-CA-C 105.854 -1.906 . . . . 72.0 105.854 177.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.502 ' H ' ' HB2' ' A' ' 55' ' ' PRO . 33.1 t70 -117.79 -15.49 10.07 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 115.534 -0.757 . . . . 62.229999999999997 111.21 -177.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.4 m -91.3 -21.91 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.812 0 N-CA-C 108.087 -1.079 . . . . 73.120000000000005 108.087 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 22.4 m -138.34 83.51 1.97 Allowed 'General case' 0 N--CA 1.414 -2.24 0 CA-C-N 114.56 -1.2 . . . . 72.239999999999995 108.375 174.613 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.8 p -112.16 139.88 34.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 108.48 -0.933 . . . . 65.129999999999995 108.48 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 15.5 m -124.44 168.83 12.52 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 109.582 -0.525 . . . . 62.200000000000003 109.582 -177.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.531 ' O ' ' HA ' ' A' ' 72' ' ' ARG . 20.5 mtp180 -68.56 -31.59 70.91 Favored 'General case' 0 C--O 1.212 -0.897 0 CA-C-O 121.042 0.449 . . . . 71.510000000000005 110.074 175.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.412 ' HG2' HG21 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -143.82 101.7 3.79 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 106.277 -1.749 . . . . 73.120000000000005 106.277 170.781 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.515 ' O ' HG22 ' A' ' 104' ' ' VAL . 19.0 t60 -98.74 -71.7 0.68 Allowed 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 114.466 -1.243 . . . . 75.030000000000001 111.075 -174.343 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -144.75 160.69 40.83 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 107.738 -1.208 . . . . 73.400000000000006 107.738 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -146.19 139.46 25.89 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.907 -0.717 . . . . 74.420000000000002 110.262 -177.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.419 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 78.1 m-85 -115.61 123.0 47.32 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.898 -0.778 . . . . 73.510000000000005 108.898 -177.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 52.8 mtm-85 -107.8 123.65 48.89 Favored 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 107.831 -1.174 . . . . 72.349999999999994 107.831 176.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.3 pp -115.42 116.08 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.128 0 C-N-CA 118.684 -1.207 . . . . 72.120000000000005 108.38 177.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.546 ' ND2' ' HG2' ' A' ' 96' ' ' GLU . 4.9 t30 -120.09 147.05 45.34 Favored 'General case' 0 C--N 1.28 -2.424 0 CA-C-N 114.121 -1.399 . . . . 61.539999999999999 107.55 -179.582 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.546 ' HG2' ' ND2' ' A' ' 95' ' ' ASN . 8.8 pt-20 -29.12 -36.6 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 126.898 2.079 . . . . 72.239999999999995 115.908 -177.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -131.95 3.04 5.24 Favored Glycine 0 CA--C 1.504 -0.6 0 C-N-CA 119.387 -1.387 . . . . 45.340000000000003 113.28 -175.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -148.05 118.2 7.28 Favored 'General case' 0 N--CA 1.411 -2.399 0 CA-C-O 122.401 1.096 . . . . 72.510000000000005 111.098 -177.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.509 ' HD1' ' SD ' ' A' ' 122' ' ' MET . 71.0 m-85 -107.09 115.83 30.86 Favored 'General case' 0 C--N 1.275 -2.663 0 CA-C-N 114.423 -1.262 . . . . 73.549999999999997 107.62 -179.432 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -110.18 135.92 50.2 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 113.612 0.967 . . . . 53.119999999999997 113.612 -173.273 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.5 p -116.33 117.64 56.15 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.116 0 CA-C-N 114.377 -1.283 . . . . 75.140000000000001 107.709 173.525 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 39.7 t -120.86 125.36 73.96 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 CA-C-N 115.831 -0.622 . . . . 73.519999999999996 110.768 -177.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.459 ' HB2' ' HB ' ' A' ' 110' ' ' THR . 18.0 t0 -92.45 115.46 28.11 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 102.333 -3.21 . . . . 74.019999999999996 102.333 168.407 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 89' ' ' HIS . 19.2 m -59.67 -23.35 25.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 113.278 0.844 . . . . 73.439999999999998 113.278 -169.165 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -152.76 16.06 0.72 Allowed Glycine 0 C--N 1.305 -1.176 0 C-N-CA 117.8 -2.143 . . . . 74.420000000000002 113.796 178.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 50.3 m 57.17 36.6 27.7 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 122.824 1.297 . . . . 34.329999999999998 107.514 -175.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 49.5 tp -73.66 -47.43 39.93 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 112.828 -1.987 . . . . 74.340000000000003 112.761 -168.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -107.4 -11.52 15.51 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 119.2 -1.0 . . . . 70.420000000000002 109.791 179.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 97.5 65.12 0.89 Allowed Glycine 0 N--CA 1.433 -1.53 0 C-N-CA 120.413 -0.899 . . . . 61.32 113.247 173.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.459 ' HB ' ' HB2' ' A' ' 103' ' ' ASP . 18.9 m -85.24 119.66 25.87 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.683 -0.858 . . . . 64.200000000000003 108.683 174.52 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.45 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 2.1 m-85 -116.91 140.87 48.95 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.419 -0.956 . . . . 64.239999999999995 108.419 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.5 p -99.58 116.46 42.81 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 N-CA-C 108.197 -1.038 . . . . 65.129999999999995 108.197 176.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 71.17 -73.53 0.1 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.131 0.972 . . . . 74.329999999999998 109.476 -175.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 48.5 ttp180 -161.3 14.37 0.1 Allowed 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 107.538 -1.282 . . . . 72.0 107.538 172.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.446 ' HG3' ' HE ' ' A' ' 117' ' ' ARG . 15.3 tp10 -102.27 116.36 63.13 Favored Pre-proline 0 N--CA 1.429 -1.479 0 CA-C-N 115.513 -0.767 . . . . 72.109999999999999 108.94 -172.504 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -76.24 103.67 1.78 Allowed 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.85 2.367 . . . . 71.310000000000002 111.195 178.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.446 ' HE ' ' HG3' ' A' ' 115' ' ' GLU . 15.1 mmt180 -130.79 157.23 43.43 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 109.348 -0.612 . . . . 74.239999999999995 109.348 -179.153 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 50.8 m-20 -76.88 -42.57 39.37 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.487 -1.301 . . . . 63.439999999999998 107.487 178.635 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -147.87 146.04 28.92 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 114.561 -1.2 . . . . 73.209999999999994 108.886 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -138.58 138.17 37.67 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 108.545 -0.909 . . . . 74.25 108.545 178.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 39.0 t -94.82 95.46 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.527 0 C-N-CA 119.477 -0.889 . . . . 71.340000000000003 108.61 177.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.509 ' SD ' ' HD1' ' A' ' 99' ' ' PHE . 25.5 ptt? 44.56 139.02 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 119.087 2.995 . . . . 72.230000000000004 119.087 177.188 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -132.97 122.81 24.81 Favored 'General case' 0 N--CA 1.401 -2.92 1 N-CA-C 99.815 -4.143 . . . . 73.010000000000005 99.815 166.308 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 13.1 t -108.04 127.39 53.74 Favored 'General case' 0 C--N 1.288 -2.077 0 C-N-CA 118.606 -1.238 . . . . 54.229999999999997 112.034 -171.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 83.84 22.35 55.69 Favored Glycine 0 N--CA 1.424 -2.113 0 N-CA-C 109.993 -1.243 . . . . 64.0 109.993 -179.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -122.76 -175.88 3.26 Favored 'General case' 0 C--O 1.249 1.053 0 N-CA-C 108.36 -0.978 . . . . 72.510000000000005 108.36 -177.381 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.469 ' OE2' ' HD3' ' A' ' 134' ' ' ARG . 40.0 mt-10 -116.65 130.98 57.05 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 121.784 0.802 . . . . 72.150000000000006 111.492 -175.027 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 66.0 mt -100.47 126.43 54.07 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 N-CA-C 107.151 -1.426 . . . . 74.019999999999996 107.151 176.472 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.45 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 34.4 tt0 -93.43 112.65 24.61 Favored 'General case' 0 C--N 1.282 -2.334 0 N-CA-C 108.339 -0.986 . . . . 65.439999999999998 108.339 -178.281 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.52 HG13 ' HB2' ' A' ' 133' ' ' PHE . 19.2 pt -101.92 97.95 6.27 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.07 0 N-CA-C 108.747 -0.834 . . . . 72.420000000000002 108.747 179.374 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 70.13 -98.86 0.66 Allowed Glycine 0 N--CA 1.432 -1.575 0 N-CA-C 109.738 -1.345 . . . . 62.200000000000003 109.738 -176.226 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -122.71 5.08 9.48 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 120.707 0.289 . . . . 62.299999999999997 110.72 177.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.52 ' HB2' HG13 ' A' ' 130' ' ' ILE . 27.1 m-85 -104.72 171.38 7.35 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 108.784 -0.821 . . . . 72.340000000000003 108.784 -179.372 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.469 ' HD3' ' OE2' ' A' ' 127' ' ' GLU . 14.0 ptp180 -130.67 132.67 45.55 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.73 0.776 . . . . 70.420000000000002 112.057 -179.201 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.403 HD11 ' HB2' ' A' ' 49' ' ' LEU . 48.9 tp -117.48 143.46 46.02 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 114.167 -1.379 . . . . 74.540000000000006 107.411 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.401 ' HB ' ' HB ' ' A' ' 50' ' ' VAL . 34.2 t -106.72 129.95 59.41 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 N-CA-C 106.553 -1.647 . . . . 71.310000000000002 106.553 177.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.401 ' CE2' ' HB2' ' A' ' 139' ' ' ALA . 70.8 t80 -121.64 119.89 33.17 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 120.964 0.411 . . . . 71.030000000000001 111.188 -174.09 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.4 mp -117.53 116.68 27.6 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 107.873 -1.158 . . . . 75.510000000000005 107.873 177.404 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.401 ' HB2' ' CE2' ' A' ' 137' ' ' PHE . . . -122.1 122.87 40.24 Favored 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 121.02 -0.272 . . . . 33.43 110.382 -175.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.483 ' N ' ' HD2' ' A' ' 141' ' ' PRO . . . 152.48 -52.72 0.48 Allowed Glycine 0 C--N 1.306 -1.095 0 C-N-CA 118.376 -1.868 . . . . 63.539999999999999 115.353 178.181 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.483 ' HD2' ' N ' ' A' ' 140' ' ' GLY . 5.2 Cg_endo -46.1 125.7 8.85 Favored 'Trans proline' 0 C--N 1.374 1.904 0 C-N-CA 123.489 2.793 . . . . 65.540000000000006 114.672 -177.242 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -91.54 120.76 32.63 Favored 'General case' 0 N--CA 1.425 -1.681 0 CA-C-N 114.809 -1.087 . . . . 71.25 108.6 179.048 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.282 -2.343 0 N-CA-C 105.858 -1.904 . . . . 64.109999999999999 105.858 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.8 ttt . . . . . 0 CA--C 1.504 -0.798 0 N-CA-C 110.096 -0.335 . . . . 73.409999999999997 110.096 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.4 t -83.45 -50.22 8.51 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 107.518 -1.29 . . . . 73.310000000000002 107.518 174.089 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.9 t70 57.48 19.13 4.99 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 126.073 1.749 . . . . 75.420000000000002 111.761 176.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -124.46 145.35 49.57 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 108.828 -0.804 . . . . 71.219999999999999 108.828 -178.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -121.67 102.87 8.49 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 107.655 -1.239 . . . . 74.209999999999994 107.655 174.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -82.13 105.52 2.58 Favored Glycine 0 C--N 1.303 -1.292 0 N-CA-C 111.178 -0.769 . . . . 73.049999999999997 111.178 -177.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.5 t -83.18 135.32 44.66 Favored Pre-proline 0 C--N 1.302 -1.463 0 N-CA-C 109.035 -0.728 . . . . 64.439999999999998 109.035 -178.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -66.75 150.15 83.51 Favored 'Trans proline' 0 C--O 1.236 0.419 0 C-N-CA 122.574 2.182 . . . . 74.120000000000005 112.072 -178.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.412 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 0.7 OUTLIER -79.79 112.19 27.51 Favored Pre-proline 0 C--N 1.316 -0.885 0 N-CA-C 109.598 -0.519 . . . . 75.140000000000001 109.598 176.983 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 9' ' ' GLU . 16.5 Cg_exo -65.23 118.09 5.15 Favored 'Trans proline' 0 C--O 1.246 0.921 0 C-N-CA 122.465 2.11 . . . . 72.549999999999997 112.256 -175.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.476 ' HA ' ' OE1' ' A' ' 11' ' ' GLN . 5.0 tp60 -93.39 81.02 4.39 Favored 'General case' 0 N--CA 1.42 -1.95 0 CA-C-O 122.115 0.96 . . . . 74.239999999999995 109.814 177.59 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.4 t -104.53 120.05 54.33 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 N-CA-C 106.634 -1.617 . . . . 74.310000000000002 106.634 177.172 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.63 140.95 51.72 Favored 'General case' 0 N--CA 1.433 -1.317 0 CA-C-O 120.943 0.401 . . . . 74.420000000000002 111.044 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.7 m -113.2 88.28 2.8 Favored 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 109.217 -0.661 . . . . 65.409999999999997 109.217 -179.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 42.7 m -100.29 95.06 6.53 Favored 'General case' 0 N--CA 1.411 -2.406 0 N-CA-C 108.901 -0.777 . . . . 73.430000000000007 108.901 178.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.0 t -101.19 98.06 8.51 Favored 'General case' 0 N--CA 1.42 -1.946 0 N-CA-C 108.135 -1.061 . . . . 52.140000000000001 108.135 -178.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 23.5 t -95.33 97.72 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 N-CA-C 109.162 -0.681 . . . . 51.039999999999999 109.162 -178.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -88.73 128.68 35.62 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 108.335 -0.987 . . . . 72.340000000000003 108.335 175.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 18.8 mtm180 -109.68 159.99 16.67 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 109.238 -0.653 . . . . 74.030000000000001 109.238 -173.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -99.62 86.01 3.25 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.782 -1.192 . . . . 75.420000000000002 107.782 174.339 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -93.35 -40.37 10.43 Favored 'General case' 0 CA--C 1.494 -1.194 0 CA-C-N 115.545 -0.752 . . . . 54.310000000000002 110.484 -178.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.9 pp -73.73 155.28 39.09 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-O 121.351 0.596 . . . . 72.409999999999997 111.9 -178.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 95.8 mt -136.56 -178.02 4.99 Favored 'General case' 0 C--N 1.294 -1.804 0 N-CA-C 106.76 -1.57 . . . . 72.439999999999998 106.76 178.158 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -76.8 104.25 7.2 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 121.344 0.592 . . . . 62.109999999999999 109.763 177.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -83.18 103.66 12.76 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.843 -0.799 . . . . 53.450000000000003 108.843 178.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 49.8 mtt -85.93 96.06 9.68 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 115.219 -0.901 . . . . 71.319999999999993 109.886 -175.066 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -111.89 118.56 35.85 Favored 'General case' 0 N--CA 1.426 -1.671 0 C-N-CA 119.883 -0.727 . . . . 65.420000000000002 109.186 175.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.413 ' OG ' ' HA ' ' A' ' 34' ' ' PRO . 10.7 t -122.06 128.48 51.42 Favored 'General case' 0 N--CA 1.408 -2.534 0 N-CA-C 105.392 -2.077 . . . . 74.540000000000006 105.392 176.533 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 58.8 p -140.94 -178.52 5.59 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 120.264 -0.574 . . . . 73.219999999999999 111.494 -175.403 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 23.5 m -74.95 127.69 33.81 Favored 'General case' 0 N--CA 1.425 -1.699 0 N-CA-C 108.188 -1.042 . . . . 64.120000000000005 108.188 177.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.05 -42.14 1.97 Allowed Glycine 0 N--CA 1.44 -1.099 0 N-CA-C 111.007 -0.837 . . . . 62.109999999999999 111.007 -179.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.9 p -78.52 161.14 27.26 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 122.405 0.282 . . . . 63.219999999999999 110.597 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.24 126.56 92.4 Favored Pre-proline 0 N--CA 1.432 -1.371 0 N-CA-C 107.299 -1.371 . . . . 53.109999999999999 107.299 173.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.413 ' HA ' ' OG ' ' A' ' 28' ' ' SER . 24.9 Cg_endo -62.32 126.43 18.51 Favored 'Trans proline' 0 C--O 1.256 1.418 0 C-N-CA 122.334 2.023 . . . . 74.120000000000005 112.899 -176.424 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -69.86 95.41 0.91 Allowed 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 106.903 -1.517 . . . . 70.519999999999996 106.903 174.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.8 p -121.24 152.55 38.72 Favored 'General case' 0 N--CA 1.408 -2.571 0 CA-C-N 115.004 -0.998 . . . . 74.439999999999998 111.682 -171.075 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.5 t -79.75 176.59 9.58 Favored 'General case' 0 N--CA 1.425 -1.693 0 CA-C-N 115.382 -0.826 . . . . 52.32 108.908 177.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -83.25 96.21 1.9 Allowed Glycine 0 N--CA 1.419 -2.434 0 N-CA-C 109.749 -1.34 . . . . 73.400000000000006 109.749 -179.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.446 ' HA ' HD13 ' A' ' 42' ' ' LEU . . . -56.5 -34.43 66.96 Favored 'General case' 0 C--N 1.293 -1.875 0 C-N-CA 125.15 1.38 . . . . 63.240000000000002 112.159 -176.524 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.8 pm0 -68.47 -13.9 62.63 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.676 -0.693 . . . . 74.450000000000003 112.444 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -83.14 -14.09 54.27 Favored 'General case' 0 C--N 1.319 -0.729 0 O-C-N 122.018 -0.426 . . . . 62.229999999999997 111.703 -179.03 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.446 HD13 ' HA ' ' A' ' 39' ' ' ALA . 9.3 mp -67.84 116.39 37.66 Favored Pre-proline 0 C--N 1.319 -0.757 0 CA-C-N 115.919 -0.582 . . . . 62.310000000000002 109.757 178.122 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -68.82 -28.25 30.28 Favored 'Trans proline' 0 N--CA 1.475 0.397 0 C-N-CA 122.512 2.141 . . . . 73.109999999999999 112.107 -177.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -104.76 23.4 13.48 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.978 0.894 . . . . 73.099999999999994 109.037 179.17 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -107.63 7.01 36.11 Favored Glycine 0 N--CA 1.433 -1.516 0 CA-C-N 114.644 -1.162 . . . . 74.430000000000007 112.186 -178.031 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.446 ' HB2' ' O ' ' A' ' 141' ' ' PRO . 8.7 m -90.19 152.96 20.85 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 121.464 0.65 . . . . 64.239999999999995 109.5 -178.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -153.73 164.15 38.81 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.234 -1.025 . . . . 64.510000000000005 108.234 -177.085 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 62' ' ' LEU . 2.5 pt? -130.12 142.13 50.62 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.402 0.62 . . . . 73.400000000000006 111.471 -179.315 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.42 ' O ' HD12 ' A' ' 49' ' ' LEU . 4.2 pp -109.78 133.25 53.36 Favored 'General case' 0 N--CA 1.423 -1.825 0 N-CA-C 107.736 -1.209 . . . . 73.25 107.736 175.275 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 48.1 t -119.08 117.46 54.31 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 N-CA-C 109.69 -0.485 . . . . 65.109999999999999 109.69 -176.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 57.3 t -93.04 114.45 29.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 106.016 -1.846 . . . . 34.229999999999997 106.016 175.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -93.39 -33.11 13.99 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.389 -0.597 . . . . 74.150000000000006 109.389 -176.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.472 ' O ' ' HB3' ' A' ' 133' ' ' PHE . 60.5 mtt180 -138.53 123.19 18.63 Favored 'General case' 0 CA--C 1.487 -1.444 0 N-CA-C 108.559 -0.904 . . . . 74.319999999999993 108.559 177.757 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.4 ' HA2' ' CD1' ' A' ' 133' ' ' PHE . . . 146.98 116.33 0.94 Allowed Glycine 0 N--CA 1.415 -2.761 0 C-N-CA 120.911 -0.662 . . . . 71.329999999999998 112.525 179.638 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.4 ' HD2' ' HA2' ' A' ' 54' ' ' GLY . 11.9 Cg_endo -59.55 -9.22 8.54 Favored 'Trans proline' 0 C--N 1.37 1.689 0 C-N-CA 124.058 3.172 . . . . 71.5 112.269 176.651 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.428 ' HA ' ' N ' ' A' ' 81' ' ' ASP . 2.3 m-20 -45.99 -49.42 16.03 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 125.39 1.476 . . . . 74.140000000000001 108.901 172.428 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -149.37 -58.65 0.21 Allowed 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 115.407 -0.815 . . . . 63.210000000000001 109.54 -179.352 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.21 31.71 63.56 Favored Glycine 0 CA--C 1.507 -0.465 0 N-CA-C 110.099 -1.2 . . . . 73.310000000000002 110.099 -176.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -152.93 176.05 12.27 Favored 'General case' 0 N--CA 1.42 -1.952 0 N-CA-C 108.834 -0.802 . . . . 44.43 108.834 -175.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -109.17 153.44 23.76 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.888 -0.597 . . . . 74.430000000000007 109.557 177.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -143.64 134.24 24.96 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 108.141 -1.059 . . . . 73.549999999999997 108.141 -179.043 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 48' ' ' LEU . 0.8 OUTLIER -104.21 135.81 44.98 Favored 'General case' 0 N--CA 1.428 -1.539 0 CA-C-O 120.877 0.37 . . . . 73.430000000000007 110.571 178.146 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 81.6 mt -82.6 115.07 21.4 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.684 -0.689 . . . . 51.439999999999998 109.471 -178.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -126.63 9.18 7.05 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 107.582 -1.266 . . . . 73.150000000000006 107.582 176.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -131.19 147.51 66.54 Favored Pre-proline 0 C--N 1.295 -1.781 0 CA-C-N 113.571 -1.649 . . . . 64.019999999999996 107.621 -175.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -57.42 -53.52 4.6 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 122.759 2.306 . . . . 71.0 114.859 -175.106 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 85.0 m -131.67 109.78 10.44 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.224 0.535 . . . . 73.019999999999996 112.365 -177.002 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 41.4 m -98.55 118.07 34.42 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.309 -0.997 . . . . 72.540000000000006 108.309 175.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.501 ' OG1' ' HG2' ' A' ' 88' ' ' ARG . 12.5 t -102.59 147.79 26.35 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 119.308 -0.957 . . . . 74.239999999999995 110.697 179.561 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -108.1 132.67 53.34 Favored 'General case' 0 N--CA 1.424 -1.726 0 CA-C-N 115.437 -0.801 . . . . 63.229999999999997 109.509 179.192 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.543 ' O ' ' HA ' ' A' ' 79' ' ' PHE . . . -161.53 -146.05 4.51 Favored Glycine 0 N--CA 1.428 -1.852 0 N-CA-C 108.645 -1.782 . . . . 64.400000000000006 108.645 176.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 18.2 ttp85 -164.76 58.76 0.13 Allowed 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.166 -1.05 . . . . 74.450000000000003 108.166 173.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 70.1 m80 -139.38 165.24 33.11 Favored Pre-proline 0 C--N 1.279 -2.499 0 N-CA-C 106.738 -1.579 . . . . 64.040000000000006 106.738 179.201 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 99.5 Cg_exo -48.99 -33.43 26.16 Favored 'Trans proline' 0 C--N 1.358 1.055 0 C-N-CA 122.715 2.277 . . . . 65.010000000000005 112.556 177.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -106.71 74.39 1.0 Allowed 'General case' 0 N--CA 1.432 -1.347 0 CA-C-O 122.016 0.912 . . . . 61.039999999999999 109.855 176.106 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 37.7 m -146.1 123.42 11.6 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 113.957 -1.474 . . . . 34.039999999999999 108.159 174.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -65.21 -52.1 56.8 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-O 120.605 0.241 . . . . 75.349999999999994 110.83 -178.235 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 41.8 pt -123.61 178.78 3.15 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 109.627 -0.509 . . . . 65.140000000000001 109.627 175.237 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.543 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 97.2 m-85 -122.89 136.98 55.06 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 112.623 0.601 . . . . 75.010000000000005 112.623 -172.101 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -117.92 132.23 56.43 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.187 -1.412 . . . . 71.25 107.187 167.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.428 ' N ' ' HA ' ' A' ' 56' ' ' ASN . 38.1 t70 -127.98 70.21 1.34 Allowed 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 122.437 1.113 . . . . 52.439999999999998 109.439 -175.183 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -122.92 -163.56 1.11 Allowed 'General case' 0 C--N 1.284 -2.273 0 CA-C-N 113.668 -1.606 . . . . 72.310000000000002 108.542 176.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 44.7 t -65.27 -38.03 81.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 C-N-CA 123.389 0.676 . . . . 64.219999999999999 112.133 -176.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 26.2 m -121.95 93.5 4.01 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.868 0.842 . . . . 74.430000000000007 112.75 -175.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 6.0 p -111.63 128.89 67.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 CA-C-N 114.91 -1.041 . . . . 35.43 110.793 -178.193 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.423 ' HB2' ' HB2' ' A' ' 89' ' ' HIS . 8.9 m -112.64 -170.4 1.66 Allowed 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.232 -0.655 . . . . 65.310000000000002 109.232 178.179 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -78.98 -76.05 0.21 Allowed 'General case' 0 C--O 1.217 -0.609 0 N-CA-C 109.982 -0.377 . . . . 71.209999999999994 109.982 177.126 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.501 ' HG2' ' OG1' ' A' ' 69' ' ' THR . 1.5 tmm_? -101.48 82.58 2.32 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 105.386 -2.079 . . . . 52.229999999999997 105.386 174.521 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.423 ' HB2' ' HB2' ' A' ' 86' ' ' SER . 67.1 t60 -87.37 -70.76 0.6 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.219 -0.901 . . . . 75.420000000000002 112.49 -170.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -110.86 147.57 34.27 Favored 'General case' 0 CA--C 1.483 -1.631 0 N-CA-C 108.793 -0.818 . . . . 72.230000000000004 108.793 -177.216 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -128.3 127.81 43.44 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-O 121.201 0.524 . . . . 75.230000000000004 110.412 178.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.532 ' HD1' ' HE3' ' A' ' 122' ' ' MET . 83.7 m-85 -105.81 113.13 26.5 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 105.602 -1.999 . . . . 75.420000000000002 105.602 177.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 71.7 mtp180 -118.45 147.32 43.72 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 121.864 0.84 . . . . 71.400000000000006 112.961 -172.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.53 117.12 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.321 0 N-CA-C 103.428 -2.804 . . . . 73.319999999999993 103.428 170.368 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 32.1 t-20 -118.36 147.25 43.71 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 108.161 -1.052 . . . . 72.019999999999996 108.161 -173.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.63 -20.09 53.62 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 113.195 0.813 . . . . 64.140000000000001 113.195 -179.104 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -78.82 -49.86 6.27 Favored Glycine 0 N--CA 1.423 -2.18 0 N-CA-C 111.14 -0.784 . . . . 71.030000000000001 111.14 173.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.411 ' HG2' ' H ' ' A' ' 99' ' ' PHE . 28.6 tt0 -177.77 -172.94 0.37 Allowed 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 107.363 -1.347 . . . . 74.319999999999993 107.363 -177.253 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.445 ' CB ' ' HB3' ' A' ' 122' ' ' MET . 89.9 m-85 -89.84 138.68 31.28 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 118.919 0.781 . . . . 70.549999999999997 109.393 -178.581 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -131.9 135.19 46.46 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 116.274 -0.421 . . . . 74.299999999999997 110.431 -174.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.6 p -128.95 117.71 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 108.934 -0.765 . . . . 71.230000000000004 108.934 174.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 19.4 m -121.09 135.55 60.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 CA-C-N 115.307 -0.86 . . . . 74.0 112.051 -178.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -99.07 107.38 19.77 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 106.093 -1.817 . . . . 75.120000000000005 106.093 170.222 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.4 m -94.21 9.35 5.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-O 121.402 0.62 . . . . 72.049999999999997 111.224 -176.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -90.04 -42.41 5.32 Favored Glycine 0 N--CA 1.428 -1.844 0 N-CA-C 108.159 -1.976 . . . . 73.420000000000002 108.159 172.034 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 39.7 m 70.23 -37.82 0.39 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.739 2.016 . . . . 53.219999999999999 114.348 174.284 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -58.66 -42.51 88.6 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 123.111 0.564 . . . . 65.120000000000005 111.658 177.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -86.05 -52.09 5.92 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.894 -0.78 . . . . 72.329999999999998 108.894 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 77.31 103.28 0.17 Allowed Glycine 0 N--CA 1.434 -1.456 0 CA-C-N 115.33 -0.85 . . . . 70.400000000000006 114.545 177.181 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 89.3 m -76.21 120.01 20.91 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 106.414 -1.698 . . . . 61.200000000000003 106.414 169.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -114.3 171.98 7.29 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.883 0.849 . . . . 72.010000000000005 111.591 -171.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.44 ' HB ' ' HB2' ' A' ' 115' ' ' GLU . 21.9 t -98.53 142.74 14.19 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.122 0 N-CA-C 104.758 -2.312 . . . . 64.030000000000001 104.758 173.328 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -40.03 -36.84 0.52 Allowed 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 114.204 1.187 . . . . 71.239999999999995 114.204 -176.119 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -118.56 -13.0 9.7 Favored 'General case' 0 C--O 1.222 -0.387 0 N-CA-C 112.386 0.513 . . . . 74.340000000000003 112.386 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.44 ' HB2' ' HB ' ' A' ' 112' ' ' VAL . 64.0 mm-40 -114.43 107.42 51.28 Favored Pre-proline 0 C--N 1.315 -0.933 0 N-CA-C 111.892 0.33 . . . . 62.43 111.892 -178.045 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -83.65 101.35 0.92 Allowed 'Trans proline' 0 N--CA 1.44 -1.665 0 C-N-CA 122.4 2.067 . . . . 62.439999999999998 110.739 176.529 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.584 ' HD2' ' OE1' ' A' ' 120' ' ' GLN . 15.5 ptp180 -153.63 152.94 31.42 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.884 -1.154 . . . . 52.310000000000002 107.884 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -81.16 -26.96 35.64 Favored 'General case' 0 C--N 1.313 -1.022 0 N-CA-C 112.425 0.528 . . . . 61.039999999999999 112.425 -175.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -129.38 139.04 51.82 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 109.273 -0.64 . . . . 25.199999999999999 109.273 178.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.584 ' OE1' ' HD2' ' A' ' 117' ' ' ARG . 51.8 tp60 -140.45 149.48 42.62 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.491 -0.777 . . . . 64.400000000000006 109.925 -176.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.4 p -79.47 121.4 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 105.764 -1.939 . . . . 63.439999999999998 105.764 169.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.532 ' HE3' ' HD1' ' A' ' 92' ' ' PHE . 10.9 ttt -71.35 115.02 10.02 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 121.575 0.702 . . . . 75.129999999999995 109.159 -170.457 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 21.5 tp60 -104.76 135.13 46.71 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.254 -0.885 . . . . 74.420000000000002 108.776 -173.036 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.1 t -78.86 131.33 36.41 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-O 121.049 0.452 . . . . 52.119999999999997 110.256 178.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 89.14 24.76 30.84 Favored Glycine 0 N--CA 1.426 -2.012 0 N-CA-C 111.024 -0.83 . . . . 71.409999999999997 111.024 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -116.49 169.45 9.32 Favored 'General case' 0 C--O 1.251 1.139 0 N-CA-C 109.16 -0.682 . . . . 64.040000000000006 109.16 -178.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.424 ' CD ' ' HE ' ' A' ' 134' ' ' ARG . 13.7 tp10 -114.07 121.22 43.16 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.819 -1.178 . . . . 65.510000000000005 107.819 -174.401 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 65.2 mt -107.93 131.43 58.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 C-N-CA 123.93 0.892 . . . . 64.439999999999998 110.577 -175.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -101.13 111.87 24.2 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.803 -0.635 . . . . 61.43 109.296 -177.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 5.1 pt -103.1 98.14 6.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 CA-C-O 121.575 0.702 . . . . 62.25 109.808 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 71.88 -100.4 0.92 Allowed Glycine 0 N--CA 1.44 -1.088 0 N-CA-C 109.228 -1.549 . . . . 75.549999999999997 109.228 -174.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -124.41 5.7 8.36 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 108.953 -0.758 . . . . 74.219999999999999 108.953 175.342 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.472 ' HB3' ' O ' ' A' ' 53' ' ' ARG . 63.0 m-85 -103.19 173.54 6.26 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 115.408 -0.815 . . . . 71.349999999999994 110.563 -175.201 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.424 ' HE ' ' CD ' ' A' ' 127' ' ' GLU . 34.2 ttt180 -132.26 125.21 30.53 Favored 'General case' 0 C--O 1.255 1.365 0 C-N-CA 119.698 -0.801 . . . . 75.129999999999995 112.988 -165.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 5.9 tt -124.57 139.7 53.63 Favored 'General case' 0 C--O 1.21 -0.984 0 C-N-CA 124.792 1.237 . . . . 71.310000000000002 109.495 -178.211 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 8.6 t -109.95 136.39 46.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 107.088 -1.449 . . . . 75.25 107.088 176.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -115.06 126.8 55.12 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 120.195 -0.602 . . . . 71.549999999999997 110.983 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.0 mp -133.35 133.07 42.01 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.961 -0.385 . . . . 72.510000000000005 109.961 178.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -93.44 141.42 28.48 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 105.102 -2.184 . . . . 61.340000000000003 105.102 170.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 177.15 -52.44 0.1 Allowed Glycine 0 C--N 1.289 -2.057 0 C-N-CA 118.273 -1.917 . . . . 44.130000000000003 114.307 -174.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.446 ' O ' ' HB2' ' A' ' 46' ' ' SER . 33.2 Cg_exo -58.89 112.0 1.07 Allowed 'Trans proline' 0 C--N 1.368 1.565 0 CA-C-N 119.906 1.853 . . . . 71.319999999999993 112.194 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -109.98 104.5 13.41 Favored 'General case' 0 C--N 1.264 -3.133 0 N-CA-C 106.452 -1.685 . . . . 53.109999999999999 106.452 177.178 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 . . . . . 0 N--CA 1.407 -2.584 0 CA-C-O 118.164 -0.922 . . . . 63.539999999999999 111.327 -171.908 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 CA--C 1.505 -0.772 0 N-CA-C 109.931 -0.396 . . . . 75.230000000000004 109.931 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.6 m -79.35 -31.6 43.05 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 108.166 -1.05 . . . . 64.200000000000003 108.166 177.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -110.03 142.91 40.8 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 114.449 -1.251 . . . . 62.310000000000002 107.989 175.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -68.86 106.52 2.73 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 109.695 -0.484 . . . . 74.099999999999994 109.695 179.116 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -67.36 110.45 3.57 Favored 'General case' 0 C--O 1.245 0.843 0 CA-C-N 114.95 -1.023 . . . . 73.200000000000003 110.785 -175.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.38 104.51 3.18 Favored Glycine 0 N--CA 1.437 -1.282 0 N-CA-C 111.145 -0.782 . . . . 44.109999999999999 111.145 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 50.3 m -101.63 124.44 40.68 Favored Pre-proline 0 C--N 1.301 -1.521 0 N-CA-C 109.838 -0.43 . . . . 75.510000000000005 109.838 -178.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -66.33 145.23 77.06 Favored 'Trans proline' 0 C--O 1.247 0.926 0 C-N-CA 121.837 1.691 . . . . 74.409999999999997 110.007 175.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -69.76 138.71 88.18 Favored Pre-proline 0 C--N 1.3 -1.548 0 CA-C-N 116.336 -0.393 . . . . 75.150000000000006 109.996 -175.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.32 134.3 60.61 Favored 'Trans proline' 0 C--O 1.252 1.185 0 C-N-CA 122.845 2.363 . . . . 74.219999999999999 113.098 -174.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 73.84 80.33 0.12 Allowed 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 125.903 1.681 . . . . 63.43 110.705 -176.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.5 p -103.38 136.57 35.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-N 114.754 -1.112 . . . . 64.310000000000002 109.189 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.28 131.54 36.04 Favored 'General case' 0 N--CA 1.42 -1.969 0 CA-C-O 120.941 0.401 . . . . 72.310000000000002 109.939 179.06 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.9 t -82.84 147.36 28.39 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 109.012 -0.736 . . . . 53.119999999999997 109.012 176.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.0 t -85.06 114.37 22.16 Favored 'General case' 0 N--CA 1.407 -2.577 0 CA-C-O 121.761 0.791 . . . . 61.329999999999998 109.311 178.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 37.4 m -138.68 85.45 2.08 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 115.131 -0.94 . . . . 63.219999999999999 108.754 175.433 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.1 p -145.54 157.71 12.92 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 N-CA-C 106.934 -1.506 . . . . 73.019999999999996 106.934 -176.402 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -72.14 135.12 46.09 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-O 121.894 0.854 . . . . 63.219999999999999 111.544 179.532 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -115.65 -155.47 0.58 Allowed 'General case' 0 C--N 1.283 -2.326 0 N-CA-C 106.471 -1.677 . . . . 73.540000000000006 106.471 -174.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.0 71.18 9.04 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 107.269 -1.382 . . . . 74.439999999999998 107.269 171.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -79.17 -24.89 42.94 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.564 -1.198 . . . . 73.129999999999995 111.362 -176.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.2 tm? 64.21 93.85 0.06 Allowed 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 125.046 1.338 . . . . 72.109999999999999 111.591 177.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 66.3 tp -113.95 92.55 4.01 Favored 'General case' 0 C--N 1.292 -1.935 0 N-CA-C 107.588 -1.264 . . . . 60.219999999999999 107.588 175.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 6.8 mmtm -147.16 100.62 3.31 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.991 -1.004 . . . . 71.239999999999995 109.623 -179.198 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -138.98 164.26 30.21 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 109.628 -0.508 . . . . 71.209999999999994 109.628 176.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 51.2 tpp -56.33 124.56 18.45 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.092 0.87 . . . . 63.399999999999999 111.188 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -104.56 -165.98 1.19 Allowed 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 109.247 -0.649 . . . . 52.310000000000002 109.247 178.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 32.0 t -63.39 118.63 8.34 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 109.231 -0.655 . . . . 71.230000000000004 109.231 177.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 43.8 m -84.27 149.77 25.87 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 109.255 -0.646 . . . . 51.450000000000003 109.255 179.074 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 22.3 m -58.21 124.34 19.1 Favored 'General case' 0 C--O 1.245 0.828 0 O-C-N 123.503 0.502 . . . . 53.009999999999998 109.819 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -66.98 117.23 8.93 Favored Glycine 0 N--CA 1.439 -1.164 0 CA-C-N 115.786 -0.643 . . . . 64.239999999999995 111.638 -177.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.6 m -83.98 133.62 34.68 Favored 'General case' 0 N--CA 1.419 -1.991 0 N-CA-C 109.262 -0.644 . . . . 63.149999999999999 109.262 -179.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.07 126.67 92.86 Favored Pre-proline 0 N--CA 1.439 -0.994 0 N-CA-C 107.841 -1.17 . . . . 65.140000000000001 107.841 174.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -61.1 141.22 93.22 Favored 'Trans proline' 0 C--O 1.242 0.68 0 C-N-CA 122.377 2.052 . . . . 72.420000000000002 111.631 -178.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -91.02 63.33 5.11 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 116.374 -0.375 . . . . 75.129999999999995 110.405 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.5 m 53.65 74.22 0.33 Allowed 'General case' 0 C--N 1.347 0.471 0 CA-C-O 121.985 0.898 . . . . 63.039999999999999 110.297 -177.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.1 t -143.55 159.64 42.06 Favored 'General case' 0 N--CA 1.41 -2.454 0 CA-C-N 115.698 -0.683 . . . . 72.120000000000005 109.607 -172.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 129.61 131.56 3.37 Favored Glycine 0 N--CA 1.433 -1.509 0 N-CA-C 110.626 -0.989 . . . . 53.240000000000002 110.626 -179.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.57 -24.47 58.92 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.739 0.78 . . . . 73.310000000000002 110.759 -176.021 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.491 ' CD ' ' H ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -83.15 -39.71 20.69 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 114.829 -1.078 . . . . 72.319999999999993 111.113 -178.357 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -82.86 -37.55 24.19 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 116.277 -0.419 . . . . 75.219999999999999 111.662 -177.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.7 mp -84.17 145.9 47.0 Favored Pre-proline 0 C--N 1.312 -1.034 0 C-N-CA 120.43 -0.508 . . . . 63.100000000000001 112.004 -177.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -79.53 39.41 0.82 Allowed 'Trans proline' 0 C--N 1.359 1.123 0 C-N-CA 123.921 3.08 . . . . 71.430000000000007 113.67 -175.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -116.52 111.97 20.71 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 120.677 0.275 . . . . 73.299999999999997 110.526 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -83.64 -25.37 46.72 Favored Glycine 0 C--N 1.316 -0.556 0 N-CA-C 109.401 -1.48 . . . . 63.200000000000003 109.401 174.259 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.9 m -132.75 151.49 51.98 Favored 'General case' 0 N--CA 1.421 -1.895 0 N-CA-C 104.926 -2.25 . . . . 51.310000000000002 104.926 175.351 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.412 ' HB3' ' CZ ' ' A' ' 137' ' ' PHE . . . -142.88 164.81 29.09 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 108.497 -0.927 . . . . 51.229999999999997 108.497 -178.055 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.514 HD12 ' HD3' ' A' ' 141' ' ' PRO . 0.0 OUTLIER -119.44 150.43 40.22 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 120.32 -0.552 . . . . 73.439999999999998 111.677 -174.544 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.476 ' O ' HD12 ' A' ' 49' ' ' LEU . 2.8 pp -109.77 138.95 45.4 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 115.312 -0.858 . . . . 73.430000000000007 109.325 176.108 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.42 HG12 ' HB3' ' A' ' 60' ' ' ARG . 29.8 m -112.66 131.79 63.21 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 N-CA-C 108.093 -1.077 . . . . 61.43 108.093 177.062 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 37.1 t -92.05 114.34 28.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 N-CA-C 104.442 -2.429 . . . . 65.200000000000003 104.442 175.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 50.5 tttp -84.72 -32.46 23.49 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 108.328 -0.99 . . . . 62.439999999999998 108.328 -173.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.492 ' HA ' ' NE ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -170.44 108.9 0.35 Allowed 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 107.721 -1.215 . . . . 72.129999999999995 107.721 174.213 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -168.86 117.75 0.74 Allowed Glycine 0 N--CA 1.424 -2.111 0 C-N-CA 120.465 -0.874 . . . . 64.430000000000007 111.099 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.417 ' HB2' ' HB2' ' A' ' 82' ' ' ASP . 85.9 Cg_exo -51.6 -12.77 1.16 Allowed 'Trans proline' 0 CA--C 1.555 1.532 0 C-N-CA 124.423 3.415 . . . . 75.239999999999995 116.127 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.484 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 31.3 p30 -71.67 -29.48 64.66 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 122.115 -0.365 . . . . 73.420000000000002 111.6 179.426 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -163.47 -148.88 0.13 Allowed 'General case' 0 C--O 1.24 0.576 0 N-CA-C 108.57 -0.9 . . . . 71.450000000000003 108.57 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 169.23 53.57 0.03 OUTLIER Glycine 0 CA--C 1.488 -1.608 0 N-CA-C 110.489 -1.044 . . . . 71.450000000000003 110.489 177.016 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -154.57 -170.24 3.47 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 108.303 -0.999 . . . . 52.439999999999998 108.303 -176.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.42 ' HB3' HG12 ' A' ' 50' ' ' VAL . 27.3 ptt180 -131.23 135.69 47.58 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 107.835 -1.172 . . . . 65.540000000000006 107.835 175.389 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -143.73 141.66 30.58 Favored 'General case' 0 C--N 1.291 -1.969 0 C-N-CA 120.518 -0.473 . . . . 74.120000000000005 111.226 178.372 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 28.3 tp -75.98 129.85 37.53 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 114.784 -1.098 . . . . 55.210000000000001 109.224 -178.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 81.9 mt -86.87 114.5 23.57 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 108.485 -0.932 . . . . 72.230000000000004 108.485 176.008 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -150.0 37.21 0.7 Allowed 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 103.761 -2.681 . . . . 73.409999999999997 103.761 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -133.98 128.64 19.74 Favored Pre-proline 0 C--N 1.297 -1.689 0 CA-C-N 113.486 -1.688 . . . . 73.340000000000003 107.768 -174.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -45.65 -55.41 3.58 Favored 'Trans proline' 0 C--N 1.362 1.237 0 C-N-CA 123.937 3.091 . . . . 75.340000000000003 113.562 -174.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.429 HG23 ' HG2' ' A' ' 93' ' ' ARG . 57.9 m -137.16 98.75 3.81 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 121.713 0.768 . . . . 71.239999999999995 112.963 179.426 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.444 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 90.1 m -80.57 112.83 18.29 Favored 'General case' 0 N--CA 1.417 -2.093 0 N-CA-C 106.42 -1.696 . . . . 75.120000000000005 106.42 174.701 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.441 ' HB ' ' HA ' ' A' ' 76' ' ' SER . 27.1 m -108.64 128.02 54.48 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 116.36 -0.382 . . . . 70.439999999999998 110.333 -175.069 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -105.0 120.02 40.45 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 108.873 -0.788 . . . . 72.239999999999995 108.873 177.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 158.39 -127.34 1.86 Allowed Glycine 0 N--CA 1.431 -1.664 0 N-CA-C 110.649 -0.98 . . . . 42.340000000000003 110.649 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.508 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 41.1 ttm180 -154.23 84.27 1.13 Allowed 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 121.436 0.636 . . . . 74.239999999999995 110.18 179.187 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 21.1 m-70 -137.3 167.18 21.87 Favored Pre-proline 0 C--N 1.288 -2.088 0 N-CA-C 107.616 -1.253 . . . . 72.349999999999994 107.616 175.097 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -60.07 -21.56 65.98 Favored 'Trans proline' 0 C--N 1.358 1.069 0 C-N-CA 122.308 2.005 . . . . 74.239999999999995 111.024 174.281 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -112.53 78.72 1.15 Allowed 'General case' 0 N--CA 1.424 -1.758 0 N-CA-C 107.963 -1.125 . . . . 72.519999999999996 107.963 177.17 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.441 ' HA ' ' HB ' ' A' ' 69' ' ' THR . 55.4 m -139.35 151.53 46.44 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 115.108 -0.951 . . . . 63.030000000000001 110.525 177.455 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -104.36 -46.85 4.28 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 109.018 -0.734 . . . . 73.230000000000004 109.018 -178.126 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 33.8 pt -133.31 156.01 41.36 Favored 'Isoleucine or valine' 0 C--O 1.245 0.865 0 CA-C-N 115.58 -0.736 . . . . 70.230000000000004 109.685 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -120.29 135.45 55.0 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.583 -0.895 . . . . 74.450000000000003 108.583 178.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.484 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 4.5 mp -75.42 106.01 6.74 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 122.849 0.46 . . . . 61.200000000000003 110.94 -178.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -86.26 63.51 8.05 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 122.718 1.246 . . . . 61.210000000000001 109.913 177.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.417 ' HB2' ' HB2' ' A' ' 55' ' ' PRO . 21.6 t70 -143.66 167.58 21.93 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 113.726 -1.579 . . . . 65.319999999999993 107.301 178.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.1 m -66.4 -33.87 66.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 117.801 0.273 . . . . 71.219999999999999 111.375 178.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 11.7 p -90.63 72.22 6.79 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-O 121.603 0.716 . . . . 75.530000000000001 112.425 179.433 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 6.9 p -113.58 113.41 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 CA-C-N 114.872 -1.058 . . . . 54.130000000000003 111.257 177.151 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 7.0 m -92.83 148.23 22.2 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 105.281 -2.118 . . . . 61.520000000000003 105.281 171.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.508 ' HB2' ' O ' ' A' ' 72' ' ' ARG . 9.1 ptm180 -73.47 -21.92 60.31 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 118.421 -1.312 . . . . 74.049999999999997 110.481 -179.57 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 26.8 ptt180 -122.24 97.77 5.63 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 106.526 -1.657 . . . . 72.310000000000002 106.526 165.215 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 8.6 t60 -109.66 -52.29 2.79 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.923 -0.711 . . . . 74.450000000000003 110.941 -173.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -144.96 131.94 20.28 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 120.188 -0.605 . . . . 71.219999999999999 110.104 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -114.91 126.81 55.22 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 108.794 -0.817 . . . . 74.019999999999996 108.794 177.014 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.444 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 79.8 m-85 -113.61 113.45 25.08 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 107.72 -1.215 . . . . 74.310000000000002 107.72 -179.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.429 ' HG2' HG23 ' A' ' 67' ' ' THR . 51.5 mtm180 -115.25 152.64 32.33 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-O 121.116 0.484 . . . . 74.420000000000002 110.977 -175.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.492 ' O ' HD12 ' A' ' 94' ' ' ILE . 2.9 pp -113.83 117.07 54.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 CA-C-O 122.414 1.102 . . . . 73.439999999999998 108.459 175.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 38.1 t-20 -103.05 147.65 26.7 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 106.893 -1.521 . . . . 74.099999999999994 106.893 -173.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -49.81 -32.94 15.2 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 112.505 0.557 . . . . 71.319999999999993 112.505 -177.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -94.19 -40.72 4.47 Favored Glycine 0 N--CA 1.422 -2.296 0 C-N-CA 120.265 -0.969 . . . . 72.349999999999994 113.371 -179.198 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -149.32 178.47 8.74 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 121.872 0.844 . . . . 73.120000000000005 112.574 -173.412 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -93.35 127.18 38.85 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 107.455 -1.313 . . . . 74.510000000000005 107.455 177.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -123.03 130.78 53.23 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 120.858 0.361 . . . . 73.420000000000002 111.973 -171.333 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 9.0 p -121.54 131.05 73.97 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 109.139 -0.689 . . . . 75.049999999999997 109.139 175.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.7 m -117.76 128.02 75.0 Favored 'Isoleucine or valine' 0 C--O 1.259 1.578 0 CA-C-O 121.569 0.699 . . . . 71.430000000000007 111.02 178.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -83.79 114.5 21.66 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.679 -1.146 . . . . 54.25 110.065 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 23.4 m -122.35 3.18 5.99 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 CA-C-O 121.923 0.868 . . . . 75.019999999999996 108.903 173.003 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -109.17 53.26 0.6 Allowed Glycine 0 N--CA 1.427 -1.955 0 CA-C-N 114.596 -1.184 . . . . 75.219999999999999 110.36 -178.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.2 p -64.85 -2.85 2.83 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.455 1.102 . . . . 53.420000000000002 112.107 -178.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.412 ' H ' HD22 ' A' ' 107' ' ' LEU . 2.9 mm? -62.83 -35.64 80.59 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 108.454 -0.943 . . . . 64.25 108.454 174.449 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -114.49 -45.93 2.99 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.237 -1.023 . . . . 64.310000000000002 108.237 177.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 94.37 120.97 3.35 Favored Glycine 0 N--CA 1.435 -1.419 0 CA-C-N 115.012 -0.994 . . . . 63.299999999999997 111.398 -178.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.4 m -79.56 119.53 22.66 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.999 -0.741 . . . . 72.239999999999995 108.999 176.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -103.4 134.42 46.8 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.967 -0.753 . . . . 74.099999999999994 108.967 178.181 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.468 HG11 ' HG2' ' A' ' 120' ' ' GLN . 61.9 t -115.91 117.93 57.15 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.359 0 N-CA-C 105.923 -1.88 . . . . 71.040000000000006 105.923 175.053 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 59.46 31.67 21.2 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-O 122.286 1.041 . . . . 55.310000000000002 108.392 -175.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 44.4 mtp180 74.39 5.03 4.56 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.127 1.371 . . . . 74.349999999999994 114.304 -178.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -103.05 134.95 19.5 Favored Pre-proline 0 C--N 1.309 -1.167 0 O-C-N 121.705 -0.622 . . . . 73.450000000000003 109.671 177.161 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -69.72 119.28 6.26 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.086 1.857 . . . . 74.230000000000004 110.096 177.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -123.35 129.98 52.07 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.715 -0.846 . . . . 70.010000000000005 108.715 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -69.64 -42.11 74.73 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 121.363 0.602 . . . . 43.109999999999999 109.904 178.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -144.61 138.39 27.38 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 105.814 -1.921 . . . . 75.530000000000001 105.814 173.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.468 ' HG2' HG11 ' A' ' 112' ' ' VAL . 57.8 tp60 -141.44 148.9 40.28 Favored 'General case' 0 C--N 1.282 -2.369 0 CA-C-O 120.732 0.301 . . . . 74.239999999999995 110.405 -177.71 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 89.1 t -80.46 120.88 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.669 0 N-CA-C 104.997 -2.223 . . . . 63.43 104.997 169.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 76.8 mtm -60.37 138.64 57.94 Favored 'General case' 0 CA--C 1.499 -0.985 0 CA-C-O 121.249 0.547 . . . . 74.230000000000004 111.339 -176.349 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 8.4 tp60 -103.79 123.48 47.15 Favored 'General case' 0 N--CA 1.417 -2.1 0 CA-C-N 115.146 -0.934 . . . . 72.329999999999998 108.483 -168.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 21.4 p -83.23 117.67 23.1 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.848 -0.615 . . . . 72.530000000000001 109.953 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 95.68 13.52 50.34 Favored Glycine 0 N--CA 1.436 -1.359 0 N-CA-C 111.631 -0.588 . . . . 71.219999999999999 111.631 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -132.5 -175.42 3.75 Favored 'General case' 0 C--O 1.248 0.976 0 N-CA-C 109.186 -0.672 . . . . 73.329999999999998 109.186 -177.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -112.03 149.05 32.59 Favored 'General case' 0 C--O 1.251 1.15 0 N-CA-C 114.997 1.48 . . . . 65.150000000000006 114.997 -171.215 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.409 ' HB ' ' HB3' ' A' ' 135' ' ' LEU . 37.3 mm -121.79 117.69 53.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 105.983 -1.858 . . . . 62.350000000000001 105.983 174.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -120.35 116.78 26.19 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 107.357 -1.349 . . . . 63.350000000000001 107.357 -177.238 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.0 tt -128.79 108.92 18.02 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.226 0 CA-C-O 121.417 0.627 . . . . 74.030000000000001 110.589 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 70.67 -103.98 1.3 Allowed Glycine 0 C--N 1.314 -0.669 0 N-CA-C 110.439 -1.064 . . . . 51.149999999999999 110.439 -177.239 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -120.09 6.56 10.79 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.056 -0.72 . . . . 72.420000000000002 109.056 173.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.472 ' CE2' HD23 ' A' ' 80' ' ' LEU . 56.3 m-85 -91.43 106.56 18.58 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 108.965 -0.754 . . . . 74.420000000000002 108.965 -177.081 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 14.5 ptt180 -96.41 120.95 37.65 Favored 'General case' 0 N--CA 1.432 -1.375 0 CA-C-O 122.168 0.985 . . . . 71.450000000000003 110.203 177.185 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.417 HD12 ' O ' ' A' ' 50' ' ' VAL . 25.3 tp -124.51 142.98 50.92 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 113.643 -1.617 . . . . 73.450000000000003 108.378 -174.577 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 29.8 t -124.5 134.89 65.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 107.499 -1.297 . . . . 71.099999999999994 107.499 176.256 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.412 ' CZ ' ' HB3' ' A' ' 47' ' ' ALA . 64.1 t80 -108.32 120.34 42.09 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.057 -0.72 . . . . 74.239999999999995 109.057 -176.097 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -121.85 144.04 49.06 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.6 0.714 . . . . 70.430000000000007 112.337 -175.453 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -91.82 80.27 5.27 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 106.533 -1.654 . . . . 62.229999999999997 106.533 172.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -77.61 -71.69 1.19 Allowed Glycine 0 C--N 1.301 -1.414 0 CA-C-N 114.791 -1.095 . . . . 70.400000000000006 113.778 -174.464 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.514 ' HD3' HD12 ' A' ' 48' ' ' LEU . 19.7 Cg_exo -65.26 133.12 33.93 Favored 'Trans proline' 0 N--CA 1.445 -1.326 0 C-N-CA 122.139 1.892 . . . . 72.430000000000007 113.023 -177.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -109.36 103.92 12.93 Favored 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 104.825 -2.287 . . . . 74.200000000000003 104.825 170.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 . . . . . 0 C--N 1.289 -2.038 0 CA-C-O 118.543 -0.741 . . . . 74.310000000000002 109.026 -173.021 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 CA--C 1.499 -0.99 0 N-CA-C 109.37 -0.604 . . . . 75.549999999999997 109.37 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.9 t -81.37 -38.39 26.69 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 106.971 -1.492 . . . . 71.329999999999998 106.971 177.132 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -88.29 155.26 19.83 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 106.796 -1.557 . . . . 74.549999999999997 106.796 175.348 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 23.5 p-10 -155.68 153.02 29.34 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 120.58 -0.448 . . . . 72.209999999999994 111.457 -178.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -131.19 144.54 51.43 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 107.143 -1.429 . . . . 60.539999999999999 107.143 176.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -136.82 -133.28 3.16 Favored Glycine 0 N--CA 1.425 -2.064 0 C-N-CA 120.233 -0.984 . . . . 32.119999999999997 112.997 -176.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.8 t -85.09 143.22 39.36 Favored Pre-proline 0 C--N 1.302 -1.474 0 C-N-CA 122.599 0.36 . . . . 50.450000000000003 111.223 -176.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -66.73 150.34 83.51 Favored 'Trans proline' 0 C--O 1.249 1.037 0 C-N-CA 122.601 2.201 . . . . 72.430000000000007 110.385 171.112 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.9 mp0 -76.94 128.34 81.62 Favored Pre-proline 0 C--O 1.245 0.861 0 N-CA-C 109.612 -0.514 . . . . 74.299999999999997 109.612 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -63.05 150.43 88.66 Favored 'Trans proline' 0 C--O 1.25 1.079 0 C-N-CA 122.817 2.344 . . . . 63.32 111.191 175.411 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -92.77 173.89 7.53 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-O 121.028 0.442 . . . . 64.109999999999999 110.698 -175.668 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.5 m -121.18 169.57 12.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-N 115.698 -0.683 . . . . 63.509999999999998 110.779 -178.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -78.49 140.94 38.55 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 109.594 -0.521 . . . . 65.329999999999998 109.594 178.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.1 t -111.47 148.52 32.96 Favored 'General case' 0 N--CA 1.422 -1.833 0 CA-C-O 121.079 0.466 . . . . 51.25 110.311 -178.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.6 p -100.51 8.79 43.29 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 112.282 0.475 . . . . 72.030000000000001 112.282 178.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.4 p -78.94 32.54 0.21 Allowed 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.421 0.689 . . . . 73.150000000000006 112.621 -177.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.9 m -112.44 132.43 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 N-CA-C 108.45 -0.945 . . . . 75.400000000000006 108.45 178.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -87.76 141.09 28.87 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 118.712 -1.195 . . . . 74.239999999999995 109.872 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -86.04 132.34 34.07 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 107.288 -1.375 . . . . 74.510000000000005 107.288 175.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.31 90.28 0.92 Allowed 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.797 0.808 . . . . 73.099999999999994 112.201 -176.262 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -100.12 -33.66 10.37 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 115.105 -0.952 . . . . 61.310000000000002 110.522 175.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 62.1 tp -79.14 88.73 4.85 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.272 0.558 . . . . 72.219999999999999 109.779 178.395 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 91.4 mt -113.84 129.84 56.54 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.795 -0.817 . . . . 64.400000000000006 108.795 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.446 ' NZ ' ' HB2' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -104.95 -10.45 17.25 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 120.238 -0.585 . . . . 73.420000000000002 112.322 -176.905 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -80.91 120.46 24.76 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 118.494 -1.283 . . . . 74.120000000000005 112.254 -177.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 21.5 ptt? -102.02 120.36 40.29 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.202 -1.407 . . . . 60.409999999999997 107.202 175.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -71.69 136.47 47.25 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 112.871 0.693 . . . . 72.430000000000007 112.871 -175.13 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.1 m -93.1 88.06 5.95 Favored 'General case' 0 N--CA 1.42 -1.965 0 N-CA-C 105.617 -1.994 . . . . 71.219999999999999 105.617 170.321 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.0 t -61.18 130.49 46.54 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 114.887 -1.051 . . . . 70.230000000000004 110.601 -173.392 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.1 t -125.2 120.73 32.12 Favored 'General case' 0 N--CA 1.425 -1.694 0 CA-C-O 121.552 0.691 . . . . 74.019999999999996 110.963 -178.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -104.6 71.62 0.25 Allowed Glycine 0 N--CA 1.438 -1.192 0 N-CA-C 108.772 -1.731 . . . . 75.319999999999993 108.772 174.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.6 m -67.22 137.01 55.87 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 123.724 0.81 . . . . 71.219999999999999 112.176 -172.076 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -85.75 140.45 35.53 Favored Pre-proline 0 C--N 1.308 -1.199 0 N-CA-C 108.419 -0.956 . . . . 63.119999999999997 108.419 176.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -73.55 105.69 2.04 Favored 'Trans proline' 0 N--CA 1.446 -1.27 0 C-N-CA 121.684 1.589 . . . . 72.299999999999997 111.831 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -92.51 70.11 4.99 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.429 -0.952 . . . . 54.049999999999997 108.429 177.316 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.6 t -144.39 143.72 31.07 Favored 'General case' 0 N--CA 1.423 -1.806 0 N-CA-C 107.678 -1.23 . . . . 74.099999999999994 107.678 -177.304 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 13.2 m 65.7 75.9 0.34 Allowed 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 124.52 1.128 . . . . 63.350000000000001 109.785 -178.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 136.98 -34.59 2.19 Favored Glycine 0 N--CA 1.432 -1.596 0 CA-C-N 114.22 -1.355 . . . . 75.049999999999997 110.121 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.93 -46.74 33.66 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 121.753 0.787 . . . . 72.230000000000004 110.237 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.88 -11.67 56.61 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.35 -0.841 . . . . 51.119999999999997 109.895 -178.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.544 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 47.6 t30 -62.72 -29.16 70.46 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.857 -1.065 . . . . 75.439999999999998 110.781 -179.121 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -107.81 89.14 5.03 Favored Pre-proline 0 N--CA 1.44 -0.96 0 CA-C-N 116.508 -0.314 . . . . 75.150000000000006 110.511 177.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.544 ' HD3' ' O ' ' A' ' 41' ' ' ASN . 63.7 Cg_endo -100.63 17.09 0.35 Allowed 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 122.726 2.284 . . . . 72.239999999999995 111.498 178.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -153.39 154.07 33.76 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 107.699 -1.222 . . . . 51.520000000000003 107.699 -179.163 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.84 30.21 56.27 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 109.178 -1.569 . . . . 62.509999999999998 109.178 -174.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.5 m -90.67 165.89 13.46 Favored 'General case' 0 N--CA 1.425 -1.692 0 CA-C-N 114.548 -0.826 . . . . 74.329999999999998 111.192 -174.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -90.86 163.42 14.41 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 108.104 -1.073 . . . . 63.350000000000001 108.104 175.59 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.45 ' HB3' ' HG ' ' A' ' 62' ' ' LEU . 2.5 pt? -133.93 159.96 39.14 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.453 0.644 . . . . 63.299999999999997 110.733 -177.253 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.417 ' HB2' HD21 ' A' ' 135' ' ' LEU . 1.1 pt? -122.97 132.84 54.33 Favored 'General case' 0 C--N 1.278 -2.528 0 CA-C-N 115.018 -0.992 . . . . 75.209999999999994 108.806 176.673 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.4 m -110.01 116.35 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.019 0 N-CA-C 107.14 -1.43 . . . . 74.329999999999998 107.14 175.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.1 t -93.03 115.62 32.25 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.467 0 N-CA-C 107.88 -1.156 . . . . 75.540000000000006 107.88 -176.21 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -72.66 -38.6 67.59 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.584 -1.265 . . . . 73.299999999999997 107.584 -177.217 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 50.9 ttt180 -176.18 111.22 0.1 Allowed 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 106.359 -1.719 . . . . 72.329999999999998 106.359 174.257 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.49 ' HA2' ' HB3' ' A' ' 133' ' ' PHE . . . -122.84 166.17 15.33 Favored Glycine 0 N--CA 1.418 -2.53 0 N-CA-C 111.412 -0.675 . . . . 61.240000000000002 111.412 -177.307 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -69.09 -23.73 33.55 Favored 'Trans proline' 0 C--N 1.322 -0.847 0 C-N-CA 122.954 2.436 . . . . 64.319999999999993 111.481 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -98.87 -52.03 3.7 Favored 'General case' 0 N--CA 1.426 -1.63 0 CA-C-N 114.595 -1.184 . . . . 73.120000000000005 111.322 -177.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -144.25 -173.08 3.92 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-O 120.808 0.337 . . . . 72.540000000000006 110.496 -173.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.38 46.02 0.41 Allowed Glycine 0 N--CA 1.435 -1.399 0 N-CA-C 109.114 -1.594 . . . . 32.450000000000003 109.114 178.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -133.67 -169.87 2.38 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.888 -0.782 . . . . 74.329999999999998 108.888 -175.186 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -125.84 135.26 51.76 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 110.462 -0.199 . . . . 65.430000000000007 110.462 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -156.26 149.3 24.2 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 112.947 0.721 . . . . 72.140000000000001 112.947 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.45 ' HG ' ' HB3' ' A' ' 48' ' ' LEU . 6.8 mp -93.06 141.98 27.8 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 124.581 1.152 . . . . 72.349999999999994 109.73 177.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -74.49 115.3 13.86 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.592 -0.443 . . . . 73.549999999999997 110.065 176.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -113.13 8.97 18.46 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 108.606 -0.887 . . . . 71.409999999999997 108.606 -179.454 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -136.69 134.4 19.45 Favored Pre-proline 0 C--N 1.3 -1.571 0 N-CA-C 112.258 0.466 . . . . 71.209999999999994 112.258 -167.292 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.444 ' HA ' ' CG2' ' A' ' 94' ' ' ILE . 9.7 Cg_endo -52.43 -62.49 0.35 Allowed 'Trans proline' 0 C--N 1.371 1.721 0 C-N-CA 124.538 3.492 . . . . 75.230000000000004 113.853 -177.619 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 94.7 m -116.49 110.64 18.87 Favored 'General case' 0 N--CA 1.422 -1.831 0 N-CA-C 109.354 -0.61 . . . . 75.409999999999997 109.354 178.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.452 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 91.2 m -109.56 113.63 26.58 Favored 'General case' 0 C--N 1.283 -2.314 0 N-CA-C 109.045 -0.724 . . . . 65.439999999999998 109.045 177.107 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.8 t -95.75 132.83 40.56 Favored 'General case' 0 C--O 1.256 1.424 0 N-CA-C 109.381 -0.6 . . . . 73.209999999999994 109.381 -178.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -127.88 124.92 38.65 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 115.739 -0.664 . . . . 51.119999999999997 110.282 -177.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.79 33.46 15.7 Favored Glycine 0 C--N 1.3 -1.445 0 C-N-CA 119.092 -1.527 . . . . 75.140000000000001 111.913 177.396 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.645 ' HA ' ' O ' ' A' ' 87' ' ' ARG . 2.1 tmt_? -123.73 87.66 2.78 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 105.993 -1.854 . . . . 74.519999999999996 105.993 176.603 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 20.3 m170 66.05 171.2 0.1 OUTLIER Pre-proline 0 CA--C 1.552 1.033 0 O-C-N 124.106 0.879 . . . . 72.219999999999999 109.795 -175.068 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -65.47 -20.18 60.91 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 121.686 1.591 . . . . 71.310000000000002 109.33 170.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -75.78 7.77 3.6 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 126.027 1.731 . . . . 74.239999999999995 112.381 -177.466 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 10.1 p -84.73 175.23 9.31 Favored 'General case' 0 C--N 1.322 -0.607 0 O-C-N 121.973 -0.454 . . . . 50.399999999999999 110.526 177.273 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -62.85 -56.74 14.71 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 108.791 -0.818 . . . . 73.230000000000004 108.791 -178.004 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.482 HD13 ' H ' ' A' ' 78' ' ' ILE . 0.2 OUTLIER -125.65 123.55 64.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 106.3 -1.741 . . . . 74.349999999999994 106.3 172.457 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -99.38 121.57 41.3 Favored 'General case' 0 C--N 1.29 -2.015 0 C-N-CA 119.829 -0.748 . . . . 72.540000000000006 112.872 -171.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.6 mp -69.09 128.95 38.46 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 107.418 -1.327 . . . . 75.439999999999998 107.418 170.54 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -116.06 24.04 11.74 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-O 122.46 1.124 . . . . 64.430000000000007 110.093 -175.003 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -103.84 -164.85 1.1 Allowed 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.745 -0.782 . . . . 74.019999999999996 109.889 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.7 p -92.19 -6.74 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.319 0 CA-C-O 121.339 0.59 . . . . 74.430000000000007 111.779 -174.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 7.4 m -87.45 12.87 11.15 Favored 'General case' 0 CA--C 1.555 1.139 0 CA-C-O 121.666 0.746 . . . . 72.329999999999998 110.543 -177.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 87.7 t -81.59 104.77 10.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-O 121.993 0.901 . . . . 73.150000000000006 110.83 -177.106 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 16.8 m -86.64 42.52 1.01 Allowed 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 124.388 1.075 . . . . 61.43 112.096 -176.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.645 ' O ' ' HA ' ' A' ' 72' ' ' ARG . 82.7 mtm180 72.65 -48.22 0.68 Allowed 'General case' 0 N--CA 1.513 2.724 0 C-N-CA 124.496 1.118 . . . . 54.420000000000002 110.39 -175.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -139.73 120.3 14.16 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 103.113 -2.921 . . . . 75.150000000000006 103.113 171.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 54.8 t60 -110.19 -71.45 0.76 Allowed 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 117.664 -1.614 . . . . 44.140000000000001 113.76 -174.025 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -117.85 143.24 46.47 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.974 -0.691 . . . . 74.109999999999999 111.911 -173.262 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.4 mm-40 -121.65 127.53 50.91 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.087 -1.079 . . . . 72.120000000000005 108.087 177.266 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.452 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 91.6 m-85 -103.67 113.47 27.01 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 106.628 -1.619 . . . . 71.430000000000007 106.628 175.391 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 89.5 mtt-85 -120.52 146.12 46.61 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 121.185 0.517 . . . . 73.519999999999996 110.795 -174.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.444 ' CG2' ' HA ' ' A' ' 66' ' ' PRO . 5.6 tt -115.87 130.93 69.72 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 N-CA-C 108.737 -0.838 . . . . 70.340000000000003 108.737 175.492 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.406 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 14.8 t-20 -118.68 146.31 44.8 Favored 'General case' 0 C--N 1.282 -2.335 0 N-CA-C 106.166 -1.79 . . . . 61.409999999999997 106.166 178.455 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.97 -10.29 20.6 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 112.886 0.699 . . . . 72.209999999999994 112.886 -176.565 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -103.81 -41.85 2.07 Favored Glycine 0 N--CA 1.436 -1.361 0 CA-C-N 116.424 -0.353 . . . . 74.439999999999998 112.661 175.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.406 ' O ' ' HB3' ' A' ' 95' ' ' ASN . 67.7 mm-40 -141.44 162.9 34.36 Favored 'General case' 0 C--O 1.216 -0.684 0 CA-C-O 121.277 0.56 . . . . 73.129999999999995 111.724 -176.5 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -108.2 121.19 44.36 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 106.674 -1.602 . . . . 74.109999999999999 106.674 173.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -125.52 135.55 52.39 Favored 'General case' 0 CA--C 1.49 -1.328 0 CA-C-O 122.087 0.946 . . . . 73.120000000000005 113.162 -176.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 6.0 p -108.28 119.38 57.76 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.333 0 CA-C-N 114.12 -1.4 . . . . 71.540000000000006 108.269 176.088 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.417 HG12 ' HB1' ' A' ' 119' ' ' ALA . 29.5 m -119.0 131.72 70.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 C-N-CA 120.595 -0.442 . . . . 62.310000000000002 109.852 -177.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -105.16 116.41 31.91 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.025 -1.472 . . . . 74.120000000000005 107.025 176.383 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.3 m -89.9 0.93 7.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-O 120.911 0.386 . . . . 71.010000000000005 111.025 -174.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -126.46 36.06 2.77 Favored Glycine 0 N--CA 1.429 -1.783 0 N-CA-C 108.673 -1.771 . . . . 54.340000000000003 108.673 175.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.7 p -68.8 7.35 0.68 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 113.826 1.047 . . . . 62.119999999999997 113.826 -175.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 78.3 mt -70.8 -21.51 62.47 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 108.885 -0.783 . . . . 61.149999999999999 108.885 176.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -77.23 -7.42 55.89 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.723 -0.671 . . . . 65.120000000000005 110.039 177.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 88.84 78.14 1.3 Allowed Glycine 0 N--CA 1.439 -1.126 0 N-CA-C 111.795 -0.522 . . . . 72.340000000000003 111.795 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.49 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 11.1 m -81.7 123.95 29.18 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 109.005 -0.739 . . . . 63.210000000000001 109.005 178.276 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -115.38 134.77 54.79 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 120.033 -0.667 . . . . 63.229999999999997 110.891 -176.13 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 29.1 m -112.68 110.37 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.135 0 N-CA-C 106.876 -1.527 . . . . 23.23 106.876 169.547 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 62.5 t30 58.18 36.66 25.97 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 125.355 1.462 . . . . 74.099999999999994 109.708 -177.065 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 52.8 mtp180 81.74 -0.62 1.57 Allowed 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 126.753 2.021 . . . . 74.329999999999998 113.545 -178.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -92.42 115.79 65.36 Favored Pre-proline 0 C--N 1.313 -1.004 0 N-CA-C 109.372 -0.603 . . . . 72.219999999999999 109.372 178.556 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.49 ' HA ' ' O ' ' A' ' 110' ' ' THR . 36.4 Cg_endo -66.34 121.5 8.8 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.905 2.403 . . . . 74.310000000000002 112.182 -179.024 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 8.8 mmm180 -136.1 163.73 29.66 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 120.833 0.349 . . . . 70.430000000000007 110.144 -177.376 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -98.94 -45.9 5.81 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.114 -1.069 . . . . 63.539999999999999 108.114 176.343 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.417 ' HB1' HG12 ' A' ' 102' ' ' VAL . . . -139.86 142.26 36.58 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 107.263 -1.384 . . . . 63.439999999999998 107.263 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -134.68 141.06 46.44 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-O 121.316 0.579 . . . . 72.129999999999995 111.126 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.3 p -90.73 134.81 28.35 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 106.337 -1.727 . . . . 61.43 106.337 177.088 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 20.9 ptt? -41.01 123.84 2.06 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 122.143 0.973 . . . . 53.140000000000001 112.847 -177.373 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -127.01 124.71 40.03 Favored 'General case' 0 N--CA 1.413 -2.325 0 N-CA-C 106.17 -1.789 . . . . 73.109999999999999 106.17 177.101 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 31.1 p -78.48 124.45 28.15 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 116.138 -0.483 . . . . 75.200000000000003 111.821 -172.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 92.67 1.38 68.32 Favored Glycine 0 N--CA 1.44 -1.089 0 CA-C-N 115.207 -0.906 . . . . 42.25 110.894 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -90.41 151.54 21.38 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 108.312 -0.995 . . . . 73.129999999999995 108.312 -177.735 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.422 ' HG2' HG22 ' A' ' 136' ' ' VAL . 39.8 mt-10 -113.31 129.3 56.57 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 112.264 0.468 . . . . 75.430000000000007 112.264 -175.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 61.9 mt -95.27 115.78 35.09 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.164 0 N-CA-C 105.9 -1.889 . . . . 75.329999999999998 105.9 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.413 ' HA ' ' O ' ' A' ' 133' ' ' PHE . 76.5 mt-30 -118.26 119.37 34.46 Favored 'General case' 0 N--CA 1.418 -2.059 0 CA-C-N 115.124 -0.944 . . . . 62.450000000000003 110.12 -172.696 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 7.5 pt -123.32 125.53 71.93 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 CA-C-N 114.962 -1.017 . . . . 75.530000000000001 109.222 179.033 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 68.5 -102.11 0.84 Allowed Glycine 0 N--CA 1.434 -1.499 0 N-CA-C 108.746 -1.741 . . . . 72.420000000000002 108.746 -171.246 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -137.32 18.76 2.94 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.947 -0.761 . . . . 61.119999999999997 108.947 174.122 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.49 ' HB3' ' HA2' ' A' ' 54' ' ' GLY . 81.6 m-85 -93.03 150.13 20.74 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.679 -0.692 . . . . 75.040000000000006 110.225 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 75.6 mtt180 -123.81 122.9 39.25 Favored 'General case' 0 C--O 1.252 1.206 0 CA-C-O 121.498 0.666 . . . . 64.439999999999998 111.47 -172.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.417 HD21 ' HB2' ' A' ' 49' ' ' LEU . 5.5 tt -123.67 129.99 51.96 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 106.682 -1.599 . . . . 73.5 106.682 177.592 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.422 HG22 ' HG2' ' A' ' 127' ' ' GLU . 12.2 t -108.14 128.73 63.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 N-CA-C 108.297 -1.001 . . . . 64.349999999999994 108.297 -178.484 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -105.92 129.38 54.08 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 120.71 -0.396 . . . . 73.519999999999996 110.408 -176.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -132.65 169.22 16.97 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.872 0.368 . . . . 74.230000000000004 110.263 -177.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -91.72 139.0 31.1 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 107.728 -1.212 . . . . 65.239999999999995 107.728 174.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -102.95 171.17 20.54 Favored Glycine 0 N--CA 1.439 -1.162 0 C-N-CA 120.119 -1.038 . . . . 71.530000000000001 113.005 -175.114 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -80.49 164.68 21.15 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 122.583 2.189 . . . . 72.019999999999996 111.586 177.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -109.27 125.56 52.42 Favored 'General case' 0 N--CA 1.425 -1.714 0 N-CA-C 108.638 -0.875 . . . . 71.209999999999994 108.638 178.012 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 . . . . . 0 N--CA 1.428 -1.55 0 O-C-N 123.403 0.439 . . . . 74.239999999999995 110.557 177.359 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.4 ptt? . . . . . 0 N--CA 1.451 -0.384 0 CA-C-O 121.659 0.742 . . . . 62.439999999999998 110.959 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.4 m -83.41 -23.92 32.15 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.559 -0.746 . . . . 74.400000000000006 109.505 176.257 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -42.71 128.35 4.09 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 126.373 1.869 . . . . 70.109999999999999 113.984 -176.346 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -134.57 145.45 48.7 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 106.837 -1.542 . . . . 53.32 106.837 174.118 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -85.07 92.87 8.47 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.899 -0.778 . . . . 75.099999999999994 108.899 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -78.74 158.81 45.36 Favored Glycine 0 N--CA 1.431 -1.671 0 N-CA-C 110.786 -0.925 . . . . 54.200000000000003 110.786 179.187 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.5 m -75.14 125.28 89.31 Favored Pre-proline 0 C--N 1.299 -1.624 0 N-CA-C 109.987 -0.375 . . . . 63.240000000000002 109.987 -178.894 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -63.92 127.73 20.2 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 121.628 1.552 . . . . 74.0 109.121 175.158 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.434 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -89.99 144.12 30.94 Favored Pre-proline 0 C--N 1.298 -1.641 0 N-CA-C 112.489 0.552 . . . . 65.310000000000002 112.489 -176.844 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 9' ' ' GLU . 4.1 Cg_exo -76.66 141.67 22.25 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.373 2.049 . . . . 53.520000000000003 111.722 178.282 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -81.51 118.31 22.63 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.498 -0.927 . . . . 72.239999999999995 108.498 179.386 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.2 p -75.62 118.62 22.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 109.521 -0.548 . . . . 61.009999999999998 109.521 178.764 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -81.55 120.92 25.65 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 109.704 -0.48 . . . . 73.25 109.704 -179.078 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.0 t -129.6 117.44 20.4 Favored 'General case' 0 N--CA 1.414 -2.262 0 CA-C-N 115.496 -0.774 . . . . 73.319999999999993 110.19 -178.495 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.9 p -95.5 101.15 12.84 Favored 'General case' 0 N--CA 1.425 -1.688 0 CA-C-N 115.856 -0.611 . . . . 71.439999999999998 110.978 179.867 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.4 t -81.16 103.18 10.78 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 108.97 -0.752 . . . . 62.43 108.97 178.702 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 42.6 t -91.77 136.43 24.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 N-CA-C 107.75 -1.204 . . . . 72.230000000000004 107.75 179.0 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -69.86 106.95 3.34 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.809 -0.812 . . . . 71.200000000000003 108.809 177.957 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 -85.09 129.89 34.71 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 115.649 -0.705 . . . . 72.530000000000001 109.716 -178.84 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.07 55.53 2.17 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 122.081 0.943 . . . . 61.409999999999997 109.787 178.846 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -78.41 -44.49 24.69 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 114.709 -1.132 . . . . 72.340000000000003 110.344 -177.499 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 57.8 tp 64.13 102.81 0.03 OUTLIER 'General case' 0 C--O 1.259 1.602 0 C-N-CA 125.361 1.464 . . . . 73.430000000000007 114.301 175.705 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 60.6 tp -89.51 132.19 35.17 Favored 'General case' 0 N--CA 1.423 -1.812 0 N-CA-C 107.051 -1.463 . . . . 62.219999999999999 107.051 172.677 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.504 ' HD2' ' H ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -111.68 174.61 5.79 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 109.223 -0.658 . . . . 74.109999999999999 109.223 -177.304 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -71.3 130.89 42.52 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.018 0.437 . . . . 65.450000000000003 110.784 -176.165 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 88.3 mtp -81.48 92.82 6.54 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.542 -0.754 . . . . 74.430000000000007 109.913 -179.006 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -82.9 169.92 15.53 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.538 -0.755 . . . . 74.140000000000001 111.108 -179.925 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.6 m -85.0 -177.38 6.55 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.955 -0.566 . . . . 65.019999999999996 111.112 -179.068 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.2 m -64.46 158.55 23.59 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 123.622 0.769 . . . . 73.200000000000003 111.958 -175.907 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.6 p -62.92 -43.52 98.57 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 114.757 1.392 . . . . 65.319999999999993 114.757 -177.974 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -165.4 -179.28 39.09 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 119.891 -1.147 . . . . 52.130000000000003 112.05 -178.809 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.5 t -104.26 132.64 50.29 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 120.929 0.395 . . . . 63.32 110.138 179.67 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -92.0 126.07 54.62 Favored Pre-proline 0 C--N 1.301 -1.503 0 CA-C-N 115.778 -0.646 . . . . 74.129999999999995 109.813 179.407 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -86.15 -178.93 2.99 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.048 1.832 . . . . 44.210000000000001 111.008 177.726 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.38 103.41 7.29 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.482 -0.562 . . . . 73.030000000000001 109.482 178.725 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.7 t -84.62 96.98 9.36 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 108.807 -0.812 . . . . 61.030000000000001 108.807 -178.449 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.4 t -111.45 152.33 27.54 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 108.378 -0.971 . . . . 72.120000000000005 108.378 -179.328 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.15 51.81 0.68 Allowed Glycine 0 C--N 1.31 -0.866 0 C-N-CA 120.795 -0.717 . . . . 52.030000000000001 111.448 -177.898 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.1 -24.69 63.25 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.099 0.476 . . . . 53.200000000000003 110.931 -177.167 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -68.42 -11.93 60.41 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.372 -0.831 . . . . 75.239999999999995 112.458 -179.545 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -76.15 -43.03 44.78 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.544 -0.462 . . . . 71.329999999999998 110.448 -178.714 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.424 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 2.7 tm? 67.75 116.5 0.03 OUTLIER Pre-proline 0 CA--C 1.564 1.518 0 C-N-CA 124.98 1.312 . . . . 72.239999999999995 111.088 -179.9 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 42' ' ' LEU . 10.4 Cg_endo -89.49 115.48 0.66 Allowed 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.668 2.245 . . . . 74.25 111.716 177.555 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.55 82.01 8.13 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.383 0.611 . . . . 74.150000000000006 111.125 -179.463 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.412 ' O ' HD11 ' A' ' 94' ' ' ILE . . . -171.34 93.61 0.1 Allowed Glycine 0 CA--C 1.48 -2.106 0 N-CA-C 107.275 -2.33 . . . . 71.109999999999999 107.275 178.182 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.3 m -90.15 153.22 20.68 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-O 122.055 0.931 . . . . 63.130000000000003 112.311 -166.989 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.27 166.56 22.2 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 107.878 -1.156 . . . . 74.150000000000006 107.878 179.149 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.45 148.32 50.58 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.163 0.506 . . . . 72.340000000000003 112.093 -179.434 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.564 HD23 HD11 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -123.51 140.3 53.15 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.72 -0.845 . . . . 74.120000000000005 108.72 176.336 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.401 ' O ' HD12 ' A' ' 135' ' ' LEU . 35.7 t -126.43 133.5 68.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 N-CA-C 108.249 -1.019 . . . . 72.400000000000006 108.249 -179.05 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.433 HG21 ' HB3' ' A' ' 57' ' ' ALA . 35.1 t -92.22 115.23 30.7 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.077 0 N-CA-C 106.328 -1.73 . . . . 61.530000000000001 106.328 177.522 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -86.02 -31.62 21.91 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 114.992 -1.004 . . . . 74.409999999999997 109.888 -172.488 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.487 ' O ' ' HB3' ' A' ' 133' ' ' PHE . 53.5 ttt180 -159.3 139.66 12.17 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.438 -0.578 . . . . 72.019999999999996 109.438 -179.218 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.409 ' HA2' ' HD3' ' A' ' 55' ' ' PRO . . . 132.68 148.83 6.08 Favored Glycine 0 N--CA 1.435 -1.387 0 C-N-CA 120.423 -0.894 . . . . 43.329999999999998 114.292 176.737 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.409 ' HD3' ' HA2' ' A' ' 54' ' ' GLY . 31.2 Cg_exo -65.59 -8.62 19.79 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 124.126 3.217 . . . . 61.409999999999997 112.418 174.132 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.403 HD21 ' HB2' ' A' ' 133' ' ' PHE . 81.5 m-20 -49.06 -56.67 8.33 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.139 0.976 . . . . 74.25 108.724 174.543 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.433 ' HB3' HG21 ' A' ' 51' ' ' VAL . . . -179.41 -172.09 0.22 Allowed 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.702 1.201 . . . . 70.140000000000001 107.968 179.729 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -154.23 30.45 0.71 Allowed Glycine 0 CA--C 1.483 -1.915 0 N-CA-C 107.809 -2.116 . . . . 72.25 107.809 178.019 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -116.88 -179.75 3.78 Favored 'General case' 0 N--CA 1.412 -2.369 0 CA-C-N 113.676 -1.262 . . . . 63.329999999999998 108.814 -175.328 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 7.6 ptt180 -138.12 131.01 29.83 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 108.312 -0.996 . . . . 63.140000000000001 108.312 -179.801 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -122.02 148.44 44.83 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 116.354 -0.385 . . . . 74.349999999999994 110.852 -172.711 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.1 tt -98.76 117.36 33.07 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.367 -0.975 . . . . 72.230000000000004 108.367 178.497 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 94.0 mt -90.76 115.58 27.95 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.656 -0.702 . . . . 74.140000000000001 109.585 179.802 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -121.37 -34.03 3.54 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 107.667 -1.235 . . . . 64.120000000000005 107.667 177.913 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 15.5 pm0 -64.99 130.15 94.76 Favored Pre-proline 0 N--CA 1.436 -1.159 0 CA-C-N 113.987 -1.461 . . . . 74.019999999999996 109.95 175.971 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -61.5 -33.06 88.55 Favored 'Trans proline' 0 C--O 1.244 0.811 0 C-N-CA 123.299 2.666 . . . . 63.340000000000003 114.269 -175.968 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.7 m -111.97 120.38 41.71 Favored 'General case' 0 N--CA 1.435 -1.183 0 O-C-N 122.177 -0.327 . . . . 72.230000000000004 110.825 -178.061 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.488 ' HB ' ' HB3' ' A' ' 92' ' ' PHE . 41.4 m -118.74 114.1 22.18 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.841 -0.799 . . . . 44.149999999999999 108.841 176.181 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 36.7 m -102.0 127.56 48.82 Favored 'General case' 0 C--N 1.312 -1.054 0 O-C-N 121.658 -0.651 . . . . 63.509999999999998 111.245 -179.462 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -106.1 125.2 50.7 Favored 'General case' 0 C--O 1.248 0.985 0 CA-C-N 115.652 -0.703 . . . . 43.210000000000001 109.153 177.985 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 167.43 -151.1 18.4 Favored Glycine 0 CA--C 1.49 -1.513 0 N-CA-C 110.624 -0.99 . . . . 74.230000000000004 110.624 179.866 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.406 ' HG2' ' HA ' ' A' ' 87' ' ' ARG . 11.6 ptp180 -130.54 83.72 2.14 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 122.573 1.178 . . . . 75.409999999999997 111.311 179.45 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 31.3 m80 -146.83 174.72 3.17 Favored Pre-proline 0 C--N 1.293 -1.874 0 N-CA-C 106.999 -1.482 . . . . 75.319999999999993 106.999 178.452 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -66.49 -22.25 51.99 Favored 'Trans proline' 0 C--N 1.354 0.848 0 N-CA-C 107.544 -1.752 . . . . 73.540000000000006 107.544 164.733 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -89.64 68.42 7.64 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 113.854 -1.521 . . . . 71.140000000000001 108.164 176.511 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 53.6 m -139.33 113.41 8.76 Favored 'General case' 0 C--N 1.275 -2.646 0 CA-C-N 114.395 -1.275 . . . . 62.109999999999999 107.56 175.54 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -71.84 -35.6 69.91 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.909 -1.041 . . . . 71.319999999999993 109.38 -174.669 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.484 ' H ' HD13 ' A' ' 78' ' ' ILE . 0.2 OUTLIER -128.41 160.56 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.252 0 N-CA-C 106.667 -1.605 . . . . 71.349999999999994 106.667 175.348 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -107.02 135.92 47.77 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-O 121.33 0.586 . . . . 75.319999999999993 111.861 -175.385 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.0 mp -125.66 137.85 53.88 Favored 'General case' 0 N--CA 1.424 -1.77 0 N-CA-C 108.061 -1.088 . . . . 70.439999999999998 108.061 179.05 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -140.37 75.76 1.52 Allowed 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.376 -1.342 . . . . 54.219999999999999 107.376 179.543 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.432 ' OD2' ' HA3' ' A' ' 131' ' ' GLY . 18.6 t70 -120.35 159.9 24.12 Favored 'General case' 0 C--N 1.275 -2.651 0 CA-C-N 113.34 -1.755 . . . . 72.150000000000006 108.209 179.761 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 10.2 p -71.45 -27.25 28.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 CA-C-O 121.176 0.513 . . . . 71.25 111.076 -178.46 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.5 p -113.04 14.7 19.65 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 113.437 0.902 . . . . 72.439999999999998 113.437 -176.809 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.8 p -82.61 120.43 34.02 Favored 'Isoleucine or valine' 0 C--O 1.253 1.261 0 C-N-CA 118.792 -1.163 . . . . 73.549999999999997 108.878 173.996 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 9.1 t -80.62 -172.4 3.59 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 115.208 -0.906 . . . . 70.129999999999995 111.602 -173.616 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.406 ' HA ' ' HG2' ' A' ' 72' ' ' ARG . 18.8 ttp180 -62.29 -51.69 66.66 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.109 0.963 . . . . 73.329999999999998 110.988 -179.584 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -134.06 97.61 3.91 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 104.608 -2.367 . . . . 55.409999999999997 104.608 177.532 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.42 ' HA ' ' HA3' ' A' ' 105' ' ' GLY . 5.9 t60 -88.76 -55.29 3.76 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 116.049 -0.523 . . . . 73.420000000000002 111.301 -168.299 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.79 151.13 36.63 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 120.278 -0.569 . . . . 75.450000000000003 110.532 -177.231 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -120.74 128.06 52.58 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 107.428 -1.323 . . . . 73.329999999999998 107.428 174.521 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.549 ' CE2' ' HB ' ' A' ' 94' ' ' ILE . 69.8 t80 -104.49 127.77 52.27 Favored 'General case' 0 C--N 1.277 -2.553 0 N-CA-C 108.888 -0.782 . . . . 74.150000000000006 108.888 178.03 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 -109.83 122.21 46.99 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 107.137 -1.431 . . . . 75.409999999999997 107.137 -179.689 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.549 ' HB ' ' CE2' ' A' ' 92' ' ' PHE . 0.0 OUTLIER -116.05 125.93 73.34 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.246 0 CA-C-O 121.777 0.799 . . . . 65.230000000000004 110.824 -177.789 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.416 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 20.7 t-20 -118.42 145.77 44.96 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 105.507 -2.035 . . . . 64.239999999999995 105.507 174.651 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -61.92 -19.14 62.38 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 112.526 0.565 . . . . 71.209999999999994 112.526 -175.19 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -104.58 -31.89 4.39 Favored Glycine 0 N--CA 1.431 -1.635 0 C-N-CA 120.72 -0.752 . . . . 64.150000000000006 113.178 178.492 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.416 ' O ' ' HB3' ' A' ' 95' ' ' ASN . 8.8 pt-20 -143.06 155.71 44.68 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 117.363 0.582 . . . . 75.439999999999998 111.604 -174.7 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.439 ' HB2' ' HB2' ' A' ' 122' ' ' MET . 57.7 m-85 -127.35 128.67 46.28 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 110.099 -0.334 . . . . 73.109999999999999 110.099 -173.813 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -128.19 135.35 49.6 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 110.262 -0.273 . . . . 70.329999999999998 110.262 -178.531 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 14.6 p -120.7 129.73 75.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 108.919 -0.771 . . . . 55.439999999999998 108.919 174.844 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 25.4 m -115.85 129.73 71.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 CA-C-O 121.445 0.64 . . . . 71.430000000000007 111.185 179.635 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -86.55 121.34 28.95 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 114.977 -1.01 . . . . 73.310000000000002 109.067 179.231 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 18.5 m -118.44 -1.16 8.81 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 CA-C-N 115.546 -0.752 . . . . 73.340000000000003 110.009 179.055 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.42 ' HA3' ' HA ' ' A' ' 89' ' ' HIS . . . -111.83 52.04 0.66 Allowed Glycine 0 N--CA 1.427 -1.956 0 N-CA-C 109.73 -1.348 . . . . 71.409999999999997 109.73 178.62 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 14.2 m -62.91 -4.92 2.43 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.538 1.135 . . . . 74.140000000000001 112.192 -177.633 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 81.2 mt -61.99 -30.2 70.77 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 124.253 1.021 . . . . 61.200000000000003 109.244 174.707 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -125.71 -40.41 2.06 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.131 -0.94 . . . . 74.299999999999997 108.771 179.251 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.74 132.21 5.14 Favored Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.349 -0.841 . . . . 72.129999999999995 113.312 178.333 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 28.9 m -81.56 136.26 35.58 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.312 -0.996 . . . . 65.329999999999998 108.312 173.353 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.427 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 18.6 m-85 -114.43 134.17 55.19 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 108.268 -1.012 . . . . 75.109999999999999 108.268 -177.595 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 60.0 t -120.76 111.04 30.23 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 N-CA-C 106.926 -1.509 . . . . 65.049999999999997 106.926 176.784 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 42.7 t-20 44.08 70.36 0.33 Allowed 'General case' 0 C--O 1.241 0.634 0 O-C-N 125.143 1.527 . . . . 72.420000000000002 111.59 -176.114 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 73.98 -26.62 0.19 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.503 1.521 . . . . 75.219999999999999 113.388 177.362 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -90.77 118.1 68.41 Favored Pre-proline 0 C--N 1.311 -1.07 0 N-CA-C 112.343 0.497 . . . . 75.329999999999998 112.343 -175.68 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -63.38 128.24 22.05 Favored 'Trans proline' 0 C--O 1.247 0.965 0 C-N-CA 122.295 1.997 . . . . 71.299999999999997 108.584 172.299 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 3.1 mmp_? -123.04 145.23 48.71 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 116.991 -0.095 . . . . 75.120000000000005 110.81 -175.356 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -95.33 -36.66 11.31 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 108.181 -1.044 . . . . 72.010000000000005 108.181 172.11 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -149.19 139.49 22.33 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 105.89 -1.893 . . . . 75.409999999999997 105.89 174.308 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 7.7 tp60 -140.09 148.55 41.91 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 110.32 -0.252 . . . . 73.200000000000003 110.32 -178.714 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 67.4 t -93.11 123.12 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 N-CA-C 105.124 -2.176 . . . . 72.129999999999995 105.124 173.239 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.439 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 83.5 mmm -78.7 143.94 35.77 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 114.204 1.187 . . . . 55.140000000000001 114.204 -173.338 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -121.89 137.14 54.9 Favored 'General case' 0 N--CA 1.419 -1.99 0 CA-C-N 113.823 -1.535 . . . . 72.129999999999995 108.852 -177.581 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 7.1 t -79.54 126.69 31.2 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 109.024 -0.732 . . . . 74.409999999999997 109.024 178.502 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 95.74 19.33 29.65 Favored Glycine 0 N--CA 1.434 -1.454 0 C-N-CA 120.747 -0.739 . . . . 74.5 111.578 -179.175 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -118.93 160.91 21.08 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.816 -0.809 . . . . 72.310000000000002 108.816 178.246 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.447 ' OE1' ' HD2' ' A' ' 134' ' ' ARG . 44.0 tt0 -115.4 131.49 56.91 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.494 0.664 . . . . 73.299999999999997 111.495 -172.183 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.412 ' N ' HD12 ' A' ' 128' ' ' ILE . 3.5 mp -105.35 131.44 54.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 107.681 -1.229 . . . . 62.409999999999997 107.681 -176.728 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.427 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 60.1 tt0 -102.26 113.21 26.3 Favored 'General case' 0 N--CA 1.425 -1.702 0 C-N-CA 119.178 -1.009 . . . . 64.319999999999993 108.375 177.849 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 8.0 pt -100.73 98.14 6.56 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.361 0 CA-C-N 114.743 -1.117 . . . . 73.230000000000004 108.549 178.826 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.432 ' HA3' ' OD2' ' A' ' 82' ' ' ASP . . . 77.73 -110.96 3.15 Favored Glycine 0 N--CA 1.426 -2.029 0 CA-C-N 113.976 -1.466 . . . . 61.310000000000002 109.522 -174.923 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.403 ' NZ ' ' HB3' ' A' ' 132' ' ' LYS . 7.8 mtpm? -104.87 -19.88 13.74 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 116.918 0.359 . . . . 73.109999999999999 110.083 175.0 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.487 ' HB3' ' O ' ' A' ' 53' ' ' ARG . 57.4 m-85 -97.77 161.76 13.6 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-O 120.856 0.36 . . . . 61.240000000000002 111.571 -171.181 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.447 ' HD2' ' OE1' ' A' ' 127' ' ' GLU . 70.3 mtm180 -121.0 140.55 51.75 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 113.817 1.043 . . . . 73.510000000000005 113.817 -169.023 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.564 HD11 HD23 ' A' ' 49' ' ' LEU . 47.6 tp -121.41 136.47 54.96 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 113.734 -1.575 . . . . 64.299999999999997 108.25 -177.325 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 10.7 p -111.21 132.4 59.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 C-N-CA 120.195 -0.602 . . . . 74.430000000000007 109.541 177.666 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -111.29 129.68 55.9 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.162 -0.472 . . . . 60.130000000000003 111.445 -176.368 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -129.45 148.82 51.4 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.308 -0.627 . . . . 72.519999999999996 109.308 176.799 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -95.36 137.83 33.89 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.286 -1.005 . . . . 73.439999999999998 108.286 175.986 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -120.23 -127.99 3.59 Favored Glycine 0 N--CA 1.435 -1.433 0 C-N-CA 119.509 -1.329 . . . . 72.430000000000007 114.339 -173.895 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -70.22 135.0 28.3 Favored 'Trans proline' 0 C--O 1.235 0.367 0 C-N-CA 123.305 2.67 . . . . 61.350000000000001 114.94 -172.491 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -110.7 117.64 34.02 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.755 -1.202 . . . . 72.340000000000003 107.755 175.529 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 . . . . . 0 C--N 1.317 -0.811 0 N-CA-C 109.66 -0.496 . . . . 72.5 109.66 -179.242 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.522 -0.109 0 N-CA-C 106.012 -1.847 . . . . 64.040000000000006 106.012 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.6 m -51.75 -42.3 62.23 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.226 0.61 . . . . 62.549999999999997 112.342 -179.066 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -157.25 109.04 2.38 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 108.813 -0.81 . . . . 64.519999999999996 108.813 177.594 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -141.26 141.66 33.96 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.774 -0.824 . . . . 70.530000000000001 108.774 177.804 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -154.19 130.92 10.77 Favored 'General case' 0 C--N 1.287 -2.145 0 N-CA-C 107.582 -1.266 . . . . 62.409999999999997 107.582 179.555 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.87 80.4 0.57 Allowed Glycine 0 CA--C 1.503 -0.709 0 N-CA-C 109.132 -1.587 . . . . 73.239999999999995 109.132 175.688 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.8 m -78.67 124.52 85.17 Favored Pre-proline 0 N--CA 1.418 -2.042 0 C-N-CA 123.675 0.79 . . . . 73.239999999999995 111.289 -169.963 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -66.36 134.73 37.08 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 122.485 2.123 . . . . 31.149999999999999 109.573 174.545 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.414 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -73.3 135.71 79.16 Favored Pre-proline 0 C--N 1.303 -1.444 0 C-N-CA 119.976 -0.69 . . . . 62.350000000000001 110.67 177.093 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 9' ' ' GLU . 38.8 Cg_exo -60.27 121.61 10.05 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 122.204 1.936 . . . . 54.509999999999998 111.82 -178.225 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -79.63 108.53 13.25 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 106.631 -1.618 . . . . 73.540000000000006 106.631 178.636 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.8 m -63.95 126.14 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.305 0 CA-C-O 121.66 0.743 . . . . 60.149999999999999 112.44 -174.008 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -88.08 141.16 28.79 Favored 'General case' 0 N--CA 1.425 -1.678 0 CA-C-N 114.953 -1.021 . . . . 73.140000000000001 109.755 178.826 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.8 t -138.65 141.78 39.06 Favored 'General case' 0 C--N 1.285 -2.231 0 N-CA-C 108.156 -1.054 . . . . 51.310000000000002 108.156 179.027 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.8 t -105.23 124.95 50.4 Favored 'General case' 0 N--CA 1.406 -2.644 0 N-CA-C 108.171 -1.048 . . . . 71.439999999999998 108.171 -179.829 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.0 m -143.03 93.53 2.51 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-N 115.691 -0.686 . . . . 64.349999999999994 110.319 -178.811 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.3 p -156.63 137.21 4.6 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 N-CA-C 108.629 -0.878 . . . . 75.030000000000001 108.629 179.333 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -167.02 174.9 7.97 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.739 -0.467 . . . . 75.510000000000005 109.739 -178.904 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -102.98 111.37 23.67 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 120.841 0.353 . . . . 71.349999999999994 110.341 178.068 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -109.37 17.87 21.02 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 109.542 -0.54 . . . . 63.399999999999999 109.542 -179.801 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -69.07 -54.92 12.54 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.122 -0.945 . . . . 74.340000000000003 111.338 -176.05 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.2 tm? 52.87 93.02 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 O-C-N 124.385 1.053 . . . . 70.409999999999997 109.357 -174.624 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 86.8 mt -71.31 110.1 5.73 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.961 -0.563 . . . . 71.420000000000002 111.391 -176.148 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.36 -173.76 4.12 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 106.211 -1.774 . . . . 64.099999999999994 106.211 176.32 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -80.59 150.64 29.43 Favored 'General case' 0 N--CA 1.433 -1.306 0 C-N-CA 118.897 -1.121 . . . . 74.530000000000001 109.528 178.181 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -67.29 164.8 17.6 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 123.408 0.683 . . . . 74.140000000000001 111.081 -178.737 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -83.91 93.22 7.98 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.837 -0.801 . . . . 74.450000000000003 108.837 176.849 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.1 m -80.82 -33.93 34.31 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 109.062 -0.718 . . . . 64.030000000000001 109.062 177.821 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.4 m 66.39 111.4 0.04 OUTLIER 'General case' 0 C--O 1.242 0.664 0 C-N-CA 125.5 1.52 . . . . 61.030000000000001 112.606 178.726 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.9 t -82.34 145.6 29.84 Favored 'General case' 0 N--CA 1.423 -1.78 0 N-CA-C 107.513 -1.292 . . . . 74.319999999999993 107.513 174.755 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -100.53 85.94 0.62 Allowed Glycine 0 N--CA 1.431 -1.634 0 C-N-CA 120.552 -0.832 . . . . 74.25 111.815 -177.173 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.9 m -71.36 118.72 14.52 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.871 -0.788 . . . . 73.230000000000004 108.871 178.582 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.98 140.46 46.56 Favored Pre-proline 0 C--N 1.293 -1.891 0 CA-C-N 115.92 -0.582 . . . . 64.430000000000007 110.097 -177.73 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -49.99 146.03 17.93 Favored 'Trans proline' 0 C--O 1.246 0.907 0 C-N-CA 123.37 2.713 . . . . 74.310000000000002 111.782 177.511 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . 81.06 -15.04 0.77 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.59 1.556 . . . . 64.120000000000005 111.775 -177.25 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.6 m -94.75 109.1 21.09 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 106.701 -1.592 . . . . 71.150000000000006 106.701 174.569 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.6 t -169.99 170.65 7.49 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 108.603 -0.888 . . . . 71.310000000000002 108.603 -174.489 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 165.05 -55.66 0.26 Allowed Glycine 0 N--CA 1.427 -1.915 0 N-CA-C 112.1 -0.4 . . . . 44.020000000000003 112.1 176.085 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.66 -32.7 70.07 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 112.503 0.557 . . . . 55.210000000000001 112.503 -172.531 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.478 ' CD ' ' H ' ' A' ' 40' ' ' GLU . 0.3 OUTLIER -83.67 -11.97 56.52 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 121.05 0.453 . . . . 72.150000000000006 110.919 179.251 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -83.46 -18.06 39.9 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-O 121.051 0.453 . . . . 70.439999999999998 110.077 177.846 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -109.81 100.46 42.92 Favored Pre-proline 0 N--CA 1.435 -1.198 0 CA-C-N 115.836 -0.62 . . . . 70.420000000000002 110.387 177.789 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -65.2 -33.8 47.96 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 121.948 1.765 . . . . 61.200000000000003 109.977 176.863 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.435 ' HB1' ' HB1' ' A' ' 142' ' ' ALA . . . -143.06 108.3 5.0 Favored 'General case' 0 N--CA 1.425 -1.697 0 N-CA-C 107.124 -1.435 . . . . 72.030000000000001 107.124 175.658 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 166.43 -19.26 0.1 OUTLIER Glycine 0 C--N 1.302 -1.348 0 N-CA-C 111.05 -0.82 . . . . 44.32 111.05 -175.527 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.2 m -89.65 152.74 21.21 Favored 'General case' 0 N--CA 1.428 -1.526 0 N-CA-C 107.228 -1.397 . . . . 63.439999999999998 107.228 176.347 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.485 ' HB3' ' CZ ' ' A' ' 137' ' ' PHE . . . -97.64 178.54 5.13 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 110.201 -0.296 . . . . 65.540000000000006 110.201 -176.991 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -134.16 158.03 44.71 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.121 0.486 . . . . 73.340000000000003 111.507 -175.524 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.6 pp -121.34 140.26 52.33 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 115.354 -0.839 . . . . 71.230000000000004 109.023 174.869 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.446 HG12 ' CB ' ' A' ' 60' ' ' ARG . 33.1 m -115.52 138.51 45.66 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 CA-C-O 121.043 0.449 . . . . 52.310000000000002 109.834 179.611 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.0 t -93.61 115.62 32.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 107.818 -1.178 . . . . 74.209999999999994 107.818 179.943 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -88.56 -36.2 16.49 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.241 0.543 . . . . 72.219999999999999 109.551 -179.411 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.424 ' O ' ' HB3' ' A' ' 133' ' ' PHE . 37.6 ttm180 -149.84 125.5 10.36 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.309 -0.997 . . . . 72.319999999999993 108.309 -179.879 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 153.94 121.85 0.83 Allowed Glycine 0 N--CA 1.418 -2.539 0 C-N-CA 120.959 -0.639 . . . . 33.520000000000003 111.662 179.821 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -55.85 -9.04 2.58 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 124.522 3.481 . . . . 52.109999999999999 113.876 178.802 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.445 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 7.2 t30 -51.86 -38.39 55.82 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 124.106 0.962 . . . . 63.350000000000001 110.786 176.01 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -178.57 -59.87 0.01 OUTLIER 'General case' 0 C--N 1.354 0.764 0 CA-C-N 116.318 -0.401 . . . . 73.209999999999994 111.735 179.738 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.55 54.07 4.12 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 109.515 -1.434 . . . . 74.310000000000002 109.515 -173.837 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -154.63 -171.52 3.88 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 107.926 -1.138 . . . . 53.0 107.926 -175.752 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.446 ' CB ' HG12 ' A' ' 50' ' ' VAL . 18.7 ptp180 -110.15 140.2 44.5 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 109.875 -0.417 . . . . 72.040000000000006 109.875 -178.368 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -135.24 119.02 17.2 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 120.673 0.273 . . . . 73.420000000000002 110.891 179.765 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.0 tt -86.55 139.56 30.73 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 107.073 -1.454 . . . . 75.239999999999995 107.073 174.724 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 87.8 mt -71.19 114.07 8.87 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 119.923 -0.711 . . . . 74.239999999999995 109.385 -176.433 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -117.45 -32.26 4.98 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 114.793 -1.094 . . . . 53.43 110.989 -172.655 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -96.97 132.25 26.22 Favored Pre-proline 0 C--N 1.303 -1.454 0 N-CA-C 107.686 -1.227 . . . . 73.239999999999995 107.686 178.653 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.454 ' HA ' HG13 ' A' ' 94' ' ' ILE . 10.5 Cg_endo -53.45 -26.48 36.09 Favored 'Trans proline' 0 C--N 1.371 1.748 0 C-N-CA 124.034 3.156 . . . . 43.439999999999998 113.411 -176.207 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 51.8 m -133.39 98.09 4.14 Favored 'General case' 0 N--CA 1.407 -2.586 0 N-CA-C 108.404 -0.961 . . . . 70.329999999999998 108.404 174.282 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 98.2 m -88.75 115.4 26.26 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 114.868 -1.06 . . . . 74.0 108.469 -178.685 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.6 t -107.78 121.51 44.87 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-O 121.554 0.693 . . . . 61.409999999999997 111.369 -177.277 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -104.7 115.32 30.12 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 114.868 -1.06 . . . . 44.399999999999999 109.022 179.185 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.725 ' O ' ' HA ' ' A' ' 88' ' ' ARG . . . 90.64 85.33 1.39 Allowed Glycine 0 CA--C 1.475 -2.446 0 N-CA-C 107.798 -2.121 . . . . 73.329999999999998 107.798 -177.375 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.416 ' HG2' ' O ' ' A' ' 75' ' ' GLU . 23.5 tpt180 -177.57 142.79 0.33 Allowed 'General case' 0 N--CA 1.407 -2.59 0 N-CA-C 102.243 -3.243 . . . . 63.009999999999998 102.243 -171.513 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -109.16 -60.55 0.04 OUTLIER Pre-proline 0 C--N 1.274 -2.705 0 N-CA-C 115.316 1.599 . . . . 73.420000000000002 115.316 -177.701 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_exo -66.67 -40.63 12.82 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 121.871 1.714 . . . . 65.109999999999999 113.862 -173.249 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.416 ' O ' ' HG2' ' A' ' 72' ' ' ARG . 38.7 tt0 -130.42 75.55 1.66 Allowed 'General case' 0 N--CA 1.422 -1.87 0 N-CA-C 107.378 -1.341 . . . . 41.340000000000003 107.378 -177.309 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.4 p -112.24 170.44 8.16 Favored 'General case' 0 C--N 1.285 -2.231 0 N-CA-C 113.365 0.876 . . . . 72.510000000000005 113.365 -171.689 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -112.14 -55.71 2.48 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 107.166 -1.42 . . . . 51.240000000000002 107.166 173.857 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 24.2 pt -125.43 152.28 32.05 Favored 'Isoleucine or valine' 0 C--O 1.25 1.12 0 CA-C-N 115.539 -0.755 . . . . 71.129999999999995 109.422 174.797 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.445 ' O ' ' HA ' ' A' ' 56' ' ' ASN . 87.8 m-85 -112.89 117.53 32.38 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 112.293 0.479 . . . . 71.400000000000006 112.293 -173.131 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.2 mp -74.12 107.39 6.28 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 108.743 -0.836 . . . . 72.430000000000007 108.743 170.1 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -82.04 1.4 35.95 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 123.993 0.917 . . . . 64.409999999999997 110.976 -178.02 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -98.4 164.44 12.28 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.55 -0.75 . . . . 62.149999999999999 109.857 -177.949 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.2 p -69.92 -18.8 22.2 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.134 0 C-N-CA 123.35 0.66 . . . . 63.549999999999997 111.64 -178.769 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 13.3 p -73.05 11.44 0.7 Allowed 'General case' 0 CA--C 1.555 1.15 0 N-CA-C 113.698 0.999 . . . . 74.230000000000004 113.698 -178.807 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.6 p -82.58 125.0 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 CA-C-O 121.436 0.636 . . . . 64.0 111.931 -177.187 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 41.9 t -84.68 169.34 14.41 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.343 -0.984 . . . . 43.420000000000002 108.343 174.624 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 52.3 mtm-85 -56.76 -40.76 76.4 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 108.946 -0.761 . . . . 73.230000000000004 108.946 175.87 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.725 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -146.07 129.45 16.82 Favored 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 105.754 -1.943 . . . . 64.510000000000005 105.754 165.392 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.401 ' HA ' ' HA3' ' A' ' 105' ' ' GLY . 30.1 t60 -108.74 -74.04 0.67 Allowed 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 113.213 0.819 . . . . 70.239999999999995 113.213 -171.088 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -117.29 119.39 35.0 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 121.652 -0.655 . . . . 61.009999999999998 109.756 -177.443 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -109.69 127.18 54.4 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 108.277 -1.009 . . . . 72.209999999999994 108.277 -179.608 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -112.33 112.8 24.63 Favored 'General case' 0 N--CA 1.425 -1.693 0 N-CA-C 107.619 -1.252 . . . . 74.219999999999999 107.619 -178.763 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 30.8 ttm-85 -101.91 143.32 31.94 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 107.819 -1.178 . . . . 71.129999999999995 107.819 179.791 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.454 HG13 ' HA ' ' A' ' 66' ' ' PRO . 2.6 pp -115.53 140.46 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.479 0 N-CA-C 107.578 -1.267 . . . . 71.450000000000003 107.578 175.298 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.455 ' C ' ' H ' ' A' ' 97' ' ' GLY . 40.0 t-20 -118.44 147.08 43.95 Favored 'General case' 0 C--N 1.268 -2.972 0 N-CA-C 104.541 -2.392 . . . . 55.130000000000003 104.541 -178.807 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -59.84 26.5 0.01 OUTLIER 'General case' 0 CA--C 1.574 1.881 0 N-CA-C 114.62 1.341 . . . . 64.349999999999994 114.62 -176.945 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.455 ' H ' ' C ' ' A' ' 95' ' ' ASN . . . -169.16 -38.31 0.03 OUTLIER Glycine 0 N--CA 1.426 -2.011 0 N-CA-C 111.074 -0.81 . . . . 71.129999999999995 111.074 -179.445 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -127.61 170.9 12.14 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.95 0.405 . . . . 73.409999999999997 111.283 -176.392 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -116.89 129.3 55.98 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 116.276 -0.42 . . . . 71.120000000000005 110.101 -179.912 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -122.07 119.52 31.64 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.907 -0.405 . . . . 74.019999999999996 109.907 -176.845 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.496 HG11 ' SD ' ' A' ' 122' ' ' MET . 27.9 m -121.93 128.92 75.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 C-N-CA 119.835 -0.746 . . . . 74.299999999999997 110.944 178.371 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 29.4 m -119.84 137.46 53.65 Favored 'Isoleucine or valine' 0 C--O 1.252 1.234 0 N-CA-C 112.76 0.652 . . . . 62.420000000000002 112.76 -178.243 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -92.68 108.37 19.93 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.485 -0.78 . . . . 72.319999999999993 110.228 174.98 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.3 m -114.56 5.46 7.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 CA-C-O 121.86 0.838 . . . . 53.310000000000002 109.709 177.417 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.401 ' HA3' ' HA ' ' A' ' 89' ' ' HIS . . . -105.86 36.32 4.48 Favored Glycine 0 N--CA 1.431 -1.676 0 N-CA-C 109.725 -1.35 . . . . 42.43 109.725 179.351 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 14.0 m -65.01 5.47 0.34 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.736 1.615 . . . . 74.239999999999995 113.158 -176.689 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.4 mp -69.37 -34.27 74.3 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 107.505 -1.295 . . . . 71.329999999999998 107.505 172.918 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -119.01 -40.06 2.87 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 107.293 -1.373 . . . . 75.519999999999996 107.293 174.1 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 104.96 141.89 11.08 Favored Glycine 0 N--CA 1.44 -1.08 0 CA-C-N 115.79 -0.641 . . . . 74.099999999999994 113.485 176.108 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 27.6 m -108.52 125.45 51.82 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 107.362 -1.347 . . . . 51.140000000000001 107.362 173.205 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -103.64 134.52 46.85 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.56 -0.533 . . . . 73.299999999999997 109.56 -176.684 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.421 HG21 ' HG2' ' A' ' 120' ' ' GLN . 7.2 p -125.77 127.51 71.42 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.428 0 N-CA-C 106.973 -1.491 . . . . 70.450000000000003 106.973 175.391 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 18.4 m120 64.71 22.6 12.62 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 109.108 -0.701 . . . . 63.219999999999999 109.108 -174.842 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 18.3 mmm180 76.54 5.41 3.53 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.729 1.212 . . . . 72.25 112.779 -175.291 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -112.41 130.07 23.73 Favored Pre-proline 0 C--N 1.315 -0.924 0 N-CA-C 110.386 -0.227 . . . . 71.400000000000006 110.386 -179.4 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -74.85 110.48 3.12 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 121.823 1.682 . . . . 74.510000000000005 109.772 175.858 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 43.2 ttt180 -126.83 154.64 44.07 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.508 -1.293 . . . . 75.310000000000002 107.508 -176.235 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -81.2 -50.52 9.48 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.271 -0.572 . . . . 75.319999999999993 110.664 -175.182 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -130.18 140.16 50.77 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 108.406 -0.961 . . . . 64.439999999999998 108.406 178.875 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.421 ' HG2' HG21 ' A' ' 112' ' ' VAL . 55.2 tp60 -139.72 148.03 41.74 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 109.692 -0.485 . . . . 70.0 109.692 -179.926 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 98.8 t -88.17 117.29 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 N-CA-C 105.195 -2.15 . . . . 74.420000000000002 105.195 167.86 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.496 ' SD ' HG11 ' A' ' 101' ' ' VAL . 4.6 tpt -55.89 116.73 3.13 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 124.071 0.948 . . . . 70.310000000000002 111.468 -171.74 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -105.26 129.83 53.53 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.662 -0.699 . . . . 63.549999999999997 109.6 -174.336 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 7.0 t -79.61 129.16 34.22 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 121.628 0.728 . . . . 54.450000000000003 112.571 -175.217 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 108.18 -11.43 37.03 Favored Glycine 0 N--CA 1.423 -2.17 0 CA-C-N 115.249 -0.887 . . . . 62.530000000000001 111.638 178.196 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -102.35 172.59 6.8 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 112.867 0.692 . . . . 73.310000000000002 112.867 -177.344 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -108.32 142.52 38.5 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-N 115.056 -0.974 . . . . 74.099999999999994 112.115 -172.891 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.4 mp -124.1 113.17 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.922 0 N-CA-C 105.74 -1.948 . . . . 74.040000000000006 105.74 178.216 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.428 ' HA ' ' O ' ' A' ' 133' ' ' PHE . 66.4 mt-30 -102.95 119.64 39.21 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 109.667 -0.494 . . . . 72.439999999999998 109.667 -177.056 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 20.9 pt -91.41 99.72 10.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 N-CA-C 107.999 -1.112 . . . . 74.310000000000002 107.999 176.884 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 79.19 -94.03 1.34 Allowed Glycine 0 N--CA 1.422 -2.299 0 N-CA-C 108.755 -1.738 . . . . 72.230000000000004 108.755 -174.376 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -137.54 15.94 2.94 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.205 0.526 . . . . 64.310000000000002 110.306 177.128 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.428 ' O ' ' HA ' ' A' ' 129' ' ' GLN . 53.1 m-85 -103.52 131.3 50.76 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 109.664 -0.495 . . . . 75.299999999999997 109.664 -179.868 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 48.7 ttt180 -95.27 121.76 37.26 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-O 121.631 0.729 . . . . 55.549999999999997 111.708 -169.214 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 9.5 mp -121.96 143.87 49.21 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 107.668 -1.234 . . . . 63.119999999999997 107.668 175.672 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 6.3 p -126.95 130.67 71.37 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.435 0 C-N-CA 120.633 -0.427 . . . . 71.200000000000003 110.318 179.342 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.485 ' CZ ' ' HB3' ' A' ' 47' ' ' ALA . 90.7 t80 -97.22 125.21 41.61 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.585 -0.734 . . . . 74.319999999999993 110.115 -176.759 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -128.56 144.24 51.11 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.385 0.612 . . . . 52.219999999999999 110.785 -179.752 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -87.01 86.21 7.3 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 106.996 -1.483 . . . . 73.340000000000003 106.996 171.926 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -75.27 -174.09 34.18 Favored Glycine 0 N--CA 1.439 -1.121 0 CA-C-N 114.983 -1.008 . . . . 52.409999999999997 113.945 -174.719 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -71.11 140.21 37.2 Favored 'Trans proline' 0 N--CA 1.447 -1.218 0 C-N-CA 122.716 2.278 . . . . 74.120000000000005 112.801 -179.14 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.435 ' HB1' ' HB1' ' A' ' 44' ' ' ALA . . . -99.72 103.97 15.66 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 107.827 -1.175 . . . . 70.109999999999999 107.827 176.916 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 . . . . . 0 C--N 1.304 -1.405 0 N-CA-C 108.736 -0.838 . . . . 62.240000000000002 108.736 -178.969 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.2 ttp . . . . . 0 CA--C 1.507 -0.684 0 N-CA-C 109.511 -0.551 . . . . 73.120000000000005 109.511 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.0 m -81.0 -48.97 11.51 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.256 -1.016 . . . . 54.130000000000003 108.256 175.965 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -157.08 132.43 9.15 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 107.86 -1.163 . . . . 63.140000000000001 107.86 -178.931 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -102.95 148.19 25.99 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.395 -0.594 . . . . 64.019999999999996 109.395 -179.408 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -117.8 102.37 9.05 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 121.178 0.513 . . . . 55.219999999999999 111.278 -176.282 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -138.12 55.23 0.68 Allowed Glycine 0 N--CA 1.438 -1.229 0 N-CA-C 109.916 -1.273 . . . . 61.310000000000002 109.916 179.398 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.427 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 11.3 t -64.8 127.98 93.14 Favored Pre-proline 0 N--CA 1.439 -0.987 0 CA-C-N 115.191 -0.504 . . . . 74.010000000000005 109.834 -177.907 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 7' ' ' THR . 31.4 Cg_exo -61.1 127.65 22.86 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.198 1.932 . . . . 43.520000000000003 111.212 179.849 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -101.74 115.69 64.5 Favored Pre-proline 0 C--N 1.302 -1.496 0 N-CA-C 109.505 -0.554 . . . . 65.439999999999998 109.505 179.606 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -73.03 128.87 13.53 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.744 2.296 . . . . 72.219999999999999 113.894 -176.59 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -106.69 108.04 19.36 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 106.057 -1.831 . . . . 74.010000000000005 106.057 176.369 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.2 p -124.54 135.48 63.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 N-CA-C 109.396 -0.594 . . . . 33.43 109.396 -179.314 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -105.92 130.77 53.8 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.121 0.486 . . . . 74.040000000000006 110.825 -178.98 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 95.6 m -151.63 106.43 3.25 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.238 -1.023 . . . . 51.350000000000001 108.238 174.693 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 17.1 p -96.99 122.98 40.58 Favored 'General case' 0 N--CA 1.412 -2.327 0 CA-C-O 121.422 0.63 . . . . 55.240000000000002 110.506 -178.049 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 27.5 t -80.66 108.78 14.6 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 114.747 -1.115 . . . . 74.030000000000001 110.336 -177.331 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 91.5 t -81.96 131.78 33.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 108.416 -0.957 . . . . 72.430000000000007 108.416 178.497 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -98.89 158.53 15.58 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 110.036 -0.357 . . . . 74.129999999999995 110.036 179.148 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -124.98 159.58 30.92 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 108.512 -0.921 . . . . 72.120000000000005 108.512 -178.789 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -84.97 83.5 8.03 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.354 -0.98 . . . . 53.299999999999997 108.354 174.208 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -77.33 -27.77 52.9 Favored 'General case' 0 CA--C 1.487 -1.45 0 CA-C-N 114.739 -1.119 . . . . 74.239999999999995 111.309 -175.041 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -135.47 139.24 43.91 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 116.053 -0.521 . . . . 73.25 109.613 -179.019 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.445 ' O ' HD12 ' A' ' 23' ' ' LEU . 4.0 pp -166.88 132.28 2.16 Favored 'General case' 0 N--CA 1.436 -1.17 0 O-C-N 124.232 0.957 . . . . 74.120000000000005 110.002 178.614 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.5 162.74 27.58 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 106.094 -1.817 . . . . 74.030000000000001 106.094 178.715 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -142.78 148.39 37.09 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 120.177 -0.609 . . . . 74.329999999999998 112.28 -179.281 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 48.7 ttm 66.53 84.55 0.15 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.658 1.224 . . . . 71.420000000000002 110.095 -175.955 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -138.58 106.37 5.64 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-N 114.927 -1.033 . . . . 72.120000000000005 109.359 -179.194 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.5 p -138.2 137.25 37.4 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 115.464 -0.789 . . . . 54.219999999999999 109.957 178.291 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 16.5 m -61.45 119.34 8.37 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 108.944 -0.762 . . . . 71.129999999999995 108.944 176.988 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 18.6 m -88.77 107.16 18.82 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 108.283 -1.006 . . . . 44.539999999999999 108.283 -177.68 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -83.15 62.04 4.69 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 121.017 -0.611 . . . . 73.010000000000005 114.179 -174.536 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 26.4 m -93.52 116.75 29.28 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 107.694 -1.224 . . . . 71.209999999999994 107.694 174.447 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -90.92 114.73 62.45 Favored Pre-proline 0 C--N 1.281 -2.393 0 CA-C-N 116.226 -0.443 . . . . 43.32 109.829 -178.751 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -68.12 119.32 6.33 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 121.75 1.633 . . . . 51.140000000000001 110.813 177.581 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -126.16 137.13 53.54 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 115.706 -0.679 . . . . 62.119999999999997 109.293 -177.716 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.8 m -57.51 -46.35 83.88 Favored 'General case' 0 N--CA 1.438 -1.068 0 O-C-N 123.984 0.803 . . . . 73.299999999999997 110.709 177.831 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 20.5 m 56.53 40.78 29.34 Favored 'General case' 0 CA--C 1.554 1.129 0 CA-C-O 123.192 1.473 . . . . 71.140000000000001 108.635 -179.241 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -111.43 33.27 5.91 Favored Glycine 0 N--CA 1.431 -1.671 0 CA-C-N 114.518 -1.219 . . . . 72.310000000000002 111.813 -176.34 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.1 -45.11 94.93 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-O 121.634 0.731 . . . . 73.209999999999994 109.767 179.657 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -71.91 -11.14 60.65 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 114.932 -1.031 . . . . 72.340000000000003 112.694 -177.734 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -72.62 -17.74 61.65 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 108.858 -0.793 . . . . 73.219999999999999 108.858 -177.863 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 50.1 tp -60.09 125.12 80.3 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-N 115.605 -0.725 . . . . 74.209999999999994 109.333 177.374 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -66.19 171.38 10.35 Favored 'Trans proline' 0 C--O 1.245 0.868 0 C-N-CA 122.644 2.229 . . . . 73.219999999999999 112.592 178.509 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.83 152.41 44.59 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.566 -0.743 . . . . 71.140000000000001 110.743 -179.726 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 105.43 37.97 2.53 Favored Glycine 0 N--CA 1.439 -1.149 0 N-CA-C 111.149 -0.78 . . . . 45.119999999999997 111.149 -176.723 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.5 ' O ' ' HA ' ' A' ' 141' ' ' PRO . 10.8 m -90.53 159.77 16.31 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.342 -0.614 . . . . 51.520000000000003 109.342 -178.282 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -113.98 178.38 4.3 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 117.741 0.246 . . . . 73.450000000000003 111.064 -176.261 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.5 pp -132.36 158.94 40.64 Favored 'General case' 0 C--O 1.244 0.788 0 N-CA-C 112.909 0.707 . . . . 61.310000000000002 112.909 -173.389 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.4 pp -119.24 147.74 43.91 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.58 -0.736 . . . . 74.040000000000006 109.817 176.914 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 25.3 t -130.23 149.86 34.02 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 C-N-CA 123.606 0.763 . . . . 51.549999999999997 109.284 -175.577 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.489 HG23 ' HD2' ' A' ' 55' ' ' PRO . 3.5 p -88.54 118.05 33.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-O 122.375 1.083 . . . . 74.319999999999993 111.05 179.475 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -95.6 -39.05 10.12 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-N 115.244 -0.889 . . . . 64.239999999999995 108.785 174.016 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -154.04 89.17 1.28 Allowed 'General case' 0 C--O 1.215 -0.748 0 N-CA-C 109.051 -0.722 . . . . 63.450000000000003 109.051 176.211 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 20.87 54.04 0.01 OUTLIER Glycine 0 N--CA 1.508 3.495 0 N-CA-C 119.842 2.697 . . . . 62.409999999999997 119.842 177.44 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.489 ' HD2' HG23 ' A' ' 51' ' ' VAL . 74.0 Cg_endo -71.91 -40.37 2.69 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 CA-C-N 120.821 2.31 . . . . 63.439999999999998 113.89 -178.783 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.565 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 17.1 m-80 -134.17 -84.42 0.43 Allowed 'General case' 0 C--O 1.209 -1.055 0 CA-C-O 121.183 0.516 . . . . 62.420000000000002 112.079 -171.504 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.64 -6.82 26.59 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.528 0.566 . . . . 73.239999999999995 112.528 -173.825 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.24 40.57 99.2 Favored Glycine 0 CA--C 1.523 0.579 0 C-N-CA 120.756 -0.735 . . . . 61.0 112.256 -178.199 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -157.09 -163.7 1.45 Allowed 'General case' 0 C--O 1.254 1.331 0 N-CA-C 108.886 -0.783 . . . . 44.520000000000003 108.886 -177.122 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -132.34 139.49 48.17 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 108.354 -0.98 . . . . 72.129999999999995 108.354 176.134 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -156.46 154.5 30.5 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.057 0.456 . . . . 71.340000000000003 111.786 179.477 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 31.2 tp -80.08 139.49 36.87 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 114.55 -1.204 . . . . 73.340000000000003 109.172 179.655 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.9 mp -82.77 114.38 21.06 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 106.52 -1.659 . . . . 74.230000000000004 106.52 173.704 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -112.42 3.8 17.14 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 116.132 -0.486 . . . . 74.219999999999999 110.233 -175.012 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -121.82 141.11 33.21 Favored Pre-proline 0 C--N 1.301 -1.541 0 N-CA-C 107.741 -1.207 . . . . 63.25 107.741 -179.391 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -55.08 -49.89 14.99 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.167 2.578 . . . . 51.200000000000003 111.924 -177.413 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' A' ' 92' ' ' PHE . 44.3 m -121.08 108.54 13.94 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-N 115.509 -0.769 . . . . 74.239999999999995 110.455 178.924 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.436 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 4.7 m -91.66 114.81 27.44 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.264 -1.013 . . . . 75.430000000000007 108.264 179.116 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 16.7 p -90.79 122.76 33.8 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 116.742 -0.208 . . . . 75.340000000000003 110.693 -179.774 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.441 ' HA ' ' O ' ' A' ' 78' ' ' ILE . . . -109.5 121.84 46.08 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 109.877 -0.416 . . . . 71.209999999999994 109.877 178.178 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -164.6 -136.22 1.96 Allowed Glycine 0 N--CA 1.432 -1.604 0 N-CA-C 111.117 -0.793 . . . . 70.439999999999998 111.117 178.52 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.463 ' NH2' ' HA ' ' A' ' 81' ' ' ASP . 4.2 tpp180 -159.57 84.65 0.77 Allowed 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.025 -1.472 . . . . 75.25 107.025 176.992 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -179.97 151.18 0.57 Allowed Pre-proline 0 C--N 1.296 -1.756 0 N-CA-C 104.745 -2.317 . . . . 75.439999999999998 104.745 -177.514 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.44 -22.15 70.52 Favored 'Trans proline' 0 N--CA 1.48 0.709 0 C-N-CA 122.41 2.073 . . . . 74.120000000000005 113.211 -178.149 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -79.54 -18.34 52.03 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.431 -0.35 . . . . 71.219999999999999 111.064 -179.148 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.0 m -88.42 131.86 34.69 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 107.162 -1.422 . . . . 65.230000000000004 107.162 176.167 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -70.84 -50.38 36.02 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 120.956 -0.297 . . . . 63.310000000000002 111.451 -176.851 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.441 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 39.2 pt -112.37 154.55 13.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 C-N-CA 120.133 -0.627 . . . . 55.530000000000001 109.883 178.991 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -116.58 136.05 53.3 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 116.399 -0.364 . . . . 72.450000000000003 110.501 -179.023 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.565 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 1.5 pt? -84.99 139.92 31.44 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 106.647 -1.612 . . . . 63.329999999999998 106.647 171.553 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.463 ' HA ' ' NH2' ' A' ' 72' ' ' ARG . 19.8 t70 -106.56 58.0 0.64 Allowed 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 118.415 -1.314 . . . . 52.329999999999998 112.583 -172.098 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -104.07 151.19 23.55 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 106.641 -1.615 . . . . 72.25 106.641 171.476 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.4 m -74.38 -12.45 15.14 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 N-CA-C 112.284 0.476 . . . . 72.329999999999998 112.284 -178.621 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -113.42 51.52 0.84 Allowed 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 106.956 -1.498 . . . . 72.329999999999998 106.956 179.16 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.47 HG23 ' HG ' ' A' ' 80' ' ' LEU . 7.6 p -82.24 135.59 24.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 115.469 -0.787 . . . . 73.540000000000006 113.004 -173.038 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 8.0 m -101.75 144.21 30.72 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.625 -0.716 . . . . 74.439999999999998 110.93 -177.925 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -67.39 120.79 14.47 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 106.172 -1.788 . . . . 74.409999999999997 106.172 170.569 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 58.1 81.35 0.15 Allowed 'General case' 0 N--CA 1.466 0.357 0 O-C-N 123.9 0.75 . . . . 73.319999999999993 110.396 -172.421 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 19.1 t60 -98.81 -35.65 10.06 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 109.398 -0.593 . . . . 72.340000000000003 109.398 -178.626 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -149.22 136.27 19.83 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 120.335 -0.546 . . . . 73.040000000000006 110.031 -179.447 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -112.89 126.98 56.05 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 108.313 -0.995 . . . . 75.150000000000006 108.313 173.989 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.452 ' O ' ' HA ' ' A' ' 67' ' ' THR . 86.1 m-85 -105.37 122.39 45.88 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.049 -1.093 . . . . 72.129999999999995 108.049 179.058 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.467 ' HB3' ' HB3' ' A' ' 100' ' ' GLU . 51.4 ttt180 -113.06 119.16 36.89 Favored 'General case' 0 C--N 1.281 -2.385 0 N-CA-C 108.34 -0.985 . . . . 61.509999999999998 108.34 179.569 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.79 116.43 52.38 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 N-CA-C 107.48 -1.304 . . . . 74.329999999999998 107.48 179.553 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.41 ' OD1' ' HG2' ' A' ' 96' ' ' GLU . 27.4 t30 -101.88 145.55 29.06 Favored 'General case' 0 C--N 1.275 -2.634 0 CA-C-N 113.758 -1.565 . . . . 75.120000000000005 106.864 -179.787 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.41 ' HG2' ' OD1' ' A' ' 95' ' ' ASN . 9.6 pt-20 -42.88 -29.5 0.33 Allowed 'General case' 0 C--N 1.313 -0.995 0 C-N-CA 125.049 1.34 . . . . 73.120000000000005 113.668 -178.388 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -138.7 29.52 2.57 Favored Glycine 0 N--CA 1.43 -1.72 0 C-N-CA 120.373 -0.918 . . . . 75.239999999999995 112.75 177.331 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.405 ' HB3' HD22 ' A' ' 95' ' ' ASN . 8.2 tp10 -165.07 152.99 11.49 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 117.883 0.841 . . . . 64.239999999999995 110.989 -179.866 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -124.96 126.87 46.16 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.845 -0.428 . . . . 72.239999999999995 109.845 -176.549 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.467 ' HB3' ' HB3' ' A' ' 93' ' ' ARG . 37.3 tt0 -132.26 135.19 46.09 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 122.568 0.347 . . . . 73.129999999999995 110.269 -175.992 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.7 p -128.7 129.01 68.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 O-C-N 121.946 -0.472 . . . . 70.349999999999994 110.908 177.608 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 97.5 t -119.47 124.53 73.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 116.008 -0.542 . . . . 72.239999999999995 110.816 179.722 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -83.6 125.16 31.52 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 123.2 0.6 . . . . 60.329999999999998 110.272 174.725 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.8 t -118.72 7.6 6.79 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 N-CA-C 107.936 -1.135 . . . . 63.100000000000001 107.936 178.393 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -116.7 45.56 1.27 Allowed Glycine 0 N--CA 1.441 -1.009 0 N-CA-C 110.498 -1.041 . . . . 23.32 110.498 -178.873 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 12.3 m -63.72 -12.62 36.29 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 123.977 0.911 . . . . 74.129999999999995 111.61 -177.538 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 92.0 mt -61.35 -35.84 78.55 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.8 0.84 . . . . 74.129999999999995 109.892 174.748 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -93.69 -37.59 11.75 Favored 'General case' 0 CA--C 1.496 -1.118 0 N-CA-C 108.327 -0.99 . . . . 64.340000000000003 108.327 178.257 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 93.65 88.63 1.62 Allowed Glycine 0 N--CA 1.432 -1.614 0 CA-C-N 114.943 -1.026 . . . . 74.019999999999996 111.499 -179.99 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 55.1 m -82.3 120.62 25.63 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 109.37 -0.604 . . . . 70.409999999999997 109.37 177.634 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.476 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 37.4 m-85 -106.2 134.93 48.56 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 107.818 -1.178 . . . . 73.310000000000002 107.818 -179.927 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 23.8 t -105.88 121.33 58.09 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.235 0 N-CA-C 106.8 -1.556 . . . . 72.239999999999995 106.8 177.898 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 61.96 25.51 15.32 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.704 1.202 . . . . 54.140000000000001 109.809 -175.102 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 65.6 mtp180 75.08 14.53 3.1 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.248 1.819 . . . . 61.210000000000001 112.363 -178.523 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 25.1 tp10 -110.76 123.94 34.29 Favored Pre-proline 0 C--N 1.307 -1.279 0 N-CA-C 108.039 -1.097 . . . . 71.310000000000002 108.039 174.798 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -57.21 103.83 0.14 Allowed 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.226 1.951 . . . . 65.439999999999998 110.762 176.073 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.408 ' HE ' ' HA ' ' A' ' 117' ' ' ARG . 1.6 tpm_? -143.41 111.07 5.92 Favored 'General case' 0 N--CA 1.414 -2.229 0 N-CA-C 105.391 -2.077 . . . . 63.25 105.391 -176.697 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -81.21 -23.73 37.92 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 120.553 -0.459 . . . . 72.409999999999997 111.638 -173.856 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -130.77 137.05 49.28 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.264 -1.384 . . . . 73.219999999999999 107.264 172.286 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.401 ' HG2' ' HG2' ' A' ' 117' ' ' ARG . 0.0 OUTLIER -140.43 145.85 37.55 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 108.229 -1.026 . . . . 74.200000000000003 108.229 -178.734 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 44.9 t -95.53 103.45 14.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 104.955 -2.239 . . . . 72.430000000000007 104.955 174.694 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 24.7 mtt -58.11 129.44 41.97 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 116.296 1.962 . . . . 54.240000000000002 116.296 -168.927 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.99 153.3 22.78 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 112.715 -2.039 . . . . 64.239999999999995 107.334 176.418 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 9.5 t -76.75 115.58 16.65 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 122.367 1.079 . . . . 64.230000000000004 109.575 -178.571 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 113.46 3.74 23.85 Favored Glycine 0 N--CA 1.426 -2.016 0 CA-C-N 114.865 -1.062 . . . . 61.340000000000003 110.821 -176.057 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -62.31 133.98 55.86 Favored 'General case' 0 CA--C 1.491 -1.305 0 CA-C-O 121.258 0.551 . . . . 75.209999999999994 111.283 178.991 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -114.33 127.66 55.97 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 115.032 -0.986 . . . . 72.120000000000005 110.32 -178.378 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.461 ' HB ' ' HB3' ' A' ' 135' ' ' LEU . 65.4 mt -97.67 118.94 45.02 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.234 0 N-CA-C 108.039 -1.097 . . . . 65.230000000000004 108.039 177.086 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.476 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 48.9 tp60 -103.39 112.71 25.73 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 115.326 -0.852 . . . . 74.400000000000006 109.148 -177.086 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.455 HG13 ' HB2' ' A' ' 133' ' ' PHE . 14.0 pt -124.34 97.9 4.91 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 108.426 -0.953 . . . . 71.430000000000007 108.426 174.25 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 68.46 -108.65 2.54 Favored Glycine 0 N--CA 1.435 -1.4 0 CA-C-N 114.865 -1.061 . . . . 50.210000000000001 110.62 -175.663 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -108.34 -1.86 19.66 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 120.769 0.318 . . . . 73.430000000000007 111.004 177.638 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.455 ' HB2' HG13 ' A' ' 130' ' ' ILE . 71.0 m-85 -93.54 147.55 22.88 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.724 0.297 . . . . 73.430000000000007 110.984 -177.902 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.421 ' HA ' ' O ' ' A' ' 128' ' ' ILE . 84.1 mtt180 -133.74 129.65 36.98 Favored 'General case' 0 C--O 1.257 1.453 0 CA-C-N 115.785 -0.643 . . . . 71.200000000000003 111.829 -178.979 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.486 HD13 ' N ' ' A' ' 136' ' ' VAL . 3.4 tm? -109.39 144.68 37.27 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 106.185 -1.783 . . . . 74.030000000000001 106.185 172.628 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.486 ' N ' HD13 ' A' ' 135' ' ' LEU . 12.9 p -130.09 128.03 64.1 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.704 0 N-CA-C 109.377 -0.601 . . . . 72.329999999999998 109.377 -178.82 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -110.69 129.88 55.71 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.656 -0.702 . . . . 71.430000000000007 109.569 -176.871 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.3 mp -127.7 140.66 51.94 Favored 'General case' 0 C--O 1.253 1.25 0 CA-C-O 121.363 0.601 . . . . 62.009999999999998 110.804 -179.455 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -86.73 87.88 7.55 Favored 'General case' 0 N--CA 1.422 -1.852 0 CA-C-N 115.339 -0.846 . . . . 74.310000000000002 109.363 179.08 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -120.27 84.13 0.37 Allowed Glycine 0 C--N 1.292 -1.884 0 N-CA-C 107.536 -2.226 . . . . 40.5 107.536 174.517 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.5 ' HA ' ' O ' ' A' ' 46' ' ' SER . 14.9 Cg_endo -59.42 120.03 7.62 Favored 'Trans proline' 0 N--CA 1.445 -1.376 0 C-N-CA 122.541 2.16 . . . . 73.299999999999997 114.775 -172.049 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -86.83 104.65 16.38 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 106.613 -1.625 . . . . 73.099999999999994 106.613 173.754 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 . . . . . 0 C--N 1.284 -2.271 0 N-CA-C 107.098 -1.445 . . . . 51.119999999999997 107.098 -175.75 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.454 ' HG3' ' H ' ' A' ' 2' ' ' SER . 22.7 ptt? . . . . . 0 N--CA 1.473 0.694 0 CA-C-O 119.394 -0.336 . . . . 71.239999999999995 111.566 . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.454 ' H ' ' HG3' ' A' ' 1' ' ' MET . 15.2 m -77.84 -38.03 47.1 Favored 'General case' 0 C--O 1.244 0.778 0 N-CA-C 105.262 -2.125 . . . . 65.519999999999996 105.262 170.897 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -73.13 146.97 45.3 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 112.917 -1.947 . . . . 62.43 107.616 173.493 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -79.2 -29.41 42.83 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.432 -0.951 . . . . 64.420000000000002 108.432 179.459 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 56.0 t30 68.03 88.88 0.11 Allowed 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 114.249 -1.341 . . . . 75.530000000000001 112.224 176.616 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 88.61 130.11 3.52 Favored Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 120.884 -0.674 . . . . 72.209999999999994 112.189 178.599 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.5 m -111.48 124.69 32.0 Favored Pre-proline 0 C--N 1.302 -1.496 0 N-CA-C 109.777 -0.453 . . . . 74.310000000000002 109.777 179.272 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -66.14 142.24 66.71 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.925 2.417 . . . . 73.549999999999997 112.098 177.736 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -121.75 146.82 46.71 Favored Pre-proline 0 C--N 1.296 -1.721 0 N-CA-C 108.113 -1.069 . . . . 72.0 108.113 178.465 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -61.44 155.14 54.31 Favored 'Trans proline' 0 C--O 1.251 1.164 0 C-N-CA 122.548 2.165 . . . . 50.409999999999997 111.97 178.053 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -66.66 150.86 48.45 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.731 -0.668 . . . . 63.439999999999998 109.934 179.548 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.2 p -88.4 129.09 40.15 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.353 0 CA-C-N 116.114 -0.494 . . . . 52.130000000000003 110.386 179.978 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -78.25 140.74 38.87 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 116.035 -0.529 . . . . 72.109999999999999 110.24 -178.862 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.8 t -101.67 142.23 33.32 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.285 -1.006 . . . . 74.340000000000003 108.285 177.01 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.9 t -157.35 158.43 35.96 Favored 'General case' 0 N--CA 1.422 -1.847 0 N-CA-C 107.555 -1.276 . . . . 74.200000000000003 107.555 -179.004 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.7 t -98.64 101.54 12.99 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.246 -1.02 . . . . 75.040000000000006 108.246 179.788 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.8 p -126.04 97.84 4.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-O 122.339 1.066 . . . . 52.340000000000003 113.299 -176.79 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -161.42 145.08 12.81 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 114.24 -1.345 . . . . 75.129999999999995 109.652 177.338 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 54.0 mtm180 -148.57 -173.66 4.4 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 107.883 -1.154 . . . . 75.239999999999995 107.883 -178.035 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -84.79 57.8 4.59 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 106.947 -1.501 . . . . 61.509999999999998 106.947 171.193 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -83.01 -23.55 33.23 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 113.911 -1.495 . . . . 50.420000000000002 110.688 -172.766 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.4 tt -72.73 140.84 48.06 Favored 'General case' 0 C--O 1.245 0.83 0 CA-C-N 115.063 -0.971 . . . . 62.439999999999998 109.507 -177.713 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.1 pp -115.37 165.47 12.94 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 116.383 -0.371 . . . . 74.239999999999995 111.877 -177.037 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.405 ' N ' ' HD2' ' A' ' 24' ' ' LYS . 3.0 mptp? -80.16 128.53 33.62 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.217 -1.031 . . . . 74.510000000000005 108.217 -179.578 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.409 ' H ' ' CD ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -98.9 168.87 9.84 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-O 121.175 0.512 . . . . 54.229999999999997 111.471 -176.017 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 83.5 mtp -120.8 176.04 5.73 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.873 -0.603 . . . . 54.399999999999999 109.755 179.652 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -87.67 153.53 21.3 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.871 -1.159 . . . . 70.219999999999999 107.871 177.836 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.3 m -103.22 159.92 15.12 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 121.009 -0.276 . . . . 55.420000000000002 110.328 -177.862 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 14.3 m -69.65 132.73 46.64 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 116.62 -0.264 . . . . 61.229999999999997 110.404 179.354 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.9 t -89.38 105.93 18.12 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-O 122.081 0.943 . . . . 75.549999999999997 109.147 177.103 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -89.61 141.26 16.03 Favored Glycine 0 N--CA 1.436 -1.308 0 CA-C-N 115.319 -0.855 . . . . 65.109999999999999 111.492 -176.828 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.8 p -87.03 157.5 19.42 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 110.138 -0.319 . . . . 74.239999999999995 110.138 178.722 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.4 116.98 64.59 Favored Pre-proline 0 C--N 1.31 -1.142 0 O-C-N 122.975 0.172 . . . . 54.030000000000001 111.25 -178.181 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -78.26 120.48 4.93 Favored 'Trans proline' 0 C--O 1.243 0.729 0 C-N-CA 122.563 2.175 . . . . 72.510000000000005 109.379 174.742 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -114.56 110.13 19.33 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 120.449 -0.5 . . . . 73.450000000000003 111.348 -179.228 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 69.8 m -77.28 135.72 38.45 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 109.28 -0.637 . . . . 73.430000000000007 109.28 175.699 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.5 m -64.77 158.38 25.02 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 115.537 -0.756 . . . . 73.310000000000002 110.323 -178.426 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -70.66 83.4 0.37 Allowed Glycine 0 N--CA 1.436 -1.315 0 N-CA-C 114.172 0.429 . . . . 64.209999999999994 114.172 -176.377 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.37 -52.98 21.89 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 109.114 -0.699 . . . . 75.420000000000002 109.114 175.931 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.49 ' CD ' ' H ' ' A' ' 40' ' ' GLU . 0.8 OUTLIER -63.86 -11.4 27.24 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.477 1.511 . . . . 75.540000000000006 111.995 179.291 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -72.92 -13.46 61.26 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 123.865 0.866 . . . . 73.420000000000002 112.256 178.31 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -58.78 154.69 35.25 Favored Pre-proline 0 CA--C 1.549 0.927 0 O-C-N 123.223 0.327 . . . . 63.329999999999998 110.684 179.824 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -61.61 165.54 13.37 Favored 'Trans proline' 0 C--O 1.247 0.966 0 C-N-CA 122.292 1.994 . . . . 51.0 112.025 177.576 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -86.27 151.81 23.29 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 116.125 -0.489 . . . . 65.340000000000003 109.911 -178.941 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.63 74.29 1.24 Allowed Glycine 0 N--CA 1.433 -1.537 0 N-CA-C 109.404 -1.479 . . . . 74.420000000000002 109.404 -176.568 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 65.8 m -89.94 165.15 14.25 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.481 0.658 . . . . 54.299999999999997 111.606 -175.94 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -119.18 163.78 16.56 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 108.329 -0.989 . . . . 73.140000000000001 108.329 179.707 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -135.17 156.29 49.25 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 120.814 0.34 . . . . 60.130000000000003 111.186 -177.821 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.418 ' H ' HD23 ' A' ' 49' ' ' LEU . 1.4 pt? -114.76 132.8 56.33 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.675 -0.861 . . . . 60.509999999999998 108.675 174.307 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 24.8 t -116.03 134.02 60.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.566 -0.901 . . . . 75.540000000000006 108.566 -178.872 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.488 HG21 ' HB3' ' A' ' 57' ' ' ALA . 24.4 t -92.74 121.5 43.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-O 121.018 0.437 . . . . 51.520000000000003 110.158 -177.893 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -94.43 -41.59 9.31 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.698 -0.683 . . . . 63.420000000000002 110.306 177.964 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -153.14 123.88 7.31 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 109.299 -0.63 . . . . 62.100000000000001 109.299 -176.505 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 151.53 130.32 1.64 Allowed Glycine 0 N--CA 1.427 -1.918 0 N-CA-C 111.261 -0.735 . . . . 53.009999999999998 111.261 178.277 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -61.47 -8.62 11.16 Favored 'Trans proline' 0 N--CA 1.481 0.761 0 C-N-CA 123.534 2.823 . . . . 70.5 113.433 178.051 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.511 ' HB2' ' HA ' ' A' ' 80' ' ' LEU . 5.1 p-10 -56.06 -41.04 74.46 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.28 0.632 . . . . 72.140000000000001 110.611 177.475 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.488 ' HB3' HG21 ' A' ' 51' ' ' VAL . . . -178.75 -168.99 0.15 Allowed 'General case' 0 C--O 1.217 -0.64 0 C-N-CA 123.936 0.894 . . . . 43.329999999999998 109.093 -179.145 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -159.48 28.95 0.39 Allowed Glycine 0 C--N 1.312 -0.775 0 N-CA-C 110.184 -1.167 . . . . 54.509999999999998 110.184 179.122 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -130.19 -166.23 1.65 Allowed 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.295 -1.002 . . . . 72.310000000000002 108.295 -175.471 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.457 ' H ' ' NE ' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -122.96 139.96 53.52 Favored 'General case' 0 N--CA 1.412 -2.335 0 N-CA-C 108.771 -0.826 . . . . 73.510000000000005 108.771 178.382 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -118.94 121.78 40.73 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 109.835 -0.432 . . . . 74.239999999999995 109.835 -177.992 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 47.7 tp -91.25 133.98 34.95 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.541 -0.911 . . . . 75.310000000000002 108.541 178.521 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 7.0 mp -83.27 114.93 21.73 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 120.394 -0.523 . . . . 64.319999999999993 111.219 -179.721 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -120.24 18.35 12.27 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.148 -1.056 . . . . 75.439999999999998 108.148 174.56 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -133.94 142.99 45.53 Favored Pre-proline 0 N--CA 1.438 -1.03 0 CA-C-N 113.881 -1.509 . . . . 75.299999999999997 108.045 178.374 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.424 ' HA ' HG13 ' A' ' 94' ' ' ILE . 26.0 Cg_endo -63.16 -31.26 75.17 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.898 2.398 . . . . 63.329999999999998 113.683 -177.371 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 41.2 m -136.49 120.75 17.93 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.82 -0.55 . . . . 72.019999999999996 110.0 179.417 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.503 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 9.2 m -102.99 119.85 39.58 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 106.471 -1.677 . . . . 72.310000000000002 106.471 176.645 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.46 HG23 ' HA ' ' A' ' 76' ' ' SER . 7.9 t -101.47 131.86 47.37 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 109.08 -0.711 . . . . 73.120000000000005 109.08 -176.604 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -127.5 119.47 26.13 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-O 120.845 0.355 . . . . 74.439999999999998 111.826 -174.577 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 60.3 44.81 97.12 Favored Glycine 0 CA--C 1.496 -1.133 0 CA-C-N 115.707 -0.678 . . . . 74.540000000000006 111.641 178.15 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 46.9 ttt180 -137.9 -31.1 0.79 Allowed 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 120.592 -0.443 . . . . 74.310000000000002 111.507 -173.619 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 49.8 m80 -128.78 160.29 63.89 Favored Pre-proline 0 C--N 1.303 -1.434 0 N-CA-C 107.815 -1.18 . . . . 74.510000000000005 107.815 179.837 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -64.32 -25.4 64.22 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 121.303 1.335 . . . . 74.310000000000002 110.195 172.479 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -99.08 29.46 3.86 Favored 'General case' 0 C--O 1.243 0.756 0 CA-C-N 115.401 -0.818 . . . . 74.340000000000003 111.58 179.422 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.46 ' HA ' HG23 ' A' ' 69' ' ' THR . 70.2 m -54.43 136.53 44.01 Favored 'General case' 0 C--O 1.244 0.814 0 CA-C-O 120.898 0.38 . . . . 75.109999999999999 111.158 178.765 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -61.27 -43.91 98.1 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 115.025 -0.989 . . . . 62.530000000000001 109.911 -177.347 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 48.4 pt -124.93 156.72 33.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 CA-C-N 115.167 -0.924 . . . . 63.43 108.649 176.766 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -106.73 136.18 46.98 Favored 'General case' 0 C--N 1.284 -2.25 0 CA-C-N 115.846 -0.615 . . . . 74.209999999999994 110.026 -179.913 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.511 ' HA ' ' HB2' ' A' ' 56' ' ' ASN . 94.2 mt -107.38 171.74 7.21 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 108.67 -0.863 . . . . 75.400000000000006 108.67 -179.471 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -66.16 122.52 17.62 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 121.971 0.891 . . . . 71.329999999999998 110.213 -178.996 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.406 ' HA ' HG12 ' A' ' 85' ' ' VAL . 17.2 m-20 -67.16 -16.54 64.37 Favored 'General case' 0 C--N 1.278 -2.535 0 CA-C-N 113.888 -1.505 . . . . 55.219999999999999 114.52 -174.784 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.3 t -90.8 -24.66 5.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-O 121.825 0.822 . . . . 61.100000000000001 109.183 -179.283 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 11.2 p -103.26 -3.34 25.8 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.702 -0.681 . . . . 64.430000000000007 112.816 -179.628 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.406 HG12 ' HA ' ' A' ' 82' ' ' ASP . 10.7 p -81.47 121.56 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 N-CA-C 107.971 -1.122 . . . . 71.209999999999994 107.971 179.254 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 27.0 p -115.03 46.31 1.46 Allowed 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 112.122 0.415 . . . . 64.420000000000002 112.122 -175.026 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 87' ' ' ARG . 68.6 mtt180 67.52 108.12 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.883 0.873 . . . . 72.209999999999994 110.928 -178.998 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.42 ' O ' HG23 ' A' ' 104' ' ' VAL . 93.7 mtt180 63.71 78.11 0.3 Allowed 'General case' 0 CA--C 1.506 -0.725 0 N-CA-C 108.815 -0.809 . . . . 63.210000000000001 108.815 178.669 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 41.1 t60 -85.34 -67.27 0.81 Allowed 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 118.701 -1.2 . . . . 74.400000000000006 113.905 -172.522 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -137.8 156.45 47.94 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 118.324 -1.351 . . . . 74.340000000000003 113.589 -173.284 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -127.1 127.76 45.15 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 114.358 -1.292 . . . . 71.109999999999999 108.104 175.172 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.503 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 79.1 m-85 -108.69 112.72 25.18 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 106.085 -1.82 . . . . 75.230000000000004 106.085 174.865 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -117.08 144.4 44.7 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 121.64 0.733 . . . . 71.209999999999994 111.535 -173.396 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.445 ' O ' HD12 ' A' ' 94' ' ' ILE . 2.8 pp -116.17 116.4 52.18 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.64 0 N-CA-C 104.119 -2.549 . . . . 74.109999999999999 104.119 167.347 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.593 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 46.6 t-20 -108.09 145.03 34.65 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 107.734 -1.209 . . . . 72.420000000000002 107.734 -172.647 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -54.66 -26.75 35.17 Favored 'General case' 0 C--N 1.311 -1.078 0 O-C-N 123.645 0.591 . . . . 74.120000000000005 111.076 178.692 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -72.7 -63.35 2.9 Favored Glycine 0 N--CA 1.43 -1.759 0 N-CA-C 110.816 -0.914 . . . . 74.409999999999997 110.816 173.785 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.593 ' O ' ' HB3' ' A' ' 95' ' ' ASN . 44.2 mt-10 -159.26 168.36 26.66 Favored 'General case' 0 C--O 1.212 -0.893 0 N-CA-C 106.202 -1.777 . . . . 73.230000000000004 106.202 -178.38 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.454 ' HB2' ' CB ' ' A' ' 122' ' ' MET . 9.3 m-85 -91.31 134.84 34.25 Favored 'General case' 0 C--N 1.295 -1.767 0 C-N-CA 119.414 -0.914 . . . . 74.530000000000001 109.534 -177.379 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -132.2 136.22 46.87 Favored 'General case' 0 CA--C 1.501 -0.904 0 N-CA-C 113.218 0.821 . . . . 72.040000000000006 113.218 -175.858 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 90.1 t -111.01 119.91 60.6 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.077 0 N-CA-C 108.11 -1.07 . . . . 65.150000000000006 108.11 176.629 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 35.3 t -119.2 116.63 51.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 116.367 -0.379 . . . . 70.540000000000006 110.012 -176.733 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -104.26 108.93 20.55 Favored 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 107.551 -1.277 . . . . 65.340000000000003 107.551 175.97 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 88' ' ' ARG . 26.3 m -92.13 -9.56 10.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-O 121.128 0.489 . . . . 44.350000000000001 110.995 -177.886 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -92.16 27.33 10.49 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 109.759 -1.336 . . . . 71.540000000000006 109.759 176.049 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.42 ' HA ' ' OG1' ' A' ' 110' ' ' THR . 1.1 p -69.52 10.03 0.41 Allowed 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 125.532 1.533 . . . . 74.340000000000003 113.282 -177.455 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.427 HD23 ' O ' ' A' ' 107' ' ' LEU . 6.0 tt -68.22 -24.78 64.96 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 106.251 -1.759 . . . . 72.140000000000001 106.251 172.994 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -78.07 -1.84 34.37 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 115.054 -0.975 . . . . 62.140000000000001 110.657 177.393 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 77.28 56.44 3.97 Favored Glycine 0 N--CA 1.439 -1.123 0 N-CA-C 110.471 -1.052 . . . . 71.329999999999998 110.471 -178.203 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.42 ' OG1' ' HA ' ' A' ' 106' ' ' SER . 17.9 m -72.89 121.42 19.98 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-O 121.606 0.717 . . . . 53.350000000000001 111.507 -176.692 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -102.13 133.27 47.25 Favored 'General case' 0 N--CA 1.416 -2.158 0 N-CA-C 106.199 -1.778 . . . . 72.340000000000003 106.199 175.449 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.442 HG13 HG12 ' A' ' 128' ' ' ILE . 25.9 t -125.17 128.78 73.12 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.063 0 N-CA-C 105.537 -2.023 . . . . 74.120000000000005 105.537 179.822 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 63.55 27.24 14.97 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 107.841 -1.17 . . . . 73.319999999999993 107.841 -173.658 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 67.72 9.31 7.0 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 124.899 1.279 . . . . 73.510000000000005 112.254 -175.226 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.572 ' OE1' ' HD2' ' A' ' 116' ' ' PRO . 9.2 tp10 -111.51 126.38 28.68 Favored Pre-proline 0 C--N 1.305 -1.359 0 N-CA-C 108.452 -0.944 . . . . 75.120000000000005 108.452 -178.826 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.572 ' HD2' ' OE1' ' A' ' 115' ' ' GLU . 32.9 Cg_exo -53.75 113.24 1.23 Allowed 'Trans proline' 0 C--O 1.25 1.099 0 C-N-CA 121.967 1.778 . . . . 74.420000000000002 109.309 173.105 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 12.5 tpp85 -160.13 143.31 13.77 Favored 'General case' 0 N--CA 1.425 -1.704 0 N-CA-C 108.508 -0.923 . . . . 74.319999999999993 108.508 -173.349 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -87.98 -41.57 13.05 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.448 -0.575 . . . . 74.129999999999995 109.448 -179.062 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -132.72 139.34 47.58 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.399 -0.963 . . . . 31.43 108.399 177.429 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.07 148.83 47.01 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 107.249 -1.389 . . . . 73.420000000000002 107.249 -176.744 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 8.7 p -84.58 134.33 27.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 108.518 -0.919 . . . . 74.209999999999994 108.518 179.876 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.454 ' CB ' ' HB2' ' A' ' 99' ' ' PHE . 1.5 tmt? -50.24 124.39 10.27 Favored 'General case' 0 C--N 1.313 -1.008 0 O-C-N 123.739 0.649 . . . . 72.030000000000001 112.671 -175.489 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -129.85 151.09 50.8 Favored 'General case' 0 N--CA 1.424 -1.761 0 CA-C-N 115.148 -0.933 . . . . 72.219999999999999 108.817 173.461 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 6.6 p -78.53 115.17 18.05 Favored 'General case' 0 C--N 1.283 -2.306 0 CA-C-N 115.738 -0.665 . . . . 71.530000000000001 109.636 177.681 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 95.16 33.55 6.52 Favored Glycine 0 N--CA 1.437 -1.271 0 N-CA-C 110.334 -1.107 . . . . 73.239999999999995 110.334 -178.234 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -91.48 150.59 21.16 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 107.125 -1.435 . . . . 72.329999999999998 107.125 -179.79 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -137.85 123.13 19.38 Favored 'General case' 0 C--N 1.29 -2.003 0 CA-C-O 122.093 0.949 . . . . 53.119999999999997 111.069 -177.082 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.442 HG12 HG13 ' A' ' 112' ' ' VAL . 58.9 mt -101.92 126.09 55.96 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.22 0 CA-C-N 114.162 -1.381 . . . . 70.420000000000002 108.46 -176.727 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.423 ' HA ' ' O ' ' A' ' 133' ' ' PHE . 29.8 tt0 -119.69 112.78 19.72 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 109.412 -0.588 . . . . 63.310000000000002 109.412 177.94 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 23.1 pt -105.64 97.48 5.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-N 115.139 -0.937 . . . . 55.520000000000003 109.981 -178.826 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 69.36 -72.6 0.45 Allowed Glycine 0 CA--C 1.526 0.747 0 CA-C-N 115.438 -0.801 . . . . 62.229999999999997 113.69 178.502 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -132.15 -12.71 3.19 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 123.096 0.558 . . . . 71.120000000000005 110.256 -176.076 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.423 ' O ' ' HA ' ' A' ' 129' ' ' GLN . 19.5 m-85 -107.72 156.31 19.24 Favored 'General case' 0 C--N 1.321 -0.656 0 O-C-N 121.76 -0.588 . . . . 72.510000000000005 112.023 -171.29 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 134' ' ' ARG . 50.4 mtp180 -131.32 127.02 36.81 Favored 'General case' 0 C--O 1.251 1.14 0 CA-C-O 121.616 0.722 . . . . 73.0 111.791 -174.745 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 58.6 tp -122.06 135.17 54.79 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 114.531 -1.213 . . . . 72.129999999999995 107.748 -179.693 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 14.9 p -112.06 138.63 40.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 N-CA-C 109.326 -0.62 . . . . 65.219999999999999 109.326 -179.737 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -116.25 129.79 56.46 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 109.334 -0.617 . . . . 64.439999999999998 109.334 -177.359 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 58.4 mt -135.66 172.5 12.92 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.306 -0.627 . . . . 64.430000000000007 109.306 -177.078 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -91.11 146.56 23.74 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 107.639 -1.245 . . . . 73.129999999999995 107.639 175.694 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.406 ' HA3' ' HD3' ' A' ' 141' ' ' PRO . . . -96.58 -127.53 5.52 Favored Glycine 0 N--CA 1.429 -1.772 0 C-N-CA 120.374 -0.917 . . . . 71.409999999999997 111.68 -176.705 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.406 ' HD3' ' HA3' ' A' ' 140' ' ' GLY . 6.6 Cg_exo -71.33 128.29 14.42 Favored 'Trans proline' 0 N--CA 1.444 -1.412 0 C-N-CA 122.192 1.928 . . . . 64.120000000000005 112.03 179.973 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -78.75 112.72 16.16 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.367 -1.345 . . . . 75.219999999999999 107.367 177.313 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 . . . . . 0 C--N 1.283 -2.298 0 N-CA-C 109.057 -0.72 . . . . 62.530000000000001 109.057 -175.694 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.7 ttt . . . . . 0 N--CA 1.456 -0.157 0 N-CA-C 108.516 -0.92 . . . . 74.150000000000006 108.516 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.3 p -82.38 -39.11 23.17 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.135 0.493 . . . . 50.399999999999999 111.821 -177.087 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -120.53 175.16 6.13 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.806 -0.634 . . . . 54.119999999999997 110.566 -172.444 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -126.54 171.33 11.17 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 107.927 -1.138 . . . . 64.430000000000007 107.927 179.187 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -105.69 167.06 10.02 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 107.402 -1.332 . . . . 74.430000000000007 107.402 173.198 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -133.15 -166.1 11.33 Favored Glycine 0 N--CA 1.424 -2.118 0 C-N-CA 119.908 -1.139 . . . . 73.530000000000001 111.656 -178.001 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.3 t -100.76 143.57 26.83 Favored Pre-proline 0 N--CA 1.417 -2.104 0 N-CA-C 108.169 -1.048 . . . . 62.310000000000002 108.169 -179.765 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -58.45 128.03 26.89 Favored 'Trans proline' 0 C--O 1.245 0.858 0 C-N-CA 122.409 2.072 . . . . 64.230000000000004 110.658 177.67 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -82.97 126.85 71.61 Favored Pre-proline 0 C--N 1.295 -1.793 0 CA-C-N 115.836 -0.62 . . . . 74.099999999999994 110.668 -176.535 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.76 151.33 28.12 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.298 1.999 . . . . 41.119999999999997 111.277 178.9 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -118.68 110.44 17.3 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.755 0.788 . . . . 73.340000000000003 111.467 179.671 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.9 p -90.23 158.02 2.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 107.283 -1.377 . . . . 64.519999999999996 107.283 177.654 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -92.28 133.32 35.94 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 120.059 -0.656 . . . . 61.140000000000001 111.527 -179.325 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.5 m -106.26 91.78 3.86 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 104.899 -2.26 . . . . 65.230000000000004 104.899 171.569 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 14.9 t -83.13 -175.19 5.71 Favored 'General case' 0 N--CA 1.413 -2.309 0 CA-C-O 121.607 0.718 . . . . 72.409999999999997 111.916 -169.005 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.1 m -81.8 40.35 0.6 Allowed 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 124.952 1.301 . . . . 71.099999999999994 111.65 -173.312 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.7 p -78.81 0.25 3.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 122.613 1.197 . . . . 72.430000000000007 110.589 -177.59 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -99.21 153.29 19.05 Favored 'General case' 0 C--N 1.273 -2.736 0 CA-C-N 114.534 -1.212 . . . . 74.219999999999999 109.255 -179.951 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 15.0 mmt180 -91.82 145.03 24.89 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 116.159 -0.473 . . . . 73.230000000000004 110.595 -179.422 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -91.59 95.16 9.77 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 106.193 -1.781 . . . . 73.230000000000004 106.193 172.417 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -78.45 -41.97 31.26 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 121.472 0.653 . . . . 74.319999999999993 109.572 -174.448 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -89.95 93.94 9.61 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 107.579 -1.267 . . . . 74.120000000000005 107.579 177.004 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 96.0 mt -81.94 111.87 18.52 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 107.466 -1.309 . . . . 72.5 107.466 176.497 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . 0.251 0.0 OUTLIER -70.28 -20.86 63.01 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 113.888 1.069 . . . . 70.340000000000003 113.888 -173.999 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 34.66 69.92 0.14 Allowed 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 125.239 1.415 . . . . 71.519999999999996 113.093 177.212 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 47.3 ttm -114.01 89.77 3.17 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-N 115.277 -0.874 . . . . 70.310000000000002 112.22 -173.124 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -137.78 119.1 14.66 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 106.165 -1.791 . . . . 53.450000000000003 106.165 174.656 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 45.8 m -142.02 148.45 38.52 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 109.745 -0.465 . . . . 75.310000000000002 109.745 -179.339 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 35.9 m -75.22 130.91 39.94 Favored 'General case' 0 N--CA 1.427 -1.579 0 O-C-N 123.624 0.578 . . . . 73.040000000000006 111.028 -177.595 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.1 t -134.24 164.27 27.75 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 107.636 -1.246 . . . . 73.010000000000005 107.636 -179.488 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -162.52 141.59 7.31 Favored Glycine 0 N--CA 1.425 -2.044 0 N-CA-C 110.946 -0.862 . . . . 51.509999999999998 110.946 179.828 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 33.9 m -110.18 129.08 55.77 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 108.254 -1.017 . . . . 53.43 108.254 175.909 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -90.76 129.17 45.5 Favored Pre-proline 0 C--N 1.288 -2.079 0 N-CA-C 109.284 -0.635 . . . . 73.25 109.284 -178.963 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -63.03 121.06 8.79 Favored 'Trans proline' 0 C--O 1.241 0.665 0 C-N-CA 122.28 1.986 . . . . 71.430000000000007 110.408 176.412 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -87.64 133.94 33.73 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 116.303 -0.408 . . . . 74.019999999999996 110.361 -178.042 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 77.8 p -149.47 142.7 25.09 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.803 -0.181 . . . . 73.010000000000005 111.044 179.735 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.0 t -168.83 115.52 0.63 Allowed 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 123.828 0.851 . . . . 64.400000000000006 109.895 172.963 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -132.41 105.85 0.62 Allowed Glycine 0 N--CA 1.419 -2.499 0 CA-C-N 115.121 -0.945 . . . . 70.329999999999998 110.995 -178.245 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.22 -26.69 67.91 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 123.416 0.686 . . . . 51.520000000000003 112.367 -179.027 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -70.11 -12.55 61.68 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.389 0.614 . . . . 65.019999999999996 111.037 -177.065 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -73.07 -26.15 61.16 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.38 -0.827 . . . . 72.140000000000001 109.661 177.01 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 62.9 tp -98.66 116.4 65.4 Favored Pre-proline 0 C--N 1.318 -0.794 0 CA-C-N 115.175 -0.921 . . . . 74.140000000000001 108.796 -178.966 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_exo -54.33 -61.54 0.4 Allowed 'Trans proline' 0 C--N 1.358 1.04 0 C-N-CA 123.228 2.618 . . . . 64.430000000000007 112.783 -178.953 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -95.42 81.25 3.56 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 121.371 0.605 . . . . 33.009999999999998 109.696 177.439 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -97.92 39.41 2.78 Favored Glycine 0 CA--C 1.497 -1.073 0 N-CA-C 109.682 -1.367 . . . . 61.25 109.682 177.78 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.0 m -100.39 156.81 17.05 Favored 'General case' 0 N--CA 1.416 -2.158 0 N-CA-C 108.988 -0.745 . . . . 64.219999999999999 108.988 -178.111 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.514 ' HB1' ' CE1' ' A' ' 137' ' ' PHE . . . -140.63 162.88 34.34 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 106.273 -1.751 . . . . 52.240000000000002 106.273 176.927 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.3 pp -134.31 142.39 47.25 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 118.246 -1.382 . . . . 64.140000000000001 111.836 179.436 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.479 ' O ' HD12 ' A' ' 49' ' ' LEU . 2.2 pp -109.38 140.81 42.61 Favored 'General case' 0 N--CA 1.424 -1.754 0 CA-C-N 115.453 -0.794 . . . . 71.409999999999997 110.266 179.51 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 45.2 t -123.6 113.5 37.6 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 N-CA-C 106.299 -1.741 . . . . 74.120000000000005 106.299 174.12 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.455 HG21 ' HB3' ' A' ' 57' ' ' ALA . 42.1 t -96.28 115.59 35.99 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.115 0 C-N-CA 118.915 -1.114 . . . . 72.409999999999997 108.49 179.476 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -68.99 -38.71 79.45 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 114.728 -1.123 . . . . 61.530000000000001 109.528 -176.559 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 26.4 ttm180 -177.25 142.3 0.35 Allowed 'General case' 0 C--O 1.244 0.773 0 CA-C-N 115.699 -0.682 . . . . 70.239999999999995 109.812 -179.95 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 143.31 165.91 10.94 Favored Glycine 0 N--CA 1.436 -1.36 0 CA-C-N 116.232 -0.44 . . . . 30.199999999999999 112.435 177.266 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -67.53 -8.21 21.55 Favored 'Trans proline' 0 N--CA 1.486 1.044 0 C-N-CA 123.659 2.906 . . . . 65.150000000000006 112.949 178.258 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.544 ' HA ' ' CB ' ' A' ' 80' ' ' LEU . 26.3 t-20 -65.15 -54.13 34.51 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.925 -0.58 . . . . 54.240000000000002 109.898 178.564 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.455 ' HB3' HG21 ' A' ' 51' ' ' VAL . . . -172.56 -176.51 1.54 Allowed 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.897 0.879 . . . . 70.349999999999994 108.822 -179.692 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -158.46 46.28 0.45 Allowed Glycine 0 CA--C 1.494 -1.235 0 N-CA-C 110.155 -1.178 . . . . 74.450000000000003 110.155 179.588 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -162.62 -173.83 3.71 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.157 -1.423 . . . . 72.030000000000001 107.157 -177.797 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.51 132.24 37.06 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 120.673 0.273 . . . . 72.239999999999995 110.46 177.73 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -156.75 155.03 30.92 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 116.002 -0.545 . . . . 75.209999999999994 110.425 -178.346 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.486 HD23 ' H ' ' A' ' 62' ' ' LEU . 2.7 pt? -79.13 139.74 37.97 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 122.063 0.935 . . . . 64.340000000000003 113.056 -178.062 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.461 HD11 HD23 ' A' ' 49' ' ' LEU . 75.3 mt -99.84 133.49 44.13 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 104.87 -2.27 . . . . 41.229999999999997 104.87 172.089 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -147.28 78.52 1.48 Allowed 'General case' 0 C--N 1.296 -1.737 0 CA-C-O 121.568 0.699 . . . . 72.430000000000007 111.449 -178.638 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -147.9 149.69 33.78 Favored Pre-proline 0 C--N 1.306 -1.299 0 N-CA-C 106.918 -1.512 . . . . 63.210000000000001 106.918 174.679 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -58.54 -40.65 72.21 Favored 'Trans proline' 0 C--N 1.366 1.455 0 C-N-CA 122.612 2.208 . . . . 73.430000000000007 110.301 -179.682 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 33.9 m -128.58 100.06 5.61 Favored 'General case' 0 N--CA 1.414 -2.264 0 CA-C-N 114.519 -1.219 . . . . 74.319999999999993 108.322 175.547 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 57.8 m -95.32 113.87 25.59 Favored 'General case' 0 N--CA 1.423 -1.807 0 N-CA-C 107.121 -1.437 . . . . 74.540000000000006 107.121 179.762 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.1 t -108.98 135.77 49.61 Favored 'General case' 0 C--N 1.283 -2.318 0 C-N-CA 120.033 -0.667 . . . . 70.519999999999996 110.717 -174.416 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -119.9 131.7 55.31 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 108.97 -0.752 . . . . 51.140000000000001 108.97 179.466 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 178.73 -122.92 0.83 Allowed Glycine 0 N--CA 1.411 -2.985 0 C-N-CA 120.641 -0.79 . . . . 72.340000000000003 111.145 179.153 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 18.7 tpt180 -146.94 14.92 1.18 Allowed 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 109.658 -0.497 . . . . 74.329999999999998 109.658 -176.078 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.439 ' HB3' ' HB3' ' A' ' 87' ' ' ARG . 38.0 p-80 -98.3 156.34 35.9 Favored Pre-proline 0 C--N 1.318 -0.765 0 N-CA-C 108.253 -1.017 . . . . 64.340000000000003 108.253 179.893 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -49.02 -30.71 18.7 Favored 'Trans proline' 0 N--CA 1.488 1.15 0 C-N-CA 123.907 3.071 . . . . 62.329999999999998 115.766 -174.831 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -93.27 12.76 23.48 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 113.298 0.851 . . . . 71.439999999999998 113.298 -177.439 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 24.2 m -65.76 135.78 55.36 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.632 -0.877 . . . . 73.239999999999995 108.632 176.738 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -68.65 -46.12 70.02 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 107.716 -1.216 . . . . 74.040000000000006 107.716 179.055 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.476 HD13 ' H ' ' A' ' 78' ' ' ILE . 0.2 OUTLIER -125.82 135.35 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 CA-C-N 113.631 -1.622 . . . . 64.519999999999996 109.226 176.929 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -103.86 117.49 34.47 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 115.83 -0.623 . . . . 75.340000000000003 109.373 178.873 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.544 ' CB ' ' HA ' ' A' ' 56' ' ' ASN . 0.9 OUTLIER -86.94 119.89 27.63 Favored 'General case' 0 N--CA 1.418 -2.062 0 N-CA-C 107.548 -1.279 . . . . 75.340000000000003 107.548 174.418 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -84.95 60.57 6.31 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 122.38 1.086 . . . . 61.030000000000001 111.918 -176.109 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -93.04 -175.33 3.83 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 106.311 -1.737 . . . . 70.230000000000004 106.311 171.71 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.6 p -126.99 -6.98 4.65 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 CA-C-O 121.861 0.839 . . . . 73.299999999999997 109.987 -179.029 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 5.8 m -115.22 15.58 16.98 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 122.303 1.049 . . . . 64.120000000000005 108.249 179.376 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.7 p -84.34 138.56 18.96 Favored 'Isoleucine or valine' 0 C--O 1.248 1.011 0 CA-C-N 115.005 -0.998 . . . . 70.439999999999998 110.796 -179.851 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 19.6 m -77.03 166.57 23.14 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.944 -0.571 . . . . 73.030000000000001 110.2 178.37 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.439 ' HB3' ' HB3' ' A' ' 73' ' ' HIS . 18.4 mmt180 -63.12 -37.75 88.43 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 121.317 0.58 . . . . 75.25 109.884 178.495 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.1 119.71 29.36 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 106.517 -1.66 . . . . 71.329999999999998 106.517 167.831 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 9.1 t60 -106.62 -63.11 1.31 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.683 -0.488 . . . . 63.030000000000001 109.683 -175.814 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -134.74 119.43 18.22 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.246 -1.02 . . . . 73.129999999999995 108.246 -179.858 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -104.92 128.04 53.0 Favored 'General case' 0 C--N 1.287 -2.123 0 C-N-CA 119.883 -0.727 . . . . 75.420000000000002 109.368 179.34 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -105.58 119.72 39.82 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 107.673 -1.232 . . . . 65.129999999999995 107.673 -176.366 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -118.59 148.96 42.14 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 109.388 -0.597 . . . . 74.400000000000006 109.388 -178.944 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 4.3 tp -115.58 127.63 73.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 CA-C-O 121.769 0.795 . . . . 74.540000000000006 109.651 -179.83 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -108.17 146.63 32.45 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 106.19 -1.781 . . . . 75.349999999999994 106.19 -179.67 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -54.93 -18.24 4.72 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 113.53 0.937 . . . . 63.229999999999997 113.53 -177.718 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -108.06 -44.51 1.18 Allowed Glycine 0 N--CA 1.431 -1.647 0 C-N-CA 121.377 -0.44 . . . . 52.020000000000003 113.037 177.666 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -133.88 175.57 9.34 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-O 121.615 0.721 . . . . 75.099999999999994 111.935 -174.687 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.412 ' HB2' ' HB3' ' A' ' 122' ' ' MET . 91.4 m-85 -104.68 137.45 42.48 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 106.508 -1.664 . . . . 73.400000000000006 106.508 174.785 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -130.54 130.05 43.61 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 118.28 0.491 . . . . 74.209999999999994 110.039 -178.226 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 6.9 p -117.29 127.64 74.77 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-O 120.926 0.393 . . . . 64.420000000000002 110.35 -179.636 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 30.9 m -118.88 121.38 66.72 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 CA-C-O 121.497 0.665 . . . . 72.340000000000003 111.873 178.544 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -83.41 124.42 30.65 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.281 -0.872 . . . . 61.219999999999999 110.506 175.473 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 6.7 m -125.89 17.42 3.99 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.227 0 CA-C-N 114.837 -1.074 . . . . 60.350000000000001 109.849 176.739 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -127.5 46.92 1.05 Allowed Glycine 0 N--CA 1.443 -0.865 0 N-CA-C 108.866 -1.694 . . . . 63.229999999999997 108.866 177.495 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.7 m -59.52 -23.49 62.87 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 124.359 1.064 . . . . 73.239999999999995 113.643 -173.039 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 85.1 mt -77.62 -21.31 52.49 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.054 -0.658 . . . . 65.349999999999994 112.0 -179.33 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -81.72 -36.0 29.13 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 107.378 -1.341 . . . . 64.329999999999998 107.378 176.008 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 103.78 88.24 2.04 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 114.635 -1.166 . . . . 75.420000000000002 113.995 176.793 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 27.9 m -99.59 120.12 39.16 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.655 -0.868 . . . . 63.329999999999998 108.655 175.211 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.405 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 29.9 m-85 -127.2 152.35 47.49 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 108.792 -0.818 . . . . 74.340000000000003 108.792 -177.726 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 74.7 t -106.32 113.41 42.93 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.111 0 N-CA-C 107.215 -1.402 . . . . 73.319999999999993 107.215 175.525 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 67.07 -73.59 0.08 Allowed 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 126.427 1.891 . . . . 73.239999999999995 109.862 -174.592 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -141.13 -12.56 0.94 Allowed 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 123.235 0.614 . . . . 75.430000000000007 111.106 177.099 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -106.78 140.72 21.64 Favored Pre-proline 0 C--N 1.321 -0.646 0 N-CA-C 112.503 0.557 . . . . 73.010000000000005 112.503 -169.787 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -71.27 93.27 0.65 Allowed 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.695 2.263 . . . . 52.240000000000002 112.777 178.562 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 12.6 mmt85 -110.54 100.51 9.31 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 106.464 -1.68 . . . . 74.329999999999998 106.464 176.032 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -75.85 -31.88 59.51 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 119.896 -0.721 . . . . 72.120000000000005 110.612 -176.101 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -124.35 136.13 53.86 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 105.265 -2.124 . . . . 73.109999999999999 105.265 167.854 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 55.7 tp60 -142.54 148.82 38.22 Favored 'General case' 0 C--N 1.283 -2.285 0 C-N-CA 120.922 -0.311 . . . . 65.430000000000007 110.928 -178.063 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.0 p -79.58 114.62 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.662 0 N-CA-C 103.893 -2.632 . . . . 75.239999999999995 103.893 167.126 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.412 ' HB3' ' HB2' ' A' ' 99' ' ' PHE . 9.7 ttt -68.52 120.35 14.43 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 115.033 -0.985 . . . . 51.039999999999999 111.079 -166.771 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 30.1 tp60 -104.25 124.9 49.98 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.252 -0.886 . . . . 73.230000000000004 110.325 -172.69 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.2 t -78.94 131.69 36.45 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 114.913 -1.04 . . . . 63.109999999999999 108.577 177.458 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 110.0 -9.73 31.73 Favored Glycine 0 N--CA 1.437 -1.266 0 CA-C-N 115.995 -0.548 . . . . 72.25 112.316 178.856 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -113.82 169.9 8.66 Favored 'General case' 0 C--O 1.25 1.118 0 N-CA-C 108.806 -0.813 . . . . 70.010000000000005 108.806 -177.357 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -110.63 144.98 38.69 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.791 0.805 . . . . 65.329999999999998 111.747 -178.25 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 65.2 mt -106.55 124.78 62.28 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 N-CA-C 107.367 -1.346 . . . . 52.32 107.367 177.139 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.405 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 58.2 tp60 -97.73 116.55 30.17 Favored 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 108.899 -0.778 . . . . 73.409999999999997 108.899 -176.896 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.1 pt -115.41 97.71 5.95 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.301 0 CA-C-O 122.177 0.989 . . . . 72.409999999999997 109.565 177.904 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 68.85 -116.55 7.4 Favored Glycine 0 N--CA 1.429 -1.786 0 CA-C-N 114.454 -1.248 . . . . 73.010000000000005 111.4 -175.697 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 17.9 tppt? -94.14 -22.14 18.65 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.239 0.542 . . . . 54.200000000000003 110.588 179.64 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -101.34 161.17 13.82 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 116.24 -0.437 . . . . 73.430000000000007 112.121 -174.919 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 9.8 ptp85 -137.28 144.37 42.66 Favored 'General case' 0 C--O 1.245 0.847 0 N-CA-C 113.419 0.896 . . . . 75.540000000000006 113.419 -172.984 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.8 tt -121.99 138.57 54.37 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 106.915 -1.513 . . . . 75.120000000000005 106.915 -179.247 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 27.7 t -106.83 130.49 58.68 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 N-CA-C 106.772 -1.566 . . . . 61.229999999999997 106.772 179.401 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.514 ' CE1' ' HB1' ' A' ' 47' ' ' ALA . 86.4 t80 -104.37 128.19 52.16 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 112.086 0.402 . . . . 74.340000000000003 112.086 -174.78 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -128.57 151.13 49.8 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 108.211 -1.033 . . . . 73.430000000000007 108.211 173.882 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -62.81 149.54 43.89 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.892 -0.781 . . . . 43.520000000000003 108.892 175.47 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.419 ' N ' ' HA ' ' A' ' 47' ' ' ALA . . . -69.42 169.32 44.27 Favored Glycine 0 N--CA 1.434 -1.485 0 C-N-CA 120.88 -0.676 . . . . 54.310000000000002 113.405 -175.499 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -55.05 139.74 80.04 Favored 'Trans proline' 0 C--O 1.241 0.637 0 C-N-CA 123.25 2.633 . . . . 74.019999999999996 111.734 -179.881 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -82.17 103.45 11.78 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 108.566 -0.902 . . . . 31.219999999999999 108.566 179.23 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 . . . . . 0 C--N 1.298 -1.642 0 N-CA-C 108.035 -1.098 . . . . 74.510000000000005 108.035 -178.046 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ptt? . . . . . 0 N--CA 1.481 1.081 0 N-CA-C 112.007 0.373 . . . . 73.299999999999997 112.007 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.4 m -77.51 -49.14 15.34 Favored 'General case' 0 C--O 1.243 0.755 0 N-CA-C 106.933 -1.506 . . . . 64.519999999999996 106.933 176.344 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -97.69 143.54 28.24 Favored 'General case' 0 N--CA 1.422 -1.841 0 N-CA-C 104.884 -2.265 . . . . 75.430000000000007 104.884 169.977 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -134.07 125.18 27.49 Favored 'General case' 0 C--N 1.287 -2.126 0 C-N-CA 120.999 -0.28 . . . . 52.329999999999998 110.288 -177.669 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -67.57 154.54 41.2 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.478 -0.783 . . . . 72.400000000000006 109.019 175.089 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -81.95 149.12 27.83 Favored Glycine 0 N--CA 1.421 -2.307 0 N-CA-C 110.736 -0.945 . . . . 74.319999999999993 110.736 179.289 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.3 m -63.28 139.61 97.58 Favored Pre-proline 0 C--N 1.303 -1.425 0 N-CA-C 107.452 -1.314 . . . . 75.239999999999995 107.452 176.568 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -51.14 137.02 45.94 Favored 'Trans proline' 0 C--O 1.25 1.1 0 C-N-CA 122.326 2.017 . . . . 71.209999999999994 110.36 177.845 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -68.58 143.68 95.46 Favored Pre-proline 0 C--N 1.307 -1.254 0 CA-C-N 116.129 -0.487 . . . . 75.329999999999998 110.183 -174.565 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -36.94 114.78 0.13 Allowed 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 124.823 3.682 . . . . 62.240000000000002 113.784 -177.079 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -102.27 156.58 17.48 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.104 -1.443 . . . . 75.319999999999993 107.104 -178.895 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.4 m -90.26 148.36 4.6 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 CA-C-O 120.895 0.378 . . . . 70.530000000000001 110.222 177.533 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -103.5 141.52 35.85 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.14 -1.059 . . . . 44.439999999999998 108.14 177.315 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.5 t -68.92 152.7 44.94 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.705 -0.85 . . . . 63.25 108.705 179.007 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.9 t -145.11 105.45 4.08 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-O 121.748 0.785 . . . . 74.450000000000003 112.039 -176.88 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.6 t -94.21 96.03 9.33 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 105.589 -2.004 . . . . 75.530000000000001 105.589 174.982 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.1 p -103.49 127.83 57.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 CA-C-O 121.986 0.898 . . . . 72.340000000000003 112.209 -173.0 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -114.08 130.18 56.58 Favored 'General case' 0 N--CA 1.425 -1.713 0 N-CA-C 106.875 -1.528 . . . . 73.329999999999998 106.875 177.92 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -94.57 172.72 8.01 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 108.954 -0.758 . . . . 72.219999999999999 108.954 179.863 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.48 78.45 3.99 Favored 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 108.714 -0.847 . . . . 75.030000000000001 108.714 175.738 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -92.6 -24.37 18.72 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.03 -0.986 . . . . 71.129999999999995 110.129 -177.432 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -70.04 137.31 51.18 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.661 -0.699 . . . . 65.540000000000006 109.429 -177.985 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -136.57 176.19 8.92 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.054 -1.091 . . . . 75.209999999999994 108.054 179.926 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -78.18 135.1 37.56 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 113.47 0.915 . . . . 73.230000000000004 113.47 -176.898 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -130.59 143.86 51.03 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 106.244 -1.762 . . . . 63.0 106.244 177.227 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 22.5 ptt? -95.7 173.19 7.6 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.746 -0.381 . . . . 74.5 110.737 -176.462 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -82.86 171.01 14.36 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.678 -0.692 . . . . 75.230000000000004 110.734 179.512 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.5 m -85.93 143.55 28.13 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 116.004 -0.544 . . . . 75.310000000000002 109.586 178.177 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 16.4 m -72.44 162.02 30.04 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.631 0.729 . . . . 72.349999999999994 112.069 -176.359 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 82.5 m -149.65 126.02 10.83 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.309 -0.997 . . . . 74.439999999999998 108.309 176.744 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -87.06 174.45 45.69 Favored Glycine 0 N--CA 1.432 -1.584 0 C-N-CA 120.778 -0.725 . . . . 44.439999999999998 111.374 178.757 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 10.0 t -97.52 157.09 16.2 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.792 -0.818 . . . . 75.140000000000001 108.792 -178.239 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.43 132.2 56.26 Favored Pre-proline 0 C--N 1.307 -1.27 0 N-CA-C 109.21 -0.663 . . . . 71.420000000000002 109.21 179.358 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -79.41 160.94 25.69 Favored 'Trans proline' 0 C--O 1.252 1.214 0 C-N-CA 122.503 2.135 . . . . 73.010000000000005 112.18 -179.324 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.1 117.28 5.8 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.399 -0.593 . . . . 73.010000000000005 109.399 178.474 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.2 m -127.04 109.1 11.53 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.408 -0.96 . . . . 64.25 108.408 -177.904 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.522 ' OG1' ' HG2' ' A' ' 66' ' ' PRO . 15.3 t -153.25 -177.51 6.37 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 109.03 -0.73 . . . . 72.5 109.03 -177.167 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -162.07 117.01 0.74 Allowed Glycine 0 N--CA 1.437 -1.239 0 N-CA-C 111.001 -0.84 . . . . 43.5 111.001 -178.285 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.8 -27.09 68.95 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 123.778 0.831 . . . . 75.340000000000003 112.382 -177.524 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -64.15 -13.17 46.39 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 113.157 0.799 . . . . 72.239999999999995 113.157 -177.527 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -76.69 -14.88 59.92 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-O 121.021 0.439 . . . . 65.140000000000001 110.533 179.72 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 73.5 mt -120.12 145.34 39.81 Favored Pre-proline 0 N--CA 1.414 -2.251 0 N-CA-C 109.074 -0.713 . . . . 45.200000000000003 109.074 -177.675 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -65.88 131.79 28.38 Favored 'Trans proline' 0 C--O 1.251 1.163 0 C-N-CA 121.726 1.617 . . . . 64.200000000000003 109.276 173.726 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.18 131.49 41.37 Favored 'General case' 0 C--O 1.248 0.99 0 CA-C-O 121.566 0.698 . . . . 72.129999999999995 112.861 -176.022 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -165.02 101.65 0.19 Allowed Glycine 0 N--CA 1.426 -2.015 0 N-CA-C 107.29 -2.324 . . . . 72.5 107.29 -179.479 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.2 m -103.09 155.26 18.52 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-O 121.179 0.514 . . . . 54.32 111.155 -174.726 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.421 ' HA ' ' N ' ' A' ' 140' ' ' GLY . . . -146.3 151.37 37.41 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.145 -1.428 . . . . 75.450000000000003 107.145 177.705 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.447 HD23 ' H ' ' A' ' 48' ' ' LEU . 2.6 pt? -123.03 151.38 41.98 Favored 'General case' 0 CA--C 1.493 -1.243 0 CA-C-O 121.576 0.703 . . . . 71.200000000000003 111.392 -175.041 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.401 ' HB3' ' CD2' ' A' ' 137' ' ' PHE . 0.9 OUTLIER -129.74 132.72 46.68 Favored 'General case' 0 C--N 1.276 -2.595 0 CA-C-N 115.259 -0.882 . . . . 71.310000000000002 108.651 175.23 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.422 HG12 ' HB3' ' A' ' 60' ' ' ARG . 23.5 m -104.37 141.41 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 N-CA-C 108.749 -0.834 . . . . 65.129999999999995 108.749 -178.222 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.454 ' HA ' ' HG ' ' A' ' 135' ' ' LEU . 39.9 t -92.92 114.97 30.68 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 N-CA-C 107.591 -1.263 . . . . 65.209999999999994 107.591 178.558 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.9 tmtm? -73.23 -44.34 59.69 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 106.157 -1.794 . . . . 61.130000000000003 106.157 -178.723 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.416 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 35.1 ttm180 -165.16 128.0 2.21 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 106.59 -1.633 . . . . 74.340000000000003 106.59 176.815 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 158.52 133.84 1.61 Allowed Glycine 0 N--CA 1.42 -2.414 0 C-N-CA 120.183 -1.008 . . . . 54.119999999999997 111.924 -179.697 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.422 ' HB2' ' HB2' ' A' ' 82' ' ' ASP . 52.2 Cg_exo -59.62 -7.83 6.3 Favored 'Trans proline' 0 N--CA 1.484 0.963 0 C-N-CA 124.201 3.267 . . . . 60.200000000000003 114.116 178.612 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -44.16 -48.16 9.16 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.565 1.146 . . . . 75.239999999999995 111.379 175.349 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -165.29 -48.14 0.03 OUTLIER 'General case' 0 CA--C 1.51 -0.581 0 CA-C-O 121.329 0.585 . . . . 33.25 109.979 -179.348 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.12 25.58 57.24 Favored Glycine 0 C--O 1.225 -0.441 0 N-CA-C 110.528 -1.029 . . . . 60.009999999999998 110.528 -177.847 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -146.84 -157.32 0.8 Allowed 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.704 -1.221 . . . . 74.299999999999997 107.704 -177.494 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.454 ' HD3' ' H ' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -129.54 141.39 50.99 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 108.251 -1.018 . . . . 72.329999999999998 108.251 177.309 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -140.6 153.69 46.17 Favored 'General case' 0 C--N 1.291 -1.955 0 C-N-CA 120.544 -0.462 . . . . 74.420000000000002 109.99 178.064 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.432 ' HG ' ' HB3' ' A' ' 48' ' ' LEU . 8.4 mp -103.68 140.61 37.36 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 115.728 -0.669 . . . . 75.129999999999995 109.605 -179.177 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 88.1 mt -72.14 114.13 9.92 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.085 -1.08 . . . . 73.209999999999994 108.085 175.388 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -117.91 4.8 12.15 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.588 -0.893 . . . . 71.010000000000005 108.588 -179.633 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.494 ' HB2' ' OG1' ' A' ' 68' ' ' THR . 1.0 OUTLIER -122.13 131.81 24.35 Favored Pre-proline 0 N--CA 1.437 -1.075 0 CA-C-N 115.893 -0.594 . . . . 54.329999999999998 109.726 -174.9 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.522 ' HG2' ' OG1' ' A' ' 37' ' ' THR . 2.8 Cg_exo -54.52 -40.15 84.92 Favored 'Trans proline' 0 C--N 1.36 1.142 0 C-N-CA 123.302 2.668 . . . . 71.340000000000003 110.904 177.822 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 97.6 m -126.34 103.28 7.56 Favored 'General case' 0 N--CA 1.42 -1.941 0 CA-C-N 114.964 -1.016 . . . . 52.25 108.716 175.829 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.494 ' OG1' ' HB2' ' A' ' 65' ' ' GLN . 38.3 m -107.24 113.07 26.25 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 108.1 -1.074 . . . . 61.409999999999997 108.1 179.047 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.1 m -105.2 121.05 43.03 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 120.469 -0.492 . . . . 73.219999999999999 109.898 -178.57 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.583 ' HB1' HD11 ' A' ' 80' ' ' LEU . . . -95.68 124.08 39.54 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 109.074 -0.713 . . . . 74.519999999999996 109.074 -179.878 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.445 ' O ' ' HA ' ' A' ' 79' ' ' PHE . . . -159.62 -179.01 34.14 Favored Glycine 0 N--CA 1.437 -1.248 0 C-N-CA 120.237 -0.983 . . . . 74.450000000000003 112.401 179.85 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.71 ' NH1' ' HA ' ' A' ' 81' ' ' ASP . 25.3 tpt180 -112.99 84.89 2.07 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.602 -0.888 . . . . 74.519999999999996 108.602 177.641 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -177.73 147.85 0.66 Allowed Pre-proline 0 C--N 1.314 -0.936 0 C-N-CA 125.509 1.524 . . . . 73.109999999999999 106.936 178.43 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -56.7 -40.47 84.09 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.787 2.325 . . . . 63.340000000000003 112.487 179.389 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -87.9 64.8 8.04 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-O 122.684 1.23 . . . . 70.439999999999998 112.467 177.855 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 19.6 m -133.59 159.9 39.08 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 104.684 -2.339 . . . . 71.040000000000006 104.684 172.601 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -64.96 -42.58 94.47 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 118.972 0.805 . . . . 71.510000000000005 109.592 -178.532 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.95 138.5 43.76 Favored 'Isoleucine or valine' 0 C--O 1.251 1.133 0 N-CA-C 106.944 -1.502 . . . . 73.109999999999999 106.944 171.735 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.445 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 53.5 p90 -107.62 125.34 51.22 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.734 -0.786 . . . . 74.420000000000002 111.813 -179.601 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.583 HD11 ' HB1' ' A' ' 70' ' ' ALA . 5.3 mp -80.51 135.83 36.18 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.76 -1.2 . . . . 75.140000000000001 107.76 178.685 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.71 ' HA ' ' NH1' ' A' ' 72' ' ' ARG . 25.5 t70 -92.13 39.81 1.03 Allowed 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.682 0.753 . . . . 74.420000000000002 111.878 -174.648 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.422 ' HB2' ' HB2' ' A' ' 55' ' ' PRO . 12.0 t70 -123.5 151.36 42.88 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.928 -0.767 . . . . 32.409999999999997 108.928 178.511 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 33.3 m -90.26 -5.89 10.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 113.015 0.746 . . . . 73.099999999999994 113.015 -174.963 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.2 t -83.65 -13.1 54.99 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-O 121.816 0.817 . . . . 71.329999999999998 108.987 178.424 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.44 HG13 ' HB2' ' A' ' 89' ' ' HIS . 51.3 t -82.83 134.49 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 CA-C-N 114.906 -1.043 . . . . 75.299999999999997 110.023 -175.998 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.534 ' OG ' HD21 ' A' ' 107' ' ' LEU . 58.3 m -82.74 -174.01 4.98 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 116.155 -0.475 . . . . 73.010000000000005 111.534 -179.949 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -56.05 -50.49 70.81 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 108.204 -1.035 . . . . 75.310000000000002 108.204 175.099 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 59.0 mtt180 -126.74 115.78 19.92 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 105.597 -2.001 . . . . 72.409999999999997 105.597 174.376 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.44 ' HB2' HG13 ' A' ' 85' ' ' VAL . 11.0 t60 -100.02 -51.34 3.72 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 121.656 0.741 . . . . 61.229999999999997 109.812 -177.149 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -145.51 145.01 30.89 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 108.416 -0.957 . . . . 61.140000000000001 108.416 -179.786 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -121.89 127.86 50.93 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-O 121.699 0.761 . . . . 63.409999999999997 109.75 178.453 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -107.82 113.69 27.1 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 107.39 -1.337 . . . . 61.149999999999999 107.39 -178.27 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 41.9 mtp180 -117.52 147.57 42.65 Favored 'General case' 0 C--N 1.283 -2.29 0 C-N-CA 119.936 -0.706 . . . . 72.510000000000005 110.277 -179.033 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.415 ' CG2' ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -116.44 122.56 70.07 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.132 0 N-CA-C 106.872 -1.529 . . . . 72.430000000000007 106.872 175.977 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -108.47 146.8 32.61 Favored 'General case' 0 C--N 1.275 -2.669 0 N-CA-C 107.434 -1.321 . . . . 74.340000000000003 107.434 -178.641 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -51.12 -22.83 2.72 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 123.769 0.827 . . . . 65.310000000000002 112.581 179.828 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -91.73 -51.33 2.51 Favored Glycine 0 N--CA 1.432 -1.618 0 C-N-CA 121.046 -0.597 . . . . 33.329999999999998 112.693 175.322 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -149.95 175.21 11.88 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 117.496 0.648 . . . . 61.310000000000002 112.387 -175.223 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.521 ' HB2' ' HB2' ' A' ' 122' ' ' MET . 63.1 m-85 -99.0 132.08 44.57 Favored 'General case' 0 C--O 1.247 0.951 0 N-CA-C 108.318 -0.993 . . . . 64.540000000000006 108.318 176.407 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -131.89 128.75 39.24 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 121.038 0.447 . . . . 74.400000000000006 111.196 -175.964 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 5.3 p -116.46 122.19 69.26 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-O 121.244 0.545 . . . . 74.230000000000004 110.507 177.804 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.7 m -119.53 136.96 55.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-N 115.736 -0.665 . . . . 75.219999999999999 109.999 177.833 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.432 ' OD2' ' HA ' ' A' ' 118' ' ' ASN . 1.4 p30 -86.39 143.12 27.98 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 118.727 -1.189 . . . . 72.230000000000004 108.345 175.409 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 15.7 m -127.68 12.31 3.29 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 CA-C-O 122.033 0.92 . . . . 74.030000000000001 109.298 176.773 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -161.67 67.69 0.24 Allowed Glycine 0 N--CA 1.427 -1.926 0 CA-C-N 114.569 -1.196 . . . . 73.409999999999997 110.965 -179.729 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.43 ' HB2' ' OD1' ' A' ' 103' ' ' ASP . 22.1 t -88.99 80.44 7.05 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 122.045 -0.68 . . . . 75.450000000000003 109.438 178.425 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.534 HD21 ' OG ' ' A' ' 86' ' ' SER . 1.9 mm? -81.03 -51.95 7.95 Favored 'General case' 0 CA--C 1.501 -0.908 0 C-N-CA 120.143 -0.623 . . . . 75.329999999999998 109.609 179.324 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -100.04 2.91 43.79 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.667 -0.697 . . . . 74.109999999999999 109.288 -175.869 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 100.93 130.72 7.15 Favored Glycine 0 N--CA 1.427 -1.955 0 CA-C-N 115.483 -0.781 . . . . 55.140000000000001 112.296 -178.662 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.442 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 26.9 m -105.68 119.52 39.35 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 106.764 -1.569 . . . . 62.119999999999997 106.764 172.79 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -125.67 144.23 50.69 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 120.843 0.354 . . . . 75.109999999999999 111.32 -173.736 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 5.2 p -121.81 111.74 32.15 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 N-CA-C 106.378 -1.712 . . . . 72.25 106.378 169.655 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 56.51 41.79 28.21 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.219 0.533 . . . . 73.019999999999996 111.228 -176.642 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 74.77 4.55 4.36 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.643 1.177 . . . . 75.239999999999995 112.782 179.749 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -97.27 115.6 65.77 Favored Pre-proline 0 C--N 1.315 -0.908 0 N-CA-C 110.008 -0.367 . . . . 75.120000000000005 110.008 178.261 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.442 ' HA ' ' O ' ' A' ' 110' ' ' THR . 41.8 Cg_endo -78.2 95.68 1.08 Allowed 'Trans proline' 0 N--CA 1.449 -1.122 0 C-N-CA 121.986 1.79 . . . . 70.219999999999999 110.688 176.866 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 27.8 mmm180 -114.23 146.32 40.56 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.601 -1.259 . . . . 54.149999999999999 107.601 -177.583 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.432 ' HA ' ' OD2' ' A' ' 103' ' ' ASP . 2.7 t-20 -84.17 -38.58 20.46 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.568 0.699 . . . . 72.420000000000002 110.46 -177.801 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -130.73 139.0 50.25 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 108.322 -0.992 . . . . 50.219999999999999 108.322 177.038 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.412 ' HA ' ' OE1' ' A' ' 120' ' ' GLN . 5.6 tp60 -139.81 145.45 38.18 Favored 'General case' 0 N--CA 1.425 -1.703 0 CA-C-O 121.299 0.571 . . . . 61.130000000000003 111.505 179.536 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 60.7 t -92.11 134.24 30.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 106.049 -1.834 . . . . 60.310000000000002 106.049 175.433 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.521 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 17.0 tmm? -39.36 127.09 1.81 Allowed 'General case' 0 N--CA 1.483 1.188 0 O-C-N 124.443 1.089 . . . . 74.120000000000005 113.366 -177.632 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -128.79 124.1 34.59 Favored 'General case' 0 N--CA 1.417 -2.088 0 N-CA-C 105.982 -1.859 . . . . 74.430000000000007 105.982 177.844 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 4.9 t -92.87 130.86 38.32 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 121.56 0.695 . . . . 54.329999999999998 112.221 -173.874 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 94.64 3.03 62.86 Favored Glycine 0 N--CA 1.438 -1.201 0 CA-C-N 115.24 -0.891 . . . . 63.119999999999997 111.393 177.784 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -106.43 168.02 9.44 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.533 -0.333 . . . . 75.400000000000006 111.157 -177.579 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -108.73 131.64 54.74 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.291 0.567 . . . . 72.439999999999998 111.88 -172.71 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 61.9 mt -119.05 113.22 40.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-N 115.344 -0.843 . . . . 62.130000000000003 109.211 179.816 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -95.32 112.75 24.41 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 109.098 -0.705 . . . . 74.030000000000001 109.098 177.425 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.5 pt -100.98 103.42 14.81 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 CA-C-O 122.127 0.965 . . . . 72.219999999999999 108.741 176.083 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 80.3 -104.96 2.31 Favored Glycine 0 N--CA 1.413 -2.86 0 CA-C-N 114.678 -1.146 . . . . 74.549999999999997 110.765 179.822 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -119.92 1.2 10.94 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 121.158 0.504 . . . . 53.509999999999998 110.954 -176.786 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.416 ' HB2' ' O ' ' A' ' 53' ' ' ARG . 20.1 p90 -127.97 160.06 33.06 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 116.265 -0.425 . . . . 74.040000000000006 110.883 -178.114 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 11.1 ptp180 -129.59 139.16 51.55 Favored 'General case' 0 C--O 1.252 1.224 0 N-CA-C 114.818 1.414 . . . . 71.109999999999999 114.818 -169.517 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.454 ' HG ' ' HA ' ' A' ' 51' ' ' VAL . 8.2 mp -121.86 144.23 48.96 Favored 'General case' 0 N--CA 1.424 -1.747 0 CA-C-N 113.406 -1.724 . . . . 73.5 108.596 179.052 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 58.3 t -107.37 124.16 63.1 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.141 0 N-CA-C 106.907 -1.516 . . . . 73.409999999999997 106.907 179.433 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.401 ' CD2' ' HB3' ' A' ' 49' ' ' LEU . 6.4 t80 -100.33 130.33 46.42 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.92 -0.4 . . . . 75.439999999999998 109.92 -173.12 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -126.55 151.72 47.52 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 121.1 0.476 . . . . 70.420000000000002 109.774 -179.847 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -69.58 135.98 50.69 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.108 -1.441 . . . . 71.239999999999995 107.108 172.766 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.421 ' N ' ' HA ' ' A' ' 47' ' ' ALA . . . -82.98 -177.25 51.92 Favored Glycine 0 N--CA 1.439 -1.131 0 C-N-CA 120.102 -1.047 . . . . 54.329999999999998 112.603 -174.907 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -73.66 123.41 8.53 Favored 'Trans proline' 0 N--CA 1.439 -1.732 0 C-N-CA 122.204 1.936 . . . . 55.340000000000003 109.715 175.922 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -96.6 107.79 20.28 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 108.93 -0.767 . . . . 71.349999999999994 108.93 -178.715 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 . . . . . 0 C--N 1.292 -1.916 0 N-CA-C 107.465 -1.309 . . . . 72.129999999999995 107.465 -179.273 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.4 ppp? . . . . . 0 C--O 1.239 0.535 0 N-CA-C 111.7 0.259 . . . . 74.450000000000003 111.7 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.6 p -65.24 -40.05 93.52 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 121.35 0.595 . . . . 72.450000000000003 111.951 -177.937 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -135.16 146.56 48.87 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 115.416 -0.811 . . . . 75.040000000000006 110.702 -174.004 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -123.3 87.21 2.71 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 122.52 1.153 . . . . 75.340000000000003 110.197 178.018 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -112.75 119.62 38.68 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 114.779 -1.101 . . . . 64.129999999999995 110.751 -179.227 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 154.51 115.86 0.56 Allowed Glycine 0 C--N 1.294 -1.759 0 N-CA-C 109.849 -1.3 . . . . 72.439999999999998 109.849 -178.692 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.3 m -82.65 124.8 77.1 Favored Pre-proline 0 C--N 1.299 -1.626 0 N-CA-C 109.236 -0.653 . . . . 73.109999999999999 109.236 -179.024 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.17 128.05 28.17 Favored 'Trans proline' 0 C--N 1.36 1.159 0 C-N-CA 122.331 2.02 . . . . 73.329999999999998 109.718 175.852 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -75.4 120.27 80.88 Favored Pre-proline 0 C--N 1.308 -1.229 0 CA-C-N 116.063 -0.517 . . . . 65.219999999999999 111.992 -173.141 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -82.16 129.55 6.07 Favored 'Trans proline' 0 N--CA 1.443 -1.487 0 C-N-CA 122.238 1.959 . . . . 75.230000000000004 110.321 175.935 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -89.21 119.58 29.83 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.624 -0.88 . . . . 74.310000000000002 108.624 179.381 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.9 m -91.77 166.82 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 116.32 -0.4 . . . . 62.240000000000002 111.389 -175.586 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -96.49 141.13 30.14 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 108.823 -0.806 . . . . 75.209999999999994 108.823 176.119 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 50.3 m -120.06 102.33 8.46 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-O 121.301 0.572 . . . . 62.43 109.911 178.89 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.9 m -123.9 141.49 51.99 Favored 'General case' 0 N--CA 1.408 -2.545 0 N-CA-C 105.644 -1.984 . . . . 71.5 105.644 177.533 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.3 t -132.17 146.4 52.0 Favored 'General case' 0 C--N 1.271 -2.805 0 N-CA-C 108.709 -0.848 . . . . 44.200000000000003 108.709 -177.888 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.7 m -86.12 138.88 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-O 121.11 0.481 . . . . 72.150000000000006 110.092 179.707 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -86.81 154.62 20.77 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 109.212 -0.662 . . . . 75.209999999999994 109.212 178.408 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 31.4 mmm180 -90.97 110.4 21.66 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 109.242 -0.651 . . . . 74.310000000000002 109.242 179.174 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.54 95.07 8.19 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.495 0.664 . . . . 74.510000000000005 110.594 -178.876 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -82.2 -33.7 29.28 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.642 -0.874 . . . . 74.530000000000001 108.642 176.417 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 59.6 tp 62.84 90.66 0.08 Allowed 'General case' 0 CA--C 1.508 -0.656 0 CA-C-N 114.139 -1.391 . . . . 64.450000000000003 109.609 -176.94 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.5 mp -76.75 114.59 15.68 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.386 -0.824 . . . . 61.229999999999997 108.847 -179.336 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -72.85 158.99 34.45 Favored 'General case' 0 C--O 1.25 1.128 0 CA-C-N 115.98 -0.555 . . . . 71.239999999999995 111.792 -175.825 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.18 174.02 6.06 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.44 -0.8 . . . . 75.409999999999997 111.12 178.556 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 16.0 tpt -134.15 122.74 23.29 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.269 -0.641 . . . . 61.439999999999998 109.269 177.929 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.84 177.82 5.97 Favored 'General case' 0 C--O 1.256 1.439 0 CA-C-O 120.946 0.403 . . . . 74.239999999999995 111.017 -179.847 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.1 t -145.68 129.87 17.57 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 107.888 -1.153 . . . . 63.039999999999999 107.888 -179.896 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.0 t -70.93 134.57 47.33 Favored 'General case' 0 N--CA 1.434 -1.231 0 O-C-N 123.73 0.644 . . . . 51.399999999999999 109.528 -179.87 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.3 t -132.16 157.59 43.89 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 108.472 -0.936 . . . . 74.439999999999998 108.472 179.512 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -75.96 85.13 0.89 Allowed Glycine 0 N--CA 1.438 -1.218 0 N-CA-C 111.363 -0.695 . . . . 63.149999999999999 111.363 179.131 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.6 t -82.04 158.93 23.6 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 109.34 -0.615 . . . . 55.140000000000001 109.34 179.306 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -87.21 129.21 52.55 Favored Pre-proline 0 C--N 1.304 -1.394 0 N-CA-C 110.358 -0.238 . . . . 74.340000000000003 110.358 -178.294 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -72.74 157.26 52.31 Favored 'Trans proline' 0 C--O 1.238 0.51 0 C-N-CA 121.999 1.799 . . . . 75.319999999999993 110.291 176.79 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -72.25 109.42 5.98 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.126 0.489 . . . . 71.25 110.8 -178.56 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.5 t -83.98 158.77 21.4 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.89 -0.595 . . . . 61.149999999999999 109.602 179.211 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -75.52 164.02 26.78 Favored 'General case' 0 N--CA 1.418 -2.072 0 N-CA-C 109.001 -0.74 . . . . 61.119999999999997 109.001 173.037 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -134.38 108.04 0.7 Allowed Glycine 0 N--CA 1.419 -2.446 0 C-N-CA 120.716 -0.754 . . . . 65.319999999999993 111.615 -176.943 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.405 ' HB2' ' HG3' ' A' ' 66' ' ' PRO . . . -60.94 -40.52 93.58 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 121.508 0.67 . . . . 63.539999999999999 110.603 178.679 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -64.21 -14.68 57.0 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.955 -1.02 . . . . 60.149999999999999 113.199 -179.394 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -77.26 -27.25 53.14 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-N 116.839 -0.164 . . . . 73.150000000000006 111.161 179.673 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -86.14 113.93 54.57 Favored Pre-proline 0 N--CA 1.437 -1.105 0 N-CA-C 109.624 -0.509 . . . . 73.150000000000006 109.624 -179.24 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -76.89 -68.48 0.02 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 121.558 1.505 . . . . 71.400000000000006 109.753 177.61 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -132.99 98.33 4.26 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 109.134 -0.691 . . . . 52.130000000000003 109.134 176.77 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -142.85 39.39 1.34 Allowed Glycine 0 C--N 1.289 -2.058 0 N-CA-C 106.635 -2.586 . . . . 55.130000000000003 106.635 177.996 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.7 m -90.88 167.42 12.45 Favored 'General case' 0 N--CA 1.414 -2.226 0 CA-C-N 113.058 -1.571 . . . . 74.109999999999999 111.383 -171.549 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.66 157.4 44.93 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 106.775 -1.565 . . . . 75.299999999999997 106.775 176.394 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.4 pp -134.63 151.97 51.44 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 119.632 -0.827 . . . . 51.130000000000003 111.787 -178.822 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -126.79 136.76 52.82 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.734 -0.666 . . . . 71.430000000000007 109.565 -179.6 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.445 ' CG2' ' HB ' ' A' ' 136' ' ' VAL . 33.5 m -114.24 128.97 71.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 109.202 -0.666 . . . . 61.030000000000001 109.202 175.475 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.6 t -95.14 125.57 47.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 109.439 -0.578 . . . . 72.420000000000002 109.439 -177.2 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -96.66 -34.07 11.52 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.879 -0.6 . . . . 72.299999999999997 110.078 176.17 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.449 ' O ' ' HB3' ' A' ' 133' ' ' PHE . 30.9 tpt180 -165.46 121.51 1.37 Allowed 'General case' 0 CA--C 1.496 -1.133 0 N-CA-C 108.992 -0.744 . . . . 74.530000000000001 108.992 175.938 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -163.19 164.88 36.3 Favored Glycine 0 N--CA 1.415 -2.714 0 N-CA-C 108.218 -1.953 . . . . 53.119999999999997 108.218 177.353 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.483 ' HB2' ' HB3' ' A' ' 82' ' ' ASP . 14.3 Cg_exo -68.82 -20.81 39.05 Favored 'Trans proline' 0 C--O 1.238 0.518 0 C-N-CA 122.385 2.057 . . . . 60.100000000000001 111.397 179.997 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.419 ' HB3' ' CA ' ' A' ' 80' ' ' LEU . 21.8 p-10 -68.52 -59.34 3.22 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 114.761 -1.109 . . . . 72.030000000000001 112.387 -178.651 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -175.75 -153.52 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 108.18 -1.044 . . . . 73.200000000000003 108.18 -173.096 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.03 54.05 0.35 Allowed Glycine 0 N--CA 1.428 -1.888 0 N-CA-C 107.708 -2.157 . . . . 22.41 107.708 178.677 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -135.91 -167.41 2.03 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 108.52 -0.918 . . . . 62.229999999999997 108.52 -173.93 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 17.7 ptp180 -116.12 144.95 43.47 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 120.546 0.213 . . . . 62.399999999999999 110.502 -177.95 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -136.81 140.48 42.5 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 108.516 -0.92 . . . . 64.420000000000002 108.516 179.97 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.1 tt -117.97 136.29 53.6 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 109.072 -0.714 . . . . 74.340000000000003 109.072 177.979 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.441 HD12 HG21 ' A' ' 68' ' ' THR . 1.2 mm? -93.36 115.27 27.84 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.853 -0.425 . . . . 72.340000000000003 109.853 -178.889 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -109.6 13.41 23.89 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 122.439 1.114 . . . . 74.349999999999994 108.569 179.082 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -123.93 144.49 45.14 Favored Pre-proline 0 C--N 1.309 -1.172 0 CA-C-N 115.307 -0.861 . . . . 71.239999999999995 109.927 -177.628 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.557 ' HA ' ' CD1' ' A' ' 94' ' ' ILE . 10.1 Cg_endo -55.34 -54.98 3.5 Favored 'Trans proline' 0 C--N 1.358 1.037 0 C-N-CA 123.468 2.779 . . . . 73.430000000000007 113.851 -177.773 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 42.6 m -113.41 108.61 17.44 Favored 'General case' 0 N--CA 1.425 -1.676 0 N-CA-C 109.581 -0.525 . . . . 64.099999999999994 109.581 -178.718 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.441 HG21 HD12 ' A' ' 63' ' ' LEU . 24.8 m -103.23 114.16 28.22 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 108.982 -0.748 . . . . 60.5 108.982 175.899 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.6 p -98.51 115.25 28.16 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 121.794 0.806 . . . . 74.420000000000002 111.814 -179.555 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.63 134.87 41.89 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 106.901 -1.518 . . . . 70.400000000000006 106.901 175.685 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.418 ' HA3' ' HB3' ' A' ' 89' ' ' HIS . . . 82.57 73.56 1.22 Allowed Glycine 0 C--N 1.3 -1.436 0 C-N-CA 119.702 -1.237 . . . . 71.209999999999994 110.327 -175.183 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 56.9 ttt180 -158.35 106.61 1.95 Allowed 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 105.206 -2.146 . . . . 72.019999999999996 105.206 -178.472 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 19.0 m-70 -52.01 -68.37 0.42 Allowed Pre-proline 0 CA--C 1.55 0.959 0 N-CA-C 116.069 1.877 . . . . 61.030000000000001 116.069 -169.999 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -66.97 -40.15 12.51 Favored 'Trans proline' 0 C--N 1.359 1.093 0 C-N-CA 121.286 1.324 . . . . 73.200000000000003 114.101 -176.18 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -125.77 75.58 1.51 Allowed 'General case' 0 C--N 1.32 -0.675 0 O-C-N 122.293 -0.254 . . . . 72.349999999999994 110.521 -175.588 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 18.0 p -78.31 123.17 26.66 Favored 'General case' 0 C--N 1.28 -2.454 0 C-N-CA 119.11 -1.036 . . . . 73.239999999999995 109.093 176.391 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -67.09 -55.56 13.76 Favored 'General case' 0 CA--C 1.485 -1.537 0 N-CA-C 107.365 -1.346 . . . . 73.219999999999999 107.365 175.696 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 45.4 pt -125.67 148.0 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.847 0 CA-C-N 115.047 -0.979 . . . . 62.119999999999997 108.427 173.998 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -97.51 136.22 38.24 Favored 'General case' 0 C--N 1.276 -2.592 0 CA-C-N 115.321 -0.854 . . . . 75.200000000000003 108.929 177.151 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.419 ' CA ' ' HB3' ' A' ' 56' ' ' ASN . 58.1 tp -144.21 -88.62 0.12 Allowed 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.799 -0.815 . . . . 62.530000000000001 108.799 -175.158 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -76.34 96.93 4.1 Favored 'General case' 0 C--N 1.261 -3.242 0 N-CA-C 108.36 -0.978 . . . . 74.040000000000006 108.36 171.478 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.483 ' HB3' ' HB2' ' A' ' 55' ' ' PRO . 14.6 t70 -81.09 -54.96 5.09 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.269 -0.878 . . . . 54.340000000000003 110.206 -179.077 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.9 t -85.11 -39.91 14.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 CA-C-N 114.882 -1.054 . . . . 74.219999999999999 109.123 -178.994 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.6 p -87.47 32.78 0.7 Allowed 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 124.386 1.075 . . . . 60.439999999999998 111.395 -178.328 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.9 p -81.3 139.87 17.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 CA-C-N 115.171 -0.922 . . . . 70.430000000000007 112.137 -171.909 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 23.3 t -128.52 -176.86 3.95 Favored 'General case' 0 N--CA 1.424 -1.767 0 N-CA-C 107.625 -1.25 . . . . 74.230000000000004 107.625 175.88 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -100.77 120.41 40.07 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 123.446 0.699 . . . . 73.340000000000003 109.227 -177.94 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 88' ' ' ARG . 11.0 mmm180 64.49 32.92 11.42 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 108.419 -0.956 . . . . 62.409999999999997 108.419 -176.372 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.418 ' HB3' ' HA3' ' A' ' 71' ' ' GLY . 67.4 t60 -46.79 -66.45 0.4 Allowed 'General case' 0 C--O 1.241 0.641 0 C-N-CA 124.759 1.224 . . . . 75.219999999999999 112.429 -175.317 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.537 ' HA ' ' HA ' ' A' ' 103' ' ' ASP . . . -141.05 141.34 34.3 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 121.147 -0.221 . . . . 54.43 110.776 -178.129 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -116.32 127.75 54.96 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.33 0.586 . . . . 63.219999999999999 110.791 177.495 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.419 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 41.5 m-85 -105.11 112.64 25.84 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 105.611 -1.996 . . . . 72.409999999999997 105.611 174.302 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -124.38 150.09 45.94 Favored 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 120.49 -0.484 . . . . 73.209999999999994 109.742 -176.522 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.557 ' CD1' ' HA ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -116.95 139.1 45.32 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.063 0 C-N-CA 118.985 -1.086 . . . . 72.310000000000002 108.444 172.233 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -119.22 145.33 46.14 Favored 'General case' 0 C--N 1.27 -2.884 0 N-CA-C 105.793 -1.929 . . . . 74.540000000000006 105.793 176.696 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.94 -20.15 8.33 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 114.038 1.125 . . . . 44.439999999999998 114.038 -173.457 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -106.46 -31.95 3.84 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 119.953 -1.118 . . . . 73.109999999999999 114.16 177.789 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -145.33 147.34 32.21 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-N 117.65 0.725 . . . . 62.009999999999998 109.803 -175.026 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.456 ' HB2' ' HB3' ' A' ' 122' ' ' MET . 30.5 m-85 -94.9 129.88 41.73 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 106.974 -1.491 . . . . 52.229999999999997 106.974 176.4 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -132.3 129.26 39.32 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 119.535 -0.866 . . . . 74.439999999999998 111.76 -175.061 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 61.4 t -114.11 118.1 57.44 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 107.842 -1.17 . . . . 73.340000000000003 107.842 177.552 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 30.8 m -121.06 130.82 74.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 CA-C-N 115.934 -0.576 . . . . 72.120000000000005 109.991 178.9 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.537 ' HA ' ' HA ' ' A' ' 90' ' ' ALA . 0.7 OUTLIER -97.0 138.78 34.0 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 117.326 -1.75 . . . . 74.319999999999993 108.406 170.718 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.8 m -124.18 -2.46 6.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 112.183 0.438 . . . . 61.409999999999997 112.183 179.948 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -89.86 -44.9 4.69 Favored Glycine 0 CA--C 1.509 -0.319 0 N-CA-C 109.752 -1.339 . . . . 65.099999999999994 109.752 175.97 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 14.2 m 58.79 29.2 18.41 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 114.414 1.264 . . . . 72.200000000000003 114.414 174.013 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 49.3 tp -85.32 -48.21 9.28 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 120.109 -0.636 . . . . 72.209999999999994 112.541 -177.659 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -87.64 -19.45 27.71 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 119.448 -0.901 . . . . 62.140000000000001 111.315 -176.247 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 97.34 127.97 5.81 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 120.418 -0.896 . . . . 74.310000000000002 113.666 176.855 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.458 HG21 ' HB3' ' A' ' 103' ' ' ASP . 5.7 p -109.47 134.33 52.01 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 123.281 0.632 . . . . 71.129999999999995 111.335 -179.407 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.462 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 26.6 m-85 -138.78 147.47 42.63 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 107.583 -1.265 . . . . 74.340000000000003 107.583 178.435 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.416 HG11 HE21 ' A' ' 120' ' ' GLN . 12.6 p -123.19 125.81 72.52 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 N-CA-C 106.088 -1.819 . . . . 74.310000000000002 106.088 171.271 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 17.6 m120 62.93 22.15 13.28 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.068 0.547 . . . . 71.219999999999999 109.796 -175.952 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 40.8 mtp180 75.05 12.25 3.46 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.334 1.453 . . . . 73.299999999999997 112.396 -177.126 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -102.85 118.27 58.68 Favored Pre-proline 0 C--N 1.31 -1.115 0 N-CA-C 105.983 -1.858 . . . . 72.230000000000004 105.983 176.27 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -46.66 119.61 3.37 Favored 'Trans proline' 0 C--N 1.362 1.273 0 C-N-CA 123.767 2.978 . . . . 74.340000000000003 112.508 -178.122 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 12.0 tpt180 -153.25 118.91 5.3 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 109.936 -0.394 . . . . 73.310000000000002 109.936 -173.627 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -81.63 -38.76 25.47 Favored 'General case' 0 C--N 1.317 -0.839 0 O-C-N 123.521 0.513 . . . . 72.239999999999995 112.103 -179.085 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -125.4 139.46 53.64 Favored 'General case' 0 N--CA 1.437 -1.119 0 C-N-CA 120.444 -0.502 . . . . 73.439999999999998 110.171 -178.857 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.416 HE21 HG11 ' A' ' 112' ' ' VAL . 6.6 tp-100 -139.36 137.95 36.18 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 109.044 -0.725 . . . . 75.340000000000003 109.044 175.66 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.2 t -111.83 97.72 6.11 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 CA-C-N 115.404 -0.816 . . . . 73.209999999999994 108.91 -177.828 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.456 ' HB3' ' HB2' ' A' ' 99' ' ' PHE . 26.3 ptt? 41.5 98.11 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 127.118 2.167 . . . . 70.319999999999993 116.293 179.091 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.458 ' HG3' ' HB2' ' A' ' 126' ' ' ASP . 52.1 tp60 -121.69 122.34 39.36 Favored 'General case' 0 N--CA 1.385 -3.706 0 N-CA-C 101.28 -3.6 . . . . 64.310000000000002 101.28 174.52 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 14.9 t -110.29 127.74 55.17 Favored 'General case' 0 C--N 1.29 -2.003 0 C-N-CA 119.194 -1.003 . . . . 62.119999999999997 110.666 -172.404 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 87.62 16.9 59.35 Favored Glycine 0 N--CA 1.425 -2.077 0 N-CA-C 110.218 -1.153 . . . . 41.340000000000003 110.218 -178.334 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.458 ' HB2' ' HG3' ' A' ' 123' ' ' GLN . 6.1 m-20 -112.61 162.15 16.01 Favored 'General case' 0 CA--C 1.484 -1.589 0 N-CA-C 112.527 0.565 . . . . 72.219999999999999 112.527 -179.68 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -107.58 122.58 46.96 Favored 'General case' 0 N--CA 1.421 -1.878 0 CA-C-N 114.761 -1.109 . . . . 63.43 111.049 -172.148 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 68.7 mt -101.37 129.87 51.79 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 N-CA-C 106.967 -1.494 . . . . 62.509999999999998 106.967 176.499 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.462 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 34.6 tt0 -110.76 125.46 53.56 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 109.2 -0.667 . . . . 72.439999999999998 109.2 -179.659 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.505 HD13 ' H ' ' A' ' 130' ' ' ILE . 0.2 OUTLIER -112.5 109.87 30.13 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 N-CA-C 108.6 -0.889 . . . . 74.420000000000002 108.6 177.667 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 71.21 -82.37 0.45 Allowed Glycine 0 C--N 1.308 -0.991 0 CA-C-N 115.735 -0.666 . . . . 41.109999999999999 112.094 -176.995 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -146.14 8.16 1.07 Allowed 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.771 -0.826 . . . . 73.200000000000003 108.771 179.118 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.449 ' HB3' ' O ' ' A' ' 53' ' ' ARG . 35.4 m-85 -104.7 150.83 24.39 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.781 -0.822 . . . . 62.350000000000001 108.781 -175.429 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.34 130.74 55.51 Favored 'General case' 0 C--O 1.258 1.505 0 C-N-CA 119.05 -1.06 . . . . 74.140000000000001 112.931 -177.701 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.7 tt -123.79 137.99 54.58 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 125.808 1.643 . . . . 65.329999999999998 107.287 -177.245 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.445 ' HB ' ' CG2' ' A' ' 50' ' ' VAL . 60.8 t -108.81 127.15 65.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 108.677 -0.86 . . . . 51.0 108.677 177.021 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -102.47 130.4 49.27 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 116.209 -0.45 . . . . 65.409999999999997 110.558 -175.071 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -125.34 148.94 48.53 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 109.239 -0.652 . . . . 71.420000000000002 109.239 178.843 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -81.33 135.23 35.68 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.433 -0.951 . . . . 73.140000000000001 108.433 176.739 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.49 153.71 52.66 Favored Glycine 0 N--CA 1.437 -1.281 0 C-N-CA 120.933 -0.651 . . . . 74.209999999999994 111.518 -178.03 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -68.01 137.56 41.43 Favored 'Trans proline' 0 N--CA 1.445 -1.336 0 C-N-CA 122.401 2.068 . . . . 45.119999999999997 113.002 -177.809 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -82.47 103.64 12.17 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 107.478 -1.304 . . . . 71.040000000000006 107.478 176.934 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 . . . . . 0 C--N 1.284 -2.269 0 N-CA-C 107.273 -1.381 . . . . 71.200000000000003 107.273 -175.771 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.0 mtp . . . . . 0 C--O 1.241 0.64 0 CA-C-O 120.755 0.312 . . . . 53.409999999999997 110.429 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.0 p -73.45 -49.53 26.38 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-N 116.484 -0.325 . . . . 71.319999999999993 110.264 -178.333 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 44.22 71.74 0.23 Allowed 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.958 1.303 . . . . 74.25 112.38 -179.806 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 49.7 t-20 -117.9 119.77 35.86 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 107.245 -1.391 . . . . 53.140000000000001 107.245 -179.803 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -94.38 112.08 23.85 Favored 'General case' 0 C--N 1.286 -2.152 0 N-CA-C 109.16 -0.682 . . . . 60.210000000000001 109.16 -177.131 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.85 123.97 8.07 Favored Glycine 0 N--CA 1.435 -1.424 0 N-CA-C 110.905 -0.878 . . . . 73.310000000000002 110.905 -178.966 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.0 p -94.42 126.13 49.29 Favored Pre-proline 0 C--N 1.299 -1.606 0 CA-C-N 116.687 0.244 . . . . 44.219999999999999 111.2 -179.099 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.493 ' O ' ' HD3' ' A' ' 10' ' ' PRO . 24.1 Cg_exo -65.39 129.76 23.49 Favored 'Trans proline' 0 C--O 1.245 0.83 0 C-N-CA 121.954 1.769 . . . . 73.549999999999997 110.309 175.748 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -103.64 95.8 7.92 Favored Pre-proline 0 C--N 1.315 -0.933 0 N-CA-C 108.23 -1.026 . . . . 71.200000000000003 108.23 178.672 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.493 ' HD3' ' O ' ' A' ' 8' ' ' PRO . 90.9 Cg_endo -92.8 179.14 1.23 Allowed 'Trans proline' 0 N--CA 1.445 -1.366 0 C-N-CA 122.823 2.349 . . . . 51.43 113.298 -174.469 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 67.96 84.79 0.15 Allowed 'General case' 0 CA--C 1.509 -0.621 0 C-N-CA 125.285 1.434 . . . . 71.019999999999996 112.14 -179.159 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 24.5 t -113.62 78.03 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 108.503 -0.925 . . . . 74.409999999999997 108.503 178.543 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -140.01 131.23 26.57 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.057 -1.09 . . . . 75.310000000000002 108.057 177.816 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.0 m -143.98 76.67 1.52 Allowed 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 106.551 -1.648 . . . . 73.099999999999994 106.551 172.93 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.1 m -99.59 90.33 4.45 Favored 'General case' 0 N--CA 1.413 -2.299 0 CA-C-N 115.406 -0.815 . . . . 74.040000000000006 110.013 -177.907 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.7 m -125.02 70.31 1.15 Allowed 'General case' 0 N--CA 1.415 -2.194 0 N-CA-C 107.148 -1.427 . . . . 71.340000000000003 107.148 175.698 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.8 m -104.13 152.57 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 CA-C-N 114.876 -1.056 . . . . 65.109999999999999 109.575 -176.966 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 59.25 74.29 0.45 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.713 1.258 . . . . 71.299999999999997 109.649 -176.849 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 15.9 mtm-85 -107.42 142.29 37.48 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.196 -1.038 . . . . 61.219999999999999 108.196 -176.908 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -90.89 79.46 5.91 Favored 'General case' 0 N--CA 1.416 -2.156 0 N-CA-C 107.686 -1.228 . . . . 72.409999999999997 107.686 173.912 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -59.57 -50.55 73.46 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-N 115.191 -0.913 . . . . 62.030000000000001 109.073 -179.793 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 62.8 tp -145.53 119.92 9.64 Favored 'General case' 0 N--CA 1.427 -1.597 0 N-CA-C 107.898 -1.149 . . . . 72.239999999999995 107.898 174.629 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.8 tt -109.62 98.85 8.14 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 106.361 -1.718 . . . . 61.219999999999999 106.361 175.991 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -140.64 88.83 2.22 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.801 -1.185 . . . . 65.200000000000003 107.801 179.878 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -78.03 145.4 35.93 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 114.826 -1.079 . . . . 64.450000000000003 111.973 -175.648 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -69.3 125.15 25.8 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 114.874 -1.057 . . . . 75.420000000000002 108.483 177.749 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -116.39 -68.66 0.9 Allowed 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.787 -1.19 . . . . 64.200000000000003 107.787 -178.225 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 49.9 m -101.52 93.93 5.63 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 108.941 -0.763 . . . . 75.299999999999997 108.941 177.187 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.9 p -82.14 -23.64 35.5 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 121.441 0.639 . . . . 44.409999999999997 110.707 -179.671 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.3 m -104.81 168.31 9.15 Favored 'General case' 0 N--CA 1.425 -1.71 0 N-CA-C 107.357 -1.349 . . . . 75.329999999999998 107.357 179.558 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -87.21 67.49 3.33 Favored Glycine 0 C--N 1.315 -0.588 0 C-N-CA 120.972 -0.633 . . . . 60.409999999999997 112.149 -178.237 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.0 p -91.72 147.61 22.86 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 122.405 0.282 . . . . 61.130000000000003 111.047 179.402 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.69 120.7 78.47 Favored Pre-proline 0 C--N 1.31 -1.112 0 N-CA-C 108.712 -0.847 . . . . 64.010000000000005 108.712 177.648 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -74.82 127.42 10.8 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 122.232 1.955 . . . . 62.5 112.713 -177.59 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -140.0 79.15 1.7 Allowed 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.617 -0.883 . . . . 55.310000000000002 108.617 176.856 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.6 m -148.19 162.25 39.82 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.823 -0.806 . . . . 55.109999999999999 108.823 -178.533 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.2 t -129.22 162.41 27.91 Favored 'General case' 0 N--CA 1.421 -1.896 0 CA-C-O 120.861 0.362 . . . . 71.519999999999996 110.114 -179.957 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -156.99 33.21 0.56 Allowed Glycine 0 N--CA 1.433 -1.517 0 N-CA-C 109.92 -1.272 . . . . 72.239999999999995 109.92 179.436 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.94 -22.82 65.92 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 123.235 0.614 . . . . 64.010000000000005 111.285 -176.852 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -84.53 -27.03 27.64 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.992 -0.549 . . . . 71.409999999999997 110.351 175.725 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 29.7 t-20 -81.13 -43.1 19.9 Favored 'General case' 0 CA--C 1.504 -0.806 0 CA-C-N 116.046 -0.525 . . . . 53.210000000000001 110.21 -175.314 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -89.06 144.31 32.5 Favored Pre-proline 0 N--CA 1.427 -1.578 0 N-CA-C 107.659 -1.237 . . . . 71.299999999999997 107.659 175.749 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -60.39 108.55 0.53 Allowed 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 121.827 1.685 . . . . 63.310000000000002 109.856 175.468 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.89 141.93 54.53 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.149 -0.932 . . . . 74.230000000000004 113.051 -175.587 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -155.35 67.69 0.3 Allowed Glycine 0 N--CA 1.433 -1.504 0 N-CA-C 108.132 -1.987 . . . . 70.120000000000005 108.132 177.812 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.568 ' O ' ' HA ' ' A' ' 141' ' ' PRO . 16.3 m -90.7 162.05 15.09 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 115.1 -0.55 . . . . 54.32 111.166 -173.993 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -136.77 177.6 7.73 Favored 'General case' 0 C--O 1.253 1.278 0 N-CA-C 107.816 -1.179 . . . . 64.219999999999999 107.816 176.482 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.447 ' H ' HD23 ' A' ' 48' ' ' LEU . 2.1 pt? -118.54 146.67 44.38 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 120.171 -0.612 . . . . 71.340000000000003 112.536 -172.471 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.425 HD23 ' H ' ' A' ' 49' ' ' LEU . 1.4 pt? -124.38 132.95 53.54 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.161 -1.051 . . . . 74.329999999999998 108.161 177.501 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 26.0 t -125.9 144.75 34.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 108.849 -0.797 . . . . 74.420000000000002 108.849 -176.823 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.423 HG21 ' HB3' ' A' ' 57' ' ' ALA . 57.7 t -92.46 127.73 44.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 108.624 -0.88 . . . . 42.420000000000002 108.624 179.795 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -94.45 -38.33 10.99 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.655 -0.702 . . . . 64.349999999999994 110.142 -179.604 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 5.5 tpm_? -160.51 114.14 2.11 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.625 -0.716 . . . . 75.319999999999993 110.125 -175.094 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 158.32 125.64 0.84 Allowed Glycine 0 N--CA 1.426 -1.968 0 O-C-N 124.106 0.879 . . . . 73.099999999999994 111.189 176.845 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.569 ' HD2' ' CZ ' ' A' ' 133' ' ' PHE . 50.4 Cg_exo -59.76 -10.63 12.32 Favored 'Trans proline' 0 N--CA 1.489 1.261 0 C-N-CA 123.291 2.661 . . . . 71.549999999999997 113.646 177.599 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.595 ' HB2' ' HA ' ' A' ' 80' ' ' LEU . 4.3 p-10 -52.44 -36.41 54.48 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.297 1.039 . . . . 73.230000000000004 110.046 179.59 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.423 ' HB3' HG21 ' A' ' 51' ' ' VAL . . . -171.93 -162.28 0.21 Allowed 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.513 1.125 . . . . 62.130000000000003 108.123 -179.681 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 172.58 62.64 0.05 OUTLIER Glycine 0 CA--C 1.491 -1.408 0 N-CA-C 110.205 -1.158 . . . . 65.209999999999994 110.205 -179.266 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -163.53 -176.4 4.68 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 107.329 -1.36 . . . . 75.049999999999997 107.329 -176.762 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -103.54 136.06 43.97 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 124.013 0.821 . . . . 74.439999999999998 109.374 176.687 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -121.76 149.93 42.59 Favored 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 108.664 -0.865 . . . . 74.409999999999997 108.664 178.161 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 38.6 tp -114.55 135.81 53.71 Favored 'General case' 0 C--N 1.285 -2.212 0 N-CA-C 106.294 -1.743 . . . . 74.099999999999994 106.294 178.122 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 94.7 mt -79.73 112.94 17.49 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 118.519 -1.272 . . . . 53.210000000000001 109.575 179.064 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -121.02 -0.59 9.99 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-O 121.58 0.705 . . . . 70.230000000000004 109.397 178.973 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -115.63 138.71 24.02 Favored Pre-proline 0 C--N 1.303 -1.431 0 N-CA-C 108.532 -0.914 . . . . 74.319999999999993 108.532 -177.693 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -63.33 -30.92 73.57 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.367 2.044 . . . . 74.329999999999998 112.055 -179.801 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 40.9 m -136.73 114.92 11.6 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 109.892 -0.41 . . . . 62.229999999999997 109.892 177.571 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 24.7 m -110.66 114.11 27.25 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 109.029 -0.73 . . . . 63.119999999999997 109.029 179.318 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 49.4 p -93.27 124.85 37.54 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.118 0.485 . . . . 70.140000000000001 111.633 -179.384 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -109.15 126.45 53.25 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 109.1 -0.704 . . . . 64.349999999999994 109.1 176.498 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -173.94 -171.92 38.78 Favored Glycine 0 N--CA 1.43 -1.706 0 C-N-CA 120.377 -0.916 . . . . 61.439999999999998 111.323 178.538 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -109.69 88.04 2.65 Favored 'General case' 0 N--CA 1.423 -1.777 0 N-CA-C 107.294 -1.373 . . . . 63.329999999999998 107.294 179.467 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 34.6 t60 -164.18 133.19 2.86 Favored Pre-proline 0 C--N 1.279 -2.476 0 N-CA-C 105.185 -2.154 . . . . 72.329999999999998 105.185 -179.872 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -51.06 -37.06 56.72 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 123.16 2.573 . . . . 61.109999999999999 112.933 -178.917 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -102.07 70.13 1.19 Allowed 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 122.569 1.176 . . . . 65.420000000000002 111.828 179.298 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 31.1 m -126.25 169.28 13.04 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 113.29 -1.777 . . . . 53.140000000000001 106.673 174.582 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -79.38 -38.53 34.7 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 119.872 -0.731 . . . . 53.439999999999998 110.579 -178.29 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 39.0 pt -136.73 171.06 17.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 108.591 -0.892 . . . . 52.310000000000002 108.591 173.125 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.53 ' O ' ' HB2' ' A' ' 56' ' ' ASN . 98.0 m-85 -105.25 137.23 43.37 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 112.448 0.536 . . . . 72.200000000000003 112.448 -175.807 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.595 ' HA ' ' HB2' ' A' ' 56' ' ' ASN . 1.7 tt -146.96 104.8 3.73 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 104.658 -2.349 . . . . 64.129999999999995 104.658 177.16 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -115.78 13.5 16.15 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 114.378 1.251 . . . . 64.120000000000005 114.378 -171.252 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.517 ' OD2' ' HB ' ' A' ' 85' ' ' VAL 0.292 3.1 p30 -31.76 -88.72 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.378 0 N-CA-C 115.785 1.772 . . . . 71.239999999999995 115.785 -174.744 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.428 ' H ' ' CG ' ' A' ' 82' ' ' ASP . 7.5 p -163.99 -46.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 C-N-CA 123.13 0.572 . . . . 70.299999999999997 110.732 178.25 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.407 ' HB ' ' CG ' ' A' ' 108' ' ' ASN . 18.0 m -110.12 27.41 9.64 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 123.337 1.541 . . . . 63.109999999999999 109.007 -177.41 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.517 ' HB ' ' OD2' ' A' ' 82' ' ' ASP . 6.3 p -82.25 138.96 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.935 0 CA-C-N 113.48 -1.691 . . . . 72.439999999999998 109.177 178.333 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 20.2 m -87.59 178.01 6.9 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 115.629 -0.714 . . . . 74.200000000000003 110.186 -179.318 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 45.5 mtm180 -64.84 -46.1 83.31 Favored 'General case' 0 C--O 1.221 -0.414 0 N-CA-C 109.964 -0.384 . . . . 72.140000000000001 109.964 178.095 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.56 112.12 17.08 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 104.985 -2.228 . . . . 74.040000000000006 104.985 163.774 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.411 ' CE1' ' HA3' ' A' ' 105' ' ' GLY . 27.2 t60 -104.64 -54.8 2.45 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 115.483 -0.781 . . . . 73.109999999999999 110.916 -170.702 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -120.01 129.67 54.37 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 108.827 -0.805 . . . . 73.200000000000003 108.827 -178.808 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -106.49 127.0 52.96 Favored 'General case' 0 C--N 1.287 -2.142 0 C-N-CA 120.159 -0.616 . . . . 71.209999999999994 109.987 178.478 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -106.94 113.07 26.33 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 106.355 -1.72 . . . . 74.519999999999996 106.355 176.784 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -128.92 150.97 50.14 Favored 'General case' 0 C--N 1.282 -2.35 0 C-N-CA 119.658 -0.817 . . . . 75.420000000000002 111.963 -176.578 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.452 HD13 ' CD2' ' A' ' 99' ' ' PHE . 4.0 tp -115.62 120.14 63.88 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 CA-C-N 114.919 -1.037 . . . . 75.150000000000006 109.252 -179.828 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -101.24 146.72 27.16 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 107.266 -1.383 . . . . 52.32 107.266 178.409 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.41 -14.21 7.16 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.436 0.532 . . . . 74.200000000000003 112.436 179.866 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -86.29 -64.85 1.44 Allowed Glycine 0 N--CA 1.42 -2.414 0 N-CA-C 110.95 -0.86 . . . . 75.129999999999995 110.95 171.427 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -146.45 177.89 8.69 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 117.306 0.553 . . . . 72.430000000000007 111.348 -175.15 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.452 ' CD2' HD13 ' A' ' 94' ' ' ILE . 89.7 m-85 -90.93 130.59 36.85 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.724 -1.213 . . . . 72.239999999999995 107.724 176.693 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -132.29 135.29 46.12 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 120.53 -0.468 . . . . 71.340000000000003 110.78 -176.63 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 5.0 p -120.91 119.69 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.095 0 CA-C-O 121.599 0.714 . . . . 71.219999999999999 109.765 179.671 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 30.5 m -119.35 128.26 75.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-N 115.228 -0.896 . . . . 73.120000000000005 111.004 -178.089 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -91.73 132.45 36.38 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 115.682 -0.69 . . . . 74.420000000000002 109.754 176.153 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 26.8 m -115.02 11.52 7.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 CA-C-O 121.274 0.559 . . . . 64.340000000000003 110.781 175.096 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.411 ' HA3' ' CE1' ' A' ' 89' ' ' HIS . . . -122.99 56.09 0.67 Allowed Glycine 0 C--O 1.247 0.928 0 N-CA-C 109.651 -1.38 . . . . 52.329999999999998 109.651 179.17 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 12.5 m -68.9 -8.56 45.29 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 113.288 0.847 . . . . 72.530000000000001 113.288 -171.773 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.6 tt -71.31 -37.78 71.78 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 107.551 -1.278 . . . . 74.409999999999997 107.551 176.829 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.407 ' CG ' ' HB ' ' A' ' 84' ' ' THR . 59.5 t30 -84.97 -42.31 15.04 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.527 -1.286 . . . . 72.409999999999997 107.527 176.746 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 88.38 122.73 1.94 Allowed Glycine 0 N--CA 1.439 -1.16 0 CA-C-N 114.971 -1.013 . . . . 64.420000000000002 114.965 174.35 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 31.5 m -100.85 140.33 35.3 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.066 -1.087 . . . . 64.129999999999995 108.066 172.781 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -127.41 168.41 14.89 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.732 0.777 . . . . 74.209999999999994 111.186 -174.69 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 13.7 p -122.81 143.66 34.94 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 N-CA-C 105.846 -1.909 . . . . 75.129999999999995 105.846 174.173 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -19.05 90.91 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 126.322 1.849 . . . . 74.299999999999997 113.874 -176.944 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 67.04 2.1 2.6 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 127.982 2.513 . . . . 61.229999999999997 115.392 175.209 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -124.86 142.31 40.61 Favored Pre-proline 0 C--N 1.312 -1.044 0 O-C-N 121.45 -0.781 . . . . 75.140000000000001 112.169 -178.822 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -79.04 98.91 1.22 Allowed 'Trans proline' 0 C--O 1.246 0.899 0 C-N-CA 122.766 2.311 . . . . 75.439999999999998 114.493 -175.998 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 65.5 mtp180 -140.2 119.91 13.35 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.417 -0.957 . . . . 74.200000000000003 108.417 174.3 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -85.92 -23.31 27.03 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 124.103 0.877 . . . . 72.299999999999997 109.92 -175.688 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -125.1 138.36 54.17 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 107.183 -1.414 . . . . 61.310000000000002 107.183 174.177 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -141.47 149.84 41.46 Favored 'General case' 0 C--N 1.288 -2.072 0 CA-C-N 116.045 -0.525 . . . . 72.0 110.899 -177.119 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.3 p -85.66 122.66 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.684 0 N-CA-C 103.372 -2.825 . . . . 62.5 103.372 170.187 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.43 ' HG2' ' CD2' ' A' ' 137' ' ' PHE . 12.3 ttt -65.69 113.3 4.17 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.426 0.631 . . . . 71.540000000000006 109.923 -168.806 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -103.64 133.92 47.84 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 115.148 -0.933 . . . . 74.329999999999998 109.944 -171.252 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.439 ' HB ' ' HB2' ' A' ' 139' ' ' ALA . 41.1 p -83.15 129.54 35.03 Favored 'General case' 0 N--CA 1.412 -2.336 0 CA-C-N 115.463 -0.789 . . . . 70.319999999999993 110.53 -177.732 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 107.75 -9.55 37.6 Favored Glycine 0 N--CA 1.416 -2.674 0 CA-C-N 115.689 -0.687 . . . . 74.129999999999995 111.654 177.239 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -116.26 176.18 5.22 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 118.504 -1.278 . . . . 70.310000000000002 112.592 -175.82 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -109.16 128.22 54.84 Favored 'General case' 0 N--CA 1.428 -1.575 0 C-N-CA 125.318 1.447 . . . . 73.140000000000001 110.348 -174.521 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 68.6 mt -115.97 130.3 70.91 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 N-CA-C 107.194 -1.409 . . . . 75.129999999999995 107.194 179.253 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -104.29 111.5 24.16 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 119.945 -0.702 . . . . 74.209999999999994 109.833 -177.682 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.8 pp -95.17 113.71 30.16 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 CA-C-N 115.567 -0.742 . . . . 65.400000000000006 110.812 179.68 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 72.28 -89.25 0.51 Allowed Glycine 0 N--CA 1.437 -1.262 0 N-CA-C 109.648 -1.381 . . . . 53.299999999999997 109.648 -174.033 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -142.3 3.8 1.56 Allowed 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 109.435 -0.58 . . . . 71.329999999999998 109.435 177.128 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.569 ' CZ ' ' HD2' ' A' ' 55' ' ' PRO . 21.7 m-85 -102.52 150.37 23.46 Favored 'General case' 0 CA--C 1.513 -0.47 0 O-C-N 122.026 -0.422 . . . . 74.310000000000002 110.42 -176.807 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -104.6 122.93 46.64 Favored 'General case' 0 C--O 1.252 1.231 0 CA-C-O 121.505 0.669 . . . . 72.430000000000007 112.331 -174.219 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 31.1 tp -117.78 138.47 52.03 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 114.546 -1.207 . . . . 71.5 107.828 179.729 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 10.2 p -115.08 138.75 44.37 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 N-CA-C 108.683 -0.858 . . . . 71.019999999999996 108.683 177.639 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.43 ' CD2' ' HG2' ' A' ' 122' ' ' MET . 42.3 t80 -114.5 123.4 49.29 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.776 -0.824 . . . . 73.230000000000004 108.776 -177.937 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -114.62 148.24 38.38 Favored 'General case' 0 C--O 1.253 1.259 0 CA-C-O 121.111 0.481 . . . . 72.219999999999999 111.549 -175.649 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.439 ' HB2' ' HB ' ' A' ' 124' ' ' THR . . . -85.18 99.31 11.0 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-N 115.491 -0.777 . . . . 73.129999999999995 109.731 177.768 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -140.09 77.17 0.32 Allowed Glycine 0 C--N 1.281 -2.526 0 N-CA-C 107.817 -2.113 . . . . 74.549999999999997 107.817 175.002 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.568 ' HA ' ' O ' ' A' ' 46' ' ' SER . 14.9 Cg_endo -59.13 113.56 1.64 Allowed 'Trans proline' 0 CA--C 1.498 -1.323 0 C-N-CA 122.674 2.249 . . . . 54.119999999999997 113.799 -173.759 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.407 ' HB3' ' HB2' ' A' ' 46' ' ' SER . . . -103.51 104.59 14.68 Favored 'General case' 0 C--N 1.269 -2.895 0 CA-C-N 113.616 -1.629 . . . . 70.140000000000001 108.706 -179.981 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 . . . . . 0 N--CA 1.402 -2.87 0 N-CA-C 107.019 -1.475 . . . . 71.329999999999998 107.019 -179.944 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.1 mtt . . . . . 0 N--CA 1.469 0.497 0 N-CA-C 109.478 -0.564 . . . . 73.430000000000007 109.478 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.4 m -76.66 -28.74 56.1 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 107.66 -1.237 . . . . 65.010000000000005 107.66 173.983 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -82.15 142.03 32.57 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 113.669 -1.605 . . . . 75.109999999999999 107.747 174.946 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -169.48 167.37 9.9 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.623 -0.51 . . . . 74.329999999999998 109.623 176.927 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -163.3 128.94 3.14 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.292 -1.003 . . . . 71.329999999999998 108.292 176.075 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -92.02 156.5 23.67 Favored Glycine 0 N--CA 1.427 -1.92 0 C-N-CA 120.619 -0.8 . . . . 53.530000000000001 111.435 179.94 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.0 m -82.7 129.71 61.24 Favored Pre-proline 0 C--N 1.294 -1.823 0 N-CA-C 109.106 -0.702 . . . . 70.230000000000004 109.106 179.131 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -66.61 127.9 18.07 Favored 'Trans proline' 0 N--CA 1.447 -1.233 0 C-N-CA 121.553 1.502 . . . . 75.420000000000002 109.321 173.295 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -83.34 136.73 42.79 Favored Pre-proline 0 C--N 1.295 -1.794 0 N-CA-C 108.524 -0.917 . . . . 75.219999999999999 108.524 179.132 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_exo -70.41 116.02 4.44 Favored 'Trans proline' 0 N--CA 1.441 -1.578 0 C-N-CA 121.426 1.417 . . . . 72.030000000000001 109.611 176.209 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 25.7 mp0 -66.96 124.22 22.4 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.429 -0.952 . . . . 70.510000000000005 108.429 179.128 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.6 m -53.36 126.51 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 O-C-N 124.279 0.987 . . . . 72.340000000000003 110.526 -178.621 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -70.23 139.37 52.23 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-N 115.539 -0.755 . . . . 53.32 110.826 -177.147 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 64.4 m -144.56 138.88 27.8 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 107.881 -1.155 . . . . 60.229999999999997 107.881 179.162 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 21.1 m -116.56 126.83 53.86 Favored 'General case' 0 N--CA 1.414 -2.243 0 N-CA-C 108.771 -0.826 . . . . 71.140000000000001 108.771 -177.025 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.4 t -60.88 -54.13 48.86 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 121.811 0.815 . . . . 72.010000000000005 110.036 179.696 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.9 m -141.5 133.3 28.09 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.906 0 CA-C-N 113.982 -1.463 . . . . 71.040000000000006 109.964 177.927 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -72.73 112.51 8.84 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 108.24 -1.022 . . . . 75.219999999999999 108.24 175.105 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 52.2 mtt180 -102.54 110.08 21.91 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 115.496 -0.775 . . . . 75.129999999999995 109.396 -177.9 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.49 67.26 7.58 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 121.181 0.515 . . . . 51.240000000000002 109.8 178.315 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -65.61 -43.94 88.06 Favored 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 108.723 -0.843 . . . . 72.340000000000003 108.723 177.721 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 94.2 mt 55.06 47.36 22.16 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 124.35 1.031 . . . . 54.25 112.235 171.623 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -96.56 104.74 16.75 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.665 -1.235 . . . . 53.039999999999999 107.665 179.725 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.511 ' HD3' ' H ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -101.73 135.86 42.55 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.833 -0.803 . . . . 73.129999999999995 108.833 178.709 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -107.27 151.44 25.46 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-O 121.074 0.464 . . . . 74.430000000000007 110.866 -179.944 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 21.5 ptp -150.98 136.42 17.8 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 106.422 -1.695 . . . . 64.310000000000002 106.422 176.122 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -72.86 87.44 1.3 Allowed 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 122.165 0.983 . . . . 72.439999999999998 112.586 -178.491 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.9 t -116.44 122.54 45.07 Favored 'General case' 0 N--CA 1.419 -1.996 0 CA-C-N 114.121 -1.4 . . . . 74.0 108.835 -177.074 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.6 t -118.83 103.52 9.7 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.566 -1.272 . . . . 74.129999999999995 107.566 177.455 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 24.4 p -101.7 111.9 24.3 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.833 -0.621 . . . . 74.319999999999993 110.505 -177.376 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -117.06 114.9 3.11 Favored Glycine 0 N--CA 1.43 -1.766 0 C-N-CA 120.724 -0.75 . . . . 61.149999999999999 111.341 -179.701 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 14.4 t -111.1 163.09 14.23 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.01 -1.107 . . . . 71.099999999999994 108.01 178.61 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -85.14 118.15 70.24 Favored Pre-proline 0 C--N 1.307 -1.247 0 N-CA-C 110.272 -0.27 . . . . 71.120000000000005 110.272 -179.589 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -73.93 145.33 35.77 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.287 1.991 . . . . 54.25 111.584 -179.569 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -90.24 87.99 7.05 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 121.352 0.596 . . . . 74.200000000000003 109.743 178.965 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.9 m -97.74 18.96 14.48 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 121.971 0.891 . . . . 73.319999999999993 110.031 179.889 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.9 p -93.83 152.77 18.67 Favored 'General case' 0 N--CA 1.419 -2.008 0 CA-C-N 114.884 -1.053 . . . . 62.32 110.394 179.739 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 115.17 -9.21 20.67 Favored Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.673 -0.775 . . . . 70.019999999999996 112.253 179.705 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.95 -28.64 60.66 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.323 0.582 . . . . 74.150000000000006 110.126 179.309 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -64.05 -11.59 30.91 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.835 0.854 . . . . 75.349999999999994 112.355 178.725 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -75.5 -13.89 60.39 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 112.959 0.725 . . . . 74.109999999999999 112.959 -179.238 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.9 pp -59.57 149.78 69.11 Favored Pre-proline 0 CA--C 1.551 0.989 0 N-CA-C 111.719 0.266 . . . . 64.319999999999993 111.719 179.649 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -67.68 -75.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.156 1.904 . . . . 75.319999999999993 112.504 179.667 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -171.03 167.68 7.15 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 108.751 -0.833 . . . . 71.299999999999997 108.751 179.728 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 138.15 59.14 0.05 OUTLIER Glycine 0 CA--C 1.494 -1.272 0 N-CA-C 109.718 -1.353 . . . . 64.310000000000002 109.718 -178.553 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.1 m -91.19 163.57 14.21 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 121.711 0.767 . . . . 63.32 112.327 -173.746 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.587 ' HA ' ' N ' ' A' ' 140' ' ' GLY . . . -126.71 165.95 18.29 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 106.981 -1.489 . . . . 71.239999999999995 106.981 176.625 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.1 pp -129.91 150.66 51.1 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 113.087 0.773 . . . . 74.209999999999994 113.087 -173.83 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.512 HD11 ' CE1' ' A' ' 61' ' ' PHE . 4.4 pp -119.46 147.73 44.07 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.614 -0.721 . . . . 71.0 109.774 178.044 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.9 t -124.87 125.58 69.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 107.745 -1.205 . . . . 74.329999999999998 107.745 179.221 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.0 t -93.02 118.1 37.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 108.394 -0.965 . . . . 74.040000000000006 108.394 178.632 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -83.77 -34.12 24.86 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.354 0.597 . . . . 73.319999999999993 110.02 -178.428 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -155.55 125.94 6.76 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.269 -0.878 . . . . 74.519999999999996 108.783 176.283 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 155.44 109.52 0.32 Allowed Glycine 0 N--CA 1.415 -2.727 0 N-CA-C 111.649 -0.58 . . . . 74.200000000000003 111.649 -179.545 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -58.5 -8.58 5.6 Favored 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 124.47 3.446 . . . . 61.140000000000001 112.808 177.997 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 50.5 m-20 -52.34 -37.28 55.59 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.213 1.405 . . . . 71.420000000000002 109.229 174.306 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -159.97 -63.45 0.07 Allowed 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.659 -0.701 . . . . 53.340000000000003 109.873 -179.872 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.89 34.27 59.21 Favored Glycine 0 C--O 1.223 -0.553 0 CA-C-N 115.981 -0.554 . . . . 74.420000000000002 111.93 -179.861 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -149.42 -173.86 4.51 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 108.15 -1.056 . . . . 63.530000000000001 108.15 -178.159 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.2 ptt180 -119.79 150.1 40.96 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 108.454 -0.943 . . . . 62.140000000000001 108.454 175.777 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.512 ' CE1' HD11 ' A' ' 49' ' ' LEU . 52.0 p90 -157.23 151.72 25.25 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.598 -0.519 . . . . 72.239999999999995 109.598 173.031 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.2 pp -88.11 140.85 29.07 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 108.886 -0.783 . . . . 62.130000000000003 108.886 176.05 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 90.9 mt -71.58 113.04 8.21 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.672 -0.862 . . . . 74.310000000000002 108.672 179.667 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -110.67 -33.48 6.55 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 114.71 -1.132 . . . . 43.340000000000003 109.542 -178.967 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 17.7 mp0 -79.23 122.27 84.01 Favored Pre-proline 0 C--N 1.308 -1.207 0 N-CA-C 107.22 -1.4 . . . . 74.310000000000002 107.22 179.728 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -51.55 -31.77 41.16 Favored 'Trans proline' 0 C--N 1.367 1.552 0 C-N-CA 123.509 2.806 . . . . 44.340000000000003 112.634 -176.8 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.4 m -134.5 97.05 3.71 Favored 'General case' 0 N--CA 1.417 -2.098 0 N-CA-C 107.904 -1.147 . . . . 62.130000000000003 107.904 173.404 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 86.0 m -91.73 118.46 30.69 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.963 -1.125 . . . . 71.549999999999997 107.963 -179.277 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 27.6 m -108.41 121.04 44.12 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-O 121.775 0.797 . . . . 70.510000000000005 111.919 -176.478 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.469 ' O ' ' HB3' ' A' ' 89' ' ' HIS . . . -98.16 103.3 15.23 Favored 'General case' 0 N--CA 1.416 -2.168 0 N-CA-C 106.876 -1.527 . . . . 51.329999999999998 106.876 174.232 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 111.07 69.86 0.59 Allowed Glycine 0 N--CA 1.429 -1.795 0 C-N-CA 119.76 -1.21 . . . . 51.240000000000002 111.224 -177.9 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -151.0 61.11 0.92 Allowed 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 104.093 -2.558 . . . . 71.040000000000006 104.093 177.993 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 16.5 t60 -37.95 -43.97 1.74 Allowed Pre-proline 0 CA--C 1.578 2.021 0 N-CA-C 116.559 2.059 . . . . 73.409999999999997 116.559 -167.338 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -60.15 -40.25 61.92 Favored 'Trans proline' 0 C--N 1.374 1.921 0 CA-C-N 121.559 1.593 . . . . 62.109999999999999 113.207 175.405 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -149.84 88.03 1.52 Allowed 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 108.946 -0.761 . . . . 74.120000000000005 108.946 -179.078 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 53.4 m -101.61 152.17 21.13 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 116.439 -0.346 . . . . 54.229999999999997 110.425 179.577 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -72.22 -43.8 63.88 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 106.136 -1.801 . . . . 74.129999999999995 106.136 171.103 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 30.0 pt -131.68 130.26 61.95 Favored 'Isoleucine or valine' 0 C--O 1.245 0.868 0 CA-C-N 114.407 -1.27 . . . . 75.140000000000001 108.507 171.802 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -90.73 116.99 29.02 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 116.314 -0.403 . . . . 73.239999999999995 109.978 -177.063 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.455 HD21 ' HB1' ' A' ' 70' ' ' ALA . 97.2 mt -66.86 172.33 4.48 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.318 0.58 . . . . 64.400000000000006 111.251 -179.859 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -73.87 -12.16 60.59 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.792 -0.64 . . . . 41.450000000000003 110.732 179.04 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.529 ' HA ' HG23 ' A' ' 85' ' ' VAL . 1.6 m-20 54.05 78.4 0.16 Allowed 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 115.085 -0.962 . . . . 73.230000000000004 113.369 -176.74 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 44.2 t -93.06 -37.04 8.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 106.92 -1.511 . . . . 63.119999999999997 106.92 173.727 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 76.1 m -179.55 84.37 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 127.971 2.508 . . . . 62.119999999999997 105.473 -178.616 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.529 HG23 ' HA ' ' A' ' 82' ' ' ASP . 78.8 t -103.34 136.18 37.33 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.192 0 CA-C-N 115.204 -0.907 . . . . 73.219999999999999 109.726 -176.662 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 23.3 t -74.3 180.0 4.23 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 115.147 -0.933 . . . . 72.319999999999993 111.04 -176.096 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 -68.15 -34.19 75.88 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 107.615 -1.254 . . . . 71.409999999999997 107.615 178.841 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.472 ' O ' HG23 ' A' ' 104' ' ' VAL . 0.2 OUTLIER -139.45 125.66 20.08 Favored 'General case' 0 CA--C 1.495 -1.145 0 N-CA-C 101.236 -3.616 . . . . 74.510000000000005 101.236 167.572 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.469 ' HB3' ' O ' ' A' ' 70' ' ' ALA . 6.7 t60 -100.65 -79.32 0.5 Allowed 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 118.619 -1.233 . . . . 73.510000000000005 112.403 -173.996 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -120.07 107.81 13.51 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.152 0.501 . . . . 73.019999999999996 109.772 -178.867 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -95.5 127.89 41.91 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 109.027 -0.731 . . . . 70.0 109.027 178.909 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -112.74 112.27 23.66 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 107.321 -1.363 . . . . 62.420000000000002 107.321 176.737 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 54.7 ttp180 -103.59 124.19 48.35 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.325 -0.991 . . . . 75.310000000000002 108.325 178.42 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.36 117.02 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.319 0 CA-C-O 122.122 0.963 . . . . 62.009999999999998 109.443 -173.243 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 -118.41 144.69 45.75 Favored 'General case' 0 C--N 1.28 -2.415 0 N-CA-C 103.174 -2.899 . . . . 62.200000000000003 103.174 172.142 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.09 -16.07 63.63 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 121.067 0.46 . . . . 64.129999999999995 112.196 -177.627 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -90.07 -45.19 4.54 Favored Glycine 0 N--CA 1.431 -1.688 0 CA-C-N 115.534 -0.757 . . . . 34.200000000000003 112.695 174.883 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -136.41 140.88 43.51 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 121.297 0.57 . . . . 62.109999999999999 110.96 -176.977 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -112.54 125.95 54.81 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 107.177 -1.416 . . . . 75.239999999999995 107.177 179.561 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -132.39 137.78 47.46 Favored 'General case' 0 C--N 1.309 -1.178 0 C-N-CA 120.051 -0.659 . . . . 74.540000000000006 112.179 -179.051 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.8 p -115.85 125.95 73.18 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 CA-C-N 115.211 -0.904 . . . . 55.539999999999999 109.551 179.518 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 46.3 t -112.97 115.52 50.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 CA-C-N 115.951 -0.568 . . . . 63.420000000000002 109.697 -179.28 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -95.95 107.5 19.78 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 121.644 0.735 . . . . 75.349999999999994 110.048 177.034 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 88' ' ' ARG . 1.3 m -114.0 16.02 8.07 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.277 0 CA-C-N 115.075 -0.966 . . . . 61.340000000000003 109.659 175.5 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -122.35 45.43 1.21 Allowed Glycine 0 N--CA 1.438 -1.189 0 N-CA-C 109.119 -1.593 . . . . 73.219999999999999 109.119 176.265 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.5 p -69.68 -13.65 62.41 Favored 'General case' 0 C--O 1.249 1.037 0 C-N-CA 124.702 1.201 . . . . 61.130000000000003 112.973 -175.427 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 49.9 tp -67.73 -43.84 79.03 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 108.212 -1.033 . . . . 73.319999999999993 108.212 175.442 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -74.77 -47.68 29.68 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 107.123 -1.436 . . . . 72.340000000000003 107.123 173.065 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 100.31 96.02 2.18 Favored Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 115.16 0.824 . . . . 63.299999999999997 115.16 175.01 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.407 HG23 HG22 ' A' ' 130' ' ' ILE . 51.7 m -91.2 120.11 31.85 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.359 -0.978 . . . . 63.219999999999999 108.359 173.044 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.492 ' HB3' ' HA ' ' A' ' 114' ' ' ARG . 59.9 m-85 -102.35 134.58 45.42 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 108.574 -0.898 . . . . 74.239999999999995 108.574 178.774 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 34.5 t -117.62 121.95 68.68 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 N-CA-C 105.415 -2.069 . . . . 75.200000000000003 105.415 176.131 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.483 ' HA ' ' OD1' ' A' ' 126' ' ' ASP . 14.2 m120 67.52 18.19 10.0 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 107.211 -1.403 . . . . 75.200000000000003 107.211 -172.672 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.492 ' HA ' ' HB3' ' A' ' 111' ' ' TYR 0.344 44.7 mtt85 68.79 12.67 8.73 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 113.626 -1.625 . . . . 74.109999999999999 114.207 -173.354 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -97.85 135.96 21.32 Favored Pre-proline 0 N--CA 1.442 -0.865 0 N-CA-C 107.866 -1.161 . . . . 73.340000000000003 107.866 174.681 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -68.61 115.81 4.1 Favored 'Trans proline' 0 C--O 1.24 0.605 0 C-N-CA 121.864 1.71 . . . . 71.040000000000006 109.12 172.787 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 37.9 mmt180 -134.76 131.11 37.17 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 107.97 -1.122 . . . . 75.239999999999995 107.97 -178.285 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -77.85 -29.49 50.5 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.823 0.821 . . . . 73.109999999999999 109.092 176.682 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -144.35 137.52 27.18 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 107.132 -1.432 . . . . 71.439999999999998 107.132 171.343 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -142.06 150.42 41.21 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 109.66 -0.496 . . . . 72.450000000000003 109.66 177.96 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 48.5 t -80.62 112.66 18.93 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.156 0 N-CA-C 105.107 -2.183 . . . . 73.099999999999994 105.107 173.414 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.41 ' HG2' ' CE2' ' A' ' 137' ' ' PHE . 22.1 ttt -64.27 122.54 16.91 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.183 -0.917 . . . . 73.400000000000006 109.325 -171.817 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 56.1 tp60 -104.73 125.91 51.28 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.766 -0.652 . . . . 72.400000000000006 111.145 -171.182 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 10.5 p -79.31 116.38 19.52 Favored 'General case' 0 N--CA 1.434 -1.232 0 C-N-CA 123.271 0.628 . . . . 74.530000000000001 109.945 178.793 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 115.33 7.11 17.06 Favored Glycine 0 N--CA 1.435 -1.38 0 C-N-CA 120.547 -0.835 . . . . 60.340000000000003 112.881 178.178 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.483 ' OD1' ' HA ' ' A' ' 113' ' ' ASN . 8.0 t70 -128.63 -165.7 1.54 Allowed 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.584 -0.895 . . . . 41.109999999999999 108.584 -179.606 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -128.99 149.86 50.64 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.773 0.797 . . . . 72.519999999999996 113.133 -172.294 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 65.8 mt -124.02 129.9 74.04 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 107.912 -1.144 . . . . 63.200000000000003 107.912 -178.188 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -117.91 112.77 20.77 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 109.616 -0.512 . . . . 64.329999999999998 109.616 -177.125 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.596 HD13 ' H ' ' A' ' 130' ' ' ILE . 0.2 OUTLIER -94.19 105.69 17.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 109.367 -0.605 . . . . 75.150000000000006 109.367 178.708 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 71.07 -104.26 1.38 Allowed Glycine 0 N--CA 1.433 -1.53 0 N-CA-C 110.297 -1.121 . . . . 70.349999999999994 110.297 -176.633 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 42.8 mtpt -123.72 14.58 9.38 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 120.996 0.427 . . . . 72.109999999999999 109.927 177.67 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -101.04 132.12 46.62 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.915 -0.402 . . . . 52.409999999999997 109.915 -179.11 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 17.8 ptt180 -96.98 121.43 38.85 Favored 'General case' 0 C--O 1.254 1.341 0 CA-C-O 121.726 0.774 . . . . 73.430000000000007 112.234 -176.773 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.439 HD21 ' HB2' ' A' ' 49' ' ' LEU . 6.4 tt -125.19 142.99 51.16 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 114.466 -1.243 . . . . 65.430000000000007 107.715 178.415 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 10.0 p -119.2 140.27 43.72 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 N-CA-C 108.661 -0.866 . . . . 74.430000000000007 108.661 177.671 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.41 ' CE2' ' HG2' ' A' ' 122' ' ' MET . 59.6 t80 -120.2 118.0 29.36 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 120.976 0.417 . . . . 73.420000000000002 110.482 -176.4 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -118.61 173.92 6.57 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 109.401 -0.592 . . . . 75.329999999999998 109.401 -176.626 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -71.1 149.89 46.02 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.629 -1.249 . . . . 73.239999999999995 107.629 172.804 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.587 ' N ' ' HA ' ' A' ' 47' ' ' ALA . . . -96.34 -160.52 32.41 Favored Glycine 0 C--N 1.287 -2.163 0 C-N-CA 120.46 -0.876 . . . . 64.230000000000004 111.478 -176.844 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -69.52 121.95 8.69 Favored 'Trans proline' 0 N--CA 1.434 -1.995 0 C-N-CA 121.823 1.682 . . . . 74.430000000000007 110.895 179.634 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -85.62 103.41 14.42 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 105.579 -2.008 . . . . 72.349999999999994 105.579 177.596 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 . . . . . 0 N--CA 1.42 -1.973 0 N-CA-C 108.141 -1.059 . . . . 72.209999999999994 108.141 -171.357 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.514 -0.42 0 N-CA-C 108.921 -0.77 . . . . 65.530000000000001 108.921 . . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.4 t -83.31 -49.93 8.88 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.4 -0.592 . . . . 53.240000000000002 109.4 -179.526 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . 0.288 0.6 OUTLIER 36.01 79.7 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 116.17 1.915 . . . . 63.299999999999997 116.17 179.486 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -163.84 171.5 15.35 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.549 -1.278 . . . . 75.439999999999998 107.549 178.327 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -107.19 105.84 16.02 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 108.843 -0.799 . . . . 75.219999999999999 108.843 177.891 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -152.68 32.89 0.82 Allowed Glycine 0 C--N 1.29 -1.995 0 N-CA-C 109.815 -1.314 . . . . 71.230000000000004 109.815 178.492 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.41 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 4.8 p -75.76 129.69 80.73 Favored Pre-proline 0 N--CA 1.424 -1.756 0 CA-C-N 115.007 -0.596 . . . . 72.310000000000002 110.381 -177.381 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 7' ' ' THR . 45.8 Cg_exo -55.49 133.03 55.69 Favored 'Trans proline' 0 C--O 1.241 0.658 0 C-N-CA 123.137 2.558 . . . . 35.229999999999997 112.587 -178.592 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -96.59 125.49 46.89 Favored Pre-proline 0 N--CA 1.431 -1.383 0 N-CA-C 107.974 -1.121 . . . . 52.240000000000002 107.974 175.987 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -55.42 136.01 71.8 Favored 'Trans proline' 0 C--O 1.245 0.835 0 C-N-CA 122.958 2.438 . . . . 61.340000000000003 112.157 -178.496 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -72.31 108.84 5.65 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.162 -0.681 . . . . 75.340000000000003 109.162 -178.885 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 36.2 t -87.88 115.82 28.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 109.657 -0.497 . . . . 53.119999999999997 109.657 -176.812 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -135.01 121.77 20.9 Favored 'General case' 0 N--CA 1.424 -1.77 0 N-CA-C 108.376 -0.972 . . . . 71.25 108.376 177.085 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.4 t -78.57 -25.07 45.26 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.215 0.531 . . . . 71.349999999999994 109.799 178.914 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.8 m 68.31 12.32 8.7 Favored 'General case' 0 CA--C 1.564 1.485 0 C-N-CA 124.426 1.09 . . . . 74.129999999999995 110.751 177.375 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.2 t -146.34 111.18 5.26 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 107.33 -1.359 . . . . 50.409999999999997 107.33 -179.452 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 46.5 t -106.9 123.78 62.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 N-CA-C 109.809 -0.441 . . . . 72.209999999999994 109.809 -176.458 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -89.23 131.4 35.36 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.434 -0.95 . . . . 72.019999999999996 108.434 176.506 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -118.4 138.48 52.42 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 110.054 -0.35 . . . . 74.450000000000003 110.054 179.718 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -97.08 74.1 2.55 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 105.995 -1.854 . . . . 53.399999999999999 105.995 171.865 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -73.48 -45.5 53.72 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 114.326 -1.306 . . . . 73.430000000000007 111.872 -169.323 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.461 HD23 ' H ' ' A' ' 22' ' ' LEU . 1.6 pt? -117.56 114.49 23.5 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-O 120.965 0.412 . . . . 71.239999999999995 110.259 -179.928 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.3 tt -83.38 113.23 20.59 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.801 -1.185 . . . . 75.540000000000006 107.801 179.539 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.442 ' C ' ' HD3' ' A' ' 24' ' ' LYS . 0.7 OUTLIER -76.52 110.79 11.36 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 107.765 -1.198 . . . . 61.409999999999997 107.765 179.015 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -116.61 178.83 4.19 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 116.108 -0.496 . . . . 73.329999999999998 109.839 -179.246 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -165.24 169.6 15.77 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 105.862 -1.903 . . . . 72.109999999999999 105.862 -179.464 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.466 ' HG3' ' O ' ' A' ' 29' ' ' SER . 10.2 tp10 -139.06 141.11 38.22 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 118.59 0.632 . . . . 73.299999999999997 110.8 -177.684 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.3 p -104.28 -26.34 12.53 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 115.709 -0.678 . . . . 75.400000000000006 110.394 179.733 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.466 ' O ' ' HG3' ' A' ' 27' ' ' GLU . 23.3 m -88.6 175.26 7.63 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 107.89 -1.152 . . . . 71.209999999999994 107.89 176.745 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.2 t -169.26 176.02 5.37 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 109.106 -0.702 . . . . 60.549999999999997 109.106 178.189 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.51 109.43 2.94 Favored Glycine 0 N--CA 1.436 -1.331 0 N-CA-C 110.432 -1.067 . . . . 72.510000000000005 110.432 179.424 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.7 p -75.36 118.57 18.4 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-O 121.149 0.499 . . . . 75.25 110.544 179.838 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -89.73 122.52 67.99 Favored Pre-proline 0 C--N 1.308 -1.216 0 CA-C-N 115.939 -0.573 . . . . 55.310000000000002 110.255 -177.4 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -91.63 -176.77 0.88 Allowed 'Trans proline' 0 N--CA 1.441 -1.595 0 C-N-CA 122.087 1.858 . . . . 64.409999999999997 110.667 175.419 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -94.12 -3.78 50.46 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 109.14 -0.689 . . . . 52.039999999999999 109.14 177.133 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.8 m -86.45 88.41 7.63 Favored 'General case' 0 N--CA 1.421 -1.876 0 CA-C-N 115.202 -0.908 . . . . 33.219999999999999 112.448 -177.83 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 18.0 m -88.38 111.95 22.33 Favored 'General case' 0 N--CA 1.417 -2.078 0 N-CA-C 105.215 -2.142 . . . . 71.200000000000003 105.215 170.804 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.0 65.79 0.79 Allowed Glycine 0 N--CA 1.425 -2.079 0 N-CA-C 109.164 -1.575 . . . . 51.130000000000003 109.164 -173.344 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.85 -28.91 69.32 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 122.525 0.33 . . . . 73.040000000000006 110.691 -177.902 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.546 ' HA ' ' O ' ' A' ' 96' ' ' GLU . 1.6 pm0 -70.45 -11.89 61.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.39 0.614 . . . . 70.409999999999997 112.471 179.733 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -84.19 -14.41 50.16 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 116.014 -0.539 . . . . 75.409999999999997 111.349 176.293 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.3 mp -106.15 109.01 62.8 Favored Pre-proline 0 N--CA 1.435 -1.207 0 CA-C-N 116.331 -0.395 . . . . 73.109999999999999 111.97 -176.514 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -66.62 -24.68 47.97 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.029 1.82 . . . . 61.32 110.451 174.942 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -95.92 24.58 5.36 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.066 -0.97 . . . . 62.109999999999999 109.933 178.977 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -89.71 70.29 2.37 Favored Glycine 0 CA--C 1.489 -1.582 0 N-CA-C 107.212 -2.355 . . . . 74.150000000000006 107.212 176.198 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.6 p -88.78 152.74 21.59 Favored 'General case' 0 C--N 1.28 -2.429 0 N-CA-C 114.294 1.22 . . . . 74.450000000000003 114.294 -170.302 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.463 ' HA ' ' H ' ' A' ' 140' ' ' GLY . . . -122.43 178.36 5.0 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 106.386 -1.709 . . . . 62.439999999999998 106.386 176.223 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -133.03 146.65 51.92 Favored 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 118.78 -1.168 . . . . 61.409999999999997 111.86 -176.742 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.44 HD23 ' H ' ' A' ' 49' ' ' LEU . 1.0 OUTLIER -109.49 131.73 54.79 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 107.365 -1.346 . . . . 74.439999999999998 107.365 176.959 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.4 t -114.07 118.49 58.56 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 N-CA-C 107.969 -1.122 . . . . 71.450000000000003 107.969 -179.077 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 6.5 t -92.86 116.19 33.42 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.151 0 N-CA-C 107.433 -1.321 . . . . 51.409999999999997 107.433 -179.44 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -74.4 -35.12 63.45 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.724 -0.843 . . . . 63.439999999999998 108.724 -178.943 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.508 ' O ' ' HB3' ' A' ' 133' ' ' PHE . 76.7 ttt180 -170.3 126.97 0.81 Allowed 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 103.578 -2.749 . . . . 71.140000000000001 103.578 176.084 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.543 ' HA2' ' HB3' ' A' ' 133' ' ' PHE . . . -151.35 174.15 30.6 Favored Glycine 0 N--CA 1.421 -2.321 0 C-N-CA 118.293 -1.908 . . . . 52.509999999999998 114.825 -174.745 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -68.65 -39.95 8.21 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 123.321 2.681 . . . . 54.329999999999998 111.748 -179.753 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -79.86 -56.26 4.4 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.609 -0.723 . . . . 72.349999999999994 110.449 -179.374 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -158.91 -160.99 0.91 Allowed 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 108.737 -0.838 . . . . 73.439999999999998 108.737 -175.801 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -152.06 46.81 0.58 Allowed Glycine 0 N--CA 1.43 -1.721 0 N-CA-C 107.384 -2.286 . . . . 70.439999999999998 107.384 -178.711 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -133.69 -172.78 3.05 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 107.384 -1.339 . . . . 65.430000000000007 107.384 -175.641 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 37.2 ptt180 -116.64 139.87 50.04 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 119.811 -0.756 . . . . 73.340000000000003 110.798 179.793 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -126.71 153.94 44.78 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.923 -0.769 . . . . 71.129999999999995 108.923 -177.239 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.0 mp -110.23 140.57 44.23 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.68 -0.859 . . . . 75.25 108.68 178.613 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -71.24 115.59 10.57 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 109.019 -0.734 . . . . 74.430000000000007 109.019 177.719 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -135.83 -26.46 1.2 Allowed 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 115.282 -0.872 . . . . 74.120000000000005 111.44 -175.32 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -108.83 125.88 30.67 Favored Pre-proline 0 C--N 1.311 -1.071 0 N-CA-C 108.49 -0.93 . . . . 75.400000000000006 108.49 179.244 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -41.41 -58.02 1.23 Allowed 'Trans proline' 0 C--N 1.37 1.676 0 C-N-CA 124.57 3.514 . . . . 73.420000000000002 114.738 -176.791 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 26.1 m -109.73 115.95 30.81 Favored 'General case' 0 N--CA 1.434 -1.271 0 C-N-CA 120.158 -0.617 . . . . 74.140000000000001 109.555 178.777 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 87.5 m -116.8 116.16 26.94 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.124 -1.435 . . . . 61.240000000000002 107.124 176.302 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.6 t -110.06 125.21 52.72 Favored 'General case' 0 N--CA 1.434 -1.235 0 C-N-CA 118.853 -1.139 . . . . 71.109999999999999 111.245 -175.576 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -100.22 110.0 22.25 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 115.161 -0.927 . . . . 43.399999999999999 109.142 179.5 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -178.96 -144.04 5.56 Favored Glycine 0 CA--C 1.468 -2.85 0 N-CA-C 109.005 -1.638 . . . . 23.329999999999998 109.005 -179.729 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 21.4 ttt180 -112.75 -89.8 0.52 Allowed 'General case' 0 N--CA 1.404 -2.763 0 C-N-CA 119.322 -0.951 . . . . 71.049999999999997 111.141 178.098 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 35.6 m170 59.97 156.96 0.1 Allowed Pre-proline 0 CA--C 1.547 0.859 0 CA-C-O 121.507 0.67 . . . . 74.540000000000006 111.576 -172.931 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -66.97 -25.55 44.52 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 121.248 1.299 . . . . 73.230000000000004 108.823 168.549 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -111.71 70.94 0.73 Allowed 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 114.355 -1.293 . . . . 54.509999999999998 108.378 -177.443 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.3 m -73.76 134.01 43.37 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.7 -0.682 . . . . 74.200000000000003 110.452 -178.948 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -78.8 -49.6 12.72 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 107.355 -1.35 . . . . 73.150000000000006 107.355 173.899 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 39.7 pt -125.43 141.84 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 N-CA-C 106.155 -1.795 . . . . 51.43 106.155 169.253 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -95.1 121.83 37.14 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-O 121.588 0.708 . . . . 61.109999999999999 111.903 -174.45 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.0 mp -88.25 118.1 27.61 Favored 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 107.777 -1.194 . . . . 72.400000000000006 107.777 172.411 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -96.65 -6.03 37.58 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.364 -1.289 . . . . 71.5 113.047 -165.699 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -78.75 -170.3 2.08 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 115.98 -0.554 . . . . 65.109999999999999 110.479 -177.554 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.8 p -122.36 7.83 5.61 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.42 0 CA-C-O 121.341 0.591 . . . . 73.430000000000007 111.63 -176.263 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 8.2 t -120.51 20.25 11.86 Favored 'General case' 0 C--N 1.308 -1.235 0 O-C-N 121.197 -0.94 . . . . 72.319999999999993 108.907 -179.775 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.465 HG22 ' O ' ' A' ' 86' ' ' SER . 6.1 p -81.42 131.27 34.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-N 114.496 -1.229 . . . . 61.509999999999998 111.737 -176.089 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.465 ' O ' HG22 ' A' ' 85' ' ' VAL . 44.7 t -70.34 157.03 38.48 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 114.629 -1.169 . . . . 50.140000000000001 108.103 175.653 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -52.58 -41.83 63.96 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.563 0.696 . . . . 70.219999999999999 110.398 179.209 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -138.0 130.81 29.82 Favored 'General case' 0 CA--C 1.488 -1.423 0 N-CA-C 103.786 -2.672 . . . . 75.530000000000001 103.786 168.299 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 37.7 t60 -107.71 -63.64 1.29 Allowed 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 119.45 -0.9 . . . . 71.430000000000007 110.588 -176.477 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -136.22 125.7 25.13 Favored 'General case' 0 C--N 1.292 -1.902 0 C-N-CA 120.08 -0.648 . . . . 75.150000000000006 110.036 -177.505 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -97.67 127.22 43.47 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 107.573 -1.269 . . . . 54.009999999999998 107.573 175.722 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -106.01 112.96 26.22 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.569 -1.271 . . . . 73.329999999999998 107.569 179.352 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -113.86 126.98 55.79 Favored 'General case' 0 C--N 1.277 -2.551 0 N-CA-C 108.524 -0.917 . . . . 65.129999999999995 108.524 -178.676 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.5 116.81 53.63 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 CA-C-O 122.048 0.928 . . . . 75.409999999999997 109.98 -178.357 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -108.7 145.75 34.57 Favored 'General case' 0 N--CA 1.419 -2.021 0 N-CA-C 106.0 -1.852 . . . . 71.430000000000007 106.0 174.506 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.546 ' O ' ' HA ' ' A' ' 40' ' ' GLU . 10.0 pt-20 -50.62 -28.03 8.0 Favored 'General case' 0 C--N 1.308 -1.197 0 O-C-N 124.059 0.85 . . . . 73.409999999999997 112.078 179.599 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.426 ' HA2' ' CB ' ' A' ' 40' ' ' GLU . . . -85.03 -51.35 3.8 Favored Glycine 0 N--CA 1.426 -2.027 0 C-N-CA 120.617 -0.801 . . . . 24.32 112.728 179.026 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -144.06 153.44 42.19 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-O 121.073 0.463 . . . . 75.329999999999998 111.087 -173.831 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.425 ' HB2' ' HB3' ' A' ' 122' ' ' MET . 60.9 m-85 -95.46 123.85 39.2 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.216 -1.031 . . . . 74.230000000000004 108.216 177.125 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -115.93 134.29 55.13 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.786 -0.45 . . . . 73.099999999999994 109.786 -178.407 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.6 p -125.33 126.2 70.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 109.272 -0.64 . . . . 74.329999999999998 109.272 177.437 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.7 t -114.56 123.68 70.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 CA-C-N 116.01 -0.541 . . . . 72.439999999999998 110.274 -179.35 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -89.5 115.91 27.27 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 121.567 0.699 . . . . 62.219999999999999 110.288 176.958 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 13.9 m -118.42 11.34 7.0 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.373 0 N-CA-C 108.184 -1.043 . . . . 62.130000000000003 108.184 173.94 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -110.17 34.57 5.34 Favored Glycine 0 N--CA 1.421 -2.335 0 N-CA-C 109.862 -1.295 . . . . 71.019999999999996 109.862 178.879 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.4 m -63.15 -9.73 12.11 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.947 1.299 . . . . 64.310000000000002 110.299 179.893 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 49.8 tp -58.27 -37.92 75.95 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 125.217 1.407 . . . . 64.439999999999998 107.825 174.707 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -110.15 -41.2 4.49 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 115.316 -0.856 . . . . 55.240000000000002 109.297 176.684 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 107.99 123.67 4.96 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 120.628 -0.796 . . . . 71.409999999999997 114.749 174.052 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 87.1 m -109.17 120.18 41.75 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.267 -1.012 . . . . 71.010000000000005 108.267 173.61 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . 0.25 40.5 p90 -123.48 135.81 54.25 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 114.407 1.262 . . . . 64.519999999999996 114.407 -177.83 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 18.2 m -105.09 136.33 39.35 Favored 'Isoleucine or valine' 0 C--O 1.257 1.448 0 CA-C-N 114.657 -1.156 . . . . 73.230000000000004 108.291 -179.994 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 62.06 -83.02 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 124.685 1.194 . . . . 41.140000000000001 108.744 -169.549 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 27.5 mmm180 -139.74 -12.67 1.13 Allowed 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 124.052 0.941 . . . . 63.32 110.843 177.654 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.459 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . 0.4 OUTLIER -110.5 131.08 22.24 Favored Pre-proline 0 C--O 1.245 0.821 0 N-CA-C 113.891 1.071 . . . . 71.450000000000003 113.891 -168.205 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 115' ' ' GLU . 24.6 Cg_exo -65.14 136.05 46.21 Favored 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 122.748 2.299 . . . . 71.409999999999997 110.17 175.282 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -131.35 164.06 26.49 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.645 -0.502 . . . . 53.340000000000003 109.645 -178.156 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -93.48 -56.03 3.07 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 108.911 -0.774 . . . . 72.439999999999998 108.911 176.733 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -130.99 139.74 50.04 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 108.778 -0.823 . . . . 71.0 108.778 179.572 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -138.88 149.94 45.42 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-O 121.536 0.684 . . . . 71.319999999999993 112.828 -178.453 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 39.7 t -92.34 105.08 16.29 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.101 0 N-CA-C 104.107 -2.553 . . . . 72.409999999999997 104.107 172.328 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.425 ' HB3' ' HB2' ' A' ' 99' ' ' PHE . 9.6 tpt -50.38 120.47 4.61 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 125.065 1.346 . . . . 72.120000000000005 110.297 -171.561 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -104.92 132.07 51.62 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 121.26 0.552 . . . . 74.310000000000002 111.577 -172.083 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.2 p -79.16 115.77 19.03 Favored 'General case' 0 N--CA 1.424 -1.73 0 CA-C-N 115.014 -0.994 . . . . 75.209999999999994 110.756 -179.201 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 119.82 -7.01 12.18 Favored Glycine 0 N--CA 1.429 -1.788 0 C-N-CA 121.033 -0.604 . . . . 65.239999999999995 112.823 177.768 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -106.8 157.9 17.39 Favored 'General case' 0 C--O 1.247 0.932 0 C-N-CA 119.944 -0.702 . . . . 55.039999999999999 111.637 -177.731 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.445 ' HA ' ' HA ' ' A' ' 136' ' ' VAL . 11.0 pt-20 -114.51 121.36 43.28 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-O 122.153 0.978 . . . . 73.349999999999994 109.081 177.587 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 71.6 mt -111.79 130.42 65.42 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.358 0 CA-C-N 113.968 -1.469 . . . . 74.230000000000004 109.962 -170.586 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.49 ' HG3' ' O ' ' A' ' 133' ' ' PHE . 42.8 tt0 -97.36 124.85 41.66 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.99 -0.684 . . . . 74.5 111.438 178.028 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 11.8 pt -105.55 101.95 13.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 114.504 -1.226 . . . . 64.530000000000001 108.481 178.355 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 72.44 -101.76 1.11 Allowed Glycine 0 N--CA 1.437 -1.278 0 N-CA-C 110.273 -1.131 . . . . 74.439999999999998 110.273 -176.559 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 32.8 mmmt -126.0 9.75 7.51 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.23 0.538 . . . . 63.310000000000002 110.307 178.6 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.543 ' HB3' ' HA2' ' A' ' 54' ' ' GLY . 78.5 m-85 -114.36 158.04 22.03 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 108.901 -0.777 . . . . 73.439999999999998 108.901 -179.013 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 51.4 ttp180 -127.49 135.61 50.62 Favored 'General case' 0 C--O 1.249 1.063 0 C-N-CA 118.567 -1.253 . . . . 73.430000000000007 112.731 -176.105 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 5.7 tt -122.16 132.11 54.29 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 114.191 -1.368 . . . . 71.299999999999997 107.465 -178.268 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 127' ' ' GLU . 9.6 p -111.12 135.17 51.11 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 N-CA-C 108.631 -0.878 . . . . 55.140000000000001 108.631 178.294 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -113.84 121.41 43.93 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 109.631 -0.507 . . . . 71.099999999999994 109.631 -175.918 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -123.27 165.98 16.04 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 109.396 -0.594 . . . . 75.409999999999997 109.396 -177.983 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -71.16 130.3 41.13 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 107.522 -1.288 . . . . 74.439999999999998 107.522 174.167 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.463 ' H ' ' HA ' ' A' ' 47' ' ' ALA . . . -116.99 -174.19 17.01 Favored Glycine 0 N--CA 1.418 -2.564 0 C-N-CA 120.115 -1.04 . . . . 64.340000000000003 112.952 -173.485 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -79.33 129.0 8.38 Favored 'Trans proline' 0 N--CA 1.428 -2.381 0 C-N-CA 122.5 2.133 . . . . 54.0 112.156 -179.626 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -95.17 104.3 16.17 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 105.57 -2.011 . . . . 63.200000000000003 105.57 172.762 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 . . . . . 0 C--N 1.303 -1.428 0 CA-C-O 118.491 -0.766 . . . . 74.120000000000005 110.653 -173.025 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 t30 . . . . . 0 C--O 1.233 0.208 0 CA-C-O 121.202 0.525 . . . . 72.530000000000001 111.077 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.01 25.75 27.01 Favored Glycine 0 N--CA 1.439 -1.134 0 C-N-CA 120.894 -0.67 . . . . 45.109999999999999 111.648 -178.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 61.7 m -87.28 123.51 69.76 Favored Pre-proline 0 N--CA 1.433 -1.278 0 N-CA-C 108.872 -0.788 . . . . 64.109999999999999 108.872 177.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -68.25 127.49 15.91 Favored 'Trans proline' 0 N--CA 1.448 -1.182 0 C-N-CA 121.659 1.573 . . . . 75.209999999999994 110.437 174.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -100.94 139.13 20.27 Favored Pre-proline 0 C--N 1.296 -1.736 0 N-CA-C 108.787 -0.82 . . . . 74.230000000000004 108.787 177.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -75.51 118.03 5.0 Favored 'Trans proline' 0 N--CA 1.441 -1.579 0 C-N-CA 121.845 1.697 . . . . 73.129999999999995 111.335 -177.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -76.82 173.74 11.34 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 108.953 -0.758 . . . . 71.400000000000006 108.953 177.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 45.1 t 61.21 81.09 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 108.189 -1.041 . . . . 64.219999999999999 108.189 -173.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -74.73 132.27 41.51 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 115.309 -0.86 . . . . 73.439999999999998 110.067 -176.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.9 t -124.21 108.71 12.57 Favored 'General case' 0 N--CA 1.407 -2.609 0 CA-C-O 121.794 0.807 . . . . 71.329999999999998 109.67 -178.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 15.2 t -112.61 -3.78 14.26 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 122.331 1.062 . . . . 65.129999999999995 108.361 176.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.6 p -92.07 35.88 0.98 Allowed 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 114.417 -1.265 . . . . 75.439999999999998 109.157 179.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.9 m . . . . . 0 N--CA 1.427 -1.612 0 CA-C-N 114.36 -1.291 . . . . 74.150000000000006 111.248 -177.027 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.471 0 N-CA-C 113.866 0.306 . . . . 62.450000000000003 113.866 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 9.0 m -113.69 153.79 28.37 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 109.715 -0.476 . . . . 54.219999999999999 109.715 -177.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.81 174.0 10.94 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.856 -0.794 . . . . 62.229999999999997 108.856 -178.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.5 pp -135.28 160.14 39.34 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 119.22 -0.992 . . . . 53.5 112.256 -177.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.9 pp -137.75 149.28 46.31 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 109.003 -0.739 . . . . 75.140000000000001 109.003 175.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 22.6 m -121.33 141.52 41.45 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.175 0 N-CA-C 107.14 -1.429 . . . . 64.010000000000005 107.14 175.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.0 t -92.85 116.81 34.81 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.614 0 N-CA-C 107.463 -1.31 . . . . 72.530000000000001 107.463 177.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.483 ' HB2' HG23 ' A' ' 136' ' ' VAL . 82.5 tttt -77.62 -21.76 51.8 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.109 -0.95 . . . . 64.409999999999997 109.214 -176.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.422 ' HB2' ' O ' ' A' ' 52' ' ' LYS . 65.6 ttt180 168.26 131.03 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.51 1.524 . . . . 73.120000000000005 109.536 163.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 175.88 152.69 9.72 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 121.044 -0.598 . . . . 42.240000000000002 112.032 178.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -69.84 -9.28 25.7 Favored 'Trans proline' 0 C--N 1.36 1.147 0 C-N-CA 123.795 2.997 . . . . 71.049999999999997 112.489 177.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -60.94 -42.64 98.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.795 -0.639 . . . . 73.209999999999994 110.656 -178.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -164.47 -58.99 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 109.254 -0.647 . . . . 64.420000000000002 109.254 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.45 32.82 36.91 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.692 -0.766 . . . . 65.140000000000001 111.614 -178.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -144.11 -164.74 1.96 Allowed 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 108.109 -1.071 . . . . 75.420000000000002 108.109 -177.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -115.48 138.56 50.89 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 120.769 0.319 . . . . 63.539999999999999 110.311 177.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -130.33 147.5 52.05 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.647 -0.706 . . . . 74.420000000000002 110.525 -170.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 93.2 mt -105.06 134.52 48.03 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.052 -0.721 . . . . 71.510000000000005 109.052 177.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.4 mp -110.78 114.37 27.68 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.221 -0.659 . . . . 75.530000000000001 109.221 178.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -131.76 4.66 4.22 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.828 -1.175 . . . . 64.25 107.828 172.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -83.56 124.79 75.05 Favored Pre-proline 0 N--CA 1.441 -0.911 0 N-CA-C 106.838 -1.542 . . . . 60.039999999999999 106.838 178.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.454 ' O ' ' HG3' ' A' ' 93' ' ' ARG . 1.2 Cg_endo -45.81 -46.23 15.74 Favored 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 123.291 2.661 . . . . 75.430000000000007 112.912 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 32.1 m -136.37 117.53 14.45 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 109.546 -0.539 . . . . 75.530000000000001 109.546 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 20.4 m -113.37 113.28 25.01 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 107.967 -1.123 . . . . 65.310000000000002 107.967 177.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.5 m -97.79 131.04 44.66 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.197 0.523 . . . . 32.509999999999998 110.756 -176.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.456 ' HB1' ' HB2' ' A' ' 80' ' ' LEU . . . -97.57 110.59 23.12 Favored 'General case' 0 N--CA 1.428 -1.526 0 CA-C-N 115.849 -0.614 . . . . 33.030000000000001 110.52 -178.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -136.47 -143.09 4.57 Favored Glycine 0 N--CA 1.437 -1.254 0 N-CA-C 108.703 -1.759 . . . . 64.230000000000004 108.703 178.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.521 ' O ' ' HD3' ' A' ' 72' ' ' ARG . 4.7 tmt_? -161.19 12.23 0.09 Allowed 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 122.128 0.965 . . . . 73.409999999999997 109.63 176.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 34.5 m170 -99.45 157.7 33.52 Favored Pre-proline 0 N--CA 1.433 -1.283 0 N-CA-C 108.03 -1.1 . . . . 72.540000000000006 108.03 -178.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_exo -56.48 -21.2 36.63 Favored 'Trans proline' 0 N--CA 1.478 0.582 0 C-N-CA 122.969 2.446 . . . . 64.140000000000001 113.88 -178.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.62 -1.68 43.21 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 112.253 0.464 . . . . 74.0 112.253 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 16.0 m -83.14 146.79 28.45 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 108.248 -1.019 . . . . 64.400000000000006 108.248 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -61.26 -60.03 4.38 Favored 'General case' 0 C--N 1.322 -0.618 0 O-C-N 123.273 0.358 . . . . 74.349999999999994 110.968 -176.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 38.2 pt -122.77 157.89 27.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-O 120.746 0.307 . . . . 64.439999999999998 110.194 176.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -97.07 126.54 42.3 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.017 -1.105 . . . . 71.209999999999994 108.017 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.456 ' HB2' ' HB1' ' A' ' 70' ' ' ALA . 1.2 tm? -108.71 -90.25 0.46 Allowed 'General case' 0 N--CA 1.418 -2.055 0 CA-C-O 121.153 0.501 . . . . 62.340000000000003 111.711 -175.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -96.81 118.04 32.38 Favored 'General case' 0 C--N 1.262 -3.211 0 CA-C-O 121.658 0.742 . . . . 74.230000000000004 109.238 -176.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -94.22 -40.25 10.1 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-N 114.412 -1.267 . . . . 63.119999999999997 112.273 -175.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 8.2 p -80.74 -31.66 12.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-N 115.63 -0.714 . . . . 45.299999999999997 110.423 -174.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 5.1 p -133.97 73.68 1.51 Allowed 'General case' 0 C--N 1.294 -1.829 0 CA-C-O 122.242 1.02 . . . . 71.340000000000003 109.291 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.402 HG12 ' H ' ' A' ' 85' ' ' VAL . 2.8 p -82.31 124.65 39.44 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 N-CA-C 114.55 1.315 . . . . 75.409999999999997 114.55 -169.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 51.0 m -96.54 139.5 32.55 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 105.514 -2.032 . . . . 63.329999999999998 105.514 167.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 8.8 ptp85 -56.69 -39.3 73.58 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 121.678 0.751 . . . . 73.340000000000003 112.045 -176.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.451 ' HB3' HG13 ' A' ' 104' ' ' VAL . 23.1 mmt180 -133.06 103.22 5.92 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 106.026 -1.842 . . . . 64.209999999999994 106.026 173.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 12.9 t60 -84.73 -69.92 0.61 Allowed 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.267 0.556 . . . . 73.010000000000005 110.341 -173.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -144.62 170.69 15.59 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.971 -0.752 . . . . 61.420000000000002 108.971 -176.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -144.45 128.19 17.24 Favored 'General case' 0 N--CA 1.419 -2.008 0 CA-C-O 121.317 0.58 . . . . 73.340000000000003 109.649 178.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -107.34 117.34 33.83 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.661 -1.237 . . . . 73.209999999999994 107.661 -177.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.454 ' HG3' ' O ' ' A' ' 66' ' ' PRO . 40.3 ttp85 -126.17 140.98 52.13 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-O 121.527 0.68 . . . . 61.310000000000002 111.053 -177.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.404 HD12 ' O ' ' A' ' 94' ' ' ILE . 2.9 pp -115.16 126.76 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.967 0 N-CA-C 106.865 -1.532 . . . . 74.540000000000006 106.865 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -118.43 146.25 44.59 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 108.698 -0.852 . . . . 73.040000000000006 108.698 -174.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.35 -29.52 4.03 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 114.267 1.21 . . . . 72.230000000000004 114.267 -177.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -96.7 -40.57 3.82 Favored Glycine 0 N--CA 1.432 -1.577 0 C-N-CA 120.755 -0.736 . . . . 71.230000000000004 114.088 177.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -150.65 171.02 17.79 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 117.417 0.608 . . . . 73.120000000000005 111.26 -172.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -105.46 128.6 53.63 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.109 -1.071 . . . . 75.239999999999995 108.109 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -132.5 135.18 45.83 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 120.321 -0.551 . . . . 71.310000000000002 111.596 -177.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.5 p -117.68 122.7 70.43 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 N-CA-C 109.166 -0.679 . . . . 74.109999999999999 109.166 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.3 m -119.95 137.63 53.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 112.694 0.627 . . . . 70.209999999999994 112.694 -177.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -83.26 126.33 32.55 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.622 -1.251 . . . . 75.540000000000006 107.622 171.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.451 HG13 ' HB3' ' A' ' 88' ' ' ARG . 8.2 p -105.33 1.8 10.32 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 CA-C-O 121.734 0.778 . . . . 75.129999999999995 110.518 -177.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 136.47 42.22 0.11 Allowed Glycine 0 N--CA 1.441 -0.976 0 C-N-CA 119.701 -1.238 . . . . 70.310000000000002 113.698 175.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 67.6 p -73.85 124.85 26.9 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-N 117.176 0.488 . . . . 53.329999999999998 109.706 178.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 51.1 tp -78.15 -26.01 47.58 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.447 0.642 . . . . 73.439999999999998 109.327 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -76.66 -23.54 53.26 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.505 -0.77 . . . . 44.109999999999999 110.388 178.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 94.93 132.56 6.86 Favored Glycine 0 N--CA 1.431 -1.634 0 CA-C-N 115.464 -0.789 . . . . 63.310000000000002 112.802 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 79.7 m -109.18 119.82 40.68 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.381 -0.97 . . . . 74.519999999999996 108.381 175.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -125.2 141.54 52.03 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 109.285 -0.635 . . . . 64.319999999999993 109.285 -175.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.474 HG21 ' HG3' ' A' ' 120' ' ' GLN . 28.3 m -98.86 111.45 28.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 N-CA-C 108.687 -0.857 . . . . 62.039999999999999 108.687 175.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 65.89 -76.99 0.04 OUTLIER 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 125.449 1.5 . . . . 70.430000000000007 109.007 -172.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -147.1 10.48 1.01 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.208 1.003 . . . . 62.140000000000001 109.916 177.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -100.58 122.0 51.05 Favored Pre-proline 0 C--O 1.242 0.664 0 CA-C-O 119.648 -0.215 . . . . 70.430000000000007 110.592 -176.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -69.91 112.99 3.25 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.527 2.151 . . . . 73.420000000000002 110.238 174.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -138.44 120.19 15.26 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 109.501 -0.555 . . . . 72.049999999999997 109.501 -177.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -86.08 -21.99 27.39 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 119.914 -0.714 . . . . 75.239999999999995 109.146 176.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -136.67 136.38 39.03 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 106.475 -1.676 . . . . 73.510000000000005 106.475 169.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.474 ' HG3' HG21 ' A' ' 112' ' ' VAL . 0.0 OUTLIER -142.95 151.07 40.53 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 109.761 -0.459 . . . . 74.310000000000002 109.761 -179.872 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.2 p -79.3 123.83 36.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 105.153 -2.166 . . . . 63.229999999999997 105.153 170.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 34.8 ttp -73.54 115.23 12.69 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 121.463 0.649 . . . . 74.120000000000005 110.452 -170.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -103.86 136.96 42.56 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 114.192 -1.367 . . . . 72.409999999999997 109.976 -172.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 40.7 p -88.45 122.27 31.75 Favored 'General case' 0 N--CA 1.411 -2.421 0 CA-C-N 115.047 -0.979 . . . . 63.350000000000001 109.506 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 120.82 -29.09 5.94 Favored Glycine 0 N--CA 1.438 -1.181 0 C-N-CA 120.816 -0.707 . . . . 73.400000000000006 112.306 177.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -93.22 164.08 13.37 Favored 'General case' 0 C--O 1.248 1.002 0 N-CA-C 109.101 -0.703 . . . . 62.399999999999999 109.101 -175.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -108.93 134.86 51.03 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-O 121.989 0.9 . . . . 62.210000000000001 112.052 -176.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 66.4 mt -97.88 121.12 48.08 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 N-CA-C 108.23 -1.026 . . . . 65.340000000000003 108.23 -178.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -89.66 112.54 23.82 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 107.98 -1.119 . . . . 73.230000000000004 107.98 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.442 HG13 ' HB2' ' A' ' 133' ' ' PHE . 6.2 pt -100.99 97.15 5.37 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.572 0 N-CA-C 108.002 -1.11 . . . . 72.129999999999995 108.002 177.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 67.6 -109.52 2.95 Favored Glycine 0 N--CA 1.427 -1.919 0 N-CA-C 109.84 -1.304 . . . . 65.450000000000003 109.84 -173.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -104.72 -17.55 14.59 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 109.237 -0.653 . . . . 73.109999999999999 109.237 176.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.442 ' HB2' HG13 ' A' ' 130' ' ' ILE . 55.1 m-85 -82.92 165.7 19.52 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.659 -0.7 . . . . 71.409999999999997 111.04 -173.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.402 ' HG3' ' HB3' ' A' ' 52' ' ' LYS . 13.1 ptt180 -126.87 122.1 33.69 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 121.719 0.771 . . . . 74.230000000000004 112.294 -170.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 7.8 tt -125.04 142.16 51.67 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.328 -1.36 . . . . 73.420000000000002 107.328 177.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.483 HG23 ' HB2' ' A' ' 52' ' ' LYS . 18.8 t -122.65 131.6 72.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 107.916 -1.142 . . . . 62.100000000000001 107.916 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -102.67 128.88 49.19 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.534 -1.284 . . . . 62.020000000000003 107.534 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -124.75 164.34 20.17 Favored 'General case' 0 C--O 1.253 1.25 0 CA-C-O 121.946 0.879 . . . . 72.400000000000006 111.42 -176.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -72.07 119.84 16.83 Favored 'General case' 0 N--CA 1.416 -2.169 0 CA-C-N 114.446 -1.252 . . . . 75.230000000000004 108.522 176.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -75.64 -160.19 8.78 Favored Glycine 0 N--CA 1.42 -2.425 0 CA-C-N 115.346 -0.843 . . . . 60.420000000000002 111.64 178.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo . . . . . 0 N--CA 1.425 -2.531 0 C-N-CA 121.892 1.728 . . . . 73.25 113.829 -176.151 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 10.0 p30 . . . . . 0 C--O 1.251 1.149 0 CA-C-O 121.376 0.608 . . . . 74.239999999999995 110.302 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -121.29 95.89 0.58 Allowed Glycine 0 N--CA 1.421 -2.338 0 N-CA-C 108.729 -1.748 . . . . 74.140000000000001 108.729 176.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.41 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 7.5 p -99.29 124.54 44.56 Favored Pre-proline 0 C--N 1.291 -1.939 0 N-CA-C 110.571 -0.159 . . . . 72.530000000000001 110.571 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 7' ' ' THR . 24.3 Cg_exo -66.41 134.87 37.45 Favored 'Trans proline' 0 C--O 1.242 0.708 0 C-N-CA 122.46 2.107 . . . . 64.420000000000002 110.016 175.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.428 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 43.7 mt-10 -92.36 129.66 40.26 Favored Pre-proline 0 C--N 1.294 -1.834 0 N-CA-C 109.821 -0.437 . . . . 72.510000000000005 109.821 -179.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 9' ' ' GLU . 71.0 Cg_exo -54.48 148.02 45.04 Favored 'Trans proline' 0 C--O 1.251 1.15 0 C-N-CA 123.683 2.922 . . . . 42.140000000000001 114.003 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -128.3 153.22 47.23 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 115.002 -0.999 . . . . 74.319999999999993 108.655 -178.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.8 p -126.27 136.38 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.805 0 N-CA-C 109.079 -0.711 . . . . 74.0 109.079 178.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -92.24 136.1 33.47 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.85 -1.167 . . . . 75.420000000000002 107.85 176.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.3 p -78.93 88.49 4.73 Favored 'General case' 0 N--CA 1.427 -1.623 0 CA-C-O 122.239 1.018 . . . . 71.099999999999994 110.948 -177.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.6 m -97.29 103.93 15.91 Favored 'General case' 0 N--CA 1.417 -2.103 0 CA-C-N 114.844 -1.071 . . . . 73.239999999999995 108.349 -177.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.8 m -111.72 154.68 24.64 Favored 'General case' 0 N--CA 1.417 -2.119 0 CA-C-N 115.832 -0.622 . . . . 63.43 109.818 -175.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 66.3 t . . . . . 0 C--N 1.291 -1.973 0 CA-C-N 115.577 -0.738 . . . . 72.239999999999995 109.267 179.376 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.622 0 N-CA-C 109.044 -1.623 . . . . 54.420000000000002 109.044 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.0 m -89.33 164.73 14.78 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 121.64 0.734 . . . . 75.109999999999999 112.658 -173.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.507 ' HB1' ' O ' ' A' ' 138' ' ' LEU . . . -131.93 165.42 23.95 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 107.94 -1.133 . . . . 61.299999999999997 107.94 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -127.6 154.8 44.79 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 120.647 -0.421 . . . . 72.099999999999994 111.802 -176.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.464 ' HB2' HD11 ' A' ' 135' ' ' LEU . 2.8 pp -126.23 144.13 50.89 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 115.829 -0.623 . . . . 61.310000000000002 109.974 177.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.494 HG12 ' HB3' ' A' ' 60' ' ' ARG . 1.8 m -128.02 138.99 53.12 Favored 'Isoleucine or valine' 0 C--O 1.252 1.207 0 N-CA-C 109.348 -0.612 . . . . 63.130000000000003 109.348 178.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.499 HG21 ' HB3' ' A' ' 57' ' ' ALA . 93.8 t -93.62 115.98 33.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 109.792 -0.447 . . . . 70.150000000000006 109.792 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -69.38 -38.17 77.88 Favored 'General case' 0 CA--C 1.506 -0.748 0 O-C-N 123.273 0.358 . . . . 63.210000000000001 110.506 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 42.6 ttt180 -168.84 135.49 1.83 Allowed 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.352 -0.84 . . . . 71.519999999999996 109.655 178.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 149.24 145.54 4.15 Favored Glycine 0 N--CA 1.416 -2.639 0 N-CA-C 110.862 -0.895 . . . . 75.109999999999999 110.862 177.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -67.63 -9.16 24.53 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.796 2.331 . . . . 61.219999999999999 112.105 177.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.436 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 87.9 m-20 -51.25 -46.8 62.48 Favored 'General case' 0 C--O 1.21 -1.009 0 C-N-CA 124.674 1.19 . . . . 74.519999999999996 110.333 175.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.499 ' HB3' HG21 ' A' ' 51' ' ' VAL . . . -172.79 -176.78 1.53 Allowed 'General case' 0 C--O 1.215 -0.714 0 N-CA-C 107.632 -1.247 . . . . 62.299999999999997 107.632 178.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -161.8 41.9 0.39 Allowed Glycine 0 C--N 1.29 -1.987 0 N-CA-C 109.938 -1.265 . . . . 65.430000000000007 109.938 -178.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -159.46 -166.39 1.78 Allowed 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 107.863 -1.162 . . . . 63.420000000000002 107.863 -176.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.494 ' HB3' HG12 ' A' ' 50' ' ' VAL . 19.6 ptt180 -115.71 135.03 54.44 Favored 'General case' 0 N--CA 1.433 -1.317 0 O-C-N 123.934 0.771 . . . . 73.25 109.294 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -126.75 121.77 32.93 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 120.772 0.32 . . . . 75.030000000000001 111.152 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 44.2 tp -88.04 119.32 28.3 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 106.913 -1.514 . . . . 60.32 106.913 177.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -79.66 114.8 18.87 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 120.57 -0.452 . . . . 72.400000000000006 110.137 -177.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -95.91 -20.82 18.47 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.663 0.744 . . . . 63.009999999999998 110.368 -176.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -97.22 139.66 21.6 Favored Pre-proline 0 C--N 1.304 -1.409 0 CA-C-N 114.91 -1.041 . . . . 74.150000000000006 112.098 -175.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.443 ' HA ' ' CG2' ' A' ' 94' ' ' ILE . 29.9 Cg_endo -64.42 -24.53 64.08 Favored 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 123.488 2.792 . . . . 74.430000000000007 114.347 -177.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.8 m -135.25 103.93 5.7 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 121.445 0.641 . . . . 72.219999999999999 109.972 178.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 17.0 m -103.13 121.69 43.16 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 115.456 -0.793 . . . . 74.230000000000004 109.658 -178.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.6 m -97.8 119.86 37.16 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 109.933 -0.395 . . . . 74.340000000000003 109.933 -177.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.82 133.84 42.56 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 121.217 0.532 . . . . 75.200000000000003 109.851 178.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -170.13 -152.71 8.18 Favored Glycine 0 N--CA 1.424 -2.139 0 N-CA-C 108.456 -1.857 . . . . 70.120000000000005 108.456 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.5 ttt180 -90.37 -38.77 13.1 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 118.765 -1.174 . . . . 61.43 111.901 -178.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -176.73 -56.22 0.0 OUTLIER Pre-proline 0 CA--C 1.569 1.677 0 N-CA-C 114.679 1.362 . . . . 73.219999999999999 114.679 -178.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -49.88 -41.65 46.73 Favored 'Trans proline' 0 C--N 1.388 2.641 0 C-N-CA 123.325 2.683 . . . . 71.409999999999997 116.697 -167.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.406 ' OE2' ' HB2' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -126.17 7.97 7.23 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 122.415 1.102 . . . . 72.129999999999995 108.34 178.31 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.5 m -82.72 121.28 26.67 Favored 'General case' 0 N--CA 1.4 -2.941 0 CA-C-N 114.082 -1.417 . . . . 73.040000000000006 108.524 -175.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -66.3 -31.63 72.54 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.777 0.799 . . . . 73.540000000000006 109.633 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.463 HD13 ' H ' ' A' ' 78' ' ' ILE . 0.2 OUTLIER -127.44 141.17 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.391 0 N-CA-C 106.322 -1.733 . . . . 73.129999999999995 106.322 172.269 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -97.47 117.73 32.37 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 120.959 0.409 . . . . 63.399999999999999 111.746 -176.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 5.9 mp -102.51 179.06 4.41 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 107.891 -1.151 . . . . 45.340000000000003 107.891 178.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.419 ' H ' ' HA ' ' A' ' 56' ' ' ASN . 15.4 t70 -163.99 84.24 0.45 Allowed 'General case' 0 N--CA 1.442 -0.841 0 CA-C-O 121.791 0.805 . . . . 74.140000000000001 110.671 178.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.495 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 11.2 t70 -97.48 165.0 12.21 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 105.458 -2.052 . . . . 73.129999999999995 105.458 170.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.8 p -69.39 -27.22 33.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 CA-C-N 119.08 0.855 . . . . 61.200000000000003 110.615 -178.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.465 ' HB ' ' ND2' ' A' ' 108' ' ' ASN . 4.2 m -119.45 36.82 4.36 Favored 'General case' 0 CA--C 1.556 1.187 0 CA-C-O 121.855 0.835 . . . . 75.409999999999997 108.756 -179.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.495 ' HB ' ' HB3' ' A' ' 82' ' ' ASP . 11.8 p -81.75 140.14 16.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 108.958 -0.756 . . . . 65.140000000000001 108.958 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 26.3 m -121.34 147.33 45.84 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 110.016 -0.365 . . . . 75.230000000000004 110.016 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.406 ' HB2' ' OE2' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -59.76 132.19 53.21 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 107.222 -1.399 . . . . 70.420000000000002 107.222 170.683 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 42.1 mtm180 58.8 74.17 0.45 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.568 0.699 . . . . 75.209999999999994 109.758 -169.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -100.13 -58.55 1.89 Allowed 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 108.181 -1.044 . . . . 62.109999999999999 108.181 -177.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -136.58 135.93 38.81 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.507 -0.924 . . . . 55.149999999999999 108.507 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -108.3 126.76 53.2 Favored 'General case' 0 C--N 1.278 -2.503 0 N-CA-C 107.88 -1.155 . . . . 74.409999999999997 107.88 178.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -104.51 112.68 25.84 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.525 -0.917 . . . . 60.420000000000002 108.525 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 35.2 ttt180 -116.65 147.55 41.82 Favored 'General case' 0 C--N 1.275 -2.657 0 N-CA-C 108.331 -0.989 . . . . 74.030000000000001 108.331 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.443 ' CG2' ' HA ' ' A' ' 66' ' ' PRO . 6.7 tt -114.62 137.67 47.25 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.341 0 N-CA-C 108.436 -0.95 . . . . 62.030000000000001 108.436 177.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -118.31 147.48 43.42 Favored 'General case' 0 N--CA 1.419 -2.003 0 N-CA-C 105.942 -1.873 . . . . 74.209999999999994 105.942 177.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -42.48 -19.13 0.01 OUTLIER 'General case' 0 CA--C 1.559 1.326 0 N-CA-C 116.719 2.118 . . . . 73.219999999999999 116.719 -174.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -119.14 -29.1 1.86 Allowed Glycine 0 N--CA 1.43 -1.73 0 C-N-CA 120.751 -0.738 . . . . 53.030000000000001 113.527 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -161.24 177.57 10.08 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-N 118.089 0.944 . . . . 34.420000000000002 109.765 -174.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -103.47 138.67 39.87 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 113.596 0.962 . . . . 72.420000000000002 113.596 -173.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -112.93 116.82 30.59 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.273 -1.01 . . . . 62.439999999999998 108.273 178.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 59.3 t -119.4 119.52 60.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 108.752 -0.832 . . . . 72.310000000000002 108.752 -178.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.6 m -111.4 131.79 61.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-O 121.417 0.627 . . . . 71.030000000000001 111.276 -179.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -91.29 113.29 25.52 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.125 -0.943 . . . . 74.049999999999997 109.486 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 19.1 m -114.79 9.88 7.72 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 CA-C-O 121.463 0.649 . . . . 74.030000000000001 109.954 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -127.75 53.29 0.8 Allowed Glycine 0 N--CA 1.431 -1.641 0 N-CA-C 110.367 -1.093 . . . . 45.340000000000003 110.367 179.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.4 m -61.42 -7.61 3.24 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 124.42 1.088 . . . . 75.349999999999994 113.059 -177.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 69.0 tp -58.15 -44.76 88.03 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 107.996 -1.112 . . . . 72.510000000000005 107.996 174.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.543 ' OD1' ' HA2' ' A' ' 131' ' ' GLY . 52.3 t-20 -98.9 -53.1 3.37 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 106.409 -1.7 . . . . 64.430000000000007 106.409 175.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 94.96 135.87 8.24 Favored Glycine 0 N--CA 1.432 -1.604 0 CA-C-N 115.037 -0.983 . . . . 62.509999999999998 112.716 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 26.9 m -91.94 123.65 35.47 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 108.211 -1.033 . . . . 64.439999999999998 108.211 173.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -102.29 133.87 46.49 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-O 120.994 0.426 . . . . 74.200000000000003 110.277 -177.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.6 p -105.23 115.74 47.67 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 N-CA-C 106.536 -1.653 . . . . 75.430000000000007 106.536 173.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 12.2 m120 64.73 -78.41 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 124.737 1.215 . . . . 73.329999999999998 110.767 -173.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 -140.18 -3.75 1.37 Allowed 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 123.703 0.801 . . . . 63.140000000000001 110.44 -176.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -118.03 130.21 24.87 Favored Pre-proline 0 C--N 1.325 -0.462 0 C-N-CA 120.688 -0.405 . . . . 75.439999999999998 111.711 -170.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -79.64 117.3 3.65 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.394 2.063 . . . . 74.340000000000003 111.104 177.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 36.9 mmt180 -118.76 153.84 33.78 Favored 'General case' 0 C--N 1.308 -1.238 0 O-C-N 121.762 -0.586 . . . . 75.019999999999996 109.868 -177.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -84.73 -25.39 28.36 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.71 0.767 . . . . 74.319999999999993 109.123 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -157.56 139.17 13.9 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 107.539 -1.282 . . . . 41.520000000000003 107.539 175.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -140.62 149.25 42.07 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-O 121.033 0.444 . . . . 73.030000000000001 110.973 178.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 41.1 t -104.52 105.04 17.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 105.294 -2.113 . . . . 72.219999999999999 105.294 175.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 65.7 mtp -103.25 151.35 22.77 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 113.488 0.921 . . . . 64.329999999999998 113.488 -171.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -113.96 153.33 29.49 Favored 'General case' 0 N--CA 1.418 -2.049 0 CA-C-N 113.813 -1.539 . . . . 72.409999999999997 108.269 -177.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.7 p -77.71 129.36 35.42 Favored 'General case' 0 N--CA 1.417 -2.093 0 CA-C-O 121.532 0.682 . . . . 41.340000000000003 111.646 -176.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 111.82 8.64 22.12 Favored Glycine 0 N--CA 1.442 -0.91 0 N-CA-C 110.539 -1.025 . . . . 34.409999999999997 110.539 -177.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -109.89 169.34 8.78 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-O 120.445 0.164 . . . . 62.130000000000003 110.989 -175.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.405 ' OE2' ' HD2' ' A' ' 134' ' ' ARG . 38.2 tt0 -108.73 139.97 42.8 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 113.299 0.851 . . . . 63.520000000000003 113.299 -172.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 58.4 mt -125.31 131.23 72.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 124.436 1.094 . . . . 74.150000000000006 109.704 -176.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -113.94 124.05 51.22 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 121.404 0.621 . . . . 73.239999999999995 110.069 173.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 27.7 mt -108.5 100.07 9.98 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 N-CA-C 107.311 -1.366 . . . . 63.329999999999998 107.311 -177.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.543 ' HA2' ' OD1' ' A' ' 108' ' ' ASN . . . 71.04 -100.6 0.87 Allowed Glycine 0 N--CA 1.425 -2.06 0 O-C-N 124.25 0.969 . . . . 62.219999999999999 110.788 -177.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -114.6 -9.81 12.59 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-O 121.16 0.505 . . . . 74.129999999999995 110.685 177.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -104.27 142.61 34.23 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 118.993 -1.083 . . . . 74.439999999999998 112.32 -171.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.405 ' HD2' ' OE2' ' A' ' 127' ' ' GLU . 11.9 ttp180 -106.79 128.78 54.53 Favored 'General case' 0 C--O 1.248 0.992 0 N-CA-C 113.792 1.034 . . . . 72.319999999999993 113.792 -167.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.464 HD11 ' HB2' ' A' ' 49' ' ' LEU . 38.8 tp -123.94 145.04 49.42 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 126.449 1.9 . . . . 62.509999999999998 109.551 -174.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.419 ' CG1' HG22 ' A' ' 50' ' ' VAL . 7.3 p -123.17 135.24 63.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 108.84 -0.8 . . . . 72.340000000000003 108.84 171.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -112.11 118.41 35.3 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.499 -0.926 . . . . 74.420000000000002 108.499 -174.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.507 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 4.5 mp -120.88 164.42 16.69 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 120.891 0.377 . . . . 72.310000000000002 111.089 -175.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -75.25 145.74 41.68 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.298 -0.63 . . . . 54.25 109.298 177.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -103.7 -178.62 25.79 Favored Glycine 0 N--CA 1.429 -1.789 0 C-N-CA 120.608 -0.806 . . . . 64.439999999999998 111.638 -178.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo . . . . . 0 C--O 1.242 0.686 0 C-N-CA 122.628 2.219 . . . . 55.32 112.515 -179.394 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 51.6 t30 . . . . . 0 N--CA 1.478 0.951 0 CA-C-O 121.266 0.555 . . . . 75.200000000000003 111.459 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -108.48 175.63 19.69 Favored Glycine 0 N--CA 1.426 -1.992 0 N-CA-C 110.258 -1.137 . . . . 74.140000000000001 110.258 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.1 m -68.98 130.92 91.15 Favored Pre-proline 0 C--N 1.3 -1.578 0 N-CA-C 108.294 -1.002 . . . . 74.239999999999995 108.294 178.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.538 ' O ' ' HD3' ' A' ' 10' ' ' PRO . 10.7 Cg_endo -53.46 149.86 29.02 Favored 'Trans proline' 0 C--N 1.358 1.059 0 C-N-CA 123.22 2.614 . . . . 53.219999999999999 111.814 -179.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -85.74 105.11 6.29 Favored Pre-proline 0 N--CA 1.422 -1.831 0 N-CA-C 107.741 -1.207 . . . . 74.239999999999995 107.741 178.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.538 ' HD3' ' O ' ' A' ' 8' ' ' PRO . 86.8 Cg_endo -103.26 155.0 0.25 Allowed 'Trans proline' 0 N--CA 1.437 -1.823 0 C-N-CA 122.596 2.197 . . . . 74.450000000000003 112.981 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -80.73 72.47 7.69 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 122.452 1.12 . . . . 74.409999999999997 109.412 173.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.8 p -62.02 142.48 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 CA-C-N 113.454 -1.703 . . . . 75.209999999999994 109.998 -177.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.05 137.59 51.39 Favored 'General case' 0 N--CA 1.423 -1.779 0 C-N-CA 119.72 -0.792 . . . . 72.120000000000005 110.16 179.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.4 m -129.53 90.99 3.08 Favored 'General case' 0 C--N 1.274 -2.674 0 N-CA-C 107.495 -1.298 . . . . 72.219999999999999 107.495 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 94.3 m -69.28 97.0 0.9 Allowed 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 115.066 -0.97 . . . . 72.209999999999994 111.183 -177.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 25.3 t -136.51 112.9 9.94 Favored 'General case' 0 N--CA 1.419 -2.005 0 N-CA-C 105.741 -1.948 . . . . 63.539999999999999 105.741 178.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.7 m . . . . . 0 C--N 1.292 -1.913 0 CA-C-N 116.051 -0.522 . . . . 45.039999999999999 111.22 -174.382 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.689 0 N-CA-C 108.122 -1.991 . . . . 54.329999999999998 108.122 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.3 m -91.14 167.84 12.06 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 114.252 -0.974 . . . . 60.299999999999997 110.033 -176.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -102.19 166.84 10.37 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 109.907 -0.405 . . . . 72.530000000000001 109.907 -179.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -134.35 152.64 51.92 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.841 -0.8 . . . . 74.040000000000006 108.841 176.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.421 ' HB2' HD11 ' A' ' 135' ' ' LEU . 4.4 pp -109.27 134.63 51.54 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 108.772 -0.825 . . . . 72.349999999999994 108.772 178.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 94.1 t -117.08 117.81 56.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 CA-C-N 116.032 -0.531 . . . . 73.239999999999995 109.604 -177.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.566 HG21 ' HB3' ' A' ' 57' ' ' ALA . 15.6 t -93.15 118.96 40.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 107.711 -1.218 . . . . 72.540000000000006 107.711 178.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -75.99 -42.35 48.49 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 115.664 -0.698 . . . . 64.340000000000003 109.156 -178.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 62.3 ttt180 -177.34 157.64 1.35 Allowed 'General case' 0 C--O 1.245 0.865 0 CA-C-N 115.047 -0.979 . . . . 71.299999999999997 108.921 -177.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 124.88 142.85 5.97 Favored Glycine 0 C--O 1.202 -1.866 0 CA-C-O 119.201 -0.777 . . . . 65.340000000000003 111.563 176.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.568 ' HD2' ' CE1' ' A' ' 133' ' ' PHE . 9.3 Cg_endo -51.62 -7.4 0.2 Allowed 'Trans proline' 0 N--CA 1.499 1.828 0 C-N-CA 124.963 3.775 . . . . 74.349999999999994 115.311 177.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.606 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -56.64 -51.59 68.14 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 108.225 -1.028 . . . . 74.430000000000007 108.225 175.079 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.566 ' HB3' HG21 ' A' ' 51' ' ' VAL . . . -179.5 -171.51 0.19 Allowed 'General case' 0 C--O 1.214 -0.783 0 N-CA-C 106.585 -1.635 . . . . 71.540000000000006 106.585 -178.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -166.96 56.4 0.23 Allowed Glycine 0 C--N 1.291 -1.932 0 N-CA-C 110.416 -1.073 . . . . 54.020000000000003 110.416 -177.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -163.04 -171.01 2.5 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.595 -1.261 . . . . 71.439999999999998 107.595 -178.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 18.4 ptp180 -136.66 138.26 40.92 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.618 -0.882 . . . . 54.329999999999998 108.618 178.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -142.0 148.23 38.22 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 120.128 -0.629 . . . . 73.349999999999994 111.686 176.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.1 tt -84.06 133.97 34.63 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 113.943 -1.481 . . . . 73.230000000000004 107.519 -177.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.5 mp -87.51 112.92 22.73 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 108.501 -0.926 . . . . 63.119999999999997 108.501 178.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -125.12 18.02 8.4 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 122.42 1.105 . . . . 62.350000000000001 108.136 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -119.2 149.31 46.96 Favored Pre-proline 0 C--N 1.296 -1.717 0 CA-C-N 113.874 -1.512 . . . . 74.409999999999997 108.257 -176.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -63.68 -35.23 59.44 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 122.409 2.073 . . . . 72.519999999999996 112.582 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 92' ' ' PHE . 44.1 m -137.53 123.06 19.68 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 116.516 -0.311 . . . . 70.439999999999998 111.133 179.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.469 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 31.3 m -98.12 116.89 31.27 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 106.566 -1.642 . . . . 72.219999999999999 106.566 171.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.505 ' HB ' ' NE2' ' A' ' 73' ' ' HIS . 0.1 OUTLIER -104.86 102.6 12.13 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-O 121.23 0.538 . . . . 71.340000000000003 112.102 -174.37 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -105.87 117.74 34.8 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.088 0.47 . . . . 54.039999999999999 110.173 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 172.41 -163.75 35.93 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.949 -1.26 . . . . 73.209999999999994 109.949 -179.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.7 ptp180 -110.96 21.45 16.44 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 122.045 0.926 . . . . 42.439999999999998 109.561 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.522 ' HD1' ' HA ' ' A' ' 88' ' ' ARG . 12.1 p-80 -84.95 163.67 45.06 Favored Pre-proline 0 C--N 1.299 -1.599 0 CA-C-N 114.672 -1.149 . . . . 72.310000000000002 109.799 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -51.01 -40.42 58.89 Favored 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 123.602 2.868 . . . . 43.340000000000003 115.693 -174.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -97.13 30.21 2.85 Favored 'General case' 0 C--N 1.318 -0.801 0 O-C-N 121.515 -0.741 . . . . 72.409999999999997 112.873 -176.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.0 p -56.91 116.9 3.47 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.268 -0.424 . . . . 75.540000000000006 111.208 178.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -67.23 -49.79 63.14 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 106.301 -1.741 . . . . 74.310000000000002 106.301 173.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 30.4 pt -134.28 138.26 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 CA-C-N 113.606 -1.634 . . . . 63.5 107.236 174.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -104.09 117.54 34.51 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 108.676 -0.861 . . . . 62.25 108.676 177.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.606 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 2.1 pt? -75.38 111.58 10.81 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.369 -0.975 . . . . 61.109999999999999 108.369 177.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -85.59 73.6 10.43 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 118.954 -1.099 . . . . 74.099999999999994 112.752 -173.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -119.85 150.8 39.87 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 115.031 -0.986 . . . . 73.519999999999996 108.901 170.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.0 p -73.38 -20.17 18.36 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 C-N-CA 122.921 0.488 . . . . 71.340000000000003 112.281 -176.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.448 ' HB ' ' ND2' ' A' ' 108' ' ' ASN . 1.3 m -89.53 6.68 39.95 Favored 'General case' 0 CA--C 1.557 1.25 0 CA-C-O 121.057 0.455 . . . . 74.409999999999997 111.943 -172.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.406 HG21 ' HG ' ' A' ' 80' ' ' LEU . 48.4 t -82.27 137.16 21.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 109.409 -0.589 . . . . 62.409999999999997 109.409 -178.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 15.3 p -86.01 -71.1 0.56 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.989 0.423 . . . . 62.109999999999999 112.104 -178.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 21.2 tpp180 -150.19 -66.96 0.2 Allowed 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 106.953 -1.499 . . . . 74.340000000000003 106.953 -178.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.522 ' HA ' ' HD1' ' A' ' 73' ' ' HIS . 48.0 mtt180 -96.56 167.81 10.92 Favored 'General case' 0 CA--C 1.486 -1.516 0 N-CA-C 106.228 -1.768 . . . . 71.400000000000006 106.228 171.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -151.49 -70.72 0.17 Allowed 'General case' 0 C--N 1.292 -1.934 0 C-N-CA 118.921 -1.112 . . . . 73.129999999999995 109.753 -177.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -133.45 104.05 6.23 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-O 121.155 0.502 . . . . 73.140000000000001 109.908 -178.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.424 ' OE1' ' HD3' ' A' ' 88' ' ' ARG . 3.0 mp0 -104.01 132.24 50.45 Favored 'General case' 0 N--CA 1.419 -1.983 0 C-N-CA 119.738 -0.785 . . . . 73.200000000000003 109.961 176.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.469 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 29.9 m-85 -97.1 112.22 24.1 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 105.287 -2.116 . . . . 71.209999999999994 105.287 175.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 72.8 mtt180 -118.3 115.31 24.46 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 106.63 -1.619 . . . . 74.5 106.63 -175.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.9 pp -115.48 143.03 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.927 0 C-N-CA 119.58 -0.848 . . . . 71.340000000000003 111.734 -172.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -117.71 146.77 43.52 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 105.219 -2.141 . . . . 53.43 105.219 175.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -49.01 -32.97 10.19 Favored 'General case' 0 C--N 1.315 -0.912 0 O-C-N 123.575 0.547 . . . . 71.510000000000005 112.453 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -85.35 -48.27 4.86 Favored Glycine 0 N--CA 1.433 -1.538 0 C-N-CA 120.733 -0.746 . . . . 64.430000000000007 112.749 179.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -133.2 131.55 40.5 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-O 121.682 0.753 . . . . 51.039999999999999 112.581 -177.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -99.74 124.55 45.12 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.209 -1.034 . . . . 72.219999999999999 108.209 -178.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -129.19 136.54 50.28 Favored 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 113.829 1.048 . . . . 60.149999999999999 113.829 -176.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.2 p -110.84 118.9 58.36 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 CA-C-N 114.73 -1.123 . . . . 65.120000000000005 108.884 175.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.8 m -120.37 120.8 63.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 N-CA-C 113.166 0.802 . . . . 61.520000000000003 113.166 -177.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.488 ' HB3' ' HB2' ' A' ' 118' ' ' ASN . 4.6 t70 -84.76 122.7 29.49 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 109.164 -0.68 . . . . 63.420000000000002 109.164 169.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 26.8 m -114.53 -1.12 9.48 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 CA-C-N 115.625 -0.716 . . . . 62.140000000000001 109.47 177.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -112.85 59.95 0.36 Allowed Glycine 0 N--CA 1.434 -1.486 0 N-CA-C 110.619 -0.993 . . . . 65.430000000000007 110.619 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 19.1 m -72.41 19.25 0.08 Allowed 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 123.671 0.788 . . . . 71.219999999999999 112.913 -175.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.2 mp -75.58 -33.61 60.6 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 109.58 -0.526 . . . . 75.219999999999999 109.58 178.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.448 ' ND2' ' HB ' ' A' ' 84' ' ' THR . 10.0 m120 -80.25 -24.27 40.25 Favored 'General case' 0 CA--C 1.5 -0.962 0 CA-C-N 116.15 -0.477 . . . . 71.030000000000001 110.54 176.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 86.59 82.58 1.15 Allowed Glycine 0 N--CA 1.428 -1.889 0 N-CA-C 109.956 -1.258 . . . . 70.430000000000007 109.956 -177.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 64.7 m -87.18 119.51 27.49 Favored 'General case' 0 N--CA 1.42 -1.938 0 CA-C-O 121.305 0.574 . . . . 62.530000000000001 109.803 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -116.66 134.07 55.26 Favored 'General case' 0 N--CA 1.425 -1.688 0 N-CA-C 107.54 -1.282 . . . . 73.120000000000005 107.54 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.458 HG12 ' O ' ' A' ' 117' ' ' ARG . 7.4 p -117.68 132.23 68.09 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.713 0 N-CA-C 107.264 -1.384 . . . . 72.430000000000007 107.264 175.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 64.93 26.33 12.79 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 107.837 -1.171 . . . . 63.130000000000003 107.837 -175.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.452 ' HG2' HH11 ' A' ' 114' ' ' ARG . 16.9 mtt-85 70.27 7.48 6.24 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 126.638 1.975 . . . . 73.310000000000002 111.698 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -106.69 144.62 29.42 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 109.831 -0.433 . . . . 71.140000000000001 109.831 -176.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -68.11 91.74 0.38 Allowed 'Trans proline' 0 C--N 1.356 0.93 0 C-N-CA 122.223 1.949 . . . . 72.340000000000003 112.402 176.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.458 ' O ' HG12 ' A' ' 112' ' ' VAL . 5.2 ptt180 -154.61 116.55 4.19 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 125.034 1.333 . . . . 72.299999999999997 108.881 174.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.488 ' HB2' ' HB3' ' A' ' 103' ' ' ASP . 23.5 p-10 -83.74 -30.99 26.24 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 114.888 -1.051 . . . . 62.219999999999999 113.125 -174.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -105.53 138.26 42.01 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.675 -0.81 . . . . 71.409999999999997 110.929 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -140.46 149.36 42.46 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 113.394 0.887 . . . . 71.030000000000001 113.394 178.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.7 p -91.34 135.76 26.09 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 N-CA-C 106.67 -1.604 . . . . 74.340000000000003 106.67 173.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 23.2 ttt -39.45 102.52 0.02 OUTLIER 'General case' 0 C--O 1.247 0.954 0 N-CA-C 114.001 1.111 . . . . 61.219999999999999 114.001 178.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.46 HE21 ' HB2' ' A' ' 126' ' ' ASP . 25.3 tt0 -123.23 123.39 40.66 Favored 'General case' 0 N--CA 1.424 -1.77 0 N-CA-C 105.605 -1.998 . . . . 74.209999999999994 105.605 173.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 7.3 t -81.92 129.06 34.65 Favored 'General case' 0 C--N 1.291 -1.959 0 C-N-CA 120.565 -0.454 . . . . 74.430000000000007 110.363 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 100.36 18.54 21.19 Favored Glycine 0 N--CA 1.433 -1.532 0 CA-C-N 115.55 -0.75 . . . . 64.420000000000002 112.18 177.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.46 ' HB2' HE21 ' A' ' 123' ' ' GLN . 25.3 t0 -110.77 150.05 29.64 Favored 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 119.581 -0.848 . . . . 72.049999999999997 109.501 -179.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -110.48 132.26 54.34 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.558 0.694 . . . . 74.239999999999995 112.519 -174.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 66.2 mt -108.42 118.43 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.591 0 CA-C-N 114.68 -1.146 . . . . 75.120000000000005 107.991 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.425 ' OE1' ' HG2' ' A' ' 114' ' ' ARG . 54.6 mt-30 -109.54 112.61 24.81 Favored 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 109.221 -0.659 . . . . 73.5 109.221 178.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.432 ' O ' HG13 ' A' ' 130' ' ' ILE . 23.4 pt -95.09 96.94 6.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 108.771 -0.825 . . . . 75.549999999999997 108.771 177.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 61.67 -85.31 0.03 OUTLIER Glycine 0 CA--C 1.528 0.853 0 CA-C-N 115.35 -0.841 . . . . 54.140000000000001 112.897 -176.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.503 ' HE3' ' CZ ' ' A' ' 133' ' ' PHE . 48.2 mtmt -113.66 -13.38 12.71 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 123.175 0.59 . . . . 32.009999999999998 111.237 -175.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.568 ' CE1' ' HD2' ' A' ' 55' ' ' PRO . 19.3 m-85 -107.3 154.07 21.81 Favored 'General case' 0 CA--C 1.501 -0.923 0 C-N-CA 119.748 -0.781 . . . . 74.219999999999999 112.227 -169.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 74.2 mtp180 -119.27 122.57 42.21 Favored 'General case' 0 C--O 1.248 0.987 0 CA-C-O 121.603 0.716 . . . . 64.329999999999998 112.623 -172.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.421 HD11 ' HB2' ' A' ' 49' ' ' LEU . 56.9 tp -123.95 131.21 53.54 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 114.466 -1.243 . . . . 73.239999999999995 107.841 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.7 t -115.58 138.76 44.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 N-CA-C 108.17 -1.048 . . . . 71.200000000000003 108.17 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -111.13 117.0 32.06 Favored 'General case' 0 C--N 1.309 -1.152 0 N-CA-C 109.302 -0.629 . . . . 74.530000000000001 109.302 -176.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -123.69 158.99 30.33 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.861 -0.422 . . . . 70.519999999999996 109.861 -177.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -79.91 140.67 36.62 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.049 -1.463 . . . . 61.140000000000001 107.049 172.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -97.96 -143.2 14.39 Favored Glycine 0 C--N 1.292 -1.861 0 C-N-CA 120.329 -0.939 . . . . 52.149999999999999 112.232 -176.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo . . . . . 0 N--CA 1.44 -1.668 0 C-N-CA 122.259 1.973 . . . . 70.299999999999997 113.662 -177.484 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 . . . . . 0 N--CA 1.439 -0.994 0 N-CA-C 107.848 -1.167 . . . . 72.209999999999994 107.848 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -94.05 76.62 1.03 Allowed Glycine 0 N--CA 1.426 -1.969 0 CA-C-N 113.987 -1.46 . . . . 54.420000000000002 110.863 -178.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.3 p -77.25 123.88 87.07 Favored Pre-proline 0 C--N 1.291 -1.978 0 CA-C-N 115.332 -0.434 . . . . 73.310000000000002 110.396 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -65.6 146.35 84.28 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 121.617 1.545 . . . . 75.530000000000001 110.384 177.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -68.6 122.57 85.18 Favored Pre-proline 0 C--N 1.302 -1.494 0 N-CA-C 109.733 -0.469 . . . . 72.519999999999996 109.733 -174.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -50.23 159.27 1.98 Allowed 'Trans proline' 0 C--N 1.37 1.686 0 C-N-CA 124.281 3.321 . . . . 73.400000000000006 112.624 -178.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 53.3 tp60 -51.14 107.0 0.15 Allowed 'General case' 0 C--O 1.242 0.7 0 C-N-CA 123.666 0.786 . . . . 73.219999999999999 112.418 -174.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.4 p -84.57 146.73 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 107.539 -1.282 . . . . 65.219999999999999 107.539 175.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -104.76 121.48 43.71 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 107.414 -1.328 . . . . 73.319999999999993 107.414 -178.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.4 m -132.94 120.33 21.3 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.96 -0.755 . . . . 52.210000000000001 108.96 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.9 t -115.08 133.01 56.41 Favored 'General case' 0 N--CA 1.412 -2.355 0 CA-C-O 121.666 0.746 . . . . 72.109999999999999 109.562 -177.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 21.0 m -92.88 127.81 38.52 Favored 'General case' 0 C--N 1.283 -2.321 0 N-CA-C 108.169 -1.049 . . . . 75.239999999999995 108.169 178.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.5 m . . . . . 0 C--N 1.282 -2.329 0 N-CA-C 108.496 -0.928 . . . . 72.109999999999999 108.496 178.799 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.413 -2.86 0 N-CA-C 111.572 -0.611 . . . . 31.420000000000002 111.572 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 42.6 m -90.85 166.69 12.94 Favored 'General case' 0 N--CA 1.407 -2.598 0 N-CA-C 107.975 -1.12 . . . . 74.109999999999999 107.975 177.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -91.59 154.38 19.1 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 109.763 -0.458 . . . . 64.319999999999993 109.763 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.4 ' H ' HD23 ' A' ' 48' ' ' LEU . 2.4 pt? -131.31 148.51 52.69 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.721 -0.844 . . . . 72.200000000000003 108.721 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.562 ' HB2' HD21 ' A' ' 135' ' ' LEU . 4.4 pp -112.66 138.59 49.23 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 109.511 -0.552 . . . . 60.229999999999997 109.511 178.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 38.7 t -114.54 120.0 63.04 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 108.087 -1.079 . . . . 63.140000000000001 108.087 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 26.3 t -93.2 115.6 32.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 107.523 -1.288 . . . . 74.430000000000007 107.523 178.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -85.38 -40.16 16.79 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.117 -0.947 . . . . 63.310000000000002 109.991 -176.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 36.9 mmt180 -144.32 153.67 42.24 Favored 'General case' 0 CA--C 1.495 -1.17 0 CA-C-N 115.589 -0.732 . . . . 75.120000000000005 110.185 -177.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 131.89 140.23 4.49 Favored Glycine 0 N--CA 1.426 -2.022 0 O-C-N 124.185 0.928 . . . . 43.219999999999999 111.57 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.442 ' HB2' ' O ' ' A' ' 81' ' ' ASP . 14.1 Cg_exo -69.08 -14.95 39.2 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 122.533 2.156 . . . . 61.420000000000002 111.508 175.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.557 ' HA ' ' H ' ' A' ' 81' ' ' ASP . 4.7 p-10 -61.72 -48.77 79.24 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.417 1.087 . . . . 73.450000000000003 111.162 178.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -166.89 171.09 11.6 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.756 -0.831 . . . . 34.130000000000003 108.756 -176.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -155.05 30.28 0.65 Allowed Glycine 0 C--N 1.303 -1.287 0 N-CA-C 110.042 -1.223 . . . . 43.109999999999999 110.042 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -132.78 -168.51 2.08 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 109.261 -0.644 . . . . 65.329999999999998 109.261 -177.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.415 ' HA ' ' O ' ' A' ' 49' ' ' LEU . 19.8 ptp180 -135.02 137.18 42.71 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 109.187 -0.671 . . . . 75.030000000000001 109.187 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.437 ' CE2' HD11 ' A' ' 49' ' ' LEU . 53.0 p90 -135.28 148.42 49.53 Favored 'General case' 0 C--N 1.293 -1.885 0 C-N-CA 120.044 -0.662 . . . . 73.219999999999999 110.579 178.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 36.2 tp -86.69 122.83 31.15 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 124.241 0.963 . . . . 74.430000000000007 108.459 -178.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.4 mp -83.99 114.56 21.8 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.103 0.478 . . . . 73.049999999999997 111.408 -176.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -129.49 7.03 5.28 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.11 -0.95 . . . . 75.109999999999999 108.576 172.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.521 ' OE1' ' HA ' ' A' ' 68' ' ' THR . 8.4 tt0 -88.87 123.52 67.42 Favored Pre-proline 0 N--CA 1.421 -1.888 0 CA-C-N 114.377 -1.283 . . . . 73.299999999999997 107.952 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -51.54 -44.93 40.81 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 123.437 2.758 . . . . 64.540000000000006 112.049 -177.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 91.2 m -136.15 99.38 4.11 Favored 'General case' 0 N--CA 1.425 -1.681 0 N-CA-C 109.026 -0.731 . . . . 70.030000000000001 109.026 174.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.521 ' HA ' ' OE1' ' A' ' 65' ' ' GLN . 16.9 m -77.7 116.45 18.25 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 107.196 -1.409 . . . . 64.040000000000006 107.196 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.503 HG22 ' CE1' ' A' ' 73' ' ' HIS . 2.3 m -92.81 92.54 7.98 Favored 'General case' 0 N--CA 1.419 -1.987 0 CA-C-O 121.152 0.501 . . . . 63.32 110.435 -171.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.464 ' HB2' HD11 ' A' ' 78' ' ' ILE . . . -97.94 131.87 44.01 Favored 'General case' 0 C--O 1.246 0.893 0 CA-C-N 115.723 -0.671 . . . . 73.230000000000004 111.007 -178.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 155.75 -137.66 5.66 Favored Glycine 0 CA--C 1.472 -2.635 0 N-CA-C 107.442 -2.263 . . . . 71.040000000000006 107.442 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -103.51 -83.33 0.49 Allowed 'General case' 0 N--CA 1.418 -2.074 0 N-CA-C 107.538 -1.282 . . . . 74.420000000000002 107.538 170.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.503 ' CE1' HG22 ' A' ' 69' ' ' THR . 31.6 m80 67.03 161.32 0.14 Allowed Pre-proline 0 N--CA 1.475 0.824 0 C-N-CA 123.994 0.918 . . . . 54.100000000000001 110.86 178.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -67.34 -22.01 46.55 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 121.903 1.736 . . . . 71.530000000000001 110.098 167.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -120.82 78.34 1.38 Allowed 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 108.519 -0.919 . . . . 74.140000000000001 108.519 -177.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.0 m -79.9 109.88 14.74 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-N 115.834 -0.621 . . . . 63.420000000000002 109.464 178.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.494 ' CG ' HE22 ' A' ' 65' ' ' GLN . 35.3 t70 -69.76 -43.11 72.91 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 106.936 -1.505 . . . . 44.229999999999997 106.936 173.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.464 HD11 ' HB2' ' A' ' 70' ' ' ALA . 0.2 OUTLIER -140.86 147.17 23.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 N-CA-C 104.753 -2.314 . . . . 74.340000000000003 104.753 170.519 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -116.83 127.48 54.35 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-O 122.009 0.909 . . . . 74.239999999999995 112.347 -173.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.552 ' HA ' ' CB ' ' A' ' 56' ' ' ASN . 8.7 mp -84.8 102.35 12.98 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 115.163 -0.926 . . . . 74.219999999999999 108.932 174.147 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.557 ' H ' ' HA ' ' A' ' 56' ' ' ASN . 37.1 t70 -80.64 64.79 5.55 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 122.836 1.303 . . . . 74.109999999999999 110.975 -178.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -131.91 146.28 52.01 Favored 'General case' 0 C--N 1.283 -2.307 0 CA-C-N 113.89 -1.504 . . . . 52.310000000000002 108.436 175.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 28.3 m -81.92 2.06 3.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 113.729 1.011 . . . . 41.32 113.729 -174.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.422 ' HB ' HD22 ' A' ' 108' ' ' ASN . 0.2 OUTLIER -108.72 12.55 25.67 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 121.816 0.817 . . . . 74.109999999999999 109.298 -179.26 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 98.8 t -83.08 132.01 32.38 Favored 'Isoleucine or valine' 0 C--O 1.244 0.789 0 CA-C-N 115.28 -0.873 . . . . 52.109999999999999 111.844 -177.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 7.6 m -103.73 165.42 11.05 Favored 'General case' 0 C--O 1.25 1.121 0 CA-C-N 115.1 -0.955 . . . . 65.450000000000003 110.252 -177.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.438 ' O ' ' HD2' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -74.13 132.69 42.5 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 107.405 -1.331 . . . . 64.25 107.405 169.11 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.442 ' H ' ' CD2' ' A' ' 73' ' ' HIS . 9.2 mmm180 61.72 83.54 0.15 Allowed 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 106.412 -1.699 . . . . 71.200000000000003 106.412 -168.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 12.5 t60 -104.87 -73.58 0.67 Allowed 'General case' 0 N--CA 1.428 -1.557 0 CA-C-N 115.366 -0.834 . . . . 73.120000000000005 110.149 -174.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.444 ' O ' ' HB3' ' A' ' 70' ' ' ALA . . . -121.71 108.87 14.04 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.633 -0.877 . . . . 74.340000000000003 108.633 -179.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -99.72 126.1 45.71 Favored 'General case' 0 C--N 1.28 -2.42 0 C-N-CA 119.373 -0.931 . . . . 72.349999999999994 109.678 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.486 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 58.5 m-85 -107.12 112.62 25.62 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 105.955 -1.868 . . . . 75.030000000000001 105.955 176.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.432 ' NH1' HG21 ' A' ' 102' ' ' VAL . 99.2 mtt180 -112.7 133.05 54.91 Favored 'General case' 0 C--N 1.277 -2.547 0 N-CA-C 109.035 -0.728 . . . . 74.349999999999994 109.035 -174.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 18.9 pt -116.76 138.14 48.35 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.429 0 C-N-CA 119.332 -0.947 . . . . 64.420000000000002 108.842 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -121.28 146.33 46.94 Favored 'General case' 0 C--N 1.266 -3.046 0 N-CA-C 106.207 -1.775 . . . . 74.230000000000004 106.207 174.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -60.08 -17.19 37.82 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.202 0.525 . . . . 73.040000000000006 112.288 177.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -91.31 -36.73 6.47 Favored Glycine 0 N--CA 1.439 -1.155 0 C-N-CA 121.415 -0.421 . . . . 61.299999999999997 113.081 178.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -169.18 161.69 10.36 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 109.46 -0.57 . . . . 75.0 109.46 -178.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.497 ' HB2' ' HB2' ' A' ' 122' ' ' MET . 59.2 m-85 -97.05 139.16 33.47 Favored 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 122.919 0.488 . . . . 51.530000000000001 110.997 -177.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -125.35 135.34 52.34 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 123.157 0.583 . . . . 74.310000000000002 111.148 -176.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.9 p -115.02 125.4 72.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 121.972 -0.455 . . . . 73.409999999999997 110.485 177.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.432 HG21 ' NH1' ' A' ' 93' ' ' ARG . 96.0 t -119.33 125.46 74.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-O 121.041 0.448 . . . . 72.230000000000004 111.2 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.435 ' HB2' ' HB ' ' A' ' 110' ' ' THR . 12.9 t70 -104.99 122.14 45.24 Favored 'General case' 0 CA--C 1.489 -1.372 0 CA-C-N 115.907 -0.588 . . . . 52.5 110.624 176.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 88' ' ' ARG . 0.9 OUTLIER -131.51 11.08 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.433 0 CA-C-N 114.976 -1.011 . . . . 71.400000000000006 109.675 173.165 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -110.22 44.94 1.4 Allowed Glycine 0 N--CA 1.438 -1.197 0 N-CA-C 109.23 -1.548 . . . . 74.439999999999998 109.23 178.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.4 m -67.58 -3.29 8.41 Favored 'General case' 0 C--N 1.31 -1.109 0 C-N-CA 124.92 1.288 . . . . 74.409999999999997 112.498 -175.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 33.7 tp -68.21 -40.26 82.17 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 107.798 -1.186 . . . . 71.349999999999994 107.798 174.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.422 HD22 ' HB ' ' A' ' 84' ' ' THR . 26.1 t-20 -89.59 -40.97 12.26 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 107.835 -1.172 . . . . 71.209999999999994 107.835 175.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 96.36 92.96 1.81 Allowed Glycine 0 N--CA 1.44 -1.086 0 CA-C-N 115.347 -0.842 . . . . 54.340000000000003 113.377 176.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.435 ' HB ' ' HB2' ' A' ' 103' ' ' ASP . 24.2 m -88.87 119.56 29.48 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.259 -1.015 . . . . 64.010000000000005 108.259 175.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.478 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 41.9 m-85 -112.6 134.83 53.93 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 108.008 -1.108 . . . . 73.409999999999997 108.008 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.3 p -109.03 136.27 45.42 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.444 0 N-CA-C 107.848 -1.167 . . . . 73.329999999999998 107.848 179.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.607 ' O ' ' HD2' ' A' ' 114' ' ' ARG . 20.5 m120 70.64 -81.46 0.03 OUTLIER 'General case' 0 CA--C 1.501 -0.904 0 N-CA-C 107.429 -1.323 . . . . 73.209999999999994 107.429 -172.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.607 ' HD2' ' O ' ' A' ' 113' ' ' ASN . 26.4 mmm180 -154.97 12.8 0.38 Allowed 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 107.648 -1.241 . . . . 71.120000000000005 107.648 173.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.426 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . 35.9 mt-10 -123.64 146.07 49.1 Favored Pre-proline 0 N--CA 1.464 0.274 0 N-CA-C 113.089 0.774 . . . . 64.150000000000006 113.089 -168.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 115' ' ' GLU . 4.9 Cg_exo -77.5 119.29 4.84 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.658 2.239 . . . . 71.299999999999997 109.809 175.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 14.8 mmm180 -136.1 148.29 48.2 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 109.391 -0.596 . . . . 64.430000000000007 109.391 -177.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -86.87 -40.54 14.79 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.534 -0.913 . . . . 63.409999999999997 108.534 173.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -142.58 137.38 30.05 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 107.663 -1.236 . . . . 64.540000000000006 107.663 172.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 24.0 tm0? -142.43 147.01 35.45 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.261 -1.014 . . . . 74.25 108.261 177.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.5 p -84.63 112.83 22.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-O 121.071 0.462 . . . . 63.350000000000001 109.758 177.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.497 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 64.2 mtt -54.22 142.16 26.98 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.873 1.064 . . . . 74.129999999999995 113.873 -171.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -122.13 135.38 54.79 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 115.209 -0.905 . . . . 72.439999999999998 109.068 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 6.7 t -79.89 132.53 36.1 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.855 -0.611 . . . . 54.240000000000002 111.538 -178.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 95.46 16.7 39.04 Favored Glycine 0 CA--C 1.488 -1.607 0 CA-C-N 115.685 -0.689 . . . . 72.510000000000005 111.855 176.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -124.92 -170.99 2.26 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.892 -0.781 . . . . 50.5 108.892 -177.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -133.59 150.83 51.62 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 113.641 0.978 . . . . 63.219999999999999 113.641 -172.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 67.5 mt -113.13 126.98 70.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 107.818 -1.178 . . . . 52.25 107.818 176.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.478 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 14.5 tp60 -102.11 111.94 24.41 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 107.306 -1.368 . . . . 72.409999999999997 107.306 -178.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.446 HG13 ' HB2' ' A' ' 133' ' ' PHE . 14.7 pt -102.35 98.46 6.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 CA-C-O 121.344 0.593 . . . . 71.219999999999999 109.784 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 66.11 -89.74 0.13 Allowed Glycine 0 N--CA 1.438 -1.205 0 CA-C-N 115.208 -0.906 . . . . 60.100000000000001 111.793 -176.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -126.33 -1.04 6.97 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 122.846 0.458 . . . . 73.120000000000005 110.123 -178.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.446 ' HB2' HG13 ' A' ' 130' ' ' ILE . 11.5 m-85 -108.85 156.33 19.78 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.44 -0.948 . . . . 75.439999999999998 108.44 -174.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -124.78 136.0 53.45 Favored 'General case' 0 C--O 1.249 1.05 0 CA-C-O 121.81 0.814 . . . . 73.209999999999994 112.642 -174.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.562 HD21 ' HB2' ' A' ' 49' ' ' LEU . 5.0 tt -124.2 139.82 53.55 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 114.086 -1.415 . . . . 75.129999999999995 107.603 -178.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 9.4 p -113.11 139.25 39.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 109.386 -0.598 . . . . 52.329999999999998 109.386 178.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -116.05 121.37 42.0 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 120.587 0.232 . . . . 73.439999999999998 111.011 -174.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -128.81 143.13 50.83 Favored 'General case' 0 C--O 1.217 -0.643 0 CA-C-O 120.856 0.36 . . . . 74.510000000000005 111.209 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -103.41 44.17 1.03 Allowed 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 105.744 -1.947 . . . . 72.129999999999995 105.744 172.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -60.08 -64.97 3.7 Favored Glycine 0 C--N 1.31 -0.881 0 CA-C-N 112.532 -2.122 . . . . 34.32 117.691 -168.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo . . . . . 0 N--CA 1.45 -1.044 0 CA-C-N 119.9 1.85 . . . . 70.400000000000006 114.116 -171.359 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 19.2 m120 . . . . . 0 CA--C 1.493 -1.246 0 N-CA-C 107.944 -1.132 . . . . 64.140000000000001 107.944 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -64.2 107.7 1.92 Allowed Glycine 0 N--CA 1.44 -1.083 0 O-C-N 123.854 0.722 . . . . 63.200000000000003 111.347 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.7 t -96.11 135.1 22.9 Favored Pre-proline 0 N--CA 1.427 -1.586 0 N-CA-C 109.62 -0.511 . . . . 63.340000000000003 109.62 -177.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -63.64 134.43 44.16 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 121.903 1.736 . . . . 71.319999999999993 109.588 174.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -102.95 141.73 23.08 Favored Pre-proline 0 C--N 1.284 -2.266 0 N-CA-C 109.087 -0.708 . . . . 72.409999999999997 109.087 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -38.69 115.1 0.2 Allowed 'Trans proline' 0 C--N 1.368 1.562 0 C-N-CA 124.334 3.356 . . . . 74.010000000000005 113.056 -176.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -64.83 122.45 16.96 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.83 -1.077 . . . . 65.409999999999997 110.848 -178.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.1 p -86.22 119.61 34.68 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 CA-C-N 115.305 -0.862 . . . . 62.43 111.221 -177.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -121.6 140.8 51.79 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 107.262 -1.385 . . . . 75.310000000000002 107.262 178.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.0 t -85.17 136.57 33.48 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 108.606 -0.887 . . . . 64.310000000000002 108.606 -178.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.8 p -93.52 16.35 13.83 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 121.695 0.76 . . . . 74.400000000000006 110.452 -179.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 18.3 m -79.5 97.28 6.37 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 115.295 -0.866 . . . . 62.439999999999998 112.004 -177.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.8 m . . . . . 0 C--N 1.305 -1.332 0 N-CA-C 107.922 -1.14 . . . . 74.329999999999998 107.922 174.133 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.033 0 N-CA-C 109.996 -1.242 . . . . 44.340000000000003 109.996 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 12.9 m -101.53 162.93 12.54 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 108.2 -1.037 . . . . 74.329999999999998 108.2 -179.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -137.97 164.54 28.77 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.398 -0.593 . . . . 54.310000000000002 109.398 -177.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.6 pp -134.89 160.01 39.63 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 120.825 0.345 . . . . 74.120000000000005 111.827 -177.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.447 ' HB2' HD11 ' A' ' 135' ' ' LEU . 3.6 pp -128.45 146.71 50.72 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 116.512 -0.313 . . . . 51.109999999999999 110.44 178.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 47.7 t -126.65 122.34 60.59 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 N-CA-C 108.314 -0.995 . . . . 72.340000000000003 108.314 178.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.542 HG21 ' HB3' ' A' ' 57' ' ' ALA . 19.6 t -93.35 118.1 38.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 N-CA-C 108.669 -0.863 . . . . 71.420000000000002 108.669 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -89.52 -31.81 17.47 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 116.079 -0.51 . . . . 63.399999999999999 111.047 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 27.9 tpt180 -156.99 129.3 7.4 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.308 -0.405 . . . . 51.439999999999998 110.147 178.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 139.71 136.05 3.32 Favored Glycine 0 N--CA 1.422 -2.277 0 CA-C-N 115.743 -0.662 . . . . 50.25 112.542 176.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.403 ' HD2' ' CE1' ' A' ' 133' ' ' PHE . 51.6 Cg_exo -59.98 -9.07 9.07 Favored 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 124.226 3.284 . . . . 74.430000000000007 111.894 175.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.583 ' ND2' ' HB2' ' A' ' 80' ' ' LEU . 20.6 t-20 -35.16 -50.75 0.53 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 127.764 2.426 . . . . 72.129999999999995 109.245 168.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.542 ' HB3' HG21 ' A' ' 51' ' ' VAL . . . -169.67 -58.14 0.02 OUTLIER 'General case' 0 CA--C 1.504 -0.793 0 CA-C-N 115.511 -0.768 . . . . 64.310000000000002 108.963 176.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.08 30.12 55.8 Favored Glycine 0 C--N 1.318 -0.42 0 N-CA-C 110.342 -1.103 . . . . 71.129999999999995 110.342 -177.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -142.58 -175.53 4.51 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 108.727 -0.842 . . . . 54.240000000000002 108.727 -176.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 16.6 ptt-85 -135.54 137.13 41.74 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.191 -0.67 . . . . 71.230000000000004 109.191 178.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -156.51 154.7 30.75 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.59 -0.277 . . . . 70.140000000000001 111.074 -179.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.1 tt -96.19 139.72 31.93 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.495 -0.775 . . . . 71.219999999999999 110.424 -178.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.2 mp -110.39 126.94 54.81 Favored 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 123.996 0.918 . . . . 60.420000000000002 108.87 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -139.04 24.08 2.56 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 121.769 0.795 . . . . 74.239999999999995 109.957 177.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -90.44 146.81 35.22 Favored Pre-proline 0 C--N 1.315 -0.92 0 N-CA-C 108.132 -1.062 . . . . 74.400000000000006 108.132 178.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -56.71 -45.42 36.94 Favored 'Trans proline' 0 C--N 1.361 1.228 0 C-N-CA 122.956 2.437 . . . . 74.109999999999999 111.664 -177.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.42 HG23 ' HG2' ' A' ' 93' ' ' ARG . 90.2 m -136.1 97.41 3.6 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 115.054 -0.975 . . . . 75.140000000000001 110.238 177.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 21.7 m -88.07 114.15 24.41 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.359 -1.348 . . . . 63.329999999999998 107.359 177.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.403 ' O ' ' HB2' ' A' ' 76' ' ' SER . 17.2 m -100.25 120.14 39.45 Favored 'General case' 0 C--O 1.25 1.131 0 C-N-CA 120.622 -0.431 . . . . 74.129999999999995 110.65 -176.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.629 ' HB1' HD21 ' A' ' 80' ' ' LEU . . . -98.01 129.72 44.87 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 123.99 0.916 . . . . 53.450000000000003 110.734 -177.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 79' ' ' PHE . . . -178.43 -106.22 0.2 Allowed Glycine 0 C--O 1.242 0.65 0 N-CA-C 110.439 -1.064 . . . . 53.549999999999997 110.439 178.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.492 ' HG2' HG21 ' A' ' 85' ' ' VAL . 18.0 mmm180 -131.38 -81.91 0.52 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.152 0.581 . . . . 74.239999999999995 110.218 174.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.503 ' HB3' ' HD3' ' A' ' 74' ' ' PRO . 10.8 t60 -150.78 -61.29 0.02 OUTLIER Pre-proline 0 CA--C 1.553 1.08 0 CA-C-O 118.867 -0.587 . . . . 52.100000000000001 111.838 -177.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.503 ' HD3' ' HB3' ' A' ' 73' ' ' HIS . 83.3 Cg_exo -50.28 -37.89 50.76 Favored 'Trans proline' 0 C--N 1.374 1.899 0 C-N-CA 122.514 2.142 . . . . 55.539999999999999 114.781 179.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.596 ' OE2' ' HD2' ' A' ' 87' ' ' ARG . 45.5 mt-10 -109.42 2.62 20.72 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 112.657 0.614 . . . . 75.010000000000005 112.657 -177.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.403 ' HB2' ' O ' ' A' ' 69' ' ' THR . 36.1 p -148.88 -175.31 4.9 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.119 -1.033 . . . . 75.010000000000005 113.023 -171.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -102.79 -42.29 5.91 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.684 0.754 . . . . 64.400000000000006 110.055 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 21.5 pt -118.91 153.17 21.19 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 115.747 -0.66 . . . . 64.239999999999995 111.087 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.472 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 40.7 p90 -105.83 129.26 54.04 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.036 -0.727 . . . . 73.420000000000002 109.036 177.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.629 HD21 ' HB1' ' A' ' 70' ' ' ALA . 1.4 pt? -156.2 6.27 0.19 Allowed 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 113.773 1.027 . . . . 42.119999999999997 113.773 -175.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -122.62 128.53 50.79 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 118.996 -1.081 . . . . 71.420000000000002 108.337 173.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -127.6 -4.11 5.96 Favored 'General case' 0 C--N 1.286 -2.159 0 CA-C-N 115.018 -0.992 . . . . 74.519999999999996 111.538 -176.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.1 p -87.36 -37.52 11.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 C-N-CA 119.043 -1.063 . . . . 75.510000000000005 109.374 -174.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.3 m -171.8 81.98 0.07 Allowed 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.08 -1.082 . . . . 70.049999999999997 108.08 -178.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.492 HG21 ' HG2' ' A' ' 72' ' ' ARG . 8.9 p -82.91 104.56 11.72 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.366 0 C-N-CA 116.535 -2.066 . . . . 63.240000000000002 109.647 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 58.2 m -76.75 -44.77 31.76 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 113.972 -1.467 . . . . 72.519999999999996 112.212 -175.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.596 ' HD2' ' OE2' ' A' ' 75' ' ' GLU . 13.7 mmt180 -166.15 -167.04 0.98 Allowed 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 105.083 -2.191 . . . . 73.510000000000005 105.083 -176.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.537 ' H ' ' HD3' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -52.78 126.61 20.62 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 106.55 -1.648 . . . . 74.109999999999999 106.55 166.431 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.405 ' NE2' ' HB ' ' A' ' 130' ' ' ILE . 40.6 t60 -92.83 -49.56 6.0 Favored 'General case' 0 C--N 1.284 -2.269 0 CA-C-N 115.501 -0.772 . . . . 62.340000000000003 111.845 -164.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -139.66 142.65 36.97 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 120.296 -0.562 . . . . 61.439999999999998 110.362 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -117.23 127.3 53.96 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 109.136 -0.69 . . . . 73.299999999999997 109.136 176.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -108.72 112.28 24.5 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 106.827 -1.546 . . . . 72.340000000000003 106.827 176.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.42 ' HG2' HG23 ' A' ' 67' ' ' THR . 20.0 mtm180 -123.74 124.67 43.23 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 109.426 -0.583 . . . . 64.430000000000007 109.426 -177.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.492 ' O ' HD12 ' A' ' 94' ' ' ILE . 2.8 pp -115.47 122.48 69.41 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.222 0 CA-C-O 121.76 0.79 . . . . 50.450000000000003 112.041 -175.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -119.08 145.65 45.74 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 107.018 -1.475 . . . . 54.32 107.018 177.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -54.81 -29.7 55.32 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 122.641 0.377 . . . . 61.130000000000003 111.937 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -80.45 -46.69 7.27 Favored Glycine 0 N--CA 1.43 -1.706 0 CA-C-O 119.692 -0.504 . . . . 32.229999999999997 112.34 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -144.99 142.76 30.08 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 117.211 0.505 . . . . 74.430000000000007 110.472 -179.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -95.67 114.79 26.57 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 106.64 -1.615 . . . . 72.140000000000001 106.64 176.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -119.61 116.25 25.64 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.332 0.587 . . . . 73.129999999999995 112.343 -170.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 5.6 p -105.88 124.44 61.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 108.265 -1.013 . . . . 71.510000000000005 108.265 172.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.487 HG12 HG13 ' A' ' 104' ' ' VAL . 33.8 t -111.66 115.01 48.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 CA-C-N 115.869 -0.605 . . . . 72.030000000000001 109.435 -176.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.577 ' HB3' ' CB ' ' A' ' 110' ' ' THR . 4.9 m-20 -85.41 109.69 18.61 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 114.796 -1.093 . . . . 74.430000000000007 108.855 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.487 HG13 HG12 ' A' ' 102' ' ' VAL . 12.3 m -118.3 16.83 7.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 111.95 0.352 . . . . 73.109999999999999 111.95 -176.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -114.22 48.43 0.94 Allowed Glycine 0 C--O 1.241 0.589 0 N-CA-C 110.771 -0.932 . . . . 54.420000000000002 110.771 177.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 6.9 m -65.52 -22.58 66.73 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 124.126 0.97 . . . . 73.109999999999999 112.425 -175.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -58.77 -42.14 88.26 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.209 0.528 . . . . 70.200000000000003 110.296 177.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -76.94 -52.9 8.59 Favored 'General case' 0 CA--C 1.485 -1.554 0 N-CA-C 106.456 -1.683 . . . . 64.140000000000001 106.456 175.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 123.91 103.0 1.55 Allowed Glycine 0 N--CA 1.406 -3.31 0 CA-C-N 113.892 -1.504 . . . . 42.5 110.116 -177.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.577 ' CB ' ' HB3' ' A' ' 103' ' ' ASP . 1.5 p -92.82 119.16 31.88 Favored 'General case' 0 N--CA 1.409 -2.525 0 N-CA-C 107.501 -1.296 . . . . 62.340000000000003 107.501 175.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.434 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 65.6 m-85 -121.99 139.44 53.68 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-O 121.554 0.692 . . . . 63.450000000000003 112.506 -172.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.697 ' HB ' ' NE ' ' A' ' 117' ' ' ARG . 7.1 p -104.87 111.71 35.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 106.333 -1.728 . . . . 65.530000000000001 106.333 170.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.445 HD22 HG22 ' A' ' 112' ' ' VAL . 46.7 m-80 54.23 35.7 23.28 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.922 0.489 . . . . 61.100000000000001 111.295 -177.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 49.2 mtm-85 83.81 3.09 0.88 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.676 1.59 . . . . 74.310000000000002 115.257 178.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -110.47 139.5 21.6 Favored Pre-proline 0 C--N 1.314 -0.957 0 C-N-CA 119.645 -0.822 . . . . 43.439999999999998 110.069 175.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.27 142.32 97.92 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 122.869 2.38 . . . . 74.200000000000003 113.767 -175.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.697 ' NE ' ' HB ' ' A' ' 112' ' ' VAL . 13.1 ptt180 -147.14 163.94 34.72 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.842 -0.617 . . . . 75.030000000000001 111.744 176.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.433 ' HA ' ' HB2' ' A' ' 103' ' ' ASP . 11.1 m120 -124.75 -17.86 5.78 Favored 'General case' 0 CA--C 1.513 -0.452 0 O-C-N 124.094 0.871 . . . . 75.209999999999994 111.959 173.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -155.42 138.28 15.33 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.162 -0.681 . . . . 73.310000000000002 109.162 174.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 21.6 tm0? -141.47 149.28 40.75 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.174 -1.047 . . . . 65.040000000000006 108.174 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.3 p -101.83 113.76 39.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 109.389 -0.597 . . . . 74.439999999999998 109.389 176.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -32.91 116.95 0.24 Allowed 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 115.796 1.776 . . . . 73.310000000000002 115.796 -172.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -118.3 145.48 45.04 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 106.795 -1.557 . . . . 65.010000000000005 106.795 172.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 15.0 t -89.46 130.94 35.72 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 119.766 -0.774 . . . . 74.099999999999994 109.856 -178.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 94.27 19.02 34.27 Favored Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 110.88 -0.888 . . . . 64.420000000000002 110.88 -178.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -96.66 142.13 29.07 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 108.538 -0.912 . . . . 42.439999999999998 108.538 -178.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -109.5 127.32 54.36 Favored 'General case' 0 N--CA 1.422 -1.867 0 CA-C-O 122.086 0.946 . . . . 45.119999999999997 111.127 179.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.511 HG12 ' NH2' ' A' ' 117' ' ' ARG . 25.6 mt -106.7 125.65 62.61 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.285 0 CA-C-N 114.477 -1.238 . . . . 53.310000000000002 108.043 -177.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.434 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 51.0 tt0 -105.42 111.9 24.79 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 107.313 -1.365 . . . . 73.099999999999994 107.313 172.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.45 HD11 ' ND2' ' A' ' 56' ' ' ASN . 17.3 pt -102.05 101.0 11.51 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 N-CA-C 108.593 -0.892 . . . . 75.450000000000003 108.593 177.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 73.62 -90.99 0.65 Allowed Glycine 0 N--CA 1.419 -2.463 0 CA-C-N 114.866 -1.061 . . . . 63.240000000000002 110.757 -177.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 45.0 tttp -131.88 3.53 4.1 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 121.117 0.484 . . . . 75.129999999999995 110.345 -176.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.403 ' CE1' ' HD2' ' A' ' 55' ' ' PRO . 34.5 m-85 -101.61 144.35 30.45 Favored 'General case' 0 C--N 1.311 -1.069 0 O-C-N 121.918 -0.489 . . . . 73.019999999999996 109.743 -176.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -106.85 121.04 43.62 Favored 'General case' 0 C--O 1.247 0.95 0 N-CA-C 107.711 -1.218 . . . . 75.349999999999994 107.711 -177.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.447 HD11 ' HB2' ' A' ' 49' ' ' LEU . 42.9 tp -123.89 142.42 51.15 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 114.993 -1.003 . . . . 72.310000000000002 108.362 -176.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 11.1 p -117.09 130.51 71.88 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 N-CA-C 107.553 -1.277 . . . . 71.5 107.553 174.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -111.47 130.27 55.77 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 116.233 -0.44 . . . . 71.319999999999993 110.055 -173.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -127.94 170.16 13.16 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.92 -0.77 . . . . 63.340000000000003 108.92 -178.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -89.53 164.61 14.72 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 109.031 -0.729 . . . . 53.329999999999998 109.031 176.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -82.87 142.96 21.96 Favored Glycine 0 N--CA 1.435 -1.394 0 N-CA-C 109.723 -1.351 . . . . 53.399999999999999 109.723 177.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo . . . . . 0 N--CA 1.444 -1.423 0 CA-C-N 119.608 1.704 . . . . 63.329999999999998 111.377 179.987 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 . . . . . 0 CA--C 1.501 -0.927 0 CA-C-O 120.971 0.415 . . . . 74.340000000000003 110.187 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -119.95 101.1 0.81 Allowed Glycine 0 N--CA 1.425 -2.045 0 N-CA-C 111.107 -0.797 . . . . 64.25 111.107 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.2 m -78.78 124.03 85.15 Favored Pre-proline 0 C--N 1.306 -1.29 0 N-CA-C 108.555 -0.906 . . . . 73.140000000000001 108.555 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -60.49 128.02 24.65 Favored 'Trans proline' 0 C--O 1.252 1.19 0 C-N-CA 122.363 2.042 . . . . 74.200000000000003 111.601 178.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -100.98 131.67 23.02 Favored Pre-proline 0 C--N 1.299 -1.604 0 CA-C-N 115.919 -0.582 . . . . 72.510000000000005 110.188 -178.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -65.1 127.18 17.85 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 121.982 1.788 . . . . 74.340000000000003 111.225 178.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -82.12 104.91 12.8 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.844 -1.169 . . . . 64.209999999999994 107.844 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 23.5 t -111.83 148.95 14.65 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 N-CA-C 107.459 -1.311 . . . . 63.229999999999997 107.459 -178.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -82.47 121.57 26.93 Favored 'General case' 0 N--CA 1.408 -2.533 0 N-CA-C 106.143 -1.799 . . . . 63.32 106.143 170.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 58.4 m -60.53 104.28 0.32 Allowed 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.78 -0.645 . . . . 71.349999999999994 109.642 -177.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 18.2 m -81.25 94.64 6.75 Favored 'General case' 0 N--CA 1.415 -2.189 0 CA-C-N 114.781 -1.1 . . . . 73.310000000000002 110.586 -174.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 21.2 m -134.35 83.68 2.05 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 114.697 -1.138 . . . . 62.340000000000003 108.221 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 39.4 t . . . . . 0 C--N 1.301 -1.533 0 N-CA-C 108.453 -0.943 . . . . 62.210000000000001 108.453 -178.275 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.488 -1.65 0 N-CA-C 107.877 -2.089 . . . . 24.32 107.877 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.402 ' HB3' ' HB2' ' A' ' 63' ' ' LEU . 10.1 m -89.47 152.12 21.63 Favored 'General case' 0 N--CA 1.422 -1.832 0 CA-C-O 121.684 0.754 . . . . 73.439999999999998 112.374 -166.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.414 ' HB1' ' O ' ' A' ' 138' ' ' LEU . . . -112.32 -164.38 0.91 Allowed 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 114.114 -1.403 . . . . 51.140000000000001 107.434 178.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.7 pp -131.07 155.4 46.98 Favored 'General case' 0 N--CA 1.438 -1.051 0 C-N-CA 120.277 -0.569 . . . . 63.310000000000002 111.96 -177.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.42 ' HB2' HD21 ' A' ' 135' ' ' LEU . 3.6 pp -132.1 141.29 49.12 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 115.771 -0.649 . . . . 74.209999999999994 109.985 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 59.8 t -119.07 126.04 75.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 109.655 -0.498 . . . . 74.140000000000001 109.655 -177.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.5 t -93.17 115.87 32.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 107.553 -1.277 . . . . 70.010000000000005 107.553 176.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.412 ' HE3' ' CG2' ' A' ' 136' ' ' VAL . 94.5 mttt -66.02 -43.93 86.23 Favored 'General case' 0 CA--C 1.496 -1.125 0 CA-C-N 115.105 -0.952 . . . . 71.409999999999997 109.088 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.412 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 30.0 tpt180 -168.9 135.13 1.75 Allowed 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.067 -1.457 . . . . 65.439999999999998 107.067 179.018 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.447 ' HA2' ' HD3' ' A' ' 55' ' ' PRO . . . 172.43 135.73 2.02 Favored Glycine 0 N--CA 1.42 -2.393 0 N-CA-C 109.267 -1.533 . . . . 72.310000000000002 109.267 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.542 ' HB2' ' O ' ' A' ' 81' ' ' ASP . 15.0 Cg_exo -67.52 -10.95 30.43 Favored 'Trans proline' 0 CA--C 1.53 0.307 0 C-N-CA 122.372 2.048 . . . . 61.539999999999999 112.723 -176.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.543 ' HA ' ' N ' ' A' ' 81' ' ' ASP . 29.5 p-10 -53.92 -42.36 68.67 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.708 0.803 . . . . 73.450000000000003 110.673 178.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -168.17 -47.18 0.02 OUTLIER 'General case' 0 N--CA 1.444 -0.732 0 O-C-N 123.411 0.444 . . . . 64.129999999999995 110.769 178.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.28 64.73 2.86 Favored Glycine 0 C--O 1.239 0.466 0 N-CA-C 110.727 -0.949 . . . . 74.219999999999999 110.727 -176.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -166.45 -178.49 4.49 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 107.449 -1.315 . . . . 72.5 107.449 -177.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 13.3 ptt180 -112.64 144.97 41.22 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 109.199 -0.667 . . . . 64.420000000000002 109.199 175.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -132.33 154.31 49.86 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 116.372 -0.377 . . . . 70.319999999999993 110.553 -177.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.1 tt -111.48 140.27 46.22 Favored 'General case' 0 C--N 1.28 -2.439 0 N-CA-C 103.544 -2.762 . . . . 71.450000000000003 103.544 173.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.402 ' HB2' ' HB3' ' A' ' 46' ' ' SER . 6.8 mp -70.38 113.74 7.82 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 118.555 -1.258 . . . . 72.010000000000005 109.115 -176.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -72.36 -60.59 2.16 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 114.081 -1.418 . . . . 62.43 109.632 -173.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.466 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 7.9 tt0 -103.02 132.92 20.66 Favored Pre-proline 0 N--CA 1.419 -1.992 0 CA-C-N 115.168 -0.924 . . . . 63.240000000000002 109.39 -178.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.466 ' HD2' ' HA ' ' A' ' 65' ' ' GLN . 5.8 Cg_exo -37.6 -46.94 1.89 Allowed 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 124.9 3.733 . . . . 75.219999999999999 113.515 175.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.452 HG23 ' HG2' ' A' ' 93' ' ' ARG . 87.3 m -106.61 96.44 6.45 Favored 'General case' 0 N--CA 1.423 -1.817 0 N-CA-C 108.189 -1.041 . . . . 64.340000000000003 108.189 173.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.451 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 22.3 m -89.16 114.61 25.92 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 108.404 -0.961 . . . . 60.030000000000001 108.404 -179.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.4 t -96.85 120.08 36.53 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.583 0.706 . . . . 72.329999999999998 109.86 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -110.28 148.94 30.92 Favored 'General case' 0 N--CA 1.428 -1.569 0 CA-C-N 115.837 -0.62 . . . . 62.530000000000001 110.579 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 147.71 -137.82 6.78 Favored Glycine 0 CA--C 1.466 -2.994 0 N-CA-C 107.389 -2.285 . . . . 64.450000000000003 107.389 -178.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.296 4.5 ptt85 -110.94 -88.94 0.5 Allowed 'General case' 0 C--N 1.284 -2.268 0 CA-C-O 118.428 -0.796 . . . . 75.109999999999999 111.857 174.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.471 ' HB3' ' HD2' ' A' ' 74' ' ' PRO . 32.7 m170 60.63 173.74 0.05 OUTLIER Pre-proline 0 CA--C 1.559 1.298 0 CA-C-N 118.598 0.635 . . . . 73.209999999999994 110.879 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.471 ' HD2' ' HB3' ' A' ' 73' ' ' HIS . 28.4 Cg_endo -66.77 -21.74 50.75 Favored 'Trans proline' 0 CA--C 1.545 1.026 0 C-N-CA 121.394 1.396 . . . . 65.299999999999997 111.81 169.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -134.33 92.96 2.99 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-O 121.337 0.589 . . . . 73.420000000000002 110.363 -176.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 13.1 m -77.38 117.32 18.76 Favored 'General case' 0 C--N 1.279 -2.494 0 N-CA-C 107.084 -1.45 . . . . 73.129999999999995 107.084 172.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -70.99 -35.06 71.96 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 108.522 -0.918 . . . . 73.400000000000006 108.522 -178.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.7 pp -130.15 162.47 37.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 106.14 -1.8 . . . . 74.150000000000006 106.14 165.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -101.33 136.64 40.85 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 113.974 1.102 . . . . 74.420000000000002 113.974 -170.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.53 ' HA ' ' HB2' ' A' ' 56' ' ' ASN . 94.4 mt -128.91 150.18 50.47 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 106.971 -1.492 . . . . 73.239999999999995 106.971 175.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.543 ' N ' ' HA ' ' A' ' 56' ' ' ASN . 16.9 t70 -156.93 94.59 1.44 Allowed 'General case' 0 C--N 1.288 -2.071 0 O-C-N 124.0 0.812 . . . . 72.519999999999996 109.425 -177.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.448 ' O ' HG12 ' A' ' 85' ' ' VAL . 14.1 t70 -157.82 152.92 25.62 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 107.802 -1.185 . . . . 72.030000000000001 107.802 175.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.6 p -61.31 -27.5 41.99 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.061 0 C-N-CA 122.893 0.477 . . . . 63.43 112.202 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 17.6 p -96.77 21.85 8.96 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 113.88 1.067 . . . . 72.430000000000007 113.88 -177.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.448 HG12 ' O ' ' A' ' 82' ' ' ASP . 13.9 p -82.06 124.74 39.45 Favored 'Isoleucine or valine' 0 C--O 1.249 1.038 0 CA-C-O 122.044 0.925 . . . . 74.239999999999995 110.266 179.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 16.2 m -80.9 163.32 23.45 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.805 -0.813 . . . . 70.549999999999997 108.805 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.49 -43.21 97.26 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 119.677 -0.809 . . . . 70.140000000000001 108.931 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -110.4 110.81 21.72 Favored 'General case' 0 N--CA 1.419 -2.02 0 N-CA-C 102.565 -3.124 . . . . 74.319999999999993 102.565 176.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 14.6 t60 -110.62 -85.88 0.55 Allowed 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 117.878 -1.529 . . . . 73.25 112.398 -172.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.414 ' HA ' ' HA ' ' A' ' 103' ' ' ASP . . . -126.6 123.82 38.51 Favored 'General case' 0 C--N 1.292 -1.932 0 C-N-CA 120.167 -0.613 . . . . 42.240000000000002 109.722 -175.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -110.04 127.53 54.89 Favored 'General case' 0 C--N 1.275 -2.642 0 C-N-CA 118.938 -1.105 . . . . 55.409999999999997 110.419 177.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.451 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 53.0 m-85 -103.41 113.64 27.3 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 114.61 -1.177 . . . . 74.430000000000007 108.116 -176.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.452 ' HG2' HG23 ' A' ' 67' ' ' THR . 48.6 mtm180 -108.78 122.6 47.5 Favored 'General case' 0 C--N 1.288 -2.109 0 N-CA-C 109.632 -0.507 . . . . 74.450000000000003 109.632 178.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.412 ' CG2' ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -115.2 116.95 54.09 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.495 0 N-CA-C 106.888 -1.523 . . . . 74.319999999999993 106.888 175.919 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -117.8 146.06 44.09 Favored 'General case' 0 C--N 1.278 -2.533 0 CA-C-N 113.575 -1.648 . . . . 74.140000000000001 106.6 178.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -56.1 -22.02 25.68 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 112.396 0.517 . . . . 72.230000000000004 112.396 -177.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -95.95 -33.6 6.28 Favored Glycine 0 N--CA 1.435 -1.368 0 C-N-CA 121.042 -0.599 . . . . 60.119999999999997 113.611 178.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -148.16 144.3 27.67 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 117.494 0.647 . . . . 73.519999999999996 111.687 -176.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.487 ' HB3' ' SD ' ' A' ' 122' ' ' MET . 5.1 m-85 -106.67 114.3 28.32 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 106.986 -1.487 . . . . 74.299999999999997 106.986 176.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -132.37 135.12 45.92 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.43 -0.794 . . . . 63.140000000000001 111.901 -176.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.5 p -114.53 119.53 61.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 109.066 -0.716 . . . . 72.129999999999995 109.066 176.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 50.0 t -110.83 114.09 46.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 108.168 -1.049 . . . . 60.140000000000001 108.168 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.414 ' HA ' ' HA ' ' A' ' 90' ' ' ALA . 19.5 t70 -105.43 127.44 52.99 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-O 121.235 0.54 . . . . 63.350000000000001 110.556 179.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 28.7 m -116.67 12.61 7.55 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.176 0 CA-C-N 115.052 -0.976 . . . . 62.240000000000002 109.51 174.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -100.89 52.5 0.92 Allowed Glycine 0 N--CA 1.437 -1.284 0 N-CA-C 110.596 -1.001 . . . . 60.140000000000001 110.596 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.5 m -60.96 -17.16 50.06 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.201 1.4 . . . . 74.040000000000006 112.331 -176.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 82.6 mt -58.3 -39.9 80.56 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.698 0.761 . . . . 74.209999999999994 109.395 174.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -90.64 -48.99 6.73 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 106.706 -1.59 . . . . 73.530000000000001 106.706 176.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.66 94.0 1.24 Allowed Glycine 0 N--CA 1.442 -0.948 0 CA-C-N 114.767 -1.106 . . . . 53.039999999999999 113.982 175.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 42.0 m -93.72 120.09 33.55 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 109.208 -0.664 . . . . 71.049999999999997 109.208 175.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -135.65 168.74 18.7 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 107.923 -1.14 . . . . 65.530000000000001 107.923 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.417 HG12 ' H ' ' A' ' 114' ' ' ARG . 52.5 t -106.84 141.67 21.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 107.932 -1.136 . . . . 72.420000000000002 107.932 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -51.48 -38.11 52.25 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 123.88 0.872 . . . . 74.329999999999998 111.563 178.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.417 ' H ' HG12 ' A' ' 112' ' ' VAL . 53.5 ttt180 -84.06 -36.46 23.04 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 116.072 -0.513 . . . . 73.099999999999994 111.343 176.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 21.3 tp10 -124.2 114.21 27.73 Favored Pre-proline 0 C--N 1.306 -1.295 0 N-CA-C 112.125 0.417 . . . . 72.150000000000006 112.125 -169.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -78.75 38.82 0.74 Allowed 'Trans proline' 0 CA--C 1.547 1.146 0 C-N-CA 123.409 2.739 . . . . 63.329999999999998 113.206 -178.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 64.8 mtm180 -109.45 145.06 36.81 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 116.197 -0.456 . . . . 71.040000000000006 110.286 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -71.28 -38.64 71.82 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 123.941 0.776 . . . . 70.25 110.992 -172.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -115.04 136.9 52.62 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 107.13 -1.433 . . . . 61.020000000000003 107.13 173.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 -142.58 150.85 40.88 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 114.518 1.303 . . . . 72.140000000000001 114.518 -177.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.1 p -79.88 128.82 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.915 0 N-CA-C 105.252 -2.129 . . . . 63.32 105.252 167.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.487 ' SD ' ' HB3' ' A' ' 99' ' ' PHE . 59.4 mtt -60.59 136.68 58.13 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 123.29 0.636 . . . . 74.319999999999993 112.095 -171.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.473 HE21 ' HB2' ' A' ' 126' ' ' ASP . 0.2 OUTLIER -108.39 125.06 51.31 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 105.435 -2.061 . . . . 74.329999999999998 105.435 178.065 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 21.7 p -78.89 115.39 18.55 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.222 0.534 . . . . 53.329999999999998 111.507 -176.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 101.53 13.77 31.77 Favored Glycine 0 N--CA 1.432 -1.606 0 C-N-CA 120.758 -0.734 . . . . 63.200000000000003 112.505 179.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.473 ' HB2' HE21 ' A' ' 123' ' ' GLN . 8.1 t70 -116.6 176.33 5.16 Favored 'General case' 0 C--O 1.248 0.986 0 C-N-CA 119.531 -0.868 . . . . 52.310000000000002 109.476 178.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.54 ' OE1' ' HD3' ' A' ' 134' ' ' ARG . 40.6 tt0 -110.48 135.11 51.65 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-O 121.296 0.57 . . . . 72.430000000000007 109.984 -171.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 67.4 mt -103.37 122.95 56.55 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.406 0 N-CA-C 107.889 -1.152 . . . . 70.239999999999995 107.889 178.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -97.32 112.45 24.26 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 115.913 -0.585 . . . . 74.049999999999997 109.454 -179.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.1 pt -102.01 98.21 6.57 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.343 0 N-CA-C 107.549 -1.278 . . . . 74.209999999999994 107.549 175.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 75.08 -113.86 4.12 Favored Glycine 0 N--CA 1.421 -2.315 0 N-CA-C 108.198 -1.961 . . . . 70.120000000000005 108.198 -172.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -124.66 6.27 8.19 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 120.971 0.415 . . . . 72.329999999999998 110.397 175.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.412 ' HB2' ' O ' ' A' ' 53' ' ' ARG . 9.4 p90 -98.78 151.64 20.57 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 109.224 -0.658 . . . . 74.340000000000003 109.224 174.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.54 ' HD3' ' OE1' ' A' ' 127' ' ' GLU . 77.9 mtt-85 -117.85 132.5 56.42 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 115.104 1.52 . . . . 74.439999999999998 115.104 -164.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.42 HD21 ' HB2' ' A' ' 49' ' ' LEU . 5.6 tt -124.3 136.33 54.03 Favored 'General case' 0 C--O 1.195 -1.773 0 CA-C-N 114.008 -1.451 . . . . 75.0 107.466 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.412 ' CG2' ' HE3' ' A' ' 52' ' ' LYS . 25.9 t -112.58 137.63 44.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.941 -0.763 . . . . 61.539999999999999 108.941 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -107.26 117.36 33.86 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 110.014 -0.365 . . . . 71.25 110.014 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.414 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 2.5 mm? -117.34 143.87 45.5 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.35 0.595 . . . . 72.439999999999998 110.976 -177.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -97.57 91.27 5.35 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.415 -0.957 . . . . 65.329999999999998 108.415 177.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -107.16 -72.28 0.79 Allowed Glycine 0 N--CA 1.43 -1.727 0 CA-C-N 115.358 -0.837 . . . . 42.109999999999999 111.176 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo . . . . . 0 N--CA 1.446 -1.28 0 C-N-CA 121.935 1.757 . . . . 64.030000000000001 112.441 179.717 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 55.7 t30 . . . . . 0 N--CA 1.45 -0.455 0 N-CA-C 109.317 -0.623 . . . . 72.200000000000003 109.317 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -73.85 106.15 1.96 Allowed Glycine 0 N--CA 1.436 -1.305 0 N-CA-C 110.66 -0.976 . . . . 63.450000000000003 110.66 178.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.1 t -98.02 126.73 39.28 Favored Pre-proline 0 C--N 1.296 -1.721 0 N-CA-C 110.122 -0.325 . . . . 72.209999999999994 110.122 -179.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -66.3 128.37 19.25 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.388 2.059 . . . . 71.540000000000006 111.205 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -90.77 131.68 36.93 Favored Pre-proline 0 C--N 1.294 -1.808 0 N-CA-C 108.898 -0.779 . . . . 71.010000000000005 108.898 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_exo -49.14 129.36 21.77 Favored 'Trans proline' 0 C--O 1.239 0.541 0 C-N-CA 123.508 2.805 . . . . 34.399999999999999 114.707 -174.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -110.18 107.95 17.93 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.007 -1.849 . . . . 71.409999999999997 106.007 174.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.6 p -114.65 107.49 23.0 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 CA-C-O 122.01 0.91 . . . . 53.030000000000001 111.7 -175.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -139.57 140.95 37.2 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 105.676 -1.972 . . . . 60.32 105.676 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 67.8 m -150.71 95.57 2.24 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 109.897 -0.408 . . . . 64.25 109.897 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.9 p -113.33 104.18 12.06 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-O 121.363 0.601 . . . . 74.0 111.547 177.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 39.9 t -164.9 115.2 1.14 Allowed 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 107.498 -1.297 . . . . 63.109999999999999 107.498 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.8 p . . . . . 0 C--N 1.309 -1.194 0 N-CA-C 109.792 -0.447 . . . . 73.319999999999993 109.792 179.589 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.48 ' HA2' ' O ' ' A' ' 141' ' ' PRO . . . . . . . . 0 CA--C 1.48 -2.154 0 N-CA-C 106.015 -2.834 . . . . 44.130000000000003 106.015 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 13.6 m -89.98 164.79 14.4 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 113.56 -1.32 . . . . 61.240000000000002 111.264 -169.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -92.91 164.58 13.26 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 116.015 -0.539 . . . . 74.439999999999998 109.773 -179.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -133.83 155.91 48.99 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 110.261 -0.274 . . . . 75.239999999999995 110.261 -178.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.473 HD23 ' O ' ' A' ' 61' ' ' PHE . 2.7 pt? -108.79 132.77 53.66 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 107.065 -1.457 . . . . 72.310000000000002 107.065 176.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.8 t -117.68 114.66 46.13 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 N-CA-C 108.661 -0.866 . . . . 65.299999999999997 108.661 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.47 HG11 ' OD1' ' A' ' 56' ' ' ASN . 61.9 t -92.9 116.03 33.09 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 N-CA-C 107.722 -1.214 . . . . 64.109999999999999 107.722 177.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.4 mmmp? -82.56 -39.12 22.75 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.381 -0.827 . . . . 62.119999999999997 108.831 -178.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.43 ' O ' ' HB3' ' A' ' 133' ' ' PHE . 72.8 ttt180 -147.86 115.65 6.4 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 115.196 -0.911 . . . . 75.400000000000006 108.94 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 175.74 134.18 1.88 Allowed Glycine 0 N--CA 1.438 -1.174 0 C-N-CA 120.127 -1.035 . . . . 72.219999999999999 113.433 176.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.55 -9.25 25.7 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 123.957 3.105 . . . . 64.510000000000005 111.897 175.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.49 ' HB2' ' HA ' ' A' ' 80' ' ' LEU . 13.2 p30 -48.54 -46.05 38.26 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.488 1.115 . . . . 54.43 111.495 177.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -171.34 -40.53 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 125.203 1.401 . . . . 75.150000000000006 107.381 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 64.6 46.35 90.34 Favored Glycine 0 CA--C 1.495 -1.192 0 N-CA-C 110.191 -1.163 . . . . 71.099999999999994 110.191 -178.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -143.11 -178.01 5.63 Favored 'General case' 0 N--CA 1.424 -1.775 0 N-CA-C 108.513 -0.921 . . . . 75.420000000000002 108.513 -173.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.445 ' HA ' ' O ' ' A' ' 49' ' ' LEU . 11.2 ptt180 -141.49 131.94 25.27 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 123.416 0.447 . . . . 73.329999999999998 109.969 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.473 ' O ' HD23 ' A' ' 49' ' ' LEU . 30.7 p90 -154.36 154.96 34.19 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 112.415 0.524 . . . . 71.540000000000006 112.415 -177.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.2 tt -81.08 139.69 35.54 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.019 -0.991 . . . . 64.140000000000001 110.874 -176.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -101.71 115.77 31.27 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 110.253 -0.277 . . . . 60.409999999999997 110.253 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -111.31 -4.45 14.93 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 122.393 1.092 . . . . 72.040000000000006 108.392 177.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.416 HE21 ' HB3' ' A' ' 77' ' ' ASP . 1.0 OUTLIER -78.73 123.6 85.31 Favored Pre-proline 0 C--N 1.314 -0.959 0 CA-C-N 114.587 -1.188 . . . . 74.120000000000005 109.98 -175.875 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.02 -27.71 85.08 Favored 'Trans proline' 0 C--N 1.361 1.225 0 C-N-CA 122.878 2.385 . . . . 73.310000000000002 111.308 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 91.8 m -134.93 116.63 14.94 Favored 'General case' 0 N--CA 1.408 -2.535 0 N-CA-C 107.13 -1.433 . . . . 71.310000000000002 107.13 173.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.423 HG23 ' HB2' ' A' ' 77' ' ' ASP . 88.9 m -105.24 114.4 28.56 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 108.969 -0.752 . . . . 72.299999999999997 108.969 -179.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 28.3 p -82.67 130.24 35.09 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 115.35 -0.841 . . . . 43.530000000000001 111.577 -178.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -108.58 115.5 30.21 Favored 'General case' 0 C--O 1.252 1.212 0 CA-C-O 121.385 0.612 . . . . 70.109999999999999 110.947 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 165.74 -158.5 31.41 Favored Glycine 0 CA--C 1.487 -1.691 0 N-CA-C 106.046 -2.822 . . . . 55.439999999999998 106.046 -179.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.8 ttp180 -159.32 78.18 0.72 Allowed 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 119.093 1.446 . . . . 75.239999999999995 111.417 174.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.48 ' HB3' ' HD3' ' A' ' 74' ' ' PRO . 13.0 t60 -175.53 -77.98 0.0 OUTLIER Pre-proline 0 CA--C 1.556 1.176 0 N-CA-C 113.392 0.886 . . . . 73.510000000000005 113.392 175.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.48 ' HD3' ' HB3' ' A' ' 73' ' ' HIS . 48.2 Cg_endo -66.71 -41.87 10.14 Favored 'Trans proline' 0 C--N 1.394 2.966 0 CA-C-N 120.839 1.335 . . . . 75.420000000000002 113.372 -169.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -166.71 114.54 0.85 Allowed 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 102.582 -3.118 . . . . 44.520000000000003 102.582 -178.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 19.7 m -136.33 103.07 5.17 Favored 'General case' 0 C--N 1.26 -3.319 0 CA-C-N 115.888 -0.597 . . . . 61.119999999999997 109.647 -178.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.423 ' HB2' HG23 ' A' ' 68' ' ' THR . 42.1 m-20 -74.07 -31.98 63.07 Favored 'General case' 0 CA--C 1.493 -1.227 0 CA-C-N 115.218 -0.901 . . . . 75.219999999999999 109.363 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 39.0 pt -119.75 137.82 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.871 0 N-CA-C 107.086 -1.45 . . . . 71.409999999999997 107.086 170.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -85.73 124.14 31.91 Favored 'General case' 0 C--N 1.284 -2.272 0 N-CA-C 108.145 -1.057 . . . . 73.140000000000001 108.145 179.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.49 ' HA ' ' HB2' ' A' ' 56' ' ' ASN . 35.4 tp -122.02 155.58 35.3 Favored 'General case' 0 N--CA 1.414 -2.248 0 CA-C-N 115.929 -0.578 . . . . 61.350000000000001 109.712 -174.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.41 ' CB ' ' HA ' ' A' ' 56' ' ' ASN . 9.8 t70 -168.94 150.32 4.57 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 104.583 -2.376 . . . . 60.409999999999997 104.583 178.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.425 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 20.8 t70 -169.41 164.28 10.61 Favored 'General case' 0 C--N 1.26 -3.298 0 N-CA-C 106.647 -1.612 . . . . 73.230000000000004 106.647 -176.255 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.8 m -63.2 -23.72 34.05 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 O-C-N 123.309 0.381 . . . . 45.140000000000001 111.367 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.572 ' HB ' ' HB2' ' A' ' 108' ' ' ASN . 45.8 m -144.2 70.77 1.3 Allowed 'General case' 0 N--CA 1.423 -1.793 0 CA-C-O 122.39 1.091 . . . . 72.109999999999999 109.802 175.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.425 ' HB ' ' HB3' ' A' ' 82' ' ' ASP . 12.5 p -95.84 140.19 17.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 114.499 -1.228 . . . . 74.049999999999997 110.466 -177.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 24.1 t -92.72 159.95 15.19 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 110.054 -0.35 . . . . 75.400000000000006 110.054 178.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 4.5 tpp180 -57.88 -47.97 81.19 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.864 0.865 . . . . 71.439999999999998 109.024 177.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -119.08 86.93 2.64 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 104.685 -2.339 . . . . 75.519999999999996 104.685 174.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 25.5 t60 -81.39 -52.49 7.22 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.962 -0.563 . . . . 64.120000000000005 111.204 -172.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.97 160.6 42.16 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 120.02 -0.672 . . . . 72.239999999999995 110.239 -177.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -131.18 127.22 37.51 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 108.345 -0.983 . . . . 75.310000000000002 108.345 174.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.42 ' HB3' ' HB ' ' A' ' 68' ' ' THR . 57.5 t80 -106.74 123.91 48.84 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 109.692 -0.484 . . . . 52.100000000000001 109.692 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -113.74 136.33 52.97 Favored 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 107.858 -1.164 . . . . 74.230000000000004 107.858 177.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 12.5 tt -116.1 131.44 68.6 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.236 0 C-N-CA 119.522 -0.871 . . . . 74.340000000000003 109.844 -178.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -109.4 145.97 35.23 Favored 'General case' 0 C--N 1.282 -2.359 0 N-CA-C 105.171 -2.159 . . . . 70.439999999999998 105.171 175.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -54.75 -22.94 15.66 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 113.226 0.825 . . . . 75.140000000000001 113.226 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -117.07 5.73 17.82 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 120.321 -0.943 . . . . 54.049999999999997 114.094 177.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -162.44 148.49 12.86 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 118.778 1.289 . . . . 62.219999999999999 111.642 -177.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -117.79 114.51 23.39 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.491 -0.929 . . . . 73.340000000000003 108.491 -176.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -132.25 135.13 46.06 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 119.638 -0.825 . . . . 61.409999999999997 112.498 -177.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.2 p -121.83 131.36 73.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-N 115.883 -0.599 . . . . 54.340000000000003 110.243 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.2 m -106.37 134.77 47.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-O 120.905 0.383 . . . . 70.120000000000005 110.907 178.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -90.0 108.95 20.03 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.283 -1.377 . . . . 53.420000000000002 107.283 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 21.2 m -113.52 11.7 8.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-N 115.942 -0.572 . . . . 74.439999999999998 111.29 -178.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -144.15 63.17 0.48 Allowed Glycine 0 N--CA 1.432 -1.584 0 N-CA-C 109.444 -1.462 . . . . 73.5 109.444 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 13.3 m -74.93 61.35 1.03 Allowed 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 123.549 0.74 . . . . 64.230000000000004 112.722 -173.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 85.4 mt -89.09 -49.11 6.95 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.467 -0.938 . . . . 72.319999999999993 108.467 176.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.572 ' HB2' ' HB ' ' A' ' 84' ' ' THR . 53.6 t30 -114.74 -33.0 5.64 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.592 -0.731 . . . . 74.310000000000002 109.506 -179.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 102.68 138.89 10.2 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.568 -0.825 . . . . 71.109999999999999 114.79 171.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.2 m -97.24 138.16 35.15 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.251 -1.018 . . . . 74.340000000000003 108.251 174.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.49 ' CE2' ' HB3' ' A' ' 116' ' ' PRO . 52.8 m-85 -130.89 151.91 50.8 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 109.321 -0.622 . . . . 72.329999999999998 109.321 -177.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.451 ' CG1' HE21 ' A' ' 120' ' ' GLN . 8.6 p -128.8 118.53 47.36 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 N-CA-C 108.017 -1.105 . . . . 64.349999999999994 108.017 168.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 48.82 51.8 15.25 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 116.21 -0.45 . . . . 75.230000000000004 111.563 -175.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 70.5 mtp180 74.42 -17.48 0.47 Allowed 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 124.763 1.225 . . . . 74.430000000000007 114.192 -179.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -76.07 115.04 43.17 Favored Pre-proline 0 C--O 1.247 0.952 0 CA-C-N 117.79 0.268 . . . . 63.130000000000003 111.23 -177.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.49 ' HB3' ' CE2' ' A' ' 111' ' ' TYR . 36.3 Cg_endo -91.8 102.9 0.22 Allowed 'Trans proline' 0 N--CA 1.443 -1.469 0 C-N-CA 123.141 2.561 . . . . 73.519999999999996 112.202 178.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.419 ' HB2' ' HG2' ' A' ' 120' ' ' GLN . 25.5 mtp180 -130.34 161.35 31.49 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 122.107 -0.37 . . . . 62.420000000000002 110.561 176.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -84.95 -8.94 58.55 Favored 'General case' 0 CA--C 1.496 -1.134 0 N-CA-C 113.434 0.902 . . . . 73.420000000000002 113.434 -177.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -153.42 137.9 16.77 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 105.432 -2.062 . . . . 71.400000000000006 105.432 170.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.451 HE21 ' CG1' ' A' ' 112' ' ' VAL . 9.0 mm100 -141.34 149.21 40.87 Favored 'General case' 0 CA--C 1.472 -2.033 0 N-CA-C 114.451 1.278 . . . . 73.219999999999999 114.451 -178.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 25.5 t -88.33 122.88 40.38 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.261 0 N-CA-C 105.878 -1.897 . . . . 71.340000000000003 105.878 174.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 52.8 mtt -70.91 139.34 50.69 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 120.85 0.357 . . . . 75.25 110.808 -178.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 60.6 tp60 -104.75 131.48 52.15 Favored 'General case' 0 N--CA 1.425 -1.723 0 N-CA-C 108.896 -0.779 . . . . 70.450000000000003 108.896 -177.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -78.51 115.6 18.33 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 115.735 -0.666 . . . . 53.329999999999998 111.177 -178.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 98.84 8.8 53.81 Favored Glycine 0 N--CA 1.438 -1.227 0 CA-C-N 115.617 -0.72 . . . . 62.109999999999999 111.687 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -125.58 -176.55 3.63 Favored 'General case' 0 C--O 1.245 0.816 0 N-CA-C 112.193 0.442 . . . . 74.120000000000005 112.193 -178.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.453 ' HG2' HG22 ' A' ' 136' ' ' VAL . 43.0 mt-10 -108.55 132.21 54.08 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 113.755 1.02 . . . . 70.230000000000004 113.755 -170.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.7 mp -114.1 120.09 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.991 0 N-CA-C 105.959 -1.867 . . . . 75.439999999999998 105.959 175.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.428 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 51.1 tt0 -103.7 122.31 44.79 Favored 'General case' 0 C--N 1.282 -2.329 0 CA-C-O 121.223 0.535 . . . . 64.510000000000005 110.264 -177.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.3 pp -103.28 98.85 7.32 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.182 0 CA-C-N 115.309 -0.86 . . . . 61.310000000000002 109.979 178.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 78.82 -106.6 2.38 Favored Glycine 0 N--CA 1.421 -2.351 0 N-CA-C 109.838 -1.305 . . . . 50.409999999999997 109.838 -176.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -111.35 -12.92 13.99 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 122.419 0.288 . . . . 74.340000000000003 111.464 177.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.43 ' HB3' ' O ' ' A' ' 53' ' ' ARG . 79.6 m-85 -97.77 151.15 20.47 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 112.605 0.594 . . . . 73.439999999999998 112.605 -172.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 20.0 mtp180 -112.49 128.3 56.29 Favored 'General case' 0 C--O 1.252 1.21 0 CA-C-O 121.949 0.881 . . . . 72.109999999999999 112.577 -168.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.425 HD11 HD12 ' A' ' 49' ' ' LEU . 5.0 tt -120.98 136.41 54.98 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 114.056 -1.429 . . . . 70.329999999999998 107.735 -178.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.453 HG22 ' HG2' ' A' ' 127' ' ' GLU . 22.0 t -109.01 127.98 65.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 106.985 -1.487 . . . . 61.020000000000003 106.985 176.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -105.67 122.86 46.93 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 109.147 -0.686 . . . . 53.399999999999999 109.147 -177.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.8 mp -130.51 159.04 38.27 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.857 -0.423 . . . . 64.329999999999998 109.857 -178.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -79.26 133.07 36.66 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 107.15 -1.426 . . . . 63.219999999999999 107.15 173.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -91.85 -160.92 36.53 Favored Glycine 0 N--CA 1.435 -1.414 0 C-N-CA 120.514 -0.851 . . . . 65.209999999999994 113.736 -173.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.48 ' O ' ' HA2' ' A' ' 45' ' ' GLY . 86.9 Cg_endo . . . . . 0 N--CA 1.452 -0.935 0 C-N-CA 122.992 2.462 . . . . 61.329999999999998 113.945 -175.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 42.9 t30 . . . . . 0 C--O 1.247 0.947 0 CA-C-O 121.351 0.596 . . . . 72.549999999999997 110.044 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -146.37 86.79 0.17 Allowed Glycine 0 N--CA 1.425 -2.062 0 N-CA-C 108.665 -1.774 . . . . 74.109999999999999 108.665 178.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.6 m -78.83 122.8 85.11 Favored Pre-proline 0 C--N 1.305 -1.339 0 CA-C-N 115.755 -0.223 . . . . 72.140000000000001 111.414 -174.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -69.22 138.43 39.52 Favored 'Trans proline' 0 C--O 1.25 1.095 0 C-N-CA 122.93 2.42 . . . . 73.420000000000002 110.804 172.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.433 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 8.4 pt-20 -95.52 137.83 21.94 Favored Pre-proline 0 C--O 1.251 1.183 0 C-N-CA 118.864 -1.134 . . . . 62.329999999999998 109.788 176.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 9' ' ' GLU . 5.3 Cg_exo -75.72 127.2 10.02 Favored 'Trans proline' 0 N--CA 1.439 -1.714 0 C-N-CA 122.242 1.961 . . . . 65.439999999999998 109.982 175.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -68.11 123.41 20.59 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 109.023 -0.732 . . . . 63.039999999999999 109.023 178.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.2 t -92.09 94.7 4.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 107.659 -1.237 . . . . 73.450000000000003 107.659 175.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.441 ' OE2' HG22 ' A' ' 15' ' ' THR . 0.4 OUTLIER -70.23 127.05 31.44 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 106.504 -1.665 . . . . 75.140000000000001 106.504 -179.123 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.6 m -100.48 -24.64 14.43 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 113.329 0.863 . . . . 73.230000000000004 113.329 -169.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.441 HG22 ' OE2' ' A' ' 13' ' ' GLU 0.313 14.0 t -83.63 72.14 10.33 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-O 123.896 1.808 . . . . 72.409999999999997 112.936 -174.314 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 57.3 m -139.37 138.55 36.69 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 104.521 -2.4 . . . . 73.319999999999993 104.521 174.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.1 t . . . . . 0 C--O 1.244 0.805 0 N-CA-C 107.35 -1.352 . . . . 72.030000000000001 107.35 -170.084 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.167 0 N-CA-C 111.06 -0.816 . . . . 52.409999999999997 111.06 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.7 m -129.67 146.1 51.48 Favored 'General case' 0 N--CA 1.414 -2.229 0 N-CA-C 107.266 -1.383 . . . . 52.420000000000002 107.266 177.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.83 175.1 10.67 Favored 'General case' 0 C--N 1.282 -2.362 0 N-CA-C 106.875 -1.528 . . . . 62.310000000000002 106.875 -178.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.8 pp -133.82 154.26 51.14 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 112.885 0.698 . . . . 75.030000000000001 112.885 -175.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.608 ' O ' ' HA ' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -118.94 140.9 49.22 Favored 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 108.312 -0.995 . . . . 73.409999999999997 108.312 175.575 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.4 HG22 ' HB3' ' A' ' 60' ' ' ARG . 27.8 t -121.3 114.32 42.8 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 108.566 -0.901 . . . . 71.219999999999999 108.566 -179.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.409 HG21 ' HB3' ' A' ' 57' ' ' ALA . 78.5 t -93.8 115.54 32.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 107.592 -1.262 . . . . 63.310000000000002 107.592 175.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 51.7 tttm -90.38 -24.1 20.89 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.771 -0.649 . . . . 65.219999999999999 110.505 -173.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 30.8 ttp-105 -146.69 119.3 8.54 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 106.878 -1.527 . . . . 74.340000000000003 106.878 176.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 143.15 116.86 1.18 Allowed Glycine 0 N--CA 1.417 -2.575 0 C-N-CA 120.176 -1.011 . . . . 74.299999999999997 112.181 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.501 ' HB2' ' HB3' ' A' ' 81' ' ' ASP . 27.8 Cg_exo -65.44 -10.81 27.59 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 123.423 2.749 . . . . 61.399999999999999 111.089 178.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.52 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 2.2 m-20 -48.38 -36.16 14.07 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 126.295 1.838 . . . . 61.130000000000003 110.212 174.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.409 ' HB3' HG21 ' A' ' 51' ' ' VAL . . . -152.16 -62.09 0.16 Allowed 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 107.978 -1.119 . . . . 55.310000000000002 107.978 175.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.61 23.83 75.36 Favored Glycine 0 CA--C 1.508 -0.363 0 CA-C-N 115.596 -0.729 . . . . 72.120000000000005 112.958 177.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -157.25 -179.43 8.19 Favored 'General case' 0 N--CA 1.428 -1.525 0 N-CA-C 108.478 -0.934 . . . . 52.130000000000003 108.478 -176.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.608 ' HA ' ' O ' ' A' ' 49' ' ' LEU . 9.8 ptp85 -111.1 133.87 53.14 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 124.04 0.838 . . . . 73.019999999999996 109.515 175.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -141.51 153.05 44.67 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.556 -0.535 . . . . 71.420000000000002 109.556 173.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.0 pp -94.41 140.4 29.86 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 112.114 0.413 . . . . 64.510000000000005 112.114 -177.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -78.6 114.94 17.95 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.646 -0.706 . . . . 65.230000000000004 109.918 178.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -146.47 16.83 1.31 Allowed 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 123.267 1.508 . . . . 63.520000000000003 107.596 175.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.452 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 28.4 tt0 -126.49 104.34 24.71 Favored Pre-proline 0 C--N 1.301 -1.535 0 CA-C-N 114.352 -1.295 . . . . 71.109999999999999 108.029 178.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.452 ' HD2' ' HA ' ' A' ' 65' ' ' GLN . 2.0 Cg_endo -45.92 -47.43 14.19 Favored 'Trans proline' 0 C--N 1.369 1.614 0 C-N-CA 124.133 3.222 . . . . 62.350000000000001 114.279 -174.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 50.3 m -113.24 97.33 6.42 Favored 'General case' 0 N--CA 1.424 -1.769 0 CA-C-O 121.319 0.58 . . . . 63.109999999999999 110.467 178.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.49 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 93.1 m -109.03 114.14 27.62 Favored 'General case' 0 N--CA 1.424 -1.771 0 N-CA-C 108.695 -0.854 . . . . 63.310000000000002 108.695 177.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 41.6 m -105.01 131.44 52.52 Favored 'General case' 0 N--CA 1.421 -1.895 0 CA-C-O 121.037 0.446 . . . . 75.230000000000004 109.904 -175.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -103.78 130.41 51.31 Favored 'General case' 0 N--CA 1.419 -1.981 0 N-CA-C 107.905 -1.146 . . . . 74.530000000000001 107.905 176.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -170.39 -140.86 3.11 Favored Glycine 0 N--CA 1.425 -2.058 0 N-CA-C 110.672 -0.971 . . . . 62.009999999999998 110.672 -178.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 27.1 ttm-85 -79.84 -59.12 2.86 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 120.469 -0.492 . . . . 75.129999999999995 109.854 -176.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 28.2 t-80 175.22 -47.76 0.0 OUTLIER Pre-proline 0 CA--C 1.562 1.431 0 O-C-N 124.203 0.939 . . . . 70.239999999999995 113.167 177.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -57.55 -27.9 78.71 Favored 'Trans proline' 0 C--N 1.384 2.421 0 C-N-CA 122.065 1.844 . . . . 55.439999999999998 114.13 -174.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.412 ' CD ' HH21 ' A' ' 87' ' ' ARG . 41.8 mt-10 -125.12 26.47 6.94 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 109.697 -0.483 . . . . 70.340000000000003 109.697 -177.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.3 m -145.01 140.37 28.1 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 122.298 -0.252 . . . . 64.230000000000004 110.558 -175.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -69.03 -42.36 76.49 Favored 'General case' 0 C--O 1.242 0.708 0 C-N-CA 120.191 -0.604 . . . . 65.319999999999993 110.394 178.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 21.0 pt -100.86 144.32 12.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 CA-C-N 115.118 -0.946 . . . . 71.420000000000002 109.934 178.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -100.61 117.73 35.32 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.106 0.479 . . . . 75.230000000000004 109.969 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.52 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 6.9 mp -98.71 122.9 42.52 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 120.842 0.353 . . . . 72.230000000000004 111.917 -178.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.501 ' HB3' ' HB2' ' A' ' 55' ' ' PRO . 24.3 t70 -99.83 73.78 1.79 Allowed 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 106.01 -1.848 . . . . 72.129999999999995 106.01 168.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.468 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 13.2 t70 -81.56 -175.87 5.74 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.141 -1.391 . . . . 72.430000000000007 107.718 -177.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.8 p -88.94 -23.64 6.23 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 N-CA-C 108.182 -1.044 . . . . 72.340000000000003 108.182 178.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 17.7 m -154.35 84.69 1.12 Allowed 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 116.033 -0.531 . . . . 74.219999999999999 110.069 176.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.468 ' HB ' ' HB3' ' A' ' 82' ' ' ASP . 7.4 p -108.7 136.28 44.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.912 -0.586 . . . . 71.420000000000002 110.03 -178.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 23.7 p -90.99 -81.98 0.3 Allowed 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.575 0.703 . . . . 73.430000000000007 111.616 -178.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.412 HH21 ' CD ' ' A' ' 75' ' ' GLU . 16.5 ptm180 -162.72 -34.09 0.04 OUTLIER 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 125.203 1.401 . . . . 72.310000000000002 108.333 -179.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 11.5 mmt180 -125.69 101.09 6.72 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 105.033 -2.21 . . . . 71.310000000000002 105.033 174.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 18.4 t60 -95.79 -60.61 1.61 Allowed 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.657 -0.868 . . . . 52.340000000000003 108.657 -173.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -145.57 144.31 30.43 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 115.771 -0.649 . . . . 64.219999999999999 110.055 -178.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -104.34 127.99 52.09 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 115.653 -0.703 . . . . 71.530000000000001 109.164 176.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.49 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 95.5 m-85 -104.68 112.02 24.96 Favored 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 107.061 -1.459 . . . . 74.340000000000003 107.061 174.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -104.4 122.1 44.79 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-N 114.528 -1.214 . . . . 74.219999999999999 110.259 -177.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.8 116.03 50.86 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.654 0 N-CA-C 105.978 -1.86 . . . . 73.209999999999994 105.978 171.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.467 ' C ' ' H ' ' A' ' 97' ' ' GLY . 52.5 t30 -114.08 148.05 37.73 Favored 'General case' 0 C--N 1.276 -2.6 0 N-CA-C 106.343 -1.725 . . . . 72.319999999999993 106.343 -178.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -52.59 24.52 0.0 OUTLIER 'General case' 0 CA--C 1.578 2.04 0 C-N-CA 126.847 2.059 . . . . 72.310000000000002 115.296 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.467 ' H ' ' C ' ' A' ' 95' ' ' ASN . . . -168.29 -43.66 0.03 OUTLIER Glycine 0 N--CA 1.426 -2.006 0 N-CA-C 110.123 -1.191 . . . . 63.420000000000002 110.123 -178.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -120.23 143.66 48.16 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 113.035 0.754 . . . . 73.430000000000007 113.035 -175.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.479 ' HB3' ' SD ' ' A' ' 122' ' ' MET . 84.1 m-85 -105.12 121.5 43.93 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 105.522 -2.029 . . . . 75.319999999999993 105.522 173.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -127.75 136.3 51.33 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 112.701 0.63 . . . . 74.230000000000004 112.701 -174.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 119' ' ' ALA . 7.2 p -115.19 118.85 60.08 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 N-CA-C 108.836 -0.801 . . . . 72.340000000000003 108.836 177.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 42.7 t -120.27 129.99 74.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-N 116.282 -0.417 . . . . 71.129999999999995 110.21 -177.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.596 ' OD2' ' HB3' ' A' ' 106' ' ' SER . 10.9 t70 -83.37 130.26 35.04 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 107.239 -1.393 . . . . 61.020000000000003 107.239 172.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.0 m -124.01 13.57 4.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 112.946 0.721 . . . . 72.140000000000001 112.946 -177.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 152.94 26.61 0.04 OUTLIER Glycine 0 N--CA 1.438 -1.209 0 C-N-CA 118.59 -1.767 . . . . 34.310000000000002 114.42 178.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.596 ' HB3' ' OD2' ' A' ' 103' ' ' ASP . 32.7 t -79.8 131.57 35.93 Favored 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 108.075 -1.083 . . . . 44.030000000000001 108.075 175.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -76.07 -18.46 59.19 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.517 0.675 . . . . 64.239999999999995 110.171 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -88.9 -37.03 15.61 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 115.186 -0.915 . . . . 72.239999999999995 109.16 178.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 92.22 121.04 2.77 Favored Glycine 0 C--N 1.306 -1.11 0 CA-C-N 114.86 -1.064 . . . . 61.310000000000002 112.589 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.401 HG23 ' HA ' ' A' ' 130' ' ' ILE . 24.0 m -85.23 120.15 26.41 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 109.147 -0.686 . . . . 60.509999999999998 109.147 176.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -139.12 163.09 33.35 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.719 -0.474 . . . . 63.310000000000002 109.719 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.527 ' HB ' ' HB3' ' A' ' 115' ' ' GLU . 23.9 t -100.36 141.49 17.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 106.511 -1.663 . . . . 65.349999999999994 106.511 177.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -60.05 -25.07 65.07 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-O 120.969 0.414 . . . . 73.129999999999995 111.419 -175.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 81.8 mtt85 -106.58 -9.28 16.64 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.387 -0.37 . . . . 65.219999999999999 111.773 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.527 ' HB3' ' HB ' ' A' ' 112' ' ' VAL . 9.5 tp10 -133.16 112.9 13.33 Favored Pre-proline 0 C--O 1.252 1.231 0 C-N-CA 119.983 -0.687 . . . . 73.329999999999998 110.858 -172.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -75.25 60.61 5.66 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.516 2.811 . . . . 63.219999999999999 111.77 177.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.443 ' HB3' ' O ' ' A' ' 119' ' ' ALA . 28.4 mmm-85 -128.92 131.86 47.6 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.919 -1.141 . . . . 73.120000000000005 107.919 -179.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 31.4 p-10 -83.62 -18.35 38.46 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-O 121.96 0.886 . . . . 74.140000000000001 109.67 177.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.443 ' O ' ' HB3' ' A' ' 117' ' ' ARG . . . -128.98 133.85 47.94 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 106.551 -1.648 . . . . 74.319999999999993 106.551 165.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.523 ' NE2' ' HG2' ' A' ' 115' ' ' GLU . 5.0 tp60 -144.59 150.77 38.02 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 123.655 0.597 . . . . 63.030000000000001 112.171 -177.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.464 ' O ' ' HG3' ' A' ' 120' ' ' GLN . 7.3 p -79.65 130.62 35.78 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 N-CA-C 106.195 -1.78 . . . . 74.099999999999994 106.195 168.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.479 ' SD ' ' HB3' ' A' ' 99' ' ' PHE . 65.2 mtt -66.92 156.2 36.46 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 112.7 0.63 . . . . 62.350000000000001 112.7 -173.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -132.67 134.6 45.04 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.374 -1.343 . . . . 74.439999999999998 107.374 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 7.6 t -79.68 128.23 33.16 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 109.122 -0.696 . . . . 72.340000000000003 109.122 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 93.46 20.75 31.27 Favored Glycine 0 N--CA 1.421 -2.3 0 C-N-CA 120.229 -0.986 . . . . 54.530000000000001 111.298 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -123.4 172.9 8.34 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.235 -1.394 . . . . 72.299999999999997 107.235 178.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -129.05 125.68 37.8 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-O 121.383 0.611 . . . . 73.109999999999999 110.826 -173.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 59.4 mt -109.49 130.77 61.95 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 CA-C-N 115.015 -0.993 . . . . 73.25 108.641 -175.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -98.43 112.64 24.59 Favored 'General case' 0 N--CA 1.423 -1.816 0 N-CA-C 108.659 -0.867 . . . . 61.340000000000003 108.659 178.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.401 ' HA ' HG23 ' A' ' 110' ' ' THR . 18.8 pt -90.92 98.36 8.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-O 121.727 0.775 . . . . 71.409999999999997 109.577 -178.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 75.28 -82.0 0.92 Allowed Glycine 0 N--CA 1.426 -2.027 0 CA-C-N 114.571 -1.195 . . . . 54.310000000000002 110.123 -176.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -136.1 -11.03 1.98 Allowed 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 109.917 -0.401 . . . . 65.150000000000006 109.917 176.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -94.5 157.08 16.16 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 113.185 0.809 . . . . 74.010000000000005 113.185 -172.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 45.9 ttt180 -99.66 120.58 39.92 Favored 'General case' 0 C--O 1.245 0.867 0 CA-C-N 115.66 -0.7 . . . . 72.120000000000005 111.452 -167.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.5 tt -125.23 129.21 49.62 Favored 'General case' 0 C--O 1.218 -0.586 0 C-N-CA 123.973 0.909 . . . . 72.209999999999994 109.721 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 40.6 t -107.83 128.05 63.41 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 N-CA-C 107.606 -1.257 . . . . 74.209999999999994 107.606 177.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -102.28 125.76 49.07 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 109.729 -0.471 . . . . 62.530000000000001 109.729 -178.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 84.2 mt -138.73 138.18 37.45 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.533 0.682 . . . . 73.450000000000003 111.282 -176.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -80.19 90.92 5.51 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 108.18 -1.045 . . . . 72.040000000000006 108.18 174.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -65.6 -79.83 0.18 Allowed Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 115.388 -0.823 . . . . 30.219999999999999 111.409 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo . . . . . 0 N--CA 1.437 -1.849 0 C-N-CA 121.608 1.539 . . . . 73.200000000000003 111.968 177.685 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 . . . . . 0 N--CA 1.441 -0.879 0 N-CA-C 109.769 -0.456 . . . . 74.299999999999997 109.769 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 159.87 138.11 2.38 Favored Glycine 0 N--CA 1.429 -1.775 0 C-N-CA 120.893 -0.67 . . . . 40.130000000000003 111.986 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.9 t -105.61 132.96 20.43 Favored Pre-proline 0 N--CA 1.427 -1.58 0 N-CA-C 109.12 -0.696 . . . . 64.450000000000003 109.12 178.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -66.84 132.28 28.01 Favored 'Trans proline' 0 C--O 1.243 0.762 0 C-N-CA 122.232 1.955 . . . . 73.430000000000007 110.342 176.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -80.89 146.45 59.61 Favored Pre-proline 0 C--N 1.306 -1.324 0 CA-C-N 116.587 -0.279 . . . . 61.210000000000001 110.501 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -62.01 139.07 77.03 Favored 'Trans proline' 0 C--O 1.243 0.765 0 C-N-CA 122.403 2.069 . . . . 64.420000000000002 110.983 178.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -84.52 137.43 33.34 Favored 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 108.154 -1.054 . . . . 71.140000000000001 108.154 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.4 m -74.44 85.34 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 CA-C-O 122.55 1.166 . . . . 73.310000000000002 111.277 178.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -92.85 137.54 32.27 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 114.737 -1.119 . . . . 73.209999999999994 108.568 -178.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.0 p -72.48 130.19 40.09 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 116.458 -0.337 . . . . 64.329999999999998 111.019 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.2 t -77.73 -8.19 57.61 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-O 122.601 1.191 . . . . 74.430000000000007 108.276 176.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.9 m -76.8 100.13 5.38 Favored 'General case' 0 N--CA 1.412 -2.367 0 CA-C-N 113.702 -1.59 . . . . 73.430000000000007 107.073 174.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.6 m . . . . . 0 N--CA 1.426 -1.673 0 CA-C-O 122.392 1.091 . . . . 63.299999999999997 111.245 -178.744 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.483 -1.958 0 N-CA-C 109.566 -1.413 . . . . 62.240000000000002 109.566 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.7 p -89.12 152.69 21.49 Favored 'General case' 0 C--N 1.279 -2.474 0 CA-C-N 114.461 -0.87 . . . . 73.540000000000006 111.446 -177.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.92 167.2 20.67 Favored 'General case' 0 C--N 1.284 -2.268 0 CA-C-N 115.166 -0.924 . . . . 75.310000000000002 109.891 -175.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.417 HD23 ' H ' ' A' ' 48' ' ' LEU . 2.2 pt? -128.89 138.87 52.26 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.387 0.613 . . . . 70.310000000000002 110.688 -177.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.7 pp -127.91 149.09 50.47 Favored 'General case' 0 C--N 1.282 -2.354 0 CA-C-N 115.671 -0.695 . . . . 74.219999999999999 110.028 178.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.44 HG12 ' CB ' ' A' ' 60' ' ' ARG . 27.2 m -125.87 140.13 49.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 N-CA-C 109.802 -0.444 . . . . 55.420000000000002 109.802 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.4 t -104.19 116.49 48.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 106.484 -1.673 . . . . 71.310000000000002 106.484 175.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -103.59 -25.04 13.34 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 120.264 -0.574 . . . . 64.25 112.184 -175.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.431 ' O ' ' HA ' ' A' ' 133' ' ' PHE . 24.9 tpt180 -141.35 115.48 9.3 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 120.213 -0.595 . . . . 71.120000000000005 110.957 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 138.15 139.35 3.84 Favored Glycine 0 N--CA 1.433 -1.517 0 C-N-CA 119.796 -1.193 . . . . 75.140000000000001 113.414 173.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -52.49 -8.06 0.36 Allowed 'Trans proline' 0 N--CA 1.506 2.26 0 C-N-CA 125.056 3.837 . . . . 64.150000000000006 115.402 176.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.474 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 37.2 t30 -58.94 -51.42 70.14 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.579 0.752 . . . . 60.119999999999997 109.565 177.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -173.81 -177.39 1.38 Allowed 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.941 -0.763 . . . . 63.299999999999997 108.941 -177.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -164.22 53.87 0.28 Allowed Glycine 0 N--CA 1.425 -2.07 0 N-CA-C 109.512 -1.435 . . . . 51.119999999999997 109.512 178.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -153.69 -176.98 6.07 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 108.523 -0.917 . . . . 63.340000000000003 108.523 -177.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.44 ' CB ' HG12 ' A' ' 50' ' ' VAL . 0.4 OUTLIER -108.55 139.2 43.65 Favored 'General case' 0 C--N 1.309 -1.192 0 O-C-N 123.885 0.741 . . . . 71.219999999999999 109.049 178.8 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -128.49 129.04 45.49 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 110.093 -0.336 . . . . 65.329999999999998 110.093 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -97.09 116.25 28.95 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 105.945 -1.872 . . . . 61.310000000000002 105.945 175.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -99.99 115.65 30.2 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 112.811 0.671 . . . . 74.219999999999999 112.811 -174.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -109.02 -5.88 15.87 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 105.956 -1.868 . . . . 72.409999999999997 105.956 168.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -66.1 112.54 9.3 Favored Pre-proline 0 N--CA 1.443 -0.787 0 CA-C-N 112.937 -1.938 . . . . 72.310000000000002 109.124 176.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -62.04 -30.83 83.47 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.663 2.242 . . . . 74.219999999999999 113.003 -177.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 85.5 m -137.17 111.07 8.21 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-O 121.024 0.44 . . . . 72.409999999999997 111.825 -178.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 55.5 m -110.14 114.08 27.3 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 108.624 -0.88 . . . . 70.439999999999998 108.624 176.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.5 p -93.33 140.82 29.13 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 122.091 -0.38 . . . . 74.310000000000002 111.048 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -116.08 140.06 49.66 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 109.473 -0.566 . . . . 62.119999999999997 109.473 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 170.01 -148.71 12.02 Favored Glycine 0 N--CA 1.421 -2.316 0 C-N-CA 120.254 -0.974 . . . . 71.109999999999999 112.372 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.464 ' HB2' ' HA ' ' A' ' 87' ' ' ARG . 56.5 ttt180 -51.47 -75.19 0.03 OUTLIER 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 125.541 1.537 . . . . 75.140000000000001 113.915 -175.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.46 ' HB3' ' CD ' ' A' ' 74' ' ' PRO . 7.9 t60 -172.12 -76.65 0.0 OUTLIER Pre-proline 0 CA--C 1.56 1.347 0 CA-C-O 118.798 -0.62 . . . . 71.200000000000003 110.798 -178.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.46 ' CD ' ' HB3' ' A' ' 73' ' ' HIS . 49.8 Cg_endo -68.55 -24.84 35.47 Favored 'Trans proline' 0 C--N 1.389 2.701 0 CA-C-N 121.135 1.441 . . . . 62.240000000000002 111.136 178.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.42 ' OE2' ' HD3' ' A' ' 72' ' ' ARG . 34.9 mt-10 -89.0 15.6 8.35 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 114.119 -1.4 . . . . 75.120000000000005 111.526 -173.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.1 p -153.44 166.85 31.37 Favored 'General case' 0 N--CA 1.421 -1.907 0 CA-C-N 116.682 -0.236 . . . . 75.319999999999993 110.751 -178.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -79.98 -46.37 16.78 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.344 -0.984 . . . . 64.099999999999994 108.344 177.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 34.5 pt -104.91 143.57 16.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 108.747 -0.834 . . . . 74.299999999999997 108.747 175.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.417 ' HB3' ' HA ' ' A' ' 73' ' ' HIS . 33.7 p90 -115.27 117.64 31.04 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 121.495 0.664 . . . . 75.329999999999998 112.49 -174.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.554 HD23 ' CE2' ' A' ' 133' ' ' PHE . 4.5 mp -90.18 111.94 23.27 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.876 -1.157 . . . . 75.340000000000003 107.876 178.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -84.29 10.34 10.74 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-O 121.702 0.763 . . . . 74.349999999999994 112.697 -173.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -77.55 146.02 36.56 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 108.995 -0.743 . . . . 74.25 108.995 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.5 p -67.87 -22.14 27.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-O 121.256 0.55 . . . . 64.319999999999993 111.828 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -96.07 23.16 6.72 Favored 'General case' 0 CA--C 1.557 1.239 0 CA-C-O 121.185 0.516 . . . . 74.030000000000001 110.751 -176.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.431 HG21 ' HB2' ' A' ' 80' ' ' LEU . 13.2 p -81.94 140.84 15.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 O-C-N 121.921 -0.487 . . . . 72.230000000000004 110.297 -178.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 19.6 m -83.03 156.33 23.44 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.549 -0.908 . . . . 62.229999999999997 108.549 175.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.464 ' HA ' ' HB2' ' A' ' 72' ' ' ARG . 36.5 mtp-105 -63.06 -54.64 34.91 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-O 121.332 0.586 . . . . 74.319999999999993 109.539 -178.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.402 ' CZ ' ' HB3' ' A' ' 75' ' ' GLU . 13.1 mmt180 -117.22 112.55 20.96 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 105.347 -2.094 . . . . 73.409999999999997 105.347 175.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.411 ' CE1' ' HB3' ' A' ' 108' ' ' ASN . 11.3 t60 -98.13 -76.74 0.52 Allowed 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.16 0.505 . . . . 71.239999999999995 110.534 -174.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.37 167.49 23.45 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.553 -0.717 . . . . 42.310000000000002 110.543 -176.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -127.87 128.19 44.76 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 115.811 -0.631 . . . . 74.019999999999996 109.507 177.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -104.69 120.24 40.88 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.423 -0.954 . . . . 73.430000000000007 108.423 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 78.9 mtt180 -119.25 141.8 48.61 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-O 121.553 0.692 . . . . 72.209999999999994 111.288 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.64 119.79 62.86 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 104.359 -2.46 . . . . 63.109999999999999 104.359 171.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.494 ' C ' ' H ' ' A' ' 97' ' ' GLY . 51.4 t-20 -111.4 147.08 35.98 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 115.299 -0.864 . . . . 54.210000000000001 109.16 -170.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -63.43 31.8 0.01 OUTLIER 'General case' 0 CA--C 1.581 2.136 0 C-N-CA 125.853 1.661 . . . . 70.510000000000005 111.869 176.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.494 ' H ' ' C ' ' A' ' 95' ' ' ASN . . . -171.1 -38.32 0.03 OUTLIER Glycine 0 N--CA 1.428 -1.887 0 N-CA-C 111.46 -0.656 . . . . 34.509999999999998 111.46 -179.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -133.11 177.41 7.69 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-O 121.509 0.671 . . . . 73.519999999999996 111.201 -177.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.486 ' HB3' ' HB3' ' A' ' 122' ' ' MET . 87.7 m-85 -122.63 121.33 36.17 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 104.418 -2.438 . . . . 74.409999999999997 104.418 171.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -131.14 127.27 37.71 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 120.661 -0.416 . . . . 54.439999999999998 111.445 -169.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 5.5 p -126.12 119.27 53.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-O 121.526 0.679 . . . . 62.200000000000003 109.472 176.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 23.3 m -119.51 136.6 56.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-N 115.425 -0.807 . . . . 75.209999999999994 112.04 -176.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.462 ' HB3' HD22 ' A' ' 118' ' ' ASN . 12.1 t70 -83.11 132.34 35.1 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 106.542 -1.651 . . . . 73.540000000000006 106.542 174.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 30.5 m -104.09 8.06 9.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 C-N-CA 119.653 -0.819 . . . . 73.340000000000003 112.285 -179.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 127.89 52.04 0.14 Allowed Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.593 -0.813 . . . . 63.530000000000001 112.447 179.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 14.2 m -80.87 126.18 31.04 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 112.319 0.488 . . . . 71.329999999999998 112.319 -176.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.0 mp -82.47 -22.06 35.33 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 107.493 -1.299 . . . . 73.409999999999997 107.493 173.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.496 ' OD1' ' HA3' ' A' ' 131' ' ' GLY . 22.8 t-20 -75.12 -30.52 60.87 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.372 -1.286 . . . . 74.310000000000002 109.989 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 92.07 117.94 2.36 Favored Glycine 0 C--O 1.221 -0.698 0 N-CA-C 114.566 0.587 . . . . 43.109999999999999 114.566 174.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 88.4 m -99.34 119.81 38.56 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-O 120.966 0.412 . . . . 54.130000000000003 110.093 178.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -115.19 134.78 54.84 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 109.411 -0.588 . . . . 73.219999999999999 109.411 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 5.4 p -113.09 121.16 64.78 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.582 0 N-CA-C 106.557 -1.645 . . . . 72.25 106.557 171.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 17.6 m120 58.9 26.27 14.7 Favored 'General case' 0 N--CA 1.48 1.05 0 O-C-N 123.163 0.289 . . . . 74.430000000000007 110.266 -175.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 80.38 6.29 1.62 Allowed 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.982 1.313 . . . . 73.349999999999994 113.467 -177.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -100.83 121.47 52.43 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 109.315 -0.624 . . . . 73.409999999999997 109.315 176.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.429 ' HA ' ' O ' ' A' ' 110' ' ' THR . 57.3 Cg_endo -78.14 126.42 7.78 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 121.993 1.795 . . . . 75.329999999999998 111.157 177.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -150.18 -176.96 5.67 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 109.908 -0.404 . . . . 72.239999999999995 109.908 177.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.462 HD22 ' HB3' ' A' ' 103' ' ' ASP . 4.0 t-20 -96.12 -57.37 2.36 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 123.189 0.306 . . . . 45.420000000000002 111.795 -177.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -117.92 139.72 50.73 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 109.629 -0.508 . . . . 62.240000000000002 109.629 -177.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 54.7 tp60 -139.25 140.73 37.77 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 116.207 -0.451 . . . . 72.140000000000001 110.472 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 59.5 t -80.25 114.22 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 104.936 -2.246 . . . . 64.420000000000002 104.936 170.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.486 ' HB3' ' HB3' ' A' ' 99' ' ' PHE . 16.6 ttt -63.36 123.01 17.62 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.973 -0.751 . . . . 73.319999999999993 108.973 -173.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -104.57 136.8 43.45 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-O 121.333 0.587 . . . . 70.239999999999995 111.457 -171.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 14.4 p -79.37 118.55 21.37 Favored 'General case' 0 N--CA 1.416 -2.158 0 CA-C-N 114.891 -1.049 . . . . 74.099999999999994 111.079 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 107.07 -13.33 40.86 Favored Glycine 0 N--CA 1.44 -1.057 0 CA-C-N 115.715 -0.675 . . . . 62.229999999999997 112.219 177.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -99.35 172.95 7.01 Favored 'General case' 0 C--O 1.25 1.088 0 N-CA-C 113.564 0.95 . . . . 74.530000000000001 113.564 -175.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.52 ' OE1' ' HD3' ' A' ' 134' ' ' ARG . 17.1 pt-20 -108.97 140.47 42.42 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 114.528 -1.214 . . . . 73.129999999999995 111.333 -174.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 71.9 mt -123.31 119.28 57.08 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 N-CA-C 106.765 -1.568 . . . . 74.209999999999994 106.765 177.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -115.75 121.88 43.79 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 109.278 -0.638 . . . . 72.129999999999995 109.278 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.503 ' O ' ' HD2' ' A' ' 133' ' ' PHE . 18.5 pt -103.83 98.68 7.13 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.171 0 N-CA-C 108.271 -1.011 . . . . 74.340000000000003 108.271 176.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.496 ' HA3' ' OD1' ' A' ' 108' ' ' ASN . . . 62.97 -95.01 0.12 Allowed Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.273 -0.876 . . . . 75.299999999999997 113.667 -178.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 3.8 ttmp? -101.72 -22.28 14.45 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 123.27 0.628 . . . . 74.150000000000006 109.891 -177.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.554 ' CE2' HD23 ' A' ' 80' ' ' LEU . 5.5 m-85 -92.17 112.14 23.96 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.617 -0.72 . . . . 71.329999999999998 110.038 -170.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.52 ' HD3' ' OE1' ' A' ' 127' ' ' GLU . 13.4 ttm180 -104.52 124.95 50.2 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 120.395 -0.522 . . . . 74.400000000000006 109.943 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.8 tt -124.25 140.33 53.07 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.547 -1.206 . . . . 63.409999999999997 108.604 -177.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 8.9 p -116.35 136.52 53.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 109.036 -0.727 . . . . 62.420000000000002 109.036 175.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -108.42 122.13 46.37 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.26 -0.427 . . . . 74.310000000000002 111.757 -173.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -121.83 150.23 42.21 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.119 -0.697 . . . . 75.209999999999994 109.119 178.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -129.4 148.64 51.34 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 109.691 -0.485 . . . . 75.549999999999997 109.691 178.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -169.21 -70.52 0.03 OUTLIER Glycine 0 C--N 1.303 -1.253 0 C-N-CA 120.019 -1.086 . . . . 41.420000000000002 112.708 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo . . . . . 0 C--N 1.357 0.988 0 C-N-CA 123.451 2.767 . . . . 61.439999999999998 116.344 -177.07 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 50.3 t30 . . . . . 0 CA--C 1.541 0.63 0 N-CA-C 110.52 -0.178 . . . . 71.299999999999997 110.52 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -58.07 149.5 34.45 Favored Glycine 0 C--O 1.239 0.449 0 N-CA-C 112.518 -0.233 . . . . 73.099999999999994 112.518 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 60.5 m -67.46 124.83 90.13 Favored Pre-proline 0 C--N 1.311 -1.105 0 C-N-CA 122.763 0.425 . . . . 63.149999999999999 111.108 -177.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -67.7 151.82 78.54 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.491 2.794 . . . . 72.200000000000003 111.28 176.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -69.97 111.87 10.55 Favored Pre-proline 0 C--N 1.315 -0.895 0 N-CA-C 105.6 -2.0 . . . . 63.229999999999997 105.6 170.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -53.61 109.9 0.43 Allowed 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 123.187 2.592 . . . . 74.209999999999994 114.507 -170.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -90.11 107.86 19.39 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 114.585 -1.188 . . . . 62.509999999999998 108.635 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 46.9 t -89.69 94.02 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.528 0 N-CA-C 108.526 -0.916 . . . . 75.400000000000006 108.526 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -70.01 134.39 48.25 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 114.877 -1.056 . . . . 73.329999999999998 109.486 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 28.5 m -65.87 112.26 3.69 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-O 121.522 0.677 . . . . 73.140000000000001 112.046 -176.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.509 HG23 ' HB2' ' A' ' 98' ' ' GLU . 86.9 m -43.61 125.23 3.93 Favored 'General case' 0 N--CA 1.42 -1.93 0 C-N-CA 127.08 2.152 . . . . 55.350000000000001 114.598 -178.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.8 t -118.32 99.85 7.11 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 113.441 -1.709 . . . . 55.32 108.243 176.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.3 m . . . . . 0 CA--C 1.516 -0.349 0 CA-C-O 120.745 0.307 . . . . 71.530000000000001 111.024 -179.178 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.62 0 N-CA-C 109.793 -1.323 . . . . 74.540000000000006 109.793 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 16.2 m -90.63 168.51 11.73 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 114.344 -0.928 . . . . 62.100000000000001 110.427 -177.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.575 ' HB1' ' HA ' ' A' ' 139' ' ' ALA . . . -95.52 177.18 5.9 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.995 -0.742 . . . . 64.409999999999997 108.995 178.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.98 160.25 38.29 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.619 0.6 . . . . 73.430000000000007 112.619 -174.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.492 HD13 HD11 ' A' ' 135' ' ' LEU . 3.0 pp -131.61 144.11 50.82 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 115.463 -0.789 . . . . 73.450000000000003 110.06 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.7 t -124.73 139.61 50.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 N-CA-C 108.411 -0.959 . . . . 73.120000000000005 108.411 -178.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.435 HG21 ' HB3' ' A' ' 57' ' ' ALA . 48.1 t -92.29 116.39 33.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-O 121.565 0.698 . . . . 50.310000000000002 109.195 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -76.71 -45.93 27.51 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 114.43 -1.259 . . . . 73.239999999999995 108.598 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.6 tpm_? -151.65 111.3 4.0 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.283 -1.006 . . . . 72.209999999999994 108.283 -176.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 161.4 118.27 0.47 Allowed Glycine 0 N--CA 1.432 -1.568 0 C-N-CA 118.851 -1.642 . . . . 75.129999999999995 114.769 176.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -63.77 -7.62 13.47 Favored 'Trans proline' 0 C--N 1.366 1.498 0 C-N-CA 123.745 2.963 . . . . 73.010000000000005 112.161 176.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.558 ' OD1' ' HG ' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -44.2 -42.01 6.19 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.657 1.183 . . . . 74.239999999999995 107.812 172.218 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.435 ' HB3' HG21 ' A' ' 51' ' ' VAL . . . -154.2 -64.55 0.14 Allowed 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.426 -0.806 . . . . 74.519999999999996 109.163 176.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.09 34.9 28.73 Favored Glycine 0 C--O 1.226 -0.39 0 C-N-CA 121.003 -0.618 . . . . 60.43 111.639 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -149.79 -164.7 2.08 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.999 -1.112 . . . . 75.230000000000004 107.999 -177.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 17.0 ptt180 -126.39 152.93 45.65 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 106.733 -1.581 . . . . 63.350000000000001 106.733 177.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.45 ' CZ ' HD11 ' A' ' 49' ' ' LEU . 51.1 p90 -156.5 149.46 24.0 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-O 121.509 0.671 . . . . 75.219999999999999 112.639 173.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 41.8 tp -87.03 140.31 29.69 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 113.784 -1.553 . . . . 71.040000000000006 107.474 178.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -78.38 114.69 17.51 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 119.709 -0.796 . . . . 73.510000000000005 110.148 177.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -127.39 -2.46 6.23 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 121.982 0.896 . . . . 64.349999999999994 109.799 178.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.426 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 6.3 pm0 -111.48 114.15 52.99 Favored Pre-proline 0 N--CA 1.42 -1.929 0 CA-C-N 115.155 -0.929 . . . . 72.019999999999996 109.466 178.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.499 ' HA ' HG13 ' A' ' 94' ' ' ILE . 9.6 Cg_endo -49.95 -34.9 39.05 Favored 'Trans proline' 0 C--N 1.371 1.756 0 C-N-CA 124.437 3.425 . . . . 63.020000000000003 115.62 -173.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 92.4 m -133.62 105.46 6.87 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-O 121.262 0.553 . . . . 73.0 109.846 177.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.521 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 3.5 m -102.19 113.13 26.14 Favored 'General case' 0 N--CA 1.422 -1.863 0 N-CA-C 108.235 -1.024 . . . . 71.430000000000007 108.235 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.465 ' HB ' ' HA ' ' A' ' 76' ' ' SER . 57.4 m -93.61 141.43 28.49 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 108.685 -0.858 . . . . 65.319999999999993 108.685 177.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.508 ' HB1' HD11 ' A' ' 80' ' ' LEU . . . -120.91 126.67 50.59 Favored 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 108.92 -0.77 . . . . 75.129999999999995 108.92 177.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -176.03 -140.8 3.59 Favored Glycine 0 N--CA 1.425 -2.091 0 C-N-CA 120.613 -0.803 . . . . 53.43 112.081 -177.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 22.8 ttm180 -114.15 -25.91 8.29 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.245 0.545 . . . . 72.409999999999997 111.837 -174.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.421 ' NE2' ' HG2' ' A' ' 87' ' ' ARG . 25.3 m-70 -99.54 157.41 34.03 Favored Pre-proline 0 C--N 1.305 -1.342 0 CA-C-N 116.386 -0.37 . . . . 70.219999999999999 110.101 -172.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -51.94 -21.38 11.98 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 124.089 3.193 . . . . 73.450000000000003 114.387 -178.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -60.51 -21.88 62.94 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.389 0.614 . . . . 61.310000000000002 110.045 176.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.465 ' HA ' ' HB ' ' A' ' 69' ' ' THR . 34.4 m -86.94 139.36 30.69 Favored 'General case' 0 N--CA 1.421 -1.9 0 CA-C-N 115.376 -0.829 . . . . 73.400000000000006 109.042 175.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -80.12 -30.68 39.08 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.204 0.526 . . . . 71.219999999999999 109.678 -179.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.453 ' H ' HD13 ' A' ' 78' ' ' ILE . 0.2 OUTLIER -126.95 136.49 60.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 109.244 -0.651 . . . . 63.100000000000001 109.244 175.39 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -103.11 117.73 35.21 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 115.809 -0.632 . . . . 74.439999999999998 109.54 -176.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.558 ' HG ' ' OD1' ' A' ' 56' ' ' ASN . 5.5 mp -70.02 115.94 9.82 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.851 -1.166 . . . . 70.409999999999997 107.851 175.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -88.44 61.59 6.21 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 122.68 1.229 . . . . 73.109999999999999 110.459 177.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -111.29 156.04 22.11 Favored 'General case' 0 C--N 1.286 -2.189 0 CA-C-N 113.136 -1.847 . . . . 71.129999999999995 107.872 174.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.9 p -74.42 -25.61 19.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 111.914 0.338 . . . . 74.450000000000003 111.914 -177.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.8 m -116.2 72.04 0.8 Allowed 'General case' 0 CA--C 1.548 0.904 0 CA-C-O 121.977 0.894 . . . . 64.140000000000001 110.829 -177.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 47.7 t -112.65 139.53 37.12 Favored 'Isoleucine or valine' 0 C--O 1.249 1.074 0 CA-C-N 115.766 -0.652 . . . . 73.319999999999993 110.844 -178.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 42.6 t -83.71 179.44 7.6 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.621 -0.881 . . . . 62.039999999999999 108.621 178.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.421 ' HG2' ' NE2' ' A' ' 73' ' ' HIS . 93.4 mtt180 -78.4 -54.09 6.56 Favored 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 105.854 -1.906 . . . . 65.230000000000004 105.854 175.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 5.6 ptm180 -105.32 100.37 9.95 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 106.105 -1.813 . . . . 74.450000000000003 106.105 171.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 11.0 t60 -99.59 -59.32 1.74 Allowed 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.959 -0.756 . . . . 74.400000000000006 108.959 -174.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -136.81 152.7 50.58 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.479 -0.934 . . . . 60.149999999999999 108.479 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -135.54 128.26 30.97 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 109.554 -0.535 . . . . 70.519999999999996 109.554 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.521 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 67.8 m-85 -101.81 115.98 31.71 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 107.762 -1.199 . . . . 74.109999999999999 107.762 179.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 18.8 mmt180 -108.33 140.0 42.23 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 109.319 -0.622 . . . . 74.129999999999995 109.319 178.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.499 HG13 ' HA ' ' A' ' 66' ' ' PRO . 2.6 pp -115.98 116.91 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.192 0 N-CA-C 106.965 -1.494 . . . . 74.109999999999999 106.965 172.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.538 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 46.6 t-20 -108.97 146.13 34.35 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 107.26 -1.385 . . . . 73.340000000000003 107.26 -174.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -59.49 -16.46 24.38 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 124.449 1.099 . . . . 74.409999999999997 111.551 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -87.42 -47.11 4.73 Favored Glycine 0 N--CA 1.431 -1.675 0 N-CA-C 111.594 -0.602 . . . . 72.310000000000002 111.594 176.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.538 ' O ' ' HB3' ' A' ' 95' ' ' ASN . 26.2 tt0 -173.36 169.15 4.51 Favored 'General case' 0 C--O 1.218 -0.573 0 N-CA-C 105.856 -1.905 . . . . 53.140000000000001 105.856 -179.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -104.49 131.71 51.56 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 119.262 0.937 . . . . 73.420000000000002 110.479 -173.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -131.7 138.13 48.55 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 122.566 1.174 . . . . 60.409999999999997 113.226 -178.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 44.3 t -102.57 129.79 53.57 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.258 0 N-CA-C 106.945 -1.502 . . . . 60.229999999999997 106.945 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.4 t -118.73 136.0 57.34 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 C-N-CA 120.926 -0.31 . . . . 72.239999999999995 110.283 -177.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -82.67 110.59 17.87 Favored 'General case' 0 N--CA 1.437 -1.109 0 N-CA-C 106.536 -1.653 . . . . 73.010000000000005 106.536 170.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 30.0 m -100.51 7.04 9.42 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 CA-C-N 114.935 -1.029 . . . . 75.230000000000004 111.518 -173.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 134.51 52.18 0.07 OUTLIER Glycine 0 N--CA 1.425 -2.084 0 C-N-CA 119.815 -1.183 . . . . 73.209999999999994 112.054 178.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 50.4 m -59.11 128.24 36.2 Favored 'General case' 0 C--O 1.25 1.131 0 N-CA-C 109.667 -0.494 . . . . 61.210000000000001 109.667 176.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.83 -51.15 63.68 Favored 'General case' 0 C--O 1.217 -0.609 0 N-CA-C 108.62 -0.882 . . . . 65.319999999999993 108.62 -178.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.435 ' OD1' ' HA2' ' A' ' 131' ' ' GLY . 7.9 p30 -91.61 -45.66 8.36 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 112.281 0.475 . . . . 63.520000000000003 112.281 177.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 143.71 139.56 3.53 Favored Glycine 0 C--O 1.219 -0.82 0 C-N-CA 119.506 -1.331 . . . . 32.450000000000003 114.063 174.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 59.8 m -105.26 120.14 40.82 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 108.908 -0.775 . . . . 44.100000000000001 108.908 174.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -122.04 137.91 54.63 Favored 'General case' 0 C--O 1.198 -1.645 0 CA-C-N 115.649 -0.705 . . . . 73.109999999999999 109.715 -174.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.541 HG21 ' HG3' ' A' ' 120' ' ' GLN . 59.6 t -99.18 117.08 43.76 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.485 0 N-CA-C 106.708 -1.59 . . . . 51.420000000000002 106.708 177.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 68.58 -71.07 0.12 Allowed 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 125.341 1.457 . . . . 73.030000000000001 108.877 -172.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 55.9 ttp85 -157.67 6.79 0.14 Allowed 'General case' 0 CA--C 1.553 1.073 0 CA-C-O 121.339 0.59 . . . . 72.450000000000003 109.775 172.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -114.8 131.74 23.29 Favored Pre-proline 0 N--CA 1.449 -0.476 0 O-C-N 121.845 -0.535 . . . . 73.439999999999998 110.026 -174.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -68.87 131.38 22.39 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.203 1.935 . . . . 62.219999999999999 112.241 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 -122.27 145.07 48.57 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 106.767 -1.568 . . . . 65.409999999999997 106.767 176.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -78.76 -46.54 18.65 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.989 -1.115 . . . . 75.120000000000005 107.989 178.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -138.35 143.48 39.9 Favored 'General case' 0 N--CA 1.421 -1.891 0 N-CA-C 106.609 -1.626 . . . . 34.539999999999999 106.609 175.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.541 ' HG3' HG21 ' A' ' 112' ' ' VAL . 22.1 tm0? -129.69 141.86 50.82 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 107.345 -1.354 . . . . 75.040000000000006 107.345 -176.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.3 p -103.15 119.05 51.06 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.297 0 N-CA-C 108.554 -0.906 . . . . 71.439999999999998 108.554 178.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.558 ' HB3' ' CE1' ' A' ' 137' ' ' PHE . 64.9 mtt -41.84 111.93 0.28 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.217 1.007 . . . . 74.230000000000004 112.588 -170.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -114.83 136.3 53.24 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-N 114.929 -1.032 . . . . 75.319999999999993 109.619 -170.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.703 ' HB ' ' HB3' ' A' ' 139' ' ' ALA . 14.6 t -79.4 127.59 32.29 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 121.666 0.746 . . . . 63.539999999999999 112.778 -176.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 80.97 33.51 29.47 Favored Glycine 0 N--CA 1.428 -1.849 0 CA-C-N 115.124 -0.943 . . . . 52.32 111.958 173.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -137.2 155.78 49.13 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.427 -0.953 . . . . 71.420000000000002 108.427 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -118.8 135.57 54.46 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-O 121.97 0.891 . . . . 73.230000000000004 113.206 -175.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 64.6 mt -111.35 130.4 64.92 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 CA-C-N 114.386 -1.279 . . . . 73.219999999999999 108.706 -177.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -91.9 111.49 23.05 Favored 'General case' 0 N--CA 1.417 -2.109 0 N-CA-C 107.707 -1.22 . . . . 73.540000000000006 107.707 175.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 10.9 pt -93.97 98.84 8.65 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 N-CA-C 107.911 -1.144 . . . . 70.409999999999997 107.911 177.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.435 ' HA2' ' OD1' ' A' ' 108' ' ' ASN . . . 79.58 -104.07 2.14 Favored Glycine 0 N--CA 1.412 -2.907 0 N-CA-C 109.363 -1.495 . . . . 65.409999999999997 109.363 -174.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -123.68 5.3 8.86 Favored 'General case' 0 C--N 1.298 -1.63 0 N-CA-C 109.965 -0.383 . . . . 74.040000000000006 109.965 178.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -113.03 152.71 29.16 Favored 'General case' 0 C--O 1.211 -0.954 0 CA-C-N 116.375 -0.375 . . . . 74.239999999999995 110.625 -177.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 66.4 mtp85 -113.61 128.31 56.39 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.52 0.676 . . . . 64.010000000000005 112.611 -170.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.492 HD11 HD13 ' A' ' 49' ' ' LEU . 45.1 tp -119.43 132.6 55.84 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 124.92 1.288 . . . . 74.310000000000002 108.552 -177.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 9.9 p -108.17 132.36 56.13 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 108.765 -0.828 . . . . 72.439999999999998 108.765 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . 0.558 ' CE1' ' HB3' ' A' ' 122' ' ' MET . 39.8 t80 -109.04 131.38 55.13 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 121.077 -0.249 . . . . 73.120000000000005 110.948 -175.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.4 mp -124.44 124.18 41.76 Favored 'General case' 0 C--O 1.244 0.79 0 CA-C-O 121.131 0.491 . . . . 71.530000000000001 109.927 177.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.703 ' HB3' ' HB ' ' A' ' 124' ' ' THR . . . -94.64 82.91 4.0 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-O 121.536 0.684 . . . . 73.120000000000005 111.072 -177.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -127.12 96.87 0.46 Allowed Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 109.021 -1.631 . . . . 71.030000000000001 109.021 177.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo . . . . . 0 C--N 1.355 0.881 0 C-N-CA 123.159 2.573 . . . . 74.030000000000001 113.271 -176.917 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.6 p30 . . . . . 0 C--O 1.245 0.866 0 CA-C-O 120.812 0.339 . . . . 64.430000000000007 110.464 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 161.23 176.47 33.37 Favored Glycine 0 N--CA 1.431 -1.688 0 N-CA-C 110.733 -0.947 . . . . 64.510000000000005 110.733 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.3 p -92.2 124.62 59.2 Favored Pre-proline 0 C--N 1.292 -1.9 0 CA-C-N 116.624 0.212 . . . . 71.099999999999994 110.909 -178.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -63.83 128.92 23.22 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.314 2.01 . . . . 72.129999999999995 110.326 176.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -86.4 130.55 49.08 Favored Pre-proline 0 C--N 1.299 -1.615 0 CA-C-N 116.32 -0.4 . . . . 74.420000000000002 111.856 -174.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -65.15 145.33 84.28 Favored 'Trans proline' 0 C--O 1.247 0.934 0 C-N-CA 122.632 2.221 . . . . 74.319999999999993 111.377 178.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -57.8 128.34 36.58 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-N 115.685 -0.689 . . . . 72.409999999999997 112.483 -178.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.4 m -73.53 76.25 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 CA-C-O 122.66 1.219 . . . . 31.239999999999998 109.903 173.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -88.83 122.59 32.37 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-N 114.231 -1.35 . . . . 74.200000000000003 111.033 -174.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.6 t -145.27 89.29 1.93 Allowed 'General case' 0 N--CA 1.407 -2.597 0 CA-C-O 122.583 1.182 . . . . 70.219999999999999 107.944 174.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 28.6 m -92.5 105.82 17.92 Favored 'General case' 0 N--CA 1.415 -2.212 0 CA-C-N 114.79 -1.096 . . . . 62.140000000000001 109.444 -177.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.9 m -72.32 113.99 9.95 Favored 'General case' 0 N--CA 1.418 -2.075 0 CA-C-N 115.065 -0.97 . . . . 63.039999999999999 109.029 177.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.1 m . . . . . 0 C--N 1.312 -1.029 0 CA-C-O 121.125 0.488 . . . . 74.140000000000001 110.506 179.556 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.484 -1.851 0 N-CA-C 107.261 -2.336 . . . . 52.109999999999999 107.261 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 20.2 m -90.89 167.08 12.7 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 114.107 -1.046 . . . . 53.219999999999999 110.609 -174.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -127.4 171.13 11.81 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.137 -1.431 . . . . 65.329999999999998 107.137 177.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -134.04 145.5 49.48 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 120.039 -0.664 . . . . 71.530000000000001 111.109 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.479 ' O ' ' HA ' ' A' ' 60' ' ' ARG . 4.1 pp -110.56 132.72 53.94 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 115.217 -0.901 . . . . 75.209999999999994 108.934 176.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 51.5 t -116.67 113.88 44.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 108.509 -0.923 . . . . 62.030000000000001 108.509 179.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 36.3 t -96.21 115.61 35.94 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 N-CA-C 109.033 -0.729 . . . . 71.329999999999998 109.033 -179.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -86.14 -32.86 21.06 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.377 0.608 . . . . 63.549999999999997 110.183 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.438 ' O ' ' HB3' ' A' ' 133' ' ' PHE . 10.1 tpt180 -147.55 131.08 16.75 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 106.535 -1.654 . . . . 73.209999999999994 106.535 179.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.426 ' HA2' ' HD2' ' A' ' 55' ' ' PRO . . . 145.14 110.74 0.7 Allowed Glycine 0 C--N 1.298 -1.555 0 N-CA-C 111.376 -0.689 . . . . 65.120000000000005 111.376 -178.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.426 ' HD2' ' HA2' ' A' ' 54' ' ' GLY . 14.3 Cg_endo -58.36 -20.7 49.42 Favored 'Trans proline' 0 C--N 1.358 1.052 0 C-N-CA 123.403 2.735 . . . . 70.140000000000001 113.689 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.448 ' HB3' ' HG ' ' A' ' 80' ' ' LEU . 7.6 p30 -48.0 -35.9 11.77 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.225 1.01 . . . . 74.319999999999993 111.82 175.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -152.21 -72.04 0.15 Allowed 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 109.241 -0.651 . . . . 73.109999999999999 109.241 176.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.96 36.64 35.37 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.652 -0.704 . . . . 64.129999999999995 111.752 -179.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -158.38 -171.61 3.54 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 107.672 -1.232 . . . . 70.340000000000003 107.672 -178.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.479 ' HA ' ' O ' ' A' ' 49' ' ' LEU . 36.6 ptt180 -113.37 133.02 55.38 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 109.546 -0.539 . . . . 74.420000000000002 109.546 178.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -135.57 134.7 39.65 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 116.483 -0.326 . . . . 75.400000000000006 110.681 -176.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.5 mp -91.57 130.16 37.43 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.921 -0.581 . . . . 73.109999999999999 109.438 178.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -71.34 121.34 18.34 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.546 0.689 . . . . 74.409999999999997 110.761 -177.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -123.78 -24.95 4.37 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.206 -1.361 . . . . 72.010000000000005 111.383 -175.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.446 ' H ' ' CD ' ' A' ' 65' ' ' GLN . 0.2 OUTLIER -92.27 141.34 24.87 Favored Pre-proline 0 C--N 1.295 -1.781 0 CA-C-N 115.021 -0.99 . . . . 73.340000000000003 111.032 -174.684 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.525 ' HA ' HG22 ' A' ' 94' ' ' ILE . 37.2 Cg_endo -66.68 -34.29 32.47 Favored 'Trans proline' 0 C--O 1.242 0.709 0 C-N-CA 123.075 2.516 . . . . 51.100000000000001 112.798 -176.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 39.5 m -132.61 99.71 4.72 Favored 'General case' 0 N--CA 1.415 -2.187 0 N-CA-C 107.57 -1.27 . . . . 73.540000000000006 107.57 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.516 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 6.1 m -90.74 112.92 24.89 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.506 -0.924 . . . . 62.130000000000003 108.506 179.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 51.7 m -94.04 119.94 33.6 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 109.296 -0.631 . . . . 75.310000000000002 109.296 177.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -109.69 120.31 42.1 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 108.59 -0.893 . . . . 63.119999999999997 108.59 178.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 175.29 -147.09 8.69 Favored Glycine 0 C--N 1.289 -2.067 0 N-CA-C 109.221 -1.552 . . . . 42.530000000000001 109.221 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.499 ' HD3' ' O ' ' A' ' 80' ' ' LEU . 10.2 tpt180 -134.32 66.16 1.55 Allowed 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 108.424 -0.954 . . . . 73.409999999999997 108.424 179.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 30.1 m170 -126.87 166.01 25.05 Favored Pre-proline 0 C--N 1.303 -1.414 0 N-CA-C 107.568 -1.271 . . . . 75.310000000000002 107.568 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -61.13 -32.94 91.71 Favored 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 121.755 1.637 . . . . 72.319999999999993 109.986 172.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 -97.82 72.3 2.25 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-O 122.35 1.071 . . . . 61.039999999999999 109.898 177.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 48.9 m -142.62 125.92 16.55 Favored 'General case' 0 C--N 1.277 -2.545 0 CA-C-N 114.087 -1.415 . . . . 72.219999999999999 107.557 174.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -69.48 -50.66 43.27 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 107.774 -1.195 . . . . 62.32 107.774 -179.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 30.1 pt -109.09 123.59 65.09 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.222 0 N-CA-C 107.083 -1.451 . . . . 74.099999999999994 107.083 172.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -108.04 116.91 32.82 Favored 'General case' 0 C--N 1.28 -2.455 0 CA-C-O 122.177 0.989 . . . . 74.409999999999997 111.524 -177.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.499 ' O ' ' HD3' ' A' ' 72' ' ' ARG . 6.3 mp -79.89 135.28 36.4 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 113.835 -1.53 . . . . 51.009999999999998 109.272 -177.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -134.13 23.79 3.85 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 105.472 -2.047 . . . . 73.319999999999993 105.472 179.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -78.44 179.19 7.17 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 111.796 -2.456 . . . . 72.219999999999999 109.906 -175.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.9 p -83.34 1.59 3.91 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-O 122.073 0.94 . . . . 55.329999999999998 110.13 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 12.0 p -109.89 14.32 23.18 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 115.932 -0.576 . . . . 65.310000000000002 111.778 -175.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.2 m -81.83 139.09 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.634 0 CA-C-O 121.346 0.593 . . . . 70.109999999999999 111.915 -174.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 13.0 p -130.98 -81.44 0.53 Allowed 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.24 -0.891 . . . . 72.140000000000001 111.367 -179.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.447 ' HG3' ' HD2' ' A' ' 88' ' ' ARG . 20.0 tpp85 -156.33 -92.39 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.002 -1.11 . . . . 50.530000000000001 108.002 178.056 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.571 ' HB3' HG23 ' A' ' 104' ' ' VAL . 5.4 mpt_? -85.65 107.06 17.37 Favored 'General case' 0 CA--C 1.493 -1.243 0 N-CA-C 105.168 -2.16 . . . . 73.530000000000001 105.168 171.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -91.53 -75.58 0.47 Allowed 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 120.287 -0.565 . . . . 65.340000000000003 110.255 -174.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -144.51 155.0 43.48 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.991 -0.744 . . . . 64.540000000000006 108.991 -178.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -140.34 128.2 21.93 Favored 'General case' 0 C--N 1.287 -2.131 0 C-N-CA 119.994 -0.682 . . . . 73.040000000000006 109.326 179.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.516 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 42.3 m-85 -97.55 113.09 24.73 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 106.887 -1.523 . . . . 70.409999999999997 106.887 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.428 HH11 ' HD3' ' A' ' 93' ' ' ARG . 46.1 mtt-85 -112.56 152.12 29.23 Favored 'General case' 0 C--N 1.269 -2.913 0 C-N-CA 120.527 -0.469 . . . . 73.340000000000003 109.922 179.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.525 HG22 ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -113.43 116.12 51.69 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.3 0 CA-C-O 123.111 1.434 . . . . 75.109999999999999 108.177 177.842 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -97.64 96.44 8.28 Favored 'General case' 0 N--CA 1.42 -1.928 0 CA-C-N 113.256 -1.793 . . . . 71.040000000000006 109.8 -173.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 43.45 13.6 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 127.477 2.311 . . . . 55.530000000000001 116.667 175.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 158.48 -13.15 0.23 Allowed Glycine 0 N--CA 1.417 -2.599 0 C-N-CA 120.234 -0.984 . . . . 63.030000000000001 113.606 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -146.36 152.82 39.71 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 118.05 -1.46 . . . . 63.43 110.513 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.414 ' CD2' ' HB ' ' A' ' 94' ' ' ILE . 89.8 m-85 -89.99 138.46 31.49 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.377 0.608 . . . . 75.340000000000003 110.851 -176.106 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -128.07 125.36 39.13 Favored 'General case' 0 C--N 1.28 -2.417 0 N-CA-C 107.61 -1.256 . . . . 70.200000000000003 107.61 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.5 p -103.07 118.55 50.18 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-O 121.602 0.715 . . . . 75.409999999999997 109.862 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 29.9 m -119.96 137.67 53.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-N 115.033 -0.985 . . . . 62.509999999999998 111.686 -179.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -83.23 122.96 29.1 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 104.742 -2.318 . . . . 72.200000000000003 104.742 171.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.571 HG23 ' HB3' ' A' ' 88' ' ' ARG . 16.8 m -106.15 9.59 9.37 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 N-CA-C 112.816 0.673 . . . . 62.509999999999998 112.816 -172.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -126.41 -45.96 0.22 Allowed Glycine 0 N--CA 1.43 -1.701 0 C-N-CA 119.018 -1.563 . . . . 55.340000000000003 112.96 -179.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 21.7 m 67.18 9.97 7.35 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.205 1.402 . . . . 71.329999999999998 110.659 -175.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 94.4 mt -74.92 -48.6 23.75 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 114.663 -1.153 . . . . 75.25 109.292 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -83.36 -50.34 8.44 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 108.643 -0.873 . . . . 65.400000000000006 108.643 175.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.01 76.99 1.32 Allowed Glycine 0 N--CA 1.431 -1.646 0 N-CA-C 109.486 -1.446 . . . . 55.109999999999999 109.486 -175.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 32.1 m -73.09 135.35 44.78 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 109.671 -0.492 . . . . 74.219999999999999 109.671 -179.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -102.18 133.2 47.43 Favored 'General case' 0 N--CA 1.422 -1.838 0 N-CA-C 106.925 -1.509 . . . . 74.25 106.925 178.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.47 HG23 HG12 ' A' ' 128' ' ' ILE . 7.5 p -128.41 137.29 57.8 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.179 0 N-CA-C 107.57 -1.27 . . . . 72.209999999999994 107.57 -175.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 60.61 21.95 11.78 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 108.149 -1.056 . . . . 75.519999999999996 108.149 -171.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 64.1 mtp180 54.7 37.38 28.18 Favored 'General case' 0 C--N 1.352 0.704 0 CA-C-N 114.412 -1.267 . . . . 73.019999999999996 112.582 -172.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -132.63 149.5 73.2 Favored Pre-proline 0 C--N 1.312 -1.061 0 N-CA-C 108.298 -1.001 . . . . 45.329999999999998 108.298 174.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -76.28 87.65 1.41 Allowed 'Trans proline' 0 N--CA 1.443 -1.476 0 C-N-CA 121.49 1.46 . . . . 52.25 110.554 174.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -120.14 149.73 41.76 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.758 -1.201 . . . . 74.030000000000001 107.758 178.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -89.27 -28.9 19.6 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 109.467 -0.568 . . . . 74.239999999999995 109.467 179.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -140.92 140.36 34.47 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 115.413 -0.812 . . . . 74.329999999999998 109.514 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.5 142.23 37.3 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.737 -1.208 . . . . 64.340000000000003 107.737 174.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 11.3 p -98.07 135.84 31.22 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.232 0 N-CA-C 109.641 -0.503 . . . . 73.239999999999995 109.641 -177.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 48.6 ttp -31.58 108.99 0.05 Allowed 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 125.97 1.708 . . . . 63.119999999999997 112.24 -177.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -133.06 138.71 46.84 Favored 'General case' 0 N--CA 1.419 -2.015 0 N-CA-C 106.763 -1.569 . . . . 65.120000000000005 106.763 179.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 12.3 t -80.06 131.37 35.76 Favored 'General case' 0 N--CA 1.423 -1.823 0 N-CA-C 109.12 -0.696 . . . . 63.32 109.12 -179.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 91.39 18.14 46.87 Favored Glycine 0 N--CA 1.438 -1.176 0 C-N-CA 120.314 -0.946 . . . . 71.450000000000003 111.125 178.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -81.51 140.64 34.44 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 106.657 -1.609 . . . . 75.530000000000001 106.657 178.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -124.77 120.88 33.03 Favored 'General case' 0 C--N 1.277 -2.552 0 CA-C-O 122.41 1.1 . . . . 55.420000000000002 110.576 -179.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.47 HG12 HG23 ' A' ' 112' ' ' VAL . 61.0 mt -103.66 128.49 56.81 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.095 0 CA-C-N 113.885 -1.507 . . . . 72.450000000000003 108.908 -174.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -120.6 124.82 46.22 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 109.793 -0.447 . . . . 63.119999999999997 109.793 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.464 HG13 ' HB2' ' A' ' 133' ' ' PHE . 22.0 pt -109.76 98.24 6.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 108.404 -0.961 . . . . 62.399999999999999 108.404 173.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 70.4 -82.81 0.36 Allowed Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.074 -0.966 . . . . 34.329999999999998 111.615 -175.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -130.77 -12.79 3.75 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 123.104 0.562 . . . . 73.430000000000007 110.182 179.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.464 ' HB2' HG13 ' A' ' 130' ' ' ILE . 42.3 m-85 -85.63 131.74 34.29 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.852 -0.795 . . . . 71.310000000000002 108.852 -176.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 21.4 ptt180 -118.33 135.05 54.54 Favored 'General case' 0 C--O 1.258 1.541 0 CA-C-O 121.993 0.902 . . . . 62.509999999999998 112.821 -175.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 5.2 tt -120.04 133.23 55.59 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 113.473 -1.694 . . . . 55.109999999999999 107.302 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 40.7 t -107.91 120.75 59.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 107.318 -1.364 . . . . 63.310000000000002 107.318 177.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -102.48 121.9 43.26 Favored 'General case' 0 C--N 1.288 -2.078 0 CA-C-N 115.7 -0.682 . . . . 73.5 109.497 -176.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -121.52 159.52 26.18 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 109.606 -0.516 . . . . 60.109999999999999 109.606 -178.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -72.0 148.78 45.58 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 106.772 -1.566 . . . . 63.009999999999998 106.772 172.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -113.86 -140.62 7.57 Favored Glycine 0 C--N 1.29 -1.983 0 C-N-CA 119.546 -1.311 . . . . 35.240000000000002 112.874 -173.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 N--CA 1.435 -1.915 0 C-N-CA 122.57 2.18 . . . . 73.109999999999999 113.061 -179.303 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.7 p30 . . . . . 0 N--CA 1.437 -1.111 0 CA-C-O 121.046 0.45 . . . . 74.25 112.131 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -179.59 -165.18 33.24 Favored Glycine 0 N--CA 1.428 -1.876 0 N-CA-C 107.67 -2.172 . . . . 74.439999999999998 107.67 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.8 p -77.29 124.26 87.02 Favored Pre-proline 0 C--N 1.3 -1.55 0 CA-C-N 118.212 1.006 . . . . 71.120000000000005 109.667 179.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -61.21 148.12 93.76 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 123.175 2.583 . . . . 74.200000000000003 112.855 -175.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -69.77 117.62 55.23 Favored Pre-proline 0 C--O 1.247 0.925 0 N-CA-C 109.556 -0.535 . . . . 71.120000000000005 109.556 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -82.24 142.53 12.11 Favored 'Trans proline' 0 N--CA 1.444 -1.44 0 C-N-CA 122.738 2.292 . . . . 74.219999999999999 112.63 -176.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -70.55 134.35 47.59 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-N 115.456 -0.793 . . . . 63.100000000000001 109.801 178.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.7 t -73.86 89.22 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 CA-C-N 115.483 -0.78 . . . . 54.43 109.591 -179.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -72.96 124.41 25.39 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 114.546 -1.206 . . . . 71.530000000000001 108.95 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.4 m -67.29 98.32 0.61 Allowed 'General case' 0 N--CA 1.427 -1.621 0 CA-C-N 115.709 -0.678 . . . . 51.240000000000002 109.844 -179.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.1 t -79.3 75.05 5.88 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 123.037 1.398 . . . . 75.030000000000001 110.394 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.8 m -155.69 164.05 39.1 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 106.452 -1.684 . . . . 71.140000000000001 106.452 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.7 m . . . . . 0 N--CA 1.427 -1.591 0 N-CA-C 108.863 -0.792 . . . . 72.540000000000006 108.863 175.648 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.485 -1.829 0 N-CA-C 109.605 -1.398 . . . . 51.32 109.605 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.568 ' HB3' ' O ' ' A' ' 63' ' ' LEU . 4.8 m -90.0 154.64 19.67 Favored 'General case' 0 N--CA 1.41 -2.448 0 CA-C-N 114.446 -0.877 . . . . 64.310000000000002 108.892 -177.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -116.26 175.89 5.35 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.303 -0.999 . . . . 64.329999999999998 108.303 -178.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -130.27 159.66 36.23 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 121.327 0.584 . . . . 65.140000000000001 111.348 -175.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.44 HD22 HD21 ' A' ' 135' ' ' LEU . 1.7 pp -122.17 147.63 45.93 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 115.356 -0.838 . . . . 73.420000000000002 110.097 177.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.483 ' CG2' ' HB ' ' A' ' 136' ' ' VAL . 24.6 m -123.28 134.05 67.37 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 108.603 -0.888 . . . . 73.430000000000007 108.603 175.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.463 HG21 ' HB3' ' A' ' 57' ' ' ALA . 48.5 t -92.54 115.69 32.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 106.457 -1.683 . . . . 63.240000000000002 106.457 176.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.402 ' HB3' ' HG3' ' A' ' 134' ' ' ARG . 76.9 tttt -73.96 -39.98 63.35 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 114.524 -1.217 . . . . 71.0 108.417 -176.118 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 31.7 tpt180 -168.31 138.51 2.55 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 107.157 -1.423 . . . . 65.209999999999994 107.157 177.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 139.28 127.67 2.47 Favored Glycine 0 N--CA 1.425 -2.077 0 C-N-CA 119.724 -1.227 . . . . 45.030000000000001 114.382 178.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.508 ' HD2' ' CE2' ' A' ' 133' ' ' PHE . 80.3 Cg_exo -54.0 -8.74 1.04 Allowed 'Trans proline' 0 C--N 1.368 1.553 0 C-N-CA 125.237 3.958 . . . . 74.219999999999999 114.117 173.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.541 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 4.3 t-20 -40.99 -45.44 2.6 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.717 1.207 . . . . 52.240000000000002 109.792 170.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.463 ' HB3' HG21 ' A' ' 51' ' ' VAL . . . -162.95 -48.55 0.04 OUTLIER 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 115.989 -0.551 . . . . 74.040000000000006 109.601 176.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 67.82 48.52 54.7 Favored Glycine 0 C--N 1.324 -0.134 0 N-CA-C 111.225 -0.75 . . . . 62.130000000000003 111.225 -179.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -161.64 -173.02 3.56 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.25 -1.018 . . . . 54.409999999999997 108.25 -178.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.464 ' HB2' HG12 ' A' ' 50' ' ' VAL . 19.1 ptp180 -140.5 135.41 31.89 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.777 -0.824 . . . . 72.340000000000003 108.777 175.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -156.46 155.42 32.01 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 120.743 0.306 . . . . 73.010000000000005 111.609 -176.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 14.7 tp -79.87 139.7 37.05 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.035 -0.984 . . . . 64.200000000000003 108.642 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.568 ' O ' ' HB3' ' A' ' 46' ' ' SER . 94.3 mt -95.17 114.09 25.84 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 120.138 -0.625 . . . . 74.120000000000005 109.623 177.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -96.86 -28.87 14.03 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 121.561 0.696 . . . . 75.230000000000004 109.786 177.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -74.77 115.8 47.65 Favored Pre-proline 0 C--N 1.309 -1.157 0 CA-C-N 114.086 -1.416 . . . . 74.329999999999998 109.621 -177.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.467 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 15.2 Cg_endo -57.93 -28.25 82.12 Favored 'Trans proline' 0 C--N 1.363 1.307 0 C-N-CA 123.045 2.497 . . . . 74.010000000000005 112.402 -176.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 90.8 m -136.46 109.86 7.91 Favored 'General case' 0 N--CA 1.418 -2.055 0 N-CA-C 108.874 -0.787 . . . . 62.350000000000001 108.874 174.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 23.4 m -105.64 114.32 28.41 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.296 -1.002 . . . . 73.329999999999998 108.296 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.495 HG22 ' HG2' ' A' ' 91' ' ' GLU . 65.6 p -91.96 133.77 35.4 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 109.802 -0.444 . . . . 71.120000000000005 109.802 -178.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -127.28 133.53 50.15 Favored 'General case' 0 C--O 1.243 0.724 0 O-C-N 122.249 -0.282 . . . . 63.229999999999997 111.118 -179.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 161.41 -105.29 0.26 Allowed Glycine 0 N--CA 1.437 -1.282 0 C-N-CA 119.894 -1.146 . . . . 63.329999999999998 114.044 175.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 66.8 ttt180 -91.19 99.54 12.52 Favored 'General case' 0 N--CA 1.42 -1.938 0 N-CA-C 107.991 -1.114 . . . . 75.549999999999997 107.991 -174.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -12.63 -68.48 0.02 OUTLIER Pre-proline 0 N--CA 1.5 2.056 0 C-N-CA 127.758 2.423 . . . . 73.430000000000007 115.306 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -66.32 -21.9 53.69 Favored 'Trans proline' 0 C--N 1.387 2.563 0 C-N-CA 122.082 1.855 . . . . 64.329999999999998 114.43 -177.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -112.86 18.29 18.29 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.428 0.632 . . . . 71.310000000000002 110.631 -175.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 40.0 m -144.35 165.71 27.14 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.365 -0.976 . . . . 71.409999999999997 108.365 178.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -81.37 -57.13 3.63 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 109.185 -0.672 . . . . 54.520000000000003 109.185 176.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 49.4 pt -106.78 166.94 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 CA-C-O 121.604 0.716 . . . . 71.329999999999998 110.712 177.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -123.27 137.02 54.96 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-N 114.954 -1.021 . . . . 74.450000000000003 109.211 -175.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.541 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 2.5 pt? -114.11 121.79 44.87 Favored 'General case' 0 N--CA 1.406 -2.664 0 N-CA-C 105.933 -1.877 . . . . 54.109999999999999 105.933 170.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -80.72 78.19 7.51 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 122.018 0.913 . . . . 72.230000000000004 110.411 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.462 ' OD2' HG22 ' A' ' 84' ' ' THR . 17.3 t70 -117.58 -167.31 1.3 Allowed 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 114.244 -1.344 . . . . 72.530000000000001 108.252 177.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.41 ' H ' ' CG ' ' A' ' 82' ' ' ASP . 11.0 p -129.65 -19.36 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 CA-C-N 118.241 0.473 . . . . 70.329999999999998 111.225 -177.104 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.462 HG22 ' OD2' ' A' ' 82' ' ' ASP . 12.3 t -99.12 20.99 12.43 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.52 0.676 . . . . 74.310000000000002 110.497 -177.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.7 p -81.24 111.02 17.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 108.607 -0.886 . . . . 71.239999999999995 108.607 178.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.8 m -76.51 -89.83 0.03 OUTLIER 'General case' 0 CA--C 1.562 1.412 0 N-CA-C 113.478 0.918 . . . . 75.140000000000001 113.478 -172.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -84.09 -48.25 10.07 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 106.802 -1.555 . . . . 75.430000000000007 106.802 177.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -162.55 176.42 10.42 Favored 'General case' 0 C--N 1.274 -2.717 0 N-CA-C 100.269 -3.974 . . . . 74.540000000000006 100.269 170.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 21.3 t60 -96.27 -74.18 0.57 Allowed 'General case' 0 C--N 1.276 -2.617 0 C-N-CA 116.443 -2.103 . . . . 62.520000000000003 111.979 -170.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.15 163.66 34.68 Favored 'General case' 0 C--N 1.294 -1.809 0 C-N-CA 120.012 -0.675 . . . . 54.130000000000003 110.474 -174.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.495 ' HG2' HG22 ' A' ' 69' ' ' THR . 52.1 mt-10 -116.21 127.35 54.69 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.624 -0.88 . . . . 75.540000000000006 108.624 175.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -100.51 112.89 25.31 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 107.595 -1.261 . . . . 74.510000000000005 107.595 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 60.0 mtp180 -103.3 112.93 26.03 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 106.89 -1.522 . . . . 62.130000000000003 106.89 -179.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.467 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -120.14 111.43 32.4 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.328 0 N-CA-C 106.954 -1.499 . . . . 74.019999999999996 106.954 -179.756 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -122.33 147.23 46.51 Favored 'General case' 0 N--CA 1.393 -3.302 0 CA-C-N 114.469 -1.241 . . . . 71.25 111.004 176.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.27 -30.35 70.41 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 107.58 -1.267 . . . . 74.109999999999999 107.58 175.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -69.58 -61.39 4.45 Favored Glycine 0 N--CA 1.429 -1.824 0 CA-C-N 113.442 -1.708 . . . . 62.0 111.304 175.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -147.2 146.63 29.9 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.962 0.381 . . . . 55.240000000000002 110.972 -179.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -104.39 116.22 31.74 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.002 -0.74 . . . . 74.439999999999998 109.002 -178.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -133.16 135.4 45.12 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 113.503 0.927 . . . . 72.140000000000001 113.503 -177.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.7 p -116.31 119.07 60.83 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.295 0 N-CA-C 108.959 -0.756 . . . . 52.229999999999997 108.959 176.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.6 p -120.84 131.75 72.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 112.591 0.589 . . . . 72.239999999999995 112.591 -177.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -83.06 136.67 34.4 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 108.596 -0.89 . . . . 71.409999999999997 108.596 172.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.6 m -89.57 -16.95 8.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-O 121.189 0.518 . . . . 73.400000000000006 111.872 -176.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 142.28 53.06 0.04 OUTLIER Glycine 0 N--CA 1.424 -2.136 0 N-CA-C 109.746 -1.341 . . . . 51.130000000000003 109.746 -173.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.6 t -154.7 28.6 0.43 Allowed 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 106.462 -1.681 . . . . 53.0 106.462 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 32.9 tp -62.64 -11.52 17.52 Favored 'General case' 0 C--N 1.356 0.882 0 C-N-CA 125.794 1.637 . . . . 72.340000000000003 111.57 -174.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -60.45 -26.76 67.0 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 115.156 -0.929 . . . . 75.530000000000001 109.472 173.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -123.54 3.45 9.45 Favored Glycine 0 N--CA 1.429 -1.785 0 C-N-CA 120.975 -0.631 . . . . 65.109999999999999 113.69 178.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.7 m -102.31 118.69 37.41 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 118.79 1.295 . . . . 63.439999999999998 109.757 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -139.16 137.32 35.98 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.483 -0.562 . . . . 64.530000000000001 109.483 -178.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.2 p -103.14 119.18 51.24 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 106.348 -1.723 . . . . 61.119999999999997 106.348 170.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 18.9 m120 70.63 -78.01 0.05 Allowed 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 108.479 -0.934 . . . . 73.329999999999998 108.479 -171.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -152.31 2.16 0.34 Allowed 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.253 -0.885 . . . . 73.140000000000001 108.862 174.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -101.19 119.01 59.04 Favored Pre-proline 0 N--CA 1.438 -1.033 0 O-C-N 122.022 -0.424 . . . . 75.230000000000004 110.976 -171.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -81.02 90.99 1.17 Allowed 'Trans proline' 0 N--CA 1.43 -2.226 0 C-N-CA 121.777 1.651 . . . . 62.329999999999998 109.538 174.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.03 -94.62 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.662 -0.699 . . . . 73.25 109.594 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 7.4 t30 167.83 -60.44 0.01 OUTLIER 'General case' 0 CA--C 1.489 -1.39 0 N-CA-C 104.431 -2.433 . . . . 70.019999999999996 104.431 175.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -123.91 138.71 54.44 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 106.313 -1.736 . . . . 61.100000000000001 106.313 171.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 55.1 tp60 -140.45 150.52 43.92 Favored 'General case' 0 C--N 1.278 -2.526 0 N-CA-C 109.868 -0.419 . . . . 71.219999999999999 109.868 -176.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 97.4 t -77.89 118.75 25.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 105.485 -2.043 . . . . 75.519999999999996 105.485 171.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 21.1 ttt -75.48 113.21 12.63 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 114.919 -1.037 . . . . 72.140000000000001 108.409 -173.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.4 ' HA ' ' OE1' ' A' ' 123' ' ' GLN . 5.7 tp60 -104.95 139.21 40.0 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.755 -0.657 . . . . 72.230000000000004 111.526 -171.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 3.5 t -79.0 131.99 36.49 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 114.932 -1.031 . . . . 74.299999999999997 110.56 -179.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 97.66 11.05 52.02 Favored Glycine 0 N--CA 1.434 -1.485 0 CA-C-N 115.604 -0.726 . . . . 53.200000000000003 112.14 177.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -124.2 173.1 8.55 Favored 'General case' 0 C--O 1.253 1.284 0 N-CA-C 108.228 -1.027 . . . . 72.530000000000001 108.228 178.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.592 ' OE2' ' HD3' ' A' ' 134' ' ' ARG . 36.9 tt0 -123.82 123.77 41.2 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 121.337 0.589 . . . . 72.030000000000001 109.665 -172.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 67.6 mt -105.18 130.37 56.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 108.645 -0.872 . . . . 73.430000000000007 108.645 -177.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -98.3 118.83 35.84 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 109.142 -0.688 . . . . 63.009999999999998 109.142 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 17.0 pt -120.06 109.04 24.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 CA-C-O 121.915 0.865 . . . . 64.209999999999994 110.002 -177.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 81.98 -124.34 6.43 Favored Glycine 0 N--CA 1.416 -2.666 0 N-CA-C 109.198 -1.561 . . . . 52.539999999999999 109.198 -178.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -102.23 -4.03 26.38 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 108.916 -0.772 . . . . 74.140000000000001 108.916 176.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.508 ' CE2' ' HD2' ' A' ' 55' ' ' PRO . 45.2 m-85 -115.82 -179.96 3.8 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.254 -0.43 . . . . 72.239999999999995 111.599 -172.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.592 ' HD3' ' OE2' ' A' ' 127' ' ' GLU . 10.4 ptp180 -137.86 140.83 40.64 Favored 'General case' 0 C--O 1.247 0.932 0 N-CA-C 113.515 0.932 . . . . 71.310000000000002 113.515 -172.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.44 HD21 HD22 ' A' ' 49' ' ' LEU . 29.5 tp -123.86 133.15 53.83 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.21 -1.359 . . . . 73.25 108.751 -175.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.483 ' HB ' ' CG2' ' A' ' 50' ' ' VAL . 25.7 t -107.81 132.29 55.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 107.689 -1.226 . . . . 74.049999999999997 107.689 178.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -104.18 123.83 48.02 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 120.617 0.246 . . . . 73.129999999999995 110.55 -176.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -126.41 138.58 53.56 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-O 121.809 0.814 . . . . 63.439999999999998 111.462 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -106.53 91.9 3.89 Favored 'General case' 0 C--N 1.278 -2.509 0 N-CA-C 107.163 -1.421 . . . . 53.409999999999997 107.163 172.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -93.63 -127.2 4.58 Favored Glycine 0 CA--C 1.497 -1.039 0 N-CA-C 110.47 -1.052 . . . . 31.239999999999998 110.47 -177.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo . . . . . 0 N--CA 1.445 -1.33 0 C-N-CA 121.588 1.525 . . . . 63.509999999999998 109.031 175.955 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.7 t30 . . . . . 0 N--CA 1.44 -0.947 0 N-CA-C 108.724 -0.843 . . . . 65.510000000000005 108.724 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -107.61 56.21 0.49 Allowed Glycine 0 N--CA 1.429 -1.811 0 C-N-CA 120.806 -0.711 . . . . 52.509999999999998 112.184 -176.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.6 m -92.59 123.21 62.54 Favored Pre-proline 0 C--N 1.303 -1.445 0 N-CA-C 109.239 -0.652 . . . . 61.32 109.239 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -67.07 128.55 18.84 Favored 'Trans proline' 0 C--O 1.243 0.744 0 C-N-CA 122.537 2.158 . . . . 73.310000000000002 111.037 175.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -85.89 144.98 40.17 Favored Pre-proline 0 C--N 1.294 -1.82 0 CA-C-N 116.137 -0.483 . . . . 65.200000000000003 109.942 -179.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -72.85 117.3 5.06 Favored 'Trans proline' 0 N--CA 1.446 -1.3 0 C-N-CA 122.207 1.938 . . . . 62.310000000000002 112.683 -177.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -100.75 136.85 39.96 Favored 'General case' 0 C--N 1.282 -2.364 0 CA-C-N 115.03 -0.986 . . . . 74.340000000000003 108.768 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.1 p -127.37 122.89 60.63 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 CA-C-O 121.72 0.771 . . . . 75.230000000000004 110.809 178.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -122.63 133.17 54.53 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 108.205 -1.035 . . . . 63.539999999999999 108.205 177.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.4 t -163.9 99.66 0.87 Allowed 'General case' 0 N--CA 1.42 -1.958 0 CA-C-O 122.054 0.931 . . . . 71.140000000000001 109.367 -178.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 21.0 m -84.44 79.26 9.63 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 108.532 -0.914 . . . . 53.130000000000003 108.532 178.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.9 p -125.47 84.45 2.28 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 115.108 -0.951 . . . . 73.25 111.53 -176.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 50.4 t . . . . . 0 C--N 1.308 -1.21 0 N-CA-C 108.024 -1.102 . . . . 62.329999999999998 108.024 -178.585 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.477 -2.294 0 N-CA-C 106.084 -2.806 . . . . 64.510000000000005 106.084 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 25.0 m -88.74 163.0 15.93 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-O 121.835 0.826 . . . . 35.229999999999997 112.405 -167.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.509 ' HA ' ' N ' ' A' ' 140' ' ' GLY . . . -129.48 171.14 12.86 Favored 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 107.604 -1.258 . . . . 54.219999999999999 107.604 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.7 pp -133.71 143.87 48.78 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 112.314 0.487 . . . . 64.150000000000006 112.314 -175.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.521 HD23 ' H ' ' A' ' 49' ' ' LEU . 2.4 pt? -109.75 132.01 54.54 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.91 -1.145 . . . . 71.239999999999995 107.91 178.044 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 23.5 t -119.04 126.37 75.3 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 109.111 -0.7 . . . . 75.230000000000004 109.111 -176.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.436 HG22 HD13 ' A' ' 135' ' ' LEU . 15.4 t -92.77 118.35 38.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.761 0 N-CA-C 107.234 -1.395 . . . . 74.340000000000003 107.234 177.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.524 ' HB2' ' HG3' ' A' ' 134' ' ' ARG . 31.8 mmmt -70.68 -38.22 73.72 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 108.72 -0.844 . . . . 75.25 108.72 -179.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.547 ' HA ' ' HE ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -174.3 133.74 0.41 Allowed 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.011 -0.995 . . . . 63.020000000000003 108.805 178.076 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -177.91 158.26 23.15 Favored Glycine 0 N--CA 1.43 -1.715 0 N-CA-C 108.648 -1.781 . . . . 53.109999999999999 108.648 176.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -68.42 -25.47 35.66 Favored 'Trans proline' 0 N--CA 1.48 0.73 0 C-N-CA 122.292 1.995 . . . . 72.209999999999994 110.477 176.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.457 ' CB ' ' HA ' ' A' ' 80' ' ' LEU . 9.7 p30 -58.55 -58.64 7.66 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 113.91 -1.495 . . . . 73.329999999999998 111.9 177.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -162.96 -179.75 6.98 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 108.761 -0.829 . . . . 53.140000000000001 108.761 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -155.31 36.04 0.65 Allowed Glycine 0 C--N 1.3 -1.46 0 N-CA-C 109.97 -1.252 . . . . 71.019999999999996 109.97 178.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -140.04 -171.25 3.14 Favored 'General case' 0 N--CA 1.424 -1.763 0 N-CA-C 108.851 -0.796 . . . . 71.310000000000002 108.851 -175.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 23.7 ptt180 -112.62 146.02 39.35 Favored 'General case' 0 C--N 1.294 -1.839 0 O-C-N 123.578 0.549 . . . . 75.329999999999998 110.577 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.516 ' O ' HD23 ' A' ' 49' ' ' LEU . 93.5 m-85 -129.45 131.64 46.78 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.885 -0.598 . . . . 72.349999999999994 109.613 178.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 53.8 tp -90.45 129.38 36.64 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.033 -0.728 . . . . 75.450000000000003 109.033 178.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -79.75 113.84 18.21 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 119.855 -0.738 . . . . 75.120000000000005 110.379 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -112.2 -24.99 9.52 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 122.186 0.994 . . . . 75.409999999999997 108.506 174.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -92.39 127.55 48.25 Favored Pre-proline 0 C--N 1.306 -1.291 0 CA-C-N 114.305 -1.316 . . . . 75.349999999999994 110.171 -174.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.461 ' O ' ' HA ' ' A' ' 93' ' ' ARG . 10.4 Cg_endo -57.78 -41.79 66.21 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 122.852 2.368 . . . . 53.310000000000002 112.783 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 32.0 m -118.34 109.35 16.18 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 109.386 -0.598 . . . . 73.299999999999997 109.386 178.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.418 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 64.1 m -106.32 115.39 30.13 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 115.913 -0.585 . . . . 72.420000000000002 109.594 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.7 m -86.49 120.61 28.0 Favored 'General case' 0 C--O 1.25 1.127 0 CA-C-N 116.184 -0.462 . . . . 74.340000000000003 109.942 -177.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -101.99 112.98 25.82 Favored 'General case' 0 C--O 1.252 1.232 0 CA-C-O 120.88 0.372 . . . . 61.210000000000001 110.445 179.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 170.4 -173.19 44.3 Favored Glycine 0 N--CA 1.426 -1.993 0 N-CA-C 110.07 -1.212 . . . . 52.240000000000002 110.07 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -119.26 95.42 4.8 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 105.808 -1.923 . . . . 64.400000000000006 105.808 178.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 8.7 m80 -134.65 178.26 1.85 Allowed Pre-proline 0 C--N 1.287 -2.127 0 N-CA-C 106.289 -1.745 . . . . 73.109999999999999 106.289 -177.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -64.21 -21.54 67.38 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 121.45 1.434 . . . . 74.519999999999996 109.732 167.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -116.66 78.79 1.24 Allowed 'General case' 0 N--CA 1.434 -1.24 0 C-N-CA 123.958 0.903 . . . . 72.400000000000006 109.754 178.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 74.2 m -104.58 118.45 36.61 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-N 115.467 -0.788 . . . . 70.209999999999994 109.482 172.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -78.01 -43.43 29.5 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 108.694 -0.854 . . . . 75.25 108.694 177.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.8 pp -120.5 166.49 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 N-CA-C 107.786 -1.191 . . . . 53.240000000000002 107.786 171.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -107.53 135.96 48.12 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 115.161 1.541 . . . . 51.119999999999997 115.161 -168.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.457 ' HA ' ' CB ' ' A' ' 56' ' ' ASN . 4.0 mm? -125.08 153.41 42.97 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 104.429 -2.434 . . . . 63.030000000000001 104.429 171.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -144.72 -14.86 0.55 Allowed 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 118.793 -1.163 . . . . 73.019999999999996 112.557 -175.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -72.89 161.49 30.65 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 123.579 0.751 . . . . 71.150000000000006 110.747 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.3 p -77.12 -16.32 14.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-O 122.202 1.001 . . . . 53.0 110.377 -176.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -82.93 11.45 6.11 Favored 'General case' 0 N--CA 1.42 -1.928 0 CA-C-N 114.768 -1.106 . . . . 54.009999999999998 112.973 -179.206 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.0 p -83.3 139.74 17.28 Favored 'Isoleucine or valine' 0 C--O 1.244 0.783 0 CA-C-O 121.068 0.461 . . . . 61.240000000000002 109.833 176.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 28.4 t -105.37 157.11 17.56 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.446 -0.946 . . . . 72.299999999999997 108.446 179.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -69.98 110.69 5.2 Favored 'General case' 0 C--O 1.249 1.035 0 N-CA-C 106.839 -1.541 . . . . 73.209999999999994 106.839 174.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 59.4 mtt180 60.49 78.15 0.29 Allowed 'General case' 0 C--N 1.316 -0.867 0 O-C-N 124.536 1.147 . . . . 70.120000000000005 107.964 -166.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 45.0 t60 -77.29 -43.06 34.54 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 113.554 -1.657 . . . . 74.420000000000002 108.46 -176.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -150.67 159.19 44.69 Favored 'General case' 0 N--CA 1.422 -1.838 0 N-CA-C 107.251 -1.389 . . . . 51.439999999999998 107.251 178.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -136.73 127.86 27.9 Favored 'General case' 0 C--N 1.283 -2.311 0 N-CA-C 107.615 -1.254 . . . . 74.340000000000003 107.615 176.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.418 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 91.9 m-85 -110.28 124.48 51.72 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.955 -0.757 . . . . 60.450000000000003 108.955 -177.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' A' ' 66' ' ' PRO . 42.7 mtp85 -119.09 138.18 53.06 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-O 121.317 0.58 . . . . 64.439999999999998 112.449 175.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.466 ' O ' HD12 ' A' ' 94' ' ' ILE . 2.8 pp -116.02 116.47 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.152 0 N-CA-C 106.664 -1.606 . . . . 64.430000000000007 106.664 173.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -118.68 147.49 43.74 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 115.452 -0.794 . . . . 72.040000000000006 110.666 -173.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -45.82 -32.22 2.48 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.896 1.278 . . . . 72.409999999999997 112.385 178.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -78.72 -59.19 2.87 Favored Glycine 0 N--CA 1.436 -1.355 0 N-CA-C 111.488 -0.645 . . . . 74.150000000000006 111.488 175.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -158.28 173.77 16.18 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 123.777 0.831 . . . . 61.240000000000002 109.304 -175.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -102.68 134.73 45.57 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.068 -1.086 . . . . 65.430000000000007 108.068 -178.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -132.31 135.73 46.41 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 114.117 1.154 . . . . 74.329999999999998 114.117 -177.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 6.9 p -110.98 127.62 67.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 CA-C-N 114.532 -1.213 . . . . 72.140000000000001 107.973 177.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.6 p -119.09 130.3 74.04 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 C-N-CA 120.347 -0.541 . . . . 73.540000000000006 111.779 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -81.37 106.22 13.17 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 105.533 -2.025 . . . . 63.210000000000001 105.533 174.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.6 m -104.35 13.86 7.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 112.761 0.652 . . . . 44.240000000000002 112.761 -175.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 114.02 73.82 0.61 Allowed Glycine 0 CA--C 1.489 -1.544 0 C-N-CA 120.537 -0.84 . . . . 53.240000000000002 111.239 178.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 14.0 p -91.76 138.23 31.72 Favored 'General case' 0 N--CA 1.416 -2.154 0 CA-C-N 115.337 -0.432 . . . . 52.140000000000001 110.218 -177.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 5.8 tt -82.75 -47.55 11.83 Favored 'General case' 0 C--N 1.315 -0.935 0 N-CA-C 108.016 -1.105 . . . . 40.219999999999999 108.016 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.463 ' OD1' ' HA3' ' A' ' 131' ' ' GLY . 11.6 t-20 -68.42 -32.64 72.82 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.679 -0.691 . . . . 72.299999999999997 109.901 179.207 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.428 ' O ' ' HA ' ' A' ' 130' ' ' ILE . . . 112.53 131.68 5.63 Favored Glycine 0 C--O 1.223 -0.573 0 CA-C-N 116.093 -0.503 . . . . 24.210000000000001 112.233 179.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -109.16 122.03 46.43 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 123.389 0.676 . . . . 54.100000000000001 109.717 176.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -123.76 133.06 53.91 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 108.616 -0.883 . . . . 51.240000000000002 108.616 178.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 45.4 t -121.35 117.45 52.77 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 N-CA-C 106.128 -1.804 . . . . 64.219999999999999 106.128 177.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.495 ' HB2' HH21 ' A' ' 117' ' ' ARG . 20.3 m120 66.88 24.74 9.66 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 108.556 -0.905 . . . . 65.340000000000003 108.556 -172.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.528 ' HG2' ' OE1' ' A' ' 129' ' ' GLN . 96.2 mtt180 75.77 2.84 3.77 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 126.001 1.72 . . . . 63.149999999999999 112.833 -178.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 55.0 mm-40 -104.97 129.49 24.75 Favored Pre-proline 0 C--N 1.311 -1.071 0 N-CA-C 109.11 -0.7 . . . . 72.329999999999998 109.11 178.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -71.56 124.76 10.57 Favored 'Trans proline' 0 C--O 1.247 0.957 0 C-N-CA 122.116 1.878 . . . . 60.0 108.881 174.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.495 HH21 ' HB2' ' A' ' 113' ' ' ASN . 47.4 mtt180 -119.98 -158.78 0.75 Allowed 'General case' 0 C--N 1.31 -1.113 0 O-C-N 121.951 -0.468 . . . . 73.209999999999994 111.24 -172.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -121.74 -45.24 2.29 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 108.104 -1.073 . . . . 71.349999999999994 108.104 174.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -156.7 138.87 14.61 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 107.28 -1.378 . . . . 60.200000000000003 107.28 171.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 53.8 tp60 -141.73 150.85 42.33 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 110.437 -0.209 . . . . 74.439999999999998 110.437 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 78.7 t -78.87 127.96 38.7 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 107.24 -1.393 . . . . 71.239999999999995 107.24 174.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 82.0 mtp -71.68 120.02 16.67 Favored 'General case' 0 CA--C 1.497 -1.085 0 CA-C-N 115.757 -0.656 . . . . 60.210000000000001 109.28 -175.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 14.2 tp60 -105.39 130.17 53.55 Favored 'General case' 0 N--CA 1.415 -2.182 0 N-CA-C 108.362 -0.977 . . . . 62.229999999999997 108.362 -177.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 18.9 p -78.35 123.54 27.1 Favored 'General case' 0 N--CA 1.424 -1.769 0 CA-C-O 121.1 0.476 . . . . 71.349999999999994 110.606 -177.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 123.62 -17.61 7.77 Favored Glycine 0 N--CA 1.416 -2.664 0 CA-C-N 115.432 -0.803 . . . . 63.140000000000001 111.791 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -104.32 -169.73 1.67 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 120.133 -0.627 . . . . 63.439999999999998 110.941 -176.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -136.97 136.11 38.25 Favored 'General case' 0 C--O 1.25 1.123 0 CA-C-O 121.829 0.823 . . . . 75.120000000000005 112.141 -171.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 74.4 mt -110.29 130.59 63.29 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 C-N-CA 125.418 1.487 . . . . 64.109999999999999 107.926 -179.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.528 ' OE1' ' HG2' ' A' ' 114' ' ' ARG . 52.0 mt-30 -109.74 133.46 53.11 Favored 'General case' 0 C--N 1.29 -2.02 0 C-N-CA 120.347 -0.541 . . . . 72.329999999999998 110.713 -178.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.528 HD13 ' H ' ' A' ' 130' ' ' ILE . 0.2 OUTLIER -107.44 97.71 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.963 0 N-CA-C 106.783 -1.562 . . . . 53.32 106.783 171.859 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.463 ' HA3' ' OD1' ' A' ' 108' ' ' ASN . . . 70.78 -115.25 5.77 Favored Glycine 0 N--CA 1.427 -1.95 0 N-CA-C 108.81 -1.716 . . . . 41.219999999999999 108.81 -170.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -112.3 2.31 16.48 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.074 0.464 . . . . 52.240000000000002 110.689 176.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -85.78 140.19 30.68 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 106.402 -1.703 . . . . 72.329999999999998 106.402 177.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.524 ' HG3' ' HB2' ' A' ' 52' ' ' LYS . 15.3 ptm180 -116.75 131.63 56.9 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.043 -1.063 . . . . 74.540000000000006 113.856 -168.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.488 HD21 HD12 ' A' ' 49' ' ' LEU . 34.3 tp -122.58 121.5 36.63 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 114.032 -1.44 . . . . 74.420000000000002 108.715 -177.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 10.7 p -106.66 137.54 36.75 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.15 0 N-CA-C 108.863 -0.791 . . . . 74.319999999999993 108.863 -178.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -114.33 115.67 27.74 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 110.293 -0.262 . . . . 70.010000000000005 110.293 -173.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -121.47 163.62 18.5 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 109.065 -0.717 . . . . 74.329999999999998 109.065 -178.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -75.3 147.03 40.53 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 109.461 -0.57 . . . . 61.310000000000002 109.461 177.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.509 ' N ' ' HA ' ' A' ' 47' ' ' ALA . . . -104.39 -149.88 20.22 Favored Glycine 0 N--CA 1.426 -2.013 0 C-N-CA 120.551 -0.833 . . . . 72.010000000000005 111.403 -176.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo . . . . . 0 N--CA 1.427 -2.391 0 C-N-CA 122.529 2.152 . . . . 62.509999999999998 112.693 179.505 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 58.6 t30 . . . . . 0 C--O 1.237 0.439 0 N-CA-C 109.816 -0.438 . . . . 71.109999999999999 109.816 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -56.63 100.03 0.1 Allowed Glycine 0 CA--C 1.506 -0.484 0 O-C-N 123.679 0.612 . . . . 64.120000000000005 112.965 -178.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.7 m -119.05 130.95 24.56 Favored Pre-proline 0 C--N 1.304 -1.375 0 N-CA-C 109.438 -0.579 . . . . 75.040000000000006 109.438 -176.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.91 127.38 16.85 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 121.667 1.578 . . . . 72.209999999999994 110.13 175.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -97.12 113.99 63.98 Favored Pre-proline 0 C--N 1.301 -1.518 0 N-CA-C 109.053 -0.721 . . . . 72.129999999999995 109.053 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -62.26 136.32 59.29 Favored 'Trans proline' 0 C--O 1.237 0.457 0 C-N-CA 123.342 2.694 . . . . 74.329999999999998 113.867 -173.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.0 tm0? -126.95 109.26 11.75 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 107.145 -1.428 . . . . 70.140000000000001 107.145 178.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.7 p -94.14 132.91 36.9 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 109.297 -0.631 . . . . 70.219999999999999 109.297 178.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -114.43 139.25 49.66 Favored 'General case' 0 N--CA 1.424 -1.727 0 N-CA-C 109.083 -0.71 . . . . 74.340000000000003 109.083 -178.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.0 m -100.86 118.41 36.87 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.735 -0.839 . . . . 74.129999999999995 108.735 -177.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 40.0 p -116.17 103.83 10.92 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 121.352 0.596 . . . . 73.109999999999999 111.843 -178.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.6 p -112.42 138.77 48.68 Favored 'General case' 0 N--CA 1.42 -1.932 0 N-CA-C 107.42 -1.326 . . . . 61.130000000000003 107.42 176.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.1 m . . . . . 0 C--N 1.3 -1.581 0 CA-C-O 121.372 0.606 . . . . 74.099999999999994 111.9 -177.7 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.376 0 N-CA-C 111.446 -0.662 . . . . 71.409999999999997 111.446 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.402 ' HB2' ' O ' ' A' ' 141' ' ' PRO . 15.5 m -112.32 153.82 26.64 Favored 'General case' 0 N--CA 1.424 -1.761 0 N-CA-C 108.707 -0.849 . . . . 75.140000000000001 108.707 177.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.439 ' O ' ' HG ' ' A' ' 62' ' ' LEU . . . -153.43 146.4 24.51 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 108.756 -0.831 . . . . 51.100000000000001 108.756 -178.062 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.43 ' HA ' ' HA ' ' A' ' 62' ' ' LEU . 2.4 pt? -130.23 160.12 34.8 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 109.484 -0.561 . . . . 72.120000000000005 109.484 -178.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.423 HD11 ' CZ ' ' A' ' 61' ' ' PHE . 3.7 pp -133.93 147.77 51.12 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 116.349 -0.387 . . . . 64.430000000000007 110.672 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.555 HG12 ' HB3' ' A' ' 60' ' ' ARG . 27.9 m -117.03 129.24 73.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 108.961 -0.755 . . . . 53.219999999999999 108.961 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.5 t -97.79 118.79 44.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 N-CA-C 107.754 -1.202 . . . . 45.130000000000003 107.754 176.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -110.81 -13.56 14.13 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.827 -0.624 . . . . 74.340000000000003 112.626 -173.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 16.6 tpp180 -150.1 125.94 10.45 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.86 -0.793 . . . . 71.129999999999995 108.86 176.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 139.9 135.76 3.28 Favored Glycine 0 C--O 1.206 -1.622 0 C-N-CA 120.722 -0.751 . . . . 54.539999999999999 112.472 176.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.543 ' HD2' ' CE1' ' A' ' 133' ' ' PHE . 39.2 Cg_exo -67.71 -8.66 23.06 Favored 'Trans proline' 0 N--CA 1.484 0.939 0 C-N-CA 123.134 2.556 . . . . 75.430000000000007 112.951 174.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -66.02 -40.13 90.81 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.203 -0.453 . . . . 73.540000000000006 110.667 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -169.26 173.56 6.61 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 109.252 -0.647 . . . . 63.310000000000002 109.252 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.93 43.61 0.41 Allowed Glycine 0 CA--C 1.487 -1.707 0 N-CA-C 108.997 -1.641 . . . . 44.200000000000003 108.997 178.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -147.15 -173.18 4.18 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.722 -0.844 . . . . 70.329999999999998 108.722 -174.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.555 ' HB3' HG12 ' A' ' 50' ' ' VAL . 14.1 ptt180 -121.69 141.48 51.11 Favored 'General case' 0 N--CA 1.434 -1.233 0 O-C-N 123.687 0.617 . . . . 73.409999999999997 110.116 179.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.423 ' CZ ' HD11 ' A' ' 49' ' ' LEU . 52.6 p90 -149.39 152.45 35.77 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 109.042 -0.725 . . . . 74.099999999999994 109.042 175.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 47' ' ' ALA . 9.2 tt -99.43 140.51 33.51 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 123.622 0.576 . . . . 63.229999999999997 109.621 -176.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 84.3 mt -81.13 114.26 19.85 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 121.279 0.562 . . . . 62.399999999999999 110.955 -176.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -122.25 -36.78 2.91 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.253 -1.017 . . . . 74.129999999999995 108.253 174.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.5 pm0 -64.46 130.18 94.54 Favored Pre-proline 0 N--CA 1.436 -1.148 0 CA-C-N 114.965 -1.016 . . . . 74.219999999999999 110.031 175.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.504 ' HA ' HG12 ' A' ' 94' ' ' ILE . 19.5 Cg_endo -60.47 -30.64 91.22 Favored 'Trans proline' 0 N--CA 1.479 0.663 0 C-N-CA 123.846 3.031 . . . . 75.120000000000005 113.477 -173.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 90.0 m -135.92 116.14 13.47 Favored 'General case' 0 N--CA 1.416 -2.158 0 CA-C-N 115.929 -0.578 . . . . 75.219999999999999 109.801 178.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.481 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 11.9 m -100.65 115.36 30.02 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 106.717 -1.586 . . . . 72.420000000000002 106.717 176.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.7 p -96.82 108.8 21.54 Favored 'General case' 0 N--CA 1.425 -1.679 0 CA-C-O 121.414 0.626 . . . . 72.430000000000007 112.169 -176.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.416 ' O ' ' HB3' ' A' ' 89' ' ' HIS . . . -102.32 92.55 4.76 Favored 'General case' 0 N--CA 1.425 -1.71 0 N-CA-C 107.836 -1.172 . . . . 71.540000000000006 107.836 174.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.587 ' O ' ' HA ' ' A' ' 88' ' ' ARG . . . 99.97 102.01 2.42 Favored Glycine 0 N--CA 1.428 -1.871 0 N-CA-C 110.5 -1.04 . . . . 42.100000000000001 110.5 -178.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.3 mmt85 -155.14 -61.1 0.11 Allowed 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 124.866 1.266 . . . . 72.420000000000002 108.488 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.465 ' HB3' ' HD2' ' A' ' 74' ' ' PRO . 94.4 m-70 -146.2 177.21 1.85 Allowed Pre-proline 0 C--N 1.295 -1.786 0 N-CA-C 106.751 -1.574 . . . . 63.420000000000002 106.751 -178.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 73' ' ' HIS . 6.3 Cg_endo -54.24 -30.69 62.97 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 121.88 1.72 . . . . 74.439999999999998 110.508 170.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -107.79 72.58 0.86 Allowed 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 115.16 -0.927 . . . . 63.140000000000001 109.678 178.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.444 ' HB2' ' O ' ' A' ' 78' ' ' ILE . 41.5 m -91.01 -174.82 4.13 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.502 -1.296 . . . . 64.120000000000005 107.502 173.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -60.9 -44.33 97.29 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 108.32 -0.992 . . . . 72.340000000000003 108.32 177.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.444 ' O ' ' HB2' ' A' ' 76' ' ' SER . 36.8 pt -128.02 143.59 40.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 105.582 -2.007 . . . . 63.210000000000001 105.582 170.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -99.48 126.45 45.41 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 118.568 -1.253 . . . . 75.219999999999999 112.113 -175.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.5 mp -85.46 89.6 7.74 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 106.361 -1.718 . . . . 74.310000000000002 106.361 175.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -45.27 -58.73 3.07 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.552 -1.204 . . . . 74.010000000000005 113.542 -173.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -162.84 -167.05 1.42 Allowed 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 106.69 -1.596 . . . . 54.219999999999999 106.69 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 83.2 t 74.3 -41.95 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.246 1.418 . . . . 72.349999999999994 112.58 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.541 ' HB ' ' CZ ' ' A' ' 133' ' ' PHE . 56.6 m -154.04 71.96 0.87 Allowed 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.358 0.599 . . . . 54.109999999999999 110.331 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.3 p -114.45 109.03 27.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 O-C-N 121.617 -0.677 . . . . 75.420000000000002 112.401 176.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 36.0 t -97.74 170.29 9.09 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.699 -0.852 . . . . 73.430000000000007 108.699 174.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 60.0 ttt180 -78.39 -8.23 58.23 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 122.952 1.358 . . . . 72.299999999999997 109.381 -179.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.587 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -170.61 125.65 0.72 Allowed 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 104.154 -2.536 . . . . 72.150000000000006 104.154 173.047 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.416 ' HB3' ' O ' ' A' ' 70' ' ' ALA . 11.7 t60 -128.46 -76.97 0.56 Allowed 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 118.939 -1.105 . . . . 74.519999999999996 112.914 -172.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -127.7 119.26 25.44 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-O 121.272 0.558 . . . . 72.129999999999995 109.605 -176.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -114.03 128.01 56.2 Favored 'General case' 0 C--N 1.276 -2.594 0 C-N-CA 120.02 -0.672 . . . . 62.219999999999999 110.439 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.481 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 56.2 m-85 -97.41 121.21 39.05 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 107.991 -1.114 . . . . 65.409999999999997 107.991 -178.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 34.3 mmt-85 -104.91 129.13 53.36 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.437 -0.949 . . . . 71.219999999999999 108.437 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.504 HG12 ' HA ' ' A' ' 66' ' ' PRO . 11.4 pt -115.88 130.96 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.201 0 C-N-CA 118.504 -1.279 . . . . 72.030000000000001 108.022 173.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.437 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 56.0 t-20 -120.03 145.47 46.79 Favored 'General case' 0 C--N 1.269 -2.93 0 N-CA-C 106.547 -1.649 . . . . 74.109999999999999 106.547 -175.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -59.7 -20.27 55.26 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-O 121.357 0.598 . . . . 64.530000000000001 110.267 174.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -77.61 -61.81 2.52 Favored Glycine 0 N--CA 1.423 -2.172 0 CA-C-N 115.488 -0.778 . . . . 63.549999999999997 111.604 174.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.437 ' O ' ' HB3' ' A' ' 95' ' ' ASN . 27.3 tt0 -157.4 -178.11 7.1 Favored 'General case' 0 CA--C 1.552 1.023 0 CA-C-N 117.475 0.637 . . . . 74.0 109.346 -176.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.638 ' HB3' ' SD ' ' A' ' 122' ' ' MET . 81.5 m-85 -109.71 130.05 55.55 Favored 'General case' 0 C--N 1.311 -1.091 0 O-C-N 121.963 -0.46 . . . . 72.099999999999994 110.52 -176.183 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -132.53 135.84 46.23 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-O 120.633 0.254 . . . . 74.400000000000006 111.464 -175.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 8.9 p -114.56 129.62 70.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 O-C-N 121.845 -0.534 . . . . 33.32 110.073 176.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 59.4 t -118.92 128.97 75.72 Favored 'Isoleucine or valine' 0 C--O 1.248 0.98 0 CA-C-N 116.313 -0.403 . . . . 75.25 111.321 -177.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -83.95 117.96 23.7 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.637 -0.71 . . . . 62.219999999999999 109.215 173.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.423 ' O ' ' HG2' ' A' ' 88' ' ' ARG . 17.8 m -118.2 8.0 6.9 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.35 0 N-CA-C 108.258 -1.016 . . . . 73.239999999999995 108.258 176.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.448 ' HA2' ' O ' ' A' ' 88' ' ' ARG . . . -91.2 -66.15 1.16 Allowed Glycine 0 N--CA 1.404 -3.446 0 CA-C-N 114.578 -1.192 . . . . 63.340000000000003 111.091 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 14.0 m 60.07 1.46 0.34 Allowed 'General case' 0 CA--C 1.566 1.573 0 C-N-CA 124.252 1.021 . . . . 62.409999999999997 112.282 -179.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 49.1 tp -72.98 -50.82 21.01 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.099 0.959 . . . . 70.310000000000002 109.656 -177.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -99.23 -35.44 9.97 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.114 -0.948 . . . . 64.230000000000004 109.397 176.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 104.05 133.84 7.98 Favored Glycine 0 N--CA 1.427 -1.964 0 N-CA-C 110.584 -1.006 . . . . 33.32 110.584 -178.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 97.7 m -101.87 119.62 39.08 Favored 'General case' 0 C--N 1.281 -2.374 0 N-CA-C 108.847 -0.797 . . . . 75.099999999999994 108.847 178.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 116' ' ' PRO . 3.9 m-85 -111.32 132.48 54.36 Favored 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 106.487 -1.671 . . . . 73.510000000000005 106.487 -177.229 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.471 HG11 ' HG3' ' A' ' 120' ' ' GLN . 7.7 p -131.16 131.92 63.51 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.776 0 C-N-CA 119.953 -0.699 . . . . 73.140000000000001 110.696 178.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 66.56 -72.46 0.08 Allowed 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 125.506 1.523 . . . . 73.010000000000005 110.841 -177.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 114' ' ' ARG . 6.7 tpt180 -154.59 4.26 0.24 Allowed 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.902 -0.59 . . . . 61.109999999999999 109.489 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.432 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . 43.8 mt-10 -132.98 134.72 24.78 Favored Pre-proline 0 C--O 1.237 0.43 0 O-C-N 121.319 -0.863 . . . . 64.400000000000006 112.487 -174.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 115' ' ' GLU . 2.9 Cg_exo -77.23 116.01 4.07 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 122.332 2.021 . . . . 52.240000000000002 108.702 170.144 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.45 HH11 ' HG3' ' A' ' 120' ' ' GLN . 7.0 ptp180 -144.06 151.41 39.61 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.112 -1.07 . . . . 74.239999999999995 108.112 -178.299 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -76.22 -42.19 46.86 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 112.529 0.566 . . . . 74.349999999999994 112.529 -174.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -125.84 140.61 52.52 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 109.331 -0.618 . . . . 75.540000000000006 109.331 179.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.471 ' HG3' HG11 ' A' ' 112' ' ' VAL . 1.6 tm0? -138.94 149.85 45.23 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 116.41 -0.359 . . . . 71.420000000000002 110.561 -178.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 81.1 t -104.5 117.68 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 N-CA-C 105.743 -1.947 . . . . 75.319999999999993 105.743 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.638 ' SD ' ' HB3' ' A' ' 99' ' ' PHE . 66.7 mtt -59.86 128.67 38.04 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 113.87 1.063 . . . . 65.120000000000005 113.87 -169.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -112.07 137.73 49.71 Favored 'General case' 0 N--CA 1.418 -2.044 0 N-CA-C 107.079 -1.452 . . . . 74.329999999999998 107.079 178.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.489 ' HB ' ' HB3' ' A' ' 139' ' ' ALA . 1.8 t -79.37 129.76 34.78 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-O 121.368 0.604 . . . . 60.420000000000002 110.826 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 83.79 38.21 10.79 Favored Glycine 0 N--CA 1.424 -2.118 0 N-CA-C 110.014 -1.234 . . . . 71.109999999999999 110.014 -178.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -125.25 166.81 15.82 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.722 -0.391 . . . . 73.349999999999994 110.985 -177.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 19.1 tp10 -107.47 120.56 42.51 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 123.405 0.682 . . . . 75.030000000000001 109.181 -172.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 61.6 mt -114.96 117.6 56.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 108.006 -1.109 . . . . 72.019999999999996 108.006 179.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -116.49 111.8 20.49 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.255 0.55 . . . . 73.209999999999994 109.787 -175.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.413 HG13 ' HB2' ' A' ' 133' ' ' PHE . 25.6 pt -101.71 98.36 6.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-O 121.83 0.824 . . . . 74.239999999999995 109.384 179.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 70.36 -100.09 0.78 Allowed Glycine 0 N--CA 1.435 -1.386 0 N-CA-C 110.384 -1.087 . . . . 63.32 110.384 -175.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -115.18 0.35 13.53 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 120.938 0.399 . . . . 75.019999999999996 110.603 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.543 ' CE1' ' HD2' ' A' ' 55' ' ' PRO . 9.7 m-30 -93.27 141.15 28.76 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.035 -0.728 . . . . 72.510000000000005 109.035 -176.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 41.0 mtm180 -121.81 122.55 39.73 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.889 0.852 . . . . 74.329999999999998 111.193 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.8 tt -124.72 131.1 53.48 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 113.744 -1.571 . . . . 70.200000000000003 108.77 -176.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 57.5 t -108.09 128.41 63.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 108.697 -0.853 . . . . 73.120000000000005 108.697 178.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -100.78 130.05 46.75 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.953 -0.567 . . . . 73.230000000000004 110.438 -176.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.4 mp -130.66 130.45 43.93 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.692 -0.484 . . . . 74.120000000000005 109.692 179.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.489 ' HB3' ' HB ' ' A' ' 124' ' ' THR . . . -122.38 117.67 26.6 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 108.07 -1.085 . . . . 73.209999999999994 108.07 177.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -174.04 -60.11 0.05 OUTLIER Glycine 0 C--N 1.294 -1.786 0 C-N-CA 120.125 -1.036 . . . . 73.319999999999993 112.673 -176.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.402 ' O ' ' HB2' ' A' ' 46' ' ' SER . 33.2 Cg_exo . . . . . 0 C--N 1.358 1.045 0 C-N-CA 121.917 1.744 . . . . 63.299999999999997 110.895 176.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 . . . . . 0 CA--C 1.493 -1.221 0 N-CA-C 107.277 -1.379 . . . . 74.0 107.277 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 93.11 45.65 3.51 Favored Glycine 0 N--CA 1.431 -1.682 0 N-CA-C 109.631 -1.388 . . . . 73.049999999999997 109.631 -175.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 55.9 m -92.28 122.91 63.86 Favored Pre-proline 0 N--CA 1.416 -2.141 0 N-CA-C 107.833 -1.173 . . . . 73.510000000000005 107.833 178.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.56 128.95 19.02 Favored 'Trans proline' 0 N--CA 1.448 -1.205 0 C-N-CA 122.211 1.941 . . . . 71.030000000000001 111.272 177.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -73.67 109.73 7.32 Favored Pre-proline 0 C--N 1.315 -0.9 0 N-CA-C 107.168 -1.419 . . . . 71.019999999999996 107.168 173.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -73.24 132.84 18.48 Favored 'Trans proline' 0 N--CA 1.443 -1.465 0 C-N-CA 122.186 1.924 . . . . 73.439999999999998 113.016 -171.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -110.27 116.73 32.0 Favored 'General case' 0 N--CA 1.422 -1.837 0 CA-C-N 115.573 -0.74 . . . . 64.340000000000003 109.323 175.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.9 p -86.01 88.84 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.519 0 CA-C-O 122.542 1.163 . . . . 72.439999999999998 110.062 178.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -125.52 120.35 30.66 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 106.667 -1.605 . . . . 55.409999999999997 106.667 178.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.5 m -113.4 98.98 7.43 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-O 121.321 0.581 . . . . 60.450000000000003 111.281 -175.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.5 m -105.85 -11.58 16.18 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 122.557 1.17 . . . . 74.150000000000006 108.459 175.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.2 t -83.26 91.83 7.36 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 114.218 -1.355 . . . . 74.519999999999996 108.24 176.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 59.8 t . . . . . 0 C--N 1.311 -1.087 0 N-CA-C 107.721 -1.215 . . . . 65.430000000000007 107.721 -178.502 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.257 0 N-CA-C 110.473 -1.051 . . . . 70.450000000000003 110.473 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.9 m -132.83 158.11 43.33 Favored 'General case' 0 N--CA 1.426 -1.635 0 N-CA-C 109.312 -0.625 . . . . 74.530000000000001 109.312 179.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -162.31 167.45 23.84 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.013 -1.477 . . . . 55.43 107.013 -177.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.405 HD22 ' HD3' ' A' ' 141' ' ' PRO . 2.1 pt? -134.55 158.26 44.43 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 109.231 -0.655 . . . . 72.0 109.231 178.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.422 ' HB2' HD21 ' A' ' 135' ' ' LEU . 4.4 pp -114.45 136.49 52.95 Favored 'General case' 0 N--CA 1.412 -2.337 0 N-CA-C 108.179 -1.045 . . . . 62.119999999999997 108.179 175.225 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 60.8 t -121.67 124.99 72.83 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.397 0 N-CA-C 107.895 -1.15 . . . . 74.310000000000002 107.895 -179.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.415 HG11 ' OD1' ' A' ' 56' ' ' ASN . 42.0 t -92.65 115.57 31.82 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 N-CA-C 107.446 -1.316 . . . . 61.149999999999999 107.446 177.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -85.12 -36.57 21.03 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-N 114.491 -1.231 . . . . 65.340000000000003 110.513 -174.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.459 ' O ' ' HB3' ' A' ' 133' ' ' PHE . 16.1 tpp180 -155.3 121.33 5.14 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 120.143 -0.623 . . . . 75.340000000000003 110.906 -178.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.421 ' HA2' ' CD1' ' A' ' 133' ' ' PHE . . . 162.08 141.97 3.27 Favored Glycine 0 C--O 1.194 -2.361 0 O-C-N 124.038 0.837 . . . . 55.049999999999997 111.102 176.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.434 ' HB2' ' OD2' ' A' ' 81' ' ' ASP . 17.0 Cg_exo -68.64 -10.07 27.99 Favored 'Trans proline' 0 N--CA 1.477 0.527 0 C-N-CA 122.45 2.1 . . . . 54.210000000000001 111.603 177.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.493 ' HB3' ' H ' ' A' ' 81' ' ' ASP . 4.4 p30 -59.35 -53.88 53.2 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 115.134 -0.939 . . . . 71.310000000000002 109.775 175.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -164.29 174.49 11.06 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-N 115.809 -0.632 . . . . 64.239999999999995 109.471 -179.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -163.45 54.36 0.29 Allowed Glycine 0 C--N 1.289 -2.083 0 N-CA-C 108.531 -1.828 . . . . 62.25 108.531 179.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -150.04 178.42 8.96 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 108.184 -1.043 . . . . 64.439999999999998 108.184 -175.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -102.36 137.81 40.11 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 108.147 -1.057 . . . . 63.409999999999997 108.147 179.151 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -132.43 129.89 39.87 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.095 -0.706 . . . . 72.310000000000002 109.095 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 52.4 tp -88.88 128.05 35.66 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 116.34 -0.391 . . . . 75.219999999999999 110.897 -176.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -77.73 115.47 17.51 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 108.267 -1.012 . . . . 63.210000000000001 108.267 176.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -143.14 -53.09 0.38 Allowed 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 115.029 -0.987 . . . . 72.510000000000005 109.348 -177.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.416 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 25.4 tt0 -69.63 121.31 82.01 Favored Pre-proline 0 C--N 1.312 -1.061 0 N-CA-C 108.505 -0.924 . . . . 72.129999999999995 108.505 177.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 65' ' ' GLN . 1.0 OUTLIER -42.07 -51.37 4.74 Favored 'Trans proline' 0 C--N 1.372 1.795 0 C-N-CA 124.745 3.63 . . . . 61.130000000000003 113.958 -173.997 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.5 m -102.97 99.88 9.8 Favored 'General case' 0 N--CA 1.415 -2.205 0 CA-C-N 116.144 -0.48 . . . . 54.25 109.844 179.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.447 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 86.2 m -98.14 114.05 26.13 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.422 -1.325 . . . . 72.209999999999994 107.422 175.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.7 m -105.58 133.92 49.54 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 112.925 0.713 . . . . 53.450000000000003 112.925 -171.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -108.63 117.5 34.34 Favored 'General case' 0 C--O 1.253 1.243 0 N-CA-C 108.386 -0.968 . . . . 64.109999999999999 108.386 175.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -158.68 -179.83 33.82 Favored Glycine 0 N--CA 1.438 -1.209 0 C-N-CA 120.158 -1.02 . . . . 62.109999999999999 111.188 -177.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.6 ttp180 -90.21 8.5 32.75 Favored 'General case' 0 CA--C 1.553 1.064 0 CA-C-O 121.949 0.881 . . . . 43.100000000000001 110.089 -176.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 60.8 m-70 -88.94 146.54 36.84 Favored Pre-proline 0 C--N 1.298 -1.64 0 N-CA-C 108.805 -0.813 . . . . 72.299999999999997 108.805 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -66.83 -28.73 42.8 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 121.729 1.619 . . . . 72.099999999999994 109.534 174.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -90.69 65.57 5.94 Favored 'General case' 0 N--CA 1.423 -1.819 0 CA-C-N 114.385 -1.28 . . . . 74.310000000000002 109.236 177.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.6 p -121.35 -174.76 2.92 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 106.066 -1.828 . . . . 71.450000000000003 106.066 175.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -100.67 -41.09 7.06 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 119.374 -0.931 . . . . 75.150000000000006 108.956 178.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 41.7 pt -114.78 150.58 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.618 0 N-CA-C 106.99 -1.485 . . . . 71.430000000000007 106.99 170.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -87.51 136.18 33.05 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 109.441 -0.577 . . . . 62.240000000000002 109.441 -179.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.462 ' HA ' ' HB2' ' A' ' 56' ' ' ASN . 50.4 tp -125.26 122.7 37.7 Favored 'General case' 0 N--CA 1.413 -2.319 0 CA-C-O 121.832 0.825 . . . . 74.099999999999994 111.043 -175.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.493 ' H ' ' HB3' ' A' ' 56' ' ' ASN . 33.9 t70 -142.59 108.5 5.17 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 114.561 -1.2 . . . . 71.540000000000006 108.304 176.078 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -137.04 161.84 34.96 Favored 'General case' 0 C--N 1.264 -3.137 0 CA-C-N 113.116 -1.856 . . . . 71.510000000000005 107.934 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.7 m -80.43 -15.46 12.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-O 121.441 0.639 . . . . 72.530000000000001 112.095 -177.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.505 ' OG1' ' HB3' ' A' ' 108' ' ' ASN . 3.1 p -128.54 45.73 2.73 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 122.261 1.029 . . . . 53.140000000000001 108.5 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.8 p -81.21 139.68 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 CA-C-N 113.672 -1.604 . . . . 62.439999999999998 110.789 -173.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 24.4 t -101.28 163.09 12.45 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 107.26 -1.385 . . . . 55.210000000000001 107.26 177.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 26.4 ttm180 -60.91 -43.3 98.73 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 108.946 -0.761 . . . . 70.329999999999998 108.946 179.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.495 ' HD3' ' H ' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -123.0 133.23 54.37 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 105.434 -2.061 . . . . 74.230000000000004 105.434 175.522 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 21.1 t60 -113.19 -68.63 0.92 Allowed 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.232 -0.987 . . . . 74.209999999999994 111.273 -174.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.37 153.65 40.75 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 116.295 -0.412 . . . . 74.409999999999997 109.889 -176.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -117.59 127.34 53.87 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 108.299 -1.0 . . . . 62.030000000000001 108.299 178.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.447 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 93.5 m-85 -100.51 115.58 30.45 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 107.744 -1.206 . . . . 72.049999999999997 107.744 178.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 61.9 mtp85 -106.85 123.13 47.71 Favored 'General case' 0 C--N 1.285 -2.238 0 N-CA-C 108.566 -0.902 . . . . 74.150000000000006 108.566 -176.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.3 tp -115.67 116.08 51.31 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 CA-C-O 121.639 0.733 . . . . 73.340000000000003 109.91 -176.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -118.71 143.81 46.64 Favored 'General case' 0 N--CA 1.41 -2.455 0 N-CA-C 103.986 -2.598 . . . . 63.32 103.986 175.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -70.91 -9.33 57.57 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 121.235 0.54 . . . . 73.150000000000006 111.658 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -80.86 -55.7 3.27 Favored Glycine 0 N--CA 1.433 -1.56 0 N-CA-C 111.025 -0.83 . . . . 51.219999999999999 111.025 171.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -148.89 166.24 29.13 Favored 'General case' 0 C--N 1.348 0.526 0 C-N-CA 122.801 0.44 . . . . 62.420000000000002 110.479 -178.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.531 ' HB2' ' HB2' ' A' ' 122' ' ' MET . 8.0 m-85 -111.03 128.74 55.96 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.947 -1.131 . . . . 72.030000000000001 107.947 -175.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -130.23 136.16 48.91 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.524 0.202 . . . . 71.510000000000005 110.89 -173.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.4 p -125.74 126.83 70.78 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-O 121.04 0.447 . . . . 71.140000000000001 110.165 175.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 51.9 t -119.21 133.41 66.14 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 CA-C-N 115.781 -0.645 . . . . 64.439999999999998 109.826 -178.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -82.9 131.53 35.19 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 107.18 -1.415 . . . . 54.109999999999999 107.18 173.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.402 HG23 ' HG2' ' A' ' 88' ' ' ARG . 17.4 m -111.97 20.22 6.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-O 121.086 0.469 . . . . 74.420000000000002 112.152 -177.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 120.06 54.85 0.25 Allowed Glycine 0 N--CA 1.433 -1.563 0 C-N-CA 119.981 -1.104 . . . . 61.329999999999998 114.367 174.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 77.7 p -78.86 145.77 34.02 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 117.253 0.526 . . . . 72.409999999999997 109.819 177.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 98.1 mt -80.19 -31.2 38.79 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 121.514 0.673 . . . . 63.539999999999999 109.931 178.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.505 ' HB3' ' OG1' ' A' ' 84' ' ' THR . 23.4 p30 -85.29 -24.52 27.68 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.01 -0.996 . . . . 63.210000000000001 112.841 -177.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 88.5 105.57 1.0 Allowed Glycine 0 N--CA 1.433 -1.502 0 C-N-CA 120.865 -0.683 . . . . 64.049999999999997 111.763 -179.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.6 m -75.63 123.94 26.38 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.794 -0.817 . . . . 73.409999999999997 108.794 176.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -136.97 153.71 50.62 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 109.796 -0.446 . . . . 71.25 109.796 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 31.1 t -98.07 142.63 14.18 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.006 0 N-CA-C 106.526 -1.657 . . . . 63.439999999999998 106.526 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 33.6 p-10 -55.21 -25.21 31.62 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 112.573 0.583 . . . . 73.319999999999993 112.573 -175.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 33.5 mtm105 -100.9 -32.51 10.62 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.369 -0.378 . . . . 71.239999999999995 111.809 177.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -130.65 125.29 21.41 Favored Pre-proline 0 C--N 1.316 -0.848 0 C-N-CA 121.078 -0.249 . . . . 63.149999999999999 111.589 -169.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.15 39.47 0.73 Allowed 'Trans proline' 0 CA--C 1.554 1.507 0 C-N-CA 122.838 2.359 . . . . 74.219999999999999 112.043 178.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.431 ' HB3' ' O ' ' A' ' 119' ' ' ALA . 31.1 mmt180 -90.51 131.33 36.31 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 123.537 0.735 . . . . 72.510000000000005 110.262 -177.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -78.64 -38.61 39.24 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.141 0.496 . . . . 43.240000000000002 110.021 174.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.431 ' O ' ' HB3' ' A' ' 117' ' ' ARG . . . -105.47 137.93 42.49 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 105.398 -2.075 . . . . 31.23 105.398 170.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -139.47 140.22 37.21 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-O 121.256 0.551 . . . . 51.119999999999997 111.932 -172.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 48.1 t -85.61 118.27 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 104.846 -2.279 . . . . 64.450000000000003 104.846 169.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.531 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 12.6 mmt -58.26 150.04 22.78 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 114.506 1.299 . . . . 63.240000000000002 114.506 -173.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -125.67 129.53 49.75 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 105.09 -2.189 . . . . 72.420000000000002 105.09 172.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 45.9 p -83.07 123.57 29.61 Favored 'General case' 0 C--N 1.283 -2.297 0 C-N-CA 121.002 -0.279 . . . . 75.109999999999999 110.676 -174.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 92.4 38.55 5.59 Favored Glycine 0 CA--C 1.497 -1.071 0 N-CA-C 109.528 -1.429 . . . . 75.25 109.528 -175.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -139.56 170.35 16.07 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 107.437 -1.32 . . . . 54.32 107.437 -176.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -140.52 139.75 35.13 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 122.285 1.04 . . . . 73.129999999999995 113.261 -174.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 60.0 mt -112.33 131.63 63.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-N 114.417 -1.265 . . . . 64.310000000000002 109.987 -175.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -93.76 112.53 24.42 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-O 121.843 0.83 . . . . 72.099999999999994 110.257 -178.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.9 pt -95.34 98.54 8.03 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 N-CA-C 107.641 -1.244 . . . . 71.099999999999994 107.641 176.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 76.06 -98.95 1.24 Allowed Glycine 0 N--CA 1.428 -1.885 0 N-CA-C 110.476 -1.05 . . . . 73.129999999999995 110.476 -176.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -127.64 10.19 6.59 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.197 0.523 . . . . 71.409999999999997 109.839 178.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.459 ' HB3' ' O ' ' A' ' 53' ' ' ARG . 57.4 m-85 -119.92 157.17 29.33 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.952 -0.567 . . . . 72.230000000000004 109.697 -175.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 20.1 ptp180 -125.77 131.33 52.52 Favored 'General case' 0 C--O 1.256 1.398 0 N-CA-C 114.087 1.143 . . . . 71.420000000000002 114.087 -170.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.422 HD21 ' HB2' ' A' ' 49' ' ' LEU . 6.5 tt -114.71 134.35 55.16 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 114.072 -1.422 . . . . 75.340000000000003 108.213 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 38.2 t -107.54 139.14 30.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 108.824 -0.806 . . . . 73.430000000000007 108.824 -176.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -115.84 126.3 53.8 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 109.883 -0.414 . . . . 75.140000000000001 109.883 -179.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 66.5 mt -132.69 137.57 46.97 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.63 -0.259 . . . . 71.099999999999994 110.749 -177.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -103.31 41.1 1.3 Allowed 'General case' 0 N--CA 1.482 1.141 0 CA-C-O 122.142 0.972 . . . . 62.119999999999997 108.719 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -75.81 -50.09 8.24 Favored Glycine 0 C--N 1.294 -1.759 0 CA-C-N 113.834 -1.53 . . . . 73.129999999999995 116.19 -174.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.405 ' HD3' HD22 ' A' ' 48' ' ' LEU . 5.8 Cg_exo . . . . . 0 C--N 1.368 1.588 0 CA-C-N 120.214 2.007 . . . . 73.319999999999993 115.407 -170.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 . . . . . 0 CA--C 1.492 -1.251 0 N-CA-C 106.878 -1.527 . . . . 73.230000000000004 106.878 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -89.4 166.28 33.13 Favored Glycine 0 N--CA 1.429 -1.792 0 C-N-CA 119.766 -1.207 . . . . 72.209999999999994 110.398 178.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.2 p -84.65 133.32 44.3 Favored Pre-proline 0 N--CA 1.421 -1.907 0 N-CA-C 109.165 -0.68 . . . . 70.129999999999995 109.165 177.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -66.2 127.49 17.63 Favored 'Trans proline' 0 N--CA 1.448 -1.157 0 N-CA-C 107.923 -1.607 . . . . 61.039999999999999 107.923 174.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -95.89 118.08 66.03 Favored Pre-proline 0 C--N 1.288 -2.07 0 N-CA-C 112.926 0.713 . . . . 75.040000000000006 112.926 -174.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -66.13 140.58 60.05 Favored 'Trans proline' 0 C--O 1.245 0.862 0 C-N-CA 122.644 2.23 . . . . 62.25 108.948 173.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -149.23 98.69 2.84 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-O 122.075 0.94 . . . . 62.130000000000003 109.161 -176.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 49.2 t -69.4 118.24 13.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 114.06 -1.427 . . . . 74.209999999999994 112.259 -172.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -95.7 135.96 36.71 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 107.308 -1.367 . . . . 73.120000000000005 107.308 173.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.5 t -152.17 151.92 31.63 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-O 121.302 0.573 . . . . 73.439999999999998 110.756 -175.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.8 m -122.13 81.52 1.84 Allowed 'General case' 0 N--CA 1.41 -2.458 0 N-CA-C 107.805 -1.183 . . . . 73.109999999999999 107.805 173.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.7 m -82.36 99.33 9.32 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 115.551 -0.75 . . . . 61.140000000000001 109.224 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.9 p . . . . . 0 C--N 1.304 -1.374 0 N-CA-C 108.659 -0.867 . . . . 71.439999999999998 108.659 -179.713 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.002 0 N-CA-C 110.409 -1.076 . . . . 70.219999999999999 110.409 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 18.8 m -134.07 166.82 21.85 Favored 'General case' 0 N--CA 1.419 -2.016 0 N-CA-C 108.761 -0.829 . . . . 73.120000000000005 108.761 -179.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.518 ' HB3' ' CZ ' ' A' ' 137' ' ' PHE . . . -151.15 -170.9 3.79 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 107.939 -1.134 . . . . 41.409999999999997 107.939 178.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.412 ' H ' HD13 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -123.22 152.25 41.47 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 120.366 -0.533 . . . . 72.420000000000002 111.399 -176.991 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.441 ' HB2' HD21 ' A' ' 135' ' ' LEU . 2.0 pp -127.78 145.01 51.06 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 115.555 -0.748 . . . . 72.549999999999997 110.922 178.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.3 m -131.28 142.34 43.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 109.394 -0.595 . . . . 61.219999999999999 109.394 178.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.508 HG21 ' HB3' ' A' ' 57' ' ' ALA . 76.5 t -93.82 115.93 33.83 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 N-CA-C 107.878 -1.156 . . . . 74.209999999999994 107.878 176.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.5 tmtm? -82.16 -38.81 24.13 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.756 -0.831 . . . . 40.020000000000003 108.756 -175.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.446 ' O ' ' HB3' ' A' ' 133' ' ' PHE . 13.8 tpp180 -142.41 117.3 9.92 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 108.181 -1.044 . . . . 72.140000000000001 108.181 -178.105 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 148.42 125.18 1.46 Allowed Glycine 0 N--CA 1.427 -1.955 0 C-N-CA 119.784 -1.198 . . . . 72.420000000000002 114.057 177.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -67.54 -8.92 23.67 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 123.768 2.979 . . . . 71.329999999999998 110.509 174.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.575 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 2.1 m-20 -51.18 -26.5 6.95 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 126.852 2.061 . . . . 72.129999999999995 111.215 177.241 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.508 ' HB3' HG21 ' A' ' 51' ' ' VAL . . . -166.88 -62.16 0.03 OUTLIER 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 123.45 0.7 . . . . 73.120000000000005 109.403 176.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 61.3 44.82 97.59 Favored Glycine 0 C--N 1.336 0.557 0 CA-C-N 115.741 -0.663 . . . . 45.420000000000002 111.85 -179.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -151.62 -171.68 4.0 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 108.927 -0.768 . . . . 74.430000000000007 108.927 -176.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.8 ptt180 -119.93 138.51 53.4 Favored 'General case' 0 C--N 1.312 -1.064 0 O-C-N 124.002 0.814 . . . . 62.43 109.221 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -138.54 129.43 26.68 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-O 120.896 0.379 . . . . 73.430000000000007 110.807 179.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 65.3 tp -91.45 129.59 37.41 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 107.505 -1.294 . . . . 74.450000000000003 107.505 176.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 79.7 mt -72.16 120.15 17.35 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 113.018 0.748 . . . . 72.099999999999994 113.018 -176.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -146.29 -39.99 0.21 Allowed 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.884 -1.053 . . . . 73.349999999999994 110.56 175.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -61.28 113.89 9.26 Favored Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 123.888 0.875 . . . . 74.409999999999997 110.297 173.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.566 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 8.4 Cg_endo -53.8 -41.31 75.51 Favored 'Trans proline' 0 C--N 1.361 1.185 0 C-N-CA 122.983 2.455 . . . . 71.0 113.253 -175.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 50.2 m -119.82 105.89 11.55 Favored 'General case' 0 N--CA 1.423 -1.8 0 CA-C-O 121.21 0.528 . . . . 72.030000000000001 109.79 178.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.485 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 40.1 m -107.01 113.8 27.5 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 107.259 -1.386 . . . . 61.539999999999999 107.259 174.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.4 p -98.04 133.64 42.23 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 116.002 -0.544 . . . . 71.040000000000006 112.369 -175.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -115.21 120.29 39.22 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 115.574 -0.739 . . . . 72.519999999999996 109.135 176.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.428 ' HA2' ' CG2' ' A' ' 85' ' ' VAL . . . 167.63 -160.44 34.05 Favored Glycine 0 N--CA 1.422 -2.254 0 N-CA-C 110.051 -1.22 . . . . 73.5 110.051 178.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.49 ' O ' ' HG2' ' A' ' 87' ' ' ARG . 18.6 tpt180 -132.42 89.56 2.67 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 109.445 -0.576 . . . . 62.219999999999999 109.445 174.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.559 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 5.1 p80 -161.59 165.76 15.93 Favored Pre-proline 0 C--N 1.304 -1.402 0 N-CA-C 107.686 -1.227 . . . . 63.520000000000003 107.686 177.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.559 ' HD2' ' HB2' ' A' ' 73' ' ' HIS . 3.1 Cg_endo -47.89 -35.44 24.61 Favored 'Trans proline' 0 C--N 1.359 1.101 0 C-N-CA 123.317 2.678 . . . . 72.329999999999998 115.7 -175.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -99.33 14.6 29.06 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 119.237 -0.985 . . . . 62.030000000000001 113.52 -175.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 24.0 m -73.2 133.24 43.96 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.635 -0.506 . . . . 75.340000000000003 109.635 176.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -80.19 -56.02 4.51 Favored 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 108.441 -0.948 . . . . 72.310000000000002 108.441 176.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 32.4 pt -97.69 134.46 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 N-CA-C 109.117 -0.697 . . . . 44.530000000000001 109.117 177.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -104.42 116.87 32.88 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 121.764 0.792 . . . . 73.030000000000001 110.529 -177.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.575 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 7.0 mp -82.02 106.53 14.01 Favored 'General case' 0 N--CA 1.422 -1.831 0 CA-C-N 114.817 -1.083 . . . . 74.519999999999996 111.09 -177.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -85.0 69.49 10.82 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 122.432 1.111 . . . . 75.340000000000003 109.743 176.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -148.62 164.26 34.82 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 113.94 -1.482 . . . . 70.319999999999993 108.279 176.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.1 p -94.69 -6.65 10.15 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-O 121.083 0.468 . . . . 63.32 111.516 -176.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.7 m -91.96 13.45 18.58 Favored 'General case' 0 CA--C 1.548 0.899 0 O-C-N 121.491 -0.755 . . . . 74.430000000000007 110.267 -177.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.428 ' CG2' ' HA2' ' A' ' 71' ' ' GLY . 10.6 p -102.77 133.11 47.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-O 121.258 0.551 . . . . 70.340000000000003 111.312 -178.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 18.3 m -102.05 169.95 8.42 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 108.94 -0.763 . . . . 51.420000000000002 108.94 176.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.49 ' HG2' ' O ' ' A' ' 72' ' ' ARG . 63.1 mtm180 -75.27 134.7 41.04 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 106.674 -1.602 . . . . 72.540000000000006 106.674 173.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.554 ' H ' ' CD2' ' A' ' 73' ' ' HIS 0.36 0.0 OUTLIER 50.38 71.76 0.39 Allowed 'General case' 0 C--O 1.22 -0.497 0 CA-C-O 122.654 1.216 . . . . 74.340000000000003 111.096 -171.507 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.453 ' HA ' ' HA3' ' A' ' 105' ' ' GLY . 11.4 t60 -95.39 -60.14 1.73 Allowed 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 113.828 -1.533 . . . . 72.209999999999994 109.846 -173.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -130.94 127.47 38.52 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 109.215 -0.661 . . . . 63.240000000000002 109.215 -179.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -109.75 127.19 54.46 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 109.049 -0.723 . . . . 72.540000000000006 109.049 177.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.485 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 97.5 m-85 -104.09 112.62 25.69 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 107.651 -1.241 . . . . 74.140000000000001 107.651 177.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 27.5 mtp85 -108.48 113.59 26.74 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 115.368 -0.833 . . . . 75.420000000000002 109.072 -177.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.566 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -128.48 124.22 61.38 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.522 0 CA-C-O 122.085 0.945 . . . . 64.120000000000005 110.077 -177.778 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -110.52 147.71 33.6 Favored 'General case' 0 C--N 1.269 -2.906 0 N-CA-C 106.765 -1.568 . . . . 63.409999999999997 106.765 177.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -42.42 -26.57 0.12 Allowed 'General case' 0 CA--C 1.56 1.354 0 N-CA-C 114.234 1.198 . . . . 73.219999999999999 114.234 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -128.77 23.85 4.96 Favored Glycine 0 N--CA 1.437 -1.249 0 C-N-CA 120.617 -0.802 . . . . 13.23 113.513 179.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -165.44 144.25 6.32 Favored 'General case' 0 C--O 1.213 -0.868 0 CA-C-N 117.852 0.826 . . . . 73.040000000000006 110.84 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.479 ' HB2' ' SD ' ' A' ' 122' ' ' MET . 1.3 p90 -132.15 115.83 16.23 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-O 121.873 0.844 . . . . 72.109999999999999 112.085 -177.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -129.9 135.24 48.12 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.468 -0.787 . . . . 64.430000000000007 111.559 -172.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.6 p -116.5 128.38 73.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 109.561 -0.533 . . . . 73.040000000000006 109.561 178.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 58.6 t -118.82 130.61 73.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-N 116.325 -0.398 . . . . 62.32 110.943 -175.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -101.31 115.24 30.04 Favored 'General case' 0 CA--C 1.496 -1.127 0 CA-C-O 121.074 0.464 . . . . 75.439999999999998 109.802 176.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 88' ' ' ARG . 5.3 m -122.42 -1.64 7.22 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 CA-C-O 121.671 0.748 . . . . 61.329999999999998 111.459 178.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.453 ' HA3' ' HA ' ' A' ' 89' ' ' HIS . . . -100.22 39.83 2.62 Favored Glycine 0 N--CA 1.429 -1.771 0 N-CA-C 109.401 -1.48 . . . . 54.439999999999998 109.401 176.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 11.4 m -63.45 4.52 0.23 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.042 1.737 . . . . 54.340000000000003 113.479 -176.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -68.95 -41.09 78.48 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 106.693 -1.595 . . . . 71.400000000000006 106.693 171.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -110.18 -41.19 4.49 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.071 -1.422 . . . . 70.120000000000005 108.355 177.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 92.65 131.53 5.67 Favored Glycine 0 N--CA 1.438 -1.202 0 N-CA-C 115.71 1.044 . . . . 74.200000000000003 115.71 173.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 18.6 m -94.65 135.59 35.94 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 105.941 -1.874 . . . . 70.329999999999998 105.941 169.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -117.69 134.42 54.92 Favored 'General case' 0 C--N 1.294 -1.833 0 C-N-CA 120.013 -0.675 . . . . 70.230000000000004 109.659 -177.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.474 HG23 ' HB2' ' A' ' 115' ' ' GLU . 22.3 m -100.43 110.56 27.75 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.935 0 N-CA-C 106.973 -1.491 . . . . 73.409999999999997 106.973 172.263 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 66.96 -79.72 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 125.843 1.657 . . . . 44.25 108.944 -171.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 51.9 mtp180 -148.11 13.8 1.0 Allowed 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 124.652 1.181 . . . . 73.129999999999995 109.147 176.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.474 ' HB2' HG23 ' A' ' 112' ' ' VAL . 32.4 mm-40 -102.51 113.74 65.72 Favored Pre-proline 0 N--CA 1.439 -1.005 0 CA-C-N 115.327 -0.851 . . . . 71.219999999999999 110.39 -175.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -84.26 94.8 0.72 Allowed 'Trans proline' 0 N--CA 1.446 -1.283 0 C-N-CA 122.444 2.096 . . . . 70.310000000000002 109.182 173.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -121.28 146.22 47.05 Favored 'General case' 0 CA--C 1.502 -0.885 0 CA-C-N 116.397 -0.365 . . . . 72.329999999999998 111.191 -174.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -66.05 -42.22 89.79 Favored 'General case' 0 C--N 1.319 -0.719 0 O-C-N 124.145 0.903 . . . . 73.109999999999999 110.73 -177.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -149.64 138.89 21.34 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 108.363 -0.977 . . . . 32.32 108.363 175.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.468 ' HG2' HG21 ' A' ' 112' ' ' VAL . 6.0 tp60 -140.98 150.49 43.15 Favored 'General case' 0 C--N 1.292 -1.935 0 C-N-CA 122.821 0.448 . . . . 75.349999999999994 110.117 -179.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 64.1 t -79.82 134.03 28.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 105.508 -2.034 . . . . 70.120000000000005 105.508 173.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.479 ' SD ' ' HB2' ' A' ' 99' ' ' PHE . 64.7 mtt -61.0 126.33 26.97 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 109.61 -0.515 . . . . 63.450000000000003 109.61 -176.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -104.95 130.35 53.15 Favored 'General case' 0 N--CA 1.418 -2.061 0 CA-C-O 121.346 0.594 . . . . 55.229999999999997 110.098 -178.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 18.6 p -78.3 131.9 37.24 Favored 'General case' 0 N--CA 1.416 -2.167 0 CA-C-N 114.782 -1.099 . . . . 74.140000000000001 109.479 -177.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 85.0 22.88 51.4 Favored Glycine 0 N--CA 1.431 -1.671 0 N-CA-C 110.647 -0.981 . . . . 74.5 110.647 179.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -123.61 171.16 9.76 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 120.165 -0.614 . . . . 71.0 109.749 -178.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -118.84 121.42 39.99 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 123.412 0.685 . . . . 74.439999999999998 110.393 -170.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 64.1 mt -106.15 118.2 53.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 N-CA-C 109.614 -0.513 . . . . 74.420000000000002 109.614 -178.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -95.14 114.17 25.94 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 109.455 -0.572 . . . . 74.430000000000007 109.455 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 9.8 pt -99.9 97.58 6.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 CA-C-O 122.215 1.007 . . . . 73.400000000000006 109.101 178.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 73.15 -87.35 0.58 Allowed Glycine 0 N--CA 1.435 -1.42 0 CA-C-N 114.498 -1.228 . . . . 43.25 111.088 -177.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -120.1 -33.03 4.03 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 120.974 0.416 . . . . 73.120000000000005 110.513 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.446 ' HB3' ' O ' ' A' ' 53' ' ' ARG . 77.9 m-85 -95.5 161.21 14.16 Favored 'General case' 0 CA--C 1.496 -1.125 0 CA-C-N 116.293 -0.412 . . . . 62.109999999999999 110.95 -173.109 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 27.9 ptt180 -131.42 141.5 49.85 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 114.155 1.168 . . . . 52.450000000000003 114.155 -171.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.441 HD21 ' HB2' ' A' ' 49' ' ' LEU . 3.4 tt -117.69 140.03 50.22 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 112.935 -1.939 . . . . 71.540000000000006 107.48 -177.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 7.7 p -115.93 131.56 68.02 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 CA-C-O 121.046 0.451 . . . . 74.239999999999995 109.787 179.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . 0.518 ' CZ ' ' HB3' ' A' ' 47' ' ' ALA . 71.4 t80 -102.91 119.0 38.07 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.53 -0.759 . . . . 74.340000000000003 109.057 -175.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.47 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 2.5 mm? -114.68 147.1 40.11 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 120.966 0.412 . . . . 64.109999999999999 111.282 -175.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -81.94 118.23 22.79 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 107.827 -1.175 . . . . 74.530000000000001 107.827 175.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -93.57 -135.92 7.74 Favored Glycine 0 N--CA 1.427 -1.913 0 C-N-CA 120.64 -0.791 . . . . 50.240000000000002 111.874 -177.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo . . . . . 0 N--CA 1.441 -1.617 0 C-N-CA 122.492 2.128 . . . . 61.310000000000002 112.305 179.691 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.6 t30 . . . . . 0 N--CA 1.437 -1.098 0 N-CA-C 108.647 -0.872 . . . . 62.140000000000001 108.647 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -143.69 108.98 0.53 Allowed Glycine 0 N--CA 1.428 -1.85 0 N-CA-C 109.892 -1.283 . . . . 65.409999999999997 109.892 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.401 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 8.7 t -94.07 125.01 54.36 Favored Pre-proline 0 C--N 1.301 -1.537 0 CA-C-O 120.801 0.334 . . . . 75.219999999999999 110.969 -177.215 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 7' ' ' THR . 22.7 Cg_exo -66.22 144.73 76.01 Favored 'Trans proline' 0 C--O 1.244 0.809 0 C-N-CA 122.22 1.947 . . . . 44.240000000000002 109.59 174.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -89.81 138.68 27.79 Favored Pre-proline 0 C--N 1.29 -2.011 0 C-N-CA 121.361 -0.136 . . . . 74.420000000000002 110.638 -177.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -74.64 103.78 1.77 Allowed 'Trans proline' 0 N--CA 1.44 -1.668 0 C-N-CA 121.24 1.293 . . . . 75.019999999999996 109.163 172.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -92.94 119.65 32.45 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 115.373 -0.831 . . . . 55.219999999999999 111.513 -174.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.9 p -88.64 136.86 22.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 CA-C-N 115.812 -0.631 . . . . 63.420000000000002 109.449 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -77.53 134.92 38.18 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 108.542 -0.91 . . . . 61.210000000000001 108.542 178.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.8 m -134.1 71.55 1.46 Allowed 'General case' 0 C--N 1.294 -1.829 0 CA-C-O 121.396 0.617 . . . . 53.310000000000002 110.241 -178.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.8 t 167.43 137.11 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 126.596 1.958 . . . . 73.430000000000007 106.638 176.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 53.4 m -152.16 37.22 0.55 Allowed 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 108.069 -1.086 . . . . 75.200000000000003 108.069 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.8 t . . . . . 0 N--CA 1.438 -1.072 0 CA-C-N 114.554 -1.203 . . . . 72.120000000000005 108.424 178.75 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.413 -2.835 0 N-CA-C 109.333 -1.507 . . . . 63.509999999999998 109.333 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.8 m -100.17 164.49 11.94 Favored 'General case' 0 C--N 1.279 -2.494 0 N-CA-C 108.815 -0.809 . . . . 74.310000000000002 108.815 178.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -124.64 132.88 53.39 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.751 -0.463 . . . . 61.350000000000001 109.751 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.436 HD23 ' H ' ' A' ' 48' ' ' LEU . 2.1 pt? -115.81 140.79 48.88 Favored 'General case' 0 C--N 1.29 -2.008 0 C-N-CA 120.312 -0.555 . . . . 75.5 110.837 179.02 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.427 ' O ' HD12 ' A' ' 49' ' ' LEU . 3.1 pp -120.39 140.01 51.96 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 115.542 -0.753 . . . . 74.230000000000004 110.352 178.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.401 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 47.4 t -117.75 126.51 74.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 108.581 -0.896 . . . . 64.519999999999996 108.581 179.403 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 53.2 t -93.1 115.56 32.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 108.942 -0.762 . . . . 64.099999999999994 108.942 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.42 ' HB2' ' HG3' ' A' ' 134' ' ' ARG . 72.7 mmtt -82.56 -46.31 13.52 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.38 -0.97 . . . . 72.5 108.38 176.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -147.84 149.1 31.67 Favored 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 106.968 -1.494 . . . . 75.030000000000001 106.968 179.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 144.99 145.67 4.34 Favored Glycine 0 N--CA 1.425 -2.045 0 N-CA-C 110.527 -1.029 . . . . 54.409999999999997 110.527 -178.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.502 ' HB2' ' H ' ' A' ' 82' ' ' ASP . 13.8 Cg_exo -67.93 -9.18 24.81 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.419 2.746 . . . . 71.319999999999993 113.359 -177.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.502 ' HB2' ' HA ' ' A' ' 80' ' ' LEU . 5.6 t-20 -42.87 -60.3 1.65 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.098 0.959 . . . . 75.540000000000006 111.451 175.356 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 174.37 -64.19 0.01 OUTLIER 'General case' 0 CA--C 1.504 -0.827 0 C-N-CA 124.814 1.245 . . . . 74.409999999999997 107.991 -178.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 116.83 52.91 0.34 Allowed Glycine 0 N--CA 1.441 -0.969 0 N-CA-C 110.023 -1.231 . . . . 62.299999999999997 110.023 -176.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -139.9 -174.3 3.87 Favored 'General case' 0 N--CA 1.434 -1.275 0 N-CA-C 108.881 -0.785 . . . . 71.129999999999995 108.881 -176.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 34.9 ptt180 -122.05 134.65 54.78 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.486 -0.931 . . . . 55.25 108.486 177.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -127.13 139.5 52.93 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 109.85 -0.426 . . . . 72.439999999999998 109.85 -177.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 58.3 tp -101.98 112.05 24.54 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 108.22 -1.03 . . . . 65.430000000000007 108.22 178.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -94.68 116.75 29.12 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.324 0.583 . . . . 54.140000000000001 110.469 -176.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -121.81 8.24 9.96 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.448 -1.315 . . . . 75.530000000000001 107.448 176.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.4 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 2.9 pt20 -93.05 115.96 65.77 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 114.139 -1.391 . . . . 71.439999999999998 109.684 178.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 65' ' ' GLN . 7.1 Cg_endo -50.52 -43.56 44.32 Favored 'Trans proline' 0 C--N 1.361 1.215 0 C-N-CA 123.541 2.827 . . . . 73.450000000000003 113.917 -174.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 31.9 m -106.85 102.77 12.11 Favored 'General case' 0 N--CA 1.423 -1.812 0 N-CA-C 109.63 -0.508 . . . . 74.120000000000005 109.63 177.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.419 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 79.4 m -108.79 114.05 27.5 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 107.444 -1.317 . . . . 74.129999999999995 107.444 176.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 14.5 t -117.61 128.79 55.28 Favored 'General case' 0 C--N 1.296 -1.761 0 C-N-CA 119.221 -0.992 . . . . 71.219999999999999 110.693 -175.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.508 ' HA ' ' O ' ' A' ' 78' ' ' ILE . . . -115.08 106.44 14.12 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 115.504 -0.771 . . . . 44.009999999999998 109.576 -176.211 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.46 73.11 1.28 Allowed Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 109.314 -1.515 . . . . 75.129999999999995 109.314 -175.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.531 ' HA ' ' O ' ' A' ' 87' ' ' ARG . 1.1 tmm_? -145.07 85.55 1.75 Allowed 'General case' 0 N--CA 1.423 -1.805 0 N-CA-C 107.294 -1.372 . . . . 73.409999999999997 107.294 -178.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.568 ' CG ' ' HD2' ' A' ' 74' ' ' PRO . 1.3 t-80 68.3 170.71 0.1 Allowed Pre-proline 0 CA--C 1.575 1.935 0 O-C-N 124.545 1.153 . . . . 74.5 109.075 177.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.568 ' HD2' ' CG ' ' A' ' 73' ' ' HIS . 96.3 Cg_exo -48.38 -39.63 35.83 Favored 'Trans proline' 0 C--N 1.369 1.645 0 C-N-CA 121.981 1.787 . . . . 55.32 112.789 175.322 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.9 pm0 -92.07 58.27 3.3 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 122.202 1.001 . . . . 73.409999999999997 111.636 178.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 66.2 m -65.28 150.47 48.19 Favored 'General case' 0 C--O 1.244 0.783 0 CA-C-N 115.143 -0.935 . . . . 75.420000000000002 108.997 175.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -68.97 -45.2 71.29 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 107.434 -1.321 . . . . 71.150000000000006 107.434 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.508 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 46.1 pt -139.97 143.82 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 N-CA-C 108.135 -1.061 . . . . 74.140000000000001 108.135 171.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -102.47 130.8 49.38 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 119.251 -0.98 . . . . 63.310000000000002 108.403 172.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.502 ' HA ' ' HB2' ' A' ' 56' ' ' ASN . 30.8 tp -108.53 -26.15 10.57 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-O 122.552 1.168 . . . . 74.540000000000006 109.786 -174.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -138.23 134.09 34.0 Favored 'General case' 0 C--N 1.266 -3.022 0 N-CA-C 105.854 -1.906 . . . . 72.0 105.854 177.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.502 ' H ' ' HB2' ' A' ' 55' ' ' PRO . 33.1 t70 -117.79 -15.49 10.07 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 115.534 -0.757 . . . . 62.229999999999997 111.21 -177.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.4 m -91.3 -21.91 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.812 0 N-CA-C 108.087 -1.079 . . . . 73.120000000000005 108.087 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 22.4 m -138.34 83.51 1.97 Allowed 'General case' 0 N--CA 1.414 -2.24 0 CA-C-N 114.56 -1.2 . . . . 72.239999999999995 108.375 174.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.8 p -112.16 139.88 34.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 108.48 -0.933 . . . . 65.129999999999995 108.48 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 15.5 m -124.44 168.83 12.52 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 109.582 -0.525 . . . . 62.200000000000003 109.582 -177.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.531 ' O ' ' HA ' ' A' ' 72' ' ' ARG . 20.5 mtp180 -68.56 -31.59 70.91 Favored 'General case' 0 C--O 1.212 -0.897 0 CA-C-O 121.042 0.449 . . . . 71.510000000000005 110.074 175.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.412 ' HG2' HG21 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -143.82 101.7 3.79 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 106.277 -1.749 . . . . 73.120000000000005 106.277 170.781 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.515 ' O ' HG22 ' A' ' 104' ' ' VAL . 19.0 t60 -98.74 -71.7 0.68 Allowed 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 114.466 -1.243 . . . . 75.030000000000001 111.075 -174.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -144.75 160.69 40.83 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 107.738 -1.208 . . . . 73.400000000000006 107.738 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -146.19 139.46 25.89 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.907 -0.717 . . . . 74.420000000000002 110.262 -177.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.419 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 78.1 m-85 -115.61 123.0 47.32 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.898 -0.778 . . . . 73.510000000000005 108.898 -177.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 52.8 mtm-85 -107.8 123.65 48.89 Favored 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 107.831 -1.174 . . . . 72.349999999999994 107.831 176.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.3 pp -115.42 116.08 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.128 0 C-N-CA 118.684 -1.207 . . . . 72.120000000000005 108.38 177.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.546 ' ND2' ' HG2' ' A' ' 96' ' ' GLU . 4.9 t30 -120.09 147.05 45.34 Favored 'General case' 0 C--N 1.28 -2.424 0 CA-C-N 114.121 -1.399 . . . . 61.539999999999999 107.55 -179.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.546 ' HG2' ' ND2' ' A' ' 95' ' ' ASN . 8.8 pt-20 -29.12 -36.6 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 126.898 2.079 . . . . 72.239999999999995 115.908 -177.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -131.95 3.04 5.24 Favored Glycine 0 CA--C 1.504 -0.6 0 C-N-CA 119.387 -1.387 . . . . 45.340000000000003 113.28 -175.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -148.05 118.2 7.28 Favored 'General case' 0 N--CA 1.411 -2.399 0 CA-C-O 122.401 1.096 . . . . 72.510000000000005 111.098 -177.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.509 ' HD1' ' SD ' ' A' ' 122' ' ' MET . 71.0 m-85 -107.09 115.83 30.86 Favored 'General case' 0 C--N 1.275 -2.663 0 CA-C-N 114.423 -1.262 . . . . 73.549999999999997 107.62 -179.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -110.18 135.92 50.2 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 113.612 0.967 . . . . 53.119999999999997 113.612 -173.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.5 p -116.33 117.64 56.15 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.116 0 CA-C-N 114.377 -1.283 . . . . 75.140000000000001 107.709 173.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 39.7 t -120.86 125.36 73.96 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 CA-C-N 115.831 -0.622 . . . . 73.519999999999996 110.768 -177.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.459 ' HB2' ' HB ' ' A' ' 110' ' ' THR . 18.0 t0 -92.45 115.46 28.11 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 102.333 -3.21 . . . . 74.019999999999996 102.333 168.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 89' ' ' HIS . 19.2 m -59.67 -23.35 25.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 113.278 0.844 . . . . 73.439999999999998 113.278 -169.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -152.76 16.06 0.72 Allowed Glycine 0 C--N 1.305 -1.176 0 C-N-CA 117.8 -2.143 . . . . 74.420000000000002 113.796 178.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 50.3 m 57.17 36.6 27.7 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 122.824 1.297 . . . . 34.329999999999998 107.514 -175.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 49.5 tp -73.66 -47.43 39.93 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 112.828 -1.987 . . . . 74.340000000000003 112.761 -168.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -107.4 -11.52 15.51 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 119.2 -1.0 . . . . 70.420000000000002 109.791 179.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 97.5 65.12 0.89 Allowed Glycine 0 N--CA 1.433 -1.53 0 C-N-CA 120.413 -0.899 . . . . 61.32 113.247 173.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.459 ' HB ' ' HB2' ' A' ' 103' ' ' ASP . 18.9 m -85.24 119.66 25.87 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.683 -0.858 . . . . 64.200000000000003 108.683 174.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.45 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 2.1 m-85 -116.91 140.87 48.95 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.419 -0.956 . . . . 64.239999999999995 108.419 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.5 p -99.58 116.46 42.81 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 N-CA-C 108.197 -1.038 . . . . 65.129999999999995 108.197 176.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 71.17 -73.53 0.1 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.131 0.972 . . . . 74.329999999999998 109.476 -175.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 48.5 ttp180 -161.3 14.37 0.1 Allowed 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 107.538 -1.282 . . . . 72.0 107.538 172.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.446 ' HG3' ' HE ' ' A' ' 117' ' ' ARG . 15.3 tp10 -102.27 116.36 63.13 Favored Pre-proline 0 N--CA 1.429 -1.479 0 CA-C-N 115.513 -0.767 . . . . 72.109999999999999 108.94 -172.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -76.24 103.67 1.78 Allowed 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.85 2.367 . . . . 71.310000000000002 111.195 178.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.446 ' HE ' ' HG3' ' A' ' 115' ' ' GLU . 15.1 mmt180 -130.79 157.23 43.43 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 109.348 -0.612 . . . . 74.239999999999995 109.348 -179.153 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 50.8 m-20 -76.88 -42.57 39.37 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.487 -1.301 . . . . 63.439999999999998 107.487 178.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -147.87 146.04 28.92 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 114.561 -1.2 . . . . 73.209999999999994 108.886 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -138.58 138.17 37.67 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 108.545 -0.909 . . . . 74.25 108.545 178.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 39.0 t -94.82 95.46 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.527 0 C-N-CA 119.477 -0.889 . . . . 71.340000000000003 108.61 177.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.509 ' SD ' ' HD1' ' A' ' 99' ' ' PHE . 25.5 ptt? 44.56 139.02 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 119.087 2.995 . . . . 72.230000000000004 119.087 177.188 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -132.97 122.81 24.81 Favored 'General case' 0 N--CA 1.401 -2.92 1 N-CA-C 99.815 -4.143 . . . . 73.010000000000005 99.815 166.308 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 13.1 t -108.04 127.39 53.74 Favored 'General case' 0 C--N 1.288 -2.077 0 C-N-CA 118.606 -1.238 . . . . 54.229999999999997 112.034 -171.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 83.84 22.35 55.69 Favored Glycine 0 N--CA 1.424 -2.113 0 N-CA-C 109.993 -1.243 . . . . 64.0 109.993 -179.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -122.76 -175.88 3.26 Favored 'General case' 0 C--O 1.249 1.053 0 N-CA-C 108.36 -0.978 . . . . 72.510000000000005 108.36 -177.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.469 ' OE2' ' HD3' ' A' ' 134' ' ' ARG . 40.0 mt-10 -116.65 130.98 57.05 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 121.784 0.802 . . . . 72.150000000000006 111.492 -175.027 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 66.0 mt -100.47 126.43 54.07 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 N-CA-C 107.151 -1.426 . . . . 74.019999999999996 107.151 176.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.45 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 34.4 tt0 -93.43 112.65 24.61 Favored 'General case' 0 C--N 1.282 -2.334 0 N-CA-C 108.339 -0.986 . . . . 65.439999999999998 108.339 -178.281 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.52 HG13 ' HB2' ' A' ' 133' ' ' PHE . 19.2 pt -101.92 97.95 6.27 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.07 0 N-CA-C 108.747 -0.834 . . . . 72.420000000000002 108.747 179.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 70.13 -98.86 0.66 Allowed Glycine 0 N--CA 1.432 -1.575 0 N-CA-C 109.738 -1.345 . . . . 62.200000000000003 109.738 -176.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -122.71 5.08 9.48 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 120.707 0.289 . . . . 62.299999999999997 110.72 177.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.52 ' HB2' HG13 ' A' ' 130' ' ' ILE . 27.1 m-85 -104.72 171.38 7.35 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 108.784 -0.821 . . . . 72.340000000000003 108.784 -179.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.469 ' HD3' ' OE2' ' A' ' 127' ' ' GLU . 14.0 ptp180 -130.67 132.67 45.55 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.73 0.776 . . . . 70.420000000000002 112.057 -179.201 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.403 HD11 ' HB2' ' A' ' 49' ' ' LEU . 48.9 tp -117.48 143.46 46.02 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 114.167 -1.379 . . . . 74.540000000000006 107.411 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.401 ' HB ' ' HB ' ' A' ' 50' ' ' VAL . 34.2 t -106.72 129.95 59.41 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 N-CA-C 106.553 -1.647 . . . . 71.310000000000002 106.553 177.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . 0.401 ' CE2' ' HB2' ' A' ' 139' ' ' ALA . 70.8 t80 -121.64 119.89 33.17 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 120.964 0.411 . . . . 71.030000000000001 111.188 -174.09 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.4 mp -117.53 116.68 27.6 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 107.873 -1.158 . . . . 75.510000000000005 107.873 177.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.401 ' HB2' ' CE2' ' A' ' 137' ' ' PHE . . . -122.1 122.87 40.24 Favored 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 121.02 -0.272 . . . . 33.43 110.382 -175.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.483 ' N ' ' HD2' ' A' ' 141' ' ' PRO . . . 152.48 -52.72 0.48 Allowed Glycine 0 C--N 1.306 -1.095 0 C-N-CA 118.376 -1.868 . . . . 63.539999999999999 115.353 178.181 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.483 ' HD2' ' N ' ' A' ' 140' ' ' GLY . 5.2 Cg_endo . . . . . 0 C--N 1.374 1.904 0 C-N-CA 123.489 2.793 . . . . 65.540000000000006 114.672 -177.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.506 -0.732 0 N-CA-C 107.655 -1.239 . . . . 74.209999999999994 107.655 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -82.13 105.52 2.58 Favored Glycine 0 C--N 1.303 -1.292 0 N-CA-C 111.178 -0.769 . . . . 73.049999999999997 111.178 -177.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.5 t -83.18 135.32 44.66 Favored Pre-proline 0 C--N 1.302 -1.463 0 N-CA-C 109.035 -0.728 . . . . 64.439999999999998 109.035 -178.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -66.75 150.15 83.51 Favored 'Trans proline' 0 C--O 1.236 0.419 0 C-N-CA 122.574 2.182 . . . . 74.120000000000005 112.072 -178.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.412 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 0.7 OUTLIER -79.79 112.19 27.51 Favored Pre-proline 0 C--N 1.316 -0.885 0 N-CA-C 109.598 -0.519 . . . . 75.140000000000001 109.598 176.983 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 9' ' ' GLU . 16.5 Cg_exo -65.23 118.09 5.15 Favored 'Trans proline' 0 C--O 1.246 0.921 0 C-N-CA 122.465 2.11 . . . . 72.549999999999997 112.256 -175.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.476 ' HA ' ' OE1' ' A' ' 11' ' ' GLN . 5.0 tp60 -93.39 81.02 4.39 Favored 'General case' 0 N--CA 1.42 -1.95 0 CA-C-O 122.115 0.96 . . . . 74.239999999999995 109.814 177.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.4 t -104.53 120.05 54.33 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 N-CA-C 106.634 -1.617 . . . . 74.310000000000002 106.634 177.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.63 140.95 51.72 Favored 'General case' 0 N--CA 1.433 -1.317 0 CA-C-O 120.943 0.401 . . . . 74.420000000000002 111.044 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.7 m -113.2 88.28 2.8 Favored 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 109.217 -0.661 . . . . 65.409999999999997 109.217 -179.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 42.7 m -100.29 95.06 6.53 Favored 'General case' 0 N--CA 1.411 -2.406 0 N-CA-C 108.901 -0.777 . . . . 73.430000000000007 108.901 178.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.0 t -101.19 98.06 8.51 Favored 'General case' 0 N--CA 1.42 -1.946 0 N-CA-C 108.135 -1.061 . . . . 52.140000000000001 108.135 -178.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 23.5 t . . . . . 0 N--CA 1.429 -1.477 0 N-CA-C 109.162 -0.681 . . . . 51.039999999999999 109.162 -178.614 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.516 0 N-CA-C 112.186 -0.365 . . . . 74.430000000000007 112.186 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.446 ' HB2' ' O ' ' A' ' 141' ' ' PRO . 8.7 m -90.19 152.96 20.85 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 121.464 0.65 . . . . 64.239999999999995 109.5 -178.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -153.73 164.15 38.81 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.234 -1.025 . . . . 64.510000000000005 108.234 -177.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 62' ' ' LEU . 2.5 pt? -130.12 142.13 50.62 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.402 0.62 . . . . 73.400000000000006 111.471 -179.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.42 ' O ' HD12 ' A' ' 49' ' ' LEU . 4.2 pp -109.78 133.25 53.36 Favored 'General case' 0 N--CA 1.423 -1.825 0 N-CA-C 107.736 -1.209 . . . . 73.25 107.736 175.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 48.1 t -119.08 117.46 54.31 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 N-CA-C 109.69 -0.485 . . . . 65.109999999999999 109.69 -176.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 57.3 t -93.04 114.45 29.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 106.016 -1.846 . . . . 34.229999999999997 106.016 175.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -93.39 -33.11 13.99 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.389 -0.597 . . . . 74.150000000000006 109.389 -176.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.472 ' O ' ' HB3' ' A' ' 133' ' ' PHE . 60.5 mtt180 -138.53 123.19 18.63 Favored 'General case' 0 CA--C 1.487 -1.444 0 N-CA-C 108.559 -0.904 . . . . 74.319999999999993 108.559 177.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.4 ' HA2' ' CD1' ' A' ' 133' ' ' PHE . . . 146.98 116.33 0.94 Allowed Glycine 0 N--CA 1.415 -2.761 0 C-N-CA 120.911 -0.662 . . . . 71.329999999999998 112.525 179.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.4 ' HD2' ' HA2' ' A' ' 54' ' ' GLY . 11.9 Cg_endo -59.55 -9.22 8.54 Favored 'Trans proline' 0 C--N 1.37 1.689 0 C-N-CA 124.058 3.172 . . . . 71.5 112.269 176.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.428 ' HA ' ' N ' ' A' ' 81' ' ' ASP . 2.3 m-20 -45.99 -49.42 16.03 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 125.39 1.476 . . . . 74.140000000000001 108.901 172.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -149.37 -58.65 0.21 Allowed 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 115.407 -0.815 . . . . 63.210000000000001 109.54 -179.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.21 31.71 63.56 Favored Glycine 0 CA--C 1.507 -0.465 0 N-CA-C 110.099 -1.2 . . . . 73.310000000000002 110.099 -176.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -152.93 176.05 12.27 Favored 'General case' 0 N--CA 1.42 -1.952 0 N-CA-C 108.834 -0.802 . . . . 44.43 108.834 -175.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -109.17 153.44 23.76 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.888 -0.597 . . . . 74.430000000000007 109.557 177.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -143.64 134.24 24.96 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 108.141 -1.059 . . . . 73.549999999999997 108.141 -179.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 48' ' ' LEU . 0.8 OUTLIER -104.21 135.81 44.98 Favored 'General case' 0 N--CA 1.428 -1.539 0 CA-C-O 120.877 0.37 . . . . 73.430000000000007 110.571 178.146 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 81.6 mt -82.6 115.07 21.4 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.684 -0.689 . . . . 51.439999999999998 109.471 -178.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -126.63 9.18 7.05 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 107.582 -1.266 . . . . 73.150000000000006 107.582 176.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -131.19 147.51 66.54 Favored Pre-proline 0 C--N 1.295 -1.781 0 CA-C-N 113.571 -1.649 . . . . 64.019999999999996 107.621 -175.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -57.42 -53.52 4.6 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 122.759 2.306 . . . . 71.0 114.859 -175.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 85.0 m -131.67 109.78 10.44 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.224 0.535 . . . . 73.019999999999996 112.365 -177.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 41.4 m -98.55 118.07 34.42 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.309 -0.997 . . . . 72.540000000000006 108.309 175.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.501 ' OG1' ' HG2' ' A' ' 88' ' ' ARG . 12.5 t -102.59 147.79 26.35 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 119.308 -0.957 . . . . 74.239999999999995 110.697 179.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -108.1 132.67 53.34 Favored 'General case' 0 N--CA 1.424 -1.726 0 CA-C-N 115.437 -0.801 . . . . 63.229999999999997 109.509 179.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.543 ' O ' ' HA ' ' A' ' 79' ' ' PHE . . . -161.53 -146.05 4.51 Favored Glycine 0 N--CA 1.428 -1.852 0 N-CA-C 108.645 -1.782 . . . . 64.400000000000006 108.645 176.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 18.2 ttp85 -164.76 58.76 0.13 Allowed 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.166 -1.05 . . . . 74.450000000000003 108.166 173.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 70.1 m80 -139.38 165.24 33.11 Favored Pre-proline 0 C--N 1.279 -2.499 0 N-CA-C 106.738 -1.579 . . . . 64.040000000000006 106.738 179.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 99.5 Cg_exo -48.99 -33.43 26.16 Favored 'Trans proline' 0 C--N 1.358 1.055 0 C-N-CA 122.715 2.277 . . . . 65.010000000000005 112.556 177.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -106.71 74.39 1.0 Allowed 'General case' 0 N--CA 1.432 -1.347 0 CA-C-O 122.016 0.912 . . . . 61.039999999999999 109.855 176.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 37.7 m -146.1 123.42 11.6 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 113.957 -1.474 . . . . 34.039999999999999 108.159 174.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -65.21 -52.1 56.8 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-O 120.605 0.241 . . . . 75.349999999999994 110.83 -178.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 41.8 pt -123.61 178.78 3.15 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 109.627 -0.509 . . . . 65.140000000000001 109.627 175.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.543 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 97.2 m-85 -122.89 136.98 55.06 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 112.623 0.601 . . . . 75.010000000000005 112.623 -172.101 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -117.92 132.23 56.43 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.187 -1.412 . . . . 71.25 107.187 167.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.428 ' N ' ' HA ' ' A' ' 56' ' ' ASN . 38.1 t70 -127.98 70.21 1.34 Allowed 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 122.437 1.113 . . . . 52.439999999999998 109.439 -175.183 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -122.92 -163.56 1.11 Allowed 'General case' 0 C--N 1.284 -2.273 0 CA-C-N 113.668 -1.606 . . . . 72.310000000000002 108.542 176.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 44.7 t -65.27 -38.03 81.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 C-N-CA 123.389 0.676 . . . . 64.219999999999999 112.133 -176.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 26.2 m -121.95 93.5 4.01 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.868 0.842 . . . . 74.430000000000007 112.75 -175.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 6.0 p -111.63 128.89 67.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 CA-C-N 114.91 -1.041 . . . . 35.43 110.793 -178.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.423 ' HB2' ' HB2' ' A' ' 89' ' ' HIS . 8.9 m -112.64 -170.4 1.66 Allowed 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.232 -0.655 . . . . 65.310000000000002 109.232 178.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -78.98 -76.05 0.21 Allowed 'General case' 0 C--O 1.217 -0.609 0 N-CA-C 109.982 -0.377 . . . . 71.209999999999994 109.982 177.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.501 ' HG2' ' OG1' ' A' ' 69' ' ' THR . 1.5 tmm_? -101.48 82.58 2.32 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 105.386 -2.079 . . . . 52.229999999999997 105.386 174.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.423 ' HB2' ' HB2' ' A' ' 86' ' ' SER . 67.1 t60 -87.37 -70.76 0.6 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.219 -0.901 . . . . 75.420000000000002 112.49 -170.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -110.86 147.57 34.27 Favored 'General case' 0 CA--C 1.483 -1.631 0 N-CA-C 108.793 -0.818 . . . . 72.230000000000004 108.793 -177.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -128.3 127.81 43.44 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-O 121.201 0.524 . . . . 75.230000000000004 110.412 178.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.532 ' HD1' ' HE3' ' A' ' 122' ' ' MET . 83.7 m-85 -105.81 113.13 26.5 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 105.602 -1.999 . . . . 75.420000000000002 105.602 177.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 71.7 mtp180 -118.45 147.32 43.72 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 121.864 0.84 . . . . 71.400000000000006 112.961 -172.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.53 117.12 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.321 0 N-CA-C 103.428 -2.804 . . . . 73.319999999999993 103.428 170.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 32.1 t-20 -118.36 147.25 43.71 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 108.161 -1.052 . . . . 72.019999999999996 108.161 -173.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.63 -20.09 53.62 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 113.195 0.813 . . . . 64.140000000000001 113.195 -179.104 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -78.82 -49.86 6.27 Favored Glycine 0 N--CA 1.423 -2.18 0 N-CA-C 111.14 -0.784 . . . . 71.030000000000001 111.14 173.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.411 ' HG2' ' H ' ' A' ' 99' ' ' PHE . 28.6 tt0 -177.77 -172.94 0.37 Allowed 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 107.363 -1.347 . . . . 74.319999999999993 107.363 -177.253 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.445 ' CB ' ' HB3' ' A' ' 122' ' ' MET . 89.9 m-85 -89.84 138.68 31.28 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 118.919 0.781 . . . . 70.549999999999997 109.393 -178.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -131.9 135.19 46.46 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 116.274 -0.421 . . . . 74.299999999999997 110.431 -174.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.6 p -128.95 117.71 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 108.934 -0.765 . . . . 71.230000000000004 108.934 174.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 19.4 m -121.09 135.55 60.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 CA-C-N 115.307 -0.86 . . . . 74.0 112.051 -178.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -99.07 107.38 19.77 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 106.093 -1.817 . . . . 75.120000000000005 106.093 170.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.4 m -94.21 9.35 5.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-O 121.402 0.62 . . . . 72.049999999999997 111.224 -176.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -90.04 -42.41 5.32 Favored Glycine 0 N--CA 1.428 -1.844 0 N-CA-C 108.159 -1.976 . . . . 73.420000000000002 108.159 172.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 39.7 m 70.23 -37.82 0.39 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.739 2.016 . . . . 53.219999999999999 114.348 174.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -58.66 -42.51 88.6 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 123.111 0.564 . . . . 65.120000000000005 111.658 177.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -86.05 -52.09 5.92 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.894 -0.78 . . . . 72.329999999999998 108.894 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 77.31 103.28 0.17 Allowed Glycine 0 N--CA 1.434 -1.456 0 CA-C-N 115.33 -0.85 . . . . 70.400000000000006 114.545 177.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 89.3 m -76.21 120.01 20.91 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 106.414 -1.698 . . . . 61.200000000000003 106.414 169.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -114.3 171.98 7.29 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.883 0.849 . . . . 72.010000000000005 111.591 -171.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.44 ' HB ' ' HB2' ' A' ' 115' ' ' GLU . 21.9 t -98.53 142.74 14.19 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.122 0 N-CA-C 104.758 -2.312 . . . . 64.030000000000001 104.758 173.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -40.03 -36.84 0.52 Allowed 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 114.204 1.187 . . . . 71.239999999999995 114.204 -176.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -118.56 -13.0 9.7 Favored 'General case' 0 C--O 1.222 -0.387 0 N-CA-C 112.386 0.513 . . . . 74.340000000000003 112.386 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.44 ' HB2' ' HB ' ' A' ' 112' ' ' VAL . 64.0 mm-40 -114.43 107.42 51.28 Favored Pre-proline 0 C--N 1.315 -0.933 0 N-CA-C 111.892 0.33 . . . . 62.43 111.892 -178.045 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -83.65 101.35 0.92 Allowed 'Trans proline' 0 N--CA 1.44 -1.665 0 C-N-CA 122.4 2.067 . . . . 62.439999999999998 110.739 176.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.584 ' HD2' ' OE1' ' A' ' 120' ' ' GLN . 15.5 ptp180 -153.63 152.94 31.42 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.884 -1.154 . . . . 52.310000000000002 107.884 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -81.16 -26.96 35.64 Favored 'General case' 0 C--N 1.313 -1.022 0 N-CA-C 112.425 0.528 . . . . 61.039999999999999 112.425 -175.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -129.38 139.04 51.82 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 109.273 -0.64 . . . . 25.199999999999999 109.273 178.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.584 ' OE1' ' HD2' ' A' ' 117' ' ' ARG . 51.8 tp60 -140.45 149.48 42.62 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.491 -0.777 . . . . 64.400000000000006 109.925 -176.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.4 p -79.47 121.4 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 105.764 -1.939 . . . . 63.439999999999998 105.764 169.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.532 ' HE3' ' HD1' ' A' ' 92' ' ' PHE . 10.9 ttt -71.35 115.02 10.02 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 121.575 0.702 . . . . 75.129999999999995 109.159 -170.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 21.5 tp60 -104.76 135.13 46.71 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.254 -0.885 . . . . 74.420000000000002 108.776 -173.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.1 t -78.86 131.33 36.41 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-O 121.049 0.452 . . . . 52.119999999999997 110.256 178.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 89.14 24.76 30.84 Favored Glycine 0 N--CA 1.426 -2.012 0 N-CA-C 111.024 -0.83 . . . . 71.409999999999997 111.024 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -116.49 169.45 9.32 Favored 'General case' 0 C--O 1.251 1.139 0 N-CA-C 109.16 -0.682 . . . . 64.040000000000006 109.16 -178.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.424 ' CD ' ' HE ' ' A' ' 134' ' ' ARG . 13.7 tp10 -114.07 121.22 43.16 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.819 -1.178 . . . . 65.510000000000005 107.819 -174.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 65.2 mt -107.93 131.43 58.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 C-N-CA 123.93 0.892 . . . . 64.439999999999998 110.577 -175.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -101.13 111.87 24.2 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.803 -0.635 . . . . 61.43 109.296 -177.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 5.1 pt -103.1 98.14 6.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 CA-C-O 121.575 0.702 . . . . 62.25 109.808 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 71.88 -100.4 0.92 Allowed Glycine 0 N--CA 1.44 -1.088 0 N-CA-C 109.228 -1.549 . . . . 75.549999999999997 109.228 -174.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -124.41 5.7 8.36 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 108.953 -0.758 . . . . 74.219999999999999 108.953 175.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.472 ' HB3' ' O ' ' A' ' 53' ' ' ARG . 63.0 m-85 -103.19 173.54 6.26 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 115.408 -0.815 . . . . 71.349999999999994 110.563 -175.201 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.424 ' HE ' ' CD ' ' A' ' 127' ' ' GLU . 34.2 ttt180 -132.26 125.21 30.53 Favored 'General case' 0 C--O 1.255 1.365 0 C-N-CA 119.698 -0.801 . . . . 75.129999999999995 112.988 -165.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 5.9 tt -124.57 139.7 53.63 Favored 'General case' 0 C--O 1.21 -0.984 0 C-N-CA 124.792 1.237 . . . . 71.310000000000002 109.495 -178.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 8.6 t -109.95 136.39 46.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 107.088 -1.449 . . . . 75.25 107.088 176.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -115.06 126.8 55.12 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 120.195 -0.602 . . . . 71.549999999999997 110.983 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.0 mp -133.35 133.07 42.01 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.961 -0.385 . . . . 72.510000000000005 109.961 178.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -93.44 141.42 28.48 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 105.102 -2.184 . . . . 61.340000000000003 105.102 170.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 177.15 -52.44 0.1 Allowed Glycine 0 C--N 1.289 -2.057 0 C-N-CA 118.273 -1.917 . . . . 44.130000000000003 114.307 -174.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.446 ' O ' ' HB2' ' A' ' 46' ' ' SER . 33.2 Cg_exo . . . . . 0 C--N 1.368 1.565 0 CA-C-N 119.906 1.853 . . . . 71.319999999999993 112.194 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 45.3 t30 . . . . . 0 C--O 1.245 0.843 0 CA-C-O 120.644 0.259 . . . . 73.200000000000003 110.785 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.38 104.51 3.18 Favored Glycine 0 N--CA 1.437 -1.282 0 N-CA-C 111.145 -0.782 . . . . 44.109999999999999 111.145 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 50.3 m -101.63 124.44 40.68 Favored Pre-proline 0 C--N 1.301 -1.521 0 N-CA-C 109.838 -0.43 . . . . 75.510000000000005 109.838 -178.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -66.33 145.23 77.06 Favored 'Trans proline' 0 C--O 1.247 0.926 0 C-N-CA 121.837 1.691 . . . . 74.409999999999997 110.007 175.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -69.76 138.71 88.18 Favored Pre-proline 0 C--N 1.3 -1.548 0 CA-C-N 116.336 -0.393 . . . . 75.150000000000006 109.996 -175.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.32 134.3 60.61 Favored 'Trans proline' 0 C--O 1.252 1.185 0 C-N-CA 122.845 2.363 . . . . 74.219999999999999 113.098 -174.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 73.84 80.33 0.12 Allowed 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 125.903 1.681 . . . . 63.43 110.705 -176.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.5 p -103.38 136.57 35.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-N 114.754 -1.112 . . . . 64.310000000000002 109.189 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.28 131.54 36.04 Favored 'General case' 0 N--CA 1.42 -1.969 0 CA-C-O 120.941 0.401 . . . . 72.310000000000002 109.939 179.06 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.9 t -82.84 147.36 28.39 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 109.012 -0.736 . . . . 53.119999999999997 109.012 176.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.0 t -85.06 114.37 22.16 Favored 'General case' 0 N--CA 1.407 -2.577 0 CA-C-O 121.761 0.791 . . . . 61.329999999999998 109.311 178.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 37.4 m -138.68 85.45 2.08 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 115.131 -0.94 . . . . 63.219999999999999 108.754 175.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.1 p . . . . . 0 C--N 1.298 -1.635 0 N-CA-C 106.934 -1.506 . . . . 73.019999999999996 106.934 -176.402 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 109.401 -1.48 . . . . 63.200000000000003 109.401 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.9 m -132.75 151.49 51.98 Favored 'General case' 0 N--CA 1.421 -1.895 0 N-CA-C 104.926 -2.25 . . . . 51.310000000000002 104.926 175.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.412 ' HB3' ' CZ ' ' A' ' 137' ' ' PHE . . . -142.88 164.81 29.09 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 108.497 -0.927 . . . . 51.229999999999997 108.497 -178.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.514 HD12 ' HD3' ' A' ' 141' ' ' PRO . 0.0 OUTLIER -119.44 150.43 40.22 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 120.32 -0.552 . . . . 73.439999999999998 111.677 -174.544 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.476 ' O ' HD12 ' A' ' 49' ' ' LEU . 2.8 pp -109.77 138.95 45.4 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 115.312 -0.858 . . . . 73.430000000000007 109.325 176.108 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.42 HG12 ' HB3' ' A' ' 60' ' ' ARG . 29.8 m -112.66 131.79 63.21 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 N-CA-C 108.093 -1.077 . . . . 61.43 108.093 177.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 37.1 t -92.05 114.34 28.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 N-CA-C 104.442 -2.429 . . . . 65.200000000000003 104.442 175.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 50.5 tttp -84.72 -32.46 23.49 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 108.328 -0.99 . . . . 62.439999999999998 108.328 -173.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.492 ' HA ' ' NE ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -170.44 108.9 0.35 Allowed 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 107.721 -1.215 . . . . 72.129999999999995 107.721 174.213 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -168.86 117.75 0.74 Allowed Glycine 0 N--CA 1.424 -2.111 0 C-N-CA 120.465 -0.874 . . . . 64.430000000000007 111.099 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.417 ' HB2' ' HB2' ' A' ' 82' ' ' ASP . 85.9 Cg_exo -51.6 -12.77 1.16 Allowed 'Trans proline' 0 CA--C 1.555 1.532 0 C-N-CA 124.423 3.415 . . . . 75.239999999999995 116.127 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.484 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 31.3 p30 -71.67 -29.48 64.66 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 122.115 -0.365 . . . . 73.420000000000002 111.6 179.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -163.47 -148.88 0.13 Allowed 'General case' 0 C--O 1.24 0.576 0 N-CA-C 108.57 -0.9 . . . . 71.450000000000003 108.57 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 169.23 53.57 0.03 OUTLIER Glycine 0 CA--C 1.488 -1.608 0 N-CA-C 110.489 -1.044 . . . . 71.450000000000003 110.489 177.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -154.57 -170.24 3.47 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 108.303 -0.999 . . . . 52.439999999999998 108.303 -176.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.42 ' HB3' HG12 ' A' ' 50' ' ' VAL . 27.3 ptt180 -131.23 135.69 47.58 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 107.835 -1.172 . . . . 65.540000000000006 107.835 175.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -143.73 141.66 30.58 Favored 'General case' 0 C--N 1.291 -1.969 0 C-N-CA 120.518 -0.473 . . . . 74.120000000000005 111.226 178.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 28.3 tp -75.98 129.85 37.53 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 114.784 -1.098 . . . . 55.210000000000001 109.224 -178.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 81.9 mt -86.87 114.5 23.57 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 108.485 -0.932 . . . . 72.230000000000004 108.485 176.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -150.0 37.21 0.7 Allowed 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 103.761 -2.681 . . . . 73.409999999999997 103.761 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -133.98 128.64 19.74 Favored Pre-proline 0 C--N 1.297 -1.689 0 CA-C-N 113.486 -1.688 . . . . 73.340000000000003 107.768 -174.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -45.65 -55.41 3.58 Favored 'Trans proline' 0 C--N 1.362 1.237 0 C-N-CA 123.937 3.091 . . . . 75.340000000000003 113.562 -174.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.429 HG23 ' HG2' ' A' ' 93' ' ' ARG . 57.9 m -137.16 98.75 3.81 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 121.713 0.768 . . . . 71.239999999999995 112.963 179.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.444 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 90.1 m -80.57 112.83 18.29 Favored 'General case' 0 N--CA 1.417 -2.093 0 N-CA-C 106.42 -1.696 . . . . 75.120000000000005 106.42 174.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.441 ' HB ' ' HA ' ' A' ' 76' ' ' SER . 27.1 m -108.64 128.02 54.48 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 116.36 -0.382 . . . . 70.439999999999998 110.333 -175.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -105.0 120.02 40.45 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 108.873 -0.788 . . . . 72.239999999999995 108.873 177.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 158.39 -127.34 1.86 Allowed Glycine 0 N--CA 1.431 -1.664 0 N-CA-C 110.649 -0.98 . . . . 42.340000000000003 110.649 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.508 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 41.1 ttm180 -154.23 84.27 1.13 Allowed 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 121.436 0.636 . . . . 74.239999999999995 110.18 179.187 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 11.2 m170 -137.3 167.18 21.87 Favored Pre-proline 0 C--N 1.288 -2.088 0 N-CA-C 107.616 -1.253 . . . . 72.349999999999994 107.616 175.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -60.07 -21.56 65.98 Favored 'Trans proline' 0 C--N 1.358 1.069 0 C-N-CA 122.308 2.005 . . . . 74.239999999999995 111.024 174.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -112.53 78.72 1.15 Allowed 'General case' 0 N--CA 1.424 -1.758 0 N-CA-C 107.963 -1.125 . . . . 72.519999999999996 107.963 177.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.441 ' HA ' ' HB ' ' A' ' 69' ' ' THR . 55.4 m -139.35 151.53 46.44 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 115.108 -0.951 . . . . 63.030000000000001 110.525 177.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -104.36 -46.85 4.28 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 109.018 -0.734 . . . . 73.230000000000004 109.018 -178.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 33.8 pt -133.31 156.01 41.36 Favored 'Isoleucine or valine' 0 C--O 1.245 0.865 0 CA-C-N 115.58 -0.736 . . . . 70.230000000000004 109.685 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -120.29 135.45 55.0 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.583 -0.895 . . . . 74.450000000000003 108.583 178.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.484 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 4.5 mp -75.42 106.01 6.74 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 122.849 0.46 . . . . 61.200000000000003 110.94 -178.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -86.26 63.51 8.05 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 122.718 1.246 . . . . 61.210000000000001 109.913 177.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.417 ' HB2' ' HB2' ' A' ' 55' ' ' PRO . 21.6 t70 -143.66 167.58 21.93 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 113.726 -1.579 . . . . 65.319999999999993 107.301 178.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.1 m -66.4 -33.87 66.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 117.801 0.273 . . . . 71.219999999999999 111.375 178.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 11.7 p -90.63 72.22 6.79 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-O 121.603 0.716 . . . . 75.530000000000001 112.425 179.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 6.9 p -113.58 113.41 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 CA-C-N 114.872 -1.058 . . . . 54.130000000000003 111.257 177.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 7.0 m -92.83 148.23 22.2 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 105.281 -2.118 . . . . 61.520000000000003 105.281 171.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.508 ' HB2' ' O ' ' A' ' 72' ' ' ARG . 9.1 ptm180 -73.47 -21.92 60.31 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 118.421 -1.312 . . . . 74.049999999999997 110.481 -179.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 26.8 ptt180 -122.24 97.77 5.63 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 106.526 -1.657 . . . . 72.310000000000002 106.526 165.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 8.6 t60 -109.66 -52.29 2.79 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.923 -0.711 . . . . 74.450000000000003 110.941 -173.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -144.96 131.94 20.28 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 120.188 -0.605 . . . . 71.219999999999999 110.104 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -114.91 126.81 55.22 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 108.794 -0.817 . . . . 74.019999999999996 108.794 177.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.444 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 79.8 m-85 -113.61 113.45 25.08 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 107.72 -1.215 . . . . 74.310000000000002 107.72 -179.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.429 ' HG2' HG23 ' A' ' 67' ' ' THR . 51.5 mtm180 -115.25 152.64 32.33 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-O 121.116 0.484 . . . . 74.420000000000002 110.977 -175.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.492 ' O ' HD12 ' A' ' 94' ' ' ILE . 2.9 pp -113.83 117.07 54.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 CA-C-O 122.414 1.102 . . . . 73.439999999999998 108.459 175.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 38.1 t-20 -103.05 147.65 26.7 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 106.893 -1.521 . . . . 74.099999999999994 106.893 -173.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -49.81 -32.94 15.2 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 112.505 0.557 . . . . 71.319999999999993 112.505 -177.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -94.19 -40.72 4.47 Favored Glycine 0 N--CA 1.422 -2.296 0 C-N-CA 120.265 -0.969 . . . . 72.349999999999994 113.371 -179.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -149.32 178.47 8.74 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 121.872 0.844 . . . . 73.120000000000005 112.574 -173.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -93.35 127.18 38.85 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 107.455 -1.313 . . . . 74.510000000000005 107.455 177.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -123.03 130.78 53.23 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 120.858 0.361 . . . . 73.420000000000002 111.973 -171.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 9.0 p -121.54 131.05 73.97 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 109.139 -0.689 . . . . 75.049999999999997 109.139 175.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.7 m -117.76 128.02 75.0 Favored 'Isoleucine or valine' 0 C--O 1.259 1.578 0 CA-C-O 121.569 0.699 . . . . 71.430000000000007 111.02 178.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -83.79 114.5 21.66 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.679 -1.146 . . . . 54.25 110.065 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 23.4 m -122.35 3.18 5.99 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 CA-C-O 121.923 0.868 . . . . 75.019999999999996 108.903 173.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -109.17 53.26 0.6 Allowed Glycine 0 N--CA 1.427 -1.955 0 CA-C-N 114.596 -1.184 . . . . 75.219999999999999 110.36 -178.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.2 p -64.85 -2.85 2.83 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.455 1.102 . . . . 53.420000000000002 112.107 -178.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.412 ' H ' HD22 ' A' ' 107' ' ' LEU . 2.9 mm? -62.83 -35.64 80.59 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 108.454 -0.943 . . . . 64.25 108.454 174.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -114.49 -45.93 2.99 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.237 -1.023 . . . . 64.310000000000002 108.237 177.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 94.37 120.97 3.35 Favored Glycine 0 N--CA 1.435 -1.419 0 CA-C-N 115.012 -0.994 . . . . 63.299999999999997 111.398 -178.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.4 m -79.56 119.53 22.66 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.999 -0.741 . . . . 72.239999999999995 108.999 176.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -103.4 134.42 46.8 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.967 -0.753 . . . . 74.099999999999994 108.967 178.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.468 HG11 ' HG2' ' A' ' 120' ' ' GLN . 61.9 t -115.91 117.93 57.15 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.359 0 N-CA-C 105.923 -1.88 . . . . 71.040000000000006 105.923 175.053 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 59.46 31.67 21.2 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-O 122.286 1.041 . . . . 55.310000000000002 108.392 -175.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 44.4 mtp180 74.39 5.03 4.56 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.127 1.371 . . . . 74.349999999999994 114.304 -178.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -103.05 134.95 19.5 Favored Pre-proline 0 C--N 1.309 -1.167 0 O-C-N 121.705 -0.622 . . . . 73.450000000000003 109.671 177.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -69.72 119.28 6.26 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.086 1.857 . . . . 74.230000000000004 110.096 177.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -123.35 129.98 52.07 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.715 -0.846 . . . . 70.010000000000005 108.715 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -69.64 -42.11 74.73 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 121.363 0.602 . . . . 43.109999999999999 109.904 178.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -144.61 138.39 27.38 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 105.814 -1.921 . . . . 75.530000000000001 105.814 173.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.468 ' HG2' HG11 ' A' ' 112' ' ' VAL . 57.8 tp60 -141.44 148.9 40.28 Favored 'General case' 0 C--N 1.282 -2.369 0 CA-C-O 120.732 0.301 . . . . 74.239999999999995 110.405 -177.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 89.1 t -80.46 120.88 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.669 0 N-CA-C 104.997 -2.223 . . . . 63.43 104.997 169.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 76.8 mtm -60.37 138.64 57.94 Favored 'General case' 0 CA--C 1.499 -0.985 0 CA-C-O 121.249 0.547 . . . . 74.230000000000004 111.339 -176.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 8.4 tp60 -103.79 123.48 47.15 Favored 'General case' 0 N--CA 1.417 -2.1 0 CA-C-N 115.146 -0.934 . . . . 72.329999999999998 108.483 -168.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 21.4 p -83.23 117.67 23.1 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.848 -0.615 . . . . 72.530000000000001 109.953 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 95.68 13.52 50.34 Favored Glycine 0 N--CA 1.436 -1.359 0 N-CA-C 111.631 -0.588 . . . . 71.219999999999999 111.631 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -132.5 -175.42 3.75 Favored 'General case' 0 C--O 1.248 0.976 0 N-CA-C 109.186 -0.672 . . . . 73.329999999999998 109.186 -177.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -112.03 149.05 32.59 Favored 'General case' 0 C--O 1.251 1.15 0 N-CA-C 114.997 1.48 . . . . 65.150000000000006 114.997 -171.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.409 ' HB ' ' HB3' ' A' ' 135' ' ' LEU . 37.3 mm -121.79 117.69 53.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 105.983 -1.858 . . . . 62.350000000000001 105.983 174.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -120.35 116.78 26.19 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 107.357 -1.349 . . . . 63.350000000000001 107.357 -177.238 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.0 tt -128.79 108.92 18.02 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.226 0 CA-C-O 121.417 0.627 . . . . 74.030000000000001 110.589 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 70.67 -103.98 1.3 Allowed Glycine 0 C--N 1.314 -0.669 0 N-CA-C 110.439 -1.064 . . . . 51.149999999999999 110.439 -177.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -120.09 6.56 10.79 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.056 -0.72 . . . . 72.420000000000002 109.056 173.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.472 ' CE2' HD23 ' A' ' 80' ' ' LEU . 56.3 m-85 -91.43 106.56 18.58 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 108.965 -0.754 . . . . 74.420000000000002 108.965 -177.081 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 14.5 ptt180 -96.41 120.95 37.65 Favored 'General case' 0 N--CA 1.432 -1.375 0 CA-C-O 122.168 0.985 . . . . 71.450000000000003 110.203 177.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.417 HD12 ' O ' ' A' ' 50' ' ' VAL . 25.3 tp -124.51 142.98 50.92 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 113.643 -1.617 . . . . 73.450000000000003 108.378 -174.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 29.8 t -124.5 134.89 65.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 107.499 -1.297 . . . . 71.099999999999994 107.499 176.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . 0.412 ' CZ ' ' HB3' ' A' ' 47' ' ' ALA . 64.1 t80 -108.32 120.34 42.09 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.057 -0.72 . . . . 74.239999999999995 109.057 -176.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -121.85 144.04 49.06 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.6 0.714 . . . . 70.430000000000007 112.337 -175.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -91.82 80.27 5.27 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 106.533 -1.654 . . . . 62.229999999999997 106.533 172.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -77.61 -71.69 1.19 Allowed Glycine 0 C--N 1.301 -1.414 0 CA-C-N 114.791 -1.095 . . . . 70.400000000000006 113.778 -174.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.514 ' HD3' HD12 ' A' ' 48' ' ' LEU . 19.7 Cg_exo . . . . . 0 N--CA 1.445 -1.326 0 C-N-CA 122.139 1.892 . . . . 72.430000000000007 113.023 -177.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 48.3 t30 . . . . . 0 C--O 1.244 0.8 0 N-CA-C 107.143 -1.429 . . . . 60.539999999999999 107.143 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -136.82 -133.28 3.16 Favored Glycine 0 N--CA 1.425 -2.064 0 C-N-CA 120.233 -0.984 . . . . 32.119999999999997 112.997 -176.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.8 t -85.09 143.22 39.36 Favored Pre-proline 0 C--N 1.302 -1.474 0 C-N-CA 122.599 0.36 . . . . 50.450000000000003 111.223 -176.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -66.73 150.34 83.51 Favored 'Trans proline' 0 C--O 1.249 1.037 0 C-N-CA 122.601 2.201 . . . . 72.430000000000007 110.385 171.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.9 mp0 -76.94 128.34 81.62 Favored Pre-proline 0 C--O 1.245 0.861 0 N-CA-C 109.612 -0.514 . . . . 74.299999999999997 109.612 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -63.05 150.43 88.66 Favored 'Trans proline' 0 C--O 1.25 1.079 0 C-N-CA 122.817 2.344 . . . . 63.32 111.191 175.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -92.77 173.89 7.53 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-O 121.028 0.442 . . . . 64.109999999999999 110.698 -175.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.5 m -121.18 169.57 12.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-N 115.698 -0.683 . . . . 63.509999999999998 110.779 -178.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -78.49 140.94 38.55 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 109.594 -0.521 . . . . 65.329999999999998 109.594 178.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.1 t -111.47 148.52 32.96 Favored 'General case' 0 N--CA 1.422 -1.833 0 CA-C-O 121.079 0.466 . . . . 51.25 110.311 -178.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.6 p -100.51 8.79 43.29 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 112.282 0.475 . . . . 72.030000000000001 112.282 178.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.4 p -78.94 32.54 0.21 Allowed 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.421 0.689 . . . . 73.150000000000006 112.621 -177.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.9 m . . . . . 0 N--CA 1.431 -1.42 0 N-CA-C 108.45 -0.945 . . . . 75.400000000000006 108.45 178.74 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.693 0 N-CA-C 109.178 -1.569 . . . . 62.509999999999998 109.178 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.5 m -90.67 165.89 13.46 Favored 'General case' 0 N--CA 1.425 -1.692 0 CA-C-N 114.548 -0.826 . . . . 74.329999999999998 111.192 -174.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -90.86 163.42 14.41 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 108.104 -1.073 . . . . 63.350000000000001 108.104 175.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.45 ' HB3' ' HG ' ' A' ' 62' ' ' LEU . 2.5 pt? -133.93 159.96 39.14 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.453 0.644 . . . . 63.299999999999997 110.733 -177.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.417 ' HB2' HD21 ' A' ' 135' ' ' LEU . 1.1 pt? -122.97 132.84 54.33 Favored 'General case' 0 C--N 1.278 -2.528 0 CA-C-N 115.018 -0.992 . . . . 75.209999999999994 108.806 176.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.4 m -110.01 116.35 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.019 0 N-CA-C 107.14 -1.43 . . . . 74.329999999999998 107.14 175.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.1 t -93.03 115.62 32.25 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.467 0 N-CA-C 107.88 -1.156 . . . . 75.540000000000006 107.88 -176.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -72.66 -38.6 67.59 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.584 -1.265 . . . . 73.299999999999997 107.584 -177.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 50.9 ttt180 -176.18 111.22 0.1 Allowed 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 106.359 -1.719 . . . . 72.329999999999998 106.359 174.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.49 ' HA2' ' HB3' ' A' ' 133' ' ' PHE . . . -122.84 166.17 15.33 Favored Glycine 0 N--CA 1.418 -2.53 0 N-CA-C 111.412 -0.675 . . . . 61.240000000000002 111.412 -177.307 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -69.09 -23.73 33.55 Favored 'Trans proline' 0 C--N 1.322 -0.847 0 C-N-CA 122.954 2.436 . . . . 64.319999999999993 111.481 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -98.87 -52.03 3.7 Favored 'General case' 0 N--CA 1.426 -1.63 0 CA-C-N 114.595 -1.184 . . . . 73.120000000000005 111.322 -177.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -144.25 -173.08 3.92 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-O 120.808 0.337 . . . . 72.540000000000006 110.496 -173.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.38 46.02 0.41 Allowed Glycine 0 N--CA 1.435 -1.399 0 N-CA-C 109.114 -1.594 . . . . 32.450000000000003 109.114 178.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -133.67 -169.87 2.38 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.888 -0.782 . . . . 74.329999999999998 108.888 -175.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -125.84 135.26 51.76 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 110.462 -0.199 . . . . 65.430000000000007 110.462 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -156.26 149.3 24.2 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 112.947 0.721 . . . . 72.140000000000001 112.947 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.45 ' HG ' ' HB3' ' A' ' 48' ' ' LEU . 6.8 mp -93.06 141.98 27.8 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 124.581 1.152 . . . . 72.349999999999994 109.73 177.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -74.49 115.3 13.86 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.592 -0.443 . . . . 73.549999999999997 110.065 176.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -113.13 8.97 18.46 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 108.606 -0.887 . . . . 71.409999999999997 108.606 -179.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -136.69 134.4 19.45 Favored Pre-proline 0 C--N 1.3 -1.571 0 N-CA-C 112.258 0.466 . . . . 71.209999999999994 112.258 -167.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.444 ' HA ' ' CG2' ' A' ' 94' ' ' ILE . 9.7 Cg_endo -52.43 -62.49 0.35 Allowed 'Trans proline' 0 C--N 1.371 1.721 0 C-N-CA 124.538 3.492 . . . . 75.230000000000004 113.853 -177.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 94.7 m -116.49 110.64 18.87 Favored 'General case' 0 N--CA 1.422 -1.831 0 N-CA-C 109.354 -0.61 . . . . 75.409999999999997 109.354 178.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.452 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 91.2 m -109.56 113.63 26.58 Favored 'General case' 0 C--N 1.283 -2.314 0 N-CA-C 109.045 -0.724 . . . . 65.439999999999998 109.045 177.107 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.8 t -95.75 132.83 40.56 Favored 'General case' 0 C--O 1.256 1.424 0 N-CA-C 109.381 -0.6 . . . . 73.209999999999994 109.381 -178.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -127.88 124.92 38.65 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 115.739 -0.664 . . . . 51.119999999999997 110.282 -177.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.79 33.46 15.7 Favored Glycine 0 C--N 1.3 -1.445 0 C-N-CA 119.092 -1.527 . . . . 75.140000000000001 111.913 177.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.645 ' HA ' ' O ' ' A' ' 87' ' ' ARG . 2.1 tmt_? -123.73 87.66 2.78 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 105.993 -1.854 . . . . 74.519999999999996 105.993 176.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 20.3 m170 66.05 171.2 0.1 OUTLIER Pre-proline 0 CA--C 1.552 1.033 0 O-C-N 124.106 0.879 . . . . 72.219999999999999 109.795 -175.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -65.47 -20.18 60.91 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 121.686 1.591 . . . . 71.310000000000002 109.33 170.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -75.78 7.77 3.6 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 126.027 1.731 . . . . 74.239999999999995 112.381 -177.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 10.1 p -84.73 175.23 9.31 Favored 'General case' 0 C--N 1.322 -0.607 0 O-C-N 121.973 -0.454 . . . . 50.399999999999999 110.526 177.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -62.85 -56.74 14.71 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 108.791 -0.818 . . . . 73.230000000000004 108.791 -178.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.482 HD13 ' H ' ' A' ' 78' ' ' ILE . 0.2 OUTLIER -125.65 123.55 64.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 106.3 -1.741 . . . . 74.349999999999994 106.3 172.457 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -99.38 121.57 41.3 Favored 'General case' 0 C--N 1.29 -2.015 0 C-N-CA 119.829 -0.748 . . . . 72.540000000000006 112.872 -171.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.6 mp -69.09 128.95 38.46 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 107.418 -1.327 . . . . 75.439999999999998 107.418 170.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -116.06 24.04 11.74 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-O 122.46 1.124 . . . . 64.430000000000007 110.093 -175.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -103.84 -164.85 1.1 Allowed 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.745 -0.782 . . . . 74.019999999999996 109.889 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.7 p -92.19 -6.74 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.319 0 CA-C-O 121.339 0.59 . . . . 74.430000000000007 111.779 -174.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 7.4 m -87.45 12.87 11.15 Favored 'General case' 0 CA--C 1.555 1.139 0 CA-C-O 121.666 0.746 . . . . 72.329999999999998 110.543 -177.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 87.7 t -81.59 104.77 10.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-O 121.993 0.901 . . . . 73.150000000000006 110.83 -177.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 16.8 m -86.64 42.52 1.01 Allowed 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 124.388 1.075 . . . . 61.43 112.096 -176.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.645 ' O ' ' HA ' ' A' ' 72' ' ' ARG . 82.7 mtm180 72.65 -48.22 0.68 Allowed 'General case' 0 N--CA 1.513 2.724 0 C-N-CA 124.496 1.118 . . . . 54.420000000000002 110.39 -175.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -139.73 120.3 14.16 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 103.113 -2.921 . . . . 75.150000000000006 103.113 171.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 54.8 t60 -110.19 -71.45 0.76 Allowed 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 117.664 -1.614 . . . . 44.140000000000001 113.76 -174.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -117.85 143.24 46.47 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.974 -0.691 . . . . 74.109999999999999 111.911 -173.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.4 mm-40 -121.65 127.53 50.91 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.087 -1.079 . . . . 72.120000000000005 108.087 177.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.452 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 91.6 m-85 -103.67 113.47 27.01 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 106.628 -1.619 . . . . 71.430000000000007 106.628 175.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 89.5 mtt-85 -120.52 146.12 46.61 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 121.185 0.517 . . . . 73.519999999999996 110.795 -174.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.444 ' CG2' ' HA ' ' A' ' 66' ' ' PRO . 5.6 tt -115.87 130.93 69.72 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 N-CA-C 108.737 -0.838 . . . . 70.340000000000003 108.737 175.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.406 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 14.8 t-20 -118.68 146.31 44.8 Favored 'General case' 0 C--N 1.282 -2.335 0 N-CA-C 106.166 -1.79 . . . . 61.409999999999997 106.166 178.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.97 -10.29 20.6 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 112.886 0.699 . . . . 72.209999999999994 112.886 -176.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -103.81 -41.85 2.07 Favored Glycine 0 N--CA 1.436 -1.361 0 CA-C-N 116.424 -0.353 . . . . 74.439999999999998 112.661 175.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.406 ' O ' ' HB3' ' A' ' 95' ' ' ASN . 67.7 mm-40 -141.44 162.9 34.36 Favored 'General case' 0 C--O 1.216 -0.684 0 CA-C-O 121.277 0.56 . . . . 73.129999999999995 111.724 -176.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -108.2 121.19 44.36 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 106.674 -1.602 . . . . 74.109999999999999 106.674 173.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -125.52 135.55 52.39 Favored 'General case' 0 CA--C 1.49 -1.328 0 CA-C-O 122.087 0.946 . . . . 73.120000000000005 113.162 -176.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 6.0 p -108.28 119.38 57.76 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.333 0 CA-C-N 114.12 -1.4 . . . . 71.540000000000006 108.269 176.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.417 HG12 ' HB1' ' A' ' 119' ' ' ALA . 29.5 m -119.0 131.72 70.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 C-N-CA 120.595 -0.442 . . . . 62.310000000000002 109.852 -177.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -105.16 116.41 31.91 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.025 -1.472 . . . . 74.120000000000005 107.025 176.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.3 m -89.9 0.93 7.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-O 120.911 0.386 . . . . 71.010000000000005 111.025 -174.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -126.46 36.06 2.77 Favored Glycine 0 N--CA 1.429 -1.783 0 N-CA-C 108.673 -1.771 . . . . 54.340000000000003 108.673 175.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.7 p -68.8 7.35 0.68 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 113.826 1.047 . . . . 62.119999999999997 113.826 -175.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 78.3 mt -70.8 -21.51 62.47 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 108.885 -0.783 . . . . 61.149999999999999 108.885 176.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -77.23 -7.42 55.89 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.723 -0.671 . . . . 65.120000000000005 110.039 177.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 88.84 78.14 1.3 Allowed Glycine 0 N--CA 1.439 -1.126 0 N-CA-C 111.795 -0.522 . . . . 72.340000000000003 111.795 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.49 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 11.1 m -81.7 123.95 29.18 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 109.005 -0.739 . . . . 63.210000000000001 109.005 178.276 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -115.38 134.77 54.79 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 120.033 -0.667 . . . . 63.229999999999997 110.891 -176.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 29.1 m -112.68 110.37 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.135 0 N-CA-C 106.876 -1.527 . . . . 23.23 106.876 169.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 62.5 t30 58.18 36.66 25.97 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 125.355 1.462 . . . . 74.099999999999994 109.708 -177.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 52.8 mtp180 81.74 -0.62 1.57 Allowed 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 126.753 2.021 . . . . 74.329999999999998 113.545 -178.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -92.42 115.79 65.36 Favored Pre-proline 0 C--N 1.313 -1.004 0 N-CA-C 109.372 -0.603 . . . . 72.219999999999999 109.372 178.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.49 ' HA ' ' O ' ' A' ' 110' ' ' THR . 36.4 Cg_endo -66.34 121.5 8.8 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.905 2.403 . . . . 74.310000000000002 112.182 -179.024 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 8.8 mmm180 -136.1 163.73 29.66 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 120.833 0.349 . . . . 70.430000000000007 110.144 -177.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -98.94 -45.9 5.81 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.114 -1.069 . . . . 63.539999999999999 108.114 176.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.417 ' HB1' HG12 ' A' ' 102' ' ' VAL . . . -139.86 142.26 36.58 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 107.263 -1.384 . . . . 63.439999999999998 107.263 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -134.68 141.06 46.44 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-O 121.316 0.579 . . . . 72.129999999999995 111.126 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.3 p -90.73 134.81 28.35 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 106.337 -1.727 . . . . 61.43 106.337 177.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 20.9 ptt? -41.01 123.84 2.06 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 122.143 0.973 . . . . 53.140000000000001 112.847 -177.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -127.01 124.71 40.03 Favored 'General case' 0 N--CA 1.413 -2.325 0 N-CA-C 106.17 -1.789 . . . . 73.109999999999999 106.17 177.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 31.1 p -78.48 124.45 28.15 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 116.138 -0.483 . . . . 75.200000000000003 111.821 -172.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 92.67 1.38 68.32 Favored Glycine 0 N--CA 1.44 -1.089 0 CA-C-N 115.207 -0.906 . . . . 42.25 110.894 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -90.41 151.54 21.38 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 108.312 -0.995 . . . . 73.129999999999995 108.312 -177.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.422 ' HG2' HG22 ' A' ' 136' ' ' VAL . 39.8 mt-10 -113.31 129.3 56.57 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 112.264 0.468 . . . . 75.430000000000007 112.264 -175.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 61.9 mt -95.27 115.78 35.09 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.164 0 N-CA-C 105.9 -1.889 . . . . 75.329999999999998 105.9 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.413 ' HA ' ' O ' ' A' ' 133' ' ' PHE . 76.5 mt-30 -118.26 119.37 34.46 Favored 'General case' 0 N--CA 1.418 -2.059 0 CA-C-N 115.124 -0.944 . . . . 62.450000000000003 110.12 -172.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 7.5 pt -123.32 125.53 71.93 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 CA-C-N 114.962 -1.017 . . . . 75.530000000000001 109.222 179.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 68.5 -102.11 0.84 Allowed Glycine 0 N--CA 1.434 -1.499 0 N-CA-C 108.746 -1.741 . . . . 72.420000000000002 108.746 -171.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -137.32 18.76 2.94 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.947 -0.761 . . . . 61.119999999999997 108.947 174.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.49 ' HB3' ' HA2' ' A' ' 54' ' ' GLY . 81.6 m-85 -93.03 150.13 20.74 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.679 -0.692 . . . . 75.040000000000006 110.225 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 75.6 mtt180 -123.81 122.9 39.25 Favored 'General case' 0 C--O 1.252 1.206 0 CA-C-O 121.498 0.666 . . . . 64.439999999999998 111.47 -172.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.417 HD21 ' HB2' ' A' ' 49' ' ' LEU . 5.5 tt -123.67 129.99 51.96 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 106.682 -1.599 . . . . 73.5 106.682 177.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.422 HG22 ' HG2' ' A' ' 127' ' ' GLU . 12.2 t -108.14 128.73 63.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 N-CA-C 108.297 -1.001 . . . . 64.349999999999994 108.297 -178.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -105.92 129.38 54.08 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 120.71 -0.396 . . . . 73.519999999999996 110.408 -176.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -132.65 169.22 16.97 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.872 0.368 . . . . 74.230000000000004 110.263 -177.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -91.72 139.0 31.1 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 107.728 -1.212 . . . . 65.239999999999995 107.728 174.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -102.95 171.17 20.54 Favored Glycine 0 N--CA 1.439 -1.162 0 C-N-CA 120.119 -1.038 . . . . 71.530000000000001 113.005 -175.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo . . . . . 0 N--CA 1.451 -0.994 0 C-N-CA 122.583 2.189 . . . . 72.019999999999996 111.586 177.868 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 54.9 t30 . . . . . 0 N--CA 1.441 -0.888 0 N-CA-C 108.899 -0.778 . . . . 75.099999999999994 108.899 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -78.74 158.81 45.36 Favored Glycine 0 N--CA 1.431 -1.671 0 N-CA-C 110.786 -0.925 . . . . 54.200000000000003 110.786 179.187 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.5 m -75.14 125.28 89.31 Favored Pre-proline 0 C--N 1.299 -1.624 0 N-CA-C 109.987 -0.375 . . . . 63.240000000000002 109.987 -178.894 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -63.92 127.73 20.2 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 121.628 1.552 . . . . 74.0 109.121 175.158 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.434 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -89.99 144.12 30.94 Favored Pre-proline 0 C--N 1.298 -1.641 0 N-CA-C 112.489 0.552 . . . . 65.310000000000002 112.489 -176.844 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 9' ' ' GLU . 4.1 Cg_exo -76.66 141.67 22.25 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.373 2.049 . . . . 53.520000000000003 111.722 178.282 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -81.51 118.31 22.63 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.498 -0.927 . . . . 72.239999999999995 108.498 179.386 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.2 p -75.62 118.62 22.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 109.521 -0.548 . . . . 61.009999999999998 109.521 178.764 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -81.55 120.92 25.65 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 109.704 -0.48 . . . . 73.25 109.704 -179.078 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.0 t -129.6 117.44 20.4 Favored 'General case' 0 N--CA 1.414 -2.262 0 CA-C-N 115.496 -0.774 . . . . 73.319999999999993 110.19 -178.495 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.9 p -95.5 101.15 12.84 Favored 'General case' 0 N--CA 1.425 -1.688 0 CA-C-N 115.856 -0.611 . . . . 71.439999999999998 110.978 179.867 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.4 t -81.16 103.18 10.78 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 108.97 -0.752 . . . . 62.43 108.97 178.702 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 42.6 t . . . . . 0 C--N 1.294 -1.827 0 N-CA-C 107.75 -1.204 . . . . 72.230000000000004 107.75 179.0 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.412 ' O ' HD11 ' A' ' 94' ' ' ILE . . . . . . . . 0 CA--C 1.48 -2.106 0 N-CA-C 107.275 -2.33 . . . . 71.109999999999999 107.275 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.3 m -90.15 153.22 20.68 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-O 122.055 0.931 . . . . 63.130000000000003 112.311 -166.989 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.27 166.56 22.2 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 107.878 -1.156 . . . . 74.150000000000006 107.878 179.149 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.45 148.32 50.58 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.163 0.506 . . . . 72.340000000000003 112.093 -179.434 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.564 HD23 HD11 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -123.51 140.3 53.15 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.72 -0.845 . . . . 74.120000000000005 108.72 176.336 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.401 ' O ' HD12 ' A' ' 135' ' ' LEU . 35.7 t -126.43 133.5 68.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 N-CA-C 108.249 -1.019 . . . . 72.400000000000006 108.249 -179.05 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.433 HG21 ' HB3' ' A' ' 57' ' ' ALA . 35.1 t -92.22 115.23 30.7 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.077 0 N-CA-C 106.328 -1.73 . . . . 61.530000000000001 106.328 177.522 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -86.02 -31.62 21.91 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 114.992 -1.004 . . . . 74.409999999999997 109.888 -172.488 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.487 ' O ' ' HB3' ' A' ' 133' ' ' PHE . 53.5 ttt180 -159.3 139.66 12.17 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.438 -0.578 . . . . 72.019999999999996 109.438 -179.218 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.409 ' HA2' ' HD3' ' A' ' 55' ' ' PRO . . . 132.68 148.83 6.08 Favored Glycine 0 N--CA 1.435 -1.387 0 C-N-CA 120.423 -0.894 . . . . 43.329999999999998 114.292 176.737 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.409 ' HD3' ' HA2' ' A' ' 54' ' ' GLY . 31.2 Cg_exo -65.59 -8.62 19.79 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 124.126 3.217 . . . . 61.409999999999997 112.418 174.132 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.403 HD21 ' HB2' ' A' ' 133' ' ' PHE . 81.5 m-20 -49.06 -56.67 8.33 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.139 0.976 . . . . 74.25 108.724 174.543 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.433 ' HB3' HG21 ' A' ' 51' ' ' VAL . . . -179.41 -172.09 0.22 Allowed 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.702 1.201 . . . . 70.140000000000001 107.968 179.729 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -154.23 30.45 0.71 Allowed Glycine 0 CA--C 1.483 -1.915 0 N-CA-C 107.809 -2.116 . . . . 72.25 107.809 178.019 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -116.88 -179.75 3.78 Favored 'General case' 0 N--CA 1.412 -2.369 0 CA-C-N 113.676 -1.262 . . . . 63.329999999999998 108.814 -175.328 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 7.6 ptt180 -138.12 131.01 29.83 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 108.312 -0.996 . . . . 63.140000000000001 108.312 -179.801 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -122.02 148.44 44.83 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 116.354 -0.385 . . . . 74.349999999999994 110.852 -172.711 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.1 tt -98.76 117.36 33.07 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.367 -0.975 . . . . 72.230000000000004 108.367 178.497 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 94.0 mt -90.76 115.58 27.95 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.656 -0.702 . . . . 74.140000000000001 109.585 179.802 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -121.37 -34.03 3.54 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 107.667 -1.235 . . . . 64.120000000000005 107.667 177.913 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 15.5 pm0 -64.99 130.15 94.76 Favored Pre-proline 0 N--CA 1.436 -1.159 0 CA-C-N 113.987 -1.461 . . . . 74.019999999999996 109.95 175.971 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -61.5 -33.06 88.55 Favored 'Trans proline' 0 C--O 1.244 0.811 0 C-N-CA 123.299 2.666 . . . . 63.340000000000003 114.269 -175.968 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.7 m -111.97 120.38 41.71 Favored 'General case' 0 N--CA 1.435 -1.183 0 O-C-N 122.177 -0.327 . . . . 72.230000000000004 110.825 -178.061 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.488 ' HB ' ' HB3' ' A' ' 92' ' ' PHE . 41.4 m -118.74 114.1 22.18 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.841 -0.799 . . . . 44.149999999999999 108.841 176.181 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 36.7 m -102.0 127.56 48.82 Favored 'General case' 0 C--N 1.312 -1.054 0 O-C-N 121.658 -0.651 . . . . 63.509999999999998 111.245 -179.462 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -106.1 125.2 50.7 Favored 'General case' 0 C--O 1.248 0.985 0 CA-C-N 115.652 -0.703 . . . . 43.210000000000001 109.153 177.985 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 167.43 -151.1 18.4 Favored Glycine 0 CA--C 1.49 -1.513 0 N-CA-C 110.624 -0.99 . . . . 74.230000000000004 110.624 179.866 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.406 ' HG2' ' HA ' ' A' ' 87' ' ' ARG . 11.6 ptp180 -130.54 83.72 2.14 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 122.573 1.178 . . . . 75.409999999999997 111.311 179.45 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 31.3 m80 -146.83 174.72 3.17 Favored Pre-proline 0 C--N 1.293 -1.874 0 N-CA-C 106.999 -1.482 . . . . 75.319999999999993 106.999 178.452 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -66.49 -22.25 51.99 Favored 'Trans proline' 0 C--N 1.354 0.848 0 N-CA-C 107.544 -1.752 . . . . 73.540000000000006 107.544 164.733 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -89.64 68.42 7.64 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 113.854 -1.521 . . . . 71.140000000000001 108.164 176.511 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 53.6 m -139.33 113.41 8.76 Favored 'General case' 0 C--N 1.275 -2.646 0 CA-C-N 114.395 -1.275 . . . . 62.109999999999999 107.56 175.54 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -71.84 -35.6 69.91 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.909 -1.041 . . . . 71.319999999999993 109.38 -174.669 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.484 HD13 ' H ' ' A' ' 78' ' ' ILE . 0.2 OUTLIER -128.41 160.56 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.252 0 N-CA-C 106.667 -1.605 . . . . 71.349999999999994 106.667 175.348 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -107.02 135.92 47.77 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-O 121.33 0.586 . . . . 75.319999999999993 111.861 -175.385 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.0 mp -125.66 137.85 53.88 Favored 'General case' 0 N--CA 1.424 -1.77 0 N-CA-C 108.061 -1.088 . . . . 70.439999999999998 108.061 179.05 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -140.37 75.76 1.52 Allowed 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.376 -1.342 . . . . 54.219999999999999 107.376 179.543 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.432 ' OD2' ' HA3' ' A' ' 131' ' ' GLY . 18.6 t70 -120.35 159.9 24.12 Favored 'General case' 0 C--N 1.275 -2.651 0 CA-C-N 113.34 -1.755 . . . . 72.150000000000006 108.209 179.761 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 10.2 p -71.45 -27.25 28.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 CA-C-O 121.176 0.513 . . . . 71.25 111.076 -178.46 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.5 p -113.04 14.7 19.65 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 113.437 0.902 . . . . 72.439999999999998 113.437 -176.809 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.8 p -82.61 120.43 34.02 Favored 'Isoleucine or valine' 0 C--O 1.253 1.261 0 C-N-CA 118.792 -1.163 . . . . 73.549999999999997 108.878 173.996 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 9.1 t -80.62 -172.4 3.59 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 115.208 -0.906 . . . . 70.129999999999995 111.602 -173.616 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.406 ' HA ' ' HG2' ' A' ' 72' ' ' ARG . 18.8 ttp180 -62.29 -51.69 66.66 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.109 0.963 . . . . 73.329999999999998 110.988 -179.584 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -134.06 97.61 3.91 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 104.608 -2.367 . . . . 55.409999999999997 104.608 177.532 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.42 ' HA ' ' HA3' ' A' ' 105' ' ' GLY . 5.9 t60 -88.76 -55.29 3.76 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 116.049 -0.523 . . . . 73.420000000000002 111.301 -168.299 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.79 151.13 36.63 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 120.278 -0.569 . . . . 75.450000000000003 110.532 -177.231 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -120.74 128.06 52.58 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 107.428 -1.323 . . . . 73.329999999999998 107.428 174.521 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.549 ' CE2' ' HB ' ' A' ' 94' ' ' ILE . 69.8 t80 -104.49 127.77 52.27 Favored 'General case' 0 C--N 1.277 -2.553 0 N-CA-C 108.888 -0.782 . . . . 74.150000000000006 108.888 178.03 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 -109.83 122.21 46.99 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 107.137 -1.431 . . . . 75.409999999999997 107.137 -179.689 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.549 ' HB ' ' CE2' ' A' ' 92' ' ' PHE . 0.0 OUTLIER -116.05 125.93 73.34 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.246 0 CA-C-O 121.777 0.799 . . . . 65.230000000000004 110.824 -177.789 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.416 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 20.7 t-20 -118.42 145.77 44.96 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 105.507 -2.035 . . . . 64.239999999999995 105.507 174.651 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -61.92 -19.14 62.38 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 112.526 0.565 . . . . 71.209999999999994 112.526 -175.19 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -104.58 -31.89 4.39 Favored Glycine 0 N--CA 1.431 -1.635 0 C-N-CA 120.72 -0.752 . . . . 64.150000000000006 113.178 178.492 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.416 ' O ' ' HB3' ' A' ' 95' ' ' ASN . 8.8 pt-20 -143.06 155.71 44.68 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 117.363 0.582 . . . . 75.439999999999998 111.604 -174.7 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.439 ' HB2' ' HB2' ' A' ' 122' ' ' MET . 57.7 m-85 -127.35 128.67 46.28 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 110.099 -0.334 . . . . 73.109999999999999 110.099 -173.813 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -128.19 135.35 49.6 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 110.262 -0.273 . . . . 70.329999999999998 110.262 -178.531 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 14.6 p -120.7 129.73 75.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 108.919 -0.771 . . . . 55.439999999999998 108.919 174.844 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 25.4 m -115.85 129.73 71.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 CA-C-O 121.445 0.64 . . . . 71.430000000000007 111.185 179.635 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -86.55 121.34 28.95 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 114.977 -1.01 . . . . 73.310000000000002 109.067 179.231 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 18.5 m -118.44 -1.16 8.81 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 CA-C-N 115.546 -0.752 . . . . 73.340000000000003 110.009 179.055 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.42 ' HA3' ' HA ' ' A' ' 89' ' ' HIS . . . -111.83 52.04 0.66 Allowed Glycine 0 N--CA 1.427 -1.956 0 N-CA-C 109.73 -1.348 . . . . 71.409999999999997 109.73 178.62 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 14.2 m -62.91 -4.92 2.43 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.538 1.135 . . . . 74.140000000000001 112.192 -177.633 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 81.2 mt -61.99 -30.2 70.77 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 124.253 1.021 . . . . 61.200000000000003 109.244 174.707 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -125.71 -40.41 2.06 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.131 -0.94 . . . . 74.299999999999997 108.771 179.251 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.74 132.21 5.14 Favored Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.349 -0.841 . . . . 72.129999999999995 113.312 178.333 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 28.9 m -81.56 136.26 35.58 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.312 -0.996 . . . . 65.329999999999998 108.312 173.353 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.427 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 18.6 m-85 -114.43 134.17 55.19 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 108.268 -1.012 . . . . 75.109999999999999 108.268 -177.595 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 60.0 t -120.76 111.04 30.23 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 N-CA-C 106.926 -1.509 . . . . 65.049999999999997 106.926 176.784 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 42.7 t-20 44.08 70.36 0.33 Allowed 'General case' 0 C--O 1.241 0.634 0 O-C-N 125.143 1.527 . . . . 72.420000000000002 111.59 -176.114 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 73.98 -26.62 0.19 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.503 1.521 . . . . 75.219999999999999 113.388 177.362 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -90.77 118.1 68.41 Favored Pre-proline 0 C--N 1.311 -1.07 0 N-CA-C 112.343 0.497 . . . . 75.329999999999998 112.343 -175.68 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -63.38 128.24 22.05 Favored 'Trans proline' 0 C--O 1.247 0.965 0 C-N-CA 122.295 1.997 . . . . 71.299999999999997 108.584 172.299 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 3.1 mmp_? -123.04 145.23 48.71 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 116.991 -0.095 . . . . 75.120000000000005 110.81 -175.356 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -95.33 -36.66 11.31 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 108.181 -1.044 . . . . 72.010000000000005 108.181 172.11 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -149.19 139.49 22.33 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 105.89 -1.893 . . . . 75.409999999999997 105.89 174.308 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 7.7 tp60 -140.09 148.55 41.91 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 110.32 -0.252 . . . . 73.200000000000003 110.32 -178.714 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 67.4 t -93.11 123.12 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 N-CA-C 105.124 -2.176 . . . . 72.129999999999995 105.124 173.239 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.439 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 83.5 mmm -78.7 143.94 35.77 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 114.204 1.187 . . . . 55.140000000000001 114.204 -173.338 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -121.89 137.14 54.9 Favored 'General case' 0 N--CA 1.419 -1.99 0 CA-C-N 113.823 -1.535 . . . . 72.129999999999995 108.852 -177.581 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 7.1 t -79.54 126.69 31.2 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 109.024 -0.732 . . . . 74.409999999999997 109.024 178.502 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 95.74 19.33 29.65 Favored Glycine 0 N--CA 1.434 -1.454 0 C-N-CA 120.747 -0.739 . . . . 74.5 111.578 -179.175 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -118.93 160.91 21.08 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.816 -0.809 . . . . 72.310000000000002 108.816 178.246 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.447 ' OE1' ' HD2' ' A' ' 134' ' ' ARG . 44.0 tt0 -115.4 131.49 56.91 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.494 0.664 . . . . 73.299999999999997 111.495 -172.183 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.412 ' N ' HD12 ' A' ' 128' ' ' ILE . 3.5 mp -105.35 131.44 54.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 107.681 -1.229 . . . . 62.409999999999997 107.681 -176.728 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.427 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 60.1 tt0 -102.26 113.21 26.3 Favored 'General case' 0 N--CA 1.425 -1.702 0 C-N-CA 119.178 -1.009 . . . . 64.319999999999993 108.375 177.849 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 8.0 pt -100.73 98.14 6.56 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.361 0 CA-C-N 114.743 -1.117 . . . . 73.230000000000004 108.549 178.826 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.432 ' HA3' ' OD2' ' A' ' 82' ' ' ASP . . . 77.73 -110.96 3.15 Favored Glycine 0 N--CA 1.426 -2.029 0 CA-C-N 113.976 -1.466 . . . . 61.310000000000002 109.522 -174.923 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.403 ' NZ ' ' HB3' ' A' ' 132' ' ' LYS . 7.8 mtpm? -104.87 -19.88 13.74 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 116.918 0.359 . . . . 73.109999999999999 110.083 175.0 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.487 ' HB3' ' O ' ' A' ' 53' ' ' ARG . 57.4 m-85 -97.77 161.76 13.6 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-O 120.856 0.36 . . . . 61.240000000000002 111.571 -171.181 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.447 ' HD2' ' OE1' ' A' ' 127' ' ' GLU . 70.3 mtm180 -121.0 140.55 51.75 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 113.817 1.043 . . . . 73.510000000000005 113.817 -169.023 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.564 HD11 HD23 ' A' ' 49' ' ' LEU . 47.6 tp -121.41 136.47 54.96 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 113.734 -1.575 . . . . 64.299999999999997 108.25 -177.325 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 10.7 p -111.21 132.4 59.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 C-N-CA 120.195 -0.602 . . . . 74.430000000000007 109.541 177.666 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -111.29 129.68 55.9 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.162 -0.472 . . . . 60.130000000000003 111.445 -176.368 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -129.45 148.82 51.4 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.308 -0.627 . . . . 72.519999999999996 109.308 176.799 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -95.36 137.83 33.89 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.286 -1.005 . . . . 73.439999999999998 108.286 175.986 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -120.23 -127.99 3.59 Favored Glycine 0 N--CA 1.435 -1.433 0 C-N-CA 119.509 -1.329 . . . . 72.430000000000007 114.339 -173.895 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo . . . . . 0 C--O 1.235 0.367 0 C-N-CA 123.305 2.67 . . . . 61.350000000000001 114.94 -172.491 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 41.9 t30 . . . . . 0 N--CA 1.434 -1.253 0 N-CA-C 107.582 -1.266 . . . . 62.409999999999997 107.582 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.87 80.4 0.57 Allowed Glycine 0 CA--C 1.503 -0.709 0 N-CA-C 109.132 -1.587 . . . . 73.239999999999995 109.132 175.688 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.8 m -78.67 124.52 85.17 Favored Pre-proline 0 N--CA 1.418 -2.042 0 C-N-CA 123.675 0.79 . . . . 73.239999999999995 111.289 -169.963 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -66.36 134.73 37.08 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 122.485 2.123 . . . . 31.149999999999999 109.573 174.545 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.414 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -73.3 135.71 79.16 Favored Pre-proline 0 C--N 1.303 -1.444 0 C-N-CA 119.976 -0.69 . . . . 62.350000000000001 110.67 177.093 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 9' ' ' GLU . 38.8 Cg_exo -60.27 121.61 10.05 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 122.204 1.936 . . . . 54.509999999999998 111.82 -178.225 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -79.63 108.53 13.25 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 106.631 -1.618 . . . . 73.540000000000006 106.631 178.636 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.8 m -63.95 126.14 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.305 0 CA-C-O 121.66 0.743 . . . . 60.149999999999999 112.44 -174.008 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -88.08 141.16 28.79 Favored 'General case' 0 N--CA 1.425 -1.678 0 CA-C-N 114.953 -1.021 . . . . 73.140000000000001 109.755 178.826 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.8 t -138.65 141.78 39.06 Favored 'General case' 0 C--N 1.285 -2.231 0 N-CA-C 108.156 -1.054 . . . . 51.310000000000002 108.156 179.027 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.8 t -105.23 124.95 50.4 Favored 'General case' 0 N--CA 1.406 -2.644 0 N-CA-C 108.171 -1.048 . . . . 71.439999999999998 108.171 -179.829 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.0 m -143.03 93.53 2.51 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-N 115.691 -0.686 . . . . 64.349999999999994 110.319 -178.811 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 C--N 1.312 -1.048 0 N-CA-C 108.629 -0.878 . . . . 75.030000000000001 108.629 179.333 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.644 0 N-CA-C 111.05 -0.82 . . . . 44.32 111.05 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.2 m -89.65 152.74 21.21 Favored 'General case' 0 N--CA 1.428 -1.526 0 N-CA-C 107.228 -1.397 . . . . 63.439999999999998 107.228 176.347 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.485 ' HB3' ' CZ ' ' A' ' 137' ' ' PHE . . . -97.64 178.54 5.13 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 110.201 -0.296 . . . . 65.540000000000006 110.201 -176.991 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -134.16 158.03 44.71 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.121 0.486 . . . . 73.340000000000003 111.507 -175.524 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.6 pp -121.34 140.26 52.33 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 115.354 -0.839 . . . . 71.230000000000004 109.023 174.869 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.446 HG12 ' CB ' ' A' ' 60' ' ' ARG . 33.1 m -115.52 138.51 45.66 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 CA-C-O 121.043 0.449 . . . . 52.310000000000002 109.834 179.611 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.0 t -93.61 115.62 32.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 107.818 -1.178 . . . . 74.209999999999994 107.818 179.943 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -88.56 -36.2 16.49 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.241 0.543 . . . . 72.219999999999999 109.551 -179.411 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.424 ' O ' ' HB3' ' A' ' 133' ' ' PHE . 37.6 ttm180 -149.84 125.5 10.36 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.309 -0.997 . . . . 72.319999999999993 108.309 -179.879 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 153.94 121.85 0.83 Allowed Glycine 0 N--CA 1.418 -2.539 0 C-N-CA 120.959 -0.639 . . . . 33.520000000000003 111.662 179.821 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -55.85 -9.04 2.58 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 124.522 3.481 . . . . 52.109999999999999 113.876 178.802 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.445 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 7.2 t30 -51.86 -38.39 55.82 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 124.106 0.962 . . . . 63.350000000000001 110.786 176.01 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -178.57 -59.87 0.01 OUTLIER 'General case' 0 C--N 1.354 0.764 0 CA-C-N 116.318 -0.401 . . . . 73.209999999999994 111.735 179.738 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.55 54.07 4.12 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 109.515 -1.434 . . . . 74.310000000000002 109.515 -173.837 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -154.63 -171.52 3.88 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 107.926 -1.138 . . . . 53.0 107.926 -175.752 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.446 ' CB ' HG12 ' A' ' 50' ' ' VAL . 18.7 ptp180 -110.15 140.2 44.5 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 109.875 -0.417 . . . . 72.040000000000006 109.875 -178.368 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -135.24 119.02 17.2 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 120.673 0.273 . . . . 73.420000000000002 110.891 179.765 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.0 tt -86.55 139.56 30.73 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 107.073 -1.454 . . . . 75.239999999999995 107.073 174.724 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 87.8 mt -71.19 114.07 8.87 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 119.923 -0.711 . . . . 74.239999999999995 109.385 -176.433 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -117.45 -32.26 4.98 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 114.793 -1.094 . . . . 53.43 110.989 -172.655 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -96.97 132.25 26.22 Favored Pre-proline 0 C--N 1.303 -1.454 0 N-CA-C 107.686 -1.227 . . . . 73.239999999999995 107.686 178.653 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.454 ' HA ' HG13 ' A' ' 94' ' ' ILE . 10.5 Cg_endo -53.45 -26.48 36.09 Favored 'Trans proline' 0 C--N 1.371 1.748 0 C-N-CA 124.034 3.156 . . . . 43.439999999999998 113.411 -176.207 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 51.8 m -133.39 98.09 4.14 Favored 'General case' 0 N--CA 1.407 -2.586 0 N-CA-C 108.404 -0.961 . . . . 70.329999999999998 108.404 174.282 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 98.2 m -88.75 115.4 26.26 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 114.868 -1.06 . . . . 74.0 108.469 -178.685 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.6 t -107.78 121.51 44.87 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-O 121.554 0.693 . . . . 61.409999999999997 111.369 -177.277 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -104.7 115.32 30.12 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 114.868 -1.06 . . . . 44.399999999999999 109.022 179.185 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.725 ' O ' ' HA ' ' A' ' 88' ' ' ARG . . . 90.64 85.33 1.39 Allowed Glycine 0 CA--C 1.475 -2.446 0 N-CA-C 107.798 -2.121 . . . . 73.329999999999998 107.798 -177.375 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.416 ' HG2' ' O ' ' A' ' 75' ' ' GLU . 23.5 tpt180 -177.57 142.79 0.33 Allowed 'General case' 0 N--CA 1.407 -2.59 0 N-CA-C 102.243 -3.243 . . . . 63.009999999999998 102.243 -171.513 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -109.16 -60.55 0.04 OUTLIER Pre-proline 0 C--N 1.274 -2.705 0 N-CA-C 115.316 1.599 . . . . 73.420000000000002 115.316 -177.701 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_exo -66.67 -40.63 12.82 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 121.871 1.714 . . . . 65.109999999999999 113.862 -173.249 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.416 ' O ' ' HG2' ' A' ' 72' ' ' ARG . 38.7 tt0 -130.42 75.55 1.66 Allowed 'General case' 0 N--CA 1.422 -1.87 0 N-CA-C 107.378 -1.341 . . . . 41.340000000000003 107.378 -177.309 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.4 p -112.24 170.44 8.16 Favored 'General case' 0 C--N 1.285 -2.231 0 N-CA-C 113.365 0.876 . . . . 72.510000000000005 113.365 -171.689 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -112.14 -55.71 2.48 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 107.166 -1.42 . . . . 51.240000000000002 107.166 173.857 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 24.2 pt -125.43 152.28 32.05 Favored 'Isoleucine or valine' 0 C--O 1.25 1.12 0 CA-C-N 115.539 -0.755 . . . . 71.129999999999995 109.422 174.797 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.445 ' O ' ' HA ' ' A' ' 56' ' ' ASN . 87.8 m-85 -112.89 117.53 32.38 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 112.293 0.479 . . . . 71.400000000000006 112.293 -173.131 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.2 mp -74.12 107.39 6.28 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 108.743 -0.836 . . . . 72.430000000000007 108.743 170.1 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -82.04 1.4 35.95 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 123.993 0.917 . . . . 64.409999999999997 110.976 -178.02 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -98.4 164.44 12.28 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.55 -0.75 . . . . 62.149999999999999 109.857 -177.949 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.2 p -69.92 -18.8 22.2 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.134 0 C-N-CA 123.35 0.66 . . . . 63.549999999999997 111.64 -178.769 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 13.3 p -73.05 11.44 0.7 Allowed 'General case' 0 CA--C 1.555 1.15 0 N-CA-C 113.698 0.999 . . . . 74.230000000000004 113.698 -178.807 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.6 p -82.58 125.0 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 CA-C-O 121.436 0.636 . . . . 64.0 111.931 -177.187 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 41.9 t -84.68 169.34 14.41 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.343 -0.984 . . . . 43.420000000000002 108.343 174.624 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 52.3 mtm-85 -56.76 -40.76 76.4 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 108.946 -0.761 . . . . 73.230000000000004 108.946 175.87 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.725 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -146.07 129.45 16.82 Favored 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 105.754 -1.943 . . . . 64.510000000000005 105.754 165.392 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.401 ' HA ' ' HA3' ' A' ' 105' ' ' GLY . 30.1 t60 -108.74 -74.04 0.67 Allowed 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 113.213 0.819 . . . . 70.239999999999995 113.213 -171.088 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -117.29 119.39 35.0 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 121.652 -0.655 . . . . 61.009999999999998 109.756 -177.443 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -109.69 127.18 54.4 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 108.277 -1.009 . . . . 72.209999999999994 108.277 -179.608 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -112.33 112.8 24.63 Favored 'General case' 0 N--CA 1.425 -1.693 0 N-CA-C 107.619 -1.252 . . . . 74.219999999999999 107.619 -178.763 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 30.8 ttm-85 -101.91 143.32 31.94 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 107.819 -1.178 . . . . 71.129999999999995 107.819 179.791 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.454 HG13 ' HA ' ' A' ' 66' ' ' PRO . 2.6 pp -115.53 140.46 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.479 0 N-CA-C 107.578 -1.267 . . . . 71.450000000000003 107.578 175.298 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.455 ' C ' ' H ' ' A' ' 97' ' ' GLY . 40.0 t-20 -118.44 147.08 43.95 Favored 'General case' 0 C--N 1.268 -2.972 0 N-CA-C 104.541 -2.392 . . . . 55.130000000000003 104.541 -178.807 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -59.84 26.5 0.01 OUTLIER 'General case' 0 CA--C 1.574 1.881 0 N-CA-C 114.62 1.341 . . . . 64.349999999999994 114.62 -176.945 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.455 ' H ' ' C ' ' A' ' 95' ' ' ASN . . . -169.16 -38.31 0.03 OUTLIER Glycine 0 N--CA 1.426 -2.011 0 N-CA-C 111.074 -0.81 . . . . 71.129999999999995 111.074 -179.445 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -127.61 170.9 12.14 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.95 0.405 . . . . 73.409999999999997 111.283 -176.392 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -116.89 129.3 55.98 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 116.276 -0.42 . . . . 71.120000000000005 110.101 -179.912 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -122.07 119.52 31.64 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.907 -0.405 . . . . 74.019999999999996 109.907 -176.845 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.496 HG11 ' SD ' ' A' ' 122' ' ' MET . 27.9 m -121.93 128.92 75.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 C-N-CA 119.835 -0.746 . . . . 74.299999999999997 110.944 178.371 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 29.4 m -119.84 137.46 53.65 Favored 'Isoleucine or valine' 0 C--O 1.252 1.234 0 N-CA-C 112.76 0.652 . . . . 62.420000000000002 112.76 -178.243 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -92.68 108.37 19.93 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.485 -0.78 . . . . 72.319999999999993 110.228 174.98 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.3 m -114.56 5.46 7.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 CA-C-O 121.86 0.838 . . . . 53.310000000000002 109.709 177.417 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.401 ' HA3' ' HA ' ' A' ' 89' ' ' HIS . . . -105.86 36.32 4.48 Favored Glycine 0 N--CA 1.431 -1.676 0 N-CA-C 109.725 -1.35 . . . . 42.43 109.725 179.351 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 14.0 m -65.01 5.47 0.34 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.736 1.615 . . . . 74.239999999999995 113.158 -176.689 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.4 mp -69.37 -34.27 74.3 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 107.505 -1.295 . . . . 71.329999999999998 107.505 172.918 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -119.01 -40.06 2.87 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 107.293 -1.373 . . . . 75.519999999999996 107.293 174.1 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 104.96 141.89 11.08 Favored Glycine 0 N--CA 1.44 -1.08 0 CA-C-N 115.79 -0.641 . . . . 74.099999999999994 113.485 176.108 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 27.6 m -108.52 125.45 51.82 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 107.362 -1.347 . . . . 51.140000000000001 107.362 173.205 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -103.64 134.52 46.85 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.56 -0.533 . . . . 73.299999999999997 109.56 -176.684 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.421 HG21 ' HG2' ' A' ' 120' ' ' GLN . 7.2 p -125.77 127.51 71.42 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.428 0 N-CA-C 106.973 -1.491 . . . . 70.450000000000003 106.973 175.391 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 18.4 m120 64.71 22.6 12.62 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 109.108 -0.701 . . . . 63.219999999999999 109.108 -174.842 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 18.3 mmm180 76.54 5.41 3.53 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.729 1.212 . . . . 72.25 112.779 -175.291 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -112.41 130.07 23.73 Favored Pre-proline 0 C--N 1.315 -0.924 0 N-CA-C 110.386 -0.227 . . . . 71.400000000000006 110.386 -179.4 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -74.85 110.48 3.12 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 121.823 1.682 . . . . 74.510000000000005 109.772 175.858 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 43.2 ttt180 -126.83 154.64 44.07 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.508 -1.293 . . . . 75.310000000000002 107.508 -176.235 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -81.2 -50.52 9.48 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.271 -0.572 . . . . 75.319999999999993 110.664 -175.182 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -130.18 140.16 50.77 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 108.406 -0.961 . . . . 64.439999999999998 108.406 178.875 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.421 ' HG2' HG21 ' A' ' 112' ' ' VAL . 55.2 tp60 -139.72 148.03 41.74 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 109.692 -0.485 . . . . 70.0 109.692 -179.926 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 98.8 t -88.17 117.29 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 N-CA-C 105.195 -2.15 . . . . 74.420000000000002 105.195 167.86 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.496 ' SD ' HG11 ' A' ' 101' ' ' VAL . 4.6 tpt -55.89 116.73 3.13 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 124.071 0.948 . . . . 70.310000000000002 111.468 -171.74 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -105.26 129.83 53.53 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.662 -0.699 . . . . 63.549999999999997 109.6 -174.336 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 7.0 t -79.61 129.16 34.22 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 121.628 0.728 . . . . 54.450000000000003 112.571 -175.217 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 108.18 -11.43 37.03 Favored Glycine 0 N--CA 1.423 -2.17 0 CA-C-N 115.249 -0.887 . . . . 62.530000000000001 111.638 178.196 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -102.35 172.59 6.8 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 112.867 0.692 . . . . 73.310000000000002 112.867 -177.344 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -108.32 142.52 38.5 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-N 115.056 -0.974 . . . . 74.099999999999994 112.115 -172.891 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.4 mp -124.1 113.17 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.922 0 N-CA-C 105.74 -1.948 . . . . 74.040000000000006 105.74 178.216 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.428 ' HA ' ' O ' ' A' ' 133' ' ' PHE . 66.4 mt-30 -102.95 119.64 39.21 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 109.667 -0.494 . . . . 72.439999999999998 109.667 -177.056 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 20.9 pt -91.41 99.72 10.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 N-CA-C 107.999 -1.112 . . . . 74.310000000000002 107.999 176.884 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 79.19 -94.03 1.34 Allowed Glycine 0 N--CA 1.422 -2.299 0 N-CA-C 108.755 -1.738 . . . . 72.230000000000004 108.755 -174.376 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -137.54 15.94 2.94 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.205 0.526 . . . . 64.310000000000002 110.306 177.128 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.428 ' O ' ' HA ' ' A' ' 129' ' ' GLN . 53.1 m-85 -103.52 131.3 50.76 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 109.664 -0.495 . . . . 75.299999999999997 109.664 -179.868 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 48.7 ttt180 -95.27 121.76 37.26 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-O 121.631 0.729 . . . . 55.549999999999997 111.708 -169.214 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 9.5 mp -121.96 143.87 49.21 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 107.668 -1.234 . . . . 63.119999999999997 107.668 175.672 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 6.3 p -126.95 130.67 71.37 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.435 0 C-N-CA 120.633 -0.427 . . . . 71.200000000000003 110.318 179.342 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . 0.485 ' CZ ' ' HB3' ' A' ' 47' ' ' ALA . 90.7 t80 -97.22 125.21 41.61 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.585 -0.734 . . . . 74.319999999999993 110.115 -176.759 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -128.56 144.24 51.11 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.385 0.612 . . . . 52.219999999999999 110.785 -179.752 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -87.01 86.21 7.3 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 106.996 -1.483 . . . . 73.340000000000003 106.996 171.926 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -75.27 -174.09 34.18 Favored Glycine 0 N--CA 1.439 -1.121 0 CA-C-N 114.983 -1.008 . . . . 52.409999999999997 113.945 -174.719 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo . . . . . 0 N--CA 1.447 -1.218 0 C-N-CA 122.716 2.278 . . . . 74.120000000000005 112.801 -179.14 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 13.6 m120 . . . . . 0 CA--C 1.506 -0.716 0 CA-C-O 121.178 0.513 . . . . 55.219999999999999 111.278 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -138.12 55.23 0.68 Allowed Glycine 0 N--CA 1.438 -1.229 0 N-CA-C 109.916 -1.273 . . . . 61.310000000000002 109.916 179.398 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.427 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 11.3 t -64.8 127.98 93.14 Favored Pre-proline 0 N--CA 1.439 -0.987 0 CA-C-N 115.191 -0.504 . . . . 74.010000000000005 109.834 -177.907 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 7' ' ' THR . 31.4 Cg_exo -61.1 127.65 22.86 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.198 1.932 . . . . 43.520000000000003 111.212 179.849 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -101.74 115.69 64.5 Favored Pre-proline 0 C--N 1.302 -1.496 0 N-CA-C 109.505 -0.554 . . . . 65.439999999999998 109.505 179.606 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -73.03 128.87 13.53 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.744 2.296 . . . . 72.219999999999999 113.894 -176.59 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -106.69 108.04 19.36 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 106.057 -1.831 . . . . 74.010000000000005 106.057 176.369 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.2 p -124.54 135.48 63.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 N-CA-C 109.396 -0.594 . . . . 33.43 109.396 -179.314 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -105.92 130.77 53.8 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.121 0.486 . . . . 74.040000000000006 110.825 -178.98 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 95.6 m -151.63 106.43 3.25 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.238 -1.023 . . . . 51.350000000000001 108.238 174.693 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 17.1 p -96.99 122.98 40.58 Favored 'General case' 0 N--CA 1.412 -2.327 0 CA-C-O 121.422 0.63 . . . . 55.240000000000002 110.506 -178.049 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 27.5 t -80.66 108.78 14.6 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 114.747 -1.115 . . . . 74.030000000000001 110.336 -177.331 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 91.5 t . . . . . 0 C--N 1.306 -1.302 0 N-CA-C 108.416 -0.957 . . . . 72.430000000000007 108.416 178.497 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.149 0 N-CA-C 111.149 -0.78 . . . . 45.119999999999997 111.149 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.5 ' O ' ' HA ' ' A' ' 141' ' ' PRO . 10.8 m -90.53 159.77 16.31 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.342 -0.614 . . . . 51.520000000000003 109.342 -178.282 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -113.98 178.38 4.3 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 117.741 0.246 . . . . 73.450000000000003 111.064 -176.261 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.5 pp -132.36 158.94 40.64 Favored 'General case' 0 C--O 1.244 0.788 0 N-CA-C 112.909 0.707 . . . . 61.310000000000002 112.909 -173.389 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.4 pp -119.24 147.74 43.91 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.58 -0.736 . . . . 74.040000000000006 109.817 176.914 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 25.3 t -130.23 149.86 34.02 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 C-N-CA 123.606 0.763 . . . . 51.549999999999997 109.284 -175.577 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.489 HG23 ' HD2' ' A' ' 55' ' ' PRO . 3.5 p -88.54 118.05 33.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-O 122.375 1.083 . . . . 74.319999999999993 111.05 179.475 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -95.6 -39.05 10.12 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-N 115.244 -0.889 . . . . 64.239999999999995 108.785 174.016 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -154.04 89.17 1.28 Allowed 'General case' 0 C--O 1.215 -0.748 0 N-CA-C 109.051 -0.722 . . . . 63.450000000000003 109.051 176.211 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 20.87 54.04 0.01 OUTLIER Glycine 0 N--CA 1.508 3.495 0 N-CA-C 119.842 2.697 . . . . 62.409999999999997 119.842 177.44 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.489 ' HD2' HG23 ' A' ' 51' ' ' VAL . 74.0 Cg_endo -71.91 -40.37 2.69 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 CA-C-N 120.821 2.31 . . . . 63.439999999999998 113.89 -178.783 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.565 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 15.6 m120 -134.17 -84.42 0.43 Allowed 'General case' 0 C--O 1.209 -1.055 0 CA-C-O 121.183 0.516 . . . . 62.420000000000002 112.079 -171.504 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.64 -6.82 26.59 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.528 0.566 . . . . 73.239999999999995 112.528 -173.825 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.24 40.57 99.2 Favored Glycine 0 CA--C 1.523 0.579 0 C-N-CA 120.756 -0.735 . . . . 61.0 112.256 -178.199 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -157.09 -163.7 1.45 Allowed 'General case' 0 C--O 1.254 1.331 0 N-CA-C 108.886 -0.783 . . . . 44.520000000000003 108.886 -177.122 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -132.34 139.49 48.17 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 108.354 -0.98 . . . . 72.129999999999995 108.354 176.134 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -156.46 154.5 30.5 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.057 0.456 . . . . 71.340000000000003 111.786 179.477 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 31.2 tp -80.08 139.49 36.87 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 114.55 -1.204 . . . . 73.340000000000003 109.172 179.655 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.9 mp -82.77 114.38 21.06 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 106.52 -1.659 . . . . 74.230000000000004 106.52 173.704 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -112.42 3.8 17.14 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 116.132 -0.486 . . . . 74.219999999999999 110.233 -175.012 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -121.82 141.11 33.21 Favored Pre-proline 0 C--N 1.301 -1.541 0 N-CA-C 107.741 -1.207 . . . . 63.25 107.741 -179.391 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -55.08 -49.89 14.99 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.167 2.578 . . . . 51.200000000000003 111.924 -177.413 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' A' ' 92' ' ' PHE . 44.3 m -121.08 108.54 13.94 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-N 115.509 -0.769 . . . . 74.239999999999995 110.455 178.924 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.436 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 4.7 m -91.66 114.81 27.44 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.264 -1.013 . . . . 75.430000000000007 108.264 179.116 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 16.7 p -90.79 122.76 33.8 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 116.742 -0.208 . . . . 75.340000000000003 110.693 -179.774 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.441 ' HA ' ' O ' ' A' ' 78' ' ' ILE . . . -109.5 121.84 46.08 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 109.877 -0.416 . . . . 71.209999999999994 109.877 178.178 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -164.6 -136.22 1.96 Allowed Glycine 0 N--CA 1.432 -1.604 0 N-CA-C 111.117 -0.793 . . . . 70.439999999999998 111.117 178.52 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.463 ' NH2' ' HA ' ' A' ' 81' ' ' ASP . 4.2 tpp180 -159.57 84.65 0.77 Allowed 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.025 -1.472 . . . . 75.25 107.025 176.992 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -179.97 151.18 0.57 Allowed Pre-proline 0 C--N 1.296 -1.756 0 N-CA-C 104.745 -2.317 . . . . 75.439999999999998 104.745 -177.514 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.44 -22.15 70.52 Favored 'Trans proline' 0 N--CA 1.48 0.709 0 C-N-CA 122.41 2.073 . . . . 74.120000000000005 113.211 -178.149 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -79.54 -18.34 52.03 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.431 -0.35 . . . . 71.219999999999999 111.064 -179.148 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.0 m -88.42 131.86 34.69 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 107.162 -1.422 . . . . 65.230000000000004 107.162 176.167 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -70.84 -50.38 36.02 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 120.956 -0.297 . . . . 63.310000000000002 111.451 -176.851 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.441 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 39.2 pt -112.37 154.55 13.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 C-N-CA 120.133 -0.627 . . . . 55.530000000000001 109.883 178.991 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -116.58 136.05 53.3 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 116.399 -0.364 . . . . 72.450000000000003 110.501 -179.023 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.565 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 1.5 pt? -84.99 139.92 31.44 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 106.647 -1.612 . . . . 63.329999999999998 106.647 171.553 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.463 ' HA ' ' NH2' ' A' ' 72' ' ' ARG . 19.8 t70 -106.56 58.0 0.64 Allowed 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 118.415 -1.314 . . . . 52.329999999999998 112.583 -172.098 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -104.07 151.19 23.55 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 106.641 -1.615 . . . . 72.25 106.641 171.476 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.4 m -74.38 -12.45 15.14 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 N-CA-C 112.284 0.476 . . . . 72.329999999999998 112.284 -178.621 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -113.42 51.52 0.84 Allowed 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 106.956 -1.498 . . . . 72.329999999999998 106.956 179.16 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.47 HG23 ' HG ' ' A' ' 80' ' ' LEU . 7.6 p -82.24 135.59 24.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 115.469 -0.787 . . . . 73.540000000000006 113.004 -173.038 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 8.0 m -101.75 144.21 30.72 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.625 -0.716 . . . . 74.439999999999998 110.93 -177.925 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -67.39 120.79 14.47 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 106.172 -1.788 . . . . 74.409999999999997 106.172 170.569 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 58.1 81.35 0.15 Allowed 'General case' 0 N--CA 1.466 0.357 0 O-C-N 123.9 0.75 . . . . 73.319999999999993 110.396 -172.421 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 19.1 t60 -98.81 -35.65 10.06 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 109.398 -0.593 . . . . 72.340000000000003 109.398 -178.626 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -149.22 136.27 19.83 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 120.335 -0.546 . . . . 73.040000000000006 110.031 -179.447 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -112.89 126.98 56.05 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 108.313 -0.995 . . . . 75.150000000000006 108.313 173.989 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.452 ' O ' ' HA ' ' A' ' 67' ' ' THR . 86.1 m-85 -105.37 122.39 45.88 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.049 -1.093 . . . . 72.129999999999995 108.049 179.058 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.467 ' HB3' ' HB3' ' A' ' 100' ' ' GLU . 51.4 ttt180 -113.06 119.16 36.89 Favored 'General case' 0 C--N 1.281 -2.385 0 N-CA-C 108.34 -0.985 . . . . 61.509999999999998 108.34 179.569 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.79 116.43 52.38 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 N-CA-C 107.48 -1.304 . . . . 74.329999999999998 107.48 179.553 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.41 ' OD1' ' HG2' ' A' ' 96' ' ' GLU . 27.4 t30 -101.88 145.55 29.06 Favored 'General case' 0 C--N 1.275 -2.634 0 CA-C-N 113.758 -1.565 . . . . 75.120000000000005 106.864 -179.787 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.41 ' HG2' ' OD1' ' A' ' 95' ' ' ASN . 9.6 pt-20 -42.88 -29.5 0.33 Allowed 'General case' 0 C--N 1.313 -0.995 0 C-N-CA 125.049 1.34 . . . . 73.120000000000005 113.668 -178.388 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -138.7 29.52 2.57 Favored Glycine 0 N--CA 1.43 -1.72 0 C-N-CA 120.373 -0.918 . . . . 75.239999999999995 112.75 177.331 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.405 ' HB3' HD22 ' A' ' 95' ' ' ASN . 8.2 tp10 -165.07 152.99 11.49 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 117.883 0.841 . . . . 64.239999999999995 110.989 -179.866 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -124.96 126.87 46.16 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.845 -0.428 . . . . 72.239999999999995 109.845 -176.549 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.467 ' HB3' ' HB3' ' A' ' 93' ' ' ARG . 37.3 tt0 -132.26 135.19 46.09 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 122.568 0.347 . . . . 73.129999999999995 110.269 -175.992 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.7 p -128.7 129.01 68.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 O-C-N 121.946 -0.472 . . . . 70.349999999999994 110.908 177.608 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 97.5 t -119.47 124.53 73.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 116.008 -0.542 . . . . 72.239999999999995 110.816 179.722 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -83.6 125.16 31.52 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 123.2 0.6 . . . . 60.329999999999998 110.272 174.725 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.8 t -118.72 7.6 6.79 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 N-CA-C 107.936 -1.135 . . . . 63.100000000000001 107.936 178.393 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -116.7 45.56 1.27 Allowed Glycine 0 N--CA 1.441 -1.009 0 N-CA-C 110.498 -1.041 . . . . 23.32 110.498 -178.873 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 12.3 m -63.72 -12.62 36.29 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 123.977 0.911 . . . . 74.129999999999995 111.61 -177.538 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 92.0 mt -61.35 -35.84 78.55 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.8 0.84 . . . . 74.129999999999995 109.892 174.748 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -93.69 -37.59 11.75 Favored 'General case' 0 CA--C 1.496 -1.118 0 N-CA-C 108.327 -0.99 . . . . 64.340000000000003 108.327 178.257 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 93.65 88.63 1.62 Allowed Glycine 0 N--CA 1.432 -1.614 0 CA-C-N 114.943 -1.026 . . . . 74.019999999999996 111.499 -179.99 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 55.1 m -82.3 120.62 25.63 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 109.37 -0.604 . . . . 70.409999999999997 109.37 177.634 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.476 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 37.4 m-85 -106.2 134.93 48.56 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 107.818 -1.178 . . . . 73.310000000000002 107.818 -179.927 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 23.8 t -105.88 121.33 58.09 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.235 0 N-CA-C 106.8 -1.556 . . . . 72.239999999999995 106.8 177.898 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 61.96 25.51 15.32 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.704 1.202 . . . . 54.140000000000001 109.809 -175.102 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 65.6 mtp180 75.08 14.53 3.1 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.248 1.819 . . . . 61.210000000000001 112.363 -178.523 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 25.1 tp10 -110.76 123.94 34.29 Favored Pre-proline 0 C--N 1.307 -1.279 0 N-CA-C 108.039 -1.097 . . . . 71.310000000000002 108.039 174.798 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -57.21 103.83 0.14 Allowed 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.226 1.951 . . . . 65.439999999999998 110.762 176.073 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.408 ' HE ' ' HA ' ' A' ' 117' ' ' ARG . 1.6 tpm_? -143.41 111.07 5.92 Favored 'General case' 0 N--CA 1.414 -2.229 0 N-CA-C 105.391 -2.077 . . . . 63.25 105.391 -176.697 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -81.21 -23.73 37.92 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 120.553 -0.459 . . . . 72.409999999999997 111.638 -173.856 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -130.77 137.05 49.28 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.264 -1.384 . . . . 73.219999999999999 107.264 172.286 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.401 ' HG2' ' HG2' ' A' ' 117' ' ' ARG . 0.0 OUTLIER -140.43 145.85 37.55 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 108.229 -1.026 . . . . 74.200000000000003 108.229 -178.734 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 44.9 t -95.53 103.45 14.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 104.955 -2.239 . . . . 72.430000000000007 104.955 174.694 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 24.7 mtt -58.11 129.44 41.97 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 116.296 1.962 . . . . 54.240000000000002 116.296 -168.927 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.496 HE21 ' CA ' ' A' ' 123' ' ' GLN . 0.0 OUTLIER -106.99 153.3 22.78 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 112.715 -2.039 . . . . 64.239999999999995 107.334 176.418 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 9.5 t -76.75 115.58 16.65 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 122.367 1.079 . . . . 64.230000000000004 109.575 -178.571 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 113.46 3.74 23.85 Favored Glycine 0 N--CA 1.426 -2.016 0 CA-C-N 114.865 -1.062 . . . . 61.340000000000003 110.821 -176.057 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -62.31 133.98 55.86 Favored 'General case' 0 CA--C 1.491 -1.305 0 CA-C-O 121.258 0.551 . . . . 75.209999999999994 111.283 178.991 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -114.33 127.66 55.97 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 115.032 -0.986 . . . . 72.120000000000005 110.32 -178.378 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.461 ' HB ' ' HB3' ' A' ' 135' ' ' LEU . 65.4 mt -97.67 118.94 45.02 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.234 0 N-CA-C 108.039 -1.097 . . . . 65.230000000000004 108.039 177.086 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.476 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 48.9 tp60 -103.39 112.71 25.73 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 115.326 -0.852 . . . . 74.400000000000006 109.148 -177.086 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.455 HG13 ' HB2' ' A' ' 133' ' ' PHE . 14.0 pt -124.34 97.9 4.91 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 108.426 -0.953 . . . . 71.430000000000007 108.426 174.25 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 68.46 -108.65 2.54 Favored Glycine 0 N--CA 1.435 -1.4 0 CA-C-N 114.865 -1.061 . . . . 50.210000000000001 110.62 -175.663 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -108.34 -1.86 19.66 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 120.769 0.318 . . . . 73.430000000000007 111.004 177.638 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.455 ' HB2' HG13 ' A' ' 130' ' ' ILE . 71.0 m-85 -93.54 147.55 22.88 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.724 0.297 . . . . 73.430000000000007 110.984 -177.902 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.421 ' HA ' ' O ' ' A' ' 128' ' ' ILE . 84.1 mtt180 -133.74 129.65 36.98 Favored 'General case' 0 C--O 1.257 1.453 0 CA-C-N 115.785 -0.643 . . . . 71.200000000000003 111.829 -178.979 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.486 HD13 ' N ' ' A' ' 136' ' ' VAL . 3.4 tm? -109.39 144.68 37.27 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 106.185 -1.783 . . . . 74.030000000000001 106.185 172.628 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.486 ' N ' HD13 ' A' ' 135' ' ' LEU . 12.9 p -130.09 128.03 64.1 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.704 0 N-CA-C 109.377 -0.601 . . . . 72.329999999999998 109.377 -178.82 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -110.69 129.88 55.71 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.656 -0.702 . . . . 71.430000000000007 109.569 -176.871 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.3 mp -127.7 140.66 51.94 Favored 'General case' 0 C--O 1.253 1.25 0 CA-C-O 121.363 0.601 . . . . 62.009999999999998 110.804 -179.455 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -86.73 87.88 7.55 Favored 'General case' 0 N--CA 1.422 -1.852 0 CA-C-N 115.339 -0.846 . . . . 74.310000000000002 109.363 179.08 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -120.27 84.13 0.37 Allowed Glycine 0 C--N 1.292 -1.884 0 N-CA-C 107.536 -2.226 . . . . 40.5 107.536 174.517 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.5 ' HA ' ' O ' ' A' ' 46' ' ' SER . 14.9 Cg_endo . . . . . 0 N--CA 1.445 -1.376 0 C-N-CA 122.541 2.16 . . . . 73.299999999999997 114.775 -172.049 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 56.0 t30 . . . . . 0 N--CA 1.468 0.466 0 N-CA-C 112.224 0.453 . . . . 75.530000000000001 112.224 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 88.61 130.11 3.52 Favored Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 120.884 -0.674 . . . . 72.209999999999994 112.189 178.599 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.5 m -111.48 124.69 32.0 Favored Pre-proline 0 C--N 1.302 -1.496 0 N-CA-C 109.777 -0.453 . . . . 74.310000000000002 109.777 179.272 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -66.14 142.24 66.71 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.925 2.417 . . . . 73.549999999999997 112.098 177.736 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -121.75 146.82 46.71 Favored Pre-proline 0 C--N 1.296 -1.721 0 N-CA-C 108.113 -1.069 . . . . 72.0 108.113 178.465 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -61.44 155.14 54.31 Favored 'Trans proline' 0 C--O 1.251 1.164 0 C-N-CA 122.548 2.165 . . . . 50.409999999999997 111.97 178.053 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -66.66 150.86 48.45 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.731 -0.668 . . . . 63.439999999999998 109.934 179.548 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.2 p -88.4 129.09 40.15 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.353 0 CA-C-N 116.114 -0.494 . . . . 52.130000000000003 110.386 179.978 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -78.25 140.74 38.87 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 116.035 -0.529 . . . . 72.109999999999999 110.24 -178.862 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.8 t -101.67 142.23 33.32 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.285 -1.006 . . . . 74.340000000000003 108.285 177.01 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.9 t -157.35 158.43 35.96 Favored 'General case' 0 N--CA 1.422 -1.847 0 N-CA-C 107.555 -1.276 . . . . 74.200000000000003 107.555 -179.004 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.7 t -98.64 101.54 12.99 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.246 -1.02 . . . . 75.040000000000006 108.246 179.788 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.8 p . . . . . 0 C--N 1.315 -0.92 0 CA-C-O 122.339 1.066 . . . . 52.340000000000003 113.299 -176.79 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.537 0 N-CA-C 109.404 -1.479 . . . . 74.420000000000002 109.404 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 65.8 m -89.94 165.15 14.25 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.481 0.658 . . . . 54.299999999999997 111.606 -175.94 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -119.18 163.78 16.56 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 108.329 -0.989 . . . . 73.140000000000001 108.329 179.707 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -135.17 156.29 49.25 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 120.814 0.34 . . . . 60.130000000000003 111.186 -177.821 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.418 ' H ' HD23 ' A' ' 49' ' ' LEU . 1.4 pt? -114.76 132.8 56.33 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.675 -0.861 . . . . 60.509999999999998 108.675 174.307 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 24.8 t -116.03 134.02 60.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.566 -0.901 . . . . 75.540000000000006 108.566 -178.872 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.488 HG21 ' HB3' ' A' ' 57' ' ' ALA . 24.4 t -92.74 121.5 43.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-O 121.018 0.437 . . . . 51.520000000000003 110.158 -177.893 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -94.43 -41.59 9.31 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.698 -0.683 . . . . 63.420000000000002 110.306 177.964 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -153.14 123.88 7.31 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 109.299 -0.63 . . . . 62.100000000000001 109.299 -176.505 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 151.53 130.32 1.64 Allowed Glycine 0 N--CA 1.427 -1.918 0 N-CA-C 111.261 -0.735 . . . . 53.009999999999998 111.261 178.277 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -61.47 -8.62 11.16 Favored 'Trans proline' 0 N--CA 1.481 0.761 0 C-N-CA 123.534 2.823 . . . . 70.5 113.433 178.051 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.511 ' HB2' ' HA ' ' A' ' 80' ' ' LEU . 5.1 p-10 -56.06 -41.04 74.46 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.28 0.632 . . . . 72.140000000000001 110.611 177.475 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.488 ' HB3' HG21 ' A' ' 51' ' ' VAL . . . -178.75 -168.99 0.15 Allowed 'General case' 0 C--O 1.217 -0.64 0 C-N-CA 123.936 0.894 . . . . 43.329999999999998 109.093 -179.145 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -159.48 28.95 0.39 Allowed Glycine 0 C--N 1.312 -0.775 0 N-CA-C 110.184 -1.167 . . . . 54.509999999999998 110.184 179.122 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -130.19 -166.23 1.65 Allowed 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.295 -1.002 . . . . 72.310000000000002 108.295 -175.471 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.457 ' H ' ' NE ' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -122.96 139.96 53.52 Favored 'General case' 0 N--CA 1.412 -2.335 0 N-CA-C 108.771 -0.826 . . . . 73.510000000000005 108.771 178.382 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -118.94 121.78 40.73 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 109.835 -0.432 . . . . 74.239999999999995 109.835 -177.992 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 47.7 tp -91.25 133.98 34.95 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.541 -0.911 . . . . 75.310000000000002 108.541 178.521 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 7.0 mp -83.27 114.93 21.73 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 120.394 -0.523 . . . . 64.319999999999993 111.219 -179.721 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -120.24 18.35 12.27 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.148 -1.056 . . . . 75.439999999999998 108.148 174.56 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -133.94 142.99 45.53 Favored Pre-proline 0 N--CA 1.438 -1.03 0 CA-C-N 113.881 -1.509 . . . . 75.299999999999997 108.045 178.374 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.424 ' HA ' HG13 ' A' ' 94' ' ' ILE . 26.0 Cg_endo -63.16 -31.26 75.17 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.898 2.398 . . . . 63.329999999999998 113.683 -177.371 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 41.2 m -136.49 120.75 17.93 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.82 -0.55 . . . . 72.019999999999996 110.0 179.417 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.503 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 9.2 m -102.99 119.85 39.58 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 106.471 -1.677 . . . . 72.310000000000002 106.471 176.645 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.46 HG23 ' HA ' ' A' ' 76' ' ' SER . 7.9 t -101.47 131.86 47.37 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 109.08 -0.711 . . . . 73.120000000000005 109.08 -176.604 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -127.5 119.47 26.13 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-O 120.845 0.355 . . . . 74.439999999999998 111.826 -174.577 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 60.3 44.81 97.12 Favored Glycine 0 CA--C 1.496 -1.133 0 CA-C-N 115.707 -0.678 . . . . 74.540000000000006 111.641 178.15 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 46.9 ttt180 -137.9 -31.1 0.79 Allowed 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 120.592 -0.443 . . . . 74.310000000000002 111.507 -173.619 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 32.3 m-70 -128.78 160.29 63.89 Favored Pre-proline 0 C--N 1.303 -1.434 0 N-CA-C 107.815 -1.18 . . . . 74.510000000000005 107.815 179.837 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -64.32 -25.4 64.22 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 121.303 1.335 . . . . 74.310000000000002 110.195 172.479 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -99.08 29.46 3.86 Favored 'General case' 0 C--O 1.243 0.756 0 CA-C-N 115.401 -0.818 . . . . 74.340000000000003 111.58 179.422 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.46 ' HA ' HG23 ' A' ' 69' ' ' THR . 70.2 m -54.43 136.53 44.01 Favored 'General case' 0 C--O 1.244 0.814 0 CA-C-O 120.898 0.38 . . . . 75.109999999999999 111.158 178.765 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -61.27 -43.91 98.1 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 115.025 -0.989 . . . . 62.530000000000001 109.911 -177.347 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 48.4 pt -124.93 156.72 33.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 CA-C-N 115.167 -0.924 . . . . 63.43 108.649 176.766 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -106.73 136.18 46.98 Favored 'General case' 0 C--N 1.284 -2.25 0 CA-C-N 115.846 -0.615 . . . . 74.209999999999994 110.026 -179.913 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.511 ' HA ' ' HB2' ' A' ' 56' ' ' ASN . 94.2 mt -107.38 171.74 7.21 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 108.67 -0.863 . . . . 75.400000000000006 108.67 -179.471 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -66.16 122.52 17.62 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 121.971 0.891 . . . . 71.329999999999998 110.213 -178.996 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.406 ' HA ' HG12 ' A' ' 85' ' ' VAL . 17.2 m-20 -67.16 -16.54 64.37 Favored 'General case' 0 C--N 1.278 -2.535 0 CA-C-N 113.888 -1.505 . . . . 55.219999999999999 114.52 -174.784 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.3 t -90.8 -24.66 5.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-O 121.825 0.822 . . . . 61.100000000000001 109.183 -179.283 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 11.2 p -103.26 -3.34 25.8 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.702 -0.681 . . . . 64.430000000000007 112.816 -179.628 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.406 HG12 ' HA ' ' A' ' 82' ' ' ASP . 10.7 p -81.47 121.56 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 N-CA-C 107.971 -1.122 . . . . 71.209999999999994 107.971 179.254 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 27.0 p -115.03 46.31 1.46 Allowed 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 112.122 0.415 . . . . 64.420000000000002 112.122 -175.026 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 87' ' ' ARG . 68.6 mtt180 67.52 108.12 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.883 0.873 . . . . 72.209999999999994 110.928 -178.998 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.42 ' O ' HG23 ' A' ' 104' ' ' VAL . 93.7 mtt180 63.71 78.11 0.3 Allowed 'General case' 0 CA--C 1.506 -0.725 0 N-CA-C 108.815 -0.809 . . . . 63.210000000000001 108.815 178.669 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 41.1 t60 -85.34 -67.27 0.81 Allowed 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 118.701 -1.2 . . . . 74.400000000000006 113.905 -172.522 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -137.8 156.45 47.94 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 118.324 -1.351 . . . . 74.340000000000003 113.589 -173.284 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -127.1 127.76 45.15 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 114.358 -1.292 . . . . 71.109999999999999 108.104 175.172 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.503 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 79.1 m-85 -108.69 112.72 25.18 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 106.085 -1.82 . . . . 75.230000000000004 106.085 174.865 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -117.08 144.4 44.7 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 121.64 0.733 . . . . 71.209999999999994 111.535 -173.396 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.445 ' O ' HD12 ' A' ' 94' ' ' ILE . 2.8 pp -116.17 116.4 52.18 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.64 0 N-CA-C 104.119 -2.549 . . . . 74.109999999999999 104.119 167.347 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.593 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 46.6 t-20 -108.09 145.03 34.65 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 107.734 -1.209 . . . . 72.420000000000002 107.734 -172.647 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -54.66 -26.75 35.17 Favored 'General case' 0 C--N 1.311 -1.078 0 O-C-N 123.645 0.591 . . . . 74.120000000000005 111.076 178.692 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -72.7 -63.35 2.9 Favored Glycine 0 N--CA 1.43 -1.759 0 N-CA-C 110.816 -0.914 . . . . 74.409999999999997 110.816 173.785 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.593 ' O ' ' HB3' ' A' ' 95' ' ' ASN . 44.2 mt-10 -159.26 168.36 26.66 Favored 'General case' 0 C--O 1.212 -0.893 0 N-CA-C 106.202 -1.777 . . . . 73.230000000000004 106.202 -178.38 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.454 ' HB2' ' CB ' ' A' ' 122' ' ' MET . 9.3 m-85 -91.31 134.84 34.25 Favored 'General case' 0 C--N 1.295 -1.767 0 C-N-CA 119.414 -0.914 . . . . 74.530000000000001 109.534 -177.379 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -132.2 136.22 46.87 Favored 'General case' 0 CA--C 1.501 -0.904 0 N-CA-C 113.218 0.821 . . . . 72.040000000000006 113.218 -175.858 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 90.1 t -111.01 119.91 60.6 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.077 0 N-CA-C 108.11 -1.07 . . . . 65.150000000000006 108.11 176.629 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 35.3 t -119.2 116.63 51.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 116.367 -0.379 . . . . 70.540000000000006 110.012 -176.733 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -104.26 108.93 20.55 Favored 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 107.551 -1.277 . . . . 65.340000000000003 107.551 175.97 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 88' ' ' ARG . 26.3 m -92.13 -9.56 10.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-O 121.128 0.489 . . . . 44.350000000000001 110.995 -177.886 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -92.16 27.33 10.49 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 109.759 -1.336 . . . . 71.540000000000006 109.759 176.049 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.42 ' HA ' ' OG1' ' A' ' 110' ' ' THR . 1.1 p -69.52 10.03 0.41 Allowed 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 125.532 1.533 . . . . 74.340000000000003 113.282 -177.455 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.427 HD23 ' O ' ' A' ' 107' ' ' LEU . 6.0 tt -68.22 -24.78 64.96 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 106.251 -1.759 . . . . 72.140000000000001 106.251 172.994 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -78.07 -1.84 34.37 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 115.054 -0.975 . . . . 62.140000000000001 110.657 177.393 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 77.28 56.44 3.97 Favored Glycine 0 N--CA 1.439 -1.123 0 N-CA-C 110.471 -1.052 . . . . 71.329999999999998 110.471 -178.203 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.42 ' OG1' ' HA ' ' A' ' 106' ' ' SER . 17.9 m -72.89 121.42 19.98 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-O 121.606 0.717 . . . . 53.350000000000001 111.507 -176.692 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -102.13 133.27 47.25 Favored 'General case' 0 N--CA 1.416 -2.158 0 N-CA-C 106.199 -1.778 . . . . 72.340000000000003 106.199 175.449 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.442 HG13 HG12 ' A' ' 128' ' ' ILE . 25.9 t -125.17 128.78 73.12 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.063 0 N-CA-C 105.537 -2.023 . . . . 74.120000000000005 105.537 179.822 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 63.55 27.24 14.97 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 107.841 -1.17 . . . . 73.319999999999993 107.841 -173.658 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 67.72 9.31 7.0 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 124.899 1.279 . . . . 73.510000000000005 112.254 -175.226 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.572 ' OE1' ' HD2' ' A' ' 116' ' ' PRO . 9.2 tp10 -111.51 126.38 28.68 Favored Pre-proline 0 C--N 1.305 -1.359 0 N-CA-C 108.452 -0.944 . . . . 75.120000000000005 108.452 -178.826 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.572 ' HD2' ' OE1' ' A' ' 115' ' ' GLU . 32.9 Cg_exo -53.75 113.24 1.23 Allowed 'Trans proline' 0 C--O 1.25 1.099 0 C-N-CA 121.967 1.778 . . . . 74.420000000000002 109.309 173.105 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 12.5 tpp85 -160.13 143.31 13.77 Favored 'General case' 0 N--CA 1.425 -1.704 0 N-CA-C 108.508 -0.923 . . . . 74.319999999999993 108.508 -173.349 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -87.98 -41.57 13.05 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.448 -0.575 . . . . 74.129999999999995 109.448 -179.062 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -132.72 139.34 47.58 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.399 -0.963 . . . . 31.43 108.399 177.429 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.07 148.83 47.01 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 107.249 -1.389 . . . . 73.420000000000002 107.249 -176.744 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 8.7 p -84.58 134.33 27.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 108.518 -0.919 . . . . 74.209999999999994 108.518 179.876 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.454 ' CB ' ' HB2' ' A' ' 99' ' ' PHE . 1.5 tmt? -50.24 124.39 10.27 Favored 'General case' 0 C--N 1.313 -1.008 0 O-C-N 123.739 0.649 . . . . 72.030000000000001 112.671 -175.489 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -129.85 151.09 50.8 Favored 'General case' 0 N--CA 1.424 -1.761 0 CA-C-N 115.148 -0.933 . . . . 72.219999999999999 108.817 173.461 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 6.6 p -78.53 115.17 18.05 Favored 'General case' 0 C--N 1.283 -2.306 0 CA-C-N 115.738 -0.665 . . . . 71.530000000000001 109.636 177.681 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 95.16 33.55 6.52 Favored Glycine 0 N--CA 1.437 -1.271 0 N-CA-C 110.334 -1.107 . . . . 73.239999999999995 110.334 -178.234 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -91.48 150.59 21.16 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 107.125 -1.435 . . . . 72.329999999999998 107.125 -179.79 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -137.85 123.13 19.38 Favored 'General case' 0 C--N 1.29 -2.003 0 CA-C-O 122.093 0.949 . . . . 53.119999999999997 111.069 -177.082 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.442 HG12 HG13 ' A' ' 112' ' ' VAL . 58.9 mt -101.92 126.09 55.96 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.22 0 CA-C-N 114.162 -1.381 . . . . 70.420000000000002 108.46 -176.727 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.423 ' HA ' ' O ' ' A' ' 133' ' ' PHE . 29.8 tt0 -119.69 112.78 19.72 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 109.412 -0.588 . . . . 63.310000000000002 109.412 177.94 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 23.1 pt -105.64 97.48 5.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-N 115.139 -0.937 . . . . 55.520000000000003 109.981 -178.826 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 69.36 -72.6 0.45 Allowed Glycine 0 CA--C 1.526 0.747 0 CA-C-N 115.438 -0.801 . . . . 62.229999999999997 113.69 178.502 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -132.15 -12.71 3.19 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 123.096 0.558 . . . . 71.120000000000005 110.256 -176.076 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.423 ' O ' ' HA ' ' A' ' 129' ' ' GLN . 19.5 m-85 -107.72 156.31 19.24 Favored 'General case' 0 C--N 1.321 -0.656 0 O-C-N 121.76 -0.588 . . . . 72.510000000000005 112.023 -171.29 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 134' ' ' ARG . 50.4 mtp180 -131.32 127.02 36.81 Favored 'General case' 0 C--O 1.251 1.14 0 CA-C-O 121.616 0.722 . . . . 73.0 111.791 -174.745 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 58.6 tp -122.06 135.17 54.79 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 114.531 -1.213 . . . . 72.129999999999995 107.748 -179.693 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 14.9 p -112.06 138.63 40.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 N-CA-C 109.326 -0.62 . . . . 65.219999999999999 109.326 -179.737 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -116.25 129.79 56.46 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 109.334 -0.617 . . . . 64.439999999999998 109.334 -177.359 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 58.4 mt -135.66 172.5 12.92 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.306 -0.627 . . . . 64.430000000000007 109.306 -177.078 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -91.11 146.56 23.74 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 107.639 -1.245 . . . . 73.129999999999995 107.639 175.694 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.406 ' HA3' ' HD3' ' A' ' 141' ' ' PRO . . . -96.58 -127.53 5.52 Favored Glycine 0 N--CA 1.429 -1.772 0 C-N-CA 120.374 -0.917 . . . . 71.409999999999997 111.68 -176.705 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.406 ' HD3' ' HA3' ' A' ' 140' ' ' GLY . 6.6 Cg_exo . . . . . 0 N--CA 1.444 -1.412 0 C-N-CA 122.192 1.928 . . . . 64.120000000000005 112.03 179.973 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 . . . . . 0 C--O 1.247 0.928 0 N-CA-C 107.402 -1.332 . . . . 74.430000000000007 107.402 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -133.15 -166.1 11.33 Favored Glycine 0 N--CA 1.424 -2.118 0 C-N-CA 119.908 -1.139 . . . . 73.530000000000001 111.656 -178.001 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.3 t -100.76 143.57 26.83 Favored Pre-proline 0 N--CA 1.417 -2.104 0 N-CA-C 108.169 -1.048 . . . . 62.310000000000002 108.169 -179.765 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -58.45 128.03 26.89 Favored 'Trans proline' 0 C--O 1.245 0.858 0 C-N-CA 122.409 2.072 . . . . 64.230000000000004 110.658 177.67 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -82.97 126.85 71.61 Favored Pre-proline 0 C--N 1.295 -1.793 0 CA-C-N 115.836 -0.62 . . . . 74.099999999999994 110.668 -176.535 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.76 151.33 28.12 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.298 1.999 . . . . 41.119999999999997 111.277 178.9 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -118.68 110.44 17.3 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.755 0.788 . . . . 73.340000000000003 111.467 179.671 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.9 p -90.23 158.02 2.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 107.283 -1.377 . . . . 64.519999999999996 107.283 177.654 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -92.28 133.32 35.94 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 120.059 -0.656 . . . . 61.140000000000001 111.527 -179.325 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.5 m -106.26 91.78 3.86 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 104.899 -2.26 . . . . 65.230000000000004 104.899 171.569 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 14.9 t -83.13 -175.19 5.71 Favored 'General case' 0 N--CA 1.413 -2.309 0 CA-C-O 121.607 0.718 . . . . 72.409999999999997 111.916 -169.005 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.1 m -81.8 40.35 0.6 Allowed 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 124.952 1.301 . . . . 71.099999999999994 111.65 -173.312 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.7 p . . . . . 0 C--N 1.323 -0.561 0 CA-C-O 122.613 1.197 . . . . 72.430000000000007 110.589 -177.59 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.073 0 N-CA-C 109.682 -1.367 . . . . 61.25 109.682 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.0 m -100.39 156.81 17.05 Favored 'General case' 0 N--CA 1.416 -2.158 0 N-CA-C 108.988 -0.745 . . . . 64.219999999999999 108.988 -178.111 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.514 ' HB1' ' CE1' ' A' ' 137' ' ' PHE . . . -140.63 162.88 34.34 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 106.273 -1.751 . . . . 52.240000000000002 106.273 176.927 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.3 pp -134.31 142.39 47.25 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 118.246 -1.382 . . . . 64.140000000000001 111.836 179.436 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.479 ' O ' HD12 ' A' ' 49' ' ' LEU . 2.2 pp -109.38 140.81 42.61 Favored 'General case' 0 N--CA 1.424 -1.754 0 CA-C-N 115.453 -0.794 . . . . 71.409999999999997 110.266 179.51 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 45.2 t -123.6 113.5 37.6 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 N-CA-C 106.299 -1.741 . . . . 74.120000000000005 106.299 174.12 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.455 HG21 ' HB3' ' A' ' 57' ' ' ALA . 42.1 t -96.28 115.59 35.99 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.115 0 C-N-CA 118.915 -1.114 . . . . 72.409999999999997 108.49 179.476 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -68.99 -38.71 79.45 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 114.728 -1.123 . . . . 61.530000000000001 109.528 -176.559 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 26.4 ttm180 -177.25 142.3 0.35 Allowed 'General case' 0 C--O 1.244 0.773 0 CA-C-N 115.699 -0.682 . . . . 70.239999999999995 109.812 -179.95 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 143.31 165.91 10.94 Favored Glycine 0 N--CA 1.436 -1.36 0 CA-C-N 116.232 -0.44 . . . . 30.199999999999999 112.435 177.266 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -67.53 -8.21 21.55 Favored 'Trans proline' 0 N--CA 1.486 1.044 0 C-N-CA 123.659 2.906 . . . . 65.150000000000006 112.949 178.258 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.544 ' HA ' ' CB ' ' A' ' 80' ' ' LEU . 26.3 t-20 -65.15 -54.13 34.51 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.925 -0.58 . . . . 54.240000000000002 109.898 178.564 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.455 ' HB3' HG21 ' A' ' 51' ' ' VAL . . . -172.56 -176.51 1.54 Allowed 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.897 0.879 . . . . 70.349999999999994 108.822 -179.692 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -158.46 46.28 0.45 Allowed Glycine 0 CA--C 1.494 -1.235 0 N-CA-C 110.155 -1.178 . . . . 74.450000000000003 110.155 179.588 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -162.62 -173.83 3.71 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.157 -1.423 . . . . 72.030000000000001 107.157 -177.797 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.51 132.24 37.06 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 120.673 0.273 . . . . 72.239999999999995 110.46 177.73 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -156.75 155.03 30.92 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 116.002 -0.545 . . . . 75.209999999999994 110.425 -178.346 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.486 HD23 ' H ' ' A' ' 62' ' ' LEU . 2.7 pt? -79.13 139.74 37.97 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 122.063 0.935 . . . . 64.340000000000003 113.056 -178.062 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.461 HD11 HD23 ' A' ' 49' ' ' LEU . 75.3 mt -99.84 133.49 44.13 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 104.87 -2.27 . . . . 41.229999999999997 104.87 172.089 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -147.28 78.52 1.48 Allowed 'General case' 0 C--N 1.296 -1.737 0 CA-C-O 121.568 0.699 . . . . 72.430000000000007 111.449 -178.638 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -147.9 149.69 33.78 Favored Pre-proline 0 C--N 1.306 -1.299 0 N-CA-C 106.918 -1.512 . . . . 63.210000000000001 106.918 174.679 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -58.54 -40.65 72.21 Favored 'Trans proline' 0 C--N 1.366 1.455 0 C-N-CA 122.612 2.208 . . . . 73.430000000000007 110.301 -179.682 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 33.9 m -128.58 100.06 5.61 Favored 'General case' 0 N--CA 1.414 -2.264 0 CA-C-N 114.519 -1.219 . . . . 74.319999999999993 108.322 175.547 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 57.8 m -95.32 113.87 25.59 Favored 'General case' 0 N--CA 1.423 -1.807 0 N-CA-C 107.121 -1.437 . . . . 74.540000000000006 107.121 179.762 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.1 t -108.98 135.77 49.61 Favored 'General case' 0 C--N 1.283 -2.318 0 C-N-CA 120.033 -0.667 . . . . 70.519999999999996 110.717 -174.416 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -119.9 131.7 55.31 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 108.97 -0.752 . . . . 51.140000000000001 108.97 179.466 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 178.73 -122.92 0.83 Allowed Glycine 0 N--CA 1.411 -2.985 0 C-N-CA 120.641 -0.79 . . . . 72.340000000000003 111.145 179.153 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 18.7 tpt180 -146.94 14.92 1.18 Allowed 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 109.658 -0.497 . . . . 74.329999999999998 109.658 -176.078 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.439 ' HB3' ' HB3' ' A' ' 87' ' ' ARG . 38.0 p-80 -98.3 156.34 35.9 Favored Pre-proline 0 C--N 1.318 -0.765 0 N-CA-C 108.253 -1.017 . . . . 64.340000000000003 108.253 179.893 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -49.02 -30.71 18.7 Favored 'Trans proline' 0 N--CA 1.488 1.15 0 C-N-CA 123.907 3.071 . . . . 62.329999999999998 115.766 -174.831 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -93.27 12.76 23.48 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 113.298 0.851 . . . . 71.439999999999998 113.298 -177.439 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 24.2 m -65.76 135.78 55.36 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.632 -0.877 . . . . 73.239999999999995 108.632 176.738 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -68.65 -46.12 70.02 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 107.716 -1.216 . . . . 74.040000000000006 107.716 179.055 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.476 HD13 ' H ' ' A' ' 78' ' ' ILE . 0.2 OUTLIER -125.82 135.35 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 CA-C-N 113.631 -1.622 . . . . 64.519999999999996 109.226 176.929 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -103.86 117.49 34.47 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 115.83 -0.623 . . . . 75.340000000000003 109.373 178.873 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.544 ' CB ' ' HA ' ' A' ' 56' ' ' ASN . 0.9 OUTLIER -86.94 119.89 27.63 Favored 'General case' 0 N--CA 1.418 -2.062 0 N-CA-C 107.548 -1.279 . . . . 75.340000000000003 107.548 174.418 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -84.95 60.57 6.31 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 122.38 1.086 . . . . 61.030000000000001 111.918 -176.109 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -93.04 -175.33 3.83 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 106.311 -1.737 . . . . 70.230000000000004 106.311 171.71 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.6 p -126.99 -6.98 4.65 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 CA-C-O 121.861 0.839 . . . . 73.299999999999997 109.987 -179.029 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 5.8 m -115.22 15.58 16.98 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 122.303 1.049 . . . . 64.120000000000005 108.249 179.376 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.7 p -84.34 138.56 18.96 Favored 'Isoleucine or valine' 0 C--O 1.248 1.011 0 CA-C-N 115.005 -0.998 . . . . 70.439999999999998 110.796 -179.851 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 19.6 m -77.03 166.57 23.14 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.944 -0.571 . . . . 73.030000000000001 110.2 178.37 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.439 ' HB3' ' HB3' ' A' ' 73' ' ' HIS . 18.4 mmt180 -63.12 -37.75 88.43 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 121.317 0.58 . . . . 75.25 109.884 178.495 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.1 119.71 29.36 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 106.517 -1.66 . . . . 71.329999999999998 106.517 167.831 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 9.1 t60 -106.62 -63.11 1.31 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.683 -0.488 . . . . 63.030000000000001 109.683 -175.814 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -134.74 119.43 18.22 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.246 -1.02 . . . . 73.129999999999995 108.246 -179.858 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -104.92 128.04 53.0 Favored 'General case' 0 C--N 1.287 -2.123 0 C-N-CA 119.883 -0.727 . . . . 75.420000000000002 109.368 179.34 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -105.58 119.72 39.82 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 107.673 -1.232 . . . . 65.129999999999995 107.673 -176.366 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -118.59 148.96 42.14 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 109.388 -0.597 . . . . 74.400000000000006 109.388 -178.944 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 4.3 tp -115.58 127.63 73.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 CA-C-O 121.769 0.795 . . . . 74.540000000000006 109.651 -179.83 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -108.17 146.63 32.45 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 106.19 -1.781 . . . . 75.349999999999994 106.19 -179.67 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -54.93 -18.24 4.72 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 113.53 0.937 . . . . 63.229999999999997 113.53 -177.718 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -108.06 -44.51 1.18 Allowed Glycine 0 N--CA 1.431 -1.647 0 C-N-CA 121.377 -0.44 . . . . 52.020000000000003 113.037 177.666 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -133.88 175.57 9.34 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-O 121.615 0.721 . . . . 75.099999999999994 111.935 -174.687 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.412 ' HB2' ' HB3' ' A' ' 122' ' ' MET . 91.4 m-85 -104.68 137.45 42.48 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 106.508 -1.664 . . . . 73.400000000000006 106.508 174.785 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -130.54 130.05 43.61 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 118.28 0.491 . . . . 74.209999999999994 110.039 -178.226 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 6.9 p -117.29 127.64 74.77 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-O 120.926 0.393 . . . . 64.420000000000002 110.35 -179.636 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 30.9 m -118.88 121.38 66.72 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 CA-C-O 121.497 0.665 . . . . 72.340000000000003 111.873 178.544 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -83.41 124.42 30.65 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.281 -0.872 . . . . 61.219999999999999 110.506 175.473 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 6.7 m -125.89 17.42 3.99 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.227 0 CA-C-N 114.837 -1.074 . . . . 60.350000000000001 109.849 176.739 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -127.5 46.92 1.05 Allowed Glycine 0 N--CA 1.443 -0.865 0 N-CA-C 108.866 -1.694 . . . . 63.229999999999997 108.866 177.495 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.7 m -59.52 -23.49 62.87 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 124.359 1.064 . . . . 73.239999999999995 113.643 -173.039 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 85.1 mt -77.62 -21.31 52.49 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.054 -0.658 . . . . 65.349999999999994 112.0 -179.33 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -81.72 -36.0 29.13 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 107.378 -1.341 . . . . 64.329999999999998 107.378 176.008 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 103.78 88.24 2.04 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 114.635 -1.166 . . . . 75.420000000000002 113.995 176.793 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 27.9 m -99.59 120.12 39.16 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.655 -0.868 . . . . 63.329999999999998 108.655 175.211 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.405 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 29.9 m-85 -127.2 152.35 47.49 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 108.792 -0.818 . . . . 74.340000000000003 108.792 -177.726 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 74.7 t -106.32 113.41 42.93 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.111 0 N-CA-C 107.215 -1.402 . . . . 73.319999999999993 107.215 175.525 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 67.07 -73.59 0.08 Allowed 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 126.427 1.891 . . . . 73.239999999999995 109.862 -174.592 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -141.13 -12.56 0.94 Allowed 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 123.235 0.614 . . . . 75.430000000000007 111.106 177.099 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -106.78 140.72 21.64 Favored Pre-proline 0 C--N 1.321 -0.646 0 N-CA-C 112.503 0.557 . . . . 73.010000000000005 112.503 -169.787 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -71.27 93.27 0.65 Allowed 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.695 2.263 . . . . 52.240000000000002 112.777 178.562 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 12.6 mmt85 -110.54 100.51 9.31 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 106.464 -1.68 . . . . 74.329999999999998 106.464 176.032 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -75.85 -31.88 59.51 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 119.896 -0.721 . . . . 72.120000000000005 110.612 -176.101 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -124.35 136.13 53.86 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 105.265 -2.124 . . . . 73.109999999999999 105.265 167.854 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 55.7 tp60 -142.54 148.82 38.22 Favored 'General case' 0 C--N 1.283 -2.285 0 C-N-CA 120.922 -0.311 . . . . 65.430000000000007 110.928 -178.063 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.0 p -79.58 114.62 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.662 0 N-CA-C 103.893 -2.632 . . . . 75.239999999999995 103.893 167.126 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.412 ' HB3' ' HB2' ' A' ' 99' ' ' PHE . 9.7 ttt -68.52 120.35 14.43 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 115.033 -0.985 . . . . 51.039999999999999 111.079 -166.771 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 30.1 tp60 -104.25 124.9 49.98 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.252 -0.886 . . . . 73.230000000000004 110.325 -172.69 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.2 t -78.94 131.69 36.45 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 114.913 -1.04 . . . . 63.109999999999999 108.577 177.458 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 110.0 -9.73 31.73 Favored Glycine 0 N--CA 1.437 -1.266 0 CA-C-N 115.995 -0.548 . . . . 72.25 112.316 178.856 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -113.82 169.9 8.66 Favored 'General case' 0 C--O 1.25 1.118 0 N-CA-C 108.806 -0.813 . . . . 70.010000000000005 108.806 -177.357 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -110.63 144.98 38.69 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.791 0.805 . . . . 65.329999999999998 111.747 -178.25 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 65.2 mt -106.55 124.78 62.28 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 N-CA-C 107.367 -1.346 . . . . 52.32 107.367 177.139 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.405 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 58.2 tp60 -97.73 116.55 30.17 Favored 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 108.899 -0.778 . . . . 73.409999999999997 108.899 -176.896 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.1 pt -115.41 97.71 5.95 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.301 0 CA-C-O 122.177 0.989 . . . . 72.409999999999997 109.565 177.904 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 68.85 -116.55 7.4 Favored Glycine 0 N--CA 1.429 -1.786 0 CA-C-N 114.454 -1.248 . . . . 73.010000000000005 111.4 -175.697 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 17.9 tppt? -94.14 -22.14 18.65 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.239 0.542 . . . . 54.200000000000003 110.588 179.64 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -101.34 161.17 13.82 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 116.24 -0.437 . . . . 73.430000000000007 112.121 -174.919 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 9.8 ptp85 -137.28 144.37 42.66 Favored 'General case' 0 C--O 1.245 0.847 0 N-CA-C 113.419 0.896 . . . . 75.540000000000006 113.419 -172.984 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.8 tt -121.99 138.57 54.37 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 106.915 -1.513 . . . . 75.120000000000005 106.915 -179.247 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 27.7 t -106.83 130.49 58.68 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 N-CA-C 106.772 -1.566 . . . . 61.229999999999997 106.772 179.401 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . 0.514 ' CE1' ' HB1' ' A' ' 47' ' ' ALA . 86.4 t80 -104.37 128.19 52.16 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 112.086 0.402 . . . . 74.340000000000003 112.086 -174.78 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -128.57 151.13 49.8 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 108.211 -1.033 . . . . 73.430000000000007 108.211 173.882 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -62.81 149.54 43.89 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.892 -0.781 . . . . 43.520000000000003 108.892 175.47 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.419 ' N ' ' HA ' ' A' ' 47' ' ' ALA . . . -69.42 169.32 44.27 Favored Glycine 0 N--CA 1.434 -1.485 0 C-N-CA 120.88 -0.676 . . . . 54.310000000000002 113.405 -175.499 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo . . . . . 0 C--O 1.241 0.637 0 C-N-CA 123.25 2.633 . . . . 74.019999999999996 111.734 -179.881 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.0 p30 . . . . . 0 C--O 1.251 1.141 0 N-CA-C 109.019 -0.734 . . . . 72.400000000000006 109.019 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -81.95 149.12 27.83 Favored Glycine 0 N--CA 1.421 -2.307 0 N-CA-C 110.736 -0.945 . . . . 74.319999999999993 110.736 179.289 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.3 m -63.28 139.61 97.58 Favored Pre-proline 0 C--N 1.303 -1.425 0 N-CA-C 107.452 -1.314 . . . . 75.239999999999995 107.452 176.568 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -51.14 137.02 45.94 Favored 'Trans proline' 0 C--O 1.25 1.1 0 C-N-CA 122.326 2.017 . . . . 71.209999999999994 110.36 177.845 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -68.58 143.68 95.46 Favored Pre-proline 0 C--N 1.307 -1.254 0 CA-C-N 116.129 -0.487 . . . . 75.329999999999998 110.183 -174.565 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -36.94 114.78 0.13 Allowed 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 124.823 3.682 . . . . 62.240000000000002 113.784 -177.079 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -102.27 156.58 17.48 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.104 -1.443 . . . . 75.319999999999993 107.104 -178.895 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.4 m -90.26 148.36 4.6 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 CA-C-O 120.895 0.378 . . . . 70.530000000000001 110.222 177.533 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -103.5 141.52 35.85 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.14 -1.059 . . . . 44.439999999999998 108.14 177.315 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.5 t -68.92 152.7 44.94 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.705 -0.85 . . . . 63.25 108.705 179.007 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.9 t -145.11 105.45 4.08 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-O 121.748 0.785 . . . . 74.450000000000003 112.039 -176.88 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.6 t -94.21 96.03 9.33 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 105.589 -2.004 . . . . 75.530000000000001 105.589 174.982 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.1 p . . . . . 0 C--N 1.301 -1.511 0 CA-C-O 121.986 0.898 . . . . 72.340000000000003 112.209 -173.0 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.426 -2.015 0 N-CA-C 107.29 -2.324 . . . . 72.5 107.29 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.2 m -103.09 155.26 18.52 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-O 121.179 0.514 . . . . 54.32 111.155 -174.726 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.421 ' HA ' ' N ' ' A' ' 140' ' ' GLY . . . -146.3 151.37 37.41 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.145 -1.428 . . . . 75.450000000000003 107.145 177.705 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.447 HD23 ' H ' ' A' ' 48' ' ' LEU . 2.6 pt? -123.03 151.38 41.98 Favored 'General case' 0 CA--C 1.493 -1.243 0 CA-C-O 121.576 0.703 . . . . 71.200000000000003 111.392 -175.041 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.401 ' HB3' ' CD2' ' A' ' 137' ' ' PHE . 0.9 OUTLIER -129.74 132.72 46.68 Favored 'General case' 0 C--N 1.276 -2.595 0 CA-C-N 115.259 -0.882 . . . . 71.310000000000002 108.651 175.23 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.422 HG12 ' HB3' ' A' ' 60' ' ' ARG . 23.5 m -104.37 141.41 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 N-CA-C 108.749 -0.834 . . . . 65.129999999999995 108.749 -178.222 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.454 ' HA ' ' HG ' ' A' ' 135' ' ' LEU . 39.9 t -92.92 114.97 30.68 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 N-CA-C 107.591 -1.263 . . . . 65.209999999999994 107.591 178.558 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.9 tmtm? -73.23 -44.34 59.69 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 106.157 -1.794 . . . . 61.130000000000003 106.157 -178.723 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.416 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 35.1 ttm180 -165.16 128.0 2.21 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 106.59 -1.633 . . . . 74.340000000000003 106.59 176.815 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 158.52 133.84 1.61 Allowed Glycine 0 N--CA 1.42 -2.414 0 C-N-CA 120.183 -1.008 . . . . 54.119999999999997 111.924 -179.697 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.422 ' HB2' ' HB2' ' A' ' 82' ' ' ASP . 52.2 Cg_exo -59.62 -7.83 6.3 Favored 'Trans proline' 0 N--CA 1.484 0.963 0 C-N-CA 124.201 3.267 . . . . 60.200000000000003 114.116 178.612 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -44.16 -48.16 9.16 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.565 1.146 . . . . 75.239999999999995 111.379 175.349 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -165.29 -48.14 0.03 OUTLIER 'General case' 0 CA--C 1.51 -0.581 0 CA-C-O 121.329 0.585 . . . . 33.25 109.979 -179.348 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.12 25.58 57.24 Favored Glycine 0 C--O 1.225 -0.441 0 N-CA-C 110.528 -1.029 . . . . 60.009999999999998 110.528 -177.847 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -146.84 -157.32 0.8 Allowed 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.704 -1.221 . . . . 74.299999999999997 107.704 -177.494 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.454 ' HD3' ' H ' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -129.54 141.39 50.99 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 108.251 -1.018 . . . . 72.329999999999998 108.251 177.309 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -140.6 153.69 46.17 Favored 'General case' 0 C--N 1.291 -1.955 0 C-N-CA 120.544 -0.462 . . . . 74.420000000000002 109.99 178.064 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.432 ' HG ' ' HB3' ' A' ' 48' ' ' LEU . 8.4 mp -103.68 140.61 37.36 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 115.728 -0.669 . . . . 75.129999999999995 109.605 -179.177 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 88.1 mt -72.14 114.13 9.92 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.085 -1.08 . . . . 73.209999999999994 108.085 175.388 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -117.91 4.8 12.15 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.588 -0.893 . . . . 71.010000000000005 108.588 -179.633 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.494 ' HB2' ' OG1' ' A' ' 68' ' ' THR . 1.0 OUTLIER -122.13 131.81 24.35 Favored Pre-proline 0 N--CA 1.437 -1.075 0 CA-C-N 115.893 -0.594 . . . . 54.329999999999998 109.726 -174.9 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.415 ' HA ' ' CG2' ' A' ' 94' ' ' ILE . 2.8 Cg_exo -54.52 -40.15 84.92 Favored 'Trans proline' 0 C--N 1.36 1.142 0 C-N-CA 123.302 2.668 . . . . 71.340000000000003 110.904 177.822 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 97.6 m -126.34 103.28 7.56 Favored 'General case' 0 N--CA 1.42 -1.941 0 CA-C-N 114.964 -1.016 . . . . 52.25 108.716 175.829 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.494 ' OG1' ' HB2' ' A' ' 65' ' ' GLN . 38.3 m -107.24 113.07 26.25 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 108.1 -1.074 . . . . 61.409999999999997 108.1 179.047 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.1 m -105.2 121.05 43.03 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 120.469 -0.492 . . . . 73.219999999999999 109.898 -178.57 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.583 ' HB1' HD11 ' A' ' 80' ' ' LEU . . . -95.68 124.08 39.54 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 109.074 -0.713 . . . . 74.519999999999996 109.074 -179.878 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.445 ' O ' ' HA ' ' A' ' 79' ' ' PHE . . . -159.62 -179.01 34.14 Favored Glycine 0 N--CA 1.437 -1.248 0 C-N-CA 120.237 -0.983 . . . . 74.450000000000003 112.401 179.85 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.71 ' NH1' ' HA ' ' A' ' 81' ' ' ASP . 25.3 tpt180 -112.99 84.89 2.07 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.602 -0.888 . . . . 74.519999999999996 108.602 177.641 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -177.73 147.85 0.66 Allowed Pre-proline 0 C--N 1.314 -0.936 0 C-N-CA 125.509 1.524 . . . . 73.109999999999999 106.936 178.43 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -56.7 -40.47 84.09 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.787 2.325 . . . . 63.340000000000003 112.487 179.389 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -87.9 64.8 8.04 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-O 122.684 1.23 . . . . 70.439999999999998 112.467 177.855 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 19.6 m -133.59 159.9 39.08 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 104.684 -2.339 . . . . 71.040000000000006 104.684 172.601 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -64.96 -42.58 94.47 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 118.972 0.805 . . . . 71.510000000000005 109.592 -178.532 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.95 138.5 43.76 Favored 'Isoleucine or valine' 0 C--O 1.251 1.133 0 N-CA-C 106.944 -1.502 . . . . 73.109999999999999 106.944 171.735 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.445 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 53.5 p90 -107.62 125.34 51.22 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.734 -0.786 . . . . 74.420000000000002 111.813 -179.601 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.583 HD11 ' HB1' ' A' ' 70' ' ' ALA . 5.3 mp -80.51 135.83 36.18 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.76 -1.2 . . . . 75.140000000000001 107.76 178.685 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.71 ' HA ' ' NH1' ' A' ' 72' ' ' ARG . 25.5 t70 -92.13 39.81 1.03 Allowed 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.682 0.753 . . . . 74.420000000000002 111.878 -174.648 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.422 ' HB2' ' HB2' ' A' ' 55' ' ' PRO . 12.0 t70 -123.5 151.36 42.88 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.928 -0.767 . . . . 32.409999999999997 108.928 178.511 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 33.3 m -90.26 -5.89 10.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 113.015 0.746 . . . . 73.099999999999994 113.015 -174.963 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.2 t -83.65 -13.1 54.99 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-O 121.816 0.817 . . . . 71.329999999999998 108.987 178.424 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.44 HG13 ' HB2' ' A' ' 89' ' ' HIS . 51.3 t -82.83 134.49 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 CA-C-N 114.906 -1.043 . . . . 75.299999999999997 110.023 -175.998 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.534 ' OG ' HD21 ' A' ' 107' ' ' LEU . 58.3 m -82.74 -174.01 4.98 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 116.155 -0.475 . . . . 73.010000000000005 111.534 -179.949 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -56.05 -50.49 70.81 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 108.204 -1.035 . . . . 75.310000000000002 108.204 175.099 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 59.0 mtt180 -126.74 115.78 19.92 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 105.597 -2.001 . . . . 72.409999999999997 105.597 174.376 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.44 ' HB2' HG13 ' A' ' 85' ' ' VAL . 11.0 t60 -100.02 -51.34 3.72 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 121.656 0.741 . . . . 61.229999999999997 109.812 -177.149 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -145.51 145.01 30.89 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 108.416 -0.957 . . . . 61.140000000000001 108.416 -179.786 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -121.89 127.86 50.93 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-O 121.699 0.761 . . . . 63.409999999999997 109.75 178.453 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -107.82 113.69 27.1 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 107.39 -1.337 . . . . 61.149999999999999 107.39 -178.27 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 41.9 mtp180 -117.52 147.57 42.65 Favored 'General case' 0 C--N 1.283 -2.29 0 C-N-CA 119.936 -0.706 . . . . 72.510000000000005 110.277 -179.033 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.415 ' CG2' ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -116.44 122.56 70.07 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.132 0 N-CA-C 106.872 -1.529 . . . . 72.430000000000007 106.872 175.977 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -108.47 146.8 32.61 Favored 'General case' 0 C--N 1.275 -2.669 0 N-CA-C 107.434 -1.321 . . . . 74.340000000000003 107.434 -178.641 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -51.12 -22.83 2.72 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 123.769 0.827 . . . . 65.310000000000002 112.581 179.828 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -91.73 -51.33 2.51 Favored Glycine 0 N--CA 1.432 -1.618 0 C-N-CA 121.046 -0.597 . . . . 33.329999999999998 112.693 175.322 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -149.95 175.21 11.88 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 117.496 0.648 . . . . 61.310000000000002 112.387 -175.223 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.521 ' HB2' ' HB2' ' A' ' 122' ' ' MET . 63.1 m-85 -99.0 132.08 44.57 Favored 'General case' 0 C--O 1.247 0.951 0 N-CA-C 108.318 -0.993 . . . . 64.540000000000006 108.318 176.407 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -131.89 128.75 39.24 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 121.038 0.447 . . . . 74.400000000000006 111.196 -175.964 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 5.3 p -116.46 122.19 69.26 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-O 121.244 0.545 . . . . 74.230000000000004 110.507 177.804 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.7 m -119.53 136.96 55.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-N 115.736 -0.665 . . . . 75.219999999999999 109.999 177.833 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.432 ' OD2' ' HA ' ' A' ' 118' ' ' ASN . 1.4 p30 -86.39 143.12 27.98 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 118.727 -1.189 . . . . 72.230000000000004 108.345 175.409 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 15.7 m -127.68 12.31 3.29 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 CA-C-O 122.033 0.92 . . . . 74.030000000000001 109.298 176.773 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -161.67 67.69 0.24 Allowed Glycine 0 N--CA 1.427 -1.926 0 CA-C-N 114.569 -1.196 . . . . 73.409999999999997 110.965 -179.729 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.43 ' HB2' ' OD1' ' A' ' 103' ' ' ASP . 22.1 t -88.99 80.44 7.05 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 122.045 -0.68 . . . . 75.450000000000003 109.438 178.425 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.534 HD21 ' OG ' ' A' ' 86' ' ' SER . 1.9 mm? -81.03 -51.95 7.95 Favored 'General case' 0 CA--C 1.501 -0.908 0 C-N-CA 120.143 -0.623 . . . . 75.329999999999998 109.609 179.324 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -100.04 2.91 43.79 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.667 -0.697 . . . . 74.109999999999999 109.288 -175.869 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 100.93 130.72 7.15 Favored Glycine 0 N--CA 1.427 -1.955 0 CA-C-N 115.483 -0.781 . . . . 55.140000000000001 112.296 -178.662 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.442 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 26.9 m -105.68 119.52 39.35 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 106.764 -1.569 . . . . 62.119999999999997 106.764 172.79 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -125.67 144.23 50.69 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 120.843 0.354 . . . . 75.109999999999999 111.32 -173.736 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 5.2 p -121.81 111.74 32.15 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 N-CA-C 106.378 -1.712 . . . . 72.25 106.378 169.655 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 56.51 41.79 28.21 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.219 0.533 . . . . 73.019999999999996 111.228 -176.642 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 74.77 4.55 4.36 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.643 1.177 . . . . 75.239999999999995 112.782 179.749 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -97.27 115.6 65.77 Favored Pre-proline 0 C--N 1.315 -0.908 0 N-CA-C 110.008 -0.367 . . . . 75.120000000000005 110.008 178.261 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.442 ' HA ' ' O ' ' A' ' 110' ' ' THR . 41.8 Cg_endo -78.2 95.68 1.08 Allowed 'Trans proline' 0 N--CA 1.449 -1.122 0 C-N-CA 121.986 1.79 . . . . 70.219999999999999 110.688 176.866 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 27.8 mmm180 -114.23 146.32 40.56 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.601 -1.259 . . . . 54.149999999999999 107.601 -177.583 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.432 ' HA ' ' OD2' ' A' ' 103' ' ' ASP . 2.7 t-20 -84.17 -38.58 20.46 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.568 0.699 . . . . 72.420000000000002 110.46 -177.801 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -130.73 139.0 50.25 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 108.322 -0.992 . . . . 50.219999999999999 108.322 177.038 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.412 ' HA ' ' OE1' ' A' ' 120' ' ' GLN . 5.6 tp60 -139.81 145.45 38.18 Favored 'General case' 0 N--CA 1.425 -1.703 0 CA-C-O 121.299 0.571 . . . . 61.130000000000003 111.505 179.536 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 60.7 t -92.11 134.24 30.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 106.049 -1.834 . . . . 60.310000000000002 106.049 175.433 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.521 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 17.0 tmm? -39.36 127.09 1.81 Allowed 'General case' 0 N--CA 1.483 1.188 0 O-C-N 124.443 1.089 . . . . 74.120000000000005 113.366 -177.632 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -128.79 124.1 34.59 Favored 'General case' 0 N--CA 1.417 -2.088 0 N-CA-C 105.982 -1.859 . . . . 74.430000000000007 105.982 177.844 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 4.9 t -92.87 130.86 38.32 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 121.56 0.695 . . . . 54.329999999999998 112.221 -173.874 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 94.64 3.03 62.86 Favored Glycine 0 N--CA 1.438 -1.201 0 CA-C-N 115.24 -0.891 . . . . 63.119999999999997 111.393 177.784 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -106.43 168.02 9.44 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.533 -0.333 . . . . 75.400000000000006 111.157 -177.579 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -108.73 131.64 54.74 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.291 0.567 . . . . 72.439999999999998 111.88 -172.71 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 61.9 mt -119.05 113.22 40.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-N 115.344 -0.843 . . . . 62.130000000000003 109.211 179.816 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -95.32 112.75 24.41 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 109.098 -0.705 . . . . 74.030000000000001 109.098 177.425 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.5 pt -100.98 103.42 14.81 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 CA-C-O 122.127 0.965 . . . . 72.219999999999999 108.741 176.083 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 80.3 -104.96 2.31 Favored Glycine 0 N--CA 1.413 -2.86 0 CA-C-N 114.678 -1.146 . . . . 74.549999999999997 110.765 179.822 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -119.92 1.2 10.94 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 121.158 0.504 . . . . 53.509999999999998 110.954 -176.786 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.416 ' HB2' ' O ' ' A' ' 53' ' ' ARG . 20.1 p90 -127.97 160.06 33.06 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 116.265 -0.425 . . . . 74.040000000000006 110.883 -178.114 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 11.1 ptp180 -129.59 139.16 51.55 Favored 'General case' 0 C--O 1.252 1.224 0 N-CA-C 114.818 1.414 . . . . 71.109999999999999 114.818 -169.517 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.454 ' HG ' ' HA ' ' A' ' 51' ' ' VAL . 8.2 mp -121.86 144.23 48.96 Favored 'General case' 0 N--CA 1.424 -1.747 0 CA-C-N 113.406 -1.724 . . . . 73.5 108.596 179.052 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 58.3 t -107.37 124.16 63.1 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.141 0 N-CA-C 106.907 -1.516 . . . . 73.409999999999997 106.907 179.433 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . 0.401 ' CD2' ' HB3' ' A' ' 49' ' ' LEU . 6.4 t80 -100.33 130.33 46.42 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.92 -0.4 . . . . 75.439999999999998 109.92 -173.12 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -126.55 151.72 47.52 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 121.1 0.476 . . . . 70.420000000000002 109.774 -179.847 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -69.58 135.98 50.69 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.108 -1.441 . . . . 71.239999999999995 107.108 172.766 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.421 ' N ' ' HA ' ' A' ' 47' ' ' ALA . . . -82.98 -177.25 51.92 Favored Glycine 0 N--CA 1.439 -1.131 0 C-N-CA 120.102 -1.047 . . . . 54.329999999999998 112.603 -174.907 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo . . . . . 0 N--CA 1.439 -1.732 0 C-N-CA 122.204 1.936 . . . . 55.340000000000003 109.715 175.922 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 18.1 m120 . . . . . 0 CA--C 1.501 -0.932 0 CA-C-O 121.061 0.457 . . . . 64.129999999999995 110.751 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 154.51 115.86 0.56 Allowed Glycine 0 C--N 1.294 -1.759 0 N-CA-C 109.849 -1.3 . . . . 72.439999999999998 109.849 -178.692 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.3 m -82.65 124.8 77.1 Favored Pre-proline 0 C--N 1.299 -1.626 0 N-CA-C 109.236 -0.653 . . . . 73.109999999999999 109.236 -179.024 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.17 128.05 28.17 Favored 'Trans proline' 0 C--N 1.36 1.159 0 C-N-CA 122.331 2.02 . . . . 73.329999999999998 109.718 175.852 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -75.4 120.27 80.88 Favored Pre-proline 0 C--N 1.308 -1.229 0 CA-C-N 116.063 -0.517 . . . . 65.219999999999999 111.992 -173.141 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -82.16 129.55 6.07 Favored 'Trans proline' 0 N--CA 1.443 -1.487 0 C-N-CA 122.238 1.959 . . . . 75.230000000000004 110.321 175.935 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -89.21 119.58 29.83 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.624 -0.88 . . . . 74.310000000000002 108.624 179.381 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.9 m -91.77 166.82 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 116.32 -0.4 . . . . 62.240000000000002 111.389 -175.586 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -96.49 141.13 30.14 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 108.823 -0.806 . . . . 75.209999999999994 108.823 176.119 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 50.3 m -120.06 102.33 8.46 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-O 121.301 0.572 . . . . 62.43 109.911 178.89 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.9 m -123.9 141.49 51.99 Favored 'General case' 0 N--CA 1.408 -2.545 0 N-CA-C 105.644 -1.984 . . . . 71.5 105.644 177.533 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.3 t -132.17 146.4 52.0 Favored 'General case' 0 C--N 1.271 -2.805 0 N-CA-C 108.709 -0.848 . . . . 44.200000000000003 108.709 -177.888 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.7 m . . . . . 0 N--CA 1.43 -1.441 0 CA-C-O 121.11 0.481 . . . . 72.150000000000006 110.092 179.707 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.482 -2.023 0 N-CA-C 106.635 -2.586 . . . . 55.130000000000003 106.635 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.7 m -90.88 167.42 12.45 Favored 'General case' 0 N--CA 1.414 -2.226 0 CA-C-N 113.058 -1.571 . . . . 74.109999999999999 111.383 -171.549 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.66 157.4 44.93 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 106.775 -1.565 . . . . 75.299999999999997 106.775 176.394 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.4 pp -134.63 151.97 51.44 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 119.632 -0.827 . . . . 51.130000000000003 111.787 -178.822 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -126.79 136.76 52.82 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.734 -0.666 . . . . 71.430000000000007 109.565 -179.6 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.445 ' CG2' ' HB ' ' A' ' 136' ' ' VAL . 33.5 m -114.24 128.97 71.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 109.202 -0.666 . . . . 61.030000000000001 109.202 175.475 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.6 t -95.14 125.57 47.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 109.439 -0.578 . . . . 72.420000000000002 109.439 -177.2 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -96.66 -34.07 11.52 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.879 -0.6 . . . . 72.299999999999997 110.078 176.17 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.449 ' O ' ' HB3' ' A' ' 133' ' ' PHE . 30.9 tpt180 -165.46 121.51 1.37 Allowed 'General case' 0 CA--C 1.496 -1.133 0 N-CA-C 108.992 -0.744 . . . . 74.530000000000001 108.992 175.938 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -163.19 164.88 36.3 Favored Glycine 0 N--CA 1.415 -2.714 0 N-CA-C 108.218 -1.953 . . . . 53.119999999999997 108.218 177.353 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.483 ' HB2' ' HB3' ' A' ' 82' ' ' ASP . 14.3 Cg_exo -68.82 -20.81 39.05 Favored 'Trans proline' 0 C--O 1.238 0.518 0 C-N-CA 122.385 2.057 . . . . 60.100000000000001 111.397 179.997 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.419 ' HB3' ' CA ' ' A' ' 80' ' ' LEU . 21.8 p-10 -68.52 -59.34 3.22 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 114.761 -1.109 . . . . 72.030000000000001 112.387 -178.651 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -175.75 -153.52 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 108.18 -1.044 . . . . 73.200000000000003 108.18 -173.096 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.03 54.05 0.35 Allowed Glycine 0 N--CA 1.428 -1.888 0 N-CA-C 107.708 -2.157 . . . . 22.41 107.708 178.677 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -135.91 -167.41 2.03 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 108.52 -0.918 . . . . 62.229999999999997 108.52 -173.93 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 17.7 ptp180 -116.12 144.95 43.47 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 120.546 0.213 . . . . 62.399999999999999 110.502 -177.95 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -136.81 140.48 42.5 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 108.516 -0.92 . . . . 64.420000000000002 108.516 179.97 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.1 tt -117.97 136.29 53.6 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 109.072 -0.714 . . . . 74.340000000000003 109.072 177.979 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.441 HD12 HG21 ' A' ' 68' ' ' THR . 1.2 mm? -93.36 115.27 27.84 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.853 -0.425 . . . . 72.340000000000003 109.853 -178.889 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -109.6 13.41 23.89 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 122.439 1.114 . . . . 74.349999999999994 108.569 179.082 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -123.93 144.49 45.14 Favored Pre-proline 0 C--N 1.309 -1.172 0 CA-C-N 115.307 -0.861 . . . . 71.239999999999995 109.927 -177.628 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.557 ' HA ' ' CD1' ' A' ' 94' ' ' ILE . 10.1 Cg_endo -55.34 -54.98 3.5 Favored 'Trans proline' 0 C--N 1.358 1.037 0 C-N-CA 123.468 2.779 . . . . 73.430000000000007 113.851 -177.773 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 42.6 m -113.41 108.61 17.44 Favored 'General case' 0 N--CA 1.425 -1.676 0 N-CA-C 109.581 -0.525 . . . . 64.099999999999994 109.581 -178.718 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.441 HG21 HD12 ' A' ' 63' ' ' LEU . 24.8 m -103.23 114.16 28.22 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 108.982 -0.748 . . . . 60.5 108.982 175.899 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.6 p -98.51 115.25 28.16 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 121.794 0.806 . . . . 74.420000000000002 111.814 -179.555 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.63 134.87 41.89 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 106.901 -1.518 . . . . 70.400000000000006 106.901 175.685 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.418 ' HA3' ' HB3' ' A' ' 89' ' ' HIS . . . 82.57 73.56 1.22 Allowed Glycine 0 C--N 1.3 -1.436 0 C-N-CA 119.702 -1.237 . . . . 71.209999999999994 110.327 -175.183 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 56.9 ttt180 -158.35 106.61 1.95 Allowed 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 105.206 -2.146 . . . . 72.019999999999996 105.206 -178.472 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 19.0 m-70 -52.01 -68.37 0.42 Allowed Pre-proline 0 CA--C 1.55 0.959 0 N-CA-C 116.069 1.877 . . . . 61.030000000000001 116.069 -169.999 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -66.97 -40.15 12.51 Favored 'Trans proline' 0 C--N 1.359 1.093 0 C-N-CA 121.286 1.324 . . . . 73.200000000000003 114.101 -176.18 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -125.77 75.58 1.51 Allowed 'General case' 0 C--N 1.32 -0.675 0 O-C-N 122.293 -0.254 . . . . 72.349999999999994 110.521 -175.588 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 18.0 p -78.31 123.17 26.66 Favored 'General case' 0 C--N 1.28 -2.454 0 C-N-CA 119.11 -1.036 . . . . 73.239999999999995 109.093 176.391 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -67.09 -55.56 13.76 Favored 'General case' 0 CA--C 1.485 -1.537 0 N-CA-C 107.365 -1.346 . . . . 73.219999999999999 107.365 175.696 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 45.4 pt -125.67 148.0 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.847 0 CA-C-N 115.047 -0.979 . . . . 62.119999999999997 108.427 173.998 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -97.51 136.22 38.24 Favored 'General case' 0 C--N 1.276 -2.592 0 CA-C-N 115.321 -0.854 . . . . 75.200000000000003 108.929 177.151 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.419 ' CA ' ' HB3' ' A' ' 56' ' ' ASN . 58.1 tp -144.21 -88.62 0.12 Allowed 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.799 -0.815 . . . . 62.530000000000001 108.799 -175.158 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -76.34 96.93 4.1 Favored 'General case' 0 C--N 1.261 -3.242 0 N-CA-C 108.36 -0.978 . . . . 74.040000000000006 108.36 171.478 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.483 ' HB3' ' HB2' ' A' ' 55' ' ' PRO . 14.6 t70 -81.09 -54.96 5.09 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.269 -0.878 . . . . 54.340000000000003 110.206 -179.077 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.9 t -85.11 -39.91 14.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 CA-C-N 114.882 -1.054 . . . . 74.219999999999999 109.123 -178.994 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.6 p -87.47 32.78 0.7 Allowed 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 124.386 1.075 . . . . 60.439999999999998 111.395 -178.328 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.9 p -81.3 139.87 17.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 CA-C-N 115.171 -0.922 . . . . 70.430000000000007 112.137 -171.909 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 23.3 t -128.52 -176.86 3.95 Favored 'General case' 0 N--CA 1.424 -1.767 0 N-CA-C 107.625 -1.25 . . . . 74.230000000000004 107.625 175.88 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -100.77 120.41 40.07 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 123.446 0.699 . . . . 73.340000000000003 109.227 -177.94 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 88' ' ' ARG . 11.0 mmm180 64.49 32.92 11.42 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 108.419 -0.956 . . . . 62.409999999999997 108.419 -176.372 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.418 ' HB3' ' HA3' ' A' ' 71' ' ' GLY . 67.4 t60 -46.79 -66.45 0.4 Allowed 'General case' 0 C--O 1.241 0.641 0 C-N-CA 124.759 1.224 . . . . 75.219999999999999 112.429 -175.317 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.537 ' HA ' ' HA ' ' A' ' 103' ' ' ASP . . . -141.05 141.34 34.3 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 121.147 -0.221 . . . . 54.43 110.776 -178.129 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -116.32 127.75 54.96 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.33 0.586 . . . . 63.219999999999999 110.791 177.495 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.419 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 41.5 m-85 -105.11 112.64 25.84 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 105.611 -1.996 . . . . 72.409999999999997 105.611 174.302 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -124.38 150.09 45.94 Favored 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 120.49 -0.484 . . . . 73.209999999999994 109.742 -176.522 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.557 ' CD1' ' HA ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -116.95 139.1 45.32 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.063 0 C-N-CA 118.985 -1.086 . . . . 72.310000000000002 108.444 172.233 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -119.22 145.33 46.14 Favored 'General case' 0 C--N 1.27 -2.884 0 N-CA-C 105.793 -1.929 . . . . 74.540000000000006 105.793 176.696 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.94 -20.15 8.33 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 114.038 1.125 . . . . 44.439999999999998 114.038 -173.457 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -106.46 -31.95 3.84 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 119.953 -1.118 . . . . 73.109999999999999 114.16 177.789 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -145.33 147.34 32.21 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-N 117.65 0.725 . . . . 62.009999999999998 109.803 -175.026 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.456 ' HB2' ' HB3' ' A' ' 122' ' ' MET . 30.5 m-85 -94.9 129.88 41.73 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 106.974 -1.491 . . . . 52.229999999999997 106.974 176.4 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -132.3 129.26 39.32 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 119.535 -0.866 . . . . 74.439999999999998 111.76 -175.061 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 61.4 t -114.11 118.1 57.44 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 107.842 -1.17 . . . . 73.340000000000003 107.842 177.552 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 30.8 m -121.06 130.82 74.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 CA-C-N 115.934 -0.576 . . . . 72.120000000000005 109.991 178.9 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.537 ' HA ' ' HA ' ' A' ' 90' ' ' ALA . 0.7 OUTLIER -97.0 138.78 34.0 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 117.326 -1.75 . . . . 74.319999999999993 108.406 170.718 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.8 m -124.18 -2.46 6.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 112.183 0.438 . . . . 61.409999999999997 112.183 179.948 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -89.86 -44.9 4.69 Favored Glycine 0 CA--C 1.509 -0.319 0 N-CA-C 109.752 -1.339 . . . . 65.099999999999994 109.752 175.97 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 14.2 m 58.79 29.2 18.41 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 114.414 1.264 . . . . 72.200000000000003 114.414 174.013 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 49.3 tp -85.32 -48.21 9.28 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 120.109 -0.636 . . . . 72.209999999999994 112.541 -177.659 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -87.64 -19.45 27.71 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 119.448 -0.901 . . . . 62.140000000000001 111.315 -176.247 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 97.34 127.97 5.81 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 120.418 -0.896 . . . . 74.310000000000002 113.666 176.855 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.458 HG21 ' HB3' ' A' ' 103' ' ' ASP . 5.7 p -109.47 134.33 52.01 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 123.281 0.632 . . . . 71.129999999999995 111.335 -179.407 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.462 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 26.6 m-85 -138.78 147.47 42.63 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 107.583 -1.265 . . . . 74.340000000000003 107.583 178.435 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.416 HG11 HE21 ' A' ' 120' ' ' GLN . 12.6 p -123.19 125.81 72.52 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 N-CA-C 106.088 -1.819 . . . . 74.310000000000002 106.088 171.271 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 17.6 m120 62.93 22.15 13.28 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.068 0.547 . . . . 71.219999999999999 109.796 -175.952 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 40.8 mtp180 75.05 12.25 3.46 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.334 1.453 . . . . 73.299999999999997 112.396 -177.126 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -102.85 118.27 58.68 Favored Pre-proline 0 C--N 1.31 -1.115 0 N-CA-C 105.983 -1.858 . . . . 72.230000000000004 105.983 176.27 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -46.66 119.61 3.37 Favored 'Trans proline' 0 C--N 1.362 1.273 0 C-N-CA 123.767 2.978 . . . . 74.340000000000003 112.508 -178.122 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 12.0 tpt180 -153.25 118.91 5.3 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 109.936 -0.394 . . . . 73.310000000000002 109.936 -173.627 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -81.63 -38.76 25.47 Favored 'General case' 0 C--N 1.317 -0.839 0 O-C-N 123.521 0.513 . . . . 72.239999999999995 112.103 -179.085 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -125.4 139.46 53.64 Favored 'General case' 0 N--CA 1.437 -1.119 0 C-N-CA 120.444 -0.502 . . . . 73.439999999999998 110.171 -178.857 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.416 HE21 HG11 ' A' ' 112' ' ' VAL . 6.6 tp-100 -139.36 137.95 36.18 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 109.044 -0.725 . . . . 75.340000000000003 109.044 175.66 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.2 t -111.83 97.72 6.11 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 CA-C-N 115.404 -0.816 . . . . 73.209999999999994 108.91 -177.828 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.456 ' HB3' ' HB2' ' A' ' 99' ' ' PHE . 26.3 ptt? 41.5 98.11 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 127.118 2.167 . . . . 70.319999999999993 116.293 179.091 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.458 ' HG3' ' HB2' ' A' ' 126' ' ' ASP . 52.1 tp60 -121.69 122.34 39.36 Favored 'General case' 0 N--CA 1.385 -3.706 0 N-CA-C 101.28 -3.6 . . . . 64.310000000000002 101.28 174.52 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 14.9 t -110.29 127.74 55.17 Favored 'General case' 0 C--N 1.29 -2.003 0 C-N-CA 119.194 -1.003 . . . . 62.119999999999997 110.666 -172.404 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 87.62 16.9 59.35 Favored Glycine 0 N--CA 1.425 -2.077 0 N-CA-C 110.218 -1.153 . . . . 41.340000000000003 110.218 -178.334 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.458 ' HB2' ' HG3' ' A' ' 123' ' ' GLN . 6.1 m-20 -112.61 162.15 16.01 Favored 'General case' 0 CA--C 1.484 -1.589 0 N-CA-C 112.527 0.565 . . . . 72.219999999999999 112.527 -179.68 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -107.58 122.58 46.96 Favored 'General case' 0 N--CA 1.421 -1.878 0 CA-C-N 114.761 -1.109 . . . . 63.43 111.049 -172.148 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 68.7 mt -101.37 129.87 51.79 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 N-CA-C 106.967 -1.494 . . . . 62.509999999999998 106.967 176.499 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.462 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 34.6 tt0 -110.76 125.46 53.56 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 109.2 -0.667 . . . . 72.439999999999998 109.2 -179.659 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.505 HD13 ' H ' ' A' ' 130' ' ' ILE . 0.2 OUTLIER -112.5 109.87 30.13 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 N-CA-C 108.6 -0.889 . . . . 74.420000000000002 108.6 177.667 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 71.21 -82.37 0.45 Allowed Glycine 0 C--N 1.308 -0.991 0 CA-C-N 115.735 -0.666 . . . . 41.109999999999999 112.094 -176.995 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -146.14 8.16 1.07 Allowed 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.771 -0.826 . . . . 73.200000000000003 108.771 179.118 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.449 ' HB3' ' O ' ' A' ' 53' ' ' ARG . 35.4 m-85 -104.7 150.83 24.39 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.781 -0.822 . . . . 62.350000000000001 108.781 -175.429 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.34 130.74 55.51 Favored 'General case' 0 C--O 1.258 1.505 0 C-N-CA 119.05 -1.06 . . . . 74.140000000000001 112.931 -177.701 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.7 tt -123.79 137.99 54.58 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 125.808 1.643 . . . . 65.329999999999998 107.287 -177.245 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.445 ' HB ' ' CG2' ' A' ' 50' ' ' VAL . 60.8 t -108.81 127.15 65.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 108.677 -0.86 . . . . 51.0 108.677 177.021 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -102.47 130.4 49.27 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 116.209 -0.45 . . . . 65.409999999999997 110.558 -175.071 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -125.34 148.94 48.53 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 109.239 -0.652 . . . . 71.420000000000002 109.239 178.843 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -81.33 135.23 35.68 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.433 -0.951 . . . . 73.140000000000001 108.433 176.739 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.49 153.71 52.66 Favored Glycine 0 N--CA 1.437 -1.281 0 C-N-CA 120.933 -0.651 . . . . 74.209999999999994 111.518 -178.03 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo . . . . . 0 N--CA 1.445 -1.336 0 C-N-CA 122.401 2.068 . . . . 45.119999999999997 113.002 -177.809 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 . . . . . 0 N--CA 1.437 -1.079 0 N-CA-C 109.16 -0.682 . . . . 60.210000000000001 109.16 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.85 123.97 8.07 Favored Glycine 0 N--CA 1.435 -1.424 0 N-CA-C 110.905 -0.878 . . . . 73.310000000000002 110.905 -178.966 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.0 p -94.42 126.13 49.29 Favored Pre-proline 0 C--N 1.299 -1.606 0 CA-C-N 116.687 0.244 . . . . 44.219999999999999 111.2 -179.099 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.493 ' O ' ' HD3' ' A' ' 10' ' ' PRO . 24.1 Cg_exo -65.39 129.76 23.49 Favored 'Trans proline' 0 C--O 1.245 0.83 0 C-N-CA 121.954 1.769 . . . . 73.549999999999997 110.309 175.748 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -103.64 95.8 7.92 Favored Pre-proline 0 C--N 1.315 -0.933 0 N-CA-C 108.23 -1.026 . . . . 71.200000000000003 108.23 178.672 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.493 ' HD3' ' O ' ' A' ' 8' ' ' PRO . 90.9 Cg_endo -92.8 179.14 1.23 Allowed 'Trans proline' 0 N--CA 1.445 -1.366 0 C-N-CA 122.823 2.349 . . . . 51.43 113.298 -174.469 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 67.96 84.79 0.15 Allowed 'General case' 0 CA--C 1.509 -0.621 0 C-N-CA 125.285 1.434 . . . . 71.019999999999996 112.14 -179.159 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 24.5 t -113.62 78.03 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 108.503 -0.925 . . . . 74.409999999999997 108.503 178.543 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -140.01 131.23 26.57 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.057 -1.09 . . . . 75.310000000000002 108.057 177.816 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.0 m -143.98 76.67 1.52 Allowed 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 106.551 -1.648 . . . . 73.099999999999994 106.551 172.93 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.1 m -99.59 90.33 4.45 Favored 'General case' 0 N--CA 1.413 -2.299 0 CA-C-N 115.406 -0.815 . . . . 74.040000000000006 110.013 -177.907 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.7 m -125.02 70.31 1.15 Allowed 'General case' 0 N--CA 1.415 -2.194 0 N-CA-C 107.148 -1.427 . . . . 71.340000000000003 107.148 175.698 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.8 m . . . . . 0 N--CA 1.428 -1.562 0 CA-C-N 114.876 -1.056 . . . . 65.109999999999999 109.575 -176.966 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.504 0 N-CA-C 108.132 -1.987 . . . . 70.120000000000005 108.132 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.568 ' O ' ' HA ' ' A' ' 141' ' ' PRO . 16.3 m -90.7 162.05 15.09 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 115.1 -0.55 . . . . 54.32 111.166 -173.993 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -136.77 177.6 7.73 Favored 'General case' 0 C--O 1.253 1.278 0 N-CA-C 107.816 -1.179 . . . . 64.219999999999999 107.816 176.482 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.447 ' H ' HD23 ' A' ' 48' ' ' LEU . 2.1 pt? -118.54 146.67 44.38 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 120.171 -0.612 . . . . 71.340000000000003 112.536 -172.471 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.425 HD23 ' H ' ' A' ' 49' ' ' LEU . 1.4 pt? -124.38 132.95 53.54 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.161 -1.051 . . . . 74.329999999999998 108.161 177.501 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 26.0 t -125.9 144.75 34.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 108.849 -0.797 . . . . 74.420000000000002 108.849 -176.823 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.423 HG21 ' HB3' ' A' ' 57' ' ' ALA . 57.7 t -92.46 127.73 44.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 108.624 -0.88 . . . . 42.420000000000002 108.624 179.795 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -94.45 -38.33 10.99 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.655 -0.702 . . . . 64.349999999999994 110.142 -179.604 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 5.5 tpm_? -160.51 114.14 2.11 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.625 -0.716 . . . . 75.319999999999993 110.125 -175.094 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 158.32 125.64 0.84 Allowed Glycine 0 N--CA 1.426 -1.968 0 O-C-N 124.106 0.879 . . . . 73.099999999999994 111.189 176.845 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.569 ' HD2' ' CZ ' ' A' ' 133' ' ' PHE . 50.4 Cg_exo -59.76 -10.63 12.32 Favored 'Trans proline' 0 N--CA 1.489 1.261 0 C-N-CA 123.291 2.661 . . . . 71.549999999999997 113.646 177.599 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.595 ' HB2' ' HA ' ' A' ' 80' ' ' LEU . 4.3 p-10 -52.44 -36.41 54.48 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.297 1.039 . . . . 73.230000000000004 110.046 179.59 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.423 ' HB3' HG21 ' A' ' 51' ' ' VAL . . . -171.93 -162.28 0.21 Allowed 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.513 1.125 . . . . 62.130000000000003 108.123 -179.681 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 172.58 62.64 0.05 OUTLIER Glycine 0 CA--C 1.491 -1.408 0 N-CA-C 110.205 -1.158 . . . . 65.209999999999994 110.205 -179.266 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -163.53 -176.4 4.68 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 107.329 -1.36 . . . . 75.049999999999997 107.329 -176.762 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -103.54 136.06 43.97 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 124.013 0.821 . . . . 74.439999999999998 109.374 176.687 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -121.76 149.93 42.59 Favored 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 108.664 -0.865 . . . . 74.409999999999997 108.664 178.161 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 38.6 tp -114.55 135.81 53.71 Favored 'General case' 0 C--N 1.285 -2.212 0 N-CA-C 106.294 -1.743 . . . . 74.099999999999994 106.294 178.122 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 94.7 mt -79.73 112.94 17.49 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 118.519 -1.272 . . . . 53.210000000000001 109.575 179.064 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -121.02 -0.59 9.99 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-O 121.58 0.705 . . . . 70.230000000000004 109.397 178.973 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -115.63 138.71 24.02 Favored Pre-proline 0 C--N 1.303 -1.431 0 N-CA-C 108.532 -0.914 . . . . 74.319999999999993 108.532 -177.693 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -63.33 -30.92 73.57 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.367 2.044 . . . . 74.329999999999998 112.055 -179.801 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 40.9 m -136.73 114.92 11.6 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 109.892 -0.41 . . . . 62.229999999999997 109.892 177.571 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 24.7 m -110.66 114.11 27.25 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 109.029 -0.73 . . . . 63.119999999999997 109.029 179.318 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 49.4 p -93.27 124.85 37.54 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.118 0.485 . . . . 70.140000000000001 111.633 -179.384 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -109.15 126.45 53.25 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 109.1 -0.704 . . . . 64.349999999999994 109.1 176.498 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -173.94 -171.92 38.78 Favored Glycine 0 N--CA 1.43 -1.706 0 C-N-CA 120.377 -0.916 . . . . 61.439999999999998 111.323 178.538 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -109.69 88.04 2.65 Favored 'General case' 0 N--CA 1.423 -1.777 0 N-CA-C 107.294 -1.373 . . . . 63.329999999999998 107.294 179.467 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.409 ' CE1' ' HG3' ' A' ' 75' ' ' GLU . 9.8 t-160 -164.18 133.19 2.86 Favored Pre-proline 0 C--N 1.279 -2.476 0 N-CA-C 105.185 -2.154 . . . . 72.329999999999998 105.185 -179.872 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -51.06 -37.06 56.72 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 123.16 2.573 . . . . 61.109999999999999 112.933 -178.917 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.409 ' HG3' ' CE1' ' A' ' 73' ' ' HIS . 5.8 pt-20 -102.07 70.13 1.19 Allowed 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 122.569 1.176 . . . . 65.420000000000002 111.828 179.298 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 31.1 m -126.25 169.28 13.04 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 113.29 -1.777 . . . . 53.140000000000001 106.673 174.582 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -79.38 -38.53 34.7 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 119.872 -0.731 . . . . 53.439999999999998 110.579 -178.29 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 39.0 pt -136.73 171.06 17.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 108.591 -0.892 . . . . 52.310000000000002 108.591 173.125 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.53 ' O ' ' HB2' ' A' ' 56' ' ' ASN . 98.0 m-85 -105.25 137.23 43.37 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 112.448 0.536 . . . . 72.200000000000003 112.448 -175.807 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.595 ' HA ' ' HB2' ' A' ' 56' ' ' ASN . 1.7 tt -146.96 104.8 3.73 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 104.658 -2.349 . . . . 64.129999999999995 104.658 177.16 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -115.78 13.5 16.15 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 114.378 1.251 . . . . 64.120000000000005 114.378 -171.252 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.517 ' OD2' ' HB ' ' A' ' 85' ' ' VAL 0.292 3.1 p30 -31.76 -88.72 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.378 0 N-CA-C 115.785 1.772 . . . . 71.239999999999995 115.785 -174.744 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.428 ' H ' ' CG ' ' A' ' 82' ' ' ASP . 7.5 p -163.99 -46.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 C-N-CA 123.13 0.572 . . . . 70.299999999999997 110.732 178.25 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.407 ' HB ' ' CG ' ' A' ' 108' ' ' ASN . 18.0 m -110.12 27.41 9.64 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 123.337 1.541 . . . . 63.109999999999999 109.007 -177.41 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.517 ' HB ' ' OD2' ' A' ' 82' ' ' ASP . 6.3 p -82.25 138.96 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.935 0 CA-C-N 113.48 -1.691 . . . . 72.439999999999998 109.177 178.333 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 20.2 m -87.59 178.01 6.9 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 115.629 -0.714 . . . . 74.200000000000003 110.186 -179.318 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 45.5 mtm180 -64.84 -46.1 83.31 Favored 'General case' 0 C--O 1.221 -0.414 0 N-CA-C 109.964 -0.384 . . . . 72.140000000000001 109.964 178.095 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.56 112.12 17.08 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 104.985 -2.228 . . . . 74.040000000000006 104.985 163.774 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.411 ' CE1' ' HA3' ' A' ' 105' ' ' GLY . 27.2 t60 -104.64 -54.8 2.45 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 115.483 -0.781 . . . . 73.109999999999999 110.916 -170.702 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -120.01 129.67 54.37 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 108.827 -0.805 . . . . 73.200000000000003 108.827 -178.808 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -106.49 127.0 52.96 Favored 'General case' 0 C--N 1.287 -2.142 0 C-N-CA 120.159 -0.616 . . . . 71.209999999999994 109.987 178.478 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -106.94 113.07 26.33 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 106.355 -1.72 . . . . 74.519999999999996 106.355 176.784 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -128.92 150.97 50.14 Favored 'General case' 0 C--N 1.282 -2.35 0 C-N-CA 119.658 -0.817 . . . . 75.420000000000002 111.963 -176.578 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.452 HD13 ' CD2' ' A' ' 99' ' ' PHE . 4.0 tp -115.62 120.14 63.88 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 CA-C-N 114.919 -1.037 . . . . 75.150000000000006 109.252 -179.828 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -101.24 146.72 27.16 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 107.266 -1.383 . . . . 52.32 107.266 178.409 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.41 -14.21 7.16 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.436 0.532 . . . . 74.200000000000003 112.436 179.866 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -86.29 -64.85 1.44 Allowed Glycine 0 N--CA 1.42 -2.414 0 N-CA-C 110.95 -0.86 . . . . 75.129999999999995 110.95 171.427 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -146.45 177.89 8.69 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 117.306 0.553 . . . . 72.430000000000007 111.348 -175.15 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.452 ' CD2' HD13 ' A' ' 94' ' ' ILE . 89.7 m-85 -90.93 130.59 36.85 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.724 -1.213 . . . . 72.239999999999995 107.724 176.693 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -132.29 135.29 46.12 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 120.53 -0.468 . . . . 71.340000000000003 110.78 -176.63 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 5.0 p -120.91 119.69 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.095 0 CA-C-O 121.599 0.714 . . . . 71.219999999999999 109.765 179.671 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 30.5 m -119.35 128.26 75.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-N 115.228 -0.896 . . . . 73.120000000000005 111.004 -178.089 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -91.73 132.45 36.38 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 115.682 -0.69 . . . . 74.420000000000002 109.754 176.153 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 26.8 m -115.02 11.52 7.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 CA-C-O 121.274 0.559 . . . . 64.340000000000003 110.781 175.096 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.411 ' HA3' ' CE1' ' A' ' 89' ' ' HIS . . . -122.99 56.09 0.67 Allowed Glycine 0 C--O 1.247 0.928 0 N-CA-C 109.651 -1.38 . . . . 52.329999999999998 109.651 179.17 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 12.5 m -68.9 -8.56 45.29 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 113.288 0.847 . . . . 72.530000000000001 113.288 -171.773 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.6 tt -71.31 -37.78 71.78 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 107.551 -1.278 . . . . 74.409999999999997 107.551 176.829 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.407 ' CG ' ' HB ' ' A' ' 84' ' ' THR . 59.5 t30 -84.97 -42.31 15.04 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.527 -1.286 . . . . 72.409999999999997 107.527 176.746 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 88.38 122.73 1.94 Allowed Glycine 0 N--CA 1.439 -1.16 0 CA-C-N 114.971 -1.013 . . . . 64.420000000000002 114.965 174.35 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 31.5 m -100.85 140.33 35.3 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.066 -1.087 . . . . 64.129999999999995 108.066 172.781 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -127.41 168.41 14.89 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.732 0.777 . . . . 74.209999999999994 111.186 -174.69 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 13.7 p -122.81 143.66 34.94 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 N-CA-C 105.846 -1.909 . . . . 75.129999999999995 105.846 174.173 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -19.05 90.91 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 126.322 1.849 . . . . 74.299999999999997 113.874 -176.944 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 67.04 2.1 2.6 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 127.982 2.513 . . . . 61.229999999999997 115.392 175.209 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -124.86 142.31 40.61 Favored Pre-proline 0 C--N 1.312 -1.044 0 O-C-N 121.45 -0.781 . . . . 75.140000000000001 112.169 -178.822 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -79.04 98.91 1.22 Allowed 'Trans proline' 0 C--O 1.246 0.899 0 C-N-CA 122.766 2.311 . . . . 75.439999999999998 114.493 -175.998 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 65.5 mtp180 -140.2 119.91 13.35 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.417 -0.957 . . . . 74.200000000000003 108.417 174.3 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -85.92 -23.31 27.03 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 124.103 0.877 . . . . 72.299999999999997 109.92 -175.688 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -125.1 138.36 54.17 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 107.183 -1.414 . . . . 61.310000000000002 107.183 174.177 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -141.47 149.84 41.46 Favored 'General case' 0 C--N 1.288 -2.072 0 CA-C-N 116.045 -0.525 . . . . 72.0 110.899 -177.119 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.3 p -85.66 122.66 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.684 0 N-CA-C 103.372 -2.825 . . . . 62.5 103.372 170.187 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.43 ' HG2' ' CD2' ' A' ' 137' ' ' PHE . 12.3 ttt -65.69 113.3 4.17 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.426 0.631 . . . . 71.540000000000006 109.923 -168.806 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -103.64 133.92 47.84 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 115.148 -0.933 . . . . 74.329999999999998 109.944 -171.252 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.439 ' HB ' ' HB2' ' A' ' 139' ' ' ALA . 41.1 p -83.15 129.54 35.03 Favored 'General case' 0 N--CA 1.412 -2.336 0 CA-C-N 115.463 -0.789 . . . . 70.319999999999993 110.53 -177.732 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 107.75 -9.55 37.6 Favored Glycine 0 N--CA 1.416 -2.674 0 CA-C-N 115.689 -0.687 . . . . 74.129999999999995 111.654 177.239 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -116.26 176.18 5.22 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 118.504 -1.278 . . . . 70.310000000000002 112.592 -175.82 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -109.16 128.22 54.84 Favored 'General case' 0 N--CA 1.428 -1.575 0 C-N-CA 125.318 1.447 . . . . 73.140000000000001 110.348 -174.521 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 68.6 mt -115.97 130.3 70.91 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 N-CA-C 107.194 -1.409 . . . . 75.129999999999995 107.194 179.253 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -104.29 111.5 24.16 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 119.945 -0.702 . . . . 74.209999999999994 109.833 -177.682 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.8 pp -95.17 113.71 30.16 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 CA-C-N 115.567 -0.742 . . . . 65.400000000000006 110.812 179.68 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 72.28 -89.25 0.51 Allowed Glycine 0 N--CA 1.437 -1.262 0 N-CA-C 109.648 -1.381 . . . . 53.299999999999997 109.648 -174.033 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -142.3 3.8 1.56 Allowed 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 109.435 -0.58 . . . . 71.329999999999998 109.435 177.128 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.569 ' CZ ' ' HD2' ' A' ' 55' ' ' PRO . 21.7 m-85 -102.52 150.37 23.46 Favored 'General case' 0 CA--C 1.513 -0.47 0 O-C-N 122.026 -0.422 . . . . 74.310000000000002 110.42 -176.807 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -104.6 122.93 46.64 Favored 'General case' 0 C--O 1.252 1.231 0 CA-C-O 121.505 0.669 . . . . 72.430000000000007 112.331 -174.219 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 31.1 tp -117.78 138.47 52.03 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 114.546 -1.207 . . . . 71.5 107.828 179.729 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 10.2 p -115.08 138.75 44.37 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 N-CA-C 108.683 -0.858 . . . . 71.019999999999996 108.683 177.639 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . 0.43 ' CD2' ' HG2' ' A' ' 122' ' ' MET . 42.3 t80 -114.5 123.4 49.29 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.776 -0.824 . . . . 73.230000000000004 108.776 -177.937 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -114.62 148.24 38.38 Favored 'General case' 0 C--O 1.253 1.259 0 CA-C-O 121.111 0.481 . . . . 72.219999999999999 111.549 -175.649 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.439 ' HB2' ' HB ' ' A' ' 124' ' ' THR . . . -85.18 99.31 11.0 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-N 115.491 -0.777 . . . . 73.129999999999995 109.731 177.768 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -140.09 77.17 0.32 Allowed Glycine 0 C--N 1.281 -2.526 0 N-CA-C 107.817 -2.113 . . . . 74.549999999999997 107.817 175.002 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.568 ' HA ' ' O ' ' A' ' 46' ' ' SER . 14.9 Cg_endo . . . . . 0 CA--C 1.498 -1.323 0 C-N-CA 122.674 2.249 . . . . 54.119999999999997 113.799 -173.759 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.4 p30 . . . . . 0 CA--C 1.508 -0.668 0 N-CA-C 108.292 -1.003 . . . . 71.329999999999998 108.292 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -92.02 156.5 23.67 Favored Glycine 0 N--CA 1.427 -1.92 0 C-N-CA 120.619 -0.8 . . . . 53.530000000000001 111.435 179.94 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.0 m -82.7 129.71 61.24 Favored Pre-proline 0 C--N 1.294 -1.823 0 N-CA-C 109.106 -0.702 . . . . 70.230000000000004 109.106 179.131 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -66.61 127.9 18.07 Favored 'Trans proline' 0 N--CA 1.447 -1.233 0 C-N-CA 121.553 1.502 . . . . 75.420000000000002 109.321 173.295 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -83.34 136.73 42.79 Favored Pre-proline 0 C--N 1.295 -1.794 0 N-CA-C 108.524 -0.917 . . . . 75.219999999999999 108.524 179.132 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_exo -70.41 116.02 4.44 Favored 'Trans proline' 0 N--CA 1.441 -1.578 0 C-N-CA 121.426 1.417 . . . . 72.030000000000001 109.611 176.209 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 25.7 mp0 -66.96 124.22 22.4 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.429 -0.952 . . . . 70.510000000000005 108.429 179.128 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.6 m -53.36 126.51 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 O-C-N 124.279 0.987 . . . . 72.340000000000003 110.526 -178.621 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -70.23 139.37 52.23 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-N 115.539 -0.755 . . . . 53.32 110.826 -177.147 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 64.4 m -144.56 138.88 27.8 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 107.881 -1.155 . . . . 60.229999999999997 107.881 179.162 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 21.1 m -116.56 126.83 53.86 Favored 'General case' 0 N--CA 1.414 -2.243 0 N-CA-C 108.771 -0.826 . . . . 71.140000000000001 108.771 -177.025 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.4 t -60.88 -54.13 48.86 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 121.811 0.815 . . . . 72.010000000000005 110.036 179.696 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.9 m . . . . . 0 C--N 1.269 -2.906 0 CA-C-N 113.982 -1.463 . . . . 71.040000000000006 109.964 177.927 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.272 0 N-CA-C 109.718 -1.353 . . . . 64.310000000000002 109.718 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.1 m -91.19 163.57 14.21 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 121.711 0.767 . . . . 63.32 112.327 -173.746 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.587 ' HA ' ' N ' ' A' ' 140' ' ' GLY . . . -126.71 165.95 18.29 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 106.981 -1.489 . . . . 71.239999999999995 106.981 176.625 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.1 pp -129.91 150.66 51.1 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 113.087 0.773 . . . . 74.209999999999994 113.087 -173.83 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.512 HD11 ' CE1' ' A' ' 61' ' ' PHE . 4.4 pp -119.46 147.73 44.07 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.614 -0.721 . . . . 71.0 109.774 178.044 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.9 t -124.87 125.58 69.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 107.745 -1.205 . . . . 74.329999999999998 107.745 179.221 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.0 t -93.02 118.1 37.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 108.394 -0.965 . . . . 74.040000000000006 108.394 178.632 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -83.77 -34.12 24.86 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.354 0.597 . . . . 73.319999999999993 110.02 -178.428 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -155.55 125.94 6.76 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.269 -0.878 . . . . 74.519999999999996 108.783 176.283 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 155.44 109.52 0.32 Allowed Glycine 0 N--CA 1.415 -2.727 0 N-CA-C 111.649 -0.58 . . . . 74.200000000000003 111.649 -179.545 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -58.5 -8.58 5.6 Favored 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 124.47 3.446 . . . . 61.140000000000001 112.808 177.997 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 50.5 m-20 -52.34 -37.28 55.59 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.213 1.405 . . . . 71.420000000000002 109.229 174.306 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -159.97 -63.45 0.07 Allowed 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.659 -0.701 . . . . 53.340000000000003 109.873 -179.872 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.89 34.27 59.21 Favored Glycine 0 C--O 1.223 -0.553 0 CA-C-N 115.981 -0.554 . . . . 74.420000000000002 111.93 -179.861 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -149.42 -173.86 4.51 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 108.15 -1.056 . . . . 63.530000000000001 108.15 -178.159 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.2 ptt180 -119.79 150.1 40.96 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 108.454 -0.943 . . . . 62.140000000000001 108.454 175.777 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.512 ' CE1' HD11 ' A' ' 49' ' ' LEU . 52.0 p90 -157.23 151.72 25.25 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.598 -0.519 . . . . 72.239999999999995 109.598 173.031 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.2 pp -88.11 140.85 29.07 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 108.886 -0.783 . . . . 62.130000000000003 108.886 176.05 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 90.9 mt -71.58 113.04 8.21 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.672 -0.862 . . . . 74.310000000000002 108.672 179.667 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -110.67 -33.48 6.55 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 114.71 -1.132 . . . . 43.340000000000003 109.542 -178.967 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -79.23 122.27 84.01 Favored Pre-proline 0 C--N 1.308 -1.207 0 N-CA-C 107.22 -1.4 . . . . 74.310000000000002 107.22 179.728 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -51.55 -31.77 41.16 Favored 'Trans proline' 0 C--N 1.367 1.552 0 C-N-CA 123.509 2.806 . . . . 44.340000000000003 112.634 -176.8 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.4 m -134.5 97.05 3.71 Favored 'General case' 0 N--CA 1.417 -2.098 0 N-CA-C 107.904 -1.147 . . . . 62.130000000000003 107.904 173.404 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 86.0 m -91.73 118.46 30.69 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.963 -1.125 . . . . 71.549999999999997 107.963 -179.277 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 27.6 m -108.41 121.04 44.12 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-O 121.775 0.797 . . . . 70.510000000000005 111.919 -176.478 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.469 ' O ' ' HB3' ' A' ' 89' ' ' HIS . . . -98.16 103.3 15.23 Favored 'General case' 0 N--CA 1.416 -2.168 0 N-CA-C 106.876 -1.527 . . . . 51.329999999999998 106.876 174.232 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 111.07 69.86 0.59 Allowed Glycine 0 N--CA 1.429 -1.795 0 C-N-CA 119.76 -1.21 . . . . 51.240000000000002 111.224 -177.9 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -151.0 61.11 0.92 Allowed 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 104.093 -2.558 . . . . 71.040000000000006 104.093 177.993 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 16.5 t60 -37.95 -43.97 1.74 Allowed Pre-proline 0 CA--C 1.578 2.021 0 N-CA-C 116.559 2.059 . . . . 73.409999999999997 116.559 -167.338 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -60.15 -40.25 61.92 Favored 'Trans proline' 0 C--N 1.374 1.921 0 CA-C-N 121.559 1.593 . . . . 62.109999999999999 113.207 175.405 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -149.84 88.03 1.52 Allowed 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 108.946 -0.761 . . . . 74.120000000000005 108.946 -179.078 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 53.4 m -101.61 152.17 21.13 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 116.439 -0.346 . . . . 54.229999999999997 110.425 179.577 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -72.22 -43.8 63.88 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 106.136 -1.801 . . . . 74.129999999999995 106.136 171.103 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 30.0 pt -131.68 130.26 61.95 Favored 'Isoleucine or valine' 0 C--O 1.245 0.868 0 CA-C-N 114.407 -1.27 . . . . 75.140000000000001 108.507 171.802 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -90.73 116.99 29.02 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 116.314 -0.403 . . . . 73.239999999999995 109.978 -177.063 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.455 HD21 ' HB1' ' A' ' 70' ' ' ALA . 97.2 mt -66.86 172.33 4.48 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.318 0.58 . . . . 64.400000000000006 111.251 -179.859 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -73.87 -12.16 60.59 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.792 -0.64 . . . . 41.450000000000003 110.732 179.04 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.529 ' HA ' HG23 ' A' ' 85' ' ' VAL . 1.6 m-20 54.05 78.4 0.16 Allowed 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 115.085 -0.962 . . . . 73.230000000000004 113.369 -176.74 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 44.2 t -93.06 -37.04 8.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 106.92 -1.511 . . . . 63.119999999999997 106.92 173.727 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 76.1 m -179.55 84.37 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 127.971 2.508 . . . . 62.119999999999997 105.473 -178.616 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.529 HG23 ' HA ' ' A' ' 82' ' ' ASP . 78.8 t -103.34 136.18 37.33 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.192 0 CA-C-N 115.204 -0.907 . . . . 73.219999999999999 109.726 -176.662 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 23.3 t -74.3 180.0 4.23 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 115.147 -0.933 . . . . 72.319999999999993 111.04 -176.096 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 -68.15 -34.19 75.88 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 107.615 -1.254 . . . . 71.409999999999997 107.615 178.841 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.472 ' O ' HG23 ' A' ' 104' ' ' VAL . 0.2 OUTLIER -139.45 125.66 20.08 Favored 'General case' 0 CA--C 1.495 -1.145 0 N-CA-C 101.236 -3.616 . . . . 74.510000000000005 101.236 167.572 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.469 ' HB3' ' O ' ' A' ' 70' ' ' ALA . 6.7 t60 -100.65 -79.32 0.5 Allowed 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 118.619 -1.233 . . . . 73.510000000000005 112.403 -173.996 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -120.07 107.81 13.51 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.152 0.501 . . . . 73.019999999999996 109.772 -178.867 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -95.5 127.89 41.91 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 109.027 -0.731 . . . . 70.0 109.027 178.909 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -112.74 112.27 23.66 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 107.321 -1.363 . . . . 62.420000000000002 107.321 176.737 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 54.7 ttp180 -103.59 124.19 48.35 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.325 -0.991 . . . . 75.310000000000002 108.325 178.42 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.36 117.02 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.319 0 CA-C-O 122.122 0.963 . . . . 62.009999999999998 109.443 -173.243 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 -118.41 144.69 45.75 Favored 'General case' 0 C--N 1.28 -2.415 0 N-CA-C 103.174 -2.899 . . . . 62.200000000000003 103.174 172.142 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.09 -16.07 63.63 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 121.067 0.46 . . . . 64.129999999999995 112.196 -177.627 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -90.07 -45.19 4.54 Favored Glycine 0 N--CA 1.431 -1.688 0 CA-C-N 115.534 -0.757 . . . . 34.200000000000003 112.695 174.883 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -136.41 140.88 43.51 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 121.297 0.57 . . . . 62.109999999999999 110.96 -176.977 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -112.54 125.95 54.81 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 107.177 -1.416 . . . . 75.239999999999995 107.177 179.561 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -132.39 137.78 47.46 Favored 'General case' 0 C--N 1.309 -1.178 0 C-N-CA 120.051 -0.659 . . . . 74.540000000000006 112.179 -179.051 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.8 p -115.85 125.95 73.18 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 CA-C-N 115.211 -0.904 . . . . 55.539999999999999 109.551 179.518 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 46.3 t -112.97 115.52 50.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 CA-C-N 115.951 -0.568 . . . . 63.420000000000002 109.697 -179.28 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -95.95 107.5 19.78 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 121.644 0.735 . . . . 75.349999999999994 110.048 177.034 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 88' ' ' ARG . 1.3 m -114.0 16.02 8.07 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.277 0 CA-C-N 115.075 -0.966 . . . . 61.340000000000003 109.659 175.5 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -122.35 45.43 1.21 Allowed Glycine 0 N--CA 1.438 -1.189 0 N-CA-C 109.119 -1.593 . . . . 73.219999999999999 109.119 176.265 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.5 p -69.68 -13.65 62.41 Favored 'General case' 0 C--O 1.249 1.037 0 C-N-CA 124.702 1.201 . . . . 61.130000000000003 112.973 -175.427 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 49.9 tp -67.73 -43.84 79.03 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 108.212 -1.033 . . . . 73.319999999999993 108.212 175.442 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -74.77 -47.68 29.68 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 107.123 -1.436 . . . . 72.340000000000003 107.123 173.065 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 100.31 96.02 2.18 Favored Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 115.16 0.824 . . . . 63.299999999999997 115.16 175.01 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.407 HG23 HG22 ' A' ' 130' ' ' ILE . 51.7 m -91.2 120.11 31.85 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.359 -0.978 . . . . 63.219999999999999 108.359 173.044 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.492 ' HB3' ' HA ' ' A' ' 114' ' ' ARG . 59.9 m-85 -102.35 134.58 45.42 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 108.574 -0.898 . . . . 74.239999999999995 108.574 178.774 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 34.5 t -117.62 121.95 68.68 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 N-CA-C 105.415 -2.069 . . . . 75.200000000000003 105.415 176.131 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.483 ' HA ' ' OD1' ' A' ' 126' ' ' ASP . 14.2 m120 67.52 18.19 10.0 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 107.211 -1.403 . . . . 75.200000000000003 107.211 -172.672 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.492 ' HA ' ' HB3' ' A' ' 111' ' ' TYR 0.344 44.7 mtt85 68.79 12.67 8.73 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 113.626 -1.625 . . . . 74.109999999999999 114.207 -173.354 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -97.85 135.96 21.32 Favored Pre-proline 0 N--CA 1.442 -0.865 0 N-CA-C 107.866 -1.161 . . . . 73.340000000000003 107.866 174.681 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -68.61 115.81 4.1 Favored 'Trans proline' 0 C--O 1.24 0.605 0 C-N-CA 121.864 1.71 . . . . 71.040000000000006 109.12 172.787 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 37.9 mmt180 -134.76 131.11 37.17 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 107.97 -1.122 . . . . 75.239999999999995 107.97 -178.285 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -77.85 -29.49 50.5 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.823 0.821 . . . . 73.109999999999999 109.092 176.682 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -144.35 137.52 27.18 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 107.132 -1.432 . . . . 71.439999999999998 107.132 171.343 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -142.06 150.42 41.21 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 109.66 -0.496 . . . . 72.450000000000003 109.66 177.96 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 48.5 t -80.62 112.66 18.93 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.156 0 N-CA-C 105.107 -2.183 . . . . 73.099999999999994 105.107 173.414 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.41 ' HG2' ' CE2' ' A' ' 137' ' ' PHE . 22.1 ttt -64.27 122.54 16.91 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.183 -0.917 . . . . 73.400000000000006 109.325 -171.817 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 56.1 tp60 -104.73 125.91 51.28 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.766 -0.652 . . . . 72.400000000000006 111.145 -171.182 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 10.5 p -79.31 116.38 19.52 Favored 'General case' 0 N--CA 1.434 -1.232 0 C-N-CA 123.271 0.628 . . . . 74.530000000000001 109.945 178.793 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 115.33 7.11 17.06 Favored Glycine 0 N--CA 1.435 -1.38 0 C-N-CA 120.547 -0.835 . . . . 60.340000000000003 112.881 178.178 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.483 ' OD1' ' HA ' ' A' ' 113' ' ' ASN . 8.0 t70 -128.63 -165.7 1.54 Allowed 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.584 -0.895 . . . . 41.109999999999999 108.584 -179.606 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -128.99 149.86 50.64 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.773 0.797 . . . . 72.519999999999996 113.133 -172.294 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 65.8 mt -124.02 129.9 74.04 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 107.912 -1.144 . . . . 63.200000000000003 107.912 -178.188 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -117.91 112.77 20.77 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 109.616 -0.512 . . . . 64.329999999999998 109.616 -177.125 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.596 HD13 ' H ' ' A' ' 130' ' ' ILE . 0.2 OUTLIER -94.19 105.69 17.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 109.367 -0.605 . . . . 75.150000000000006 109.367 178.708 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 71.07 -104.26 1.38 Allowed Glycine 0 N--CA 1.433 -1.53 0 N-CA-C 110.297 -1.121 . . . . 70.349999999999994 110.297 -176.633 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 42.8 mtpt -123.72 14.58 9.38 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 120.996 0.427 . . . . 72.109999999999999 109.927 177.67 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -101.04 132.12 46.62 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.915 -0.402 . . . . 52.409999999999997 109.915 -179.11 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 17.8 ptt180 -96.98 121.43 38.85 Favored 'General case' 0 C--O 1.254 1.341 0 CA-C-O 121.726 0.774 . . . . 73.430000000000007 112.234 -176.773 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.439 HD21 ' HB2' ' A' ' 49' ' ' LEU . 6.4 tt -125.19 142.99 51.16 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 114.466 -1.243 . . . . 65.430000000000007 107.715 178.415 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 10.0 p -119.2 140.27 43.72 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 N-CA-C 108.661 -0.866 . . . . 74.430000000000007 108.661 177.671 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . 0.41 ' CE2' ' HG2' ' A' ' 122' ' ' MET . 59.6 t80 -120.2 118.0 29.36 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 120.976 0.417 . . . . 73.420000000000002 110.482 -176.4 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -118.61 173.92 6.57 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 109.401 -0.592 . . . . 75.329999999999998 109.401 -176.626 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -71.1 149.89 46.02 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.629 -1.249 . . . . 73.239999999999995 107.629 172.804 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.587 ' N ' ' HA ' ' A' ' 47' ' ' ALA . . . -96.34 -160.52 32.41 Favored Glycine 0 C--N 1.287 -2.163 0 C-N-CA 120.46 -0.876 . . . . 64.230000000000004 111.478 -176.844 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo . . . . . 0 N--CA 1.434 -1.995 0 C-N-CA 121.823 1.682 . . . . 74.430000000000007 110.895 179.634 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 . . . . . 0 N--CA 1.443 -0.798 0 N-CA-C 108.843 -0.799 . . . . 75.219999999999999 108.843 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -152.68 32.89 0.82 Allowed Glycine 0 C--N 1.29 -1.995 0 N-CA-C 109.815 -1.314 . . . . 71.230000000000004 109.815 178.492 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.41 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 4.8 p -75.76 129.69 80.73 Favored Pre-proline 0 N--CA 1.424 -1.756 0 CA-C-N 115.007 -0.596 . . . . 72.310000000000002 110.381 -177.381 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 7' ' ' THR . 45.8 Cg_exo -55.49 133.03 55.69 Favored 'Trans proline' 0 C--O 1.241 0.658 0 C-N-CA 123.137 2.558 . . . . 35.229999999999997 112.587 -178.592 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -96.59 125.49 46.89 Favored Pre-proline 0 N--CA 1.431 -1.383 0 N-CA-C 107.974 -1.121 . . . . 52.240000000000002 107.974 175.987 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -55.42 136.01 71.8 Favored 'Trans proline' 0 C--O 1.245 0.835 0 C-N-CA 122.958 2.438 . . . . 61.340000000000003 112.157 -178.496 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -72.31 108.84 5.65 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.162 -0.681 . . . . 75.340000000000003 109.162 -178.885 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 36.2 t -87.88 115.82 28.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 109.657 -0.497 . . . . 53.119999999999997 109.657 -176.812 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -135.01 121.77 20.9 Favored 'General case' 0 N--CA 1.424 -1.77 0 N-CA-C 108.376 -0.972 . . . . 71.25 108.376 177.085 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.4 t -78.57 -25.07 45.26 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.215 0.531 . . . . 71.349999999999994 109.799 178.914 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.8 m 68.31 12.32 8.7 Favored 'General case' 0 CA--C 1.564 1.485 0 C-N-CA 124.426 1.09 . . . . 74.129999999999995 110.751 177.375 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.2 t -146.34 111.18 5.26 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 107.33 -1.359 . . . . 50.409999999999997 107.33 -179.452 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 46.5 t . . . . . 0 C--N 1.297 -1.687 0 N-CA-C 109.809 -0.441 . . . . 72.209999999999994 109.809 -176.458 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.489 -1.582 0 N-CA-C 107.212 -2.355 . . . . 74.150000000000006 107.212 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.6 p -88.78 152.74 21.59 Favored 'General case' 0 C--N 1.28 -2.429 0 N-CA-C 114.294 1.22 . . . . 74.450000000000003 114.294 -170.302 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.463 ' HA ' ' H ' ' A' ' 140' ' ' GLY . . . -122.43 178.36 5.0 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 106.386 -1.709 . . . . 62.439999999999998 106.386 176.223 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -133.03 146.65 51.92 Favored 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 118.78 -1.168 . . . . 61.409999999999997 111.86 -176.742 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.44 HD23 ' H ' ' A' ' 49' ' ' LEU . 1.0 OUTLIER -109.49 131.73 54.79 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 107.365 -1.346 . . . . 74.439999999999998 107.365 176.959 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.4 t -114.07 118.49 58.56 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 N-CA-C 107.969 -1.122 . . . . 71.450000000000003 107.969 -179.077 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 6.5 t -92.86 116.19 33.42 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.151 0 N-CA-C 107.433 -1.321 . . . . 51.409999999999997 107.433 -179.44 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -74.4 -35.12 63.45 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.724 -0.843 . . . . 63.439999999999998 108.724 -178.943 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.508 ' O ' ' HB3' ' A' ' 133' ' ' PHE . 76.7 ttt180 -170.3 126.97 0.81 Allowed 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 103.578 -2.749 . . . . 71.140000000000001 103.578 176.084 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.543 ' HA2' ' HB3' ' A' ' 133' ' ' PHE . . . -151.35 174.15 30.6 Favored Glycine 0 N--CA 1.421 -2.321 0 C-N-CA 118.293 -1.908 . . . . 52.509999999999998 114.825 -174.745 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -68.65 -39.95 8.21 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 123.321 2.681 . . . . 54.329999999999998 111.748 -179.753 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -79.86 -56.26 4.4 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.609 -0.723 . . . . 72.349999999999994 110.449 -179.374 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -158.91 -160.99 0.91 Allowed 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 108.737 -0.838 . . . . 73.439999999999998 108.737 -175.801 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -152.06 46.81 0.58 Allowed Glycine 0 N--CA 1.43 -1.721 0 N-CA-C 107.384 -2.286 . . . . 70.439999999999998 107.384 -178.711 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -133.69 -172.78 3.05 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 107.384 -1.339 . . . . 65.430000000000007 107.384 -175.641 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 37.2 ptt180 -116.64 139.87 50.04 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 119.811 -0.756 . . . . 73.340000000000003 110.798 179.793 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -126.71 153.94 44.78 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.923 -0.769 . . . . 71.129999999999995 108.923 -177.239 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.0 mp -110.23 140.57 44.23 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.68 -0.859 . . . . 75.25 108.68 178.613 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -71.24 115.59 10.57 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 109.019 -0.734 . . . . 74.430000000000007 109.019 177.719 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -135.83 -26.46 1.2 Allowed 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 115.282 -0.872 . . . . 74.120000000000005 111.44 -175.32 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -108.83 125.88 30.67 Favored Pre-proline 0 C--N 1.311 -1.071 0 N-CA-C 108.49 -0.93 . . . . 75.400000000000006 108.49 179.244 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -41.41 -58.02 1.23 Allowed 'Trans proline' 0 C--N 1.37 1.676 0 C-N-CA 124.57 3.514 . . . . 73.420000000000002 114.738 -176.791 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 26.1 m -109.73 115.95 30.81 Favored 'General case' 0 N--CA 1.434 -1.271 0 C-N-CA 120.158 -0.617 . . . . 74.140000000000001 109.555 178.777 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 87.5 m -116.8 116.16 26.94 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.124 -1.435 . . . . 61.240000000000002 107.124 176.302 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.6 t -110.06 125.21 52.72 Favored 'General case' 0 N--CA 1.434 -1.235 0 C-N-CA 118.853 -1.139 . . . . 71.109999999999999 111.245 -175.576 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -100.22 110.0 22.25 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 115.161 -0.927 . . . . 43.399999999999999 109.142 179.5 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -178.96 -144.04 5.56 Favored Glycine 0 CA--C 1.468 -2.85 0 N-CA-C 109.005 -1.638 . . . . 23.329999999999998 109.005 -179.729 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 21.4 ttt180 -112.75 -89.8 0.52 Allowed 'General case' 0 N--CA 1.404 -2.763 0 C-N-CA 119.322 -0.951 . . . . 71.049999999999997 111.141 178.098 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 35.6 m170 59.97 156.96 0.1 Allowed Pre-proline 0 CA--C 1.547 0.859 0 CA-C-O 121.507 0.67 . . . . 74.540000000000006 111.576 -172.931 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -66.97 -25.55 44.52 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 121.248 1.299 . . . . 73.230000000000004 108.823 168.549 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -111.71 70.94 0.73 Allowed 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 114.355 -1.293 . . . . 54.509999999999998 108.378 -177.443 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.3 m -73.76 134.01 43.37 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.7 -0.682 . . . . 74.200000000000003 110.452 -178.948 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -78.8 -49.6 12.72 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 107.355 -1.35 . . . . 73.150000000000006 107.355 173.899 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 39.7 pt -125.43 141.84 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 N-CA-C 106.155 -1.795 . . . . 51.43 106.155 169.253 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -95.1 121.83 37.14 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-O 121.588 0.708 . . . . 61.109999999999999 111.903 -174.45 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.0 mp -88.25 118.1 27.61 Favored 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 107.777 -1.194 . . . . 72.400000000000006 107.777 172.411 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -96.65 -6.03 37.58 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.364 -1.289 . . . . 71.5 113.047 -165.699 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -78.75 -170.3 2.08 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 115.98 -0.554 . . . . 65.109999999999999 110.479 -177.554 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.8 p -122.36 7.83 5.61 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.42 0 CA-C-O 121.341 0.591 . . . . 73.430000000000007 111.63 -176.263 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 8.2 t -120.51 20.25 11.86 Favored 'General case' 0 C--N 1.308 -1.235 0 O-C-N 121.197 -0.94 . . . . 72.319999999999993 108.907 -179.775 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.465 HG22 ' O ' ' A' ' 86' ' ' SER . 6.1 p -81.42 131.27 34.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-N 114.496 -1.229 . . . . 61.509999999999998 111.737 -176.089 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.465 ' O ' HG22 ' A' ' 85' ' ' VAL . 44.7 t -70.34 157.03 38.48 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 114.629 -1.169 . . . . 50.140000000000001 108.103 175.653 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -52.58 -41.83 63.96 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.563 0.696 . . . . 70.219999999999999 110.398 179.209 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -138.0 130.81 29.82 Favored 'General case' 0 CA--C 1.488 -1.423 0 N-CA-C 103.786 -2.672 . . . . 75.530000000000001 103.786 168.299 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 37.7 t60 -107.71 -63.64 1.29 Allowed 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 119.45 -0.9 . . . . 71.430000000000007 110.588 -176.477 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -136.22 125.7 25.13 Favored 'General case' 0 C--N 1.292 -1.902 0 C-N-CA 120.08 -0.648 . . . . 75.150000000000006 110.036 -177.505 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -97.67 127.22 43.47 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 107.573 -1.269 . . . . 54.009999999999998 107.573 175.722 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -106.01 112.96 26.22 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.569 -1.271 . . . . 73.329999999999998 107.569 179.352 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -113.86 126.98 55.79 Favored 'General case' 0 C--N 1.277 -2.551 0 N-CA-C 108.524 -0.917 . . . . 65.129999999999995 108.524 -178.676 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.5 116.81 53.63 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 CA-C-O 122.048 0.928 . . . . 75.409999999999997 109.98 -178.357 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -108.7 145.75 34.57 Favored 'General case' 0 N--CA 1.419 -2.021 0 N-CA-C 106.0 -1.852 . . . . 71.430000000000007 106.0 174.506 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -50.62 -28.03 8.0 Favored 'General case' 0 C--N 1.308 -1.197 0 O-C-N 124.059 0.85 . . . . 73.409999999999997 112.078 179.599 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -85.03 -51.35 3.8 Favored Glycine 0 N--CA 1.426 -2.027 0 C-N-CA 120.617 -0.801 . . . . 24.32 112.728 179.026 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -144.06 153.44 42.19 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-O 121.073 0.463 . . . . 75.329999999999998 111.087 -173.831 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.425 ' HB2' ' HB3' ' A' ' 122' ' ' MET . 60.9 m-85 -95.46 123.85 39.2 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.216 -1.031 . . . . 74.230000000000004 108.216 177.125 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -115.93 134.29 55.13 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.786 -0.45 . . . . 73.099999999999994 109.786 -178.407 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.6 p -125.33 126.2 70.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 109.272 -0.64 . . . . 74.329999999999998 109.272 177.437 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.7 t -114.56 123.68 70.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 CA-C-N 116.01 -0.541 . . . . 72.439999999999998 110.274 -179.35 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -89.5 115.91 27.27 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 121.567 0.699 . . . . 62.219999999999999 110.288 176.958 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 13.9 m -118.42 11.34 7.0 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.373 0 N-CA-C 108.184 -1.043 . . . . 62.130000000000003 108.184 173.94 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -110.17 34.57 5.34 Favored Glycine 0 N--CA 1.421 -2.335 0 N-CA-C 109.862 -1.295 . . . . 71.019999999999996 109.862 178.879 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.4 m -63.15 -9.73 12.11 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.947 1.299 . . . . 64.310000000000002 110.299 179.893 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 49.8 tp -58.27 -37.92 75.95 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 125.217 1.407 . . . . 64.439999999999998 107.825 174.707 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -110.15 -41.2 4.49 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 115.316 -0.856 . . . . 55.240000000000002 109.297 176.684 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 107.99 123.67 4.96 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 120.628 -0.796 . . . . 71.409999999999997 114.749 174.052 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 87.1 m -109.17 120.18 41.75 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.267 -1.012 . . . . 71.010000000000005 108.267 173.61 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . 0.25 40.5 p90 -123.48 135.81 54.25 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 114.407 1.262 . . . . 64.519999999999996 114.407 -177.83 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 18.2 m -105.09 136.33 39.35 Favored 'Isoleucine or valine' 0 C--O 1.257 1.448 0 CA-C-N 114.657 -1.156 . . . . 73.230000000000004 108.291 -179.994 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 12.6 m120 62.06 -83.02 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 124.685 1.194 . . . . 41.140000000000001 108.744 -169.549 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 27.5 mmm180 -139.74 -12.67 1.13 Allowed 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 124.052 0.941 . . . . 63.32 110.843 177.654 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.459 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . 0.4 OUTLIER -110.5 131.08 22.24 Favored Pre-proline 0 C--O 1.245 0.821 0 N-CA-C 113.891 1.071 . . . . 71.450000000000003 113.891 -168.205 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 115' ' ' GLU . 24.6 Cg_exo -65.14 136.05 46.21 Favored 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 122.748 2.299 . . . . 71.409999999999997 110.17 175.282 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -131.35 164.06 26.49 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.645 -0.502 . . . . 53.340000000000003 109.645 -178.156 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -93.48 -56.03 3.07 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 108.911 -0.774 . . . . 72.439999999999998 108.911 176.733 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -130.99 139.74 50.04 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 108.778 -0.823 . . . . 71.0 108.778 179.572 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -138.88 149.94 45.42 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-O 121.536 0.684 . . . . 71.319999999999993 112.828 -178.453 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 39.7 t -92.34 105.08 16.29 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.101 0 N-CA-C 104.107 -2.553 . . . . 72.409999999999997 104.107 172.328 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.425 ' HB3' ' HB2' ' A' ' 99' ' ' PHE . 9.6 tpt -50.38 120.47 4.61 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 125.065 1.346 . . . . 72.120000000000005 110.297 -171.561 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -104.92 132.07 51.62 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 121.26 0.552 . . . . 74.310000000000002 111.577 -172.083 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.2 p -79.16 115.77 19.03 Favored 'General case' 0 N--CA 1.424 -1.73 0 CA-C-N 115.014 -0.994 . . . . 75.209999999999994 110.756 -179.201 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 119.82 -7.01 12.18 Favored Glycine 0 N--CA 1.429 -1.788 0 C-N-CA 121.033 -0.604 . . . . 65.239999999999995 112.823 177.768 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -106.8 157.9 17.39 Favored 'General case' 0 C--O 1.247 0.932 0 C-N-CA 119.944 -0.702 . . . . 55.039999999999999 111.637 -177.731 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.445 ' HA ' ' HA ' ' A' ' 136' ' ' VAL . 11.0 pt-20 -114.51 121.36 43.28 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-O 122.153 0.978 . . . . 73.349999999999994 109.081 177.587 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 71.6 mt -111.79 130.42 65.42 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.358 0 CA-C-N 113.968 -1.469 . . . . 74.230000000000004 109.962 -170.586 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.49 ' HG3' ' O ' ' A' ' 133' ' ' PHE . 42.8 tt0 -97.36 124.85 41.66 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.99 -0.684 . . . . 74.5 111.438 178.028 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 11.8 pt -105.55 101.95 13.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 114.504 -1.226 . . . . 64.530000000000001 108.481 178.355 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 72.44 -101.76 1.11 Allowed Glycine 0 N--CA 1.437 -1.278 0 N-CA-C 110.273 -1.131 . . . . 74.439999999999998 110.273 -176.559 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 32.8 mmmt -126.0 9.75 7.51 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.23 0.538 . . . . 63.310000000000002 110.307 178.6 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.543 ' HB3' ' HA2' ' A' ' 54' ' ' GLY . 78.5 m-85 -114.36 158.04 22.03 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 108.901 -0.777 . . . . 73.439999999999998 108.901 -179.013 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 51.4 ttp180 -127.49 135.61 50.62 Favored 'General case' 0 C--O 1.249 1.063 0 C-N-CA 118.567 -1.253 . . . . 73.430000000000007 112.731 -176.105 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 5.7 tt -122.16 132.11 54.29 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 114.191 -1.368 . . . . 71.299999999999997 107.465 -178.268 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 127' ' ' GLU . 9.6 p -111.12 135.17 51.11 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 N-CA-C 108.631 -0.878 . . . . 55.140000000000001 108.631 178.294 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -113.84 121.41 43.93 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 109.631 -0.507 . . . . 71.099999999999994 109.631 -175.918 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -123.27 165.98 16.04 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 109.396 -0.594 . . . . 75.409999999999997 109.396 -177.983 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -71.16 130.3 41.13 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 107.522 -1.288 . . . . 74.439999999999998 107.522 174.167 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.463 ' H ' ' HA ' ' A' ' 47' ' ' ALA . . . -116.99 -174.19 17.01 Favored Glycine 0 N--CA 1.418 -2.564 0 C-N-CA 120.115 -1.04 . . . . 64.340000000000003 112.952 -173.485 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo . . . . . 0 N--CA 1.428 -2.381 0 C-N-CA 122.5 2.133 . . . . 54.0 112.156 -179.626 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.8 ptt? . . . . . 0 CA--C 1.514 -0.429 0 CA-C-O 121.521 0.677 . . . . 73.420000000000002 110.678 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.3 p -73.32 -34.86 65.93 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 115.699 -0.682 . . . . 61.340000000000003 111.232 -177.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -93.03 152.5 19.26 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 109.15 -0.685 . . . . 73.200000000000003 109.15 178.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 18.0 m120 73.07 -34.59 0.3 Allowed 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 125.074 1.35 . . . . 54.119999999999997 113.802 176.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -75.73 -23.42 56.05 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 121.202 0.525 . . . . 72.530000000000001 111.077 177.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.01 25.75 27.01 Favored Glycine 0 N--CA 1.439 -1.134 0 C-N-CA 120.894 -0.67 . . . . 45.109999999999999 111.648 -178.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 61.7 m -87.28 123.51 69.76 Favored Pre-proline 0 N--CA 1.433 -1.278 0 N-CA-C 108.872 -0.788 . . . . 64.109999999999999 108.872 177.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -68.25 127.49 15.91 Favored 'Trans proline' 0 N--CA 1.448 -1.182 0 C-N-CA 121.659 1.573 . . . . 75.209999999999994 110.437 174.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -100.94 139.13 20.27 Favored Pre-proline 0 C--N 1.296 -1.736 0 N-CA-C 108.787 -0.82 . . . . 74.230000000000004 108.787 177.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -75.51 118.03 5.0 Favored 'Trans proline' 0 N--CA 1.441 -1.579 0 C-N-CA 121.845 1.697 . . . . 73.129999999999995 111.335 -177.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -76.82 173.74 11.34 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 108.953 -0.758 . . . . 71.400000000000006 108.953 177.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 45.1 t 61.21 81.09 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 108.189 -1.041 . . . . 64.219999999999999 108.189 -173.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -74.73 132.27 41.51 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 115.309 -0.86 . . . . 73.439999999999998 110.067 -176.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.9 t -124.21 108.71 12.57 Favored 'General case' 0 N--CA 1.407 -2.609 0 CA-C-O 121.794 0.807 . . . . 71.329999999999998 109.67 -178.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 15.2 t -112.61 -3.78 14.26 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 122.331 1.062 . . . . 65.129999999999995 108.361 176.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.6 p -92.07 35.88 0.98 Allowed 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 114.417 -1.265 . . . . 75.439999999999998 109.157 179.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.9 m -70.36 158.83 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.612 0 CA-C-N 114.36 -1.291 . . . . 74.150000000000006 111.248 -177.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -136.04 170.67 15.63 Favored 'General case' 0 C--N 1.274 -2.704 0 N-CA-C 106.954 -1.499 . . . . 64.409999999999997 106.954 178.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.8 mpt_? -78.0 129.88 35.82 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 109.44 -0.578 . . . . 63.130000000000003 109.44 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.85 97.28 6.61 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 107.819 -1.178 . . . . 71.519999999999996 107.819 176.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -81.42 -22.14 38.43 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 109.251 -0.648 . . . . 74.319999999999993 109.251 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 58.1 tp 73.19 88.08 0.1 Allowed 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 125.806 1.642 . . . . 74.340000000000003 111.09 -179.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.647 ' H ' HD23 ' A' ' 23' ' ' LEU . 2.2 pt? -86.59 124.04 32.44 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.655 -1.239 . . . . 65.430000000000007 107.655 175.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.4 mtpt -100.46 110.12 22.28 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 120.283 -0.567 . . . . 71.140000000000001 111.487 -176.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -78.83 147.4 33.25 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.729 -0.669 . . . . 74.450000000000003 110.0 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 25.2 ptp -166.76 -179.24 4.68 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.94 -0.763 . . . . 65.109999999999999 108.94 -177.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -143.42 152.52 41.66 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.302 -0.999 . . . . 63.420000000000002 108.302 177.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.0 t -133.18 -30.45 1.33 Allowed 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 110.021 -0.362 . . . . 64.219999999999999 110.021 -179.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 41.9 m -88.87 140.21 29.67 Favored 'General case' 0 N--CA 1.439 -1.006 0 O-C-N 122.159 -0.338 . . . . 54.119999999999997 110.152 -178.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.9 p -67.73 106.9 2.38 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 122.826 0.45 . . . . 72.5 110.965 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -136.09 51.4 0.81 Allowed Glycine 0 N--CA 1.429 -1.789 0 C-N-CA 120.606 -0.807 . . . . 64.519999999999996 113.096 -176.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 47.2 m -85.66 138.98 31.76 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 106.47 -1.678 . . . . 74.409999999999997 106.47 174.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.52 116.05 11.8 Favored Pre-proline 0 C--O 1.241 0.642 0 O-C-N 124.021 0.825 . . . . 61.340000000000003 110.448 -177.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -64.22 115.93 3.44 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.805 2.337 . . . . 72.319999999999993 113.613 -175.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.95 108.97 11.59 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.647 -1.242 . . . . 74.549999999999997 107.647 176.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.2 m 67.73 100.06 0.05 Allowed 'General case' 0 C--O 1.239 0.502 0 O-C-N 124.427 1.079 . . . . 63.340000000000003 111.139 -177.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 23.5 m -79.93 81.47 6.19 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 109.032 -0.729 . . . . 71.120000000000005 109.032 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -150.05 -138.21 2.86 Favored Glycine 0 N--CA 1.425 -2.043 0 N-CA-C 110.804 -0.918 . . . . 74.310000000000002 110.804 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.06 -32.83 72.46 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 123.312 0.645 . . . . 71.310000000000002 112.288 -176.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -82.25 -12.61 57.96 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 112.43 0.53 . . . . 74.010000000000005 112.43 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -83.79 -45.8 12.91 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 108.261 -1.014 . . . . 74.329999999999998 108.261 176.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.4 mp -72.81 157.91 88.04 Favored Pre-proline 0 C--N 1.318 -0.792 0 CA-C-N 114.627 -1.169 . . . . 71.230000000000004 111.131 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.434 ' HG3' ' H ' ' A' ' 140' ' ' GLY . 55.9 Cg_endo -85.76 176.59 5.32 Favored 'Trans proline' 0 C--O 1.24 0.592 0 C-N-CA 122.573 2.182 . . . . 44.409999999999997 112.524 -178.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -115.63 109.79 18.26 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 116.404 -0.362 . . . . 53.229999999999997 110.791 -179.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 84.24 -55.2 5.0 Favored Glycine 0 C--N 1.314 -0.661 0 N-CA-C 113.866 0.306 . . . . 62.450000000000003 113.866 175.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 9.0 m -113.69 153.79 28.37 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 109.715 -0.476 . . . . 54.219999999999999 109.715 -177.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.81 174.0 10.94 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.856 -0.794 . . . . 62.229999999999997 108.856 -178.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.5 pp -135.28 160.14 39.34 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 119.22 -0.992 . . . . 53.5 112.256 -177.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.9 pp -137.75 149.28 46.31 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 109.003 -0.739 . . . . 75.140000000000001 109.003 175.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 22.6 m -121.33 141.52 41.45 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.175 0 N-CA-C 107.14 -1.429 . . . . 64.010000000000005 107.14 175.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.0 t -92.85 116.81 34.81 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.614 0 N-CA-C 107.463 -1.31 . . . . 72.530000000000001 107.463 177.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.483 ' HB2' HG23 ' A' ' 136' ' ' VAL . 82.5 tttt -77.62 -21.76 51.8 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.109 -0.95 . . . . 64.409999999999997 109.214 -176.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.422 ' HB2' ' O ' ' A' ' 52' ' ' LYS . 65.6 ttt180 168.26 131.03 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.51 1.524 . . . . 73.120000000000005 109.536 163.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 175.88 152.69 9.72 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 121.044 -0.598 . . . . 42.240000000000002 112.032 178.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -69.84 -9.28 25.7 Favored 'Trans proline' 0 C--N 1.36 1.147 0 C-N-CA 123.795 2.997 . . . . 71.049999999999997 112.489 177.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -60.94 -42.64 98.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.795 -0.639 . . . . 73.209999999999994 110.656 -178.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -164.47 -58.99 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 109.254 -0.647 . . . . 64.420000000000002 109.254 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.45 32.82 36.91 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.692 -0.766 . . . . 65.140000000000001 111.614 -178.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -144.11 -164.74 1.96 Allowed 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 108.109 -1.071 . . . . 75.420000000000002 108.109 -177.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -115.48 138.56 50.89 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 120.769 0.319 . . . . 63.539999999999999 110.311 177.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -130.33 147.5 52.05 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.647 -0.706 . . . . 74.420000000000002 110.525 -170.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 93.2 mt -105.06 134.52 48.03 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.052 -0.721 . . . . 71.510000000000005 109.052 177.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.4 mp -110.78 114.37 27.68 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.221 -0.659 . . . . 75.530000000000001 109.221 178.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -131.76 4.66 4.22 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.828 -1.175 . . . . 64.25 107.828 172.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -83.56 124.79 75.05 Favored Pre-proline 0 N--CA 1.441 -0.911 0 N-CA-C 106.838 -1.542 . . . . 60.039999999999999 106.838 178.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.454 ' O ' ' HG3' ' A' ' 93' ' ' ARG . 1.2 Cg_endo -45.81 -46.23 15.74 Favored 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 123.291 2.661 . . . . 75.430000000000007 112.912 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 32.1 m -136.37 117.53 14.45 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 109.546 -0.539 . . . . 75.530000000000001 109.546 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 20.4 m -113.37 113.28 25.01 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 107.967 -1.123 . . . . 65.310000000000002 107.967 177.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.5 m -97.79 131.04 44.66 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.197 0.523 . . . . 32.509999999999998 110.756 -176.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.456 ' HB1' ' HB2' ' A' ' 80' ' ' LEU . . . -97.57 110.59 23.12 Favored 'General case' 0 N--CA 1.428 -1.526 0 CA-C-N 115.849 -0.614 . . . . 33.030000000000001 110.52 -178.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -136.47 -143.09 4.57 Favored Glycine 0 N--CA 1.437 -1.254 0 N-CA-C 108.703 -1.759 . . . . 64.230000000000004 108.703 178.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.521 ' O ' ' HD3' ' A' ' 72' ' ' ARG . 4.7 tmt_? -161.19 12.23 0.09 Allowed 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 122.128 0.965 . . . . 73.409999999999997 109.63 176.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 34.5 m170 -99.45 157.7 33.52 Favored Pre-proline 0 N--CA 1.433 -1.283 0 N-CA-C 108.03 -1.1 . . . . 72.540000000000006 108.03 -178.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_exo -56.48 -21.2 36.63 Favored 'Trans proline' 0 N--CA 1.478 0.582 0 C-N-CA 122.969 2.446 . . . . 64.140000000000001 113.88 -178.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.62 -1.68 43.21 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 112.253 0.464 . . . . 74.0 112.253 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 16.0 m -83.14 146.79 28.45 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 108.248 -1.019 . . . . 64.400000000000006 108.248 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -61.26 -60.03 4.38 Favored 'General case' 0 C--N 1.322 -0.618 0 O-C-N 123.273 0.358 . . . . 74.349999999999994 110.968 -176.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 38.2 pt -122.77 157.89 27.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-O 120.746 0.307 . . . . 64.439999999999998 110.194 176.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -97.07 126.54 42.3 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.017 -1.105 . . . . 71.209999999999994 108.017 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.456 ' HB2' ' HB1' ' A' ' 70' ' ' ALA . 1.2 tm? -108.71 -90.25 0.46 Allowed 'General case' 0 N--CA 1.418 -2.055 0 CA-C-O 121.153 0.501 . . . . 62.340000000000003 111.711 -175.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -96.81 118.04 32.38 Favored 'General case' 0 C--N 1.262 -3.211 0 CA-C-O 121.658 0.742 . . . . 74.230000000000004 109.238 -176.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -94.22 -40.25 10.1 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-N 114.412 -1.267 . . . . 63.119999999999997 112.273 -175.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 8.2 p -80.74 -31.66 12.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-N 115.63 -0.714 . . . . 45.299999999999997 110.423 -174.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 5.1 p -133.97 73.68 1.51 Allowed 'General case' 0 C--N 1.294 -1.829 0 CA-C-O 122.242 1.02 . . . . 71.340000000000003 109.291 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.402 HG12 ' H ' ' A' ' 85' ' ' VAL . 2.8 p -82.31 124.65 39.44 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 N-CA-C 114.55 1.315 . . . . 75.409999999999997 114.55 -169.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 51.0 m -96.54 139.5 32.55 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 105.514 -2.032 . . . . 63.329999999999998 105.514 167.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 8.8 ptp85 -56.69 -39.3 73.58 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 121.678 0.751 . . . . 73.340000000000003 112.045 -176.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.451 ' HB3' HG13 ' A' ' 104' ' ' VAL . 23.1 mmt180 -133.06 103.22 5.92 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 106.026 -1.842 . . . . 64.209999999999994 106.026 173.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 12.9 t60 -84.73 -69.92 0.61 Allowed 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.267 0.556 . . . . 73.010000000000005 110.341 -173.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -144.62 170.69 15.59 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.971 -0.752 . . . . 61.420000000000002 108.971 -176.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -144.45 128.19 17.24 Favored 'General case' 0 N--CA 1.419 -2.008 0 CA-C-O 121.317 0.58 . . . . 73.340000000000003 109.649 178.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -107.34 117.34 33.83 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.661 -1.237 . . . . 73.209999999999994 107.661 -177.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.454 ' HG3' ' O ' ' A' ' 66' ' ' PRO . 40.3 ttp85 -126.17 140.98 52.13 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-O 121.527 0.68 . . . . 61.310000000000002 111.053 -177.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.404 HD12 ' O ' ' A' ' 94' ' ' ILE . 2.9 pp -115.16 126.76 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.967 0 N-CA-C 106.865 -1.532 . . . . 74.540000000000006 106.865 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -118.43 146.25 44.59 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 108.698 -0.852 . . . . 73.040000000000006 108.698 -174.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.35 -29.52 4.03 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 114.267 1.21 . . . . 72.230000000000004 114.267 -177.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -96.7 -40.57 3.82 Favored Glycine 0 N--CA 1.432 -1.577 0 C-N-CA 120.755 -0.736 . . . . 71.230000000000004 114.088 177.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -150.65 171.02 17.79 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 117.417 0.608 . . . . 73.120000000000005 111.26 -172.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -105.46 128.6 53.63 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.109 -1.071 . . . . 75.239999999999995 108.109 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -132.5 135.18 45.83 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 120.321 -0.551 . . . . 71.310000000000002 111.596 -177.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.5 p -117.68 122.7 70.43 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 N-CA-C 109.166 -0.679 . . . . 74.109999999999999 109.166 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.3 m -119.95 137.63 53.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 112.694 0.627 . . . . 70.209999999999994 112.694 -177.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -83.26 126.33 32.55 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.622 -1.251 . . . . 75.540000000000006 107.622 171.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.451 HG13 ' HB3' ' A' ' 88' ' ' ARG . 8.2 p -105.33 1.8 10.32 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 CA-C-O 121.734 0.778 . . . . 75.129999999999995 110.518 -177.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 136.47 42.22 0.11 Allowed Glycine 0 N--CA 1.441 -0.976 0 C-N-CA 119.701 -1.238 . . . . 70.310000000000002 113.698 175.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 67.6 p -73.85 124.85 26.9 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-N 117.176 0.488 . . . . 53.329999999999998 109.706 178.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 51.1 tp -78.15 -26.01 47.58 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.447 0.642 . . . . 73.439999999999998 109.327 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -76.66 -23.54 53.26 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.505 -0.77 . . . . 44.109999999999999 110.388 178.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 94.93 132.56 6.86 Favored Glycine 0 N--CA 1.431 -1.634 0 CA-C-N 115.464 -0.789 . . . . 63.310000000000002 112.802 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 79.7 m -109.18 119.82 40.68 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.381 -0.97 . . . . 74.519999999999996 108.381 175.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -125.2 141.54 52.03 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 109.285 -0.635 . . . . 64.319999999999993 109.285 -175.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.474 HG21 ' HG3' ' A' ' 120' ' ' GLN . 28.3 m -98.86 111.45 28.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 N-CA-C 108.687 -0.857 . . . . 62.039999999999999 108.687 175.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 65.89 -76.99 0.04 OUTLIER 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 125.449 1.5 . . . . 70.430000000000007 109.007 -172.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -147.1 10.48 1.01 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.208 1.003 . . . . 62.140000000000001 109.916 177.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -100.58 122.0 51.05 Favored Pre-proline 0 C--O 1.242 0.664 0 CA-C-O 119.648 -0.215 . . . . 70.430000000000007 110.592 -176.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -69.91 112.99 3.25 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.527 2.151 . . . . 73.420000000000002 110.238 174.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -138.44 120.19 15.26 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 109.501 -0.555 . . . . 72.049999999999997 109.501 -177.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -86.08 -21.99 27.39 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 119.914 -0.714 . . . . 75.239999999999995 109.146 176.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -136.67 136.38 39.03 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 106.475 -1.676 . . . . 73.510000000000005 106.475 169.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.474 ' HG3' HG21 ' A' ' 112' ' ' VAL . 0.0 OUTLIER -142.95 151.07 40.53 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 109.761 -0.459 . . . . 74.310000000000002 109.761 -179.872 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.2 p -79.3 123.83 36.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 105.153 -2.166 . . . . 63.229999999999997 105.153 170.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 34.8 ttp -73.54 115.23 12.69 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 121.463 0.649 . . . . 74.120000000000005 110.452 -170.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -103.86 136.96 42.56 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 114.192 -1.367 . . . . 72.409999999999997 109.976 -172.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 40.7 p -88.45 122.27 31.75 Favored 'General case' 0 N--CA 1.411 -2.421 0 CA-C-N 115.047 -0.979 . . . . 63.350000000000001 109.506 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 120.82 -29.09 5.94 Favored Glycine 0 N--CA 1.438 -1.181 0 C-N-CA 120.816 -0.707 . . . . 73.400000000000006 112.306 177.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -93.22 164.08 13.37 Favored 'General case' 0 C--O 1.248 1.002 0 N-CA-C 109.101 -0.703 . . . . 62.399999999999999 109.101 -175.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -108.93 134.86 51.03 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-O 121.989 0.9 . . . . 62.210000000000001 112.052 -176.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 66.4 mt -97.88 121.12 48.08 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 N-CA-C 108.23 -1.026 . . . . 65.340000000000003 108.23 -178.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -89.66 112.54 23.82 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 107.98 -1.119 . . . . 73.230000000000004 107.98 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.442 HG13 ' HB2' ' A' ' 133' ' ' PHE . 6.2 pt -100.99 97.15 5.37 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.572 0 N-CA-C 108.002 -1.11 . . . . 72.129999999999995 108.002 177.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 67.6 -109.52 2.95 Favored Glycine 0 N--CA 1.427 -1.919 0 N-CA-C 109.84 -1.304 . . . . 65.450000000000003 109.84 -173.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -104.72 -17.55 14.59 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 109.237 -0.653 . . . . 73.109999999999999 109.237 176.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.442 ' HB2' HG13 ' A' ' 130' ' ' ILE . 55.1 m-85 -82.92 165.7 19.52 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.659 -0.7 . . . . 71.409999999999997 111.04 -173.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.402 ' HG3' ' HB3' ' A' ' 52' ' ' LYS . 13.1 ptt180 -126.87 122.1 33.69 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 121.719 0.771 . . . . 74.230000000000004 112.294 -170.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 7.8 tt -125.04 142.16 51.67 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.328 -1.36 . . . . 73.420000000000002 107.328 177.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.483 HG23 ' HB2' ' A' ' 52' ' ' LYS . 18.8 t -122.65 131.6 72.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 107.916 -1.142 . . . . 62.100000000000001 107.916 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -102.67 128.88 49.19 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.534 -1.284 . . . . 62.020000000000003 107.534 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -124.75 164.34 20.17 Favored 'General case' 0 C--O 1.253 1.25 0 CA-C-O 121.946 0.879 . . . . 72.400000000000006 111.42 -176.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -72.07 119.84 16.83 Favored 'General case' 0 N--CA 1.416 -2.169 0 CA-C-N 114.446 -1.252 . . . . 75.230000000000004 108.522 176.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.434 ' H ' ' HG3' ' A' ' 43' ' ' PRO . . . -75.64 -160.19 8.78 Favored Glycine 0 N--CA 1.42 -2.425 0 CA-C-N 115.346 -0.843 . . . . 60.420000000000002 111.64 178.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -76.78 125.96 8.49 Favored 'Trans proline' 0 N--CA 1.425 -2.531 0 C-N-CA 121.892 1.728 . . . . 73.25 113.829 -176.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -109.59 102.92 11.72 Favored 'General case' 0 C--N 1.28 -2.422 0 N-CA-C 102.552 -3.129 . . . . 71.140000000000001 102.552 166.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 . . . . . 0 C--N 1.291 -1.936 0 N-CA-C 107.966 -1.124 . . . . 74.010000000000005 107.966 -169.167 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.6 mmt . . . . . 0 CA--C 1.499 -0.982 0 CA-C-O 120.818 0.342 . . . . 52.109999999999999 111.413 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.4 m -76.73 -42.77 40.0 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 105.867 -1.901 . . . . 75.329999999999998 105.867 171.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 16.5 t70 56.57 84.3 0.09 Allowed 'General case' 0 C--O 1.244 0.804 0 CA-C-N 113.593 -1.64 . . . . 72.040000000000006 110.568 178.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 33.5 p30 -90.7 170.53 10.06 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 114.878 -1.056 . . . . 73.219999999999999 111.302 -175.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -101.49 149.44 24.07 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.376 0.608 . . . . 74.239999999999995 110.302 177.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -121.29 95.89 0.58 Allowed Glycine 0 N--CA 1.421 -2.338 0 N-CA-C 108.729 -1.748 . . . . 74.140000000000001 108.729 176.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.41 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 7.5 p -99.29 124.54 44.56 Favored Pre-proline 0 C--N 1.291 -1.939 0 N-CA-C 110.571 -0.159 . . . . 72.530000000000001 110.571 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 7' ' ' THR . 24.3 Cg_exo -66.41 134.87 37.45 Favored 'Trans proline' 0 C--O 1.242 0.708 0 C-N-CA 122.46 2.107 . . . . 64.420000000000002 110.016 175.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.428 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 43.7 mt-10 -92.36 129.66 40.26 Favored Pre-proline 0 C--N 1.294 -1.834 0 N-CA-C 109.821 -0.437 . . . . 72.510000000000005 109.821 -179.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 9' ' ' GLU . 71.0 Cg_exo -54.48 148.02 45.04 Favored 'Trans proline' 0 C--O 1.251 1.15 0 C-N-CA 123.683 2.922 . . . . 42.140000000000001 114.003 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -128.3 153.22 47.23 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 115.002 -0.999 . . . . 74.319999999999993 108.655 -178.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.8 p -126.27 136.38 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.805 0 N-CA-C 109.079 -0.711 . . . . 74.0 109.079 178.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -92.24 136.1 33.47 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.85 -1.167 . . . . 75.420000000000002 107.85 176.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.3 p -78.93 88.49 4.73 Favored 'General case' 0 N--CA 1.427 -1.623 0 CA-C-O 122.239 1.018 . . . . 71.099999999999994 110.948 -177.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.6 m -97.29 103.93 15.91 Favored 'General case' 0 N--CA 1.417 -2.103 0 CA-C-N 114.844 -1.071 . . . . 73.239999999999995 108.349 -177.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.8 m -111.72 154.68 24.64 Favored 'General case' 0 N--CA 1.417 -2.119 0 CA-C-N 115.832 -0.622 . . . . 63.43 109.818 -175.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 66.3 t -87.02 123.41 39.85 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 CA-C-N 115.577 -0.738 . . . . 72.239999999999995 109.267 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -100.01 107.63 19.62 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 109.854 -0.424 . . . . 73.109999999999999 109.854 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 19.0 mtp180 -103.11 163.04 12.47 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.905 -0.589 . . . . 73.400000000000006 110.752 178.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -118.12 79.22 1.34 Allowed 'General case' 0 N--CA 1.432 -1.348 0 CA-C-O 121.828 0.823 . . . . 70.400000000000006 109.114 175.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -93.16 -29.82 15.55 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.137 -0.938 . . . . 71.230000000000004 110.79 -178.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 91.1 mt -82.36 84.06 7.27 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 121.779 0.799 . . . . 74.010000000000005 112.721 -176.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.2 tt -155.45 121.75 5.21 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 103.988 -2.597 . . . . 72.209999999999994 103.988 176.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -117.15 -35.75 3.97 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 114.359 1.244 . . . . 75.510000000000005 114.359 -174.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -162.59 164.9 26.52 Favored 'General case' 0 CA--C 1.513 -0.459 0 C-N-CA 119.893 -0.723 . . . . 72.510000000000005 112.254 -176.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 84.8 mtp -139.13 19.07 2.61 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.349 -0.982 . . . . 74.120000000000005 108.349 176.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.33 112.2 8.19 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 114.794 -1.094 . . . . 73.120000000000005 110.504 -177.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 40.4 m -139.44 141.14 37.47 Favored 'General case' 0 N--CA 1.422 -1.863 0 CA-C-N 115.453 -0.794 . . . . 70.109999999999999 109.064 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.8 p -77.73 132.67 38.24 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 123.275 0.63 . . . . 74.319999999999993 109.892 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 25.4 p -82.27 148.89 28.12 Favored 'General case' 0 C--O 1.257 1.491 0 CA-C-O 120.504 0.192 . . . . 74.030000000000001 111.428 -179.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -62.18 124.7 34.33 Favored Glycine 0 N--CA 1.438 -1.233 0 N-CA-C 110.971 -0.852 . . . . 53.450000000000003 110.971 177.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 28.4 m -86.02 128.84 34.94 Favored 'General case' 0 N--CA 1.414 -2.262 0 N-CA-C 109.794 -0.447 . . . . 53.109999999999999 109.794 -177.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.17 114.25 45.3 Favored Pre-proline 0 C--N 1.302 -1.459 0 CA-C-N 114.746 -1.115 . . . . 75.400000000000006 108.713 -179.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -77.94 107.79 2.41 Favored 'Trans proline' 0 N--CA 1.441 -1.589 0 C-N-CA 122.165 1.91 . . . . 65.400000000000006 113.792 -176.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -101.21 -37.37 8.57 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 106.519 -1.66 . . . . 64.420000000000002 106.519 172.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.0 m -75.72 79.51 2.67 Favored 'General case' 0 N--CA 1.423 -1.825 0 CA-C-N 114.411 -1.268 . . . . 61.210000000000001 110.156 177.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 93.1 m -98.64 -27.99 13.75 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.691 -0.686 . . . . 55.240000000000002 109.55 176.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.81 69.87 1.37 Allowed Glycine 0 N--CA 1.431 -1.696 0 CA-C-N 115.888 -0.596 . . . . 73.25 112.516 177.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.28 -25.04 63.76 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 123.321 0.648 . . . . 35.409999999999997 111.929 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -79.56 -30.08 41.54 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 116.342 -0.39 . . . . 60.229999999999997 111.523 178.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -84.78 -37.46 20.78 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-O 121.182 0.515 . . . . 74.340000000000003 111.872 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.429 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 6.6 tt -73.65 121.03 84.17 Favored Pre-proline 0 C--N 1.308 -1.224 0 CA-C-N 115.287 -0.869 . . . . 63.340000000000003 109.515 -177.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 42' ' ' LEU . 30.6 Cg_exo -63.73 142.29 82.56 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 122.939 2.426 . . . . 54.149999999999999 112.061 178.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.19 97.89 3.05 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.448 0.642 . . . . 71.230000000000004 111.343 -177.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -148.27 89.9 0.14 Allowed Glycine 0 N--CA 1.432 -1.622 0 N-CA-C 109.044 -1.623 . . . . 54.420000000000002 109.044 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.0 m -89.33 164.73 14.78 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 121.64 0.734 . . . . 75.109999999999999 112.658 -173.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.507 ' HB1' ' O ' ' A' ' 138' ' ' LEU . . . -131.93 165.42 23.95 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 107.94 -1.133 . . . . 61.299999999999997 107.94 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -127.6 154.8 44.79 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 120.647 -0.421 . . . . 72.099999999999994 111.802 -176.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.464 ' HB2' HD11 ' A' ' 135' ' ' LEU . 2.8 pp -126.23 144.13 50.89 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 115.829 -0.623 . . . . 61.310000000000002 109.974 177.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.494 HG12 ' HB3' ' A' ' 60' ' ' ARG . 1.8 m -128.02 138.99 53.12 Favored 'Isoleucine or valine' 0 C--O 1.252 1.207 0 N-CA-C 109.348 -0.612 . . . . 63.130000000000003 109.348 178.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.499 HG21 ' HB3' ' A' ' 57' ' ' ALA . 93.8 t -93.62 115.98 33.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 109.792 -0.447 . . . . 70.150000000000006 109.792 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -69.38 -38.17 77.88 Favored 'General case' 0 CA--C 1.506 -0.748 0 O-C-N 123.273 0.358 . . . . 63.210000000000001 110.506 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 42.6 ttt180 -168.84 135.49 1.83 Allowed 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.352 -0.84 . . . . 71.519999999999996 109.655 178.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 149.24 145.54 4.15 Favored Glycine 0 N--CA 1.416 -2.639 0 N-CA-C 110.862 -0.895 . . . . 75.109999999999999 110.862 177.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -67.63 -9.16 24.53 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.796 2.331 . . . . 61.219999999999999 112.105 177.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.436 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 87.9 m-20 -51.25 -46.8 62.48 Favored 'General case' 0 C--O 1.21 -1.009 0 C-N-CA 124.674 1.19 . . . . 74.519999999999996 110.333 175.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.499 ' HB3' HG21 ' A' ' 51' ' ' VAL . . . -172.79 -176.78 1.53 Allowed 'General case' 0 C--O 1.215 -0.714 0 N-CA-C 107.632 -1.247 . . . . 62.299999999999997 107.632 178.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -161.8 41.9 0.39 Allowed Glycine 0 C--N 1.29 -1.987 0 N-CA-C 109.938 -1.265 . . . . 65.430000000000007 109.938 -178.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -159.46 -166.39 1.78 Allowed 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 107.863 -1.162 . . . . 63.420000000000002 107.863 -176.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.494 ' HB3' HG12 ' A' ' 50' ' ' VAL . 19.6 ptt180 -115.71 135.03 54.44 Favored 'General case' 0 N--CA 1.433 -1.317 0 O-C-N 123.934 0.771 . . . . 73.25 109.294 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -126.75 121.77 32.93 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 120.772 0.32 . . . . 75.030000000000001 111.152 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 44.2 tp -88.04 119.32 28.3 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 106.913 -1.514 . . . . 60.32 106.913 177.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -79.66 114.8 18.87 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 120.57 -0.452 . . . . 72.400000000000006 110.137 -177.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -95.91 -20.82 18.47 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.663 0.744 . . . . 63.009999999999998 110.368 -176.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -97.22 139.66 21.6 Favored Pre-proline 0 C--N 1.304 -1.409 0 CA-C-N 114.91 -1.041 . . . . 74.150000000000006 112.098 -175.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.443 ' HA ' ' CG2' ' A' ' 94' ' ' ILE . 29.9 Cg_endo -64.42 -24.53 64.08 Favored 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 123.488 2.792 . . . . 74.430000000000007 114.347 -177.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.8 m -135.25 103.93 5.7 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 121.445 0.641 . . . . 72.219999999999999 109.972 178.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 17.0 m -103.13 121.69 43.16 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 115.456 -0.793 . . . . 74.230000000000004 109.658 -178.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.6 m -97.8 119.86 37.16 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 109.933 -0.395 . . . . 74.340000000000003 109.933 -177.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.82 133.84 42.56 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 121.217 0.532 . . . . 75.200000000000003 109.851 178.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -170.13 -152.71 8.18 Favored Glycine 0 N--CA 1.424 -2.139 0 N-CA-C 108.456 -1.857 . . . . 70.120000000000005 108.456 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.5 ttt180 -90.37 -38.77 13.1 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 118.765 -1.174 . . . . 61.43 111.901 -178.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -176.73 -56.22 0.0 OUTLIER Pre-proline 0 CA--C 1.569 1.677 0 N-CA-C 114.679 1.362 . . . . 73.219999999999999 114.679 -178.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -49.88 -41.65 46.73 Favored 'Trans proline' 0 C--N 1.388 2.641 0 C-N-CA 123.325 2.683 . . . . 71.409999999999997 116.697 -167.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.406 ' OE2' ' HB2' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -126.17 7.97 7.23 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 122.415 1.102 . . . . 72.129999999999995 108.34 178.31 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.5 m -82.72 121.28 26.67 Favored 'General case' 0 N--CA 1.4 -2.941 0 CA-C-N 114.082 -1.417 . . . . 73.040000000000006 108.524 -175.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -66.3 -31.63 72.54 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.777 0.799 . . . . 73.540000000000006 109.633 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.463 ' H ' HD13 ' A' ' 78' ' ' ILE . 0.2 OUTLIER -127.44 141.17 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.391 0 N-CA-C 106.322 -1.733 . . . . 73.129999999999995 106.322 172.269 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -97.47 117.73 32.37 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 120.959 0.409 . . . . 63.399999999999999 111.746 -176.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 5.9 mp -102.51 179.06 4.41 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 107.891 -1.151 . . . . 45.340000000000003 107.891 178.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.419 ' H ' ' HA ' ' A' ' 56' ' ' ASN . 15.4 t70 -163.99 84.24 0.45 Allowed 'General case' 0 N--CA 1.442 -0.841 0 CA-C-O 121.791 0.805 . . . . 74.140000000000001 110.671 178.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.495 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 11.2 t70 -97.48 165.0 12.21 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 105.458 -2.052 . . . . 73.129999999999995 105.458 170.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.8 p -69.39 -27.22 33.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 CA-C-N 119.08 0.855 . . . . 61.200000000000003 110.615 -178.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.465 ' HB ' ' ND2' ' A' ' 108' ' ' ASN . 4.2 m -119.45 36.82 4.36 Favored 'General case' 0 CA--C 1.556 1.187 0 CA-C-O 121.855 0.835 . . . . 75.409999999999997 108.756 -179.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.495 ' HB ' ' HB3' ' A' ' 82' ' ' ASP . 11.8 p -81.75 140.14 16.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 108.958 -0.756 . . . . 65.140000000000001 108.958 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 26.3 m -121.34 147.33 45.84 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 110.016 -0.365 . . . . 75.230000000000004 110.016 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.406 ' HB2' ' OE2' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -59.76 132.19 53.21 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 107.222 -1.399 . . . . 70.420000000000002 107.222 170.683 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 42.1 mtm180 58.8 74.17 0.45 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.568 0.699 . . . . 75.209999999999994 109.758 -169.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -100.13 -58.55 1.89 Allowed 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 108.181 -1.044 . . . . 62.109999999999999 108.181 -177.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -136.58 135.93 38.81 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.507 -0.924 . . . . 55.149999999999999 108.507 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -108.3 126.76 53.2 Favored 'General case' 0 C--N 1.278 -2.503 0 N-CA-C 107.88 -1.155 . . . . 74.409999999999997 107.88 178.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -104.51 112.68 25.84 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.525 -0.917 . . . . 60.420000000000002 108.525 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 35.2 ttt180 -116.65 147.55 41.82 Favored 'General case' 0 C--N 1.275 -2.657 0 N-CA-C 108.331 -0.989 . . . . 74.030000000000001 108.331 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.443 ' CG2' ' HA ' ' A' ' 66' ' ' PRO . 6.7 tt -114.62 137.67 47.25 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.341 0 N-CA-C 108.436 -0.95 . . . . 62.030000000000001 108.436 177.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -118.31 147.48 43.42 Favored 'General case' 0 N--CA 1.419 -2.003 0 N-CA-C 105.942 -1.873 . . . . 74.209999999999994 105.942 177.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -42.48 -19.13 0.01 OUTLIER 'General case' 0 CA--C 1.559 1.326 0 N-CA-C 116.719 2.118 . . . . 73.219999999999999 116.719 -174.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -119.14 -29.1 1.86 Allowed Glycine 0 N--CA 1.43 -1.73 0 C-N-CA 120.751 -0.738 . . . . 53.030000000000001 113.527 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -161.24 177.57 10.08 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-N 118.089 0.944 . . . . 34.420000000000002 109.765 -174.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -103.47 138.67 39.87 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 113.596 0.962 . . . . 72.420000000000002 113.596 -173.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -112.93 116.82 30.59 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.273 -1.01 . . . . 62.439999999999998 108.273 178.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 59.3 t -119.4 119.52 60.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 108.752 -0.832 . . . . 72.310000000000002 108.752 -178.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.6 m -111.4 131.79 61.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-O 121.417 0.627 . . . . 71.030000000000001 111.276 -179.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -91.29 113.29 25.52 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.125 -0.943 . . . . 74.049999999999997 109.486 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 19.1 m -114.79 9.88 7.72 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 CA-C-O 121.463 0.649 . . . . 74.030000000000001 109.954 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -127.75 53.29 0.8 Allowed Glycine 0 N--CA 1.431 -1.641 0 N-CA-C 110.367 -1.093 . . . . 45.340000000000003 110.367 179.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.4 m -61.42 -7.61 3.24 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 124.42 1.088 . . . . 75.349999999999994 113.059 -177.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 69.0 tp -58.15 -44.76 88.03 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 107.996 -1.112 . . . . 72.510000000000005 107.996 174.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.543 ' OD1' ' HA2' ' A' ' 131' ' ' GLY . 52.3 t-20 -98.9 -53.1 3.37 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 106.409 -1.7 . . . . 64.430000000000007 106.409 175.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 94.96 135.87 8.24 Favored Glycine 0 N--CA 1.432 -1.604 0 CA-C-N 115.037 -0.983 . . . . 62.509999999999998 112.716 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 26.9 m -91.94 123.65 35.47 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 108.211 -1.033 . . . . 64.439999999999998 108.211 173.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -102.29 133.87 46.49 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-O 120.994 0.426 . . . . 74.200000000000003 110.277 -177.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.6 p -105.23 115.74 47.67 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 N-CA-C 106.536 -1.653 . . . . 75.430000000000007 106.536 173.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 12.2 m120 64.73 -78.41 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 124.737 1.215 . . . . 73.329999999999998 110.767 -173.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 -140.18 -3.75 1.37 Allowed 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 123.703 0.801 . . . . 63.140000000000001 110.44 -176.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -118.03 130.21 24.87 Favored Pre-proline 0 C--N 1.325 -0.462 0 C-N-CA 120.688 -0.405 . . . . 75.439999999999998 111.711 -170.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -79.64 117.3 3.65 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.394 2.063 . . . . 74.340000000000003 111.104 177.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 36.9 mmt180 -118.76 153.84 33.78 Favored 'General case' 0 C--N 1.308 -1.238 0 O-C-N 121.762 -0.586 . . . . 75.019999999999996 109.868 -177.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -84.73 -25.39 28.36 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.71 0.767 . . . . 74.319999999999993 109.123 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -157.56 139.17 13.9 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 107.539 -1.282 . . . . 41.520000000000003 107.539 175.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -140.62 149.25 42.07 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-O 121.033 0.444 . . . . 73.030000000000001 110.973 178.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 41.1 t -104.52 105.04 17.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 105.294 -2.113 . . . . 72.219999999999999 105.294 175.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 65.7 mtp -103.25 151.35 22.77 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 113.488 0.921 . . . . 64.329999999999998 113.488 -171.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -113.96 153.33 29.49 Favored 'General case' 0 N--CA 1.418 -2.049 0 CA-C-N 113.813 -1.539 . . . . 72.409999999999997 108.269 -177.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.7 p -77.71 129.36 35.42 Favored 'General case' 0 N--CA 1.417 -2.093 0 CA-C-O 121.532 0.682 . . . . 41.340000000000003 111.646 -176.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 111.82 8.64 22.12 Favored Glycine 0 N--CA 1.442 -0.91 0 N-CA-C 110.539 -1.025 . . . . 34.409999999999997 110.539 -177.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -109.89 169.34 8.78 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-O 120.445 0.164 . . . . 62.130000000000003 110.989 -175.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.405 ' OE2' ' HD2' ' A' ' 134' ' ' ARG . 38.2 tt0 -108.73 139.97 42.8 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 113.299 0.851 . . . . 63.520000000000003 113.299 -172.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 58.4 mt -125.31 131.23 72.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 124.436 1.094 . . . . 74.150000000000006 109.704 -176.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -113.94 124.05 51.22 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 121.404 0.621 . . . . 73.239999999999995 110.069 173.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 27.7 mt -108.5 100.07 9.98 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 N-CA-C 107.311 -1.366 . . . . 63.329999999999998 107.311 -177.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.543 ' HA2' ' OD1' ' A' ' 108' ' ' ASN . . . 71.04 -100.6 0.87 Allowed Glycine 0 N--CA 1.425 -2.06 0 O-C-N 124.25 0.969 . . . . 62.219999999999999 110.788 -177.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -114.6 -9.81 12.59 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-O 121.16 0.505 . . . . 74.129999999999995 110.685 177.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -104.27 142.61 34.23 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 118.993 -1.083 . . . . 74.439999999999998 112.32 -171.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.405 ' HD2' ' OE2' ' A' ' 127' ' ' GLU . 11.9 ttp180 -106.79 128.78 54.53 Favored 'General case' 0 C--O 1.248 0.992 0 N-CA-C 113.792 1.034 . . . . 72.319999999999993 113.792 -167.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.464 HD11 ' HB2' ' A' ' 49' ' ' LEU . 38.8 tp -123.94 145.04 49.42 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 126.449 1.9 . . . . 62.509999999999998 109.551 -174.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.419 ' CG1' HG22 ' A' ' 50' ' ' VAL . 7.3 p -123.17 135.24 63.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 108.84 -0.8 . . . . 72.340000000000003 108.84 171.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -112.11 118.41 35.3 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.499 -0.926 . . . . 74.420000000000002 108.499 -174.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.507 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 4.5 mp -120.88 164.42 16.69 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 120.891 0.377 . . . . 72.310000000000002 111.089 -175.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -75.25 145.74 41.68 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.298 -0.63 . . . . 54.25 109.298 177.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -103.7 -178.62 25.79 Favored Glycine 0 N--CA 1.429 -1.789 0 C-N-CA 120.608 -0.806 . . . . 64.439999999999998 111.638 -178.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -70.64 149.0 60.59 Favored 'Trans proline' 0 C--O 1.242 0.686 0 C-N-CA 122.628 2.219 . . . . 55.32 112.515 -179.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -82.2 113.54 20.1 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 106.258 -1.756 . . . . 74.209999999999994 106.258 173.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 . . . . . 0 C--N 1.289 -2.034 0 N-CA-C 109.595 -0.52 . . . . 74.439999999999998 109.595 -174.876 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 CA--C 1.509 -0.616 0 N-CA-C 109.069 -0.715 . . . . 75.329999999999998 109.069 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.8 m -82.1 -28.25 32.4 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 107.458 -1.312 . . . . 74.109999999999999 107.458 174.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -151.52 137.11 17.83 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 105.716 -1.957 . . . . 73.200000000000003 105.716 174.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -100.75 163.08 12.49 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 111.724 0.268 . . . . 62.100000000000001 111.724 -174.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 51.6 t30 54.41 84.1 0.07 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.823 1.249 . . . . 75.200000000000003 111.459 -178.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -108.48 175.63 19.69 Favored Glycine 0 N--CA 1.426 -1.992 0 N-CA-C 110.258 -1.137 . . . . 74.140000000000001 110.258 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.1 m -68.98 130.92 91.15 Favored Pre-proline 0 C--N 1.3 -1.578 0 N-CA-C 108.294 -1.002 . . . . 74.239999999999995 108.294 178.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.538 ' O ' ' HD3' ' A' ' 10' ' ' PRO . 10.7 Cg_endo -53.46 149.86 29.02 Favored 'Trans proline' 0 C--N 1.358 1.059 0 C-N-CA 123.22 2.614 . . . . 53.219999999999999 111.814 -179.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -85.74 105.11 6.29 Favored Pre-proline 0 N--CA 1.422 -1.831 0 N-CA-C 107.741 -1.207 . . . . 74.239999999999995 107.741 178.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.538 ' HD3' ' O ' ' A' ' 8' ' ' PRO . 86.8 Cg_endo -103.26 155.0 0.25 Allowed 'Trans proline' 0 N--CA 1.437 -1.823 0 C-N-CA 122.596 2.197 . . . . 74.450000000000003 112.981 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -80.73 72.47 7.69 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 122.452 1.12 . . . . 74.409999999999997 109.412 173.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.8 p -62.02 142.48 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 CA-C-N 113.454 -1.703 . . . . 75.209999999999994 109.998 -177.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.05 137.59 51.39 Favored 'General case' 0 N--CA 1.423 -1.779 0 C-N-CA 119.72 -0.792 . . . . 72.120000000000005 110.16 179.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.4 m -129.53 90.99 3.08 Favored 'General case' 0 C--N 1.274 -2.674 0 N-CA-C 107.495 -1.298 . . . . 72.219999999999999 107.495 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 94.3 m -69.28 97.0 0.9 Allowed 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 115.066 -0.97 . . . . 72.209999999999994 111.183 -177.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 25.3 t -136.51 112.9 9.94 Favored 'General case' 0 N--CA 1.419 -2.005 0 N-CA-C 105.741 -1.948 . . . . 63.539999999999999 105.741 178.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.7 m -102.76 -173.27 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 CA-C-N 116.051 -0.522 . . . . 45.039999999999999 111.22 -174.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -81.09 134.59 35.68 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 116.232 -0.44 . . . . 61.340000000000003 110.523 178.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -77.07 102.45 6.51 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.908 -0.587 . . . . 74.420000000000002 109.584 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.02 91.79 5.51 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.26 0.552 . . . . 74.030000000000001 110.781 -177.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -71.6 -36.85 70.95 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.02 -0.991 . . . . 73.25 110.667 -178.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.4 tt 76.61 120.52 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.469 1.107 . . . . 62.299999999999997 110.348 -178.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -70.99 127.7 33.47 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 107.521 -1.288 . . . . 73.25 107.521 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.6 167.06 4.7 Favored 'General case' 0 C--N 1.313 -0.998 0 O-C-N 124.023 0.827 . . . . 71.400000000000006 113.045 -176.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -72.89 -167.6 0.39 Allowed 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.03 -0.986 . . . . 72.510000000000005 112.761 -171.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 83.6 mtp -84.4 101.95 12.39 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.072 -1.084 . . . . 54.32 108.072 176.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -69.02 161.52 28.81 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.991 -0.744 . . . . 71.209999999999994 108.991 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.6 t -81.13 171.56 14.77 Favored 'General case' 0 N--CA 1.42 -1.939 0 N-CA-C 107.878 -1.156 . . . . 73.140000000000001 107.878 176.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 20.4 m -89.46 -165.09 1.26 Allowed 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.215 -1.032 . . . . 73.010000000000005 108.215 178.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 38.8 m -62.41 125.52 24.18 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 108.814 -0.81 . . . . 73.340000000000003 108.814 175.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.17 -104.24 0.28 Allowed Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 120.975 -0.631 . . . . 45.140000000000001 113.498 -175.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.0 t -91.07 150.54 21.37 Favored 'General case' 0 N--CA 1.428 -1.572 0 CA-C-O 121.306 0.574 . . . . 64.25 110.895 -176.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -90.4 113.06 56.2 Favored Pre-proline 0 N--CA 1.43 -1.435 0 N-CA-C 108.244 -1.021 . . . . 72.049999999999997 108.244 176.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -64.7 118.88 5.82 Favored 'Trans proline' 0 C--O 1.25 1.091 0 C-N-CA 122.703 2.269 . . . . 71.430000000000007 111.406 -179.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.95 122.75 23.94 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.526 -0.761 . . . . 62.219999999999999 111.652 -175.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.0 t -90.62 99.57 12.58 Favored 'General case' 0 N--CA 1.421 -1.906 0 N-CA-C 108.114 -1.069 . . . . 50.409999999999997 108.114 176.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.4 p -95.04 18.49 12.0 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 115.434 -0.803 . . . . 73.150000000000006 111.215 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.48 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . 99.31 95.92 2.09 Favored Glycine 0 N--CA 1.439 -1.144 0 C-N-CA 120.925 -0.655 . . . . 71.340000000000003 111.488 179.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.23 -27.22 67.8 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 122.498 0.319 . . . . 53.549999999999997 111.744 -176.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -83.12 -16.9 44.97 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.004 0.431 . . . . 51.109999999999999 110.933 179.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -83.32 -33.32 25.94 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 108.706 -0.849 . . . . 73.129999999999995 108.706 176.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 38' ' ' GLY . 89.0 mt -65.77 149.1 97.82 Favored Pre-proline 0 C--O 1.247 0.959 0 CA-C-N 115.23 -0.895 . . . . 75.530000000000001 109.249 176.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -61.99 156.78 47.4 Favored 'Trans proline' 0 C--O 1.25 1.087 0 C-N-CA 122.644 2.229 . . . . 74.150000000000006 112.447 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -78.73 102.88 8.31 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 115.683 -0.69 . . . . 61.119999999999997 109.863 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -166.45 46.15 0.26 Allowed Glycine 0 C--N 1.292 -1.872 0 N-CA-C 108.122 -1.991 . . . . 54.329999999999998 108.122 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.3 m -91.14 167.84 12.06 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 114.252 -0.974 . . . . 60.299999999999997 110.033 -176.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -102.19 166.84 10.37 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 109.907 -0.405 . . . . 72.530000000000001 109.907 -179.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -134.35 152.64 51.92 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.841 -0.8 . . . . 74.040000000000006 108.841 176.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.421 ' HB2' HD11 ' A' ' 135' ' ' LEU . 4.4 pp -109.27 134.63 51.54 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 108.772 -0.825 . . . . 72.349999999999994 108.772 178.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 94.1 t -117.08 117.81 56.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 CA-C-N 116.032 -0.531 . . . . 73.239999999999995 109.604 -177.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.566 HG21 ' HB3' ' A' ' 57' ' ' ALA . 15.6 t -93.15 118.96 40.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 107.711 -1.218 . . . . 72.540000000000006 107.711 178.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -75.99 -42.35 48.49 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 115.664 -0.698 . . . . 64.340000000000003 109.156 -178.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 62.3 ttt180 -177.34 157.64 1.35 Allowed 'General case' 0 C--O 1.245 0.865 0 CA-C-N 115.047 -0.979 . . . . 71.299999999999997 108.921 -177.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 124.88 142.85 5.97 Favored Glycine 0 C--O 1.202 -1.866 0 CA-C-O 119.201 -0.777 . . . . 65.340000000000003 111.563 176.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.568 ' HD2' ' CE1' ' A' ' 133' ' ' PHE . 9.3 Cg_endo -51.62 -7.4 0.2 Allowed 'Trans proline' 0 N--CA 1.499 1.828 0 C-N-CA 124.963 3.775 . . . . 74.349999999999994 115.311 177.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.606 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -56.64 -51.59 68.14 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 108.225 -1.028 . . . . 74.430000000000007 108.225 175.079 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.566 ' HB3' HG21 ' A' ' 51' ' ' VAL . . . -179.5 -171.51 0.19 Allowed 'General case' 0 C--O 1.214 -0.783 0 N-CA-C 106.585 -1.635 . . . . 71.540000000000006 106.585 -178.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -166.96 56.4 0.23 Allowed Glycine 0 C--N 1.291 -1.932 0 N-CA-C 110.416 -1.073 . . . . 54.020000000000003 110.416 -177.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -163.04 -171.01 2.5 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.595 -1.261 . . . . 71.439999999999998 107.595 -178.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 18.4 ptp180 -136.66 138.26 40.92 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.618 -0.882 . . . . 54.329999999999998 108.618 178.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -142.0 148.23 38.22 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 120.128 -0.629 . . . . 73.349999999999994 111.686 176.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.1 tt -84.06 133.97 34.63 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 113.943 -1.481 . . . . 73.230000000000004 107.519 -177.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.5 mp -87.51 112.92 22.73 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 108.501 -0.926 . . . . 63.119999999999997 108.501 178.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -125.12 18.02 8.4 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 122.42 1.105 . . . . 62.350000000000001 108.136 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -119.2 149.31 46.96 Favored Pre-proline 0 C--N 1.296 -1.717 0 CA-C-N 113.874 -1.512 . . . . 74.409999999999997 108.257 -176.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -63.68 -35.23 59.44 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 122.409 2.073 . . . . 72.519999999999996 112.582 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 92' ' ' PHE . 44.1 m -137.53 123.06 19.68 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 116.516 -0.311 . . . . 70.439999999999998 111.133 179.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.469 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 31.3 m -98.12 116.89 31.27 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 106.566 -1.642 . . . . 72.219999999999999 106.566 171.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.505 ' HB ' ' NE2' ' A' ' 73' ' ' HIS . 0.1 OUTLIER -104.86 102.6 12.13 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-O 121.23 0.538 . . . . 71.340000000000003 112.102 -174.37 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -105.87 117.74 34.8 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.088 0.47 . . . . 54.039999999999999 110.173 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 172.41 -163.75 35.93 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.949 -1.26 . . . . 73.209999999999994 109.949 -179.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.7 ptp180 -110.96 21.45 16.44 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 122.045 0.926 . . . . 42.439999999999998 109.561 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.522 ' HD1' ' HA ' ' A' ' 88' ' ' ARG . 12.1 p-80 -84.95 163.67 45.06 Favored Pre-proline 0 C--N 1.299 -1.599 0 CA-C-N 114.672 -1.149 . . . . 72.310000000000002 109.799 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -51.01 -40.42 58.89 Favored 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 123.602 2.868 . . . . 43.340000000000003 115.693 -174.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -97.13 30.21 2.85 Favored 'General case' 0 C--N 1.318 -0.801 0 O-C-N 121.515 -0.741 . . . . 72.409999999999997 112.873 -176.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.0 p -56.91 116.9 3.47 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.268 -0.424 . . . . 75.540000000000006 111.208 178.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -67.23 -49.79 63.14 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 106.301 -1.741 . . . . 74.310000000000002 106.301 173.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 30.4 pt -134.28 138.26 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 CA-C-N 113.606 -1.634 . . . . 63.5 107.236 174.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -104.09 117.54 34.51 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 108.676 -0.861 . . . . 62.25 108.676 177.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.606 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 2.1 pt? -75.38 111.58 10.81 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.369 -0.975 . . . . 61.109999999999999 108.369 177.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -85.59 73.6 10.43 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 118.954 -1.099 . . . . 74.099999999999994 112.752 -173.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -119.85 150.8 39.87 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 115.031 -0.986 . . . . 73.519999999999996 108.901 170.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.0 p -73.38 -20.17 18.36 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 C-N-CA 122.921 0.488 . . . . 71.340000000000003 112.281 -176.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.448 ' HB ' ' ND2' ' A' ' 108' ' ' ASN . 1.3 m -89.53 6.68 39.95 Favored 'General case' 0 CA--C 1.557 1.25 0 CA-C-O 121.057 0.455 . . . . 74.409999999999997 111.943 -172.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.406 HG21 ' HG ' ' A' ' 80' ' ' LEU . 48.4 t -82.27 137.16 21.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 109.409 -0.589 . . . . 62.409999999999997 109.409 -178.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 15.3 p -86.01 -71.1 0.56 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.989 0.423 . . . . 62.109999999999999 112.104 -178.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 21.2 tpp180 -150.19 -66.96 0.2 Allowed 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 106.953 -1.499 . . . . 74.340000000000003 106.953 -178.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.522 ' HA ' ' HD1' ' A' ' 73' ' ' HIS . 48.0 mtt180 -96.56 167.81 10.92 Favored 'General case' 0 CA--C 1.486 -1.516 0 N-CA-C 106.228 -1.768 . . . . 71.400000000000006 106.228 171.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -151.49 -70.72 0.17 Allowed 'General case' 0 C--N 1.292 -1.934 0 C-N-CA 118.921 -1.112 . . . . 73.129999999999995 109.753 -177.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -133.45 104.05 6.23 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-O 121.155 0.502 . . . . 73.140000000000001 109.908 -178.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.424 ' OE1' ' HD3' ' A' ' 88' ' ' ARG . 3.0 mp0 -104.01 132.24 50.45 Favored 'General case' 0 N--CA 1.419 -1.983 0 C-N-CA 119.738 -0.785 . . . . 73.200000000000003 109.961 176.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.469 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 29.9 m-85 -97.1 112.22 24.1 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 105.287 -2.116 . . . . 71.209999999999994 105.287 175.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 72.8 mtt180 -118.3 115.31 24.46 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 106.63 -1.619 . . . . 74.5 106.63 -175.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.9 pp -115.48 143.03 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.927 0 C-N-CA 119.58 -0.848 . . . . 71.340000000000003 111.734 -172.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -117.71 146.77 43.52 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 105.219 -2.141 . . . . 53.43 105.219 175.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -49.01 -32.97 10.19 Favored 'General case' 0 C--N 1.315 -0.912 0 O-C-N 123.575 0.547 . . . . 71.510000000000005 112.453 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -85.35 -48.27 4.86 Favored Glycine 0 N--CA 1.433 -1.538 0 C-N-CA 120.733 -0.746 . . . . 64.430000000000007 112.749 179.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -133.2 131.55 40.5 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-O 121.682 0.753 . . . . 51.039999999999999 112.581 -177.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -99.74 124.55 45.12 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.209 -1.034 . . . . 72.219999999999999 108.209 -178.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -129.19 136.54 50.28 Favored 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 113.829 1.048 . . . . 60.149999999999999 113.829 -176.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.2 p -110.84 118.9 58.36 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 CA-C-N 114.73 -1.123 . . . . 65.120000000000005 108.884 175.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.8 m -120.37 120.8 63.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 N-CA-C 113.166 0.802 . . . . 61.520000000000003 113.166 -177.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.488 ' HB3' ' HB2' ' A' ' 118' ' ' ASN . 4.6 t70 -84.76 122.7 29.49 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 109.164 -0.68 . . . . 63.420000000000002 109.164 169.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 26.8 m -114.53 -1.12 9.48 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 CA-C-N 115.625 -0.716 . . . . 62.140000000000001 109.47 177.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -112.85 59.95 0.36 Allowed Glycine 0 N--CA 1.434 -1.486 0 N-CA-C 110.619 -0.993 . . . . 65.430000000000007 110.619 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 19.1 m -72.41 19.25 0.08 Allowed 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 123.671 0.788 . . . . 71.219999999999999 112.913 -175.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.2 mp -75.58 -33.61 60.6 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 109.58 -0.526 . . . . 75.219999999999999 109.58 178.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.448 ' ND2' ' HB ' ' A' ' 84' ' ' THR . 10.0 m120 -80.25 -24.27 40.25 Favored 'General case' 0 CA--C 1.5 -0.962 0 CA-C-N 116.15 -0.477 . . . . 71.030000000000001 110.54 176.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 86.59 82.58 1.15 Allowed Glycine 0 N--CA 1.428 -1.889 0 N-CA-C 109.956 -1.258 . . . . 70.430000000000007 109.956 -177.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 64.7 m -87.18 119.51 27.49 Favored 'General case' 0 N--CA 1.42 -1.938 0 CA-C-O 121.305 0.574 . . . . 62.530000000000001 109.803 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -116.66 134.07 55.26 Favored 'General case' 0 N--CA 1.425 -1.688 0 N-CA-C 107.54 -1.282 . . . . 73.120000000000005 107.54 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.458 HG12 ' O ' ' A' ' 117' ' ' ARG . 7.4 p -117.68 132.23 68.09 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.713 0 N-CA-C 107.264 -1.384 . . . . 72.430000000000007 107.264 175.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 64.93 26.33 12.79 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 107.837 -1.171 . . . . 63.130000000000003 107.837 -175.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.452 ' HG2' HH11 ' A' ' 114' ' ' ARG . 16.9 mtt-85 70.27 7.48 6.24 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 126.638 1.975 . . . . 73.310000000000002 111.698 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -106.69 144.62 29.42 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 109.831 -0.433 . . . . 71.140000000000001 109.831 -176.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -68.11 91.74 0.38 Allowed 'Trans proline' 0 C--N 1.356 0.93 0 C-N-CA 122.223 1.949 . . . . 72.340000000000003 112.402 176.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.458 ' O ' HG12 ' A' ' 112' ' ' VAL . 5.2 ptt180 -154.61 116.55 4.19 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 125.034 1.333 . . . . 72.299999999999997 108.881 174.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.488 ' HB2' ' HB3' ' A' ' 103' ' ' ASP . 23.5 p-10 -83.74 -30.99 26.24 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 114.888 -1.051 . . . . 62.219999999999999 113.125 -174.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -105.53 138.26 42.01 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.675 -0.81 . . . . 71.409999999999997 110.929 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -140.46 149.36 42.46 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 113.394 0.887 . . . . 71.030000000000001 113.394 178.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.7 p -91.34 135.76 26.09 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 N-CA-C 106.67 -1.604 . . . . 74.340000000000003 106.67 173.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 23.2 ttt -39.45 102.52 0.02 OUTLIER 'General case' 0 C--O 1.247 0.954 0 N-CA-C 114.001 1.111 . . . . 61.219999999999999 114.001 178.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.46 HE21 ' HB2' ' A' ' 126' ' ' ASP . 25.3 tt0 -123.23 123.39 40.66 Favored 'General case' 0 N--CA 1.424 -1.77 0 N-CA-C 105.605 -1.998 . . . . 74.209999999999994 105.605 173.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 7.3 t -81.92 129.06 34.65 Favored 'General case' 0 C--N 1.291 -1.959 0 C-N-CA 120.565 -0.454 . . . . 74.430000000000007 110.363 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 100.36 18.54 21.19 Favored Glycine 0 N--CA 1.433 -1.532 0 CA-C-N 115.55 -0.75 . . . . 64.420000000000002 112.18 177.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.46 ' HB2' HE21 ' A' ' 123' ' ' GLN . 25.3 t0 -110.77 150.05 29.64 Favored 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 119.581 -0.848 . . . . 72.049999999999997 109.501 -179.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -110.48 132.26 54.34 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.558 0.694 . . . . 74.239999999999995 112.519 -174.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 66.2 mt -108.42 118.43 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.591 0 CA-C-N 114.68 -1.146 . . . . 75.120000000000005 107.991 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.425 ' OE1' ' HG2' ' A' ' 114' ' ' ARG . 54.6 mt-30 -109.54 112.61 24.81 Favored 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 109.221 -0.659 . . . . 73.5 109.221 178.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.432 ' O ' HG13 ' A' ' 130' ' ' ILE . 23.4 pt -95.09 96.94 6.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 108.771 -0.825 . . . . 75.549999999999997 108.771 177.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 61.67 -85.31 0.03 OUTLIER Glycine 0 CA--C 1.528 0.853 0 CA-C-N 115.35 -0.841 . . . . 54.140000000000001 112.897 -176.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.503 ' HE3' ' CZ ' ' A' ' 133' ' ' PHE . 48.2 mtmt -113.66 -13.38 12.71 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 123.175 0.59 . . . . 32.009999999999998 111.237 -175.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.568 ' CE1' ' HD2' ' A' ' 55' ' ' PRO . 19.3 m-85 -107.3 154.07 21.81 Favored 'General case' 0 CA--C 1.501 -0.923 0 C-N-CA 119.748 -0.781 . . . . 74.219999999999999 112.227 -169.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 74.2 mtp180 -119.27 122.57 42.21 Favored 'General case' 0 C--O 1.248 0.987 0 CA-C-O 121.603 0.716 . . . . 64.329999999999998 112.623 -172.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.421 HD11 ' HB2' ' A' ' 49' ' ' LEU . 56.9 tp -123.95 131.21 53.54 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 114.466 -1.243 . . . . 73.239999999999995 107.841 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.7 t -115.58 138.76 44.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 N-CA-C 108.17 -1.048 . . . . 71.200000000000003 108.17 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -111.13 117.0 32.06 Favored 'General case' 0 C--N 1.309 -1.152 0 N-CA-C 109.302 -0.629 . . . . 74.530000000000001 109.302 -176.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -123.69 158.99 30.33 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.861 -0.422 . . . . 70.519999999999996 109.861 -177.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -79.91 140.67 36.62 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.049 -1.463 . . . . 61.140000000000001 107.049 172.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -97.96 -143.2 14.39 Favored Glycine 0 C--N 1.292 -1.861 0 C-N-CA 120.329 -0.939 . . . . 52.149999999999999 112.232 -176.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -64.91 120.43 7.67 Favored 'Trans proline' 0 N--CA 1.44 -1.668 0 C-N-CA 122.259 1.973 . . . . 70.299999999999997 113.662 -177.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -104.27 103.89 13.71 Favored 'General case' 0 C--N 1.279 -2.484 0 N-CA-C 106.744 -1.576 . . . . 55.130000000000003 106.744 175.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 . . . . . 0 C--N 1.291 -1.946 0 N-CA-C 108.109 -1.071 . . . . 70.25 108.109 -176.51 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.0 mtt . . . . . 0 N--CA 1.474 0.772 0 N-CA-C 109.572 -0.529 . . . . 55.310000000000002 109.572 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.6 p -77.02 -27.33 54.53 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 107.675 -1.231 . . . . 62.409999999999997 107.675 173.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -88.03 144.8 26.32 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 106.613 -1.625 . . . . 73.109999999999999 106.613 172.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -168.12 172.18 8.92 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.52 -0.918 . . . . 73.530000000000001 108.52 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -134.67 66.36 1.54 Allowed 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.848 -1.167 . . . . 72.209999999999994 107.848 173.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -94.05 76.62 1.03 Allowed Glycine 0 N--CA 1.426 -1.969 0 CA-C-N 113.987 -1.46 . . . . 54.420000000000002 110.863 -178.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.3 p -77.25 123.88 87.07 Favored Pre-proline 0 C--N 1.291 -1.978 0 CA-C-N 115.332 -0.434 . . . . 73.310000000000002 110.396 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -65.6 146.35 84.28 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 121.617 1.545 . . . . 75.530000000000001 110.384 177.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -68.6 122.57 85.18 Favored Pre-proline 0 C--N 1.302 -1.494 0 N-CA-C 109.733 -0.469 . . . . 72.519999999999996 109.733 -174.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -50.23 159.27 1.98 Allowed 'Trans proline' 0 C--N 1.37 1.686 0 C-N-CA 124.281 3.321 . . . . 73.400000000000006 112.624 -178.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 53.3 tp60 -51.14 107.0 0.15 Allowed 'General case' 0 C--O 1.242 0.7 0 C-N-CA 123.666 0.786 . . . . 73.219999999999999 112.418 -174.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.4 p -84.57 146.73 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 107.539 -1.282 . . . . 65.219999999999999 107.539 175.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -104.76 121.48 43.71 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 107.414 -1.328 . . . . 73.319999999999993 107.414 -178.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.4 m -132.94 120.33 21.3 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.96 -0.755 . . . . 52.210000000000001 108.96 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.9 t -115.08 133.01 56.41 Favored 'General case' 0 N--CA 1.412 -2.355 0 CA-C-O 121.666 0.746 . . . . 72.109999999999999 109.562 -177.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 21.0 m -92.88 127.81 38.52 Favored 'General case' 0 C--N 1.283 -2.321 0 N-CA-C 108.169 -1.049 . . . . 75.239999999999995 108.169 178.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.5 m -116.85 167.28 10.12 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.329 0 N-CA-C 108.496 -0.928 . . . . 72.109999999999999 108.496 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -81.21 116.2 20.98 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 109.305 -0.628 . . . . 64.5 109.305 177.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -56.47 112.08 1.16 Allowed 'General case' 0 C--O 1.241 0.626 0 CA-C-O 121.658 0.742 . . . . 71.140000000000001 112.094 177.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -117.96 63.67 0.75 Allowed 'General case' 0 N--CA 1.418 -2.055 0 CA-C-O 121.975 0.893 . . . . 60.039999999999999 109.381 178.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -80.96 -30.9 35.08 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 114.009 -1.451 . . . . 62.219999999999999 109.348 176.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . 0.293 0.9 OUTLIER 47.41 78.63 0.07 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.468 1.507 . . . . 74.340000000000003 112.981 -176.473 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.4 pp -104.11 158.53 16.37 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.18 -0.918 . . . . 75.010000000000005 111.371 -178.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 6.6 mtpm? -112.7 121.17 43.96 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.746 -0.835 . . . . 73.340000000000003 108.746 -178.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -91.13 155.3 18.73 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.295 -0.631 . . . . 72.040000000000006 109.295 -178.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.62 159.97 16.89 Favored 'General case' 0 C--O 1.25 1.122 0 CA-C-O 120.669 0.271 . . . . 72.230000000000004 110.754 -176.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -163.25 157.02 19.79 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 107.032 -1.47 . . . . 62.439999999999998 107.032 -177.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.8 m -78.7 -45.47 21.22 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 119.907 -0.717 . . . . 64.140000000000001 110.03 177.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 44.8 m -82.37 75.58 9.28 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-O 121.381 0.61 . . . . 63.409999999999997 111.362 178.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.1 t 178.93 170.06 0.89 Allowed 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 106.106 -1.813 . . . . 72.409999999999997 106.106 176.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.39 104.51 2.82 Favored Glycine 0 N--CA 1.43 -1.763 0 N-CA-C 110.268 -1.133 . . . . 74.439999999999998 110.268 -176.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 8.9 t -88.04 138.55 31.35 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.443 0.64 . . . . 73.239999999999995 111.106 -177.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -90.7 145.18 31.62 Favored Pre-proline 0 C--N 1.3 -1.572 0 N-CA-C 107.958 -1.127 . . . . 72.019999999999996 107.958 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -63.93 103.04 0.39 Allowed 'Trans proline' 0 C--O 1.246 0.884 0 C-N-CA 121.829 1.686 . . . . 74.239999999999995 111.098 178.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -92.81 98.98 11.74 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 115.001 -1.0 . . . . 62.409999999999997 108.842 -178.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.3 m 75.26 -12.99 0.9 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.179 1.392 . . . . 75.540000000000006 112.463 -178.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 52.2 m -70.99 114.45 9.06 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-O 121.595 0.712 . . . . 64.319999999999993 109.119 175.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 106.73 -32.73 7.0 Favored Glycine 0 N--CA 1.421 -2.325 0 N-CA-C 109.01 -1.636 . . . . 54.420000000000002 109.01 -175.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.96 -25.93 56.35 Favored 'General case' 0 CA--C 1.499 -1.016 0 CA-C-N 115.028 -0.586 . . . . 60.549999999999997 110.12 -175.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.04 -37.22 85.31 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 115.333 -0.849 . . . . 72.140000000000001 109.982 -178.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -77.11 -25.09 51.77 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.749 -0.66 . . . . 74.040000000000006 110.542 177.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.9 tm? 64.01 88.53 0.11 Allowed Pre-proline 0 C--O 1.24 0.553 0 N-CA-C 104.097 -2.557 . . . . 63.409999999999997 104.097 -166.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -88.62 160.21 6.43 Favored 'Trans proline' 0 N--CA 1.432 -2.121 0 C-N-CA 122.436 2.091 . . . . 73.109999999999999 114.726 -164.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -84.11 93.47 8.13 Favored 'General case' 0 N--CA 1.407 -2.615 0 N-CA-C 103.483 -2.784 . . . . 64.209999999999994 103.483 167.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -139.74 77.05 0.32 Allowed Glycine 0 N--CA 1.413 -2.86 0 CA-C-N 115.313 -0.858 . . . . 31.420000000000002 111.572 -173.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 42.6 m -90.85 166.69 12.94 Favored 'General case' 0 N--CA 1.407 -2.598 0 N-CA-C 107.975 -1.12 . . . . 74.109999999999999 107.975 177.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -91.59 154.38 19.1 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 109.763 -0.458 . . . . 64.319999999999993 109.763 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.4 ' H ' HD23 ' A' ' 48' ' ' LEU . 2.4 pt? -131.31 148.51 52.69 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.721 -0.844 . . . . 72.200000000000003 108.721 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.562 ' HB2' HD21 ' A' ' 135' ' ' LEU . 4.4 pp -112.66 138.59 49.23 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 109.511 -0.552 . . . . 60.229999999999997 109.511 178.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 38.7 t -114.54 120.0 63.04 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 108.087 -1.079 . . . . 63.140000000000001 108.087 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 26.3 t -93.2 115.6 32.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 107.523 -1.288 . . . . 74.430000000000007 107.523 178.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -85.38 -40.16 16.79 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.117 -0.947 . . . . 63.310000000000002 109.991 -176.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 36.9 mmt180 -144.32 153.67 42.24 Favored 'General case' 0 CA--C 1.495 -1.17 0 CA-C-N 115.589 -0.732 . . . . 75.120000000000005 110.185 -177.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 131.89 140.23 4.49 Favored Glycine 0 N--CA 1.426 -2.022 0 O-C-N 124.185 0.928 . . . . 43.219999999999999 111.57 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.442 ' HB2' ' O ' ' A' ' 81' ' ' ASP . 14.1 Cg_exo -69.08 -14.95 39.2 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 122.533 2.156 . . . . 61.420000000000002 111.508 175.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.557 ' HA ' ' H ' ' A' ' 81' ' ' ASP . 4.7 p-10 -61.72 -48.77 79.24 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.417 1.087 . . . . 73.450000000000003 111.162 178.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -166.89 171.09 11.6 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.756 -0.831 . . . . 34.130000000000003 108.756 -176.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -155.05 30.28 0.65 Allowed Glycine 0 C--N 1.303 -1.287 0 N-CA-C 110.042 -1.223 . . . . 43.109999999999999 110.042 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -132.78 -168.51 2.08 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 109.261 -0.644 . . . . 65.329999999999998 109.261 -177.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.415 ' HA ' ' O ' ' A' ' 49' ' ' LEU . 19.8 ptp180 -135.02 137.18 42.71 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 109.187 -0.671 . . . . 75.030000000000001 109.187 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.437 ' CE2' HD11 ' A' ' 49' ' ' LEU . 53.0 p90 -135.28 148.42 49.53 Favored 'General case' 0 C--N 1.293 -1.885 0 C-N-CA 120.044 -0.662 . . . . 73.219999999999999 110.579 178.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 36.2 tp -86.69 122.83 31.15 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 124.241 0.963 . . . . 74.430000000000007 108.459 -178.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.4 mp -83.99 114.56 21.8 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.103 0.478 . . . . 73.049999999999997 111.408 -176.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -129.49 7.03 5.28 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.11 -0.95 . . . . 75.109999999999999 108.576 172.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.521 ' OE1' ' HA ' ' A' ' 68' ' ' THR . 8.4 tt0 -88.87 123.52 67.42 Favored Pre-proline 0 N--CA 1.421 -1.888 0 CA-C-N 114.377 -1.283 . . . . 73.299999999999997 107.952 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -51.54 -44.93 40.81 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 123.437 2.758 . . . . 64.540000000000006 112.049 -177.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 91.2 m -136.15 99.38 4.11 Favored 'General case' 0 N--CA 1.425 -1.681 0 N-CA-C 109.026 -0.731 . . . . 70.030000000000001 109.026 174.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.521 ' HA ' ' OE1' ' A' ' 65' ' ' GLN . 16.9 m -77.7 116.45 18.25 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 107.196 -1.409 . . . . 64.040000000000006 107.196 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.503 HG22 ' CE1' ' A' ' 73' ' ' HIS . 2.3 m -92.81 92.54 7.98 Favored 'General case' 0 N--CA 1.419 -1.987 0 CA-C-O 121.152 0.501 . . . . 63.32 110.435 -171.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.464 ' HB2' HD11 ' A' ' 78' ' ' ILE . . . -97.94 131.87 44.01 Favored 'General case' 0 C--O 1.246 0.893 0 CA-C-N 115.723 -0.671 . . . . 73.230000000000004 111.007 -178.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 155.75 -137.66 5.66 Favored Glycine 0 CA--C 1.472 -2.635 0 N-CA-C 107.442 -2.263 . . . . 71.040000000000006 107.442 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -103.51 -83.33 0.49 Allowed 'General case' 0 N--CA 1.418 -2.074 0 N-CA-C 107.538 -1.282 . . . . 74.420000000000002 107.538 170.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.503 ' CE1' HG22 ' A' ' 69' ' ' THR . 31.6 m80 67.03 161.32 0.14 Allowed Pre-proline 0 N--CA 1.475 0.824 0 C-N-CA 123.994 0.918 . . . . 54.100000000000001 110.86 178.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -67.34 -22.01 46.55 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 121.903 1.736 . . . . 71.530000000000001 110.098 167.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -120.82 78.34 1.38 Allowed 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 108.519 -0.919 . . . . 74.140000000000001 108.519 -177.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.0 m -79.9 109.88 14.74 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-N 115.834 -0.621 . . . . 63.420000000000002 109.464 178.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.494 ' CG ' HE22 ' A' ' 65' ' ' GLN . 35.3 t70 -69.76 -43.11 72.91 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 106.936 -1.505 . . . . 44.229999999999997 106.936 173.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.464 HD11 ' HB2' ' A' ' 70' ' ' ALA . 0.2 OUTLIER -140.86 147.17 23.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 N-CA-C 104.753 -2.314 . . . . 74.340000000000003 104.753 170.519 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -116.83 127.48 54.35 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-O 122.009 0.909 . . . . 74.239999999999995 112.347 -173.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.552 ' HA ' ' CB ' ' A' ' 56' ' ' ASN . 8.7 mp -84.8 102.35 12.98 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 115.163 -0.926 . . . . 74.219999999999999 108.932 174.147 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.557 ' H ' ' HA ' ' A' ' 56' ' ' ASN . 37.1 t70 -80.64 64.79 5.55 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 122.836 1.303 . . . . 74.109999999999999 110.975 -178.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -131.91 146.28 52.01 Favored 'General case' 0 C--N 1.283 -2.307 0 CA-C-N 113.89 -1.504 . . . . 52.310000000000002 108.436 175.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 28.3 m -81.92 2.06 3.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 113.729 1.011 . . . . 41.32 113.729 -174.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.422 ' HB ' HD22 ' A' ' 108' ' ' ASN . 0.2 OUTLIER -108.72 12.55 25.67 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 121.816 0.817 . . . . 74.109999999999999 109.298 -179.26 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 98.8 t -83.08 132.01 32.38 Favored 'Isoleucine or valine' 0 C--O 1.244 0.789 0 CA-C-N 115.28 -0.873 . . . . 52.109999999999999 111.844 -177.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 7.6 m -103.73 165.42 11.05 Favored 'General case' 0 C--O 1.25 1.121 0 CA-C-N 115.1 -0.955 . . . . 65.450000000000003 110.252 -177.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.438 ' O ' ' HD2' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -74.13 132.69 42.5 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 107.405 -1.331 . . . . 64.25 107.405 169.11 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.442 ' H ' ' CD2' ' A' ' 73' ' ' HIS . 9.2 mmm180 61.72 83.54 0.15 Allowed 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 106.412 -1.699 . . . . 71.200000000000003 106.412 -168.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 12.5 t60 -104.87 -73.58 0.67 Allowed 'General case' 0 N--CA 1.428 -1.557 0 CA-C-N 115.366 -0.834 . . . . 73.120000000000005 110.149 -174.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.444 ' O ' ' HB3' ' A' ' 70' ' ' ALA . . . -121.71 108.87 14.04 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.633 -0.877 . . . . 74.340000000000003 108.633 -179.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -99.72 126.1 45.71 Favored 'General case' 0 C--N 1.28 -2.42 0 C-N-CA 119.373 -0.931 . . . . 72.349999999999994 109.678 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.486 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 58.5 m-85 -107.12 112.62 25.62 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 105.955 -1.868 . . . . 75.030000000000001 105.955 176.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.432 ' NH1' HG21 ' A' ' 102' ' ' VAL . 99.2 mtt180 -112.7 133.05 54.91 Favored 'General case' 0 C--N 1.277 -2.547 0 N-CA-C 109.035 -0.728 . . . . 74.349999999999994 109.035 -174.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 18.9 pt -116.76 138.14 48.35 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.429 0 C-N-CA 119.332 -0.947 . . . . 64.420000000000002 108.842 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -121.28 146.33 46.94 Favored 'General case' 0 C--N 1.266 -3.046 0 N-CA-C 106.207 -1.775 . . . . 74.230000000000004 106.207 174.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -60.08 -17.19 37.82 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.202 0.525 . . . . 73.040000000000006 112.288 177.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -91.31 -36.73 6.47 Favored Glycine 0 N--CA 1.439 -1.155 0 C-N-CA 121.415 -0.421 . . . . 61.299999999999997 113.081 178.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -169.18 161.69 10.36 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 109.46 -0.57 . . . . 75.0 109.46 -178.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.497 ' HB2' ' HB2' ' A' ' 122' ' ' MET . 59.2 m-85 -97.05 139.16 33.47 Favored 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 122.919 0.488 . . . . 51.530000000000001 110.997 -177.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -125.35 135.34 52.34 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 123.157 0.583 . . . . 74.310000000000002 111.148 -176.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.9 p -115.02 125.4 72.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 121.972 -0.455 . . . . 73.409999999999997 110.485 177.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.432 HG21 ' NH1' ' A' ' 93' ' ' ARG . 96.0 t -119.33 125.46 74.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-O 121.041 0.448 . . . . 72.230000000000004 111.2 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.435 ' HB2' ' HB ' ' A' ' 110' ' ' THR . 12.9 t70 -104.99 122.14 45.24 Favored 'General case' 0 CA--C 1.489 -1.372 0 CA-C-N 115.907 -0.588 . . . . 52.5 110.624 176.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 88' ' ' ARG . 0.9 OUTLIER -131.51 11.08 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.433 0 CA-C-N 114.976 -1.011 . . . . 71.400000000000006 109.675 173.165 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -110.22 44.94 1.4 Allowed Glycine 0 N--CA 1.438 -1.197 0 N-CA-C 109.23 -1.548 . . . . 74.439999999999998 109.23 178.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.4 m -67.58 -3.29 8.41 Favored 'General case' 0 C--N 1.31 -1.109 0 C-N-CA 124.92 1.288 . . . . 74.409999999999997 112.498 -175.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 33.7 tp -68.21 -40.26 82.17 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 107.798 -1.186 . . . . 71.349999999999994 107.798 174.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.422 HD22 ' HB ' ' A' ' 84' ' ' THR . 26.1 t-20 -89.59 -40.97 12.26 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 107.835 -1.172 . . . . 71.209999999999994 107.835 175.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 96.36 92.96 1.81 Allowed Glycine 0 N--CA 1.44 -1.086 0 CA-C-N 115.347 -0.842 . . . . 54.340000000000003 113.377 176.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.435 ' HB ' ' HB2' ' A' ' 103' ' ' ASP . 24.2 m -88.87 119.56 29.48 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.259 -1.015 . . . . 64.010000000000005 108.259 175.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.478 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 41.9 m-85 -112.6 134.83 53.93 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 108.008 -1.108 . . . . 73.409999999999997 108.008 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.3 p -109.03 136.27 45.42 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.444 0 N-CA-C 107.848 -1.167 . . . . 73.329999999999998 107.848 179.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.607 ' O ' ' HD2' ' A' ' 114' ' ' ARG . 20.5 m120 70.64 -81.46 0.03 OUTLIER 'General case' 0 CA--C 1.501 -0.904 0 N-CA-C 107.429 -1.323 . . . . 73.209999999999994 107.429 -172.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.607 ' HD2' ' O ' ' A' ' 113' ' ' ASN . 26.4 mmm180 -154.97 12.8 0.38 Allowed 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 107.648 -1.241 . . . . 71.120000000000005 107.648 173.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.426 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . 35.9 mt-10 -123.64 146.07 49.1 Favored Pre-proline 0 N--CA 1.464 0.274 0 N-CA-C 113.089 0.774 . . . . 64.150000000000006 113.089 -168.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 115' ' ' GLU . 4.9 Cg_exo -77.5 119.29 4.84 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.658 2.239 . . . . 71.299999999999997 109.809 175.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 14.8 mmm180 -136.1 148.29 48.2 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 109.391 -0.596 . . . . 64.430000000000007 109.391 -177.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -86.87 -40.54 14.79 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.534 -0.913 . . . . 63.409999999999997 108.534 173.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -142.58 137.38 30.05 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 107.663 -1.236 . . . . 64.540000000000006 107.663 172.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 24.0 tm0? -142.43 147.01 35.45 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.261 -1.014 . . . . 74.25 108.261 177.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.5 p -84.63 112.83 22.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-O 121.071 0.462 . . . . 63.350000000000001 109.758 177.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.497 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 64.2 mtt -54.22 142.16 26.98 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.873 1.064 . . . . 74.129999999999995 113.873 -171.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -122.13 135.38 54.79 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 115.209 -0.905 . . . . 72.439999999999998 109.068 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 6.7 t -79.89 132.53 36.1 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.855 -0.611 . . . . 54.240000000000002 111.538 -178.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 95.46 16.7 39.04 Favored Glycine 0 CA--C 1.488 -1.607 0 CA-C-N 115.685 -0.689 . . . . 72.510000000000005 111.855 176.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -124.92 -170.99 2.26 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.892 -0.781 . . . . 50.5 108.892 -177.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -133.59 150.83 51.62 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 113.641 0.978 . . . . 63.219999999999999 113.641 -172.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 67.5 mt -113.13 126.98 70.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 107.818 -1.178 . . . . 52.25 107.818 176.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.478 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 14.5 tp60 -102.11 111.94 24.41 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 107.306 -1.368 . . . . 72.409999999999997 107.306 -178.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.446 HG13 ' HB2' ' A' ' 133' ' ' PHE . 14.7 pt -102.35 98.46 6.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 CA-C-O 121.344 0.593 . . . . 71.219999999999999 109.784 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 66.11 -89.74 0.13 Allowed Glycine 0 N--CA 1.438 -1.205 0 CA-C-N 115.208 -0.906 . . . . 60.100000000000001 111.793 -176.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -126.33 -1.04 6.97 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 122.846 0.458 . . . . 73.120000000000005 110.123 -178.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.446 ' HB2' HG13 ' A' ' 130' ' ' ILE . 11.5 m-85 -108.85 156.33 19.78 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.44 -0.948 . . . . 75.439999999999998 108.44 -174.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -124.78 136.0 53.45 Favored 'General case' 0 C--O 1.249 1.05 0 CA-C-O 121.81 0.814 . . . . 73.209999999999994 112.642 -174.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.562 HD21 ' HB2' ' A' ' 49' ' ' LEU . 5.0 tt -124.2 139.82 53.55 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 114.086 -1.415 . . . . 75.129999999999995 107.603 -178.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 9.4 p -113.11 139.25 39.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 109.386 -0.598 . . . . 52.329999999999998 109.386 178.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -116.05 121.37 42.0 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 120.587 0.232 . . . . 73.439999999999998 111.011 -174.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -128.81 143.13 50.83 Favored 'General case' 0 C--O 1.217 -0.643 0 CA-C-O 120.856 0.36 . . . . 74.510000000000005 111.209 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -103.41 44.17 1.03 Allowed 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 105.744 -1.947 . . . . 72.129999999999995 105.744 172.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -60.08 -64.97 3.7 Favored Glycine 0 C--N 1.31 -0.881 0 CA-C-N 112.532 -2.122 . . . . 34.32 117.691 -168.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -76.76 120.96 5.69 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 CA-C-N 119.9 1.85 . . . . 70.400000000000006 114.116 -171.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -110.68 103.52 12.09 Favored 'General case' 0 C--N 1.286 -2.196 0 N-CA-C 107.955 -1.128 . . . . 70.120000000000005 107.955 174.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 . . . . . 0 N--CA 1.404 -2.729 0 CA-C-O 119.191 -0.433 . . . . 71.030000000000001 110.054 179.34 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.0 mtt . . . . . 0 C--O 1.244 0.766 0 N-CA-C 106.489 -1.671 . . . . 64.299999999999997 106.489 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.0 p -66.65 -44.2 82.53 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 106.807 -1.553 . . . . 75.140000000000001 106.807 169.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 67.57 3.39 3.36 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.744 1.617 . . . . 74.439999999999998 113.652 173.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 22.1 p-10 -100.23 103.83 15.3 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-O 121.98 0.895 . . . . 63.219999999999999 109.841 178.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -86.71 112.98 22.18 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 107.944 -1.132 . . . . 64.140000000000001 107.944 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -64.2 107.7 1.92 Allowed Glycine 0 N--CA 1.44 -1.083 0 O-C-N 123.854 0.722 . . . . 63.200000000000003 111.347 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.7 t -96.11 135.1 22.9 Favored Pre-proline 0 N--CA 1.427 -1.586 0 N-CA-C 109.62 -0.511 . . . . 63.340000000000003 109.62 -177.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -63.64 134.43 44.16 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 121.903 1.736 . . . . 71.319999999999993 109.588 174.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -102.95 141.73 23.08 Favored Pre-proline 0 C--N 1.284 -2.266 0 N-CA-C 109.087 -0.708 . . . . 72.409999999999997 109.087 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -38.69 115.1 0.2 Allowed 'Trans proline' 0 C--N 1.368 1.562 0 C-N-CA 124.334 3.356 . . . . 74.010000000000005 113.056 -176.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -64.83 122.45 16.96 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.83 -1.077 . . . . 65.409999999999997 110.848 -178.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.1 p -86.22 119.61 34.68 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 CA-C-N 115.305 -0.862 . . . . 62.43 111.221 -177.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -121.6 140.8 51.79 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 107.262 -1.385 . . . . 75.310000000000002 107.262 178.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.0 t -85.17 136.57 33.48 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 108.606 -0.887 . . . . 64.310000000000002 108.606 -178.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.8 p -93.52 16.35 13.83 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 121.695 0.76 . . . . 74.400000000000006 110.452 -179.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 18.3 m -79.5 97.28 6.37 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 115.295 -0.866 . . . . 62.439999999999998 112.004 -177.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.8 m -126.38 142.92 41.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 107.922 -1.14 . . . . 74.329999999999998 107.922 174.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -83.85 154.03 23.69 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.421 -0.585 . . . . 70.549999999999997 109.421 -176.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.551 ' HB2' ' OD1' ' A' ' 21' ' ' ASP . 19.9 mtm180 -112.5 -163.29 0.84 Allowed 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 108.4 -0.963 . . . . 72.099999999999994 108.4 -177.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -87.67 40.97 0.96 Allowed 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 109.347 -0.612 . . . . 71.340000000000003 109.347 175.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.551 ' OD1' ' HB2' ' A' ' 19' ' ' ARG . 2.6 m-20 -55.17 -44.92 75.65 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 124.871 1.268 . . . . 71.219999999999999 111.861 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 94.8 mt -90.52 103.9 16.54 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.328 -0.99 . . . . 74.409999999999997 108.328 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.7 tt -63.0 121.74 14.31 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 108.143 -1.058 . . . . 72.25 108.143 -178.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 15.2 ptmm? -74.68 -176.56 2.86 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-N 116.055 -0.521 . . . . 64.409999999999997 111.089 -178.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -83.13 148.93 27.19 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.389 -0.967 . . . . 71.230000000000004 108.389 175.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 58.5 ttp -82.88 116.91 22.39 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.005 0.431 . . . . 73.129999999999995 109.901 -177.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -85.59 168.87 14.06 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 108.968 -0.753 . . . . 75.099999999999994 108.968 175.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.5 m -50.91 -34.0 26.6 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 113.738 1.014 . . . . 71.430000000000007 113.738 -173.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.7 m 55.77 49.53 16.01 Favored 'General case' 0 C--N 1.351 0.663 0 CA-C-O 121.728 0.775 . . . . 74.519999999999996 108.99 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 23.5 m -58.35 114.85 2.62 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-N 113.845 -1.525 . . . . 63.409999999999997 112.461 -173.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -86.25 96.04 2.09 Favored Glycine 0 N--CA 1.42 -2.376 0 N-CA-C 107.609 -2.196 . . . . 74.329999999999998 107.609 172.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 32.2 p -66.13 151.3 47.23 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 122.033 0.133 . . . . 73.310000000000002 110.708 -176.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.75 122.11 69.23 Favored Pre-proline 0 N--CA 1.443 -0.784 0 N-CA-C 107.973 -1.121 . . . . 72.409999999999997 107.973 177.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -45.74 109.47 0.19 Allowed 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 123.72 2.947 . . . . 74.019999999999996 113.276 -174.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -106.22 97.15 7.0 Favored 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 106.332 -1.729 . . . . 44.439999999999998 106.332 176.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.4 t -107.23 140.37 40.21 Favored 'General case' 0 N--CA 1.415 -2.208 0 CA-C-N 115.663 -0.699 . . . . 73.510000000000005 111.236 -173.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 25.2 m -90.14 -19.64 24.03 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 107.36 -1.348 . . . . 74.439999999999998 107.36 175.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 160.18 97.63 0.12 Allowed Glycine 0 N--CA 1.44 -1.087 0 N-CA-C 109.749 -1.34 . . . . 73.549999999999997 109.749 -179.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.82 -23.52 67.31 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 122.745 0.418 . . . . 52.450000000000003 112.096 -176.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -62.94 -11.25 17.39 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.872 -0.604 . . . . 74.409999999999997 112.025 177.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.428 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 7.2 t30 -61.45 -32.03 72.0 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 123.523 0.729 . . . . 71.299999999999997 109.967 173.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 6.0 tt -112.63 91.93 18.62 Favored Pre-proline 0 CA--C 1.557 1.214 0 N-CA-C 108.206 -1.035 . . . . 60.119999999999997 108.206 -178.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.428 ' HD3' ' O ' ' A' ' 41' ' ' ASN . 73.9 Cg_endo -97.15 5.42 1.55 Allowed 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.652 2.235 . . . . 60.149999999999999 113.299 -177.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -108.74 23.34 14.68 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.748 0.785 . . . . 54.32 110.362 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -145.71 30.19 1.69 Allowed Glycine 0 C--N 1.296 -1.663 0 N-CA-C 109.996 -1.242 . . . . 44.340000000000003 109.996 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 12.9 m -101.53 162.93 12.54 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 108.2 -1.037 . . . . 74.329999999999998 108.2 -179.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -137.97 164.54 28.77 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.398 -0.593 . . . . 54.310000000000002 109.398 -177.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.6 pp -134.89 160.01 39.63 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 120.825 0.345 . . . . 74.120000000000005 111.827 -177.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.447 ' HB2' HD11 ' A' ' 135' ' ' LEU . 3.6 pp -128.45 146.71 50.72 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 116.512 -0.313 . . . . 51.109999999999999 110.44 178.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 47.7 t -126.65 122.34 60.59 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 N-CA-C 108.314 -0.995 . . . . 72.340000000000003 108.314 178.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.542 HG21 ' HB3' ' A' ' 57' ' ' ALA . 19.6 t -93.35 118.1 38.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 N-CA-C 108.669 -0.863 . . . . 71.420000000000002 108.669 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -89.52 -31.81 17.47 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 116.079 -0.51 . . . . 63.399999999999999 111.047 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 27.9 tpt180 -156.99 129.3 7.4 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.308 -0.405 . . . . 51.439999999999998 110.147 178.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 139.71 136.05 3.32 Favored Glycine 0 N--CA 1.422 -2.277 0 CA-C-N 115.743 -0.662 . . . . 50.25 112.542 176.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.403 ' HD2' ' CE1' ' A' ' 133' ' ' PHE . 51.6 Cg_exo -59.98 -9.07 9.07 Favored 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 124.226 3.284 . . . . 74.430000000000007 111.894 175.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.583 ' ND2' ' HB2' ' A' ' 80' ' ' LEU . 20.6 t-20 -35.16 -50.75 0.53 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 127.764 2.426 . . . . 72.129999999999995 109.245 168.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.542 ' HB3' HG21 ' A' ' 51' ' ' VAL . . . -169.67 -58.14 0.02 OUTLIER 'General case' 0 CA--C 1.504 -0.793 0 CA-C-N 115.511 -0.768 . . . . 64.310000000000002 108.963 176.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.08 30.12 55.8 Favored Glycine 0 C--N 1.318 -0.42 0 N-CA-C 110.342 -1.103 . . . . 71.129999999999995 110.342 -177.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -142.58 -175.53 4.51 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 108.727 -0.842 . . . . 54.240000000000002 108.727 -176.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 16.6 ptt-85 -135.54 137.13 41.74 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.191 -0.67 . . . . 71.230000000000004 109.191 178.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -156.51 154.7 30.75 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.59 -0.277 . . . . 70.140000000000001 111.074 -179.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.1 tt -96.19 139.72 31.93 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.495 -0.775 . . . . 71.219999999999999 110.424 -178.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.2 mp -110.39 126.94 54.81 Favored 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 123.996 0.918 . . . . 60.420000000000002 108.87 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -139.04 24.08 2.56 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 121.769 0.795 . . . . 74.239999999999995 109.957 177.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -90.44 146.81 35.22 Favored Pre-proline 0 C--N 1.315 -0.92 0 N-CA-C 108.132 -1.062 . . . . 74.400000000000006 108.132 178.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -56.71 -45.42 36.94 Favored 'Trans proline' 0 C--N 1.361 1.228 0 C-N-CA 122.956 2.437 . . . . 74.109999999999999 111.664 -177.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.42 HG23 ' HG2' ' A' ' 93' ' ' ARG . 90.2 m -136.1 97.41 3.6 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 115.054 -0.975 . . . . 75.140000000000001 110.238 177.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 21.7 m -88.07 114.15 24.41 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.359 -1.348 . . . . 63.329999999999998 107.359 177.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.403 ' O ' ' HB2' ' A' ' 76' ' ' SER . 17.2 m -100.25 120.14 39.45 Favored 'General case' 0 C--O 1.25 1.131 0 C-N-CA 120.622 -0.431 . . . . 74.129999999999995 110.65 -176.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.629 ' HB1' HD21 ' A' ' 80' ' ' LEU . . . -98.01 129.72 44.87 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 123.99 0.916 . . . . 53.450000000000003 110.734 -177.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 79' ' ' PHE . . . -178.43 -106.22 0.2 Allowed Glycine 0 C--O 1.242 0.65 0 N-CA-C 110.439 -1.064 . . . . 53.549999999999997 110.439 178.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.492 ' HG2' HG21 ' A' ' 85' ' ' VAL . 18.0 mmm180 -131.38 -81.91 0.52 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.152 0.581 . . . . 74.239999999999995 110.218 174.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.503 ' HB3' ' HD3' ' A' ' 74' ' ' PRO . 10.8 t60 -150.78 -61.29 0.02 OUTLIER Pre-proline 0 CA--C 1.553 1.08 0 CA-C-O 118.867 -0.587 . . . . 52.100000000000001 111.838 -177.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.503 ' HD3' ' HB3' ' A' ' 73' ' ' HIS . 83.3 Cg_exo -50.28 -37.89 50.76 Favored 'Trans proline' 0 C--N 1.374 1.899 0 C-N-CA 122.514 2.142 . . . . 55.539999999999999 114.781 179.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.596 ' OE2' ' HD2' ' A' ' 87' ' ' ARG . 45.5 mt-10 -109.42 2.62 20.72 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 112.657 0.614 . . . . 75.010000000000005 112.657 -177.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.403 ' HB2' ' O ' ' A' ' 69' ' ' THR . 36.1 p -148.88 -175.31 4.9 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.119 -1.033 . . . . 75.010000000000005 113.023 -171.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -102.79 -42.29 5.91 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.684 0.754 . . . . 64.400000000000006 110.055 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 21.5 pt -118.91 153.17 21.19 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 115.747 -0.66 . . . . 64.239999999999995 111.087 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.472 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 40.7 p90 -105.83 129.26 54.04 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.036 -0.727 . . . . 73.420000000000002 109.036 177.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.629 HD21 ' HB1' ' A' ' 70' ' ' ALA . 1.4 pt? -156.2 6.27 0.19 Allowed 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 113.773 1.027 . . . . 42.119999999999997 113.773 -175.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -122.62 128.53 50.79 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 118.996 -1.081 . . . . 71.420000000000002 108.337 173.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -127.6 -4.11 5.96 Favored 'General case' 0 C--N 1.286 -2.159 0 CA-C-N 115.018 -0.992 . . . . 74.519999999999996 111.538 -176.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.1 p -87.36 -37.52 11.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 C-N-CA 119.043 -1.063 . . . . 75.510000000000005 109.374 -174.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.3 m -171.8 81.98 0.07 Allowed 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.08 -1.082 . . . . 70.049999999999997 108.08 -178.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.492 HG21 ' HG2' ' A' ' 72' ' ' ARG . 8.9 p -82.91 104.56 11.72 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.366 0 C-N-CA 116.535 -2.066 . . . . 63.240000000000002 109.647 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 58.2 m -76.75 -44.77 31.76 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 113.972 -1.467 . . . . 72.519999999999996 112.212 -175.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.596 ' HD2' ' OE2' ' A' ' 75' ' ' GLU . 13.7 mmt180 -166.15 -167.04 0.98 Allowed 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 105.083 -2.191 . . . . 73.510000000000005 105.083 -176.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.537 ' H ' ' HD3' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -52.78 126.61 20.62 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 106.55 -1.648 . . . . 74.109999999999999 106.55 166.431 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.405 ' NE2' ' HB ' ' A' ' 130' ' ' ILE . 40.6 t60 -92.83 -49.56 6.0 Favored 'General case' 0 C--N 1.284 -2.269 0 CA-C-N 115.501 -0.772 . . . . 62.340000000000003 111.845 -164.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -139.66 142.65 36.97 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 120.296 -0.562 . . . . 61.439999999999998 110.362 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -117.23 127.3 53.96 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 109.136 -0.69 . . . . 73.299999999999997 109.136 176.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -108.72 112.28 24.5 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 106.827 -1.546 . . . . 72.340000000000003 106.827 176.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.42 ' HG2' HG23 ' A' ' 67' ' ' THR . 20.0 mtm180 -123.74 124.67 43.23 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 109.426 -0.583 . . . . 64.430000000000007 109.426 -177.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.492 ' O ' HD12 ' A' ' 94' ' ' ILE . 2.8 pp -115.47 122.48 69.41 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.222 0 CA-C-O 121.76 0.79 . . . . 50.450000000000003 112.041 -175.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -119.08 145.65 45.74 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 107.018 -1.475 . . . . 54.32 107.018 177.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -54.81 -29.7 55.32 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 122.641 0.377 . . . . 61.130000000000003 111.937 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -80.45 -46.69 7.27 Favored Glycine 0 N--CA 1.43 -1.706 0 CA-C-O 119.692 -0.504 . . . . 32.229999999999997 112.34 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -144.99 142.76 30.08 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 117.211 0.505 . . . . 74.430000000000007 110.472 -179.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -95.67 114.79 26.57 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 106.64 -1.615 . . . . 72.140000000000001 106.64 176.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -119.61 116.25 25.64 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.332 0.587 . . . . 73.129999999999995 112.343 -170.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 5.6 p -105.88 124.44 61.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 108.265 -1.013 . . . . 71.510000000000005 108.265 172.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.487 HG12 HG13 ' A' ' 104' ' ' VAL . 33.8 t -111.66 115.01 48.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 CA-C-N 115.869 -0.605 . . . . 72.030000000000001 109.435 -176.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.577 ' HB3' ' CB ' ' A' ' 110' ' ' THR . 4.9 m-20 -85.41 109.69 18.61 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 114.796 -1.093 . . . . 74.430000000000007 108.855 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.487 HG13 HG12 ' A' ' 102' ' ' VAL . 12.3 m -118.3 16.83 7.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 111.95 0.352 . . . . 73.109999999999999 111.95 -176.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -114.22 48.43 0.94 Allowed Glycine 0 C--O 1.241 0.589 0 N-CA-C 110.771 -0.932 . . . . 54.420000000000002 110.771 177.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 6.9 m -65.52 -22.58 66.73 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 124.126 0.97 . . . . 73.109999999999999 112.425 -175.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -58.77 -42.14 88.26 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.209 0.528 . . . . 70.200000000000003 110.296 177.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -76.94 -52.9 8.59 Favored 'General case' 0 CA--C 1.485 -1.554 0 N-CA-C 106.456 -1.683 . . . . 64.140000000000001 106.456 175.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 123.91 103.0 1.55 Allowed Glycine 0 N--CA 1.406 -3.31 0 CA-C-N 113.892 -1.504 . . . . 42.5 110.116 -177.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.577 ' CB ' ' HB3' ' A' ' 103' ' ' ASP . 1.5 p -92.82 119.16 31.88 Favored 'General case' 0 N--CA 1.409 -2.525 0 N-CA-C 107.501 -1.296 . . . . 62.340000000000003 107.501 175.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.434 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 65.6 m-85 -121.99 139.44 53.68 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-O 121.554 0.692 . . . . 63.450000000000003 112.506 -172.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.697 ' HB ' ' NE ' ' A' ' 117' ' ' ARG . 7.1 p -104.87 111.71 35.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 106.333 -1.728 . . . . 65.530000000000001 106.333 170.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.445 HD22 HG22 ' A' ' 112' ' ' VAL . 46.7 m-80 54.23 35.7 23.28 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.922 0.489 . . . . 61.100000000000001 111.295 -177.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 49.2 mtm-85 83.81 3.09 0.88 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.676 1.59 . . . . 74.310000000000002 115.257 178.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -110.47 139.5 21.6 Favored Pre-proline 0 C--N 1.314 -0.957 0 C-N-CA 119.645 -0.822 . . . . 43.439999999999998 110.069 175.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.27 142.32 97.92 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 122.869 2.38 . . . . 74.200000000000003 113.767 -175.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.697 ' NE ' ' HB ' ' A' ' 112' ' ' VAL . 13.1 ptt180 -147.14 163.94 34.72 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.842 -0.617 . . . . 75.030000000000001 111.744 176.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.433 ' HA ' ' HB2' ' A' ' 103' ' ' ASP . 11.1 m120 -124.75 -17.86 5.78 Favored 'General case' 0 CA--C 1.513 -0.452 0 O-C-N 124.094 0.871 . . . . 75.209999999999994 111.959 173.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -155.42 138.28 15.33 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.162 -0.681 . . . . 73.310000000000002 109.162 174.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 21.6 tm0? -141.47 149.28 40.75 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.174 -1.047 . . . . 65.040000000000006 108.174 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.3 p -101.83 113.76 39.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 109.389 -0.597 . . . . 74.439999999999998 109.389 176.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -32.91 116.95 0.24 Allowed 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 115.796 1.776 . . . . 73.310000000000002 115.796 -172.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -118.3 145.48 45.04 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 106.795 -1.557 . . . . 65.010000000000005 106.795 172.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 15.0 t -89.46 130.94 35.72 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 119.766 -0.774 . . . . 74.099999999999994 109.856 -178.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 94.27 19.02 34.27 Favored Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 110.88 -0.888 . . . . 64.420000000000002 110.88 -178.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -96.66 142.13 29.07 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 108.538 -0.912 . . . . 42.439999999999998 108.538 -178.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -109.5 127.32 54.36 Favored 'General case' 0 N--CA 1.422 -1.867 0 CA-C-O 122.086 0.946 . . . . 45.119999999999997 111.127 179.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.511 HG12 ' NH2' ' A' ' 117' ' ' ARG . 25.6 mt -106.7 125.65 62.61 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.285 0 CA-C-N 114.477 -1.238 . . . . 53.310000000000002 108.043 -177.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.434 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 51.0 tt0 -105.42 111.9 24.79 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 107.313 -1.365 . . . . 73.099999999999994 107.313 172.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.45 HD11 ' ND2' ' A' ' 56' ' ' ASN . 17.3 pt -102.05 101.0 11.51 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 N-CA-C 108.593 -0.892 . . . . 75.450000000000003 108.593 177.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 73.62 -90.99 0.65 Allowed Glycine 0 N--CA 1.419 -2.463 0 CA-C-N 114.866 -1.061 . . . . 63.240000000000002 110.757 -177.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 45.0 tttp -131.88 3.53 4.1 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 121.117 0.484 . . . . 75.129999999999995 110.345 -176.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.403 ' CE1' ' HD2' ' A' ' 55' ' ' PRO . 34.5 m-85 -101.61 144.35 30.45 Favored 'General case' 0 C--N 1.311 -1.069 0 O-C-N 121.918 -0.489 . . . . 73.019999999999996 109.743 -176.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -106.85 121.04 43.62 Favored 'General case' 0 C--O 1.247 0.95 0 N-CA-C 107.711 -1.218 . . . . 75.349999999999994 107.711 -177.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.447 HD11 ' HB2' ' A' ' 49' ' ' LEU . 42.9 tp -123.89 142.42 51.15 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 114.993 -1.003 . . . . 72.310000000000002 108.362 -176.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 11.1 p -117.09 130.51 71.88 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 N-CA-C 107.553 -1.277 . . . . 71.5 107.553 174.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -111.47 130.27 55.77 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 116.233 -0.44 . . . . 71.319999999999993 110.055 -173.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -127.94 170.16 13.16 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.92 -0.77 . . . . 63.340000000000003 108.92 -178.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -89.53 164.61 14.72 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 109.031 -0.729 . . . . 53.329999999999998 109.031 176.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -82.87 142.96 21.96 Favored Glycine 0 N--CA 1.435 -1.394 0 N-CA-C 109.723 -1.351 . . . . 53.399999999999999 109.723 177.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -75.23 119.65 5.67 Favored 'Trans proline' 0 N--CA 1.444 -1.423 0 CA-C-N 119.608 1.704 . . . . 63.329999999999998 111.377 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -109.24 110.04 21.13 Favored 'General case' 0 C--N 1.283 -2.308 0 N-CA-C 108.529 -0.915 . . . . 71.450000000000003 108.529 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.426 -1.642 0 CA-C-N 115.941 -0.572 . . . . 72.439999999999998 111.403 -178.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.9 mtt . . . . . 0 N--CA 1.474 0.734 0 N-CA-C 109.603 -0.517 . . . . 64.109999999999999 109.603 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.3 p -82.42 -48.24 11.34 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 107.698 -1.223 . . . . 64.120000000000005 107.698 173.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -103.26 124.45 48.65 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 106.585 -1.635 . . . . 74.540000000000006 106.585 174.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -111.93 148.74 33.07 Favored 'General case' 0 C--N 1.287 -2.129 0 C-N-CA 120.832 -0.347 . . . . 74.519999999999996 110.655 -177.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -92.23 113.45 25.73 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 116.092 -0.504 . . . . 74.340000000000003 110.187 -178.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -119.95 101.1 0.81 Allowed Glycine 0 N--CA 1.425 -2.045 0 N-CA-C 111.107 -0.797 . . . . 64.25 111.107 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.2 m -78.78 124.03 85.15 Favored Pre-proline 0 C--N 1.306 -1.29 0 N-CA-C 108.555 -0.906 . . . . 73.140000000000001 108.555 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -60.49 128.02 24.65 Favored 'Trans proline' 0 C--O 1.252 1.19 0 C-N-CA 122.363 2.042 . . . . 74.200000000000003 111.601 178.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -100.98 131.67 23.02 Favored Pre-proline 0 C--N 1.299 -1.604 0 CA-C-N 115.919 -0.582 . . . . 72.510000000000005 110.188 -178.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -65.1 127.18 17.85 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 121.982 1.788 . . . . 74.340000000000003 111.225 178.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -82.12 104.91 12.8 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.844 -1.169 . . . . 64.209999999999994 107.844 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 23.5 t -111.83 148.95 14.65 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 N-CA-C 107.459 -1.311 . . . . 63.229999999999997 107.459 -178.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -82.47 121.57 26.93 Favored 'General case' 0 N--CA 1.408 -2.533 0 N-CA-C 106.143 -1.799 . . . . 63.32 106.143 170.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 58.4 m -60.53 104.28 0.32 Allowed 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.78 -0.645 . . . . 71.349999999999994 109.642 -177.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 18.2 m -81.25 94.64 6.75 Favored 'General case' 0 N--CA 1.415 -2.189 0 CA-C-N 114.781 -1.1 . . . . 73.310000000000002 110.586 -174.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 21.2 m -134.35 83.68 2.05 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 114.697 -1.138 . . . . 62.340000000000003 108.221 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 39.4 t -108.51 113.69 44.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 108.453 -0.943 . . . . 62.210000000000001 108.453 -178.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -109.89 164.03 12.97 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 108.725 -0.843 . . . . 72.150000000000006 108.725 178.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.4 ' HD2' ' N ' ' A' ' 19' ' ' ARG . 7.3 mpt_? -113.38 175.51 5.42 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 109.418 -0.586 . . . . 75.400000000000006 109.418 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.79 34.21 0.18 Allowed 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 123.567 0.747 . . . . 55.520000000000003 111.77 -177.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -71.34 -32.72 68.88 Favored 'General case' 0 CA--C 1.504 -0.793 0 C-N-CA 124.072 0.949 . . . . 73.239999999999995 110.015 -176.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -74.22 99.09 3.33 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.347 -0.842 . . . . 65.319999999999993 110.214 -177.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 91.3 mt -94.85 166.53 11.93 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.789 -0.641 . . . . 72.450000000000003 110.014 -179.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -74.24 105.69 5.54 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 106.506 -1.665 . . . . 72.340000000000003 106.506 175.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -75.51 132.68 40.92 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.762 -0.458 . . . . 73.049999999999997 109.762 178.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -90.29 127.1 36.06 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.786 -0.643 . . . . 74.430000000000007 110.309 -176.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -99.75 169.15 9.45 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 115.582 -0.736 . . . . 71.450000000000003 109.871 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 16.7 p -142.04 150.85 41.81 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.927 -0.768 . . . . 51.5 108.927 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.6 m -102.67 169.62 8.52 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 109.841 -0.429 . . . . 74.310000000000002 109.841 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.8 t -130.02 143.24 50.69 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 109.839 -0.43 . . . . 63.450000000000003 109.839 -179.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -90.18 -170.48 43.88 Favored Glycine 0 N--CA 1.441 -1.03 0 N-CA-C 111.695 -0.562 . . . . 72.150000000000006 111.695 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 24.9 m -83.77 149.93 26.13 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 122.809 0.444 . . . . 73.430000000000007 110.621 -178.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -89.82 120.87 69.41 Favored Pre-proline 0 C--N 1.311 -1.069 0 N-CA-C 109.432 -0.581 . . . . 31.510000000000002 109.432 176.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -72.74 127.57 12.46 Favored 'Trans proline' 0 C--O 1.238 0.488 0 C-N-CA 122.651 2.234 . . . . 74.420000000000002 111.622 177.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -91.64 90.87 7.76 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.299 -1.0 . . . . 63.310000000000002 108.299 176.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.2 m -57.52 114.62 2.32 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 115.111 -0.949 . . . . 44.140000000000001 112.202 -176.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.3 t -148.54 155.88 41.71 Favored 'General case' 0 N--CA 1.42 -1.942 0 N-CA-C 106.396 -1.705 . . . . 53.0 106.396 178.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 126.47 99.15 1.1 Allowed Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 110.718 -0.953 . . . . 71.540000000000006 110.718 -177.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.01 -34.2 71.1 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 121.212 0.529 . . . . 54.520000000000003 111.329 -175.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.416 ' CD ' ' H ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -84.37 -34.36 23.61 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.408 -0.815 . . . . 73.450000000000003 110.588 -178.704 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -77.58 -43.08 32.94 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.832 -1.076 . . . . 74.150000000000006 112.059 -174.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.447 ' HB2' ' CG ' ' A' ' 66' ' ' PRO . 86.2 mt -84.54 150.34 56.58 Favored Pre-proline 0 C--N 1.302 -1.484 0 O-C-N 122.257 -0.277 . . . . 71.329999999999998 110.696 -176.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 42' ' ' LEU . 46.8 Cg_exo -61.24 130.46 32.32 Favored 'Trans proline' 0 N--CA 1.482 0.849 0 C-N-CA 123.807 3.005 . . . . 54.310000000000002 113.057 -178.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -99.81 -171.09 1.99 Allowed 'General case' 0 C--O 1.245 0.841 0 CA-C-O 121.277 0.56 . . . . 73.409999999999997 111.069 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 128.47 53.97 0.12 Allowed Glycine 0 CA--C 1.488 -1.65 0 N-CA-C 107.877 -2.089 . . . . 24.32 107.877 -177.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.402 ' HB3' ' HB2' ' A' ' 63' ' ' LEU . 10.1 m -89.47 152.12 21.63 Favored 'General case' 0 N--CA 1.422 -1.832 0 CA-C-O 121.684 0.754 . . . . 73.439999999999998 112.374 -166.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.414 ' HB1' ' O ' ' A' ' 138' ' ' LEU . . . -112.32 -164.38 0.91 Allowed 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 114.114 -1.403 . . . . 51.140000000000001 107.434 178.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.7 pp -131.07 155.4 46.98 Favored 'General case' 0 N--CA 1.438 -1.051 0 C-N-CA 120.277 -0.569 . . . . 63.310000000000002 111.96 -177.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.42 ' HB2' HD21 ' A' ' 135' ' ' LEU . 3.6 pp -132.1 141.29 49.12 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 115.771 -0.649 . . . . 74.209999999999994 109.985 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 59.8 t -119.07 126.04 75.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 109.655 -0.498 . . . . 74.140000000000001 109.655 -177.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.5 t -93.17 115.87 32.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 107.553 -1.277 . . . . 70.010000000000005 107.553 176.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.412 ' HE3' ' CG2' ' A' ' 136' ' ' VAL . 94.5 mttt -66.02 -43.93 86.23 Favored 'General case' 0 CA--C 1.496 -1.125 0 CA-C-N 115.105 -0.952 . . . . 71.409999999999997 109.088 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.412 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 30.0 tpt180 -168.9 135.13 1.75 Allowed 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.067 -1.457 . . . . 65.439999999999998 107.067 179.018 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.447 ' HA2' ' HD3' ' A' ' 55' ' ' PRO . . . 172.43 135.73 2.02 Favored Glycine 0 N--CA 1.42 -2.393 0 N-CA-C 109.267 -1.533 . . . . 72.310000000000002 109.267 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.542 ' HB2' ' O ' ' A' ' 81' ' ' ASP . 15.0 Cg_exo -67.52 -10.95 30.43 Favored 'Trans proline' 0 CA--C 1.53 0.307 0 C-N-CA 122.372 2.048 . . . . 61.539999999999999 112.723 -176.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.543 ' HA ' ' N ' ' A' ' 81' ' ' ASP . 29.5 p-10 -53.92 -42.36 68.67 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.708 0.803 . . . . 73.450000000000003 110.673 178.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -168.17 -47.18 0.02 OUTLIER 'General case' 0 N--CA 1.444 -0.732 0 O-C-N 123.411 0.444 . . . . 64.129999999999995 110.769 178.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.28 64.73 2.86 Favored Glycine 0 C--O 1.239 0.466 0 N-CA-C 110.727 -0.949 . . . . 74.219999999999999 110.727 -176.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -166.45 -178.49 4.49 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 107.449 -1.315 . . . . 72.5 107.449 -177.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 13.3 ptt180 -112.64 144.97 41.22 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 109.199 -0.667 . . . . 64.420000000000002 109.199 175.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -132.33 154.31 49.86 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 116.372 -0.377 . . . . 70.319999999999993 110.553 -177.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.1 tt -111.48 140.27 46.22 Favored 'General case' 0 C--N 1.28 -2.439 0 N-CA-C 103.544 -2.762 . . . . 71.450000000000003 103.544 173.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.402 ' HB2' ' HB3' ' A' ' 46' ' ' SER . 6.8 mp -70.38 113.74 7.82 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 118.555 -1.258 . . . . 72.010000000000005 109.115 -176.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -72.36 -60.59 2.16 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 114.081 -1.418 . . . . 62.43 109.632 -173.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.466 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 7.9 tt0 -103.02 132.92 20.66 Favored Pre-proline 0 N--CA 1.419 -1.992 0 CA-C-N 115.168 -0.924 . . . . 63.240000000000002 109.39 -178.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.466 ' HD2' ' HA ' ' A' ' 65' ' ' GLN . 5.8 Cg_exo -37.6 -46.94 1.89 Allowed 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 124.9 3.733 . . . . 75.219999999999999 113.515 175.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.452 HG23 ' HG2' ' A' ' 93' ' ' ARG . 87.3 m -106.61 96.44 6.45 Favored 'General case' 0 N--CA 1.423 -1.817 0 N-CA-C 108.189 -1.041 . . . . 64.340000000000003 108.189 173.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.451 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 22.3 m -89.16 114.61 25.92 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 108.404 -0.961 . . . . 60.030000000000001 108.404 -179.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.4 t -96.85 120.08 36.53 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.583 0.706 . . . . 72.329999999999998 109.86 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -110.28 148.94 30.92 Favored 'General case' 0 N--CA 1.428 -1.569 0 CA-C-N 115.837 -0.62 . . . . 62.530000000000001 110.579 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 147.71 -137.82 6.78 Favored Glycine 0 CA--C 1.466 -2.994 0 N-CA-C 107.389 -2.285 . . . . 64.450000000000003 107.389 -178.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.296 4.5 ptt85 -110.94 -88.94 0.5 Allowed 'General case' 0 C--N 1.284 -2.268 0 CA-C-O 118.428 -0.796 . . . . 75.109999999999999 111.857 174.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.471 ' HB3' ' HD2' ' A' ' 74' ' ' PRO . 32.7 m170 60.63 173.74 0.05 OUTLIER Pre-proline 0 CA--C 1.559 1.298 0 CA-C-N 118.598 0.635 . . . . 73.209999999999994 110.879 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.471 ' HD2' ' HB3' ' A' ' 73' ' ' HIS . 28.4 Cg_endo -66.77 -21.74 50.75 Favored 'Trans proline' 0 CA--C 1.545 1.026 0 C-N-CA 121.394 1.396 . . . . 65.299999999999997 111.81 169.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -134.33 92.96 2.99 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-O 121.337 0.589 . . . . 73.420000000000002 110.363 -176.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 13.1 m -77.38 117.32 18.76 Favored 'General case' 0 C--N 1.279 -2.494 0 N-CA-C 107.084 -1.45 . . . . 73.129999999999995 107.084 172.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -70.99 -35.06 71.96 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 108.522 -0.918 . . . . 73.400000000000006 108.522 -178.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.7 pp -130.15 162.47 37.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 106.14 -1.8 . . . . 74.150000000000006 106.14 165.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -101.33 136.64 40.85 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 113.974 1.102 . . . . 74.420000000000002 113.974 -170.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.53 ' HA ' ' HB2' ' A' ' 56' ' ' ASN . 94.4 mt -128.91 150.18 50.47 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 106.971 -1.492 . . . . 73.239999999999995 106.971 175.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.543 ' N ' ' HA ' ' A' ' 56' ' ' ASN . 16.9 t70 -156.93 94.59 1.44 Allowed 'General case' 0 C--N 1.288 -2.071 0 O-C-N 124.0 0.812 . . . . 72.519999999999996 109.425 -177.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.448 ' O ' HG12 ' A' ' 85' ' ' VAL . 14.1 t70 -157.82 152.92 25.62 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 107.802 -1.185 . . . . 72.030000000000001 107.802 175.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.6 p -61.31 -27.5 41.99 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.061 0 C-N-CA 122.893 0.477 . . . . 63.43 112.202 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 17.6 p -96.77 21.85 8.96 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 113.88 1.067 . . . . 72.430000000000007 113.88 -177.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.448 HG12 ' O ' ' A' ' 82' ' ' ASP . 13.9 p -82.06 124.74 39.45 Favored 'Isoleucine or valine' 0 C--O 1.249 1.038 0 CA-C-O 122.044 0.925 . . . . 74.239999999999995 110.266 179.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 16.2 m -80.9 163.32 23.45 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.805 -0.813 . . . . 70.549999999999997 108.805 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.49 -43.21 97.26 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 119.677 -0.809 . . . . 70.140000000000001 108.931 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -110.4 110.81 21.72 Favored 'General case' 0 N--CA 1.419 -2.02 0 N-CA-C 102.565 -3.124 . . . . 74.319999999999993 102.565 176.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 14.6 t60 -110.62 -85.88 0.55 Allowed 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 117.878 -1.529 . . . . 73.25 112.398 -172.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.414 ' HA ' ' HA ' ' A' ' 103' ' ' ASP . . . -126.6 123.82 38.51 Favored 'General case' 0 C--N 1.292 -1.932 0 C-N-CA 120.167 -0.613 . . . . 42.240000000000002 109.722 -175.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -110.04 127.53 54.89 Favored 'General case' 0 C--N 1.275 -2.642 0 C-N-CA 118.938 -1.105 . . . . 55.409999999999997 110.419 177.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.451 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 53.0 m-85 -103.41 113.64 27.3 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 114.61 -1.177 . . . . 74.430000000000007 108.116 -176.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.452 ' HG2' HG23 ' A' ' 67' ' ' THR . 48.6 mtm180 -108.78 122.6 47.5 Favored 'General case' 0 C--N 1.288 -2.109 0 N-CA-C 109.632 -0.507 . . . . 74.450000000000003 109.632 178.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.412 ' CG2' ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -115.2 116.95 54.09 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.495 0 N-CA-C 106.888 -1.523 . . . . 74.319999999999993 106.888 175.919 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -117.8 146.06 44.09 Favored 'General case' 0 C--N 1.278 -2.533 0 CA-C-N 113.575 -1.648 . . . . 74.140000000000001 106.6 178.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -56.1 -22.02 25.68 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 112.396 0.517 . . . . 72.230000000000004 112.396 -177.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -95.95 -33.6 6.28 Favored Glycine 0 N--CA 1.435 -1.368 0 C-N-CA 121.042 -0.599 . . . . 60.119999999999997 113.611 178.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -148.16 144.3 27.67 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 117.494 0.647 . . . . 73.519999999999996 111.687 -176.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.487 ' HB3' ' SD ' ' A' ' 122' ' ' MET . 5.1 m-85 -106.67 114.3 28.32 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 106.986 -1.487 . . . . 74.299999999999997 106.986 176.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -132.37 135.12 45.92 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.43 -0.794 . . . . 63.140000000000001 111.901 -176.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.5 p -114.53 119.53 61.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 109.066 -0.716 . . . . 72.129999999999995 109.066 176.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 50.0 t -110.83 114.09 46.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 108.168 -1.049 . . . . 60.140000000000001 108.168 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.414 ' HA ' ' HA ' ' A' ' 90' ' ' ALA . 19.5 t70 -105.43 127.44 52.99 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-O 121.235 0.54 . . . . 63.350000000000001 110.556 179.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 28.7 m -116.67 12.61 7.55 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.176 0 CA-C-N 115.052 -0.976 . . . . 62.240000000000002 109.51 174.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -100.89 52.5 0.92 Allowed Glycine 0 N--CA 1.437 -1.284 0 N-CA-C 110.596 -1.001 . . . . 60.140000000000001 110.596 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.5 m -60.96 -17.16 50.06 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.201 1.4 . . . . 74.040000000000006 112.331 -176.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 82.6 mt -58.3 -39.9 80.56 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.698 0.761 . . . . 74.209999999999994 109.395 174.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -90.64 -48.99 6.73 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 106.706 -1.59 . . . . 73.530000000000001 106.706 176.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.66 94.0 1.24 Allowed Glycine 0 N--CA 1.442 -0.948 0 CA-C-N 114.767 -1.106 . . . . 53.039999999999999 113.982 175.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 42.0 m -93.72 120.09 33.55 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 109.208 -0.664 . . . . 71.049999999999997 109.208 175.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -135.65 168.74 18.7 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 107.923 -1.14 . . . . 65.530000000000001 107.923 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.417 HG12 ' H ' ' A' ' 114' ' ' ARG . 52.5 t -106.84 141.67 21.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 107.932 -1.136 . . . . 72.420000000000002 107.932 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -51.48 -38.11 52.25 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 123.88 0.872 . . . . 74.329999999999998 111.563 178.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.417 ' H ' HG12 ' A' ' 112' ' ' VAL . 53.5 ttt180 -84.06 -36.46 23.04 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 116.072 -0.513 . . . . 73.099999999999994 111.343 176.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 21.3 tp10 -124.2 114.21 27.73 Favored Pre-proline 0 C--N 1.306 -1.295 0 N-CA-C 112.125 0.417 . . . . 72.150000000000006 112.125 -169.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -78.75 38.82 0.74 Allowed 'Trans proline' 0 CA--C 1.547 1.146 0 C-N-CA 123.409 2.739 . . . . 63.329999999999998 113.206 -178.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 64.8 mtm180 -109.45 145.06 36.81 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 116.197 -0.456 . . . . 71.040000000000006 110.286 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -71.28 -38.64 71.82 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 123.941 0.776 . . . . 70.25 110.992 -172.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -115.04 136.9 52.62 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 107.13 -1.433 . . . . 61.020000000000003 107.13 173.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 -142.58 150.85 40.88 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 114.518 1.303 . . . . 72.140000000000001 114.518 -177.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.1 p -79.88 128.82 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.915 0 N-CA-C 105.252 -2.129 . . . . 63.32 105.252 167.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.487 ' SD ' ' HB3' ' A' ' 99' ' ' PHE . 59.4 mtt -60.59 136.68 58.13 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 123.29 0.636 . . . . 74.319999999999993 112.095 -171.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.473 HE21 ' HB2' ' A' ' 126' ' ' ASP . 0.2 OUTLIER -108.39 125.06 51.31 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 105.435 -2.061 . . . . 74.329999999999998 105.435 178.065 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 21.7 p -78.89 115.39 18.55 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.222 0.534 . . . . 53.329999999999998 111.507 -176.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 101.53 13.77 31.77 Favored Glycine 0 N--CA 1.432 -1.606 0 C-N-CA 120.758 -0.734 . . . . 63.200000000000003 112.505 179.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.473 ' HB2' HE21 ' A' ' 123' ' ' GLN . 8.1 t70 -116.6 176.33 5.16 Favored 'General case' 0 C--O 1.248 0.986 0 C-N-CA 119.531 -0.868 . . . . 52.310000000000002 109.476 178.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.54 ' OE1' ' HD3' ' A' ' 134' ' ' ARG . 40.6 tt0 -110.48 135.11 51.65 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-O 121.296 0.57 . . . . 72.430000000000007 109.984 -171.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 67.4 mt -103.37 122.95 56.55 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.406 0 N-CA-C 107.889 -1.152 . . . . 70.239999999999995 107.889 178.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -97.32 112.45 24.26 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 115.913 -0.585 . . . . 74.049999999999997 109.454 -179.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.1 pt -102.01 98.21 6.57 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.343 0 N-CA-C 107.549 -1.278 . . . . 74.209999999999994 107.549 175.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 75.08 -113.86 4.12 Favored Glycine 0 N--CA 1.421 -2.315 0 N-CA-C 108.198 -1.961 . . . . 70.120000000000005 108.198 -172.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -124.66 6.27 8.19 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 120.971 0.415 . . . . 72.329999999999998 110.397 175.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.412 ' HB2' ' O ' ' A' ' 53' ' ' ARG . 9.4 p90 -98.78 151.64 20.57 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 109.224 -0.658 . . . . 74.340000000000003 109.224 174.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.54 ' HD3' ' OE1' ' A' ' 127' ' ' GLU . 77.9 mtt-85 -117.85 132.5 56.42 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 115.104 1.52 . . . . 74.439999999999998 115.104 -164.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.42 HD21 ' HB2' ' A' ' 49' ' ' LEU . 5.6 tt -124.3 136.33 54.03 Favored 'General case' 0 C--O 1.195 -1.773 0 CA-C-N 114.008 -1.451 . . . . 75.0 107.466 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.412 ' CG2' ' HE3' ' A' ' 52' ' ' LYS . 25.9 t -112.58 137.63 44.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.941 -0.763 . . . . 61.539999999999999 108.941 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -107.26 117.36 33.86 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 110.014 -0.365 . . . . 71.25 110.014 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.414 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 2.5 mm? -117.34 143.87 45.5 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.35 0.595 . . . . 72.439999999999998 110.976 -177.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -97.57 91.27 5.35 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.415 -0.957 . . . . 65.329999999999998 108.415 177.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -107.16 -72.28 0.79 Allowed Glycine 0 N--CA 1.43 -1.727 0 CA-C-N 115.358 -0.837 . . . . 42.109999999999999 111.176 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -75.87 128.79 11.06 Favored 'Trans proline' 0 N--CA 1.446 -1.28 0 C-N-CA 121.935 1.757 . . . . 64.030000000000001 112.441 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -110.75 111.5 22.72 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 107.59 -1.263 . . . . 54.130000000000003 107.59 174.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 . . . . . 0 N--CA 1.425 -1.712 0 N-CA-C 108.619 -0.882 . . . . 63.119999999999997 108.619 -178.365 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 ppp? . . . . . 0 N--CA 1.466 0.37 0 N-CA-C 112.662 0.616 . . . . 65.420000000000002 112.662 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.2 m -74.67 -29.98 61.42 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-O 120.981 0.419 . . . . 71.129999999999995 109.914 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.0 t70 66.17 101.79 0.04 OUTLIER 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 122.492 1.139 . . . . 64.400000000000006 113.357 178.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -118.67 138.02 52.9 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 114.118 -1.401 . . . . 63.130000000000003 108.198 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -150.93 156.67 41.67 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 109.317 -0.623 . . . . 72.200000000000003 109.317 -174.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -73.85 106.15 1.96 Allowed Glycine 0 N--CA 1.436 -1.305 0 N-CA-C 110.66 -0.976 . . . . 63.450000000000003 110.66 178.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.1 t -98.02 126.73 39.28 Favored Pre-proline 0 C--N 1.296 -1.721 0 N-CA-C 110.122 -0.325 . . . . 72.209999999999994 110.122 -179.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -66.3 128.37 19.25 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.388 2.059 . . . . 71.540000000000006 111.205 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -90.77 131.68 36.93 Favored Pre-proline 0 C--N 1.294 -1.808 0 N-CA-C 108.898 -0.779 . . . . 71.010000000000005 108.898 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_exo -49.14 129.36 21.77 Favored 'Trans proline' 0 C--O 1.239 0.541 0 C-N-CA 123.508 2.805 . . . . 34.399999999999999 114.707 -174.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -110.18 107.95 17.93 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.007 -1.849 . . . . 71.409999999999997 106.007 174.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.6 p -114.65 107.49 23.0 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 CA-C-O 122.01 0.91 . . . . 53.030000000000001 111.7 -175.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -139.57 140.95 37.2 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 105.676 -1.972 . . . . 60.32 105.676 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 67.8 m -150.71 95.57 2.24 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 109.897 -0.408 . . . . 64.25 109.897 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.9 p -113.33 104.18 12.06 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-O 121.363 0.601 . . . . 74.0 111.547 177.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 39.9 t -164.9 115.2 1.14 Allowed 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 107.498 -1.297 . . . . 63.109999999999999 107.498 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.8 p -141.69 144.73 25.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 N-CA-C 109.792 -0.447 . . . . 73.319999999999993 109.792 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -128.98 158.1 39.8 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.364 -0.976 . . . . 73.109999999999999 108.364 175.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 16.3 ptt85 -127.4 138.11 52.91 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.416 0.627 . . . . 75.430000000000007 112.235 -176.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -99.94 42.06 1.13 Allowed 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.705 -0.679 . . . . 64.510000000000005 110.529 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -69.99 -15.76 63.08 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 116.373 -0.376 . . . . 65.219999999999999 111.983 -178.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.421 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 45.4 tp -79.15 156.89 28.05 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 107.653 -1.24 . . . . 74.409999999999997 107.653 175.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.421 ' HB2' ' O ' ' A' ' 22' ' ' LEU . 9.7 mp 75.55 34.69 0.58 Allowed 'General case' 0 N--CA 1.483 1.212 0 CA-C-O 122.057 0.932 . . . . 52.119999999999997 110.515 -177.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -87.99 115.72 25.65 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.588 -1.187 . . . . 72.219999999999999 108.363 177.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -106.39 -177.95 3.51 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.549 -0.75 . . . . 71.019999999999996 109.374 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -144.73 139.76 28.11 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.817 -0.808 . . . . 75.040000000000006 108.817 178.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -78.07 135.14 37.67 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 108.939 -0.763 . . . . 62.32 108.939 177.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.5 m -79.07 155.73 28.66 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.326 -0.852 . . . . 71.430000000000007 111.999 -172.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 14.5 m -94.22 148.93 21.71 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 115.473 -0.785 . . . . 71.310000000000002 109.168 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.0 t -109.42 -177.51 3.31 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.222 -1.399 . . . . 70.549999999999997 107.222 177.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -116.31 178.7 17.52 Favored Glycine 0 C--N 1.304 -1.206 0 C-N-CA 120.504 -0.855 . . . . 54.030000000000001 111.145 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.3 m -76.69 138.24 39.88 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 109.897 -0.408 . . . . 73.019999999999996 109.897 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -78.49 143.32 63.6 Favored Pre-proline 0 C--N 1.304 -1.403 0 N-CA-C 108.734 -0.839 . . . . 73.409999999999997 108.734 177.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -63.11 110.15 1.1 Allowed 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.038 1.825 . . . . 73.400000000000006 110.186 177.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -158.22 116.78 3.07 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 115.001 -0.999 . . . . 70.349999999999994 108.489 -177.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.3 p -80.01 144.91 32.84 Favored 'General case' 0 N--CA 1.422 -1.842 0 O-C-N 123.85 0.719 . . . . 71.549999999999997 109.207 176.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.6 t -109.91 157.53 19.14 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-O 121.102 0.477 . . . . 75.140000000000001 110.11 -177.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -133.83 50.79 0.86 Allowed Glycine 0 N--CA 1.409 -3.106 0 N-CA-C 108.287 -1.925 . . . . 64.099999999999994 108.287 174.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.17 -29.51 70.85 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 123.373 0.669 . . . . 73.409999999999997 111.07 -178.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -72.14 -15.11 61.97 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 116.219 -0.446 . . . . 74.209999999999994 111.559 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -71.25 -29.93 65.71 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.91 0.862 . . . . 72.209999999999994 109.11 177.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -84.27 151.63 59.98 Favored Pre-proline 0 N--CA 1.422 -1.854 0 N-CA-C 107.516 -1.291 . . . . 73.329999999999998 107.516 177.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -68.11 176.53 5.33 Favored 'Trans proline' 0 C--O 1.253 1.245 0 C-N-CA 122.006 1.804 . . . . 62.039999999999999 111.647 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.432 ' HB3' ' HB2' ' A' ' 143' ' ' GLU . . . -69.44 108.5 3.78 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.858 0.837 . . . . 52.439999999999998 110.99 -178.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.48 ' HA2' ' O ' ' A' ' 141' ' ' PRO . . . -158.52 48.83 0.42 Allowed Glycine 0 CA--C 1.48 -2.154 0 N-CA-C 106.015 -2.834 . . . . 44.130000000000003 106.015 178.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 13.6 m -89.98 164.79 14.4 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 113.56 -1.32 . . . . 61.240000000000002 111.264 -169.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -92.91 164.58 13.26 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 116.015 -0.539 . . . . 74.439999999999998 109.773 -179.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -133.83 155.91 48.99 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 110.261 -0.274 . . . . 75.239999999999995 110.261 -178.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.473 HD23 ' O ' ' A' ' 61' ' ' PHE . 2.7 pt? -108.79 132.77 53.66 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 107.065 -1.457 . . . . 72.310000000000002 107.065 176.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.8 t -117.68 114.66 46.13 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 N-CA-C 108.661 -0.866 . . . . 65.299999999999997 108.661 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.47 HG11 ' OD1' ' A' ' 56' ' ' ASN . 61.9 t -92.9 116.03 33.09 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 N-CA-C 107.722 -1.214 . . . . 64.109999999999999 107.722 177.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.4 mmmp? -82.56 -39.12 22.75 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.381 -0.827 . . . . 62.119999999999997 108.831 -178.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.43 ' O ' ' HB3' ' A' ' 133' ' ' PHE . 72.8 ttt180 -147.86 115.65 6.4 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 115.196 -0.911 . . . . 75.400000000000006 108.94 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 175.74 134.18 1.88 Allowed Glycine 0 N--CA 1.438 -1.174 0 C-N-CA 120.127 -1.035 . . . . 72.219999999999999 113.433 176.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.55 -9.25 25.7 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 123.957 3.105 . . . . 64.510000000000005 111.897 175.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.49 ' HB2' ' HA ' ' A' ' 80' ' ' LEU . 13.2 p30 -48.54 -46.05 38.26 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.488 1.115 . . . . 54.43 111.495 177.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -171.34 -40.53 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 125.203 1.401 . . . . 75.150000000000006 107.381 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 64.6 46.35 90.34 Favored Glycine 0 CA--C 1.495 -1.192 0 N-CA-C 110.191 -1.163 . . . . 71.099999999999994 110.191 -178.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -143.11 -178.01 5.63 Favored 'General case' 0 N--CA 1.424 -1.775 0 N-CA-C 108.513 -0.921 . . . . 75.420000000000002 108.513 -173.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.445 ' HA ' ' O ' ' A' ' 49' ' ' LEU . 11.2 ptt180 -141.49 131.94 25.27 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 123.416 0.447 . . . . 73.329999999999998 109.969 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.473 ' O ' HD23 ' A' ' 49' ' ' LEU . 30.7 p90 -154.36 154.96 34.19 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 112.415 0.524 . . . . 71.540000000000006 112.415 -177.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.2 tt -81.08 139.69 35.54 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.019 -0.991 . . . . 64.140000000000001 110.874 -176.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -101.71 115.77 31.27 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 110.253 -0.277 . . . . 60.409999999999997 110.253 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -111.31 -4.45 14.93 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 122.393 1.092 . . . . 72.040000000000006 108.392 177.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.416 HE21 ' HB3' ' A' ' 77' ' ' ASP . 1.0 OUTLIER -78.73 123.6 85.31 Favored Pre-proline 0 C--N 1.314 -0.959 0 CA-C-N 114.587 -1.188 . . . . 74.120000000000005 109.98 -175.875 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.02 -27.71 85.08 Favored 'Trans proline' 0 C--N 1.361 1.225 0 C-N-CA 122.878 2.385 . . . . 73.310000000000002 111.308 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 91.8 m -134.93 116.63 14.94 Favored 'General case' 0 N--CA 1.408 -2.535 0 N-CA-C 107.13 -1.433 . . . . 71.310000000000002 107.13 173.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.423 HG23 ' HB2' ' A' ' 77' ' ' ASP . 88.9 m -105.24 114.4 28.56 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 108.969 -0.752 . . . . 72.299999999999997 108.969 -179.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 28.3 p -82.67 130.24 35.09 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 115.35 -0.841 . . . . 43.530000000000001 111.577 -178.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -108.58 115.5 30.21 Favored 'General case' 0 C--O 1.252 1.212 0 CA-C-O 121.385 0.612 . . . . 70.109999999999999 110.947 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 165.74 -158.5 31.41 Favored Glycine 0 CA--C 1.487 -1.691 0 N-CA-C 106.046 -2.822 . . . . 55.439999999999998 106.046 -179.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.8 ttp180 -159.32 78.18 0.72 Allowed 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 119.093 1.446 . . . . 75.239999999999995 111.417 174.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.48 ' HB3' ' HD3' ' A' ' 74' ' ' PRO . 13.0 t60 -175.53 -77.98 0.0 OUTLIER Pre-proline 0 CA--C 1.556 1.176 0 N-CA-C 113.392 0.886 . . . . 73.510000000000005 113.392 175.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.48 ' HD3' ' HB3' ' A' ' 73' ' ' HIS . 48.2 Cg_endo -66.71 -41.87 10.14 Favored 'Trans proline' 0 C--N 1.394 2.966 0 CA-C-N 120.839 1.335 . . . . 75.420000000000002 113.372 -169.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -166.71 114.54 0.85 Allowed 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 102.582 -3.118 . . . . 44.520000000000003 102.582 -178.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 19.7 m -136.33 103.07 5.17 Favored 'General case' 0 C--N 1.26 -3.319 0 CA-C-N 115.888 -0.597 . . . . 61.119999999999997 109.647 -178.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.423 ' HB2' HG23 ' A' ' 68' ' ' THR . 42.1 m-20 -74.07 -31.98 63.07 Favored 'General case' 0 CA--C 1.493 -1.227 0 CA-C-N 115.218 -0.901 . . . . 75.219999999999999 109.363 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 39.0 pt -119.75 137.82 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.871 0 N-CA-C 107.086 -1.45 . . . . 71.409999999999997 107.086 170.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -85.73 124.14 31.91 Favored 'General case' 0 C--N 1.284 -2.272 0 N-CA-C 108.145 -1.057 . . . . 73.140000000000001 108.145 179.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.49 ' HA ' ' HB2' ' A' ' 56' ' ' ASN . 35.4 tp -122.02 155.58 35.3 Favored 'General case' 0 N--CA 1.414 -2.248 0 CA-C-N 115.929 -0.578 . . . . 61.350000000000001 109.712 -174.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.41 ' CB ' ' HA ' ' A' ' 56' ' ' ASN . 9.8 t70 -168.94 150.32 4.57 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 104.583 -2.376 . . . . 60.409999999999997 104.583 178.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.425 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 20.8 t70 -169.41 164.28 10.61 Favored 'General case' 0 C--N 1.26 -3.298 0 N-CA-C 106.647 -1.612 . . . . 73.230000000000004 106.647 -176.255 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.8 m -63.2 -23.72 34.05 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 O-C-N 123.309 0.381 . . . . 45.140000000000001 111.367 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.572 ' HB ' ' HB2' ' A' ' 108' ' ' ASN . 45.8 m -144.2 70.77 1.3 Allowed 'General case' 0 N--CA 1.423 -1.793 0 CA-C-O 122.39 1.091 . . . . 72.109999999999999 109.802 175.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.425 ' HB ' ' HB3' ' A' ' 82' ' ' ASP . 12.5 p -95.84 140.19 17.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 114.499 -1.228 . . . . 74.049999999999997 110.466 -177.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 24.1 t -92.72 159.95 15.19 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 110.054 -0.35 . . . . 75.400000000000006 110.054 178.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 4.5 tpp180 -57.88 -47.97 81.19 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.864 0.865 . . . . 71.439999999999998 109.024 177.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -119.08 86.93 2.64 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 104.685 -2.339 . . . . 75.519999999999996 104.685 174.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 25.5 t60 -81.39 -52.49 7.22 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.962 -0.563 . . . . 64.120000000000005 111.204 -172.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.97 160.6 42.16 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 120.02 -0.672 . . . . 72.239999999999995 110.239 -177.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -131.18 127.22 37.51 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 108.345 -0.983 . . . . 75.310000000000002 108.345 174.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.42 ' HB3' ' HB ' ' A' ' 68' ' ' THR . 57.5 t80 -106.74 123.91 48.84 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 109.692 -0.484 . . . . 52.100000000000001 109.692 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -113.74 136.33 52.97 Favored 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 107.858 -1.164 . . . . 74.230000000000004 107.858 177.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 12.5 tt -116.1 131.44 68.6 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.236 0 C-N-CA 119.522 -0.871 . . . . 74.340000000000003 109.844 -178.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -109.4 145.97 35.23 Favored 'General case' 0 C--N 1.282 -2.359 0 N-CA-C 105.171 -2.159 . . . . 70.439999999999998 105.171 175.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -54.75 -22.94 15.66 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 113.226 0.825 . . . . 75.140000000000001 113.226 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -117.07 5.73 17.82 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 120.321 -0.943 . . . . 54.049999999999997 114.094 177.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -162.44 148.49 12.86 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 118.778 1.289 . . . . 62.219999999999999 111.642 -177.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -117.79 114.51 23.39 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.491 -0.929 . . . . 73.340000000000003 108.491 -176.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -132.25 135.13 46.06 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 119.638 -0.825 . . . . 61.409999999999997 112.498 -177.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.2 p -121.83 131.36 73.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-N 115.883 -0.599 . . . . 54.340000000000003 110.243 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.2 m -106.37 134.77 47.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-O 120.905 0.383 . . . . 70.120000000000005 110.907 178.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -90.0 108.95 20.03 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.283 -1.377 . . . . 53.420000000000002 107.283 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 21.2 m -113.52 11.7 8.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-N 115.942 -0.572 . . . . 74.439999999999998 111.29 -178.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -144.15 63.17 0.48 Allowed Glycine 0 N--CA 1.432 -1.584 0 N-CA-C 109.444 -1.462 . . . . 73.5 109.444 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 13.3 m -74.93 61.35 1.03 Allowed 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 123.549 0.74 . . . . 64.230000000000004 112.722 -173.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 85.4 mt -89.09 -49.11 6.95 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.467 -0.938 . . . . 72.319999999999993 108.467 176.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.572 ' HB2' ' HB ' ' A' ' 84' ' ' THR . 53.6 t30 -114.74 -33.0 5.64 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.592 -0.731 . . . . 74.310000000000002 109.506 -179.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 102.68 138.89 10.2 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.568 -0.825 . . . . 71.109999999999999 114.79 171.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.2 m -97.24 138.16 35.15 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.251 -1.018 . . . . 74.340000000000003 108.251 174.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.49 ' CE2' ' HB3' ' A' ' 116' ' ' PRO . 52.8 m-85 -130.89 151.91 50.8 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 109.321 -0.622 . . . . 72.329999999999998 109.321 -177.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.451 ' CG1' HE21 ' A' ' 120' ' ' GLN . 8.6 p -128.8 118.53 47.36 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 N-CA-C 108.017 -1.105 . . . . 64.349999999999994 108.017 168.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 48.82 51.8 15.25 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 116.21 -0.45 . . . . 75.230000000000004 111.563 -175.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 70.5 mtp180 74.42 -17.48 0.47 Allowed 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 124.763 1.225 . . . . 74.430000000000007 114.192 -179.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -76.07 115.04 43.17 Favored Pre-proline 0 C--O 1.247 0.952 0 CA-C-N 117.79 0.268 . . . . 63.130000000000003 111.23 -177.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.49 ' HB3' ' CE2' ' A' ' 111' ' ' TYR . 36.3 Cg_endo -91.8 102.9 0.22 Allowed 'Trans proline' 0 N--CA 1.443 -1.469 0 C-N-CA 123.141 2.561 . . . . 73.519999999999996 112.202 178.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.419 ' HB2' ' HG2' ' A' ' 120' ' ' GLN . 25.5 mtp180 -130.34 161.35 31.49 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 122.107 -0.37 . . . . 62.420000000000002 110.561 176.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -84.95 -8.94 58.55 Favored 'General case' 0 CA--C 1.496 -1.134 0 N-CA-C 113.434 0.902 . . . . 73.420000000000002 113.434 -177.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -153.42 137.9 16.77 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 105.432 -2.062 . . . . 71.400000000000006 105.432 170.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.451 HE21 ' CG1' ' A' ' 112' ' ' VAL . 9.0 mm100 -141.34 149.21 40.87 Favored 'General case' 0 CA--C 1.472 -2.033 0 N-CA-C 114.451 1.278 . . . . 73.219999999999999 114.451 -178.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 25.5 t -88.33 122.88 40.38 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.261 0 N-CA-C 105.878 -1.897 . . . . 71.340000000000003 105.878 174.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 52.8 mtt -70.91 139.34 50.69 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 120.85 0.357 . . . . 75.25 110.808 -178.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 60.6 tp60 -104.75 131.48 52.15 Favored 'General case' 0 N--CA 1.425 -1.723 0 N-CA-C 108.896 -0.779 . . . . 70.450000000000003 108.896 -177.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -78.51 115.6 18.33 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 115.735 -0.666 . . . . 53.329999999999998 111.177 -178.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 98.84 8.8 53.81 Favored Glycine 0 N--CA 1.438 -1.227 0 CA-C-N 115.617 -0.72 . . . . 62.109999999999999 111.687 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -125.58 -176.55 3.63 Favored 'General case' 0 C--O 1.245 0.816 0 N-CA-C 112.193 0.442 . . . . 74.120000000000005 112.193 -178.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.453 ' HG2' HG22 ' A' ' 136' ' ' VAL . 43.0 mt-10 -108.55 132.21 54.08 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 113.755 1.02 . . . . 70.230000000000004 113.755 -170.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.7 mp -114.1 120.09 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.991 0 N-CA-C 105.959 -1.867 . . . . 75.439999999999998 105.959 175.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.428 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 51.1 tt0 -103.7 122.31 44.79 Favored 'General case' 0 C--N 1.282 -2.329 0 CA-C-O 121.223 0.535 . . . . 64.510000000000005 110.264 -177.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.3 pp -103.28 98.85 7.32 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.182 0 CA-C-N 115.309 -0.86 . . . . 61.310000000000002 109.979 178.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 78.82 -106.6 2.38 Favored Glycine 0 N--CA 1.421 -2.351 0 N-CA-C 109.838 -1.305 . . . . 50.409999999999997 109.838 -176.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -111.35 -12.92 13.99 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 122.419 0.288 . . . . 74.340000000000003 111.464 177.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.43 ' HB3' ' O ' ' A' ' 53' ' ' ARG . 79.6 m-85 -97.77 151.15 20.47 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 112.605 0.594 . . . . 73.439999999999998 112.605 -172.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 20.0 mtp180 -112.49 128.3 56.29 Favored 'General case' 0 C--O 1.252 1.21 0 CA-C-O 121.949 0.881 . . . . 72.109999999999999 112.577 -168.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.425 HD11 HD12 ' A' ' 49' ' ' LEU . 5.0 tt -120.98 136.41 54.98 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 114.056 -1.429 . . . . 70.329999999999998 107.735 -178.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.453 HG22 ' HG2' ' A' ' 127' ' ' GLU . 22.0 t -109.01 127.98 65.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 106.985 -1.487 . . . . 61.020000000000003 106.985 176.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -105.67 122.86 46.93 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 109.147 -0.686 . . . . 53.399999999999999 109.147 -177.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.8 mp -130.51 159.04 38.27 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.857 -0.423 . . . . 64.329999999999998 109.857 -178.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -79.26 133.07 36.66 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 107.15 -1.426 . . . . 63.219999999999999 107.15 173.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -91.85 -160.92 36.53 Favored Glycine 0 N--CA 1.435 -1.414 0 C-N-CA 120.514 -0.851 . . . . 65.209999999999994 113.736 -173.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.48 ' O ' ' HA2' ' A' ' 45' ' ' GLY . 86.9 Cg_endo -81.45 158.88 19.64 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.992 2.462 . . . . 61.329999999999998 113.945 -175.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -107.12 107.63 18.7 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 108.075 -1.083 . . . . 72.439999999999998 108.075 176.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.432 ' HB2' ' HB3' ' A' ' 44' ' ' ALA . 13.5 mm-40 . . . . . 0 N--CA 1.426 -1.67 0 C-N-CA 123.049 0.54 . . . . 64.329999999999998 110.769 -176.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.0 mmm . . . . . 0 C--O 1.244 0.805 0 CA-C-O 119.965 -0.064 . . . . 72.209999999999994 111.022 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.8 p -66.88 -49.22 66.33 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 106.904 -1.517 . . . . 63.409999999999997 106.904 171.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -96.97 148.55 22.85 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 104.77 -2.308 . . . . 73.239999999999995 104.77 167.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -144.39 152.49 40.76 Favored 'General case' 0 C--N 1.292 -1.932 0 O-C-N 122.081 -0.387 . . . . 75.319999999999993 110.404 -176.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -153.16 94.88 1.89 Allowed 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.351 0.596 . . . . 72.549999999999997 110.044 -177.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -146.37 86.79 0.17 Allowed Glycine 0 N--CA 1.425 -2.062 0 N-CA-C 108.665 -1.774 . . . . 74.109999999999999 108.665 178.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.6 m -78.83 122.8 85.11 Favored Pre-proline 0 C--N 1.305 -1.339 0 CA-C-N 115.755 -0.223 . . . . 72.140000000000001 111.414 -174.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -69.22 138.43 39.52 Favored 'Trans proline' 0 C--O 1.25 1.095 0 C-N-CA 122.93 2.42 . . . . 73.420000000000002 110.804 172.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.433 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 8.4 pt-20 -95.52 137.83 21.94 Favored Pre-proline 0 C--O 1.251 1.183 0 C-N-CA 118.864 -1.134 . . . . 62.329999999999998 109.788 176.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 9' ' ' GLU . 5.3 Cg_exo -75.72 127.2 10.02 Favored 'Trans proline' 0 N--CA 1.439 -1.714 0 C-N-CA 122.242 1.961 . . . . 65.439999999999998 109.982 175.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -68.11 123.41 20.59 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 109.023 -0.732 . . . . 63.039999999999999 109.023 178.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.2 t -92.09 94.7 4.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 107.659 -1.237 . . . . 73.450000000000003 107.659 175.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.441 ' OE2' HG22 ' A' ' 15' ' ' THR . 0.4 OUTLIER -70.23 127.05 31.44 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 106.504 -1.665 . . . . 75.140000000000001 106.504 -179.123 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.6 m -100.48 -24.64 14.43 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 113.329 0.863 . . . . 73.230000000000004 113.329 -169.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.441 HG22 ' OE2' ' A' ' 13' ' ' GLU 0.313 14.0 t -83.63 72.14 10.33 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-O 123.896 1.808 . . . . 72.409999999999997 112.936 -174.314 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 57.3 m -139.37 138.55 36.69 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 104.521 -2.4 . . . . 73.319999999999993 104.521 174.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.1 t 71.19 110.13 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.244 0.805 0 N-CA-C 107.35 -1.352 . . . . 72.030000000000001 107.35 -170.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -125.26 139.4 53.75 Favored 'General case' 0 C--N 1.288 -2.074 0 CA-C-N 116.045 -0.525 . . . . 73.049999999999997 110.985 -174.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 60.0 mtt85 -111.52 102.23 10.59 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 107.862 -1.162 . . . . 63.549999999999997 107.862 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.16 86.28 7.05 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.284 0.564 . . . . 73.129999999999995 110.098 -178.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -81.88 -39.73 23.43 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.326 -0.99 . . . . 44.240000000000002 108.326 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 66.4 tp -79.81 100.78 8.14 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-N 114.928 -1.033 . . . . 61.140000000000001 109.997 177.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -117.73 142.49 47.2 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 103.033 -2.951 . . . . 64.019999999999996 103.033 174.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -64.21 133.9 53.74 Favored 'General case' 0 C--O 1.244 0.808 0 N-CA-C 113.577 0.954 . . . . 71.040000000000006 113.577 -176.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -70.26 162.33 28.66 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 113.709 -1.587 . . . . 73.219999999999999 110.57 -177.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 59.8 ttp -83.0 93.46 7.57 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-O 121.306 0.574 . . . . 74.040000000000006 109.718 178.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.6 ' HG2' ' H ' ' A' ' 28' ' ' SER . 22.4 tt0 -100.13 -157.62 0.62 Allowed 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 106.677 -1.601 . . . . 72.109999999999999 106.677 -179.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.6 ' H ' ' HG2' ' A' ' 27' ' ' GLU . 14.5 m -59.07 133.29 55.96 Favored 'General case' 0 C--O 1.248 1.016 0 CA-C-N 118.049 0.386 . . . . 74.340000000000003 109.988 179.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 45.7 m -75.53 131.91 40.37 Favored 'General case' 0 N--CA 1.419 -1.995 0 CA-C-O 121.554 0.692 . . . . 52.32 110.3 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.3 t -90.02 122.21 32.81 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 114.888 -1.051 . . . . 71.329999999999998 110.004 -176.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -77.85 -33.3 42.23 Favored Glycine 0 CA--C 1.488 -1.603 0 N-CA-C 109.25 -1.54 . . . . 62.240000000000002 109.25 178.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.48 ' CG2' ' HA ' ' A' ' 98' ' ' GLU . 35.2 m -71.85 142.87 49.58 Favored 'General case' 0 N--CA 1.408 -2.552 0 N-CA-C 107.588 -1.264 . . . . 74.109999999999999 107.588 174.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -83.79 114.43 53.85 Favored Pre-proline 0 C--N 1.308 -1.196 0 N-CA-C 111.525 0.195 . . . . 74.430000000000007 111.525 -173.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -62.03 122.47 10.99 Favored 'Trans proline' 0 C--O 1.245 0.844 0 C-N-CA 121.842 1.694 . . . . 72.200000000000003 110.24 179.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -79.6 23.36 0.42 Allowed 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.384 0.612 . . . . 54.520000000000003 112.384 -174.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.5 m -75.95 -30.02 58.51 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-O 121.262 0.553 . . . . 73.409999999999997 109.795 178.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 11.6 t -162.42 127.16 3.23 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 107.51 -1.293 . . . . 75.409999999999997 107.51 177.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.68 68.55 1.61 Allowed Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.823 -0.703 . . . . 72.5 111.399 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.42 -34.54 76.19 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 120.709 0.29 . . . . 73.329999999999998 110.852 -178.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -60.21 -10.3 4.38 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 124.611 1.165 . . . . 73.219999999999999 113.936 -178.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -63.04 -14.98 54.79 Favored 'General case' 0 C--N 1.28 -2.429 0 C-N-CA 125.042 1.337 . . . . 75.420000000000002 111.634 178.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.434 ' HB3' ' HA2' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -43.39 139.38 2.53 Favored Pre-proline 0 CA--C 1.555 1.147 0 N-CA-C 114.959 1.466 . . . . 71.209999999999994 114.959 -178.296 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -77.14 -18.34 14.42 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 122.645 2.23 . . . . 50.200000000000003 112.585 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.432 ' C ' HD23 ' A' ' 42' ' ' LEU . . . -162.93 129.14 3.36 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 107.702 -1.221 . . . . 72.150000000000006 107.702 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.71 -28.55 60.92 Favored Glycine 0 CA--C 1.495 -1.167 0 N-CA-C 111.06 -0.816 . . . . 52.409999999999997 111.06 178.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.7 m -129.67 146.1 51.48 Favored 'General case' 0 N--CA 1.414 -2.229 0 N-CA-C 107.266 -1.383 . . . . 52.420000000000002 107.266 177.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.83 175.1 10.67 Favored 'General case' 0 C--N 1.282 -2.362 0 N-CA-C 106.875 -1.528 . . . . 62.310000000000002 106.875 -178.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.8 pp -133.82 154.26 51.14 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 112.885 0.698 . . . . 75.030000000000001 112.885 -175.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.608 ' O ' ' HA ' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -118.94 140.9 49.22 Favored 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 108.312 -0.995 . . . . 73.409999999999997 108.312 175.575 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.4 HG22 ' HB3' ' A' ' 60' ' ' ARG . 27.8 t -121.3 114.32 42.8 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 108.566 -0.901 . . . . 71.219999999999999 108.566 -179.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.409 HG21 ' HB3' ' A' ' 57' ' ' ALA . 78.5 t -93.8 115.54 32.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 107.592 -1.262 . . . . 63.310000000000002 107.592 175.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 51.7 tttm -90.38 -24.1 20.89 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.771 -0.649 . . . . 65.219999999999999 110.505 -173.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 30.8 ttp-105 -146.69 119.3 8.54 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 106.878 -1.527 . . . . 74.340000000000003 106.878 176.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 143.15 116.86 1.18 Allowed Glycine 0 N--CA 1.417 -2.575 0 C-N-CA 120.176 -1.011 . . . . 74.299999999999997 112.181 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.501 ' HB2' ' HB3' ' A' ' 81' ' ' ASP . 27.8 Cg_exo -65.44 -10.81 27.59 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 123.423 2.749 . . . . 61.399999999999999 111.089 178.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.52 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 2.2 m-20 -48.38 -36.16 14.07 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 126.295 1.838 . . . . 61.130000000000003 110.212 174.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.409 ' HB3' HG21 ' A' ' 51' ' ' VAL . . . -152.16 -62.09 0.16 Allowed 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 107.978 -1.119 . . . . 55.310000000000002 107.978 175.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.61 23.83 75.36 Favored Glycine 0 CA--C 1.508 -0.363 0 CA-C-N 115.596 -0.729 . . . . 72.120000000000005 112.958 177.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -157.25 -179.43 8.19 Favored 'General case' 0 N--CA 1.428 -1.525 0 N-CA-C 108.478 -0.934 . . . . 52.130000000000003 108.478 -176.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.608 ' HA ' ' O ' ' A' ' 49' ' ' LEU . 9.8 ptp85 -111.1 133.87 53.14 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 124.04 0.838 . . . . 73.019999999999996 109.515 175.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -141.51 153.05 44.67 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.556 -0.535 . . . . 71.420000000000002 109.556 173.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.0 pp -94.41 140.4 29.86 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 112.114 0.413 . . . . 64.510000000000005 112.114 -177.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -78.6 114.94 17.95 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.646 -0.706 . . . . 65.230000000000004 109.918 178.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -146.47 16.83 1.31 Allowed 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 123.267 1.508 . . . . 63.520000000000003 107.596 175.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.452 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 28.4 tt0 -126.49 104.34 24.71 Favored Pre-proline 0 C--N 1.301 -1.535 0 CA-C-N 114.352 -1.295 . . . . 71.109999999999999 108.029 178.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.452 ' HD2' ' HA ' ' A' ' 65' ' ' GLN . 2.0 Cg_endo -45.92 -47.43 14.19 Favored 'Trans proline' 0 C--N 1.369 1.614 0 C-N-CA 124.133 3.222 . . . . 62.350000000000001 114.279 -174.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 50.3 m -113.24 97.33 6.42 Favored 'General case' 0 N--CA 1.424 -1.769 0 CA-C-O 121.319 0.58 . . . . 63.109999999999999 110.467 178.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.49 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 93.1 m -109.03 114.14 27.62 Favored 'General case' 0 N--CA 1.424 -1.771 0 N-CA-C 108.695 -0.854 . . . . 63.310000000000002 108.695 177.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 41.6 m -105.01 131.44 52.52 Favored 'General case' 0 N--CA 1.421 -1.895 0 CA-C-O 121.037 0.446 . . . . 75.230000000000004 109.904 -175.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -103.78 130.41 51.31 Favored 'General case' 0 N--CA 1.419 -1.981 0 N-CA-C 107.905 -1.146 . . . . 74.530000000000001 107.905 176.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -170.39 -140.86 3.11 Favored Glycine 0 N--CA 1.425 -2.058 0 N-CA-C 110.672 -0.971 . . . . 62.009999999999998 110.672 -178.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 27.1 ttm-85 -79.84 -59.12 2.86 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 120.469 -0.492 . . . . 75.129999999999995 109.854 -176.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 28.2 t-80 175.22 -47.76 0.0 OUTLIER Pre-proline 0 CA--C 1.562 1.431 0 O-C-N 124.203 0.939 . . . . 70.239999999999995 113.167 177.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -57.55 -27.9 78.71 Favored 'Trans proline' 0 C--N 1.384 2.421 0 C-N-CA 122.065 1.844 . . . . 55.439999999999998 114.13 -174.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.412 ' CD ' HH21 ' A' ' 87' ' ' ARG . 41.8 mt-10 -125.12 26.47 6.94 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 109.697 -0.483 . . . . 70.340000000000003 109.697 -177.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.3 m -145.01 140.37 28.1 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 122.298 -0.252 . . . . 64.230000000000004 110.558 -175.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -69.03 -42.36 76.49 Favored 'General case' 0 C--O 1.242 0.708 0 C-N-CA 120.191 -0.604 . . . . 65.319999999999993 110.394 178.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 21.0 pt -100.86 144.32 12.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 CA-C-N 115.118 -0.946 . . . . 71.420000000000002 109.934 178.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -100.61 117.73 35.32 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.106 0.479 . . . . 75.230000000000004 109.969 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.52 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 6.9 mp -98.71 122.9 42.52 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 120.842 0.353 . . . . 72.230000000000004 111.917 -178.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.501 ' HB3' ' HB2' ' A' ' 55' ' ' PRO . 24.3 t70 -99.83 73.78 1.79 Allowed 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 106.01 -1.848 . . . . 72.129999999999995 106.01 168.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.468 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 13.2 t70 -81.56 -175.87 5.74 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.141 -1.391 . . . . 72.430000000000007 107.718 -177.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.8 p -88.94 -23.64 6.23 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 N-CA-C 108.182 -1.044 . . . . 72.340000000000003 108.182 178.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 17.7 m -154.35 84.69 1.12 Allowed 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 116.033 -0.531 . . . . 74.219999999999999 110.069 176.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.468 ' HB ' ' HB3' ' A' ' 82' ' ' ASP . 7.4 p -108.7 136.28 44.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.912 -0.586 . . . . 71.420000000000002 110.03 -178.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 23.7 p -90.99 -81.98 0.3 Allowed 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.575 0.703 . . . . 73.430000000000007 111.616 -178.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.412 HH21 ' CD ' ' A' ' 75' ' ' GLU . 16.5 ptm180 -162.72 -34.09 0.04 OUTLIER 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 125.203 1.401 . . . . 72.310000000000002 108.333 -179.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 11.5 mmt180 -125.69 101.09 6.72 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 105.033 -2.21 . . . . 71.310000000000002 105.033 174.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 18.4 t60 -95.79 -60.61 1.61 Allowed 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.657 -0.868 . . . . 52.340000000000003 108.657 -173.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -145.57 144.31 30.43 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 115.771 -0.649 . . . . 64.219999999999999 110.055 -178.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -104.34 127.99 52.09 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 115.653 -0.703 . . . . 71.530000000000001 109.164 176.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.49 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 95.5 m-85 -104.68 112.02 24.96 Favored 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 107.061 -1.459 . . . . 74.340000000000003 107.061 174.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -104.4 122.1 44.79 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-N 114.528 -1.214 . . . . 74.219999999999999 110.259 -177.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.8 116.03 50.86 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.654 0 N-CA-C 105.978 -1.86 . . . . 73.209999999999994 105.978 171.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.467 ' C ' ' H ' ' A' ' 97' ' ' GLY . 52.5 t30 -114.08 148.05 37.73 Favored 'General case' 0 C--N 1.276 -2.6 0 N-CA-C 106.343 -1.725 . . . . 72.319999999999993 106.343 -178.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -52.59 24.52 0.0 OUTLIER 'General case' 0 CA--C 1.578 2.04 0 C-N-CA 126.847 2.059 . . . . 72.310000000000002 115.296 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.467 ' H ' ' C ' ' A' ' 95' ' ' ASN . . . -168.29 -43.66 0.03 OUTLIER Glycine 0 N--CA 1.426 -2.006 0 N-CA-C 110.123 -1.191 . . . . 63.420000000000002 110.123 -178.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.48 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 43.8 mt-10 -120.23 143.66 48.16 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 113.035 0.754 . . . . 73.430000000000007 113.035 -175.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.479 ' HB3' ' SD ' ' A' ' 122' ' ' MET . 84.1 m-85 -105.12 121.5 43.93 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 105.522 -2.029 . . . . 75.319999999999993 105.522 173.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -127.75 136.3 51.33 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 112.701 0.63 . . . . 74.230000000000004 112.701 -174.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 119' ' ' ALA . 7.2 p -115.19 118.85 60.08 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 N-CA-C 108.836 -0.801 . . . . 72.340000000000003 108.836 177.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 42.7 t -120.27 129.99 74.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-N 116.282 -0.417 . . . . 71.129999999999995 110.21 -177.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.596 ' OD2' ' HB3' ' A' ' 106' ' ' SER . 10.9 t70 -83.37 130.26 35.04 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 107.239 -1.393 . . . . 61.020000000000003 107.239 172.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.0 m -124.01 13.57 4.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 112.946 0.721 . . . . 72.140000000000001 112.946 -177.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 152.94 26.61 0.04 OUTLIER Glycine 0 N--CA 1.438 -1.209 0 C-N-CA 118.59 -1.767 . . . . 34.310000000000002 114.42 178.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.596 ' HB3' ' OD2' ' A' ' 103' ' ' ASP . 32.7 t -79.8 131.57 35.93 Favored 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 108.075 -1.083 . . . . 44.030000000000001 108.075 175.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -76.07 -18.46 59.19 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.517 0.675 . . . . 64.239999999999995 110.171 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -88.9 -37.03 15.61 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 115.186 -0.915 . . . . 72.239999999999995 109.16 178.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 92.22 121.04 2.77 Favored Glycine 0 C--N 1.306 -1.11 0 CA-C-N 114.86 -1.064 . . . . 61.310000000000002 112.589 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.401 HG23 ' HA ' ' A' ' 130' ' ' ILE . 24.0 m -85.23 120.15 26.41 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 109.147 -0.686 . . . . 60.509999999999998 109.147 176.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -139.12 163.09 33.35 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.719 -0.474 . . . . 63.310000000000002 109.719 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.527 ' HB ' ' HB3' ' A' ' 115' ' ' GLU . 23.9 t -100.36 141.49 17.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 106.511 -1.663 . . . . 65.349999999999994 106.511 177.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -60.05 -25.07 65.07 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-O 120.969 0.414 . . . . 73.129999999999995 111.419 -175.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 81.8 mtt85 -106.58 -9.28 16.64 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.387 -0.37 . . . . 65.219999999999999 111.773 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.527 ' HB3' ' HB ' ' A' ' 112' ' ' VAL . 9.5 tp10 -133.16 112.9 13.33 Favored Pre-proline 0 C--O 1.252 1.231 0 C-N-CA 119.983 -0.687 . . . . 73.329999999999998 110.858 -172.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -75.25 60.61 5.66 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.516 2.811 . . . . 63.219999999999999 111.77 177.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.443 ' HB3' ' O ' ' A' ' 119' ' ' ALA . 28.4 mmm-85 -128.92 131.86 47.6 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.919 -1.141 . . . . 73.120000000000005 107.919 -179.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 31.4 p-10 -83.62 -18.35 38.46 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-O 121.96 0.886 . . . . 74.140000000000001 109.67 177.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.443 ' O ' ' HB3' ' A' ' 117' ' ' ARG . . . -128.98 133.85 47.94 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 106.551 -1.648 . . . . 74.319999999999993 106.551 165.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.523 ' NE2' ' HG2' ' A' ' 115' ' ' GLU . 5.0 tp60 -144.59 150.77 38.02 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 123.655 0.597 . . . . 63.030000000000001 112.171 -177.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.464 ' O ' ' HG3' ' A' ' 120' ' ' GLN . 7.3 p -79.65 130.62 35.78 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 N-CA-C 106.195 -1.78 . . . . 74.099999999999994 106.195 168.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.479 ' SD ' ' HB3' ' A' ' 99' ' ' PHE . 65.2 mtt -66.92 156.2 36.46 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 112.7 0.63 . . . . 62.350000000000001 112.7 -173.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -132.67 134.6 45.04 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.374 -1.343 . . . . 74.439999999999998 107.374 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 7.6 t -79.68 128.23 33.16 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 109.122 -0.696 . . . . 72.340000000000003 109.122 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 93.46 20.75 31.27 Favored Glycine 0 N--CA 1.421 -2.3 0 C-N-CA 120.229 -0.986 . . . . 54.530000000000001 111.298 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -123.4 172.9 8.34 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.235 -1.394 . . . . 72.299999999999997 107.235 178.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -129.05 125.68 37.8 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-O 121.383 0.611 . . . . 73.109999999999999 110.826 -173.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 59.4 mt -109.49 130.77 61.95 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 CA-C-N 115.015 -0.993 . . . . 73.25 108.641 -175.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -98.43 112.64 24.59 Favored 'General case' 0 N--CA 1.423 -1.816 0 N-CA-C 108.659 -0.867 . . . . 61.340000000000003 108.659 178.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.401 ' HA ' HG23 ' A' ' 110' ' ' THR . 18.8 pt -90.92 98.36 8.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-O 121.727 0.775 . . . . 71.409999999999997 109.577 -178.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 75.28 -82.0 0.92 Allowed Glycine 0 N--CA 1.426 -2.027 0 CA-C-N 114.571 -1.195 . . . . 54.310000000000002 110.123 -176.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -136.1 -11.03 1.98 Allowed 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 109.917 -0.401 . . . . 65.150000000000006 109.917 176.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -94.5 157.08 16.16 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 113.185 0.809 . . . . 74.010000000000005 113.185 -172.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 45.9 ttt180 -99.66 120.58 39.92 Favored 'General case' 0 C--O 1.245 0.867 0 CA-C-N 115.66 -0.7 . . . . 72.120000000000005 111.452 -167.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.5 tt -125.23 129.21 49.62 Favored 'General case' 0 C--O 1.218 -0.586 0 C-N-CA 123.973 0.909 . . . . 72.209999999999994 109.721 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 40.6 t -107.83 128.05 63.41 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 N-CA-C 107.606 -1.257 . . . . 74.209999999999994 107.606 177.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -102.28 125.76 49.07 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 109.729 -0.471 . . . . 62.530000000000001 109.729 -178.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 84.2 mt -138.73 138.18 37.45 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.533 0.682 . . . . 73.450000000000003 111.282 -176.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -80.19 90.92 5.51 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 108.18 -1.045 . . . . 72.040000000000006 108.18 174.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -65.6 -79.83 0.18 Allowed Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 115.388 -0.823 . . . . 30.219999999999999 111.409 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -81.45 120.95 3.7 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 C-N-CA 121.608 1.539 . . . . 73.200000000000003 111.968 177.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -91.05 104.13 16.75 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 107.212 -1.403 . . . . 44.229999999999997 107.212 176.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 . . . . . 0 C--N 1.289 -2.037 0 N-CA-C 108.013 -1.106 . . . . 74.400000000000006 108.013 -173.218 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.2 mtt . . . . . 0 CA--C 1.491 -1.293 0 N-CA-C 107.883 -1.155 . . . . 73.140000000000001 107.883 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.5 t -76.64 -37.86 55.62 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 109.357 -0.609 . . . . 73.540000000000006 109.357 178.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . 0.31 5.1 p-10 37.81 76.25 0.06 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.209 1.404 . . . . 63.0 113.465 -178.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -76.25 95.19 3.68 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 114.311 -1.313 . . . . 61.439999999999998 110.603 -177.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -101.91 136.41 41.8 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 114.95 -1.023 . . . . 74.299999999999997 109.769 177.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 159.87 138.11 2.38 Favored Glycine 0 N--CA 1.429 -1.775 0 C-N-CA 120.893 -0.67 . . . . 40.130000000000003 111.986 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.9 t -105.61 132.96 20.43 Favored Pre-proline 0 N--CA 1.427 -1.58 0 N-CA-C 109.12 -0.696 . . . . 64.450000000000003 109.12 178.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -66.84 132.28 28.01 Favored 'Trans proline' 0 C--O 1.243 0.762 0 C-N-CA 122.232 1.955 . . . . 73.430000000000007 110.342 176.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -80.89 146.45 59.61 Favored Pre-proline 0 C--N 1.306 -1.324 0 CA-C-N 116.587 -0.279 . . . . 61.210000000000001 110.501 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -62.01 139.07 77.03 Favored 'Trans proline' 0 C--O 1.243 0.765 0 C-N-CA 122.403 2.069 . . . . 64.420000000000002 110.983 178.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -84.52 137.43 33.34 Favored 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 108.154 -1.054 . . . . 71.140000000000001 108.154 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.4 m -74.44 85.34 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 CA-C-O 122.55 1.166 . . . . 73.310000000000002 111.277 178.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -92.85 137.54 32.27 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 114.737 -1.119 . . . . 73.209999999999994 108.568 -178.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.0 p -72.48 130.19 40.09 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 116.458 -0.337 . . . . 64.329999999999998 111.019 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.2 t -77.73 -8.19 57.61 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-O 122.601 1.191 . . . . 74.430000000000007 108.276 176.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.9 m -76.8 100.13 5.38 Favored 'General case' 0 N--CA 1.412 -2.367 0 CA-C-N 113.702 -1.59 . . . . 73.430000000000007 107.073 174.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.6 m -81.95 91.66 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.673 0 CA-C-O 122.392 1.091 . . . . 63.299999999999997 111.245 -178.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.449 ' CZ ' ' HB3' ' A' ' 141' ' ' PRO . 49.3 t80 -83.04 116.81 22.45 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 106.672 -1.603 . . . . 64.129999999999995 106.672 179.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.435 ' O ' ' HA ' ' A' ' 141' ' ' PRO . 98.9 mtt180 -59.24 103.94 0.22 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.719 0.771 . . . . 64.299999999999997 112.446 -175.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -126.17 69.87 1.22 Allowed 'General case' 0 N--CA 1.42 -1.961 0 N-CA-C 108.49 -0.93 . . . . 65.319999999999993 108.49 177.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.539 ' HB3' ' HB3' ' A' ' 142' ' ' ALA . 18.2 t70 -63.77 -41.88 97.88 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 114.859 -1.064 . . . . 52.140000000000001 109.625 177.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 54.2 tp 54.86 95.23 0.02 OUTLIER 'General case' 0 C--O 1.242 0.681 0 O-C-N 124.48 1.113 . . . . 73.150000000000006 112.247 178.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.427 ' O ' HD12 ' A' ' 23' ' ' LEU . 4.6 pp -82.02 129.02 34.67 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 115.897 -0.592 . . . . 72.420000000000002 109.974 178.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -121.02 63.45 0.87 Allowed 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 122.531 1.158 . . . . 75.239999999999995 109.688 176.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -75.73 119.13 19.32 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 106.466 -1.679 . . . . 71.120000000000005 106.466 179.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 53.0 ttm -66.44 131.55 46.31 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 109.42 -0.585 . . . . 74.230000000000004 109.42 -179.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -44.76 96.03 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.134 1.374 . . . . 70.409999999999997 112.636 -178.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.6 m -122.55 67.35 0.95 Allowed 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 107.722 -1.214 . . . . 74.030000000000001 107.722 178.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 44.6 t -144.01 142.06 30.48 Favored 'General case' 0 N--CA 1.414 -2.264 0 CA-C-N 114.754 -1.112 . . . . 75.420000000000002 108.908 -174.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.4 m -124.79 16.76 8.68 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.2 -1.037 . . . . 74.340000000000003 108.2 177.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 71.49 53.78 9.65 Favored Glycine 0 N--CA 1.44 -1.097 0 CA-C-N 114.945 -1.025 . . . . 44.450000000000003 111.5 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 52.6 p -90.1 153.9 20.19 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 109.314 -0.625 . . . . 65.209999999999994 109.314 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.412 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . . . -74.24 112.74 18.3 Favored Pre-proline 0 C--O 1.245 0.835 0 N-CA-C 109.443 -0.577 . . . . 74.310000000000002 109.443 178.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 33' ' ' ALA . 2.0 Cg_endo -80.78 108.72 2.13 Favored 'Trans proline' 0 N--CA 1.439 -1.677 0 C-N-CA 122.218 1.946 . . . . 64.409999999999997 113.272 -177.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -89.66 -25.25 21.34 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 107.127 -1.434 . . . . 65.510000000000005 107.127 173.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 45.8 m -74.71 158.34 33.73 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 114.808 -1.087 . . . . 51.229999999999997 109.422 174.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.3 t -141.71 152.37 43.79 Favored 'General case' 0 N--CA 1.421 -1.883 0 N-CA-C 109.088 -0.708 . . . . 73.299999999999997 109.088 -178.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -153.41 16.16 0.66 Allowed Glycine 0 N--CA 1.42 -2.381 0 CA-C-N 115.946 -0.57 . . . . 71.319999999999993 112.063 178.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -56.62 -40.1 74.77 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 117.403 0.602 . . . . 72.349999999999994 112.365 -178.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -83.9 -23.19 31.32 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-O 121.139 0.495 . . . . 62.020000000000003 111.321 178.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -83.88 -39.06 20.34 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 116.062 -0.517 . . . . 74.510000000000005 111.612 -175.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -83.04 134.37 46.5 Favored Pre-proline 0 C--N 1.294 -1.822 0 N-CA-C 105.726 -1.953 . . . . 62.219999999999999 105.726 178.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -60.87 -176.75 0.15 Allowed 'Trans proline' 0 CA--C 1.545 1.05 0 C-N-CA 122.62 2.213 . . . . 74.099999999999994 112.377 177.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.513 ' O ' ' HA ' ' A' ' 142' ' ' ALA . . . -79.8 88.62 5.23 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.465 -0.772 . . . . 72.319999999999993 109.416 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -82.08 67.95 3.59 Favored Glycine 0 CA--C 1.483 -1.958 0 N-CA-C 109.566 -1.413 . . . . 62.240000000000002 109.566 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.7 p -89.12 152.69 21.49 Favored 'General case' 0 C--N 1.279 -2.474 0 CA-C-N 114.461 -0.87 . . . . 73.540000000000006 111.446 -177.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.92 167.2 20.67 Favored 'General case' 0 C--N 1.284 -2.268 0 CA-C-N 115.166 -0.924 . . . . 75.310000000000002 109.891 -175.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.417 HD23 ' H ' ' A' ' 48' ' ' LEU . 2.2 pt? -128.89 138.87 52.26 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.387 0.613 . . . . 70.310000000000002 110.688 -177.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.7 pp -127.91 149.09 50.47 Favored 'General case' 0 C--N 1.282 -2.354 0 CA-C-N 115.671 -0.695 . . . . 74.219999999999999 110.028 178.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.44 HG12 ' CB ' ' A' ' 60' ' ' ARG . 27.2 m -125.87 140.13 49.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 N-CA-C 109.802 -0.444 . . . . 55.420000000000002 109.802 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.4 t -104.19 116.49 48.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 106.484 -1.673 . . . . 71.310000000000002 106.484 175.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -103.59 -25.04 13.34 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 120.264 -0.574 . . . . 64.25 112.184 -175.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.431 ' O ' ' HA ' ' A' ' 133' ' ' PHE . 24.9 tpt180 -141.35 115.48 9.3 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 120.213 -0.595 . . . . 71.120000000000005 110.957 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 138.15 139.35 3.84 Favored Glycine 0 N--CA 1.433 -1.517 0 C-N-CA 119.796 -1.193 . . . . 75.140000000000001 113.414 173.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -52.49 -8.06 0.36 Allowed 'Trans proline' 0 N--CA 1.506 2.26 0 C-N-CA 125.056 3.837 . . . . 64.150000000000006 115.402 176.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.474 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 37.2 t30 -58.94 -51.42 70.14 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.579 0.752 . . . . 60.119999999999997 109.565 177.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -173.81 -177.39 1.38 Allowed 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.941 -0.763 . . . . 63.299999999999997 108.941 -177.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -164.22 53.87 0.28 Allowed Glycine 0 N--CA 1.425 -2.07 0 N-CA-C 109.512 -1.435 . . . . 51.119999999999997 109.512 178.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -153.69 -176.98 6.07 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 108.523 -0.917 . . . . 63.340000000000003 108.523 -177.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.44 ' CB ' HG12 ' A' ' 50' ' ' VAL . 0.4 OUTLIER -108.55 139.2 43.65 Favored 'General case' 0 C--N 1.309 -1.192 0 O-C-N 123.885 0.741 . . . . 71.219999999999999 109.049 178.8 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -128.49 129.04 45.49 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 110.093 -0.336 . . . . 65.329999999999998 110.093 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -97.09 116.25 28.95 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 105.945 -1.872 . . . . 61.310000000000002 105.945 175.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -99.99 115.65 30.2 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 112.811 0.671 . . . . 74.219999999999999 112.811 -174.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -109.02 -5.88 15.87 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 105.956 -1.868 . . . . 72.409999999999997 105.956 168.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -66.1 112.54 9.3 Favored Pre-proline 0 N--CA 1.443 -0.787 0 CA-C-N 112.937 -1.938 . . . . 72.310000000000002 109.124 176.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -62.04 -30.83 83.47 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.663 2.242 . . . . 74.219999999999999 113.003 -177.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 85.5 m -137.17 111.07 8.21 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-O 121.024 0.44 . . . . 72.409999999999997 111.825 -178.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 55.5 m -110.14 114.08 27.3 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 108.624 -0.88 . . . . 70.439999999999998 108.624 176.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.5 p -93.33 140.82 29.13 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 122.091 -0.38 . . . . 74.310000000000002 111.048 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -116.08 140.06 49.66 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 109.473 -0.566 . . . . 62.119999999999997 109.473 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 170.01 -148.71 12.02 Favored Glycine 0 N--CA 1.421 -2.316 0 C-N-CA 120.254 -0.974 . . . . 71.109999999999999 112.372 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.464 ' HB2' ' HA ' ' A' ' 87' ' ' ARG . 56.5 ttt180 -51.47 -75.19 0.03 OUTLIER 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 125.541 1.537 . . . . 75.140000000000001 113.915 -175.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.46 ' HB3' ' CD ' ' A' ' 74' ' ' PRO . 7.9 t60 -172.12 -76.65 0.0 OUTLIER Pre-proline 0 CA--C 1.56 1.347 0 CA-C-O 118.798 -0.62 . . . . 71.200000000000003 110.798 -178.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.46 ' CD ' ' HB3' ' A' ' 73' ' ' HIS . 49.8 Cg_endo -68.55 -24.84 35.47 Favored 'Trans proline' 0 C--N 1.389 2.701 0 CA-C-N 121.135 1.441 . . . . 62.240000000000002 111.136 178.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.42 ' OE2' ' HD3' ' A' ' 72' ' ' ARG . 34.9 mt-10 -89.0 15.6 8.35 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 114.119 -1.4 . . . . 75.120000000000005 111.526 -173.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.1 p -153.44 166.85 31.37 Favored 'General case' 0 N--CA 1.421 -1.907 0 CA-C-N 116.682 -0.236 . . . . 75.319999999999993 110.751 -178.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -79.98 -46.37 16.78 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.344 -0.984 . . . . 64.099999999999994 108.344 177.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 34.5 pt -104.91 143.57 16.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 108.747 -0.834 . . . . 74.299999999999997 108.747 175.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.417 ' HB3' ' HA ' ' A' ' 73' ' ' HIS . 33.7 p90 -115.27 117.64 31.04 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 121.495 0.664 . . . . 75.329999999999998 112.49 -174.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.554 HD23 ' CE2' ' A' ' 133' ' ' PHE . 4.5 mp -90.18 111.94 23.27 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.876 -1.157 . . . . 75.340000000000003 107.876 178.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -84.29 10.34 10.74 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-O 121.702 0.763 . . . . 74.349999999999994 112.697 -173.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -77.55 146.02 36.56 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 108.995 -0.743 . . . . 74.25 108.995 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.5 p -67.87 -22.14 27.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-O 121.256 0.55 . . . . 64.319999999999993 111.828 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -96.07 23.16 6.72 Favored 'General case' 0 CA--C 1.557 1.239 0 CA-C-O 121.185 0.516 . . . . 74.030000000000001 110.751 -176.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.431 HG21 ' HB2' ' A' ' 80' ' ' LEU . 13.2 p -81.94 140.84 15.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 O-C-N 121.921 -0.487 . . . . 72.230000000000004 110.297 -178.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 19.6 m -83.03 156.33 23.44 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.549 -0.908 . . . . 62.229999999999997 108.549 175.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.464 ' HA ' ' HB2' ' A' ' 72' ' ' ARG . 36.5 mtp-105 -63.06 -54.64 34.91 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-O 121.332 0.586 . . . . 74.319999999999993 109.539 -178.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.402 ' CZ ' ' HB3' ' A' ' 75' ' ' GLU . 13.1 mmt180 -117.22 112.55 20.96 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 105.347 -2.094 . . . . 73.409999999999997 105.347 175.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.411 ' CE1' ' HB3' ' A' ' 108' ' ' ASN . 11.3 t60 -98.13 -76.74 0.52 Allowed 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.16 0.505 . . . . 71.239999999999995 110.534 -174.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.37 167.49 23.45 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.553 -0.717 . . . . 42.310000000000002 110.543 -176.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -127.87 128.19 44.76 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 115.811 -0.631 . . . . 74.019999999999996 109.507 177.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -104.69 120.24 40.88 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.423 -0.954 . . . . 73.430000000000007 108.423 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 78.9 mtt180 -119.25 141.8 48.61 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-O 121.553 0.692 . . . . 72.209999999999994 111.288 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.64 119.79 62.86 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 104.359 -2.46 . . . . 63.109999999999999 104.359 171.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.494 ' C ' ' H ' ' A' ' 97' ' ' GLY . 51.4 t-20 -111.4 147.08 35.98 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 115.299 -0.864 . . . . 54.210000000000001 109.16 -170.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -63.43 31.8 0.01 OUTLIER 'General case' 0 CA--C 1.581 2.136 0 C-N-CA 125.853 1.661 . . . . 70.510000000000005 111.869 176.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.494 ' H ' ' C ' ' A' ' 95' ' ' ASN . . . -171.1 -38.32 0.03 OUTLIER Glycine 0 N--CA 1.428 -1.887 0 N-CA-C 111.46 -0.656 . . . . 34.509999999999998 111.46 -179.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -133.11 177.41 7.69 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-O 121.509 0.671 . . . . 73.519999999999996 111.201 -177.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.486 ' HB3' ' HB3' ' A' ' 122' ' ' MET . 87.7 m-85 -122.63 121.33 36.17 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 104.418 -2.438 . . . . 74.409999999999997 104.418 171.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -131.14 127.27 37.71 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 120.661 -0.416 . . . . 54.439999999999998 111.445 -169.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 5.5 p -126.12 119.27 53.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-O 121.526 0.679 . . . . 62.200000000000003 109.472 176.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 23.3 m -119.51 136.6 56.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-N 115.425 -0.807 . . . . 75.209999999999994 112.04 -176.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.462 ' HB3' HD22 ' A' ' 118' ' ' ASN . 12.1 t70 -83.11 132.34 35.1 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 106.542 -1.651 . . . . 73.540000000000006 106.542 174.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 30.5 m -104.09 8.06 9.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 C-N-CA 119.653 -0.819 . . . . 73.340000000000003 112.285 -179.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 127.89 52.04 0.14 Allowed Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.593 -0.813 . . . . 63.530000000000001 112.447 179.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 14.2 m -80.87 126.18 31.04 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 112.319 0.488 . . . . 71.329999999999998 112.319 -176.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.0 mp -82.47 -22.06 35.33 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 107.493 -1.299 . . . . 73.409999999999997 107.493 173.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.496 ' OD1' ' HA3' ' A' ' 131' ' ' GLY . 22.8 t-20 -75.12 -30.52 60.87 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.372 -1.286 . . . . 74.310000000000002 109.989 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 92.07 117.94 2.36 Favored Glycine 0 C--O 1.221 -0.698 0 N-CA-C 114.566 0.587 . . . . 43.109999999999999 114.566 174.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 88.4 m -99.34 119.81 38.56 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-O 120.966 0.412 . . . . 54.130000000000003 110.093 178.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -115.19 134.78 54.84 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 109.411 -0.588 . . . . 73.219999999999999 109.411 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 5.4 p -113.09 121.16 64.78 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.582 0 N-CA-C 106.557 -1.645 . . . . 72.25 106.557 171.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 17.6 m120 58.9 26.27 14.7 Favored 'General case' 0 N--CA 1.48 1.05 0 O-C-N 123.163 0.289 . . . . 74.430000000000007 110.266 -175.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 80.38 6.29 1.62 Allowed 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.982 1.313 . . . . 73.349999999999994 113.467 -177.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -100.83 121.47 52.43 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 109.315 -0.624 . . . . 73.409999999999997 109.315 176.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.429 ' HA ' ' O ' ' A' ' 110' ' ' THR . 57.3 Cg_endo -78.14 126.42 7.78 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 121.993 1.795 . . . . 75.329999999999998 111.157 177.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -150.18 -176.96 5.67 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 109.908 -0.404 . . . . 72.239999999999995 109.908 177.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.462 HD22 ' HB3' ' A' ' 103' ' ' ASP . 4.0 t-20 -96.12 -57.37 2.36 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 123.189 0.306 . . . . 45.420000000000002 111.795 -177.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -117.92 139.72 50.73 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 109.629 -0.508 . . . . 62.240000000000002 109.629 -177.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 54.7 tp60 -139.25 140.73 37.77 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 116.207 -0.451 . . . . 72.140000000000001 110.472 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 59.5 t -80.25 114.22 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 104.936 -2.246 . . . . 64.420000000000002 104.936 170.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.486 ' HB3' ' HB3' ' A' ' 99' ' ' PHE . 16.6 ttt -63.36 123.01 17.62 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.973 -0.751 . . . . 73.319999999999993 108.973 -173.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -104.57 136.8 43.45 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-O 121.333 0.587 . . . . 70.239999999999995 111.457 -171.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 14.4 p -79.37 118.55 21.37 Favored 'General case' 0 N--CA 1.416 -2.158 0 CA-C-N 114.891 -1.049 . . . . 74.099999999999994 111.079 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 107.07 -13.33 40.86 Favored Glycine 0 N--CA 1.44 -1.057 0 CA-C-N 115.715 -0.675 . . . . 62.229999999999997 112.219 177.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -99.35 172.95 7.01 Favored 'General case' 0 C--O 1.25 1.088 0 N-CA-C 113.564 0.95 . . . . 74.530000000000001 113.564 -175.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.52 ' OE1' ' HD3' ' A' ' 134' ' ' ARG . 17.1 pt-20 -108.97 140.47 42.42 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 114.528 -1.214 . . . . 73.129999999999995 111.333 -174.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 71.9 mt -123.31 119.28 57.08 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 N-CA-C 106.765 -1.568 . . . . 74.209999999999994 106.765 177.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -115.75 121.88 43.79 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 109.278 -0.638 . . . . 72.129999999999995 109.278 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.503 ' O ' ' HD2' ' A' ' 133' ' ' PHE . 18.5 pt -103.83 98.68 7.13 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.171 0 N-CA-C 108.271 -1.011 . . . . 74.340000000000003 108.271 176.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.496 ' HA3' ' OD1' ' A' ' 108' ' ' ASN . . . 62.97 -95.01 0.12 Allowed Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.273 -0.876 . . . . 75.299999999999997 113.667 -178.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 3.8 ttmp? -101.72 -22.28 14.45 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 123.27 0.628 . . . . 74.150000000000006 109.891 -177.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.554 ' CE2' HD23 ' A' ' 80' ' ' LEU . 5.5 m-85 -92.17 112.14 23.96 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.617 -0.72 . . . . 71.329999999999998 110.038 -170.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.52 ' HD3' ' OE1' ' A' ' 127' ' ' GLU . 13.4 ttm180 -104.52 124.95 50.2 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 120.395 -0.522 . . . . 74.400000000000006 109.943 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.8 tt -124.25 140.33 53.07 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.547 -1.206 . . . . 63.409999999999997 108.604 -177.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 8.9 p -116.35 136.52 53.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 109.036 -0.727 . . . . 62.420000000000002 109.036 175.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -108.42 122.13 46.37 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.26 -0.427 . . . . 74.310000000000002 111.757 -173.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -121.83 150.23 42.21 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.119 -0.697 . . . . 75.209999999999994 109.119 178.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -129.4 148.64 51.34 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 109.691 -0.485 . . . . 75.549999999999997 109.691 178.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -169.21 -70.52 0.03 OUTLIER Glycine 0 C--N 1.303 -1.253 0 C-N-CA 120.019 -1.086 . . . . 41.420000000000002 112.708 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.449 ' HB3' ' CZ ' ' A' ' 18' ' ' PHE . 10.5 Cg_endo -56.12 102.7 0.1 Allowed 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 123.451 2.767 . . . . 61.439999999999998 116.344 -177.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.539 ' HB3' ' HB3' ' A' ' 21' ' ' ASP . . . -111.78 103.37 11.63 Favored 'General case' 0 C--N 1.267 -3.0 0 CA-C-N 113.207 -1.815 . . . . 72.420000000000002 106.417 174.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.425 ' HG3' ' HD2' ' A' ' 19' ' ' ARG . 41.1 tt0 . . . . . 0 C--N 1.291 -1.96 0 O-C-N 123.292 0.37 . . . . 63.32 110.518 -174.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.4 ttm . . . . . 0 N--CA 1.472 0.639 0 N-CA-C 109.437 -0.579 . . . . 73.349999999999994 109.437 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.9 t -79.7 -37.08 36.53 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 106.297 -1.742 . . . . 74.510000000000005 106.297 173.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -75.34 145.21 41.91 Favored 'General case' 0 C--O 1.254 1.318 0 N-CA-C 105.965 -1.865 . . . . 75.319999999999993 105.965 170.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 57.3 64.03 1.72 Allowed 'General case' 0 C--O 1.242 0.678 0 CA-C-O 122.787 1.279 . . . . 54.420000000000002 108.028 -176.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -69.38 167.24 16.95 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 113.1 -1.864 . . . . 71.299999999999997 110.52 -174.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -58.07 149.5 34.45 Favored Glycine 0 C--O 1.239 0.449 0 N-CA-C 112.518 -0.233 . . . . 73.099999999999994 112.518 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 60.5 m -67.46 124.83 90.13 Favored Pre-proline 0 C--N 1.311 -1.105 0 C-N-CA 122.763 0.425 . . . . 63.149999999999999 111.108 -177.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -67.7 151.82 78.54 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.491 2.794 . . . . 72.200000000000003 111.28 176.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -69.97 111.87 10.55 Favored Pre-proline 0 C--N 1.315 -0.895 0 N-CA-C 105.6 -2.0 . . . . 63.229999999999997 105.6 170.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -53.61 109.9 0.43 Allowed 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 123.187 2.592 . . . . 74.209999999999994 114.507 -170.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -90.11 107.86 19.39 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 114.585 -1.188 . . . . 62.509999999999998 108.635 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 46.9 t -89.69 94.02 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.528 0 N-CA-C 108.526 -0.916 . . . . 75.400000000000006 108.526 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -70.01 134.39 48.25 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 114.877 -1.056 . . . . 73.329999999999998 109.486 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 28.5 m -65.87 112.26 3.69 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-O 121.522 0.677 . . . . 73.140000000000001 112.046 -176.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.509 HG23 ' HB2' ' A' ' 98' ' ' GLU . 86.9 m -43.61 125.23 3.93 Favored 'General case' 0 N--CA 1.42 -1.93 0 C-N-CA 127.08 2.152 . . . . 55.350000000000001 114.598 -178.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.8 t -118.32 99.85 7.11 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 113.441 -1.709 . . . . 55.32 108.243 176.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.3 m -129.57 170.9 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 CA-C-O 120.745 0.307 . . . . 71.530000000000001 111.024 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -98.49 95.47 7.33 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 121.191 0.519 . . . . 71.409999999999997 110.499 177.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 41.8 ttm-85 65.75 95.77 0.05 Allowed 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 125.098 1.359 . . . . 74.329999999999998 112.562 178.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -86.63 -4.27 59.15 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.541 0.686 . . . . 55.420000000000002 110.458 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -64.92 -49.49 70.19 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.476 -1.238 . . . . 72.420000000000002 108.646 178.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 68.0 tp -150.34 112.08 4.52 Favored 'General case' 0 N--CA 1.425 -1.684 0 CA-C-N 114.364 -1.289 . . . . 74.040000000000006 108.619 -176.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -104.08 118.73 37.35 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.431 -1.322 . . . . 44.25 107.431 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -95.61 130.77 42.36 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.447 -0.575 . . . . 54.520000000000003 109.447 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.454 ' H ' ' CD ' ' A' ' 25' ' ' GLU . 1.6 mp0 -71.64 93.52 1.25 Allowed 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.856 -0.794 . . . . 71.25 108.856 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 54.1 mtt -80.33 109.16 14.55 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 108.331 -0.989 . . . . 74.310000000000002 108.331 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -114.36 140.73 48.41 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.11 0.481 . . . . 73.099999999999994 111.182 -178.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.4 p -93.75 104.35 16.44 Favored 'General case' 0 N--CA 1.414 -2.248 0 CA-C-N 115.809 -0.632 . . . . 74.120000000000005 110.926 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.8 t -75.94 -18.71 59.23 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.143 -1.058 . . . . 74.140000000000001 108.143 177.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.5 t -161.15 132.64 5.57 Favored 'General case' 0 N--CA 1.415 -2.204 0 N-CA-C 104.587 -2.375 . . . . 74.140000000000001 104.587 177.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 142.74 -152.31 23.78 Favored Glycine 0 N--CA 1.438 -1.202 0 C-N-CA 119.753 -1.213 . . . . 64.409999999999997 112.025 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.7 t -110.7 148.88 31.35 Favored 'General case' 0 N--CA 1.433 -1.275 0 CA-C-O 121.088 0.471 . . . . 61.539999999999999 110.778 -177.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.409 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . . . -91.43 119.05 68.74 Favored Pre-proline 0 C--N 1.31 -1.139 0 CA-C-N 115.766 -0.652 . . . . 74.109999999999999 109.973 178.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 33' ' ' ALA . 13.3 Cg_exo -69.87 117.2 4.95 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.42 2.08 . . . . 61.520000000000003 111.535 178.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -143.92 30.4 1.31 Allowed 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.176 -1.046 . . . . 65.420000000000002 108.176 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.9 p -78.2 1.05 22.73 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.844 -1.071 . . . . 65.329999999999998 112.891 -176.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.0 t -76.18 -178.7 4.61 Favored 'General case' 0 CA--C 1.557 1.247 0 N-CA-C 109.793 -0.447 . . . . 62.240000000000002 109.793 178.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -79.53 74.39 2.25 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.977 -0.154 . . . . 73.010000000000005 113.454 -175.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.49 -34.21 63.02 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.252 0.548 . . . . 74.409999999999997 110.206 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -77.21 -23.39 51.42 Favored 'General case' 0 C--O 1.245 0.844 0 CA-C-O 121.487 0.66 . . . . 75.540000000000006 109.55 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -75.7 -34.85 60.43 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.137 -0.938 . . . . 53.329999999999998 109.325 177.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 31.3 tp 69.47 116.98 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 125.509 1.523 . . . . 74.400000000000006 109.517 -177.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -56.2 111.14 0.69 Allowed 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 122.576 2.184 . . . . 74.109999999999999 113.628 -176.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -115.37 152.98 31.85 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 108.163 -1.051 . . . . 24.34 108.163 177.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.4 32.45 31.07 Favored Glycine 0 CA--C 1.504 -0.62 0 N-CA-C 109.793 -1.323 . . . . 74.540000000000006 109.793 -176.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 16.2 m -90.63 168.51 11.73 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 114.344 -0.928 . . . . 62.100000000000001 110.427 -177.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.575 ' HB1' ' HA ' ' A' ' 139' ' ' ALA . . . -95.52 177.18 5.9 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.995 -0.742 . . . . 64.409999999999997 108.995 178.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.98 160.25 38.29 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.619 0.6 . . . . 73.430000000000007 112.619 -174.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.492 HD13 HD11 ' A' ' 135' ' ' LEU . 3.0 pp -131.61 144.11 50.82 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 115.463 -0.789 . . . . 73.450000000000003 110.06 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.7 t -124.73 139.61 50.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 N-CA-C 108.411 -0.959 . . . . 73.120000000000005 108.411 -178.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.435 HG21 ' HB3' ' A' ' 57' ' ' ALA . 48.1 t -92.29 116.39 33.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-O 121.565 0.698 . . . . 50.310000000000002 109.195 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -76.71 -45.93 27.51 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 114.43 -1.259 . . . . 73.239999999999995 108.598 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.6 tpm_? -151.65 111.3 4.0 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.283 -1.006 . . . . 72.209999999999994 108.283 -176.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 161.4 118.27 0.47 Allowed Glycine 0 N--CA 1.432 -1.568 0 C-N-CA 118.851 -1.642 . . . . 75.129999999999995 114.769 176.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -63.77 -7.62 13.47 Favored 'Trans proline' 0 C--N 1.366 1.498 0 C-N-CA 123.745 2.963 . . . . 73.010000000000005 112.161 176.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.558 ' OD1' ' HG ' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -44.2 -42.01 6.19 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.657 1.183 . . . . 74.239999999999995 107.812 172.218 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.435 ' HB3' HG21 ' A' ' 51' ' ' VAL . . . -154.2 -64.55 0.14 Allowed 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.426 -0.806 . . . . 74.519999999999996 109.163 176.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.09 34.9 28.73 Favored Glycine 0 C--O 1.226 -0.39 0 C-N-CA 121.003 -0.618 . . . . 60.43 111.639 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -149.79 -164.7 2.08 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.999 -1.112 . . . . 75.230000000000004 107.999 -177.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 17.0 ptt180 -126.39 152.93 45.65 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 106.733 -1.581 . . . . 63.350000000000001 106.733 177.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.45 ' CZ ' HD11 ' A' ' 49' ' ' LEU . 51.1 p90 -156.5 149.46 24.0 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-O 121.509 0.671 . . . . 75.219999999999999 112.639 173.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 41.8 tp -87.03 140.31 29.69 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 113.784 -1.553 . . . . 71.040000000000006 107.474 178.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -78.38 114.69 17.51 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 119.709 -0.796 . . . . 73.510000000000005 110.148 177.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -127.39 -2.46 6.23 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 121.982 0.896 . . . . 64.349999999999994 109.799 178.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.426 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 6.3 pm0 -111.48 114.15 52.99 Favored Pre-proline 0 N--CA 1.42 -1.929 0 CA-C-N 115.155 -0.929 . . . . 72.019999999999996 109.466 178.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.499 ' HA ' HG13 ' A' ' 94' ' ' ILE . 9.6 Cg_endo -49.95 -34.9 39.05 Favored 'Trans proline' 0 C--N 1.371 1.756 0 C-N-CA 124.437 3.425 . . . . 63.020000000000003 115.62 -173.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 92.4 m -133.62 105.46 6.87 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-O 121.262 0.553 . . . . 73.0 109.846 177.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.521 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 3.5 m -102.19 113.13 26.14 Favored 'General case' 0 N--CA 1.422 -1.863 0 N-CA-C 108.235 -1.024 . . . . 71.430000000000007 108.235 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.465 ' HB ' ' HA ' ' A' ' 76' ' ' SER . 57.4 m -93.61 141.43 28.49 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 108.685 -0.858 . . . . 65.319999999999993 108.685 177.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.508 ' HB1' HD11 ' A' ' 80' ' ' LEU . . . -120.91 126.67 50.59 Favored 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 108.92 -0.77 . . . . 75.129999999999995 108.92 177.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -176.03 -140.8 3.59 Favored Glycine 0 N--CA 1.425 -2.091 0 C-N-CA 120.613 -0.803 . . . . 53.43 112.081 -177.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 22.8 ttm180 -114.15 -25.91 8.29 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.245 0.545 . . . . 72.409999999999997 111.837 -174.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.421 ' NE2' ' HG2' ' A' ' 87' ' ' ARG . 25.3 m-70 -99.54 157.41 34.03 Favored Pre-proline 0 C--N 1.305 -1.342 0 CA-C-N 116.386 -0.37 . . . . 70.219999999999999 110.101 -172.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -51.94 -21.38 11.98 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 124.089 3.193 . . . . 73.450000000000003 114.387 -178.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -60.51 -21.88 62.94 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.389 0.614 . . . . 61.310000000000002 110.045 176.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.465 ' HA ' ' HB ' ' A' ' 69' ' ' THR . 34.4 m -86.94 139.36 30.69 Favored 'General case' 0 N--CA 1.421 -1.9 0 CA-C-N 115.376 -0.829 . . . . 73.400000000000006 109.042 175.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -80.12 -30.68 39.08 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.204 0.526 . . . . 71.219999999999999 109.678 -179.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.453 ' H ' HD13 ' A' ' 78' ' ' ILE . 0.2 OUTLIER -126.95 136.49 60.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 109.244 -0.651 . . . . 63.100000000000001 109.244 175.39 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -103.11 117.73 35.21 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 115.809 -0.632 . . . . 74.439999999999998 109.54 -176.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.558 ' HG ' ' OD1' ' A' ' 56' ' ' ASN . 5.5 mp -70.02 115.94 9.82 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.851 -1.166 . . . . 70.409999999999997 107.851 175.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -88.44 61.59 6.21 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 122.68 1.229 . . . . 73.109999999999999 110.459 177.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -111.29 156.04 22.11 Favored 'General case' 0 C--N 1.286 -2.189 0 CA-C-N 113.136 -1.847 . . . . 71.129999999999995 107.872 174.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.9 p -74.42 -25.61 19.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 111.914 0.338 . . . . 74.450000000000003 111.914 -177.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.8 m -116.2 72.04 0.8 Allowed 'General case' 0 CA--C 1.548 0.904 0 CA-C-O 121.977 0.894 . . . . 64.140000000000001 110.829 -177.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 47.7 t -112.65 139.53 37.12 Favored 'Isoleucine or valine' 0 C--O 1.249 1.074 0 CA-C-N 115.766 -0.652 . . . . 73.319999999999993 110.844 -178.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 42.6 t -83.71 179.44 7.6 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.621 -0.881 . . . . 62.039999999999999 108.621 178.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.421 ' HG2' ' NE2' ' A' ' 73' ' ' HIS . 93.4 mtt180 -78.4 -54.09 6.56 Favored 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 105.854 -1.906 . . . . 65.230000000000004 105.854 175.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 5.6 ptm180 -105.32 100.37 9.95 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 106.105 -1.813 . . . . 74.450000000000003 106.105 171.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 11.0 t60 -99.59 -59.32 1.74 Allowed 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.959 -0.756 . . . . 74.400000000000006 108.959 -174.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -136.81 152.7 50.58 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.479 -0.934 . . . . 60.149999999999999 108.479 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -135.54 128.26 30.97 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 109.554 -0.535 . . . . 70.519999999999996 109.554 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.521 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 67.8 m-85 -101.81 115.98 31.71 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 107.762 -1.199 . . . . 74.109999999999999 107.762 179.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 18.8 mmt180 -108.33 140.0 42.23 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 109.319 -0.622 . . . . 74.129999999999995 109.319 178.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.499 HG13 ' HA ' ' A' ' 66' ' ' PRO . 2.6 pp -115.98 116.91 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.192 0 N-CA-C 106.965 -1.494 . . . . 74.109999999999999 106.965 172.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.538 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 46.6 t-20 -108.97 146.13 34.35 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 107.26 -1.385 . . . . 73.340000000000003 107.26 -174.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -59.49 -16.46 24.38 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 124.449 1.099 . . . . 74.409999999999997 111.551 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -87.42 -47.11 4.73 Favored Glycine 0 N--CA 1.431 -1.675 0 N-CA-C 111.594 -0.602 . . . . 72.310000000000002 111.594 176.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.538 ' O ' ' HB3' ' A' ' 95' ' ' ASN . 26.2 tt0 -173.36 169.15 4.51 Favored 'General case' 0 C--O 1.218 -0.573 0 N-CA-C 105.856 -1.905 . . . . 53.140000000000001 105.856 -179.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -104.49 131.71 51.56 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 119.262 0.937 . . . . 73.420000000000002 110.479 -173.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -131.7 138.13 48.55 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 122.566 1.174 . . . . 60.409999999999997 113.226 -178.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 44.3 t -102.57 129.79 53.57 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.258 0 N-CA-C 106.945 -1.502 . . . . 60.229999999999997 106.945 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.4 t -118.73 136.0 57.34 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 C-N-CA 120.926 -0.31 . . . . 72.239999999999995 110.283 -177.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -82.67 110.59 17.87 Favored 'General case' 0 N--CA 1.437 -1.109 0 N-CA-C 106.536 -1.653 . . . . 73.010000000000005 106.536 170.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 30.0 m -100.51 7.04 9.42 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 CA-C-N 114.935 -1.029 . . . . 75.230000000000004 111.518 -173.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 134.51 52.18 0.07 OUTLIER Glycine 0 N--CA 1.425 -2.084 0 C-N-CA 119.815 -1.183 . . . . 73.209999999999994 112.054 178.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 50.4 m -59.11 128.24 36.2 Favored 'General case' 0 C--O 1.25 1.131 0 N-CA-C 109.667 -0.494 . . . . 61.210000000000001 109.667 176.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.83 -51.15 63.68 Favored 'General case' 0 C--O 1.217 -0.609 0 N-CA-C 108.62 -0.882 . . . . 65.319999999999993 108.62 -178.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.435 ' OD1' ' HA2' ' A' ' 131' ' ' GLY . 7.9 p30 -91.61 -45.66 8.36 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 112.281 0.475 . . . . 63.520000000000003 112.281 177.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 143.71 139.56 3.53 Favored Glycine 0 C--O 1.219 -0.82 0 C-N-CA 119.506 -1.331 . . . . 32.450000000000003 114.063 174.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 59.8 m -105.26 120.14 40.82 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 108.908 -0.775 . . . . 44.100000000000001 108.908 174.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -122.04 137.91 54.63 Favored 'General case' 0 C--O 1.198 -1.645 0 CA-C-N 115.649 -0.705 . . . . 73.109999999999999 109.715 -174.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.541 HG21 ' HG3' ' A' ' 120' ' ' GLN . 59.6 t -99.18 117.08 43.76 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.485 0 N-CA-C 106.708 -1.59 . . . . 51.420000000000002 106.708 177.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 68.58 -71.07 0.12 Allowed 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 125.341 1.457 . . . . 73.030000000000001 108.877 -172.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 55.9 ttp85 -157.67 6.79 0.14 Allowed 'General case' 0 CA--C 1.553 1.073 0 CA-C-O 121.339 0.59 . . . . 72.450000000000003 109.775 172.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -114.8 131.74 23.29 Favored Pre-proline 0 N--CA 1.449 -0.476 0 O-C-N 121.845 -0.535 . . . . 73.439999999999998 110.026 -174.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -68.87 131.38 22.39 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.203 1.935 . . . . 62.219999999999999 112.241 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 -122.27 145.07 48.57 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 106.767 -1.568 . . . . 65.409999999999997 106.767 176.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -78.76 -46.54 18.65 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.989 -1.115 . . . . 75.120000000000005 107.989 178.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -138.35 143.48 39.9 Favored 'General case' 0 N--CA 1.421 -1.891 0 N-CA-C 106.609 -1.626 . . . . 34.539999999999999 106.609 175.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.541 ' HG3' HG21 ' A' ' 112' ' ' VAL . 22.1 tm0? -129.69 141.86 50.82 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 107.345 -1.354 . . . . 75.040000000000006 107.345 -176.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.3 p -103.15 119.05 51.06 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.297 0 N-CA-C 108.554 -0.906 . . . . 71.439999999999998 108.554 178.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.558 ' HB3' ' CE1' ' A' ' 137' ' ' PHE . 64.9 mtt -41.84 111.93 0.28 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.217 1.007 . . . . 74.230000000000004 112.588 -170.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -114.83 136.3 53.24 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-N 114.929 -1.032 . . . . 75.319999999999993 109.619 -170.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.703 ' HB ' ' HB3' ' A' ' 139' ' ' ALA . 14.6 t -79.4 127.59 32.29 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 121.666 0.746 . . . . 63.539999999999999 112.778 -176.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 80.97 33.51 29.47 Favored Glycine 0 N--CA 1.428 -1.849 0 CA-C-N 115.124 -0.943 . . . . 52.32 111.958 173.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -137.2 155.78 49.13 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.427 -0.953 . . . . 71.420000000000002 108.427 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -118.8 135.57 54.46 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-O 121.97 0.891 . . . . 73.230000000000004 113.206 -175.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 64.6 mt -111.35 130.4 64.92 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 CA-C-N 114.386 -1.279 . . . . 73.219999999999999 108.706 -177.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -91.9 111.49 23.05 Favored 'General case' 0 N--CA 1.417 -2.109 0 N-CA-C 107.707 -1.22 . . . . 73.540000000000006 107.707 175.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 10.9 pt -93.97 98.84 8.65 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 N-CA-C 107.911 -1.144 . . . . 70.409999999999997 107.911 177.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.435 ' HA2' ' OD1' ' A' ' 108' ' ' ASN . . . 79.58 -104.07 2.14 Favored Glycine 0 N--CA 1.412 -2.907 0 N-CA-C 109.363 -1.495 . . . . 65.409999999999997 109.363 -174.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -123.68 5.3 8.86 Favored 'General case' 0 C--N 1.298 -1.63 0 N-CA-C 109.965 -0.383 . . . . 74.040000000000006 109.965 178.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -113.03 152.71 29.16 Favored 'General case' 0 C--O 1.211 -0.954 0 CA-C-N 116.375 -0.375 . . . . 74.239999999999995 110.625 -177.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 66.4 mtp85 -113.61 128.31 56.39 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.52 0.676 . . . . 64.010000000000005 112.611 -170.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.492 HD11 HD13 ' A' ' 49' ' ' LEU . 45.1 tp -119.43 132.6 55.84 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 124.92 1.288 . . . . 74.310000000000002 108.552 -177.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 9.9 p -108.17 132.36 56.13 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 108.765 -0.828 . . . . 72.439999999999998 108.765 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.558 ' CE1' ' HB3' ' A' ' 122' ' ' MET . 39.8 t80 -109.04 131.38 55.13 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 121.077 -0.249 . . . . 73.120000000000005 110.948 -175.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.4 mp -124.44 124.18 41.76 Favored 'General case' 0 C--O 1.244 0.79 0 CA-C-O 121.131 0.491 . . . . 71.530000000000001 109.927 177.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.703 ' HB3' ' HB ' ' A' ' 124' ' ' THR . . . -94.64 82.91 4.0 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-O 121.536 0.684 . . . . 73.120000000000005 111.072 -177.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -127.12 96.87 0.46 Allowed Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 109.021 -1.631 . . . . 71.030000000000001 109.021 177.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -50.12 117.37 3.07 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 123.159 2.573 . . . . 74.030000000000001 113.271 -176.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -109.95 105.89 15.22 Favored 'General case' 0 C--N 1.276 -2.63 0 CA-C-N 114.266 -1.334 . . . . 65.230000000000004 109.82 178.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 . . . . . 0 C--N 1.291 -1.937 0 N-CA-C 105.747 -1.946 . . . . 63.549999999999997 105.747 177.574 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.9 mtt . . . . . 0 CA--C 1.516 -0.346 0 N-CA-C 108.221 -1.029 . . . . 74.010000000000005 108.221 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.0 t -82.22 -31.48 30.27 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 106.685 -1.598 . . . . 73.200000000000003 106.685 172.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -71.39 148.66 46.75 Favored 'General case' 0 C--O 1.247 0.933 0 CA-C-N 114.459 -1.246 . . . . 74.519999999999996 108.286 174.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -93.92 127.03 39.47 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 109.295 -0.632 . . . . 74.230000000000004 109.295 177.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -148.25 166.52 27.7 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 116.325 -0.398 . . . . 64.430000000000007 110.464 -179.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 161.23 176.47 33.37 Favored Glycine 0 N--CA 1.431 -1.688 0 N-CA-C 110.733 -0.947 . . . . 64.510000000000005 110.733 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.3 p -92.2 124.62 59.2 Favored Pre-proline 0 C--N 1.292 -1.9 0 CA-C-N 116.624 0.212 . . . . 71.099999999999994 110.909 -178.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -63.83 128.92 23.22 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.314 2.01 . . . . 72.129999999999995 110.326 176.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -86.4 130.55 49.08 Favored Pre-proline 0 C--N 1.299 -1.615 0 CA-C-N 116.32 -0.4 . . . . 74.420000000000002 111.856 -174.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -65.15 145.33 84.28 Favored 'Trans proline' 0 C--O 1.247 0.934 0 C-N-CA 122.632 2.221 . . . . 74.319999999999993 111.377 178.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -57.8 128.34 36.58 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-N 115.685 -0.689 . . . . 72.409999999999997 112.483 -178.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.4 m -73.53 76.25 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 CA-C-O 122.66 1.219 . . . . 31.239999999999998 109.903 173.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -88.83 122.59 32.37 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-N 114.231 -1.35 . . . . 74.200000000000003 111.033 -174.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.6 t -145.27 89.29 1.93 Allowed 'General case' 0 N--CA 1.407 -2.597 0 CA-C-O 122.583 1.182 . . . . 70.219999999999999 107.944 174.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 28.6 m -92.5 105.82 17.92 Favored 'General case' 0 N--CA 1.415 -2.212 0 CA-C-N 114.79 -1.096 . . . . 62.140000000000001 109.444 -177.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.9 m -72.32 113.99 9.95 Favored 'General case' 0 N--CA 1.418 -2.075 0 CA-C-N 115.065 -0.97 . . . . 63.039999999999999 109.029 177.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.1 m -65.7 133.41 30.83 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-O 121.125 0.488 . . . . 74.140000000000001 110.506 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -88.32 129.22 35.44 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 115.099 -0.955 . . . . 75.310000000000002 109.853 -177.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 -89.13 144.74 25.91 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 112.935 0.717 . . . . 72.120000000000005 112.935 -177.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.04 16.57 0.72 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.346 -0.843 . . . . 71.530000000000001 111.217 177.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -88.94 -17.1 30.21 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.812 -1.181 . . . . 63.439999999999998 107.812 176.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 65.94 72.85 0.39 Allowed 'General case' 0 CA--C 1.506 -0.738 0 CA-C-N 114.491 -1.231 . . . . 62.43 112.762 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.4 tt -116.15 113.45 23.11 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 105.331 -2.1 . . . . 72.5 105.331 175.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.475 ' HD3' ' H ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -102.52 101.55 11.74 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 120.964 0.411 . . . . 63.200000000000003 110.239 -177.96 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -56.11 122.69 12.27 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.977 -1.01 . . . . 75.420000000000002 111.603 -179.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 65.5 mtt -93.05 -1.42 56.57 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 115.812 -0.631 . . . . 73.140000000000001 109.979 175.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -67.05 148.11 52.33 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.972 -1.013 . . . . 75.450000000000003 108.803 175.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.1 t -69.56 170.41 10.74 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 121.2 0.524 . . . . 42.119999999999997 111.13 -174.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 26.3 p -67.2 142.35 57.01 Favored 'General case' 0 N--CA 1.427 -1.624 0 CA-C-N 115.418 -0.81 . . . . 71.25 112.387 -174.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.1 t -133.76 112.54 11.45 Favored 'General case' 0 N--CA 1.414 -2.245 0 N-CA-C 108.881 -0.785 . . . . 63.240000000000002 108.881 177.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 129.69 -57.33 0.72 Allowed Glycine 0 N--CA 1.432 -1.572 0 N-CA-C 110.829 -0.908 . . . . 65.219999999999999 110.829 -178.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 15.6 m -91.81 138.38 31.6 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.112 -0.699 . . . . 75.430000000000007 109.112 179.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -89.7 117.61 68.28 Favored Pre-proline 0 C--N 1.313 -1.013 0 N-CA-C 109.755 -0.461 . . . . 73.530000000000001 109.755 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -65.69 120.75 7.99 Favored 'Trans proline' 0 C--O 1.236 0.419 0 C-N-CA 122.736 2.291 . . . . 73.299999999999997 111.532 178.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -93.25 100.99 13.25 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 109.088 -0.708 . . . . 62.140000000000001 109.088 178.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.7 m -101.8 163.38 12.28 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.879 -0.785 . . . . 63.049999999999997 108.879 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 13.3 t -156.61 -177.7 6.8 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 108.08 -1.081 . . . . 72.530000000000001 108.08 178.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.18 107.44 0.53 Allowed Glycine 0 N--CA 1.427 -1.908 0 C-N-CA 120.406 -0.902 . . . . 61.140000000000001 111.949 -175.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.0 -33.69 61.86 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 121.089 0.471 . . . . 62.32 110.14 178.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -74.89 -11.87 60.23 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.399 0.619 . . . . 73.319999999999993 110.367 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -76.09 -27.41 57.16 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.292 -0.867 . . . . 70.200000000000003 109.74 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 96.1 mt -102.91 147.75 34.56 Favored Pre-proline 0 N--CA 1.419 -2.016 0 CA-C-N 115.222 -0.899 . . . . 72.129999999999995 109.678 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -63.21 162.42 26.68 Favored 'Trans proline' 0 C--O 1.251 1.154 0 C-N-CA 122.652 2.235 . . . . 72.510000000000005 111.437 175.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -47.26 106.9 0.1 Allowed 'General case' 0 C--O 1.238 0.494 0 C-N-CA 124.802 1.241 . . . . 22.43 112.987 -176.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -148.83 46.69 0.67 Allowed Glycine 0 CA--C 1.484 -1.851 0 N-CA-C 107.261 -2.336 . . . . 52.109999999999999 107.261 177.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 20.2 m -90.89 167.08 12.7 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 114.107 -1.046 . . . . 53.219999999999999 110.609 -174.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -127.4 171.13 11.81 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.137 -1.431 . . . . 65.329999999999998 107.137 177.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -134.04 145.5 49.48 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 120.039 -0.664 . . . . 71.530000000000001 111.109 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.479 ' O ' ' HA ' ' A' ' 60' ' ' ARG . 4.1 pp -110.56 132.72 53.94 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 115.217 -0.901 . . . . 75.209999999999994 108.934 176.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 51.5 t -116.67 113.88 44.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 108.509 -0.923 . . . . 62.030000000000001 108.509 179.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 36.3 t -96.21 115.61 35.94 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 N-CA-C 109.033 -0.729 . . . . 71.329999999999998 109.033 -179.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -86.14 -32.86 21.06 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.377 0.608 . . . . 63.549999999999997 110.183 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.438 ' O ' ' HB3' ' A' ' 133' ' ' PHE . 10.1 tpt180 -147.55 131.08 16.75 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 106.535 -1.654 . . . . 73.209999999999994 106.535 179.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.426 ' HA2' ' HD2' ' A' ' 55' ' ' PRO . . . 145.14 110.74 0.7 Allowed Glycine 0 C--N 1.298 -1.555 0 N-CA-C 111.376 -0.689 . . . . 65.120000000000005 111.376 -178.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.426 ' HD2' ' HA2' ' A' ' 54' ' ' GLY . 14.3 Cg_endo -58.36 -20.7 49.42 Favored 'Trans proline' 0 C--N 1.358 1.052 0 C-N-CA 123.403 2.735 . . . . 70.140000000000001 113.689 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.448 ' HB3' ' HG ' ' A' ' 80' ' ' LEU . 7.6 p30 -48.0 -35.9 11.77 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.225 1.01 . . . . 74.319999999999993 111.82 175.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -152.21 -72.04 0.15 Allowed 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 109.241 -0.651 . . . . 73.109999999999999 109.241 176.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.96 36.64 35.37 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.652 -0.704 . . . . 64.129999999999995 111.752 -179.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -158.38 -171.61 3.54 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 107.672 -1.232 . . . . 70.340000000000003 107.672 -178.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.479 ' HA ' ' O ' ' A' ' 49' ' ' LEU . 36.6 ptt180 -113.37 133.02 55.38 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 109.546 -0.539 . . . . 74.420000000000002 109.546 178.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -135.57 134.7 39.65 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 116.483 -0.326 . . . . 75.400000000000006 110.681 -176.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.5 mp -91.57 130.16 37.43 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.921 -0.581 . . . . 73.109999999999999 109.438 178.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -71.34 121.34 18.34 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.546 0.689 . . . . 74.409999999999997 110.761 -177.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -123.78 -24.95 4.37 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.206 -1.361 . . . . 72.010000000000005 111.383 -175.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.446 ' H ' ' CD ' ' A' ' 65' ' ' GLN . 0.2 OUTLIER -92.27 141.34 24.87 Favored Pre-proline 0 C--N 1.295 -1.781 0 CA-C-N 115.021 -0.99 . . . . 73.340000000000003 111.032 -174.684 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.525 ' HA ' HG22 ' A' ' 94' ' ' ILE . 37.2 Cg_endo -66.68 -34.29 32.47 Favored 'Trans proline' 0 C--O 1.242 0.709 0 C-N-CA 123.075 2.516 . . . . 51.100000000000001 112.798 -176.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 39.5 m -132.61 99.71 4.72 Favored 'General case' 0 N--CA 1.415 -2.187 0 N-CA-C 107.57 -1.27 . . . . 73.540000000000006 107.57 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.516 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 6.1 m -90.74 112.92 24.89 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.506 -0.924 . . . . 62.130000000000003 108.506 179.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 51.7 m -94.04 119.94 33.6 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 109.296 -0.631 . . . . 75.310000000000002 109.296 177.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -109.69 120.31 42.1 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 108.59 -0.893 . . . . 63.119999999999997 108.59 178.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 175.29 -147.09 8.69 Favored Glycine 0 C--N 1.289 -2.067 0 N-CA-C 109.221 -1.552 . . . . 42.530000000000001 109.221 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.499 ' HD3' ' O ' ' A' ' 80' ' ' LEU . 10.2 tpt180 -134.32 66.16 1.55 Allowed 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 108.424 -0.954 . . . . 73.409999999999997 108.424 179.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 30.1 m170 -126.87 166.01 25.05 Favored Pre-proline 0 C--N 1.303 -1.414 0 N-CA-C 107.568 -1.271 . . . . 75.310000000000002 107.568 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -61.13 -32.94 91.71 Favored 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 121.755 1.637 . . . . 72.319999999999993 109.986 172.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 -97.82 72.3 2.25 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-O 122.35 1.071 . . . . 61.039999999999999 109.898 177.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 48.9 m -142.62 125.92 16.55 Favored 'General case' 0 C--N 1.277 -2.545 0 CA-C-N 114.087 -1.415 . . . . 72.219999999999999 107.557 174.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -69.48 -50.66 43.27 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 107.774 -1.195 . . . . 62.32 107.774 -179.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 30.1 pt -109.09 123.59 65.09 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.222 0 N-CA-C 107.083 -1.451 . . . . 74.099999999999994 107.083 172.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -108.04 116.91 32.82 Favored 'General case' 0 C--N 1.28 -2.455 0 CA-C-O 122.177 0.989 . . . . 74.409999999999997 111.524 -177.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.499 ' O ' ' HD3' ' A' ' 72' ' ' ARG . 6.3 mp -79.89 135.28 36.4 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 113.835 -1.53 . . . . 51.009999999999998 109.272 -177.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -134.13 23.79 3.85 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 105.472 -2.047 . . . . 73.319999999999993 105.472 179.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -78.44 179.19 7.17 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 111.796 -2.456 . . . . 72.219999999999999 109.906 -175.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.9 p -83.34 1.59 3.91 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-O 122.073 0.94 . . . . 55.329999999999998 110.13 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 12.0 p -109.89 14.32 23.18 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 115.932 -0.576 . . . . 65.310000000000002 111.778 -175.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.2 m -81.83 139.09 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.634 0 CA-C-O 121.346 0.593 . . . . 70.109999999999999 111.915 -174.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 13.0 p -130.98 -81.44 0.53 Allowed 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.24 -0.891 . . . . 72.140000000000001 111.367 -179.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.447 ' HG3' ' HD2' ' A' ' 88' ' ' ARG . 20.0 tpp85 -156.33 -92.39 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.002 -1.11 . . . . 50.530000000000001 108.002 178.056 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.571 ' HB3' HG23 ' A' ' 104' ' ' VAL . 5.4 mpt_? -85.65 107.06 17.37 Favored 'General case' 0 CA--C 1.493 -1.243 0 N-CA-C 105.168 -2.16 . . . . 73.530000000000001 105.168 171.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -91.53 -75.58 0.47 Allowed 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 120.287 -0.565 . . . . 65.340000000000003 110.255 -174.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -144.51 155.0 43.48 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.991 -0.744 . . . . 64.540000000000006 108.991 -178.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -140.34 128.2 21.93 Favored 'General case' 0 C--N 1.287 -2.131 0 C-N-CA 119.994 -0.682 . . . . 73.040000000000006 109.326 179.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.516 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 42.3 m-85 -97.55 113.09 24.73 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 106.887 -1.523 . . . . 70.409999999999997 106.887 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.428 HH11 ' HD3' ' A' ' 93' ' ' ARG . 46.1 mtt-85 -112.56 152.12 29.23 Favored 'General case' 0 C--N 1.269 -2.913 0 C-N-CA 120.527 -0.469 . . . . 73.340000000000003 109.922 179.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.525 HG22 ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -113.43 116.12 51.69 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.3 0 CA-C-O 123.111 1.434 . . . . 75.109999999999999 108.177 177.842 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -97.64 96.44 8.28 Favored 'General case' 0 N--CA 1.42 -1.928 0 CA-C-N 113.256 -1.793 . . . . 71.040000000000006 109.8 -173.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 43.45 13.6 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 127.477 2.311 . . . . 55.530000000000001 116.667 175.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 158.48 -13.15 0.23 Allowed Glycine 0 N--CA 1.417 -2.599 0 C-N-CA 120.234 -0.984 . . . . 63.030000000000001 113.606 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -146.36 152.82 39.71 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 118.05 -1.46 . . . . 63.43 110.513 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.414 ' CD2' ' HB ' ' A' ' 94' ' ' ILE . 89.8 m-85 -89.99 138.46 31.49 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.377 0.608 . . . . 75.340000000000003 110.851 -176.106 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -128.07 125.36 39.13 Favored 'General case' 0 C--N 1.28 -2.417 0 N-CA-C 107.61 -1.256 . . . . 70.200000000000003 107.61 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.5 p -103.07 118.55 50.18 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-O 121.602 0.715 . . . . 75.409999999999997 109.862 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 29.9 m -119.96 137.67 53.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-N 115.033 -0.985 . . . . 62.509999999999998 111.686 -179.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -83.23 122.96 29.1 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 104.742 -2.318 . . . . 72.200000000000003 104.742 171.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.571 HG23 ' HB3' ' A' ' 88' ' ' ARG . 16.8 m -106.15 9.59 9.37 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 N-CA-C 112.816 0.673 . . . . 62.509999999999998 112.816 -172.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -126.41 -45.96 0.22 Allowed Glycine 0 N--CA 1.43 -1.701 0 C-N-CA 119.018 -1.563 . . . . 55.340000000000003 112.96 -179.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 21.7 m 67.18 9.97 7.35 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.205 1.402 . . . . 71.329999999999998 110.659 -175.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 94.4 mt -74.92 -48.6 23.75 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 114.663 -1.153 . . . . 75.25 109.292 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -83.36 -50.34 8.44 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 108.643 -0.873 . . . . 65.400000000000006 108.643 175.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.01 76.99 1.32 Allowed Glycine 0 N--CA 1.431 -1.646 0 N-CA-C 109.486 -1.446 . . . . 55.109999999999999 109.486 -175.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 32.1 m -73.09 135.35 44.78 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 109.671 -0.492 . . . . 74.219999999999999 109.671 -179.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -102.18 133.2 47.43 Favored 'General case' 0 N--CA 1.422 -1.838 0 N-CA-C 106.925 -1.509 . . . . 74.25 106.925 178.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.47 HG23 HG12 ' A' ' 128' ' ' ILE . 7.5 p -128.41 137.29 57.8 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.179 0 N-CA-C 107.57 -1.27 . . . . 72.209999999999994 107.57 -175.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 60.61 21.95 11.78 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 108.149 -1.056 . . . . 75.519999999999996 108.149 -171.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 64.1 mtp180 54.7 37.38 28.18 Favored 'General case' 0 C--N 1.352 0.704 0 CA-C-N 114.412 -1.267 . . . . 73.019999999999996 112.582 -172.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -132.63 149.5 73.2 Favored Pre-proline 0 C--N 1.312 -1.061 0 N-CA-C 108.298 -1.001 . . . . 45.329999999999998 108.298 174.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -76.28 87.65 1.41 Allowed 'Trans proline' 0 N--CA 1.443 -1.476 0 C-N-CA 121.49 1.46 . . . . 52.25 110.554 174.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -120.14 149.73 41.76 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.758 -1.201 . . . . 74.030000000000001 107.758 178.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -89.27 -28.9 19.6 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 109.467 -0.568 . . . . 74.239999999999995 109.467 179.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -140.92 140.36 34.47 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 115.413 -0.812 . . . . 74.329999999999998 109.514 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.5 142.23 37.3 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.737 -1.208 . . . . 64.340000000000003 107.737 174.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 11.3 p -98.07 135.84 31.22 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.232 0 N-CA-C 109.641 -0.503 . . . . 73.239999999999995 109.641 -177.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 48.6 ttp -31.58 108.99 0.05 Allowed 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 125.97 1.708 . . . . 63.119999999999997 112.24 -177.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -133.06 138.71 46.84 Favored 'General case' 0 N--CA 1.419 -2.015 0 N-CA-C 106.763 -1.569 . . . . 65.120000000000005 106.763 179.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 12.3 t -80.06 131.37 35.76 Favored 'General case' 0 N--CA 1.423 -1.823 0 N-CA-C 109.12 -0.696 . . . . 63.32 109.12 -179.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 91.39 18.14 46.87 Favored Glycine 0 N--CA 1.438 -1.176 0 C-N-CA 120.314 -0.946 . . . . 71.450000000000003 111.125 178.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -81.51 140.64 34.44 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 106.657 -1.609 . . . . 75.530000000000001 106.657 178.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -124.77 120.88 33.03 Favored 'General case' 0 C--N 1.277 -2.552 0 CA-C-O 122.41 1.1 . . . . 55.420000000000002 110.576 -179.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.47 HG12 HG23 ' A' ' 112' ' ' VAL . 61.0 mt -103.66 128.49 56.81 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.095 0 CA-C-N 113.885 -1.507 . . . . 72.450000000000003 108.908 -174.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -120.6 124.82 46.22 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 109.793 -0.447 . . . . 63.119999999999997 109.793 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.464 HG13 ' HB2' ' A' ' 133' ' ' PHE . 22.0 pt -109.76 98.24 6.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 108.404 -0.961 . . . . 62.399999999999999 108.404 173.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 70.4 -82.81 0.36 Allowed Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.074 -0.966 . . . . 34.329999999999998 111.615 -175.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -130.77 -12.79 3.75 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 123.104 0.562 . . . . 73.430000000000007 110.182 179.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.464 ' HB2' HG13 ' A' ' 130' ' ' ILE . 42.3 m-85 -85.63 131.74 34.29 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.852 -0.795 . . . . 71.310000000000002 108.852 -176.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 21.4 ptt180 -118.33 135.05 54.54 Favored 'General case' 0 C--O 1.258 1.541 0 CA-C-O 121.993 0.902 . . . . 62.509999999999998 112.821 -175.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 5.2 tt -120.04 133.23 55.59 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 113.473 -1.694 . . . . 55.109999999999999 107.302 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 40.7 t -107.91 120.75 59.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 107.318 -1.364 . . . . 63.310000000000002 107.318 177.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -102.48 121.9 43.26 Favored 'General case' 0 C--N 1.288 -2.078 0 CA-C-N 115.7 -0.682 . . . . 73.5 109.497 -176.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -121.52 159.52 26.18 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 109.606 -0.516 . . . . 60.109999999999999 109.606 -178.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -72.0 148.78 45.58 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 106.772 -1.566 . . . . 63.009999999999998 106.772 172.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -113.86 -140.62 7.57 Favored Glycine 0 C--N 1.29 -1.983 0 C-N-CA 119.546 -1.311 . . . . 35.240000000000002 112.874 -173.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -77.92 118.41 4.43 Favored 'Trans proline' 0 N--CA 1.435 -1.915 0 C-N-CA 122.57 2.18 . . . . 73.109999999999999 113.061 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -109.95 104.54 13.47 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 105.972 -1.862 . . . . 34.119999999999997 105.972 173.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 . . . . . 0 C--N 1.296 -1.723 0 N-CA-C 109.185 -0.672 . . . . 60.520000000000003 109.185 -174.643 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.3 ptm . . . . . 0 C--O 1.222 -0.379 0 CA-C-O 121.409 0.623 . . . . 74.030000000000001 111.117 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.2 m -83.2 -36.26 24.79 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.138 0.494 . . . . 42.229999999999997 111.001 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -102.27 126.79 49.37 Favored 'General case' 0 CA--C 1.489 -1.377 0 CA-C-N 116.121 -0.491 . . . . 60.420000000000002 112.19 -174.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -82.97 92.89 7.43 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 105.423 -2.066 . . . . 73.219999999999999 105.423 171.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -104.18 163.69 12.23 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 114.969 -1.014 . . . . 74.25 112.131 -170.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -179.59 -165.18 33.24 Favored Glycine 0 N--CA 1.428 -1.876 0 N-CA-C 107.67 -2.172 . . . . 74.439999999999998 107.67 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.8 p -77.29 124.26 87.02 Favored Pre-proline 0 C--N 1.3 -1.55 0 CA-C-N 118.212 1.006 . . . . 71.120000000000005 109.667 179.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -61.21 148.12 93.76 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 123.175 2.583 . . . . 74.200000000000003 112.855 -175.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -69.77 117.62 55.23 Favored Pre-proline 0 C--O 1.247 0.925 0 N-CA-C 109.556 -0.535 . . . . 71.120000000000005 109.556 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -82.24 142.53 12.11 Favored 'Trans proline' 0 N--CA 1.444 -1.44 0 C-N-CA 122.738 2.292 . . . . 74.219999999999999 112.63 -176.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -70.55 134.35 47.59 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-N 115.456 -0.793 . . . . 63.100000000000001 109.801 178.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.7 t -73.86 89.22 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 CA-C-N 115.483 -0.78 . . . . 54.43 109.591 -179.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -72.96 124.41 25.39 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 114.546 -1.206 . . . . 71.530000000000001 108.95 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.4 m -67.29 98.32 0.61 Allowed 'General case' 0 N--CA 1.427 -1.621 0 CA-C-N 115.709 -0.678 . . . . 51.240000000000002 109.844 -179.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.1 t -79.3 75.05 5.88 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 123.037 1.398 . . . . 75.030000000000001 110.394 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.8 m -155.69 164.05 39.1 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 106.452 -1.684 . . . . 71.140000000000001 106.452 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.7 m -73.34 136.55 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.591 0 N-CA-C 108.863 -0.792 . . . . 72.540000000000006 108.863 175.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -129.28 -178.28 4.59 Favored 'General case' 0 C--N 1.277 -2.583 0 N-CA-C 106.902 -1.518 . . . . 73.510000000000005 106.902 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 28.8 mmm180 -81.87 160.74 23.39 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 109.548 -0.538 . . . . 72.400000000000006 109.548 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.0 27.17 1.4 Allowed 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.748 0.785 . . . . 61.439999999999998 109.381 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -58.78 -50.31 74.43 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 125.13 1.372 . . . . 74.409999999999997 110.375 -179.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 60.8 tp -157.52 101.86 1.87 Allowed 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.597 -0.728 . . . . 75.219999999999999 109.099 177.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 91.9 mt -93.55 158.42 15.71 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.662 -0.866 . . . . 73.329999999999998 108.662 177.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.464 ' HD2' ' N ' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -94.08 140.6 29.53 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 120.65 -0.42 . . . . 74.129999999999995 110.436 -177.135 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -60.7 121.88 13.37 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 114.673 1.361 . . . . 74.099999999999994 114.673 -177.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 11.1 tmm? -90.32 125.31 35.48 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 106.214 -1.773 . . . . 73.219999999999999 106.214 172.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -140.08 150.95 44.96 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.795 -1.187 . . . . 74.219999999999999 107.795 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.3 p -145.52 -37.6 0.27 Allowed 'General case' 0 C--N 1.293 -1.861 0 O-C-N 123.644 0.59 . . . . 54.140000000000001 109.422 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.4 m 60.82 23.16 13.16 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 124.397 1.079 . . . . 54.509999999999998 110.154 -179.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.4 m -98.19 114.26 26.44 Favored 'General case' 0 N--CA 1.411 -2.42 0 CA-C-N 114.566 -1.197 . . . . 42.100000000000001 109.025 -178.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.31 72.5 2.63 Favored Glycine 0 N--CA 1.438 -1.202 0 N-CA-C 109.494 -1.442 . . . . 43.210000000000001 109.494 177.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 10.6 t -69.57 140.15 53.78 Favored 'General case' 0 N--CA 1.426 -1.663 0 CA-C-N 115.004 -0.598 . . . . 73.230000000000004 110.536 -177.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.3 139.19 64.15 Favored Pre-proline 0 C--N 1.303 -1.431 0 CA-C-N 114.901 -1.045 . . . . 62.200000000000003 109.601 -178.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -68.5 136.75 37.45 Favored 'Trans proline' 0 N--CA 1.446 -1.292 0 C-N-CA 121.675 1.584 . . . . 42.030000000000001 109.569 175.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.82 -48.97 78.2 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-O 120.669 0.271 . . . . 54.549999999999997 110.324 -179.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.4 m 66.27 -0.11 1.55 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.925 1.29 . . . . 71.219999999999999 112.247 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 13.1 p -94.66 140.13 30.3 Favored 'General case' 0 N--CA 1.423 -1.812 0 CA-C-O 120.994 0.426 . . . . 54.109999999999999 111.5 -177.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 97.83 -8.68 63.64 Favored Glycine 0 N--CA 1.438 -1.22 0 CA-C-N 115.958 -0.565 . . . . 74.409999999999997 111.823 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.14 -21.21 62.22 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.03 0.443 . . . . 53.140000000000001 110.526 -178.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -68.75 -11.17 60.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.652 -0.704 . . . . 74.040000000000006 111.971 178.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -61.56 -30.25 70.54 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.778 0.799 . . . . 74.299999999999997 109.033 174.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.568 ' HG ' ' O ' ' A' ' 44' ' ' ALA . 46.3 tp -117.57 95.0 46.93 Favored Pre-proline 0 N--CA 1.413 -2.295 0 CA-C-N 114.861 -1.063 . . . . 73.150000000000006 108.768 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.488 ' HA ' ' OE1' ' A' ' 96' ' ' GLU . 83.1 Cg_endo -97.2 23.11 0.32 Allowed 'Trans proline' 0 C--O 1.239 0.55 0 C-N-CA 123.425 2.75 . . . . 65.530000000000001 110.318 178.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.568 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -143.11 173.09 11.88 Favored 'General case' 0 N--CA 1.422 -1.84 0 N-CA-C 106.06 -1.829 . . . . 74.239999999999995 106.06 -178.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 111.47 58.13 0.47 Allowed Glycine 0 C--N 1.28 -2.582 0 N-CA-C 109.605 -1.398 . . . . 51.32 109.605 -176.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.568 ' HB3' ' O ' ' A' ' 63' ' ' LEU . 4.8 m -90.0 154.64 19.67 Favored 'General case' 0 N--CA 1.41 -2.448 0 CA-C-N 114.446 -0.877 . . . . 64.310000000000002 108.892 -177.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -116.26 175.89 5.35 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.303 -0.999 . . . . 64.329999999999998 108.303 -178.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -130.27 159.66 36.23 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 121.327 0.584 . . . . 65.140000000000001 111.348 -175.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.44 HD22 HD21 ' A' ' 135' ' ' LEU . 1.7 pp -122.17 147.63 45.93 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 115.356 -0.838 . . . . 73.420000000000002 110.097 177.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.483 ' CG2' ' HB ' ' A' ' 136' ' ' VAL . 24.6 m -123.28 134.05 67.37 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 108.603 -0.888 . . . . 73.430000000000007 108.603 175.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.463 HG21 ' HB3' ' A' ' 57' ' ' ALA . 48.5 t -92.54 115.69 32.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 106.457 -1.683 . . . . 63.240000000000002 106.457 176.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.402 ' HB3' ' HG3' ' A' ' 134' ' ' ARG . 76.9 tttt -73.96 -39.98 63.35 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 114.524 -1.217 . . . . 71.0 108.417 -176.118 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 31.7 tpt180 -168.31 138.51 2.55 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 107.157 -1.423 . . . . 65.209999999999994 107.157 177.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 139.28 127.67 2.47 Favored Glycine 0 N--CA 1.425 -2.077 0 C-N-CA 119.724 -1.227 . . . . 45.030000000000001 114.382 178.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.508 ' HD2' ' CE2' ' A' ' 133' ' ' PHE . 80.3 Cg_exo -54.0 -8.74 1.04 Allowed 'Trans proline' 0 C--N 1.368 1.553 0 C-N-CA 125.237 3.958 . . . . 74.219999999999999 114.117 173.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.541 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 4.3 t-20 -40.99 -45.44 2.6 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.717 1.207 . . . . 52.240000000000002 109.792 170.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.463 ' HB3' HG21 ' A' ' 51' ' ' VAL . . . -162.95 -48.55 0.04 OUTLIER 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 115.989 -0.551 . . . . 74.040000000000006 109.601 176.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 67.82 48.52 54.7 Favored Glycine 0 C--N 1.324 -0.134 0 N-CA-C 111.225 -0.75 . . . . 62.130000000000003 111.225 -179.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -161.64 -173.02 3.56 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.25 -1.018 . . . . 54.409999999999997 108.25 -178.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.464 ' HB2' HG12 ' A' ' 50' ' ' VAL . 19.1 ptp180 -140.5 135.41 31.89 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.777 -0.824 . . . . 72.340000000000003 108.777 175.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -156.46 155.42 32.01 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 120.743 0.306 . . . . 73.010000000000005 111.609 -176.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 14.7 tp -79.87 139.7 37.05 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.035 -0.984 . . . . 64.200000000000003 108.642 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.568 ' O ' ' HB3' ' A' ' 46' ' ' SER . 94.3 mt -95.17 114.09 25.84 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 120.138 -0.625 . . . . 74.120000000000005 109.623 177.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -96.86 -28.87 14.03 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 121.561 0.696 . . . . 75.230000000000004 109.786 177.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -74.77 115.8 47.65 Favored Pre-proline 0 C--N 1.309 -1.157 0 CA-C-N 114.086 -1.416 . . . . 74.329999999999998 109.621 -177.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.467 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 15.2 Cg_endo -57.93 -28.25 82.12 Favored 'Trans proline' 0 C--N 1.363 1.307 0 C-N-CA 123.045 2.497 . . . . 74.010000000000005 112.402 -176.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 90.8 m -136.46 109.86 7.91 Favored 'General case' 0 N--CA 1.418 -2.055 0 N-CA-C 108.874 -0.787 . . . . 62.350000000000001 108.874 174.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 23.4 m -105.64 114.32 28.41 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.296 -1.002 . . . . 73.329999999999998 108.296 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.495 HG22 ' HG2' ' A' ' 91' ' ' GLU . 65.6 p -91.96 133.77 35.4 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 109.802 -0.444 . . . . 71.120000000000005 109.802 -178.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -127.28 133.53 50.15 Favored 'General case' 0 C--O 1.243 0.724 0 O-C-N 122.249 -0.282 . . . . 63.229999999999997 111.118 -179.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 161.41 -105.29 0.26 Allowed Glycine 0 N--CA 1.437 -1.282 0 C-N-CA 119.894 -1.146 . . . . 63.329999999999998 114.044 175.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 66.8 ttt180 -91.19 99.54 12.52 Favored 'General case' 0 N--CA 1.42 -1.938 0 N-CA-C 107.991 -1.114 . . . . 75.549999999999997 107.991 -174.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -12.63 -68.48 0.02 OUTLIER Pre-proline 0 N--CA 1.5 2.056 0 C-N-CA 127.758 2.423 . . . . 73.430000000000007 115.306 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -66.32 -21.9 53.69 Favored 'Trans proline' 0 C--N 1.387 2.563 0 C-N-CA 122.082 1.855 . . . . 64.329999999999998 114.43 -177.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -112.86 18.29 18.29 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.428 0.632 . . . . 71.310000000000002 110.631 -175.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 40.0 m -144.35 165.71 27.14 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.365 -0.976 . . . . 71.409999999999997 108.365 178.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -81.37 -57.13 3.63 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 109.185 -0.672 . . . . 54.520000000000003 109.185 176.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 49.4 pt -106.78 166.94 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 CA-C-O 121.604 0.716 . . . . 71.329999999999998 110.712 177.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -123.27 137.02 54.96 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-N 114.954 -1.021 . . . . 74.450000000000003 109.211 -175.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.541 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 2.5 pt? -114.11 121.79 44.87 Favored 'General case' 0 N--CA 1.406 -2.664 0 N-CA-C 105.933 -1.877 . . . . 54.109999999999999 105.933 170.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -80.72 78.19 7.51 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 122.018 0.913 . . . . 72.230000000000004 110.411 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.462 ' OD2' HG22 ' A' ' 84' ' ' THR . 17.3 t70 -117.58 -167.31 1.3 Allowed 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 114.244 -1.344 . . . . 72.530000000000001 108.252 177.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.41 ' H ' ' CG ' ' A' ' 82' ' ' ASP . 11.0 p -129.65 -19.36 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 CA-C-N 118.241 0.473 . . . . 70.329999999999998 111.225 -177.104 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.462 HG22 ' OD2' ' A' ' 82' ' ' ASP . 12.3 t -99.12 20.99 12.43 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.52 0.676 . . . . 74.310000000000002 110.497 -177.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.7 p -81.24 111.02 17.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 108.607 -0.886 . . . . 71.239999999999995 108.607 178.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.8 m -76.51 -89.83 0.03 OUTLIER 'General case' 0 CA--C 1.562 1.412 0 N-CA-C 113.478 0.918 . . . . 75.140000000000001 113.478 -172.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -84.09 -48.25 10.07 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 106.802 -1.555 . . . . 75.430000000000007 106.802 177.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -162.55 176.42 10.42 Favored 'General case' 0 C--N 1.274 -2.717 0 N-CA-C 100.269 -3.974 . . . . 74.540000000000006 100.269 170.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 21.3 t60 -96.27 -74.18 0.57 Allowed 'General case' 0 C--N 1.276 -2.617 0 C-N-CA 116.443 -2.103 . . . . 62.520000000000003 111.979 -170.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.15 163.66 34.68 Favored 'General case' 0 C--N 1.294 -1.809 0 C-N-CA 120.012 -0.675 . . . . 54.130000000000003 110.474 -174.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.495 ' HG2' HG22 ' A' ' 69' ' ' THR . 52.1 mt-10 -116.21 127.35 54.69 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.624 -0.88 . . . . 75.540000000000006 108.624 175.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -100.51 112.89 25.31 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 107.595 -1.261 . . . . 74.510000000000005 107.595 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 60.0 mtp180 -103.3 112.93 26.03 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 106.89 -1.522 . . . . 62.130000000000003 106.89 -179.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.467 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -120.14 111.43 32.4 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.328 0 N-CA-C 106.954 -1.499 . . . . 74.019999999999996 106.954 -179.756 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -122.33 147.23 46.51 Favored 'General case' 0 N--CA 1.393 -3.302 0 CA-C-N 114.469 -1.241 . . . . 71.25 111.004 176.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.488 ' OE1' ' HA ' ' A' ' 43' ' ' PRO . 0.7 OUTLIER -61.27 -30.35 70.41 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 107.58 -1.267 . . . . 74.109999999999999 107.58 175.572 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -69.58 -61.39 4.45 Favored Glycine 0 N--CA 1.429 -1.824 0 CA-C-N 113.442 -1.708 . . . . 62.0 111.304 175.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -147.2 146.63 29.9 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.962 0.381 . . . . 55.240000000000002 110.972 -179.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -104.39 116.22 31.74 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.002 -0.74 . . . . 74.439999999999998 109.002 -178.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -133.16 135.4 45.12 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 113.503 0.927 . . . . 72.140000000000001 113.503 -177.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.7 p -116.31 119.07 60.83 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.295 0 N-CA-C 108.959 -0.756 . . . . 52.229999999999997 108.959 176.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.6 p -120.84 131.75 72.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 112.591 0.589 . . . . 72.239999999999995 112.591 -177.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -83.06 136.67 34.4 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 108.596 -0.89 . . . . 71.409999999999997 108.596 172.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.6 m -89.57 -16.95 8.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-O 121.189 0.518 . . . . 73.400000000000006 111.872 -176.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 142.28 53.06 0.04 OUTLIER Glycine 0 N--CA 1.424 -2.136 0 N-CA-C 109.746 -1.341 . . . . 51.130000000000003 109.746 -173.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.6 t -154.7 28.6 0.43 Allowed 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 106.462 -1.681 . . . . 53.0 106.462 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 32.9 tp -62.64 -11.52 17.52 Favored 'General case' 0 C--N 1.356 0.882 0 C-N-CA 125.794 1.637 . . . . 72.340000000000003 111.57 -174.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -60.45 -26.76 67.0 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 115.156 -0.929 . . . . 75.530000000000001 109.472 173.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -123.54 3.45 9.45 Favored Glycine 0 N--CA 1.429 -1.785 0 C-N-CA 120.975 -0.631 . . . . 65.109999999999999 113.69 178.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.7 m -102.31 118.69 37.41 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 118.79 1.295 . . . . 63.439999999999998 109.757 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -139.16 137.32 35.98 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.483 -0.562 . . . . 64.530000000000001 109.483 -178.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.2 p -103.14 119.18 51.24 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 106.348 -1.723 . . . . 61.119999999999997 106.348 170.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 18.9 m120 70.63 -78.01 0.05 Allowed 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 108.479 -0.934 . . . . 73.329999999999998 108.479 -171.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -152.31 2.16 0.34 Allowed 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.253 -0.885 . . . . 73.140000000000001 108.862 174.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -101.19 119.01 59.04 Favored Pre-proline 0 N--CA 1.438 -1.033 0 O-C-N 122.022 -0.424 . . . . 75.230000000000004 110.976 -171.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -81.02 90.99 1.17 Allowed 'Trans proline' 0 N--CA 1.43 -2.226 0 C-N-CA 121.777 1.651 . . . . 62.329999999999998 109.538 174.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.03 -94.62 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.662 -0.699 . . . . 73.25 109.594 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 7.4 t30 167.83 -60.44 0.01 OUTLIER 'General case' 0 CA--C 1.489 -1.39 0 N-CA-C 104.431 -2.433 . . . . 70.019999999999996 104.431 175.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -123.91 138.71 54.44 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 106.313 -1.736 . . . . 61.100000000000001 106.313 171.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 55.1 tp60 -140.45 150.52 43.92 Favored 'General case' 0 C--N 1.278 -2.526 0 N-CA-C 109.868 -0.419 . . . . 71.219999999999999 109.868 -176.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 97.4 t -77.89 118.75 25.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 105.485 -2.043 . . . . 75.519999999999996 105.485 171.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 21.1 ttt -75.48 113.21 12.63 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 114.919 -1.037 . . . . 72.140000000000001 108.409 -173.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.4 ' HA ' ' OE1' ' A' ' 123' ' ' GLN . 5.7 tp60 -104.95 139.21 40.0 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.755 -0.657 . . . . 72.230000000000004 111.526 -171.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 3.5 t -79.0 131.99 36.49 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 114.932 -1.031 . . . . 74.299999999999997 110.56 -179.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 97.66 11.05 52.02 Favored Glycine 0 N--CA 1.434 -1.485 0 CA-C-N 115.604 -0.726 . . . . 53.200000000000003 112.14 177.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -124.2 173.1 8.55 Favored 'General case' 0 C--O 1.253 1.284 0 N-CA-C 108.228 -1.027 . . . . 72.530000000000001 108.228 178.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.592 ' OE2' ' HD3' ' A' ' 134' ' ' ARG . 36.9 tt0 -123.82 123.77 41.2 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 121.337 0.589 . . . . 72.030000000000001 109.665 -172.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 67.6 mt -105.18 130.37 56.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 108.645 -0.872 . . . . 73.430000000000007 108.645 -177.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -98.3 118.83 35.84 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 109.142 -0.688 . . . . 63.009999999999998 109.142 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 17.0 pt -120.06 109.04 24.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 CA-C-O 121.915 0.865 . . . . 64.209999999999994 110.002 -177.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 81.98 -124.34 6.43 Favored Glycine 0 N--CA 1.416 -2.666 0 N-CA-C 109.198 -1.561 . . . . 52.539999999999999 109.198 -178.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -102.23 -4.03 26.38 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 108.916 -0.772 . . . . 74.140000000000001 108.916 176.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.508 ' CE2' ' HD2' ' A' ' 55' ' ' PRO . 45.2 m-85 -115.82 -179.96 3.8 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.254 -0.43 . . . . 72.239999999999995 111.599 -172.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.592 ' HD3' ' OE2' ' A' ' 127' ' ' GLU . 10.4 ptp180 -137.86 140.83 40.64 Favored 'General case' 0 C--O 1.247 0.932 0 N-CA-C 113.515 0.932 . . . . 71.310000000000002 113.515 -172.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.44 HD21 HD22 ' A' ' 49' ' ' LEU . 29.5 tp -123.86 133.15 53.83 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.21 -1.359 . . . . 73.25 108.751 -175.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.483 ' HB ' ' CG2' ' A' ' 50' ' ' VAL . 25.7 t -107.81 132.29 55.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 107.689 -1.226 . . . . 74.049999999999997 107.689 178.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -104.18 123.83 48.02 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 120.617 0.246 . . . . 73.129999999999995 110.55 -176.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -126.41 138.58 53.56 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-O 121.809 0.814 . . . . 63.439999999999998 111.462 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -106.53 91.9 3.89 Favored 'General case' 0 C--N 1.278 -2.509 0 N-CA-C 107.163 -1.421 . . . . 53.409999999999997 107.163 172.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -93.63 -127.2 4.58 Favored Glycine 0 CA--C 1.497 -1.039 0 N-CA-C 110.47 -1.052 . . . . 31.239999999999998 110.47 -177.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -65.22 122.2 9.86 Favored 'Trans proline' 0 N--CA 1.445 -1.33 0 C-N-CA 121.588 1.525 . . . . 63.509999999999998 109.031 175.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -75.46 106.92 7.25 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 123.949 0.781 . . . . 55.109999999999999 110.413 -176.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.401 ' O ' ' HB1' ' A' ' 44' ' ' ALA . 51.3 mt-10 . . . . . 0 N--CA 1.396 -3.14 0 CA-C-O 117.936 -1.031 . . . . 65.299999999999997 108.359 176.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 pmm? . . . . . 0 N--CA 1.472 0.666 0 N-CA-C 111.538 0.199 . . . . 62.420000000000002 111.538 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.1 m -67.44 -42.59 82.87 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 107.76 -1.2 . . . . 74.409999999999997 107.76 175.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 51.9 64.21 1.94 Allowed 'General case' 0 C--O 1.239 0.548 0 C-N-CA 124.861 1.265 . . . . 73.530000000000001 113.388 176.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 29.2 t30 -134.46 100.86 4.78 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 114.713 -1.131 . . . . 71.150000000000006 108.715 178.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -81.86 92.13 6.65 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.724 -0.843 . . . . 65.510000000000005 108.724 178.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -107.61 56.21 0.49 Allowed Glycine 0 N--CA 1.429 -1.811 0 C-N-CA 120.806 -0.711 . . . . 52.509999999999998 112.184 -176.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.6 m -92.59 123.21 62.54 Favored Pre-proline 0 C--N 1.303 -1.445 0 N-CA-C 109.239 -0.652 . . . . 61.32 109.239 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -67.07 128.55 18.84 Favored 'Trans proline' 0 C--O 1.243 0.744 0 C-N-CA 122.537 2.158 . . . . 73.310000000000002 111.037 175.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -85.89 144.98 40.17 Favored Pre-proline 0 C--N 1.294 -1.82 0 CA-C-N 116.137 -0.483 . . . . 65.200000000000003 109.942 -179.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -72.85 117.3 5.06 Favored 'Trans proline' 0 N--CA 1.446 -1.3 0 C-N-CA 122.207 1.938 . . . . 62.310000000000002 112.683 -177.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -100.75 136.85 39.96 Favored 'General case' 0 C--N 1.282 -2.364 0 CA-C-N 115.03 -0.986 . . . . 74.340000000000003 108.768 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.1 p -127.37 122.89 60.63 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 CA-C-O 121.72 0.771 . . . . 75.230000000000004 110.809 178.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -122.63 133.17 54.53 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 108.205 -1.035 . . . . 63.539999999999999 108.205 177.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.4 t -163.9 99.66 0.87 Allowed 'General case' 0 N--CA 1.42 -1.958 0 CA-C-O 122.054 0.931 . . . . 71.140000000000001 109.367 -178.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 21.0 m -84.44 79.26 9.63 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 108.532 -0.914 . . . . 53.130000000000003 108.532 178.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.9 p -125.47 84.45 2.28 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 115.108 -0.951 . . . . 73.25 111.53 -176.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 50.4 t -129.64 141.71 45.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 108.024 -1.102 . . . . 62.329999999999998 108.024 -178.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -100.07 78.24 2.07 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.733 0.778 . . . . 71.030000000000001 109.583 175.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 21.7 ttp180 -111.16 8.98 21.88 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 115.146 -0.934 . . . . 74.310000000000002 108.605 -179.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 60.76 33.87 20.01 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 114.984 -1.007 . . . . 61.100000000000001 109.202 -177.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -49.81 -44.49 49.19 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.41 1.884 . . . . 72.219999999999999 110.101 -177.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 56.3 tp -148.47 84.67 1.49 Allowed 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 106.444 -1.687 . . . . 65.120000000000005 106.444 172.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -138.99 101.35 4.27 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.819 -0.808 . . . . 64.510000000000005 108.819 -176.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -105.23 166.75 10.19 Favored 'General case' 0 C--N 1.288 -2.098 0 CA-C-N 115.468 -0.787 . . . . 63.539999999999999 109.076 178.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 67.68 76.72 0.27 Allowed 'General case' 0 C--O 1.237 0.412 0 O-C-N 124.595 1.185 . . . . 70.230000000000004 108.844 -174.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 25.6 ptt? -119.88 154.07 34.91 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.949 -0.76 . . . . 51.329999999999998 108.949 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -69.2 110.57 4.64 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 123.663 0.602 . . . . 64.049999999999997 110.036 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.7 m -141.96 149.82 40.6 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.424 -0.954 . . . . 73.25 108.424 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.525 ' CB ' ' HA ' ' A' ' 61' ' ' PHE . 60.9 p -107.73 127.87 54.06 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 120.967 0.413 . . . . 72.150000000000006 111.211 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.1 m -155.22 100.77 2.18 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.102 -1.444 . . . . 63.299999999999997 107.102 178.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -84.55 173.48 49.58 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 111.442 -0.663 . . . . 61.409999999999997 111.442 -177.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.6 m -108.09 114.63 28.67 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.901 -0.777 . . . . 60.149999999999999 108.901 -179.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.19 117.36 53.67 Favored Pre-proline 0 C--N 1.305 -1.337 0 O-C-N 123.726 0.641 . . . . 75.400000000000006 110.967 -177.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -66.9 132.65 28.92 Favored 'Trans proline' 0 C--O 1.246 0.9 0 C-N-CA 122.648 2.232 . . . . 62.219999999999999 110.451 175.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -79.7 102.87 9.23 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 107.431 -1.322 . . . . 31.210000000000001 107.431 177.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 65.9 m -147.03 155.67 42.41 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-N 116.293 -0.412 . . . . 62.350000000000001 109.906 -175.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 17.7 m -88.11 -8.47 55.41 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.753 -0.832 . . . . 73.099999999999994 108.753 178.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -49.37 113.53 1.78 Allowed Glycine 0 N--CA 1.419 -2.451 0 C-N-CA 125.453 1.501 . . . . 41.32 113.107 176.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.514 ' O ' ' HD3' ' A' ' 43' ' ' PRO . . . -55.89 -24.09 35.18 Favored 'General case' 0 C--N 1.277 -2.569 0 CA-C-N 113.074 -1.563 . . . . 75.219999999999999 113.035 -178.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -66.36 -14.7 62.48 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 122.988 0.515 . . . . 75.140000000000001 112.022 178.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -83.0 -13.55 55.73 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.01 0.433 . . . . 55.0 110.938 176.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -77.74 -50.09 2.0 Favored Pre-proline 0 CA--C 1.57 1.726 0 N-CA-C 113.884 1.068 . . . . 72.409999999999997 113.884 -177.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.514 ' HD3' ' O ' ' A' ' 39' ' ' ALA . 8.0 Cg_exo -73.56 98.02 1.01 Allowed 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 121.657 1.571 . . . . 75.209999999999994 112.348 -178.181 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -87.37 66.97 9.35 Favored 'General case' 0 C--O 1.249 1.047 0 CA-C-O 122.42 1.105 . . . . 55.32 111.302 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -112.61 70.45 0.22 Allowed Glycine 0 CA--C 1.477 -2.294 0 N-CA-C 106.084 -2.806 . . . . 64.510000000000005 106.084 175.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 25.0 m -88.74 163.0 15.93 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-O 121.835 0.826 . . . . 35.229999999999997 112.405 -167.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.509 ' HA ' ' N ' ' A' ' 140' ' ' GLY . . . -129.48 171.14 12.86 Favored 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 107.604 -1.258 . . . . 54.219999999999999 107.604 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.7 pp -133.71 143.87 48.78 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 112.314 0.487 . . . . 64.150000000000006 112.314 -175.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.521 ' H ' HD23 ' A' ' 49' ' ' LEU . 2.4 pt? -109.75 132.01 54.54 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.91 -1.145 . . . . 71.239999999999995 107.91 178.044 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 23.5 t -119.04 126.37 75.3 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 109.111 -0.7 . . . . 75.230000000000004 109.111 -176.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.436 HG22 HD13 ' A' ' 135' ' ' LEU . 15.4 t -92.77 118.35 38.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.761 0 N-CA-C 107.234 -1.395 . . . . 74.340000000000003 107.234 177.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.524 ' HB2' ' HG3' ' A' ' 134' ' ' ARG . 31.8 mmmt -70.68 -38.22 73.72 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 108.72 -0.844 . . . . 75.25 108.72 -179.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.547 ' HE ' ' HA ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -174.3 133.74 0.41 Allowed 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.011 -0.995 . . . . 63.020000000000003 108.805 178.076 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -177.91 158.26 23.15 Favored Glycine 0 N--CA 1.43 -1.715 0 N-CA-C 108.648 -1.781 . . . . 53.109999999999999 108.648 176.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -68.42 -25.47 35.66 Favored 'Trans proline' 0 N--CA 1.48 0.73 0 C-N-CA 122.292 1.995 . . . . 72.209999999999994 110.477 176.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.457 ' CB ' ' HA ' ' A' ' 80' ' ' LEU . 9.7 p30 -58.55 -58.64 7.66 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 113.91 -1.495 . . . . 73.329999999999998 111.9 177.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -162.96 -179.75 6.98 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 108.761 -0.829 . . . . 53.140000000000001 108.761 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -155.31 36.04 0.65 Allowed Glycine 0 C--N 1.3 -1.46 0 N-CA-C 109.97 -1.252 . . . . 71.019999999999996 109.97 178.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -140.04 -171.25 3.14 Favored 'General case' 0 N--CA 1.424 -1.763 0 N-CA-C 108.851 -0.796 . . . . 71.310000000000002 108.851 -175.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 23.7 ptt180 -112.62 146.02 39.35 Favored 'General case' 0 C--N 1.294 -1.839 0 O-C-N 123.578 0.549 . . . . 75.329999999999998 110.577 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.525 ' HA ' ' CB ' ' A' ' 29' ' ' SER . 93.5 m-85 -129.45 131.64 46.78 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.885 -0.598 . . . . 72.349999999999994 109.613 178.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 53.8 tp -90.45 129.38 36.64 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.033 -0.728 . . . . 75.450000000000003 109.033 178.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -79.75 113.84 18.21 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 119.855 -0.738 . . . . 75.120000000000005 110.379 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -112.2 -24.99 9.52 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 122.186 0.994 . . . . 75.409999999999997 108.506 174.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -92.39 127.55 48.25 Favored Pre-proline 0 C--N 1.306 -1.291 0 CA-C-N 114.305 -1.316 . . . . 75.349999999999994 110.171 -174.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.461 ' O ' ' HA ' ' A' ' 93' ' ' ARG . 10.4 Cg_endo -57.78 -41.79 66.21 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 122.852 2.368 . . . . 53.310000000000002 112.783 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 32.0 m -118.34 109.35 16.18 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 109.386 -0.598 . . . . 73.299999999999997 109.386 178.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.418 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 64.1 m -106.32 115.39 30.13 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 115.913 -0.585 . . . . 72.420000000000002 109.594 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.7 m -86.49 120.61 28.0 Favored 'General case' 0 C--O 1.25 1.127 0 CA-C-N 116.184 -0.462 . . . . 74.340000000000003 109.942 -177.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -101.99 112.98 25.82 Favored 'General case' 0 C--O 1.252 1.232 0 CA-C-O 120.88 0.372 . . . . 61.210000000000001 110.445 179.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 170.4 -173.19 44.3 Favored Glycine 0 N--CA 1.426 -1.993 0 N-CA-C 110.07 -1.212 . . . . 52.240000000000002 110.07 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -119.26 95.42 4.8 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 105.808 -1.923 . . . . 64.400000000000006 105.808 178.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 8.7 m80 -134.65 178.26 1.85 Allowed Pre-proline 0 C--N 1.287 -2.127 0 N-CA-C 106.289 -1.745 . . . . 73.109999999999999 106.289 -177.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -64.21 -21.54 67.38 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 121.45 1.434 . . . . 74.519999999999996 109.732 167.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -116.66 78.79 1.24 Allowed 'General case' 0 N--CA 1.434 -1.24 0 C-N-CA 123.958 0.903 . . . . 72.400000000000006 109.754 178.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 74.2 m -104.58 118.45 36.61 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-N 115.467 -0.788 . . . . 70.209999999999994 109.482 172.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -78.01 -43.43 29.5 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 108.694 -0.854 . . . . 75.25 108.694 177.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.8 pp -120.5 166.49 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 N-CA-C 107.786 -1.191 . . . . 53.240000000000002 107.786 171.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -107.53 135.96 48.12 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 115.161 1.541 . . . . 51.119999999999997 115.161 -168.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.457 ' HA ' ' CB ' ' A' ' 56' ' ' ASN . 4.0 mm? -125.08 153.41 42.97 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 104.429 -2.434 . . . . 63.030000000000001 104.429 171.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -144.72 -14.86 0.55 Allowed 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 118.793 -1.163 . . . . 73.019999999999996 112.557 -175.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -72.89 161.49 30.65 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 123.579 0.751 . . . . 71.150000000000006 110.747 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.3 p -77.12 -16.32 14.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-O 122.202 1.001 . . . . 53.0 110.377 -176.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -82.93 11.45 6.11 Favored 'General case' 0 N--CA 1.42 -1.928 0 CA-C-N 114.768 -1.106 . . . . 54.009999999999998 112.973 -179.206 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.0 p -83.3 139.74 17.28 Favored 'Isoleucine or valine' 0 C--O 1.244 0.783 0 CA-C-O 121.068 0.461 . . . . 61.240000000000002 109.833 176.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 28.4 t -105.37 157.11 17.56 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.446 -0.946 . . . . 72.299999999999997 108.446 179.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -69.98 110.69 5.2 Favored 'General case' 0 C--O 1.249 1.035 0 N-CA-C 106.839 -1.541 . . . . 73.209999999999994 106.839 174.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 59.4 mtt180 60.49 78.15 0.29 Allowed 'General case' 0 C--N 1.316 -0.867 0 O-C-N 124.536 1.147 . . . . 70.120000000000005 107.964 -166.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 45.0 t60 -77.29 -43.06 34.54 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 113.554 -1.657 . . . . 74.420000000000002 108.46 -176.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -150.67 159.19 44.69 Favored 'General case' 0 N--CA 1.422 -1.838 0 N-CA-C 107.251 -1.389 . . . . 51.439999999999998 107.251 178.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -136.73 127.86 27.9 Favored 'General case' 0 C--N 1.283 -2.311 0 N-CA-C 107.615 -1.254 . . . . 74.340000000000003 107.615 176.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.418 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 91.9 m-85 -110.28 124.48 51.72 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.955 -0.757 . . . . 60.450000000000003 108.955 -177.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' A' ' 66' ' ' PRO . 42.7 mtp85 -119.09 138.18 53.06 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-O 121.317 0.58 . . . . 64.439999999999998 112.449 175.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.466 ' O ' HD12 ' A' ' 94' ' ' ILE . 2.8 pp -116.02 116.47 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.152 0 N-CA-C 106.664 -1.606 . . . . 64.430000000000007 106.664 173.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -118.68 147.49 43.74 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 115.452 -0.794 . . . . 72.040000000000006 110.666 -173.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -45.82 -32.22 2.48 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.896 1.278 . . . . 72.409999999999997 112.385 178.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -78.72 -59.19 2.87 Favored Glycine 0 N--CA 1.436 -1.355 0 N-CA-C 111.488 -0.645 . . . . 74.150000000000006 111.488 175.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -158.28 173.77 16.18 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 123.777 0.831 . . . . 61.240000000000002 109.304 -175.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -102.68 134.73 45.57 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.068 -1.086 . . . . 65.430000000000007 108.068 -178.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -132.31 135.73 46.41 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 114.117 1.154 . . . . 74.329999999999998 114.117 -177.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 6.9 p -110.98 127.62 67.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 CA-C-N 114.532 -1.213 . . . . 72.140000000000001 107.973 177.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.6 p -119.09 130.3 74.04 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 C-N-CA 120.347 -0.541 . . . . 73.540000000000006 111.779 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -81.37 106.22 13.17 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 105.533 -2.025 . . . . 63.210000000000001 105.533 174.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.6 m -104.35 13.86 7.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 112.761 0.652 . . . . 44.240000000000002 112.761 -175.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 114.02 73.82 0.61 Allowed Glycine 0 CA--C 1.489 -1.544 0 C-N-CA 120.537 -0.84 . . . . 53.240000000000002 111.239 178.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 14.0 p -91.76 138.23 31.72 Favored 'General case' 0 N--CA 1.416 -2.154 0 CA-C-N 115.337 -0.432 . . . . 52.140000000000001 110.218 -177.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 5.8 tt -82.75 -47.55 11.83 Favored 'General case' 0 C--N 1.315 -0.935 0 N-CA-C 108.016 -1.105 . . . . 40.219999999999999 108.016 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.463 ' OD1' ' HA3' ' A' ' 131' ' ' GLY . 11.6 t-20 -68.42 -32.64 72.82 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.679 -0.691 . . . . 72.299999999999997 109.901 179.207 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.428 ' O ' ' HA ' ' A' ' 130' ' ' ILE . . . 112.53 131.68 5.63 Favored Glycine 0 C--O 1.223 -0.573 0 CA-C-N 116.093 -0.503 . . . . 24.210000000000001 112.233 179.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -109.16 122.03 46.43 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 123.389 0.676 . . . . 54.100000000000001 109.717 176.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -123.76 133.06 53.91 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 108.616 -0.883 . . . . 51.240000000000002 108.616 178.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 45.4 t -121.35 117.45 52.77 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 N-CA-C 106.128 -1.804 . . . . 64.219999999999999 106.128 177.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.495 ' HB2' HH21 ' A' ' 117' ' ' ARG . 20.3 m120 66.88 24.74 9.66 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 108.556 -0.905 . . . . 65.340000000000003 108.556 -172.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.528 ' HG2' ' OE1' ' A' ' 129' ' ' GLN . 96.2 mtt180 75.77 2.84 3.77 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 126.001 1.72 . . . . 63.149999999999999 112.833 -178.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 55.0 mm-40 -104.97 129.49 24.75 Favored Pre-proline 0 C--N 1.311 -1.071 0 N-CA-C 109.11 -0.7 . . . . 72.329999999999998 109.11 178.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -71.56 124.76 10.57 Favored 'Trans proline' 0 C--O 1.247 0.957 0 C-N-CA 122.116 1.878 . . . . 60.0 108.881 174.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.495 HH21 ' HB2' ' A' ' 113' ' ' ASN . 47.4 mtt180 -119.98 -158.78 0.75 Allowed 'General case' 0 C--N 1.31 -1.113 0 O-C-N 121.951 -0.468 . . . . 73.209999999999994 111.24 -172.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -121.74 -45.24 2.29 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 108.104 -1.073 . . . . 71.349999999999994 108.104 174.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -156.7 138.87 14.61 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 107.28 -1.378 . . . . 60.200000000000003 107.28 171.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 53.8 tp60 -141.73 150.85 42.33 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 110.437 -0.209 . . . . 74.439999999999998 110.437 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 78.7 t -78.87 127.96 38.7 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 107.24 -1.393 . . . . 71.239999999999995 107.24 174.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 82.0 mtp -71.68 120.02 16.67 Favored 'General case' 0 CA--C 1.497 -1.085 0 CA-C-N 115.757 -0.656 . . . . 60.210000000000001 109.28 -175.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 14.2 tp60 -105.39 130.17 53.55 Favored 'General case' 0 N--CA 1.415 -2.182 0 N-CA-C 108.362 -0.977 . . . . 62.229999999999997 108.362 -177.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 18.9 p -78.35 123.54 27.1 Favored 'General case' 0 N--CA 1.424 -1.769 0 CA-C-O 121.1 0.476 . . . . 71.349999999999994 110.606 -177.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 123.62 -17.61 7.77 Favored Glycine 0 N--CA 1.416 -2.664 0 CA-C-N 115.432 -0.803 . . . . 63.140000000000001 111.791 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -104.32 -169.73 1.67 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 120.133 -0.627 . . . . 63.439999999999998 110.941 -176.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -136.97 136.11 38.25 Favored 'General case' 0 C--O 1.25 1.123 0 CA-C-O 121.829 0.823 . . . . 75.120000000000005 112.141 -171.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 74.4 mt -110.29 130.59 63.29 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 C-N-CA 125.418 1.487 . . . . 64.109999999999999 107.926 -179.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.528 ' OE1' ' HG2' ' A' ' 114' ' ' ARG . 52.0 mt-30 -109.74 133.46 53.11 Favored 'General case' 0 C--N 1.29 -2.02 0 C-N-CA 120.347 -0.541 . . . . 72.329999999999998 110.713 -178.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.528 ' H ' HD13 ' A' ' 130' ' ' ILE . 0.2 OUTLIER -107.44 97.71 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.963 0 N-CA-C 106.783 -1.562 . . . . 53.32 106.783 171.859 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.463 ' HA3' ' OD1' ' A' ' 108' ' ' ASN . . . 70.78 -115.25 5.77 Favored Glycine 0 N--CA 1.427 -1.95 0 N-CA-C 108.81 -1.716 . . . . 41.219999999999999 108.81 -170.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -112.3 2.31 16.48 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.074 0.464 . . . . 52.240000000000002 110.689 176.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -85.78 140.19 30.68 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 106.402 -1.703 . . . . 72.329999999999998 106.402 177.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.524 ' HG3' ' HB2' ' A' ' 52' ' ' LYS . 15.3 ptm180 -116.75 131.63 56.9 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.043 -1.063 . . . . 74.540000000000006 113.856 -168.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.488 HD21 HD12 ' A' ' 49' ' ' LEU . 34.3 tp -122.58 121.5 36.63 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 114.032 -1.44 . . . . 74.420000000000002 108.715 -177.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 10.7 p -106.66 137.54 36.75 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.15 0 N-CA-C 108.863 -0.791 . . . . 74.319999999999993 108.863 -178.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -114.33 115.67 27.74 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 110.293 -0.262 . . . . 70.010000000000005 110.293 -173.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -121.47 163.62 18.5 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 109.065 -0.717 . . . . 74.329999999999998 109.065 -178.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -75.3 147.03 40.53 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 109.461 -0.57 . . . . 61.310000000000002 109.461 177.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.509 ' N ' ' HA ' ' A' ' 47' ' ' ALA . . . -104.39 -149.88 20.22 Favored Glycine 0 N--CA 1.426 -2.013 0 C-N-CA 120.551 -0.833 . . . . 72.010000000000005 111.403 -176.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -95.76 164.76 1.4 Allowed 'Trans proline' 0 N--CA 1.427 -2.391 0 C-N-CA 122.529 2.152 . . . . 62.509999999999998 112.693 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -92.91 112.6 24.61 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 106.77 -1.567 . . . . 75.450000000000003 106.77 174.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 . . . . . 0 N--CA 1.426 -1.643 0 CA-C-O 118.557 -0.735 . . . . 70.530000000000001 109.46 -175.609 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 CA--C 1.508 -0.647 0 N-CA-C 109.283 -0.636 . . . . 51.130000000000003 109.283 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.4 m -69.19 -47.67 64.24 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.649 -0.5 . . . . 64.409999999999997 109.649 179.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.7 t70 67.03 174.2 0.25 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.333 1.453 . . . . 72.230000000000004 110.604 178.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -130.16 -5.35 4.39 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 121.705 -0.622 . . . . 71.219999999999999 110.715 -178.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 58.6 t30 61.81 95.29 0.04 OUTLIER 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.911 1.284 . . . . 71.109999999999999 109.816 -174.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -56.63 100.03 0.1 Allowed Glycine 0 CA--C 1.506 -0.484 0 O-C-N 123.679 0.612 . . . . 64.120000000000005 112.965 -178.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.7 m -119.05 130.95 24.56 Favored Pre-proline 0 C--N 1.304 -1.375 0 N-CA-C 109.438 -0.579 . . . . 75.040000000000006 109.438 -176.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.91 127.38 16.85 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 121.667 1.578 . . . . 72.209999999999994 110.13 175.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -97.12 113.99 63.98 Favored Pre-proline 0 C--N 1.301 -1.518 0 N-CA-C 109.053 -0.721 . . . . 72.129999999999995 109.053 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -62.26 136.32 59.29 Favored 'Trans proline' 0 C--O 1.237 0.457 0 C-N-CA 123.342 2.694 . . . . 74.329999999999998 113.867 -173.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.0 tm0? -126.95 109.26 11.75 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 107.145 -1.428 . . . . 70.140000000000001 107.145 178.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.7 p -94.14 132.91 36.9 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 109.297 -0.631 . . . . 70.219999999999999 109.297 178.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -114.43 139.25 49.66 Favored 'General case' 0 N--CA 1.424 -1.727 0 N-CA-C 109.083 -0.71 . . . . 74.340000000000003 109.083 -178.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.0 m -100.86 118.41 36.87 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.735 -0.839 . . . . 74.129999999999995 108.735 -177.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 40.0 p -116.17 103.83 10.92 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 121.352 0.596 . . . . 73.109999999999999 111.843 -178.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.6 p -112.42 138.77 48.68 Favored 'General case' 0 N--CA 1.42 -1.932 0 N-CA-C 107.42 -1.326 . . . . 61.130000000000003 107.42 176.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.1 m -120.76 135.56 60.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 CA-C-O 121.372 0.606 . . . . 74.099999999999994 111.9 -177.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -155.54 135.88 13.17 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 106.401 -1.703 . . . . 63.32 106.401 177.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.32 -164.44 1.02 Allowed 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.867 -0.79 . . . . 73.239999999999995 108.867 -173.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.84 80.83 8.04 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 106.188 -1.782 . . . . 74.409999999999997 106.188 170.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -91.15 -2.35 57.56 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 114.439 -1.255 . . . . 73.230000000000004 113.997 -171.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 58.2 tp -93.08 99.63 12.2 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 119.938 -0.705 . . . . 74.540000000000006 111.416 179.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 53.5 tp -97.08 145.54 25.88 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 108.084 -1.08 . . . . 72.450000000000003 108.084 176.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.99 177.24 8.5 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.961 -0.755 . . . . 75.25 108.961 -178.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.73 -177.53 4.47 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.558 -0.534 . . . . 64.430000000000007 109.558 179.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.31 157.64 28.77 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.846 -1.168 . . . . 71.230000000000004 107.846 177.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -92.45 174.6 7.2 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 121.262 0.554 . . . . 71.530000000000001 111.473 177.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.9 m -107.28 -176.71 3.15 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 106.753 -1.573 . . . . 72.219999999999999 106.753 177.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.6 t -126.33 139.36 53.35 Favored 'General case' 0 N--CA 1.428 -1.543 0 C-N-CA 120.181 -0.608 . . . . 73.439999999999998 109.549 -178.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.2 t -132.89 128.17 35.99 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.652 -0.87 . . . . 74.230000000000004 108.652 177.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -123.01 114.11 2.33 Favored Glycine 0 N--CA 1.435 -1.375 0 N-CA-C 111.419 -0.673 . . . . 22.34 111.419 -177.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.9 p -67.87 154.81 40.76 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 123.243 0.617 . . . . 73.430000000000007 112.294 -177.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -83.87 130.9 53.4 Favored Pre-proline 0 C--N 1.312 -1.061 0 CA-C-N 116.139 -0.482 . . . . 75.299999999999997 109.918 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -75.94 109.05 2.82 Favored 'Trans proline' 0 N--CA 1.443 -1.442 0 C-N-CA 122.162 1.908 . . . . 54.32 110.543 176.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -102.8 116.99 33.66 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.623 -0.717 . . . . 65.129999999999995 109.367 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.0 t -138.1 124.62 20.77 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.029 0.442 . . . . 65.019999999999996 109.88 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.509 ' O ' ' HG2' ' A' ' 40' ' ' GLU . 91.0 m -127.65 158.25 38.07 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.099 -1.075 . . . . 41.509999999999998 108.099 179.181 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -81.32 -48.47 5.96 Favored Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 119.83 -1.176 . . . . 53.140000000000001 110.978 177.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -56.11 -19.76 14.56 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 124.526 1.13 . . . . 75.549999999999997 113.856 -178.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.509 ' HG2' ' O ' ' A' ' 37' ' ' THR . 11.6 pt-20 -65.67 -29.34 69.88 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.705 0.631 . . . . 64.340000000000003 112.705 -175.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -83.07 -16.47 46.82 Favored 'General case' 0 CA--C 1.505 -0.773 0 C-N-CA 119.183 -1.007 . . . . 74.340000000000003 110.004 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 tm? 75.92 104.97 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 125.723 1.609 . . . . 74.329999999999998 110.371 -179.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -79.96 173.03 13.23 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.779 2.319 . . . . 73.049999999999997 112.721 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -140.1 -167.46 2.31 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.75 -0.463 . . . . 75.25 109.75 -177.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -82.21 -12.48 80.7 Favored Glycine 0 CA--C 1.508 -0.376 0 N-CA-C 111.446 -0.662 . . . . 71.409999999999997 111.446 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.402 ' HB2' ' O ' ' A' ' 141' ' ' PRO . 15.5 m -112.32 153.82 26.64 Favored 'General case' 0 N--CA 1.424 -1.761 0 N-CA-C 108.707 -0.849 . . . . 75.140000000000001 108.707 177.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.439 ' O ' ' HG ' ' A' ' 62' ' ' LEU . . . -153.43 146.4 24.51 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 108.756 -0.831 . . . . 51.100000000000001 108.756 -178.062 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.43 ' HA ' ' HA ' ' A' ' 62' ' ' LEU . 2.4 pt? -130.23 160.12 34.8 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 109.484 -0.561 . . . . 72.120000000000005 109.484 -178.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.423 HD11 ' CZ ' ' A' ' 61' ' ' PHE . 3.7 pp -133.93 147.77 51.12 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 116.349 -0.387 . . . . 64.430000000000007 110.672 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.555 HG12 ' HB3' ' A' ' 60' ' ' ARG . 27.9 m -117.03 129.24 73.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 108.961 -0.755 . . . . 53.219999999999999 108.961 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.5 t -97.79 118.79 44.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 N-CA-C 107.754 -1.202 . . . . 45.130000000000003 107.754 176.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -110.81 -13.56 14.13 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.827 -0.624 . . . . 74.340000000000003 112.626 -173.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 16.6 tpp180 -150.1 125.94 10.45 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.86 -0.793 . . . . 71.129999999999995 108.86 176.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 139.9 135.76 3.28 Favored Glycine 0 C--O 1.206 -1.622 0 C-N-CA 120.722 -0.751 . . . . 54.539999999999999 112.472 176.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.543 ' HD2' ' CE1' ' A' ' 133' ' ' PHE . 39.2 Cg_exo -67.71 -8.66 23.06 Favored 'Trans proline' 0 N--CA 1.484 0.939 0 C-N-CA 123.134 2.556 . . . . 75.430000000000007 112.951 174.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -66.02 -40.13 90.81 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.203 -0.453 . . . . 73.540000000000006 110.667 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -169.26 173.56 6.61 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 109.252 -0.647 . . . . 63.310000000000002 109.252 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.93 43.61 0.41 Allowed Glycine 0 CA--C 1.487 -1.707 0 N-CA-C 108.997 -1.641 . . . . 44.200000000000003 108.997 178.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -147.15 -173.18 4.18 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.722 -0.844 . . . . 70.329999999999998 108.722 -174.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.555 ' HB3' HG12 ' A' ' 50' ' ' VAL . 14.1 ptt180 -121.69 141.48 51.11 Favored 'General case' 0 N--CA 1.434 -1.233 0 O-C-N 123.687 0.617 . . . . 73.409999999999997 110.116 179.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.423 ' CZ ' HD11 ' A' ' 49' ' ' LEU . 52.6 p90 -149.39 152.45 35.77 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 109.042 -0.725 . . . . 74.099999999999994 109.042 175.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 47' ' ' ALA . 9.2 tt -99.43 140.51 33.51 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 123.622 0.576 . . . . 63.229999999999997 109.621 -176.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 84.3 mt -81.13 114.26 19.85 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 121.279 0.562 . . . . 62.399999999999999 110.955 -176.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -122.25 -36.78 2.91 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.253 -1.017 . . . . 74.129999999999995 108.253 174.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.5 pm0 -64.46 130.18 94.54 Favored Pre-proline 0 N--CA 1.436 -1.148 0 CA-C-N 114.965 -1.016 . . . . 74.219999999999999 110.031 175.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.504 ' HA ' HG12 ' A' ' 94' ' ' ILE . 19.5 Cg_endo -60.47 -30.64 91.22 Favored 'Trans proline' 0 N--CA 1.479 0.663 0 C-N-CA 123.846 3.031 . . . . 75.120000000000005 113.477 -173.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 90.0 m -135.92 116.14 13.47 Favored 'General case' 0 N--CA 1.416 -2.158 0 CA-C-N 115.929 -0.578 . . . . 75.219999999999999 109.801 178.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.481 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 11.9 m -100.65 115.36 30.02 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 106.717 -1.586 . . . . 72.420000000000002 106.717 176.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.7 p -96.82 108.8 21.54 Favored 'General case' 0 N--CA 1.425 -1.679 0 CA-C-O 121.414 0.626 . . . . 72.430000000000007 112.169 -176.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.416 ' O ' ' HB3' ' A' ' 89' ' ' HIS . . . -102.32 92.55 4.76 Favored 'General case' 0 N--CA 1.425 -1.71 0 N-CA-C 107.836 -1.172 . . . . 71.540000000000006 107.836 174.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.587 ' O ' ' HA ' ' A' ' 88' ' ' ARG . . . 99.97 102.01 2.42 Favored Glycine 0 N--CA 1.428 -1.871 0 N-CA-C 110.5 -1.04 . . . . 42.100000000000001 110.5 -178.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.3 mmt85 -155.14 -61.1 0.11 Allowed 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 124.866 1.266 . . . . 72.420000000000002 108.488 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.465 ' HB3' ' HD2' ' A' ' 74' ' ' PRO . 94.4 m-70 -146.2 177.21 1.85 Allowed Pre-proline 0 C--N 1.295 -1.786 0 N-CA-C 106.751 -1.574 . . . . 63.420000000000002 106.751 -178.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 73' ' ' HIS . 6.3 Cg_endo -54.24 -30.69 62.97 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 121.88 1.72 . . . . 74.439999999999998 110.508 170.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -107.79 72.58 0.86 Allowed 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 115.16 -0.927 . . . . 63.140000000000001 109.678 178.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.444 ' HB2' ' O ' ' A' ' 78' ' ' ILE . 41.5 m -91.01 -174.82 4.13 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.502 -1.296 . . . . 64.120000000000005 107.502 173.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -60.9 -44.33 97.29 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 108.32 -0.992 . . . . 72.340000000000003 108.32 177.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.444 ' O ' ' HB2' ' A' ' 76' ' ' SER . 36.8 pt -128.02 143.59 40.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 105.582 -2.007 . . . . 63.210000000000001 105.582 170.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -99.48 126.45 45.41 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 118.568 -1.253 . . . . 75.219999999999999 112.113 -175.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.5 mp -85.46 89.6 7.74 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 106.361 -1.718 . . . . 74.310000000000002 106.361 175.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -45.27 -58.73 3.07 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.552 -1.204 . . . . 74.010000000000005 113.542 -173.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -162.84 -167.05 1.42 Allowed 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 106.69 -1.596 . . . . 54.219999999999999 106.69 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 83.2 t 74.3 -41.95 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.246 1.418 . . . . 72.349999999999994 112.58 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.541 ' HB ' ' CZ ' ' A' ' 133' ' ' PHE . 56.6 m -154.04 71.96 0.87 Allowed 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.358 0.599 . . . . 54.109999999999999 110.331 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.3 p -114.45 109.03 27.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 O-C-N 121.617 -0.677 . . . . 75.420000000000002 112.401 176.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 36.0 t -97.74 170.29 9.09 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.699 -0.852 . . . . 73.430000000000007 108.699 174.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 60.0 ttt180 -78.39 -8.23 58.23 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 122.952 1.358 . . . . 72.299999999999997 109.381 -179.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.587 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -170.61 125.65 0.72 Allowed 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 104.154 -2.536 . . . . 72.150000000000006 104.154 173.047 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.416 ' HB3' ' O ' ' A' ' 70' ' ' ALA . 11.7 t60 -128.46 -76.97 0.56 Allowed 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 118.939 -1.105 . . . . 74.519999999999996 112.914 -172.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -127.7 119.26 25.44 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-O 121.272 0.558 . . . . 72.129999999999995 109.605 -176.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -114.03 128.01 56.2 Favored 'General case' 0 C--N 1.276 -2.594 0 C-N-CA 120.02 -0.672 . . . . 62.219999999999999 110.439 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.481 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 56.2 m-85 -97.41 121.21 39.05 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 107.991 -1.114 . . . . 65.409999999999997 107.991 -178.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 34.3 mmt-85 -104.91 129.13 53.36 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.437 -0.949 . . . . 71.219999999999999 108.437 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.504 HG12 ' HA ' ' A' ' 66' ' ' PRO . 11.4 pt -115.88 130.96 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.201 0 C-N-CA 118.504 -1.279 . . . . 72.030000000000001 108.022 173.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.437 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 56.0 t-20 -120.03 145.47 46.79 Favored 'General case' 0 C--N 1.269 -2.93 0 N-CA-C 106.547 -1.649 . . . . 74.109999999999999 106.547 -175.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -59.7 -20.27 55.26 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-O 121.357 0.598 . . . . 64.530000000000001 110.267 174.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -77.61 -61.81 2.52 Favored Glycine 0 N--CA 1.423 -2.172 0 CA-C-N 115.488 -0.778 . . . . 63.549999999999997 111.604 174.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.437 ' O ' ' HB3' ' A' ' 95' ' ' ASN . 27.3 tt0 -157.4 -178.11 7.1 Favored 'General case' 0 CA--C 1.552 1.023 0 CA-C-N 117.475 0.637 . . . . 74.0 109.346 -176.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.638 ' HB3' ' SD ' ' A' ' 122' ' ' MET . 81.5 m-85 -109.71 130.05 55.55 Favored 'General case' 0 C--N 1.311 -1.091 0 O-C-N 121.963 -0.46 . . . . 72.099999999999994 110.52 -176.183 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -132.53 135.84 46.23 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-O 120.633 0.254 . . . . 74.400000000000006 111.464 -175.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 8.9 p -114.56 129.62 70.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 O-C-N 121.845 -0.534 . . . . 33.32 110.073 176.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 59.4 t -118.92 128.97 75.72 Favored 'Isoleucine or valine' 0 C--O 1.248 0.98 0 CA-C-N 116.313 -0.403 . . . . 75.25 111.321 -177.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -83.95 117.96 23.7 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.637 -0.71 . . . . 62.219999999999999 109.215 173.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.423 ' O ' ' HG2' ' A' ' 88' ' ' ARG . 17.8 m -118.2 8.0 6.9 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.35 0 N-CA-C 108.258 -1.016 . . . . 73.239999999999995 108.258 176.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.448 ' HA2' ' O ' ' A' ' 88' ' ' ARG . . . -91.2 -66.15 1.16 Allowed Glycine 0 N--CA 1.404 -3.446 0 CA-C-N 114.578 -1.192 . . . . 63.340000000000003 111.091 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 14.0 m 60.07 1.46 0.34 Allowed 'General case' 0 CA--C 1.566 1.573 0 C-N-CA 124.252 1.021 . . . . 62.409999999999997 112.282 -179.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 49.1 tp -72.98 -50.82 21.01 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.099 0.959 . . . . 70.310000000000002 109.656 -177.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -99.23 -35.44 9.97 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.114 -0.948 . . . . 64.230000000000004 109.397 176.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 104.05 133.84 7.98 Favored Glycine 0 N--CA 1.427 -1.964 0 N-CA-C 110.584 -1.006 . . . . 33.32 110.584 -178.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 97.7 m -101.87 119.62 39.08 Favored 'General case' 0 C--N 1.281 -2.374 0 N-CA-C 108.847 -0.797 . . . . 75.099999999999994 108.847 178.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 116' ' ' PRO . 3.9 m-85 -111.32 132.48 54.36 Favored 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 106.487 -1.671 . . . . 73.510000000000005 106.487 -177.229 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.471 HG11 ' HG3' ' A' ' 120' ' ' GLN . 7.7 p -131.16 131.92 63.51 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.776 0 C-N-CA 119.953 -0.699 . . . . 73.140000000000001 110.696 178.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 66.56 -72.46 0.08 Allowed 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 125.506 1.523 . . . . 73.010000000000005 110.841 -177.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 114' ' ' ARG . 6.7 tpt180 -154.59 4.26 0.24 Allowed 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.902 -0.59 . . . . 61.109999999999999 109.489 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.432 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . 43.8 mt-10 -132.98 134.72 24.78 Favored Pre-proline 0 C--O 1.237 0.43 0 O-C-N 121.319 -0.863 . . . . 64.400000000000006 112.487 -174.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 115' ' ' GLU . 2.9 Cg_exo -77.23 116.01 4.07 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 122.332 2.021 . . . . 52.240000000000002 108.702 170.144 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.45 HH11 ' HG3' ' A' ' 120' ' ' GLN . 7.0 ptp180 -144.06 151.41 39.61 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.112 -1.07 . . . . 74.239999999999995 108.112 -178.299 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -76.22 -42.19 46.86 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 112.529 0.566 . . . . 74.349999999999994 112.529 -174.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -125.84 140.61 52.52 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 109.331 -0.618 . . . . 75.540000000000006 109.331 179.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.471 ' HG3' HG11 ' A' ' 112' ' ' VAL . 1.6 tm0? -138.94 149.85 45.23 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 116.41 -0.359 . . . . 71.420000000000002 110.561 -178.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 81.1 t -104.5 117.68 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 N-CA-C 105.743 -1.947 . . . . 75.319999999999993 105.743 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.638 ' SD ' ' HB3' ' A' ' 99' ' ' PHE . 66.7 mtt -59.86 128.67 38.04 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 113.87 1.063 . . . . 65.120000000000005 113.87 -169.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -112.07 137.73 49.71 Favored 'General case' 0 N--CA 1.418 -2.044 0 N-CA-C 107.079 -1.452 . . . . 74.329999999999998 107.079 178.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.489 ' HB ' ' HB3' ' A' ' 139' ' ' ALA . 1.8 t -79.37 129.76 34.78 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-O 121.368 0.604 . . . . 60.420000000000002 110.826 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 83.79 38.21 10.79 Favored Glycine 0 N--CA 1.424 -2.118 0 N-CA-C 110.014 -1.234 . . . . 71.109999999999999 110.014 -178.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -125.25 166.81 15.82 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.722 -0.391 . . . . 73.349999999999994 110.985 -177.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 19.1 tp10 -107.47 120.56 42.51 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 123.405 0.682 . . . . 75.030000000000001 109.181 -172.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 61.6 mt -114.96 117.6 56.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 108.006 -1.109 . . . . 72.019999999999996 108.006 179.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -116.49 111.8 20.49 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.255 0.55 . . . . 73.209999999999994 109.787 -175.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.413 HG13 ' HB2' ' A' ' 133' ' ' PHE . 25.6 pt -101.71 98.36 6.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-O 121.83 0.824 . . . . 74.239999999999995 109.384 179.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 70.36 -100.09 0.78 Allowed Glycine 0 N--CA 1.435 -1.386 0 N-CA-C 110.384 -1.087 . . . . 63.32 110.384 -175.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -115.18 0.35 13.53 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 120.938 0.399 . . . . 75.019999999999996 110.603 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.543 ' CE1' ' HD2' ' A' ' 55' ' ' PRO . 9.7 m-30 -93.27 141.15 28.76 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.035 -0.728 . . . . 72.510000000000005 109.035 -176.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 41.0 mtm180 -121.81 122.55 39.73 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.889 0.852 . . . . 74.329999999999998 111.193 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.8 tt -124.72 131.1 53.48 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 113.744 -1.571 . . . . 70.200000000000003 108.77 -176.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 57.5 t -108.09 128.41 63.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 108.697 -0.853 . . . . 73.120000000000005 108.697 178.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -100.78 130.05 46.75 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.953 -0.567 . . . . 73.230000000000004 110.438 -176.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.4 mp -130.66 130.45 43.93 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.692 -0.484 . . . . 74.120000000000005 109.692 179.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.489 ' HB3' ' HB ' ' A' ' 124' ' ' THR . . . -122.38 117.67 26.6 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 108.07 -1.085 . . . . 73.209999999999994 108.07 177.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -174.04 -60.11 0.05 OUTLIER Glycine 0 C--N 1.294 -1.786 0 C-N-CA 120.125 -1.036 . . . . 73.319999999999993 112.673 -176.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.402 ' O ' ' HB2' ' A' ' 46' ' ' SER . 33.2 Cg_exo -61.88 123.36 12.47 Favored 'Trans proline' 0 C--N 1.358 1.045 0 C-N-CA 121.917 1.744 . . . . 63.299999999999997 110.895 176.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -96.88 109.5 22.2 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 115.304 -0.862 . . . . 55.130000000000003 111.065 -175.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 . . . . . 0 N--CA 1.408 -2.542 0 N-CA-C 108.16 -1.052 . . . . 64.239999999999995 108.16 177.123 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ptt? . . . . . 0 C--O 1.237 0.431 0 CA-C-O 122.09 0.948 . . . . 71.140000000000001 110.527 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.9 t -82.24 -49.15 10.42 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 115.278 -0.874 . . . . 74.349999999999994 111.974 -174.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -107.29 139.03 42.39 Favored 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 120.675 -0.41 . . . . 75.129999999999995 109.908 -176.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -95.58 120.05 35.14 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.3 0.571 . . . . 50.039999999999999 111.928 -176.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -118.03 145.49 44.74 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.277 -1.379 . . . . 74.0 107.277 175.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 93.11 45.65 3.51 Favored Glycine 0 N--CA 1.431 -1.682 0 N-CA-C 109.631 -1.388 . . . . 73.049999999999997 109.631 -175.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 55.9 m -92.28 122.91 63.86 Favored Pre-proline 0 N--CA 1.416 -2.141 0 N-CA-C 107.833 -1.173 . . . . 73.510000000000005 107.833 178.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.56 128.95 19.02 Favored 'Trans proline' 0 N--CA 1.448 -1.205 0 C-N-CA 122.211 1.941 . . . . 71.030000000000001 111.272 177.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -73.67 109.73 7.32 Favored Pre-proline 0 C--N 1.315 -0.9 0 N-CA-C 107.168 -1.419 . . . . 71.019999999999996 107.168 173.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -73.24 132.84 18.48 Favored 'Trans proline' 0 N--CA 1.443 -1.465 0 C-N-CA 122.186 1.924 . . . . 73.439999999999998 113.016 -171.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -110.27 116.73 32.0 Favored 'General case' 0 N--CA 1.422 -1.837 0 CA-C-N 115.573 -0.74 . . . . 64.340000000000003 109.323 175.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.9 p -86.01 88.84 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.519 0 CA-C-O 122.542 1.163 . . . . 72.439999999999998 110.062 178.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -125.52 120.35 30.66 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 106.667 -1.605 . . . . 55.409999999999997 106.667 178.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.5 m -113.4 98.98 7.43 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-O 121.321 0.581 . . . . 60.450000000000003 111.281 -175.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.5 m -105.85 -11.58 16.18 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 122.557 1.17 . . . . 74.150000000000006 108.459 175.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.2 t -83.26 91.83 7.36 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 114.218 -1.355 . . . . 74.519999999999996 108.24 176.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 59.8 t -134.41 130.51 53.98 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 N-CA-C 107.721 -1.215 . . . . 65.430000000000007 107.721 -178.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -127.92 144.63 51.1 Favored 'General case' 0 N--CA 1.424 -1.753 0 C-N-CA 119.826 -0.75 . . . . 71.030000000000001 111.445 179.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 85.1 mtt180 -100.0 41.62 1.15 Allowed 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.384 -1.339 . . . . 74.140000000000001 107.384 -177.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 69.49 18.77 7.73 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.784 1.234 . . . . 73.150000000000006 110.234 -174.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -49.85 -49.23 49.9 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.704 1.202 . . . . 74.349999999999994 111.941 -178.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.529 HD23 ' H ' ' A' ' 22' ' ' LEU . 1.7 pt? -111.11 27.38 9.73 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.384 0.611 . . . . 62.049999999999997 111.033 -177.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.6 tt -110.27 97.07 6.63 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 107.447 -1.316 . . . . 75.420000000000002 107.447 178.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.522 ' HG3' ' H ' ' A' ' 25' ' ' GLU . 0.1 OUTLIER -128.83 -71.68 0.63 Allowed 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.832 -0.622 . . . . 74.099999999999994 112.349 -177.501 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.522 ' H ' ' HG3' ' A' ' 24' ' ' LYS . 39.4 mt-10 -126.9 90.33 3.14 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.918 -0.771 . . . . 71.150000000000006 108.918 -177.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 70.6 mtm -93.07 133.06 36.62 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 116.269 -0.423 . . . . 72.450000000000003 111.025 -177.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -78.77 103.99 9.08 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.415 -0.811 . . . . 65.200000000000003 109.642 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.3 p -79.66 89.22 5.14 Favored 'General case' 0 N--CA 1.423 -1.809 0 CA-C-N 115.67 -0.695 . . . . 71.099999999999994 110.663 179.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 29.6 t 69.88 96.34 0.07 Allowed 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 114.908 -1.042 . . . . 73.400000000000006 110.219 -177.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.1 t -120.19 127.62 52.62 Favored 'General case' 0 N--CA 1.424 -1.743 0 N-CA-C 109.045 -0.724 . . . . 61.530000000000001 109.045 177.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -152.45 -141.28 3.27 Favored Glycine 0 N--CA 1.416 -2.637 0 N-CA-C 111.012 -0.835 . . . . 72.340000000000003 111.012 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.3 t -110.43 151.57 27.34 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 109.623 -0.51 . . . . 75.200000000000003 109.623 -178.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.65 114.16 47.85 Favored Pre-proline 0 C--N 1.31 -1.137 0 N-CA-C 108.982 -0.747 . . . . 25.210000000000001 108.982 177.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -79.85 114.65 3.2 Favored 'Trans proline' 0 N--CA 1.445 -1.376 0 C-N-CA 121.929 1.753 . . . . 72.25 111.81 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -96.98 111.64 23.76 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.401 -0.818 . . . . 73.030000000000001 109.541 179.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.7 m -77.45 104.87 8.22 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 115.759 -0.655 . . . . 64.530000000000001 109.316 -179.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 20.6 m -86.16 83.13 7.81 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-O 121.819 0.819 . . . . 74.340000000000003 108.965 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -135.66 43.96 1.21 Allowed Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 108.343 -1.903 . . . . 75.510000000000005 108.343 177.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.402 ' HB1' ' HG3' ' A' ' 96' ' ' GLU . . . -63.87 -20.9 66.18 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 124.096 0.958 . . . . 43.119999999999997 111.839 -174.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -62.13 -36.65 82.44 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.352 0.596 . . . . 72.319999999999993 109.655 177.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -73.19 -28.55 62.26 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.142 -0.935 . . . . 74.109999999999999 111.211 -178.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -89.47 111.49 45.93 Favored Pre-proline 0 C--N 1.316 -0.867 0 CA-C-N 116.653 -0.248 . . . . 72.010000000000005 110.55 -178.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -82.48 -0.15 10.02 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.635 2.223 . . . . 75.140000000000001 111.587 178.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -144.48 110.28 5.34 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 108.217 -1.031 . . . . 65.530000000000001 108.217 177.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -122.52 47.93 0.99 Allowed Glycine 0 C--N 1.3 -1.441 0 N-CA-C 110.473 -1.051 . . . . 70.450000000000003 110.473 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.9 m -132.83 158.11 43.33 Favored 'General case' 0 N--CA 1.426 -1.635 0 N-CA-C 109.312 -0.625 . . . . 74.530000000000001 109.312 179.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -162.31 167.45 23.84 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.013 -1.477 . . . . 55.43 107.013 -177.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.405 HD22 ' HD3' ' A' ' 141' ' ' PRO . 2.1 pt? -134.55 158.26 44.43 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 109.231 -0.655 . . . . 72.0 109.231 178.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.422 ' HB2' HD21 ' A' ' 135' ' ' LEU . 4.4 pp -114.45 136.49 52.95 Favored 'General case' 0 N--CA 1.412 -2.337 0 N-CA-C 108.179 -1.045 . . . . 62.119999999999997 108.179 175.225 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 60.8 t -121.67 124.99 72.83 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.397 0 N-CA-C 107.895 -1.15 . . . . 74.310000000000002 107.895 -179.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.415 HG11 ' OD1' ' A' ' 56' ' ' ASN . 42.0 t -92.65 115.57 31.82 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 N-CA-C 107.446 -1.316 . . . . 61.149999999999999 107.446 177.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -85.12 -36.57 21.03 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-N 114.491 -1.231 . . . . 65.340000000000003 110.513 -174.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.459 ' O ' ' HB3' ' A' ' 133' ' ' PHE . 16.1 tpp180 -155.3 121.33 5.14 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 120.143 -0.623 . . . . 75.340000000000003 110.906 -178.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.421 ' HA2' ' CD1' ' A' ' 133' ' ' PHE . . . 162.08 141.97 3.27 Favored Glycine 0 C--O 1.194 -2.361 0 O-C-N 124.038 0.837 . . . . 55.049999999999997 111.102 176.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.434 ' HB2' ' OD2' ' A' ' 81' ' ' ASP . 17.0 Cg_exo -68.64 -10.07 27.99 Favored 'Trans proline' 0 N--CA 1.477 0.527 0 C-N-CA 122.45 2.1 . . . . 54.210000000000001 111.603 177.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.493 ' HB3' ' H ' ' A' ' 81' ' ' ASP . 4.4 p30 -59.35 -53.88 53.2 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 115.134 -0.939 . . . . 71.310000000000002 109.775 175.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -164.29 174.49 11.06 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-N 115.809 -0.632 . . . . 64.239999999999995 109.471 -179.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -163.45 54.36 0.29 Allowed Glycine 0 C--N 1.289 -2.083 0 N-CA-C 108.531 -1.828 . . . . 62.25 108.531 179.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -150.04 178.42 8.96 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 108.184 -1.043 . . . . 64.439999999999998 108.184 -175.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -102.36 137.81 40.11 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 108.147 -1.057 . . . . 63.409999999999997 108.147 179.151 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -132.43 129.89 39.87 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.095 -0.706 . . . . 72.310000000000002 109.095 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 52.4 tp -88.88 128.05 35.66 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 116.34 -0.391 . . . . 75.219999999999999 110.897 -176.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -77.73 115.47 17.51 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 108.267 -1.012 . . . . 63.210000000000001 108.267 176.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -143.14 -53.09 0.38 Allowed 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 115.029 -0.987 . . . . 72.510000000000005 109.348 -177.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.416 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 25.4 tt0 -69.63 121.31 82.01 Favored Pre-proline 0 C--N 1.312 -1.061 0 N-CA-C 108.505 -0.924 . . . . 72.129999999999995 108.505 177.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 65' ' ' GLN . 1.0 OUTLIER -42.07 -51.37 4.74 Favored 'Trans proline' 0 C--N 1.372 1.795 0 C-N-CA 124.745 3.63 . . . . 61.130000000000003 113.958 -173.997 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.5 m -102.97 99.88 9.8 Favored 'General case' 0 N--CA 1.415 -2.205 0 CA-C-N 116.144 -0.48 . . . . 54.25 109.844 179.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.447 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 86.2 m -98.14 114.05 26.13 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.422 -1.325 . . . . 72.209999999999994 107.422 175.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.7 m -105.58 133.92 49.54 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 112.925 0.713 . . . . 53.450000000000003 112.925 -171.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -108.63 117.5 34.34 Favored 'General case' 0 C--O 1.253 1.243 0 N-CA-C 108.386 -0.968 . . . . 64.109999999999999 108.386 175.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -158.68 -179.83 33.82 Favored Glycine 0 N--CA 1.438 -1.209 0 C-N-CA 120.158 -1.02 . . . . 62.109999999999999 111.188 -177.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.6 ttp180 -90.21 8.5 32.75 Favored 'General case' 0 CA--C 1.553 1.064 0 CA-C-O 121.949 0.881 . . . . 43.100000000000001 110.089 -176.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 60.8 m-70 -88.94 146.54 36.84 Favored Pre-proline 0 C--N 1.298 -1.64 0 N-CA-C 108.805 -0.813 . . . . 72.299999999999997 108.805 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -66.83 -28.73 42.8 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 121.729 1.619 . . . . 72.099999999999994 109.534 174.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -90.69 65.57 5.94 Favored 'General case' 0 N--CA 1.423 -1.819 0 CA-C-N 114.385 -1.28 . . . . 74.310000000000002 109.236 177.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.6 p -121.35 -174.76 2.92 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 106.066 -1.828 . . . . 71.450000000000003 106.066 175.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -100.67 -41.09 7.06 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 119.374 -0.931 . . . . 75.150000000000006 108.956 178.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 41.7 pt -114.78 150.58 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.618 0 N-CA-C 106.99 -1.485 . . . . 71.430000000000007 106.99 170.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -87.51 136.18 33.05 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 109.441 -0.577 . . . . 62.240000000000002 109.441 -179.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.462 ' HA ' ' HB2' ' A' ' 56' ' ' ASN . 50.4 tp -125.26 122.7 37.7 Favored 'General case' 0 N--CA 1.413 -2.319 0 CA-C-O 121.832 0.825 . . . . 74.099999999999994 111.043 -175.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.493 ' H ' ' HB3' ' A' ' 56' ' ' ASN . 33.9 t70 -142.59 108.5 5.17 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 114.561 -1.2 . . . . 71.540000000000006 108.304 176.078 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -137.04 161.84 34.96 Favored 'General case' 0 C--N 1.264 -3.137 0 CA-C-N 113.116 -1.856 . . . . 71.510000000000005 107.934 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.7 m -80.43 -15.46 12.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-O 121.441 0.639 . . . . 72.530000000000001 112.095 -177.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.505 ' OG1' ' HB3' ' A' ' 108' ' ' ASN . 3.1 p -128.54 45.73 2.73 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 122.261 1.029 . . . . 53.140000000000001 108.5 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.8 p -81.21 139.68 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 CA-C-N 113.672 -1.604 . . . . 62.439999999999998 110.789 -173.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 24.4 t -101.28 163.09 12.45 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 107.26 -1.385 . . . . 55.210000000000001 107.26 177.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 26.4 ttm180 -60.91 -43.3 98.73 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 108.946 -0.761 . . . . 70.329999999999998 108.946 179.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.495 ' H ' ' HD3' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -123.0 133.23 54.37 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 105.434 -2.061 . . . . 74.230000000000004 105.434 175.522 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 21.1 t60 -113.19 -68.63 0.92 Allowed 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.232 -0.987 . . . . 74.209999999999994 111.273 -174.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.37 153.65 40.75 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 116.295 -0.412 . . . . 74.409999999999997 109.889 -176.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -117.59 127.34 53.87 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 108.299 -1.0 . . . . 62.030000000000001 108.299 178.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.447 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 93.5 m-85 -100.51 115.58 30.45 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 107.744 -1.206 . . . . 72.049999999999997 107.744 178.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 61.9 mtp85 -106.85 123.13 47.71 Favored 'General case' 0 C--N 1.285 -2.238 0 N-CA-C 108.566 -0.902 . . . . 74.150000000000006 108.566 -176.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.3 tp -115.67 116.08 51.31 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 CA-C-O 121.639 0.733 . . . . 73.340000000000003 109.91 -176.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -118.71 143.81 46.64 Favored 'General case' 0 N--CA 1.41 -2.455 0 N-CA-C 103.986 -2.598 . . . . 63.32 103.986 175.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.402 ' HG3' ' HB1' ' A' ' 39' ' ' ALA . 6.0 pt-20 -70.91 -9.33 57.57 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 121.235 0.54 . . . . 73.150000000000006 111.658 179.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -80.86 -55.7 3.27 Favored Glycine 0 N--CA 1.433 -1.56 0 N-CA-C 111.025 -0.83 . . . . 51.219999999999999 111.025 171.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -148.89 166.24 29.13 Favored 'General case' 0 C--N 1.348 0.526 0 C-N-CA 122.801 0.44 . . . . 62.420000000000002 110.479 -178.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.531 ' HB2' ' HB2' ' A' ' 122' ' ' MET . 8.0 m-85 -111.03 128.74 55.96 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.947 -1.131 . . . . 72.030000000000001 107.947 -175.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -130.23 136.16 48.91 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.524 0.202 . . . . 71.510000000000005 110.89 -173.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.4 p -125.74 126.83 70.78 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-O 121.04 0.447 . . . . 71.140000000000001 110.165 175.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 51.9 t -119.21 133.41 66.14 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 CA-C-N 115.781 -0.645 . . . . 64.439999999999998 109.826 -178.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -82.9 131.53 35.19 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 107.18 -1.415 . . . . 54.109999999999999 107.18 173.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.402 HG23 ' HG2' ' A' ' 88' ' ' ARG . 17.4 m -111.97 20.22 6.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-O 121.086 0.469 . . . . 74.420000000000002 112.152 -177.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 120.06 54.85 0.25 Allowed Glycine 0 N--CA 1.433 -1.563 0 C-N-CA 119.981 -1.104 . . . . 61.329999999999998 114.367 174.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 77.7 p -78.86 145.77 34.02 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 117.253 0.526 . . . . 72.409999999999997 109.819 177.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 98.1 mt -80.19 -31.2 38.79 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 121.514 0.673 . . . . 63.539999999999999 109.931 178.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.505 ' HB3' ' OG1' ' A' ' 84' ' ' THR . 23.4 p30 -85.29 -24.52 27.68 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.01 -0.996 . . . . 63.210000000000001 112.841 -177.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 88.5 105.57 1.0 Allowed Glycine 0 N--CA 1.433 -1.502 0 C-N-CA 120.865 -0.683 . . . . 64.049999999999997 111.763 -179.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.6 m -75.63 123.94 26.38 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.794 -0.817 . . . . 73.409999999999997 108.794 176.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -136.97 153.71 50.62 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 109.796 -0.446 . . . . 71.25 109.796 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 31.1 t -98.07 142.63 14.18 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.006 0 N-CA-C 106.526 -1.657 . . . . 63.439999999999998 106.526 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 33.6 p-10 -55.21 -25.21 31.62 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 112.573 0.583 . . . . 73.319999999999993 112.573 -175.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 33.5 mtm105 -100.9 -32.51 10.62 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.369 -0.378 . . . . 71.239999999999995 111.809 177.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -130.65 125.29 21.41 Favored Pre-proline 0 C--N 1.316 -0.848 0 C-N-CA 121.078 -0.249 . . . . 63.149999999999999 111.589 -169.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.15 39.47 0.73 Allowed 'Trans proline' 0 CA--C 1.554 1.507 0 C-N-CA 122.838 2.359 . . . . 74.219999999999999 112.043 178.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.431 ' HB3' ' O ' ' A' ' 119' ' ' ALA . 31.1 mmt180 -90.51 131.33 36.31 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 123.537 0.735 . . . . 72.510000000000005 110.262 -177.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -78.64 -38.61 39.24 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.141 0.496 . . . . 43.240000000000002 110.021 174.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.431 ' O ' ' HB3' ' A' ' 117' ' ' ARG . . . -105.47 137.93 42.49 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 105.398 -2.075 . . . . 31.23 105.398 170.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -139.47 140.22 37.21 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-O 121.256 0.551 . . . . 51.119999999999997 111.932 -172.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 48.1 t -85.61 118.27 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 104.846 -2.279 . . . . 64.450000000000003 104.846 169.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.531 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 12.6 mmt -58.26 150.04 22.78 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 114.506 1.299 . . . . 63.240000000000002 114.506 -173.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -125.67 129.53 49.75 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 105.09 -2.189 . . . . 72.420000000000002 105.09 172.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 45.9 p -83.07 123.57 29.61 Favored 'General case' 0 C--N 1.283 -2.297 0 C-N-CA 121.002 -0.279 . . . . 75.109999999999999 110.676 -174.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 92.4 38.55 5.59 Favored Glycine 0 CA--C 1.497 -1.071 0 N-CA-C 109.528 -1.429 . . . . 75.25 109.528 -175.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -139.56 170.35 16.07 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 107.437 -1.32 . . . . 54.32 107.437 -176.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -140.52 139.75 35.13 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 122.285 1.04 . . . . 73.129999999999995 113.261 -174.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 60.0 mt -112.33 131.63 63.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-N 114.417 -1.265 . . . . 64.310000000000002 109.987 -175.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -93.76 112.53 24.42 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-O 121.843 0.83 . . . . 72.099999999999994 110.257 -178.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.9 pt -95.34 98.54 8.03 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 N-CA-C 107.641 -1.244 . . . . 71.099999999999994 107.641 176.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 76.06 -98.95 1.24 Allowed Glycine 0 N--CA 1.428 -1.885 0 N-CA-C 110.476 -1.05 . . . . 73.129999999999995 110.476 -176.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -127.64 10.19 6.59 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.197 0.523 . . . . 71.409999999999997 109.839 178.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.459 ' HB3' ' O ' ' A' ' 53' ' ' ARG . 57.4 m-85 -119.92 157.17 29.33 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.952 -0.567 . . . . 72.230000000000004 109.697 -175.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 20.1 ptp180 -125.77 131.33 52.52 Favored 'General case' 0 C--O 1.256 1.398 0 N-CA-C 114.087 1.143 . . . . 71.420000000000002 114.087 -170.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.422 HD21 ' HB2' ' A' ' 49' ' ' LEU . 6.5 tt -114.71 134.35 55.16 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 114.072 -1.422 . . . . 75.340000000000003 108.213 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 38.2 t -107.54 139.14 30.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 108.824 -0.806 . . . . 73.430000000000007 108.824 -176.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -115.84 126.3 53.8 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 109.883 -0.414 . . . . 75.140000000000001 109.883 -179.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 66.5 mt -132.69 137.57 46.97 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.63 -0.259 . . . . 71.099999999999994 110.749 -177.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -103.31 41.1 1.3 Allowed 'General case' 0 N--CA 1.482 1.141 0 CA-C-O 122.142 0.972 . . . . 62.119999999999997 108.719 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -75.81 -50.09 8.24 Favored Glycine 0 C--N 1.294 -1.759 0 CA-C-N 113.834 -1.53 . . . . 73.129999999999995 116.19 -174.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.405 ' HD3' HD22 ' A' ' 48' ' ' LEU . 5.8 Cg_exo -74.64 121.9 7.01 Favored 'Trans proline' 0 C--N 1.368 1.588 0 CA-C-N 120.214 2.007 . . . . 73.319999999999993 115.407 -170.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -110.38 126.98 54.84 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 105.882 -1.896 . . . . 74.319999999999993 105.882 173.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.425 -1.691 0 CA-C-O 118.199 -0.905 . . . . 73.099999999999994 112.311 -177.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 mmt . . . . . 0 CA--C 1.491 -1.31 0 N-CA-C 107.613 -1.254 . . . . 64.120000000000005 107.613 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.2 p -68.92 -30.62 69.12 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 108.725 -0.842 . . . . 72.319999999999993 108.725 177.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.7 t70 72.66 -50.85 0.7 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.243 1.817 . . . . 72.200000000000003 112.739 169.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -85.35 104.87 15.57 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.38 -0.6 . . . . 53.409999999999997 109.38 176.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -161.6 151.44 16.82 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 106.878 -1.527 . . . . 73.230000000000004 106.878 178.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -89.4 166.28 33.13 Favored Glycine 0 N--CA 1.429 -1.792 0 C-N-CA 119.766 -1.207 . . . . 72.209999999999994 110.398 178.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.2 p -84.65 133.32 44.3 Favored Pre-proline 0 N--CA 1.421 -1.907 0 N-CA-C 109.165 -0.68 . . . . 70.129999999999995 109.165 177.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -66.2 127.49 17.63 Favored 'Trans proline' 0 N--CA 1.448 -1.157 0 N-CA-C 107.923 -1.607 . . . . 61.039999999999999 107.923 174.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -95.89 118.08 66.03 Favored Pre-proline 0 C--N 1.288 -2.07 0 N-CA-C 112.926 0.713 . . . . 75.040000000000006 112.926 -174.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -66.13 140.58 60.05 Favored 'Trans proline' 0 C--O 1.245 0.862 0 C-N-CA 122.644 2.23 . . . . 62.25 108.948 173.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -149.23 98.69 2.84 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-O 122.075 0.94 . . . . 62.130000000000003 109.161 -176.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 49.2 t -69.4 118.24 13.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 114.06 -1.427 . . . . 74.209999999999994 112.259 -172.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -95.7 135.96 36.71 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 107.308 -1.367 . . . . 73.120000000000005 107.308 173.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.5 t -152.17 151.92 31.63 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-O 121.302 0.573 . . . . 73.439999999999998 110.756 -175.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.8 m -122.13 81.52 1.84 Allowed 'General case' 0 N--CA 1.41 -2.458 0 N-CA-C 107.805 -1.183 . . . . 73.109999999999999 107.805 173.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.7 m -82.36 99.33 9.32 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 115.551 -0.75 . . . . 61.140000000000001 109.224 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.9 p -138.06 136.61 44.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 108.659 -0.867 . . . . 71.439999999999998 108.659 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -94.1 163.99 13.25 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 109.073 -0.714 . . . . 71.019999999999996 109.073 -178.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.5 mtm180 -103.21 132.67 49.29 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 109.519 -0.549 . . . . 74.430000000000007 109.519 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.9 93.37 7.49 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 107.119 -1.437 . . . . 70.549999999999997 107.119 172.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -79.84 -53.22 6.99 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.972 -0.558 . . . . 63.200000000000003 109.95 -176.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 56.84 64.08 1.76 Allowed 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 115.416 -0.811 . . . . 73.430000000000007 111.082 -176.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 85.2 mt -88.08 140.58 29.34 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 115.421 -0.809 . . . . 74.019999999999996 109.315 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.446 ' HD2' ' H ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -124.45 32.59 5.45 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 121.87 0.843 . . . . 71.329999999999998 109.295 179.811 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -72.79 104.11 3.88 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 114.591 -1.186 . . . . 75.010000000000005 108.736 -178.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 57.7 mtt -123.17 119.78 31.25 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.982 -1.118 . . . . 73.420000000000002 107.982 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -136.76 160.44 38.85 Favored 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 120.206 -0.597 . . . . 71.239999999999995 111.569 175.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.407 ' O ' ' HB3' ' A' ' 139' ' ' ALA . 32.8 t -139.65 74.23 1.46 Allowed 'General case' 0 N--CA 1.407 -2.578 0 N-CA-C 106.386 -1.709 . . . . 75.099999999999994 106.386 172.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.2 t -72.89 88.11 1.34 Allowed 'General case' 0 N--CA 1.424 -1.754 0 CA-C-O 121.955 0.883 . . . . 72.519999999999996 108.964 177.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.2 p -133.51 126.72 31.67 Favored 'General case' 0 N--CA 1.414 -2.239 0 CA-C-N 114.172 -1.376 . . . . 74.219999999999999 107.939 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -78.83 64.77 3.6 Favored Glycine 0 C--N 1.323 -0.182 0 N-CA-C 111.217 -0.753 . . . . 54.119999999999997 111.217 179.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 8.8 m -98.85 142.67 30.08 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 123.377 0.671 . . . . 65.510000000000005 109.681 -176.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.414 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . . . -73.74 113.12 19.87 Favored Pre-proline 0 N--CA 1.436 -1.139 0 N-CA-C 106.634 -1.617 . . . . 33.329999999999998 106.634 173.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 33' ' ' ALA . 3.4 Cg_endo -86.78 177.48 4.13 Favored 'Trans proline' 0 N--CA 1.436 -1.872 0 C-N-CA 121.845 1.697 . . . . 73.409999999999997 113.554 -173.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -154.75 170.6 21.22 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 105.906 -1.887 . . . . 73.209999999999994 105.906 176.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.402 ' HB3' ' HB2' ' A' ' 39' ' ' ALA . 11.7 m -65.94 95.98 0.29 Allowed 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 121.584 0.707 . . . . 71.120000000000005 109.526 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 25.7 m -76.28 99.61 4.83 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 115.314 -0.857 . . . . 55.119999999999997 110.464 -175.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.401 ' O ' ' HD3' ' A' ' 43' ' ' PRO . . . 62.78 56.63 20.03 Favored Glycine 0 C--O 1.214 -1.125 0 CA-C-N 115.493 -0.776 . . . . 63.329999999999998 111.664 -178.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.402 ' HB2' ' HB3' ' A' ' 36' ' ' SER . . . -61.74 -37.1 82.99 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 123.058 0.543 . . . . 74.109999999999999 111.587 -176.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -83.07 -20.32 35.15 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.124 -0.489 . . . . 65.0 111.307 -179.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -83.61 -36.36 23.95 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.325 -0.991 . . . . 43.130000000000003 108.325 177.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 52.15 77.69 0.44 Allowed Pre-proline 0 N--CA 1.44 -0.947 0 C-N-CA 127.297 2.239 . . . . 74.430000000000007 111.509 -178.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' A' ' 38' ' ' GLY . 1.8 Cg_endo -85.41 -72.35 0.01 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.406 0 C-N-CA 122.474 2.116 . . . . 72.239999999999995 109.87 175.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -150.85 102.78 3.02 Favored 'General case' 0 N--CA 1.424 -1.748 0 N-CA-C 107.43 -1.322 . . . . 61.039999999999999 107.43 176.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -103.0 33.34 6.66 Favored Glycine 0 C--N 1.306 -1.108 0 N-CA-C 110.409 -1.076 . . . . 70.219999999999999 110.409 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 18.8 m -134.07 166.82 21.85 Favored 'General case' 0 N--CA 1.419 -2.016 0 N-CA-C 108.761 -0.829 . . . . 73.120000000000005 108.761 -179.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.518 ' HB3' ' CZ ' ' A' ' 137' ' ' PHE . . . -151.15 -170.9 3.79 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 107.939 -1.134 . . . . 41.409999999999997 107.939 178.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.412 ' H ' HD13 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -123.22 152.25 41.47 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 120.366 -0.533 . . . . 72.420000000000002 111.399 -176.991 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.441 ' HB2' HD21 ' A' ' 135' ' ' LEU . 2.0 pp -127.78 145.01 51.06 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 115.555 -0.748 . . . . 72.549999999999997 110.922 178.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.3 m -131.28 142.34 43.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 109.394 -0.595 . . . . 61.219999999999999 109.394 178.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.508 HG21 ' HB3' ' A' ' 57' ' ' ALA . 76.5 t -93.82 115.93 33.83 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 N-CA-C 107.878 -1.156 . . . . 74.209999999999994 107.878 176.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.5 tmtm? -82.16 -38.81 24.13 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.756 -0.831 . . . . 40.020000000000003 108.756 -175.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.446 ' O ' ' HB3' ' A' ' 133' ' ' PHE . 13.8 tpp180 -142.41 117.3 9.92 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 108.181 -1.044 . . . . 72.140000000000001 108.181 -178.105 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 148.42 125.18 1.46 Allowed Glycine 0 N--CA 1.427 -1.955 0 C-N-CA 119.784 -1.198 . . . . 72.420000000000002 114.057 177.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -67.54 -8.92 23.67 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 123.768 2.979 . . . . 71.329999999999998 110.509 174.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.575 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 2.1 m-20 -51.18 -26.5 6.95 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 126.852 2.061 . . . . 72.129999999999995 111.215 177.241 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.508 ' HB3' HG21 ' A' ' 51' ' ' VAL . . . -166.88 -62.16 0.03 OUTLIER 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 123.45 0.7 . . . . 73.120000000000005 109.403 176.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 61.3 44.82 97.59 Favored Glycine 0 C--N 1.336 0.557 0 CA-C-N 115.741 -0.663 . . . . 45.420000000000002 111.85 -179.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -151.62 -171.68 4.0 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 108.927 -0.768 . . . . 74.430000000000007 108.927 -176.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.8 ptt180 -119.93 138.51 53.4 Favored 'General case' 0 C--N 1.312 -1.064 0 O-C-N 124.002 0.814 . . . . 62.43 109.221 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -138.54 129.43 26.68 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-O 120.896 0.379 . . . . 73.430000000000007 110.807 179.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 65.3 tp -91.45 129.59 37.41 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 107.505 -1.294 . . . . 74.450000000000003 107.505 176.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 79.7 mt -72.16 120.15 17.35 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 113.018 0.748 . . . . 72.099999999999994 113.018 -176.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -146.29 -39.99 0.21 Allowed 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.884 -1.053 . . . . 73.349999999999994 110.56 175.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -61.28 113.89 9.26 Favored Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 123.888 0.875 . . . . 74.409999999999997 110.297 173.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.566 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 8.4 Cg_endo -53.8 -41.31 75.51 Favored 'Trans proline' 0 C--N 1.361 1.185 0 C-N-CA 122.983 2.455 . . . . 71.0 113.253 -175.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 50.2 m -119.82 105.89 11.55 Favored 'General case' 0 N--CA 1.423 -1.8 0 CA-C-O 121.21 0.528 . . . . 72.030000000000001 109.79 178.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.485 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 40.1 m -107.01 113.8 27.5 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 107.259 -1.386 . . . . 61.539999999999999 107.259 174.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.4 p -98.04 133.64 42.23 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 116.002 -0.544 . . . . 71.040000000000006 112.369 -175.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -115.21 120.29 39.22 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 115.574 -0.739 . . . . 72.519999999999996 109.135 176.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.428 ' HA2' ' CG2' ' A' ' 85' ' ' VAL . . . 167.63 -160.44 34.05 Favored Glycine 0 N--CA 1.422 -2.254 0 N-CA-C 110.051 -1.22 . . . . 73.5 110.051 178.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.49 ' O ' ' HG2' ' A' ' 87' ' ' ARG . 18.6 tpt180 -132.42 89.56 2.67 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 109.445 -0.576 . . . . 62.219999999999999 109.445 174.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.559 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 5.1 p80 -161.59 165.76 15.93 Favored Pre-proline 0 C--N 1.304 -1.402 0 N-CA-C 107.686 -1.227 . . . . 63.520000000000003 107.686 177.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.559 ' HD2' ' HB2' ' A' ' 73' ' ' HIS . 3.1 Cg_endo -47.89 -35.44 24.61 Favored 'Trans proline' 0 C--N 1.359 1.101 0 C-N-CA 123.317 2.678 . . . . 72.329999999999998 115.7 -175.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -99.33 14.6 29.06 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 119.237 -0.985 . . . . 62.030000000000001 113.52 -175.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 24.0 m -73.2 133.24 43.96 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.635 -0.506 . . . . 75.340000000000003 109.635 176.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -80.19 -56.02 4.51 Favored 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 108.441 -0.948 . . . . 72.310000000000002 108.441 176.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 32.4 pt -97.69 134.46 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 N-CA-C 109.117 -0.697 . . . . 44.530000000000001 109.117 177.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -104.42 116.87 32.88 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 121.764 0.792 . . . . 73.030000000000001 110.529 -177.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.575 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 7.0 mp -82.02 106.53 14.01 Favored 'General case' 0 N--CA 1.422 -1.831 0 CA-C-N 114.817 -1.083 . . . . 74.519999999999996 111.09 -177.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -85.0 69.49 10.82 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 122.432 1.111 . . . . 75.340000000000003 109.743 176.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -148.62 164.26 34.82 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 113.94 -1.482 . . . . 70.319999999999993 108.279 176.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.1 p -94.69 -6.65 10.15 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-O 121.083 0.468 . . . . 63.32 111.516 -176.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.7 m -91.96 13.45 18.58 Favored 'General case' 0 CA--C 1.548 0.899 0 O-C-N 121.491 -0.755 . . . . 74.430000000000007 110.267 -177.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.428 ' CG2' ' HA2' ' A' ' 71' ' ' GLY . 10.6 p -102.77 133.11 47.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-O 121.258 0.551 . . . . 70.340000000000003 111.312 -178.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 18.3 m -102.05 169.95 8.42 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 108.94 -0.763 . . . . 51.420000000000002 108.94 176.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.49 ' HG2' ' O ' ' A' ' 72' ' ' ARG . 63.1 mtm180 -75.27 134.7 41.04 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 106.674 -1.602 . . . . 72.540000000000006 106.674 173.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.554 ' H ' ' CD2' ' A' ' 73' ' ' HIS 0.36 0.0 OUTLIER 50.38 71.76 0.39 Allowed 'General case' 0 C--O 1.22 -0.497 0 CA-C-O 122.654 1.216 . . . . 74.340000000000003 111.096 -171.507 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.453 ' HA ' ' HA3' ' A' ' 105' ' ' GLY . 11.4 t60 -95.39 -60.14 1.73 Allowed 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 113.828 -1.533 . . . . 72.209999999999994 109.846 -173.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -130.94 127.47 38.52 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 109.215 -0.661 . . . . 63.240000000000002 109.215 -179.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -109.75 127.19 54.46 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 109.049 -0.723 . . . . 72.540000000000006 109.049 177.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.485 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 97.5 m-85 -104.09 112.62 25.69 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 107.651 -1.241 . . . . 74.140000000000001 107.651 177.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 27.5 mtp85 -108.48 113.59 26.74 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 115.368 -0.833 . . . . 75.420000000000002 109.072 -177.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.566 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -128.48 124.22 61.38 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.522 0 CA-C-O 122.085 0.945 . . . . 64.120000000000005 110.077 -177.778 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -110.52 147.71 33.6 Favored 'General case' 0 C--N 1.269 -2.906 0 N-CA-C 106.765 -1.568 . . . . 63.409999999999997 106.765 177.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -42.42 -26.57 0.12 Allowed 'General case' 0 CA--C 1.56 1.354 0 N-CA-C 114.234 1.198 . . . . 73.219999999999999 114.234 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -128.77 23.85 4.96 Favored Glycine 0 N--CA 1.437 -1.249 0 C-N-CA 120.617 -0.802 . . . . 13.23 113.513 179.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -165.44 144.25 6.32 Favored 'General case' 0 C--O 1.213 -0.868 0 CA-C-N 117.852 0.826 . . . . 73.040000000000006 110.84 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.479 ' HB2' ' SD ' ' A' ' 122' ' ' MET . 1.3 p90 -132.15 115.83 16.23 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-O 121.873 0.844 . . . . 72.109999999999999 112.085 -177.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -129.9 135.24 48.12 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.468 -0.787 . . . . 64.430000000000007 111.559 -172.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.6 p -116.5 128.38 73.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 109.561 -0.533 . . . . 73.040000000000006 109.561 178.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 58.6 t -118.82 130.61 73.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-N 116.325 -0.398 . . . . 62.32 110.943 -175.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -101.31 115.24 30.04 Favored 'General case' 0 CA--C 1.496 -1.127 0 CA-C-O 121.074 0.464 . . . . 75.439999999999998 109.802 176.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 88' ' ' ARG . 5.3 m -122.42 -1.64 7.22 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 CA-C-O 121.671 0.748 . . . . 61.329999999999998 111.459 178.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.453 ' HA3' ' HA ' ' A' ' 89' ' ' HIS . . . -100.22 39.83 2.62 Favored Glycine 0 N--CA 1.429 -1.771 0 N-CA-C 109.401 -1.48 . . . . 54.439999999999998 109.401 176.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 11.4 m -63.45 4.52 0.23 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.042 1.737 . . . . 54.340000000000003 113.479 -176.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -68.95 -41.09 78.48 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 106.693 -1.595 . . . . 71.400000000000006 106.693 171.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -110.18 -41.19 4.49 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.071 -1.422 . . . . 70.120000000000005 108.355 177.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 92.65 131.53 5.67 Favored Glycine 0 N--CA 1.438 -1.202 0 N-CA-C 115.71 1.044 . . . . 74.200000000000003 115.71 173.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 18.6 m -94.65 135.59 35.94 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 105.941 -1.874 . . . . 70.329999999999998 105.941 169.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -117.69 134.42 54.92 Favored 'General case' 0 C--N 1.294 -1.833 0 C-N-CA 120.013 -0.675 . . . . 70.230000000000004 109.659 -177.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.474 HG23 ' HB2' ' A' ' 115' ' ' GLU . 22.3 m -100.43 110.56 27.75 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.935 0 N-CA-C 106.973 -1.491 . . . . 73.409999999999997 106.973 172.263 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 66.96 -79.72 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 125.843 1.657 . . . . 44.25 108.944 -171.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 51.9 mtp180 -148.11 13.8 1.0 Allowed 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 124.652 1.181 . . . . 73.129999999999995 109.147 176.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.474 ' HB2' HG23 ' A' ' 112' ' ' VAL . 32.4 mm-40 -102.51 113.74 65.72 Favored Pre-proline 0 N--CA 1.439 -1.005 0 CA-C-N 115.327 -0.851 . . . . 71.219999999999999 110.39 -175.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -84.26 94.8 0.72 Allowed 'Trans proline' 0 N--CA 1.446 -1.283 0 C-N-CA 122.444 2.096 . . . . 70.310000000000002 109.182 173.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -121.28 146.22 47.05 Favored 'General case' 0 CA--C 1.502 -0.885 0 CA-C-N 116.397 -0.365 . . . . 72.329999999999998 111.191 -174.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -66.05 -42.22 89.79 Favored 'General case' 0 C--N 1.319 -0.719 0 O-C-N 124.145 0.903 . . . . 73.109999999999999 110.73 -177.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -149.64 138.89 21.34 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 108.363 -0.977 . . . . 32.32 108.363 175.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.468 ' HG2' HG21 ' A' ' 112' ' ' VAL . 6.0 tp60 -140.98 150.49 43.15 Favored 'General case' 0 C--N 1.292 -1.935 0 C-N-CA 122.821 0.448 . . . . 75.349999999999994 110.117 -179.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 64.1 t -79.82 134.03 28.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 105.508 -2.034 . . . . 70.120000000000005 105.508 173.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.479 ' SD ' ' HB2' ' A' ' 99' ' ' PHE . 64.7 mtt -61.0 126.33 26.97 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 109.61 -0.515 . . . . 63.450000000000003 109.61 -176.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -104.95 130.35 53.15 Favored 'General case' 0 N--CA 1.418 -2.061 0 CA-C-O 121.346 0.594 . . . . 55.229999999999997 110.098 -178.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 18.6 p -78.3 131.9 37.24 Favored 'General case' 0 N--CA 1.416 -2.167 0 CA-C-N 114.782 -1.099 . . . . 74.140000000000001 109.479 -177.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 85.0 22.88 51.4 Favored Glycine 0 N--CA 1.431 -1.671 0 N-CA-C 110.647 -0.981 . . . . 74.5 110.647 179.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -123.61 171.16 9.76 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 120.165 -0.614 . . . . 71.0 109.749 -178.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -118.84 121.42 39.99 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 123.412 0.685 . . . . 74.439999999999998 110.393 -170.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 64.1 mt -106.15 118.2 53.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 N-CA-C 109.614 -0.513 . . . . 74.420000000000002 109.614 -178.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -95.14 114.17 25.94 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 109.455 -0.572 . . . . 74.430000000000007 109.455 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 9.8 pt -99.9 97.58 6.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 CA-C-O 122.215 1.007 . . . . 73.400000000000006 109.101 178.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 73.15 -87.35 0.58 Allowed Glycine 0 N--CA 1.435 -1.42 0 CA-C-N 114.498 -1.228 . . . . 43.25 111.088 -177.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -120.1 -33.03 4.03 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 120.974 0.416 . . . . 73.120000000000005 110.513 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.446 ' HB3' ' O ' ' A' ' 53' ' ' ARG . 77.9 m-85 -95.5 161.21 14.16 Favored 'General case' 0 CA--C 1.496 -1.125 0 CA-C-N 116.293 -0.412 . . . . 62.109999999999999 110.95 -173.109 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 27.9 ptt180 -131.42 141.5 49.85 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 114.155 1.168 . . . . 52.450000000000003 114.155 -171.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.441 HD21 ' HB2' ' A' ' 49' ' ' LEU . 3.4 tt -117.69 140.03 50.22 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 112.935 -1.939 . . . . 71.540000000000006 107.48 -177.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 7.7 p -115.93 131.56 68.02 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 CA-C-O 121.046 0.451 . . . . 74.239999999999995 109.787 179.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.518 ' CZ ' ' HB3' ' A' ' 47' ' ' ALA . 71.4 t80 -102.91 119.0 38.07 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.53 -0.759 . . . . 74.340000000000003 109.057 -175.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.47 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 2.5 mm? -114.68 147.1 40.11 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 120.966 0.412 . . . . 64.109999999999999 111.282 -175.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 28' ' ' SER . . . -81.94 118.23 22.79 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 107.827 -1.175 . . . . 74.530000000000001 107.827 175.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -93.57 -135.92 7.74 Favored Glycine 0 N--CA 1.427 -1.913 0 C-N-CA 120.64 -0.791 . . . . 50.240000000000002 111.874 -177.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -78.82 129.41 9.07 Favored 'Trans proline' 0 N--CA 1.441 -1.617 0 C-N-CA 122.492 2.128 . . . . 61.310000000000002 112.305 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -92.84 102.3 14.68 Favored 'General case' 0 N--CA 1.42 -1.953 0 N-CA-C 104.835 -2.283 . . . . 45.520000000000003 104.835 172.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 . . . . . 0 C--N 1.277 -2.571 0 N-CA-C 108.745 -0.835 . . . . 73.430000000000007 108.745 -170.284 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.516 -0.346 0 N-CA-C 108.835 -0.802 . . . . 74.400000000000006 108.835 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.1 t -82.97 -37.58 23.87 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 110.693 -0.114 . . . . 43.229999999999997 110.693 -178.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 56.81 42.05 27.16 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-O 121.967 0.889 . . . . 74.549999999999997 111.465 -177.18 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 30.6 p-10 -101.88 -4.05 26.88 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.517 -0.765 . . . . 50.439999999999998 109.79 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -106.37 86.26 2.32 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 108.647 -0.872 . . . . 62.140000000000001 108.647 176.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -143.69 108.98 0.53 Allowed Glycine 0 N--CA 1.428 -1.85 0 N-CA-C 109.892 -1.283 . . . . 65.409999999999997 109.892 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.401 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 8.7 t -94.07 125.01 54.36 Favored Pre-proline 0 C--N 1.301 -1.537 0 CA-C-O 120.801 0.334 . . . . 75.219999999999999 110.969 -177.215 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 7' ' ' THR . 22.7 Cg_exo -66.22 144.73 76.01 Favored 'Trans proline' 0 C--O 1.244 0.809 0 C-N-CA 122.22 1.947 . . . . 44.240000000000002 109.59 174.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -89.81 138.68 27.79 Favored Pre-proline 0 C--N 1.29 -2.011 0 C-N-CA 121.361 -0.136 . . . . 74.420000000000002 110.638 -177.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -74.64 103.78 1.77 Allowed 'Trans proline' 0 N--CA 1.44 -1.668 0 C-N-CA 121.24 1.293 . . . . 75.019999999999996 109.163 172.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -92.94 119.65 32.45 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 115.373 -0.831 . . . . 55.219999999999999 111.513 -174.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.9 p -88.64 136.86 22.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 CA-C-N 115.812 -0.631 . . . . 63.420000000000002 109.449 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -77.53 134.92 38.18 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 108.542 -0.91 . . . . 61.210000000000001 108.542 178.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.8 m -134.1 71.55 1.46 Allowed 'General case' 0 C--N 1.294 -1.829 0 CA-C-O 121.396 0.617 . . . . 53.310000000000002 110.241 -178.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.8 t 167.43 137.11 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 126.596 1.958 . . . . 73.430000000000007 106.638 176.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 53.4 m -152.16 37.22 0.55 Allowed 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 108.069 -1.086 . . . . 75.200000000000003 108.069 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.8 t -65.1 119.02 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 CA-C-N 114.554 -1.203 . . . . 72.120000000000005 108.424 178.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -74.39 99.16 3.45 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.989 0.9 . . . . 72.409999999999997 110.593 -179.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 74.1 mtp180 -110.28 153.17 25.23 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 114.476 -1.238 . . . . 75.099999999999994 110.752 -175.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -146.84 89.33 1.81 Allowed 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 104.901 -2.259 . . . . 64.129999999999995 104.901 174.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.411 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 46.0 m-20 -67.56 -53.81 25.22 Favored 'General case' 0 CA--C 1.502 -0.895 0 CA-C-N 115.788 -0.642 . . . . 73.420000000000002 111.468 -171.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.411 ' HB2' ' O ' ' A' ' 21' ' ' ASP . 1.4 tm? 177.95 109.7 0.03 OUTLIER 'General case' 0 C--O 1.236 0.355 0 O-C-N 123.752 0.658 . . . . 52.329999999999998 109.596 175.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.505 ' O ' HD22 ' A' ' 23' ' ' LEU 0.274 0.0 OUTLIER -145.01 90.19 2.03 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 122.187 0.994 . . . . 73.219999999999999 109.289 172.49 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.89 175.47 6.79 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.074 -0.967 . . . . 65.239999999999995 113.435 -172.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -82.2 106.44 14.09 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-O 121.456 0.646 . . . . 70.450000000000003 109.616 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 46.3 tpp -129.01 133.0 47.58 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 109.053 -0.721 . . . . 64.310000000000002 109.053 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -84.8 143.31 29.18 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.888 -1.153 . . . . 71.310000000000002 107.888 176.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.9 t -98.62 148.01 24.24 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 108.058 -1.09 . . . . 71.019999999999996 108.058 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 28.7 m -84.44 90.12 7.54 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 121.583 0.706 . . . . 71.150000000000006 110.178 179.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 60.1 m -119.35 101.0 7.65 Favored 'General case' 0 N--CA 1.422 -1.832 0 N-CA-C 108.262 -1.014 . . . . 74.409999999999997 108.262 177.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -103.39 -146.35 16.62 Favored Glycine 0 N--CA 1.426 -2.001 0 C-N-CA 120.694 -0.765 . . . . 60.109999999999999 111.361 -179.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 24.0 m -110.68 148.83 31.45 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 108.363 -0.977 . . . . 75.109999999999999 108.363 179.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -90.51 112.6 53.89 Favored Pre-proline 0 N--CA 1.439 -0.984 0 N-CA-C 108.405 -0.961 . . . . 73.549999999999997 108.405 175.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -79.31 135.88 12.29 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.386 2.057 . . . . 72.239999999999995 111.3 178.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -112.67 122.83 48.82 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.689 -0.856 . . . . 61.340000000000003 108.689 177.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 27.0 t -104.04 96.61 6.78 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 109.177 -0.675 . . . . 74.439999999999998 109.177 -177.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.4 m -105.88 145.03 31.78 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.712 -0.847 . . . . 63.329999999999998 108.712 -178.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -146.23 64.35 0.44 Allowed Glycine 0 N--CA 1.44 -1.041 0 N-CA-C 108.742 -1.743 . . . . 72.209999999999994 108.742 179.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.96 -30.37 61.63 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.944 1.09 . . . . 71.299999999999997 113.944 -171.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -66.87 -34.28 77.44 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.982 0.42 . . . . 63.340000000000003 111.043 -178.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -84.15 -43.59 14.84 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-N 116.339 -0.391 . . . . 73.25 110.395 177.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.407 HD12 ' HB3' ' A' ' 96' ' ' GLU . 58.0 tp 56.95 73.83 0.75 Allowed Pre-proline 0 C--O 1.252 1.222 0 CA-C-N 114.402 -1.272 . . . . 73.409999999999997 110.833 -174.05 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -63.83 137.58 58.98 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.706 2.271 . . . . 75.349999999999994 110.834 177.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -84.26 143.93 29.25 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 109.332 -0.618 . . . . 55.329999999999998 109.332 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 177.57 110.67 0.28 Allowed Glycine 0 N--CA 1.413 -2.835 0 N-CA-C 109.333 -1.507 . . . . 63.509999999999998 109.333 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.8 m -100.17 164.49 11.94 Favored 'General case' 0 C--N 1.279 -2.494 0 N-CA-C 108.815 -0.809 . . . . 74.310000000000002 108.815 178.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -124.64 132.88 53.39 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.751 -0.463 . . . . 61.350000000000001 109.751 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.436 HD23 ' H ' ' A' ' 48' ' ' LEU . 2.1 pt? -115.81 140.79 48.88 Favored 'General case' 0 C--N 1.29 -2.008 0 C-N-CA 120.312 -0.555 . . . . 75.5 110.837 179.02 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.427 ' O ' HD12 ' A' ' 49' ' ' LEU . 3.1 pp -120.39 140.01 51.96 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 115.542 -0.753 . . . . 74.230000000000004 110.352 178.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.401 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 47.4 t -117.75 126.51 74.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 108.581 -0.896 . . . . 64.519999999999996 108.581 179.403 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 53.2 t -93.1 115.56 32.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 108.942 -0.762 . . . . 64.099999999999994 108.942 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.42 ' HB2' ' HG3' ' A' ' 134' ' ' ARG . 72.7 mmtt -82.56 -46.31 13.52 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.38 -0.97 . . . . 72.5 108.38 176.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -147.84 149.1 31.67 Favored 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 106.968 -1.494 . . . . 75.030000000000001 106.968 179.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 144.99 145.67 4.34 Favored Glycine 0 N--CA 1.425 -2.045 0 N-CA-C 110.527 -1.029 . . . . 54.409999999999997 110.527 -178.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.502 ' HB2' ' H ' ' A' ' 82' ' ' ASP . 13.8 Cg_exo -67.93 -9.18 24.81 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.419 2.746 . . . . 71.319999999999993 113.359 -177.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.502 ' HB2' ' HA ' ' A' ' 80' ' ' LEU . 5.6 t-20 -42.87 -60.3 1.65 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.098 0.959 . . . . 75.540000000000006 111.451 175.356 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 174.37 -64.19 0.01 OUTLIER 'General case' 0 CA--C 1.504 -0.827 0 C-N-CA 124.814 1.245 . . . . 74.409999999999997 107.991 -178.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 116.83 52.91 0.34 Allowed Glycine 0 N--CA 1.441 -0.969 0 N-CA-C 110.023 -1.231 . . . . 62.299999999999997 110.023 -176.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -139.9 -174.3 3.87 Favored 'General case' 0 N--CA 1.434 -1.275 0 N-CA-C 108.881 -0.785 . . . . 71.129999999999995 108.881 -176.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 34.9 ptt180 -122.05 134.65 54.78 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.486 -0.931 . . . . 55.25 108.486 177.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -127.13 139.5 52.93 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 109.85 -0.426 . . . . 72.439999999999998 109.85 -177.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 58.3 tp -101.98 112.05 24.54 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 108.22 -1.03 . . . . 65.430000000000007 108.22 178.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -94.68 116.75 29.12 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.324 0.583 . . . . 54.140000000000001 110.469 -176.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -121.81 8.24 9.96 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.448 -1.315 . . . . 75.530000000000001 107.448 176.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.4 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 2.9 pt20 -93.05 115.96 65.77 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 114.139 -1.391 . . . . 71.439999999999998 109.684 178.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 65' ' ' GLN . 7.1 Cg_endo -50.52 -43.56 44.32 Favored 'Trans proline' 0 C--N 1.361 1.215 0 C-N-CA 123.541 2.827 . . . . 73.450000000000003 113.917 -174.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 31.9 m -106.85 102.77 12.11 Favored 'General case' 0 N--CA 1.423 -1.812 0 N-CA-C 109.63 -0.508 . . . . 74.120000000000005 109.63 177.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.419 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 79.4 m -108.79 114.05 27.5 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 107.444 -1.317 . . . . 74.129999999999995 107.444 176.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 14.5 t -117.61 128.79 55.28 Favored 'General case' 0 C--N 1.296 -1.761 0 C-N-CA 119.221 -0.992 . . . . 71.219999999999999 110.693 -175.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.508 ' HA ' ' O ' ' A' ' 78' ' ' ILE . . . -115.08 106.44 14.12 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 115.504 -0.771 . . . . 44.009999999999998 109.576 -176.211 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.46 73.11 1.28 Allowed Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 109.314 -1.515 . . . . 75.129999999999995 109.314 -175.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.531 ' HA ' ' O ' ' A' ' 87' ' ' ARG . 1.1 tmm_? -145.07 85.55 1.75 Allowed 'General case' 0 N--CA 1.423 -1.805 0 N-CA-C 107.294 -1.372 . . . . 73.409999999999997 107.294 -178.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.568 ' CG ' ' HD2' ' A' ' 74' ' ' PRO . 1.3 t-80 68.3 170.71 0.1 Allowed Pre-proline 0 CA--C 1.575 1.935 0 O-C-N 124.545 1.153 . . . . 74.5 109.075 177.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.568 ' HD2' ' CG ' ' A' ' 73' ' ' HIS . 96.3 Cg_exo -48.38 -39.63 35.83 Favored 'Trans proline' 0 C--N 1.369 1.645 0 C-N-CA 121.981 1.787 . . . . 55.32 112.789 175.322 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.9 pm0 -92.07 58.27 3.3 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 122.202 1.001 . . . . 73.409999999999997 111.636 178.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 66.2 m -65.28 150.47 48.19 Favored 'General case' 0 C--O 1.244 0.783 0 CA-C-N 115.143 -0.935 . . . . 75.420000000000002 108.997 175.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -68.97 -45.2 71.29 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 107.434 -1.321 . . . . 71.150000000000006 107.434 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.508 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 46.1 pt -139.97 143.82 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 N-CA-C 108.135 -1.061 . . . . 74.140000000000001 108.135 171.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -102.47 130.8 49.38 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 119.251 -0.98 . . . . 63.310000000000002 108.403 172.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.502 ' HA ' ' HB2' ' A' ' 56' ' ' ASN . 30.8 tp -108.53 -26.15 10.57 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-O 122.552 1.168 . . . . 74.540000000000006 109.786 -174.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -138.23 134.09 34.0 Favored 'General case' 0 C--N 1.266 -3.022 0 N-CA-C 105.854 -1.906 . . . . 72.0 105.854 177.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.502 ' H ' ' HB2' ' A' ' 55' ' ' PRO . 33.1 t70 -117.79 -15.49 10.07 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 115.534 -0.757 . . . . 62.229999999999997 111.21 -177.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.4 m -91.3 -21.91 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.812 0 N-CA-C 108.087 -1.079 . . . . 73.120000000000005 108.087 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 22.4 m -138.34 83.51 1.97 Allowed 'General case' 0 N--CA 1.414 -2.24 0 CA-C-N 114.56 -1.2 . . . . 72.239999999999995 108.375 174.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.8 p -112.16 139.88 34.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 108.48 -0.933 . . . . 65.129999999999995 108.48 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 15.5 m -124.44 168.83 12.52 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 109.582 -0.525 . . . . 62.200000000000003 109.582 -177.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.531 ' O ' ' HA ' ' A' ' 72' ' ' ARG . 20.5 mtp180 -68.56 -31.59 70.91 Favored 'General case' 0 C--O 1.212 -0.897 0 CA-C-O 121.042 0.449 . . . . 71.510000000000005 110.074 175.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.412 ' HG2' HG21 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -143.82 101.7 3.79 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 106.277 -1.749 . . . . 73.120000000000005 106.277 170.781 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.515 ' O ' HG22 ' A' ' 104' ' ' VAL . 19.0 t60 -98.74 -71.7 0.68 Allowed 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 114.466 -1.243 . . . . 75.030000000000001 111.075 -174.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -144.75 160.69 40.83 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 107.738 -1.208 . . . . 73.400000000000006 107.738 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -146.19 139.46 25.89 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.907 -0.717 . . . . 74.420000000000002 110.262 -177.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.419 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 78.1 m-85 -115.61 123.0 47.32 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.898 -0.778 . . . . 73.510000000000005 108.898 -177.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 52.8 mtm-85 -107.8 123.65 48.89 Favored 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 107.831 -1.174 . . . . 72.349999999999994 107.831 176.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.3 pp -115.42 116.08 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.128 0 C-N-CA 118.684 -1.207 . . . . 72.120000000000005 108.38 177.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.546 ' ND2' ' HG2' ' A' ' 96' ' ' GLU . 4.9 t30 -120.09 147.05 45.34 Favored 'General case' 0 C--N 1.28 -2.424 0 CA-C-N 114.121 -1.399 . . . . 61.539999999999999 107.55 -179.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.546 ' HG2' ' ND2' ' A' ' 95' ' ' ASN . 8.8 pt-20 -29.12 -36.6 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 126.898 2.079 . . . . 72.239999999999995 115.908 -177.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -131.95 3.04 5.24 Favored Glycine 0 CA--C 1.504 -0.6 0 C-N-CA 119.387 -1.387 . . . . 45.340000000000003 113.28 -175.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -148.05 118.2 7.28 Favored 'General case' 0 N--CA 1.411 -2.399 0 CA-C-O 122.401 1.096 . . . . 72.510000000000005 111.098 -177.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.509 ' HD1' ' SD ' ' A' ' 122' ' ' MET . 71.0 m-85 -107.09 115.83 30.86 Favored 'General case' 0 C--N 1.275 -2.663 0 CA-C-N 114.423 -1.262 . . . . 73.549999999999997 107.62 -179.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -110.18 135.92 50.2 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 113.612 0.967 . . . . 53.119999999999997 113.612 -173.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.5 p -116.33 117.64 56.15 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.116 0 CA-C-N 114.377 -1.283 . . . . 75.140000000000001 107.709 173.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 39.7 t -120.86 125.36 73.96 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 CA-C-N 115.831 -0.622 . . . . 73.519999999999996 110.768 -177.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.459 ' HB2' ' HB ' ' A' ' 110' ' ' THR . 18.0 t0 -92.45 115.46 28.11 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 102.333 -3.21 . . . . 74.019999999999996 102.333 168.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 89' ' ' HIS . 19.2 m -59.67 -23.35 25.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 113.278 0.844 . . . . 73.439999999999998 113.278 -169.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -152.76 16.06 0.72 Allowed Glycine 0 C--N 1.305 -1.176 0 C-N-CA 117.8 -2.143 . . . . 74.420000000000002 113.796 178.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 50.3 m 57.17 36.6 27.7 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 122.824 1.297 . . . . 34.329999999999998 107.514 -175.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 49.5 tp -73.66 -47.43 39.93 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 112.828 -1.987 . . . . 74.340000000000003 112.761 -168.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -107.4 -11.52 15.51 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 119.2 -1.0 . . . . 70.420000000000002 109.791 179.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 97.5 65.12 0.89 Allowed Glycine 0 N--CA 1.433 -1.53 0 C-N-CA 120.413 -0.899 . . . . 61.32 113.247 173.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.459 ' HB ' ' HB2' ' A' ' 103' ' ' ASP . 18.9 m -85.24 119.66 25.87 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.683 -0.858 . . . . 64.200000000000003 108.683 174.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.45 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 2.1 m-85 -116.91 140.87 48.95 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.419 -0.956 . . . . 64.239999999999995 108.419 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.5 p -99.58 116.46 42.81 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 N-CA-C 108.197 -1.038 . . . . 65.129999999999995 108.197 176.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 71.17 -73.53 0.1 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.131 0.972 . . . . 74.329999999999998 109.476 -175.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 48.5 ttp180 -161.3 14.37 0.1 Allowed 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 107.538 -1.282 . . . . 72.0 107.538 172.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.446 ' HG3' ' HE ' ' A' ' 117' ' ' ARG . 15.3 tp10 -102.27 116.36 63.13 Favored Pre-proline 0 N--CA 1.429 -1.479 0 CA-C-N 115.513 -0.767 . . . . 72.109999999999999 108.94 -172.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -76.24 103.67 1.78 Allowed 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.85 2.367 . . . . 71.310000000000002 111.195 178.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.446 ' HE ' ' HG3' ' A' ' 115' ' ' GLU . 15.1 mmt180 -130.79 157.23 43.43 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 109.348 -0.612 . . . . 74.239999999999995 109.348 -179.153 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 50.8 m-20 -76.88 -42.57 39.37 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.487 -1.301 . . . . 63.439999999999998 107.487 178.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -147.87 146.04 28.92 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 114.561 -1.2 . . . . 73.209999999999994 108.886 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -138.58 138.17 37.67 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 108.545 -0.909 . . . . 74.25 108.545 178.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 39.0 t -94.82 95.46 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.527 0 C-N-CA 119.477 -0.889 . . . . 71.340000000000003 108.61 177.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.509 ' SD ' ' HD1' ' A' ' 99' ' ' PHE . 25.5 ptt? 44.56 139.02 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 119.087 2.995 . . . . 72.230000000000004 119.087 177.188 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -132.97 122.81 24.81 Favored 'General case' 0 N--CA 1.401 -2.92 1 N-CA-C 99.815 -4.143 . . . . 73.010000000000005 99.815 166.308 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 13.1 t -108.04 127.39 53.74 Favored 'General case' 0 C--N 1.288 -2.077 0 C-N-CA 118.606 -1.238 . . . . 54.229999999999997 112.034 -171.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 83.84 22.35 55.69 Favored Glycine 0 N--CA 1.424 -2.113 0 N-CA-C 109.993 -1.243 . . . . 64.0 109.993 -179.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -122.76 -175.88 3.26 Favored 'General case' 0 C--O 1.249 1.053 0 N-CA-C 108.36 -0.978 . . . . 72.510000000000005 108.36 -177.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.469 ' OE2' ' HD3' ' A' ' 134' ' ' ARG . 40.0 mt-10 -116.65 130.98 57.05 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 121.784 0.802 . . . . 72.150000000000006 111.492 -175.027 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 66.0 mt -100.47 126.43 54.07 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 N-CA-C 107.151 -1.426 . . . . 74.019999999999996 107.151 176.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.45 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 34.4 tt0 -93.43 112.65 24.61 Favored 'General case' 0 C--N 1.282 -2.334 0 N-CA-C 108.339 -0.986 . . . . 65.439999999999998 108.339 -178.281 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.52 HG13 ' HB2' ' A' ' 133' ' ' PHE . 19.2 pt -101.92 97.95 6.27 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.07 0 N-CA-C 108.747 -0.834 . . . . 72.420000000000002 108.747 179.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 70.13 -98.86 0.66 Allowed Glycine 0 N--CA 1.432 -1.575 0 N-CA-C 109.738 -1.345 . . . . 62.200000000000003 109.738 -176.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -122.71 5.08 9.48 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 120.707 0.289 . . . . 62.299999999999997 110.72 177.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.52 ' HB2' HG13 ' A' ' 130' ' ' ILE . 27.1 m-85 -104.72 171.38 7.35 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 108.784 -0.821 . . . . 72.340000000000003 108.784 -179.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.469 ' HD3' ' OE2' ' A' ' 127' ' ' GLU . 14.0 ptp180 -130.67 132.67 45.55 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.73 0.776 . . . . 70.420000000000002 112.057 -179.201 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.403 HD11 ' HB2' ' A' ' 49' ' ' LEU . 48.9 tp -117.48 143.46 46.02 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 114.167 -1.379 . . . . 74.540000000000006 107.411 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.401 ' HB ' ' HB ' ' A' ' 50' ' ' VAL . 34.2 t -106.72 129.95 59.41 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 N-CA-C 106.553 -1.647 . . . . 71.310000000000002 106.553 177.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.401 ' CE2' ' HB2' ' A' ' 139' ' ' ALA . 70.8 t80 -121.64 119.89 33.17 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 120.964 0.411 . . . . 71.030000000000001 111.188 -174.09 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.4 mp -117.53 116.68 27.6 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 107.873 -1.158 . . . . 75.510000000000005 107.873 177.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.401 ' HB2' ' CE2' ' A' ' 137' ' ' PHE . . . -122.1 122.87 40.24 Favored 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 121.02 -0.272 . . . . 33.43 110.382 -175.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.483 ' N ' ' HD2' ' A' ' 141' ' ' PRO . . . 152.48 -52.72 0.48 Allowed Glycine 0 C--N 1.306 -1.095 0 C-N-CA 118.376 -1.868 . . . . 63.539999999999999 115.353 178.181 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.483 ' HD2' ' N ' ' A' ' 140' ' ' GLY . 5.2 Cg_endo -46.1 125.7 8.85 Favored 'Trans proline' 0 C--N 1.374 1.904 0 C-N-CA 123.489 2.793 . . . . 65.540000000000006 114.672 -177.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -91.54 120.76 32.63 Favored 'General case' 0 N--CA 1.425 -1.681 0 CA-C-N 114.809 -1.087 . . . . 71.25 108.6 179.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.282 -2.343 0 N-CA-C 105.858 -1.904 . . . . 64.109999999999999 105.858 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.8 ttt . . . . . 0 CA--C 1.504 -0.798 0 N-CA-C 110.096 -0.335 . . . . 73.409999999999997 110.096 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.4 t -83.45 -50.22 8.51 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 107.518 -1.29 . . . . 73.310000000000002 107.518 174.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.9 t70 57.48 19.13 4.99 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 126.073 1.749 . . . . 75.420000000000002 111.761 176.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -124.46 145.35 49.57 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 108.828 -0.804 . . . . 71.219999999999999 108.828 -178.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -121.67 102.87 8.49 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 107.655 -1.239 . . . . 74.209999999999994 107.655 174.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -82.13 105.52 2.58 Favored Glycine 0 C--N 1.303 -1.292 0 N-CA-C 111.178 -0.769 . . . . 73.049999999999997 111.178 -177.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.5 t -83.18 135.32 44.66 Favored Pre-proline 0 C--N 1.302 -1.463 0 N-CA-C 109.035 -0.728 . . . . 64.439999999999998 109.035 -178.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -66.75 150.15 83.51 Favored 'Trans proline' 0 C--O 1.236 0.419 0 C-N-CA 122.574 2.182 . . . . 74.120000000000005 112.072 -178.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.412 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 0.7 OUTLIER -79.79 112.19 27.51 Favored Pre-proline 0 C--N 1.316 -0.885 0 N-CA-C 109.598 -0.519 . . . . 75.140000000000001 109.598 176.983 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 9' ' ' GLU . 16.5 Cg_exo -65.23 118.09 5.15 Favored 'Trans proline' 0 C--O 1.246 0.921 0 C-N-CA 122.465 2.11 . . . . 72.549999999999997 112.256 -175.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.476 ' HA ' ' OE1' ' A' ' 11' ' ' GLN . 5.0 tp60 -93.39 81.02 4.39 Favored 'General case' 0 N--CA 1.42 -1.95 0 CA-C-O 122.115 0.96 . . . . 74.239999999999995 109.814 177.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.4 t -104.53 120.05 54.33 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 N-CA-C 106.634 -1.617 . . . . 74.310000000000002 106.634 177.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.63 140.95 51.72 Favored 'General case' 0 N--CA 1.433 -1.317 0 CA-C-O 120.943 0.401 . . . . 74.420000000000002 111.044 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.7 m -113.2 88.28 2.8 Favored 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 109.217 -0.661 . . . . 65.409999999999997 109.217 -179.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 42.7 m -100.29 95.06 6.53 Favored 'General case' 0 N--CA 1.411 -2.406 0 N-CA-C 108.901 -0.777 . . . . 73.430000000000007 108.901 178.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.0 t -101.19 98.06 8.51 Favored 'General case' 0 N--CA 1.42 -1.946 0 N-CA-C 108.135 -1.061 . . . . 52.140000000000001 108.135 -178.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 23.5 t -95.33 97.72 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 N-CA-C 109.162 -0.681 . . . . 51.039999999999999 109.162 -178.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -88.73 128.68 35.62 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 108.335 -0.987 . . . . 72.340000000000003 108.335 175.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 18.8 mtm180 -109.68 159.99 16.67 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 109.238 -0.653 . . . . 74.030000000000001 109.238 -173.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -99.62 86.01 3.25 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.782 -1.192 . . . . 75.420000000000002 107.782 174.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -93.35 -40.37 10.43 Favored 'General case' 0 CA--C 1.494 -1.194 0 CA-C-N 115.545 -0.752 . . . . 54.310000000000002 110.484 -178.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.9 pp -73.73 155.28 39.09 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-O 121.351 0.596 . . . . 72.409999999999997 111.9 -178.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 95.8 mt -136.56 -178.02 4.99 Favored 'General case' 0 C--N 1.294 -1.804 0 N-CA-C 106.76 -1.57 . . . . 72.439999999999998 106.76 178.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -76.8 104.25 7.2 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 121.344 0.592 . . . . 62.109999999999999 109.763 177.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -83.18 103.66 12.76 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.843 -0.799 . . . . 53.450000000000003 108.843 178.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 49.8 mtt -85.93 96.06 9.68 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 115.219 -0.901 . . . . 71.319999999999993 109.886 -175.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -111.89 118.56 35.85 Favored 'General case' 0 N--CA 1.426 -1.671 0 C-N-CA 119.883 -0.727 . . . . 65.420000000000002 109.186 175.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.413 ' OG ' ' HA ' ' A' ' 34' ' ' PRO . 10.7 t -122.06 128.48 51.42 Favored 'General case' 0 N--CA 1.408 -2.534 0 N-CA-C 105.392 -2.077 . . . . 74.540000000000006 105.392 176.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 58.8 p -140.94 -178.52 5.59 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 120.264 -0.574 . . . . 73.219999999999999 111.494 -175.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 23.5 m -74.95 127.69 33.81 Favored 'General case' 0 N--CA 1.425 -1.699 0 N-CA-C 108.188 -1.042 . . . . 64.120000000000005 108.188 177.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.05 -42.14 1.97 Allowed Glycine 0 N--CA 1.44 -1.099 0 N-CA-C 111.007 -0.837 . . . . 62.109999999999999 111.007 -179.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.9 p -78.52 161.14 27.26 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 122.405 0.282 . . . . 63.219999999999999 110.597 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.24 126.56 92.4 Favored Pre-proline 0 N--CA 1.432 -1.371 0 N-CA-C 107.299 -1.371 . . . . 53.109999999999999 107.299 173.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.413 ' HA ' ' OG ' ' A' ' 28' ' ' SER . 24.9 Cg_endo -62.32 126.43 18.51 Favored 'Trans proline' 0 C--O 1.256 1.418 0 C-N-CA 122.334 2.023 . . . . 74.120000000000005 112.899 -176.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -69.86 95.41 0.91 Allowed 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 106.903 -1.517 . . . . 70.519999999999996 106.903 174.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.8 p -121.24 152.55 38.72 Favored 'General case' 0 N--CA 1.408 -2.571 0 CA-C-N 115.004 -0.998 . . . . 74.439999999999998 111.682 -171.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.5 t -79.75 176.59 9.58 Favored 'General case' 0 N--CA 1.425 -1.693 0 CA-C-N 115.382 -0.826 . . . . 52.32 108.908 177.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -83.25 96.21 1.9 Allowed Glycine 0 N--CA 1.419 -2.434 0 N-CA-C 109.749 -1.34 . . . . 73.400000000000006 109.749 -179.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.446 ' HA ' HD13 ' A' ' 42' ' ' LEU . . . -56.5 -34.43 66.96 Favored 'General case' 0 C--N 1.293 -1.875 0 C-N-CA 125.15 1.38 . . . . 63.240000000000002 112.159 -176.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.8 pm0 -68.47 -13.9 62.63 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.676 -0.693 . . . . 74.450000000000003 112.444 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -83.14 -14.09 54.27 Favored 'General case' 0 C--N 1.319 -0.729 0 O-C-N 122.018 -0.426 . . . . 62.229999999999997 111.703 -179.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.446 HD13 ' HA ' ' A' ' 39' ' ' ALA . 9.3 mp -67.84 116.39 37.66 Favored Pre-proline 0 C--N 1.319 -0.757 0 CA-C-N 115.919 -0.582 . . . . 62.310000000000002 109.757 178.122 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -68.82 -28.25 30.28 Favored 'Trans proline' 0 N--CA 1.475 0.397 0 C-N-CA 122.512 2.141 . . . . 73.109999999999999 112.107 -177.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -104.76 23.4 13.48 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.978 0.894 . . . . 73.099999999999994 109.037 179.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -107.63 7.01 36.11 Favored Glycine 0 N--CA 1.433 -1.516 0 CA-C-N 114.644 -1.162 . . . . 74.430000000000007 112.186 -178.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.446 ' HB2' ' O ' ' A' ' 141' ' ' PRO . 8.7 m -90.19 152.96 20.85 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 121.464 0.65 . . . . 64.239999999999995 109.5 -178.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -153.73 164.15 38.81 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.234 -1.025 . . . . 64.510000000000005 108.234 -177.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 62' ' ' LEU . 2.5 pt? -130.12 142.13 50.62 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.402 0.62 . . . . 73.400000000000006 111.471 -179.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.42 ' O ' HD12 ' A' ' 49' ' ' LEU . 4.2 pp -109.78 133.25 53.36 Favored 'General case' 0 N--CA 1.423 -1.825 0 N-CA-C 107.736 -1.209 . . . . 73.25 107.736 175.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 48.1 t -119.08 117.46 54.31 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 N-CA-C 109.69 -0.485 . . . . 65.109999999999999 109.69 -176.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 57.3 t -93.04 114.45 29.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 106.016 -1.846 . . . . 34.229999999999997 106.016 175.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -93.39 -33.11 13.99 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.389 -0.597 . . . . 74.150000000000006 109.389 -176.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.472 ' O ' ' HB3' ' A' ' 133' ' ' PHE . 60.5 mtt180 -138.53 123.19 18.63 Favored 'General case' 0 CA--C 1.487 -1.444 0 N-CA-C 108.559 -0.904 . . . . 74.319999999999993 108.559 177.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.4 ' HA2' ' CD1' ' A' ' 133' ' ' PHE . . . 146.98 116.33 0.94 Allowed Glycine 0 N--CA 1.415 -2.761 0 C-N-CA 120.911 -0.662 . . . . 71.329999999999998 112.525 179.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.4 ' HD2' ' HA2' ' A' ' 54' ' ' GLY . 11.9 Cg_endo -59.55 -9.22 8.54 Favored 'Trans proline' 0 C--N 1.37 1.689 0 C-N-CA 124.058 3.172 . . . . 71.5 112.269 176.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.428 ' HA ' ' N ' ' A' ' 81' ' ' ASP . 2.3 m-20 -45.99 -49.42 16.03 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 125.39 1.476 . . . . 74.140000000000001 108.901 172.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -149.37 -58.65 0.21 Allowed 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 115.407 -0.815 . . . . 63.210000000000001 109.54 -179.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.21 31.71 63.56 Favored Glycine 0 CA--C 1.507 -0.465 0 N-CA-C 110.099 -1.2 . . . . 73.310000000000002 110.099 -176.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -152.93 176.05 12.27 Favored 'General case' 0 N--CA 1.42 -1.952 0 N-CA-C 108.834 -0.802 . . . . 44.43 108.834 -175.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -109.17 153.44 23.76 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.888 -0.597 . . . . 74.430000000000007 109.557 177.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -143.64 134.24 24.96 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 108.141 -1.059 . . . . 73.549999999999997 108.141 -179.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 48' ' ' LEU . 0.8 OUTLIER -104.21 135.81 44.98 Favored 'General case' 0 N--CA 1.428 -1.539 0 CA-C-O 120.877 0.37 . . . . 73.430000000000007 110.571 178.146 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 81.6 mt -82.6 115.07 21.4 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.684 -0.689 . . . . 51.439999999999998 109.471 -178.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -126.63 9.18 7.05 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 107.582 -1.266 . . . . 73.150000000000006 107.582 176.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -131.19 147.51 66.54 Favored Pre-proline 0 C--N 1.295 -1.781 0 CA-C-N 113.571 -1.649 . . . . 64.019999999999996 107.621 -175.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -57.42 -53.52 4.6 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 122.759 2.306 . . . . 71.0 114.859 -175.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 85.0 m -131.67 109.78 10.44 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.224 0.535 . . . . 73.019999999999996 112.365 -177.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 41.4 m -98.55 118.07 34.42 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.309 -0.997 . . . . 72.540000000000006 108.309 175.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.501 ' OG1' ' HG2' ' A' ' 88' ' ' ARG . 12.5 t -102.59 147.79 26.35 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 119.308 -0.957 . . . . 74.239999999999995 110.697 179.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -108.1 132.67 53.34 Favored 'General case' 0 N--CA 1.424 -1.726 0 CA-C-N 115.437 -0.801 . . . . 63.229999999999997 109.509 179.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.543 ' O ' ' HA ' ' A' ' 79' ' ' PHE . . . -161.53 -146.05 4.51 Favored Glycine 0 N--CA 1.428 -1.852 0 N-CA-C 108.645 -1.782 . . . . 64.400000000000006 108.645 176.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 18.2 ttp85 -164.76 58.76 0.13 Allowed 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.166 -1.05 . . . . 74.450000000000003 108.166 173.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 70.1 m80 -139.38 165.24 33.11 Favored Pre-proline 0 C--N 1.279 -2.499 0 N-CA-C 106.738 -1.579 . . . . 64.040000000000006 106.738 179.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 99.5 Cg_exo -48.99 -33.43 26.16 Favored 'Trans proline' 0 C--N 1.358 1.055 0 C-N-CA 122.715 2.277 . . . . 65.010000000000005 112.556 177.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -106.71 74.39 1.0 Allowed 'General case' 0 N--CA 1.432 -1.347 0 CA-C-O 122.016 0.912 . . . . 61.039999999999999 109.855 176.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 37.7 m -146.1 123.42 11.6 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 113.957 -1.474 . . . . 34.039999999999999 108.159 174.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -65.21 -52.1 56.8 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-O 120.605 0.241 . . . . 75.349999999999994 110.83 -178.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 41.8 pt -123.61 178.78 3.15 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 109.627 -0.509 . . . . 65.140000000000001 109.627 175.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.543 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 97.2 m-85 -122.89 136.98 55.06 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 112.623 0.601 . . . . 75.010000000000005 112.623 -172.101 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -117.92 132.23 56.43 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.187 -1.412 . . . . 71.25 107.187 167.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.428 ' N ' ' HA ' ' A' ' 56' ' ' ASN . 38.1 t70 -127.98 70.21 1.34 Allowed 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 122.437 1.113 . . . . 52.439999999999998 109.439 -175.183 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -122.92 -163.56 1.11 Allowed 'General case' 0 C--N 1.284 -2.273 0 CA-C-N 113.668 -1.606 . . . . 72.310000000000002 108.542 176.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 44.7 t -65.27 -38.03 81.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 C-N-CA 123.389 0.676 . . . . 64.219999999999999 112.133 -176.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 26.2 m -121.95 93.5 4.01 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.868 0.842 . . . . 74.430000000000007 112.75 -175.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 6.0 p -111.63 128.89 67.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 CA-C-N 114.91 -1.041 . . . . 35.43 110.793 -178.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.423 ' HB2' ' HB2' ' A' ' 89' ' ' HIS . 8.9 m -112.64 -170.4 1.66 Allowed 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.232 -0.655 . . . . 65.310000000000002 109.232 178.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -78.98 -76.05 0.21 Allowed 'General case' 0 C--O 1.217 -0.609 0 N-CA-C 109.982 -0.377 . . . . 71.209999999999994 109.982 177.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.501 ' HG2' ' OG1' ' A' ' 69' ' ' THR . 1.5 tmm_? -101.48 82.58 2.32 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 105.386 -2.079 . . . . 52.229999999999997 105.386 174.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.423 ' HB2' ' HB2' ' A' ' 86' ' ' SER . 67.1 t60 -87.37 -70.76 0.6 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.219 -0.901 . . . . 75.420000000000002 112.49 -170.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -110.86 147.57 34.27 Favored 'General case' 0 CA--C 1.483 -1.631 0 N-CA-C 108.793 -0.818 . . . . 72.230000000000004 108.793 -177.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -128.3 127.81 43.44 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-O 121.201 0.524 . . . . 75.230000000000004 110.412 178.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.532 ' HD1' ' HE3' ' A' ' 122' ' ' MET . 83.7 m-85 -105.81 113.13 26.5 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 105.602 -1.999 . . . . 75.420000000000002 105.602 177.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 71.7 mtp180 -118.45 147.32 43.72 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 121.864 0.84 . . . . 71.400000000000006 112.961 -172.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.53 117.12 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.321 0 N-CA-C 103.428 -2.804 . . . . 73.319999999999993 103.428 170.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 32.1 t-20 -118.36 147.25 43.71 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 108.161 -1.052 . . . . 72.019999999999996 108.161 -173.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.63 -20.09 53.62 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 113.195 0.813 . . . . 64.140000000000001 113.195 -179.104 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -78.82 -49.86 6.27 Favored Glycine 0 N--CA 1.423 -2.18 0 N-CA-C 111.14 -0.784 . . . . 71.030000000000001 111.14 173.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.411 ' HG2' ' H ' ' A' ' 99' ' ' PHE . 28.6 tt0 -177.77 -172.94 0.37 Allowed 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 107.363 -1.347 . . . . 74.319999999999993 107.363 -177.253 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.445 ' CB ' ' HB3' ' A' ' 122' ' ' MET . 89.9 m-85 -89.84 138.68 31.28 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 118.919 0.781 . . . . 70.549999999999997 109.393 -178.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -131.9 135.19 46.46 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 116.274 -0.421 . . . . 74.299999999999997 110.431 -174.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.6 p -128.95 117.71 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 108.934 -0.765 . . . . 71.230000000000004 108.934 174.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 19.4 m -121.09 135.55 60.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 CA-C-N 115.307 -0.86 . . . . 74.0 112.051 -178.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -99.07 107.38 19.77 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 106.093 -1.817 . . . . 75.120000000000005 106.093 170.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.4 m -94.21 9.35 5.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-O 121.402 0.62 . . . . 72.049999999999997 111.224 -176.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -90.04 -42.41 5.32 Favored Glycine 0 N--CA 1.428 -1.844 0 N-CA-C 108.159 -1.976 . . . . 73.420000000000002 108.159 172.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 39.7 m 70.23 -37.82 0.39 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.739 2.016 . . . . 53.219999999999999 114.348 174.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -58.66 -42.51 88.6 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 123.111 0.564 . . . . 65.120000000000005 111.658 177.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -86.05 -52.09 5.92 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.894 -0.78 . . . . 72.329999999999998 108.894 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 77.31 103.28 0.17 Allowed Glycine 0 N--CA 1.434 -1.456 0 CA-C-N 115.33 -0.85 . . . . 70.400000000000006 114.545 177.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 89.3 m -76.21 120.01 20.91 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 106.414 -1.698 . . . . 61.200000000000003 106.414 169.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -114.3 171.98 7.29 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.883 0.849 . . . . 72.010000000000005 111.591 -171.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.44 ' HB ' ' HB2' ' A' ' 115' ' ' GLU . 21.9 t -98.53 142.74 14.19 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.122 0 N-CA-C 104.758 -2.312 . . . . 64.030000000000001 104.758 173.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -40.03 -36.84 0.52 Allowed 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 114.204 1.187 . . . . 71.239999999999995 114.204 -176.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -118.56 -13.0 9.7 Favored 'General case' 0 C--O 1.222 -0.387 0 N-CA-C 112.386 0.513 . . . . 74.340000000000003 112.386 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.44 ' HB2' ' HB ' ' A' ' 112' ' ' VAL . 64.0 mm-40 -114.43 107.42 51.28 Favored Pre-proline 0 C--N 1.315 -0.933 0 N-CA-C 111.892 0.33 . . . . 62.43 111.892 -178.045 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -83.65 101.35 0.92 Allowed 'Trans proline' 0 N--CA 1.44 -1.665 0 C-N-CA 122.4 2.067 . . . . 62.439999999999998 110.739 176.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.584 ' HD2' ' OE1' ' A' ' 120' ' ' GLN . 15.5 ptp180 -153.63 152.94 31.42 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.884 -1.154 . . . . 52.310000000000002 107.884 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -81.16 -26.96 35.64 Favored 'General case' 0 C--N 1.313 -1.022 0 N-CA-C 112.425 0.528 . . . . 61.039999999999999 112.425 -175.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -129.38 139.04 51.82 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 109.273 -0.64 . . . . 25.199999999999999 109.273 178.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.584 ' OE1' ' HD2' ' A' ' 117' ' ' ARG . 51.8 tp60 -140.45 149.48 42.62 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.491 -0.777 . . . . 64.400000000000006 109.925 -176.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.4 p -79.47 121.4 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 105.764 -1.939 . . . . 63.439999999999998 105.764 169.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.532 ' HE3' ' HD1' ' A' ' 92' ' ' PHE . 10.9 ttt -71.35 115.02 10.02 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 121.575 0.702 . . . . 75.129999999999995 109.159 -170.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 21.5 tp60 -104.76 135.13 46.71 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.254 -0.885 . . . . 74.420000000000002 108.776 -173.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.1 t -78.86 131.33 36.41 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-O 121.049 0.452 . . . . 52.119999999999997 110.256 178.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 89.14 24.76 30.84 Favored Glycine 0 N--CA 1.426 -2.012 0 N-CA-C 111.024 -0.83 . . . . 71.409999999999997 111.024 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -116.49 169.45 9.32 Favored 'General case' 0 C--O 1.251 1.139 0 N-CA-C 109.16 -0.682 . . . . 64.040000000000006 109.16 -178.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.424 ' CD ' ' HE ' ' A' ' 134' ' ' ARG . 13.7 tp10 -114.07 121.22 43.16 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.819 -1.178 . . . . 65.510000000000005 107.819 -174.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 65.2 mt -107.93 131.43 58.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 C-N-CA 123.93 0.892 . . . . 64.439999999999998 110.577 -175.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -101.13 111.87 24.2 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.803 -0.635 . . . . 61.43 109.296 -177.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 5.1 pt -103.1 98.14 6.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 CA-C-O 121.575 0.702 . . . . 62.25 109.808 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 71.88 -100.4 0.92 Allowed Glycine 0 N--CA 1.44 -1.088 0 N-CA-C 109.228 -1.549 . . . . 75.549999999999997 109.228 -174.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -124.41 5.7 8.36 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 108.953 -0.758 . . . . 74.219999999999999 108.953 175.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.472 ' HB3' ' O ' ' A' ' 53' ' ' ARG . 63.0 m-85 -103.19 173.54 6.26 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 115.408 -0.815 . . . . 71.349999999999994 110.563 -175.201 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.424 ' HE ' ' CD ' ' A' ' 127' ' ' GLU . 34.2 ttt180 -132.26 125.21 30.53 Favored 'General case' 0 C--O 1.255 1.365 0 C-N-CA 119.698 -0.801 . . . . 75.129999999999995 112.988 -165.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 5.9 tt -124.57 139.7 53.63 Favored 'General case' 0 C--O 1.21 -0.984 0 C-N-CA 124.792 1.237 . . . . 71.310000000000002 109.495 -178.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 8.6 t -109.95 136.39 46.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 107.088 -1.449 . . . . 75.25 107.088 176.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -115.06 126.8 55.12 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 120.195 -0.602 . . . . 71.549999999999997 110.983 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.0 mp -133.35 133.07 42.01 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.961 -0.385 . . . . 72.510000000000005 109.961 178.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -93.44 141.42 28.48 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 105.102 -2.184 . . . . 61.340000000000003 105.102 170.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 177.15 -52.44 0.1 Allowed Glycine 0 C--N 1.289 -2.057 0 C-N-CA 118.273 -1.917 . . . . 44.130000000000003 114.307 -174.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.446 ' O ' ' HB2' ' A' ' 46' ' ' SER . 33.2 Cg_exo -58.89 112.0 1.07 Allowed 'Trans proline' 0 C--N 1.368 1.565 0 CA-C-N 119.906 1.853 . . . . 71.319999999999993 112.194 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -109.98 104.5 13.41 Favored 'General case' 0 C--N 1.264 -3.133 0 N-CA-C 106.452 -1.685 . . . . 53.109999999999999 106.452 177.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 . . . . . 0 N--CA 1.407 -2.584 0 CA-C-O 118.164 -0.922 . . . . 63.539999999999999 111.327 -171.908 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 CA--C 1.505 -0.772 0 N-CA-C 109.931 -0.396 . . . . 75.230000000000004 109.931 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.6 m -79.35 -31.6 43.05 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 108.166 -1.05 . . . . 64.200000000000003 108.166 177.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -110.03 142.91 40.8 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 114.449 -1.251 . . . . 62.310000000000002 107.989 175.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -68.86 106.52 2.73 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 109.695 -0.484 . . . . 74.099999999999994 109.695 179.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -67.36 110.45 3.57 Favored 'General case' 0 C--O 1.245 0.843 0 CA-C-N 114.95 -1.023 . . . . 73.200000000000003 110.785 -175.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.38 104.51 3.18 Favored Glycine 0 N--CA 1.437 -1.282 0 N-CA-C 111.145 -0.782 . . . . 44.109999999999999 111.145 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 50.3 m -101.63 124.44 40.68 Favored Pre-proline 0 C--N 1.301 -1.521 0 N-CA-C 109.838 -0.43 . . . . 75.510000000000005 109.838 -178.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -66.33 145.23 77.06 Favored 'Trans proline' 0 C--O 1.247 0.926 0 C-N-CA 121.837 1.691 . . . . 74.409999999999997 110.007 175.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -69.76 138.71 88.18 Favored Pre-proline 0 C--N 1.3 -1.548 0 CA-C-N 116.336 -0.393 . . . . 75.150000000000006 109.996 -175.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.32 134.3 60.61 Favored 'Trans proline' 0 C--O 1.252 1.185 0 C-N-CA 122.845 2.363 . . . . 74.219999999999999 113.098 -174.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 73.84 80.33 0.12 Allowed 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 125.903 1.681 . . . . 63.43 110.705 -176.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.5 p -103.38 136.57 35.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-N 114.754 -1.112 . . . . 64.310000000000002 109.189 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.28 131.54 36.04 Favored 'General case' 0 N--CA 1.42 -1.969 0 CA-C-O 120.941 0.401 . . . . 72.310000000000002 109.939 179.06 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.9 t -82.84 147.36 28.39 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 109.012 -0.736 . . . . 53.119999999999997 109.012 176.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.0 t -85.06 114.37 22.16 Favored 'General case' 0 N--CA 1.407 -2.577 0 CA-C-O 121.761 0.791 . . . . 61.329999999999998 109.311 178.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 37.4 m -138.68 85.45 2.08 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 115.131 -0.94 . . . . 63.219999999999999 108.754 175.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.1 p -145.54 157.71 12.92 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 N-CA-C 106.934 -1.506 . . . . 73.019999999999996 106.934 -176.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -72.14 135.12 46.09 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-O 121.894 0.854 . . . . 63.219999999999999 111.544 179.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -115.65 -155.47 0.58 Allowed 'General case' 0 C--N 1.283 -2.326 0 N-CA-C 106.471 -1.677 . . . . 73.540000000000006 106.471 -174.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.0 71.18 9.04 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 107.269 -1.382 . . . . 74.439999999999998 107.269 171.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -79.17 -24.89 42.94 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.564 -1.198 . . . . 73.129999999999995 111.362 -176.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.2 tm? 64.21 93.85 0.06 Allowed 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 125.046 1.338 . . . . 72.109999999999999 111.591 177.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 66.3 tp -113.95 92.55 4.01 Favored 'General case' 0 C--N 1.292 -1.935 0 N-CA-C 107.588 -1.264 . . . . 60.219999999999999 107.588 175.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 6.8 mmtm -147.16 100.62 3.31 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.991 -1.004 . . . . 71.239999999999995 109.623 -179.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -138.98 164.26 30.21 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 109.628 -0.508 . . . . 71.209999999999994 109.628 176.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 51.2 tpp -56.33 124.56 18.45 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.092 0.87 . . . . 63.399999999999999 111.188 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -104.56 -165.98 1.19 Allowed 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 109.247 -0.649 . . . . 52.310000000000002 109.247 178.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 32.0 t -63.39 118.63 8.34 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 109.231 -0.655 . . . . 71.230000000000004 109.231 177.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 43.8 m -84.27 149.77 25.87 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 109.255 -0.646 . . . . 51.450000000000003 109.255 179.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 22.3 m -58.21 124.34 19.1 Favored 'General case' 0 C--O 1.245 0.828 0 O-C-N 123.503 0.502 . . . . 53.009999999999998 109.819 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -66.98 117.23 8.93 Favored Glycine 0 N--CA 1.439 -1.164 0 CA-C-N 115.786 -0.643 . . . . 64.239999999999995 111.638 -177.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.6 m -83.98 133.62 34.68 Favored 'General case' 0 N--CA 1.419 -1.991 0 N-CA-C 109.262 -0.644 . . . . 63.149999999999999 109.262 -179.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.07 126.67 92.86 Favored Pre-proline 0 N--CA 1.439 -0.994 0 N-CA-C 107.841 -1.17 . . . . 65.140000000000001 107.841 174.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -61.1 141.22 93.22 Favored 'Trans proline' 0 C--O 1.242 0.68 0 C-N-CA 122.377 2.052 . . . . 72.420000000000002 111.631 -178.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -91.02 63.33 5.11 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 116.374 -0.375 . . . . 75.129999999999995 110.405 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.5 m 53.65 74.22 0.33 Allowed 'General case' 0 C--N 1.347 0.471 0 CA-C-O 121.985 0.898 . . . . 63.039999999999999 110.297 -177.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.1 t -143.55 159.64 42.06 Favored 'General case' 0 N--CA 1.41 -2.454 0 CA-C-N 115.698 -0.683 . . . . 72.120000000000005 109.607 -172.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 129.61 131.56 3.37 Favored Glycine 0 N--CA 1.433 -1.509 0 N-CA-C 110.626 -0.989 . . . . 53.240000000000002 110.626 -179.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.57 -24.47 58.92 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.739 0.78 . . . . 73.310000000000002 110.759 -176.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.491 ' CD ' ' H ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -83.15 -39.71 20.69 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 114.829 -1.078 . . . . 72.319999999999993 111.113 -178.357 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -82.86 -37.55 24.19 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 116.277 -0.419 . . . . 75.219999999999999 111.662 -177.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.7 mp -84.17 145.9 47.0 Favored Pre-proline 0 C--N 1.312 -1.034 0 C-N-CA 120.43 -0.508 . . . . 63.100000000000001 112.004 -177.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -79.53 39.41 0.82 Allowed 'Trans proline' 0 C--N 1.359 1.123 0 C-N-CA 123.921 3.08 . . . . 71.430000000000007 113.67 -175.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -116.52 111.97 20.71 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 120.677 0.275 . . . . 73.299999999999997 110.526 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -83.64 -25.37 46.72 Favored Glycine 0 C--N 1.316 -0.556 0 N-CA-C 109.401 -1.48 . . . . 63.200000000000003 109.401 174.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.9 m -132.75 151.49 51.98 Favored 'General case' 0 N--CA 1.421 -1.895 0 N-CA-C 104.926 -2.25 . . . . 51.310000000000002 104.926 175.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.412 ' HB3' ' CZ ' ' A' ' 137' ' ' PHE . . . -142.88 164.81 29.09 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 108.497 -0.927 . . . . 51.229999999999997 108.497 -178.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.514 HD12 ' HD3' ' A' ' 141' ' ' PRO . 0.0 OUTLIER -119.44 150.43 40.22 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 120.32 -0.552 . . . . 73.439999999999998 111.677 -174.544 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.476 ' O ' HD12 ' A' ' 49' ' ' LEU . 2.8 pp -109.77 138.95 45.4 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 115.312 -0.858 . . . . 73.430000000000007 109.325 176.108 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.42 HG12 ' HB3' ' A' ' 60' ' ' ARG . 29.8 m -112.66 131.79 63.21 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 N-CA-C 108.093 -1.077 . . . . 61.43 108.093 177.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 37.1 t -92.05 114.34 28.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 N-CA-C 104.442 -2.429 . . . . 65.200000000000003 104.442 175.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 50.5 tttp -84.72 -32.46 23.49 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 108.328 -0.99 . . . . 62.439999999999998 108.328 -173.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.492 ' HA ' ' NE ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -170.44 108.9 0.35 Allowed 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 107.721 -1.215 . . . . 72.129999999999995 107.721 174.213 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -168.86 117.75 0.74 Allowed Glycine 0 N--CA 1.424 -2.111 0 C-N-CA 120.465 -0.874 . . . . 64.430000000000007 111.099 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.417 ' HB2' ' HB2' ' A' ' 82' ' ' ASP . 85.9 Cg_exo -51.6 -12.77 1.16 Allowed 'Trans proline' 0 CA--C 1.555 1.532 0 C-N-CA 124.423 3.415 . . . . 75.239999999999995 116.127 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.484 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 31.3 p30 -71.67 -29.48 64.66 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 122.115 -0.365 . . . . 73.420000000000002 111.6 179.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -163.47 -148.88 0.13 Allowed 'General case' 0 C--O 1.24 0.576 0 N-CA-C 108.57 -0.9 . . . . 71.450000000000003 108.57 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 169.23 53.57 0.03 OUTLIER Glycine 0 CA--C 1.488 -1.608 0 N-CA-C 110.489 -1.044 . . . . 71.450000000000003 110.489 177.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -154.57 -170.24 3.47 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 108.303 -0.999 . . . . 52.439999999999998 108.303 -176.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.42 ' HB3' HG12 ' A' ' 50' ' ' VAL . 27.3 ptt180 -131.23 135.69 47.58 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 107.835 -1.172 . . . . 65.540000000000006 107.835 175.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -143.73 141.66 30.58 Favored 'General case' 0 C--N 1.291 -1.969 0 C-N-CA 120.518 -0.473 . . . . 74.120000000000005 111.226 178.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 28.3 tp -75.98 129.85 37.53 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 114.784 -1.098 . . . . 55.210000000000001 109.224 -178.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 81.9 mt -86.87 114.5 23.57 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 108.485 -0.932 . . . . 72.230000000000004 108.485 176.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -150.0 37.21 0.7 Allowed 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 103.761 -2.681 . . . . 73.409999999999997 103.761 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -133.98 128.64 19.74 Favored Pre-proline 0 C--N 1.297 -1.689 0 CA-C-N 113.486 -1.688 . . . . 73.340000000000003 107.768 -174.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -45.65 -55.41 3.58 Favored 'Trans proline' 0 C--N 1.362 1.237 0 C-N-CA 123.937 3.091 . . . . 75.340000000000003 113.562 -174.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.429 HG23 ' HG2' ' A' ' 93' ' ' ARG . 57.9 m -137.16 98.75 3.81 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 121.713 0.768 . . . . 71.239999999999995 112.963 179.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.444 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 90.1 m -80.57 112.83 18.29 Favored 'General case' 0 N--CA 1.417 -2.093 0 N-CA-C 106.42 -1.696 . . . . 75.120000000000005 106.42 174.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.441 ' HB ' ' HA ' ' A' ' 76' ' ' SER . 27.1 m -108.64 128.02 54.48 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 116.36 -0.382 . . . . 70.439999999999998 110.333 -175.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -105.0 120.02 40.45 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 108.873 -0.788 . . . . 72.239999999999995 108.873 177.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 158.39 -127.34 1.86 Allowed Glycine 0 N--CA 1.431 -1.664 0 N-CA-C 110.649 -0.98 . . . . 42.340000000000003 110.649 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.508 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 41.1 ttm180 -154.23 84.27 1.13 Allowed 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 121.436 0.636 . . . . 74.239999999999995 110.18 179.187 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 11.2 m170 -137.3 167.18 21.87 Favored Pre-proline 0 C--N 1.288 -2.088 0 N-CA-C 107.616 -1.253 . . . . 72.349999999999994 107.616 175.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -60.07 -21.56 65.98 Favored 'Trans proline' 0 C--N 1.358 1.069 0 C-N-CA 122.308 2.005 . . . . 74.239999999999995 111.024 174.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -112.53 78.72 1.15 Allowed 'General case' 0 N--CA 1.424 -1.758 0 N-CA-C 107.963 -1.125 . . . . 72.519999999999996 107.963 177.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.441 ' HA ' ' HB ' ' A' ' 69' ' ' THR . 55.4 m -139.35 151.53 46.44 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 115.108 -0.951 . . . . 63.030000000000001 110.525 177.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -104.36 -46.85 4.28 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 109.018 -0.734 . . . . 73.230000000000004 109.018 -178.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 33.8 pt -133.31 156.01 41.36 Favored 'Isoleucine or valine' 0 C--O 1.245 0.865 0 CA-C-N 115.58 -0.736 . . . . 70.230000000000004 109.685 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -120.29 135.45 55.0 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.583 -0.895 . . . . 74.450000000000003 108.583 178.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.484 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 4.5 mp -75.42 106.01 6.74 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 122.849 0.46 . . . . 61.200000000000003 110.94 -178.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -86.26 63.51 8.05 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 122.718 1.246 . . . . 61.210000000000001 109.913 177.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.417 ' HB2' ' HB2' ' A' ' 55' ' ' PRO . 21.6 t70 -143.66 167.58 21.93 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 113.726 -1.579 . . . . 65.319999999999993 107.301 178.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.1 m -66.4 -33.87 66.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 117.801 0.273 . . . . 71.219999999999999 111.375 178.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 11.7 p -90.63 72.22 6.79 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-O 121.603 0.716 . . . . 75.530000000000001 112.425 179.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 6.9 p -113.58 113.41 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 CA-C-N 114.872 -1.058 . . . . 54.130000000000003 111.257 177.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 7.0 m -92.83 148.23 22.2 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 105.281 -2.118 . . . . 61.520000000000003 105.281 171.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.508 ' HB2' ' O ' ' A' ' 72' ' ' ARG . 9.1 ptm180 -73.47 -21.92 60.31 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 118.421 -1.312 . . . . 74.049999999999997 110.481 -179.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 26.8 ptt180 -122.24 97.77 5.63 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 106.526 -1.657 . . . . 72.310000000000002 106.526 165.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 8.6 t60 -109.66 -52.29 2.79 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.923 -0.711 . . . . 74.450000000000003 110.941 -173.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -144.96 131.94 20.28 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 120.188 -0.605 . . . . 71.219999999999999 110.104 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -114.91 126.81 55.22 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 108.794 -0.817 . . . . 74.019999999999996 108.794 177.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.444 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 79.8 m-85 -113.61 113.45 25.08 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 107.72 -1.215 . . . . 74.310000000000002 107.72 -179.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.429 ' HG2' HG23 ' A' ' 67' ' ' THR . 51.5 mtm180 -115.25 152.64 32.33 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-O 121.116 0.484 . . . . 74.420000000000002 110.977 -175.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.492 ' O ' HD12 ' A' ' 94' ' ' ILE . 2.9 pp -113.83 117.07 54.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 CA-C-O 122.414 1.102 . . . . 73.439999999999998 108.459 175.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 38.1 t-20 -103.05 147.65 26.7 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 106.893 -1.521 . . . . 74.099999999999994 106.893 -173.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -49.81 -32.94 15.2 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 112.505 0.557 . . . . 71.319999999999993 112.505 -177.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -94.19 -40.72 4.47 Favored Glycine 0 N--CA 1.422 -2.296 0 C-N-CA 120.265 -0.969 . . . . 72.349999999999994 113.371 -179.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -149.32 178.47 8.74 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 121.872 0.844 . . . . 73.120000000000005 112.574 -173.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -93.35 127.18 38.85 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 107.455 -1.313 . . . . 74.510000000000005 107.455 177.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -123.03 130.78 53.23 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 120.858 0.361 . . . . 73.420000000000002 111.973 -171.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 9.0 p -121.54 131.05 73.97 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 109.139 -0.689 . . . . 75.049999999999997 109.139 175.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.7 m -117.76 128.02 75.0 Favored 'Isoleucine or valine' 0 C--O 1.259 1.578 0 CA-C-O 121.569 0.699 . . . . 71.430000000000007 111.02 178.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -83.79 114.5 21.66 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.679 -1.146 . . . . 54.25 110.065 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 23.4 m -122.35 3.18 5.99 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 CA-C-O 121.923 0.868 . . . . 75.019999999999996 108.903 173.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -109.17 53.26 0.6 Allowed Glycine 0 N--CA 1.427 -1.955 0 CA-C-N 114.596 -1.184 . . . . 75.219999999999999 110.36 -178.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.2 p -64.85 -2.85 2.83 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.455 1.102 . . . . 53.420000000000002 112.107 -178.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.412 ' H ' HD22 ' A' ' 107' ' ' LEU . 2.9 mm? -62.83 -35.64 80.59 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 108.454 -0.943 . . . . 64.25 108.454 174.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -114.49 -45.93 2.99 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.237 -1.023 . . . . 64.310000000000002 108.237 177.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 94.37 120.97 3.35 Favored Glycine 0 N--CA 1.435 -1.419 0 CA-C-N 115.012 -0.994 . . . . 63.299999999999997 111.398 -178.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.4 m -79.56 119.53 22.66 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.999 -0.741 . . . . 72.239999999999995 108.999 176.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -103.4 134.42 46.8 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.967 -0.753 . . . . 74.099999999999994 108.967 178.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.468 HG11 ' HG2' ' A' ' 120' ' ' GLN . 61.9 t -115.91 117.93 57.15 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.359 0 N-CA-C 105.923 -1.88 . . . . 71.040000000000006 105.923 175.053 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 59.46 31.67 21.2 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-O 122.286 1.041 . . . . 55.310000000000002 108.392 -175.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 44.4 mtp180 74.39 5.03 4.56 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.127 1.371 . . . . 74.349999999999994 114.304 -178.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -103.05 134.95 19.5 Favored Pre-proline 0 C--N 1.309 -1.167 0 O-C-N 121.705 -0.622 . . . . 73.450000000000003 109.671 177.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -69.72 119.28 6.26 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.086 1.857 . . . . 74.230000000000004 110.096 177.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -123.35 129.98 52.07 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.715 -0.846 . . . . 70.010000000000005 108.715 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -69.64 -42.11 74.73 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 121.363 0.602 . . . . 43.109999999999999 109.904 178.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -144.61 138.39 27.38 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 105.814 -1.921 . . . . 75.530000000000001 105.814 173.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.468 ' HG2' HG11 ' A' ' 112' ' ' VAL . 57.8 tp60 -141.44 148.9 40.28 Favored 'General case' 0 C--N 1.282 -2.369 0 CA-C-O 120.732 0.301 . . . . 74.239999999999995 110.405 -177.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 89.1 t -80.46 120.88 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.669 0 N-CA-C 104.997 -2.223 . . . . 63.43 104.997 169.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 76.8 mtm -60.37 138.64 57.94 Favored 'General case' 0 CA--C 1.499 -0.985 0 CA-C-O 121.249 0.547 . . . . 74.230000000000004 111.339 -176.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 8.4 tp60 -103.79 123.48 47.15 Favored 'General case' 0 N--CA 1.417 -2.1 0 CA-C-N 115.146 -0.934 . . . . 72.329999999999998 108.483 -168.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 21.4 p -83.23 117.67 23.1 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.848 -0.615 . . . . 72.530000000000001 109.953 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 95.68 13.52 50.34 Favored Glycine 0 N--CA 1.436 -1.359 0 N-CA-C 111.631 -0.588 . . . . 71.219999999999999 111.631 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -132.5 -175.42 3.75 Favored 'General case' 0 C--O 1.248 0.976 0 N-CA-C 109.186 -0.672 . . . . 73.329999999999998 109.186 -177.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -112.03 149.05 32.59 Favored 'General case' 0 C--O 1.251 1.15 0 N-CA-C 114.997 1.48 . . . . 65.150000000000006 114.997 -171.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.409 ' HB ' ' HB3' ' A' ' 135' ' ' LEU . 37.3 mm -121.79 117.69 53.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 105.983 -1.858 . . . . 62.350000000000001 105.983 174.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -120.35 116.78 26.19 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 107.357 -1.349 . . . . 63.350000000000001 107.357 -177.238 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.0 tt -128.79 108.92 18.02 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.226 0 CA-C-O 121.417 0.627 . . . . 74.030000000000001 110.589 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 70.67 -103.98 1.3 Allowed Glycine 0 C--N 1.314 -0.669 0 N-CA-C 110.439 -1.064 . . . . 51.149999999999999 110.439 -177.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -120.09 6.56 10.79 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.056 -0.72 . . . . 72.420000000000002 109.056 173.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.472 ' CE2' HD23 ' A' ' 80' ' ' LEU . 56.3 m-85 -91.43 106.56 18.58 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 108.965 -0.754 . . . . 74.420000000000002 108.965 -177.081 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 14.5 ptt180 -96.41 120.95 37.65 Favored 'General case' 0 N--CA 1.432 -1.375 0 CA-C-O 122.168 0.985 . . . . 71.450000000000003 110.203 177.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.417 HD12 ' O ' ' A' ' 50' ' ' VAL . 25.3 tp -124.51 142.98 50.92 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 113.643 -1.617 . . . . 73.450000000000003 108.378 -174.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 29.8 t -124.5 134.89 65.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 107.499 -1.297 . . . . 71.099999999999994 107.499 176.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.412 ' CZ ' ' HB3' ' A' ' 47' ' ' ALA . 64.1 t80 -108.32 120.34 42.09 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.057 -0.72 . . . . 74.239999999999995 109.057 -176.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -121.85 144.04 49.06 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.6 0.714 . . . . 70.430000000000007 112.337 -175.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -91.82 80.27 5.27 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 106.533 -1.654 . . . . 62.229999999999997 106.533 172.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -77.61 -71.69 1.19 Allowed Glycine 0 C--N 1.301 -1.414 0 CA-C-N 114.791 -1.095 . . . . 70.400000000000006 113.778 -174.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.514 ' HD3' HD12 ' A' ' 48' ' ' LEU . 19.7 Cg_exo -65.26 133.12 33.93 Favored 'Trans proline' 0 N--CA 1.445 -1.326 0 C-N-CA 122.139 1.892 . . . . 72.430000000000007 113.023 -177.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -109.36 103.92 12.93 Favored 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 104.825 -2.287 . . . . 74.200000000000003 104.825 170.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 . . . . . 0 C--N 1.289 -2.038 0 CA-C-O 118.543 -0.741 . . . . 74.310000000000002 109.026 -173.021 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 CA--C 1.499 -0.99 0 N-CA-C 109.37 -0.604 . . . . 75.549999999999997 109.37 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.9 t -81.37 -38.39 26.69 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 106.971 -1.492 . . . . 71.329999999999998 106.971 177.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -88.29 155.26 19.83 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 106.796 -1.557 . . . . 74.549999999999997 106.796 175.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -155.68 153.02 29.34 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 120.58 -0.448 . . . . 72.209999999999994 111.457 -178.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -131.19 144.54 51.43 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 107.143 -1.429 . . . . 60.539999999999999 107.143 176.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -136.82 -133.28 3.16 Favored Glycine 0 N--CA 1.425 -2.064 0 C-N-CA 120.233 -0.984 . . . . 32.119999999999997 112.997 -176.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.8 t -85.09 143.22 39.36 Favored Pre-proline 0 C--N 1.302 -1.474 0 C-N-CA 122.599 0.36 . . . . 50.450000000000003 111.223 -176.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -66.73 150.34 83.51 Favored 'Trans proline' 0 C--O 1.249 1.037 0 C-N-CA 122.601 2.201 . . . . 72.430000000000007 110.385 171.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.9 mp0 -76.94 128.34 81.62 Favored Pre-proline 0 C--O 1.245 0.861 0 N-CA-C 109.612 -0.514 . . . . 74.299999999999997 109.612 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -63.05 150.43 88.66 Favored 'Trans proline' 0 C--O 1.25 1.079 0 C-N-CA 122.817 2.344 . . . . 63.32 111.191 175.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -92.77 173.89 7.53 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-O 121.028 0.442 . . . . 64.109999999999999 110.698 -175.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.5 m -121.18 169.57 12.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-N 115.698 -0.683 . . . . 63.509999999999998 110.779 -178.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -78.49 140.94 38.55 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 109.594 -0.521 . . . . 65.329999999999998 109.594 178.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.1 t -111.47 148.52 32.96 Favored 'General case' 0 N--CA 1.422 -1.833 0 CA-C-O 121.079 0.466 . . . . 51.25 110.311 -178.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.6 p -100.51 8.79 43.29 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 112.282 0.475 . . . . 72.030000000000001 112.282 178.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.4 p -78.94 32.54 0.21 Allowed 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.421 0.689 . . . . 73.150000000000006 112.621 -177.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.9 m -112.44 132.43 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 N-CA-C 108.45 -0.945 . . . . 75.400000000000006 108.45 178.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -87.76 141.09 28.87 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 118.712 -1.195 . . . . 74.239999999999995 109.872 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -86.04 132.34 34.07 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 107.288 -1.375 . . . . 74.510000000000005 107.288 175.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.31 90.28 0.92 Allowed 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.797 0.808 . . . . 73.099999999999994 112.201 -176.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -100.12 -33.66 10.37 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 115.105 -0.952 . . . . 61.310000000000002 110.522 175.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 62.1 tp -79.14 88.73 4.85 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.272 0.558 . . . . 72.219999999999999 109.779 178.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 91.4 mt -113.84 129.84 56.54 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.795 -0.817 . . . . 64.400000000000006 108.795 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.446 ' NZ ' ' HB2' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -104.95 -10.45 17.25 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 120.238 -0.585 . . . . 73.420000000000002 112.322 -176.905 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -80.91 120.46 24.76 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 118.494 -1.283 . . . . 74.120000000000005 112.254 -177.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 21.5 ptt? -102.02 120.36 40.29 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.202 -1.407 . . . . 60.409999999999997 107.202 175.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -71.69 136.47 47.25 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 112.871 0.693 . . . . 72.430000000000007 112.871 -175.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.1 m -93.1 88.06 5.95 Favored 'General case' 0 N--CA 1.42 -1.965 0 N-CA-C 105.617 -1.994 . . . . 71.219999999999999 105.617 170.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.0 t -61.18 130.49 46.54 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 114.887 -1.051 . . . . 70.230000000000004 110.601 -173.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.1 t -125.2 120.73 32.12 Favored 'General case' 0 N--CA 1.425 -1.694 0 CA-C-O 121.552 0.691 . . . . 74.019999999999996 110.963 -178.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -104.6 71.62 0.25 Allowed Glycine 0 N--CA 1.438 -1.192 0 N-CA-C 108.772 -1.731 . . . . 75.319999999999993 108.772 174.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.6 m -67.22 137.01 55.87 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 123.724 0.81 . . . . 71.219999999999999 112.176 -172.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -85.75 140.45 35.53 Favored Pre-proline 0 C--N 1.308 -1.199 0 N-CA-C 108.419 -0.956 . . . . 63.119999999999997 108.419 176.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -73.55 105.69 2.04 Favored 'Trans proline' 0 N--CA 1.446 -1.27 0 C-N-CA 121.684 1.589 . . . . 72.299999999999997 111.831 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -92.51 70.11 4.99 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.429 -0.952 . . . . 54.049999999999997 108.429 177.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.6 t -144.39 143.72 31.07 Favored 'General case' 0 N--CA 1.423 -1.806 0 N-CA-C 107.678 -1.23 . . . . 74.099999999999994 107.678 -177.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 13.2 m 65.7 75.9 0.34 Allowed 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 124.52 1.128 . . . . 63.350000000000001 109.785 -178.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 136.98 -34.59 2.19 Favored Glycine 0 N--CA 1.432 -1.596 0 CA-C-N 114.22 -1.355 . . . . 75.049999999999997 110.121 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.93 -46.74 33.66 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 121.753 0.787 . . . . 72.230000000000004 110.237 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.88 -11.67 56.61 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.35 -0.841 . . . . 51.119999999999997 109.895 -178.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.544 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 47.6 t30 -62.72 -29.16 70.46 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.857 -1.065 . . . . 75.439999999999998 110.781 -179.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -107.81 89.14 5.03 Favored Pre-proline 0 N--CA 1.44 -0.96 0 CA-C-N 116.508 -0.314 . . . . 75.150000000000006 110.511 177.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.544 ' HD3' ' O ' ' A' ' 41' ' ' ASN . 63.7 Cg_endo -100.63 17.09 0.35 Allowed 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 122.726 2.284 . . . . 72.239999999999995 111.498 178.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -153.39 154.07 33.76 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 107.699 -1.222 . . . . 51.520000000000003 107.699 -179.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.84 30.21 56.27 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 109.178 -1.569 . . . . 62.509999999999998 109.178 -174.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.5 m -90.67 165.89 13.46 Favored 'General case' 0 N--CA 1.425 -1.692 0 CA-C-N 114.548 -0.826 . . . . 74.329999999999998 111.192 -174.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -90.86 163.42 14.41 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 108.104 -1.073 . . . . 63.350000000000001 108.104 175.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.45 ' HB3' ' HG ' ' A' ' 62' ' ' LEU . 2.5 pt? -133.93 159.96 39.14 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.453 0.644 . . . . 63.299999999999997 110.733 -177.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.417 ' HB2' HD21 ' A' ' 135' ' ' LEU . 1.1 pt? -122.97 132.84 54.33 Favored 'General case' 0 C--N 1.278 -2.528 0 CA-C-N 115.018 -0.992 . . . . 75.209999999999994 108.806 176.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.4 m -110.01 116.35 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.019 0 N-CA-C 107.14 -1.43 . . . . 74.329999999999998 107.14 175.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.1 t -93.03 115.62 32.25 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.467 0 N-CA-C 107.88 -1.156 . . . . 75.540000000000006 107.88 -176.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -72.66 -38.6 67.59 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.584 -1.265 . . . . 73.299999999999997 107.584 -177.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 50.9 ttt180 -176.18 111.22 0.1 Allowed 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 106.359 -1.719 . . . . 72.329999999999998 106.359 174.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.49 ' HA2' ' HB3' ' A' ' 133' ' ' PHE . . . -122.84 166.17 15.33 Favored Glycine 0 N--CA 1.418 -2.53 0 N-CA-C 111.412 -0.675 . . . . 61.240000000000002 111.412 -177.307 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -69.09 -23.73 33.55 Favored 'Trans proline' 0 C--N 1.322 -0.847 0 C-N-CA 122.954 2.436 . . . . 64.319999999999993 111.481 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -98.87 -52.03 3.7 Favored 'General case' 0 N--CA 1.426 -1.63 0 CA-C-N 114.595 -1.184 . . . . 73.120000000000005 111.322 -177.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -144.25 -173.08 3.92 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-O 120.808 0.337 . . . . 72.540000000000006 110.496 -173.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.38 46.02 0.41 Allowed Glycine 0 N--CA 1.435 -1.399 0 N-CA-C 109.114 -1.594 . . . . 32.450000000000003 109.114 178.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -133.67 -169.87 2.38 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.888 -0.782 . . . . 74.329999999999998 108.888 -175.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -125.84 135.26 51.76 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 110.462 -0.199 . . . . 65.430000000000007 110.462 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -156.26 149.3 24.2 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 112.947 0.721 . . . . 72.140000000000001 112.947 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.45 ' HG ' ' HB3' ' A' ' 48' ' ' LEU . 6.8 mp -93.06 141.98 27.8 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 124.581 1.152 . . . . 72.349999999999994 109.73 177.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -74.49 115.3 13.86 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.592 -0.443 . . . . 73.549999999999997 110.065 176.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -113.13 8.97 18.46 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 108.606 -0.887 . . . . 71.409999999999997 108.606 -179.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -136.69 134.4 19.45 Favored Pre-proline 0 C--N 1.3 -1.571 0 N-CA-C 112.258 0.466 . . . . 71.209999999999994 112.258 -167.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.444 ' HA ' ' CG2' ' A' ' 94' ' ' ILE . 9.7 Cg_endo -52.43 -62.49 0.35 Allowed 'Trans proline' 0 C--N 1.371 1.721 0 C-N-CA 124.538 3.492 . . . . 75.230000000000004 113.853 -177.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 94.7 m -116.49 110.64 18.87 Favored 'General case' 0 N--CA 1.422 -1.831 0 N-CA-C 109.354 -0.61 . . . . 75.409999999999997 109.354 178.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.452 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 91.2 m -109.56 113.63 26.58 Favored 'General case' 0 C--N 1.283 -2.314 0 N-CA-C 109.045 -0.724 . . . . 65.439999999999998 109.045 177.107 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.8 t -95.75 132.83 40.56 Favored 'General case' 0 C--O 1.256 1.424 0 N-CA-C 109.381 -0.6 . . . . 73.209999999999994 109.381 -178.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -127.88 124.92 38.65 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 115.739 -0.664 . . . . 51.119999999999997 110.282 -177.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.79 33.46 15.7 Favored Glycine 0 C--N 1.3 -1.445 0 C-N-CA 119.092 -1.527 . . . . 75.140000000000001 111.913 177.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.645 ' HA ' ' O ' ' A' ' 87' ' ' ARG . 2.1 tmt_? -123.73 87.66 2.78 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 105.993 -1.854 . . . . 74.519999999999996 105.993 176.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 20.3 m170 66.05 171.2 0.1 OUTLIER Pre-proline 0 CA--C 1.552 1.033 0 O-C-N 124.106 0.879 . . . . 72.219999999999999 109.795 -175.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -65.47 -20.18 60.91 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 121.686 1.591 . . . . 71.310000000000002 109.33 170.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -75.78 7.77 3.6 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 126.027 1.731 . . . . 74.239999999999995 112.381 -177.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 10.1 p -84.73 175.23 9.31 Favored 'General case' 0 C--N 1.322 -0.607 0 O-C-N 121.973 -0.454 . . . . 50.399999999999999 110.526 177.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -62.85 -56.74 14.71 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 108.791 -0.818 . . . . 73.230000000000004 108.791 -178.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.482 HD13 ' H ' ' A' ' 78' ' ' ILE . 0.2 OUTLIER -125.65 123.55 64.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 106.3 -1.741 . . . . 74.349999999999994 106.3 172.457 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -99.38 121.57 41.3 Favored 'General case' 0 C--N 1.29 -2.015 0 C-N-CA 119.829 -0.748 . . . . 72.540000000000006 112.872 -171.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.6 mp -69.09 128.95 38.46 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 107.418 -1.327 . . . . 75.439999999999998 107.418 170.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -116.06 24.04 11.74 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-O 122.46 1.124 . . . . 64.430000000000007 110.093 -175.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -103.84 -164.85 1.1 Allowed 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.745 -0.782 . . . . 74.019999999999996 109.889 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.7 p -92.19 -6.74 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.319 0 CA-C-O 121.339 0.59 . . . . 74.430000000000007 111.779 -174.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 7.4 m -87.45 12.87 11.15 Favored 'General case' 0 CA--C 1.555 1.139 0 CA-C-O 121.666 0.746 . . . . 72.329999999999998 110.543 -177.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 87.7 t -81.59 104.77 10.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-O 121.993 0.901 . . . . 73.150000000000006 110.83 -177.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 16.8 m -86.64 42.52 1.01 Allowed 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 124.388 1.075 . . . . 61.43 112.096 -176.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.645 ' O ' ' HA ' ' A' ' 72' ' ' ARG . 82.7 mtm180 72.65 -48.22 0.68 Allowed 'General case' 0 N--CA 1.513 2.724 0 C-N-CA 124.496 1.118 . . . . 54.420000000000002 110.39 -175.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -139.73 120.3 14.16 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 103.113 -2.921 . . . . 75.150000000000006 103.113 171.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 54.8 t60 -110.19 -71.45 0.76 Allowed 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 117.664 -1.614 . . . . 44.140000000000001 113.76 -174.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -117.85 143.24 46.47 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.974 -0.691 . . . . 74.109999999999999 111.911 -173.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.4 mm-40 -121.65 127.53 50.91 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.087 -1.079 . . . . 72.120000000000005 108.087 177.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.452 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 91.6 m-85 -103.67 113.47 27.01 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 106.628 -1.619 . . . . 71.430000000000007 106.628 175.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 89.5 mtt-85 -120.52 146.12 46.61 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 121.185 0.517 . . . . 73.519999999999996 110.795 -174.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.444 ' CG2' ' HA ' ' A' ' 66' ' ' PRO . 5.6 tt -115.87 130.93 69.72 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 N-CA-C 108.737 -0.838 . . . . 70.340000000000003 108.737 175.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.406 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 14.8 t-20 -118.68 146.31 44.8 Favored 'General case' 0 C--N 1.282 -2.335 0 N-CA-C 106.166 -1.79 . . . . 61.409999999999997 106.166 178.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.97 -10.29 20.6 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 112.886 0.699 . . . . 72.209999999999994 112.886 -176.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -103.81 -41.85 2.07 Favored Glycine 0 N--CA 1.436 -1.361 0 CA-C-N 116.424 -0.353 . . . . 74.439999999999998 112.661 175.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.406 ' O ' ' HB3' ' A' ' 95' ' ' ASN . 67.7 mm-40 -141.44 162.9 34.36 Favored 'General case' 0 C--O 1.216 -0.684 0 CA-C-O 121.277 0.56 . . . . 73.129999999999995 111.724 -176.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -108.2 121.19 44.36 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 106.674 -1.602 . . . . 74.109999999999999 106.674 173.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -125.52 135.55 52.39 Favored 'General case' 0 CA--C 1.49 -1.328 0 CA-C-O 122.087 0.946 . . . . 73.120000000000005 113.162 -176.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 6.0 p -108.28 119.38 57.76 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.333 0 CA-C-N 114.12 -1.4 . . . . 71.540000000000006 108.269 176.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.417 HG12 ' HB1' ' A' ' 119' ' ' ALA . 29.5 m -119.0 131.72 70.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 C-N-CA 120.595 -0.442 . . . . 62.310000000000002 109.852 -177.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -105.16 116.41 31.91 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.025 -1.472 . . . . 74.120000000000005 107.025 176.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.3 m -89.9 0.93 7.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-O 120.911 0.386 . . . . 71.010000000000005 111.025 -174.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -126.46 36.06 2.77 Favored Glycine 0 N--CA 1.429 -1.783 0 N-CA-C 108.673 -1.771 . . . . 54.340000000000003 108.673 175.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.7 p -68.8 7.35 0.68 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 113.826 1.047 . . . . 62.119999999999997 113.826 -175.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 78.3 mt -70.8 -21.51 62.47 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 108.885 -0.783 . . . . 61.149999999999999 108.885 176.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -77.23 -7.42 55.89 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.723 -0.671 . . . . 65.120000000000005 110.039 177.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 88.84 78.14 1.3 Allowed Glycine 0 N--CA 1.439 -1.126 0 N-CA-C 111.795 -0.522 . . . . 72.340000000000003 111.795 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.49 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 11.1 m -81.7 123.95 29.18 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 109.005 -0.739 . . . . 63.210000000000001 109.005 178.276 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -115.38 134.77 54.79 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 120.033 -0.667 . . . . 63.229999999999997 110.891 -176.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 29.1 m -112.68 110.37 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.135 0 N-CA-C 106.876 -1.527 . . . . 23.23 106.876 169.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 62.5 t30 58.18 36.66 25.97 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 125.355 1.462 . . . . 74.099999999999994 109.708 -177.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 52.8 mtp180 81.74 -0.62 1.57 Allowed 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 126.753 2.021 . . . . 74.329999999999998 113.545 -178.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -92.42 115.79 65.36 Favored Pre-proline 0 C--N 1.313 -1.004 0 N-CA-C 109.372 -0.603 . . . . 72.219999999999999 109.372 178.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.49 ' HA ' ' O ' ' A' ' 110' ' ' THR . 36.4 Cg_endo -66.34 121.5 8.8 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.905 2.403 . . . . 74.310000000000002 112.182 -179.024 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 8.8 mmm180 -136.1 163.73 29.66 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 120.833 0.349 . . . . 70.430000000000007 110.144 -177.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -98.94 -45.9 5.81 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.114 -1.069 . . . . 63.539999999999999 108.114 176.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.417 ' HB1' HG12 ' A' ' 102' ' ' VAL . . . -139.86 142.26 36.58 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 107.263 -1.384 . . . . 63.439999999999998 107.263 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -134.68 141.06 46.44 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-O 121.316 0.579 . . . . 72.129999999999995 111.126 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.3 p -90.73 134.81 28.35 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 106.337 -1.727 . . . . 61.43 106.337 177.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 20.9 ptt? -41.01 123.84 2.06 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 122.143 0.973 . . . . 53.140000000000001 112.847 -177.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -127.01 124.71 40.03 Favored 'General case' 0 N--CA 1.413 -2.325 0 N-CA-C 106.17 -1.789 . . . . 73.109999999999999 106.17 177.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 31.1 p -78.48 124.45 28.15 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 116.138 -0.483 . . . . 75.200000000000003 111.821 -172.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 92.67 1.38 68.32 Favored Glycine 0 N--CA 1.44 -1.089 0 CA-C-N 115.207 -0.906 . . . . 42.25 110.894 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -90.41 151.54 21.38 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 108.312 -0.995 . . . . 73.129999999999995 108.312 -177.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.422 ' HG2' HG22 ' A' ' 136' ' ' VAL . 39.8 mt-10 -113.31 129.3 56.57 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 112.264 0.468 . . . . 75.430000000000007 112.264 -175.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 61.9 mt -95.27 115.78 35.09 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.164 0 N-CA-C 105.9 -1.889 . . . . 75.329999999999998 105.9 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.413 ' HA ' ' O ' ' A' ' 133' ' ' PHE . 76.5 mt-30 -118.26 119.37 34.46 Favored 'General case' 0 N--CA 1.418 -2.059 0 CA-C-N 115.124 -0.944 . . . . 62.450000000000003 110.12 -172.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 7.5 pt -123.32 125.53 71.93 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 CA-C-N 114.962 -1.017 . . . . 75.530000000000001 109.222 179.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 68.5 -102.11 0.84 Allowed Glycine 0 N--CA 1.434 -1.499 0 N-CA-C 108.746 -1.741 . . . . 72.420000000000002 108.746 -171.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -137.32 18.76 2.94 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.947 -0.761 . . . . 61.119999999999997 108.947 174.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.49 ' HB3' ' HA2' ' A' ' 54' ' ' GLY . 81.6 m-85 -93.03 150.13 20.74 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.679 -0.692 . . . . 75.040000000000006 110.225 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 75.6 mtt180 -123.81 122.9 39.25 Favored 'General case' 0 C--O 1.252 1.206 0 CA-C-O 121.498 0.666 . . . . 64.439999999999998 111.47 -172.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.417 HD21 ' HB2' ' A' ' 49' ' ' LEU . 5.5 tt -123.67 129.99 51.96 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 106.682 -1.599 . . . . 73.5 106.682 177.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.422 HG22 ' HG2' ' A' ' 127' ' ' GLU . 12.2 t -108.14 128.73 63.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 N-CA-C 108.297 -1.001 . . . . 64.349999999999994 108.297 -178.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -105.92 129.38 54.08 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 120.71 -0.396 . . . . 73.519999999999996 110.408 -176.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -132.65 169.22 16.97 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.872 0.368 . . . . 74.230000000000004 110.263 -177.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -91.72 139.0 31.1 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 107.728 -1.212 . . . . 65.239999999999995 107.728 174.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -102.95 171.17 20.54 Favored Glycine 0 N--CA 1.439 -1.162 0 C-N-CA 120.119 -1.038 . . . . 71.530000000000001 113.005 -175.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -80.49 164.68 21.15 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 122.583 2.189 . . . . 72.019999999999996 111.586 177.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -109.27 125.56 52.42 Favored 'General case' 0 N--CA 1.425 -1.714 0 N-CA-C 108.638 -0.875 . . . . 71.209999999999994 108.638 178.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 . . . . . 0 N--CA 1.428 -1.55 0 O-C-N 123.403 0.439 . . . . 74.239999999999995 110.557 177.359 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.4 ptt? . . . . . 0 N--CA 1.451 -0.384 0 CA-C-O 121.659 0.742 . . . . 62.439999999999998 110.959 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.4 m -83.41 -23.92 32.15 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.559 -0.746 . . . . 74.400000000000006 109.505 176.257 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -42.71 128.35 4.09 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 126.373 1.869 . . . . 70.109999999999999 113.984 -176.346 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -134.57 145.45 48.7 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 106.837 -1.542 . . . . 53.32 106.837 174.118 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -85.07 92.87 8.47 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.899 -0.778 . . . . 75.099999999999994 108.899 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -78.74 158.81 45.36 Favored Glycine 0 N--CA 1.431 -1.671 0 N-CA-C 110.786 -0.925 . . . . 54.200000000000003 110.786 179.187 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.5 m -75.14 125.28 89.31 Favored Pre-proline 0 C--N 1.299 -1.624 0 N-CA-C 109.987 -0.375 . . . . 63.240000000000002 109.987 -178.894 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -63.92 127.73 20.2 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 121.628 1.552 . . . . 74.0 109.121 175.158 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.434 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -89.99 144.12 30.94 Favored Pre-proline 0 C--N 1.298 -1.641 0 N-CA-C 112.489 0.552 . . . . 65.310000000000002 112.489 -176.844 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 9' ' ' GLU . 4.1 Cg_exo -76.66 141.67 22.25 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.373 2.049 . . . . 53.520000000000003 111.722 178.282 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -81.51 118.31 22.63 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.498 -0.927 . . . . 72.239999999999995 108.498 179.386 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.2 p -75.62 118.62 22.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 109.521 -0.548 . . . . 61.009999999999998 109.521 178.764 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -81.55 120.92 25.65 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 109.704 -0.48 . . . . 73.25 109.704 -179.078 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.0 t -129.6 117.44 20.4 Favored 'General case' 0 N--CA 1.414 -2.262 0 CA-C-N 115.496 -0.774 . . . . 73.319999999999993 110.19 -178.495 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.9 p -95.5 101.15 12.84 Favored 'General case' 0 N--CA 1.425 -1.688 0 CA-C-N 115.856 -0.611 . . . . 71.439999999999998 110.978 179.867 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.4 t -81.16 103.18 10.78 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 108.97 -0.752 . . . . 62.43 108.97 178.702 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 42.6 t -91.77 136.43 24.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 N-CA-C 107.75 -1.204 . . . . 72.230000000000004 107.75 179.0 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -69.86 106.95 3.34 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.809 -0.812 . . . . 71.200000000000003 108.809 177.957 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 -85.09 129.89 34.71 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 115.649 -0.705 . . . . 72.530000000000001 109.716 -178.84 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.07 55.53 2.17 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 122.081 0.943 . . . . 61.409999999999997 109.787 178.846 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -78.41 -44.49 24.69 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 114.709 -1.132 . . . . 72.340000000000003 110.344 -177.499 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 57.8 tp 64.13 102.81 0.03 OUTLIER 'General case' 0 C--O 1.259 1.602 0 C-N-CA 125.361 1.464 . . . . 73.430000000000007 114.301 175.705 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 60.6 tp -89.51 132.19 35.17 Favored 'General case' 0 N--CA 1.423 -1.812 0 N-CA-C 107.051 -1.463 . . . . 62.219999999999999 107.051 172.677 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.504 ' HD2' ' H ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -111.68 174.61 5.79 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 109.223 -0.658 . . . . 74.109999999999999 109.223 -177.304 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -71.3 130.89 42.52 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.018 0.437 . . . . 65.450000000000003 110.784 -176.165 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 88.3 mtp -81.48 92.82 6.54 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.542 -0.754 . . . . 74.430000000000007 109.913 -179.006 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -82.9 169.92 15.53 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.538 -0.755 . . . . 74.140000000000001 111.108 -179.925 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.6 m -85.0 -177.38 6.55 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.955 -0.566 . . . . 65.019999999999996 111.112 -179.068 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.2 m -64.46 158.55 23.59 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 123.622 0.769 . . . . 73.200000000000003 111.958 -175.907 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.6 p -62.92 -43.52 98.57 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 114.757 1.392 . . . . 65.319999999999993 114.757 -177.974 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -165.4 -179.28 39.09 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 119.891 -1.147 . . . . 52.130000000000003 112.05 -178.809 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.5 t -104.26 132.64 50.29 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 120.929 0.395 . . . . 63.32 110.138 179.67 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -92.0 126.07 54.62 Favored Pre-proline 0 C--N 1.301 -1.503 0 CA-C-N 115.778 -0.646 . . . . 74.129999999999995 109.813 179.407 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -86.15 -178.93 2.99 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.048 1.832 . . . . 44.210000000000001 111.008 177.726 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.38 103.41 7.29 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.482 -0.562 . . . . 73.030000000000001 109.482 178.725 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.7 t -84.62 96.98 9.36 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 108.807 -0.812 . . . . 61.030000000000001 108.807 -178.449 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.4 t -111.45 152.33 27.54 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 108.378 -0.971 . . . . 72.120000000000005 108.378 -179.328 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.15 51.81 0.68 Allowed Glycine 0 C--N 1.31 -0.866 0 C-N-CA 120.795 -0.717 . . . . 52.030000000000001 111.448 -177.898 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.1 -24.69 63.25 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.099 0.476 . . . . 53.200000000000003 110.931 -177.167 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -68.42 -11.93 60.41 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.372 -0.831 . . . . 75.239999999999995 112.458 -179.545 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -76.15 -43.03 44.78 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.544 -0.462 . . . . 71.329999999999998 110.448 -178.714 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.424 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 2.7 tm? 67.75 116.5 0.03 OUTLIER Pre-proline 0 CA--C 1.564 1.518 0 C-N-CA 124.98 1.312 . . . . 72.239999999999995 111.088 -179.9 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 42' ' ' LEU . 10.4 Cg_endo -89.49 115.48 0.66 Allowed 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.668 2.245 . . . . 74.25 111.716 177.555 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.55 82.01 8.13 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.383 0.611 . . . . 74.150000000000006 111.125 -179.463 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.412 ' O ' HD11 ' A' ' 94' ' ' ILE . . . -171.34 93.61 0.1 Allowed Glycine 0 CA--C 1.48 -2.106 0 N-CA-C 107.275 -2.33 . . . . 71.109999999999999 107.275 178.182 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.3 m -90.15 153.22 20.68 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-O 122.055 0.931 . . . . 63.130000000000003 112.311 -166.989 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.27 166.56 22.2 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 107.878 -1.156 . . . . 74.150000000000006 107.878 179.149 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.45 148.32 50.58 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.163 0.506 . . . . 72.340000000000003 112.093 -179.434 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.564 HD23 HD11 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -123.51 140.3 53.15 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.72 -0.845 . . . . 74.120000000000005 108.72 176.336 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.401 ' O ' HD12 ' A' ' 135' ' ' LEU . 35.7 t -126.43 133.5 68.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 N-CA-C 108.249 -1.019 . . . . 72.400000000000006 108.249 -179.05 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.433 HG21 ' HB3' ' A' ' 57' ' ' ALA . 35.1 t -92.22 115.23 30.7 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.077 0 N-CA-C 106.328 -1.73 . . . . 61.530000000000001 106.328 177.522 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -86.02 -31.62 21.91 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 114.992 -1.004 . . . . 74.409999999999997 109.888 -172.488 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.487 ' O ' ' HB3' ' A' ' 133' ' ' PHE . 53.5 ttt180 -159.3 139.66 12.17 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.438 -0.578 . . . . 72.019999999999996 109.438 -179.218 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.409 ' HA2' ' HD3' ' A' ' 55' ' ' PRO . . . 132.68 148.83 6.08 Favored Glycine 0 N--CA 1.435 -1.387 0 C-N-CA 120.423 -0.894 . . . . 43.329999999999998 114.292 176.737 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.409 ' HD3' ' HA2' ' A' ' 54' ' ' GLY . 31.2 Cg_exo -65.59 -8.62 19.79 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 124.126 3.217 . . . . 61.409999999999997 112.418 174.132 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.403 HD21 ' HB2' ' A' ' 133' ' ' PHE . 81.5 m-20 -49.06 -56.67 8.33 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.139 0.976 . . . . 74.25 108.724 174.543 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.433 ' HB3' HG21 ' A' ' 51' ' ' VAL . . . -179.41 -172.09 0.22 Allowed 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.702 1.201 . . . . 70.140000000000001 107.968 179.729 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -154.23 30.45 0.71 Allowed Glycine 0 CA--C 1.483 -1.915 0 N-CA-C 107.809 -2.116 . . . . 72.25 107.809 178.019 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -116.88 -179.75 3.78 Favored 'General case' 0 N--CA 1.412 -2.369 0 CA-C-N 113.676 -1.262 . . . . 63.329999999999998 108.814 -175.328 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 7.6 ptt180 -138.12 131.01 29.83 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 108.312 -0.996 . . . . 63.140000000000001 108.312 -179.801 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -122.02 148.44 44.83 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 116.354 -0.385 . . . . 74.349999999999994 110.852 -172.711 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.1 tt -98.76 117.36 33.07 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.367 -0.975 . . . . 72.230000000000004 108.367 178.497 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 94.0 mt -90.76 115.58 27.95 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.656 -0.702 . . . . 74.140000000000001 109.585 179.802 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -121.37 -34.03 3.54 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 107.667 -1.235 . . . . 64.120000000000005 107.667 177.913 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 15.5 pm0 -64.99 130.15 94.76 Favored Pre-proline 0 N--CA 1.436 -1.159 0 CA-C-N 113.987 -1.461 . . . . 74.019999999999996 109.95 175.971 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -61.5 -33.06 88.55 Favored 'Trans proline' 0 C--O 1.244 0.811 0 C-N-CA 123.299 2.666 . . . . 63.340000000000003 114.269 -175.968 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.7 m -111.97 120.38 41.71 Favored 'General case' 0 N--CA 1.435 -1.183 0 O-C-N 122.177 -0.327 . . . . 72.230000000000004 110.825 -178.061 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.488 ' HB ' ' HB3' ' A' ' 92' ' ' PHE . 41.4 m -118.74 114.1 22.18 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.841 -0.799 . . . . 44.149999999999999 108.841 176.181 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 36.7 m -102.0 127.56 48.82 Favored 'General case' 0 C--N 1.312 -1.054 0 O-C-N 121.658 -0.651 . . . . 63.509999999999998 111.245 -179.462 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -106.1 125.2 50.7 Favored 'General case' 0 C--O 1.248 0.985 0 CA-C-N 115.652 -0.703 . . . . 43.210000000000001 109.153 177.985 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 167.43 -151.1 18.4 Favored Glycine 0 CA--C 1.49 -1.513 0 N-CA-C 110.624 -0.99 . . . . 74.230000000000004 110.624 179.866 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.406 ' HG2' ' HA ' ' A' ' 87' ' ' ARG . 11.6 ptp180 -130.54 83.72 2.14 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 122.573 1.178 . . . . 75.409999999999997 111.311 179.45 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 31.3 m80 -146.83 174.72 3.17 Favored Pre-proline 0 C--N 1.293 -1.874 0 N-CA-C 106.999 -1.482 . . . . 75.319999999999993 106.999 178.452 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -66.49 -22.25 51.99 Favored 'Trans proline' 0 C--N 1.354 0.848 0 N-CA-C 107.544 -1.752 . . . . 73.540000000000006 107.544 164.733 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -89.64 68.42 7.64 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 113.854 -1.521 . . . . 71.140000000000001 108.164 176.511 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 53.6 m -139.33 113.41 8.76 Favored 'General case' 0 C--N 1.275 -2.646 0 CA-C-N 114.395 -1.275 . . . . 62.109999999999999 107.56 175.54 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -71.84 -35.6 69.91 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.909 -1.041 . . . . 71.319999999999993 109.38 -174.669 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.484 ' H ' HD13 ' A' ' 78' ' ' ILE . 0.2 OUTLIER -128.41 160.56 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.252 0 N-CA-C 106.667 -1.605 . . . . 71.349999999999994 106.667 175.348 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -107.02 135.92 47.77 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-O 121.33 0.586 . . . . 75.319999999999993 111.861 -175.385 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.0 mp -125.66 137.85 53.88 Favored 'General case' 0 N--CA 1.424 -1.77 0 N-CA-C 108.061 -1.088 . . . . 70.439999999999998 108.061 179.05 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -140.37 75.76 1.52 Allowed 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.376 -1.342 . . . . 54.219999999999999 107.376 179.543 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.432 ' OD2' ' HA3' ' A' ' 131' ' ' GLY . 18.6 t70 -120.35 159.9 24.12 Favored 'General case' 0 C--N 1.275 -2.651 0 CA-C-N 113.34 -1.755 . . . . 72.150000000000006 108.209 179.761 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 10.2 p -71.45 -27.25 28.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 CA-C-O 121.176 0.513 . . . . 71.25 111.076 -178.46 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.5 p -113.04 14.7 19.65 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 113.437 0.902 . . . . 72.439999999999998 113.437 -176.809 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.8 p -82.61 120.43 34.02 Favored 'Isoleucine or valine' 0 C--O 1.253 1.261 0 C-N-CA 118.792 -1.163 . . . . 73.549999999999997 108.878 173.996 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 9.1 t -80.62 -172.4 3.59 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 115.208 -0.906 . . . . 70.129999999999995 111.602 -173.616 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.406 ' HA ' ' HG2' ' A' ' 72' ' ' ARG . 18.8 ttp180 -62.29 -51.69 66.66 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.109 0.963 . . . . 73.329999999999998 110.988 -179.584 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -134.06 97.61 3.91 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 104.608 -2.367 . . . . 55.409999999999997 104.608 177.532 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.42 ' HA ' ' HA3' ' A' ' 105' ' ' GLY . 5.9 t60 -88.76 -55.29 3.76 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 116.049 -0.523 . . . . 73.420000000000002 111.301 -168.299 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.79 151.13 36.63 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 120.278 -0.569 . . . . 75.450000000000003 110.532 -177.231 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -120.74 128.06 52.58 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 107.428 -1.323 . . . . 73.329999999999998 107.428 174.521 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.549 ' CE2' ' HB ' ' A' ' 94' ' ' ILE . 69.8 t80 -104.49 127.77 52.27 Favored 'General case' 0 C--N 1.277 -2.553 0 N-CA-C 108.888 -0.782 . . . . 74.150000000000006 108.888 178.03 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 -109.83 122.21 46.99 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 107.137 -1.431 . . . . 75.409999999999997 107.137 -179.689 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.549 ' HB ' ' CE2' ' A' ' 92' ' ' PHE . 0.0 OUTLIER -116.05 125.93 73.34 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.246 0 CA-C-O 121.777 0.799 . . . . 65.230000000000004 110.824 -177.789 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.416 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 20.7 t-20 -118.42 145.77 44.96 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 105.507 -2.035 . . . . 64.239999999999995 105.507 174.651 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -61.92 -19.14 62.38 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 112.526 0.565 . . . . 71.209999999999994 112.526 -175.19 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -104.58 -31.89 4.39 Favored Glycine 0 N--CA 1.431 -1.635 0 C-N-CA 120.72 -0.752 . . . . 64.150000000000006 113.178 178.492 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.416 ' O ' ' HB3' ' A' ' 95' ' ' ASN . 8.8 pt-20 -143.06 155.71 44.68 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 117.363 0.582 . . . . 75.439999999999998 111.604 -174.7 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.439 ' HB2' ' HB2' ' A' ' 122' ' ' MET . 57.7 m-85 -127.35 128.67 46.28 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 110.099 -0.334 . . . . 73.109999999999999 110.099 -173.813 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -128.19 135.35 49.6 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 110.262 -0.273 . . . . 70.329999999999998 110.262 -178.531 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 14.6 p -120.7 129.73 75.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 108.919 -0.771 . . . . 55.439999999999998 108.919 174.844 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 25.4 m -115.85 129.73 71.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 CA-C-O 121.445 0.64 . . . . 71.430000000000007 111.185 179.635 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -86.55 121.34 28.95 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 114.977 -1.01 . . . . 73.310000000000002 109.067 179.231 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 18.5 m -118.44 -1.16 8.81 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 CA-C-N 115.546 -0.752 . . . . 73.340000000000003 110.009 179.055 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.42 ' HA3' ' HA ' ' A' ' 89' ' ' HIS . . . -111.83 52.04 0.66 Allowed Glycine 0 N--CA 1.427 -1.956 0 N-CA-C 109.73 -1.348 . . . . 71.409999999999997 109.73 178.62 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 14.2 m -62.91 -4.92 2.43 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.538 1.135 . . . . 74.140000000000001 112.192 -177.633 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 81.2 mt -61.99 -30.2 70.77 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 124.253 1.021 . . . . 61.200000000000003 109.244 174.707 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -125.71 -40.41 2.06 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.131 -0.94 . . . . 74.299999999999997 108.771 179.251 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.74 132.21 5.14 Favored Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.349 -0.841 . . . . 72.129999999999995 113.312 178.333 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 28.9 m -81.56 136.26 35.58 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.312 -0.996 . . . . 65.329999999999998 108.312 173.353 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.427 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 18.6 m-85 -114.43 134.17 55.19 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 108.268 -1.012 . . . . 75.109999999999999 108.268 -177.595 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 60.0 t -120.76 111.04 30.23 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 N-CA-C 106.926 -1.509 . . . . 65.049999999999997 106.926 176.784 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 42.7 t-20 44.08 70.36 0.33 Allowed 'General case' 0 C--O 1.241 0.634 0 O-C-N 125.143 1.527 . . . . 72.420000000000002 111.59 -176.114 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 73.98 -26.62 0.19 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.503 1.521 . . . . 75.219999999999999 113.388 177.362 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -90.77 118.1 68.41 Favored Pre-proline 0 C--N 1.311 -1.07 0 N-CA-C 112.343 0.497 . . . . 75.329999999999998 112.343 -175.68 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -63.38 128.24 22.05 Favored 'Trans proline' 0 C--O 1.247 0.965 0 C-N-CA 122.295 1.997 . . . . 71.299999999999997 108.584 172.299 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 3.1 mmp_? -123.04 145.23 48.71 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 116.991 -0.095 . . . . 75.120000000000005 110.81 -175.356 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -95.33 -36.66 11.31 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 108.181 -1.044 . . . . 72.010000000000005 108.181 172.11 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -149.19 139.49 22.33 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 105.89 -1.893 . . . . 75.409999999999997 105.89 174.308 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 7.7 tp60 -140.09 148.55 41.91 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 110.32 -0.252 . . . . 73.200000000000003 110.32 -178.714 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 67.4 t -93.11 123.12 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 N-CA-C 105.124 -2.176 . . . . 72.129999999999995 105.124 173.239 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.439 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 83.5 mmm -78.7 143.94 35.77 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 114.204 1.187 . . . . 55.140000000000001 114.204 -173.338 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -121.89 137.14 54.9 Favored 'General case' 0 N--CA 1.419 -1.99 0 CA-C-N 113.823 -1.535 . . . . 72.129999999999995 108.852 -177.581 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 7.1 t -79.54 126.69 31.2 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 109.024 -0.732 . . . . 74.409999999999997 109.024 178.502 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 95.74 19.33 29.65 Favored Glycine 0 N--CA 1.434 -1.454 0 C-N-CA 120.747 -0.739 . . . . 74.5 111.578 -179.175 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -118.93 160.91 21.08 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.816 -0.809 . . . . 72.310000000000002 108.816 178.246 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.447 ' OE1' ' HD2' ' A' ' 134' ' ' ARG . 44.0 tt0 -115.4 131.49 56.91 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.494 0.664 . . . . 73.299999999999997 111.495 -172.183 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.412 ' N ' HD12 ' A' ' 128' ' ' ILE . 3.5 mp -105.35 131.44 54.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 107.681 -1.229 . . . . 62.409999999999997 107.681 -176.728 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.427 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 60.1 tt0 -102.26 113.21 26.3 Favored 'General case' 0 N--CA 1.425 -1.702 0 C-N-CA 119.178 -1.009 . . . . 64.319999999999993 108.375 177.849 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 8.0 pt -100.73 98.14 6.56 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.361 0 CA-C-N 114.743 -1.117 . . . . 73.230000000000004 108.549 178.826 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.432 ' HA3' ' OD2' ' A' ' 82' ' ' ASP . . . 77.73 -110.96 3.15 Favored Glycine 0 N--CA 1.426 -2.029 0 CA-C-N 113.976 -1.466 . . . . 61.310000000000002 109.522 -174.923 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.403 ' NZ ' ' HB3' ' A' ' 132' ' ' LYS . 7.8 mtpm? -104.87 -19.88 13.74 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 116.918 0.359 . . . . 73.109999999999999 110.083 175.0 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.487 ' HB3' ' O ' ' A' ' 53' ' ' ARG . 57.4 m-85 -97.77 161.76 13.6 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-O 120.856 0.36 . . . . 61.240000000000002 111.571 -171.181 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.447 ' HD2' ' OE1' ' A' ' 127' ' ' GLU . 70.3 mtm180 -121.0 140.55 51.75 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 113.817 1.043 . . . . 73.510000000000005 113.817 -169.023 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.564 HD11 HD23 ' A' ' 49' ' ' LEU . 47.6 tp -121.41 136.47 54.96 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 113.734 -1.575 . . . . 64.299999999999997 108.25 -177.325 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 10.7 p -111.21 132.4 59.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 C-N-CA 120.195 -0.602 . . . . 74.430000000000007 109.541 177.666 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -111.29 129.68 55.9 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.162 -0.472 . . . . 60.130000000000003 111.445 -176.368 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -129.45 148.82 51.4 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.308 -0.627 . . . . 72.519999999999996 109.308 176.799 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -95.36 137.83 33.89 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.286 -1.005 . . . . 73.439999999999998 108.286 175.986 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -120.23 -127.99 3.59 Favored Glycine 0 N--CA 1.435 -1.433 0 C-N-CA 119.509 -1.329 . . . . 72.430000000000007 114.339 -173.895 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -70.22 135.0 28.3 Favored 'Trans proline' 0 C--O 1.235 0.367 0 C-N-CA 123.305 2.67 . . . . 61.350000000000001 114.94 -172.491 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -110.7 117.64 34.02 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.755 -1.202 . . . . 72.340000000000003 107.755 175.529 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 . . . . . 0 C--N 1.317 -0.811 0 N-CA-C 109.66 -0.496 . . . . 72.5 109.66 -179.242 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.522 -0.109 0 N-CA-C 106.012 -1.847 . . . . 64.040000000000006 106.012 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.6 m -51.75 -42.3 62.23 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.226 0.61 . . . . 62.549999999999997 112.342 -179.066 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -157.25 109.04 2.38 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 108.813 -0.81 . . . . 64.519999999999996 108.813 177.594 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -141.26 141.66 33.96 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.774 -0.824 . . . . 70.530000000000001 108.774 177.804 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -154.19 130.92 10.77 Favored 'General case' 0 C--N 1.287 -2.145 0 N-CA-C 107.582 -1.266 . . . . 62.409999999999997 107.582 179.555 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.87 80.4 0.57 Allowed Glycine 0 CA--C 1.503 -0.709 0 N-CA-C 109.132 -1.587 . . . . 73.239999999999995 109.132 175.688 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.8 m -78.67 124.52 85.17 Favored Pre-proline 0 N--CA 1.418 -2.042 0 C-N-CA 123.675 0.79 . . . . 73.239999999999995 111.289 -169.963 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -66.36 134.73 37.08 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 122.485 2.123 . . . . 31.149999999999999 109.573 174.545 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.414 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -73.3 135.71 79.16 Favored Pre-proline 0 C--N 1.303 -1.444 0 C-N-CA 119.976 -0.69 . . . . 62.350000000000001 110.67 177.093 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 9' ' ' GLU . 38.8 Cg_exo -60.27 121.61 10.05 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 122.204 1.936 . . . . 54.509999999999998 111.82 -178.225 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -79.63 108.53 13.25 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 106.631 -1.618 . . . . 73.540000000000006 106.631 178.636 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.8 m -63.95 126.14 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.305 0 CA-C-O 121.66 0.743 . . . . 60.149999999999999 112.44 -174.008 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -88.08 141.16 28.79 Favored 'General case' 0 N--CA 1.425 -1.678 0 CA-C-N 114.953 -1.021 . . . . 73.140000000000001 109.755 178.826 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.8 t -138.65 141.78 39.06 Favored 'General case' 0 C--N 1.285 -2.231 0 N-CA-C 108.156 -1.054 . . . . 51.310000000000002 108.156 179.027 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.8 t -105.23 124.95 50.4 Favored 'General case' 0 N--CA 1.406 -2.644 0 N-CA-C 108.171 -1.048 . . . . 71.439999999999998 108.171 -179.829 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.0 m -143.03 93.53 2.51 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-N 115.691 -0.686 . . . . 64.349999999999994 110.319 -178.811 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.3 p -156.63 137.21 4.6 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 N-CA-C 108.629 -0.878 . . . . 75.030000000000001 108.629 179.333 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -167.02 174.9 7.97 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.739 -0.467 . . . . 75.510000000000005 109.739 -178.904 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -102.98 111.37 23.67 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 120.841 0.353 . . . . 71.349999999999994 110.341 178.068 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -109.37 17.87 21.02 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 109.542 -0.54 . . . . 63.399999999999999 109.542 -179.801 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -69.07 -54.92 12.54 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.122 -0.945 . . . . 74.340000000000003 111.338 -176.05 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.2 tm? 52.87 93.02 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 O-C-N 124.385 1.053 . . . . 70.409999999999997 109.357 -174.624 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 86.8 mt -71.31 110.1 5.73 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.961 -0.563 . . . . 71.420000000000002 111.391 -176.148 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.36 -173.76 4.12 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 106.211 -1.774 . . . . 64.099999999999994 106.211 176.32 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -80.59 150.64 29.43 Favored 'General case' 0 N--CA 1.433 -1.306 0 C-N-CA 118.897 -1.121 . . . . 74.530000000000001 109.528 178.181 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -67.29 164.8 17.6 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 123.408 0.683 . . . . 74.140000000000001 111.081 -178.737 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -83.91 93.22 7.98 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.837 -0.801 . . . . 74.450000000000003 108.837 176.849 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.1 m -80.82 -33.93 34.31 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 109.062 -0.718 . . . . 64.030000000000001 109.062 177.821 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.4 m 66.39 111.4 0.04 OUTLIER 'General case' 0 C--O 1.242 0.664 0 C-N-CA 125.5 1.52 . . . . 61.030000000000001 112.606 178.726 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.9 t -82.34 145.6 29.84 Favored 'General case' 0 N--CA 1.423 -1.78 0 N-CA-C 107.513 -1.292 . . . . 74.319999999999993 107.513 174.755 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -100.53 85.94 0.62 Allowed Glycine 0 N--CA 1.431 -1.634 0 C-N-CA 120.552 -0.832 . . . . 74.25 111.815 -177.173 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.9 m -71.36 118.72 14.52 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.871 -0.788 . . . . 73.230000000000004 108.871 178.582 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.98 140.46 46.56 Favored Pre-proline 0 C--N 1.293 -1.891 0 CA-C-N 115.92 -0.582 . . . . 64.430000000000007 110.097 -177.73 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -49.99 146.03 17.93 Favored 'Trans proline' 0 C--O 1.246 0.907 0 C-N-CA 123.37 2.713 . . . . 74.310000000000002 111.782 177.511 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . 81.06 -15.04 0.77 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.59 1.556 . . . . 64.120000000000005 111.775 -177.25 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.6 m -94.75 109.1 21.09 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 106.701 -1.592 . . . . 71.150000000000006 106.701 174.569 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.6 t -169.99 170.65 7.49 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 108.603 -0.888 . . . . 71.310000000000002 108.603 -174.489 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 165.05 -55.66 0.26 Allowed Glycine 0 N--CA 1.427 -1.915 0 N-CA-C 112.1 -0.4 . . . . 44.020000000000003 112.1 176.085 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.66 -32.7 70.07 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 112.503 0.557 . . . . 55.210000000000001 112.503 -172.531 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.478 ' CD ' ' H ' ' A' ' 40' ' ' GLU . 0.3 OUTLIER -83.67 -11.97 56.52 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 121.05 0.453 . . . . 72.150000000000006 110.919 179.251 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -83.46 -18.06 39.9 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-O 121.051 0.453 . . . . 70.439999999999998 110.077 177.846 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -109.81 100.46 42.92 Favored Pre-proline 0 N--CA 1.435 -1.198 0 CA-C-N 115.836 -0.62 . . . . 70.420000000000002 110.387 177.789 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -65.2 -33.8 47.96 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 121.948 1.765 . . . . 61.200000000000003 109.977 176.863 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.435 ' HB1' ' HB1' ' A' ' 142' ' ' ALA . . . -143.06 108.3 5.0 Favored 'General case' 0 N--CA 1.425 -1.697 0 N-CA-C 107.124 -1.435 . . . . 72.030000000000001 107.124 175.658 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 166.43 -19.26 0.1 OUTLIER Glycine 0 C--N 1.302 -1.348 0 N-CA-C 111.05 -0.82 . . . . 44.32 111.05 -175.527 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.2 m -89.65 152.74 21.21 Favored 'General case' 0 N--CA 1.428 -1.526 0 N-CA-C 107.228 -1.397 . . . . 63.439999999999998 107.228 176.347 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.485 ' HB3' ' CZ ' ' A' ' 137' ' ' PHE . . . -97.64 178.54 5.13 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 110.201 -0.296 . . . . 65.540000000000006 110.201 -176.991 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -134.16 158.03 44.71 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.121 0.486 . . . . 73.340000000000003 111.507 -175.524 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.6 pp -121.34 140.26 52.33 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 115.354 -0.839 . . . . 71.230000000000004 109.023 174.869 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.446 HG12 ' CB ' ' A' ' 60' ' ' ARG . 33.1 m -115.52 138.51 45.66 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 CA-C-O 121.043 0.449 . . . . 52.310000000000002 109.834 179.611 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.0 t -93.61 115.62 32.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 107.818 -1.178 . . . . 74.209999999999994 107.818 179.943 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -88.56 -36.2 16.49 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.241 0.543 . . . . 72.219999999999999 109.551 -179.411 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.424 ' O ' ' HB3' ' A' ' 133' ' ' PHE . 37.6 ttm180 -149.84 125.5 10.36 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.309 -0.997 . . . . 72.319999999999993 108.309 -179.879 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 153.94 121.85 0.83 Allowed Glycine 0 N--CA 1.418 -2.539 0 C-N-CA 120.959 -0.639 . . . . 33.520000000000003 111.662 179.821 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -55.85 -9.04 2.58 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 124.522 3.481 . . . . 52.109999999999999 113.876 178.802 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.445 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 7.2 t30 -51.86 -38.39 55.82 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 124.106 0.962 . . . . 63.350000000000001 110.786 176.01 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -178.57 -59.87 0.01 OUTLIER 'General case' 0 C--N 1.354 0.764 0 CA-C-N 116.318 -0.401 . . . . 73.209999999999994 111.735 179.738 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.55 54.07 4.12 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 109.515 -1.434 . . . . 74.310000000000002 109.515 -173.837 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -154.63 -171.52 3.88 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 107.926 -1.138 . . . . 53.0 107.926 -175.752 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.446 ' CB ' HG12 ' A' ' 50' ' ' VAL . 18.7 ptp180 -110.15 140.2 44.5 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 109.875 -0.417 . . . . 72.040000000000006 109.875 -178.368 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -135.24 119.02 17.2 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 120.673 0.273 . . . . 73.420000000000002 110.891 179.765 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.0 tt -86.55 139.56 30.73 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 107.073 -1.454 . . . . 75.239999999999995 107.073 174.724 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 87.8 mt -71.19 114.07 8.87 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 119.923 -0.711 . . . . 74.239999999999995 109.385 -176.433 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -117.45 -32.26 4.98 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 114.793 -1.094 . . . . 53.43 110.989 -172.655 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -96.97 132.25 26.22 Favored Pre-proline 0 C--N 1.303 -1.454 0 N-CA-C 107.686 -1.227 . . . . 73.239999999999995 107.686 178.653 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.454 ' HA ' HG13 ' A' ' 94' ' ' ILE . 10.5 Cg_endo -53.45 -26.48 36.09 Favored 'Trans proline' 0 C--N 1.371 1.748 0 C-N-CA 124.034 3.156 . . . . 43.439999999999998 113.411 -176.207 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 51.8 m -133.39 98.09 4.14 Favored 'General case' 0 N--CA 1.407 -2.586 0 N-CA-C 108.404 -0.961 . . . . 70.329999999999998 108.404 174.282 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 98.2 m -88.75 115.4 26.26 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 114.868 -1.06 . . . . 74.0 108.469 -178.685 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.6 t -107.78 121.51 44.87 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-O 121.554 0.693 . . . . 61.409999999999997 111.369 -177.277 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -104.7 115.32 30.12 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 114.868 -1.06 . . . . 44.399999999999999 109.022 179.185 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.725 ' O ' ' HA ' ' A' ' 88' ' ' ARG . . . 90.64 85.33 1.39 Allowed Glycine 0 CA--C 1.475 -2.446 0 N-CA-C 107.798 -2.121 . . . . 73.329999999999998 107.798 -177.375 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.416 ' HG2' ' O ' ' A' ' 75' ' ' GLU . 23.5 tpt180 -177.57 142.79 0.33 Allowed 'General case' 0 N--CA 1.407 -2.59 0 N-CA-C 102.243 -3.243 . . . . 63.009999999999998 102.243 -171.513 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -109.16 -60.55 0.04 OUTLIER Pre-proline 0 C--N 1.274 -2.705 0 N-CA-C 115.316 1.599 . . . . 73.420000000000002 115.316 -177.701 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_exo -66.67 -40.63 12.82 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 121.871 1.714 . . . . 65.109999999999999 113.862 -173.249 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.416 ' O ' ' HG2' ' A' ' 72' ' ' ARG . 38.7 tt0 -130.42 75.55 1.66 Allowed 'General case' 0 N--CA 1.422 -1.87 0 N-CA-C 107.378 -1.341 . . . . 41.340000000000003 107.378 -177.309 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.4 p -112.24 170.44 8.16 Favored 'General case' 0 C--N 1.285 -2.231 0 N-CA-C 113.365 0.876 . . . . 72.510000000000005 113.365 -171.689 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -112.14 -55.71 2.48 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 107.166 -1.42 . . . . 51.240000000000002 107.166 173.857 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 24.2 pt -125.43 152.28 32.05 Favored 'Isoleucine or valine' 0 C--O 1.25 1.12 0 CA-C-N 115.539 -0.755 . . . . 71.129999999999995 109.422 174.797 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.445 ' O ' ' HA ' ' A' ' 56' ' ' ASN . 87.8 m-85 -112.89 117.53 32.38 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 112.293 0.479 . . . . 71.400000000000006 112.293 -173.131 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.2 mp -74.12 107.39 6.28 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 108.743 -0.836 . . . . 72.430000000000007 108.743 170.1 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -82.04 1.4 35.95 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 123.993 0.917 . . . . 64.409999999999997 110.976 -178.02 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -98.4 164.44 12.28 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.55 -0.75 . . . . 62.149999999999999 109.857 -177.949 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.2 p -69.92 -18.8 22.2 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.134 0 C-N-CA 123.35 0.66 . . . . 63.549999999999997 111.64 -178.769 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 13.3 p -73.05 11.44 0.7 Allowed 'General case' 0 CA--C 1.555 1.15 0 N-CA-C 113.698 0.999 . . . . 74.230000000000004 113.698 -178.807 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.6 p -82.58 125.0 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 CA-C-O 121.436 0.636 . . . . 64.0 111.931 -177.187 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 41.9 t -84.68 169.34 14.41 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.343 -0.984 . . . . 43.420000000000002 108.343 174.624 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 52.3 mtm-85 -56.76 -40.76 76.4 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 108.946 -0.761 . . . . 73.230000000000004 108.946 175.87 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.725 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -146.07 129.45 16.82 Favored 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 105.754 -1.943 . . . . 64.510000000000005 105.754 165.392 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.401 ' HA ' ' HA3' ' A' ' 105' ' ' GLY . 30.1 t60 -108.74 -74.04 0.67 Allowed 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 113.213 0.819 . . . . 70.239999999999995 113.213 -171.088 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -117.29 119.39 35.0 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 121.652 -0.655 . . . . 61.009999999999998 109.756 -177.443 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -109.69 127.18 54.4 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 108.277 -1.009 . . . . 72.209999999999994 108.277 -179.608 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -112.33 112.8 24.63 Favored 'General case' 0 N--CA 1.425 -1.693 0 N-CA-C 107.619 -1.252 . . . . 74.219999999999999 107.619 -178.763 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 30.8 ttm-85 -101.91 143.32 31.94 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 107.819 -1.178 . . . . 71.129999999999995 107.819 179.791 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.454 HG13 ' HA ' ' A' ' 66' ' ' PRO . 2.6 pp -115.53 140.46 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.479 0 N-CA-C 107.578 -1.267 . . . . 71.450000000000003 107.578 175.298 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.455 ' C ' ' H ' ' A' ' 97' ' ' GLY . 40.0 t-20 -118.44 147.08 43.95 Favored 'General case' 0 C--N 1.268 -2.972 0 N-CA-C 104.541 -2.392 . . . . 55.130000000000003 104.541 -178.807 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -59.84 26.5 0.01 OUTLIER 'General case' 0 CA--C 1.574 1.881 0 N-CA-C 114.62 1.341 . . . . 64.349999999999994 114.62 -176.945 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.455 ' H ' ' C ' ' A' ' 95' ' ' ASN . . . -169.16 -38.31 0.03 OUTLIER Glycine 0 N--CA 1.426 -2.011 0 N-CA-C 111.074 -0.81 . . . . 71.129999999999995 111.074 -179.445 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -127.61 170.9 12.14 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.95 0.405 . . . . 73.409999999999997 111.283 -176.392 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -116.89 129.3 55.98 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 116.276 -0.42 . . . . 71.120000000000005 110.101 -179.912 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -122.07 119.52 31.64 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.907 -0.405 . . . . 74.019999999999996 109.907 -176.845 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.496 HG11 ' SD ' ' A' ' 122' ' ' MET . 27.9 m -121.93 128.92 75.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 C-N-CA 119.835 -0.746 . . . . 74.299999999999997 110.944 178.371 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 29.4 m -119.84 137.46 53.65 Favored 'Isoleucine or valine' 0 C--O 1.252 1.234 0 N-CA-C 112.76 0.652 . . . . 62.420000000000002 112.76 -178.243 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -92.68 108.37 19.93 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.485 -0.78 . . . . 72.319999999999993 110.228 174.98 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.3 m -114.56 5.46 7.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 CA-C-O 121.86 0.838 . . . . 53.310000000000002 109.709 177.417 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.401 ' HA3' ' HA ' ' A' ' 89' ' ' HIS . . . -105.86 36.32 4.48 Favored Glycine 0 N--CA 1.431 -1.676 0 N-CA-C 109.725 -1.35 . . . . 42.43 109.725 179.351 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 14.0 m -65.01 5.47 0.34 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.736 1.615 . . . . 74.239999999999995 113.158 -176.689 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.4 mp -69.37 -34.27 74.3 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 107.505 -1.295 . . . . 71.329999999999998 107.505 172.918 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -119.01 -40.06 2.87 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 107.293 -1.373 . . . . 75.519999999999996 107.293 174.1 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 104.96 141.89 11.08 Favored Glycine 0 N--CA 1.44 -1.08 0 CA-C-N 115.79 -0.641 . . . . 74.099999999999994 113.485 176.108 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 27.6 m -108.52 125.45 51.82 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 107.362 -1.347 . . . . 51.140000000000001 107.362 173.205 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -103.64 134.52 46.85 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.56 -0.533 . . . . 73.299999999999997 109.56 -176.684 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.421 HG21 ' HG2' ' A' ' 120' ' ' GLN . 7.2 p -125.77 127.51 71.42 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.428 0 N-CA-C 106.973 -1.491 . . . . 70.450000000000003 106.973 175.391 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 18.4 m120 64.71 22.6 12.62 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 109.108 -0.701 . . . . 63.219999999999999 109.108 -174.842 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 18.3 mmm180 76.54 5.41 3.53 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.729 1.212 . . . . 72.25 112.779 -175.291 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -112.41 130.07 23.73 Favored Pre-proline 0 C--N 1.315 -0.924 0 N-CA-C 110.386 -0.227 . . . . 71.400000000000006 110.386 -179.4 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -74.85 110.48 3.12 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 121.823 1.682 . . . . 74.510000000000005 109.772 175.858 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 43.2 ttt180 -126.83 154.64 44.07 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.508 -1.293 . . . . 75.310000000000002 107.508 -176.235 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -81.2 -50.52 9.48 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.271 -0.572 . . . . 75.319999999999993 110.664 -175.182 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -130.18 140.16 50.77 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 108.406 -0.961 . . . . 64.439999999999998 108.406 178.875 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.421 ' HG2' HG21 ' A' ' 112' ' ' VAL . 55.2 tp60 -139.72 148.03 41.74 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 109.692 -0.485 . . . . 70.0 109.692 -179.926 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 98.8 t -88.17 117.29 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 N-CA-C 105.195 -2.15 . . . . 74.420000000000002 105.195 167.86 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.496 ' SD ' HG11 ' A' ' 101' ' ' VAL . 4.6 tpt -55.89 116.73 3.13 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 124.071 0.948 . . . . 70.310000000000002 111.468 -171.74 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -105.26 129.83 53.53 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.662 -0.699 . . . . 63.549999999999997 109.6 -174.336 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 7.0 t -79.61 129.16 34.22 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 121.628 0.728 . . . . 54.450000000000003 112.571 -175.217 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 108.18 -11.43 37.03 Favored Glycine 0 N--CA 1.423 -2.17 0 CA-C-N 115.249 -0.887 . . . . 62.530000000000001 111.638 178.196 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -102.35 172.59 6.8 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 112.867 0.692 . . . . 73.310000000000002 112.867 -177.344 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -108.32 142.52 38.5 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-N 115.056 -0.974 . . . . 74.099999999999994 112.115 -172.891 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.4 mp -124.1 113.17 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.922 0 N-CA-C 105.74 -1.948 . . . . 74.040000000000006 105.74 178.216 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.428 ' HA ' ' O ' ' A' ' 133' ' ' PHE . 66.4 mt-30 -102.95 119.64 39.21 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 109.667 -0.494 . . . . 72.439999999999998 109.667 -177.056 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 20.9 pt -91.41 99.72 10.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 N-CA-C 107.999 -1.112 . . . . 74.310000000000002 107.999 176.884 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 79.19 -94.03 1.34 Allowed Glycine 0 N--CA 1.422 -2.299 0 N-CA-C 108.755 -1.738 . . . . 72.230000000000004 108.755 -174.376 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -137.54 15.94 2.94 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.205 0.526 . . . . 64.310000000000002 110.306 177.128 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.428 ' O ' ' HA ' ' A' ' 129' ' ' GLN . 53.1 m-85 -103.52 131.3 50.76 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 109.664 -0.495 . . . . 75.299999999999997 109.664 -179.868 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 48.7 ttt180 -95.27 121.76 37.26 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-O 121.631 0.729 . . . . 55.549999999999997 111.708 -169.214 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 9.5 mp -121.96 143.87 49.21 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 107.668 -1.234 . . . . 63.119999999999997 107.668 175.672 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 6.3 p -126.95 130.67 71.37 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.435 0 C-N-CA 120.633 -0.427 . . . . 71.200000000000003 110.318 179.342 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.485 ' CZ ' ' HB3' ' A' ' 47' ' ' ALA . 90.7 t80 -97.22 125.21 41.61 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.585 -0.734 . . . . 74.319999999999993 110.115 -176.759 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -128.56 144.24 51.11 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.385 0.612 . . . . 52.219999999999999 110.785 -179.752 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -87.01 86.21 7.3 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 106.996 -1.483 . . . . 73.340000000000003 106.996 171.926 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -75.27 -174.09 34.18 Favored Glycine 0 N--CA 1.439 -1.121 0 CA-C-N 114.983 -1.008 . . . . 52.409999999999997 113.945 -174.719 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -71.11 140.21 37.2 Favored 'Trans proline' 0 N--CA 1.447 -1.218 0 C-N-CA 122.716 2.278 . . . . 74.120000000000005 112.801 -179.14 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.435 ' HB1' ' HB1' ' A' ' 44' ' ' ALA . . . -99.72 103.97 15.66 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 107.827 -1.175 . . . . 70.109999999999999 107.827 176.916 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 . . . . . 0 C--N 1.304 -1.405 0 N-CA-C 108.736 -0.838 . . . . 62.240000000000002 108.736 -178.969 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.2 ttp . . . . . 0 CA--C 1.507 -0.684 0 N-CA-C 109.511 -0.551 . . . . 73.120000000000005 109.511 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.0 m -81.0 -48.97 11.51 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.256 -1.016 . . . . 54.130000000000003 108.256 175.965 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -157.08 132.43 9.15 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 107.86 -1.163 . . . . 63.140000000000001 107.86 -178.931 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -102.95 148.19 25.99 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.395 -0.594 . . . . 64.019999999999996 109.395 -179.408 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -117.8 102.37 9.05 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 121.178 0.513 . . . . 55.219999999999999 111.278 -176.282 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -138.12 55.23 0.68 Allowed Glycine 0 N--CA 1.438 -1.229 0 N-CA-C 109.916 -1.273 . . . . 61.310000000000002 109.916 179.398 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.427 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 11.3 t -64.8 127.98 93.14 Favored Pre-proline 0 N--CA 1.439 -0.987 0 CA-C-N 115.191 -0.504 . . . . 74.010000000000005 109.834 -177.907 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 7' ' ' THR . 31.4 Cg_exo -61.1 127.65 22.86 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.198 1.932 . . . . 43.520000000000003 111.212 179.849 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -101.74 115.69 64.5 Favored Pre-proline 0 C--N 1.302 -1.496 0 N-CA-C 109.505 -0.554 . . . . 65.439999999999998 109.505 179.606 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -73.03 128.87 13.53 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.744 2.296 . . . . 72.219999999999999 113.894 -176.59 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -106.69 108.04 19.36 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 106.057 -1.831 . . . . 74.010000000000005 106.057 176.369 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.2 p -124.54 135.48 63.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 N-CA-C 109.396 -0.594 . . . . 33.43 109.396 -179.314 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -105.92 130.77 53.8 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.121 0.486 . . . . 74.040000000000006 110.825 -178.98 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 95.6 m -151.63 106.43 3.25 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.238 -1.023 . . . . 51.350000000000001 108.238 174.693 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 17.1 p -96.99 122.98 40.58 Favored 'General case' 0 N--CA 1.412 -2.327 0 CA-C-O 121.422 0.63 . . . . 55.240000000000002 110.506 -178.049 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 27.5 t -80.66 108.78 14.6 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 114.747 -1.115 . . . . 74.030000000000001 110.336 -177.331 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 91.5 t -81.96 131.78 33.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 108.416 -0.957 . . . . 72.430000000000007 108.416 178.497 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -98.89 158.53 15.58 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 110.036 -0.357 . . . . 74.129999999999995 110.036 179.148 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -124.98 159.58 30.92 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 108.512 -0.921 . . . . 72.120000000000005 108.512 -178.789 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -84.97 83.5 8.03 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.354 -0.98 . . . . 53.299999999999997 108.354 174.208 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -77.33 -27.77 52.9 Favored 'General case' 0 CA--C 1.487 -1.45 0 CA-C-N 114.739 -1.119 . . . . 74.239999999999995 111.309 -175.041 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -135.47 139.24 43.91 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 116.053 -0.521 . . . . 73.25 109.613 -179.019 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.445 ' O ' HD12 ' A' ' 23' ' ' LEU . 4.0 pp -166.88 132.28 2.16 Favored 'General case' 0 N--CA 1.436 -1.17 0 O-C-N 124.232 0.957 . . . . 74.120000000000005 110.002 178.614 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.5 162.74 27.58 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 106.094 -1.817 . . . . 74.030000000000001 106.094 178.715 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -142.78 148.39 37.09 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 120.177 -0.609 . . . . 74.329999999999998 112.28 -179.281 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 48.7 ttm 66.53 84.55 0.15 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.658 1.224 . . . . 71.420000000000002 110.095 -175.955 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -138.58 106.37 5.64 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-N 114.927 -1.033 . . . . 72.120000000000005 109.359 -179.194 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.5 p -138.2 137.25 37.4 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 115.464 -0.789 . . . . 54.219999999999999 109.957 178.291 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 16.5 m -61.45 119.34 8.37 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 108.944 -0.762 . . . . 71.129999999999995 108.944 176.988 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 18.6 m -88.77 107.16 18.82 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 108.283 -1.006 . . . . 44.539999999999999 108.283 -177.68 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -83.15 62.04 4.69 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 121.017 -0.611 . . . . 73.010000000000005 114.179 -174.536 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 26.4 m -93.52 116.75 29.28 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 107.694 -1.224 . . . . 71.209999999999994 107.694 174.447 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -90.92 114.73 62.45 Favored Pre-proline 0 C--N 1.281 -2.393 0 CA-C-N 116.226 -0.443 . . . . 43.32 109.829 -178.751 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -68.12 119.32 6.33 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 121.75 1.633 . . . . 51.140000000000001 110.813 177.581 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -126.16 137.13 53.54 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 115.706 -0.679 . . . . 62.119999999999997 109.293 -177.716 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.8 m -57.51 -46.35 83.88 Favored 'General case' 0 N--CA 1.438 -1.068 0 O-C-N 123.984 0.803 . . . . 73.299999999999997 110.709 177.831 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 20.5 m 56.53 40.78 29.34 Favored 'General case' 0 CA--C 1.554 1.129 0 CA-C-O 123.192 1.473 . . . . 71.140000000000001 108.635 -179.241 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -111.43 33.27 5.91 Favored Glycine 0 N--CA 1.431 -1.671 0 CA-C-N 114.518 -1.219 . . . . 72.310000000000002 111.813 -176.34 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.1 -45.11 94.93 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-O 121.634 0.731 . . . . 73.209999999999994 109.767 179.657 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -71.91 -11.14 60.65 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 114.932 -1.031 . . . . 72.340000000000003 112.694 -177.734 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -72.62 -17.74 61.65 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 108.858 -0.793 . . . . 73.219999999999999 108.858 -177.863 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 50.1 tp -60.09 125.12 80.3 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-N 115.605 -0.725 . . . . 74.209999999999994 109.333 177.374 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -66.19 171.38 10.35 Favored 'Trans proline' 0 C--O 1.245 0.868 0 C-N-CA 122.644 2.229 . . . . 73.219999999999999 112.592 178.509 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.83 152.41 44.59 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.566 -0.743 . . . . 71.140000000000001 110.743 -179.726 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 105.43 37.97 2.53 Favored Glycine 0 N--CA 1.439 -1.149 0 N-CA-C 111.149 -0.78 . . . . 45.119999999999997 111.149 -176.723 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.5 ' O ' ' HA ' ' A' ' 141' ' ' PRO . 10.8 m -90.53 159.77 16.31 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.342 -0.614 . . . . 51.520000000000003 109.342 -178.282 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -113.98 178.38 4.3 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 117.741 0.246 . . . . 73.450000000000003 111.064 -176.261 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.5 pp -132.36 158.94 40.64 Favored 'General case' 0 C--O 1.244 0.788 0 N-CA-C 112.909 0.707 . . . . 61.310000000000002 112.909 -173.389 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.4 pp -119.24 147.74 43.91 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.58 -0.736 . . . . 74.040000000000006 109.817 176.914 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 25.3 t -130.23 149.86 34.02 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 C-N-CA 123.606 0.763 . . . . 51.549999999999997 109.284 -175.577 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.489 HG23 ' HD2' ' A' ' 55' ' ' PRO . 3.5 p -88.54 118.05 33.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-O 122.375 1.083 . . . . 74.319999999999993 111.05 179.475 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -95.6 -39.05 10.12 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-N 115.244 -0.889 . . . . 64.239999999999995 108.785 174.016 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -154.04 89.17 1.28 Allowed 'General case' 0 C--O 1.215 -0.748 0 N-CA-C 109.051 -0.722 . . . . 63.450000000000003 109.051 176.211 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 20.87 54.04 0.01 OUTLIER Glycine 0 N--CA 1.508 3.495 0 N-CA-C 119.842 2.697 . . . . 62.409999999999997 119.842 177.44 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.489 ' HD2' HG23 ' A' ' 51' ' ' VAL . 74.0 Cg_endo -71.91 -40.37 2.69 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 CA-C-N 120.821 2.31 . . . . 63.439999999999998 113.89 -178.783 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.565 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 15.6 m120 -134.17 -84.42 0.43 Allowed 'General case' 0 C--O 1.209 -1.055 0 CA-C-O 121.183 0.516 . . . . 62.420000000000002 112.079 -171.504 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.64 -6.82 26.59 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.528 0.566 . . . . 73.239999999999995 112.528 -173.825 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.24 40.57 99.2 Favored Glycine 0 CA--C 1.523 0.579 0 C-N-CA 120.756 -0.735 . . . . 61.0 112.256 -178.199 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -157.09 -163.7 1.45 Allowed 'General case' 0 C--O 1.254 1.331 0 N-CA-C 108.886 -0.783 . . . . 44.520000000000003 108.886 -177.122 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -132.34 139.49 48.17 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 108.354 -0.98 . . . . 72.129999999999995 108.354 176.134 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -156.46 154.5 30.5 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.057 0.456 . . . . 71.340000000000003 111.786 179.477 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 31.2 tp -80.08 139.49 36.87 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 114.55 -1.204 . . . . 73.340000000000003 109.172 179.655 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.9 mp -82.77 114.38 21.06 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 106.52 -1.659 . . . . 74.230000000000004 106.52 173.704 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -112.42 3.8 17.14 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 116.132 -0.486 . . . . 74.219999999999999 110.233 -175.012 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -121.82 141.11 33.21 Favored Pre-proline 0 C--N 1.301 -1.541 0 N-CA-C 107.741 -1.207 . . . . 63.25 107.741 -179.391 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -55.08 -49.89 14.99 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.167 2.578 . . . . 51.200000000000003 111.924 -177.413 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' A' ' 92' ' ' PHE . 44.3 m -121.08 108.54 13.94 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-N 115.509 -0.769 . . . . 74.239999999999995 110.455 178.924 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.436 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 4.7 m -91.66 114.81 27.44 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.264 -1.013 . . . . 75.430000000000007 108.264 179.116 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 16.7 p -90.79 122.76 33.8 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 116.742 -0.208 . . . . 75.340000000000003 110.693 -179.774 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.441 ' HA ' ' O ' ' A' ' 78' ' ' ILE . . . -109.5 121.84 46.08 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 109.877 -0.416 . . . . 71.209999999999994 109.877 178.178 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -164.6 -136.22 1.96 Allowed Glycine 0 N--CA 1.432 -1.604 0 N-CA-C 111.117 -0.793 . . . . 70.439999999999998 111.117 178.52 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.463 ' NH2' ' HA ' ' A' ' 81' ' ' ASP . 4.2 tpp180 -159.57 84.65 0.77 Allowed 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.025 -1.472 . . . . 75.25 107.025 176.992 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -179.97 151.18 0.57 Allowed Pre-proline 0 C--N 1.296 -1.756 0 N-CA-C 104.745 -2.317 . . . . 75.439999999999998 104.745 -177.514 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.44 -22.15 70.52 Favored 'Trans proline' 0 N--CA 1.48 0.709 0 C-N-CA 122.41 2.073 . . . . 74.120000000000005 113.211 -178.149 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -79.54 -18.34 52.03 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.431 -0.35 . . . . 71.219999999999999 111.064 -179.148 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.0 m -88.42 131.86 34.69 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 107.162 -1.422 . . . . 65.230000000000004 107.162 176.167 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -70.84 -50.38 36.02 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 120.956 -0.297 . . . . 63.310000000000002 111.451 -176.851 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.441 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 39.2 pt -112.37 154.55 13.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 C-N-CA 120.133 -0.627 . . . . 55.530000000000001 109.883 178.991 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -116.58 136.05 53.3 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 116.399 -0.364 . . . . 72.450000000000003 110.501 -179.023 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.565 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 1.5 pt? -84.99 139.92 31.44 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 106.647 -1.612 . . . . 63.329999999999998 106.647 171.553 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.463 ' HA ' ' NH2' ' A' ' 72' ' ' ARG . 19.8 t70 -106.56 58.0 0.64 Allowed 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 118.415 -1.314 . . . . 52.329999999999998 112.583 -172.098 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -104.07 151.19 23.55 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 106.641 -1.615 . . . . 72.25 106.641 171.476 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.4 m -74.38 -12.45 15.14 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 N-CA-C 112.284 0.476 . . . . 72.329999999999998 112.284 -178.621 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -113.42 51.52 0.84 Allowed 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 106.956 -1.498 . . . . 72.329999999999998 106.956 179.16 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.47 HG23 ' HG ' ' A' ' 80' ' ' LEU . 7.6 p -82.24 135.59 24.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 115.469 -0.787 . . . . 73.540000000000006 113.004 -173.038 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 8.0 m -101.75 144.21 30.72 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.625 -0.716 . . . . 74.439999999999998 110.93 -177.925 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -67.39 120.79 14.47 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 106.172 -1.788 . . . . 74.409999999999997 106.172 170.569 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 58.1 81.35 0.15 Allowed 'General case' 0 N--CA 1.466 0.357 0 O-C-N 123.9 0.75 . . . . 73.319999999999993 110.396 -172.421 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 19.1 t60 -98.81 -35.65 10.06 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 109.398 -0.593 . . . . 72.340000000000003 109.398 -178.626 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -149.22 136.27 19.83 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 120.335 -0.546 . . . . 73.040000000000006 110.031 -179.447 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -112.89 126.98 56.05 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 108.313 -0.995 . . . . 75.150000000000006 108.313 173.989 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.452 ' O ' ' HA ' ' A' ' 67' ' ' THR . 86.1 m-85 -105.37 122.39 45.88 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.049 -1.093 . . . . 72.129999999999995 108.049 179.058 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.467 ' HB3' ' HB3' ' A' ' 100' ' ' GLU . 51.4 ttt180 -113.06 119.16 36.89 Favored 'General case' 0 C--N 1.281 -2.385 0 N-CA-C 108.34 -0.985 . . . . 61.509999999999998 108.34 179.569 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.79 116.43 52.38 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 N-CA-C 107.48 -1.304 . . . . 74.329999999999998 107.48 179.553 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.41 ' OD1' ' HG2' ' A' ' 96' ' ' GLU . 27.4 t30 -101.88 145.55 29.06 Favored 'General case' 0 C--N 1.275 -2.634 0 CA-C-N 113.758 -1.565 . . . . 75.120000000000005 106.864 -179.787 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.41 ' HG2' ' OD1' ' A' ' 95' ' ' ASN . 9.6 pt-20 -42.88 -29.5 0.33 Allowed 'General case' 0 C--N 1.313 -0.995 0 C-N-CA 125.049 1.34 . . . . 73.120000000000005 113.668 -178.388 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -138.7 29.52 2.57 Favored Glycine 0 N--CA 1.43 -1.72 0 C-N-CA 120.373 -0.918 . . . . 75.239999999999995 112.75 177.331 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.405 ' HB3' HD22 ' A' ' 95' ' ' ASN . 8.2 tp10 -165.07 152.99 11.49 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 117.883 0.841 . . . . 64.239999999999995 110.989 -179.866 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -124.96 126.87 46.16 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.845 -0.428 . . . . 72.239999999999995 109.845 -176.549 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.467 ' HB3' ' HB3' ' A' ' 93' ' ' ARG . 37.3 tt0 -132.26 135.19 46.09 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 122.568 0.347 . . . . 73.129999999999995 110.269 -175.992 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.7 p -128.7 129.01 68.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 O-C-N 121.946 -0.472 . . . . 70.349999999999994 110.908 177.608 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 97.5 t -119.47 124.53 73.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 116.008 -0.542 . . . . 72.239999999999995 110.816 179.722 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -83.6 125.16 31.52 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 123.2 0.6 . . . . 60.329999999999998 110.272 174.725 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.8 t -118.72 7.6 6.79 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 N-CA-C 107.936 -1.135 . . . . 63.100000000000001 107.936 178.393 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -116.7 45.56 1.27 Allowed Glycine 0 N--CA 1.441 -1.009 0 N-CA-C 110.498 -1.041 . . . . 23.32 110.498 -178.873 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 12.3 m -63.72 -12.62 36.29 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 123.977 0.911 . . . . 74.129999999999995 111.61 -177.538 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 92.0 mt -61.35 -35.84 78.55 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.8 0.84 . . . . 74.129999999999995 109.892 174.748 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -93.69 -37.59 11.75 Favored 'General case' 0 CA--C 1.496 -1.118 0 N-CA-C 108.327 -0.99 . . . . 64.340000000000003 108.327 178.257 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 93.65 88.63 1.62 Allowed Glycine 0 N--CA 1.432 -1.614 0 CA-C-N 114.943 -1.026 . . . . 74.019999999999996 111.499 -179.99 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 55.1 m -82.3 120.62 25.63 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 109.37 -0.604 . . . . 70.409999999999997 109.37 177.634 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.476 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 37.4 m-85 -106.2 134.93 48.56 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 107.818 -1.178 . . . . 73.310000000000002 107.818 -179.927 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 23.8 t -105.88 121.33 58.09 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.235 0 N-CA-C 106.8 -1.556 . . . . 72.239999999999995 106.8 177.898 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 61.96 25.51 15.32 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.704 1.202 . . . . 54.140000000000001 109.809 -175.102 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 65.6 mtp180 75.08 14.53 3.1 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.248 1.819 . . . . 61.210000000000001 112.363 -178.523 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 25.1 tp10 -110.76 123.94 34.29 Favored Pre-proline 0 C--N 1.307 -1.279 0 N-CA-C 108.039 -1.097 . . . . 71.310000000000002 108.039 174.798 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -57.21 103.83 0.14 Allowed 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.226 1.951 . . . . 65.439999999999998 110.762 176.073 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.408 ' HE ' ' HA ' ' A' ' 117' ' ' ARG . 1.6 tpm_? -143.41 111.07 5.92 Favored 'General case' 0 N--CA 1.414 -2.229 0 N-CA-C 105.391 -2.077 . . . . 63.25 105.391 -176.697 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -81.21 -23.73 37.92 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 120.553 -0.459 . . . . 72.409999999999997 111.638 -173.856 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -130.77 137.05 49.28 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.264 -1.384 . . . . 73.219999999999999 107.264 172.286 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.401 ' HG2' ' HG2' ' A' ' 117' ' ' ARG . 0.0 OUTLIER -140.43 145.85 37.55 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 108.229 -1.026 . . . . 74.200000000000003 108.229 -178.734 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 44.9 t -95.53 103.45 14.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 104.955 -2.239 . . . . 72.430000000000007 104.955 174.694 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 24.7 mtt -58.11 129.44 41.97 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 116.296 1.962 . . . . 54.240000000000002 116.296 -168.927 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.496 HE21 ' CA ' ' A' ' 123' ' ' GLN . 0.0 OUTLIER -106.99 153.3 22.78 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 112.715 -2.039 . . . . 64.239999999999995 107.334 176.418 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 9.5 t -76.75 115.58 16.65 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 122.367 1.079 . . . . 64.230000000000004 109.575 -178.571 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 113.46 3.74 23.85 Favored Glycine 0 N--CA 1.426 -2.016 0 CA-C-N 114.865 -1.062 . . . . 61.340000000000003 110.821 -176.057 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -62.31 133.98 55.86 Favored 'General case' 0 CA--C 1.491 -1.305 0 CA-C-O 121.258 0.551 . . . . 75.209999999999994 111.283 178.991 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -114.33 127.66 55.97 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 115.032 -0.986 . . . . 72.120000000000005 110.32 -178.378 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.461 ' HB ' ' HB3' ' A' ' 135' ' ' LEU . 65.4 mt -97.67 118.94 45.02 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.234 0 N-CA-C 108.039 -1.097 . . . . 65.230000000000004 108.039 177.086 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.476 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 48.9 tp60 -103.39 112.71 25.73 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 115.326 -0.852 . . . . 74.400000000000006 109.148 -177.086 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.455 HG13 ' HB2' ' A' ' 133' ' ' PHE . 14.0 pt -124.34 97.9 4.91 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 108.426 -0.953 . . . . 71.430000000000007 108.426 174.25 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 68.46 -108.65 2.54 Favored Glycine 0 N--CA 1.435 -1.4 0 CA-C-N 114.865 -1.061 . . . . 50.210000000000001 110.62 -175.663 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -108.34 -1.86 19.66 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 120.769 0.318 . . . . 73.430000000000007 111.004 177.638 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.455 ' HB2' HG13 ' A' ' 130' ' ' ILE . 71.0 m-85 -93.54 147.55 22.88 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.724 0.297 . . . . 73.430000000000007 110.984 -177.902 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.421 ' HA ' ' O ' ' A' ' 128' ' ' ILE . 84.1 mtt180 -133.74 129.65 36.98 Favored 'General case' 0 C--O 1.257 1.453 0 CA-C-N 115.785 -0.643 . . . . 71.200000000000003 111.829 -178.979 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.486 HD13 ' N ' ' A' ' 136' ' ' VAL . 3.4 tm? -109.39 144.68 37.27 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 106.185 -1.783 . . . . 74.030000000000001 106.185 172.628 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.486 ' N ' HD13 ' A' ' 135' ' ' LEU . 12.9 p -130.09 128.03 64.1 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.704 0 N-CA-C 109.377 -0.601 . . . . 72.329999999999998 109.377 -178.82 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -110.69 129.88 55.71 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.656 -0.702 . . . . 71.430000000000007 109.569 -176.871 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.3 mp -127.7 140.66 51.94 Favored 'General case' 0 C--O 1.253 1.25 0 CA-C-O 121.363 0.601 . . . . 62.009999999999998 110.804 -179.455 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -86.73 87.88 7.55 Favored 'General case' 0 N--CA 1.422 -1.852 0 CA-C-N 115.339 -0.846 . . . . 74.310000000000002 109.363 179.08 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -120.27 84.13 0.37 Allowed Glycine 0 C--N 1.292 -1.884 0 N-CA-C 107.536 -2.226 . . . . 40.5 107.536 174.517 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.5 ' HA ' ' O ' ' A' ' 46' ' ' SER . 14.9 Cg_endo -59.42 120.03 7.62 Favored 'Trans proline' 0 N--CA 1.445 -1.376 0 C-N-CA 122.541 2.16 . . . . 73.299999999999997 114.775 -172.049 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -86.83 104.65 16.38 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 106.613 -1.625 . . . . 73.099999999999994 106.613 173.754 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 . . . . . 0 C--N 1.284 -2.271 0 N-CA-C 107.098 -1.445 . . . . 51.119999999999997 107.098 -175.75 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.454 ' HG3' ' H ' ' A' ' 2' ' ' SER . 22.7 ptt? . . . . . 0 N--CA 1.473 0.694 0 CA-C-O 119.394 -0.336 . . . . 71.239999999999995 111.566 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.454 ' H ' ' HG3' ' A' ' 1' ' ' MET . 15.2 m -77.84 -38.03 47.1 Favored 'General case' 0 C--O 1.244 0.778 0 N-CA-C 105.262 -2.125 . . . . 65.519999999999996 105.262 170.897 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -73.13 146.97 45.3 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 112.917 -1.947 . . . . 62.43 107.616 173.493 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -79.2 -29.41 42.83 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.432 -0.951 . . . . 64.420000000000002 108.432 179.459 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 56.0 t30 68.03 88.88 0.11 Allowed 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 114.249 -1.341 . . . . 75.530000000000001 112.224 176.616 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 88.61 130.11 3.52 Favored Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 120.884 -0.674 . . . . 72.209999999999994 112.189 178.599 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.5 m -111.48 124.69 32.0 Favored Pre-proline 0 C--N 1.302 -1.496 0 N-CA-C 109.777 -0.453 . . . . 74.310000000000002 109.777 179.272 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -66.14 142.24 66.71 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.925 2.417 . . . . 73.549999999999997 112.098 177.736 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -121.75 146.82 46.71 Favored Pre-proline 0 C--N 1.296 -1.721 0 N-CA-C 108.113 -1.069 . . . . 72.0 108.113 178.465 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -61.44 155.14 54.31 Favored 'Trans proline' 0 C--O 1.251 1.164 0 C-N-CA 122.548 2.165 . . . . 50.409999999999997 111.97 178.053 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -66.66 150.86 48.45 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.731 -0.668 . . . . 63.439999999999998 109.934 179.548 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.2 p -88.4 129.09 40.15 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.353 0 CA-C-N 116.114 -0.494 . . . . 52.130000000000003 110.386 179.978 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -78.25 140.74 38.87 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 116.035 -0.529 . . . . 72.109999999999999 110.24 -178.862 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.8 t -101.67 142.23 33.32 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.285 -1.006 . . . . 74.340000000000003 108.285 177.01 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.9 t -157.35 158.43 35.96 Favored 'General case' 0 N--CA 1.422 -1.847 0 N-CA-C 107.555 -1.276 . . . . 74.200000000000003 107.555 -179.004 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.7 t -98.64 101.54 12.99 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.246 -1.02 . . . . 75.040000000000006 108.246 179.788 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.8 p -126.04 97.84 4.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-O 122.339 1.066 . . . . 52.340000000000003 113.299 -176.79 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -161.42 145.08 12.81 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 114.24 -1.345 . . . . 75.129999999999995 109.652 177.338 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 54.0 mtm180 -148.57 -173.66 4.4 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 107.883 -1.154 . . . . 75.239999999999995 107.883 -178.035 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -84.79 57.8 4.59 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 106.947 -1.501 . . . . 61.509999999999998 106.947 171.193 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -83.01 -23.55 33.23 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 113.911 -1.495 . . . . 50.420000000000002 110.688 -172.766 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.4 tt -72.73 140.84 48.06 Favored 'General case' 0 C--O 1.245 0.83 0 CA-C-N 115.063 -0.971 . . . . 62.439999999999998 109.507 -177.713 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.1 pp -115.37 165.47 12.94 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 116.383 -0.371 . . . . 74.239999999999995 111.877 -177.037 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.405 ' N ' ' HD2' ' A' ' 24' ' ' LYS . 3.0 mptp? -80.16 128.53 33.62 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.217 -1.031 . . . . 74.510000000000005 108.217 -179.578 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.409 ' H ' ' CD ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -98.9 168.87 9.84 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-O 121.175 0.512 . . . . 54.229999999999997 111.471 -176.017 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 83.5 mtp -120.8 176.04 5.73 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.873 -0.603 . . . . 54.399999999999999 109.755 179.652 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -87.67 153.53 21.3 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.871 -1.159 . . . . 70.219999999999999 107.871 177.836 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.3 m -103.22 159.92 15.12 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 121.009 -0.276 . . . . 55.420000000000002 110.328 -177.862 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 14.3 m -69.65 132.73 46.64 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 116.62 -0.264 . . . . 61.229999999999997 110.404 179.354 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.9 t -89.38 105.93 18.12 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-O 122.081 0.943 . . . . 75.549999999999997 109.147 177.103 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -89.61 141.26 16.03 Favored Glycine 0 N--CA 1.436 -1.308 0 CA-C-N 115.319 -0.855 . . . . 65.109999999999999 111.492 -176.828 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.8 p -87.03 157.5 19.42 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 110.138 -0.319 . . . . 74.239999999999995 110.138 178.722 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.4 116.98 64.59 Favored Pre-proline 0 C--N 1.31 -1.142 0 O-C-N 122.975 0.172 . . . . 54.030000000000001 111.25 -178.181 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -78.26 120.48 4.93 Favored 'Trans proline' 0 C--O 1.243 0.729 0 C-N-CA 122.563 2.175 . . . . 72.510000000000005 109.379 174.742 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -114.56 110.13 19.33 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 120.449 -0.5 . . . . 73.450000000000003 111.348 -179.228 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 69.8 m -77.28 135.72 38.45 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 109.28 -0.637 . . . . 73.430000000000007 109.28 175.699 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.5 m -64.77 158.38 25.02 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 115.537 -0.756 . . . . 73.310000000000002 110.323 -178.426 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -70.66 83.4 0.37 Allowed Glycine 0 N--CA 1.436 -1.315 0 N-CA-C 114.172 0.429 . . . . 64.209999999999994 114.172 -176.377 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.37 -52.98 21.89 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 109.114 -0.699 . . . . 75.420000000000002 109.114 175.931 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.49 ' CD ' ' H ' ' A' ' 40' ' ' GLU . 0.8 OUTLIER -63.86 -11.4 27.24 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.477 1.511 . . . . 75.540000000000006 111.995 179.291 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -72.92 -13.46 61.26 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 123.865 0.866 . . . . 73.420000000000002 112.256 178.31 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -58.78 154.69 35.25 Favored Pre-proline 0 CA--C 1.549 0.927 0 O-C-N 123.223 0.327 . . . . 63.329999999999998 110.684 179.824 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -61.61 165.54 13.37 Favored 'Trans proline' 0 C--O 1.247 0.966 0 C-N-CA 122.292 1.994 . . . . 51.0 112.025 177.576 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -86.27 151.81 23.29 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 116.125 -0.489 . . . . 65.340000000000003 109.911 -178.941 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.63 74.29 1.24 Allowed Glycine 0 N--CA 1.433 -1.537 0 N-CA-C 109.404 -1.479 . . . . 74.420000000000002 109.404 -176.568 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 65.8 m -89.94 165.15 14.25 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.481 0.658 . . . . 54.299999999999997 111.606 -175.94 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -119.18 163.78 16.56 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 108.329 -0.989 . . . . 73.140000000000001 108.329 179.707 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -135.17 156.29 49.25 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 120.814 0.34 . . . . 60.130000000000003 111.186 -177.821 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.418 ' H ' HD23 ' A' ' 49' ' ' LEU . 1.4 pt? -114.76 132.8 56.33 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.675 -0.861 . . . . 60.509999999999998 108.675 174.307 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 24.8 t -116.03 134.02 60.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.566 -0.901 . . . . 75.540000000000006 108.566 -178.872 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.488 HG21 ' HB3' ' A' ' 57' ' ' ALA . 24.4 t -92.74 121.5 43.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-O 121.018 0.437 . . . . 51.520000000000003 110.158 -177.893 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -94.43 -41.59 9.31 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.698 -0.683 . . . . 63.420000000000002 110.306 177.964 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -153.14 123.88 7.31 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 109.299 -0.63 . . . . 62.100000000000001 109.299 -176.505 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 151.53 130.32 1.64 Allowed Glycine 0 N--CA 1.427 -1.918 0 N-CA-C 111.261 -0.735 . . . . 53.009999999999998 111.261 178.277 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -61.47 -8.62 11.16 Favored 'Trans proline' 0 N--CA 1.481 0.761 0 C-N-CA 123.534 2.823 . . . . 70.5 113.433 178.051 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.511 ' HB2' ' HA ' ' A' ' 80' ' ' LEU . 5.1 p-10 -56.06 -41.04 74.46 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.28 0.632 . . . . 72.140000000000001 110.611 177.475 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.488 ' HB3' HG21 ' A' ' 51' ' ' VAL . . . -178.75 -168.99 0.15 Allowed 'General case' 0 C--O 1.217 -0.64 0 C-N-CA 123.936 0.894 . . . . 43.329999999999998 109.093 -179.145 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -159.48 28.95 0.39 Allowed Glycine 0 C--N 1.312 -0.775 0 N-CA-C 110.184 -1.167 . . . . 54.509999999999998 110.184 179.122 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -130.19 -166.23 1.65 Allowed 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.295 -1.002 . . . . 72.310000000000002 108.295 -175.471 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.457 ' H ' ' NE ' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -122.96 139.96 53.52 Favored 'General case' 0 N--CA 1.412 -2.335 0 N-CA-C 108.771 -0.826 . . . . 73.510000000000005 108.771 178.382 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -118.94 121.78 40.73 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 109.835 -0.432 . . . . 74.239999999999995 109.835 -177.992 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 47.7 tp -91.25 133.98 34.95 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.541 -0.911 . . . . 75.310000000000002 108.541 178.521 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 7.0 mp -83.27 114.93 21.73 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 120.394 -0.523 . . . . 64.319999999999993 111.219 -179.721 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -120.24 18.35 12.27 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.148 -1.056 . . . . 75.439999999999998 108.148 174.56 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -133.94 142.99 45.53 Favored Pre-proline 0 N--CA 1.438 -1.03 0 CA-C-N 113.881 -1.509 . . . . 75.299999999999997 108.045 178.374 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.424 ' HA ' HG13 ' A' ' 94' ' ' ILE . 26.0 Cg_endo -63.16 -31.26 75.17 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.898 2.398 . . . . 63.329999999999998 113.683 -177.371 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 41.2 m -136.49 120.75 17.93 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.82 -0.55 . . . . 72.019999999999996 110.0 179.417 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.503 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 9.2 m -102.99 119.85 39.58 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 106.471 -1.677 . . . . 72.310000000000002 106.471 176.645 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.46 HG23 ' HA ' ' A' ' 76' ' ' SER . 7.9 t -101.47 131.86 47.37 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 109.08 -0.711 . . . . 73.120000000000005 109.08 -176.604 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -127.5 119.47 26.13 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-O 120.845 0.355 . . . . 74.439999999999998 111.826 -174.577 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 60.3 44.81 97.12 Favored Glycine 0 CA--C 1.496 -1.133 0 CA-C-N 115.707 -0.678 . . . . 74.540000000000006 111.641 178.15 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 46.9 ttt180 -137.9 -31.1 0.79 Allowed 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 120.592 -0.443 . . . . 74.310000000000002 111.507 -173.619 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 32.3 m-70 -128.78 160.29 63.89 Favored Pre-proline 0 C--N 1.303 -1.434 0 N-CA-C 107.815 -1.18 . . . . 74.510000000000005 107.815 179.837 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -64.32 -25.4 64.22 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 121.303 1.335 . . . . 74.310000000000002 110.195 172.479 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -99.08 29.46 3.86 Favored 'General case' 0 C--O 1.243 0.756 0 CA-C-N 115.401 -0.818 . . . . 74.340000000000003 111.58 179.422 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.46 ' HA ' HG23 ' A' ' 69' ' ' THR . 70.2 m -54.43 136.53 44.01 Favored 'General case' 0 C--O 1.244 0.814 0 CA-C-O 120.898 0.38 . . . . 75.109999999999999 111.158 178.765 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -61.27 -43.91 98.1 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 115.025 -0.989 . . . . 62.530000000000001 109.911 -177.347 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 48.4 pt -124.93 156.72 33.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 CA-C-N 115.167 -0.924 . . . . 63.43 108.649 176.766 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -106.73 136.18 46.98 Favored 'General case' 0 C--N 1.284 -2.25 0 CA-C-N 115.846 -0.615 . . . . 74.209999999999994 110.026 -179.913 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.511 ' HA ' ' HB2' ' A' ' 56' ' ' ASN . 94.2 mt -107.38 171.74 7.21 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 108.67 -0.863 . . . . 75.400000000000006 108.67 -179.471 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -66.16 122.52 17.62 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 121.971 0.891 . . . . 71.329999999999998 110.213 -178.996 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.406 ' HA ' HG12 ' A' ' 85' ' ' VAL . 17.2 m-20 -67.16 -16.54 64.37 Favored 'General case' 0 C--N 1.278 -2.535 0 CA-C-N 113.888 -1.505 . . . . 55.219999999999999 114.52 -174.784 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.3 t -90.8 -24.66 5.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-O 121.825 0.822 . . . . 61.100000000000001 109.183 -179.283 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 11.2 p -103.26 -3.34 25.8 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.702 -0.681 . . . . 64.430000000000007 112.816 -179.628 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.406 HG12 ' HA ' ' A' ' 82' ' ' ASP . 10.7 p -81.47 121.56 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 N-CA-C 107.971 -1.122 . . . . 71.209999999999994 107.971 179.254 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 27.0 p -115.03 46.31 1.46 Allowed 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 112.122 0.415 . . . . 64.420000000000002 112.122 -175.026 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 87' ' ' ARG . 68.6 mtt180 67.52 108.12 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.883 0.873 . . . . 72.209999999999994 110.928 -178.998 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.42 ' O ' HG23 ' A' ' 104' ' ' VAL . 93.7 mtt180 63.71 78.11 0.3 Allowed 'General case' 0 CA--C 1.506 -0.725 0 N-CA-C 108.815 -0.809 . . . . 63.210000000000001 108.815 178.669 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 41.1 t60 -85.34 -67.27 0.81 Allowed 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 118.701 -1.2 . . . . 74.400000000000006 113.905 -172.522 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -137.8 156.45 47.94 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 118.324 -1.351 . . . . 74.340000000000003 113.589 -173.284 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -127.1 127.76 45.15 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 114.358 -1.292 . . . . 71.109999999999999 108.104 175.172 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.503 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 79.1 m-85 -108.69 112.72 25.18 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 106.085 -1.82 . . . . 75.230000000000004 106.085 174.865 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -117.08 144.4 44.7 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 121.64 0.733 . . . . 71.209999999999994 111.535 -173.396 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.445 ' O ' HD12 ' A' ' 94' ' ' ILE . 2.8 pp -116.17 116.4 52.18 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.64 0 N-CA-C 104.119 -2.549 . . . . 74.109999999999999 104.119 167.347 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.593 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 46.6 t-20 -108.09 145.03 34.65 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 107.734 -1.209 . . . . 72.420000000000002 107.734 -172.647 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -54.66 -26.75 35.17 Favored 'General case' 0 C--N 1.311 -1.078 0 O-C-N 123.645 0.591 . . . . 74.120000000000005 111.076 178.692 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -72.7 -63.35 2.9 Favored Glycine 0 N--CA 1.43 -1.759 0 N-CA-C 110.816 -0.914 . . . . 74.409999999999997 110.816 173.785 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.593 ' O ' ' HB3' ' A' ' 95' ' ' ASN . 44.2 mt-10 -159.26 168.36 26.66 Favored 'General case' 0 C--O 1.212 -0.893 0 N-CA-C 106.202 -1.777 . . . . 73.230000000000004 106.202 -178.38 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.454 ' HB2' ' CB ' ' A' ' 122' ' ' MET . 9.3 m-85 -91.31 134.84 34.25 Favored 'General case' 0 C--N 1.295 -1.767 0 C-N-CA 119.414 -0.914 . . . . 74.530000000000001 109.534 -177.379 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -132.2 136.22 46.87 Favored 'General case' 0 CA--C 1.501 -0.904 0 N-CA-C 113.218 0.821 . . . . 72.040000000000006 113.218 -175.858 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 90.1 t -111.01 119.91 60.6 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.077 0 N-CA-C 108.11 -1.07 . . . . 65.150000000000006 108.11 176.629 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 35.3 t -119.2 116.63 51.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 116.367 -0.379 . . . . 70.540000000000006 110.012 -176.733 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -104.26 108.93 20.55 Favored 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 107.551 -1.277 . . . . 65.340000000000003 107.551 175.97 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 88' ' ' ARG . 26.3 m -92.13 -9.56 10.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-O 121.128 0.489 . . . . 44.350000000000001 110.995 -177.886 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -92.16 27.33 10.49 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 109.759 -1.336 . . . . 71.540000000000006 109.759 176.049 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.42 ' HA ' ' OG1' ' A' ' 110' ' ' THR . 1.1 p -69.52 10.03 0.41 Allowed 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 125.532 1.533 . . . . 74.340000000000003 113.282 -177.455 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.427 HD23 ' O ' ' A' ' 107' ' ' LEU . 6.0 tt -68.22 -24.78 64.96 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 106.251 -1.759 . . . . 72.140000000000001 106.251 172.994 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -78.07 -1.84 34.37 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 115.054 -0.975 . . . . 62.140000000000001 110.657 177.393 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 77.28 56.44 3.97 Favored Glycine 0 N--CA 1.439 -1.123 0 N-CA-C 110.471 -1.052 . . . . 71.329999999999998 110.471 -178.203 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.42 ' OG1' ' HA ' ' A' ' 106' ' ' SER . 17.9 m -72.89 121.42 19.98 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-O 121.606 0.717 . . . . 53.350000000000001 111.507 -176.692 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -102.13 133.27 47.25 Favored 'General case' 0 N--CA 1.416 -2.158 0 N-CA-C 106.199 -1.778 . . . . 72.340000000000003 106.199 175.449 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.442 HG13 HG12 ' A' ' 128' ' ' ILE . 25.9 t -125.17 128.78 73.12 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.063 0 N-CA-C 105.537 -2.023 . . . . 74.120000000000005 105.537 179.822 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 63.55 27.24 14.97 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 107.841 -1.17 . . . . 73.319999999999993 107.841 -173.658 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 67.72 9.31 7.0 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 124.899 1.279 . . . . 73.510000000000005 112.254 -175.226 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.572 ' OE1' ' HD2' ' A' ' 116' ' ' PRO . 9.2 tp10 -111.51 126.38 28.68 Favored Pre-proline 0 C--N 1.305 -1.359 0 N-CA-C 108.452 -0.944 . . . . 75.120000000000005 108.452 -178.826 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.572 ' HD2' ' OE1' ' A' ' 115' ' ' GLU . 32.9 Cg_exo -53.75 113.24 1.23 Allowed 'Trans proline' 0 C--O 1.25 1.099 0 C-N-CA 121.967 1.778 . . . . 74.420000000000002 109.309 173.105 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 12.5 tpp85 -160.13 143.31 13.77 Favored 'General case' 0 N--CA 1.425 -1.704 0 N-CA-C 108.508 -0.923 . . . . 74.319999999999993 108.508 -173.349 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -87.98 -41.57 13.05 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.448 -0.575 . . . . 74.129999999999995 109.448 -179.062 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -132.72 139.34 47.58 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.399 -0.963 . . . . 31.43 108.399 177.429 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.07 148.83 47.01 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 107.249 -1.389 . . . . 73.420000000000002 107.249 -176.744 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 8.7 p -84.58 134.33 27.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 108.518 -0.919 . . . . 74.209999999999994 108.518 179.876 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.454 ' CB ' ' HB2' ' A' ' 99' ' ' PHE . 1.5 tmt? -50.24 124.39 10.27 Favored 'General case' 0 C--N 1.313 -1.008 0 O-C-N 123.739 0.649 . . . . 72.030000000000001 112.671 -175.489 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -129.85 151.09 50.8 Favored 'General case' 0 N--CA 1.424 -1.761 0 CA-C-N 115.148 -0.933 . . . . 72.219999999999999 108.817 173.461 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 6.6 p -78.53 115.17 18.05 Favored 'General case' 0 C--N 1.283 -2.306 0 CA-C-N 115.738 -0.665 . . . . 71.530000000000001 109.636 177.681 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 95.16 33.55 6.52 Favored Glycine 0 N--CA 1.437 -1.271 0 N-CA-C 110.334 -1.107 . . . . 73.239999999999995 110.334 -178.234 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -91.48 150.59 21.16 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 107.125 -1.435 . . . . 72.329999999999998 107.125 -179.79 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -137.85 123.13 19.38 Favored 'General case' 0 C--N 1.29 -2.003 0 CA-C-O 122.093 0.949 . . . . 53.119999999999997 111.069 -177.082 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.442 HG12 HG13 ' A' ' 112' ' ' VAL . 58.9 mt -101.92 126.09 55.96 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.22 0 CA-C-N 114.162 -1.381 . . . . 70.420000000000002 108.46 -176.727 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.423 ' HA ' ' O ' ' A' ' 133' ' ' PHE . 29.8 tt0 -119.69 112.78 19.72 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 109.412 -0.588 . . . . 63.310000000000002 109.412 177.94 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 23.1 pt -105.64 97.48 5.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-N 115.139 -0.937 . . . . 55.520000000000003 109.981 -178.826 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 69.36 -72.6 0.45 Allowed Glycine 0 CA--C 1.526 0.747 0 CA-C-N 115.438 -0.801 . . . . 62.229999999999997 113.69 178.502 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -132.15 -12.71 3.19 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 123.096 0.558 . . . . 71.120000000000005 110.256 -176.076 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.423 ' O ' ' HA ' ' A' ' 129' ' ' GLN . 19.5 m-85 -107.72 156.31 19.24 Favored 'General case' 0 C--N 1.321 -0.656 0 O-C-N 121.76 -0.588 . . . . 72.510000000000005 112.023 -171.29 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 134' ' ' ARG . 50.4 mtp180 -131.32 127.02 36.81 Favored 'General case' 0 C--O 1.251 1.14 0 CA-C-O 121.616 0.722 . . . . 73.0 111.791 -174.745 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 58.6 tp -122.06 135.17 54.79 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 114.531 -1.213 . . . . 72.129999999999995 107.748 -179.693 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 14.9 p -112.06 138.63 40.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 N-CA-C 109.326 -0.62 . . . . 65.219999999999999 109.326 -179.737 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -116.25 129.79 56.46 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 109.334 -0.617 . . . . 64.439999999999998 109.334 -177.359 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 58.4 mt -135.66 172.5 12.92 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.306 -0.627 . . . . 64.430000000000007 109.306 -177.078 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -91.11 146.56 23.74 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 107.639 -1.245 . . . . 73.129999999999995 107.639 175.694 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.406 ' HA3' ' HD3' ' A' ' 141' ' ' PRO . . . -96.58 -127.53 5.52 Favored Glycine 0 N--CA 1.429 -1.772 0 C-N-CA 120.374 -0.917 . . . . 71.409999999999997 111.68 -176.705 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.406 ' HD3' ' HA3' ' A' ' 140' ' ' GLY . 6.6 Cg_exo -71.33 128.29 14.42 Favored 'Trans proline' 0 N--CA 1.444 -1.412 0 C-N-CA 122.192 1.928 . . . . 64.120000000000005 112.03 179.973 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -78.75 112.72 16.16 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.367 -1.345 . . . . 75.219999999999999 107.367 177.313 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 . . . . . 0 C--N 1.283 -2.298 0 N-CA-C 109.057 -0.72 . . . . 62.530000000000001 109.057 -175.694 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.7 ttt . . . . . 0 N--CA 1.456 -0.157 0 N-CA-C 108.516 -0.92 . . . . 74.150000000000006 108.516 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.3 p -82.38 -39.11 23.17 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.135 0.493 . . . . 50.399999999999999 111.821 -177.087 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -120.53 175.16 6.13 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.806 -0.634 . . . . 54.119999999999997 110.566 -172.444 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -126.54 171.33 11.17 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 107.927 -1.138 . . . . 64.430000000000007 107.927 179.187 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -105.69 167.06 10.02 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 107.402 -1.332 . . . . 74.430000000000007 107.402 173.198 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -133.15 -166.1 11.33 Favored Glycine 0 N--CA 1.424 -2.118 0 C-N-CA 119.908 -1.139 . . . . 73.530000000000001 111.656 -178.001 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.3 t -100.76 143.57 26.83 Favored Pre-proline 0 N--CA 1.417 -2.104 0 N-CA-C 108.169 -1.048 . . . . 62.310000000000002 108.169 -179.765 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -58.45 128.03 26.89 Favored 'Trans proline' 0 C--O 1.245 0.858 0 C-N-CA 122.409 2.072 . . . . 64.230000000000004 110.658 177.67 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -82.97 126.85 71.61 Favored Pre-proline 0 C--N 1.295 -1.793 0 CA-C-N 115.836 -0.62 . . . . 74.099999999999994 110.668 -176.535 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.76 151.33 28.12 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.298 1.999 . . . . 41.119999999999997 111.277 178.9 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -118.68 110.44 17.3 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.755 0.788 . . . . 73.340000000000003 111.467 179.671 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.9 p -90.23 158.02 2.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 107.283 -1.377 . . . . 64.519999999999996 107.283 177.654 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -92.28 133.32 35.94 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 120.059 -0.656 . . . . 61.140000000000001 111.527 -179.325 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.5 m -106.26 91.78 3.86 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 104.899 -2.26 . . . . 65.230000000000004 104.899 171.569 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 14.9 t -83.13 -175.19 5.71 Favored 'General case' 0 N--CA 1.413 -2.309 0 CA-C-O 121.607 0.718 . . . . 72.409999999999997 111.916 -169.005 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.1 m -81.8 40.35 0.6 Allowed 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 124.952 1.301 . . . . 71.099999999999994 111.65 -173.312 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.7 p -78.81 0.25 3.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 122.613 1.197 . . . . 72.430000000000007 110.589 -177.59 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -99.21 153.29 19.05 Favored 'General case' 0 C--N 1.273 -2.736 0 CA-C-N 114.534 -1.212 . . . . 74.219999999999999 109.255 -179.951 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 15.0 mmt180 -91.82 145.03 24.89 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 116.159 -0.473 . . . . 73.230000000000004 110.595 -179.422 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -91.59 95.16 9.77 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 106.193 -1.781 . . . . 73.230000000000004 106.193 172.417 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -78.45 -41.97 31.26 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 121.472 0.653 . . . . 74.319999999999993 109.572 -174.448 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -89.95 93.94 9.61 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 107.579 -1.267 . . . . 74.120000000000005 107.579 177.004 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 96.0 mt -81.94 111.87 18.52 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 107.466 -1.309 . . . . 72.5 107.466 176.497 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . 0.251 0.0 OUTLIER -70.28 -20.86 63.01 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 113.888 1.069 . . . . 70.340000000000003 113.888 -173.999 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 34.66 69.92 0.14 Allowed 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 125.239 1.415 . . . . 71.519999999999996 113.093 177.212 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 47.3 ttm -114.01 89.77 3.17 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-N 115.277 -0.874 . . . . 70.310000000000002 112.22 -173.124 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -137.78 119.1 14.66 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 106.165 -1.791 . . . . 53.450000000000003 106.165 174.656 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 45.8 m -142.02 148.45 38.52 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 109.745 -0.465 . . . . 75.310000000000002 109.745 -179.339 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 35.9 m -75.22 130.91 39.94 Favored 'General case' 0 N--CA 1.427 -1.579 0 O-C-N 123.624 0.578 . . . . 73.040000000000006 111.028 -177.595 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.1 t -134.24 164.27 27.75 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 107.636 -1.246 . . . . 73.010000000000005 107.636 -179.488 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -162.52 141.59 7.31 Favored Glycine 0 N--CA 1.425 -2.044 0 N-CA-C 110.946 -0.862 . . . . 51.509999999999998 110.946 179.828 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 33.9 m -110.18 129.08 55.77 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 108.254 -1.017 . . . . 53.43 108.254 175.909 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -90.76 129.17 45.5 Favored Pre-proline 0 C--N 1.288 -2.079 0 N-CA-C 109.284 -0.635 . . . . 73.25 109.284 -178.963 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -63.03 121.06 8.79 Favored 'Trans proline' 0 C--O 1.241 0.665 0 C-N-CA 122.28 1.986 . . . . 71.430000000000007 110.408 176.412 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -87.64 133.94 33.73 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 116.303 -0.408 . . . . 74.019999999999996 110.361 -178.042 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 77.8 p -149.47 142.7 25.09 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.803 -0.181 . . . . 73.010000000000005 111.044 179.735 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.0 t -168.83 115.52 0.63 Allowed 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 123.828 0.851 . . . . 64.400000000000006 109.895 172.963 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -132.41 105.85 0.62 Allowed Glycine 0 N--CA 1.419 -2.499 0 CA-C-N 115.121 -0.945 . . . . 70.329999999999998 110.995 -178.245 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.22 -26.69 67.91 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 123.416 0.686 . . . . 51.520000000000003 112.367 -179.027 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -70.11 -12.55 61.68 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.389 0.614 . . . . 65.019999999999996 111.037 -177.065 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -73.07 -26.15 61.16 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.38 -0.827 . . . . 72.140000000000001 109.661 177.01 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 62.9 tp -98.66 116.4 65.4 Favored Pre-proline 0 C--N 1.318 -0.794 0 CA-C-N 115.175 -0.921 . . . . 74.140000000000001 108.796 -178.966 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_exo -54.33 -61.54 0.4 Allowed 'Trans proline' 0 C--N 1.358 1.04 0 C-N-CA 123.228 2.618 . . . . 64.430000000000007 112.783 -178.953 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -95.42 81.25 3.56 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 121.371 0.605 . . . . 33.009999999999998 109.696 177.439 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -97.92 39.41 2.78 Favored Glycine 0 CA--C 1.497 -1.073 0 N-CA-C 109.682 -1.367 . . . . 61.25 109.682 177.78 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.0 m -100.39 156.81 17.05 Favored 'General case' 0 N--CA 1.416 -2.158 0 N-CA-C 108.988 -0.745 . . . . 64.219999999999999 108.988 -178.111 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.514 ' HB1' ' CE1' ' A' ' 137' ' ' PHE . . . -140.63 162.88 34.34 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 106.273 -1.751 . . . . 52.240000000000002 106.273 176.927 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.3 pp -134.31 142.39 47.25 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 118.246 -1.382 . . . . 64.140000000000001 111.836 179.436 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.479 ' O ' HD12 ' A' ' 49' ' ' LEU . 2.2 pp -109.38 140.81 42.61 Favored 'General case' 0 N--CA 1.424 -1.754 0 CA-C-N 115.453 -0.794 . . . . 71.409999999999997 110.266 179.51 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 45.2 t -123.6 113.5 37.6 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 N-CA-C 106.299 -1.741 . . . . 74.120000000000005 106.299 174.12 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.455 HG21 ' HB3' ' A' ' 57' ' ' ALA . 42.1 t -96.28 115.59 35.99 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.115 0 C-N-CA 118.915 -1.114 . . . . 72.409999999999997 108.49 179.476 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -68.99 -38.71 79.45 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 114.728 -1.123 . . . . 61.530000000000001 109.528 -176.559 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 26.4 ttm180 -177.25 142.3 0.35 Allowed 'General case' 0 C--O 1.244 0.773 0 CA-C-N 115.699 -0.682 . . . . 70.239999999999995 109.812 -179.95 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 143.31 165.91 10.94 Favored Glycine 0 N--CA 1.436 -1.36 0 CA-C-N 116.232 -0.44 . . . . 30.199999999999999 112.435 177.266 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -67.53 -8.21 21.55 Favored 'Trans proline' 0 N--CA 1.486 1.044 0 C-N-CA 123.659 2.906 . . . . 65.150000000000006 112.949 178.258 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.544 ' HA ' ' CB ' ' A' ' 80' ' ' LEU . 26.3 t-20 -65.15 -54.13 34.51 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.925 -0.58 . . . . 54.240000000000002 109.898 178.564 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.455 ' HB3' HG21 ' A' ' 51' ' ' VAL . . . -172.56 -176.51 1.54 Allowed 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.897 0.879 . . . . 70.349999999999994 108.822 -179.692 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -158.46 46.28 0.45 Allowed Glycine 0 CA--C 1.494 -1.235 0 N-CA-C 110.155 -1.178 . . . . 74.450000000000003 110.155 179.588 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -162.62 -173.83 3.71 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.157 -1.423 . . . . 72.030000000000001 107.157 -177.797 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.51 132.24 37.06 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 120.673 0.273 . . . . 72.239999999999995 110.46 177.73 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -156.75 155.03 30.92 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 116.002 -0.545 . . . . 75.209999999999994 110.425 -178.346 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.486 HD23 ' H ' ' A' ' 62' ' ' LEU . 2.7 pt? -79.13 139.74 37.97 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 122.063 0.935 . . . . 64.340000000000003 113.056 -178.062 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.461 HD11 HD23 ' A' ' 49' ' ' LEU . 75.3 mt -99.84 133.49 44.13 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 104.87 -2.27 . . . . 41.229999999999997 104.87 172.089 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -147.28 78.52 1.48 Allowed 'General case' 0 C--N 1.296 -1.737 0 CA-C-O 121.568 0.699 . . . . 72.430000000000007 111.449 -178.638 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -147.9 149.69 33.78 Favored Pre-proline 0 C--N 1.306 -1.299 0 N-CA-C 106.918 -1.512 . . . . 63.210000000000001 106.918 174.679 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -58.54 -40.65 72.21 Favored 'Trans proline' 0 C--N 1.366 1.455 0 C-N-CA 122.612 2.208 . . . . 73.430000000000007 110.301 -179.682 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 33.9 m -128.58 100.06 5.61 Favored 'General case' 0 N--CA 1.414 -2.264 0 CA-C-N 114.519 -1.219 . . . . 74.319999999999993 108.322 175.547 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 57.8 m -95.32 113.87 25.59 Favored 'General case' 0 N--CA 1.423 -1.807 0 N-CA-C 107.121 -1.437 . . . . 74.540000000000006 107.121 179.762 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.1 t -108.98 135.77 49.61 Favored 'General case' 0 C--N 1.283 -2.318 0 C-N-CA 120.033 -0.667 . . . . 70.519999999999996 110.717 -174.416 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -119.9 131.7 55.31 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 108.97 -0.752 . . . . 51.140000000000001 108.97 179.466 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 178.73 -122.92 0.83 Allowed Glycine 0 N--CA 1.411 -2.985 0 C-N-CA 120.641 -0.79 . . . . 72.340000000000003 111.145 179.153 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 18.7 tpt180 -146.94 14.92 1.18 Allowed 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 109.658 -0.497 . . . . 74.329999999999998 109.658 -176.078 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.439 ' HB3' ' HB3' ' A' ' 87' ' ' ARG . 38.0 p-80 -98.3 156.34 35.9 Favored Pre-proline 0 C--N 1.318 -0.765 0 N-CA-C 108.253 -1.017 . . . . 64.340000000000003 108.253 179.893 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -49.02 -30.71 18.7 Favored 'Trans proline' 0 N--CA 1.488 1.15 0 C-N-CA 123.907 3.071 . . . . 62.329999999999998 115.766 -174.831 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -93.27 12.76 23.48 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 113.298 0.851 . . . . 71.439999999999998 113.298 -177.439 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 24.2 m -65.76 135.78 55.36 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.632 -0.877 . . . . 73.239999999999995 108.632 176.738 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -68.65 -46.12 70.02 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 107.716 -1.216 . . . . 74.040000000000006 107.716 179.055 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.476 HD13 ' H ' ' A' ' 78' ' ' ILE . 0.2 OUTLIER -125.82 135.35 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 CA-C-N 113.631 -1.622 . . . . 64.519999999999996 109.226 176.929 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -103.86 117.49 34.47 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 115.83 -0.623 . . . . 75.340000000000003 109.373 178.873 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.544 ' CB ' ' HA ' ' A' ' 56' ' ' ASN . 0.9 OUTLIER -86.94 119.89 27.63 Favored 'General case' 0 N--CA 1.418 -2.062 0 N-CA-C 107.548 -1.279 . . . . 75.340000000000003 107.548 174.418 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -84.95 60.57 6.31 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 122.38 1.086 . . . . 61.030000000000001 111.918 -176.109 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -93.04 -175.33 3.83 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 106.311 -1.737 . . . . 70.230000000000004 106.311 171.71 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.6 p -126.99 -6.98 4.65 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 CA-C-O 121.861 0.839 . . . . 73.299999999999997 109.987 -179.029 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 5.8 m -115.22 15.58 16.98 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 122.303 1.049 . . . . 64.120000000000005 108.249 179.376 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.7 p -84.34 138.56 18.96 Favored 'Isoleucine or valine' 0 C--O 1.248 1.011 0 CA-C-N 115.005 -0.998 . . . . 70.439999999999998 110.796 -179.851 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 19.6 m -77.03 166.57 23.14 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.944 -0.571 . . . . 73.030000000000001 110.2 178.37 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.439 ' HB3' ' HB3' ' A' ' 73' ' ' HIS . 18.4 mmt180 -63.12 -37.75 88.43 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 121.317 0.58 . . . . 75.25 109.884 178.495 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.1 119.71 29.36 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 106.517 -1.66 . . . . 71.329999999999998 106.517 167.831 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 9.1 t60 -106.62 -63.11 1.31 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.683 -0.488 . . . . 63.030000000000001 109.683 -175.814 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -134.74 119.43 18.22 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.246 -1.02 . . . . 73.129999999999995 108.246 -179.858 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -104.92 128.04 53.0 Favored 'General case' 0 C--N 1.287 -2.123 0 C-N-CA 119.883 -0.727 . . . . 75.420000000000002 109.368 179.34 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -105.58 119.72 39.82 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 107.673 -1.232 . . . . 65.129999999999995 107.673 -176.366 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -118.59 148.96 42.14 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 109.388 -0.597 . . . . 74.400000000000006 109.388 -178.944 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 4.3 tp -115.58 127.63 73.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 CA-C-O 121.769 0.795 . . . . 74.540000000000006 109.651 -179.83 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -108.17 146.63 32.45 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 106.19 -1.781 . . . . 75.349999999999994 106.19 -179.67 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -54.93 -18.24 4.72 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 113.53 0.937 . . . . 63.229999999999997 113.53 -177.718 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -108.06 -44.51 1.18 Allowed Glycine 0 N--CA 1.431 -1.647 0 C-N-CA 121.377 -0.44 . . . . 52.020000000000003 113.037 177.666 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -133.88 175.57 9.34 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-O 121.615 0.721 . . . . 75.099999999999994 111.935 -174.687 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.412 ' HB2' ' HB3' ' A' ' 122' ' ' MET . 91.4 m-85 -104.68 137.45 42.48 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 106.508 -1.664 . . . . 73.400000000000006 106.508 174.785 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -130.54 130.05 43.61 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 118.28 0.491 . . . . 74.209999999999994 110.039 -178.226 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 6.9 p -117.29 127.64 74.77 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-O 120.926 0.393 . . . . 64.420000000000002 110.35 -179.636 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 30.9 m -118.88 121.38 66.72 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 CA-C-O 121.497 0.665 . . . . 72.340000000000003 111.873 178.544 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -83.41 124.42 30.65 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.281 -0.872 . . . . 61.219999999999999 110.506 175.473 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 6.7 m -125.89 17.42 3.99 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.227 0 CA-C-N 114.837 -1.074 . . . . 60.350000000000001 109.849 176.739 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -127.5 46.92 1.05 Allowed Glycine 0 N--CA 1.443 -0.865 0 N-CA-C 108.866 -1.694 . . . . 63.229999999999997 108.866 177.495 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.7 m -59.52 -23.49 62.87 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 124.359 1.064 . . . . 73.239999999999995 113.643 -173.039 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 85.1 mt -77.62 -21.31 52.49 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.054 -0.658 . . . . 65.349999999999994 112.0 -179.33 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -81.72 -36.0 29.13 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 107.378 -1.341 . . . . 64.329999999999998 107.378 176.008 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 103.78 88.24 2.04 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 114.635 -1.166 . . . . 75.420000000000002 113.995 176.793 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 27.9 m -99.59 120.12 39.16 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.655 -0.868 . . . . 63.329999999999998 108.655 175.211 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.405 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 29.9 m-85 -127.2 152.35 47.49 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 108.792 -0.818 . . . . 74.340000000000003 108.792 -177.726 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 74.7 t -106.32 113.41 42.93 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.111 0 N-CA-C 107.215 -1.402 . . . . 73.319999999999993 107.215 175.525 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 67.07 -73.59 0.08 Allowed 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 126.427 1.891 . . . . 73.239999999999995 109.862 -174.592 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -141.13 -12.56 0.94 Allowed 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 123.235 0.614 . . . . 75.430000000000007 111.106 177.099 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -106.78 140.72 21.64 Favored Pre-proline 0 C--N 1.321 -0.646 0 N-CA-C 112.503 0.557 . . . . 73.010000000000005 112.503 -169.787 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -71.27 93.27 0.65 Allowed 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.695 2.263 . . . . 52.240000000000002 112.777 178.562 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 12.6 mmt85 -110.54 100.51 9.31 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 106.464 -1.68 . . . . 74.329999999999998 106.464 176.032 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -75.85 -31.88 59.51 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 119.896 -0.721 . . . . 72.120000000000005 110.612 -176.101 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -124.35 136.13 53.86 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 105.265 -2.124 . . . . 73.109999999999999 105.265 167.854 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 55.7 tp60 -142.54 148.82 38.22 Favored 'General case' 0 C--N 1.283 -2.285 0 C-N-CA 120.922 -0.311 . . . . 65.430000000000007 110.928 -178.063 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.0 p -79.58 114.62 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.662 0 N-CA-C 103.893 -2.632 . . . . 75.239999999999995 103.893 167.126 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.412 ' HB3' ' HB2' ' A' ' 99' ' ' PHE . 9.7 ttt -68.52 120.35 14.43 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 115.033 -0.985 . . . . 51.039999999999999 111.079 -166.771 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 30.1 tp60 -104.25 124.9 49.98 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.252 -0.886 . . . . 73.230000000000004 110.325 -172.69 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.2 t -78.94 131.69 36.45 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 114.913 -1.04 . . . . 63.109999999999999 108.577 177.458 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 110.0 -9.73 31.73 Favored Glycine 0 N--CA 1.437 -1.266 0 CA-C-N 115.995 -0.548 . . . . 72.25 112.316 178.856 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -113.82 169.9 8.66 Favored 'General case' 0 C--O 1.25 1.118 0 N-CA-C 108.806 -0.813 . . . . 70.010000000000005 108.806 -177.357 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -110.63 144.98 38.69 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.791 0.805 . . . . 65.329999999999998 111.747 -178.25 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 65.2 mt -106.55 124.78 62.28 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 N-CA-C 107.367 -1.346 . . . . 52.32 107.367 177.139 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.405 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 58.2 tp60 -97.73 116.55 30.17 Favored 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 108.899 -0.778 . . . . 73.409999999999997 108.899 -176.896 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.1 pt -115.41 97.71 5.95 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.301 0 CA-C-O 122.177 0.989 . . . . 72.409999999999997 109.565 177.904 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 68.85 -116.55 7.4 Favored Glycine 0 N--CA 1.429 -1.786 0 CA-C-N 114.454 -1.248 . . . . 73.010000000000005 111.4 -175.697 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 17.9 tppt? -94.14 -22.14 18.65 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.239 0.542 . . . . 54.200000000000003 110.588 179.64 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -101.34 161.17 13.82 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 116.24 -0.437 . . . . 73.430000000000007 112.121 -174.919 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 9.8 ptp85 -137.28 144.37 42.66 Favored 'General case' 0 C--O 1.245 0.847 0 N-CA-C 113.419 0.896 . . . . 75.540000000000006 113.419 -172.984 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.8 tt -121.99 138.57 54.37 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 106.915 -1.513 . . . . 75.120000000000005 106.915 -179.247 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 27.7 t -106.83 130.49 58.68 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 N-CA-C 106.772 -1.566 . . . . 61.229999999999997 106.772 179.401 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.514 ' CE1' ' HB1' ' A' ' 47' ' ' ALA . 86.4 t80 -104.37 128.19 52.16 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 112.086 0.402 . . . . 74.340000000000003 112.086 -174.78 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -128.57 151.13 49.8 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 108.211 -1.033 . . . . 73.430000000000007 108.211 173.882 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -62.81 149.54 43.89 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.892 -0.781 . . . . 43.520000000000003 108.892 175.47 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.419 ' N ' ' HA ' ' A' ' 47' ' ' ALA . . . -69.42 169.32 44.27 Favored Glycine 0 N--CA 1.434 -1.485 0 C-N-CA 120.88 -0.676 . . . . 54.310000000000002 113.405 -175.499 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -55.05 139.74 80.04 Favored 'Trans proline' 0 C--O 1.241 0.637 0 C-N-CA 123.25 2.633 . . . . 74.019999999999996 111.734 -179.881 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -82.17 103.45 11.78 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 108.566 -0.902 . . . . 31.219999999999999 108.566 179.23 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 . . . . . 0 C--N 1.298 -1.642 0 N-CA-C 108.035 -1.098 . . . . 74.510000000000005 108.035 -178.046 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ptt? . . . . . 0 N--CA 1.481 1.081 0 N-CA-C 112.007 0.373 . . . . 73.299999999999997 112.007 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.4 m -77.51 -49.14 15.34 Favored 'General case' 0 C--O 1.243 0.755 0 N-CA-C 106.933 -1.506 . . . . 64.519999999999996 106.933 176.344 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -97.69 143.54 28.24 Favored 'General case' 0 N--CA 1.422 -1.841 0 N-CA-C 104.884 -2.265 . . . . 75.430000000000007 104.884 169.977 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -134.07 125.18 27.49 Favored 'General case' 0 C--N 1.287 -2.126 0 C-N-CA 120.999 -0.28 . . . . 52.329999999999998 110.288 -177.669 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -67.57 154.54 41.2 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.478 -0.783 . . . . 72.400000000000006 109.019 175.089 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -81.95 149.12 27.83 Favored Glycine 0 N--CA 1.421 -2.307 0 N-CA-C 110.736 -0.945 . . . . 74.319999999999993 110.736 179.289 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.3 m -63.28 139.61 97.58 Favored Pre-proline 0 C--N 1.303 -1.425 0 N-CA-C 107.452 -1.314 . . . . 75.239999999999995 107.452 176.568 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -51.14 137.02 45.94 Favored 'Trans proline' 0 C--O 1.25 1.1 0 C-N-CA 122.326 2.017 . . . . 71.209999999999994 110.36 177.845 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -68.58 143.68 95.46 Favored Pre-proline 0 C--N 1.307 -1.254 0 CA-C-N 116.129 -0.487 . . . . 75.329999999999998 110.183 -174.565 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -36.94 114.78 0.13 Allowed 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 124.823 3.682 . . . . 62.240000000000002 113.784 -177.079 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -102.27 156.58 17.48 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.104 -1.443 . . . . 75.319999999999993 107.104 -178.895 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.4 m -90.26 148.36 4.6 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 CA-C-O 120.895 0.378 . . . . 70.530000000000001 110.222 177.533 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -103.5 141.52 35.85 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.14 -1.059 . . . . 44.439999999999998 108.14 177.315 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.5 t -68.92 152.7 44.94 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.705 -0.85 . . . . 63.25 108.705 179.007 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.9 t -145.11 105.45 4.08 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-O 121.748 0.785 . . . . 74.450000000000003 112.039 -176.88 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.6 t -94.21 96.03 9.33 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 105.589 -2.004 . . . . 75.530000000000001 105.589 174.982 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.1 p -103.49 127.83 57.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 CA-C-O 121.986 0.898 . . . . 72.340000000000003 112.209 -173.0 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -114.08 130.18 56.58 Favored 'General case' 0 N--CA 1.425 -1.713 0 N-CA-C 106.875 -1.528 . . . . 73.329999999999998 106.875 177.92 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -94.57 172.72 8.01 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 108.954 -0.758 . . . . 72.219999999999999 108.954 179.863 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.48 78.45 3.99 Favored 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 108.714 -0.847 . . . . 75.030000000000001 108.714 175.738 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -92.6 -24.37 18.72 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.03 -0.986 . . . . 71.129999999999995 110.129 -177.432 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -70.04 137.31 51.18 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.661 -0.699 . . . . 65.540000000000006 109.429 -177.985 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -136.57 176.19 8.92 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.054 -1.091 . . . . 75.209999999999994 108.054 179.926 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -78.18 135.1 37.56 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 113.47 0.915 . . . . 73.230000000000004 113.47 -176.898 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -130.59 143.86 51.03 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 106.244 -1.762 . . . . 63.0 106.244 177.227 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 22.5 ptt? -95.7 173.19 7.6 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.746 -0.381 . . . . 74.5 110.737 -176.462 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -82.86 171.01 14.36 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.678 -0.692 . . . . 75.230000000000004 110.734 179.512 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.5 m -85.93 143.55 28.13 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 116.004 -0.544 . . . . 75.310000000000002 109.586 178.177 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 16.4 m -72.44 162.02 30.04 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.631 0.729 . . . . 72.349999999999994 112.069 -176.359 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 82.5 m -149.65 126.02 10.83 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.309 -0.997 . . . . 74.439999999999998 108.309 176.744 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -87.06 174.45 45.69 Favored Glycine 0 N--CA 1.432 -1.584 0 C-N-CA 120.778 -0.725 . . . . 44.439999999999998 111.374 178.757 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 10.0 t -97.52 157.09 16.2 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.792 -0.818 . . . . 75.140000000000001 108.792 -178.239 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.43 132.2 56.26 Favored Pre-proline 0 C--N 1.307 -1.27 0 N-CA-C 109.21 -0.663 . . . . 71.420000000000002 109.21 179.358 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -79.41 160.94 25.69 Favored 'Trans proline' 0 C--O 1.252 1.214 0 C-N-CA 122.503 2.135 . . . . 73.010000000000005 112.18 -179.324 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.1 117.28 5.8 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.399 -0.593 . . . . 73.010000000000005 109.399 178.474 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.2 m -127.04 109.1 11.53 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.408 -0.96 . . . . 64.25 108.408 -177.904 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.522 ' OG1' ' HG2' ' A' ' 66' ' ' PRO . 15.3 t -153.25 -177.51 6.37 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 109.03 -0.73 . . . . 72.5 109.03 -177.167 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -162.07 117.01 0.74 Allowed Glycine 0 N--CA 1.437 -1.239 0 N-CA-C 111.001 -0.84 . . . . 43.5 111.001 -178.285 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.8 -27.09 68.95 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 123.778 0.831 . . . . 75.340000000000003 112.382 -177.524 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -64.15 -13.17 46.39 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 113.157 0.799 . . . . 72.239999999999995 113.157 -177.527 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -76.69 -14.88 59.92 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-O 121.021 0.439 . . . . 65.140000000000001 110.533 179.72 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 73.5 mt -120.12 145.34 39.81 Favored Pre-proline 0 N--CA 1.414 -2.251 0 N-CA-C 109.074 -0.713 . . . . 45.200000000000003 109.074 -177.675 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -65.88 131.79 28.38 Favored 'Trans proline' 0 C--O 1.251 1.163 0 C-N-CA 121.726 1.617 . . . . 64.200000000000003 109.276 173.726 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.18 131.49 41.37 Favored 'General case' 0 C--O 1.248 0.99 0 CA-C-O 121.566 0.698 . . . . 72.129999999999995 112.861 -176.022 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -165.02 101.65 0.19 Allowed Glycine 0 N--CA 1.426 -2.015 0 N-CA-C 107.29 -2.324 . . . . 72.5 107.29 -179.479 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.2 m -103.09 155.26 18.52 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-O 121.179 0.514 . . . . 54.32 111.155 -174.726 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.421 ' HA ' ' N ' ' A' ' 140' ' ' GLY . . . -146.3 151.37 37.41 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.145 -1.428 . . . . 75.450000000000003 107.145 177.705 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.447 HD23 ' H ' ' A' ' 48' ' ' LEU . 2.6 pt? -123.03 151.38 41.98 Favored 'General case' 0 CA--C 1.493 -1.243 0 CA-C-O 121.576 0.703 . . . . 71.200000000000003 111.392 -175.041 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.401 ' HB3' ' CD2' ' A' ' 137' ' ' PHE . 0.9 OUTLIER -129.74 132.72 46.68 Favored 'General case' 0 C--N 1.276 -2.595 0 CA-C-N 115.259 -0.882 . . . . 71.310000000000002 108.651 175.23 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.422 HG12 ' HB3' ' A' ' 60' ' ' ARG . 23.5 m -104.37 141.41 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 N-CA-C 108.749 -0.834 . . . . 65.129999999999995 108.749 -178.222 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.454 ' HA ' ' HG ' ' A' ' 135' ' ' LEU . 39.9 t -92.92 114.97 30.68 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 N-CA-C 107.591 -1.263 . . . . 65.209999999999994 107.591 178.558 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.9 tmtm? -73.23 -44.34 59.69 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 106.157 -1.794 . . . . 61.130000000000003 106.157 -178.723 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.416 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 35.1 ttm180 -165.16 128.0 2.21 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 106.59 -1.633 . . . . 74.340000000000003 106.59 176.815 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 158.52 133.84 1.61 Allowed Glycine 0 N--CA 1.42 -2.414 0 C-N-CA 120.183 -1.008 . . . . 54.119999999999997 111.924 -179.697 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.422 ' HB2' ' HB2' ' A' ' 82' ' ' ASP . 52.2 Cg_exo -59.62 -7.83 6.3 Favored 'Trans proline' 0 N--CA 1.484 0.963 0 C-N-CA 124.201 3.267 . . . . 60.200000000000003 114.116 178.612 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -44.16 -48.16 9.16 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.565 1.146 . . . . 75.239999999999995 111.379 175.349 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -165.29 -48.14 0.03 OUTLIER 'General case' 0 CA--C 1.51 -0.581 0 CA-C-O 121.329 0.585 . . . . 33.25 109.979 -179.348 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.12 25.58 57.24 Favored Glycine 0 C--O 1.225 -0.441 0 N-CA-C 110.528 -1.029 . . . . 60.009999999999998 110.528 -177.847 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -146.84 -157.32 0.8 Allowed 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.704 -1.221 . . . . 74.299999999999997 107.704 -177.494 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.454 ' HD3' ' H ' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -129.54 141.39 50.99 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 108.251 -1.018 . . . . 72.329999999999998 108.251 177.309 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -140.6 153.69 46.17 Favored 'General case' 0 C--N 1.291 -1.955 0 C-N-CA 120.544 -0.462 . . . . 74.420000000000002 109.99 178.064 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.432 ' HG ' ' HB3' ' A' ' 48' ' ' LEU . 8.4 mp -103.68 140.61 37.36 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 115.728 -0.669 . . . . 75.129999999999995 109.605 -179.177 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 88.1 mt -72.14 114.13 9.92 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.085 -1.08 . . . . 73.209999999999994 108.085 175.388 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -117.91 4.8 12.15 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.588 -0.893 . . . . 71.010000000000005 108.588 -179.633 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.494 ' HB2' ' OG1' ' A' ' 68' ' ' THR . 1.0 OUTLIER -122.13 131.81 24.35 Favored Pre-proline 0 N--CA 1.437 -1.075 0 CA-C-N 115.893 -0.594 . . . . 54.329999999999998 109.726 -174.9 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.522 ' HG2' ' OG1' ' A' ' 37' ' ' THR . 2.8 Cg_exo -54.52 -40.15 84.92 Favored 'Trans proline' 0 C--N 1.36 1.142 0 C-N-CA 123.302 2.668 . . . . 71.340000000000003 110.904 177.822 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 97.6 m -126.34 103.28 7.56 Favored 'General case' 0 N--CA 1.42 -1.941 0 CA-C-N 114.964 -1.016 . . . . 52.25 108.716 175.829 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.494 ' OG1' ' HB2' ' A' ' 65' ' ' GLN . 38.3 m -107.24 113.07 26.25 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 108.1 -1.074 . . . . 61.409999999999997 108.1 179.047 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.1 m -105.2 121.05 43.03 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 120.469 -0.492 . . . . 73.219999999999999 109.898 -178.57 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.583 ' HB1' HD11 ' A' ' 80' ' ' LEU . . . -95.68 124.08 39.54 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 109.074 -0.713 . . . . 74.519999999999996 109.074 -179.878 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.445 ' O ' ' HA ' ' A' ' 79' ' ' PHE . . . -159.62 -179.01 34.14 Favored Glycine 0 N--CA 1.437 -1.248 0 C-N-CA 120.237 -0.983 . . . . 74.450000000000003 112.401 179.85 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.71 ' NH1' ' HA ' ' A' ' 81' ' ' ASP . 25.3 tpt180 -112.99 84.89 2.07 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.602 -0.888 . . . . 74.519999999999996 108.602 177.641 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -177.73 147.85 0.66 Allowed Pre-proline 0 C--N 1.314 -0.936 0 C-N-CA 125.509 1.524 . . . . 73.109999999999999 106.936 178.43 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -56.7 -40.47 84.09 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.787 2.325 . . . . 63.340000000000003 112.487 179.389 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -87.9 64.8 8.04 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-O 122.684 1.23 . . . . 70.439999999999998 112.467 177.855 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 19.6 m -133.59 159.9 39.08 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 104.684 -2.339 . . . . 71.040000000000006 104.684 172.601 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -64.96 -42.58 94.47 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 118.972 0.805 . . . . 71.510000000000005 109.592 -178.532 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.95 138.5 43.76 Favored 'Isoleucine or valine' 0 C--O 1.251 1.133 0 N-CA-C 106.944 -1.502 . . . . 73.109999999999999 106.944 171.735 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.445 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 53.5 p90 -107.62 125.34 51.22 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.734 -0.786 . . . . 74.420000000000002 111.813 -179.601 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.583 HD11 ' HB1' ' A' ' 70' ' ' ALA . 5.3 mp -80.51 135.83 36.18 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.76 -1.2 . . . . 75.140000000000001 107.76 178.685 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.71 ' HA ' ' NH1' ' A' ' 72' ' ' ARG . 25.5 t70 -92.13 39.81 1.03 Allowed 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.682 0.753 . . . . 74.420000000000002 111.878 -174.648 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.422 ' HB2' ' HB2' ' A' ' 55' ' ' PRO . 12.0 t70 -123.5 151.36 42.88 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.928 -0.767 . . . . 32.409999999999997 108.928 178.511 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 33.3 m -90.26 -5.89 10.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 113.015 0.746 . . . . 73.099999999999994 113.015 -174.963 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.2 t -83.65 -13.1 54.99 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-O 121.816 0.817 . . . . 71.329999999999998 108.987 178.424 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.44 HG13 ' HB2' ' A' ' 89' ' ' HIS . 51.3 t -82.83 134.49 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 CA-C-N 114.906 -1.043 . . . . 75.299999999999997 110.023 -175.998 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.534 ' OG ' HD21 ' A' ' 107' ' ' LEU . 58.3 m -82.74 -174.01 4.98 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 116.155 -0.475 . . . . 73.010000000000005 111.534 -179.949 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -56.05 -50.49 70.81 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 108.204 -1.035 . . . . 75.310000000000002 108.204 175.099 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 59.0 mtt180 -126.74 115.78 19.92 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 105.597 -2.001 . . . . 72.409999999999997 105.597 174.376 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.44 ' HB2' HG13 ' A' ' 85' ' ' VAL . 11.0 t60 -100.02 -51.34 3.72 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 121.656 0.741 . . . . 61.229999999999997 109.812 -177.149 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -145.51 145.01 30.89 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 108.416 -0.957 . . . . 61.140000000000001 108.416 -179.786 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -121.89 127.86 50.93 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-O 121.699 0.761 . . . . 63.409999999999997 109.75 178.453 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -107.82 113.69 27.1 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 107.39 -1.337 . . . . 61.149999999999999 107.39 -178.27 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 41.9 mtp180 -117.52 147.57 42.65 Favored 'General case' 0 C--N 1.283 -2.29 0 C-N-CA 119.936 -0.706 . . . . 72.510000000000005 110.277 -179.033 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.415 ' CG2' ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -116.44 122.56 70.07 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.132 0 N-CA-C 106.872 -1.529 . . . . 72.430000000000007 106.872 175.977 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -108.47 146.8 32.61 Favored 'General case' 0 C--N 1.275 -2.669 0 N-CA-C 107.434 -1.321 . . . . 74.340000000000003 107.434 -178.641 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -51.12 -22.83 2.72 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 123.769 0.827 . . . . 65.310000000000002 112.581 179.828 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -91.73 -51.33 2.51 Favored Glycine 0 N--CA 1.432 -1.618 0 C-N-CA 121.046 -0.597 . . . . 33.329999999999998 112.693 175.322 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -149.95 175.21 11.88 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 117.496 0.648 . . . . 61.310000000000002 112.387 -175.223 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.521 ' HB2' ' HB2' ' A' ' 122' ' ' MET . 63.1 m-85 -99.0 132.08 44.57 Favored 'General case' 0 C--O 1.247 0.951 0 N-CA-C 108.318 -0.993 . . . . 64.540000000000006 108.318 176.407 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -131.89 128.75 39.24 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 121.038 0.447 . . . . 74.400000000000006 111.196 -175.964 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 5.3 p -116.46 122.19 69.26 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-O 121.244 0.545 . . . . 74.230000000000004 110.507 177.804 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.7 m -119.53 136.96 55.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-N 115.736 -0.665 . . . . 75.219999999999999 109.999 177.833 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.432 ' OD2' ' HA ' ' A' ' 118' ' ' ASN . 1.4 p30 -86.39 143.12 27.98 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 118.727 -1.189 . . . . 72.230000000000004 108.345 175.409 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 15.7 m -127.68 12.31 3.29 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 CA-C-O 122.033 0.92 . . . . 74.030000000000001 109.298 176.773 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -161.67 67.69 0.24 Allowed Glycine 0 N--CA 1.427 -1.926 0 CA-C-N 114.569 -1.196 . . . . 73.409999999999997 110.965 -179.729 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.43 ' HB2' ' OD1' ' A' ' 103' ' ' ASP . 22.1 t -88.99 80.44 7.05 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 122.045 -0.68 . . . . 75.450000000000003 109.438 178.425 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.534 HD21 ' OG ' ' A' ' 86' ' ' SER . 1.9 mm? -81.03 -51.95 7.95 Favored 'General case' 0 CA--C 1.501 -0.908 0 C-N-CA 120.143 -0.623 . . . . 75.329999999999998 109.609 179.324 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -100.04 2.91 43.79 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.667 -0.697 . . . . 74.109999999999999 109.288 -175.869 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 100.93 130.72 7.15 Favored Glycine 0 N--CA 1.427 -1.955 0 CA-C-N 115.483 -0.781 . . . . 55.140000000000001 112.296 -178.662 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.442 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 26.9 m -105.68 119.52 39.35 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 106.764 -1.569 . . . . 62.119999999999997 106.764 172.79 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -125.67 144.23 50.69 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 120.843 0.354 . . . . 75.109999999999999 111.32 -173.736 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 5.2 p -121.81 111.74 32.15 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 N-CA-C 106.378 -1.712 . . . . 72.25 106.378 169.655 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 56.51 41.79 28.21 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.219 0.533 . . . . 73.019999999999996 111.228 -176.642 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 74.77 4.55 4.36 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.643 1.177 . . . . 75.239999999999995 112.782 179.749 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -97.27 115.6 65.77 Favored Pre-proline 0 C--N 1.315 -0.908 0 N-CA-C 110.008 -0.367 . . . . 75.120000000000005 110.008 178.261 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.442 ' HA ' ' O ' ' A' ' 110' ' ' THR . 41.8 Cg_endo -78.2 95.68 1.08 Allowed 'Trans proline' 0 N--CA 1.449 -1.122 0 C-N-CA 121.986 1.79 . . . . 70.219999999999999 110.688 176.866 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 27.8 mmm180 -114.23 146.32 40.56 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.601 -1.259 . . . . 54.149999999999999 107.601 -177.583 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.432 ' HA ' ' OD2' ' A' ' 103' ' ' ASP . 2.7 t-20 -84.17 -38.58 20.46 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.568 0.699 . . . . 72.420000000000002 110.46 -177.801 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -130.73 139.0 50.25 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 108.322 -0.992 . . . . 50.219999999999999 108.322 177.038 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.412 ' HA ' ' OE1' ' A' ' 120' ' ' GLN . 5.6 tp60 -139.81 145.45 38.18 Favored 'General case' 0 N--CA 1.425 -1.703 0 CA-C-O 121.299 0.571 . . . . 61.130000000000003 111.505 179.536 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 60.7 t -92.11 134.24 30.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 106.049 -1.834 . . . . 60.310000000000002 106.049 175.433 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.521 ' HB2' ' HB2' ' A' ' 99' ' ' PHE . 17.0 tmm? -39.36 127.09 1.81 Allowed 'General case' 0 N--CA 1.483 1.188 0 O-C-N 124.443 1.089 . . . . 74.120000000000005 113.366 -177.632 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -128.79 124.1 34.59 Favored 'General case' 0 N--CA 1.417 -2.088 0 N-CA-C 105.982 -1.859 . . . . 74.430000000000007 105.982 177.844 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 4.9 t -92.87 130.86 38.32 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 121.56 0.695 . . . . 54.329999999999998 112.221 -173.874 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 94.64 3.03 62.86 Favored Glycine 0 N--CA 1.438 -1.201 0 CA-C-N 115.24 -0.891 . . . . 63.119999999999997 111.393 177.784 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -106.43 168.02 9.44 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.533 -0.333 . . . . 75.400000000000006 111.157 -177.579 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -108.73 131.64 54.74 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.291 0.567 . . . . 72.439999999999998 111.88 -172.71 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 61.9 mt -119.05 113.22 40.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-N 115.344 -0.843 . . . . 62.130000000000003 109.211 179.816 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -95.32 112.75 24.41 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 109.098 -0.705 . . . . 74.030000000000001 109.098 177.425 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.5 pt -100.98 103.42 14.81 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 CA-C-O 122.127 0.965 . . . . 72.219999999999999 108.741 176.083 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 80.3 -104.96 2.31 Favored Glycine 0 N--CA 1.413 -2.86 0 CA-C-N 114.678 -1.146 . . . . 74.549999999999997 110.765 179.822 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -119.92 1.2 10.94 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 121.158 0.504 . . . . 53.509999999999998 110.954 -176.786 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.416 ' HB2' ' O ' ' A' ' 53' ' ' ARG . 20.1 p90 -127.97 160.06 33.06 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 116.265 -0.425 . . . . 74.040000000000006 110.883 -178.114 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 11.1 ptp180 -129.59 139.16 51.55 Favored 'General case' 0 C--O 1.252 1.224 0 N-CA-C 114.818 1.414 . . . . 71.109999999999999 114.818 -169.517 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.454 ' HG ' ' HA ' ' A' ' 51' ' ' VAL . 8.2 mp -121.86 144.23 48.96 Favored 'General case' 0 N--CA 1.424 -1.747 0 CA-C-N 113.406 -1.724 . . . . 73.5 108.596 179.052 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 58.3 t -107.37 124.16 63.1 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.141 0 N-CA-C 106.907 -1.516 . . . . 73.409999999999997 106.907 179.433 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.401 ' CD2' ' HB3' ' A' ' 49' ' ' LEU . 6.4 t80 -100.33 130.33 46.42 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.92 -0.4 . . . . 75.439999999999998 109.92 -173.12 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -126.55 151.72 47.52 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 121.1 0.476 . . . . 70.420000000000002 109.774 -179.847 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -69.58 135.98 50.69 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.108 -1.441 . . . . 71.239999999999995 107.108 172.766 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.421 ' N ' ' HA ' ' A' ' 47' ' ' ALA . . . -82.98 -177.25 51.92 Favored Glycine 0 N--CA 1.439 -1.131 0 C-N-CA 120.102 -1.047 . . . . 54.329999999999998 112.603 -174.907 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -73.66 123.41 8.53 Favored 'Trans proline' 0 N--CA 1.439 -1.732 0 C-N-CA 122.204 1.936 . . . . 55.340000000000003 109.715 175.922 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -96.6 107.79 20.28 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 108.93 -0.767 . . . . 71.349999999999994 108.93 -178.715 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 . . . . . 0 C--N 1.292 -1.916 0 N-CA-C 107.465 -1.309 . . . . 72.129999999999995 107.465 -179.273 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.4 ppp? . . . . . 0 C--O 1.239 0.535 0 N-CA-C 111.7 0.259 . . . . 74.450000000000003 111.7 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.6 p -65.24 -40.05 93.52 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 121.35 0.595 . . . . 72.450000000000003 111.951 -177.937 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -135.16 146.56 48.87 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 115.416 -0.811 . . . . 75.040000000000006 110.702 -174.004 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -123.3 87.21 2.71 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 122.52 1.153 . . . . 75.340000000000003 110.197 178.018 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -112.75 119.62 38.68 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 114.779 -1.101 . . . . 64.129999999999995 110.751 -179.227 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 154.51 115.86 0.56 Allowed Glycine 0 C--N 1.294 -1.759 0 N-CA-C 109.849 -1.3 . . . . 72.439999999999998 109.849 -178.692 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.3 m -82.65 124.8 77.1 Favored Pre-proline 0 C--N 1.299 -1.626 0 N-CA-C 109.236 -0.653 . . . . 73.109999999999999 109.236 -179.024 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.17 128.05 28.17 Favored 'Trans proline' 0 C--N 1.36 1.159 0 C-N-CA 122.331 2.02 . . . . 73.329999999999998 109.718 175.852 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -75.4 120.27 80.88 Favored Pre-proline 0 C--N 1.308 -1.229 0 CA-C-N 116.063 -0.517 . . . . 65.219999999999999 111.992 -173.141 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -82.16 129.55 6.07 Favored 'Trans proline' 0 N--CA 1.443 -1.487 0 C-N-CA 122.238 1.959 . . . . 75.230000000000004 110.321 175.935 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -89.21 119.58 29.83 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.624 -0.88 . . . . 74.310000000000002 108.624 179.381 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.9 m -91.77 166.82 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 116.32 -0.4 . . . . 62.240000000000002 111.389 -175.586 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -96.49 141.13 30.14 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 108.823 -0.806 . . . . 75.209999999999994 108.823 176.119 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 50.3 m -120.06 102.33 8.46 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-O 121.301 0.572 . . . . 62.43 109.911 178.89 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.9 m -123.9 141.49 51.99 Favored 'General case' 0 N--CA 1.408 -2.545 0 N-CA-C 105.644 -1.984 . . . . 71.5 105.644 177.533 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.3 t -132.17 146.4 52.0 Favored 'General case' 0 C--N 1.271 -2.805 0 N-CA-C 108.709 -0.848 . . . . 44.200000000000003 108.709 -177.888 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.7 m -86.12 138.88 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-O 121.11 0.481 . . . . 72.150000000000006 110.092 179.707 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -86.81 154.62 20.77 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 109.212 -0.662 . . . . 75.209999999999994 109.212 178.408 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 31.4 mmm180 -90.97 110.4 21.66 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 109.242 -0.651 . . . . 74.310000000000002 109.242 179.174 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.54 95.07 8.19 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.495 0.664 . . . . 74.510000000000005 110.594 -178.876 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -82.2 -33.7 29.28 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.642 -0.874 . . . . 74.530000000000001 108.642 176.417 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 59.6 tp 62.84 90.66 0.08 Allowed 'General case' 0 CA--C 1.508 -0.656 0 CA-C-N 114.139 -1.391 . . . . 64.450000000000003 109.609 -176.94 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.5 mp -76.75 114.59 15.68 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.386 -0.824 . . . . 61.229999999999997 108.847 -179.336 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -72.85 158.99 34.45 Favored 'General case' 0 C--O 1.25 1.128 0 CA-C-N 115.98 -0.555 . . . . 71.239999999999995 111.792 -175.825 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.18 174.02 6.06 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.44 -0.8 . . . . 75.409999999999997 111.12 178.556 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 16.0 tpt -134.15 122.74 23.29 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.269 -0.641 . . . . 61.439999999999998 109.269 177.929 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.84 177.82 5.97 Favored 'General case' 0 C--O 1.256 1.439 0 CA-C-O 120.946 0.403 . . . . 74.239999999999995 111.017 -179.847 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.1 t -145.68 129.87 17.57 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 107.888 -1.153 . . . . 63.039999999999999 107.888 -179.896 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.0 t -70.93 134.57 47.33 Favored 'General case' 0 N--CA 1.434 -1.231 0 O-C-N 123.73 0.644 . . . . 51.399999999999999 109.528 -179.87 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.3 t -132.16 157.59 43.89 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 108.472 -0.936 . . . . 74.439999999999998 108.472 179.512 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -75.96 85.13 0.89 Allowed Glycine 0 N--CA 1.438 -1.218 0 N-CA-C 111.363 -0.695 . . . . 63.149999999999999 111.363 179.131 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.6 t -82.04 158.93 23.6 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 109.34 -0.615 . . . . 55.140000000000001 109.34 179.306 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -87.21 129.21 52.55 Favored Pre-proline 0 C--N 1.304 -1.394 0 N-CA-C 110.358 -0.238 . . . . 74.340000000000003 110.358 -178.294 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -72.74 157.26 52.31 Favored 'Trans proline' 0 C--O 1.238 0.51 0 C-N-CA 121.999 1.799 . . . . 75.319999999999993 110.291 176.79 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -72.25 109.42 5.98 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.126 0.489 . . . . 71.25 110.8 -178.56 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.5 t -83.98 158.77 21.4 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.89 -0.595 . . . . 61.149999999999999 109.602 179.211 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -75.52 164.02 26.78 Favored 'General case' 0 N--CA 1.418 -2.072 0 N-CA-C 109.001 -0.74 . . . . 61.119999999999997 109.001 173.037 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -134.38 108.04 0.7 Allowed Glycine 0 N--CA 1.419 -2.446 0 C-N-CA 120.716 -0.754 . . . . 65.319999999999993 111.615 -176.943 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.405 ' HB2' ' HG3' ' A' ' 66' ' ' PRO . . . -60.94 -40.52 93.58 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 121.508 0.67 . . . . 63.539999999999999 110.603 178.679 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -64.21 -14.68 57.0 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.955 -1.02 . . . . 60.149999999999999 113.199 -179.394 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -77.26 -27.25 53.14 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-N 116.839 -0.164 . . . . 73.150000000000006 111.161 179.673 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -86.14 113.93 54.57 Favored Pre-proline 0 N--CA 1.437 -1.105 0 N-CA-C 109.624 -0.509 . . . . 73.150000000000006 109.624 -179.24 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -76.89 -68.48 0.02 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 121.558 1.505 . . . . 71.400000000000006 109.753 177.61 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -132.99 98.33 4.26 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 109.134 -0.691 . . . . 52.130000000000003 109.134 176.77 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -142.85 39.39 1.34 Allowed Glycine 0 C--N 1.289 -2.058 0 N-CA-C 106.635 -2.586 . . . . 55.130000000000003 106.635 177.996 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.7 m -90.88 167.42 12.45 Favored 'General case' 0 N--CA 1.414 -2.226 0 CA-C-N 113.058 -1.571 . . . . 74.109999999999999 111.383 -171.549 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.66 157.4 44.93 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 106.775 -1.565 . . . . 75.299999999999997 106.775 176.394 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.4 pp -134.63 151.97 51.44 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 119.632 -0.827 . . . . 51.130000000000003 111.787 -178.822 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -126.79 136.76 52.82 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.734 -0.666 . . . . 71.430000000000007 109.565 -179.6 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.445 ' CG2' ' HB ' ' A' ' 136' ' ' VAL . 33.5 m -114.24 128.97 71.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 109.202 -0.666 . . . . 61.030000000000001 109.202 175.475 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.6 t -95.14 125.57 47.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 109.439 -0.578 . . . . 72.420000000000002 109.439 -177.2 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -96.66 -34.07 11.52 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.879 -0.6 . . . . 72.299999999999997 110.078 176.17 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.449 ' O ' ' HB3' ' A' ' 133' ' ' PHE . 30.9 tpt180 -165.46 121.51 1.37 Allowed 'General case' 0 CA--C 1.496 -1.133 0 N-CA-C 108.992 -0.744 . . . . 74.530000000000001 108.992 175.938 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -163.19 164.88 36.3 Favored Glycine 0 N--CA 1.415 -2.714 0 N-CA-C 108.218 -1.953 . . . . 53.119999999999997 108.218 177.353 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.483 ' HB2' ' HB3' ' A' ' 82' ' ' ASP . 14.3 Cg_exo -68.82 -20.81 39.05 Favored 'Trans proline' 0 C--O 1.238 0.518 0 C-N-CA 122.385 2.057 . . . . 60.100000000000001 111.397 179.997 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.419 ' HB3' ' CA ' ' A' ' 80' ' ' LEU . 21.8 p-10 -68.52 -59.34 3.22 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 114.761 -1.109 . . . . 72.030000000000001 112.387 -178.651 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -175.75 -153.52 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 108.18 -1.044 . . . . 73.200000000000003 108.18 -173.096 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.03 54.05 0.35 Allowed Glycine 0 N--CA 1.428 -1.888 0 N-CA-C 107.708 -2.157 . . . . 22.41 107.708 178.677 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -135.91 -167.41 2.03 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 108.52 -0.918 . . . . 62.229999999999997 108.52 -173.93 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 17.7 ptp180 -116.12 144.95 43.47 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 120.546 0.213 . . . . 62.399999999999999 110.502 -177.95 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -136.81 140.48 42.5 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 108.516 -0.92 . . . . 64.420000000000002 108.516 179.97 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.1 tt -117.97 136.29 53.6 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 109.072 -0.714 . . . . 74.340000000000003 109.072 177.979 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.441 HD12 HG21 ' A' ' 68' ' ' THR . 1.2 mm? -93.36 115.27 27.84 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.853 -0.425 . . . . 72.340000000000003 109.853 -178.889 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -109.6 13.41 23.89 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 122.439 1.114 . . . . 74.349999999999994 108.569 179.082 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -123.93 144.49 45.14 Favored Pre-proline 0 C--N 1.309 -1.172 0 CA-C-N 115.307 -0.861 . . . . 71.239999999999995 109.927 -177.628 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.557 ' HA ' ' CD1' ' A' ' 94' ' ' ILE . 10.1 Cg_endo -55.34 -54.98 3.5 Favored 'Trans proline' 0 C--N 1.358 1.037 0 C-N-CA 123.468 2.779 . . . . 73.430000000000007 113.851 -177.773 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 42.6 m -113.41 108.61 17.44 Favored 'General case' 0 N--CA 1.425 -1.676 0 N-CA-C 109.581 -0.525 . . . . 64.099999999999994 109.581 -178.718 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.441 HG21 HD12 ' A' ' 63' ' ' LEU . 24.8 m -103.23 114.16 28.22 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 108.982 -0.748 . . . . 60.5 108.982 175.899 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.6 p -98.51 115.25 28.16 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 121.794 0.806 . . . . 74.420000000000002 111.814 -179.555 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.63 134.87 41.89 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 106.901 -1.518 . . . . 70.400000000000006 106.901 175.685 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.418 ' HA3' ' HB3' ' A' ' 89' ' ' HIS . . . 82.57 73.56 1.22 Allowed Glycine 0 C--N 1.3 -1.436 0 C-N-CA 119.702 -1.237 . . . . 71.209999999999994 110.327 -175.183 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 56.9 ttt180 -158.35 106.61 1.95 Allowed 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 105.206 -2.146 . . . . 72.019999999999996 105.206 -178.472 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 19.0 m-70 -52.01 -68.37 0.42 Allowed Pre-proline 0 CA--C 1.55 0.959 0 N-CA-C 116.069 1.877 . . . . 61.030000000000001 116.069 -169.999 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -66.97 -40.15 12.51 Favored 'Trans proline' 0 C--N 1.359 1.093 0 C-N-CA 121.286 1.324 . . . . 73.200000000000003 114.101 -176.18 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -125.77 75.58 1.51 Allowed 'General case' 0 C--N 1.32 -0.675 0 O-C-N 122.293 -0.254 . . . . 72.349999999999994 110.521 -175.588 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 18.0 p -78.31 123.17 26.66 Favored 'General case' 0 C--N 1.28 -2.454 0 C-N-CA 119.11 -1.036 . . . . 73.239999999999995 109.093 176.391 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -67.09 -55.56 13.76 Favored 'General case' 0 CA--C 1.485 -1.537 0 N-CA-C 107.365 -1.346 . . . . 73.219999999999999 107.365 175.696 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 45.4 pt -125.67 148.0 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.847 0 CA-C-N 115.047 -0.979 . . . . 62.119999999999997 108.427 173.998 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -97.51 136.22 38.24 Favored 'General case' 0 C--N 1.276 -2.592 0 CA-C-N 115.321 -0.854 . . . . 75.200000000000003 108.929 177.151 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.419 ' CA ' ' HB3' ' A' ' 56' ' ' ASN . 58.1 tp -144.21 -88.62 0.12 Allowed 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.799 -0.815 . . . . 62.530000000000001 108.799 -175.158 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -76.34 96.93 4.1 Favored 'General case' 0 C--N 1.261 -3.242 0 N-CA-C 108.36 -0.978 . . . . 74.040000000000006 108.36 171.478 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.483 ' HB3' ' HB2' ' A' ' 55' ' ' PRO . 14.6 t70 -81.09 -54.96 5.09 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.269 -0.878 . . . . 54.340000000000003 110.206 -179.077 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.9 t -85.11 -39.91 14.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 CA-C-N 114.882 -1.054 . . . . 74.219999999999999 109.123 -178.994 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.6 p -87.47 32.78 0.7 Allowed 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 124.386 1.075 . . . . 60.439999999999998 111.395 -178.328 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.9 p -81.3 139.87 17.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 CA-C-N 115.171 -0.922 . . . . 70.430000000000007 112.137 -171.909 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 23.3 t -128.52 -176.86 3.95 Favored 'General case' 0 N--CA 1.424 -1.767 0 N-CA-C 107.625 -1.25 . . . . 74.230000000000004 107.625 175.88 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -100.77 120.41 40.07 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 123.446 0.699 . . . . 73.340000000000003 109.227 -177.94 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 88' ' ' ARG . 11.0 mmm180 64.49 32.92 11.42 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 108.419 -0.956 . . . . 62.409999999999997 108.419 -176.372 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.418 ' HB3' ' HA3' ' A' ' 71' ' ' GLY . 67.4 t60 -46.79 -66.45 0.4 Allowed 'General case' 0 C--O 1.241 0.641 0 C-N-CA 124.759 1.224 . . . . 75.219999999999999 112.429 -175.317 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.537 ' HA ' ' HA ' ' A' ' 103' ' ' ASP . . . -141.05 141.34 34.3 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 121.147 -0.221 . . . . 54.43 110.776 -178.129 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -116.32 127.75 54.96 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.33 0.586 . . . . 63.219999999999999 110.791 177.495 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.419 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 41.5 m-85 -105.11 112.64 25.84 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 105.611 -1.996 . . . . 72.409999999999997 105.611 174.302 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -124.38 150.09 45.94 Favored 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 120.49 -0.484 . . . . 73.209999999999994 109.742 -176.522 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.557 ' CD1' ' HA ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -116.95 139.1 45.32 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.063 0 C-N-CA 118.985 -1.086 . . . . 72.310000000000002 108.444 172.233 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -119.22 145.33 46.14 Favored 'General case' 0 C--N 1.27 -2.884 0 N-CA-C 105.793 -1.929 . . . . 74.540000000000006 105.793 176.696 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.94 -20.15 8.33 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 114.038 1.125 . . . . 44.439999999999998 114.038 -173.457 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -106.46 -31.95 3.84 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 119.953 -1.118 . . . . 73.109999999999999 114.16 177.789 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -145.33 147.34 32.21 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-N 117.65 0.725 . . . . 62.009999999999998 109.803 -175.026 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.456 ' HB2' ' HB3' ' A' ' 122' ' ' MET . 30.5 m-85 -94.9 129.88 41.73 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 106.974 -1.491 . . . . 52.229999999999997 106.974 176.4 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -132.3 129.26 39.32 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 119.535 -0.866 . . . . 74.439999999999998 111.76 -175.061 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 61.4 t -114.11 118.1 57.44 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 107.842 -1.17 . . . . 73.340000000000003 107.842 177.552 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 30.8 m -121.06 130.82 74.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 CA-C-N 115.934 -0.576 . . . . 72.120000000000005 109.991 178.9 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.537 ' HA ' ' HA ' ' A' ' 90' ' ' ALA . 0.7 OUTLIER -97.0 138.78 34.0 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 117.326 -1.75 . . . . 74.319999999999993 108.406 170.718 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.8 m -124.18 -2.46 6.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 112.183 0.438 . . . . 61.409999999999997 112.183 179.948 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -89.86 -44.9 4.69 Favored Glycine 0 CA--C 1.509 -0.319 0 N-CA-C 109.752 -1.339 . . . . 65.099999999999994 109.752 175.97 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 14.2 m 58.79 29.2 18.41 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 114.414 1.264 . . . . 72.200000000000003 114.414 174.013 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 49.3 tp -85.32 -48.21 9.28 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 120.109 -0.636 . . . . 72.209999999999994 112.541 -177.659 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -87.64 -19.45 27.71 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 119.448 -0.901 . . . . 62.140000000000001 111.315 -176.247 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 97.34 127.97 5.81 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 120.418 -0.896 . . . . 74.310000000000002 113.666 176.855 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.458 HG21 ' HB3' ' A' ' 103' ' ' ASP . 5.7 p -109.47 134.33 52.01 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 123.281 0.632 . . . . 71.129999999999995 111.335 -179.407 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.462 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 26.6 m-85 -138.78 147.47 42.63 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 107.583 -1.265 . . . . 74.340000000000003 107.583 178.435 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.416 HG11 HE21 ' A' ' 120' ' ' GLN . 12.6 p -123.19 125.81 72.52 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 N-CA-C 106.088 -1.819 . . . . 74.310000000000002 106.088 171.271 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 17.6 m120 62.93 22.15 13.28 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.068 0.547 . . . . 71.219999999999999 109.796 -175.952 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 40.8 mtp180 75.05 12.25 3.46 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.334 1.453 . . . . 73.299999999999997 112.396 -177.126 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -102.85 118.27 58.68 Favored Pre-proline 0 C--N 1.31 -1.115 0 N-CA-C 105.983 -1.858 . . . . 72.230000000000004 105.983 176.27 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -46.66 119.61 3.37 Favored 'Trans proline' 0 C--N 1.362 1.273 0 C-N-CA 123.767 2.978 . . . . 74.340000000000003 112.508 -178.122 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 12.0 tpt180 -153.25 118.91 5.3 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 109.936 -0.394 . . . . 73.310000000000002 109.936 -173.627 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -81.63 -38.76 25.47 Favored 'General case' 0 C--N 1.317 -0.839 0 O-C-N 123.521 0.513 . . . . 72.239999999999995 112.103 -179.085 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -125.4 139.46 53.64 Favored 'General case' 0 N--CA 1.437 -1.119 0 C-N-CA 120.444 -0.502 . . . . 73.439999999999998 110.171 -178.857 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.416 HE21 HG11 ' A' ' 112' ' ' VAL . 6.6 tp-100 -139.36 137.95 36.18 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 109.044 -0.725 . . . . 75.340000000000003 109.044 175.66 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.2 t -111.83 97.72 6.11 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 CA-C-N 115.404 -0.816 . . . . 73.209999999999994 108.91 -177.828 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.456 ' HB3' ' HB2' ' A' ' 99' ' ' PHE . 26.3 ptt? 41.5 98.11 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 127.118 2.167 . . . . 70.319999999999993 116.293 179.091 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.458 ' HG3' ' HB2' ' A' ' 126' ' ' ASP . 52.1 tp60 -121.69 122.34 39.36 Favored 'General case' 0 N--CA 1.385 -3.706 0 N-CA-C 101.28 -3.6 . . . . 64.310000000000002 101.28 174.52 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 14.9 t -110.29 127.74 55.17 Favored 'General case' 0 C--N 1.29 -2.003 0 C-N-CA 119.194 -1.003 . . . . 62.119999999999997 110.666 -172.404 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 87.62 16.9 59.35 Favored Glycine 0 N--CA 1.425 -2.077 0 N-CA-C 110.218 -1.153 . . . . 41.340000000000003 110.218 -178.334 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.458 ' HB2' ' HG3' ' A' ' 123' ' ' GLN . 6.1 m-20 -112.61 162.15 16.01 Favored 'General case' 0 CA--C 1.484 -1.589 0 N-CA-C 112.527 0.565 . . . . 72.219999999999999 112.527 -179.68 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -107.58 122.58 46.96 Favored 'General case' 0 N--CA 1.421 -1.878 0 CA-C-N 114.761 -1.109 . . . . 63.43 111.049 -172.148 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 68.7 mt -101.37 129.87 51.79 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 N-CA-C 106.967 -1.494 . . . . 62.509999999999998 106.967 176.499 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.462 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 34.6 tt0 -110.76 125.46 53.56 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 109.2 -0.667 . . . . 72.439999999999998 109.2 -179.659 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.505 HD13 ' H ' ' A' ' 130' ' ' ILE . 0.2 OUTLIER -112.5 109.87 30.13 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 N-CA-C 108.6 -0.889 . . . . 74.420000000000002 108.6 177.667 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 71.21 -82.37 0.45 Allowed Glycine 0 C--N 1.308 -0.991 0 CA-C-N 115.735 -0.666 . . . . 41.109999999999999 112.094 -176.995 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -146.14 8.16 1.07 Allowed 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.771 -0.826 . . . . 73.200000000000003 108.771 179.118 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.449 ' HB3' ' O ' ' A' ' 53' ' ' ARG . 35.4 m-85 -104.7 150.83 24.39 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.781 -0.822 . . . . 62.350000000000001 108.781 -175.429 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.34 130.74 55.51 Favored 'General case' 0 C--O 1.258 1.505 0 C-N-CA 119.05 -1.06 . . . . 74.140000000000001 112.931 -177.701 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.7 tt -123.79 137.99 54.58 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 125.808 1.643 . . . . 65.329999999999998 107.287 -177.245 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.445 ' HB ' ' CG2' ' A' ' 50' ' ' VAL . 60.8 t -108.81 127.15 65.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 108.677 -0.86 . . . . 51.0 108.677 177.021 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -102.47 130.4 49.27 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 116.209 -0.45 . . . . 65.409999999999997 110.558 -175.071 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -125.34 148.94 48.53 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 109.239 -0.652 . . . . 71.420000000000002 109.239 178.843 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -81.33 135.23 35.68 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.433 -0.951 . . . . 73.140000000000001 108.433 176.739 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.49 153.71 52.66 Favored Glycine 0 N--CA 1.437 -1.281 0 C-N-CA 120.933 -0.651 . . . . 74.209999999999994 111.518 -178.03 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -68.01 137.56 41.43 Favored 'Trans proline' 0 N--CA 1.445 -1.336 0 C-N-CA 122.401 2.068 . . . . 45.119999999999997 113.002 -177.809 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -82.47 103.64 12.17 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 107.478 -1.304 . . . . 71.040000000000006 107.478 176.934 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 . . . . . 0 C--N 1.284 -2.269 0 N-CA-C 107.273 -1.381 . . . . 71.200000000000003 107.273 -175.771 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.0 mtp . . . . . 0 C--O 1.241 0.64 0 CA-C-O 120.755 0.312 . . . . 53.409999999999997 110.429 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.0 p -73.45 -49.53 26.38 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-N 116.484 -0.325 . . . . 71.319999999999993 110.264 -178.333 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 44.22 71.74 0.23 Allowed 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.958 1.303 . . . . 74.25 112.38 -179.806 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 49.7 t-20 -117.9 119.77 35.86 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 107.245 -1.391 . . . . 53.140000000000001 107.245 -179.803 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -94.38 112.08 23.85 Favored 'General case' 0 C--N 1.286 -2.152 0 N-CA-C 109.16 -0.682 . . . . 60.210000000000001 109.16 -177.131 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.85 123.97 8.07 Favored Glycine 0 N--CA 1.435 -1.424 0 N-CA-C 110.905 -0.878 . . . . 73.310000000000002 110.905 -178.966 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.0 p -94.42 126.13 49.29 Favored Pre-proline 0 C--N 1.299 -1.606 0 CA-C-N 116.687 0.244 . . . . 44.219999999999999 111.2 -179.099 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.493 ' O ' ' HD3' ' A' ' 10' ' ' PRO . 24.1 Cg_exo -65.39 129.76 23.49 Favored 'Trans proline' 0 C--O 1.245 0.83 0 C-N-CA 121.954 1.769 . . . . 73.549999999999997 110.309 175.748 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -103.64 95.8 7.92 Favored Pre-proline 0 C--N 1.315 -0.933 0 N-CA-C 108.23 -1.026 . . . . 71.200000000000003 108.23 178.672 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.493 ' HD3' ' O ' ' A' ' 8' ' ' PRO . 90.9 Cg_endo -92.8 179.14 1.23 Allowed 'Trans proline' 0 N--CA 1.445 -1.366 0 C-N-CA 122.823 2.349 . . . . 51.43 113.298 -174.469 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 67.96 84.79 0.15 Allowed 'General case' 0 CA--C 1.509 -0.621 0 C-N-CA 125.285 1.434 . . . . 71.019999999999996 112.14 -179.159 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 24.5 t -113.62 78.03 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 108.503 -0.925 . . . . 74.409999999999997 108.503 178.543 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -140.01 131.23 26.57 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.057 -1.09 . . . . 75.310000000000002 108.057 177.816 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.0 m -143.98 76.67 1.52 Allowed 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 106.551 -1.648 . . . . 73.099999999999994 106.551 172.93 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.1 m -99.59 90.33 4.45 Favored 'General case' 0 N--CA 1.413 -2.299 0 CA-C-N 115.406 -0.815 . . . . 74.040000000000006 110.013 -177.907 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.7 m -125.02 70.31 1.15 Allowed 'General case' 0 N--CA 1.415 -2.194 0 N-CA-C 107.148 -1.427 . . . . 71.340000000000003 107.148 175.698 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.8 m -104.13 152.57 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 CA-C-N 114.876 -1.056 . . . . 65.109999999999999 109.575 -176.966 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 59.25 74.29 0.45 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.713 1.258 . . . . 71.299999999999997 109.649 -176.849 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 15.9 mtm-85 -107.42 142.29 37.48 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.196 -1.038 . . . . 61.219999999999999 108.196 -176.908 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -90.89 79.46 5.91 Favored 'General case' 0 N--CA 1.416 -2.156 0 N-CA-C 107.686 -1.228 . . . . 72.409999999999997 107.686 173.912 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -59.57 -50.55 73.46 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-N 115.191 -0.913 . . . . 62.030000000000001 109.073 -179.793 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 62.8 tp -145.53 119.92 9.64 Favored 'General case' 0 N--CA 1.427 -1.597 0 N-CA-C 107.898 -1.149 . . . . 72.239999999999995 107.898 174.629 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.8 tt -109.62 98.85 8.14 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 106.361 -1.718 . . . . 61.219999999999999 106.361 175.991 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -140.64 88.83 2.22 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.801 -1.185 . . . . 65.200000000000003 107.801 179.878 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -78.03 145.4 35.93 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 114.826 -1.079 . . . . 64.450000000000003 111.973 -175.648 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -69.3 125.15 25.8 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 114.874 -1.057 . . . . 75.420000000000002 108.483 177.749 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -116.39 -68.66 0.9 Allowed 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.787 -1.19 . . . . 64.200000000000003 107.787 -178.225 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 49.9 m -101.52 93.93 5.63 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 108.941 -0.763 . . . . 75.299999999999997 108.941 177.187 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.9 p -82.14 -23.64 35.5 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 121.441 0.639 . . . . 44.409999999999997 110.707 -179.671 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.3 m -104.81 168.31 9.15 Favored 'General case' 0 N--CA 1.425 -1.71 0 N-CA-C 107.357 -1.349 . . . . 75.329999999999998 107.357 179.558 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -87.21 67.49 3.33 Favored Glycine 0 C--N 1.315 -0.588 0 C-N-CA 120.972 -0.633 . . . . 60.409999999999997 112.149 -178.237 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.0 p -91.72 147.61 22.86 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 122.405 0.282 . . . . 61.130000000000003 111.047 179.402 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.69 120.7 78.47 Favored Pre-proline 0 C--N 1.31 -1.112 0 N-CA-C 108.712 -0.847 . . . . 64.010000000000005 108.712 177.648 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -74.82 127.42 10.8 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 122.232 1.955 . . . . 62.5 112.713 -177.59 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -140.0 79.15 1.7 Allowed 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.617 -0.883 . . . . 55.310000000000002 108.617 176.856 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.6 m -148.19 162.25 39.82 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.823 -0.806 . . . . 55.109999999999999 108.823 -178.533 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.2 t -129.22 162.41 27.91 Favored 'General case' 0 N--CA 1.421 -1.896 0 CA-C-O 120.861 0.362 . . . . 71.519999999999996 110.114 -179.957 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -156.99 33.21 0.56 Allowed Glycine 0 N--CA 1.433 -1.517 0 N-CA-C 109.92 -1.272 . . . . 72.239999999999995 109.92 179.436 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.94 -22.82 65.92 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 123.235 0.614 . . . . 64.010000000000005 111.285 -176.852 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -84.53 -27.03 27.64 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.992 -0.549 . . . . 71.409999999999997 110.351 175.725 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.538 HD22 HD22 ' A' ' 42' ' ' LEU . 9.1 t30 -81.13 -43.1 19.9 Favored 'General case' 0 CA--C 1.504 -0.806 0 CA-C-N 116.046 -0.525 . . . . 53.210000000000001 110.21 -175.314 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.538 HD22 HD22 ' A' ' 41' ' ' ASN . 3.5 mm? -89.06 144.31 32.5 Favored Pre-proline 0 N--CA 1.427 -1.578 0 N-CA-C 107.659 -1.237 . . . . 71.299999999999997 107.659 175.749 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -60.39 108.55 0.53 Allowed 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 121.827 1.685 . . . . 63.310000000000002 109.856 175.468 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.89 141.93 54.53 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.149 -0.932 . . . . 74.230000000000004 113.051 -175.587 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -155.35 67.69 0.3 Allowed Glycine 0 N--CA 1.433 -1.504 0 N-CA-C 108.132 -1.987 . . . . 70.120000000000005 108.132 177.812 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.568 ' O ' ' HA ' ' A' ' 141' ' ' PRO . 16.3 m -90.7 162.05 15.09 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 115.1 -0.55 . . . . 54.32 111.166 -173.993 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -136.77 177.6 7.73 Favored 'General case' 0 C--O 1.253 1.278 0 N-CA-C 107.816 -1.179 . . . . 64.219999999999999 107.816 176.482 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.447 HD23 ' H ' ' A' ' 48' ' ' LEU . 2.1 pt? -118.54 146.67 44.38 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 120.171 -0.612 . . . . 71.340000000000003 112.536 -172.471 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.425 ' H ' HD23 ' A' ' 49' ' ' LEU . 1.4 pt? -124.38 132.95 53.54 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.161 -1.051 . . . . 74.329999999999998 108.161 177.501 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 26.0 t -125.9 144.75 34.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 108.849 -0.797 . . . . 74.420000000000002 108.849 -176.823 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.423 HG21 ' HB3' ' A' ' 57' ' ' ALA . 57.7 t -92.46 127.73 44.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 108.624 -0.88 . . . . 42.420000000000002 108.624 179.795 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -94.45 -38.33 10.99 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.655 -0.702 . . . . 64.349999999999994 110.142 -179.604 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 5.5 tpm_? -160.51 114.14 2.11 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.625 -0.716 . . . . 75.319999999999993 110.125 -175.094 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 158.32 125.64 0.84 Allowed Glycine 0 N--CA 1.426 -1.968 0 O-C-N 124.106 0.879 . . . . 73.099999999999994 111.189 176.845 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.569 ' HD2' ' CZ ' ' A' ' 133' ' ' PHE . 50.4 Cg_exo -59.76 -10.63 12.32 Favored 'Trans proline' 0 N--CA 1.489 1.261 0 C-N-CA 123.291 2.661 . . . . 71.549999999999997 113.646 177.599 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.595 ' HB2' ' HA ' ' A' ' 80' ' ' LEU . 4.3 p-10 -52.44 -36.41 54.48 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.297 1.039 . . . . 73.230000000000004 110.046 179.59 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.423 ' HB3' HG21 ' A' ' 51' ' ' VAL . . . -171.93 -162.28 0.21 Allowed 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.513 1.125 . . . . 62.130000000000003 108.123 -179.681 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 172.58 62.64 0.05 OUTLIER Glycine 0 CA--C 1.491 -1.408 0 N-CA-C 110.205 -1.158 . . . . 65.209999999999994 110.205 -179.266 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -163.53 -176.4 4.68 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 107.329 -1.36 . . . . 75.049999999999997 107.329 -176.762 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -103.54 136.06 43.97 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 124.013 0.821 . . . . 74.439999999999998 109.374 176.687 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -121.76 149.93 42.59 Favored 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 108.664 -0.865 . . . . 74.409999999999997 108.664 178.161 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 38.6 tp -114.55 135.81 53.71 Favored 'General case' 0 C--N 1.285 -2.212 0 N-CA-C 106.294 -1.743 . . . . 74.099999999999994 106.294 178.122 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 94.7 mt -79.73 112.94 17.49 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 118.519 -1.272 . . . . 53.210000000000001 109.575 179.064 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -121.02 -0.59 9.99 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-O 121.58 0.705 . . . . 70.230000000000004 109.397 178.973 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -115.63 138.71 24.02 Favored Pre-proline 0 C--N 1.303 -1.431 0 N-CA-C 108.532 -0.914 . . . . 74.319999999999993 108.532 -177.693 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -63.33 -30.92 73.57 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.367 2.044 . . . . 74.329999999999998 112.055 -179.801 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 40.9 m -136.73 114.92 11.6 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 109.892 -0.41 . . . . 62.229999999999997 109.892 177.571 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 24.7 m -110.66 114.11 27.25 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 109.029 -0.73 . . . . 63.119999999999997 109.029 179.318 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 49.4 p -93.27 124.85 37.54 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.118 0.485 . . . . 70.140000000000001 111.633 -179.384 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -109.15 126.45 53.25 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 109.1 -0.704 . . . . 64.349999999999994 109.1 176.498 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -173.94 -171.92 38.78 Favored Glycine 0 N--CA 1.43 -1.706 0 C-N-CA 120.377 -0.916 . . . . 61.439999999999998 111.323 178.538 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -109.69 88.04 2.65 Favored 'General case' 0 N--CA 1.423 -1.777 0 N-CA-C 107.294 -1.373 . . . . 63.329999999999998 107.294 179.467 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.409 ' CE1' ' HG3' ' A' ' 75' ' ' GLU . 9.8 t-160 -164.18 133.19 2.86 Favored Pre-proline 0 C--N 1.279 -2.476 0 N-CA-C 105.185 -2.154 . . . . 72.329999999999998 105.185 -179.872 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -51.06 -37.06 56.72 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 123.16 2.573 . . . . 61.109999999999999 112.933 -178.917 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.409 ' HG3' ' CE1' ' A' ' 73' ' ' HIS . 5.8 pt-20 -102.07 70.13 1.19 Allowed 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 122.569 1.176 . . . . 65.420000000000002 111.828 179.298 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 31.1 m -126.25 169.28 13.04 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 113.29 -1.777 . . . . 53.140000000000001 106.673 174.582 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -79.38 -38.53 34.7 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 119.872 -0.731 . . . . 53.439999999999998 110.579 -178.29 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 39.0 pt -136.73 171.06 17.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 108.591 -0.892 . . . . 52.310000000000002 108.591 173.125 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.53 ' O ' ' HB2' ' A' ' 56' ' ' ASN . 98.0 m-85 -105.25 137.23 43.37 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 112.448 0.536 . . . . 72.200000000000003 112.448 -175.807 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.595 ' HA ' ' HB2' ' A' ' 56' ' ' ASN . 1.7 tt -146.96 104.8 3.73 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 104.658 -2.349 . . . . 64.129999999999995 104.658 177.16 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -115.78 13.5 16.15 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 114.378 1.251 . . . . 64.120000000000005 114.378 -171.252 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.517 ' OD2' ' HB ' ' A' ' 85' ' ' VAL 0.292 3.1 p30 -31.76 -88.72 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.378 0 N-CA-C 115.785 1.772 . . . . 71.239999999999995 115.785 -174.744 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.428 ' H ' ' CG ' ' A' ' 82' ' ' ASP . 7.5 p -163.99 -46.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 C-N-CA 123.13 0.572 . . . . 70.299999999999997 110.732 178.25 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.407 ' HB ' ' CG ' ' A' ' 108' ' ' ASN . 18.0 m -110.12 27.41 9.64 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 123.337 1.541 . . . . 63.109999999999999 109.007 -177.41 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.517 ' HB ' ' OD2' ' A' ' 82' ' ' ASP . 6.3 p -82.25 138.96 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.935 0 CA-C-N 113.48 -1.691 . . . . 72.439999999999998 109.177 178.333 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 20.2 m -87.59 178.01 6.9 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 115.629 -0.714 . . . . 74.200000000000003 110.186 -179.318 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 45.5 mtm180 -64.84 -46.1 83.31 Favored 'General case' 0 C--O 1.221 -0.414 0 N-CA-C 109.964 -0.384 . . . . 72.140000000000001 109.964 178.095 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.56 112.12 17.08 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 104.985 -2.228 . . . . 74.040000000000006 104.985 163.774 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.411 ' CE1' ' HA3' ' A' ' 105' ' ' GLY . 27.2 t60 -104.64 -54.8 2.45 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 115.483 -0.781 . . . . 73.109999999999999 110.916 -170.702 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -120.01 129.67 54.37 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 108.827 -0.805 . . . . 73.200000000000003 108.827 -178.808 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -106.49 127.0 52.96 Favored 'General case' 0 C--N 1.287 -2.142 0 C-N-CA 120.159 -0.616 . . . . 71.209999999999994 109.987 178.478 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -106.94 113.07 26.33 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 106.355 -1.72 . . . . 74.519999999999996 106.355 176.784 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -128.92 150.97 50.14 Favored 'General case' 0 C--N 1.282 -2.35 0 C-N-CA 119.658 -0.817 . . . . 75.420000000000002 111.963 -176.578 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.452 HD13 ' CD2' ' A' ' 99' ' ' PHE . 4.0 tp -115.62 120.14 63.88 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 CA-C-N 114.919 -1.037 . . . . 75.150000000000006 109.252 -179.828 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -101.24 146.72 27.16 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 107.266 -1.383 . . . . 52.32 107.266 178.409 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.41 -14.21 7.16 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.436 0.532 . . . . 74.200000000000003 112.436 179.866 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -86.29 -64.85 1.44 Allowed Glycine 0 N--CA 1.42 -2.414 0 N-CA-C 110.95 -0.86 . . . . 75.129999999999995 110.95 171.427 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -146.45 177.89 8.69 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 117.306 0.553 . . . . 72.430000000000007 111.348 -175.15 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.452 ' CD2' HD13 ' A' ' 94' ' ' ILE . 89.7 m-85 -90.93 130.59 36.85 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.724 -1.213 . . . . 72.239999999999995 107.724 176.693 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -132.29 135.29 46.12 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 120.53 -0.468 . . . . 71.340000000000003 110.78 -176.63 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 5.0 p -120.91 119.69 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.095 0 CA-C-O 121.599 0.714 . . . . 71.219999999999999 109.765 179.671 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 30.5 m -119.35 128.26 75.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-N 115.228 -0.896 . . . . 73.120000000000005 111.004 -178.089 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -91.73 132.45 36.38 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 115.682 -0.69 . . . . 74.420000000000002 109.754 176.153 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 26.8 m -115.02 11.52 7.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 CA-C-O 121.274 0.559 . . . . 64.340000000000003 110.781 175.096 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.411 ' HA3' ' CE1' ' A' ' 89' ' ' HIS . . . -122.99 56.09 0.67 Allowed Glycine 0 C--O 1.247 0.928 0 N-CA-C 109.651 -1.38 . . . . 52.329999999999998 109.651 179.17 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 12.5 m -68.9 -8.56 45.29 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 113.288 0.847 . . . . 72.530000000000001 113.288 -171.773 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.6 tt -71.31 -37.78 71.78 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 107.551 -1.278 . . . . 74.409999999999997 107.551 176.829 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.407 ' CG ' ' HB ' ' A' ' 84' ' ' THR . 59.5 t30 -84.97 -42.31 15.04 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.527 -1.286 . . . . 72.409999999999997 107.527 176.746 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 88.38 122.73 1.94 Allowed Glycine 0 N--CA 1.439 -1.16 0 CA-C-N 114.971 -1.013 . . . . 64.420000000000002 114.965 174.35 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 31.5 m -100.85 140.33 35.3 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.066 -1.087 . . . . 64.129999999999995 108.066 172.781 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -127.41 168.41 14.89 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.732 0.777 . . . . 74.209999999999994 111.186 -174.69 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 13.7 p -122.81 143.66 34.94 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 N-CA-C 105.846 -1.909 . . . . 75.129999999999995 105.846 174.173 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -19.05 90.91 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 126.322 1.849 . . . . 74.299999999999997 113.874 -176.944 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 67.04 2.1 2.6 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 127.982 2.513 . . . . 61.229999999999997 115.392 175.209 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -124.86 142.31 40.61 Favored Pre-proline 0 C--N 1.312 -1.044 0 O-C-N 121.45 -0.781 . . . . 75.140000000000001 112.169 -178.822 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -79.04 98.91 1.22 Allowed 'Trans proline' 0 C--O 1.246 0.899 0 C-N-CA 122.766 2.311 . . . . 75.439999999999998 114.493 -175.998 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 65.5 mtp180 -140.2 119.91 13.35 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.417 -0.957 . . . . 74.200000000000003 108.417 174.3 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -85.92 -23.31 27.03 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 124.103 0.877 . . . . 72.299999999999997 109.92 -175.688 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -125.1 138.36 54.17 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 107.183 -1.414 . . . . 61.310000000000002 107.183 174.177 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -141.47 149.84 41.46 Favored 'General case' 0 C--N 1.288 -2.072 0 CA-C-N 116.045 -0.525 . . . . 72.0 110.899 -177.119 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.3 p -85.66 122.66 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.684 0 N-CA-C 103.372 -2.825 . . . . 62.5 103.372 170.187 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.43 ' HG2' ' CD2' ' A' ' 137' ' ' PHE . 12.3 ttt -65.69 113.3 4.17 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.426 0.631 . . . . 71.540000000000006 109.923 -168.806 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -103.64 133.92 47.84 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 115.148 -0.933 . . . . 74.329999999999998 109.944 -171.252 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.439 ' HB ' ' HB2' ' A' ' 139' ' ' ALA . 41.1 p -83.15 129.54 35.03 Favored 'General case' 0 N--CA 1.412 -2.336 0 CA-C-N 115.463 -0.789 . . . . 70.319999999999993 110.53 -177.732 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 107.75 -9.55 37.6 Favored Glycine 0 N--CA 1.416 -2.674 0 CA-C-N 115.689 -0.687 . . . . 74.129999999999995 111.654 177.239 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -116.26 176.18 5.22 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 118.504 -1.278 . . . . 70.310000000000002 112.592 -175.82 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -109.16 128.22 54.84 Favored 'General case' 0 N--CA 1.428 -1.575 0 C-N-CA 125.318 1.447 . . . . 73.140000000000001 110.348 -174.521 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 68.6 mt -115.97 130.3 70.91 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 N-CA-C 107.194 -1.409 . . . . 75.129999999999995 107.194 179.253 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -104.29 111.5 24.16 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 119.945 -0.702 . . . . 74.209999999999994 109.833 -177.682 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.8 pp -95.17 113.71 30.16 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 CA-C-N 115.567 -0.742 . . . . 65.400000000000006 110.812 179.68 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 72.28 -89.25 0.51 Allowed Glycine 0 N--CA 1.437 -1.262 0 N-CA-C 109.648 -1.381 . . . . 53.299999999999997 109.648 -174.033 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -142.3 3.8 1.56 Allowed 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 109.435 -0.58 . . . . 71.329999999999998 109.435 177.128 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.569 ' CZ ' ' HD2' ' A' ' 55' ' ' PRO . 21.7 m-85 -102.52 150.37 23.46 Favored 'General case' 0 CA--C 1.513 -0.47 0 O-C-N 122.026 -0.422 . . . . 74.310000000000002 110.42 -176.807 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -104.6 122.93 46.64 Favored 'General case' 0 C--O 1.252 1.231 0 CA-C-O 121.505 0.669 . . . . 72.430000000000007 112.331 -174.219 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 31.1 tp -117.78 138.47 52.03 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 114.546 -1.207 . . . . 71.5 107.828 179.729 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 10.2 p -115.08 138.75 44.37 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 N-CA-C 108.683 -0.858 . . . . 71.019999999999996 108.683 177.639 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.43 ' CD2' ' HG2' ' A' ' 122' ' ' MET . 42.3 t80 -114.5 123.4 49.29 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.776 -0.824 . . . . 73.230000000000004 108.776 -177.937 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -114.62 148.24 38.38 Favored 'General case' 0 C--O 1.253 1.259 0 CA-C-O 121.111 0.481 . . . . 72.219999999999999 111.549 -175.649 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.439 ' HB2' ' HB ' ' A' ' 124' ' ' THR . . . -85.18 99.31 11.0 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-N 115.491 -0.777 . . . . 73.129999999999995 109.731 177.768 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -140.09 77.17 0.32 Allowed Glycine 0 C--N 1.281 -2.526 0 N-CA-C 107.817 -2.113 . . . . 74.549999999999997 107.817 175.002 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.568 ' HA ' ' O ' ' A' ' 46' ' ' SER . 14.9 Cg_endo -59.13 113.56 1.64 Allowed 'Trans proline' 0 CA--C 1.498 -1.323 0 C-N-CA 122.674 2.249 . . . . 54.119999999999997 113.799 -173.759 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.407 ' HB3' ' HB2' ' A' ' 46' ' ' SER . . . -103.51 104.59 14.68 Favored 'General case' 0 C--N 1.269 -2.895 0 CA-C-N 113.616 -1.629 . . . . 70.140000000000001 108.706 -179.981 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 . . . . . 0 N--CA 1.402 -2.87 0 N-CA-C 107.019 -1.475 . . . . 71.329999999999998 107.019 -179.944 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.1 mtt . . . . . 0 N--CA 1.469 0.497 0 N-CA-C 109.478 -0.564 . . . . 73.430000000000007 109.478 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.4 m -76.66 -28.74 56.1 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 107.66 -1.237 . . . . 65.010000000000005 107.66 173.983 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -82.15 142.03 32.57 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 113.669 -1.605 . . . . 75.109999999999999 107.747 174.946 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -169.48 167.37 9.9 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.623 -0.51 . . . . 74.329999999999998 109.623 176.927 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -163.3 128.94 3.14 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.292 -1.003 . . . . 71.329999999999998 108.292 176.075 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -92.02 156.5 23.67 Favored Glycine 0 N--CA 1.427 -1.92 0 C-N-CA 120.619 -0.8 . . . . 53.530000000000001 111.435 179.94 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.0 m -82.7 129.71 61.24 Favored Pre-proline 0 C--N 1.294 -1.823 0 N-CA-C 109.106 -0.702 . . . . 70.230000000000004 109.106 179.131 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -66.61 127.9 18.07 Favored 'Trans proline' 0 N--CA 1.447 -1.233 0 C-N-CA 121.553 1.502 . . . . 75.420000000000002 109.321 173.295 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -83.34 136.73 42.79 Favored Pre-proline 0 C--N 1.295 -1.794 0 N-CA-C 108.524 -0.917 . . . . 75.219999999999999 108.524 179.132 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_exo -70.41 116.02 4.44 Favored 'Trans proline' 0 N--CA 1.441 -1.578 0 C-N-CA 121.426 1.417 . . . . 72.030000000000001 109.611 176.209 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 25.7 mp0 -66.96 124.22 22.4 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.429 -0.952 . . . . 70.510000000000005 108.429 179.128 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.6 m -53.36 126.51 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 O-C-N 124.279 0.987 . . . . 72.340000000000003 110.526 -178.621 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -70.23 139.37 52.23 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-N 115.539 -0.755 . . . . 53.32 110.826 -177.147 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 64.4 m -144.56 138.88 27.8 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 107.881 -1.155 . . . . 60.229999999999997 107.881 179.162 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 21.1 m -116.56 126.83 53.86 Favored 'General case' 0 N--CA 1.414 -2.243 0 N-CA-C 108.771 -0.826 . . . . 71.140000000000001 108.771 -177.025 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.4 t -60.88 -54.13 48.86 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 121.811 0.815 . . . . 72.010000000000005 110.036 179.696 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.9 m -141.5 133.3 28.09 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.906 0 CA-C-N 113.982 -1.463 . . . . 71.040000000000006 109.964 177.927 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -72.73 112.51 8.84 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 108.24 -1.022 . . . . 75.219999999999999 108.24 175.105 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 52.2 mtt180 -102.54 110.08 21.91 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 115.496 -0.775 . . . . 75.129999999999995 109.396 -177.9 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.49 67.26 7.58 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 121.181 0.515 . . . . 51.240000000000002 109.8 178.315 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -65.61 -43.94 88.06 Favored 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 108.723 -0.843 . . . . 72.340000000000003 108.723 177.721 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 94.2 mt 55.06 47.36 22.16 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 124.35 1.031 . . . . 54.25 112.235 171.623 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -96.56 104.74 16.75 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.665 -1.235 . . . . 53.039999999999999 107.665 179.725 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.511 ' HD3' ' H ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -101.73 135.86 42.55 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.833 -0.803 . . . . 73.129999999999995 108.833 178.709 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -107.27 151.44 25.46 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-O 121.074 0.464 . . . . 74.430000000000007 110.866 -179.944 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 21.5 ptp -150.98 136.42 17.8 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 106.422 -1.695 . . . . 64.310000000000002 106.422 176.122 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -72.86 87.44 1.3 Allowed 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 122.165 0.983 . . . . 72.439999999999998 112.586 -178.491 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.9 t -116.44 122.54 45.07 Favored 'General case' 0 N--CA 1.419 -1.996 0 CA-C-N 114.121 -1.4 . . . . 74.0 108.835 -177.074 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.6 t -118.83 103.52 9.7 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.566 -1.272 . . . . 74.129999999999995 107.566 177.455 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 24.4 p -101.7 111.9 24.3 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.833 -0.621 . . . . 74.319999999999993 110.505 -177.376 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -117.06 114.9 3.11 Favored Glycine 0 N--CA 1.43 -1.766 0 C-N-CA 120.724 -0.75 . . . . 61.149999999999999 111.341 -179.701 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 14.4 t -111.1 163.09 14.23 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.01 -1.107 . . . . 71.099999999999994 108.01 178.61 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -85.14 118.15 70.24 Favored Pre-proline 0 C--N 1.307 -1.247 0 N-CA-C 110.272 -0.27 . . . . 71.120000000000005 110.272 -179.589 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -73.93 145.33 35.77 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.287 1.991 . . . . 54.25 111.584 -179.569 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -90.24 87.99 7.05 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 121.352 0.596 . . . . 74.200000000000003 109.743 178.965 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.9 m -97.74 18.96 14.48 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 121.971 0.891 . . . . 73.319999999999993 110.031 179.889 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.9 p -93.83 152.77 18.67 Favored 'General case' 0 N--CA 1.419 -2.008 0 CA-C-N 114.884 -1.053 . . . . 62.32 110.394 179.739 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 115.17 -9.21 20.67 Favored Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.673 -0.775 . . . . 70.019999999999996 112.253 179.705 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.95 -28.64 60.66 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.323 0.582 . . . . 74.150000000000006 110.126 179.309 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -64.05 -11.59 30.91 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.835 0.854 . . . . 75.349999999999994 112.355 178.725 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -75.5 -13.89 60.39 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 112.959 0.725 . . . . 74.109999999999999 112.959 -179.238 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.9 pp -59.57 149.78 69.11 Favored Pre-proline 0 CA--C 1.551 0.989 0 N-CA-C 111.719 0.266 . . . . 64.319999999999993 111.719 179.649 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -67.68 -75.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.156 1.904 . . . . 75.319999999999993 112.504 179.667 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -171.03 167.68 7.15 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 108.751 -0.833 . . . . 71.299999999999997 108.751 179.728 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 138.15 59.14 0.05 OUTLIER Glycine 0 CA--C 1.494 -1.272 0 N-CA-C 109.718 -1.353 . . . . 64.310000000000002 109.718 -178.553 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.1 m -91.19 163.57 14.21 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 121.711 0.767 . . . . 63.32 112.327 -173.746 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.587 ' HA ' ' N ' ' A' ' 140' ' ' GLY . . . -126.71 165.95 18.29 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 106.981 -1.489 . . . . 71.239999999999995 106.981 176.625 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.1 pp -129.91 150.66 51.1 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 113.087 0.773 . . . . 74.209999999999994 113.087 -173.83 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.512 HD11 ' CE1' ' A' ' 61' ' ' PHE . 4.4 pp -119.46 147.73 44.07 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.614 -0.721 . . . . 71.0 109.774 178.044 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.9 t -124.87 125.58 69.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 107.745 -1.205 . . . . 74.329999999999998 107.745 179.221 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.0 t -93.02 118.1 37.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 108.394 -0.965 . . . . 74.040000000000006 108.394 178.632 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -83.77 -34.12 24.86 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.354 0.597 . . . . 73.319999999999993 110.02 -178.428 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -155.55 125.94 6.76 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.269 -0.878 . . . . 74.519999999999996 108.783 176.283 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 155.44 109.52 0.32 Allowed Glycine 0 N--CA 1.415 -2.727 0 N-CA-C 111.649 -0.58 . . . . 74.200000000000003 111.649 -179.545 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -58.5 -8.58 5.6 Favored 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 124.47 3.446 . . . . 61.140000000000001 112.808 177.997 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 50.5 m-20 -52.34 -37.28 55.59 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.213 1.405 . . . . 71.420000000000002 109.229 174.306 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -159.97 -63.45 0.07 Allowed 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.659 -0.701 . . . . 53.340000000000003 109.873 -179.872 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.89 34.27 59.21 Favored Glycine 0 C--O 1.223 -0.553 0 CA-C-N 115.981 -0.554 . . . . 74.420000000000002 111.93 -179.861 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -149.42 -173.86 4.51 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 108.15 -1.056 . . . . 63.530000000000001 108.15 -178.159 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.2 ptt180 -119.79 150.1 40.96 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 108.454 -0.943 . . . . 62.140000000000001 108.454 175.777 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.512 ' CE1' HD11 ' A' ' 49' ' ' LEU . 52.0 p90 -157.23 151.72 25.25 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.598 -0.519 . . . . 72.239999999999995 109.598 173.031 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.2 pp -88.11 140.85 29.07 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 108.886 -0.783 . . . . 62.130000000000003 108.886 176.05 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 90.9 mt -71.58 113.04 8.21 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.672 -0.862 . . . . 74.310000000000002 108.672 179.667 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -110.67 -33.48 6.55 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 114.71 -1.132 . . . . 43.340000000000003 109.542 -178.967 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -79.23 122.27 84.01 Favored Pre-proline 0 C--N 1.308 -1.207 0 N-CA-C 107.22 -1.4 . . . . 74.310000000000002 107.22 179.728 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -51.55 -31.77 41.16 Favored 'Trans proline' 0 C--N 1.367 1.552 0 C-N-CA 123.509 2.806 . . . . 44.340000000000003 112.634 -176.8 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.4 m -134.5 97.05 3.71 Favored 'General case' 0 N--CA 1.417 -2.098 0 N-CA-C 107.904 -1.147 . . . . 62.130000000000003 107.904 173.404 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 86.0 m -91.73 118.46 30.69 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.963 -1.125 . . . . 71.549999999999997 107.963 -179.277 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 27.6 m -108.41 121.04 44.12 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-O 121.775 0.797 . . . . 70.510000000000005 111.919 -176.478 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.469 ' O ' ' HB3' ' A' ' 89' ' ' HIS . . . -98.16 103.3 15.23 Favored 'General case' 0 N--CA 1.416 -2.168 0 N-CA-C 106.876 -1.527 . . . . 51.329999999999998 106.876 174.232 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 111.07 69.86 0.59 Allowed Glycine 0 N--CA 1.429 -1.795 0 C-N-CA 119.76 -1.21 . . . . 51.240000000000002 111.224 -177.9 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -151.0 61.11 0.92 Allowed 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 104.093 -2.558 . . . . 71.040000000000006 104.093 177.993 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 16.5 t60 -37.95 -43.97 1.74 Allowed Pre-proline 0 CA--C 1.578 2.021 0 N-CA-C 116.559 2.059 . . . . 73.409999999999997 116.559 -167.338 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -60.15 -40.25 61.92 Favored 'Trans proline' 0 C--N 1.374 1.921 0 CA-C-N 121.559 1.593 . . . . 62.109999999999999 113.207 175.405 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -149.84 88.03 1.52 Allowed 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 108.946 -0.761 . . . . 74.120000000000005 108.946 -179.078 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 53.4 m -101.61 152.17 21.13 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 116.439 -0.346 . . . . 54.229999999999997 110.425 179.577 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -72.22 -43.8 63.88 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 106.136 -1.801 . . . . 74.129999999999995 106.136 171.103 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 30.0 pt -131.68 130.26 61.95 Favored 'Isoleucine or valine' 0 C--O 1.245 0.868 0 CA-C-N 114.407 -1.27 . . . . 75.140000000000001 108.507 171.802 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -90.73 116.99 29.02 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 116.314 -0.403 . . . . 73.239999999999995 109.978 -177.063 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.455 HD21 ' HB1' ' A' ' 70' ' ' ALA . 97.2 mt -66.86 172.33 4.48 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.318 0.58 . . . . 64.400000000000006 111.251 -179.859 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -73.87 -12.16 60.59 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.792 -0.64 . . . . 41.450000000000003 110.732 179.04 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.529 ' HA ' HG23 ' A' ' 85' ' ' VAL . 1.6 m-20 54.05 78.4 0.16 Allowed 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 115.085 -0.962 . . . . 73.230000000000004 113.369 -176.74 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 44.2 t -93.06 -37.04 8.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 106.92 -1.511 . . . . 63.119999999999997 106.92 173.727 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 76.1 m -179.55 84.37 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 127.971 2.508 . . . . 62.119999999999997 105.473 -178.616 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.529 HG23 ' HA ' ' A' ' 82' ' ' ASP . 78.8 t -103.34 136.18 37.33 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.192 0 CA-C-N 115.204 -0.907 . . . . 73.219999999999999 109.726 -176.662 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 23.3 t -74.3 180.0 4.23 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 115.147 -0.933 . . . . 72.319999999999993 111.04 -176.096 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 -68.15 -34.19 75.88 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 107.615 -1.254 . . . . 71.409999999999997 107.615 178.841 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.472 ' O ' HG23 ' A' ' 104' ' ' VAL . 0.2 OUTLIER -139.45 125.66 20.08 Favored 'General case' 0 CA--C 1.495 -1.145 0 N-CA-C 101.236 -3.616 . . . . 74.510000000000005 101.236 167.572 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.469 ' HB3' ' O ' ' A' ' 70' ' ' ALA . 6.7 t60 -100.65 -79.32 0.5 Allowed 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 118.619 -1.233 . . . . 73.510000000000005 112.403 -173.996 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -120.07 107.81 13.51 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.152 0.501 . . . . 73.019999999999996 109.772 -178.867 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -95.5 127.89 41.91 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 109.027 -0.731 . . . . 70.0 109.027 178.909 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -112.74 112.27 23.66 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 107.321 -1.363 . . . . 62.420000000000002 107.321 176.737 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 54.7 ttp180 -103.59 124.19 48.35 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.325 -0.991 . . . . 75.310000000000002 108.325 178.42 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.36 117.02 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.319 0 CA-C-O 122.122 0.963 . . . . 62.009999999999998 109.443 -173.243 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 -118.41 144.69 45.75 Favored 'General case' 0 C--N 1.28 -2.415 0 N-CA-C 103.174 -2.899 . . . . 62.200000000000003 103.174 172.142 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.09 -16.07 63.63 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 121.067 0.46 . . . . 64.129999999999995 112.196 -177.627 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -90.07 -45.19 4.54 Favored Glycine 0 N--CA 1.431 -1.688 0 CA-C-N 115.534 -0.757 . . . . 34.200000000000003 112.695 174.883 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -136.41 140.88 43.51 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 121.297 0.57 . . . . 62.109999999999999 110.96 -176.977 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -112.54 125.95 54.81 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 107.177 -1.416 . . . . 75.239999999999995 107.177 179.561 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -132.39 137.78 47.46 Favored 'General case' 0 C--N 1.309 -1.178 0 C-N-CA 120.051 -0.659 . . . . 74.540000000000006 112.179 -179.051 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.8 p -115.85 125.95 73.18 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 CA-C-N 115.211 -0.904 . . . . 55.539999999999999 109.551 179.518 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 46.3 t -112.97 115.52 50.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 CA-C-N 115.951 -0.568 . . . . 63.420000000000002 109.697 -179.28 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -95.95 107.5 19.78 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 121.644 0.735 . . . . 75.349999999999994 110.048 177.034 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 88' ' ' ARG . 1.3 m -114.0 16.02 8.07 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.277 0 CA-C-N 115.075 -0.966 . . . . 61.340000000000003 109.659 175.5 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -122.35 45.43 1.21 Allowed Glycine 0 N--CA 1.438 -1.189 0 N-CA-C 109.119 -1.593 . . . . 73.219999999999999 109.119 176.265 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.5 p -69.68 -13.65 62.41 Favored 'General case' 0 C--O 1.249 1.037 0 C-N-CA 124.702 1.201 . . . . 61.130000000000003 112.973 -175.427 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 49.9 tp -67.73 -43.84 79.03 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 108.212 -1.033 . . . . 73.319999999999993 108.212 175.442 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -74.77 -47.68 29.68 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 107.123 -1.436 . . . . 72.340000000000003 107.123 173.065 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 100.31 96.02 2.18 Favored Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 115.16 0.824 . . . . 63.299999999999997 115.16 175.01 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.407 HG23 HG22 ' A' ' 130' ' ' ILE . 51.7 m -91.2 120.11 31.85 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.359 -0.978 . . . . 63.219999999999999 108.359 173.044 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.492 ' HB3' ' HA ' ' A' ' 114' ' ' ARG . 59.9 m-85 -102.35 134.58 45.42 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 108.574 -0.898 . . . . 74.239999999999995 108.574 178.774 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 34.5 t -117.62 121.95 68.68 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 N-CA-C 105.415 -2.069 . . . . 75.200000000000003 105.415 176.131 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.483 ' HA ' ' OD1' ' A' ' 126' ' ' ASP . 14.2 m120 67.52 18.19 10.0 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 107.211 -1.403 . . . . 75.200000000000003 107.211 -172.672 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.492 ' HA ' ' HB3' ' A' ' 111' ' ' TYR 0.344 44.7 mtt85 68.79 12.67 8.73 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 113.626 -1.625 . . . . 74.109999999999999 114.207 -173.354 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -97.85 135.96 21.32 Favored Pre-proline 0 N--CA 1.442 -0.865 0 N-CA-C 107.866 -1.161 . . . . 73.340000000000003 107.866 174.681 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -68.61 115.81 4.1 Favored 'Trans proline' 0 C--O 1.24 0.605 0 C-N-CA 121.864 1.71 . . . . 71.040000000000006 109.12 172.787 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 37.9 mmt180 -134.76 131.11 37.17 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 107.97 -1.122 . . . . 75.239999999999995 107.97 -178.285 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -77.85 -29.49 50.5 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.823 0.821 . . . . 73.109999999999999 109.092 176.682 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -144.35 137.52 27.18 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 107.132 -1.432 . . . . 71.439999999999998 107.132 171.343 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -142.06 150.42 41.21 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 109.66 -0.496 . . . . 72.450000000000003 109.66 177.96 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 48.5 t -80.62 112.66 18.93 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.156 0 N-CA-C 105.107 -2.183 . . . . 73.099999999999994 105.107 173.414 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.41 ' HG2' ' CE2' ' A' ' 137' ' ' PHE . 22.1 ttt -64.27 122.54 16.91 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.183 -0.917 . . . . 73.400000000000006 109.325 -171.817 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 56.1 tp60 -104.73 125.91 51.28 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.766 -0.652 . . . . 72.400000000000006 111.145 -171.182 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 10.5 p -79.31 116.38 19.52 Favored 'General case' 0 N--CA 1.434 -1.232 0 C-N-CA 123.271 0.628 . . . . 74.530000000000001 109.945 178.793 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 115.33 7.11 17.06 Favored Glycine 0 N--CA 1.435 -1.38 0 C-N-CA 120.547 -0.835 . . . . 60.340000000000003 112.881 178.178 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.483 ' OD1' ' HA ' ' A' ' 113' ' ' ASN . 8.0 t70 -128.63 -165.7 1.54 Allowed 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.584 -0.895 . . . . 41.109999999999999 108.584 -179.606 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -128.99 149.86 50.64 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.773 0.797 . . . . 72.519999999999996 113.133 -172.294 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 65.8 mt -124.02 129.9 74.04 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 107.912 -1.144 . . . . 63.200000000000003 107.912 -178.188 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -117.91 112.77 20.77 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 109.616 -0.512 . . . . 64.329999999999998 109.616 -177.125 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.596 HD13 ' H ' ' A' ' 130' ' ' ILE . 0.2 OUTLIER -94.19 105.69 17.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 109.367 -0.605 . . . . 75.150000000000006 109.367 178.708 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 71.07 -104.26 1.38 Allowed Glycine 0 N--CA 1.433 -1.53 0 N-CA-C 110.297 -1.121 . . . . 70.349999999999994 110.297 -176.633 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 42.8 mtpt -123.72 14.58 9.38 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 120.996 0.427 . . . . 72.109999999999999 109.927 177.67 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -101.04 132.12 46.62 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.915 -0.402 . . . . 52.409999999999997 109.915 -179.11 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 17.8 ptt180 -96.98 121.43 38.85 Favored 'General case' 0 C--O 1.254 1.341 0 CA-C-O 121.726 0.774 . . . . 73.430000000000007 112.234 -176.773 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.439 HD21 ' HB2' ' A' ' 49' ' ' LEU . 6.4 tt -125.19 142.99 51.16 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 114.466 -1.243 . . . . 65.430000000000007 107.715 178.415 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 10.0 p -119.2 140.27 43.72 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 N-CA-C 108.661 -0.866 . . . . 74.430000000000007 108.661 177.671 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.41 ' CE2' ' HG2' ' A' ' 122' ' ' MET . 59.6 t80 -120.2 118.0 29.36 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 120.976 0.417 . . . . 73.420000000000002 110.482 -176.4 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -118.61 173.92 6.57 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 109.401 -0.592 . . . . 75.329999999999998 109.401 -176.626 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -71.1 149.89 46.02 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.629 -1.249 . . . . 73.239999999999995 107.629 172.804 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.587 ' N ' ' HA ' ' A' ' 47' ' ' ALA . . . -96.34 -160.52 32.41 Favored Glycine 0 C--N 1.287 -2.163 0 C-N-CA 120.46 -0.876 . . . . 64.230000000000004 111.478 -176.844 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -69.52 121.95 8.69 Favored 'Trans proline' 0 N--CA 1.434 -1.995 0 C-N-CA 121.823 1.682 . . . . 74.430000000000007 110.895 179.634 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -85.62 103.41 14.42 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 105.579 -2.008 . . . . 72.349999999999994 105.579 177.596 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 . . . . . 0 N--CA 1.42 -1.973 0 N-CA-C 108.141 -1.059 . . . . 72.209999999999994 108.141 -171.357 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.514 -0.42 0 N-CA-C 108.921 -0.77 . . . . 65.530000000000001 108.921 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.4 t -83.31 -49.93 8.88 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.4 -0.592 . . . . 53.240000000000002 109.4 -179.526 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . 0.288 0.6 OUTLIER 36.01 79.7 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 116.17 1.915 . . . . 63.299999999999997 116.17 179.486 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -163.84 171.5 15.35 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.549 -1.278 . . . . 75.439999999999998 107.549 178.327 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -107.19 105.84 16.02 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 108.843 -0.799 . . . . 75.219999999999999 108.843 177.891 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -152.68 32.89 0.82 Allowed Glycine 0 C--N 1.29 -1.995 0 N-CA-C 109.815 -1.314 . . . . 71.230000000000004 109.815 178.492 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.41 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 4.8 p -75.76 129.69 80.73 Favored Pre-proline 0 N--CA 1.424 -1.756 0 CA-C-N 115.007 -0.596 . . . . 72.310000000000002 110.381 -177.381 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 7' ' ' THR . 45.8 Cg_exo -55.49 133.03 55.69 Favored 'Trans proline' 0 C--O 1.241 0.658 0 C-N-CA 123.137 2.558 . . . . 35.229999999999997 112.587 -178.592 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -96.59 125.49 46.89 Favored Pre-proline 0 N--CA 1.431 -1.383 0 N-CA-C 107.974 -1.121 . . . . 52.240000000000002 107.974 175.987 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -55.42 136.01 71.8 Favored 'Trans proline' 0 C--O 1.245 0.835 0 C-N-CA 122.958 2.438 . . . . 61.340000000000003 112.157 -178.496 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -72.31 108.84 5.65 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.162 -0.681 . . . . 75.340000000000003 109.162 -178.885 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 36.2 t -87.88 115.82 28.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 109.657 -0.497 . . . . 53.119999999999997 109.657 -176.812 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -135.01 121.77 20.9 Favored 'General case' 0 N--CA 1.424 -1.77 0 N-CA-C 108.376 -0.972 . . . . 71.25 108.376 177.085 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.4 t -78.57 -25.07 45.26 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.215 0.531 . . . . 71.349999999999994 109.799 178.914 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.8 m 68.31 12.32 8.7 Favored 'General case' 0 CA--C 1.564 1.485 0 C-N-CA 124.426 1.09 . . . . 74.129999999999995 110.751 177.375 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.2 t -146.34 111.18 5.26 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 107.33 -1.359 . . . . 50.409999999999997 107.33 -179.452 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 46.5 t -106.9 123.78 62.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 N-CA-C 109.809 -0.441 . . . . 72.209999999999994 109.809 -176.458 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -89.23 131.4 35.36 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.434 -0.95 . . . . 72.019999999999996 108.434 176.506 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -118.4 138.48 52.42 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 110.054 -0.35 . . . . 74.450000000000003 110.054 179.718 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -97.08 74.1 2.55 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 105.995 -1.854 . . . . 53.399999999999999 105.995 171.865 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -73.48 -45.5 53.72 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 114.326 -1.306 . . . . 73.430000000000007 111.872 -169.323 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.461 HD23 ' H ' ' A' ' 22' ' ' LEU . 1.6 pt? -117.56 114.49 23.5 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-O 120.965 0.412 . . . . 71.239999999999995 110.259 -179.928 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.3 tt -83.38 113.23 20.59 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.801 -1.185 . . . . 75.540000000000006 107.801 179.539 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.442 ' C ' ' HD3' ' A' ' 24' ' ' LYS . 0.7 OUTLIER -76.52 110.79 11.36 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 107.765 -1.198 . . . . 61.409999999999997 107.765 179.015 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -116.61 178.83 4.19 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 116.108 -0.496 . . . . 73.329999999999998 109.839 -179.246 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -165.24 169.6 15.77 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 105.862 -1.903 . . . . 72.109999999999999 105.862 -179.464 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.466 ' HG3' ' O ' ' A' ' 29' ' ' SER . 10.2 tp10 -139.06 141.11 38.22 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 118.59 0.632 . . . . 73.299999999999997 110.8 -177.684 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.3 p -104.28 -26.34 12.53 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 115.709 -0.678 . . . . 75.400000000000006 110.394 179.733 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.466 ' O ' ' HG3' ' A' ' 27' ' ' GLU . 23.3 m -88.6 175.26 7.63 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 107.89 -1.152 . . . . 71.209999999999994 107.89 176.745 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.2 t -169.26 176.02 5.37 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 109.106 -0.702 . . . . 60.549999999999997 109.106 178.189 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.51 109.43 2.94 Favored Glycine 0 N--CA 1.436 -1.331 0 N-CA-C 110.432 -1.067 . . . . 72.510000000000005 110.432 179.424 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.7 p -75.36 118.57 18.4 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-O 121.149 0.499 . . . . 75.25 110.544 179.838 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -89.73 122.52 67.99 Favored Pre-proline 0 C--N 1.308 -1.216 0 CA-C-N 115.939 -0.573 . . . . 55.310000000000002 110.255 -177.4 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -91.63 -176.77 0.88 Allowed 'Trans proline' 0 N--CA 1.441 -1.595 0 C-N-CA 122.087 1.858 . . . . 64.409999999999997 110.667 175.419 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -94.12 -3.78 50.46 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 109.14 -0.689 . . . . 52.039999999999999 109.14 177.133 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.8 m -86.45 88.41 7.63 Favored 'General case' 0 N--CA 1.421 -1.876 0 CA-C-N 115.202 -0.908 . . . . 33.219999999999999 112.448 -177.83 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 18.0 m -88.38 111.95 22.33 Favored 'General case' 0 N--CA 1.417 -2.078 0 N-CA-C 105.215 -2.142 . . . . 71.200000000000003 105.215 170.804 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.0 65.79 0.79 Allowed Glycine 0 N--CA 1.425 -2.079 0 N-CA-C 109.164 -1.575 . . . . 51.130000000000003 109.164 -173.344 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.85 -28.91 69.32 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 122.525 0.33 . . . . 73.040000000000006 110.691 -177.902 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.546 ' HA ' ' O ' ' A' ' 96' ' ' GLU . 1.6 pm0 -70.45 -11.89 61.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.39 0.614 . . . . 70.409999999999997 112.471 179.733 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -84.19 -14.41 50.16 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 116.014 -0.539 . . . . 75.409999999999997 111.349 176.293 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.3 mp -106.15 109.01 62.8 Favored Pre-proline 0 N--CA 1.435 -1.207 0 CA-C-N 116.331 -0.395 . . . . 73.109999999999999 111.97 -176.514 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -66.62 -24.68 47.97 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.029 1.82 . . . . 61.32 110.451 174.942 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -95.92 24.58 5.36 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.066 -0.97 . . . . 62.109999999999999 109.933 178.977 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -89.71 70.29 2.37 Favored Glycine 0 CA--C 1.489 -1.582 0 N-CA-C 107.212 -2.355 . . . . 74.150000000000006 107.212 176.198 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.6 p -88.78 152.74 21.59 Favored 'General case' 0 C--N 1.28 -2.429 0 N-CA-C 114.294 1.22 . . . . 74.450000000000003 114.294 -170.302 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.463 ' HA ' ' H ' ' A' ' 140' ' ' GLY . . . -122.43 178.36 5.0 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 106.386 -1.709 . . . . 62.439999999999998 106.386 176.223 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -133.03 146.65 51.92 Favored 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 118.78 -1.168 . . . . 61.409999999999997 111.86 -176.742 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.44 HD23 ' H ' ' A' ' 49' ' ' LEU . 1.0 OUTLIER -109.49 131.73 54.79 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 107.365 -1.346 . . . . 74.439999999999998 107.365 176.959 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.4 t -114.07 118.49 58.56 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 N-CA-C 107.969 -1.122 . . . . 71.450000000000003 107.969 -179.077 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 6.5 t -92.86 116.19 33.42 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.151 0 N-CA-C 107.433 -1.321 . . . . 51.409999999999997 107.433 -179.44 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -74.4 -35.12 63.45 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.724 -0.843 . . . . 63.439999999999998 108.724 -178.943 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.508 ' O ' ' HB3' ' A' ' 133' ' ' PHE . 76.7 ttt180 -170.3 126.97 0.81 Allowed 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 103.578 -2.749 . . . . 71.140000000000001 103.578 176.084 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.543 ' HA2' ' HB3' ' A' ' 133' ' ' PHE . . . -151.35 174.15 30.6 Favored Glycine 0 N--CA 1.421 -2.321 0 C-N-CA 118.293 -1.908 . . . . 52.509999999999998 114.825 -174.745 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -68.65 -39.95 8.21 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 123.321 2.681 . . . . 54.329999999999998 111.748 -179.753 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -79.86 -56.26 4.4 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.609 -0.723 . . . . 72.349999999999994 110.449 -179.374 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -158.91 -160.99 0.91 Allowed 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 108.737 -0.838 . . . . 73.439999999999998 108.737 -175.801 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -152.06 46.81 0.58 Allowed Glycine 0 N--CA 1.43 -1.721 0 N-CA-C 107.384 -2.286 . . . . 70.439999999999998 107.384 -178.711 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -133.69 -172.78 3.05 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 107.384 -1.339 . . . . 65.430000000000007 107.384 -175.641 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 37.2 ptt180 -116.64 139.87 50.04 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 119.811 -0.756 . . . . 73.340000000000003 110.798 179.793 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -126.71 153.94 44.78 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.923 -0.769 . . . . 71.129999999999995 108.923 -177.239 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.0 mp -110.23 140.57 44.23 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.68 -0.859 . . . . 75.25 108.68 178.613 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -71.24 115.59 10.57 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 109.019 -0.734 . . . . 74.430000000000007 109.019 177.719 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -135.83 -26.46 1.2 Allowed 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 115.282 -0.872 . . . . 74.120000000000005 111.44 -175.32 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -108.83 125.88 30.67 Favored Pre-proline 0 C--N 1.311 -1.071 0 N-CA-C 108.49 -0.93 . . . . 75.400000000000006 108.49 179.244 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -41.41 -58.02 1.23 Allowed 'Trans proline' 0 C--N 1.37 1.676 0 C-N-CA 124.57 3.514 . . . . 73.420000000000002 114.738 -176.791 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 26.1 m -109.73 115.95 30.81 Favored 'General case' 0 N--CA 1.434 -1.271 0 C-N-CA 120.158 -0.617 . . . . 74.140000000000001 109.555 178.777 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 87.5 m -116.8 116.16 26.94 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.124 -1.435 . . . . 61.240000000000002 107.124 176.302 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.6 t -110.06 125.21 52.72 Favored 'General case' 0 N--CA 1.434 -1.235 0 C-N-CA 118.853 -1.139 . . . . 71.109999999999999 111.245 -175.576 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -100.22 110.0 22.25 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 115.161 -0.927 . . . . 43.399999999999999 109.142 179.5 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -178.96 -144.04 5.56 Favored Glycine 0 CA--C 1.468 -2.85 0 N-CA-C 109.005 -1.638 . . . . 23.329999999999998 109.005 -179.729 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 21.4 ttt180 -112.75 -89.8 0.52 Allowed 'General case' 0 N--CA 1.404 -2.763 0 C-N-CA 119.322 -0.951 . . . . 71.049999999999997 111.141 178.098 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 35.6 m170 59.97 156.96 0.1 Allowed Pre-proline 0 CA--C 1.547 0.859 0 CA-C-O 121.507 0.67 . . . . 74.540000000000006 111.576 -172.931 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -66.97 -25.55 44.52 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 121.248 1.299 . . . . 73.230000000000004 108.823 168.549 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -111.71 70.94 0.73 Allowed 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 114.355 -1.293 . . . . 54.509999999999998 108.378 -177.443 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.3 m -73.76 134.01 43.37 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.7 -0.682 . . . . 74.200000000000003 110.452 -178.948 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -78.8 -49.6 12.72 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 107.355 -1.35 . . . . 73.150000000000006 107.355 173.899 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 39.7 pt -125.43 141.84 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 N-CA-C 106.155 -1.795 . . . . 51.43 106.155 169.253 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -95.1 121.83 37.14 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-O 121.588 0.708 . . . . 61.109999999999999 111.903 -174.45 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.0 mp -88.25 118.1 27.61 Favored 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 107.777 -1.194 . . . . 72.400000000000006 107.777 172.411 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -96.65 -6.03 37.58 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.364 -1.289 . . . . 71.5 113.047 -165.699 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -78.75 -170.3 2.08 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 115.98 -0.554 . . . . 65.109999999999999 110.479 -177.554 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.8 p -122.36 7.83 5.61 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.42 0 CA-C-O 121.341 0.591 . . . . 73.430000000000007 111.63 -176.263 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 8.2 t -120.51 20.25 11.86 Favored 'General case' 0 C--N 1.308 -1.235 0 O-C-N 121.197 -0.94 . . . . 72.319999999999993 108.907 -179.775 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.465 HG22 ' O ' ' A' ' 86' ' ' SER . 6.1 p -81.42 131.27 34.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-N 114.496 -1.229 . . . . 61.509999999999998 111.737 -176.089 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.465 ' O ' HG22 ' A' ' 85' ' ' VAL . 44.7 t -70.34 157.03 38.48 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 114.629 -1.169 . . . . 50.140000000000001 108.103 175.653 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -52.58 -41.83 63.96 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.563 0.696 . . . . 70.219999999999999 110.398 179.209 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -138.0 130.81 29.82 Favored 'General case' 0 CA--C 1.488 -1.423 0 N-CA-C 103.786 -2.672 . . . . 75.530000000000001 103.786 168.299 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 37.7 t60 -107.71 -63.64 1.29 Allowed 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 119.45 -0.9 . . . . 71.430000000000007 110.588 -176.477 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -136.22 125.7 25.13 Favored 'General case' 0 C--N 1.292 -1.902 0 C-N-CA 120.08 -0.648 . . . . 75.150000000000006 110.036 -177.505 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -97.67 127.22 43.47 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 107.573 -1.269 . . . . 54.009999999999998 107.573 175.722 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -106.01 112.96 26.22 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.569 -1.271 . . . . 73.329999999999998 107.569 179.352 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -113.86 126.98 55.79 Favored 'General case' 0 C--N 1.277 -2.551 0 N-CA-C 108.524 -0.917 . . . . 65.129999999999995 108.524 -178.676 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.5 116.81 53.63 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 CA-C-O 122.048 0.928 . . . . 75.409999999999997 109.98 -178.357 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -108.7 145.75 34.57 Favored 'General case' 0 N--CA 1.419 -2.021 0 N-CA-C 106.0 -1.852 . . . . 71.430000000000007 106.0 174.506 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.546 ' O ' ' HA ' ' A' ' 40' ' ' GLU . 10.0 pt-20 -50.62 -28.03 8.0 Favored 'General case' 0 C--N 1.308 -1.197 0 O-C-N 124.059 0.85 . . . . 73.409999999999997 112.078 179.599 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.426 ' HA2' ' CB ' ' A' ' 40' ' ' GLU . . . -85.03 -51.35 3.8 Favored Glycine 0 N--CA 1.426 -2.027 0 C-N-CA 120.617 -0.801 . . . . 24.32 112.728 179.026 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -144.06 153.44 42.19 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-O 121.073 0.463 . . . . 75.329999999999998 111.087 -173.831 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.425 ' HB2' ' HB3' ' A' ' 122' ' ' MET . 60.9 m-85 -95.46 123.85 39.2 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.216 -1.031 . . . . 74.230000000000004 108.216 177.125 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -115.93 134.29 55.13 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.786 -0.45 . . . . 73.099999999999994 109.786 -178.407 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.6 p -125.33 126.2 70.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 109.272 -0.64 . . . . 74.329999999999998 109.272 177.437 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.7 t -114.56 123.68 70.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 CA-C-N 116.01 -0.541 . . . . 72.439999999999998 110.274 -179.35 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -89.5 115.91 27.27 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 121.567 0.699 . . . . 62.219999999999999 110.288 176.958 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 13.9 m -118.42 11.34 7.0 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.373 0 N-CA-C 108.184 -1.043 . . . . 62.130000000000003 108.184 173.94 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -110.17 34.57 5.34 Favored Glycine 0 N--CA 1.421 -2.335 0 N-CA-C 109.862 -1.295 . . . . 71.019999999999996 109.862 178.879 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.4 m -63.15 -9.73 12.11 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.947 1.299 . . . . 64.310000000000002 110.299 179.893 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 49.8 tp -58.27 -37.92 75.95 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 125.217 1.407 . . . . 64.439999999999998 107.825 174.707 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -110.15 -41.2 4.49 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 115.316 -0.856 . . . . 55.240000000000002 109.297 176.684 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 107.99 123.67 4.96 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 120.628 -0.796 . . . . 71.409999999999997 114.749 174.052 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 87.1 m -109.17 120.18 41.75 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.267 -1.012 . . . . 71.010000000000005 108.267 173.61 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . 0.25 40.5 p90 -123.48 135.81 54.25 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 114.407 1.262 . . . . 64.519999999999996 114.407 -177.83 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 18.2 m -105.09 136.33 39.35 Favored 'Isoleucine or valine' 0 C--O 1.257 1.448 0 CA-C-N 114.657 -1.156 . . . . 73.230000000000004 108.291 -179.994 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 12.6 m120 62.06 -83.02 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 124.685 1.194 . . . . 41.140000000000001 108.744 -169.549 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 27.5 mmm180 -139.74 -12.67 1.13 Allowed 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 124.052 0.941 . . . . 63.32 110.843 177.654 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.459 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . 0.4 OUTLIER -110.5 131.08 22.24 Favored Pre-proline 0 C--O 1.245 0.821 0 N-CA-C 113.891 1.071 . . . . 71.450000000000003 113.891 -168.205 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 115' ' ' GLU . 24.6 Cg_exo -65.14 136.05 46.21 Favored 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 122.748 2.299 . . . . 71.409999999999997 110.17 175.282 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -131.35 164.06 26.49 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.645 -0.502 . . . . 53.340000000000003 109.645 -178.156 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -93.48 -56.03 3.07 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 108.911 -0.774 . . . . 72.439999999999998 108.911 176.733 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -130.99 139.74 50.04 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 108.778 -0.823 . . . . 71.0 108.778 179.572 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -138.88 149.94 45.42 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-O 121.536 0.684 . . . . 71.319999999999993 112.828 -178.453 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 39.7 t -92.34 105.08 16.29 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.101 0 N-CA-C 104.107 -2.553 . . . . 72.409999999999997 104.107 172.328 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.425 ' HB3' ' HB2' ' A' ' 99' ' ' PHE . 9.6 tpt -50.38 120.47 4.61 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 125.065 1.346 . . . . 72.120000000000005 110.297 -171.561 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -104.92 132.07 51.62 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 121.26 0.552 . . . . 74.310000000000002 111.577 -172.083 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.2 p -79.16 115.77 19.03 Favored 'General case' 0 N--CA 1.424 -1.73 0 CA-C-N 115.014 -0.994 . . . . 75.209999999999994 110.756 -179.201 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 119.82 -7.01 12.18 Favored Glycine 0 N--CA 1.429 -1.788 0 C-N-CA 121.033 -0.604 . . . . 65.239999999999995 112.823 177.768 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -106.8 157.9 17.39 Favored 'General case' 0 C--O 1.247 0.932 0 C-N-CA 119.944 -0.702 . . . . 55.039999999999999 111.637 -177.731 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.445 ' HA ' ' HA ' ' A' ' 136' ' ' VAL . 11.0 pt-20 -114.51 121.36 43.28 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-O 122.153 0.978 . . . . 73.349999999999994 109.081 177.587 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 71.6 mt -111.79 130.42 65.42 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.358 0 CA-C-N 113.968 -1.469 . . . . 74.230000000000004 109.962 -170.586 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.49 ' HG3' ' O ' ' A' ' 133' ' ' PHE . 42.8 tt0 -97.36 124.85 41.66 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.99 -0.684 . . . . 74.5 111.438 178.028 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 11.8 pt -105.55 101.95 13.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 114.504 -1.226 . . . . 64.530000000000001 108.481 178.355 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 72.44 -101.76 1.11 Allowed Glycine 0 N--CA 1.437 -1.278 0 N-CA-C 110.273 -1.131 . . . . 74.439999999999998 110.273 -176.559 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 32.8 mmmt -126.0 9.75 7.51 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.23 0.538 . . . . 63.310000000000002 110.307 178.6 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.543 ' HB3' ' HA2' ' A' ' 54' ' ' GLY . 78.5 m-85 -114.36 158.04 22.03 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 108.901 -0.777 . . . . 73.439999999999998 108.901 -179.013 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 51.4 ttp180 -127.49 135.61 50.62 Favored 'General case' 0 C--O 1.249 1.063 0 C-N-CA 118.567 -1.253 . . . . 73.430000000000007 112.731 -176.105 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 5.7 tt -122.16 132.11 54.29 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 114.191 -1.368 . . . . 71.299999999999997 107.465 -178.268 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 127' ' ' GLU . 9.6 p -111.12 135.17 51.11 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 N-CA-C 108.631 -0.878 . . . . 55.140000000000001 108.631 178.294 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -113.84 121.41 43.93 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 109.631 -0.507 . . . . 71.099999999999994 109.631 -175.918 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -123.27 165.98 16.04 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 109.396 -0.594 . . . . 75.409999999999997 109.396 -177.983 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -71.16 130.3 41.13 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 107.522 -1.288 . . . . 74.439999999999998 107.522 174.167 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.463 ' H ' ' HA ' ' A' ' 47' ' ' ALA . . . -116.99 -174.19 17.01 Favored Glycine 0 N--CA 1.418 -2.564 0 C-N-CA 120.115 -1.04 . . . . 64.340000000000003 112.952 -173.485 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -79.33 129.0 8.38 Favored 'Trans proline' 0 N--CA 1.428 -2.381 0 C-N-CA 122.5 2.133 . . . . 54.0 112.156 -179.626 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -95.17 104.3 16.17 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 105.57 -2.011 . . . . 63.200000000000003 105.57 172.762 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 . . . . . 0 C--N 1.303 -1.428 0 CA-C-O 118.491 -0.766 . . . . 74.120000000000005 110.653 -173.025 . . . . . . . . 0 0 . 1 stop_ save_